1 Q0 15277467 1 41.235584 imi_mug_run_2_treatment "product" "others"
1 Q0 24073999 2 40.983337 imi_mug_run_2_treatment "braf inhibitor"
1 Q0 12810628 3 40.981216 imi_mug_run_2_treatment "level"
1 Q0 27883956 4 40.039738 imi_mug_run_2_treatment "braf inhibitor" "vemurafenib" "dabrafenib"
1 Q0 25180764 5 39.600952 imi_mug_run_2_treatment "mek inhibitor" "medicine"
1 Q0 27679543 6 39.50893 imi_mug_run_2_treatment "vemurafenib" "aim" "braf inhibitor"
1 Q0 21343559 7 39.482056 imi_mug_run_2_treatment "braf inhibitor"
1 Q0 18374154 8 39.298126 imi_mug_run_2_treatment "glutamic acid"
1 Q0 23615632 9 39.26657 imi_mug_run_2_treatment "combinations" "braf inhibitor" "mediated"
1 Q0 27210749 10 39.231216 imi_mug_run_2_treatment "mediated"
1 Q0 27928645 11 39.05252 imi_mug_run_2_treatment "vemurafenib" "bafilomycin a1" "braf inhibitor"
1 Q0 27146499 12 38.942726 imi_mug_run_2_treatment "trametinib" "mek inhibitor" "braf inhibitor"
1 Q0 26851802 13 38.888252 imi_mug_run_2_treatment "level" "adjuvant" "mediated"
1 Q0 24709886 14 38.81027 imi_mug_run_2_treatment "canertinib" "vemurafenib" "kinase inhibitor"
1 Q0 29491057 15 38.71109 imi_mug_run_2_treatment "vemurafenib" "dabrafenib" "braf inhibitor"
1 Q0 14500344 16 38.697662 imi_mug_run_2_treatment "agar"
1 Q0 25841454 17 38.632103 imi_mug_run_2_treatment "mapk inhibitors" "duration"
1 Q0 17962436 18 38.50761 imi_mug_run_2_treatment "product"
1 Q0 26743513 19 38.17182 imi_mug_run_2_treatment "various"
1 Q0 24469106 20 38.128124 imi_mug_run_2_treatment "combinations" "mediated" "braf inhibitor"
1 Q0 24055054 21 38.08175 imi_mug_run_2_treatment "trametinib" "dabrafenib" "mek inhibitor"
1 Q0 29094184 22 38.03901 imi_mug_run_2_treatment "peptide vaccine" "calcium phosphate" "immunosuppressive"
1 Q0 23307859 23 37.94577 imi_mug_run_2_treatment "immunosuppressive" "braf inhibitor" "cytokines"
1 Q0 26001180 24 37.92661 imi_mug_run_2_treatment "ras" "agent"
1 Q0 29483645 25 37.859985 imi_mug_run_2_treatment "vemurafenib"
1 Q0 12619120 26 37.854393 imi_mug_run_2_treatment "glutamic acid"
1 Q0 20350535 27 37.782627 imi_mug_run_2_treatment "drug" "sorafenib" "agent"
1 Q0 23174497 28 37.780552 imi_mug_run_2_treatment "vemurafenib" "braf inhibitor"
1 Q0 29232305 29 37.76967 imi_mug_run_2_treatment "braf inhibitor" "glutamic acid" "new drugs"
1 Q0 24516336 30 37.76377 imi_mug_run_2_treatment "dabrafenib"
1 Q0 27592869 31 37.75679 imi_mug_run_2_treatment "mek inhibitor"
1 Q0 28868285 32 37.74459 imi_mug_run_2_treatment "aim"
1 Q0 27169980 33 37.73571 imi_mug_run_2_treatment "drug" "vemurafenib" "braf inhibitor"
1 Q0 30482852 34 37.64908 imi_mug_run_2_treatment "vemurafenib" "braf inhibitor" "unc2025"
1 Q0 24200969 35 37.59069 imi_mug_run_2_treatment "azd6244" "mek inhibitor azd6244"
1 Q0 18279546 36 37.573544 imi_mug_run_2_treatment "lead"
1 Q0 24670642 37 37.49064 imi_mug_run_2_treatment "drug" "drugs" "mek inhibitor"
1 Q0 28927118 38 37.48499 imi_mug_run_2_treatment "medicine"
1 Q0 23342664 39 37.372414 imi_mug_run_2_treatment "various"
1 Q0 25442222 40 37.36638 imi_mug_run_2_treatment "aim" "braf inhibitor"
1 Q0 25051202 41 37.361404 imi_mug_run_2_treatment "formalin"
1 Q0 29310328 42 37.35383 imi_mug_run_2_treatment "braf inhibitor"
1 Q0 12460918 43 37.30875 imi_mug_run_2_treatment "ras" "mediated"
1 Q0 25848750 44 37.30294 imi_mug_run_2_treatment "mediated"
1 Q0 25624498 45 37.283722 imi_mug_run_2_treatment "braf inhibitor" "mediated" "ras"
1 Q0 24080641 46 37.28116 imi_mug_run_2_treatment "vemurafenib"
1 Q0 26073081 47 37.28115 imi_mug_run_2_treatment "braf inhibitor" "drugs" "cytotoxic"
1 Q0 24893747 48 37.270287 imi_mug_run_2_treatment "drugs" "vemurafenib"
1 Q0 24471189 49 37.17752 imi_mug_run_2_treatment "level"
1 Q0 28299583 50 37.149094 imi_mug_run_2_treatment "combinations" "drugs" "braf inhibitor"
1 Q0 23403819 51 37.141594 imi_mug_run_2_treatment "braf inhibitor" "level" "vemurafenib"
1 Q0 25344914 52 37.10105 imi_mug_run_2_treatment "favor" "vemurafenib" "dabrafenib"
1 Q0 25472943 53 37.081264 imi_mug_run_2_treatment "blockade" "cytostatic" "mek inhibitor"
1 Q0 24121489 54 37.059044 imi_mug_run_2_treatment "tak-632" "tak-733" "vemurafenib"
1 Q0 25385327 55 37.005234 imi_mug_run_2_treatment "immunosuppressive" "ras" "lead"
1 Q0 30248172 56 36.9965 imi_mug_run_2_treatment "combinations" "trametinib" "vemurafenib"
1 Q0 16567964 57 36.982758 imi_mug_run_2_treatment "mitogen"
1 Q0 16899595 58 36.962288 imi_mug_run_2_treatment "aim"
1 Q0 25646931 59 36.902397 imi_mug_run_2_treatment "zoledronic acid" "liver" "cisplatin"
1 Q0 25376477 60 36.902206 imi_mug_run_2_treatment "braf inhibitor" "mek inhibitor"
1 Q0 26098773 61 36.78694 imi_mug_run_2_treatment "vemurafenib" "mapk inhibitors"
1 Q0 15613230 62 36.76777 imi_mug_run_2_treatment "liver"
1 Q0 27354627 63 36.752857 imi_mug_run_2_treatment "resveratrol" "level" "vemurafenib"
1 Q0 14522889 64 36.74096 imi_mug_run_2_treatment "serine"
1 Q0 26451873 65 36.706444 imi_mug_run_2_treatment "interferon" "vaccines" "vaccine"
1 Q0 19282848 66 36.660606 imi_mug_run_2_treatment "pd325901"
1 Q0 22850568 67 36.62423 imi_mug_run_2_treatment "vemurafenib" "immune modulators" "mediators"
1 Q0 27860480 68 36.59793 imi_mug_run_2_treatment "aim"
1 Q0 23621583 69 36.578346 imi_mug_run_2_treatment "dabrafenib" "braf inhibitor" "trametinib"
1 Q0 23770823 70 36.572052 imi_mug_run_2_treatment "braf inhibitor"
1 Q0 25819940 71 36.53728 imi_mug_run_2_treatment "ors"
1 Q0 23369684 72 36.53728 imi_mug_run_2_treatment "drug" "drugs" "ipilimumab"
1 Q0 27793752 73 36.512794 imi_mug_run_2_treatment "carnitine" "anabolic"
1 Q0 25888143 74 36.511353 imi_mug_run_2_treatment "various" "mitogen" "tumor infiltrating lymphocytes"
1 Q0 26616061 75 36.4282 imi_mug_run_2_treatment "braf inhibitor"
1 Q0 24858661 76 36.407223 imi_mug_run_2_treatment "dabrafenib"
1 Q0 23026937 77 36.404858 imi_mug_run_2_treatment "basis" "braf inhibitor"
1 Q0 24684646 78 36.397003 imi_mug_run_2_treatment "aim"
1 Q0 17409425 79 36.383804 imi_mug_run_2_treatment "mediated" "bay 43-9006"
1 Q0 24971404 80 36.364548 imi_mug_run_2_treatment "dabrafenib"
1 Q0 25142146 81 36.336697 imi_mug_run_2_treatment "sch772984" "vemurafenib"
1 Q0 12873990 82 36.30895 imi_mug_run_2_treatment "tandem" "ras"
1 Q0 26984758 83 36.30332 imi_mug_run_2_treatment "adjuvant" "cytotoxic" "hsp70"
1 Q0 25117819 84 36.276787 imi_mug_run_2_treatment "cytokines" "vemurafenib"
1 Q0 23447565 85 36.276787 imi_mug_run_2_treatment "drug" "lead" "obatoclax"
1 Q0 24145418 86 36.276787 imi_mug_run_2_treatment "phenformin" "biguanides" "metformin"
1 Q0 27308505 87 36.272316 imi_mug_run_2_treatment "erythropoietin" "others" "braf inhibitor"
1 Q0 15195137 88 36.26257 imi_mug_run_2_treatment "ras"
1 Q0 29929490 89 36.24205 imi_mug_run_2_treatment "braf inhibitor" "chemotherapeutic agent" "vemurafenib"
1 Q0 25319388 90 36.232544 imi_mug_run_2_treatment "level"
1 Q0 14522897 91 36.20278 imi_mug_run_2_treatment "ras" "aim"
1 Q0 24732172 92 36.194584 imi_mug_run_2_treatment "shh" "mediated" "braf inhibitor"
1 Q0 22157295 93 36.194267 imi_mug_run_2_treatment "others"
1 Q0 18715233 94 36.17064 imi_mug_run_2_treatment "serine" "ci-1040" "genesis"
1 Q0 19156138 95 36.096046 imi_mug_run_2_treatment "drug combinations"
1 Q0 20951940 96 36.096046 imi_mug_run_2_treatment "kinase inhibitor" "plx4032" "braf inhibitor"
1 Q0 25538140 97 36.09287 imi_mug_run_2_treatment "drug" "braf inhibitor"
1 Q0 26825657 98 36.064865 imi_mug_run_2_treatment "glutamic acid"
1 Q0 15694309 99 36.011658 imi_mug_run_2_treatment "genesis"
1 Q0 23237741 100 35.96661 imi_mug_run_2_treatment "braf inhibitor" "vemurafenib" "dabrafenib"
1 Q0 27320919 101 35.905533 imi_mug_run_2_treatment "pdx" "braf inhibitor"
1 Q0 18421705 102 35.899883 imi_mug_run_2_treatment "various" "genesis"
1 Q0 29419849 103 35.864204 imi_mug_run_2_treatment "braf inhibitor"
1 Q0 17384209 104 35.838142 imi_mug_run_2_treatment "plasma" "medicine"
1 Q0 22904646 105 35.8239 imi_mug_run_2_treatment "vemurafenib" "braf inhibitor"
1 Q0 21635872 106 35.81825 imi_mug_run_2_treatment "braf inhibitor" "basis"
1 Q0 23454771 107 35.79914 imi_mug_run_2_treatment "braf inhibitor"
1 Q0 29084636 108 35.794228 imi_mug_run_2_treatment "mek inhibitor" "braf inhibitor" "aim"
1 Q0 24403169 109 35.742348 imi_mug_run_2_treatment "trametinib" "dabrafenib" "drugs"
1 Q0 26684394 110 35.721115 imi_mug_run_2_treatment "lead"
1 Q0 28344857 111 35.707165 imi_mug_run_2_treatment "trametinib" "drugs" "mitogen"
1 Q0 28923400 112 35.704964 imi_mug_run_2_treatment "braf inhibitor" "therapeutics" "agent"
1 Q0 25653539 113 35.691025 imi_mug_run_2_treatment "dabrafenib" "drugs" "ipilimumab"
1 Q0 23095503 114 35.67707 imi_mug_run_2_treatment "level"
1 Q0 25583765 115 35.64971 imi_mug_run_2_treatment "braf inhibitor" "dabrafenib"
1 Q0 25886620 116 35.648888 imi_mug_run_2_treatment "duration" "braf inhibitor"
1 Q0 25752325 117 35.648888 imi_mug_run_2_treatment "braf inhibitor"
1 Q0 26974965 118 35.599197 imi_mug_run_2_treatment "combinations" "drugs" "interleukin-7"
1 Q0 26790143 119 35.595604 imi_mug_run_2_treatment "various" "vemurafenib" "prima-1"
1 Q0 21826607 120 35.569763 imi_mug_run_2_treatment "ras" "lead"
1 Q0 23715079 121 35.555313 imi_mug_run_2_treatment "vemurafenib" "liver"
1 Q0 28092671 122 35.533173 imi_mug_run_2_treatment "pde4" "ras" "cyclic amp"
1 Q0 25648338 123 35.480698 imi_mug_run_2_treatment "trametinib" "vemurafenib" "dabrafenib"
1 Q0 28401596 124 35.476906 imi_mug_run_2_treatment "mek inhibitor"
1 Q0 22895053 125 35.467957 imi_mug_run_2_treatment "combinations" "drugs" "lead"
1 Q0 25960652 126 35.463875 imi_mug_run_2_treatment "vindolinine"
1 Q0 23535073 127 35.462296 imi_mug_run_2_treatment "pf-3758309" "ras" "vemurafenib"
1 Q0 25351955 128 35.403442 imi_mug_run_2_treatment "agonists" "cytokines" "vemurafenib"
1 Q0 30347273 129 35.36949 imi_mug_run_2_treatment "octaarginine" "mediated"
1 Q0 25643238 130 35.3554 imi_mug_run_2_treatment "trametinib" "dabrafenib" "vemurafenib"
1 Q0 23360189 131 35.352337 imi_mug_run_2_treatment "vemurafenib" "zelboraf"
1 Q0 25713167 132 35.333694 imi_mug_run_2_treatment "various" "mediated"
1 Q0 16540682 133 35.32373 imi_mug_run_2_treatment "vaccines" "cytotoxic"
1 Q0 27515299 134 35.32025 imi_mug_run_2_treatment "drug" "mek inhibitor" "mediated"
1 Q0 15024080 135 35.319138 imi_mug_run_2_treatment "mediated" "ras" "program"
1 Q0 29168975 136 35.319138 imi_mug_run_2_treatment "vemurafenib"
1 Q0 23802768 137 35.318382 imi_mug_run_2_treatment "vemurafenib" "formalin" "aim"
1 Q0 19724275 138 35.30815 imi_mug_run_2_treatment "pd98059" "calcineurin inhibitors" "mek inhibitor"
1 Q0 22798288 139 35.302185 imi_mug_run_2_treatment "mek inhibitor" "tak-733"
1 Q0 29456854 140 35.291756 imi_mug_run_2_treatment "kinase inhibitor"
1 Q0 30190840 141 35.266148 imi_mug_run_2_treatment "mek inhibitor" "trametinib" "dabrafenib"
1 Q0 25500121 142 35.170094 imi_mug_run_2_treatment "drug" "drugs" "mediated"
1 Q0 23475878 143 35.130825 imi_mug_run_2_treatment "braf inhibitor"
1 Q0 29299145 144 35.127857 imi_mug_run_2_treatment "braf inhibitor" "verteporfin" "agent"
1 Q0 25426645 145 35.12393 imi_mug_run_2_treatment "vemurafenib" "braf inhibitor"
1 Q0 24476679 146 35.115986 imi_mug_run_2_treatment "braf inhibitor" "ras" "mek inhibitor"
1 Q0 29295999 147 35.115986 imi_mug_run_2_treatment "mediated"
1 Q0 22740817 148 35.10608 imi_mug_run_2_treatment "formalin"
1 Q0 25070294 149 35.103615 imi_mug_run_2_treatment "adjuvant"
1 Q0 25031620 150 35.09839 imi_mug_run_2_treatment "drugs" "ras"
1 Q0 21753785 151 35.09664 imi_mug_run_2_treatment "dacarbazine" "braf inhibitor" "su5402"
1 Q0 25014231 152 35.09337 imi_mug_run_2_treatment "dabrafenib" "braf inhibitor" "mek inhibitor"
1 Q0 29416666 153 35.089615 imi_mug_run_2_treatment "drug" "temozolomide" "vemurafenib"
1 Q0 25079100 154 35.05757 imi_mug_run_2_treatment "combinations" "drugs" "ipilimumab"
1 Q0 24023633 155 35.031425 imi_mug_run_2_treatment "various" "vemurafenib" "sunitinib"
1 Q0 24933606 156 35.030663 imi_mug_run_2_treatment "trametinib" "mek inhibitor"
1 Q0 24201813 157 35.00895 imi_mug_run_2_treatment "braf inhibitor" "plx4032" "vemurafenib"
1 Q0 24194739 158 34.998917 imi_mug_run_2_treatment "blockade" "immunosuppressive" "monoclonal antibodies"
1 Q0 23855428 159 34.978783 imi_mug_run_2_treatment "braf inhibitor"
1 Q0 24616537 160 34.94902 imi_mug_run_2_treatment "interferon" "vemurafenib" "ipilimumab"
1 Q0 25477091 161 34.94213 imi_mug_run_2_treatment "drug"
1 Q0 27081804 162 34.92303 imi_mug_run_2_treatment "drugs" "new drugs" "mek inhibitor"
1 Q0 22281663 163 34.907413 imi_mug_run_2_treatment "mart-1" "isolate" "level"
1 Q0 28052651 164 34.901855 imi_mug_run_2_treatment "braf inhibitor"
1 Q0 24535907 165 34.89112 imi_mug_run_2_treatment "glutamic acid"
1 Q0 21750866 166 34.87787 imi_mug_run_2_treatment "ras"
1 Q0 26156293 167 34.870888 imi_mug_run_2_treatment "vemurafenib"
1 Q0 20149136 168 34.869995 imi_mug_run_2_treatment "plx4032" "drug" "kinase inhibitor"
1 Q0 19464601 169 34.85421 imi_mug_run_2_treatment "ras" "new drugs"
1 Q0 26878440 170 34.8537 imi_mug_run_2_treatment "i3c" "combinations" "indole-3-carbinol"
1 Q0 28504036 171 34.848694 imi_mug_run_2_treatment "braf inhibitor"
1 Q0 26659191 172 34.84366 imi_mug_run_2_treatment "braf inhibitor"
1 Q0 20689758 173 34.840736 imi_mug_run_2_treatment "plx4032" "drug" "mediators"
1 Q0 29307636 174 34.839638 imi_mug_run_2_treatment "basis"
1 Q0 23414587 175 34.8369 imi_mug_run_2_treatment "mek162" "pharmaceuticals" "basis"
1 Q0 21717063 176 34.824017 imi_mug_run_2_treatment "plx4032" "braf inhibitor" "agent"
1 Q0 23248257 177 34.806786 imi_mug_run_2_treatment "trametinib" "braf inhibitor" "gsk1120212"
1 Q0 21656352 178 34.7912 imi_mug_run_2_treatment "therapeutics" "plx4032" "gsk2118436"
1 Q0 30018031 179 34.77551 imi_mug_run_2_treatment "mek inhibitor" "vemurafenib" "binimetinib"
1 Q0 15313890 180 34.760365 imi_mug_run_2_treatment "mediated" "ras"
1 Q0 24265155 181 34.732018 imi_mug_run_2_treatment "braf inhibitor" "drug" "ras"
1 Q0 23415641 182 34.71841 imi_mug_run_2_treatment "ras" "braf inhibitor"
1 Q0 29356698 183 34.711105 imi_mug_run_2_treatment "encorafenib" "vemurafenib" "binimetinib"
1 Q0 29202777 184 34.698906 imi_mug_run_2_treatment "pdx" "vemurafenib" "aim"
1 Q0 21827678 185 34.683784 imi_mug_run_2_treatment "genesis"
1 Q0 19659611 186 34.65885 imi_mug_run_2_treatment "mediated" "level"
1 Q0 26636909 187 34.654884 imi_mug_run_2_treatment "plasma"
1 Q0 24733413 188 34.650368 imi_mug_run_2_treatment "others"
1 Q0 24667377 189 34.639366 imi_mug_run_2_treatment "ras" "drugs" "protease"
1 Q0 26286024 190 34.63492 imi_mug_run_2_treatment "drug" "braf inhibitor"
1 Q0 25456393 191 34.631638 imi_mug_run_2_treatment "prompt"
1 Q0 27481005 192 34.620705 imi_mug_run_2_treatment "adjuvant" "immunosuppressive" "cytokines"
1 Q0 29148538 193 34.61539 imi_mug_run_2_treatment "mek inhibitor"
1 Q0 28891408 194 34.611523 imi_mug_run_2_treatment "trametinib" "dabrafenib" "adjuvant"
1 Q0 24291778 195 34.610237 imi_mug_run_2_treatment "vemurafenib" "dabrafenib"
1 Q0 28408301 196 34.604843 imi_mug_run_2_treatment "drug" "kinase inhibitor" "braf inhibitor"
1 Q0 23894707 197 34.601746 imi_mug_run_2_treatment "antineoplastic"
1 Q0 29050218 198 34.59381 imi_mug_run_2_treatment "vemurafenib" "mediated" "mek inhibitor"
1 Q0 24795008 199 34.586395 imi_mug_run_2_treatment "balance"
1 Q0 15208655 200 34.585968 imi_mug_run_2_treatment "various" "mediated"
1 Q0 24625306 201 34.581657 imi_mug_run_2_treatment "drugs"
1 Q0 26731560 202 34.558727 imi_mug_run_2_treatment "mek inhibitor" "trametinib" "vemurafenib"
1 Q0 19663727 203 34.555542 imi_mug_run_2_treatment "sorafenib" "agent" "braf inhibitor"
1 Q0 23744355 204 34.48059 imi_mug_run_2_treatment "combinations" "saha" "hdac inhibitor"
1 Q0 27203149 205 34.438217 imi_mug_run_2_treatment "kinase inhibitor"
1 Q0 29243224 206 34.423584 imi_mug_run_2_treatment "palbociclib" "braf inhibitor" "drug"
1 Q0 24583796 207 34.379227 imi_mug_run_2_treatment "trametinib" "dabrafenib" "drugs"
1 Q0 25370473 208 34.356403 imi_mug_run_2_treatment "dabrafenib" "braf inhibitor" "vemurafenib"
1 Q0 24489105 209 34.352455 imi_mug_run_2_treatment "braf inhibitor" "ccl4" "cytotoxic"
1 Q0 20818844 210 34.348763 imi_mug_run_2_treatment "plx4032" "pharmaceuticals" "rg7204"
1 Q0 26365896 211 34.30852 imi_mug_run_2_treatment "glucose" "glutamine" "drugs"
1 Q0 25686114 212 34.30852 imi_mug_run_2_treatment "vemurafenib" "immunotherapeutic agent" "ipilimumab"
1 Q0 21570823 213 34.303154 imi_mug_run_2_treatment "level"
1 Q0 17001349 214 34.29906 imi_mug_run_2_treatment "bay 43-9006"
1 Q0 19682280 215 34.29906 imi_mug_run_2_treatment "pd184352" "basis"
1 Q0 21447722 216 34.24833 imi_mug_run_2_treatment "drug" "plx4032" "rg7204"
1 Q0 27297629 217 34.238255 imi_mug_run_2_treatment "drug" "pdx" "vemurafenib"
1 Q0 15330192 218 34.23745 imi_mug_run_2_treatment "basis"
1 Q0 22614973 219 34.235264 imi_mug_run_2_treatment "various" "blockade" "braf inhibitor"
1 Q0 26217117 220 34.227806 imi_mug_run_2_treatment "combinations" "mek inhibitor" "trametinib"
1 Q0 28058658 221 34.22573 imi_mug_run_2_treatment "combinations" "mek inhibitor" "vemurafenib"
1 Q0 24456413 222 34.21412 imi_mug_run_2_treatment "ras" "therapeutics" "vemurafenib"
1 Q0 24196789 223 34.21412 imi_mug_run_2_treatment "braf inhibitor" "vemurafenib" "dabrafenib"
1 Q0 25183499 224 34.20241 imi_mug_run_2_treatment "basis" "immunosuppressive" "braf inhibitor"
1 Q0 27338362 225 34.171432 imi_mug_run_2_treatment "level"
1 Q0 22453012 226 34.167877 imi_mug_run_2_treatment "braf inhibitor" "lead" "level"
1 Q0 25306614 227 34.167877 imi_mug_run_2_treatment "various"
1 Q0 29880840 228 34.167877 imi_mug_run_2_treatment "various" "mediated"
1 Q0 24393566 229 34.16221 imi_mug_run_2_treatment "aminoacid"
1 Q0 16801397 230 34.15228 imi_mug_run_2_treatment "immunosuppressive" "il-12" "u0126"
1 Q0 24520098 231 34.15228 imi_mug_run_2_treatment "vemurafenib" "mek inhibitor" "trametinib"
1 Q0 26984388 232 34.150322 imi_mug_run_2_treatment "vemurafenib" "cobimetinib" "mek inhibitor"
1 Q0 29721178 233 34.146065 imi_mug_run_2_treatment "animals" "plasma"
1 Q0 19398955 234 34.11019 imi_mug_run_2_treatment "mediated" "ras" "therapeutics"
1 Q0 18458053 235 34.095604 imi_mug_run_2_treatment "plx4032" "blockade"
1 Q0 25746038 236 34.07509 imi_mug_run_2_treatment "various"
1 Q0 27095081 237 34.073215 imi_mug_run_2_treatment "plasma" "trametinib" "dabrafenib"
1 Q0 28134726 238 34.069145 imi_mug_run_2_treatment "ras" "aim"
1 Q0 17210691 239 34.038296 imi_mug_run_2_treatment "tnf-alpha" "cisplatin" "drugs"
1 Q0 16901402 240 34.035267 imi_mug_run_2_treatment "drug" "ras" "sorafenib"
1 Q0 23306863 241 34.026558 imi_mug_run_2_treatment "vemurafenib" "u0126" "blockade"
1 Q0 29551771 242 34.006145 imi_mug_run_2_treatment "braf inhibitor"
1 Q0 24569374 243 34.005302 imi_mug_run_2_treatment "braf inhibitor" "duration"
1 Q0 26600396 244 34.005302 imi_mug_run_2_treatment "aim"
1 Q0 25073704 245 33.95117 imi_mug_run_2_treatment "etv" "vemurafenib" "dabrafenib"
1 Q0 22962325 246 33.938965 imi_mug_run_2_treatment "drug" "braf inhibitor" "medicine"
1 Q0 22584957 247 33.920464 imi_mug_run_2_treatment "dabrafenib" "vemurafenib" "ras"
1 Q0 26399561 248 33.900368 imi_mug_run_2_treatment "aim"
1 Q0 21606968 249 33.896233 imi_mug_run_2_treatment "plx4032" "gsk2118436" "vemurafenib"
1 Q0 25408648 250 33.873398 imi_mug_run_2_treatment "various" "vemurafenib" "braf inhibitor"
1 Q0 23626542 251 33.873398 imi_mug_run_2_treatment "vemurafenib" "braf inhibitor"
1 Q0 27232329 252 33.834267 imi_mug_run_2_treatment "lead"
1 Q0 23290787 253 33.824795 imi_mug_run_2_treatment "mek inhibitor" "trametinib" "vemurafenib"
1 Q0 26137449 254 33.78753 imi_mug_run_2_treatment "selumetinib" "vemurafenib" "zstk474"
1 Q0 29684526 255 33.782642 imi_mug_run_2_treatment "folic acid"
1 Q0 23432625 256 33.779503 imi_mug_run_2_treatment "trametinib" "drugs" "mek inhibitor"
1 Q0 21917148 257 33.77245 imi_mug_run_2_treatment "drug" "braf inhibitor" "collagen"
1 Q0 27342756 258 33.754135 imi_mug_run_2_treatment "braf inhibitor"
1 Q0 27042173 259 33.752666 imi_mug_run_2_treatment "drugs" "vemurafenib" "dabrafenib"
1 Q0 29371951 260 33.718178 imi_mug_run_2_treatment "lead"
1 Q0 26366702 261 33.703594 imi_mug_run_2_treatment "plasma" "basis"
1 Q0 21156289 262 33.695618 imi_mug_run_2_treatment "braf inhibitor"
1 Q0 26308130 263 33.683968 imi_mug_run_2_treatment "various" "braf inhibitor"
1 Q0 25738144 264 33.683216 imi_mug_run_2_treatment "various" "lead" "agent"
1 Q0 24980819 265 33.683216 imi_mug_run_2_treatment "vemurafenib" "mediated" "cytokines"
1 Q0 27500726 266 33.683216 imi_mug_run_2_treatment "mediated"
1 Q0 21041578 267 33.67154 imi_mug_run_2_treatment "braf inhibitor"
1 Q0 24962553 268 33.6611 imi_mug_run_2_treatment "drugs" "ipilimumab" "blockade"
1 Q0 24531394 269 33.641262 imi_mug_run_2_treatment "vemurafenib" "braf inhibitor"
1 Q0 30263945 270 33.636772 imi_mug_run_2_treatment "braf inhibitor"
1 Q0 24259661 271 33.63225 imi_mug_run_2_treatment "dabrafenib" "vemurafenib" "braf inhibitor"
1 Q0 23833299 272 33.630066 imi_mug_run_2_treatment "dabrafenib" "dacarbazine" "gsk2118436"
1 Q0 15179189 273 33.61864 imi_mug_run_2_treatment "ras"
1 Q0 27238082 274 33.593132 imi_mug_run_2_treatment "braf inhibitor"
1 Q0 25768829 275 33.571186 imi_mug_run_2_treatment "basis" "braf inhibitor"
1 Q0 28112278 276 33.56984 imi_mug_run_2_treatment "various" "cobimetinib" "vemurafenib"
1 Q0 25854919 277 33.53108 imi_mug_run_2_treatment "combinations" "dovitinib" "braf inhibitor"
1 Q0 24941944 278 33.516403 imi_mug_run_2_treatment "various" "enzymes" "dtic"
1 Q0 30376464 279 33.513474 imi_mug_run_2_treatment "vemurafenib"
1 Q0 23594535 280 33.50944 imi_mug_run_2_treatment "suppressor"
1 Q0 26669314 281 33.486477 imi_mug_run_2_treatment "interferon"
1 Q0 15578519 282 33.459663 imi_mug_run_2_treatment "level" "duration"
1 Q0 23242808 283 33.459663 imi_mug_run_2_treatment "drug" "dasatinib" "vemurafenib"
1 Q0 30410366 284 33.456497 imi_mug_run_2_treatment "trametinib" "vemurafenib" "dabrafenib"
1 Q0 21176117 285 33.425392 imi_mug_run_2_treatment "various"
1 Q0 21362156 286 33.425392 imi_mug_run_2_treatment "genesis"
1 Q0 29026704 287 33.41375 imi_mug_run_2_treatment "therapeutic agents" "tandem" "sorafenib"
1 Q0 21393075 288 33.403423 imi_mug_run_2_treatment "braf inhibitor"
1 Q0 29628797 289 33.388092 imi_mug_run_2_treatment "braf inhibitor" "agent" "new drugs"
1 Q0 23807941 290 33.376514 imi_mug_run_2_treatment "dabrafenib" "agent" "trametinib"
1 Q0 26848795 291 33.37467 imi_mug_run_2_treatment "level"
1 Q0 18227705 292 33.363625 imi_mug_run_2_treatment "various"
1 Q0 23102192 293 33.35769 imi_mug_run_2_treatment "kinase inhibitor" "vemurafenib" "medicines"
1 Q0 24919155 294 33.342583 imi_mug_run_2_treatment "suppressor"
1 Q0 29116432 295 33.334896 imi_mug_run_2_treatment "interferon"
1 Q0 23624923 296 33.33278 imi_mug_run_2_treatment "glv-1h68" "ras" "mediated"
1 Q0 25899612 297 33.319134 imi_mug_run_2_treatment "monoclonal antibodies"
1 Q0 22423265 298 33.315502 imi_mug_run_2_treatment "level"
1 Q0 25364391 299 33.299 imi_mug_run_2_treatment "vemurafenib" "drug" "drugs"
1 Q0 23377457 300 33.29515 imi_mug_run_2_treatment "drugs"
1 Q0 28797232 301 33.29151 imi_mug_run_2_treatment "blockade"
1 Q0 21139585 302 33.29005 imi_mug_run_2_treatment "drugs" "cytotoxic drugs" "ras"
1 Q0 26829212 303 33.279537 imi_mug_run_2_treatment "atra" "mediated"
1 Q0 25361077 304 33.270393 imi_mug_run_2_treatment "mediated"
1 Q0 26989536 305 33.270393 imi_mug_run_2_treatment "vemurafenib" "braf inhibitor"
1 Q0 26678033 306 33.25131 imi_mug_run_2_treatment "blockade" "mtor inhibitor"
1 Q0 28497782 307 33.23801 imi_mug_run_2_treatment "various" "mediated" "ras"
1 Q0 24812130 308 33.235863 imi_mug_run_2_treatment "ipilimumab" "interleukin-2" "trametinib"
1 Q0 25755684 309 33.22868 imi_mug_run_2_treatment "drugs" "mek inhibitor" "trametinib"
1 Q0 28595656 310 33.22868 imi_mug_run_2_treatment "ras" "braf inhibitor" "mediated"
1 Q0 26488003 311 33.21578 imi_mug_run_2_treatment "agent" "braf inhibitor"
1 Q0 24958825 312 33.205715 imi_mug_run_2_treatment "ipilimumab" "duration" "vemurafenib"
1 Q0 15657897 313 33.203545 imi_mug_run_2_treatment "mediated"
1 Q0 25766129 314 33.193985 imi_mug_run_2_treatment "ssm"
1 Q0 24335665 315 33.16533 imi_mug_run_2_treatment "various" "level"
1 Q0 24051957 316 33.161705 imi_mug_run_2_treatment "plx4032" "braf inhibitor" "as703026"
1 Q0 18790768 317 33.15267 imi_mug_run_2_treatment "braf inhibitor" "drug"
1 Q0 30110681 318 33.144485 imi_mug_run_2_treatment "aim"
1 Q0 17119447 319 33.140762 imi_mug_run_2_treatment "ras" "level"
1 Q0 23673558 320 33.140762 imi_mug_run_2_treatment "dtic" "dacarbazine"
1 Q0 23264894 321 33.134876 imi_mug_run_2_treatment "vemurafenib" "antineoplastic" "braf inhibitor"
1 Q0 25602684 322 33.134716 imi_mug_run_2_treatment "combinations" "braf inhibitor"
1 Q0 15588860 323 33.109436 imi_mug_run_2_treatment "glutamic acid"
1 Q0 22742884 324 33.080166 imi_mug_run_2_treatment "dacarbazine" "kinase inhibitor" "vemurafenib"
1 Q0 27180965 325 33.077652 imi_mug_run_2_treatment "various" "ras" "drugs"
1 Q0 28003758 326 33.075756 imi_mug_run_2_treatment "drugs" "braf inhibitor"
1 Q0 21793228 327 33.063812 imi_mug_run_2_treatment "mart-1"
1 Q0 30237393 328 33.063812 imi_mug_run_2_treatment "drug" "drugs" "mediated"
1 Q0 25762352 329 33.056717 imi_mug_run_2_treatment "braf inhibitor" "vemurafenib" "dabrafenib"
1 Q0 28278423 330 33.056717 imi_mug_run_2_treatment "digoxin" "mek inhibitor" "trametinib"
1 Q0 25651238 331 33.026463 imi_mug_run_2_treatment "dabrafenib" "adjuvant" "drugs"
1 Q0 16354196 332 32.98471 imi_mug_run_2_treatment "matrix"
1 Q0 24950457 333 32.979942 imi_mug_run_2_treatment "amuvatinib" "cytotoxic" "kinase inhibitor"
1 Q0 17516929 334 32.973747 imi_mug_run_2_treatment "others"
1 Q0 24037523 335 32.965473 imi_mug_run_2_treatment "hydroxytamoxifen"
1 Q0 30508500 336 32.964012 imi_mug_run_2_treatment "plx4032" "braf inhibitor" "drug"
1 Q0 24345920 337 32.961098 imi_mug_run_2_treatment "mek inhibitor"
1 Q0 23294221 338 32.938187 imi_mug_run_2_treatment "drugs" "drug combinations" "vemurafenib"
1 Q0 23489693 339 32.927475 imi_mug_run_2_treatment "ndp-msh" "ras" "mek inhibitor"
1 Q0 20823850 340 32.927475 imi_mug_run_2_treatment "drug" "plx4032" "blockade"
1 Q0 28810295 341 32.918617 imi_mug_run_2_treatment "others"
1 Q0 23903755 342 32.91667 imi_mug_run_2_treatment "mitogen"
1 Q0 26668268 343 32.91667 imi_mug_run_2_treatment "braf inhibitor" "plx4032"
1 Q0 27520988 344 32.90577 imi_mug_run_2_treatment "vemurafenib" "braf inhibitor"
1 Q0 23843700 345 32.846764 imi_mug_run_2_treatment "various"
1 Q0 28537004 346 32.829094 imi_mug_run_2_treatment "various" "braf inhibitor" "mek inhibitor"
1 Q0 26061438 347 32.817604 imi_mug_run_2_treatment "braf inhibitor"
1 Q0 25797743 348 32.81715 imi_mug_run_2_treatment "dabrafenib" "eosin" "formalin"
1 Q0 30247203 349 32.81328 imi_mug_run_2_treatment "adjuvant"
1 Q0 28114255 350 32.796513 imi_mug_run_2_treatment "drug" "mek inhibitor" "glembatumumab"
1 Q0 29050198 351 32.788216 imi_mug_run_2_treatment "level"
1 Q0 25452114 352 32.772736 imi_mug_run_2_treatment "trametinib" "dabrafenib" "mapk inhibitors"
1 Q0 29697386 353 32.77193 imi_mug_run_2_treatment "plasma"
1 Q0 29970025 354 32.76831 imi_mug_run_2_treatment "ipilimumab" "braf inhibitor"
1 Q0 22356324 355 32.755074 imi_mug_run_2_treatment "vemurafenib" "duration" "plx4032"
1 Q0 20182446 356 32.751873 imi_mug_run_2_treatment "ras"
1 Q0 30124539 357 32.751873 imi_mug_run_2_treatment "gefitinib" "vemurafenib" "pelitinib"
1 Q0 25185693 358 32.7417 imi_mug_run_2_treatment "vemurafenib" "dacarbazine" "dtic"
1 Q0 23617343 359 32.738503 imi_mug_run_2_treatment "vemurafenib" "braf inhibitor"
1 Q0 19861964 360 32.733955 imi_mug_run_2_treatment "arry-142886" "azd6244" "aim"
1 Q0 24419498 361 32.724415 imi_mug_run_2_treatment "braf inhibitor" "mek inhibitor" "trametinib"
1 Q0 30386910 362 32.714798 imi_mug_run_2_treatment "vemurafenib" "ipilimumab" "dabrafenib"
1 Q0 25989506 363 32.69024 imi_mug_run_2_treatment "ras" "plx4032" "collagen"
1 Q0 26672083 364 32.68003 imi_mug_run_2_treatment "selumetinib" "temozolomide" "redux"
1 Q0 25912549 365 32.672203 imi_mug_run_2_treatment "braf inhibitor" "paclitaxel" "mitotic inhibitor"
1 Q0 24117833 366 32.668804 imi_mug_run_2_treatment "aim"
1 Q0 25873177 367 32.66267 imi_mug_run_2_treatment "drug" "matrix"
1 Q0 24333389 368 32.661034 imi_mug_run_2_treatment "program" "vemurafenib" "dabrafenib"
1 Q0 25228337 369 32.654446 imi_mug_run_2_treatment "braf inhibitor"
1 Q0 24183461 370 32.64975 imi_mug_run_2_treatment "mek inhibitor" "braf inhibitor"
1 Q0 24398428 371 32.641907 imi_mug_run_2_treatment "ganetespib" "vemurafenib" "agent"
1 Q0 23848983 372 32.632355 imi_mug_run_2_treatment "plx4032" "gsk1120212" "cytokines"
1 Q0 25576527 373 32.632355 imi_mug_run_2_treatment "braf inhibitor"
1 Q0 18323787 374 32.62814 imi_mug_run_2_treatment "kinase inhibitor"
1 Q0 25265494 375 32.624313 imi_mug_run_2_treatment "vemurafenib" "cobimetinib" "drug"
1 Q0 15917418 376 32.623173 imi_mug_run_2_treatment "various"
1 Q0 25265492 377 32.614082 imi_mug_run_2_treatment "trametinib" "dabrafenib" "stopping"
1 Q0 25944484 378 32.610935 imi_mug_run_2_treatment "braf inhibitor" "mek inhibitor" "trametinib"
1 Q0 28147313 379 32.60788 imi_mug_run_2_treatment "mediated" "amg 337"
1 Q0 25145427 380 32.605026 imi_mug_run_2_treatment "trametinib" "mek inhibitor" "agent"
1 Q0 24484235 381 32.584766 imi_mug_run_2_treatment "ipilimumab" "program" "vemurafenib"
1 Q0 23438383 382 32.56986 imi_mug_run_2_treatment "agent" "braf inhibitor" "vemurafenib"
1 Q0 25543407 383 32.561306 imi_mug_run_2_treatment "eosin"
1 Q0 22576211 384 32.561306 imi_mug_run_2_treatment "metformin" "drugs" "antidiabetic drug"
1 Q0 27246822 385 32.561306 imi_mug_run_2_treatment "dabrafenib" "trametinib" "vemurafenib"
1 Q0 28827320 386 32.561306 imi_mug_run_2_treatment "braf inhibitor" "mediated"
1 Q0 28374786 387 32.542183 imi_mug_run_2_treatment "mediated" "agent" "therapeutic agents"
1 Q0 30277012 388 32.53128 imi_mug_run_2_treatment "drug" "mediated"
1 Q0 25795251 389 32.525826 imi_mug_run_2_treatment "vemurafenib" "water" "braf inhibitor"
1 Q0 26710785 390 32.525764 imi_mug_run_2_treatment "level" "aim" "vemurafenib"
1 Q0 25787767 391 32.52487 imi_mug_run_2_treatment "trametinib" "dabrafenib" "braf inhibitor"
1 Q0 25063807 392 32.512096 imi_mug_run_2_treatment "vemurafenib" "cisplatin" "melphalan"
1 Q0 25198196 393 32.481766 imi_mug_run_2_treatment "vemurafenib" "dacarbazine" "immunomodulator"
1 Q0 26926151 394 32.481697 imi_mug_run_2_treatment "mek inhibitor" "dabrafenib" "trametinib"
1 Q0 24625733 395 32.479294 imi_mug_run_2_treatment "braf inhibitor" "gossypol" "mediated"
1 Q0 24054424 396 32.476326 imi_mug_run_2_treatment "drugs" "interferon alfa" "interferon"
1 Q0 27765851 397 32.47071 imi_mug_run_2_treatment "vemurafenib" "glucose" "lactate"
1 Q0 24425783 398 32.462624 imi_mug_run_2_treatment "agent" "blockade"
1 Q0 23207793 399 32.436275 imi_mug_run_2_treatment "combinations"
1 Q0 24325952 400 32.42488 imi_mug_run_2_treatment "dabrafenib" "lead" "mek inhibitor"
1 Q0 24341237 401 32.409935 imi_mug_run_2_treatment "drugs" "immunosuppressive" "imatinib"
1 Q0 24737949 402 32.409195 imi_mug_run_2_treatment "combinations" "drug" "drugs"
1 Q0 26813076 403 32.40365 imi_mug_run_2_treatment "ras"
1 Q0 24161908 404 32.39983 imi_mug_run_2_treatment "vemurafenib" "plx4032" "elesclomol"
1 Q0 14722037 405 32.348473 imi_mug_run_2_treatment "level"
1 Q0 23420410 406 32.334236 imi_mug_run_2_treatment "braf inhibitor" "imatinib" "mek inhibitor"
1 Q0 23110010 407 32.331886 imi_mug_run_2_treatment "isolate"
1 Q0 27622011 408 32.319237 imi_mug_run_2_treatment "trametinib" "dabrafenib" "combinations"
1 Q0 17690212 409 32.310356 imi_mug_run_2_treatment "lead"
1 Q0 26110554 410 32.27823 imi_mug_run_2_treatment "braf inhibitor"
1 Q0 27273450 411 32.271126 imi_mug_run_2_treatment "vemurafenib" "agar" "braf inhibitor"
1 Q0 25942671 412 32.260662 imi_mug_run_2_treatment "vemurafenib" "medication" "braf inhibitor"
1 Q0 25294877 413 32.236027 imi_mug_run_2_treatment "braf inhibitor" "drug" "egcg"
1 Q0 19649202 414 32.22264 imi_mug_run_2_treatment "pd0325901" "antiangiogenic" "mek inhibitor"
1 Q0 28527094 415 32.221943 imi_mug_run_2_treatment "vemurafenib" "plasma" "favor"
1 Q0 25159853 416 32.214058 imi_mug_run_2_treatment "ipilimumab" "dabrafenib"
1 Q0 25526431 417 32.20956 imi_mug_run_2_treatment "vemurafenib" "dabrafenib" "braf inhibitor"
1 Q0 25380183 418 32.202915 imi_mug_run_2_treatment "braf inhibitor"
1 Q0 23584600 419 32.1952 imi_mug_run_2_treatment "various" "formalin" "vemurafenib"
1 Q0 25962795 420 32.1952 imi_mug_run_2_treatment "trametinib" "vemurafenib" "dabrafenib"
1 Q0 23584575 421 32.189476 imi_mug_run_2_treatment "vemurafenib" "drugs" "new drugs"
1 Q0 24531699 422 32.187187 imi_mug_run_2_treatment "imatinib" "tyrosine kinase inhibitor" "vemurafenib"
1 Q0 26640592 423 32.184437 imi_mug_run_2_treatment "various" "plx4032" "vaccine"
1 Q0 22554099 424 32.180206 imi_mug_run_2_treatment "vemurafenib" "dacarbazine" "ipilimumab"
1 Q0 26107021 425 32.175068 imi_mug_run_2_treatment "trametinib" "mek inhibitor" "duration"
1 Q0 26519363 426 32.144608 imi_mug_run_2_treatment "agent" "braf inhibitor"
1 Q0 30344946 427 32.14382 imi_mug_run_2_treatment "braf inhibitor" "duration"
1 Q0 25437182 428 32.135437 imi_mug_run_2_treatment "vemurafenib" "dabrafenib"
1 Q0 26063764 429 32.122185 imi_mug_run_2_treatment "mra"
1 Q0 24582505 430 32.105324 imi_mug_run_2_treatment "vemurafenib" "drug" "kinase inhibitor"
1 Q0 26500770 431 32.07513 imi_mug_run_2_treatment "various" "vitamin e" "antioxidant"
1 Q0 24720932 432 32.067986 imi_mug_run_2_treatment "dabrafenib" "drug" "various combinations"
1 Q0 25339196 433 32.059093 imi_mug_run_2_treatment "interferon" "kinase inhibitor" "level"
1 Q0 20401974 434 32.05602 imi_mug_run_2_treatment "drugs" "braf inhibitor"
1 Q0 25812921 435 32.05602 imi_mug_run_2_treatment "trametinib" "mek inhibitor" "dabrafenib"
1 Q0 27791198 436 32.054924 imi_mug_run_2_treatment "braf inhibitor"
1 Q0 22617000 437 32.04522 imi_mug_run_2_treatment "vemurafenib"
1 Q0 14691295 438 32.035927 imi_mug_run_2_treatment "ras" "glutamic acid"
1 Q0 22056813 439 32.027267 imi_mug_run_2_treatment "mediated" "sorafenib" "mek inhibitor"
1 Q0 22661223 440 32.01936 imi_mug_run_2_treatment "agent"
1 Q0 24569370 441 32.014732 imi_mug_run_2_treatment "combinations" "vemurafenib" "drug"
1 Q0 25363723 442 32.013725 imi_mug_run_2_treatment "autologous"
1 Q0 23890088 443 32.004898 imi_mug_run_2_treatment "sorafenib" "vemurafenib"
1 Q0 22934253 444 31.977283 imi_mug_run_2_treatment "vemurafenib" "tyr" "dabrafenib"
1 Q0 24600206 445 31.97567 imi_mug_run_2_treatment "dacarbazine" "insulin" "drug"
1 Q0 26498143 446 31.974287 imi_mug_run_2_treatment "braf inhibitor"
1 Q0 23852164 447 31.934357 imi_mug_run_2_treatment "vemurafenib"
1 Q0 26605311 448 31.929792 imi_mug_run_2_treatment "revolution"
1 Q0 23094782 449 31.928974 imi_mug_run_2_treatment "vemurafenib" "ipilimumab" "adjuvant"
1 Q0 29187493 450 31.927872 imi_mug_run_2_treatment "aim" "nervous system"
1 Q0 25749811 451 31.925068 imi_mug_run_2_treatment "aim"
1 Q0 26048310 452 31.916286 imi_mug_run_2_treatment "antineoplastic" "aloe-emodin" "adjuvant"
1 Q0 28963969 453 31.913284 imi_mug_run_2_treatment "braf inhibitor" "drug" "mediated"
1 Q0 22083257 454 31.904852 imi_mug_run_2_treatment "vemurafenib" "dacarbazine" "drug"
1 Q0 22437314 455 31.897085 imi_mug_run_2_treatment "braf inhibitor gsk2118436" "braf inhibitor"
1 Q0 24714776 456 31.894108 imi_mug_run_2_treatment "sorafenib" "carboplatin" "paclitaxel"
1 Q0 16417231 457 31.889578 imi_mug_run_2_treatment "ras"
1 Q0 26070258 458 31.889578 imi_mug_run_2_treatment "nab-paclitaxel" "vemurafenib" "taxanes"
1 Q0 23557327 459 31.867329 imi_mug_run_2_treatment "duration"
1 Q0 27226731 460 31.856644 imi_mug_run_2_treatment "dabrafenib" "drug's" "medication"
1 Q0 29698368 461 31.854248 imi_mug_run_2_treatment "drug" "vemurafenib" "braf inhibitor"
1 Q0 25948295 462 31.84267 imi_mug_run_2_treatment "mediated" "vemurafenib"
1 Q0 27923592 463 31.831589 imi_mug_run_2_treatment "gna" "braf inhibitor"
1 Q0 21639808 464 31.829632 imi_mug_run_2_treatment "dacarbazine" "kinase inhibitor" "vemurafenib"
1 Q0 22663011 465 31.829632 imi_mug_run_2_treatment "trametinib" "dacarbazine" "paclitaxel"
1 Q0 30018526 466 31.828602 imi_mug_run_2_treatment "cobimetinib" "vemurafenib" "mek inhibitor"
1 Q0 24098023 467 31.8139 imi_mug_run_2_treatment "medicine" "formalin"
1 Q0 24971403 468 31.809885 imi_mug_run_2_treatment "agent" "vemurafenib"
1 Q0 27151331 469 31.804958 imi_mug_run_2_treatment "mek inhibitor"
1 Q0 27490749 470 31.796673 imi_mug_run_2_treatment "drugs"
1 Q0 22277029 471 31.796558 imi_mug_run_2_treatment "plx4032" "agar" "mediated"
1 Q0 16474847 472 31.786695 imi_mug_run_2_treatment "nitric oxide" "s-methylisothiourea" "u0126"
1 Q0 25382067 473 31.778425 imi_mug_run_2_treatment "mek inhibitor" "trametinib" "dabrafenib"
1 Q0 22516966 474 31.776958 imi_mug_run_2_treatment "braf inhibitor"
1 Q0 26145173 475 31.768456 imi_mug_run_2_treatment "product"
1 Q0 14501284 476 31.750526 imi_mug_run_2_treatment "lysine" "level"
1 Q0 30501438 477 31.721258 imi_mug_run_2_treatment "mek inhibitor" "braf inhibitor"
1 Q0 26181250 478 31.66476 imi_mug_run_2_treatment "nivolumab" "braf inhibitor" "investigational drug"
1 Q0 26630683 479 31.664124 imi_mug_run_2_treatment "various" "aim"
1 Q0 24795014 480 31.6633 imi_mug_run_2_treatment "braf inhibitor"
1 Q0 23317446 481 31.657835 imi_mug_run_2_treatment "dabrafenib" "gsk2118436" "therapeutic agents"
1 Q0 27255157 482 31.64608 imi_mug_run_2_treatment "dabrafenib" "vemurafenib" "braf inhibitor"
1 Q0 24857132 483 31.6363 imi_mug_run_2_treatment "drugs" "ipilimumab"
1 Q0 26497853 484 31.615755 imi_mug_run_2_treatment "vemurafenib" "mcl-1 inhibitor" "drug combination"
1 Q0 22235286 485 31.615719 imi_mug_run_2_treatment "braf inhibitor"
1 Q0 27447748 486 31.603273 imi_mug_run_2_treatment "combinations" "ipilimumab" "mek inhibitor"
1 Q0 23893853 487 31.591558 imi_mug_run_2_treatment "ras" "vemurafenib" "dabrafenib"
1 Q0 28640105 488 31.576538 imi_mug_run_2_treatment "binimetinib" "encorafenib"
1 Q0 24531984 489 31.561245 imi_mug_run_2_treatment "amino acids" "glutamine" "leucine"
1 Q0 25622086 490 31.557137 imi_mug_run_2_treatment "vemurafenib" "dacarbazine" "braf inhibitor"
1 Q0 21962474 491 31.542728 imi_mug_run_2_treatment "ras" "basis" "vemurafenib"
1 Q0 25179409 492 31.526155 imi_mug_run_2_treatment "medicine"
1 Q0 23285177 493 31.5144 imi_mug_run_2_treatment "braf inhibitor" "drug"
1 Q0 27196754 494 31.511879 imi_mug_run_2_treatment "sar260301" "combinations" "mapk inhibitors"
1 Q0 28106277 495 31.511442 imi_mug_run_2_treatment "mek inhibitor" "vemurafenib" "tra"
1 Q0 29232304 496 31.509663 imi_mug_run_2_treatment "basis"
1 Q0 27000992 497 31.490427 imi_mug_run_2_treatment "braf inhibitor"
1 Q0 23302800 498 31.488155 imi_mug_run_2_treatment "vemurafenib" "drug"
1 Q0 26577700 499 31.488155 imi_mug_run_2_treatment "combinations" "glucose" "mek inhibitor"
1 Q0 27613168 500 31.466923 imi_mug_run_2_treatment "combinations" "trametinib" "vemurafenib"
1 Q0 23087082 501 31.466589 imi_mug_run_2_treatment "abt-737" "mediated" "abt-263"
1 Q0 29076950 502 31.458288 imi_mug_run_2_treatment "vemurafenib" "duration"
1 Q0 17570501 503 31.435112 imi_mug_run_2_treatment "ras" "various" "hot spot"
1 Q0 19861408 504 31.42492 imi_mug_run_2_treatment "ras" "agent" "genesis"
1 Q0 23329082 505 31.41161 imi_mug_run_2_treatment "vemurafenib" "dacarbazine" "zelboraf"
1 Q0 27192168 506 31.408136 imi_mug_run_2_treatment "aim" "adjuvant"
1 Q0 19493000 507 31.406757 imi_mug_run_2_treatment "ptc"
1 Q0 25018652 508 31.401028 imi_mug_run_2_treatment "trametinib" "dabrafenib" "braf inhibitor"
1 Q0 23935925 509 31.400925 imi_mug_run_2_treatment "shh" "nvp-lde225" "cyclopamine"
1 Q0 24424456 510 31.398052 imi_mug_run_2_treatment "mediated"
1 Q0 26266008 511 31.393873 imi_mug_run_2_treatment "agent" "dabrafenib" "liver"
1 Q0 22805292 512 31.3871 imi_mug_run_2_treatment "trametinib" "mek inhibitor" "braf inhibitor"
1 Q0 25026375 513 31.374405 imi_mug_run_2_treatment "plx4032" "lead"
1 Q0 30222203 514 31.374405 imi_mug_run_2_treatment "vemurafenib" "immunosuppressive" "cytotoxic"
1 Q0 23924408 515 31.368505 imi_mug_run_2_treatment "vemurafenib"
1 Q0 15641040 516 31.366783 imi_mug_run_2_treatment "various"
1 Q0 27447557 517 31.364758 imi_mug_run_2_treatment "vemurafenib" "drug combination" "braf inhibitor"
1 Q0 26787892 518 31.35879 imi_mug_run_2_treatment "cnc" "basis"
1 Q0 22156613 519 31.35034 imi_mug_run_2_treatment "braf inhibitor" "vemurafenib"
1 Q0 20667740 520 31.345734 imi_mug_run_2_treatment "imidazole" "braf inhibitor" "piperazin"
1 Q0 20629085 521 31.342978 imi_mug_run_2_treatment "adjuvant" "cytotoxic" "agent"
1 Q0 30237495 522 31.341753 imi_mug_run_2_treatment "mek inhibitor" "lead" "braf inhibitor"
1 Q0 27220785 523 31.321028 imi_mug_run_2_treatment "drugs" "ipilimumab" "nivolumab"
1 Q0 30320090 524 31.317572 imi_mug_run_2_treatment "trametinib" "dabrafenib" "liver"
1 Q0 26648623 525 31.312315 imi_mug_run_2_treatment "mek inhibitor" "braf inhibitor" "drugs"
1 Q0 20605766 526 31.288172 imi_mug_run_2_treatment "level"
1 Q0 23658559 527 31.287971 imi_mug_run_2_treatment "trametinib" "ci-1040" "vemurafenib"
1 Q0 23036672 528 31.267628 imi_mug_run_2_treatment "vemurafenib" "prompt"
1 Q0 20551059 529 31.267609 imi_mug_run_2_treatment "various" "mediated" "duration"
1 Q0 25836739 530 31.264153 imi_mug_run_2_treatment "various" "combinations" "basis"
1 Q0 24331719 531 31.259132 imi_mug_run_2_treatment "new drugs"
1 Q0 21051014 532 31.23932 imi_mug_run_2_treatment "drugs" "tyrosine" "plx4032"
1 Q0 26218930 533 31.231222 imi_mug_run_2_treatment "mapk inhibitors" "trametinib" "duration"
1 Q0 27141346 534 31.216076 imi_mug_run_2_treatment "blockade" "braf inhibitor"
1 Q0 24413374 535 31.210651 imi_mug_run_2_treatment "vemurafenib" "ipilimumab" "new drugs"
1 Q0 24297954 536 31.20662 imi_mug_run_2_treatment "braf inhibitor"
1 Q0 16291983 537 31.194859 imi_mug_run_2_treatment "ras" "basis"
1 Q0 20531415 538 31.189117 imi_mug_run_2_treatment "braf inhibitor" "brdu"
1 Q0 26302068 539 31.187809 imi_mug_run_2_treatment "mediated" "nrg" "vemurafenib"
1 Q0 24407165 540 31.180023 imi_mug_run_2_treatment "vemurafenib" "braf inhibitor"
1 Q0 25287827 541 31.177305 imi_mug_run_2_treatment "dabrafenib" "braf inhibitor" "trametinib"
1 Q0 22796458 542 31.172237 imi_mug_run_2_treatment "combinations" "tyr"
1 Q0 25806238 543 31.160551 imi_mug_run_2_treatment "dabrafenib" "drugs" "ras"
1 Q0 27993725 544 31.145737 imi_mug_run_2_treatment "level" "mart-1"
1 Q0 24673301 545 31.126486 imi_mug_run_2_treatment "balance"
1 Q0 25890285 546 31.108799 imi_mug_run_2_treatment "tgfb1" "level"
1 Q0 27652325 547 31.10518 imi_mug_run_2_treatment "mapk inhibitors"
1 Q0 24258979 548 31.104523 imi_mug_run_2_treatment "braf inhibitor"
1 Q0 26601866 549 31.100395 imi_mug_run_2_treatment "trametinib" "vemurafenib" "dabrafenib"
1 Q0 29507054 550 31.098629 imi_mug_run_2_treatment "combinations" "pdx" "dinaciclib"
1 Q0 22817889 551 31.091549 imi_mug_run_2_treatment "basis"
1 Q0 29110248 552 31.091549 imi_mug_run_2_treatment "drug"
1 Q0 28599981 553 31.081715 imi_mug_run_2_treatment "kinase inhibitor" "drug" "vemurafenib"
1 Q0 27020391 554 31.081062 imi_mug_run_2_treatment "aim"
1 Q0 27147251 555 31.081041 imi_mug_run_2_treatment "aim"
1 Q0 26058727 556 31.053524 imi_mug_run_2_treatment "braf inhibitor"
1 Q0 22350184 557 31.049328 imi_mug_run_2_treatment "dacarbazine" "ipilimumab" "drug"
1 Q0 25056119 558 31.043373 imi_mug_run_2_treatment "vemurafenib" "dabrafenib" "mediated"
1 Q0 25873166 559 31.02558 imi_mug_run_2_treatment "braf inhibitor" "matrix"
1 Q0 23273605 560 31.024075 imi_mug_run_2_treatment "vemurafenib"
1 Q0 27429963 561 31.016453 imi_mug_run_2_treatment "arsenal" "vemurafenib" "dabrafenib"
1 Q0 25627962 562 31.015972 imi_mug_run_2_treatment "vemurafenib"
1 Q0 26828826 563 31.00504 imi_mug_run_2_treatment "mek inhibitor" "pd0325901" "basis"
1 Q0 30468696 564 30.975033 imi_mug_run_2_treatment "binimetinib" "encorafenib" "mek inhibitor"
1 Q0 14708620 565 30.963758 imi_mug_run_2_treatment "various"
1 Q0 24352115 566 30.953743 imi_mug_run_2_treatment "vemurafenib" "braf inhibitor" "dabrafenib"
1 Q0 23658295 567 30.952814 imi_mug_run_2_treatment "drugs"
1 Q0 29590606 568 30.941898 imi_mug_run_2_treatment "drug" "experimental drug" "favor"
1 Q0 27382311 569 30.928356 imi_mug_run_2_treatment "vemurafenib" "agent" "cobimetinib"
1 Q0 24114495 570 30.922504 imi_mug_run_2_treatment "vemurafenib" "drug" "ipilimumab"
1 Q0 18679422 571 30.920456 imi_mug_run_2_treatment "mediated"
1 Q0 29387237 572 30.919155 imi_mug_run_2_treatment "aim"
1 Q0 30231333 573 30.91769 imi_mug_run_2_treatment "combinations" "nivolumab" "agonists"
1 Q0 29210065 574 30.911629 imi_mug_run_2_treatment "panobinostat" "histone deacetylase inhibitor" "mapk inhibitors"
1 Q0 28263969 575 30.901121 imi_mug_run_2_treatment "drug" "level" "vemurafenib"
1 Q0 25357015 576 30.89302 imi_mug_run_2_treatment "various"
1 Q0 29045061 577 30.89257 imi_mug_run_2_treatment "therapeutic agents"
1 Q0 22614711 578 30.884945 imi_mug_run_2_treatment "aim"
1 Q0 29356790 579 30.88352 imi_mug_run_2_treatment "dabrafenib" "trametinib" "vemurafenib"
1 Q0 29547721 580 30.87365 imi_mug_run_2_treatment "vitamins" "sulfate" "chondroitin"
1 Q0 17507627 581 30.857197 imi_mug_run_2_treatment "basis"
1 Q0 17018604 582 30.844303 imi_mug_run_2_treatment "ras" "cyclic amp" "balance"
1 Q0 26353041 583 30.835506 imi_mug_run_2_treatment "various" "ipilimumab" "trametinib"
1 Q0 30046005 584 30.835506 imi_mug_run_2_treatment "mediated"
1 Q0 18794803 585 30.834341 imi_mug_run_2_treatment "sorafenib" "mediated"
1 Q0 25933211 586 30.825409 imi_mug_run_2_treatment "vemurafenib" "plasma" "level"
1 Q0 30040088 587 30.811646 imi_mug_run_2_treatment "agent"
1 Q0 22744255 588 30.81015 imi_mug_run_2_treatment "braf inhibitor gsk2118436" "braf inhibitor"
1 Q0 16098042 589 30.804377 imi_mug_run_2_treatment "ras"
1 Q0 24474376 590 30.790573 imi_mug_run_2_treatment "vemurafenib" "medication" "enzyme inhibitor"
1 Q0 23306915 591 30.78587 imi_mug_run_2_treatment "dacarbazine" "ipilimumab" "cytokines"
1 Q0 30428063 592 30.777027 imi_mug_run_2_treatment "paclitaxel" "trametinib" "pazopanib"
1 Q0 29215399 593 30.77478 imi_mug_run_2_treatment "trametinib" "dabrafenib" "liver"
1 Q0 25442471 594 30.774353 imi_mug_run_2_treatment "duration" "vemurafenib" "dabrafenib"
1 Q0 22945644 595 30.76844 imi_mug_run_2_treatment "mediators" "duration" "vemurafenib"
1 Q0 23992377 596 30.764593 imi_mug_run_2_treatment "protein kinase inhibitors" "dacarbazine" "drugs"
1 Q0 29180872 597 30.763542 imi_mug_run_2_treatment "agent" "mitogen"
1 Q0 26852222 598 30.75679 imi_mug_run_2_treatment "braf inhibitor" "aim"
1 Q0 30264293 599 30.755697 imi_mug_run_2_treatment "e6201"
1 Q0 23413975 600 30.753592 imi_mug_run_2_treatment "mek inhibitor"
1 Q0 22112480 601 30.75323 imi_mug_run_2_treatment "mitogen"
1 Q0 26815318 602 30.74295 imi_mug_run_2_treatment "chondroitin sulphate"
1 Q0 23499336 603 30.740547 imi_mug_run_2_treatment "lead"
1 Q0 15140228 604 30.737812 imi_mug_run_2_treatment "tandem" "ras"
1 Q0 25399552 605 30.737782 imi_mug_run_2_treatment "dacarbazine" "drug" "nivolumab"
1 Q0 30220966 606 30.734066 imi_mug_run_2_treatment "plasma" "program" "level"
1 Q0 25349308 607 30.73333 imi_mug_run_2_treatment "vemurafenib" "at13387" "combinations"
1 Q0 26828592 608 30.730404 imi_mug_run_2_treatment "plx-4032" "vemurafenib" "mitogen"
1 Q0 24946815 609 30.723574 imi_mug_run_2_treatment "vemurafenib" "mediated" "ras"
1 Q0 18985043 610 30.721094 imi_mug_run_2_treatment "ras" "product"
1 Q0 22020039 611 30.710354 imi_mug_run_2_treatment "ras" "basis"
1 Q0 22085568 612 30.703827 imi_mug_run_2_treatment "ipilimumab" "vemurafenib"
1 Q0 23692905 613 30.703827 imi_mug_run_2_treatment "cytotoxic" "ipilimumab" "vemurafenib"
1 Q0 28503307 614 30.679806 imi_mug_run_2_treatment "braf inhibitor"
1 Q0 24651527 615 30.651016 imi_mug_run_2_treatment "adc" "drug" "drug combinations"
1 Q0 28205616 616 30.638947 imi_mug_run_2_treatment "zalcitabine" "drug" "glucose"
1 Q0 16424035 617 30.637201 imi_mug_run_2_treatment "therapeutics"
1 Q0 26564811 618 30.632008 imi_mug_run_2_treatment "drug" "mediated"
1 Q0 28724377 619 30.628033 imi_mug_run_2_treatment "mek inhibitor" "drugs" "il-12"
1 Q0 28278349 620 30.62379 imi_mug_run_2_treatment "glutamic acid"
1 Q0 30523048 621 30.617105 imi_mug_run_2_treatment "various" "braf inhibitor" "drug"
1 Q0 24446739 622 30.60929 imi_mug_run_2_treatment "kinase inhibitor" "others" "braf inhibitor"
1 Q0 20551065 623 30.608324 imi_mug_run_2_treatment "rg7204" "plx4032"
1 Q0 28216139 624 30.57481 imi_mug_run_2_treatment "level"
1 Q0 30116025 625 30.573608 imi_mug_run_2_treatment "drug" "mek inhibitor" "selumetinib"
1 Q0 25275294 626 30.571854 imi_mug_run_2_treatment "various"
1 Q0 22511720 627 30.567045 imi_mug_run_2_treatment "ras"
1 Q0 26397052 628 30.565449 imi_mug_run_2_treatment "braf inhibitor" "drugs" "ipilimumab"
1 Q0 14695152 629 30.546736 imi_mug_run_2_treatment "ras" "lead"
1 Q0 25993155 630 30.529522 imi_mug_run_2_treatment "agent" "combinations" "trametinib"
1 Q0 28323782 631 30.52916 imi_mug_run_2_treatment "lead"
1 Q0 20576522 632 30.518362 imi_mug_run_2_treatment "plasma"
1 Q0 14679157 633 30.502184 imi_mug_run_2_treatment "ras"
1 Q0 24824730 634 30.500408 imi_mug_run_2_treatment "vemurafenib" "erlotinib" "braf inhibitor"
1 Q0 26175403 635 30.48879 imi_mug_run_2_treatment "vemurafenib" "dabrafenib" "various combinations"
1 Q0 25865802 636 30.488647 imi_mug_run_2_treatment "aim"
1 Q0 24966667 637 30.470787 imi_mug_run_2_treatment "vemurafenib" "braf inhibitor"
1 Q0 28614138 638 30.470787 imi_mug_run_2_treatment "vemurafenib" "pembrolizumab" "braf inhibitor"
1 Q0 30429474 639 30.466526 imi_mug_run_2_treatment "resveratrol" "agonists" "program"
1 Q0 26244818 640 30.463009 imi_mug_run_2_treatment "dacarbazine" "drugs" "mediated"
1 Q0 27864876 641 30.461937 imi_mug_run_2_treatment "various"
1 Q0 28738051 642 30.439241 imi_mug_run_2_treatment "mek inhibitor" "drug" "lead"
1 Q0 30192303 643 30.433495 imi_mug_run_2_treatment "vemurafenib" "braf inhibitor"
1 Q0 25165098 644 30.432007 imi_mug_run_2_treatment "liver"
1 Q0 19880519 645 30.429829 imi_mug_run_2_treatment "agent"
1 Q0 23812671 646 30.425362 imi_mug_run_2_treatment "vemurafenib" "cytotoxic" "vemurafenib's"
1 Q0 26458607 647 30.414833 imi_mug_run_2_treatment "vemurafenib" "liver"
1 Q0 30489553 648 30.412426 imi_mug_run_2_treatment "trametinib" "mitogen" "braf inhibitor"
1 Q0 27200295 649 30.410208 imi_mug_run_2_treatment "favoring"
1 Q0 26857260 650 30.387539 imi_mug_run_2_treatment "vemurafenib" "drugs" "vemurafenib's"
1 Q0 28067895 651 30.358429 imi_mug_run_2_treatment "ras"
1 Q0 26096022 652 30.351894 imi_mug_run_2_treatment "braf inhibitor" "genesis"
1 Q0 22594895 653 30.35111 imi_mug_run_2_treatment "various" "agent"
1 Q0 23463675 654 30.348148 imi_mug_run_2_treatment "hot spot" "aim"
1 Q0 23399605 655 30.34231 imi_mug_run_2_treatment "drugs"
1 Q0 23975010 656 30.34168 imi_mug_run_2_treatment "various" "ras" "mek inhibitor"
1 Q0 26447389 657 30.338062 imi_mug_run_2_treatment "braf inhibitor" "vemurafenib" "dabrafenib"
1 Q0 22333219 658 30.335638 imi_mug_run_2_treatment "pegylated interferon alpha-2b" "ipilimumab" "vemurafenib"
1 Q0 20529342 659 30.335333 imi_mug_run_2_treatment "mta" "drug" "ras"
1 Q0 22217739 660 30.334044 imi_mug_run_2_treatment "various" "new drugs" "vemurafenib"
1 Q0 22453013 661 30.333488 imi_mug_run_2_treatment "combinations"
1 Q0 23709751 662 30.329731 imi_mug_run_2_treatment "combinations" "drugs" "ipilimumab"
1 Q0 26586345 663 30.32658 imi_mug_run_2_treatment "braf inhibitor" "encorafenib"
1 Q0 26440571 664 30.324982 imi_mug_run_2_treatment "mek inhibitor" "trametinib" "vemurafenib"
1 Q0 27188223 665 30.324158 imi_mug_run_2_treatment "com" "new drugs" "trametinib"
1 Q0 25841455 666 30.32169 imi_mug_run_2_treatment "ras"
1 Q0 25952101 667 30.31753 imi_mug_run_2_treatment "aim"
1 Q0 24451790 668 30.312368 imi_mug_run_2_treatment "ipilimumab" "vemurafenib" "braf inhibitor"
1 Q0 26279295 669 30.308903 imi_mug_run_2_treatment "enzymes" "drugs" "plx4032"
1 Q0 16193861 670 30.305838 imi_mug_run_2_treatment "medicine" "ras" "lead"
1 Q0 24133630 671 30.305569 imi_mug_run_2_treatment "vemurafenib" "monolayer" "braf inhibitor"
1 Q0 20425073 672 30.29504 imi_mug_run_2_treatment "plx4032" "rg7204"
1 Q0 26977879 673 30.29504 imi_mug_run_2_treatment "drug" "protease inhibitor" "nelfinavir"
1 Q0 29114545 674 30.288078 imi_mug_run_2_treatment "drug" "mapk inhibitors" "serine"
1 Q0 27052162 675 30.280537 imi_mug_run_2_treatment "type i interferons" "mediated"
1 Q0 22281684 676 30.271465 imi_mug_run_2_treatment "drug" "plx4032" "drugs"
1 Q0 25243790 677 30.252985 imi_mug_run_2_treatment "various" "egfr inhibitor" "braf inhibitor"
1 Q0 25502142 678 30.247196 imi_mug_run_2_treatment "drug" "drugs" "vemurafenib"
1 Q0 24664307 679 30.244312 imi_mug_run_2_treatment "agent" "trametinib" "vemurafenib"
1 Q0 22292133 680 30.231253 imi_mug_run_2_treatment "ras" "serine"
1 Q0 23318787 681 30.228931 imi_mug_run_2_treatment "adjuvant" "therapeutic agents"
1 Q0 21430780 682 30.213013 imi_mug_run_2_treatment "leflunomide" "crest"
1 Q0 28357489 683 30.211441 imi_mug_run_2_treatment "lead"
1 Q0 12591721 684 30.19637 imi_mug_run_2_treatment "ras" "mediated"
1 Q0 26918352 685 30.19637 imi_mug_run_2_treatment "vemurafenib" "braf inhibitor"
1 Q0 24258972 686 30.194912 imi_mug_run_2_treatment "drugs" "medicine"
1 Q0 29094484 687 30.193703 imi_mug_run_2_treatment "glucose" "mek inhibitor" "braf inhibitor"
1 Q0 24710085 688 30.186367 imi_mug_run_2_treatment "various"
1 Q0 22735384 689 30.166931 imi_mug_run_2_treatment "dacarbazine" "dabrafenib"
1 Q0 25411185 690 30.142323 imi_mug_run_2_treatment "plasma"
1 Q0 25204436 691 30.142323 imi_mug_run_2_treatment "flt" "plx3603" "braf inhibitor"
1 Q0 28217853 692 30.14182 imi_mug_run_2_treatment "formalin"
1 Q0 26171248 693 30.13765 imi_mug_run_2_treatment "dabrafenib" "dacarbazine" "vemurafenib"
1 Q0 27327499 694 30.13765 imi_mug_run_2_treatment "vemurafenib" "drug" "agent"
1 Q0 27655717 695 30.13765 imi_mug_run_2_treatment "combinations" "mapk inhibitors" "prompt"
1 Q0 25705882 696 30.124235 imi_mug_run_2_treatment "braf inhibitor" "basis"
1 Q0 30145328 697 30.124235 imi_mug_run_2_treatment "combinations" "mediated"
1 Q0 23326492 698 30.11809 imi_mug_run_2_treatment "ppa" "vemurafenib" "braf inhibitor"
1 Q0 29754815 699 30.10794 imi_mug_run_2_treatment "drug" "vorinostat" "histone deacetylase inhibitor"
1 Q0 28994264 700 30.084349 imi_mug_run_2_treatment "duration"
1 Q0 23321925 701 30.083889 imi_mug_run_2_treatment "vemurafenib"
1 Q0 26876618 702 30.074959 imi_mug_run_2_treatment "drug" "sorafenib" "cytotoxic"
1 Q0 23319765 703 30.073383 imi_mug_run_2_treatment "combinations" "ras" "vemurafenib"
1 Q0 24812131 704 30.066704 imi_mug_run_2_treatment "trametinib" "dabrafenib"
1 Q0 20357817 705 30.063574 imi_mug_run_2_treatment "lead"
1 Q0 30299387 706 30.061867 imi_mug_run_2_treatment "aim"
1 Q0 25939769 707 30.055328 imi_mug_run_2_treatment "plx4032" "vemurafenib" "therapeutics"
1 Q0 22293660 708 30.042282 imi_mug_run_2_treatment "selumetinib" "azd6244" "ras"
1 Q0 23204132 709 30.029049 imi_mug_run_2_treatment "braf inhibitor" "mediated"
1 Q0 26569587 710 30.016666 imi_mug_run_2_treatment "vemurafenib" "nrg" "braf inhibitor"
1 Q0 29048432 711 30.007513 imi_mug_run_2_treatment "drug" "mediators" "kinase inhibitor"
1 Q0 27124486 712 30.007172 imi_mug_run_2_treatment "trametinib" "dabrafenib" "braf inhibitor"
1 Q0 22091682 713 30.001606 imi_mug_run_2_treatment "ipilimumab" "vemurafenib" "blockade"
1 Q0 23908690 714 29.997927 imi_mug_run_2_treatment "mek inhibitor" "mediated" "u0126"
1 Q0 26419469 715 29.996037 imi_mug_run_2_treatment "vemurafenib" "dabrafenib" "braf inhibitor"
1 Q0 21981139 716 29.996037 imi_mug_run_2_treatment "therapeutics" "drugs" "therapeutic agents"
1 Q0 23211290 717 29.964195 imi_mug_run_2_treatment "melan-a"
1 Q0 16964379 718 29.963009 imi_mug_run_2_treatment "mediated" "glutamic acid" "mediators"
1 Q0 29558679 719 29.959835 imi_mug_run_2_treatment "drug" "mediated" "vemurafenib"
1 Q0 19788535 720 29.951502 imi_mug_run_2_treatment "basis"
1 Q0 30089785 721 29.951502 imi_mug_run_2_treatment "mediated" "animals"
1 Q0 26396549 722 29.947493 imi_mug_run_2_treatment "mitogen" "others"
1 Q0 23116250 723 29.939144 imi_mug_run_2_treatment "vemurafenib" "drug" "dacarbazine"
1 Q0 25600339 724 29.929253 imi_mug_run_2_treatment "agent" "braf inhibitor"
1 Q0 25619724 725 29.923677 imi_mug_run_2_treatment "ras" "combinations" "mediated"
1 Q0 30376465 726 29.909168 imi_mug_run_2_treatment "trametinib" "vemurafenib" "anticonvulsants"
1 Q0 23246082 727 29.899363 imi_mug_run_2_treatment "ras"
1 Q0 28612614 728 29.882626 imi_mug_run_2_treatment "various" "drugs" "aim"
1 Q0 22261672 729 29.880644 imi_mug_run_2_treatment "drugs"
1 Q0 22743761 730 29.878628 imi_mug_run_2_treatment "vemurafenib" "ipilimumab" "imatinib"
1 Q0 22826788 731 29.875895 imi_mug_run_2_treatment "vemurafenib" "kinase inhibitor" "dacarbazine"
1 Q0 29559732 732 29.870573 imi_mug_run_2_treatment "ras"
1 Q0 21430779 733 29.868298 imi_mug_run_2_treatment "lysine" "genesis"
1 Q0 22997239 734 29.861347 imi_mug_run_2_treatment "kinase inhibitor" "mek inhibitor" "mediated"
1 Q0 24903021 735 29.849424 imi_mug_run_2_treatment "blockade" "immunosuppressive" "cytokines"
1 Q0 25542447 736 29.849318 imi_mug_run_2_treatment "braf inhibitor" "drug" "mediated"
1 Q0 26168233 737 29.828903 imi_mug_run_2_treatment "collagen" "braf inhibitor"
1 Q0 23694694 738 29.828903 imi_mug_run_2_treatment "aim"
1 Q0 23581649 739 29.819448 imi_mug_run_2_treatment "vemurafenib" "braf inhibitor"
1 Q0 20140953 740 29.812159 imi_mug_run_2_treatment "interferon" "formalin"
1 Q0 23528057 741 29.807655 imi_mug_run_2_treatment "aim"
1 Q0 26095797 742 29.807243 imi_mug_run_2_treatment "plasma"
1 Q0 22608338 743 29.794262 imi_mug_run_2_treatment "dabrafenib" "basis"
1 Q0 24971022 744 29.767715 imi_mug_run_2_treatment "drugs" "prompt" "monoclonal antibodies"
1 Q0 23460959 745 29.7673 imi_mug_run_2_treatment "drugs" "vemurafenib" "braf inhibitor"
1 Q0 25980594 746 29.761341 imi_mug_run_2_treatment "vemurafenib"
1 Q0 23603840 747 29.752653 imi_mug_run_2_treatment "basis" "lead" "phosphate"
1 Q0 26414886 748 29.752653 imi_mug_run_2_treatment "kinase inhibitor" "vemurafenib" "dabrafenib"
1 Q0 25174976 749 29.737175 imi_mug_run_2_treatment "silymarin" "silybum marianum"
1 Q0 22406360 750 29.73222 imi_mug_run_2_treatment "insulin-like growth factor 2"
1 Q0 25145549 751 29.73207 imi_mug_run_2_treatment "various" "ipilimumab" "vemurafenib"
1 Q0 25988349 752 29.731525 imi_mug_run_2_treatment "vemurafenib" "dacarbazine" "ipilimumab"
1 Q0 26201960 753 29.7281 imi_mug_run_2_treatment "pd0332991" "kinase inhibitor" "protein kinase inhibitors"
1 Q0 26446943 754 29.720322 imi_mug_run_2_treatment "trametinib" "dabrafenib" "plasma"
1 Q0 25789737 755 29.715296 imi_mug_run_2_treatment "vemurafenib"
1 Q0 24576830 756 29.712448 imi_mug_run_2_treatment "ras" "mek inhibitor" "pd0325901"
1 Q0 23025996 757 29.710917 imi_mug_run_2_treatment "antitumor agents" "salicylamide"
1 Q0 16908931 758 29.704432 imi_mug_run_2_treatment "imatinib"
1 Q0 17260012 759 29.704432 imi_mug_run_2_treatment "various"
1 Q0 19441164 760 29.704432 imi_mug_run_2_treatment "maspin" "level"
1 Q0 20414921 761 29.704432 imi_mug_run_2_treatment "cytotoxic" "ras" "therapeutics"
1 Q0 26112748 762 29.699097 imi_mug_run_2_treatment "vemurafenib" "mediated" "blockade"
1 Q0 24342721 763 29.697617 imi_mug_run_2_treatment "various" "ras" "lead"
1 Q0 24490764 764 29.69471 imi_mug_run_2_treatment "mk-2206" "carboplatin" "paclitaxel"
1 Q0 22382362 765 29.694666 imi_mug_run_2_treatment "ipilimumab" "ddc" "vemurafenib"
1 Q0 26977874 766 29.690237 imi_mug_run_2_treatment "protease inhibitor" "drug" "nelfinavir"
1 Q0 23918947 767 29.688396 imi_mug_run_2_treatment "dabrafenib" "gsk2118436" "braf inhibitor"
1 Q0 23020132 768 29.680487 imi_mug_run_2_treatment "dabrafenib" "trametinib" "braf inhibitor"
1 Q0 25746037 769 29.678627 imi_mug_run_2_treatment "vemurafenib" "duration"
1 Q0 27467728 770 29.674646 imi_mug_run_2_treatment "blockade" "braf inhibitor"
1 Q0 19383316 771 29.673393 imi_mug_run_2_treatment "various" "hsp70" "aim"
1 Q0 25501056 772 29.670742 imi_mug_run_2_treatment "vemurafenib" "dacarbazine" "carboplatin"
1 Q0 24238212 773 29.670742 imi_mug_run_2_treatment "ras" "pd0325901"
1 Q0 29271794 774 29.654858 imi_mug_run_2_treatment "braf inhibitor"
1 Q0 27566656 775 29.636406 imi_mug_run_2_treatment "various" "drugs" "fluorophore"
1 Q0 29595366 776 29.634401 imi_mug_run_2_treatment "trametinib" "dabrafenib" "medicines"
1 Q0 27783987 777 29.61998 imi_mug_run_2_treatment "bortezomib" "interferon-alpha" "ixazomib"
1 Q0 29481571 778 29.612791 imi_mug_run_2_treatment "vemurafenib" "tyr" "plx4032"
1 Q0 22351689 779 29.610456 imi_mug_run_2_treatment "raf265"
1 Q0 26753005 780 29.610039 imi_mug_run_2_treatment "combinations" "duration" "therapeutic agents"
1 Q0 27041702 781 29.609142 imi_mug_run_2_treatment "level" "plasma"
1 Q0 27464255 782 29.608578 imi_mug_run_2_treatment "dabrafenib" "blockade" "braf inhibitor"
1 Q0 15005091 783 29.603666 imi_mug_run_2_treatment "lead" "others"
1 Q0 23712190 784 29.59679 imi_mug_run_2_treatment "various" "ras" "mediated"
1 Q0 27903987 785 29.594997 imi_mug_run_2_treatment "cd271" "mapk inhibitors" "palbociclib"
1 Q0 30100999 786 29.594234 imi_mug_run_2_treatment "plx4032" "pf477736" "vemurafenib"
1 Q0 24167759 787 29.579414 imi_mug_run_2_treatment "various" "vemurafenib"
1 Q0 22180178 788 29.57639 imi_mug_run_2_treatment "ras" "nervous system"
1 Q0 27467925 789 29.572721 imi_mug_run_2_treatment "therapeutics"
1 Q0 21349766 790 29.5706 imi_mug_run_2_treatment "mitogen"
1 Q0 25037456 791 29.558506 imi_mug_run_2_treatment "ppa" "agent" "vemurafenib"
1 Q0 18945298 792 29.55037 imi_mug_run_2_treatment "ras" "aim"
1 Q0 24466036 793 29.536118 imi_mug_run_2_treatment "collagen" "caffeic acid phenethyl ester" "matrix"
1 Q0 25370533 794 29.527876 imi_mug_run_2_treatment "blockade"
1 Q0 29505523 795 29.52251 imi_mug_run_2_treatment "mms" "formalin"
1 Q0 21505227 796 29.51898 imi_mug_run_2_treatment "braf inhibitor" "lead" "plx4032"
1 Q0 22553342 797 29.504074 imi_mug_run_2_treatment "antitumor agents" "cytotoxic drugs" "monoclonal antibodies"
1 Q0 26771234 798 29.501865 imi_mug_run_2_treatment "arginine" "braf inhibitor" "mediated"
1 Q0 23549875 799 29.485783 imi_mug_run_2_treatment "mtor inhibitor" "blockade"
1 Q0 19274086 800 29.480188 imi_mug_run_2_treatment "ras" "thr" "mediated"
1 Q0 25350317 801 29.469837 imi_mug_run_2_treatment "retinoid" "drug" "abt-737"
1 Q0 29956724 802 29.463009 imi_mug_run_2_treatment "abt-888" "drug" "veliparib"
1 Q0 23800008 803 29.457008 imi_mug_run_2_treatment "vemurafenib" "dacarbazine" "duration"
1 Q0 27418645 804 29.456835 imi_mug_run_2_treatment "mediated"
1 Q0 27448964 805 29.456787 imi_mug_run_2_treatment "various" "vemurafenib" "braf inhibitor"
1 Q0 28960564 806 29.448093 imi_mug_run_2_treatment "braf inhibitor" "ipilimumab"
1 Q0 18089783 807 29.44764 imi_mug_run_2_treatment "agar" "mek inhibitor"
1 Q0 27403706 808 29.446474 imi_mug_run_2_treatment "ipilimumab" "nivolumab" "adjuvant"
1 Q0 25941608 809 29.444721 imi_mug_run_2_treatment "blockade"
1 Q0 30159130 810 29.444721 imi_mug_run_2_treatment "vemurafenib" "drug" "braf inhibitor"
1 Q0 30175642 811 29.439419 imi_mug_run_2_treatment "aim" "pooled"
1 Q0 28197745 812 29.43406 imi_mug_run_2_treatment "drug combinations" "mek inhibitor"
1 Q0 28221865 813 29.430275 imi_mug_run_2_treatment "nivo" "dacarbazine" "drug"
1 Q0 23051966 814 29.417698 imi_mug_run_2_treatment "dabrafenib" "lipase"
1 Q0 28039443 815 29.414818 imi_mug_run_2_treatment "lead"
1 Q0 24770508 816 29.409655 imi_mug_run_2_treatment "interferon" "drug" "ipilimumab"
1 Q0 26282084 817 29.406654 imi_mug_run_2_treatment "genesis"
1 Q0 24941796 818 29.39932 imi_mug_run_2_treatment "ly294002" "u0126" "mek inhibitor"
1 Q0 16609049 819 29.395332 imi_mug_run_2_treatment "ras"
1 Q0 26452227 820 29.379541 imi_mug_run_2_treatment "vemurafenib" "topical corticosteroid" "braf inhibitor"
1 Q0 27699043 821 29.377098 imi_mug_run_2_treatment "dabrafenib" "trametinib" "vemurafenib"
1 Q0 21478863 822 29.376524 imi_mug_run_2_treatment "enzymes" "ras" "cyclic amp"
1 Q0 28238077 823 29.376524 imi_mug_run_2_treatment "combinations"
1 Q0 23251002 824 29.371239 imi_mug_run_2_treatment "drug" "vemurafenib"
1 Q0 16116595 825 29.35823 imi_mug_run_2_treatment "mlana" "tyr" "magea3"
1 Q0 22594466 826 29.35823 imi_mug_run_2_treatment "dabrafenib" "dacarbazine" "braf inhibitor"
1 Q0 27436149 827 29.35823 imi_mug_run_2_treatment "drug" "vemurafenib" "matrix metalloproteinase inhibitor"
1 Q0 22034865 828 29.34413 imi_mug_run_2_treatment "agent"
1 Q0 24265153 829 29.344017 imi_mug_run_2_treatment "combinations" "vemurafenib" "dabrafenib"
1 Q0 24490176 830 29.344017 imi_mug_run_2_treatment "vemurafenib" "agent" "ipilimumab"
1 Q0 26157547 831 29.343754 imi_mug_run_2_treatment "braf inhibitor" "mediated"
1 Q0 26517521 832 29.328083 imi_mug_run_2_treatment "sorafenib"
1 Q0 26512791 833 29.324097 imi_mug_run_2_treatment "trametinib" "dabrafenib" "corticosteroids"
1 Q0 25000258 834 29.322474 imi_mug_run_2_treatment "canertinib"
1 Q0 24721680 835 29.316116 imi_mug_run_2_treatment "ssm"
1 Q0 24352648 836 29.30614 imi_mug_run_2_treatment "ras" "basis"
1 Q0 24812408 837 29.303532 imi_mug_run_2_treatment "vemurafenib" "drug" "cytokines"
1 Q0 25615552 838 29.303532 imi_mug_run_2_treatment "vemurafenib" "braf inhibitor"
1 Q0 30169430 839 29.303532 imi_mug_run_2_treatment "corticosteroids" "binimetinib" "encorafenib"
1 Q0 26206099 840 29.292765 imi_mug_run_2_treatment "basis" "aim"
1 Q0 29214089 841 29.281286 imi_mug_run_2_treatment "liver"
1 Q0 27788045 842 29.274895 imi_mug_run_2_treatment "drugs" "ras"
1 Q0 26381028 843 29.255983 imi_mug_run_2_treatment "drug" "vemurafenib" "dabrafenib"
1 Q0 27219630 844 29.25306 imi_mug_run_2_treatment "cobimetinib" "combinations" "vemurafenib"
1 Q0 24610826 845 29.249825 imi_mug_run_2_treatment "drugs" "lead"
1 Q0 25956405 846 29.248508 imi_mug_run_2_treatment "vemurafenib"
1 Q0 26347206 847 29.244457 imi_mug_run_2_treatment "dabrafenib" "favor" "braf inhibitor"
1 Q0 12447372 848 29.243984 imi_mug_run_2_treatment "ras"
1 Q0 25690538 849 29.231853 imi_mug_run_2_treatment "vemurafenib" "dabrafenib"
1 Q0 24720363 850 29.230104 imi_mug_run_2_treatment "gold"
1 Q0 28882690 851 29.228157 imi_mug_run_2_treatment "curcumin" "iron" "sodium"
1 Q0 26970965 852 29.203548 imi_mug_run_2_treatment "mek inhibitor"
1 Q0 22216021 853 29.202229 imi_mug_run_2_treatment "drug" "drugs" "cytotoxic"
1 Q0 21169256 854 29.19136 imi_mug_run_2_treatment "plx4032" "kinase inhibitor" "rg7204"
1 Q0 21244632 855 29.1821 imi_mug_run_2_treatment "kinase inhibitor" "drugs" "imatinib"
1 Q0 30457212 856 29.175098 imi_mug_run_2_treatment "mitogen"
1 Q0 24604154 857 29.174778 imi_mug_run_2_treatment "vemurafenib"
1 Q0 22194965 858 29.168072 imi_mug_run_2_treatment "vemurafenib" "combinations" "drugs"
1 Q0 21554046 859 29.165894 imi_mug_run_2_treatment "mercaptopurine" "thiopurine"
1 Q0 27835901 860 29.165894 imi_mug_run_2_treatment "drug" "vemurafenib" "braf inhibitor"
1 Q0 23795354 861 29.162277 imi_mug_run_2_treatment "aim"
1 Q0 24567366 862 29.154919 imi_mug_run_2_treatment "docetaxel" "selumetinib" "basis"
1 Q0 30521084 863 29.144152 imi_mug_run_2_treatment "trametinib" "dabrafenib"
1 Q0 30234146 864 29.14336 imi_mug_run_2_treatment "braf inhibitor"
1 Q0 28452072 865 29.141691 imi_mug_run_2_treatment "antioxidant" "aim"
1 Q0 15046639 866 29.141335 imi_mug_run_2_treatment "ras" "glutamic acid"
1 Q0 29413908 867 29.141335 imi_mug_run_2_treatment "drug combinations" "survives"
1 Q0 29464063 868 29.138073 imi_mug_run_2_treatment "flavopiridol" "quisinostat" "pdx"
1 Q0 24463458 869 29.13802 imi_mug_run_2_treatment "braf inhibitor" "drugs" "vemurafenib"
1 Q0 29285235 870 29.134083 imi_mug_run_2_treatment "benzbromarone" "vemurafenib" "braf inhibitor"
1 Q0 24596183 871 29.131363 imi_mug_run_2_treatment "trametinib" "dabrafenib"
1 Q0 24458518 872 29.130348 imi_mug_run_2_treatment "hot spot"
1 Q0 22433222 873 29.130348 imi_mug_run_2_treatment "ras"
1 Q0 23994118 874 29.12873 imi_mug_run_2_treatment "braf inhibitor" "vemurafenib"
1 Q0 24283590 875 29.126774 imi_mug_run_2_treatment "drug" "plx8394"
1 Q0 24563339 876 29.122799 imi_mug_run_2_treatment "therapeutics" "hydrogen peroxide" "mouse monoclonal antibody"
1 Q0 26978007 877 29.122799 imi_mug_run_2_treatment "vemurafenib" "abemaciclib" "mediated"
1 Q0 24448821 878 29.120647 imi_mug_run_2_treatment "e6201" "mek inhibitor" "vemurafenib"
1 Q0 27138260 879 29.11903 imi_mug_run_2_treatment "corticosteroids" "intravenous immunoglobulin" "trametinib"
1 Q0 28893027 880 29.11903 imi_mug_run_2_treatment "vemurafenib" "dabrafenib" "trametinib"
1 Q0 19473026 881 29.116796 imi_mug_run_2_treatment "various" "serine" "ras"
1 Q0 25839886 882 29.112415 imi_mug_run_2_treatment "dabrafenib" "interleukin-2" "braf inhibitor"
1 Q0 27759578 883 29.112415 imi_mug_run_2_treatment "vemurafenib" "dabrafenib" "others"
1 Q0 28487464 884 29.104008 imi_mug_run_2_treatment "lead" "basis"
1 Q0 23376011 885 29.098637 imi_mug_run_2_treatment "imidazole" "imidazoles" "ras"
1 Q0 28089569 886 29.078922 imi_mug_run_2_treatment "hypolipidemic agents" "basis"
1 Q0 18032947 887 29.0779 imi_mug_run_2_treatment "various"
1 Q0 27776007 888 29.0779 imi_mug_run_2_treatment "basis"
1 Q0 21802280 889 29.074553 imi_mug_run_2_treatment "various" "combinations" "immunomodulators"
1 Q0 15363539 890 29.06906 imi_mug_run_2_treatment "ras"
1 Q0 18473997 891 29.057375 imi_mug_run_2_treatment "ras" "glycine" "sorafenib"
1 Q0 27572607 892 29.0386 imi_mug_run_2_treatment "dabrafenib" "drug" "bevacizumab"
1 Q0 29177235 893 29.011835 imi_mug_run_2_treatment "ipilimumab"
1 Q0 15060100 894 28.996885 imi_mug_run_2_treatment "genesis"
1 Q0 24955706 895 28.996885 imi_mug_run_2_treatment "various" "agent" "vemurafenib"
1 Q0 26483610 896 28.996246 imi_mug_run_2_treatment "experimental drug"
1 Q0 23251089 897 28.991932 imi_mug_run_2_treatment "dabrafenib" "combinations" "dacarbazine"
1 Q0 29466692 898 28.980602 imi_mug_run_2_treatment "monoclonal antibodies" "ipilimumab"
1 Q0 29487283 899 28.97831 imi_mug_run_2_treatment "mapk inhibitors" "antioxidant" "cystine"
1 Q0 24882974 900 28.977596 imi_mug_run_2_treatment "ras"
1 Q0 23189245 901 28.968554 imi_mug_run_2_treatment "braf inhibitor"
1 Q0 22767597 902 28.959927 imi_mug_run_2_treatment "vemurafenib" "drug" "drugs"
1 Q0 28858076 903 28.957455 imi_mug_run_2_treatment "level"
1 Q0 23770856 904 28.938393 imi_mug_run_2_treatment "mediated" "mek inhibitor" "braf inhibitor"
1 Q0 25037139 905 28.925797 imi_mug_run_2_treatment "braf inhibitor" "vemurafenib" "cobimetinib"
1 Q0 30471144 906 28.92384 imi_mug_run_2_treatment "mediated" "tyr" "suppressor"
1 Q0 24502370 907 28.905544 imi_mug_run_2_treatment "various" "protein kinase inhibitors" "combinations"
1 Q0 26016850 908 28.903416 imi_mug_run_2_treatment "combinations" "mediators" "ipilimumab"
1 Q0 27194447 909 28.902765 imi_mug_run_2_treatment "plasma"
1 Q0 27145091 910 28.893415 imi_mug_run_2_treatment "ptc"
1 Q0 28543695 911 28.882679 imi_mug_run_2_treatment "lead"
1 Q0 23860532 912 28.881618 imi_mug_run_2_treatment "isolate" "aim"
1 Q0 16170021 913 28.879662 imi_mug_run_2_treatment "u0126"
1 Q0 24434634 914 28.851635 imi_mug_run_2_treatment "ipilimumab" "mek inhibitor"
1 Q0 25725450 915 28.851635 imi_mug_run_2_treatment "vemurafenib" "drug" "cd271"
1 Q0 27572939 916 28.851635 imi_mug_run_2_treatment "gant61" "drug" "obatoclax"
1 Q0 24108467 917 28.848251 imi_mug_run_2_treatment "vemurafenib" "braf inhibitor"
1 Q0 26844986 918 28.848202 imi_mug_run_2_treatment "mediators"
1 Q0 25562798 919 28.845701 imi_mug_run_2_treatment "vemurafenib" "therapeutics" "dacarbazine"
1 Q0 25673642 920 28.84242 imi_mug_run_2_treatment "dabrafenib" "braf inhibitor"
1 Q0 28277830 921 28.840092 imi_mug_run_2_treatment "masitinib" "binimetinib" "mek inhibitor"
1 Q0 25654738 922 28.83104 imi_mug_run_2_treatment "combinations" "basis" "favor"
1 Q0 22880048 923 28.83104 imi_mug_run_2_treatment "therapeutic agents" "mek inhibitor" "braf inhibitor"
1 Q0 23579338 924 28.815731 imi_mug_run_2_treatment "vemurafenib" "braf inhibitor"
1 Q0 22432863 925 28.793463 imi_mug_run_2_treatment "drugs" "ipilimumab" "vemurafenib"
1 Q0 27137746 926 28.793463 imi_mug_run_2_treatment "combinations" "drugs" "therapeutics"
1 Q0 20716222 927 28.789495 imi_mug_run_2_treatment "various" "mercaptopurine" "thiopurines"
1 Q0 23362874 928 28.782774 imi_mug_run_2_treatment "ras"
1 Q0 29161237 929 28.780151 imi_mug_run_2_treatment "trametinib" "dabrafenib" "braf inhibitor"
1 Q0 23594689 930 28.77967 imi_mug_run_2_treatment "various"
1 Q0 25806780 931 28.778809 imi_mug_run_2_treatment "temozolomide" "cytotoxic" "braf inhibitor"
1 Q0 26200476 932 28.768818 imi_mug_run_2_treatment "braf inhibitor" "dabrafenib" "vemurafenib"
1 Q0 26924126 933 28.767523 imi_mug_run_2_treatment "basis" "balance"
1 Q0 28963614 934 28.757263 imi_mug_run_2_treatment "vemurafenib" "level" "aim"
1 Q0 27307593 935 28.754675 imi_mug_run_2_treatment "buparlisib" "antitumor agent" "drugs"
1 Q0 16001072 936 28.748945 imi_mug_run_2_treatment "genesis"
1 Q0 24095280 937 28.739746 imi_mug_run_2_treatment "braf inhibitor"
1 Q0 28767374 938 28.73948 imi_mug_run_2_treatment "drugs" "aim"
1 Q0 28543697 939 28.73446 imi_mug_run_2_treatment "therapeutic agents"
1 Q0 26811525 940 28.734375 imi_mug_run_2_treatment "dabrafenib" "braf inhibitor" "trametinib"
1 Q0 23001925 941 28.721752 imi_mug_run_2_treatment "level"
1 Q0 25333256 942 28.72064 imi_mug_run_2_treatment "vemurafenib" "braf inhibitor"
1 Q0 30325319 943 28.719706 imi_mug_run_2_treatment "various" "ras"
1 Q0 23153455 944 28.716843 imi_mug_run_2_treatment "vemurafenib" "mediated" "abc"
1 Q0 28463413 945 28.707142 imi_mug_run_2_treatment "blockade" "agent" "drugs"
1 Q0 28938534 946 28.69269 imi_mug_run_2_treatment "drugs" "cytotoxic" "mek inhibitor"
1 Q0 24649552 947 28.683565 imi_mug_run_2_treatment "new drugs"
1 Q0 24969466 948 28.681515 imi_mug_run_2_treatment "plasma" "medicine" "vemurafenib"
1 Q0 26101714 949 28.679596 imi_mug_run_2_treatment "vemurafenib" "mek inhibitor" "drug combinations"
1 Q0 27341594 950 28.665514 imi_mug_run_2_treatment "directed" "braf inhibitor"
1 Q0 22394203 951 28.663843 imi_mug_run_2_treatment "various" "sorafenib" "drug"
1 Q0 23645591 952 28.659431 imi_mug_run_2_treatment "mapk inhibitors" "drug" "drugs"
1 Q0 21692705 953 28.654757 imi_mug_run_2_treatment "melanoma vaccines" "melanoma vaccine"
1 Q0 29227333 954 28.653633 imi_mug_run_2_treatment "plasma" "level" "monoclonal antibodies"
1 Q0 30238891 955 28.65313 imi_mug_run_2_treatment "protein kinase inhibitors" "serine"
1 Q0 25618774 956 28.649141 imi_mug_run_2_treatment "glucose"
1 Q0 16457759 957 28.635704 imi_mug_run_2_treatment "lead"
1 Q0 27164828 958 28.634375 imi_mug_run_2_treatment "combinations" "adjuvant" "mek inhibitor"
1 Q0 21206909 959 28.625345 imi_mug_run_2_treatment "sorafenib" "duration" "braf inhibitor"
1 Q0 29309612 960 28.618046 imi_mug_run_2_treatment "nicotinamide" "anabolic" "oxygen"
1 Q0 27541170 961 28.613676 imi_mug_run_2_treatment "protein kinase inhibitor"
1 Q0 25971842 962 28.607952 imi_mug_run_2_treatment "vemurafenib" "mediated" "ras"
1 Q0 29843107 963 28.600975 imi_mug_run_2_treatment "ipilimumab" "blockade" "nivolumab"
1 Q0 28242136 964 28.586979 imi_mug_run_2_treatment "trametinib" "dabrafenib" "drugs"
1 Q0 29417221 965 28.579567 imi_mug_run_2_treatment "aim"
1 Q0 27461037 966 28.571266 imi_mug_run_2_treatment "combinations" "drugs" "mapk inhibitors"
1 Q0 28224120 967 28.571266 imi_mug_run_2_treatment "interferon" "kinase inhibitor" "ipilimumab"
1 Q0 21188111 968 28.562431 imi_mug_run_2_treatment "adjuvant" "interferon alpha-2b" "interleukin-2"
1 Q0 26993606 969 28.562431 imi_mug_run_2_treatment "ras" "tma"
1 Q0 28445541 970 28.555458 imi_mug_run_2_treatment "ras"
1 Q0 26619946 971 28.54153 imi_mug_run_2_treatment "various" "combinations" "trametinib"
1 Q0 27115320 972 28.538761 imi_mug_run_2_treatment "pembrolizumab" "ipilimumab"
1 Q0 29880484 973 28.534199 imi_mug_run_2_treatment "mediated" "braf inhibitor" "rigosertib"
1 Q0 22171948 974 28.52503 imi_mug_run_2_treatment "ras" "lead" "px-866"
1 Q0 28557366 975 28.487785 imi_mug_run_2_treatment "braf inhibitor" "vemurafenib"
1 Q0 22535842 976 28.482653 imi_mug_run_2_treatment "various" "mediated" "mapk inhibitors"
1 Q0 27911979 977 28.48134 imi_mug_run_2_treatment "braf inhibitor" "ipilimumab"
1 Q0 22131348 978 28.479591 imi_mug_run_2_treatment "drug"
1 Q0 28130756 979 28.470734 imi_mug_run_2_treatment "asa" "formalin"
1 Q0 28744830 980 28.455982 imi_mug_run_2_treatment "dabrafenib" "drug" "drugs"
1 Q0 28811486 981 28.42558 imi_mug_run_2_treatment "drugs" "vemurafenib" "braf inhibitor"
1 Q0 19233913 982 28.42266 imi_mug_run_2_treatment "magea3" "mlana" "isolate"
1 Q0 24735930 983 28.398184 imi_mug_run_2_treatment "dabrafenib" "mapk inhibitors" "trametinib"
1 Q0 25329694 984 28.391611 imi_mug_run_2_treatment "ras" "vemurafenib" "braf inhibitor"
1 Q0 29195116 985 28.3874 imi_mug_run_2_treatment "braf inhibitor"
1 Q0 18559533 986 28.38642 imi_mug_run_2_treatment "drug" "therapeutics" "lead"
1 Q0 27648299 987 28.376337 imi_mug_run_2_treatment "braf inhibitor"
1 Q0 23928771 988 28.368546 imi_mug_run_2_treatment "vemurafenib" "braf inhibitor"
1 Q0 26299806 989 28.366688 imi_mug_run_2_treatment "sorafenib" "lead" "blockade"
1 Q0 29552321 990 28.36562 imi_mug_run_2_treatment "vemurafenib" "fotemustine" "agent"
1 Q0 17873516 991 28.360138 imi_mug_run_2_treatment "interferon alpha" "mediated" "bay 43-9006"
1 Q0 23444215 992 28.358059 imi_mug_run_2_treatment "selumetinib" "mek inhibitor" "arry-142886"
1 Q0 26601858 993 28.351315 imi_mug_run_2_treatment "various" "food"
1 Q0 18300768 994 28.348358 imi_mug_run_2_treatment "kinase inhibitor" "therapeutics" "agent"
1 Q0 15837158 995 28.34812 imi_mug_run_2_treatment "interferon" "imidazole" "dacarbazine"
1 Q0 19383313 996 28.338036 imi_mug_run_2_treatment "ras"
1 Q0 27401151 997 28.310947 imi_mug_run_2_treatment "trametinib" "dabrafenib"
1 Q0 25810704 998 28.294752 imi_mug_run_2_treatment "dabrafenib" "vemurafenib"
1 Q0 24858900 999 28.293648 imi_mug_run_2_treatment "calcitonin" "plasma" "ptc"
2 Q0 25435907 1 44.156013 imi_mug_run_2_treatment "medicine" "trametinib" "icc"
2 Q0 27627051 2 42.323418 imi_mug_run_2_treatment "icc" "aim"
2 Q0 23844038 3 38.59812 imi_mug_run_2_treatment "dabrafenib" "braf inhibitor" "mek inhibitor"
2 Q0 28480077 4 38.1146 imi_mug_run_2_treatment "dabrafenib" "drug" "trametinib"
2 Q0 24372748 5 34.551327 imi_mug_run_2_treatment "aim"
2 Q0 24122810 6 34.28331 imi_mug_run_2_treatment "pd173074" "lead"
2 Q0 30124336 7 34.16383 imi_mug_run_2_treatment "drugs"
2 Q0 26500333 8 34.160103 imi_mug_run_2_treatment "lead" "aim"
2 Q0 26189129 9 32.07133 imi_mug_run_2_treatment "various" "icc"
2 Q0 28975832 10 30.900675 imi_mug_run_2_treatment "adjuvant" "gemcitabine" "oxaliplatin"
2 Q0 23391413 11 30.497604 imi_mug_run_2_treatment "formalin"
2 Q0 22178589 12 29.530449 imi_mug_run_2_treatment "trastuzumab" "lapatinib" "cytokines"
2 Q0 12692057 13 29.415985 imi_mug_run_2_treatment "ras" "aim" "liver"
2 Q0 28078132 14 28.868744 imi_mug_run_2_treatment "icc" "trametinib" "duration"
2 Q0 29698701 15 26.877817 imi_mug_run_2_treatment "icc"
2 Q0 23295441 16 26.814152 imi_mug_run_2_treatment "icc" "ras" "cytokines"
2 Q0 26287849 17 25.477306 imi_mug_run_2_treatment "various" "vemurafenib" "cetuximab"
2 Q0 26405193 18 25.024815 imi_mug_run_2_treatment "level"
2 Q0 27823638 19 24.76492 imi_mug_run_2_treatment "various" "ras" "therapeutic agents"
2 Q0 24146220 20 24.06709 imi_mug_run_2_treatment "gemcitabine" "irinotecan" "panitumumab"
2 Q0 25608663 21 22.710453 imi_mug_run_2_treatment "lead"
2 Q0 24889489 22 21.32241 imi_mug_run_2_treatment "icc"
2 Q0 27102149 23 21.32241 imi_mug_run_2_treatment "icc" "cisplatin" "gemcitabine"
2 Q0 29460642 24 19.975279 imi_mug_run_2_treatment "nivolumab"
2 Q0 22180306 25 19.8939 imi_mug_run_2_treatment "product" "liver"
2 Q0 26687137 26 19.101128 imi_mug_run_2_treatment "irinotecan" "panitumumab" "vemurafenib"
2 Q0 24852144 27 16.565369 imi_mug_run_2_treatment "mek inhibitor" "topical corticosteroids" "drugs"
2 Q0 25384085 28 16.508125 imi_mug_run_2_treatment "amp" "basis"
2 Q0 27181912 29 16.504974 imi_mug_run_2_treatment "plasma" "ras"
2 Q0 29893894 30 14.418768 imi_mug_run_2_treatment "gemcitabine" "cisplatin" "s-1"
3 Q0 29568923 1 41.48229 imi_mug_run_2_treatment "androgen"
3 Q0 23272087 2 41.44509 imi_mug_run_2_treatment "androgen"
3 Q0 26336104 3 40.62202 imi_mug_run_2_treatment "casodex" "androgen" "mediated"
3 Q0 15837784 4 40.24021 imi_mug_run_2_treatment "acetate" "generic" "level"
3 Q0 16997395 5 39.662758 imi_mug_run_2_treatment "serine"
3 Q0 23890999 6 39.54966 imi_mug_run_2_treatment "suppressor" "tyrosine"
3 Q0 14522255 7 38.856667 imi_mug_run_2_treatment "androgen"
3 Q0 28182994 8 38.01456 imi_mug_run_2_treatment "parp inhibitor" "olaparib" "kinase inhibitor"
3 Q0 19029835 9 37.551258 imi_mug_run_2_treatment "androgen" "dag-lactone" "acetate"
3 Q0 16896035 10 36.59776 imi_mug_run_2_treatment "enzymes" "androgens"
3 Q0 22290195 11 36.566013 imi_mug_run_2_treatment "various" "androgen" "testosterone"
3 Q0 17085682 12 36.45722 imi_mug_run_2_treatment "ors"
3 Q0 29147215 13 36.368942 imi_mug_run_2_treatment "egcg" "androgen" "epigallocatechin-3-gallate"
3 Q0 15342382 14 36.34838 imi_mug_run_2_treatment "mediated"
3 Q0 19164922 15 36.306057 imi_mug_run_2_treatment "drug" "aurothiomalate" "mediated"
3 Q0 30296942 16 36.123753 imi_mug_run_2_treatment "mediated"
3 Q0 19407851 17 36.095562 imi_mug_run_2_treatment "androgen"
3 Q0 19446741 18 35.99951 imi_mug_run_2_treatment "mediated"
3 Q0 29923647 19 35.98693 imi_mug_run_2_treatment "level"
3 Q0 29845714 20 35.946728 imi_mug_run_2_treatment "kinase inhibitor"
3 Q0 22829980 21 35.866703 imi_mug_run_2_treatment "androgen"
3 Q0 27861151 22 35.827217 imi_mug_run_2_treatment "tma"
3 Q0 8909246 23 35.810474 imi_mug_run_2_treatment "various" "color"
3 Q0 17108217 24 35.538296 imi_mug_run_2_treatment "plasma" "ras"
3 Q0 14983937 25 35.450706 imi_mug_run_2_treatment "level"
3 Q0 22179824 26 35.443665 imi_mug_run_2_treatment "mediated" "lead"
3 Q0 27188668 27 35.385136 imi_mug_run_2_treatment "enzymes" "parp inhibitors" "drugs"
3 Q0 25540025 28 35.232018 imi_mug_run_2_treatment "aim"
3 Q0 17387331 29 35.149506 imi_mug_run_2_treatment "androgens" "testosterone"
3 Q0 25425963 30 35.032043 imi_mug_run_2_treatment "epidermal growth factor"
3 Q0 29057879 31 34.879425 imi_mug_run_2_treatment "androgen" "mediated"
3 Q0 16322300 32 34.845425 imi_mug_run_2_treatment "endostatin"
3 Q0 21874567 33 34.725212 imi_mug_run_2_treatment "angiotensin"
3 Q0 15734999 34 34.647514 imi_mug_run_2_treatment "level"
3 Q0 11059687 35 34.470707 imi_mug_run_2_treatment "various" "beta-galactosidase" "mediated"
3 Q0 20590366 36 34.44561 imi_mug_run_2_treatment "adjuvant"
3 Q0 22566699 37 34.40751 imi_mug_run_2_treatment "aim" "androgen" "mediated"
3 Q0 15805289 38 34.40409 imi_mug_run_2_treatment "drug" "ucn-01"
3 Q0 18314628 39 34.229652 imi_mug_run_2_treatment "various" "tma" "collagen"
3 Q0 28487881 40 34.14291 imi_mug_run_2_treatment "medicine" "platinum"
3 Q0 23636138 41 34.098083 imi_mug_run_2_treatment "androgen"
3 Q0 22761195 42 34.05492 imi_mug_run_2_treatment "androgen"
3 Q0 21903863 43 34.037285 imi_mug_run_2_treatment "glucose" "animals"
3 Q0 29530483 44 33.914497 imi_mug_run_2_treatment "mediated"
3 Q0 8661103 45 33.89331 imi_mug_run_2_treatment "yeast" "liver"
3 Q0 26625310 46 33.841156 imi_mug_run_2_treatment "docetaxel"
3 Q0 28870994 47 33.8144 imi_mug_run_2_treatment "androgen"
3 Q0 9383000 48 33.77589 imi_mug_run_2_treatment "aim"
3 Q0 22561209 49 33.770035 imi_mug_run_2_treatment "ucn-01" "berberine" "alkaloid"
3 Q0 16278679 50 33.72299 imi_mug_run_2_treatment "androgen"
3 Q0 26683224 51 33.628372 imi_mug_run_2_treatment "n-acetylcysteine" "ambroxol" "antioxidant"
3 Q0 22960274 52 33.549004 imi_mug_run_2_treatment "etoposide" "drug"
3 Q0 30278883 53 33.5028 imi_mug_run_2_treatment "parp inhibitors" "taxane" "docetaxel"
3 Q0 10475264 54 33.402157 imi_mug_run_2_treatment "oxygen" "adjuvant" "hyperbaric oxygen"
3 Q0 29386061 55 33.295036 imi_mug_run_2_treatment "cancer drug" "radiosensitizer"
3 Q0 28895177 56 33.267403 imi_mug_run_2_treatment "olaparib" "diphosphate"
3 Q0 27268642 57 33.233707 imi_mug_run_2_treatment "various" "ors" "aim"
3 Q0 27433846 58 33.12591 imi_mug_run_2_treatment "others"
3 Q0 12661032 59 33.123627 imi_mug_run_2_treatment "various"
3 Q0 26210103 60 32.977634 imi_mug_run_2_treatment "androgen" "drugs" "androgens"
3 Q0 10379873 61 32.957916 imi_mug_run_2_treatment "isolate"
3 Q0 18158069 62 32.92014 imi_mug_run_2_treatment "crystal violet"
3 Q0 21134073 63 32.852127 imi_mug_run_2_treatment "curcumin" "testosterone" "isoflavones"
3 Q0 23758150 64 32.812134 imi_mug_run_2_treatment "basis" "animals" "plasma"
3 Q0 22200977 65 32.81045 imi_mug_run_2_treatment "mediated" "mediators"
3 Q0 18528861 66 32.72149 imi_mug_run_2_treatment "mediated"
3 Q0 17219200 67 32.711163 imi_mug_run_2_treatment "oxygen" "mediated"
3 Q0 28712484 68 32.68532 imi_mug_run_2_treatment "platinum" "poly(adp-ribose) polymerase inhibitors"
3 Q0 19549916 69 32.614647 imi_mug_run_2_treatment "tyrosine"
3 Q0 28845385 70 32.525887 imi_mug_run_2_treatment "calcitonin" "adrenomedullin"
3 Q0 11170749 71 32.524353 imi_mug_run_2_treatment "sts"
3 Q0 28323658 72 32.49782 imi_mug_run_2_treatment "medicine" "ipilimumab" "lead"
3 Q0 10440873 73 32.47599 imi_mug_run_2_treatment "phe" "tyr"
3 Q0 9853138 74 32.360886 imi_mug_run_2_treatment "beam"
3 Q0 8718527 75 32.350105 imi_mug_run_2_treatment "mediated"
3 Q0 25571723 76 32.34303 imi_mug_run_2_treatment "interleukin"
3 Q0 24686169 77 32.342903 imi_mug_run_2_treatment "androgen"
3 Q0 29248950 78 32.3319 imi_mug_run_2_treatment "plasma"
3 Q0 17531338 79 32.274208 imi_mug_run_2_treatment "dsb"
3 Q0 29051371 80 32.2211 imi_mug_run_2_treatment "noradrenaline"
3 Q0 27536883 81 32.142525 imi_mug_run_2_treatment "tamoxifen"
3 Q0 23995785 82 32.078987 imi_mug_run_2_treatment "mediated"
3 Q0 21277099 83 31.99516 imi_mug_run_2_treatment "histone deacetylase inhibitor" "plasma" "agent"
3 Q0 17363566 84 31.975716 imi_mug_run_2_treatment "androgen" "mediated"
3 Q0 11156215 85 31.9264 imi_mug_run_2_treatment "p23" "aim"
3 Q0 16849544 86 31.864994 imi_mug_run_2_treatment "androgen"
3 Q0 22832221 87 31.86131 imi_mug_run_2_treatment "kinase inhibitor" "etoposide" "methotrexate"
3 Q0 28602099 88 31.843456 imi_mug_run_2_treatment "zerumbone" "dsb" "methyl methanesulfonate"
3 Q0 21267413 89 31.837564 imi_mug_run_2_treatment "androgen"
3 Q0 7559077 90 31.822605 imi_mug_run_2_treatment "tyr" "tac"
3 Q0 27317574 91 31.815397 imi_mug_run_2_treatment "poly(adp-ribose) polymerase inhibitor" "poly(adp-ribose) polymerase inhibitors" "olaparib"
3 Q0 23846904 92 31.72435 imi_mug_run_2_treatment "lead" "blockade"
3 Q0 26332574 93 31.714123 imi_mug_run_2_treatment "proteases" "mediators" "tissue inhibitor of metalloproteinase 3"
3 Q0 24651496 94 31.695534 imi_mug_run_2_treatment "animals"
3 Q0 22880034 95 31.667759 imi_mug_run_2_treatment "therapeutics" "isolating"
3 Q0 30009504 96 31.636297 imi_mug_run_2_treatment "amino acid" "androgens"
3 Q0 11597138 97 31.626198 imi_mug_run_2_treatment "various" "sts"
3 Q0 8558713 98 31.59161 imi_mug_run_2_treatment "color"
3 Q0 20026870 99 31.577154 imi_mug_run_2_treatment "angiotensin"
3 Q0 27468562 100 31.571648 imi_mug_run_2_treatment "pat"
3 Q0 25660097 101 31.525335 imi_mug_run_2_treatment "basis"
3 Q0 30459527 102 31.523453 imi_mug_run_2_treatment "ors"
3 Q0 25176644 103 31.498617 imi_mug_run_2_treatment "mediated"
3 Q0 17418805 104 31.466572 imi_mug_run_2_treatment "various" "androgen"
3 Q0 23650284 105 31.463703 imi_mug_run_2_treatment "androgen"
3 Q0 22349817 106 31.454712 imi_mug_run_2_treatment "mediated"
3 Q0 11522620 107 31.43645 imi_mug_run_2_treatment "azacytidine"
3 Q0 26516160 108 31.406847 imi_mug_run_2_treatment "silibinin" "dsb" "radiosensitizer"
3 Q0 17172433 109 31.397188 imi_mug_run_2_treatment "androgen" "agent" "caffeine"
3 Q0 28540598 110 31.377747 imi_mug_run_2_treatment "parp inhibitors" "olaparib"
3 Q0 19661334 111 31.32713 imi_mug_run_2_treatment "product" "suppressor"
3 Q0 16614120 112 31.26943 imi_mug_run_2_treatment "ile"
3 Q0 20978201 113 31.26755 imi_mug_run_2_treatment "etoposide" "camptothecin" "cisplatin"
3 Q0 10521795 114 31.259129 imi_mug_run_2_treatment "various"
3 Q0 24282282 115 31.24932 imi_mug_run_2_treatment "mediated"
3 Q0 16618725 116 31.246702 imi_mug_run_2_treatment "tandem"
3 Q0 20936707 117 31.244448 imi_mug_run_2_treatment "isolate"
3 Q0 20190808 118 31.24409 imi_mug_run_2_treatment "androgen" "various" "matrix"
3 Q0 23466879 119 31.212793 imi_mug_run_2_treatment "caffeic acid phenethyl ester" "anti-inflammatory agent" "antioxidant"
3 Q0 17185378 120 31.2127 imi_mug_run_2_treatment "anti-androgens" "combinations" "androgen"
3 Q0 25088203 121 31.17379 imi_mug_run_2_treatment "etop" "serine" "etoposide"
3 Q0 21122140 122 31.173658 imi_mug_run_2_treatment "various" "broccoli" "sulforaphane"
3 Q0 19948822 123 31.172142 imi_mug_run_2_treatment "androgen"
3 Q0 19402094 124 31.158497 imi_mug_run_2_treatment "androgen"
3 Q0 9865716 125 31.14544 imi_mug_run_2_treatment "isolate"
3 Q0 10371356 126 31.134804 imi_mug_run_2_treatment "various"
3 Q0 17283142 127 31.116295 imi_mug_run_2_treatment "androgen" "mediated"
3 Q0 24780839 128 31.085928 imi_mug_run_2_treatment "enzalutamide" "pma" "androgen"
3 Q0 23462369 129 31.085928 imi_mug_run_2_treatment "caffeic acid phenethyl ester" "antioxidant" "drugs"
3 Q0 26416453 130 31.07045 imi_mug_run_2_treatment "aim"
3 Q0 21556510 131 31.062073 imi_mug_run_2_treatment "various"
3 Q0 8630227 132 31.032406 imi_mug_run_2_treatment "mediated"
3 Q0 20579941 133 31.028954 imi_mug_run_2_treatment "androgen"
3 Q0 25741004 134 31.024498 imi_mug_run_2_treatment "interferon" "antiviral"
3 Q0 29179998 135 31.005459 imi_mug_run_2_treatment "androgen"
3 Q0 22159221 136 30.997766 imi_mug_run_2_treatment "omega-3 pufa" "androgens" "level"
3 Q0 18451178 137 30.997616 imi_mug_run_2_treatment "mediated"
3 Q0 1668728 138 30.975586 imi_mug_run_2_treatment "lead"
3 Q0 8339265 139 30.969406 imi_mug_run_2_treatment "calcium" "mediated"
3 Q0 16007164 140 30.95195 imi_mug_run_2_treatment "azacytidine"
3 Q0 25906751 141 30.938866 imi_mug_run_2_treatment "lead"
3 Q0 24800880 142 30.89053 imi_mug_run_2_treatment "s-adenosylmethionine" "folate"
3 Q0 30291535 143 30.888401 imi_mug_run_2_treatment "tma"
3 Q0 26510020 144 30.866653 imi_mug_run_2_treatment "olaparib" "parp inhibitor" "diphosphate"
3 Q0 29282359 145 30.851416 imi_mug_run_2_treatment "lead" "others"
3 Q0 17426252 146 30.824211 imi_mug_run_2_treatment "androgen" "dihydrotestosterone"
3 Q0 29439820 147 30.765408 imi_mug_run_2_treatment "enzalutamide" "abiraterone"
3 Q0 29786791 148 30.732922 imi_mug_run_2_treatment "androgen" "estrogen" "lead"
3 Q0 21703427 149 30.724874 imi_mug_run_2_treatment "androgen"
3 Q0 24583925 150 30.724556 imi_mug_run_2_treatment "level" "suppressor"
3 Q0 26296757 151 30.6937 imi_mug_run_2_treatment "lead"
3 Q0 22350410 152 30.6851 imi_mug_run_2_treatment "ras" "pd325901"
3 Q0 28167296 153 30.684977 imi_mug_run_2_treatment "androgens" "brdu" "mediated"
3 Q0 8608977 154 30.684128 imi_mug_run_2_treatment "basis"
3 Q0 23056207 155 30.680326 imi_mug_run_2_treatment "enzymes" "lysine"
3 Q0 22114138 156 30.660578 imi_mug_run_2_treatment "camptothecin" "cisplatin" "methyl methanesulfonate"
3 Q0 27590317 157 30.652113 imi_mug_run_2_treatment "platinum" "parp inhibitors" "therapeutics"
3 Q0 29304771 158 30.650269 imi_mug_run_2_treatment "hub"
3 Q0 26418896 159 30.590973 imi_mug_run_2_treatment "product"
3 Q0 28657667 160 30.5317 imi_mug_run_2_treatment "protein c" "aim"
3 Q0 24934715 161 30.51366 imi_mug_run_2_treatment "progesterone" "estradiol" "igf1"
3 Q0 24447801 162 30.448593 imi_mug_run_2_treatment "various" "sps" "antioxidant"
3 Q0 9583683 163 30.432722 imi_mug_run_2_treatment "product" "level"
3 Q0 22252602 164 30.427946 imi_mug_run_2_treatment "therapeutic agents" "program"
3 Q0 17616663 165 30.424803 imi_mug_run_2_treatment "androgen"
3 Q0 23794398 166 30.397604 imi_mug_run_2_treatment "suppressor"
3 Q0 24523142 167 30.332077 imi_mug_run_2_treatment "various" "level"
3 Q0 23563654 168 30.320072 imi_mug_run_2_treatment "various" "mediated" "others"
3 Q0 18483239 169 30.31659 imi_mug_run_2_treatment "androgen"
3 Q0 23300485 170 30.315214 imi_mug_run_2_treatment "androgens"
3 Q0 26563471 171 30.308878 imi_mug_run_2_treatment "drug" "duration" "enzalutamide"
3 Q0 19800578 172 30.306911 imi_mug_run_2_treatment "mediated"
3 Q0 19396154 173 30.305397 imi_mug_run_2_treatment "zonal"
3 Q0 19741607 174 30.250925 imi_mug_run_2_treatment "androgen" "androgens" "mediated"
3 Q0 19906297 175 30.140564 imi_mug_run_2_treatment "androgen" "factor 7"
3 Q0 10451697 176 30.107288 imi_mug_run_2_treatment "endocrine therapy"
3 Q0 15300251 177 30.094208 imi_mug_run_2_treatment "mediated"
3 Q0 20585617 178 30.0579 imi_mug_run_2_treatment "suppressor" "animals"
3 Q0 20626841 179 30.055521 imi_mug_run_2_treatment "sulforaphane" "broccoli"
3 Q0 12520532 180 30.036152 imi_mug_run_2_treatment "vitamin d" "dihydroxyvitamin d" "level"
3 Q0 7669736 181 30.028164 imi_mug_run_2_treatment "endocrine therapy"
3 Q0 28058701 182 30.009209 imi_mug_run_2_treatment "aim"
3 Q0 25939393 183 29.989937 imi_mug_run_2_treatment "tma" "color"
3 Q0 23874600 184 29.953842 imi_mug_run_2_treatment "iron" "oxygen" "therapeutic agent"
3 Q0 21694442 185 29.937468 imi_mug_run_2_treatment "enzymes" "plasma"
3 Q0 24882580 186 29.931427 imi_mug_run_2_treatment "suppressor" "collagen"
3 Q0 25122198 187 29.92051 imi_mug_run_2_treatment "androgen" "protease"
3 Q0 15755877 188 29.88573 imi_mug_run_2_treatment "liver"
3 Q0 9669667 189 29.860023 imi_mug_run_2_treatment "level"
3 Q0 28875501 190 29.836555 imi_mug_run_2_treatment "amino acid"
3 Q0 22780967 191 29.81393 imi_mug_run_2_treatment "androgen" "maspin"
3 Q0 29029019 192 29.809666 imi_mug_run_2_treatment "mediated"
3 Q0 17108102 193 29.769958 imi_mug_run_2_treatment "androgen"
3 Q0 28156002 194 29.690489 imi_mug_run_2_treatment "pdx" "androgen" "docetaxel"
3 Q0 26614400 195 29.658348 imi_mug_run_2_treatment "androgen" "ras"
3 Q0 24378408 196 29.656313 imi_mug_run_2_treatment "tma"
3 Q0 11454719 197 29.65144 imi_mug_run_2_treatment "suppressor"
3 Q0 17465223 198 29.65144 imi_mug_run_2_treatment "level" "aim"
3 Q0 24632071 199 29.64683 imi_mug_run_2_treatment "mediated" "epidermal growth factor"
3 Q0 22311173 200 29.628761 imi_mug_run_2_treatment "level"
3 Q0 26917215 201 29.622719 imi_mug_run_2_treatment "medicine"
3 Q0 12684669 202 29.594791 imi_mug_run_2_treatment "beta-galactosidase"
3 Q0 20807814 203 29.588093 imi_mug_run_2_treatment "isolate"
3 Q0 9815624 204 29.562323 imi_mug_run_2_treatment "kinase inhibitor" "basis"
3 Q0 24324828 205 29.52787 imi_mug_run_2_treatment "thr" "lead"
3 Q0 11225974 206 29.525461 imi_mug_run_2_treatment "mediated" "aim" "seki"
3 Q0 9321930 207 29.513145 imi_mug_run_2_treatment "various"
3 Q0 12195425 208 29.506325 imi_mug_run_2_treatment "level"
3 Q0 20232320 209 29.501778 imi_mug_run_2_treatment "nt-2" "retinoic acid"
3 Q0 22898899 210 29.433891 imi_mug_run_2_treatment "mediated"
3 Q0 26505164 211 29.42857 imi_mug_run_2_treatment "oxygen" "mediated"
3 Q0 12753724 212 29.389004 imi_mug_run_2_treatment "androgen" "genesis"
3 Q0 20004998 213 29.337126 imi_mug_run_2_treatment "level"
3 Q0 18579187 214 29.297215 imi_mug_run_2_treatment "oxygen" "hyperbaric oxygen" "air"
3 Q0 12196249 215 29.280449 imi_mug_run_2_treatment "suppressor"
3 Q0 27955654 216 29.274189 imi_mug_run_2_treatment "various" "agar" "monolayer"
3 Q0 9171999 217 29.26359 imi_mug_run_2_treatment "tyr" "agent" "tac"
3 Q0 20056632 218 29.251154 imi_mug_run_2_treatment "enzymes"
3 Q0 27749330 219 29.233559 imi_mug_run_2_treatment "combinations" "parp inhibitors" "drugs"
3 Q0 11433524 220 29.225067 imi_mug_run_2_treatment "sts"
3 Q0 29744289 221 29.184229 imi_mug_run_2_treatment "mediated" "epidermal growth factor"
3 Q0 23555183 222 29.173122 imi_mug_run_2_treatment "tandem" "mediated"
3 Q0 29113300 223 29.161667 imi_mug_run_2_treatment "androgen" "testosterone"
3 Q0 21761361 224 29.151815 imi_mug_run_2_treatment "isolate"
3 Q0 12140757 225 29.15129 imi_mug_run_2_treatment "androgens" "androgen" "anti-androgen"
3 Q0 23670050 226 29.148916 imi_mug_run_2_treatment "various" "azd5363" "chloroquine"
3 Q0 25295534 227 29.14319 imi_mug_run_2_treatment "androgen" "mediated"
3 Q0 20395202 228 29.126745 imi_mug_run_2_treatment "serine"
3 Q0 20665530 229 29.105698 imi_mug_run_2_treatment "titanocene dichloride" "crystal violet" "docetaxel"
3 Q0 22753496 230 29.101349 imi_mug_run_2_treatment "androgen"
3 Q0 30349055 231 29.066532 imi_mug_run_2_treatment "drug" "mediated" "adc"
3 Q0 11745466 232 29.055809 imi_mug_run_2_treatment "androgen" "level"
3 Q0 24464914 233 29.053219 imi_mug_run_2_treatment "annexin a1"
3 Q0 15138484 234 29.039188 imi_mug_run_2_treatment "dsb"
3 Q0 10643942 235 29.002956 imi_mug_run_2_treatment "enzymes" "oxygen"
3 Q0 22045666 236 28.999622 imi_mug_run_2_treatment "androgen" "lead" "color"
3 Q0 17401460 237 28.91621 imi_mug_run_2_treatment "androgen" "color" "level"
3 Q0 26684029 238 28.915028 imi_mug_run_2_treatment "tma" "level"
3 Q0 30400006 239 28.896349 imi_mug_run_2_treatment "lactate" "parp inhibitor" "glucose"
3 Q0 29368341 240 28.87004 imi_mug_run_2_treatment "color"
3 Q0 19223576 241 28.869335 imi_mug_run_2_treatment "psoralidin" "androgen" "aipc"
3 Q0 28929505 242 28.85879 imi_mug_run_2_treatment "level"
3 Q0 19026724 243 28.845818 imi_mug_run_2_treatment "zinc"
3 Q0 12190124 244 28.84144 imi_mug_run_2_treatment "level"
3 Q0 19250219 245 28.834755 imi_mug_run_2_treatment "anti-inflammatory"
3 Q0 27450452 246 28.819696 imi_mug_run_2_treatment "androgen" "therapeutic androgen" "mediated"
3 Q0 11307147 247 28.817432 imi_mug_run_2_treatment "enzymes" "isoleucine"
3 Q0 8886839 248 28.812384 imi_mug_run_2_treatment "androgen"
3 Q0 23624841 249 28.804884 imi_mug_run_2_treatment "various"
3 Q0 16998812 250 28.75142 imi_mug_run_2_treatment "enzymes" "androgen"
3 Q0 19284555 251 28.75142 imi_mug_run_2_treatment "agar"
3 Q0 26424596 252 28.74734 imi_mug_run_2_treatment "serine"
3 Q0 17164371 253 28.737858 imi_mug_run_2_treatment "igfbp-3" "plasma"
3 Q0 26519476 254 28.734285 imi_mug_run_2_treatment "mediated" "buffer"
3 Q0 20126983 255 28.727575 imi_mug_run_2_treatment "androgen" "mediated"
3 Q0 18030357 256 28.70562 imi_mug_run_2_treatment "amp" "mediated" "phellodendron amurense bark extract"
3 Q0 21620777 257 28.692959 imi_mug_run_2_treatment "androgen" "mediated"
3 Q0 20451417 258 28.689688 imi_mug_run_2_treatment "androgen" "various" "mediated"
3 Q0 28830008 259 28.661812 imi_mug_run_2_treatment "androgen" "tma"
3 Q0 11684680 260 28.600582 imi_mug_run_2_treatment "androgen" "vitamin d" "mediators"
3 Q0 17334343 261 28.59797 imi_mug_run_2_treatment "androgen"
3 Q0 28789927 262 28.590807 imi_mug_run_2_treatment "others"
3 Q0 10972993 263 28.515179 imi_mug_run_2_treatment "androgen"
3 Q0 26371515 264 28.498455 imi_mug_run_2_treatment "androgen" "yeast" "mediated"
3 Q0 15781644 265 28.476788 imi_mug_run_2_treatment "androgen" "mediated" "cyclic amp"
3 Q0 10512760 266 28.463648 imi_mug_run_2_treatment "various"
3 Q0 9506758 267 28.456367 imi_mug_run_2_treatment "aim"
3 Q0 21706325 268 28.38187 imi_mug_run_2_treatment "various combinations"
3 Q0 23321494 269 28.378004 imi_mug_run_2_treatment "pi3k/mtor inhibitor bez235" "mtor inhibitor" "radiosensitizer"
3 Q0 11891011 270 28.370623 imi_mug_run_2_treatment "antiserum" "parathyroid hormone-related protein" "pthrp"
3 Q0 16353137 271 28.369148 imi_mug_run_2_treatment "various" "balance" "dna methylation inhibitor"
3 Q0 24480624 272 28.346981 imi_mug_run_2_treatment "serine" "generic" "mediated"
3 Q0 24861463 273 28.336576 imi_mug_run_2_treatment "phosphate" "mediated" "androgen"
3 Q0 21289624 274 28.334396 imi_mug_run_2_treatment "mediators"
3 Q0 24367088 275 28.329956 imi_mug_run_2_treatment "program"
3 Q0 11344205 276 28.306335 imi_mug_run_2_treatment "mediated" "messenger" "aim"
3 Q0 11027414 277 28.257221 imi_mug_run_2_treatment "androgen" "fluorocytosine" "fluorouracil"
3 Q0 9716373 278 28.246937 imi_mug_run_2_treatment "androgen" "r1881"
3 Q0 24105629 279 28.218956 imi_mug_run_2_treatment "androgen" "estradiol" "animals"
3 Q0 20372835 280 28.20829 imi_mug_run_2_treatment "androgens" "androgen" "fructose"
3 Q0 25780911 281 28.192543 imi_mug_run_2_treatment "lead" "level"
3 Q0 8104329 282 28.179907 imi_mug_run_2_treatment "phe"
3 Q0 29782499 283 28.179495 imi_mug_run_2_treatment "human cap"
3 Q0 21601955 284 28.17651 imi_mug_run_2_treatment "androgen" "lead" "abiraterone acetate"
3 Q0 25254494 285 28.145447 imi_mug_run_2_treatment "sam"
3 Q0 11102958 286 28.131876 imi_mug_run_2_treatment "calcium"
3 Q0 11793440 287 28.121613 imi_mug_run_2_treatment "aim" "suppressor"
3 Q0 17061036 288 28.109833 imi_mug_run_2_treatment "others"
3 Q0 10422797 289 28.101803 imi_mug_run_2_treatment "lead"
3 Q0 12424611 290 28.100353 imi_mug_run_2_treatment "androgen"
3 Q0 10414500 291 28.09523 imi_mug_run_2_treatment "basis"
3 Q0 10748873 292 28.091438 imi_mug_run_2_treatment "biotin" "others" "monoclonal antibodies"
3 Q0 23358109 293 28.04641 imi_mug_run_2_treatment "glycine" "fiber"
3 Q0 27185910 294 28.04641 imi_mug_run_2_treatment "docetaxel" "dihydrotestosterone"
3 Q0 21256211 295 28.000746 imi_mug_run_2_treatment "oxygen" "n-acetylcysteine" "mediated"
3 Q0 28323888 296 27.928772 imi_mug_run_2_treatment "mediated"
3 Q0 9809035 297 27.91615 imi_mug_run_2_treatment "color" "level"
3 Q0 22532249 298 27.91615 imi_mug_run_2_treatment "aloe-emodin" "androgen" "emodin"
3 Q0 22158653 299 27.91615 imi_mug_run_2_treatment "drug" "testosterone"
3 Q0 29699892 300 27.895113 imi_mug_run_2_treatment "docetaxel"
3 Q0 29324844 301 27.88257 imi_mug_run_2_treatment "lys" "m-csf" "tam"
3 Q0 16490787 302 27.879704 imi_mug_run_2_treatment "matrix"
3 Q0 29755115 303 27.852795 imi_mug_run_2_treatment "monolayer"
3 Q0 10677309 304 27.845098 imi_mug_run_2_treatment "others"
3 Q0 25881002 305 27.840897 imi_mug_run_2_treatment "suppressor"
3 Q0 12874760 306 27.802572 imi_mug_run_2_treatment "suppressor"
3 Q0 8187060 307 27.802332 imi_mug_run_2_treatment "tyrosine"
3 Q0 10717253 308 27.797325 imi_mug_run_2_treatment "suppressor"
3 Q0 17132090 309 27.796288 imi_mug_run_2_treatment "androgen" "charcoal" "suppressor"
3 Q0 24709423 310 27.69469 imi_mug_run_2_treatment "epidermal growth factor"
3 Q0 27756608 311 27.683197 imi_mug_run_2_treatment "androgen" "androgens" "casodex"
3 Q0 21556560 312 27.673565 imi_mug_run_2_treatment "phenylalanine" "serine" "tca"
3 Q0 22030624 313 27.66988 imi_mug_run_2_treatment "cytotoxic drugs"
3 Q0 25627799 314 27.654053 imi_mug_run_2_treatment "plumbagin"
3 Q0 20516122 315 27.615662 imi_mug_run_2_treatment "basis"
3 Q0 18494814 316 27.598978 imi_mug_run_2_treatment "androgen" "androgens" "mediated"
3 Q0 20442300 317 27.508926 imi_mug_run_2_treatment "spink1" "aim" "endocrine therapy"
3 Q0 21945437 318 27.480927 imi_mug_run_2_treatment "androgen" "cpt-11"
3 Q0 9560261 319 27.480282 imi_mug_run_2_treatment "agent"
3 Q0 27596623 320 27.472933 imi_mug_run_2_treatment "dsb" "parp inhibitors" "mediated"
3 Q0 28845585 321 27.465631 imi_mug_run_2_treatment "various" "tma" "aim"
3 Q0 21925305 322 27.45403 imi_mug_run_2_treatment "androgen"
3 Q0 24098661 323 27.392647 imi_mug_run_2_treatment "various" "level"
3 Q0 24252502 324 27.37487 imi_mug_run_2_treatment "iniparib" "olaparib" "drug"
3 Q0 28112153 325 27.347118 imi_mug_run_2_treatment "androgen" "mediated" "suppressor"
3 Q0 21872824 326 27.345802 imi_mug_run_2_treatment "serine"
3 Q0 27500376 327 27.338661 imi_mug_run_2_treatment "color"
3 Q0 24434284 328 27.327953 imi_mug_run_2_treatment "androgen" "topo i inhibitor" "topoisomerase i inhibitor"
3 Q0 16203770 329 27.321682 imi_mug_run_2_treatment "androgen" "interleukin-6"
3 Q0 20842667 330 27.32116 imi_mug_run_2_treatment "mediated"
3 Q0 24556717 331 27.317755 imi_mug_run_2_treatment "taxane" "taxanes" "docetaxel"
3 Q0 7549122 332 27.258497 imi_mug_run_2_treatment "level"
3 Q0 2217208 333 27.232399 imi_mug_run_2_treatment "genesis"
3 Q0 25737954 334 27.193054 imi_mug_run_2_treatment "insulin" "mediated" "ras"
3 Q0 29344228 335 27.191267 imi_mug_run_2_treatment "level"
3 Q0 27148588 336 27.188776 imi_mug_run_2_treatment "androgen" "medicine" "level"
3 Q0 25175909 337 27.18721 imi_mug_run_2_treatment "therapeutics"
3 Q0 24752784 338 27.185919 imi_mug_run_2_treatment "androgen"
3 Q0 1329054 339 27.158861 imi_mug_run_2_treatment "level"
3 Q0 17296351 340 27.135565 imi_mug_run_2_treatment "drugs" "histone deacetylase inhibitors"
3 Q0 16251457 341 27.132282 imi_mug_run_2_treatment "yeast"
3 Q0 27613518 342 27.118294 imi_mug_run_2_treatment "parp inhibitors" "parp inhibitor"
3 Q0 21381033 343 27.065672 imi_mug_run_2_treatment "lead" "suppressor"
3 Q0 25625310 344 27.044615 imi_mug_run_2_treatment "androgen" "aim"
3 Q0 21836023 345 27.03933 imi_mug_run_2_treatment "vitamin d" "testosterone propionate" "level"
3 Q0 29262808 346 27.038393 imi_mug_run_2_treatment "enzymes"
3 Q0 23857602 347 27.030842 imi_mug_run_2_treatment "antiestrogen" "drugs" "basis"
3 Q0 17875689 348 27.019203 imi_mug_run_2_treatment "level" "others"
3 Q0 19805094 349 26.973988 imi_mug_run_2_treatment "mediated" "lymphotoxin"
3 Q0 21761425 350 26.961514 imi_mug_run_2_treatment "mediated" "animals"
3 Q0 23902739 351 26.942635 imi_mug_run_2_treatment "mediated" "basis"
3 Q0 10814674 352 26.940584 imi_mug_run_2_treatment "cytotoxic" "basis"
3 Q0 26053094 353 26.933905 imi_mug_run_2_treatment "agar" "clb"
3 Q0 9570735 354 26.929573 imi_mug_run_2_treatment "androgen" "androgens" "balance"
3 Q0 29719442 355 26.929443 imi_mug_run_2_treatment "pharmaceuticals" "platinum agents"
3 Q0 12497583 356 26.927439 imi_mug_run_2_treatment "various"
3 Q0 26196517 357 26.927439 imi_mug_run_2_treatment "androgen" "anti androgen" "enzalutamide"
3 Q0 14562033 358 26.921186 imi_mug_run_2_treatment "vinorelbine" "androgen" "spl"
3 Q0 10667593 359 26.914782 imi_mug_run_2_treatment "dsb" "product" "level"
3 Q0 20678261 360 26.904335 imi_mug_run_2_treatment "basis"
3 Q0 24684754 361 26.88054 imi_mug_run_2_treatment "excel"
3 Q0 15846060 362 26.877522 imi_mug_run_2_treatment "serine" "prompt" "monoclonal antibodies"
3 Q0 18497957 363 26.851175 imi_mug_run_2_treatment "others"
3 Q0 21339738 364 26.837852 imi_mug_run_2_treatment "drug"
3 Q0 20018680 365 26.835457 imi_mug_run_2_treatment "mediated"
3 Q0 26987799 366 26.787308 imi_mug_run_2_treatment "suppressor"
3 Q0 18264724 367 26.778822 imi_mug_run_2_treatment "various"
3 Q0 14583476 368 26.762287 imi_mug_run_2_treatment "antiviral"
3 Q0 9788441 369 26.748672 imi_mug_run_2_treatment "various"
3 Q0 25712341 370 26.748672 imi_mug_run_2_treatment "bortezomib"
3 Q0 22762987 371 26.742405 imi_mug_run_2_treatment "androgen"
3 Q0 28039468 372 26.738758 imi_mug_run_2_treatment "lead"
3 Q0 29522753 373 26.735811 imi_mug_run_2_treatment "cisplatin" "kinase inhibitor" "level"
3 Q0 24681585 374 26.735483 imi_mug_run_2_treatment "balance"
3 Q0 22847890 375 26.725441 imi_mug_run_2_treatment "medicine"
3 Q0 25056375 376 26.716911 imi_mug_run_2_treatment "spink1" "aim"
3 Q0 23500889 377 26.70496 imi_mug_run_2_treatment "efipladib" "blockade"
3 Q0 10767628 378 26.702637 imi_mug_run_2_treatment "lead"
3 Q0 24023351 379 26.665083 imi_mug_run_2_treatment "aim"
3 Q0 28762374 380 26.6609 imi_mug_run_2_treatment "spink1"
3 Q0 22585167 381 26.637556 imi_mug_run_2_treatment "basis"
3 Q0 17064299 382 26.623621 imi_mug_run_2_treatment "aim"
3 Q0 29172272 383 26.614546 imi_mug_run_2_treatment "sodium bisulfite"
3 Q0 14991898 384 26.58052 imi_mug_run_2_treatment "vasodilator"
3 Q0 15557796 385 26.572636 imi_mug_run_2_treatment "basis"
3 Q0 27308347 386 26.539444 imi_mug_run_2_treatment "various"
3 Q0 19056816 387 26.53784 imi_mug_run_2_treatment "vitamin d" "calcitriol" "dihydroxyvitamin d"
3 Q0 17102593 388 26.5027 imi_mug_run_2_treatment "matrix"
3 Q0 22029423 389 26.495098 imi_mug_run_2_treatment "androgen" "resveratrol" "radiation sensitizers"
3 Q0 25896712 390 26.491766 imi_mug_run_2_treatment "mediators" "level"
3 Q0 24035881 391 26.441517 imi_mug_run_2_treatment "level"
3 Q0 12917204 392 26.382425 imi_mug_run_2_treatment "lead"
3 Q0 20590547 393 26.375084 imi_mug_run_2_treatment "various" "level"
3 Q0 21629734 394 26.348797 imi_mug_run_2_treatment "dsb" "cytotoxic"
3 Q0 21914348 395 26.347418 imi_mug_run_2_treatment "liver"
3 Q0 29851094 396 26.332253 imi_mug_run_2_treatment "androgen" "androgens" "charcoal"
3 Q0 11376801 397 26.324749 imi_mug_run_2_treatment "fluorochrome" "lead"
3 Q0 17726745 398 26.324223 imi_mug_run_2_treatment "various" "aim"
3 Q0 10728697 399 26.315437 imi_mug_run_2_treatment "antiserum" "basis"
3 Q0 20631921 400 26.313583 imi_mug_run_2_treatment "androgen" "level"
3 Q0 28093285 401 26.295414 imi_mug_run_2_treatment "mediated"
3 Q0 24691970 402 26.294777 imi_mug_run_2_treatment "ors" "pooled"
3 Q0 23686257 403 26.29357 imi_mug_run_2_treatment "isoflavones" "estrogen" "biochanin a"
3 Q0 9607587 404 26.279442 imi_mug_run_2_treatment "level"
3 Q0 18593932 405 26.277979 imi_mug_run_2_treatment "topoisomerase inhibitor" "camptothecin"
3 Q0 16763719 406 26.270573 imi_mug_run_2_treatment "retinoic acid" "agent" "aim"
3 Q0 26928463 407 26.270319 imi_mug_run_2_treatment "carboplatin" "metrics" "basis"
3 Q0 18089489 408 26.251749 imi_mug_run_2_treatment "ptm"
3 Q0 28228262 409 26.242762 imi_mug_run_2_treatment "azd7762" "enzalutamide"
3 Q0 20799949 410 26.240194 imi_mug_run_2_treatment "ors"
3 Q0 22276117 411 26.240194 imi_mug_run_2_treatment "level"
3 Q0 22728709 412 26.215334 imi_mug_run_2_treatment "drugs" "level"
3 Q0 27259260 413 26.212275 imi_mug_run_2_treatment "cisplatin" "kinase inhibitor" "tma"
3 Q0 14747659 414 26.20829 imi_mug_run_2_treatment "various" "mediated"
3 Q0 26700622 415 26.20829 imi_mug_run_2_treatment "androgen"
3 Q0 23201680 416 26.177368 imi_mug_run_2_treatment "mediated"
3 Q0 18165275 417 26.156286 imi_mug_run_2_treatment "level"
3 Q0 17333338 418 26.15501 imi_mug_run_2_treatment "basis"
3 Q0 11805335 419 26.149616 imi_mug_run_2_treatment "level"
3 Q0 18701470 420 26.148964 imi_mug_run_2_treatment "antineoplastic"
3 Q0 25591593 421 26.147142 imi_mug_run_2_treatment "androgen" "protease" "serine"
3 Q0 22261283 422 26.142372 imi_mug_run_2_treatment "mediated" "level"
3 Q0 30023007 423 26.130056 imi_mug_run_2_treatment "combinations" "parp inhibitor" "olaparib"
3 Q0 9397200 424 26.115934 imi_mug_run_2_treatment "suppressor" "sts" "mediated"
3 Q0 23171135 425 26.085964 imi_mug_run_2_treatment "blockade"
3 Q0 25175604 426 26.040737 imi_mug_run_2_treatment "tamoxifen"
3 Q0 26074876 427 26.023594 imi_mug_run_2_treatment "balance"
3 Q0 26552734 428 26.013786 imi_mug_run_2_treatment "aim"
3 Q0 29605876 429 25.981419 imi_mug_run_2_treatment "docetaxel"
3 Q0 21058196 430 25.978699 imi_mug_run_2_treatment "vitamin a" "vitamin c" "antioxidant"
3 Q0 23381786 431 25.970745 imi_mug_run_2_treatment "camptothecin" "cisplatin"
3 Q0 18819930 432 25.93643 imi_mug_run_2_treatment "mediated"
3 Q0 8769716 433 25.922344 imi_mug_run_2_treatment "arginine" "histidine"
3 Q0 25015118 434 25.916378 imi_mug_run_2_treatment "dsb" "therapeutic agent"
3 Q0 18451161 435 25.904457 imi_mug_run_2_treatment "igf1" "igfbp-3" "liver"
3 Q0 12505357 436 25.854815 imi_mug_run_2_treatment "product" "animals"
3 Q0 18337456 437 25.837261 imi_mug_run_2_treatment "nh2"
3 Q0 8649800 438 25.830082 imi_mug_run_2_treatment "tcc"
3 Q0 10646852 439 25.828972 imi_mug_run_2_treatment "amino acids"
3 Q0 27322458 440 25.827631 imi_mug_run_2_treatment "drug" "anti-androgen" "chloroquine"
3 Q0 27117783 441 25.82375 imi_mug_run_2_treatment "mediated" "program"
3 Q0 16186802 442 25.804577 imi_mug_run_2_treatment "androgen" "agar" "suppressor"
3 Q0 23936028 443 25.782742 imi_mug_run_2_treatment "animals"
3 Q0 30015382 444 25.777805 imi_mug_run_2_treatment "androgen" "platinum" "level"
3 Q0 25859557 445 25.76788 imi_mug_run_2_treatment "gw9662" "suppressor"
3 Q0 15994952 446 25.729553 imi_mug_run_2_treatment "level"
3 Q0 18663430 447 25.728012 imi_mug_run_2_treatment "androgen" "beta-carboline" "mediated"
3 Q0 23580416 448 25.699974 imi_mug_run_2_treatment "various" "estrogen" "mediated"
3 Q0 24841718 449 25.677347 imi_mug_run_2_treatment "olaparib" "parp inhibitor" "mediated"
3 Q0 16737764 450 25.544823 imi_mug_run_2_treatment "aim"
3 Q0 27638859 451 25.522137 imi_mug_run_2_treatment "abt-888" "cpt-11" "irinotecan"
3 Q0 22923499 452 25.514532 imi_mug_run_2_treatment "serine" "mediated" "level"
3 Q0 22200742 453 25.51238 imi_mug_run_2_treatment "agent"
3 Q0 29863497 454 25.509876 imi_mug_run_2_treatment "various"
3 Q0 22593802 455 25.50361 imi_mug_run_2_treatment "mediated" "epidermal growth factor" "pd98059"
3 Q0 24726882 456 25.494675 imi_mug_run_2_treatment "mica" "drugs" "mediated"
3 Q0 22960283 457 25.485394 imi_mug_run_2_treatment "androgens"
3 Q0 27988859 458 25.454065 imi_mug_run_2_treatment "aim"
3 Q0 12473172 459 25.390697 imi_mug_run_2_treatment "medicine" "basis"
3 Q0 7534899 460 25.382479 imi_mug_run_2_treatment "ras" "liver" "animals"
3 Q0 15928302 461 25.376175 imi_mug_run_2_treatment "program"
3 Q0 9331564 462 25.375507 imi_mug_run_2_treatment "endocrine therapy"
3 Q0 20651226 463 25.375507 imi_mug_run_2_treatment "protease" "yeast" "matrix"
3 Q0 16638864 464 25.359268 imi_mug_run_2_treatment "ile" "tgfb1"
3 Q0 29023981 465 25.358223 imi_mug_run_2_treatment "various"
3 Q0 22426160 466 25.341228 imi_mug_run_2_treatment "various" "ginseng root" "sb202190"
3 Q0 17034599 467 25.339464 imi_mug_run_2_treatment "sildenafil" "terazosin"
3 Q0 29761525 468 25.338924 imi_mug_run_2_treatment "tma"
3 Q0 21189328 469 25.33865 imi_mug_run_2_treatment "androgen" "yeast" "level"
3 Q0 16533773 470 25.3381 imi_mug_run_2_treatment "various" "dsb"
3 Q0 23365634 471 25.314919 imi_mug_run_2_treatment "hcpt" "genistein" "dna topoisomerase i inhibitor"
3 Q0 19781682 472 25.297495 imi_mug_run_2_treatment "basis"
3 Q0 23994645 473 25.286901 imi_mug_run_2_treatment "color"
3 Q0 11336792 474 25.27694 imi_mug_run_2_treatment "androgen" "u0126"
3 Q0 7530484 475 25.27455 imi_mug_run_2_treatment "aim" "fcm" "others"
3 Q0 27271795 476 25.27455 imi_mug_run_2_treatment "androgen" "dihydrotestosterone"
3 Q0 26438152 477 25.240643 imi_mug_run_2_treatment "gemcitabine" "carboplatin" "serine"
3 Q0 23580590 478 25.219984 imi_mug_run_2_treatment "androgen" "mediated" "lead"
3 Q0 27174589 479 25.219297 imi_mug_run_2_treatment "mediated" "lead" "color"
3 Q0 15738655 480 25.19685 imi_mug_run_2_treatment "pioglitazone" "various" "androgen"
3 Q0 29308088 481 25.179453 imi_mug_run_2_treatment "lcr" "others"
3 Q0 23258740 482 25.179163 imi_mug_run_2_treatment "akt inhibitor azd5363" "azd5363" "chloroquine"
3 Q0 25567291 483 25.177172 imi_mug_run_2_treatment "abc" "estrogens" "androgen"
3 Q0 23348902 484 25.170532 imi_mug_run_2_treatment "spink1" "color"
3 Q0 22667764 485 25.161543 imi_mug_run_2_treatment "plasma"
3 Q0 23561577 486 25.14442 imi_mug_run_2_treatment "plasma" "level"
3 Q0 16281503 487 25.12148 imi_mug_run_2_treatment "dihydrotestosterone" "ap4" "basis"
3 Q0 16423882 488 25.106556 imi_mug_run_2_treatment "vitamin d"
3 Q0 22869595 489 25.102621 imi_mug_run_2_treatment "mediated"
3 Q0 25788262 490 25.065746 imi_mug_run_2_treatment "androgen" "caffeic acid phenethyl ester" "bcl-2 inhibitor"
3 Q0 19153073 491 25.05647 imi_mug_run_2_treatment "level"
3 Q0 30195037 492 25.03547 imi_mug_run_2_treatment "testosterone" "aim" "testosterone propionate"
3 Q0 11796715 493 25.006487 imi_mug_run_2_treatment "level" "proteases"
3 Q0 25861265 494 24.993288 imi_mug_run_2_treatment "dsb"
3 Q0 23653096 495 24.970078 imi_mug_run_2_treatment "product"
3 Q0 10866324 496 24.963343 imi_mug_run_2_treatment "favor"
3 Q0 27542403 497 24.909218 imi_mug_run_2_treatment "mediated" "level"
3 Q0 23851489 498 24.876421 imi_mug_run_2_treatment "suppressor"
3 Q0 27738792 499 24.847681 imi_mug_run_2_treatment "various" "spink1" "spink1's"
3 Q0 11665719 500 24.847364 imi_mug_run_2_treatment "various" "product"
3 Q0 23925578 501 24.841965 imi_mug_run_2_treatment "ptc" "program" "matrix"
3 Q0 25948589 502 24.824108 imi_mug_run_2_treatment "isolate"
3 Q0 26913603 503 24.809181 imi_mug_run_2_treatment "mediated"
3 Q0 30522863 504 24.720814 imi_mug_run_2_treatment "olaparib" "drugs" "enzalutamide"
3 Q0 15289825 505 24.699009 imi_mug_run_2_treatment "lead"
3 Q0 24163230 506 24.696423 imi_mug_run_2_treatment "panobinostat" "mtor inhibitor"
3 Q0 8780156 507 24.690573 imi_mug_run_2_treatment "androgen" "animals"
3 Q0 25608836 508 24.689297 imi_mug_run_2_treatment "progesterone" "cck-8" "medroxyprogesterone acetate"
3 Q0 17671224 509 24.68871 imi_mug_run_2_treatment "androgen" "animals" "lead"
3 Q0 24662052 510 24.653612 imi_mug_run_2_treatment "immunosuppressive" "cytokines"
3 Q0 30171229 511 24.647009 imi_mug_run_2_treatment "adjuvant"
3 Q0 25368522 512 24.637493 imi_mug_run_2_treatment "dsb"
3 Q0 22461624 513 24.616407 imi_mug_run_2_treatment "oxygen" "mediated"
3 Q0 9892107 514 24.610802 imi_mug_run_2_treatment "sts" "liver"
3 Q0 17164260 515 24.610653 imi_mug_run_2_treatment "various" "oestrogen"
3 Q0 23993957 516 24.61053 imi_mug_run_2_treatment "cck-8" "mdc"
3 Q0 27053337 517 24.60422 imi_mug_run_2_treatment "basis"
3 Q0 25935535 518 24.582142 imi_mug_run_2_treatment "dapi"
3 Q0 20736744 519 24.575949 imi_mug_run_2_treatment "color"
3 Q0 28477117 520 24.56758 imi_mug_run_2_treatment "gln" "thr" "suppressor"
3 Q0 16400190 521 24.557947 imi_mug_run_2_treatment "various" "level"
3 Q0 11956160 522 24.555206 imi_mug_run_2_treatment "igfbp-3" "histone deacetylase inhibitor" "growth inhibitor"
3 Q0 26645406 523 24.52145 imi_mug_run_2_treatment "mediated" "oxygen"
3 Q0 12497108 524 24.516954 imi_mug_run_2_treatment "product"
3 Q0 18213629 525 24.514872 imi_mug_run_2_treatment "growth inhibitor"
3 Q0 27127882 526 24.514872 imi_mug_run_2_treatment "docetaxel"
3 Q0 29246212 527 24.503014 imi_mug_run_2_treatment "dsb" "cytotoxic"
3 Q0 25159481 528 24.4478 imi_mug_run_2_treatment "various" "sodium" "dsb"
3 Q0 25425972 529 24.443224 imi_mug_run_2_treatment "adjuvant" "cyclophosphamide" "fluorouracil"
3 Q0 27304073 530 24.403547 imi_mug_run_2_treatment "topo"
3 Q0 17320491 531 24.386227 imi_mug_run_2_treatment "androgen" "level"
3 Q0 8665503 532 24.345272 imi_mug_run_2_treatment "product" "lead"
3 Q0 17971903 533 24.336674 imi_mug_run_2_treatment "prazosin" "terazosin" "doxazosin"
3 Q0 24568192 534 24.331707 imi_mug_run_2_treatment "various" "prostaglandin e2" "isoproterenol"
3 Q0 17319789 535 24.32845 imi_mug_run_2_treatment "level"
3 Q0 10408707 536 24.327192 imi_mug_run_2_treatment "various"
3 Q0 20615625 537 24.302383 imi_mug_run_2_treatment "metformin" "drug" "amp"
3 Q0 23196798 538 24.299618 imi_mug_run_2_treatment "aim"
3 Q0 11849780 539 24.266018 imi_mug_run_2_treatment "hyperbaric oxygen"
3 Q0 29928473 540 24.236313 imi_mug_run_2_treatment "elder" "aim"
3 Q0 28039461 541 24.234535 imi_mug_run_2_treatment "various" "ors"
3 Q0 20889973 542 24.225937 imi_mug_run_2_treatment "oxygen" "antioxidant" "nervous system"
3 Q0 25076860 543 24.204529 imi_mug_run_2_treatment "gly" "lead"
3 Q0 30259128 544 24.186365 imi_mug_run_2_treatment "drug" "clorgyline" "mao inhibitor"
3 Q0 25862169 545 24.1862 imi_mug_run_2_treatment "oxygen" "n-acetyl cysteine" "antioxidant"
3 Q0 17342748 546 24.1846 imi_mug_run_2_treatment "har" "agonists" "androgen"
3 Q0 16808618 547 24.18371 imi_mug_run_2_treatment "lead"
3 Q0 30128886 548 24.166214 imi_mug_run_2_treatment "various" "duration"
3 Q0 26691941 549 24.164227 imi_mug_run_2_treatment "various"
3 Q0 2247918 550 24.12883 imi_mug_run_2_treatment "level"
3 Q0 18037553 551 24.124216 imi_mug_run_2_treatment "antioxidants" "tempol" "n-acetyl-l-cysteine"
3 Q0 22258408 552 24.112244 imi_mug_run_2_treatment "ras" "oxygen"
3 Q0 25512053 553 24.075127 imi_mug_run_2_treatment "mediators"
3 Q0 27658045 554 24.071136 imi_mug_run_2_treatment "mediated" "chitosan" "basis"
3 Q0 9111862 555 24.069363 imi_mug_run_2_treatment "mediated" "cytotoxic"
3 Q0 15516988 556 24.059895 imi_mug_run_2_treatment "level"
3 Q0 26269117 557 24.057816 imi_mug_run_2_treatment "level" "dmso" "mdc"
3 Q0 18097482 558 24.040215 imi_mug_run_2_treatment "chloroquine" "mediated" "drug"
3 Q0 17431766 559 24.034891 imi_mug_run_2_treatment "ors"
3 Q0 29682192 560 24.020134 imi_mug_run_2_treatment "platinum"
3 Q0 21385925 561 24.007072 imi_mug_run_2_treatment "estrogens" "dsb" "mediated"
3 Q0 16254014 562 24.000149 imi_mug_run_2_treatment "level" "mediated" "animals"
3 Q0 15473314 563 23.980558 imi_mug_run_2_treatment "lead"
3 Q0 25560806 564 23.968178 imi_mug_run_2_treatment "platinum" "drugs" "platinum agents"
3 Q0 22151803 565 23.963541 imi_mug_run_2_treatment "aim"
3 Q0 21445571 566 23.960821 imi_mug_run_2_treatment "matrix"
3 Q0 29472706 567 23.959772 imi_mug_run_2_treatment "tamoxifen"
3 Q0 15240830 568 23.951012 imi_mug_run_2_treatment "androgen" "tnf-alpha"
3 Q0 23512991 569 23.93119 imi_mug_run_2_treatment "dsb" "camptothecin" "etoposide"
3 Q0 28465777 570 23.92658 imi_mug_run_2_treatment "metrics"
3 Q0 28732227 571 23.903103 imi_mug_run_2_treatment "type i interferon" "antiviral"
3 Q0 22869592 572 23.881596 imi_mug_run_2_treatment "therapeutics"
3 Q0 23408238 573 23.8737 imi_mug_run_2_treatment "suppressor"
3 Q0 12127691 574 23.860039 imi_mug_run_2_treatment "adc"
3 Q0 24857596 575 23.835926 imi_mug_run_2_treatment "mediated" "dsb" "cisplatin"
3 Q0 21102523 576 23.819094 imi_mug_run_2_treatment "mediated" "level"
3 Q0 17342750 577 23.818283 imi_mug_run_2_treatment "various"
3 Q0 8908194 578 23.80208 imi_mug_run_2_treatment "insulin" "hydrocortisone" "ras"
3 Q0 22856547 579 23.799791 imi_mug_run_2_treatment "melatonin" "melatonin's" "mediated"
3 Q0 8946204 580 23.78299 imi_mug_run_2_treatment "basis"
3 Q0 28686074 581 23.777601 imi_mug_run_2_treatment "cisplatin" "therapeutics" "cisplatin injection"
3 Q0 22611469 582 23.755554 imi_mug_run_2_treatment "transforming growth factor beta 1"
3 Q0 20940396 583 23.749138 imi_mug_run_2_treatment "mediated" "rad001"
3 Q0 15892892 584 23.748163 imi_mug_run_2_treatment "yeast" "histidine"
3 Q0 19433067 585 23.748163 imi_mug_run_2_treatment "androgen" "mediated" "diindolylmethane"
3 Q0 18668224 586 23.746025 imi_mug_run_2_treatment "alcohol"
3 Q0 26091350 587 23.746025 imi_mug_run_2_treatment "anti-androgens" "androgen" "tyrosine kinase inhibitor"
3 Q0 21743498 588 23.733948 imi_mug_run_2_treatment "level"
3 Q0 20053781 589 23.722366 imi_mug_run_2_treatment "insulin" "chemotherapeutic agent" "drug"
3 Q0 18325490 590 23.71851 imi_mug_run_2_treatment "animals" "su5402" "shh"
3 Q0 9842961 591 23.714643 imi_mug_run_2_treatment "fcm"
3 Q0 18044730 592 23.68703 imi_mug_run_2_treatment "various" "animals"
3 Q0 28981098 593 23.680195 imi_mug_run_2_treatment "androgen" "ap4" "oestrogen"
3 Q0 9893751 594 23.660711 imi_mug_run_2_treatment "suppressor"
3 Q0 25809148 595 23.65758 imi_mug_run_2_treatment "spink1" "aim"
3 Q0 27612029 596 23.652693 imi_mug_run_2_treatment "resveratrol" "rhapontigenin" "piceatannol"
3 Q0 20620173 597 23.631529 imi_mug_run_2_treatment "collagen" "mediated" "mtor inhibitor"
3 Q0 14706517 598 23.628979 imi_mug_run_2_treatment "lead" "others"
3 Q0 20497039 599 23.625029 imi_mug_run_2_treatment "docetaxel" "drug" "cytotoxic drugs"
3 Q0 11850786 600 23.6186 imi_mug_run_2_treatment "yeast" "lead"
3 Q0 26517239 601 23.616554 imi_mug_run_2_treatment "cisplatin" "kinase inhibitor" "gemcitabine"
3 Q0 21467296 602 23.6151 imi_mug_run_2_treatment "oxygen"
3 Q0 23741392 603 23.61319 imi_mug_run_2_treatment "hme"
3 Q0 22420423 604 23.60722 imi_mug_run_2_treatment "mitomycin" "epirubicin" "fluorouracil"
3 Q0 23018874 605 23.587837 imi_mug_run_2_treatment "tma" "color" "others"
3 Q0 18518979 606 23.583935 imi_mug_run_2_treatment "mediated"
3 Q0 23935957 607 23.574322 imi_mug_run_2_treatment "dsb"
3 Q0 27102301 608 23.54458 imi_mug_run_2_treatment "various" "tamoxifen"
3 Q0 12210491 609 23.520111 imi_mug_run_2_treatment "leu" "thr" "glu"
3 Q0 27308314 610 23.514683 imi_mug_run_2_treatment "mediated" "aim"
3 Q0 25937285 611 23.501026 imi_mug_run_2_treatment "phosphate" "glucose" "glutamine"
3 Q0 25761890 612 23.492966 imi_mug_run_2_treatment "protein kinase inhibitor"
3 Q0 23693077 613 23.486828 imi_mug_run_2_treatment "topo" "mediated" "agent"
3 Q0 17623063 614 23.477875 imi_mug_run_2_treatment "level" "leu" "phe"
3 Q0 24069304 615 23.471748 imi_mug_run_2_treatment "agent"
3 Q0 18265979 616 23.469103 imi_mug_run_2_treatment "mediated"
3 Q0 19017637 617 23.457203 imi_mug_run_2_treatment "wormwood" "artemisinin" "phosphatase inhibitor"
3 Q0 22981675 618 23.444147 imi_mug_run_2_treatment "serine"
3 Q0 20173741 619 23.438175 imi_mug_run_2_treatment "suppressor"
3 Q0 16809004 620 23.433634 imi_mug_run_2_treatment "level" "mediated" "nervous system"
3 Q0 19903334 621 23.431763 imi_mug_run_2_treatment "caffeine" "mediated"
3 Q0 3044579 622 23.420193 imi_mug_run_2_treatment "various" "cytotoxic" "level"
3 Q0 12477976 623 23.40757 imi_mug_run_2_treatment "glycine" "product" "liver"
3 Q0 25053011 624 23.405502 imi_mug_run_2_treatment "mediated"
3 Q0 23892089 625 23.374176 imi_mug_run_2_treatment "pat" "pooled"
3 Q0 24480460 626 23.37322 imi_mug_run_2_treatment "cisplatin" "mediated"
3 Q0 27466510 627 23.3497 imi_mug_run_2_treatment "aim"
3 Q0 12612651 628 23.335247 imi_mug_run_2_treatment "lead"
3 Q0 25605158 629 23.331268 imi_mug_run_2_treatment "ors" "pooled"
3 Q0 21980462 630 23.329655 imi_mug_run_2_treatment "level"
3 Q0 15269203 631 23.323742 imi_mug_run_2_treatment "drug" "agent" "irofulven"
3 Q0 24145123 632 23.316956 imi_mug_run_2_treatment "oxaliplatin" "drugs" "mediated"
3 Q0 21395549 633 23.315788 imi_mug_run_2_treatment "ras" "various" "angiotensin"
3 Q0 23154512 634 23.298126 imi_mug_run_2_treatment "dsb"
3 Q0 9377551 635 23.271477 imi_mug_run_2_treatment "androgen"
3 Q0 28647209 636 23.264154 imi_mug_run_2_treatment "kazak"
3 Q0 21273599 637 23.25932 imi_mug_run_2_treatment "indole" "oxygen"
3 Q0 22763242 638 23.25932 imi_mug_run_2_treatment "cisplatin" "oxygen" "n-acetyl-l-cysteine"
3 Q0 16885336 639 23.257797 imi_mug_run_2_treatment "mediated" "suppressor"
3 Q0 28394299 640 23.257797 imi_mug_run_2_treatment "level" "mediated"
3 Q0 28825373 641 23.252594 imi_mug_run_2_treatment "product" "lead"
3 Q0 9135004 642 23.23793 imi_mug_run_2_treatment "immunol"
3 Q0 17982490 643 23.237043 imi_mug_run_2_treatment "suppressor"
3 Q0 28477132 644 23.232134 imi_mug_run_2_treatment "serine"
3 Q0 25466890 645 23.199282 imi_mug_run_2_treatment "mediated"
3 Q0 26291700 646 23.188976 imi_mug_run_2_treatment "liver"
3 Q0 23939379 647 23.188889 imi_mug_run_2_treatment "mediated"
3 Q0 11398197 648 23.180836 imi_mug_run_2_treatment "various" "mediated"
3 Q0 14562025 649 23.173485 imi_mug_run_2_treatment "basis"
3 Q0 25529796 650 23.145061 imi_mug_run_2_treatment "lysine" "oxygen" "mediated"
3 Q0 29860718 651 23.136139 imi_mug_run_2_treatment "plasma"
3 Q0 16888681 652 23.127846 imi_mug_run_2_treatment "androgen" "bicalutamide" "level"
3 Q0 21859827 653 23.122164 imi_mug_run_2_treatment "oxygen" "mediated" "chemotherapy agents"
3 Q0 18557758 654 23.06778 imi_mug_run_2_treatment "various" "androgens" "crest"
3 Q0 26586399 655 23.061169 imi_mug_run_2_treatment "sodium glycididazole"
3 Q0 28747635 656 23.054794 imi_mug_run_2_treatment "suppressor"
3 Q0 15073328 657 23.035074 imi_mug_run_2_treatment "mediated" "program"
3 Q0 21209379 658 23.035074 imi_mug_run_2_treatment "level"
3 Q0 11139252 659 23.024897 imi_mug_run_2_treatment "product"
3 Q0 21051589 660 23.008747 imi_mug_run_2_treatment "androgen" "interleukin-6" "il-6"
3 Q0 30198376 661 22.998634 imi_mug_run_2_treatment "abt-263" "cfs-1686"
3 Q0 15039971 662 22.985092 imi_mug_run_2_treatment "product"
3 Q0 25480786 663 22.981546 imi_mug_run_2_treatment "serine" "mediated" "others"
3 Q0 15735753 664 22.976974 imi_mug_run_2_treatment "suppressor"
3 Q0 22661295 665 22.976974 imi_mug_run_2_treatment "androgen"
3 Q0 28319045 666 22.974401 imi_mug_run_2_treatment "mediated"
3 Q0 24083995 667 22.967482 imi_mug_run_2_treatment "spink1" "endocrine therapy"
3 Q0 28973420 668 22.966282 imi_mug_run_2_treatment "serine" "adriamycin"
3 Q0 21935375 669 22.966188 imi_mug_run_2_treatment "various" "mediated"
3 Q0 29797234 670 22.936373 imi_mug_run_2_treatment "drug" "chemotherapeutic agent" "artesunate"
3 Q0 25773855 671 22.934032 imi_mug_run_2_treatment "silibinin" "drug" "drugs"
3 Q0 9400992 672 22.933044 imi_mug_run_2_treatment "yeast" "lead"
3 Q0 9707615 673 22.927141 imi_mug_run_2_treatment "mediated" "lead"
3 Q0 26861919 674 22.924274 imi_mug_run_2_treatment "color"
3 Q0 21665257 675 22.922264 imi_mug_run_2_treatment "lead"
3 Q0 29352223 676 22.894821 imi_mug_run_2_treatment "epirubicin" "mediated" "level"
3 Q0 20490800 677 22.89051 imi_mug_run_2_treatment "drugs" "drug" "artemisone"
3 Q0 14645548 678 22.876171 imi_mug_run_2_treatment "serine" "mediated" "ly294002"
3 Q0 29128564 679 22.872908 imi_mug_run_2_treatment "favor"
3 Q0 9916992 680 22.864954 imi_mug_run_2_treatment "cytotoxic" "level"
3 Q0 27838786 681 22.864159 imi_mug_run_2_treatment "fluorouracil"
3 Q0 21034966 682 22.843218 imi_mug_run_2_treatment "cisplatin"
3 Q0 19401701 683 22.819517 imi_mug_run_2_treatment "various" "mediated" "curcumin"
3 Q0 21518729 684 22.811258 imi_mug_run_2_treatment "epirubicin" "caffeine"
3 Q0 17084711 685 22.804693 imi_mug_run_2_treatment "chloroquine"
3 Q0 9463314 686 22.800465 imi_mug_run_2_treatment "level"
3 Q0 22535887 687 22.792393 imi_mug_run_2_treatment "androgens" "anti-androgens" "androgen"
3 Q0 25925376 688 22.786367 imi_mug_run_2_treatment "insulin" "thiazolidinediones"
3 Q0 25434580 689 22.786367 imi_mug_run_2_treatment "level"
3 Q0 27121065 690 22.78508 imi_mug_run_2_treatment "mediated"
3 Q0 26100239 691 22.773514 imi_mug_run_2_treatment "nsaids" "pge2" "anti-inflammatory"
3 Q0 9520945 692 22.746378 imi_mug_run_2_treatment "animals" "androgen"
3 Q0 9645768 693 22.746378 imi_mug_run_2_treatment "animals" "androgen"
3 Q0 28387728 694 22.725178 imi_mug_run_2_treatment "etoposide" "serine"
3 Q0 28527622 695 22.721035 imi_mug_run_2_treatment "various" "ddc" "lead"
3 Q0 11410879 696 22.693981 imi_mug_run_2_treatment "program"
3 Q0 27127173 697 22.693068 imi_mug_run_2_treatment "androgen" "bicalutamide" "level"
3 Q0 18026134 698 22.680822 imi_mug_run_2_treatment "igf-1"
3 Q0 21765465 699 22.67397 imi_mug_run_2_treatment "serine"
3 Q0 29123407 700 22.669516 imi_mug_run_2_treatment "ors"
3 Q0 9719026 701 22.650784 imi_mug_run_2_treatment "androgen" "level"
3 Q0 14630541 702 22.648926 imi_mug_run_2_treatment "various" "mediated" "product"
3 Q0 25086746 703 22.646305 imi_mug_run_2_treatment "mediated"
3 Q0 30384829 704 22.64569 imi_mug_run_2_treatment "ors"
3 Q0 8843193 705 22.641237 imi_mug_run_2_treatment "level"
3 Q0 10223244 706 22.639948 imi_mug_run_2_treatment "basis"
3 Q0 26674120 707 22.636377 imi_mug_run_2_treatment "platinum"
3 Q0 29284790 708 22.629139 imi_mug_run_2_treatment "mediated"
3 Q0 26001649 709 22.625313 imi_mug_run_2_treatment "antiviral"
3 Q0 10550055 710 22.623209 imi_mug_run_2_treatment "glutamine" "serine" "suppressor"
3 Q0 29451339 711 22.605324 imi_mug_run_2_treatment "androgen"
3 Q0 30042009 712 22.603453 imi_mug_run_2_treatment "oxaliplatin" "irinotecan" "ras"
3 Q0 26640144 713 22.599125 imi_mug_run_2_treatment "ras" "histone deacetylase inhibitor lbh589"
3 Q0 18632643 714 22.59652 imi_mug_run_2_treatment "drug" "aurothiomalate" "gemcitabine"
3 Q0 11723137 715 22.57275 imi_mug_run_2_treatment "oxygen"
3 Q0 21664238 716 22.562326 imi_mug_run_2_treatment "agonist" "androgens" "retinoic acid"
3 Q0 17582598 717 22.535477 imi_mug_run_2_treatment "ors"
3 Q0 15213104 718 22.532038 imi_mug_run_2_treatment "antioxidant" "antioxidants" "agent"
3 Q0 25659035 719 22.527096 imi_mug_run_2_treatment "mediated" "drugs" "etoposide"
3 Q0 21187516 720 22.516743 imi_mug_run_2_treatment "aim"
3 Q0 29445900 721 22.512522 imi_mug_run_2_treatment "various" "level"
3 Q0 16690595 722 22.503681 imi_mug_run_2_treatment "caffeine"
3 Q0 22552540 723 22.484005 imi_mug_run_2_treatment "various" "proteasome inhibitor" "bortezomib"
3 Q0 15642165 724 22.469498 imi_mug_run_2_treatment "msm" "animals"
3 Q0 24672777 725 22.46898 imi_mug_run_2_treatment "androgen"
3 Q0 21389785 726 22.465435 imi_mug_run_2_treatment "mitogen"
3 Q0 25043304 727 22.45715 imi_mug_run_2_treatment "replication inhibitors" "kinase inhibitor"
3 Q0 26889902 728 22.447987 imi_mug_run_2_treatment "hla-g"
3 Q0 17457059 729 22.43232 imi_mug_run_2_treatment "various" "aim"
3 Q0 19823874 730 22.412321 imi_mug_run_2_treatment "basis" "bps"
3 Q0 20709753 731 22.404953 imi_mug_run_2_treatment "oxygen" "kinase inhibitor" "selenium"
3 Q0 23632475 732 22.404953 imi_mug_run_2_treatment "metformin"
3 Q0 11821961 733 22.393177 imi_mug_run_2_treatment "dsb"
3 Q0 22529920 734 22.381872 imi_mug_run_2_treatment "various" "medicine"
3 Q0 23974097 735 22.381872 imi_mug_run_2_treatment "mediated"
3 Q0 18080842 736 22.372898 imi_mug_run_2_treatment "mediated" "bile acid"
3 Q0 15558185 737 22.369143 imi_mug_run_2_treatment "androgen" "aim"
3 Q0 7585512 738 22.358774 imi_mug_run_2_treatment "mediated" "suppressor"
3 Q0 27991924 739 22.358315 imi_mug_run_2_treatment "anakinra" "interleukin" "level"
3 Q0 29616191 740 22.3437 imi_mug_run_2_treatment "lead"
3 Q0 11285218 741 22.316788 imi_mug_run_2_treatment "superoxide dismutase"
3 Q0 10561187 742 22.307274 imi_mug_run_2_treatment "yeast"
3 Q0 17428325 743 22.303463 imi_mug_run_2_treatment "aim"
3 Q0 27602502 744 22.303192 imi_mug_run_2_treatment "topoisomerase inhibitors"
3 Q0 15101044 745 22.297974 imi_mug_run_2_treatment "level"
3 Q0 29209046 746 22.291306 imi_mug_run_2_treatment "mediated"
3 Q0 22438227 747 22.28895 imi_mug_run_2_treatment "dtc"
3 Q0 19886863 748 22.277704 imi_mug_run_2_treatment "mediated" "suppressor" "androgen"
3 Q0 12827413 749 22.277409 imi_mug_run_2_treatment "various" "fluorophore" "level"
3 Q0 23962904 750 22.274073 imi_mug_run_2_treatment "gold" "aurothiomalate" "duration"
3 Q0 10802669 751 22.270128 imi_mug_run_2_treatment "serine"
3 Q0 14745549 752 22.269867 imi_mug_run_2_treatment "mediated"
3 Q0 23761041 753 22.259054 imi_mug_run_2_treatment "various"
3 Q0 10526131 754 22.258783 imi_mug_run_2_treatment "product" "others" "monoclonal antibodies"
3 Q0 23128467 755 22.24706 imi_mug_run_2_treatment "various" "n-acetylcysteine" "antioxidant"
3 Q0 29088757 756 22.244736 imi_mug_run_2_treatment "cisplatin" "cetuximab" "drugs"
3 Q0 20945390 757 22.236362 imi_mug_run_2_treatment "various" "aurothiomalate"
3 Q0 23715497 758 22.213156 imi_mug_run_2_treatment "ors"
3 Q0 21878536 759 22.203688 imi_mug_run_2_treatment "medicine"
3 Q0 30108746 760 22.202194 imi_mug_run_2_treatment "drugs"
3 Q0 12447382 761 22.199017 imi_mug_run_2_treatment "thr"
3 Q0 19626507 762 22.190235 imi_mug_run_2_treatment "growth hormone"
3 Q0 22536770 763 22.185867 imi_mug_run_2_treatment "vitamin d" "agonists" "dihydroxyvitamin d"
3 Q0 17697391 764 22.18158 imi_mug_run_2_treatment "phosphate"
3 Q0 22860005 765 22.181416 imi_mug_run_2_treatment "androgen"
3 Q0 11571711 766 22.180565 imi_mug_run_2_treatment "various" "cy5.5"
3 Q0 17482558 767 22.178621 imi_mug_run_2_treatment "estrogen" "androgens" "androgen"
3 Q0 20177704 768 22.172743 imi_mug_run_2_treatment "various"
3 Q0 25450480 769 22.150375 imi_mug_run_2_treatment "jaridonin" "mediated" "oxygen"
3 Q0 22022528 770 22.14887 imi_mug_run_2_treatment "androgen" "androgens" "mediated"
3 Q0 24664372 771 22.13056 imi_mug_run_2_treatment "pma" "il-6" "celastrol"
3 Q0 28477111 772 22.12534 imi_mug_run_2_treatment "hts" "serine"
3 Q0 22266865 773 22.114347 imi_mug_run_2_treatment "androgen" "tandem"
3 Q0 25827888 774 22.106983 imi_mug_run_2_treatment "drugs" "mediated" "others"
3 Q0 22468268 775 22.094675 imi_mug_run_2_treatment "basis"
3 Q0 28659719 776 22.091404 imi_mug_run_2_treatment "drug" "pressor"
3 Q0 25015038 777 22.08865 imi_mug_run_2_treatment "androgen" "serine"
3 Q0 15485651 778 22.08307 imi_mug_run_2_treatment "alpha subunit" "igf-1" "tyrosine"
3 Q0 25585815 779 22.036415 imi_mug_run_2_treatment "dsb" "level"
3 Q0 16938570 780 22.029873 imi_mug_run_2_treatment "color"
3 Q0 8886993 781 22.015816 imi_mug_run_2_treatment "various" "mediators" "lead"
3 Q0 24933654 782 22.014019 imi_mug_run_2_treatment "resveratrol" "enzymes" "oxygen"
3 Q0 11677656 783 22.002272 imi_mug_run_2_treatment "caffeine" "methyl xanthines" "radiosensitizer"
3 Q0 26097887 784 21.956171 imi_mug_run_2_treatment "serine" "parp inhibitor" "cytotoxic"
3 Q0 18181094 785 21.948435 imi_mug_run_2_treatment "angiotensin" "angiotensin ii" "drugs"
3 Q0 30385821 786 21.941158 imi_mug_run_2_treatment "azd0156" "irinotecan" "mediated"
3 Q0 26732650 787 21.934925 imi_mug_run_2_treatment "mediated"
3 Q0 10412041 788 21.934193 imi_mug_run_2_treatment "dihydrotestosterone"
3 Q0 22639407 789 21.931906 imi_mug_run_2_treatment "trastuzumab" "aim"
3 Q0 25232030 790 21.915672 imi_mug_run_2_treatment "agent" "dsb"
3 Q0 30118648 791 21.902313 imi_mug_run_2_treatment "plasma" "crizotinib"
3 Q0 20544271 792 21.901163 imi_mug_run_2_treatment "pooled"
3 Q0 24179529 793 21.85146 imi_mug_run_2_treatment "mediated"
3 Q0 15987456 794 21.847895 imi_mug_run_2_treatment "isoleucine" "mediated"
3 Q0 23913163 795 21.844841 imi_mug_run_2_treatment "mediated" "prophylactic" "monoclonal antibodies"
3 Q0 24819391 796 21.839123 imi_mug_run_2_treatment "oil"
3 Q0 25970706 797 21.832731 imi_mug_run_2_treatment "antioxidant" "mediated" "level"
3 Q0 18634022 798 21.831488 imi_mug_run_2_treatment "isolate"
3 Q0 22374981 799 21.83103 imi_mug_run_2_treatment "bisulfite"
3 Q0 22350747 800 21.829111 imi_mug_run_2_treatment "animals" "product" "basis"
3 Q0 23880210 801 21.823925 imi_mug_run_2_treatment "nsaid" "nsaids" "anti-inflammatory"
3 Q0 25093639 802 21.821983 imi_mug_run_2_treatment "fiber" "animals"
3 Q0 25701194 803 21.816387 imi_mug_run_2_treatment "various" "cddp" "topoisomerase i inhibitor"
3 Q0 16906133 804 21.77742 imi_mug_run_2_treatment "serine" "lead" "level"
3 Q0 15279808 805 21.77723 imi_mug_run_2_treatment "product" "lead"
3 Q0 30124550 806 21.77723 imi_mug_run_2_treatment "tribe"
3 Q0 11378498 807 21.768139 imi_mug_run_2_treatment "lead" "nervous system"
3 Q0 11181458 808 21.763084 imi_mug_run_2_treatment "lead"
3 Q0 20133707 809 21.761425 imi_mug_run_2_treatment "mediated"
3 Q0 29434792 810 21.761425 imi_mug_run_2_treatment "pine needle oil" "various" "medicines"
3 Q0 27958289 811 21.753475 imi_mug_run_2_treatment "mediated"
3 Q0 27410227 812 21.737392 imi_mug_run_2_treatment "drugs" "medicine" "level"
3 Q0 30430607 813 21.72838 imi_mug_run_2_treatment "various"
3 Q0 23293085 814 21.720428 imi_mug_run_2_treatment "cytokines" "therapeutic agent"
3 Q0 12949948 815 21.711872 imi_mug_run_2_treatment "pdt" "m-thpc" "mediated"
3 Q0 22079189 816 21.710365 imi_mug_run_2_treatment "various" "enzymes" "oxygen"
3 Q0 19052253 817 21.706253 imi_mug_run_2_treatment "glucose" "vitamin-d" "thioredoxin"
3 Q0 21232124 818 21.69529 imi_mug_run_2_treatment "various" "level"
3 Q0 25436982 819 21.694265 imi_mug_run_2_treatment "estrogen" "glucose" "androgens"
3 Q0 22745041 820 21.694265 imi_mug_run_2_treatment "cytokines" "asc"
3 Q0 21360561 821 21.685879 imi_mug_run_2_treatment "androgen" "selenium"
3 Q0 21467295 822 21.67658 imi_mug_run_2_treatment "phosphate" "glucose" "suppressor"
3 Q0 10639175 823 21.6747 imi_mug_run_2_treatment "nervous system"
3 Q0 10082576 824 21.665928 imi_mug_run_2_treatment "mediated"
3 Q0 10999741 825 21.6587 imi_mug_run_2_treatment "mediated" "monoclonal antibodies"
3 Q0 10500142 826 21.6587 imi_mug_run_2_treatment "serine" "level"
3 Q0 23211021 827 21.655994 imi_mug_run_2_treatment "cddp" "cisplatin" "food"
3 Q0 9048833 828 21.652195 imi_mug_run_2_treatment "cytotoxic" "psa-3" "basis"
3 Q0 28543935 829 21.647661 imi_mug_run_2_treatment "oxygen"
3 Q0 11438715 830 21.63796 imi_mug_run_2_treatment "suppressor"
3 Q0 9219834 831 21.63029 imi_mug_run_2_treatment "various"
3 Q0 17634425 832 21.626133 imi_mug_run_2_treatment "kinase inhibitor"
3 Q0 11181576 833 21.607397 imi_mug_run_2_treatment "yeast"
3 Q0 27106737 834 21.607397 imi_mug_run_2_treatment "aim"
3 Q0 15048089 835 21.60342 imi_mug_run_2_treatment "serine" "suppressor"
3 Q0 24662325 836 21.588182 imi_mug_run_2_treatment "androgen"
3 Q0 10657015 837 21.584484 imi_mug_run_2_treatment "cytotoxic"
3 Q0 19081794 838 21.576263 imi_mug_run_2_treatment "pace" "androgen" "tamoxifen"
3 Q0 10051159 839 21.572048 imi_mug_run_2_treatment "various"
3 Q0 24763056 840 21.56905 imi_mug_run_2_treatment "dsb" "mediated" "basis"
3 Q0 18066087 841 21.558987 imi_mug_run_2_treatment "agent"
3 Q0 23408915 842 21.558582 imi_mug_run_2_treatment "suppressor"
3 Q0 16820092 843 21.55666 imi_mug_run_2_treatment "color"
3 Q0 21603857 844 21.525612 imi_mug_run_2_treatment "pooled"
3 Q0 12520005 845 21.510296 imi_mug_run_2_treatment "edu" "sage"
3 Q0 29111814 846 21.50193 imi_mug_run_2_treatment "sarsaparilla" "kinase inhibitor" "water"
3 Q0 12496286 847 21.499912 imi_mug_run_2_treatment "cytotoxic" "dsb"
3 Q0 17166755 848 21.496284 imi_mug_run_2_treatment "aim"
3 Q0 17998902 849 21.490026 imi_mug_run_2_treatment "mediated"
3 Q0 16329039 850 21.490026 imi_mug_run_2_treatment "product" "aim"
3 Q0 19061978 851 21.490026 imi_mug_run_2_treatment "mediated" "agent" "animals"
3 Q0 9843217 852 21.490026 imi_mug_run_2_treatment "serine" "inositol"
3 Q0 1337629 853 21.489475 imi_mug_run_2_treatment "urokinase" "plasminogen activator"
3 Q0 26250606 854 21.489475 imi_mug_run_2_treatment "azd6244" "drug combination" "ras"
3 Q0 11429421 855 21.486652 imi_mug_run_2_treatment "suppressor"
3 Q0 17052263 856 21.485348 imi_mug_run_2_treatment "aza" "agent"
3 Q0 12796033 857 21.471586 imi_mug_run_2_treatment "antimetabolites" "epirubicin" "busulfan"
3 Q0 10716718 858 21.471586 imi_mug_run_2_treatment "animals"
3 Q0 29317520 859 21.455925 imi_mug_run_2_treatment "mediated"
3 Q0 23555296 860 21.455013 imi_mug_run_2_treatment "dsb"
3 Q0 12969974 861 21.44737 imi_mug_run_2_treatment "mediated"
3 Q0 16849690 862 21.44737 imi_mug_run_2_treatment "cisplatin" "various" "mediated"
3 Q0 24469230 863 21.43841 imi_mug_run_2_treatment "basis"
3 Q0 23582881 864 21.434998 imi_mug_run_2_treatment "everolimus" "agent"
3 Q0 23969480 865 21.422375 imi_mug_run_2_treatment "others"
3 Q0 10467728 866 21.420591 imi_mug_run_2_treatment "product"
3 Q0 12850144 867 21.420542 imi_mug_run_2_treatment "calcium" "ionomycin" "ionophore"
3 Q0 19079244 868 21.405085 imi_mug_run_2_treatment "dsb" "lead" "lys"
3 Q0 20124459 869 21.405085 imi_mug_run_2_treatment "parp inhibitors" "olaparib" "azd2281"
3 Q0 16897747 870 21.39275 imi_mug_run_2_treatment "com" "basis"
3 Q0 27347141 871 21.39217 imi_mug_run_2_treatment "alkaloids" "oxygen"
3 Q0 26528698 872 21.386461 imi_mug_run_2_treatment "interleukin 6" "il-6"
3 Q0 29921885 873 21.376472 imi_mug_run_2_treatment "oxygen" "mediated" "kinase inhibitor"
3 Q0 15975956 874 21.363201 imi_mug_run_2_treatment "resveratrol" "caffeine" "chemopreventive agents"
3 Q0 28212573 875 21.358019 imi_mug_run_2_treatment "cisplatin" "parp inhibitors" "pdx"
3 Q0 17916567 876 21.322598 imi_mug_run_2_treatment "androgen" "charcoal" "dihydrotestosterone"
3 Q0 24478054 877 21.318033 imi_mug_run_2_treatment "mediated" "ap4"
3 Q0 28779143 878 21.30309 imi_mug_run_2_treatment "tamoxifen" "fulvestrant" "endocrine therapy"
3 Q0 18511169 879 21.28491 imi_mug_run_2_treatment "mediated" "caffeine" "blockade"
3 Q0 26595875 880 21.28491 imi_mug_run_2_treatment "oxygen" "suppressor"
3 Q0 9000145 881 21.27402 imi_mug_run_2_treatment "antisera"
3 Q0 16774833 882 21.26294 imi_mug_run_2_treatment "mediated" "dsb" "lead"
3 Q0 24965423 883 21.253265 imi_mug_run_2_treatment "hla-g"
3 Q0 29186352 884 21.252893 imi_mug_run_2_treatment "mediated" "prolactin" "collagen"
3 Q0 9623796 885 21.251328 imi_mug_run_2_treatment "mta" "methionine" "s-adenosylmethionine"
3 Q0 21490603 886 21.23088 imi_mug_run_2_treatment "drugs"
3 Q0 20160076 887 21.225853 imi_mug_run_2_treatment "oxygen"
3 Q0 15603757 888 21.223425 imi_mug_run_2_treatment "product"
3 Q0 17932249 889 21.210596 imi_mug_run_2_treatment "dsb"
3 Q0 29463243 890 21.205235 imi_mug_run_2_treatment "fluorouracil" "gemcitabine" "cytotoxic"
3 Q0 10839545 891 21.199884 imi_mug_run_2_treatment "hydroxyurea" "serine"
3 Q0 29500880 892 21.199184 imi_mug_run_2_treatment "triptolide" "fluorouracil" "paclitaxel"
3 Q0 28968864 893 21.194967 imi_mug_run_2_treatment "camptothecin" "oxygen" "dsb"
3 Q0 14987398 894 21.193562 imi_mug_run_2_treatment "lead"
3 Q0 28383660 895 21.188667 imi_mug_run_2_treatment "dsb"
3 Q0 11472063 896 21.184843 imi_mug_run_2_treatment "suppressor" "liver"
3 Q0 21885618 897 21.177973 imi_mug_run_2_treatment "mediated" "acetylcholine" "atropine"
3 Q0 29082250 898 21.157743 imi_mug_run_2_treatment "lead" "drugs" "mediated"
3 Q0 29293464 899 21.155052 imi_mug_run_2_treatment "aim"
3 Q0 26344566 900 21.14526 imi_mug_run_2_treatment "lys" "oxygen" "product"
3 Q0 24572510 901 21.14526 imi_mug_run_2_treatment "dsb"
3 Q0 16325375 902 21.138906 imi_mug_run_2_treatment "level"
3 Q0 20869334 903 21.131737 imi_mug_run_2_treatment "level"
3 Q0 11443540 904 21.131536 imi_mug_run_2_treatment "others"
3 Q0 27690730 905 21.131496 imi_mug_run_2_treatment "copper" "antioxidants" "metal chelator"
3 Q0 14681694 906 21.126024 imi_mug_run_2_treatment "viral vector"
3 Q0 20932476 907 21.125092 imi_mug_run_2_treatment "mediated" "leucine" "lysine"
3 Q0 26124008 908 21.122883 imi_mug_run_2_treatment "ferulic acid" "phenolic" "lead"
3 Q0 24988892 909 21.121769 imi_mug_run_2_treatment "interleukin 6" "il-6" "camptothecin"
3 Q0 24706497 910 21.120499 imi_mug_run_2_treatment "caffeine" "sp600125" "level"
3 Q0 21850541 911 21.114582 imi_mug_run_2_treatment "oestrogen"
3 Q0 16423061 912 21.110378 imi_mug_run_2_treatment "androgen" "level"
3 Q0 15680327 913 21.101452 imi_mug_run_2_treatment "mediated" "level"
3 Q0 9363685 914 21.101452 imi_mug_run_2_treatment "oxygen"
3 Q0 27552096 915 21.098171 imi_mug_run_2_treatment "tamoxifen" "adjuvant"
3 Q0 17699764 916 21.071833 imi_mug_run_2_treatment "animals"
3 Q0 9043869 917 21.062561 imi_mug_run_2_treatment "product"
3 Q0 21184746 918 21.055763 imi_mug_run_2_treatment "various" "mustard" "kinase inhibitor"
3 Q0 15905204 919 21.036106 imi_mug_run_2_treatment "mediated" "lead"
3 Q0 9778451 920 21.032433 imi_mug_run_2_treatment "level" "animals"
3 Q0 19147782 921 20.998165 imi_mug_run_2_treatment "ors"
3 Q0 29973717 922 20.996906 imi_mug_run_2_treatment "parp inhibitor" "parp inhibitors" "olaparib"
3 Q0 27922010 923 20.983335 imi_mug_run_2_treatment "drugs" "drug" "ras"
3 Q0 25742469 924 20.975761 imi_mug_run_2_treatment "dsb"
3 Q0 27308506 925 20.966423 imi_mug_run_2_treatment "therapeutics"
3 Q0 15707575 926 20.965437 imi_mug_run_2_treatment "nervous system"
3 Q0 14732919 927 20.962324 imi_mug_run_2_treatment "level"
3 Q0 18091327 928 20.958996 imi_mug_run_2_treatment "gln" "antisera"
3 Q0 9096660 929 20.955206 imi_mug_run_2_treatment "various" "level"
3 Q0 16618753 930 20.95435 imi_mug_run_2_treatment "nh2" "level"
3 Q0 9521587 931 20.941633 imi_mug_run_2_treatment "glutamic acid"
3 Q0 11078475 932 20.922506 imi_mug_run_2_treatment "lead"
3 Q0 21157431 933 20.922506 imi_mug_run_2_treatment "phosphate" "oxygen" "dsb"
3 Q0 16781197 934 20.920446 imi_mug_run_2_treatment "n-acetyl cysteine" "antioxidant" "n-acetyl-l-cysteine"
3 Q0 17979628 935 20.919744 imi_mug_run_2_treatment "lead"
3 Q0 25870146 936 20.918434 imi_mug_run_2_treatment "antioxidants" "oxygen"
3 Q0 24210080 937 20.917288 imi_mug_run_2_treatment "radiosensitizer" "mediated" "darinaparsin"
3 Q0 24943687 938 20.910278 imi_mug_run_2_treatment "arecoline" "mediated" "aim"
3 Q0 14532133 939 20.907755 imi_mug_run_2_treatment "various" "mediated" "dsb"
3 Q0 25598069 940 20.907755 imi_mug_run_2_treatment "level"
3 Q0 19431188 941 20.904875 imi_mug_run_2_treatment "serine" "dsb"
3 Q0 10212258 942 20.897259 imi_mug_run_2_treatment "mediated"
3 Q0 16883603 943 20.89096 imi_mug_run_2_treatment "hdac inhibitor" "mediated"
3 Q0 14978791 944 20.877783 imi_mug_run_2_treatment "sage" "com" "lead"
3 Q0 18674748 945 20.877783 imi_mug_run_2_treatment "level"
3 Q0 28986972 946 20.877783 imi_mug_run_2_treatment "tumor infiltrating lymphocytes"
3 Q0 21833744 947 20.869991 imi_mug_run_2_treatment "level" "others"
3 Q0 9735416 948 20.858173 imi_mug_run_2_treatment "favoring"
3 Q0 20177072 949 20.858173 imi_mug_run_2_treatment "human mammary gland"
3 Q0 11536304 950 20.84938 imi_mug_run_2_treatment "kinase inhibitor" "bisulfite" "methylated"
3 Q0 18652909 951 20.844582 imi_mug_run_2_treatment "vitamin a" "various" "lecithin"
3 Q0 16180724 952 20.843435 imi_mug_run_2_treatment "program"
3 Q0 23912341 953 20.839619 imi_mug_run_2_treatment "lead"
3 Q0 21245467 954 20.839619 imi_mug_run_2_treatment "drugs" "program"
3 Q0 23734213 955 20.836212 imi_mug_run_2_treatment "mediated" "yeast"
3 Q0 19282387 956 20.791576 imi_mug_run_2_treatment "androgen"
3 Q0 11604086 957 20.783722 imi_mug_run_2_treatment "yeast" "product" "lead"
3 Q0 25483091 958 20.777775 imi_mug_run_2_treatment "various" "hme"
3 Q0 25384174 959 20.772379 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
3 Q0 16971224 960 20.772095 imi_mug_run_2_treatment "level" "aim"
3 Q0 10441482 961 20.767488 imi_mug_run_2_treatment "nnk" "butanone"
3 Q0 24505404 962 20.765713 imi_mug_run_2_treatment "cucurbitacin b" "mediated" "n-acetyl-l-cysteine"
3 Q0 9244351 963 20.756413 imi_mug_run_2_treatment "various" "drug" "neocarzinostatin"
3 Q0 26320393 964 20.753578 imi_mug_run_2_treatment "serine" "aim"
3 Q0 20396981 965 20.70066 imi_mug_run_2_treatment "aim"
3 Q0 30257201 966 20.70066 imi_mug_run_2_treatment "bfl" "bcl-2 inhibitor" "cytotoxic"
3 Q0 15743681 967 20.693552 imi_mug_run_2_treatment "isolate"
3 Q0 24247298 968 20.68471 imi_mug_run_2_treatment "clofibrate"
3 Q0 9241281 969 20.683634 imi_mug_run_2_treatment "combinations" "level"
3 Q0 10713094 970 20.673283 imi_mug_run_2_treatment "serine" "wortmannin"
3 Q0 27461642 971 20.660131 imi_mug_run_2_treatment "various" "duration" "aim"
3 Q0 9088271 972 20.646902 imi_mug_run_2_treatment "calcium"
3 Q0 17912448 973 20.636684 imi_mug_run_2_treatment "glutamic acid" "mediated" "monoclonal antibodies"
3 Q0 17654723 974 20.63366 imi_mug_run_2_treatment "various"
3 Q0 14528023 975 20.63174 imi_mug_run_2_treatment "tac" "mediated"
3 Q0 23022474 976 20.613302 imi_mug_run_2_treatment "mediated" "therapeutics"
3 Q0 25705129 977 20.612017 imi_mug_run_2_treatment "antioxidant" "h2o2" "level"
3 Q0 24012678 978 20.607914 imi_mug_run_2_treatment "mediated"
3 Q0 19879149 979 20.579544 imi_mug_run_2_treatment "serine"
3 Q0 26851027 980 20.56837 imi_mug_run_2_treatment "mediated" "calcium" "dantrolene"
3 Q0 11025389 981 20.561172 imi_mug_run_2_treatment "basis"
3 Q0 17632790 982 20.558207 imi_mug_run_2_treatment "dsb" "lead"
3 Q0 15269180 983 20.558207 imi_mug_run_2_treatment "mediated"
3 Q0 23928469 984 20.558207 imi_mug_run_2_treatment "topotecan" "dsb" "mediated"
3 Q0 26512707 985 20.538595 imi_mug_run_2_treatment "dsb"
3 Q0 24240686 986 20.524485 imi_mug_run_2_treatment "serine" "level" "suppressor"
3 Q0 22653913 987 20.524485 imi_mug_run_2_treatment "serine"
3 Q0 22207345 988 20.514189 imi_mug_run_2_treatment "vitamin d" "mediated" "dihydroxyvitamin d"
3 Q0 10949395 989 20.481441 imi_mug_run_2_treatment "platinum"
4 Q0 9892105 1 53.888245 imi_mug_run_2_treatment "gastrin"
4 Q0 25820598 2 49.86545 imi_mug_run_2_treatment "basis"
4 Q0 27864121 3 46.92198 imi_mug_run_2_treatment "color"
4 Q0 28099468 4 46.852806 imi_mug_run_2_treatment "suppressor"
4 Q0 28160563 5 45.32332 imi_mug_run_2_treatment "cisplatin" "fluorouracil"
4 Q0 2253224 6 45.159798 imi_mug_run_2_treatment "ras"
4 Q0 15640503 7 44.83158 imi_mug_run_2_treatment "fluorouracil"
4 Q0 16490596 8 44.780373 imi_mug_run_2_treatment "level"
4 Q0 16309427 9 44.629448 imi_mug_run_2_treatment "ras"
4 Q0 23238628 10 44.598507 imi_mug_run_2_treatment "silver" "trastuzumab"
4 Q0 25047501 11 43.983177 imi_mug_run_2_treatment "kato" "monolayer"
4 Q0 29686309 12 43.751 imi_mug_run_2_treatment "various" "mediated"
4 Q0 23460348 13 43.605694 imi_mug_run_2_treatment "trastuzumab"
4 Q0 26489445 14 43.46012 imi_mug_run_2_treatment "formalin" "basis" "level"
4 Q0 25743022 15 42.936565 imi_mug_run_2_treatment "aim"
4 Q0 24492292 16 42.820107 imi_mug_run_2_treatment "trastuzumab" "saracatinib" "drug"
4 Q0 20331976 17 42.74079 imi_mug_run_2_treatment "tyrosine"
4 Q0 22591714 18 42.34755 imi_mug_run_2_treatment "kinase inhibitor" "mediated" "product"
4 Q0 30008904 19 42.179337 imi_mug_run_2_treatment "trastuzumab" "oxaliplatin" "capecitabine"
4 Q0 22899293 20 42.04499 imi_mug_run_2_treatment "level" "monoclonal antibodies"
4 Q0 24935174 21 42.04428 imi_mug_run_2_treatment "therapeutics" "azd6244"
4 Q0 17431415 22 41.899063 imi_mug_run_2_treatment "various combinations" "color" "level"
4 Q0 26435392 23 40.85829 imi_mug_run_2_treatment "mediated"
4 Q0 21406037 24 40.721844 imi_mug_run_2_treatment "drugs" "trastuzumab" "therapeutic agents"
4 Q0 30123134 25 40.70854 imi_mug_run_2_treatment "drug" "drugs" "atra"
4 Q0 23327903 26 40.593636 imi_mug_run_2_treatment "aim"
4 Q0 27048593 27 40.460045 imi_mug_run_2_treatment "forchlorfenuron" "basis" "level"
4 Q0 1970690 28 40.308025 imi_mug_run_2_treatment "epidermal growth factor"
4 Q0 7904177 29 40.284645 imi_mug_run_2_treatment "product"
4 Q0 12527905 30 40.138477 imi_mug_run_2_treatment "estrogens" "estradiol" "tamoxifen"
4 Q0 23658725 31 40.13025 imi_mug_run_2_treatment "suppressor"
4 Q0 19956838 32 40.045204 imi_mug_run_2_treatment "various" "drug" "insulin"
4 Q0 22292935 33 39.79935 imi_mug_run_2_treatment "level"
4 Q0 16770086 34 39.462147 imi_mug_run_2_treatment "level" "aim" "liver"
4 Q0 1351679 35 39.377186 imi_mug_run_2_treatment "level"
4 Q0 20658094 36 39.37473 imi_mug_run_2_treatment "lead"
4 Q0 27363335 37 39.277714 imi_mug_run_2_treatment "combinations" "trastuzumab" "pertuzumab"
4 Q0 7656779 38 39.18447 imi_mug_run_2_treatment "level"
4 Q0 25590580 39 39.08327 imi_mug_run_2_treatment "ras" "aim"
4 Q0 10535875 40 38.91649 imi_mug_run_2_treatment "various" "aim"
4 Q0 24505629 41 38.8861 imi_mug_run_2_treatment "various"
4 Q0 24186136 42 38.834923 imi_mug_run_2_treatment "product"
4 Q0 16273224 43 38.794563 imi_mug_run_2_treatment "mediated" "therapeutic agents" "lead"
4 Q0 19269014 44 38.71354 imi_mug_run_2_treatment "trastuzumab" "her-2"
4 Q0 19945923 45 38.600315 imi_mug_run_2_treatment "tandem" "level"
4 Q0 21220473 46 38.567516 imi_mug_run_2_treatment "trastuzumab"
4 Q0 24668364 47 38.535034 imi_mug_run_2_treatment "trastuzumab" "cetuximab"
4 Q0 12790321 48 38.421593 imi_mug_run_2_treatment "plasminogen activator" "epidermal growth factor"
4 Q0 11153605 49 38.394665 imi_mug_run_2_treatment "aim"
4 Q0 27156933 50 38.377815 imi_mug_run_2_treatment "adjuvant" "trastuzumab"
4 Q0 23445612 51 38.27764 imi_mug_run_2_treatment "kinase inhibitor" "lapatinib" "drugs"
4 Q0 8096076 52 38.127094 imi_mug_run_2_treatment "m-amsa" "mitoxantrone" "topoisomerase inhibitors"
4 Q0 10474685 53 38.07692 imi_mug_run_2_treatment "digoxigenin" "aim"
4 Q0 1979253 54 37.889755 imi_mug_run_2_treatment "various"
4 Q0 25760308 55 37.850418 imi_mug_run_2_treatment "aim"
4 Q0 18506690 56 37.81254 imi_mug_run_2_treatment "aim"
4 Q0 24982406 57 37.764782 imi_mug_run_2_treatment "aim"
4 Q0 26955870 58 37.678864 imi_mug_run_2_treatment "various" "trastuzumab" "anti-erbb2 monoclonal antibody"
4 Q0 23493349 59 37.67862 imi_mug_run_2_treatment "azd4547" "fgfr inhibitor azd4547"
4 Q0 30120594 60 37.4802 imi_mug_run_2_treatment "color"
4 Q0 30442682 61 37.373917 imi_mug_run_2_treatment "drug" "bispecific antibodies" "therapeutics"
4 Q0 8453595 62 37.309006 imi_mug_run_2_treatment "various" "kato"
4 Q0 26314265 63 37.253254 imi_mug_run_2_treatment "combinations" "level"
4 Q0 21191688 64 37.19127 imi_mug_run_2_treatment "lead"
4 Q0 19331129 65 37.00727 imi_mug_run_2_treatment "combinations" "color"
4 Q0 26449765 66 36.948578 imi_mug_run_2_treatment "trastuzumab" "cetuximab" "lapatinib"
4 Q0 24530706 67 36.92437 imi_mug_run_2_treatment "mediated"
4 Q0 25509354 68 36.84101 imi_mug_run_2_treatment "various"
4 Q0 24718467 69 36.731583 imi_mug_run_2_treatment "aim" "monoclonal antibodies"
4 Q0 28027945 70 36.575165 imi_mug_run_2_treatment "medicine"
4 Q0 14719064 71 36.572403 imi_mug_run_2_treatment "gastrin"
4 Q0 22792519 72 36.384247 imi_mug_run_2_treatment "aim"
4 Q0 29044505 73 36.352646 imi_mug_run_2_treatment "various" "adjuvant"
4 Q0 11819416 74 36.33716 imi_mug_run_2_treatment "aim"
4 Q0 25882375 75 36.33299 imi_mug_run_2_treatment "crizotinib"
4 Q0 21424128 76 36.31705 imi_mug_run_2_treatment "various" "kinase inhibitor" "basis"
4 Q0 29352243 77 36.3143 imi_mug_run_2_treatment "tyrphostin" "mediated" "as1411"
4 Q0 10635296 78 36.261368 imi_mug_run_2_treatment "ras"
4 Q0 8585979 79 36.197426 imi_mug_run_2_treatment "ras"
4 Q0 20869748 80 36.08352 imi_mug_run_2_treatment "various"
4 Q0 26217940 81 35.99344 imi_mug_run_2_treatment "drugs"
4 Q0 7676688 82 35.99084 imi_mug_run_2_treatment "sam"
4 Q0 11786427 83 35.978214 imi_mug_run_2_treatment "androgen" "level" "trastuzumab"
4 Q0 18787015 84 35.885067 imi_mug_run_2_treatment "her-2"
4 Q0 21743497 85 35.792484 imi_mug_run_2_treatment "trastuzumab" "level"
4 Q0 18719096 86 35.66262 imi_mug_run_2_treatment "kinase inhibitor" "ras" "lapatinib"
4 Q0 22729845 87 35.506733 imi_mug_run_2_treatment "crizotinib" "kinase inhibitor" "mediated"
4 Q0 19545448 88 35.457047 imi_mug_run_2_treatment "ras" "level"
4 Q0 21787752 89 35.447678 imi_mug_run_2_treatment "agar"
4 Q0 15493579 90 35.44308 imi_mug_run_2_treatment "ras"
4 Q0 20696687 91 35.43563 imi_mug_run_2_treatment "various"
4 Q0 24982352 92 35.391953 imi_mug_run_2_treatment "various"
4 Q0 18258606 93 35.38686 imi_mug_run_2_treatment "mediated" "ag825" "ag1478"
4 Q0 28327938 94 35.311905 imi_mug_run_2_treatment "trastuzumab" "level" "plasma"
4 Q0 22315472 95 35.27996 imi_mug_run_2_treatment "ras" "agent" "dovitinib"
4 Q0 27067842 96 35.243153 imi_mug_run_2_treatment "trastuzumab"
4 Q0 20424000 97 35.14161 imi_mug_run_2_treatment "s-1" "trastuzumab" "lapatinib"
4 Q0 27366209 98 35.05401 imi_mug_run_2_treatment "aim"
4 Q0 24782606 99 35.052708 imi_mug_run_2_treatment "various" "drugs" "trastuzumab"
4 Q0 11525306 100 35.01718 imi_mug_run_2_treatment "plasminogen activator" "epidermal growth factor"
4 Q0 15300811 101 34.984818 imi_mug_run_2_treatment "mbc" "basis"
4 Q0 11114748 102 34.97266 imi_mug_run_2_treatment "various" "tyrosine" "sam"
4 Q0 29792724 103 34.926987 imi_mug_run_2_treatment "trastuzumab" "therapeutic antibody" "level"
4 Q0 9499914 104 34.83501 imi_mug_run_2_treatment "drugs" "product" "lead"
4 Q0 24566388 105 34.767193 imi_mug_run_2_treatment "mediated"
4 Q0 17369913 106 34.59585 imi_mug_run_2_treatment "estrogen"
4 Q0 29409051 107 34.586422 imi_mug_run_2_treatment "lapatinib" "plasma" "oxaliplatin"
4 Q0 25706252 108 34.425186 imi_mug_run_2_treatment "her-2" "adjuvant" "drugs"
4 Q0 27920471 109 34.384796 imi_mug_run_2_treatment "aim"
4 Q0 21516080 110 34.365326 imi_mug_run_2_treatment "trastuzumab" "basis"
4 Q0 26600930 111 34.3637 imi_mug_run_2_treatment "fluorouracil" "trastuzumab" "platinum"
4 Q0 9369962 112 34.32106 imi_mug_run_2_treatment "color"
4 Q0 16601278 113 34.299633 imi_mug_run_2_treatment "various" "drug" "herceptin"
4 Q0 10469452 114 34.18198 imi_mug_run_2_treatment "level" "lead"
4 Q0 15511476 115 34.1358 imi_mug_run_2_treatment "trastuzumab" "level"
4 Q0 16607561 116 34.13283 imi_mug_run_2_treatment "level"
4 Q0 20518902 117 34.10085 imi_mug_run_2_treatment "basis"
4 Q0 9413949 118 34.06142 imi_mug_run_2_treatment "ras"
4 Q0 27652326 119 34.036854 imi_mug_run_2_treatment "matrix"
4 Q0 26893657 120 33.982544 imi_mug_run_2_treatment "cisplatin"
4 Q0 26071215 121 33.977108 imi_mug_run_2_treatment "hla-g" "silver" "color"
4 Q0 16397024 122 33.9336 imi_mug_run_2_treatment "ras" "mediated"
4 Q0 15609344 123 33.92675 imi_mug_run_2_treatment "kato"
4 Q0 7912163 124 33.864334 imi_mug_run_2_treatment "drug" "tamoxifen" "adjuvant"
4 Q0 27926948 125 33.813534 imi_mug_run_2_treatment "level"
4 Q0 15668283 126 33.797607 imi_mug_run_2_treatment "trastuzumab" "her-2"
4 Q0 8104440 127 33.729004 imi_mug_run_2_treatment "enzymes" "anticancer agents" "retinoic acid"
4 Q0 30463996 128 33.684757 imi_mug_run_2_treatment "afatinib" "trastuzumab" "kinase inhibitor"
4 Q0 26404902 129 33.683395 imi_mug_run_2_treatment "crizotinib" "trastuzumab" "apatinib"
4 Q0 8664033 130 33.67221 imi_mug_run_2_treatment "plasma"
4 Q0 30520849 131 33.593735 imi_mug_run_2_treatment "trastuzumab" "bispecific antibody" "cytotoxic"
4 Q0 19881546 132 33.5924 imi_mug_run_2_treatment "mediated"
4 Q0 9885379 133 33.497353 imi_mug_run_2_treatment "ras"
4 Q0 24120871 134 33.476883 imi_mug_run_2_treatment "adjuvant" "trastuzumab"
4 Q0 12727839 135 33.470848 imi_mug_run_2_treatment "level"
4 Q0 24005419 136 33.33158 imi_mug_run_2_treatment "various"
4 Q0 11410482 137 33.30918 imi_mug_run_2_treatment "topo" "enzymes" "alkylator"
4 Q0 26514491 138 33.252472 imi_mug_run_2_treatment "product" "aim"
4 Q0 27197264 139 33.21563 imi_mug_run_2_treatment "antiangiogenesis agents" "monoclonal antibodies"
4 Q0 12362975 140 33.150425 imi_mug_run_2_treatment "estrogen"
4 Q0 16681882 141 33.11773 imi_mug_run_2_treatment "digoxin" "methylated"
4 Q0 22614071 142 33.087997 imi_mug_run_2_treatment "fluorouracil" "trastuzumab" "cisplatin"
4 Q0 17001161 143 33.0846 imi_mug_run_2_treatment "mbc"
4 Q0 16868827 144 33.081097 imi_mug_run_2_treatment "adjuvant" "endocrine therapy" "monoclonal antibodies"
4 Q0 26122232 145 33.032738 imi_mug_run_2_treatment "basis" "shape"
4 Q0 24421342 146 33.02059 imi_mug_run_2_treatment "trastuzumab" "immunotoxins"
4 Q0 24061039 147 32.975426 imi_mug_run_2_treatment "therapeutics"
4 Q0 22253521 148 32.970688 imi_mug_run_2_treatment "aim"
4 Q0 28901323 149 32.937363 imi_mug_run_2_treatment "trastuzumab"
4 Q0 19424877 150 32.87158 imi_mug_run_2_treatment "aspirin" "hoechst 33258" "agent"
4 Q0 20201928 151 32.832787 imi_mug_run_2_treatment "ag825" "ethanol" "human plasma"
4 Q0 15743507 152 32.811783 imi_mug_run_2_treatment "aim"
4 Q0 25649416 153 32.792355 imi_mug_run_2_treatment "tma" "color" "level"
4 Q0 12631589 154 32.771763 imi_mug_run_2_treatment "her-2"
4 Q0 9925423 155 32.696133 imi_mug_run_2_treatment "various" "ras"
4 Q0 19272639 156 32.638836 imi_mug_run_2_treatment "cisplatin" "cyclophosphamide" "paclitaxel"
4 Q0 23720052 157 32.629925 imi_mug_run_2_treatment "mediated"
4 Q0 21034468 158 32.59589 imi_mug_run_2_treatment "mediated" "ethanol" "antioxidant"
4 Q0 11156524 159 32.59446 imi_mug_run_2_treatment "various" "mediated" "lead"
4 Q0 14720371 160 32.53972 imi_mug_run_2_treatment "aim" "suppressor"
4 Q0 25414785 161 32.529575 imi_mug_run_2_treatment "sodium chloride"
4 Q0 22046346 162 32.51511 imi_mug_run_2_treatment "kinase inhibitor" "lapatinib" "cl-387785"
4 Q0 11321488 163 32.510593 imi_mug_run_2_treatment "color" "formaldehyde"
4 Q0 19466878 164 32.5097 imi_mug_run_2_treatment "drug" "drugs" "investigational drugs"
4 Q0 22440694 165 32.46193 imi_mug_run_2_treatment "various"
4 Q0 10066072 166 32.44404 imi_mug_run_2_treatment "tamoxifen" "antiestrogen" "adjuvant"
4 Q0 29095284 167 32.391937 imi_mug_run_2_treatment "trastuzumab" "ors" "aim"
4 Q0 21749294 168 32.38041 imi_mug_run_2_treatment "various" "agent"
4 Q0 7742600 169 32.330757 imi_mug_run_2_treatment "lead"
4 Q0 16414259 170 32.309486 imi_mug_run_2_treatment "tyrosine" "aim"
4 Q0 18339869 171 32.27791 imi_mug_run_2_treatment "mediated"
4 Q0 27791982 172 32.27021 imi_mug_run_2_treatment "lapatinib"
4 Q0 22760626 173 32.24629 imi_mug_run_2_treatment "trastuzumab" "aim"
4 Q0 7611785 174 32.185734 imi_mug_run_2_treatment "biotin"
4 Q0 10607920 175 32.15291 imi_mug_run_2_treatment "drug" "mediated" "lead"
4 Q0 18594210 176 32.147152 imi_mug_run_2_treatment "trastuzumab" "adjuvant" "agar"
4 Q0 28124769 177 32.139465 imi_mug_run_2_treatment "various"
4 Q0 9758367 178 32.119003 imi_mug_run_2_treatment "various"
4 Q0 24291029 179 32.10469 imi_mug_run_2_treatment "zinc" "tma"
4 Q0 1346086 180 32.098354 imi_mug_run_2_treatment "tissue inhibitor of metalloproteinase"
4 Q0 22711713 181 32.05825 imi_mug_run_2_treatment "trastuzumab" "medicines" "cetuximab"
4 Q0 23898077 182 32.046814 imi_mug_run_2_treatment "plasma" "level"
4 Q0 20371687 183 32.04071 imi_mug_run_2_treatment "level" "cyclophosphamide" "epirubicin"
4 Q0 26755150 184 32.0335 imi_mug_run_2_treatment "gold"
4 Q0 22752927 185 32.027195 imi_mug_run_2_treatment "trastuzumab" "agent"
4 Q0 25315765 186 32.01784 imi_mug_run_2_treatment "suppressor"
4 Q0 28028034 187 31.970684 imi_mug_run_2_treatment "kinase inhibitor" "everolimus" "pazopanib"
4 Q0 15289843 188 31.91877 imi_mug_run_2_treatment "various"
4 Q0 21169738 189 31.851751 imi_mug_run_2_treatment "trastuzumab" "drug" "medicines"
4 Q0 23198549 190 31.823744 imi_mug_run_2_treatment "lead"
4 Q0 23334330 191 31.8169 imi_mug_run_2_treatment "level"
4 Q0 17570480 192 31.806572 imi_mug_run_2_treatment "her-2"
4 Q0 19331154 193 31.776443 imi_mug_run_2_treatment "epidermal growth factor" "basis"
4 Q0 12942124 194 31.760735 imi_mug_run_2_treatment "lead"
4 Q0 18097546 195 31.758701 imi_mug_run_2_treatment "trastuzumab" "cisplatin" "oxaliplatin"
4 Q0 24115812 196 31.688852 imi_mug_run_2_treatment "drugs" "trastuzumab"
4 Q0 21345138 197 31.684057 imi_mug_run_2_treatment "trastuzumab"
4 Q0 18441328 198 31.652416 imi_mug_run_2_treatment "monoclonal antibodies"
4 Q0 24053468 199 31.646763 imi_mug_run_2_treatment "suppressor"
4 Q0 10809364 200 31.643995 imi_mug_run_2_treatment "biotin"
4 Q0 25789534 201 31.593555 imi_mug_run_2_treatment "trastuzumab"
4 Q0 21993851 202 31.58904 imi_mug_run_2_treatment "cytotoxic" "level"
4 Q0 24879917 203 31.561367 imi_mug_run_2_treatment "her-2"
4 Q0 27787520 204 31.559143 imi_mug_run_2_treatment "aim"
4 Q0 27008850 205 31.55316 imi_mug_run_2_treatment "silver" "aim" "others"
4 Q0 18781152 206 31.550407 imi_mug_run_2_treatment "various" "tma" "animals"
4 Q0 27542246 207 31.531305 imi_mug_run_2_treatment "mediated" "various" "drugs"
4 Q0 25109760 208 31.46359 imi_mug_run_2_treatment "level"
4 Q0 23529353 209 31.417744 imi_mug_run_2_treatment "epidermal growth factor" "ras" "trastuzumab"
4 Q0 8695221 210 31.385017 imi_mug_run_2_treatment "oestrogen" "toremifene" "level"
4 Q0 19787624 211 31.374798 imi_mug_run_2_treatment "interleukin-2" "tnf-alpha" "cytokines"
4 Q0 19214513 212 31.3586 imi_mug_run_2_treatment "trastuzumab" "color"
4 Q0 11205461 213 31.348291 imi_mug_run_2_treatment "tamoxifen" "adjuvant" "aim"
4 Q0 18361882 214 31.298685 imi_mug_run_2_treatment "product"
4 Q0 24127447 215 31.25755 imi_mug_run_2_treatment "trastuzumab" "level" "aim"
4 Q0 24492513 216 31.254059 imi_mug_run_2_treatment "trastuzumab"
4 Q0 29125480 217 31.2401 imi_mug_run_2_treatment "drugs" "trastuzumab"
4 Q0 24782605 218 31.229023 imi_mug_run_2_treatment "trastuzumab" "cisplatin" "capecitabine"
4 Q0 29089858 219 31.17229 imi_mug_run_2_treatment "cisplatin" "fluorouracil"
4 Q0 17100565 220 31.169518 imi_mug_run_2_treatment "various" "drug" "herceptin"
4 Q0 17101326 221 31.130764 imi_mug_run_2_treatment "adenosine triphosphate" "tyrosine kinase inhibitor" "aim"
4 Q0 17311002 222 31.111658 imi_mug_run_2_treatment "hki-272" "kinase inhibitor" "drugs"
4 Q0 8806095 223 31.07639 imi_mug_run_2_treatment "various" "cytotoxic drugs"
4 Q0 11107048 224 31.066486 imi_mug_run_2_treatment "kato"
4 Q0 30030278 225 31.019402 imi_mug_run_2_treatment "ado-trastuzumab emtansine"
4 Q0 28670959 226 31.003046 imi_mug_run_2_treatment "matrix"
4 Q0 22461643 227 30.983044 imi_mug_run_2_treatment "trastuzumab" "tyrosine kinase inhibitor" "lapatinib"
4 Q0 29786108 228 30.98244 imi_mug_run_2_treatment "lapatinib" "tyrosine" "aim"
4 Q0 18382352 229 30.980518 imi_mug_run_2_treatment "silver"
4 Q0 15646832 230 30.98045 imi_mug_run_2_treatment "drug" "herceptin"
4 Q0 24354242 231 30.97896 imi_mug_run_2_treatment "phenol" "biotin" "guanidinium"
4 Q0 21466710 232 30.970484 imi_mug_run_2_treatment "liver"
4 Q0 16153159 233 30.93705 imi_mug_run_2_treatment "lead" "level"
4 Q0 25038874 234 30.891922 imi_mug_run_2_treatment "trastuzumab"
4 Q0 29245994 235 30.891922 imi_mug_run_2_treatment "medicine" "level"
4 Q0 24118504 236 30.885096 imi_mug_run_2_treatment "crizotinib" "tas-115" "mediated"
4 Q0 9613121 237 30.88167 imi_mug_run_2_treatment "various"
4 Q0 18948375 238 30.870346 imi_mug_run_2_treatment "cytokines"
4 Q0 1352298 239 30.84053 imi_mug_run_2_treatment "aim"
4 Q0 28133304 240 30.831215 imi_mug_run_2_treatment "panitumumab" "ras" "bevacizumab"
4 Q0 12853564 241 30.81245 imi_mug_run_2_treatment "basis"
4 Q0 11555101 242 30.790169 imi_mug_run_2_treatment "trf"
4 Q0 8732100 243 30.765068 imi_mug_run_2_treatment "mediated"
4 Q0 25401468 244 30.711143 imi_mug_run_2_treatment "trastuzumab" "blockade"
4 Q0 24185685 245 30.682766 imi_mug_run_2_treatment "aim"
4 Q0 16440414 246 30.664898 imi_mug_run_2_treatment "level" "aim"
4 Q0 15929174 247 30.60021 imi_mug_run_2_treatment "enzyme digestion" "methylated" "basis"
4 Q0 26254407 248 30.575638 imi_mug_run_2_treatment "color"
4 Q0 16341380 249 30.565825 imi_mug_run_2_treatment "aim"
4 Q0 29143776 250 30.543358 imi_mug_run_2_treatment "glycan" "enzymes" "mediated"
4 Q0 25124601 251 30.526802 imi_mug_run_2_treatment "rice" "plasminogen activator"
4 Q0 17031648 252 30.523893 imi_mug_run_2_treatment "trastuzumab" "various" "agent"
4 Q0 19226453 253 30.503857 imi_mug_run_2_treatment "tyrosine"
4 Q0 9712416 254 30.498589 imi_mug_run_2_treatment "level"
4 Q0 23783485 255 30.498564 imi_mug_run_2_treatment "irinotecan" "aim"
4 Q0 26052681 256 30.495386 imi_mug_run_2_treatment "agar"
4 Q0 27175302 257 30.478188 imi_mug_run_2_treatment "product"
4 Q0 12888924 258 30.473759 imi_mug_run_2_treatment "others"
4 Q0 26846307 259 30.460941 imi_mug_run_2_treatment "cisplatin" "drug" "mediated"
4 Q0 21925125 260 30.459396 imi_mug_run_2_treatment "various" "lysine" "trastuzumab"
4 Q0 22961779 261 30.458265 imi_mug_run_2_treatment "aim"
4 Q0 17013533 262 30.429598 imi_mug_run_2_treatment "aim"
4 Q0 22064554 263 30.427877 imi_mug_run_2_treatment "trastuzumab"
4 Q0 25249557 264 30.411503 imi_mug_run_2_treatment "kinase inhibitor" "pazopanib" "kato"
4 Q0 24713241 265 30.407413 imi_mug_run_2_treatment "silver" "color"
4 Q0 1680817 266 30.39886 imi_mug_run_2_treatment "anti-estrogens" "tamoxifen" "toremifene"
4 Q0 29465762 267 30.390905 imi_mug_run_2_treatment "various" "drug" "drugs"
4 Q0 20542421 268 30.363264 imi_mug_run_2_treatment "her-2" "trastuzumab" "adjuvant"
4 Q0 27596216 269 30.340338 imi_mug_run_2_treatment "drugs" "her-2" "lead"
4 Q0 30348707 270 30.339012 imi_mug_run_2_treatment "trastuzumab"
4 Q0 9310246 271 30.329332 imi_mug_run_2_treatment "genesis"
4 Q0 9284825 272 30.320042 imi_mug_run_2_treatment "level" "color"
4 Q0 11984589 273 30.305021 imi_mug_run_2_treatment "herceptin" "trastuzumab"
4 Q0 21900593 274 30.27322 imi_mug_run_2_treatment "cetuximab" "therapeutic antibody"
4 Q0 25697906 275 30.233452 imi_mug_run_2_treatment "drugs"
4 Q0 9625824 276 30.214218 imi_mug_run_2_treatment "biotin" "favor"
4 Q0 14632727 277 30.20202 imi_mug_run_2_treatment "her-2" "drugs"
4 Q0 28784859 278 30.182545 imi_mug_run_2_treatment "various" "trastuzumab"
4 Q0 15107620 279 30.154331 imi_mug_run_2_treatment "therapeutics"
4 Q0 23660785 280 30.139215 imi_mug_run_2_treatment "her-2" "vascular endothelial growth factor"
4 Q0 22751336 281 30.118639 imi_mug_run_2_treatment "trastuzumab" "aim"
4 Q0 24004449 282 30.115433 imi_mug_run_2_treatment "docetaxel" "level"
4 Q0 28713919 283 30.100061 imi_mug_run_2_treatment "ganetespib" "sta-9090"
4 Q0 26626802 284 30.0867 imi_mug_run_2_treatment "trastuzumab"
4 Q0 18454306 285 30.081854 imi_mug_run_2_treatment "duet" "pharmaceuticals"
4 Q0 7526801 286 30.077427 imi_mug_run_2_treatment "various"
4 Q0 27811012 287 30.073767 imi_mug_run_2_treatment "lapatinib"
4 Q0 29941010 288 30.05308 imi_mug_run_2_treatment "lapatinib" "trastuzumab" "aim"
4 Q0 15055305 289 30.035387 imi_mug_run_2_treatment "combinations"
4 Q0 22143936 290 30.01059 imi_mug_run_2_treatment "her-2"
4 Q0 26811654 291 29.989153 imi_mug_run_2_treatment "adjuvant" "trastuzumab" "aim"
4 Q0 15300809 292 29.967632 imi_mug_run_2_treatment "anti-cancer agents" "biotin"
4 Q0 11920778 293 29.962181 imi_mug_run_2_treatment "adjuvant" "duration"
4 Q0 11360601 294 29.943539 imi_mug_run_2_treatment "oligo"
4 Q0 16937537 295 29.934692 imi_mug_run_2_treatment "aim"
4 Q0 16971224 296 29.929893 imi_mug_run_2_treatment "level" "aim"
4 Q0 18422971 297 29.927109 imi_mug_run_2_treatment "various" "trastuzumab" "herceptin"
4 Q0 25874002 298 29.91541 imi_mug_run_2_treatment "trastuzumab" "silver"
4 Q0 24861025 299 29.910782 imi_mug_run_2_treatment "trastuzumab" "therapeutics" "tyrosine"
4 Q0 11304576 300 29.90588 imi_mug_run_2_treatment "level"
4 Q0 12917629 301 29.868565 imi_mug_run_2_treatment "mediated" "ethanol" "hydrogen peroxide"
4 Q0 19228734 302 29.859123 imi_mug_run_2_treatment "mediated" "level" "taxol"
4 Q0 16412566 303 29.850845 imi_mug_run_2_treatment "ile" "phe"
4 Q0 19513620 304 29.83176 imi_mug_run_2_treatment "cisplatin" "herceptin" "ag825"
4 Q0 1352878 305 29.786627 imi_mug_run_2_treatment "immunotoxins" "cytotoxic" "immunotoxin"
4 Q0 27802183 306 29.777294 imi_mug_run_2_treatment "fluoropyrimidine" "platinum"
4 Q0 12439118 307 29.763103 imi_mug_run_2_treatment "aim"
4 Q0 15329759 308 29.754292 imi_mug_run_2_treatment "various" "herceptin"
4 Q0 21415234 309 29.73592 imi_mug_run_2_treatment "lapatinib" "agent" "tyrosine kinase inhibitor"
4 Q0 24311197 310 29.706533 imi_mug_run_2_treatment "level" "trastuzumab"
4 Q0 10430778 311 29.630177 imi_mug_run_2_treatment "therapeutic agents" "level"
4 Q0 15695389 312 29.61721 imi_mug_run_2_treatment "herceptin" "trastuzumab" "level"
4 Q0 24917219 313 29.595455 imi_mug_run_2_treatment "trastuzumab" "color"
4 Q0 12553037 314 29.591953 imi_mug_run_2_treatment "estrogen" "estradiol" "therapeutic agents"
4 Q0 25881479 315 29.570665 imi_mug_run_2_treatment "drugs" "trastuzumab"
4 Q0 11737892 316 29.543587 imi_mug_run_2_treatment "cytotoxic" "her-2"
4 Q0 29434871 317 29.535366 imi_mug_run_2_treatment "thr" "cddp" "mediated"
4 Q0 7477377 318 29.517933 imi_mug_run_2_treatment "acetylcholine" "crest"
4 Q0 20185938 319 29.50433 imi_mug_run_2_treatment "trastuzumab" "cisplatin" "fluorouracil"
4 Q0 27765041 320 29.498096 imi_mug_run_2_treatment "mediated"
4 Q0 20544396 321 29.493574 imi_mug_run_2_treatment "mediated" "aim"
4 Q0 22410801 322 29.475498 imi_mug_run_2_treatment "trastuzumab" "color" "aim"
4 Q0 12620387 323 29.475458 imi_mug_run_2_treatment "suppressor"
4 Q0 29169184 324 29.466278 imi_mug_run_2_treatment "drugs"
4 Q0 21855114 325 29.448698 imi_mug_run_2_treatment "color" "trastuzumab" "silver"
4 Q0 27416801 326 29.441647 imi_mug_run_2_treatment "alcohol"
4 Q0 26401016 327 29.441006 imi_mug_run_2_treatment "drug"
4 Q0 16001683 328 29.436966 imi_mug_run_2_treatment "various" "lead"
4 Q0 21505336 329 29.435642 imi_mug_run_2_treatment "trastuzumab" "basis"
4 Q0 26899482 330 29.395899 imi_mug_run_2_treatment "gat" "matrix"
4 Q0 22200761 331 29.389044 imi_mug_run_2_treatment "mediated"
4 Q0 19077306 332 29.373093 imi_mug_run_2_treatment "proteasome inhibitor" "thr" "mediated"
4 Q0 23552733 333 29.37147 imi_mug_run_2_treatment "trastuzumab" "level" "pertuzumab"
4 Q0 9662069 334 29.365955 imi_mug_run_2_treatment "psk"
4 Q0 24141978 335 29.349552 imi_mug_run_2_treatment "cetuximab"
4 Q0 9824203 336 29.346802 imi_mug_run_2_treatment "basis" "level"
4 Q0 19337752 337 29.335238 imi_mug_run_2_treatment "mediated"
4 Q0 27805295 338 29.335238 imi_mug_run_2_treatment "therapeutics"
4 Q0 30005627 339 29.321796 imi_mug_run_2_treatment "lead"
4 Q0 29325228 340 29.31277 imi_mug_run_2_treatment "afatinib" "kinase inhibitor" "trastuzumab"
4 Q0 27437872 341 29.289095 imi_mug_run_2_treatment "ras" "igf-1" "mediated"
4 Q0 21472111 342 29.282759 imi_mug_run_2_treatment "her-2" "aim"
4 Q0 17721278 343 29.282278 imi_mug_run_2_treatment "tma"
4 Q0 16030402 344 29.277521 imi_mug_run_2_treatment "fluorouracil" "tandem" "folate"
4 Q0 25350844 345 29.27474 imi_mug_run_2_treatment "lapatinib" "drug"
4 Q0 22238368 346 29.255566 imi_mug_run_2_treatment "pha-665752" "lapatinib" "mediated"
4 Q0 9572489 347 29.251038 imi_mug_run_2_treatment "taxotere" "taxol" "thioridazine"
4 Q0 24457912 348 29.241508 imi_mug_run_2_treatment "drugs" "level"
4 Q0 23430266 349 29.241085 imi_mug_run_2_treatment "trastuzumab" "color"
4 Q0 15827559 350 29.238438 imi_mug_run_2_treatment "hydrogen peroxide" "oxygen" "mediated"
4 Q0 20331626 351 29.234821 imi_mug_run_2_treatment "herceptin" "agent" "level"
4 Q0 18774637 352 29.23437 imi_mug_run_2_treatment "lapatinib" "cisplatin" "fluorouracil"
4 Q0 17704139 353 29.219038 imi_mug_run_2_treatment "various" "androgen" "mediated"
4 Q0 15743501 354 29.218761 imi_mug_run_2_treatment "level"
4 Q0 1461175 355 29.213732 imi_mug_run_2_treatment "estrogen" "tamoxifen"
4 Q0 15457249 356 29.212273 imi_mug_run_2_treatment "enzymes"
4 Q0 17947490 357 29.205414 imi_mug_run_2_treatment "chemopreventive agent"
4 Q0 22539939 358 29.201923 imi_mug_run_2_treatment "level"
4 Q0 24798404 359 29.201422 imi_mug_run_2_treatment "oxygen" "ag825"
4 Q0 25731499 360 29.192152 imi_mug_run_2_treatment "cisplatin" "capecitabine" "trastuzumab"
4 Q0 27077364 361 29.18885 imi_mug_run_2_treatment "lead" "program"
4 Q0 29190909 362 29.175598 imi_mug_run_2_treatment "mediated"
4 Q0 21573474 363 29.171623 imi_mug_run_2_treatment "various"
4 Q0 16286993 364 29.166931 imi_mug_run_2_treatment "biotin" "abc" "aim"
4 Q0 28415602 365 29.156792 imi_mug_run_2_treatment "lapatinib" "tyrosine kinase inhibitor" "lead"
4 Q0 21301968 366 29.153376 imi_mug_run_2_treatment "prompt"
4 Q0 30060823 367 29.149843 imi_mug_run_2_treatment "mediated" "level"
4 Q0 20649976 368 29.148224 imi_mug_run_2_treatment "cannabinoid" "cannabinoids" "marijuana"
4 Q0 2029195 369 29.147434 imi_mug_run_2_treatment "sam"
4 Q0 26937130 370 29.136276 imi_mug_run_2_treatment "therapeutic agents"
4 Q0 26980732 371 29.13129 imi_mug_run_2_treatment "panitumumab" "agent"
4 Q0 22977193 372 29.115885 imi_mug_run_2_treatment "s-1" "adjuvant" "formalin"
4 Q0 11419427 373 29.111376 imi_mug_run_2_treatment "prophylactic" "enzyme digestion"
4 Q0 21673090 374 29.110577 imi_mug_run_2_treatment "lapatinib" "tyrosine" "proteasome inhibitors"
4 Q0 29285258 375 29.080536 imi_mug_run_2_treatment "trastuzumab" "matrix"
4 Q0 14743203 376 29.067348 imi_mug_run_2_treatment "herceptin" "trastuzumab"
4 Q0 24122996 377 29.066181 imi_mug_run_2_treatment "paclitaxel"
4 Q0 17641418 378 29.045118 imi_mug_run_2_treatment "product" "aim"
4 Q0 17963294 379 29.029367 imi_mug_run_2_treatment "agent" "level" "methylated"
4 Q0 24937171 380 29.022057 imi_mug_run_2_treatment "ras" "androgen"
4 Q0 17083569 381 29.01686 imi_mug_run_2_treatment "various" "methyltransferase inhibitor"
4 Q0 8433394 382 29.011473 imi_mug_run_2_treatment "staurosporine" "drug" "messenger"
4 Q0 21761116 383 29.001865 imi_mug_run_2_treatment "cytokines" "genesis"
4 Q0 20542996 384 28.969915 imi_mug_run_2_treatment "lapatinib" "trastuzumab" "nervous system"
4 Q0 25628830 385 28.961231 imi_mug_run_2_treatment "il-10" "interleukin-10" "immunosuppressive"
4 Q0 26936914 386 28.959595 imi_mug_run_2_treatment "abiraterone" "leuprolide" "lapatinib"
4 Q0 15895459 387 28.947172 imi_mug_run_2_treatment "salted" "prophylactic"
4 Q0 7889468 388 28.946865 imi_mug_run_2_treatment "egf" "epidermal growth factor" "basis"
4 Q0 12870086 389 28.942825 imi_mug_run_2_treatment "various combinations" "ras"
4 Q0 27065318 390 28.937449 imi_mug_run_2_treatment "trastuzumab" "level"
4 Q0 28852882 391 28.911163 imi_mug_run_2_treatment "color" "formalin"
4 Q0 19751438 392 28.87471 imi_mug_run_2_treatment "level" "histidine"
4 Q0 29089060 393 28.868599 imi_mug_run_2_treatment "formalin" "others"
4 Q0 18769124 394 28.863436 imi_mug_run_2_treatment "trastuzumab" "drug" "herceptin"
4 Q0 15363548 395 28.863216 imi_mug_run_2_treatment "combinations" "cisplatin" "drugs"
4 Q0 26645663 396 28.808805 imi_mug_run_2_treatment "therapeutic agents"
4 Q0 26261492 397 28.807926 imi_mug_run_2_treatment "kinase inhibitor" "herceptin" "lapatinib"
4 Q0 23599643 398 28.78017 imi_mug_run_2_treatment "herceptin" "aim"
4 Q0 24835103 399 28.73717 imi_mug_run_2_treatment "trastuzumab" "monoclonal antibodies"
4 Q0 27305410 400 28.732944 imi_mug_run_2_treatment "drugs"
4 Q0 24690483 401 28.729885 imi_mug_run_2_treatment "calcium"
4 Q0 17409443 402 28.708906 imi_mug_run_2_treatment "tocopheryl succinate" "vitamin e succinate"
4 Q0 28460431 403 28.705782 imi_mug_run_2_treatment "crizotinib"
4 Q0 18424576 404 28.687296 imi_mug_run_2_treatment "various" "basis" "aim"
4 Q0 17589931 405 28.684084 imi_mug_run_2_treatment "aim"
4 Q0 11948459 406 28.672913 imi_mug_run_2_treatment "level" "trastuzumab"
4 Q0 7903175 407 28.661972 imi_mug_run_2_treatment "estrogen"
4 Q0 29279289 408 28.65572 imi_mug_run_2_treatment "icc" "ras"
4 Q0 20498641 409 28.639336 imi_mug_run_2_treatment "paclitaxel" "mediated"
4 Q0 22151982 410 28.63466 imi_mug_run_2_treatment "aim" "level"
4 Q0 29631408 411 28.626738 imi_mug_run_2_treatment "trastuzumab"
4 Q0 15580295 412 28.625694 imi_mug_run_2_treatment "mediated" "lactate" "animals"
4 Q0 19588488 413 28.614496 imi_mug_run_2_treatment "genesis"
4 Q0 22800479 414 28.583597 imi_mug_run_2_treatment "product"
4 Q0 28625044 415 28.581413 imi_mug_run_2_treatment "various" "trastuzumab" "level"
4 Q0 7584099 416 28.577982 imi_mug_run_2_treatment "monoclonal antibodies"
4 Q0 15678850 417 28.576931 imi_mug_run_2_treatment "antiserum"
4 Q0 26936618 418 28.57294 imi_mug_run_2_treatment "cerulenin" "mediated" "deoxyglucose"
4 Q0 21394646 419 28.547976 imi_mug_run_2_treatment "level" "tma" "trastuzumab"
4 Q0 21088503 420 28.544336 imi_mug_run_2_treatment "celastrol" "trastuzumab" "therapeutics"
4 Q0 22914212 421 28.53479 imi_mug_run_2_treatment "epidermal growth factor" "level"
4 Q0 17109515 422 28.524628 imi_mug_run_2_treatment "lmd" "level" "aim"
4 Q0 20936496 423 28.504118 imi_mug_run_2_treatment "enzymes" "herceptin" "antioxidant"
4 Q0 16585203 424 28.501076 imi_mug_run_2_treatment "therapeutics" "basis"
4 Q0 21710689 425 28.488958 imi_mug_run_2_treatment "heat shock protein 70"
4 Q0 26285240 426 28.488659 imi_mug_run_2_treatment "favoring" "trastuzumab" "pertuzumab"
4 Q0 15753384 427 28.474445 imi_mug_run_2_treatment "mediated" "protease" "lead"
4 Q0 21676433 428 28.464127 imi_mug_run_2_treatment "basis"
4 Q0 8752152 429 28.400948 imi_mug_run_2_treatment "level"
4 Q0 18409049 430 28.3925 imi_mug_run_2_treatment "h-89" "tam" "tamoxifen"
4 Q0 9520947 431 28.39241 imi_mug_run_2_treatment "others" "basis"
4 Q0 25086186 432 28.382378 imi_mug_run_2_treatment "ras" "others"
4 Q0 27345410 433 28.381685 imi_mug_run_2_treatment "azacytidine"
4 Q0 26977021 434 28.373127 imi_mug_run_2_treatment "hsp70" "mediated" "drug"
4 Q0 17196954 435 28.367758 imi_mug_run_2_treatment "asa"
4 Q0 25081321 436 28.364985 imi_mug_run_2_treatment "drug" "ibrutinib" "pi3k/mtor inhibitor bez235"
4 Q0 29573334 437 28.350195 imi_mug_run_2_treatment "regorafenib" "kato"
4 Q0 17938205 438 28.315987 imi_mug_run_2_treatment "level"
4 Q0 30466782 439 28.313536 imi_mug_run_2_treatment "ras" "kinase inhibitor" "crizotinib"
4 Q0 24122876 440 28.310373 imi_mug_run_2_treatment "glutamine" "mediated"
4 Q0 10408862 441 28.301617 imi_mug_run_2_treatment "icc"
4 Q0 16452223 442 28.29923 imi_mug_run_2_treatment "lapatinib" "proteosome inhibitor" "mediated"
4 Q0 12894578 443 28.287937 imi_mug_run_2_treatment "oestrogen"
4 Q0 21769432 444 28.282404 imi_mug_run_2_treatment "mediated"
4 Q0 29302045 445 28.257145 imi_mug_run_2_treatment "trastuzumab"
4 Q0 23661506 446 28.251305 imi_mug_run_2_treatment "level"
4 Q0 23788757 447 28.247108 imi_mug_run_2_treatment "silver" "color" "aim"
4 Q0 27029001 448 28.240856 imi_mug_run_2_treatment "mediated"
4 Q0 16375577 449 28.232683 imi_mug_run_2_treatment "level"
4 Q0 16097066 450 28.222065 imi_mug_run_2_treatment "urea" "aim"
4 Q0 9875670 451 28.214302 imi_mug_run_2_treatment "dna immunization" "cancer vaccine" "genetic immunization"
4 Q0 25596742 452 28.202276 imi_mug_run_2_treatment "mediated" "kinase inhibitor" "lapatinib"
4 Q0 15687687 453 28.196136 imi_mug_run_2_treatment "therapeutic agents"
4 Q0 8099571 454 28.193832 imi_mug_run_2_treatment "estrogen" "progesterone"
4 Q0 23819947 455 28.189789 imi_mug_run_2_treatment "trastuzumab" "crizotinib"
4 Q0 20379846 456 28.18869 imi_mug_run_2_treatment "tamoxifen" "mediated" "proteasome inhibitors"
4 Q0 29715459 457 28.187809 imi_mug_run_2_treatment "paclitaxel" "mediated" "level"
4 Q0 25372287 458 28.178791 imi_mug_run_2_treatment "level"
4 Q0 30310315 459 28.16035 imi_mug_run_2_treatment "aim"
4 Q0 25203738 460 28.15993 imi_mug_run_2_treatment "various"
4 Q0 18466392 461 28.159668 imi_mug_run_2_treatment "urokinase-type plasminogen activator" "pge2" "cox-2 inhibitor"
4 Q0 25238247 462 28.14801 imi_mug_run_2_treatment "lapatinib" "blockade"
4 Q0 28514745 463 28.134909 imi_mug_run_2_treatment "human antibody" "trastuzumab" "mediated"
4 Q0 24499832 464 28.127102 imi_mug_run_2_treatment "lnd"
4 Q0 16003726 465 28.123554 imi_mug_run_2_treatment "gefitinib"
4 Q0 16091755 466 28.114338 imi_mug_run_2_treatment "lapatinib" "trastuzumab"
4 Q0 28306722 467 28.111572 imi_mug_run_2_treatment "matrix" "aim" "shape"
4 Q0 24888777 468 28.098423 imi_mug_run_2_treatment "trastuzumab" "cyclophosphamide" "epirubicin"
4 Q0 17942920 469 28.089062 imi_mug_run_2_treatment "kinase inhibitor" "herceptin" "trastuzumab"
4 Q0 21097718 470 28.074327 imi_mug_run_2_treatment "fer"
4 Q0 17266042 471 28.066257 imi_mug_run_2_treatment "tamoxifen" "mediated"
4 Q0 21419042 472 28.0616 imi_mug_run_2_treatment "mediated" "aim"
4 Q0 20124457 473 28.04892 imi_mug_run_2_treatment "lapatinib" "calcium" "drug"
4 Q0 18765569 474 28.036928 imi_mug_run_2_treatment "epidermal growth factor"
4 Q0 20443098 475 28.026726 imi_mug_run_2_treatment "trastuzumab"
4 Q0 28442738 476 28.025166 imi_mug_run_2_treatment "mediated"
4 Q0 9408753 477 28.017082 imi_mug_run_2_treatment "level"
4 Q0 27891760 478 27.99759 imi_mug_run_2_treatment "ras"
4 Q0 22481979 479 27.98556 imi_mug_run_2_treatment "trastuzumab"
4 Q0 23943608 480 27.985056 imi_mug_run_2_treatment "trastuzumab" "lapatinib" "combination drug"
4 Q0 15093533 481 27.977703 imi_mug_run_2_treatment "mediated" "herceptin" "trastuzumab"
4 Q0 26122239 482 27.97334 imi_mug_run_2_treatment "aim" "drugs" "eosin"
4 Q0 28881678 483 27.965822 imi_mug_run_2_treatment "drug" "crizotinib" "mediated"
4 Q0 30094493 484 27.964779 imi_mug_run_2_treatment "aromatase inhibitors"
4 Q0 20961995 485 27.940231 imi_mug_run_2_treatment "estrogen"
4 Q0 21717426 486 27.93122 imi_mug_run_2_treatment "bisulfite" "mediated" "methylated"
4 Q0 10744051 487 27.926666 imi_mug_run_2_treatment "fluorouracil" "phosphate" "level"
4 Q0 21127496 488 27.92588 imi_mug_run_2_treatment "tocopheryl succinate" "recombinant tnf-related apoptosis-inducing ligand" "aim"
4 Q0 26999718 489 27.924747 imi_mug_run_2_treatment "trastuzumab" "pertuzumab" "mediated"
4 Q0 8275429 490 27.923344 imi_mug_run_2_treatment "collagenase" "level" "plasminogen activator"
4 Q0 20068093 491 27.904446 imi_mug_run_2_treatment "balance"
4 Q0 23900832 492 27.888615 imi_mug_run_2_treatment "ile"
4 Q0 22534547 493 27.876135 imi_mug_run_2_treatment "docetaxel" "trastuzumab" "combinations"
4 Q0 27542243 494 27.868704 imi_mug_run_2_treatment "her-2" "blockade"
4 Q0 16901783 495 27.861656 imi_mug_run_2_treatment "mediated"
4 Q0 10878580 496 27.86127 imi_mug_run_2_treatment "mediated" "taxol" "lead"
4 Q0 26729612 497 27.852585 imi_mug_run_2_treatment "level"
4 Q0 21811552 498 27.850172 imi_mug_run_2_treatment "animals" "immunomodulator" "folic acid"
4 Q0 15987433 499 27.825844 imi_mug_run_2_treatment "aim"
4 Q0 29845222 500 27.780943 imi_mug_run_2_treatment "paeonol" "drugs" "basis"
4 Q0 27752391 501 27.776566 imi_mug_run_2_treatment "aim"
4 Q0 11925613 502 27.764143 imi_mug_run_2_treatment "aim"
4 Q0 16947083 503 27.763645 imi_mug_run_2_treatment "drugs"
4 Q0 28300085 504 27.758041 imi_mug_run_2_treatment "mediated"
4 Q0 26498357 505 27.731777 imi_mug_run_2_treatment "level" "suppressor"
4 Q0 16596232 506 27.730316 imi_mug_run_2_treatment "tnf-alpha" "il-4"
4 Q0 25806223 507 27.722958 imi_mug_run_2_treatment "drugs" "trastuzumab" "gefitinib"
4 Q0 28243814 508 27.712809 imi_mug_run_2_treatment "level"
4 Q0 16784538 509 27.709263 imi_mug_run_2_treatment "various" "pooled"
4 Q0 7795277 510 27.706419 imi_mug_run_2_treatment "verapamil" "drugs" "anti-cancer agents"
4 Q0 7584078 511 27.69915 imi_mug_run_2_treatment "fluorocytosine" "fluorouracil" "cytotoxic"
4 Q0 22161215 512 27.689953 imi_mug_run_2_treatment "methyltransferase inhibitor"
4 Q0 16407820 513 27.686665 imi_mug_run_2_treatment "mediated" "plasminogen activator" "agent"
4 Q0 26072398 514 27.676165 imi_mug_run_2_treatment "drug"
4 Q0 9560059 515 27.663746 imi_mug_run_2_treatment "level"
4 Q0 1980125 516 27.661476 imi_mug_run_2_treatment "level"
4 Q0 20448329 517 27.659563 imi_mug_run_2_treatment "prompt"
4 Q0 25333815 518 27.645294 imi_mug_run_2_treatment "various" "tor" "mediated"
4 Q0 10919006 519 27.613144 imi_mug_run_2_treatment "aim"
4 Q0 11175365 520 27.60274 imi_mug_run_2_treatment "tcc" "therapeutics" "level"
4 Q0 19668225 521 27.597536 imi_mug_run_2_treatment "deoxyglucose" "mediated" "level"
4 Q0 22393464 522 27.5958 imi_mug_run_2_treatment "agonist" "others"
4 Q0 2098274 523 27.586006 imi_mug_run_2_treatment "sex hormones" "epidermal growth factor" "lead"
4 Q0 26716506 524 27.581493 imi_mug_run_2_treatment "trastuzumab" "therapeutic agents"
4 Q0 10499598 525 27.58088 imi_mug_run_2_treatment "erb-38" "immunotoxin" "liver"
4 Q0 24247619 526 27.578297 imi_mug_run_2_treatment "phb" "prohibitin" "aim"
4 Q0 23318431 527 27.577156 imi_mug_run_2_treatment "antioxidants" "oxygen" "tyrosine"
4 Q0 21134821 528 27.57232 imi_mug_run_2_treatment "trastuzumab" "adjuvant" "cisplatin"
4 Q0 12569555 529 27.547203 imi_mug_run_2_treatment "methylated"
4 Q0 29177434 530 27.512905 imi_mug_run_2_treatment "paclitaxel" "azd4547" "tyrosine kinase inhibitor"
4 Q0 22674190 531 27.512081 imi_mug_run_2_treatment "herceptin" "kinase inhibitor" "pertuzumab"
4 Q0 28629429 532 27.498396 imi_mug_run_2_treatment "tandem"
4 Q0 27203740 533 27.483131 imi_mug_run_2_treatment "herceptin"
4 Q0 9696394 534 27.478836 imi_mug_run_2_treatment "level" "tyrosine" "tyrosine kinase inhibitor"
4 Q0 22589274 535 27.475637 imi_mug_run_2_treatment "gemcitabine" "hub" "trastuzumab"
4 Q0 7904515 536 27.474108 imi_mug_run_2_treatment "her-2"
4 Q0 16437709 537 27.469494 imi_mug_run_2_treatment "aim"
4 Q0 24367169 538 27.456467 imi_mug_run_2_treatment "lapatinib" "various" "drug"
4 Q0 24253382 539 27.43289 imi_mug_run_2_treatment "leucine" "mediated"
4 Q0 12717826 540 27.422678 imi_mug_run_2_treatment "adm" "vcr" "drug"
4 Q0 24463007 541 27.41851 imi_mug_run_2_treatment "tamoxifen" "endocrine therapy" "selective estrogen receptor modulator"
4 Q0 29278885 542 27.415277 imi_mug_run_2_treatment "trastuzumab"
4 Q0 17611641 543 27.413082 imi_mug_run_2_treatment "maltase-glucoamylase" "ddc"
4 Q0 20406949 544 27.398909 imi_mug_run_2_treatment "dasatinib" "various" "pha-665752"
4 Q0 25770459 545 27.388233 imi_mug_run_2_treatment "drug" "herceptin"
4 Q0 22464443 546 27.383366 imi_mug_run_2_treatment "mediators"
4 Q0 18381441 547 27.380774 imi_mug_run_2_treatment "tyrosine" "gefitinib" "erlotinib"
4 Q0 26801760 548 27.380774 imi_mug_run_2_treatment "krc-00715" "cytotoxic" "krc-00509"
4 Q0 23915743 549 27.378656 imi_mug_run_2_treatment "drug"
4 Q0 25623979 550 27.372337 imi_mug_run_2_treatment "various" "animals"
4 Q0 26622585 551 27.368748 imi_mug_run_2_treatment "aim"
4 Q0 25719557 552 27.36809 imi_mug_run_2_treatment "gefitinib" "erlotinib"
4 Q0 22969966 553 27.3377 imi_mug_run_2_treatment "tyrosine"
4 Q0 23851309 554 27.324951 imi_mug_run_2_treatment "trastuzumab"
4 Q0 24322659 555 27.313145 imi_mug_run_2_treatment "metformin" "mediated"
4 Q0 24046294 556 27.293457 imi_mug_run_2_treatment "immunoglobulin g" "bispecific antibody" "pertuzumab"
4 Q0 9010095 557 27.286486 imi_mug_run_2_treatment "ras"
4 Q0 23271292 558 27.285103 imi_mug_run_2_treatment "herceptin" "dsb"
4 Q0 29751042 559 27.282124 imi_mug_run_2_treatment "trastuzumab"
4 Q0 23467725 560 27.279028 imi_mug_run_2_treatment "various" "trastuzumab"
4 Q0 23089982 561 27.26324 imi_mug_run_2_treatment "lapatinib" "drug" "kinase inhibitor"
4 Q0 26942872 562 27.258963 imi_mug_run_2_treatment "epidermal growth factor"
4 Q0 28111342 563 27.228771 imi_mug_run_2_treatment "herceptin" "her2 monoclonal antibody"
4 Q0 19208461 564 27.222921 imi_mug_run_2_treatment "therapeutics"
4 Q0 16949920 565 27.215158 imi_mug_run_2_treatment "drugs"
4 Q0 24582974 566 27.213762 imi_mug_run_2_treatment "combinations"
4 Q0 25590338 567 27.206211 imi_mug_run_2_treatment "lapatinib" "trastuzumab" "mediated"
4 Q0 24889042 568 27.190842 imi_mug_run_2_treatment "trastuzumab" "formalin" "level"
4 Q0 27185371 569 27.18586 imi_mug_run_2_treatment "program" "blockade"
4 Q0 17699716 570 27.176228 imi_mug_run_2_treatment "mtor inhibitor"
4 Q0 23770845 571 27.138353 imi_mug_run_2_treatment "gw9662" "level"
4 Q0 20728210 572 27.134949 imi_mug_run_2_treatment "trastuzumab" "cisplatin" "medication"
4 Q0 15609325 573 27.134209 imi_mug_run_2_treatment "com" "antiangiogenic" "aim"
4 Q0 20579853 574 27.131348 imi_mug_run_2_treatment "aim"
4 Q0 28096336 575 27.130484 imi_mug_run_2_treatment "program" "balance"
4 Q0 22248472 576 27.122173 imi_mug_run_2_treatment "bispecific antibody" "human serum albumin" "trastuzumab"
4 Q0 27474152 577 27.1129 imi_mug_run_2_treatment "therapeutics" "lapatinib"
4 Q0 23233651 578 27.101437 imi_mug_run_2_treatment "cisplatin" "epirubicin" "fluorouracil"
4 Q0 15385631 579 27.097633 imi_mug_run_2_treatment "trastuzumab" "herceptin" "balance"
4 Q0 25566992 580 27.094517 imi_mug_run_2_treatment "iff" "mediated" "matrix"
4 Q0 23910175 581 27.089954 imi_mug_run_2_treatment "color" "level" "aim"
4 Q0 20197472 582 27.069443 imi_mug_run_2_treatment "trastuzumab" "lapatinib" "mediated"
4 Q0 15017643 583 27.062809 imi_mug_run_2_treatment "aim"
4 Q0 22882541 584 27.062809 imi_mug_run_2_treatment "silver"
4 Q0 12584562 585 27.061892 imi_mug_run_2_treatment "mediated"
4 Q0 23612964 586 27.061892 imi_mug_run_2_treatment "tyrosine" "lapatinib"
4 Q0 25791465 587 27.061028 imi_mug_run_2_treatment "matrix"
4 Q0 19673023 588 27.043737 imi_mug_run_2_treatment "bisulfite" "methylated" "aim"
4 Q0 29790169 589 27.025246 imi_mug_run_2_treatment "silver"
4 Q0 20711231 590 27.023031 imi_mug_run_2_treatment "mediated" "ras" "drug"
4 Q0 11315254 591 27.021927 imi_mug_run_2_treatment "plasminogen activator" "epidermal growth factor"
4 Q0 19435870 592 27.020203 imi_mug_run_2_treatment "nonsteroidal anti-inflammatory drug" "anti-inflammatory" "drug"
4 Q0 28782986 593 26.988594 imi_mug_run_2_treatment "silver"
4 Q0 16824932 594 26.965405 imi_mug_run_2_treatment "oxygen" "level" "aim"
4 Q0 11062025 595 26.962532 imi_mug_run_2_treatment "drugs" "various" "fluorouracil"
4 Q0 18031393 596 26.949745 imi_mug_run_2_treatment "aim"
4 Q0 20814902 597 26.934319 imi_mug_run_2_treatment "various"
4 Q0 27879270 598 26.928299 imi_mug_run_2_treatment "antiestrogen" "drug" "antiestrogens"
4 Q0 18936791 599 26.917881 imi_mug_run_2_treatment "trastuzumab" "tyrosine kinase inhibitor" "lapatinib"
4 Q0 21966428 600 26.916933 imi_mug_run_2_treatment "protease"
4 Q0 17036397 601 26.913914 imi_mug_run_2_treatment "color" "level" "aim"
4 Q0 12115729 602 26.903315 imi_mug_run_2_treatment "mediated" "level"
4 Q0 16958676 603 26.853645 imi_mug_run_2_treatment "ethanol" "oxygen"
4 Q0 24121271 604 26.837893 imi_mug_run_2_treatment "program"
4 Q0 12133467 605 26.83677 imi_mug_run_2_treatment "interleukin-1 receptor antagonist" "product" "interleukin"
4 Q0 26880697 606 26.834665 imi_mug_run_2_treatment "trastuzumab" "pembrolizumab" "avelumab"
4 Q0 11289714 607 26.819828 imi_mug_run_2_treatment "mediated"
4 Q0 24510342 608 26.812408 imi_mug_run_2_treatment "drugs"
4 Q0 28052014 609 26.80572 imi_mug_run_2_treatment "silver" "color"
4 Q0 22505344 610 26.802269 imi_mug_run_2_treatment "androgen" "trastuzumab" "pertuzumab"
4 Q0 16309200 611 26.79813 imi_mug_run_2_treatment "color"
4 Q0 23519125 612 26.7695 imi_mug_run_2_treatment "saha" "hdac inhibitor" "panobinostat"
4 Q0 27578417 613 26.765396 imi_mug_run_2_treatment "trastuzumab"
4 Q0 24439740 614 26.76204 imi_mug_run_2_treatment "lavage fluids"
4 Q0 17687647 615 26.74168 imi_mug_run_2_treatment "ile" "isoleucine"
4 Q0 16963728 616 26.738754 imi_mug_run_2_treatment "urokinase-type plasminogen activator" "plasminogen activator" "plau"
4 Q0 17139607 617 26.729448 imi_mug_run_2_treatment "mediated" "eosin" "basis"
4 Q0 21384344 618 26.723583 imi_mug_run_2_treatment "mediated"
4 Q0 7912561 619 26.709175 imi_mug_run_2_treatment "combinations"
4 Q0 7960236 620 26.706726 imi_mug_run_2_treatment "various"
4 Q0 1682035 621 26.704803 imi_mug_run_2_treatment "basis"
4 Q0 30349368 622 26.703655 imi_mug_run_2_treatment "level"
4 Q0 16488535 623 26.700176 imi_mug_run_2_treatment "resveratrol" "estrogen"
4 Q0 24709902 624 26.671637 imi_mug_run_2_treatment "nervous system"
4 Q0 11956082 625 26.671036 imi_mug_run_2_treatment "combinations" "flavopiridol" "herceptin"
4 Q0 21165559 626 26.6622 imi_mug_run_2_treatment "level" "matrix"
4 Q0 10738122 627 26.642832 imi_mug_run_2_treatment "progesterone" "cyclophosphamide" "oestrogen"
4 Q0 17717428 628 26.633598 imi_mug_run_2_treatment "aim"
4 Q0 24493355 629 26.623692 imi_mug_run_2_treatment "prophylactic"
4 Q0 19098003 630 26.612152 imi_mug_run_2_treatment "lead" "cancer drug" "drugs"
4 Q0 22789781 631 26.598358 imi_mug_run_2_treatment "trastuzumab" "cetuximab" "bsab"
4 Q0 19826412 632 26.591434 imi_mug_run_2_treatment "tyr" "paclitaxel" "ras"
4 Q0 21613411 633 26.581728 imi_mug_run_2_treatment "androgen" "dihydrotestosterone" "tcc"
4 Q0 18804092 634 26.570618 imi_mug_run_2_treatment "antral" "gastrin"
4 Q0 12477051 635 26.570044 imi_mug_run_2_treatment "hdac inhibitor" "sodium butyrate" "histone deacetylase inhibitors"
4 Q0 23971878 636 26.551949 imi_mug_run_2_treatment "lapatinib" "oxygen" "mediated"
4 Q0 20429623 637 26.549103 imi_mug_run_2_treatment "estrogen"
4 Q0 16273612 638 26.547699 imi_mug_run_2_treatment "aim"
4 Q0 17452776 639 26.538082 imi_mug_run_2_treatment "aim"
4 Q0 23288635 640 26.526615 imi_mug_run_2_treatment "cytotoxic drugs" "trastuzumab"
4 Q0 21655918 641 26.523926 imi_mug_run_2_treatment "kinase inhibitor" "foretinib" "kato"
4 Q0 19826038 642 26.513802 imi_mug_run_2_treatment "sndx-275" "hdac inhibitor sndx-275" "therapeutic agent"
4 Q0 16319978 643 26.507948 imi_mug_run_2_treatment "estrogen" "plasma"
4 Q0 21497990 644 26.507948 imi_mug_run_2_treatment "combinations" "sndx-275" "hdac inhibitor"
4 Q0 24551203 645 26.49501 imi_mug_run_2_treatment "psoralen" "mediated" "methoxypsoralen"
4 Q0 7954259 646 26.472984 imi_mug_run_2_treatment "adjuvant" "product"
4 Q0 20847831 647 26.465067 imi_mug_run_2_treatment "lapatinib" "estrogen" "tamoxifen"
4 Q0 21086124 648 26.454746 imi_mug_run_2_treatment "trastuzumab" "paclitaxel" "herceptin"
4 Q0 19688278 649 26.44821 imi_mug_run_2_treatment "gat"
4 Q0 27597738 650 26.425488 imi_mug_run_2_treatment "neratinib" "lapatinib" "mediated"
4 Q0 12692839 651 26.422667 imi_mug_run_2_treatment "various"
4 Q0 22104159 652 26.413507 imi_mug_run_2_treatment "trastuzumab" "antineoplastic" "silver"
4 Q0 14697248 653 26.399506 imi_mug_run_2_treatment "pd98059" "trastuzumab"
4 Q0 14982856 654 26.37847 imi_mug_run_2_treatment "mediated"
4 Q0 23232401 655 26.369093 imi_mug_run_2_treatment "therapeutics" "trastuzumab"
4 Q0 11156523 656 26.365118 imi_mug_run_2_treatment "cdk inhibitor"
4 Q0 25986173 657 26.35294 imi_mug_run_2_treatment "ras"
4 Q0 27863425 658 26.345541 imi_mug_run_2_treatment "wortmannin" "mediated"
4 Q0 29290541 659 26.337675 imi_mug_run_2_treatment "others"
4 Q0 11796015 660 26.330666 imi_mug_run_2_treatment "immunotoxin" "erb-38" "mediated"
4 Q0 29907770 661 26.322937 imi_mug_run_2_treatment "glucose" "lactate" "level"
4 Q0 20060649 662 26.319935 imi_mug_run_2_treatment "drugs" "oestrogen" "parp inhibitors"
4 Q0 23555166 663 26.31051 imi_mug_run_2_treatment "vitamins" "vitamin e" "food"
4 Q0 22461520 664 26.295076 imi_mug_run_2_treatment "ly294002" "androgen" "wortmannin"
4 Q0 24384723 665 26.293945 imi_mug_run_2_treatment "lapatinib" "mediated" "epidermal growth factor receptor inhibitor"
4 Q0 25890325 666 26.293528 imi_mug_run_2_treatment "cyclophosphamide" "epirubicin" "docetaxel"
4 Q0 12755489 667 26.286304 imi_mug_run_2_treatment "trastuzumab" "her-2"
4 Q0 12553494 668 26.285664 imi_mug_run_2_treatment "trastuzumab" "aim"
4 Q0 10474684 669 26.259785 imi_mug_run_2_treatment "sam" "aim"
4 Q0 19287982 670 26.256622 imi_mug_run_2_treatment "keratinocyte growth factor" "sam" "aim"
4 Q0 16818618 671 26.249971 imi_mug_run_2_treatment "hki-272" "kinase inhibitor" "interleukin-3"
4 Q0 23146959 672 26.245632 imi_mug_run_2_treatment "level" "plasma" "aim"
4 Q0 20937558 673 26.243343 imi_mug_run_2_treatment "aim"
4 Q0 29992451 674 26.237823 imi_mug_run_2_treatment "trastuzumab"
4 Q0 12384528 675 26.22792 imi_mug_run_2_treatment "tyr" "herceptin" "taxol"
4 Q0 7913873 676 26.207518 imi_mug_run_2_treatment "various"
4 Q0 30385370 677 26.203434 imi_mug_run_2_treatment "aim"
4 Q0 7914379 678 26.201384 imi_mug_run_2_treatment "level"
4 Q0 18395971 679 26.174463 imi_mug_run_2_treatment "tk inhibitors"
4 Q0 17214955 680 26.159904 imi_mug_run_2_treatment "level" "u73122"
4 Q0 19561085 681 26.146591 imi_mug_run_2_treatment "various" "mediated"
4 Q0 28028387 682 26.144073 imi_mug_run_2_treatment "herceptin" "trastuzumab" "aim"
4 Q0 26933086 683 26.134401 imi_mug_run_2_treatment "mediated"
4 Q0 22751462 684 26.132763 imi_mug_run_2_treatment "various" "therapeutics" "others"
4 Q0 24839254 685 26.108557 imi_mug_run_2_treatment "bile acid" "tace" "taurochenodeoxycholic acid"
4 Q0 24615340 686 26.098902 imi_mug_run_2_treatment "drugs" "mediated" "ink-128"
4 Q0 11244953 687 26.08905 imi_mug_run_2_treatment "trf"
4 Q0 25225290 688 26.086414 imi_mug_run_2_treatment "pma" "kinase inhibitor" "hub"
4 Q0 29163776 689 26.078657 imi_mug_run_2_treatment "drug" "mediated"
4 Q0 24966791 690 26.05611 imi_mug_run_2_treatment "level" "aim"
4 Q0 25143129 691 26.054821 imi_mug_run_2_treatment "color"
4 Q0 1373318 692 26.051174 imi_mug_run_2_treatment "drugs"
4 Q0 10098763 693 26.03041 imi_mug_run_2_treatment "endocrine therapy" "tamoxifen"
4 Q0 18777950 694 26.029625 imi_mug_run_2_treatment "trastuzumab" "adjuvant" "lapatinib"
4 Q0 19298655 695 26.029274 imi_mug_run_2_treatment "fats" "oxygen" "gw9662"
4 Q0 19821025 696 26.015701 imi_mug_run_2_treatment "estrogen" "progesterone" "tyrosine"
4 Q0 28508152 697 26.009449 imi_mug_run_2_treatment "trastuzumab"
4 Q0 26863927 698 26.002773 imi_mug_run_2_treatment "drugs" "investigational drugs" "trastuzumab"
4 Q0 14739033 699 25.992672 imi_mug_run_2_treatment "nrg" "blockade"
4 Q0 11279343 700 25.988703 imi_mug_run_2_treatment "level"
4 Q0 17525746 701 25.968378 imi_mug_run_2_treatment "trastuzumab" "tyrosine" "herceptin"
4 Q0 11003564 702 25.96159 imi_mug_run_2_treatment "various combinations"
4 Q0 8758793 703 25.936333 imi_mug_run_2_treatment "cisplatinum" "drugs" "fluorouracil"
4 Q0 29717480 704 25.930014 imi_mug_run_2_treatment "lead" "basis"
4 Q0 30304546 705 25.925282 imi_mug_run_2_treatment "adjuvant" "afatinib"
4 Q0 19372587 706 25.91585 imi_mug_run_2_treatment "taxol" "mediated"
4 Q0 20622016 707 25.898294 imi_mug_run_2_treatment "various" "mediated" "ras"
4 Q0 24280377 708 25.888788 imi_mug_run_2_treatment "mediated"
4 Q0 20335174 709 25.880608 imi_mug_run_2_treatment "agar" "tyrosol"
4 Q0 10567214 710 25.868387 imi_mug_run_2_treatment "monoclonal antibodies"
4 Q0 23007710 711 25.868317 imi_mug_run_2_treatment "lapatinib" "gemcitabine" "agent"
4 Q0 19040570 712 25.861189 imi_mug_run_2_treatment "antral" "ulex europaeus"
4 Q0 12792823 713 25.85831 imi_mug_run_2_treatment "ndp"
4 Q0 18922900 714 25.855198 imi_mug_run_2_treatment "mediated"
4 Q0 24971884 715 25.855198 imi_mug_run_2_treatment "lapatinib" "tyrosine kinase inhibitor" "lead"
4 Q0 12937837 716 25.852907 imi_mug_run_2_treatment "adc"
4 Q0 20522955 717 25.83484 imi_mug_run_2_treatment "corosolic acid" "fluorouracil" "paclitaxel"
4 Q0 16406776 718 25.830242 imi_mug_run_2_treatment "glycan" "oligo"
4 Q0 29577179 719 25.826319 imi_mug_run_2_treatment "phenol" "aim"
4 Q0 17288526 720 25.821157 imi_mug_run_2_treatment "mediated"
4 Q0 23911227 721 25.815222 imi_mug_run_2_treatment "trastuzumab" "crizotinib"
4 Q0 25003395 722 25.807508 imi_mug_run_2_treatment "various" "tyrosine"
4 Q0 15489929 723 25.804037 imi_mug_run_2_treatment "level"
4 Q0 19005469 724 25.796404 imi_mug_run_2_treatment "tamoxifen" "cancer drug" "oestrogen"
4 Q0 23474764 725 25.793362 imi_mug_run_2_treatment "mediated"
4 Q0 25723113 726 25.778027 imi_mug_run_2_treatment "estrogen" "basis"
4 Q0 17392524 727 25.773336 imi_mug_run_2_treatment "bortezomib" "azd6244" "therapeutics"
4 Q0 18516291 728 25.76052 imi_mug_run_2_treatment "flutamide" "testosterone" "antiandrogen"
4 Q0 28197365 729 25.746042 imi_mug_run_2_treatment "various" "mediated"
4 Q0 19697624 730 25.74493 imi_mug_run_2_treatment "aim"
4 Q0 22331080 731 25.730421 imi_mug_run_2_treatment "vaccine" "therapeutic vaccine" "cancer vaccine"
4 Q0 19318561 732 25.694256 imi_mug_run_2_treatment "androgen" "sdm" "kinase inhibitor"
4 Q0 22266114 733 25.677008 imi_mug_run_2_treatment "glucose" "mediated" "drugs"
4 Q0 25232273 734 25.675745 imi_mug_run_2_treatment "trastuzumab" "oxaliplatin" "capecitabine"
4 Q0 1359495 735 25.673405 imi_mug_run_2_treatment "enzymes"
4 Q0 19221498 736 25.671688 imi_mug_run_2_treatment "metformin" "drug" "level"
4 Q0 11859708 737 25.655262 imi_mug_run_2_treatment "color" "biotin"
4 Q0 25407459 738 25.629967 imi_mug_run_2_treatment "mubritinib" "pd173074" "therapeutic agents"
4 Q0 26391955 739 25.618607 imi_mug_run_2_treatment "tyrosine"
4 Q0 21876697 740 25.616419 imi_mug_run_2_treatment "trastuzumab"
4 Q0 28422721 741 25.613844 imi_mug_run_2_treatment "androgen"
4 Q0 17458592 742 25.612675 imi_mug_run_2_treatment "suppressor" "abc" "aim"
4 Q0 22448335 743 25.59971 imi_mug_run_2_treatment "trastuzumab" "program" "lead"
4 Q0 23856074 744 25.59863 imi_mug_run_2_treatment "bxl0124" "vitamin d analog"
4 Q0 22260838 745 25.586967 imi_mug_run_2_treatment "her-2"
4 Q0 15289240 746 25.576786 imi_mug_run_2_treatment "aim"
4 Q0 23792450 747 25.574232 imi_mug_run_2_treatment "herceptin" "level"
4 Q0 24914385 748 25.573275 imi_mug_run_2_treatment "level" "aim"
4 Q0 30118648 749 25.5657 imi_mug_run_2_treatment "plasma" "crizotinib"
4 Q0 21686266 750 25.545868 imi_mug_run_2_treatment "ras" "mediated" "others"
4 Q0 23516391 751 25.542427 imi_mug_run_2_treatment "foretinib" "agent" "mediators"
4 Q0 26472163 752 25.53269 imi_mug_run_2_treatment "various"
4 Q0 17304506 753 25.513828 imi_mug_run_2_treatment "various" "level" "ly294002"
4 Q0 21644065 754 25.497355 imi_mug_run_2_treatment "urea"
4 Q0 25215939 755 25.495163 imi_mug_run_2_treatment "androgen" "tyrosine" "epidermal growth factor"
4 Q0 27564098 756 25.487696 imi_mug_run_2_treatment "trastuzumab" "human antibody" "pertuzumab"
4 Q0 21205074 757 25.478382 imi_mug_run_2_treatment "fluorouracil" "cisplatin" "agent"
4 Q0 11571643 758 25.466972 imi_mug_run_2_treatment "anti-cancer agents" "drug" "taxol"
4 Q0 21867536 759 25.46624 imi_mug_run_2_treatment "mediated" "trastuzumab"
4 Q0 17245212 760 25.456497 imi_mug_run_2_treatment "gastrin" "plasma" "urea"
4 Q0 9769953 761 25.452084 imi_mug_run_2_treatment "genesis"
4 Q0 20103628 762 25.451202 imi_mug_run_2_treatment "trastuzumab" "cancer drug" "mediated"
4 Q0 26272486 763 25.450113 imi_mug_run_2_treatment "lavage fluids"
4 Q0 26301495 764 25.447105 imi_mug_run_2_treatment "trastuzumab"
4 Q0 26000013 765 25.43853 imi_mug_run_2_treatment "various" "monoclonal antibodies"
4 Q0 11953857 766 25.42736 imi_mug_run_2_treatment "epidermal growth factor"
4 Q0 17176074 767 25.423943 imi_mug_run_2_treatment "herceptin" "level"
4 Q0 19906305 768 25.40282 imi_mug_run_2_treatment "serine"
4 Q0 22952421 769 25.396847 imi_mug_run_2_treatment "mediated"
4 Q0 12032832 770 25.388985 imi_mug_run_2_treatment "various"
4 Q0 26600931 771 25.372961 imi_mug_run_2_treatment "various" "drugs" "monoclonal antibodies"
4 Q0 20051960 772 25.372417 imi_mug_run_2_treatment "trastuzumab" "cytotoxic"
4 Q0 12970877 773 25.366516 imi_mug_run_2_treatment "phe" "aim"
4 Q0 15868442 774 25.365402 imi_mug_run_2_treatment "tamoxifen"
4 Q0 18795950 775 25.361336 imi_mug_run_2_treatment "herceptin"
4 Q0 18729063 776 25.359814 imi_mug_run_2_treatment "drugs" "vaccines"
4 Q0 29636108 777 25.353088 imi_mug_run_2_treatment "various" "others"
4 Q0 25055117 778 25.351603 imi_mug_run_2_treatment "various" "crizotinib" "drugs"
4 Q0 26096373 779 25.351242 imi_mug_run_2_treatment "her-2" "aim"
4 Q0 9337349 780 25.347393 imi_mug_run_2_treatment "chemotherapeutic agent" "drug" "acetone"
4 Q0 15324690 781 25.325481 imi_mug_run_2_treatment "trastuzumab"
4 Q0 22070017 782 25.320986 imi_mug_run_2_treatment "trastuzumab" "cetuximab" "level"
4 Q0 28947957 783 25.317806 imi_mug_run_2_treatment "trastuzumab"
4 Q0 10861310 784 25.30838 imi_mug_run_2_treatment "various" "drug" "combinations"
4 Q0 24281706 785 25.302128 imi_mug_run_2_treatment "trastuzumab" "pertuzumab" "drugs"
4 Q0 22482406 786 25.299084 imi_mug_run_2_treatment "aim"
4 Q0 11706391 787 25.289505 imi_mug_run_2_treatment "paclitaxel" "trastuzumab" "mediated"
4 Q0 21503962 788 25.287222 imi_mug_run_2_treatment "kinase inhibitor" "proteasome inhibitor" "mp-412"
4 Q0 29734245 789 25.285288 imi_mug_run_2_treatment "basis"
4 Q0 25322965 790 25.267996 imi_mug_run_2_treatment "plasma"
4 Q0 23912956 791 25.264484 imi_mug_run_2_treatment "pdgfb" "epidermal growth factor" "product"
4 Q0 7889467 792 25.258492 imi_mug_run_2_treatment "cyclin-dependent kinase inhibitor"
4 Q0 12907618 793 25.24388 imi_mug_run_2_treatment "kinase inhibitor" "tarceva" "egfr inhibitor"
4 Q0 8455947 794 25.232382 imi_mug_run_2_treatment "estrogens"
4 Q0 18458039 795 25.231571 imi_mug_run_2_treatment "lapatinib"
4 Q0 27940449 796 25.21797 imi_mug_run_2_treatment "mbc" "endocrine therapy"
4 Q0 1398227 797 25.210655 imi_mug_run_2_treatment "ras" "monoclonal antibodies"
4 Q0 17243161 798 25.207233 imi_mug_run_2_treatment "trastuzumab" "combinations"
4 Q0 23146892 799 25.204742 imi_mug_run_2_treatment "oxygen"
4 Q0 17200344 800 25.182114 imi_mug_run_2_treatment "proteasome inhibitor" "aim"
4 Q0 7605658 801 25.173265 imi_mug_run_2_treatment "level"
4 Q0 16904607 802 25.164825 imi_mug_run_2_treatment "guo"
4 Q0 26073079 803 25.13779 imi_mug_run_2_treatment "various"
4 Q0 22969225 804 25.136108 imi_mug_run_2_treatment "histidine" "aim"
4 Q0 11689293 805 25.123665 imi_mug_run_2_treatment "adjuvant" "level" "tamoxifen"
4 Q0 12234993 806 25.118366 imi_mug_run_2_treatment "pki-166" "androgen" "tyrosine kinase inhibitor"
4 Q0 17146442 807 25.104574 imi_mug_run_2_treatment "agar" "mediated" "ag825"
4 Q0 29139039 808 25.103859 imi_mug_run_2_treatment "various" "adc"
4 Q0 20656317 809 25.091797 imi_mug_run_2_treatment "trastuzumab" "level" "her-2"
4 Q0 23474757 810 25.091236 imi_mug_run_2_treatment "lapatinib" "agent"
4 Q0 24168763 811 25.081623 imi_mug_run_2_treatment "mediated" "sar256212" "paclitaxel"
4 Q0 16834533 812 25.07936 imi_mug_run_2_treatment "drug" "ps-341" "dtp"
4 Q0 24692179 813 25.078289 imi_mug_run_2_treatment "mediated" "lapatinib" "egfr inhibitor"
4 Q0 26719032 814 25.076262 imi_mug_run_2_treatment "calcium" "tandem" "yeast"
4 Q0 21499233 815 25.074133 imi_mug_run_2_treatment "trastuzumab" "adjuvant" "product"
4 Q0 25738885 816 25.070538 imi_mug_run_2_treatment "various" "copper" "disulfiram"
4 Q0 7880720 817 25.044258 imi_mug_run_2_treatment "oestrogen"
4 Q0 25520867 818 25.038294 imi_mug_run_2_treatment "mediated" "ras"
4 Q0 25656118 819 25.02842 imi_mug_run_2_treatment "paclitaxel" "cisplatin" "capecitabine"
4 Q0 7667291 820 25.023285 imi_mug_run_2_treatment "various" "therapeutics" "color"
4 Q0 19127259 821 25.015162 imi_mug_run_2_treatment "cetuximab" "level" "fluorouracil"
4 Q0 16187281 822 25.010422 imi_mug_run_2_treatment "mediated" "ras"
4 Q0 8176843 823 25.009726 imi_mug_run_2_treatment "ras"
4 Q0 27387915 824 25.00555 imi_mug_run_2_treatment "ras" "silver"
4 Q0 21267790 825 25.002758 imi_mug_run_2_treatment "silver" "level"
4 Q0 19619937 826 24.987364 imi_mug_run_2_treatment "epc" "isolate"
4 Q0 18422755 827 24.965843 imi_mug_run_2_treatment "cetuximab" "interleukin-2" "human immunoglobulin g"
4 Q0 15256466 828 24.956724 imi_mug_run_2_treatment "antiangiogenic" "epidermal growth factor" "agent"
4 Q0 20832392 829 24.951933 imi_mug_run_2_treatment "alcohol" "hsp70"
4 Q0 19718021 830 24.950294 imi_mug_run_2_treatment "epidermal growth factor"
4 Q0 26964772 831 24.950294 imi_mug_run_2_treatment "afatinib" "plasma"
4 Q0 8697969 832 24.946222 imi_mug_run_2_treatment "level"
4 Q0 24656091 833 24.926975 imi_mug_run_2_treatment "trastuzumab" "aim"
4 Q0 25889497 834 24.923553 imi_mug_run_2_treatment "trastuzumab" "lead" "t-dm1"
4 Q0 17145873 835 24.92295 imi_mug_run_2_treatment "mediated"
4 Q0 23155275 836 24.91132 imi_mug_run_2_treatment "color"
4 Q0 11796827 837 24.905457 imi_mug_run_2_treatment "her-2"
4 Q0 10022814 838 24.897036 imi_mug_run_2_treatment "oligos" "ras"
4 Q0 16461907 839 24.895565 imi_mug_run_2_treatment "pha-665752" "drug" "tyrosine kinase inhibitor"
4 Q0 14749494 840 24.894424 imi_mug_run_2_treatment "drug" "nrg" "herceptin"
4 Q0 3102422 841 24.886986 imi_mug_run_2_treatment "genesis"
4 Q0 30391779 842 24.885138 imi_mug_run_2_treatment "trastuzumab"
4 Q0 1355402 843 24.877583 imi_mug_run_2_treatment "product"
4 Q0 19132482 844 24.877338 imi_mug_run_2_treatment "basis"
4 Q0 26530403 845 24.8741 imi_mug_run_2_treatment "trastuzumab" "aim"
4 Q0 10967128 846 24.851355 imi_mug_run_2_treatment "level"
4 Q0 10738256 847 24.833061 imi_mug_run_2_treatment "animals" "monoclonal antibodies"
4 Q0 15375338 848 24.83101 imi_mug_run_2_treatment "methylene blue"
4 Q0 20438546 849 24.818748 imi_mug_run_2_treatment "coagulation factors" "lead" "liver"
4 Q0 20043086 850 24.81094 imi_mug_run_2_treatment "plasminogen activator"
4 Q0 10706127 851 24.810379 imi_mug_run_2_treatment "color" "level" "aim"
4 Q0 21862872 852 24.805336 imi_mug_run_2_treatment "metformin" "trastuzumab" "dasatinib"
4 Q0 18083065 853 24.80449 imi_mug_run_2_treatment "letrozole" "tamoxifen" "drug"
4 Q0 30425522 854 24.803959 imi_mug_run_2_treatment "afatinib" "glycine"
4 Q0 26810187 855 24.803455 imi_mug_run_2_treatment "her-2" "trastuzumab" "adjuvant"
4 Q0 25565860 856 24.794624 imi_mug_run_2_treatment "formalin" "aim"
4 Q0 12451999 857 24.793888 imi_mug_run_2_treatment "icc" "elder"
4 Q0 18454161 858 24.79168 imi_mug_run_2_treatment "trastuzumab" "herceptin" "anhydrotetracycline"
4 Q0 18724389 859 24.784163 imi_mug_run_2_treatment "protein c" "mediated"
4 Q0 14532980 860 24.781628 imi_mug_run_2_treatment "duration"
4 Q0 11071470 861 24.780254 imi_mug_run_2_treatment "product" "aim"
4 Q0 25479078 862 24.770111 imi_mug_run_2_treatment "trastuzumab" "aim"
4 Q0 15582575 863 24.770039 imi_mug_run_2_treatment "vitamin e" "oxygen" "superoxide dismutase"
4 Q0 17568183 864 24.757862 imi_mug_run_2_treatment "il-6" "medicine" "salt"
4 Q0 25749810 865 24.757568 imi_mug_run_2_treatment "trastuzumab" "her-2" "aim"
4 Q0 22544433 866 24.756577 imi_mug_run_2_treatment "adjuvant" "antiangiogenic" "anti-vegf"
4 Q0 22190871 867 24.75389 imi_mug_run_2_treatment "lapatinib" "kinase inhibitor" "program"
4 Q0 17224938 868 24.753391 imi_mug_run_2_treatment "aim"
4 Q0 20051871 869 24.742668 imi_mug_run_2_treatment "gen-1" "genistein" "estradiol"
4 Q0 15741050 870 24.730488 imi_mug_run_2_treatment "various" "rutin" "quercetin"
4 Q0 19409371 871 24.7228 imi_mug_run_2_treatment "various" "trastuzumab" "drugs"
4 Q0 15545967 872 24.718662 imi_mug_run_2_treatment "trastuzumab" "platinum"
4 Q0 2820743 873 24.70732 imi_mug_run_2_treatment "cytostatic drugs" "monolayer"
4 Q0 25792810 874 24.706612 imi_mug_run_2_treatment "emodin" "oxygen" "n-acetylcysteine"
4 Q0 17164260 875 24.703285 imi_mug_run_2_treatment "various" "oestrogen"
4 Q0 1285215 876 24.691454 imi_mug_run_2_treatment "product"
4 Q0 12016390 877 24.680557 imi_mug_run_2_treatment "various"
4 Q0 19072471 878 24.677582 imi_mug_run_2_treatment "letrozole" "adjuvant" "tamoxifen"
4 Q0 12530026 879 24.664516 imi_mug_run_2_treatment "others"
4 Q0 12174876 880 24.66078 imi_mug_run_2_treatment "cisplatin" "drugs" "emodin"
4 Q0 26692570 881 24.657532 imi_mug_run_2_treatment "isoproterenol" "agonist" "antineoplastic drugs"
4 Q0 27931797 882 24.655357 imi_mug_run_2_treatment "acetate" "mediated"
4 Q0 19411062 883 24.6265 imi_mug_run_2_treatment "trastuzumab" "blockade"
4 Q0 16682622 884 24.622898 imi_mug_run_2_treatment "lapatinib" "tyrosine" "mediated"
4 Q0 26358791 885 24.60285 imi_mug_run_2_treatment "trastuzumab" "fulvestrant" "pertuzumab"
4 Q0 17003495 886 24.595455 imi_mug_run_2_treatment "prostaglandin"
4 Q0 16868940 887 24.594234 imi_mug_run_2_treatment "product"
4 Q0 25660204 888 24.591259 imi_mug_run_2_treatment "drug" "trastuzumab" "agent"
4 Q0 15800983 889 24.564754 imi_mug_run_2_treatment "aim"
4 Q0 28938602 890 24.55099 imi_mug_run_2_treatment "mediated" "lapatinib" "ly294002"
4 Q0 15734482 891 24.549479 imi_mug_run_2_treatment "various"
4 Q0 20056314 892 24.549133 imi_mug_run_2_treatment "chloroquine"
4 Q0 15262439 893 24.544819 imi_mug_run_2_treatment "level"
4 Q0 7585656 894 24.543736 imi_mug_run_2_treatment "adjuvant" "level"
4 Q0 28292264 895 24.535582 imi_mug_run_2_treatment "crizotinib" "pdx" "her-2"
4 Q0 20847829 896 24.535135 imi_mug_run_2_treatment "trastuzumab"
4 Q0 22190870 897 24.528181 imi_mug_run_2_treatment "trastuzumab" "herceptin" "others"
4 Q0 18559507 898 24.511635 imi_mug_run_2_treatment "level"
4 Q0 27986464 899 24.492626 imi_mug_run_2_treatment "level"
4 Q0 15856022 900 24.483637 imi_mug_run_2_treatment "drug" "herceptin" "tyrosine"
4 Q0 24747692 901 24.481422 imi_mug_run_2_treatment "drugs" "mediated"
4 Q0 8605112 902 24.47797 imi_mug_run_2_treatment "various"
4 Q0 20856229 903 24.47734 imi_mug_run_2_treatment "hyaluronate"
4 Q0 16857791 904 24.476122 imi_mug_run_2_treatment "trastuzumab"
4 Q0 19751177 905 24.474329 imi_mug_run_2_treatment "trastuzumab" "pertuzumab" "monoclonal antibodies"
4 Q0 27462779 906 24.471886 imi_mug_run_2_treatment "trastuzumab" "adjuvant"
4 Q0 28885562 907 24.439579 imi_mug_run_2_treatment "cytotoxic"
4 Q0 19424599 908 24.439304 imi_mug_run_2_treatment "docetaxel" "drug" "mediated"
4 Q0 27109096 909 24.42294 imi_mug_run_2_treatment "mediated" "lapatinib"
4 Q0 12099646 910 24.422691 imi_mug_run_2_treatment "various"
4 Q0 20012671 911 24.42228 imi_mug_run_2_treatment "basis"
4 Q0 16254685 912 24.41442 imi_mug_run_2_treatment "serine" "suppressor"
4 Q0 15010812 913 24.408081 imi_mug_run_2_treatment "tandem"
4 Q0 27014419 914 24.405355 imi_mug_run_2_treatment "cisplatin" "s-1" "formalin"
4 Q0 24004612 915 24.396091 imi_mug_run_2_treatment "therapeutics"
4 Q0 30107476 916 24.395676 imi_mug_run_2_treatment "various" "mediated"
4 Q0 15862947 917 24.392849 imi_mug_run_2_treatment "estrogen"
4 Q0 19861407 918 24.392849 imi_mug_run_2_treatment "estrogen" "estradiol" "estrogenic compounds"
4 Q0 9585252 919 24.387136 imi_mug_run_2_treatment "tyrosine" "agent"
4 Q0 26251698 920 24.386261 imi_mug_run_2_treatment "level"
4 Q0 20304052 921 24.37811 imi_mug_run_2_treatment "vitamin d analog" "bxl0124" "vitamin d"
4 Q0 12366664 922 24.37463 imi_mug_run_2_treatment "various"
4 Q0 25636205 923 24.372173 imi_mug_run_2_treatment "platinum"
4 Q0 12574167 924 24.354933 imi_mug_run_2_treatment "mediated" "hsp70"
4 Q0 17189388 925 24.35371 imi_mug_run_2_treatment "taxol" "drugs" "monoclonal antibodies"
4 Q0 25070180 926 24.340174 imi_mug_run_2_treatment "lapatinib" "roscovitine" "kinase inhibitor"
4 Q0 16061662 927 24.340076 imi_mug_run_2_treatment "herceptin" "tyrosine" "epidermal growth factor"
4 Q0 15665275 928 24.339952 imi_mug_run_2_treatment "lapatinib" "antiestrogen" "estrogen"
4 Q0 2544146 929 24.313786 imi_mug_run_2_treatment "sam" "ras" "kato"
4 Q0 16266989 930 24.307196 imi_mug_run_2_treatment "various" "therapeutics"
4 Q0 9619847 931 24.296923 imi_mug_run_2_treatment "aim"
4 Q0 21403841 932 24.29497 imi_mug_run_2_treatment "mediated"
4 Q0 18039470 933 24.280552 imi_mug_run_2_treatment "herceptin"
4 Q0 17911008 934 24.2793 imi_mug_run_2_treatment "trastuzumab" "hyaluronan" "mediated"
4 Q0 21136925 935 24.2793 imi_mug_run_2_treatment "trastuzumab" "aim" "others"
4 Q0 26884344 936 24.276623 imi_mug_run_2_treatment "s-1" "gimeracil" "tegafur"
4 Q0 20160030 937 24.27489 imi_mug_run_2_treatment "level"
4 Q0 19390941 938 24.260384 imi_mug_run_2_treatment "ors" "taxane"
4 Q0 18490651 939 24.234144 imi_mug_run_2_treatment "trastuzumab" "lapatinib" "drug"
4 Q0 24914388 940 24.219389 imi_mug_run_2_treatment "isolate" "aim"
4 Q0 22387177 941 24.215204 imi_mug_run_2_treatment "various" "enzymes" "docetaxel"
4 Q0 11966534 942 24.213755 imi_mug_run_2_treatment "aim"
4 Q0 17879382 943 24.208847 imi_mug_run_2_treatment "ptx" "antitumor agent" "paclitaxel"
4 Q0 20679487 944 24.195091 imi_mug_run_2_treatment "thr" "epidermal growth factor" "ras"
4 Q0 18644987 945 24.187607 imi_mug_run_2_treatment "hdac inhibitor" "st71"
4 Q0 28453704 946 24.167871 imi_mug_run_2_treatment "trastuzumab" "level"
4 Q0 24961464 947 24.155602 imi_mug_run_2_treatment "parathyroid hormone" "cytokines" "il-6"
4 Q0 27002940 948 24.148428 imi_mug_run_2_treatment "ras" "basis"
4 Q0 23807774 949 24.139338 imi_mug_run_2_treatment "level"
4 Q0 17283152 950 24.129448 imi_mug_run_2_treatment "trastuzumab" "lapatinib"
4 Q0 18413839 951 24.129162 imi_mug_run_2_treatment "exel-7647" "lapatinib" "nh2"
4 Q0 29714649 952 24.11966 imi_mug_run_2_treatment "trastuzumab" "pertuzumab" "nivolumab"
4 Q0 22892392 953 24.09871 imi_mug_run_2_treatment "lapatinib" "tamoxifen" "antioestrogen"
4 Q0 24360119 954 24.093292 imi_mug_run_2_treatment "mediated"
4 Q0 20056944 955 24.088776 imi_mug_run_2_treatment "drugs" "epidermal growth factor"
4 Q0 16510594 956 24.07203 imi_mug_run_2_treatment "ras" "level" "mediated"
4 Q0 27459504 957 24.071463 imi_mug_run_2_treatment "mediated" "suppressor"
4 Q0 12941816 958 24.066408 imi_mug_run_2_treatment "mediated"
4 Q0 29799521 959 24.065796 imi_mug_run_2_treatment "lapatinib" "mediated"
4 Q0 27900589 960 24.061443 imi_mug_run_2_treatment "trastuzumab" "leucine" "her2 monoclonal antibody"
4 Q0 27179038 961 24.060312 imi_mug_run_2_treatment "level" "mediated" "agent"
4 Q0 19046792 962 24.058584 imi_mug_run_2_treatment "mediators" "level"
4 Q0 16467098 963 24.057236 imi_mug_run_2_treatment "etoposide" "herceptin" "taxol"
4 Q0 25043310 964 24.046673 imi_mug_run_2_treatment "plasma"
4 Q0 25306619 965 24.042473 imi_mug_run_2_treatment "formalin"
4 Q0 15504247 966 24.041061 imi_mug_run_2_treatment "various"
4 Q0 16299242 967 24.025621 imi_mug_run_2_treatment "drug" "gefitinib" "erlotinib"
4 Q0 26107192 968 24.018555 imi_mug_run_2_treatment "various"
4 Q0 17626164 969 24.01687 imi_mug_run_2_treatment "various"
4 Q0 26792292 970 24.016415 imi_mug_run_2_treatment "methylated" "demethylating agent"
4 Q0 17572496 971 24.011477 imi_mug_run_2_treatment "cytostatic" "aim" "matrix"
4 Q0 23447672 972 24.00389 imi_mug_run_2_treatment "mediated"
4 Q0 11330837 973 23.999578 imi_mug_run_2_treatment "serine"
4 Q0 16585198 974 23.993717 imi_mug_run_2_treatment "mediated" "favor" "basis"
4 Q0 24304688 975 23.989937 imi_mug_run_2_treatment "various" "glutamine"
4 Q0 9625302 976 23.979315 imi_mug_run_2_treatment "level" "cytotoxic" "basis"
4 Q0 28781955 977 23.968245 imi_mug_run_2_treatment "ras" "sch772984" "agar"
4 Q0 8721956 978 23.96621 imi_mug_run_2_treatment "product"
4 Q0 15236312 979 23.96298 imi_mug_run_2_treatment "color"
4 Q0 7688814 980 23.949194 imi_mug_run_2_treatment "aim" "monoclonal antibodies"
4 Q0 18202008 981 23.943144 imi_mug_run_2_treatment "trastuzumab" "embelin" "mediated"
4 Q0 24452693 982 23.942463 imi_mug_run_2_treatment "tcn" "triciribine" "trastuzumab"
4 Q0 21323863 983 23.907639 imi_mug_run_2_treatment "human igg"
4 Q0 17416003 984 23.907011 imi_mug_run_2_treatment "tam" "tamoxifen" "level"
4 Q0 10537329 985 23.898775 imi_mug_run_2_treatment "basis"
4 Q0 11162510 986 23.895826 imi_mug_run_2_treatment "mediated" "herceptin" "therapeutics"
4 Q0 28243898 987 23.892876 imi_mug_run_2_treatment "lead"
4 Q0 25682441 988 23.885075 imi_mug_run_2_treatment "cisplatin" "s-1" "formalin"
4 Q0 23263912 989 23.879955 imi_mug_run_2_treatment "capecitabine" "paclitaxel" "medication"
4 Q0 21210970 990 23.85448 imi_mug_run_2_treatment "mediated" "lead"
4 Q0 14614020 991 23.841484 imi_mug_run_2_treatment "tcc" "product"
4 Q0 18980964 992 23.83796 imi_mug_run_2_treatment "lapatinib" "trastuzumab" "herceptin"
4 Q0 25633808 993 23.83796 imi_mug_run_2_treatment "trastuzumab" "pertuzumab" "level"
4 Q0 28817097 994 23.826624 imi_mug_run_2_treatment "monoclonal antibodies"
4 Q0 24165569 995 23.826176 imi_mug_run_2_treatment "erythropoietin"
4 Q0 9380415 996 23.816294 imi_mug_run_2_treatment "basis"
4 Q0 25428673 997 23.800112 imi_mug_run_2_treatment "enzymes" "product"
4 Q0 30248295 998 23.795486 imi_mug_run_2_treatment "formalin" "aim"
4 Q0 20825649 999 23.793444 imi_mug_run_2_treatment "mediated" "therapeutics"
5 Q0 19424877 1 44.215843 imi_mug_run_2_treatment "aspirin" "hoechst 33258" "agent"
5 Q0 29279289 2 42.196373 imi_mug_run_2_treatment "icc" "ras"
5 Q0 29636108 3 41.21276 imi_mug_run_2_treatment "various" "others"
5 Q0 12451999 4 40.483597 imi_mug_run_2_treatment "icc" "elder"
5 Q0 17146442 5 40.135323 imi_mug_run_2_treatment "agar" "mediated" "ag825"
5 Q0 12366664 6 33.455814 imi_mug_run_2_treatment "various"
5 Q0 11156524 7 32.59446 imi_mug_run_2_treatment "various" "mediated" "lead"
5 Q0 23827764 8 32.286736 imi_mug_run_2_treatment "aim"
5 Q0 16770086 9 32.264915 imi_mug_run_2_treatment "level" "aim" "liver"
5 Q0 29352243 10 31.857733 imi_mug_run_2_treatment "tyrphostin" "mediated" "as1411"
5 Q0 29941010 11 31.740007 imi_mug_run_2_treatment "lapatinib" "trastuzumab" "aim"
5 Q0 27542246 12 31.531305 imi_mug_run_2_treatment "mediated" "various" "drugs"
5 Q0 10366459 13 31.2792 imi_mug_run_2_treatment "aim"
5 Q0 29089858 14 31.17229 imi_mug_run_2_treatment "cisplatin" "fluorouracil"
5 Q0 30030278 15 31.019402 imi_mug_run_2_treatment "ado-trastuzumab emtansine"
5 Q0 21787752 16 30.98224 imi_mug_run_2_treatment "agar"
5 Q0 27596216 17 30.340338 imi_mug_run_2_treatment "drugs" "her-2" "lead"
5 Q0 15300809 18 29.967632 imi_mug_run_2_treatment "anti-cancer agents" "biotin"
5 Q0 11920778 19 29.962181 imi_mug_run_2_treatment "adjuvant" "duration"
5 Q0 11360601 20 29.943539 imi_mug_run_2_treatment "oligo"
5 Q0 19228734 21 29.859123 imi_mug_run_2_treatment "mediated" "level" "taxol"
5 Q0 16601278 22 29.851082 imi_mug_run_2_treatment "various" "drug" "herceptin"
5 Q0 19513620 23 29.83176 imi_mug_run_2_treatment "cisplatin" "herceptin" "ag825"
5 Q0 28160563 24 29.797443 imi_mug_run_2_treatment "cisplatin" "fluorouracil"
5 Q0 12553037 25 29.591953 imi_mug_run_2_treatment "estrogen" "estradiol" "therapeutic agents"
5 Q0 28099468 26 29.567902 imi_mug_run_2_treatment "suppressor"
5 Q0 27765041 27 29.498096 imi_mug_run_2_treatment "mediated"
5 Q0 27416801 28 29.441647 imi_mug_run_2_treatment "alcohol"
5 Q0 22200761 29 29.389044 imi_mug_run_2_treatment "mediated"
5 Q0 23552733 30 29.37147 imi_mug_run_2_treatment "trastuzumab" "level" "pertuzumab"
5 Q0 9572489 31 29.251038 imi_mug_run_2_treatment "taxotere" "taxol" "thioridazine"
5 Q0 16309427 32 29.247162 imi_mug_run_2_treatment "ras"
5 Q0 20331626 33 29.234821 imi_mug_run_2_treatment "herceptin" "agent" "level"
5 Q0 17704139 34 29.219038 imi_mug_run_2_treatment "various" "androgen" "mediated"
5 Q0 15457249 35 29.212273 imi_mug_run_2_treatment "enzymes"
5 Q0 24798404 36 29.201422 imi_mug_run_2_treatment "oxygen" "ag825"
5 Q0 16286993 37 29.166931 imi_mug_run_2_treatment "biotin" "abc" "aim"
5 Q0 28415602 38 29.156792 imi_mug_run_2_treatment "lapatinib" "tyrosine kinase inhibitor" "lead"
5 Q0 20649976 39 29.148224 imi_mug_run_2_treatment "cannabinoid" "cannabinoids" "marijuana"
5 Q0 27363335 40 29.135586 imi_mug_run_2_treatment "combinations" "trastuzumab" "pertuzumab"
5 Q0 21673090 41 29.110577 imi_mug_run_2_treatment "lapatinib" "tyrosine" "proteasome inhibitors"
5 Q0 29285258 42 29.080536 imi_mug_run_2_treatment "trastuzumab" "matrix"
5 Q0 27048593 43 29.051956 imi_mug_run_2_treatment "forchlorfenuron" "basis" "level"
5 Q0 24937171 44 29.022057 imi_mug_run_2_treatment "ras" "androgen"
5 Q0 20542996 45 28.969915 imi_mug_run_2_treatment "lapatinib" "trastuzumab" "nervous system"
5 Q0 19945923 46 28.969372 imi_mug_run_2_treatment "tandem" "level"
5 Q0 20201928 47 28.96074 imi_mug_run_2_treatment "ag825" "ethanol" "human plasma"
5 Q0 26936914 48 28.959595 imi_mug_run_2_treatment "abiraterone" "leuprolide" "lapatinib"
5 Q0 24879636 49 28.953209 imi_mug_run_2_treatment "product"
5 Q0 27065318 50 28.937449 imi_mug_run_2_treatment "trastuzumab" "level"
5 Q0 18769124 51 28.863436 imi_mug_run_2_treatment "trastuzumab" "drug" "herceptin"
5 Q0 9892105 52 28.813967 imi_mug_run_2_treatment "gastrin"
5 Q0 26645663 53 28.808805 imi_mug_run_2_treatment "therapeutic agents"
5 Q0 26261492 54 28.807926 imi_mug_run_2_treatment "kinase inhibitor" "herceptin" "lapatinib"
5 Q0 7904177 55 28.772194 imi_mug_run_2_treatment "product"
5 Q0 24835103 56 28.73717 imi_mug_run_2_treatment "trastuzumab" "monoclonal antibodies"
5 Q0 17409443 57 28.708906 imi_mug_run_2_treatment "tocopheryl succinate" "vitamin e succinate"
5 Q0 7903175 58 28.661972 imi_mug_run_2_treatment "estrogen"
5 Q0 20498641 59 28.639336 imi_mug_run_2_treatment "paclitaxel" "mediated"
5 Q0 7584099 60 28.577982 imi_mug_run_2_treatment "monoclonal antibodies"
5 Q0 15678850 61 28.576931 imi_mug_run_2_treatment "antiserum"
5 Q0 26936618 62 28.57294 imi_mug_run_2_treatment "cerulenin" "mediated" "deoxyglucose"
5 Q0 21088503 63 28.544336 imi_mug_run_2_treatment "celastrol" "trastuzumab" "therapeutics"
5 Q0 22914212 64 28.53479 imi_mug_run_2_treatment "epidermal growth factor" "level"
5 Q0 16585203 65 28.501076 imi_mug_run_2_treatment "therapeutics" "basis"
5 Q0 21710689 66 28.488958 imi_mug_run_2_treatment "heat shock protein 70"
5 Q0 15753384 67 28.474445 imi_mug_run_2_treatment "mediated" "protease" "lead"
5 Q0 18409049 68 28.3925 imi_mug_run_2_treatment "h-89" "tam" "tamoxifen"
5 Q0 27345410 69 28.381685 imi_mug_run_2_treatment "azacytidine"
5 Q0 26977021 70 28.373127 imi_mug_run_2_treatment "hsp70" "mediated" "drug"
5 Q0 25081321 71 28.364985 imi_mug_run_2_treatment "drug" "ibrutinib" "pi3k/mtor inhibitor bez235"
5 Q0 18719096 72 28.3506 imi_mug_run_2_treatment "kinase inhibitor" "ras" "lapatinib"
5 Q0 24122876 73 28.310373 imi_mug_run_2_treatment "glutamine" "mediated"
5 Q0 16452223 74 28.29923 imi_mug_run_2_treatment "lapatinib" "proteosome inhibitor" "mediated"
5 Q0 12894578 75 28.287937 imi_mug_run_2_treatment "oestrogen"
5 Q0 8664033 76 28.271553 imi_mug_run_2_treatment "plasma"
5 Q0 10607920 77 28.266119 imi_mug_run_2_treatment "drug" "mediated" "lead"
5 Q0 25509354 78 28.266119 imi_mug_run_2_treatment "various"
5 Q0 23661506 79 28.251305 imi_mug_run_2_treatment "level"
5 Q0 27029001 80 28.240856 imi_mug_run_2_treatment "mediated"
5 Q0 9875670 81 28.214302 imi_mug_run_2_treatment "dna immunization" "cancer vaccine" "genetic immunization"
5 Q0 25596742 82 28.202276 imi_mug_run_2_treatment "mediated" "kinase inhibitor" "lapatinib"
5 Q0 20379846 83 28.18869 imi_mug_run_2_treatment "tamoxifen" "mediated" "proteasome inhibitors"
5 Q0 29715459 84 28.187809 imi_mug_run_2_treatment "paclitaxel" "mediated" "level"
5 Q0 11153605 85 28.15755 imi_mug_run_2_treatment "aim"
5 Q0 25238247 86 28.14801 imi_mug_run_2_treatment "lapatinib" "blockade"
5 Q0 21034468 87 28.140682 imi_mug_run_2_treatment "mediated" "ethanol" "antioxidant"
5 Q0 16003726 88 28.123554 imi_mug_run_2_treatment "gefitinib"
5 Q0 16091755 89 28.114338 imi_mug_run_2_treatment "lapatinib" "trastuzumab"
5 Q0 28306722 90 28.111572 imi_mug_run_2_treatment "matrix" "aim" "shape"
5 Q0 17266042 91 28.066257 imi_mug_run_2_treatment "tamoxifen" "mediated"
5 Q0 21419042 92 28.0616 imi_mug_run_2_treatment "mediated" "aim"
5 Q0 7656779 93 28.053978 imi_mug_run_2_treatment "level"
5 Q0 20124457 94 28.04892 imi_mug_run_2_treatment "lapatinib" "calcium" "drug"
5 Q0 18765569 95 28.036928 imi_mug_run_2_treatment "epidermal growth factor"
5 Q0 28442738 96 28.025166 imi_mug_run_2_treatment "mediated"
5 Q0 8695221 97 28.008022 imi_mug_run_2_treatment "oestrogen" "toremifene" "level"
5 Q0 24492292 98 28.003387 imi_mug_run_2_treatment "trastuzumab" "saracatinib" "drug"
5 Q0 23943608 99 27.985056 imi_mug_run_2_treatment "trastuzumab" "lapatinib" "combination drug"
5 Q0 15093533 100 27.977703 imi_mug_run_2_treatment "mediated" "herceptin" "trastuzumab"
5 Q0 29686309 101 27.975945 imi_mug_run_2_treatment "various" "mediated"
5 Q0 21127496 102 27.92588 imi_mug_run_2_treatment "tocopheryl succinate" "recombinant tnf-related apoptosis-inducing ligand" "aim"
5 Q0 26999718 103 27.924747 imi_mug_run_2_treatment "trastuzumab" "pertuzumab" "mediated"
5 Q0 21749294 104 27.914974 imi_mug_run_2_treatment "various" "agent"
5 Q0 20068093 105 27.904446 imi_mug_run_2_treatment "balance"
5 Q0 28670312 106 27.896349 imi_mug_run_2_treatment "tgfb1" "suppressor" "il-10"
5 Q0 23900832 107 27.888615 imi_mug_run_2_treatment "ile"
5 Q0 10878580 108 27.86127 imi_mug_run_2_treatment "mediated" "taxol" "lead"
5 Q0 23460348 109 27.859467 imi_mug_run_2_treatment "trastuzumab"
5 Q0 15987433 110 27.825844 imi_mug_run_2_treatment "aim"
5 Q0 27791982 111 27.813646 imi_mug_run_2_treatment "lapatinib"
5 Q0 11786427 112 27.80698 imi_mug_run_2_treatment "androgen" "level" "trastuzumab"
5 Q0 16947083 113 27.763645 imi_mug_run_2_treatment "drugs"
5 Q0 28300085 114 27.758041 imi_mug_run_2_treatment "mediated"
5 Q0 16407820 115 27.686665 imi_mug_run_2_treatment "mediated" "plasminogen activator" "agent"
5 Q0 29044505 116 27.649376 imi_mug_run_2_treatment "various" "adjuvant"
5 Q0 27926948 117 27.648148 imi_mug_run_2_treatment "level"
5 Q0 25333815 118 27.645294 imi_mug_run_2_treatment "various" "tor" "mediated"
5 Q0 11175365 119 27.60274 imi_mug_run_2_treatment "tcc" "therapeutics" "level"
5 Q0 19668225 120 27.597536 imi_mug_run_2_treatment "deoxyglucose" "mediated" "level"
5 Q0 22393464 121 27.5958 imi_mug_run_2_treatment "agonist" "others"
5 Q0 29792724 122 27.5958 imi_mug_run_2_treatment "trastuzumab" "therapeutic antibody" "level"
5 Q0 26716506 123 27.581493 imi_mug_run_2_treatment "trastuzumab" "therapeutic agents"
5 Q0 10499598 124 27.58088 imi_mug_run_2_treatment "erb-38" "immunotoxin" "liver"
5 Q0 23318431 125 27.577156 imi_mug_run_2_treatment "antioxidants" "oxygen" "tyrosine"
5 Q0 30520849 126 27.541225 imi_mug_run_2_treatment "trastuzumab" "bispecific antibody" "cytotoxic"
5 Q0 11410482 127 27.536434 imi_mug_run_2_treatment "topo" "enzymes" "alkylator"
5 Q0 22674190 128 27.512081 imi_mug_run_2_treatment "herceptin" "kinase inhibitor" "pertuzumab"
5 Q0 9696394 129 27.478836 imi_mug_run_2_treatment "level" "tyrosine" "tyrosine kinase inhibitor"
5 Q0 24463007 130 27.41851 imi_mug_run_2_treatment "tamoxifen" "endocrine therapy" "selective estrogen receptor modulator"
5 Q0 22464443 131 27.383366 imi_mug_run_2_treatment "mediators"
5 Q0 24492513 132 27.375008 imi_mug_run_2_treatment "trastuzumab"
5 Q0 30123134 133 27.36245 imi_mug_run_2_treatment "drug" "drugs" "atra"
5 Q0 22969966 134 27.3377 imi_mug_run_2_treatment "tyrosine"
5 Q0 24322659 135 27.313145 imi_mug_run_2_treatment "metformin" "mediated"
5 Q0 24046294 136 27.293457 imi_mug_run_2_treatment "immunoglobulin g" "bispecific antibody" "pertuzumab"
5 Q0 23271292 137 27.285103 imi_mug_run_2_treatment "herceptin" "dsb"
5 Q0 23089982 138 27.26324 imi_mug_run_2_treatment "lapatinib" "drug" "kinase inhibitor"
5 Q0 22046346 139 27.259361 imi_mug_run_2_treatment "kinase inhibitor" "lapatinib" "cl-387785"
5 Q0 9712416 140 27.258667 imi_mug_run_2_treatment "level"
5 Q0 25590338 141 27.206211 imi_mug_run_2_treatment "lapatinib" "trastuzumab" "mediated"
5 Q0 23770845 142 27.138353 imi_mug_run_2_treatment "gw9662" "level"
5 Q0 28096336 143 27.130484 imi_mug_run_2_treatment "program" "balance"
5 Q0 27474152 144 27.1129 imi_mug_run_2_treatment "therapeutics" "lapatinib"
5 Q0 15385631 145 27.097633 imi_mug_run_2_treatment "trastuzumab" "herceptin" "balance"
5 Q0 25566992 146 27.094517 imi_mug_run_2_treatment "iff" "mediated" "matrix"
5 Q0 20197472 147 27.069443 imi_mug_run_2_treatment "trastuzumab" "lapatinib" "mediated"
5 Q0 12584562 148 27.061892 imi_mug_run_2_treatment "mediated"
5 Q0 23612964 149 27.061892 imi_mug_run_2_treatment "tyrosine" "lapatinib"
5 Q0 25791465 150 27.061028 imi_mug_run_2_treatment "matrix"
5 Q0 16153159 151 27.050262 imi_mug_run_2_treatment "lead" "level"
5 Q0 10066072 152 27.041594 imi_mug_run_2_treatment "tamoxifen" "antiestrogen" "adjuvant"
5 Q0 20711231 153 27.023031 imi_mug_run_2_treatment "mediated" "ras" "drug"
5 Q0 19435870 154 27.020203 imi_mug_run_2_treatment "nonsteroidal anti-inflammatory drug" "anti-inflammatory" "drug"
5 Q0 18948375 155 26.983557 imi_mug_run_2_treatment "cytokines"
5 Q0 11062025 156 26.962532 imi_mug_run_2_treatment "drugs" "various" "fluorouracil"
5 Q0 1351679 157 26.949623 imi_mug_run_2_treatment "level"
5 Q0 27879270 158 26.928299 imi_mug_run_2_treatment "antiestrogen" "drug" "antiestrogens"
5 Q0 18936791 159 26.917881 imi_mug_run_2_treatment "trastuzumab" "tyrosine kinase inhibitor" "lapatinib"
5 Q0 19787624 160 26.914152 imi_mug_run_2_treatment "interleukin-2" "tnf-alpha" "cytokines"
5 Q0 16414259 161 26.896328 imi_mug_run_2_treatment "tyrosine" "aim"
5 Q0 9499914 162 26.896114 imi_mug_run_2_treatment "drugs" "product" "lead"
5 Q0 11205461 163 26.893084 imi_mug_run_2_treatment "tamoxifen" "adjuvant" "aim"
5 Q0 12527905 164 26.844582 imi_mug_run_2_treatment "estrogens" "estradiol" "tamoxifen"
5 Q0 24121271 165 26.837893 imi_mug_run_2_treatment "program"
5 Q0 22505344 166 26.802269 imi_mug_run_2_treatment "androgen" "trastuzumab" "pertuzumab"
5 Q0 23519125 167 26.7695 imi_mug_run_2_treatment "saha" "hdac inhibitor" "panobinostat"
5 Q0 17687647 168 26.74168 imi_mug_run_2_treatment "ile" "isoleucine"
5 Q0 16963728 169 26.738754 imi_mug_run_2_treatment "urokinase-type plasminogen activator" "plasminogen activator" "plau"
5 Q0 21384344 170 26.723583 imi_mug_run_2_treatment "mediated"
5 Q0 16488535 171 26.700176 imi_mug_run_2_treatment "resveratrol" "estrogen"
5 Q0 24709902 172 26.671637 imi_mug_run_2_treatment "nervous system"
5 Q0 11956082 173 26.671036 imi_mug_run_2_treatment "combinations" "flavopiridol" "herceptin"
5 Q0 17311002 174 26.655094 imi_mug_run_2_treatment "hki-272" "kinase inhibitor" "drugs"
5 Q0 26755150 175 26.632845 imi_mug_run_2_treatment "gold"
5 Q0 22789781 176 26.598358 imi_mug_run_2_treatment "trastuzumab" "cetuximab" "bsab"
5 Q0 21613411 177 26.581728 imi_mug_run_2_treatment "androgen" "dihydrotestosterone" "tcc"
5 Q0 12631589 178 26.579021 imi_mug_run_2_treatment "her-2"
5 Q0 12477051 179 26.570044 imi_mug_run_2_treatment "hdac inhibitor" "sodium butyrate" "histone deacetylase inhibitors"
5 Q0 23971878 180 26.551949 imi_mug_run_2_treatment "lapatinib" "oxygen" "mediated"
5 Q0 17452776 181 26.538082 imi_mug_run_2_treatment "aim"
5 Q0 8096076 182 26.527683 imi_mug_run_2_treatment "m-amsa" "mitoxantrone" "topoisomerase inhibitors"
5 Q0 19826038 183 26.513802 imi_mug_run_2_treatment "sndx-275" "hdac inhibitor sndx-275" "therapeutic agent"
5 Q0 16319978 184 26.507948 imi_mug_run_2_treatment "estrogen" "plasma"
5 Q0 21497990 185 26.507948 imi_mug_run_2_treatment "combinations" "sndx-275" "hdac inhibitor"
5 Q0 18339869 186 26.505161 imi_mug_run_2_treatment "mediated"
5 Q0 24551203 187 26.49501 imi_mug_run_2_treatment "psoralen" "mediated" "methoxypsoralen"
5 Q0 7954259 188 26.472984 imi_mug_run_2_treatment "adjuvant" "product"
5 Q0 20847831 189 26.465067 imi_mug_run_2_treatment "lapatinib" "estrogen" "tamoxifen"
5 Q0 21086124 190 26.454746 imi_mug_run_2_treatment "trastuzumab" "paclitaxel" "herceptin"
5 Q0 27597738 191 26.425488 imi_mug_run_2_treatment "neratinib" "lapatinib" "mediated"
5 Q0 14697248 192 26.399506 imi_mug_run_2_treatment "pd98059" "trastuzumab"
5 Q0 17570480 193 26.399284 imi_mug_run_2_treatment "her-2"
5 Q0 14982856 194 26.37847 imi_mug_run_2_treatment "mediated"
5 Q0 23232401 195 26.369093 imi_mug_run_2_treatment "therapeutics" "trastuzumab"
5 Q0 11156523 196 26.365118 imi_mug_run_2_treatment "cdk inhibitor"
5 Q0 12853564 197 26.35724 imi_mug_run_2_treatment "basis"
5 Q0 27863425 198 26.345541 imi_mug_run_2_treatment "wortmannin" "mediated"
5 Q0 29907770 199 26.322937 imi_mug_run_2_treatment "glucose" "lactate" "level"
5 Q0 22461520 200 26.295076 imi_mug_run_2_treatment "ly294002" "androgen" "wortmannin"
5 Q0 24384723 201 26.293945 imi_mug_run_2_treatment "lapatinib" "mediated" "epidermal growth factor receptor inhibitor"
5 Q0 12553494 202 26.285664 imi_mug_run_2_treatment "trastuzumab" "aim"
5 Q0 10474685 203 26.271507 imi_mug_run_2_treatment "digoxigenin" "aim"
5 Q0 16818618 204 26.249971 imi_mug_run_2_treatment "hki-272" "kinase inhibitor" "interleukin-3"
5 Q0 23720052 205 26.241138 imi_mug_run_2_treatment "mediated"
5 Q0 12384528 206 26.22792 imi_mug_run_2_treatment "tyr" "herceptin" "taxol"
5 Q0 24186136 207 26.227436 imi_mug_run_2_treatment "product"
5 Q0 15870923 208 26.18131 imi_mug_run_2_treatment "tyrosine" "vascular endothelial growth factor"
5 Q0 24120871 209 26.171265 imi_mug_run_2_treatment "adjuvant" "trastuzumab"
5 Q0 17214955 210 26.159904 imi_mug_run_2_treatment "level" "u73122"
5 Q0 15511476 211 26.14735 imi_mug_run_2_treatment "trastuzumab" "level"
5 Q0 19561085 212 26.146591 imi_mug_run_2_treatment "various" "mediated"
5 Q0 19077306 213 26.136597 imi_mug_run_2_treatment "proteasome inhibitor" "thr" "mediated"
5 Q0 23529353 214 26.136032 imi_mug_run_2_treatment "epidermal growth factor" "ras" "trastuzumab"
5 Q0 26933086 215 26.134401 imi_mug_run_2_treatment "mediated"
5 Q0 24839254 216 26.108557 imi_mug_run_2_treatment "bile acid" "tace" "taurochenodeoxycholic acid"
5 Q0 24615340 217 26.098902 imi_mug_run_2_treatment "drugs" "mediated" "ink-128"
5 Q0 25225290 218 26.086414 imi_mug_run_2_treatment "pma" "kinase inhibitor" "hub"
5 Q0 29163776 219 26.078657 imi_mug_run_2_treatment "drug" "mediated"
5 Q0 25124601 220 26.061367 imi_mug_run_2_treatment "rice" "plasminogen activator"
5 Q0 10098763 221 26.03041 imi_mug_run_2_treatment "endocrine therapy" "tamoxifen"
5 Q0 18777950 222 26.029625 imi_mug_run_2_treatment "trastuzumab" "adjuvant" "lapatinib"
5 Q0 19298655 223 26.029274 imi_mug_run_2_treatment "fats" "oxygen" "gw9662"
5 Q0 14739033 224 25.992672 imi_mug_run_2_treatment "nrg" "blockade"
5 Q0 12942124 225 25.989847 imi_mug_run_2_treatment "lead"
5 Q0 12917629 226 25.985918 imi_mug_run_2_treatment "mediated" "ethanol" "hydrogen peroxide"
5 Q0 17525746 227 25.968378 imi_mug_run_2_treatment "trastuzumab" "tyrosine" "herceptin"
5 Q0 27077364 228 25.956268 imi_mug_run_2_treatment "lead" "program"
5 Q0 17369913 229 25.945389 imi_mug_run_2_treatment "estrogen"
5 Q0 1680817 230 25.943653 imi_mug_run_2_treatment "anti-estrogens" "tamoxifen" "toremifene"
5 Q0 8758793 231 25.936333 imi_mug_run_2_treatment "cisplatinum" "drugs" "fluorouracil"
5 Q0 26449765 232 25.930416 imi_mug_run_2_treatment "trastuzumab" "cetuximab" "lapatinib"
5 Q0 30304546 233 25.925282 imi_mug_run_2_treatment "adjuvant" "afatinib"
5 Q0 19372587 234 25.91585 imi_mug_run_2_treatment "taxol" "mediated"
5 Q0 24280377 235 25.888788 imi_mug_run_2_treatment "mediated"
5 Q0 20335174 236 25.880608 imi_mug_run_2_treatment "agar" "tyrosol"
5 Q0 10567214 237 25.868387 imi_mug_run_2_treatment "monoclonal antibodies"
5 Q0 23007710 238 25.868317 imi_mug_run_2_treatment "lapatinib" "gemcitabine" "agent"
5 Q0 12792823 239 25.85831 imi_mug_run_2_treatment "ndp"
5 Q0 18922900 240 25.855198 imi_mug_run_2_treatment "mediated"
5 Q0 24971884 241 25.855198 imi_mug_run_2_treatment "lapatinib" "tyrosine kinase inhibitor" "lead"
5 Q0 12937837 242 25.852907 imi_mug_run_2_treatment "adc"
5 Q0 15489929 243 25.804037 imi_mug_run_2_treatment "level"
5 Q0 19005469 244 25.796404 imi_mug_run_2_treatment "tamoxifen" "cancer drug" "oestrogen"
5 Q0 23474764 245 25.793362 imi_mug_run_2_treatment "mediated"
5 Q0 17392524 246 25.773336 imi_mug_run_2_treatment "bortezomib" "azd6244" "therapeutics"
5 Q0 18516291 247 25.76052 imi_mug_run_2_treatment "flutamide" "testosterone" "antiandrogen"
5 Q0 18594210 248 25.76052 imi_mug_run_2_treatment "trastuzumab" "adjuvant" "agar"
5 Q0 8608524 249 25.74582 imi_mug_run_2_treatment "duration"
5 Q0 19697624 250 25.74493 imi_mug_run_2_treatment "aim"
5 Q0 19214513 251 25.741394 imi_mug_run_2_treatment "trastuzumab" "color"
5 Q0 15695389 252 25.730421 imi_mug_run_2_treatment "herceptin" "trastuzumab" "level"
5 Q0 22331080 253 25.730421 imi_mug_run_2_treatment "vaccine" "therapeutic vaccine" "cancer vaccine"
5 Q0 19318561 254 25.694256 imi_mug_run_2_treatment "androgen" "sdm" "kinase inhibitor"
5 Q0 27652326 255 25.687977 imi_mug_run_2_treatment "matrix"
5 Q0 22266114 256 25.677008 imi_mug_run_2_treatment "glucose" "mediated" "drugs"
5 Q0 19221498 257 25.671688 imi_mug_run_2_treatment "metformin" "drug" "level"
5 Q0 17001161 258 25.619165 imi_mug_run_2_treatment "mbc"
5 Q0 26391955 259 25.618607 imi_mug_run_2_treatment "tyrosine"
5 Q0 18454306 260 25.616419 imi_mug_run_2_treatment "duet" "pharmaceuticals"
5 Q0 21876697 261 25.616419 imi_mug_run_2_treatment "trastuzumab"
5 Q0 28422721 262 25.613844 imi_mug_run_2_treatment "androgen"
5 Q0 23856074 263 25.59863 imi_mug_run_2_treatment "bxl0124" "vitamin d analog"
5 Q0 23792450 264 25.574232 imi_mug_run_2_treatment "herceptin" "level"
5 Q0 21686266 265 25.545868 imi_mug_run_2_treatment "ras" "mediated" "others"
5 Q0 30463996 266 25.527643 imi_mug_run_2_treatment "afatinib" "trastuzumab" "kinase inhibitor"
5 Q0 24668364 267 25.519825 imi_mug_run_2_treatment "trastuzumab" "cetuximab"
5 Q0 17304506 268 25.513828 imi_mug_run_2_treatment "various" "level" "ly294002"
5 Q0 25215939 269 25.495163 imi_mug_run_2_treatment "androgen" "tyrosine" "epidermal growth factor"
5 Q0 27564098 270 25.487696 imi_mug_run_2_treatment "trastuzumab" "human antibody" "pertuzumab"
5 Q0 11571643 271 25.466972 imi_mug_run_2_treatment "anti-cancer agents" "drug" "taxol"
5 Q0 21867536 272 25.46624 imi_mug_run_2_treatment "mediated" "trastuzumab"
5 Q0 24861025 273 25.455574 imi_mug_run_2_treatment "trastuzumab" "therapeutics" "tyrosine"
5 Q0 20103628 274 25.451202 imi_mug_run_2_treatment "trastuzumab" "cancer drug" "mediated"
5 Q0 11953857 275 25.42736 imi_mug_run_2_treatment "epidermal growth factor"
5 Q0 17176074 276 25.423943 imi_mug_run_2_treatment "herceptin" "level"
5 Q0 12216070 277 25.403078 imi_mug_run_2_treatment "level"
5 Q0 19906305 278 25.40282 imi_mug_run_2_treatment "serine"
5 Q0 22952421 279 25.396847 imi_mug_run_2_treatment "mediated"
5 Q0 12032832 280 25.388985 imi_mug_run_2_treatment "various"
5 Q0 20051960 281 25.372417 imi_mug_run_2_treatment "trastuzumab" "cytotoxic"
5 Q0 15868442 282 25.365402 imi_mug_run_2_treatment "tamoxifen"
5 Q0 18795950 283 25.361336 imi_mug_run_2_treatment "herceptin"
5 Q0 18729063 284 25.359814 imi_mug_run_2_treatment "drugs" "vaccines"
5 Q0 9337349 285 25.347393 imi_mug_run_2_treatment "chemotherapeutic agent" "drug" "acetone"
5 Q0 15324690 286 25.325481 imi_mug_run_2_treatment "trastuzumab"
5 Q0 22070017 287 25.320986 imi_mug_run_2_treatment "trastuzumab" "cetuximab" "level"
5 Q0 28947957 288 25.317806 imi_mug_run_2_treatment "trastuzumab"
5 Q0 10861310 289 25.30838 imi_mug_run_2_treatment "various" "drug" "combinations"
5 Q0 15329759 290 25.299084 imi_mug_run_2_treatment "various" "herceptin"
5 Q0 22482406 291 25.299084 imi_mug_run_2_treatment "aim"
5 Q0 11706391 292 25.289505 imi_mug_run_2_treatment "paclitaxel" "trastuzumab" "mediated"
5 Q0 21503962 293 25.287222 imi_mug_run_2_treatment "kinase inhibitor" "proteasome inhibitor" "mp-412"
5 Q0 7912163 294 25.276308 imi_mug_run_2_treatment "drug" "tamoxifen" "adjuvant"
5 Q0 23912956 295 25.264484 imi_mug_run_2_treatment "pdgfb" "epidermal growth factor" "product"
5 Q0 12907618 296 25.24388 imi_mug_run_2_treatment "kinase inhibitor" "tarceva" "egfr inhibitor"
5 Q0 18458039 297 25.231571 imi_mug_run_2_treatment "lapatinib"
5 Q0 17243161 298 25.207233 imi_mug_run_2_treatment "trastuzumab" "combinations"
5 Q0 23146892 299 25.204742 imi_mug_run_2_treatment "oxygen"
5 Q0 16904607 300 25.164825 imi_mug_run_2_treatment "guo"
5 Q0 14647415 301 25.141075 imi_mug_run_2_treatment "ras" "mediated" "fluorouracil"
5 Q0 11689293 302 25.123665 imi_mug_run_2_treatment "adjuvant" "level" "tamoxifen"
5 Q0 12234993 303 25.118366 imi_mug_run_2_treatment "pki-166" "androgen" "tyrosine kinase inhibitor"
5 Q0 23474757 304 25.091236 imi_mug_run_2_treatment "lapatinib" "agent"
5 Q0 24168763 305 25.081623 imi_mug_run_2_treatment "mediated" "sar256212" "paclitaxel"
5 Q0 16834533 306 25.07936 imi_mug_run_2_treatment "drug" "ps-341" "dtp"
5 Q0 24692179 307 25.078289 imi_mug_run_2_treatment "mediated" "lapatinib" "egfr inhibitor"
5 Q0 26719032 308 25.076262 imi_mug_run_2_treatment "calcium" "tandem" "yeast"
5 Q0 21499233 309 25.074133 imi_mug_run_2_treatment "trastuzumab" "adjuvant" "product"
5 Q0 25738885 310 25.070538 imi_mug_run_2_treatment "various" "copper" "disulfiram"
5 Q0 7477377 311 25.052498 imi_mug_run_2_treatment "acetylcholine" "crest"
5 Q0 25520867 312 25.038294 imi_mug_run_2_treatment "mediated" "ras"
5 Q0 7667291 313 25.023285 imi_mug_run_2_treatment "various" "therapeutics" "color"
5 Q0 18787015 314 24.973606 imi_mug_run_2_treatment "her-2"
5 Q0 19718021 315 24.950294 imi_mug_run_2_treatment "epidermal growth factor"
5 Q0 26964772 316 24.950294 imi_mug_run_2_treatment "afatinib" "plasma"
5 Q0 26899482 317 24.935255 imi_mug_run_2_treatment "gat" "matrix"
5 Q0 18258606 318 24.93253 imi_mug_run_2_treatment "mediated" "ag825" "ag1478"
5 Q0 17145873 319 24.92295 imi_mug_run_2_treatment "mediated"
5 Q0 11796827 320 24.905457 imi_mug_run_2_treatment "her-2"
5 Q0 11984589 321 24.897734 imi_mug_run_2_treatment "herceptin" "trastuzumab"
5 Q0 10022814 322 24.897036 imi_mug_run_2_treatment "oligos" "ras"
5 Q0 14749494 323 24.894424 imi_mug_run_2_treatment "drug" "nrg" "herceptin"
5 Q0 10738256 324 24.833061 imi_mug_run_2_treatment "animals" "monoclonal antibodies"
5 Q0 10094882 325 24.814854 imi_mug_run_2_treatment "various" "aim"
5 Q0 20043086 326 24.81094 imi_mug_run_2_treatment "plasminogen activator"
5 Q0 21862872 327 24.805336 imi_mug_run_2_treatment "metformin" "trastuzumab" "dasatinib"
5 Q0 18083065 328 24.80449 imi_mug_run_2_treatment "letrozole" "tamoxifen" "drug"
5 Q0 30425522 329 24.803959 imi_mug_run_2_treatment "afatinib" "glycine"
5 Q0 18454161 330 24.79168 imi_mug_run_2_treatment "trastuzumab" "herceptin" "anhydrotetracycline"
5 Q0 15582575 331 24.770039 imi_mug_run_2_treatment "vitamin e" "oxygen" "superoxide dismutase"
5 Q0 15743501 332 24.758116 imi_mug_run_2_treatment "level"
5 Q0 22544433 333 24.756577 imi_mug_run_2_treatment "adjuvant" "antiangiogenic" "anti-vegf"
5 Q0 22190871 334 24.75389 imi_mug_run_2_treatment "lapatinib" "kinase inhibitor" "program"
5 Q0 17224938 335 24.753391 imi_mug_run_2_treatment "aim"
5 Q0 15107620 336 24.747042 imi_mug_run_2_treatment "therapeutics"
5 Q0 20051871 337 24.742668 imi_mug_run_2_treatment "gen-1" "genistein" "estradiol"
5 Q0 15741050 338 24.730488 imi_mug_run_2_treatment "various" "rutin" "quercetin"
5 Q0 19409371 339 24.7228 imi_mug_run_2_treatment "various" "trastuzumab" "drugs"
5 Q0 15545967 340 24.718662 imi_mug_run_2_treatment "trastuzumab" "platinum"
5 Q0 25792810 341 24.706612 imi_mug_run_2_treatment "emodin" "oxygen" "n-acetylcysteine"
5 Q0 17164260 342 24.703285 imi_mug_run_2_treatment "various" "oestrogen"
5 Q0 1285215 343 24.691454 imi_mug_run_2_treatment "product"
5 Q0 12016390 344 24.680557 imi_mug_run_2_treatment "various"
5 Q0 19072471 345 24.677582 imi_mug_run_2_treatment "letrozole" "adjuvant" "tamoxifen"
5 Q0 12530026 346 24.664516 imi_mug_run_2_treatment "others"
5 Q0 12174876 347 24.66078 imi_mug_run_2_treatment "cisplatin" "drugs" "emodin"
5 Q0 26692570 348 24.657532 imi_mug_run_2_treatment "isoproterenol" "agonist" "antineoplastic drugs"
5 Q0 27931797 349 24.655357 imi_mug_run_2_treatment "acetate" "mediated"
5 Q0 15743507 350 24.650661 imi_mug_run_2_treatment "aim"
5 Q0 28784859 351 24.650623 imi_mug_run_2_treatment "various" "trastuzumab"
5 Q0 19411062 352 24.6265 imi_mug_run_2_treatment "trastuzumab" "blockade"
5 Q0 16682622 353 24.622898 imi_mug_run_2_treatment "lapatinib" "tyrosine" "mediated"
5 Q0 14743203 354 24.606705 imi_mug_run_2_treatment "herceptin" "trastuzumab"
5 Q0 26358791 355 24.60285 imi_mug_run_2_treatment "trastuzumab" "fulvestrant" "pertuzumab"
5 Q0 17003495 356 24.595455 imi_mug_run_2_treatment "prostaglandin"
5 Q0 25660204 357 24.591259 imi_mug_run_2_treatment "drug" "trastuzumab" "agent"
5 Q0 18382352 358 24.579071 imi_mug_run_2_treatment "silver"
5 Q0 28938602 359 24.55099 imi_mug_run_2_treatment "mediated" "lapatinib" "ly294002"
5 Q0 20056314 360 24.549133 imi_mug_run_2_treatment "chloroquine"
5 Q0 20847829 361 24.535135 imi_mug_run_2_treatment "trastuzumab"
5 Q0 22899293 362 24.534155 imi_mug_run_2_treatment "level" "monoclonal antibodies"
5 Q0 22190870 363 24.528181 imi_mug_run_2_treatment "trastuzumab" "herceptin" "others"
5 Q0 24747692 364 24.481422 imi_mug_run_2_treatment "drugs" "mediated"
5 Q0 16857791 365 24.476122 imi_mug_run_2_treatment "trastuzumab"
5 Q0 19751177 366 24.474329 imi_mug_run_2_treatment "trastuzumab" "pertuzumab" "monoclonal antibodies"
5 Q0 1352298 367 24.451748 imi_mug_run_2_treatment "aim"
5 Q0 28885562 368 24.439579 imi_mug_run_2_treatment "cytotoxic"
5 Q0 19424599 369 24.439304 imi_mug_run_2_treatment "docetaxel" "drug" "mediated"
5 Q0 12888924 370 24.426142 imi_mug_run_2_treatment "others"
5 Q0 27109096 371 24.42294 imi_mug_run_2_treatment "mediated" "lapatinib"
5 Q0 12099646 372 24.422691 imi_mug_run_2_treatment "various"
5 Q0 20012671 373 24.42228 imi_mug_run_2_treatment "basis"
5 Q0 2269935 374 24.412096 imi_mug_run_2_treatment "level"
5 Q0 30107476 375 24.395676 imi_mug_run_2_treatment "various" "mediated"
5 Q0 15862947 376 24.392849 imi_mug_run_2_treatment "estrogen"
5 Q0 19861407 377 24.392849 imi_mug_run_2_treatment "estrogen" "estradiol" "estrogenic compounds"
5 Q0 20304052 378 24.37811 imi_mug_run_2_treatment "vitamin d analog" "bxl0124" "vitamin d"
5 Q0 24421342 379 24.372242 imi_mug_run_2_treatment "trastuzumab" "immunotoxins"
5 Q0 25636205 380 24.372173 imi_mug_run_2_treatment "platinum"
5 Q0 12574167 381 24.354933 imi_mug_run_2_treatment "mediated" "hsp70"
5 Q0 17189388 382 24.35371 imi_mug_run_2_treatment "taxol" "drugs" "monoclonal antibodies"
5 Q0 23658725 383 24.345123 imi_mug_run_2_treatment "suppressor"
5 Q0 16061662 384 24.340076 imi_mug_run_2_treatment "herceptin" "tyrosine" "epidermal growth factor"
5 Q0 15665275 385 24.339952 imi_mug_run_2_treatment "lapatinib" "antiestrogen" "estrogen"
5 Q0 18039470 386 24.280552 imi_mug_run_2_treatment "herceptin"
5 Q0 17911008 387 24.2793 imi_mug_run_2_treatment "trastuzumab" "hyaluronan" "mediated"
5 Q0 21136925 388 24.2793 imi_mug_run_2_treatment "trastuzumab" "aim" "others"
5 Q0 15640503 389 24.27489 imi_mug_run_2_treatment "fluorouracil"
5 Q0 20160030 390 24.27489 imi_mug_run_2_treatment "level"
5 Q0 18490651 391 24.234144 imi_mug_run_2_treatment "trastuzumab" "lapatinib" "drug"
5 Q0 22387177 392 24.215204 imi_mug_run_2_treatment "various" "enzymes" "docetaxel"
5 Q0 17879382 393 24.208847 imi_mug_run_2_treatment "ptx" "antitumor agent" "paclitaxel"
5 Q0 20679487 394 24.195091 imi_mug_run_2_treatment "thr" "epidermal growth factor" "ras"
5 Q0 18644987 395 24.187607 imi_mug_run_2_treatment "hdac inhibitor" "st71"
5 Q0 15580295 396 24.160257 imi_mug_run_2_treatment "mediated" "lactate" "animals"
5 Q0 24961464 397 24.155602 imi_mug_run_2_treatment "parathyroid hormone" "cytokines" "il-6"
5 Q0 11737892 398 24.150795 imi_mug_run_2_treatment "cytotoxic" "her-2"
5 Q0 17283152 399 24.129448 imi_mug_run_2_treatment "trastuzumab" "lapatinib"
5 Q0 22892392 400 24.09871 imi_mug_run_2_treatment "lapatinib" "tamoxifen" "antioestrogen"
5 Q0 20056944 401 24.088776 imi_mug_run_2_treatment "drugs" "epidermal growth factor"
5 Q0 16510594 402 24.07203 imi_mug_run_2_treatment "ras" "level" "mediated"
5 Q0 19331129 403 24.06979 imi_mug_run_2_treatment "combinations" "color"
5 Q0 20961995 404 24.068182 imi_mug_run_2_treatment "estrogen"
5 Q0 29799521 405 24.065796 imi_mug_run_2_treatment "lapatinib" "mediated"
5 Q0 16467098 406 24.057236 imi_mug_run_2_treatment "etoposide" "herceptin" "taxol"
5 Q0 20936496 407 24.038681 imi_mug_run_2_treatment "enzymes" "herceptin" "antioxidant"
5 Q0 17626164 408 24.01687 imi_mug_run_2_treatment "various"
5 Q0 17572496 409 24.011477 imi_mug_run_2_treatment "cytostatic" "aim" "matrix"
5 Q0 23447672 410 24.00389 imi_mug_run_2_treatment "mediated"
5 Q0 11330837 411 23.999578 imi_mug_run_2_treatment "serine"
5 Q0 16585198 412 23.993717 imi_mug_run_2_treatment "mediated" "favor" "basis"
5 Q0 24304688 413 23.989937 imi_mug_run_2_treatment "various" "glutamine"
5 Q0 9625302 414 23.979315 imi_mug_run_2_treatment "level" "cytotoxic" "basis"
5 Q0 28781955 415 23.968245 imi_mug_run_2_treatment "ras" "sch772984" "agar"
5 Q0 18202008 416 23.943144 imi_mug_run_2_treatment "trastuzumab" "embelin" "mediated"
5 Q0 24452693 417 23.942463 imi_mug_run_2_treatment "tcn" "triciribine" "trastuzumab"
5 Q0 1661047 418 23.925488 imi_mug_run_2_treatment "aim"
5 Q0 21323863 419 23.907639 imi_mug_run_2_treatment "human igg"
5 Q0 17416003 420 23.907011 imi_mug_run_2_treatment "tam" "tamoxifen" "level"
5 Q0 17306351 421 23.90105 imi_mug_run_2_treatment "ras" "cyclin-dependent kinase inhibitor"
5 Q0 10537329 422 23.898775 imi_mug_run_2_treatment "basis"
5 Q0 11162510 423 23.895826 imi_mug_run_2_treatment "mediated" "herceptin" "therapeutics"
5 Q0 21900593 424 23.895826 imi_mug_run_2_treatment "cetuximab" "therapeutic antibody"
5 Q0 28243898 425 23.892876 imi_mug_run_2_treatment "lead"
5 Q0 11275796 426 23.889236 imi_mug_run_2_treatment "level" "aim"
5 Q0 10408862 427 23.845053 imi_mug_run_2_treatment "icc"
5 Q0 18980964 428 23.83796 imi_mug_run_2_treatment "lapatinib" "trastuzumab" "herceptin"
5 Q0 25633808 429 23.83796 imi_mug_run_2_treatment "trastuzumab" "pertuzumab" "level"
5 Q0 28817097 430 23.826624 imi_mug_run_2_treatment "monoclonal antibodies"
5 Q0 24165569 431 23.826176 imi_mug_run_2_treatment "erythropoietin"
5 Q0 30248295 432 23.795486 imi_mug_run_2_treatment "formalin" "aim"
5 Q0 20825649 433 23.793444 imi_mug_run_2_treatment "mediated" "therapeutics"
5 Q0 22022496 434 23.787277 imi_mug_run_2_treatment "estrogen" "progesterone" "therapeutic agents"
5 Q0 16375577 435 23.767248 imi_mug_run_2_treatment "level"
5 Q0 1352878 436 23.753677 imi_mug_run_2_treatment "immunotoxins" "cytotoxic" "immunotoxin"
5 Q0 25820598 437 23.753166 imi_mug_run_2_treatment "basis"
5 Q0 15142456 438 23.744362 imi_mug_run_2_treatment "epidermal growth factor"
5 Q0 21288302 439 23.7407 imi_mug_run_2_treatment "herceptin" "immunoconjugates" "cytotoxic"
5 Q0 15687687 440 23.735489 imi_mug_run_2_treatment "therapeutic agents"
5 Q0 14633703 441 23.726606 imi_mug_run_2_treatment "serine" "mediated" "zd1839"
5 Q0 29894706 442 23.722801 imi_mug_run_2_treatment "mediated"
5 Q0 17426253 443 23.721287 imi_mug_run_2_treatment "various" "tyrosine" "epidermal growth factor"
5 Q0 23585570 444 23.714909 imi_mug_run_2_treatment "mediated" "oxygen" "matrix"
5 Q0 11571533 445 23.713884 imi_mug_run_2_treatment "protamine"
5 Q0 17290345 446 23.704987 imi_mug_run_2_treatment "tcc" "ras"
5 Q0 16029927 447 23.696953 imi_mug_run_2_treatment "ras" "mediated"
5 Q0 30098331 448 23.69402 imi_mug_run_2_treatment "mediated" "pma" "hsp70"
5 Q0 21559015 449 23.676561 imi_mug_run_2_treatment "trastuzumab" "immunoconjugate"
5 Q0 26314265 450 23.672636 imi_mug_run_2_treatment "combinations" "level"
5 Q0 17329190 451 23.64584 imi_mug_run_2_treatment "oestrogen"
5 Q0 23334330 452 23.643682 imi_mug_run_2_treatment "level"
5 Q0 11709727 453 23.63768 imi_mug_run_2_treatment "ly294002" "wortmannin" "mediated"
5 Q0 15493579 454 23.632496 imi_mug_run_2_treatment "ras"
5 Q0 17942920 455 23.632496 imi_mug_run_2_treatment "kinase inhibitor" "herceptin" "trastuzumab"
5 Q0 12060608 456 23.608627 imi_mug_run_2_treatment "combinations" "therapeutics" "isolate"
5 Q0 25970488 457 23.589828 imi_mug_run_2_treatment "dha" "urokinase plasminogen activator" "docosahexaenoic acid"
5 Q0 15771902 458 23.588547 imi_mug_run_2_treatment "ras" "interleukin 1"
5 Q0 15156151 459 23.571877 imi_mug_run_2_treatment "tyr" "fibres"
5 Q0 17888033 460 23.557209 imi_mug_run_2_treatment "various" "gefitinib" "mp-412"
5 Q0 22425775 461 23.52934 imi_mug_run_2_treatment "endocrine therapy" "tamoxifen" "antagonist g"
5 Q0 22851698 462 23.514517 imi_mug_run_2_treatment "mediated" "monolayer" "tyrosine"
5 Q0 11745477 463 23.505505 imi_mug_run_2_treatment "various" "zd1839" "iressa"
5 Q0 22373082 464 23.498432 imi_mug_run_2_treatment "mediated" "animals"
5 Q0 29434871 465 23.487734 imi_mug_run_2_treatment "thr" "cddp" "mediated"
5 Q0 12866575 466 23.477509 imi_mug_run_2_treatment "estrogen"
5 Q0 17043217 467 23.474518 imi_mug_run_2_treatment "agonists" "mediated" "agonist"
5 Q0 20518902 468 23.474068 imi_mug_run_2_treatment "basis"
5 Q0 12376557 469 23.464342 imi_mug_run_2_treatment "various" "gm1" "anti-erbb2 monoclonal antibody"
5 Q0 17477367 470 23.432583 imi_mug_run_2_treatment "oxygen"
5 Q0 19707333 471 23.424147 imi_mug_run_2_treatment "trastuzumab" "lapatinib" "adjuvant"
5 Q0 11351242 472 23.419575 imi_mug_run_2_treatment "various" "aim" "sulfate"
5 Q0 26435392 473 23.416454 imi_mug_run_2_treatment "mediated"
5 Q0 16901783 474 23.40509 imi_mug_run_2_treatment "mediated"
5 Q0 19331811 475 23.391449 imi_mug_run_2_treatment "pki166" "monoclonal antibodies"
5 Q0 19956838 476 23.39007 imi_mug_run_2_treatment "various" "drug" "insulin"
5 Q0 19967068 477 23.38538 imi_mug_run_2_treatment "tyrphostin" "ag879" "ag825"
5 Q0 29143776 478 23.381603 imi_mug_run_2_treatment "glycan" "enzymes" "mediated"
5 Q0 22102915 479 23.3708 imi_mug_run_2_treatment "aim"
5 Q0 11706392 480 23.356216 imi_mug_run_2_treatment "trastuzumab" "therapeutics" "antineoplastic drug"
5 Q0 22899247 481 23.353573 imi_mug_run_2_treatment "product" "lead"
5 Q0 10233167 482 23.349571 imi_mug_run_2_treatment "epidermal growth factor"
5 Q0 16956305 483 23.342522 imi_mug_run_2_treatment "trastuzumab" "drug" "bevacizumab"
5 Q0 17604714 484 23.311619 imi_mug_run_2_treatment "drug" "herceptin" "her-2"
5 Q0 18039657 485 23.286007 imi_mug_run_2_treatment "gly" "mediated"
5 Q0 16450376 486 23.274776 imi_mug_run_2_treatment "ethanol" "mediated" "antioxidants"
5 Q0 7584078 487 23.242584 imi_mug_run_2_treatment "fluorocytosine" "fluorouracil" "cytotoxic"
5 Q0 26155288 488 23.242529 imi_mug_run_2_treatment "rhg-csf" "normal saline"
5 Q0 25350844 489 23.22711 imi_mug_run_2_treatment "lapatinib" "drug"
5 Q0 9815855 490 23.223602 imi_mug_run_2_treatment "tamoxifen" "endocrine therapy"
5 Q0 22553354 491 23.21911 imi_mug_run_2_treatment "cannabinoid" "betulinic acid" "agent"
5 Q0 26859680 492 23.206244 imi_mug_run_2_treatment "trastuzumab" "chemotherapeutic agent" "drug"
5 Q0 30456437 493 23.198717 imi_mug_run_2_treatment "mbc" "aromatase inhibitor"
5 Q0 22056878 494 23.191427 imi_mug_run_2_treatment "atra" "combinations" "lapatinib"
5 Q0 18777951 495 23.185375 imi_mug_run_2_treatment "trastuzumab" "adjuvant" "monoclonal antibodies"
5 Q0 19017630 496 23.178764 imi_mug_run_2_treatment "blockade" "trastuzumab" "oxygen"
5 Q0 28125512 497 23.173582 imi_mug_run_2_treatment "trastuzumab" "matrix" "pertuzumab"
5 Q0 20406983 498 23.154411 imi_mug_run_2_treatment "ps341" "proteasome inhibitor" "bortezomib"
5 Q0 10535875 499 23.131363 imi_mug_run_2_treatment "various" "aim"
5 Q0 2218496 500 23.131363 imi_mug_run_2_treatment "product"
5 Q0 19822081 501 23.131363 imi_mug_run_2_treatment "vaccines"
5 Q0 9590694 502 23.121635 imi_mug_run_2_treatment "interleukin-6" "il-6"
5 Q0 24817309 503 23.121635 imi_mug_run_2_treatment "mediated"
5 Q0 20565902 504 23.111288 imi_mug_run_2_treatment "calphostin" "epidermal growth factor" "pd98059"
5 Q0 8585979 505 23.093418 imi_mug_run_2_treatment "ras"
5 Q0 23279575 506 23.089964 imi_mug_run_2_treatment "drugs"
5 Q0 20133707 507 23.071514 imi_mug_run_2_treatment "mediated"
5 Q0 23420759 508 23.058994 imi_mug_run_2_treatment "level" "trastuzumab"
5 Q0 16384610 509 23.026897 imi_mug_run_2_treatment "drug" "trastuzumab" "cytostatic"
5 Q0 12115729 510 23.025383 imi_mug_run_2_treatment "mediated" "level"
5 Q0 7910405 511 23.022484 imi_mug_run_2_treatment "interferon gamma" "cytotoxic"
5 Q0 27203740 512 23.022484 imi_mug_run_2_treatment "herceptin"
5 Q0 24367169 513 22.9999 imi_mug_run_2_treatment "lapatinib" "various" "drug"
5 Q0 23647160 514 22.998526 imi_mug_run_2_treatment "serpin b5" "serpinb5" "phosphate"
5 Q0 15300811 515 22.996103 imi_mug_run_2_treatment "mbc" "basis"
5 Q0 12239347 516 22.98979 imi_mug_run_2_treatment "mediated"
5 Q0 20332114 517 22.983326 imi_mug_run_2_treatment "mediated"
5 Q0 10318765 518 22.978485 imi_mug_run_2_treatment "epidermal growth factor" "anti-erbb2 monoclonal antibody" "tyrosine kinase inhibitor"
5 Q0 7872717 519 22.96615 imi_mug_run_2_treatment "level"
5 Q0 25414785 520 22.95326 imi_mug_run_2_treatment "sodium chloride"
5 Q0 25089830 521 22.9459 imi_mug_run_2_treatment "various" "human serum albumin" "drug"
5 Q0 11417997 522 22.941624 imi_mug_run_2_treatment "genesis"
5 Q0 26001389 523 22.937443 imi_mug_run_2_treatment "mediated" "trastuzumab" "cetuximab"
5 Q0 24818668 524 22.937443 imi_mug_run_2_treatment "various" "mediated"
5 Q0 10645007 525 22.923153 imi_mug_run_2_treatment "oestrogen" "estrogenic"
5 Q0 27284958 526 22.908184 imi_mug_run_2_treatment "mbc"
5 Q0 26167451 527 22.906597 imi_mug_run_2_treatment "lead"
5 Q0 18841159 528 22.906504 imi_mug_run_2_treatment "epidermal growth factor" "therapeutics" "therapeutic agent"
5 Q0 17636013 529 22.886198 imi_mug_run_2_treatment "glucose" "mediated"
5 Q0 20607690 530 22.883707 imi_mug_run_2_treatment "lapatinib" "ag879" "erbb1 inhibitor"
5 Q0 23254686 531 22.848742 imi_mug_run_2_treatment "level" "cancer vaccines"
5 Q0 25246633 532 22.847643 imi_mug_run_2_treatment "trastuzumab" "drug" "program"
5 Q0 25003657 533 22.846066 imi_mug_run_2_treatment "various" "cytotoxic" "peptide t"
5 Q0 12727839 534 22.831882 imi_mug_run_2_treatment "level"
5 Q0 10534770 535 22.82851 imi_mug_run_2_treatment "various"
5 Q0 12503030 536 22.820244 imi_mug_run_2_treatment "trastuzumab" "herceptin" "hsp70"
5 Q0 23321163 537 22.81915 imi_mug_run_2_treatment "oestrogen" "isoflavone" "soybean"
5 Q0 21220473 538 22.81105 imi_mug_run_2_treatment "trastuzumab"
5 Q0 25853036 539 22.800182 imi_mug_run_2_treatment "immunotoxin" "immunotoxins" "therapeutics"
5 Q0 9735325 540 22.790304 imi_mug_run_2_treatment "agar" "tyrphostin ag 825" "ras"
5 Q0 17177846 541 22.790066 imi_mug_run_2_treatment "drug" "fdurd" "arabinofuranosylcytosine"
5 Q0 20695903 542 22.788706 imi_mug_run_2_treatment "mediated" "matrix"
5 Q0 12049736 543 22.77655 imi_mug_run_2_treatment "taxol" "tyrosine" "mediated"
5 Q0 24205104 544 22.774673 imi_mug_run_2_treatment "various" "pha-665752" "lapatinib"
5 Q0 10738122 545 22.760187 imi_mug_run_2_treatment "progesterone" "cyclophosphamide" "oestrogen"
5 Q0 28637868 546 22.743107 imi_mug_run_2_treatment "tamoxifen" "level"
5 Q0 26980732 547 22.729843 imi_mug_run_2_treatment "panitumumab" "agent"
5 Q0 17699716 548 22.727676 imi_mug_run_2_treatment "mtor inhibitor"
5 Q0 24987437 549 22.727676 imi_mug_run_2_treatment "estrogen" "chinese herbs" "aim"
5 Q0 19294521 550 22.7268 imi_mug_run_2_treatment "androgen" "mediated"
5 Q0 10430778 551 22.721806 imi_mug_run_2_treatment "therapeutic agents" "level"
5 Q0 17148612 552 22.719904 imi_mug_run_2_treatment "herceptin"
5 Q0 28805349 553 22.719904 imi_mug_run_2_treatment "brdu" "therapeutic agents"
5 Q0 20847929 554 22.715965 imi_mug_run_2_treatment "lapatinib" "adjuvant" "tyrosine kinase inhibitor"
5 Q0 11194458 555 22.710838 imi_mug_run_2_treatment "estrogen"
5 Q0 27356767 556 22.708008 imi_mug_run_2_treatment "epidermal growth factor" "level"
5 Q0 15609325 557 22.685658 imi_mug_run_2_treatment "com" "antiangiogenic" "aim"
5 Q0 28791631 558 22.678152 imi_mug_run_2_treatment "various" "tyrosine" "epidermal growth factor"
5 Q0 22248472 559 22.665607 imi_mug_run_2_treatment "bispecific antibody" "human serum albumin" "trastuzumab"
5 Q0 18462377 560 22.656202 imi_mug_run_2_treatment "therapeutics" "erlotinib" "erbb1 inhibitor"
5 Q0 24715245 561 22.635988 imi_mug_run_2_treatment "sts"
5 Q0 16489002 562 22.629807 imi_mug_run_2_treatment "vascular endothelial growth factor" "mediated" "antiangiogenic"
5 Q0 8825138 563 22.626484 imi_mug_run_2_treatment "estrogen" "level"
5 Q0 12053195 564 22.624247 imi_mug_run_2_treatment "human antibody" "mtx"
5 Q0 25383500 565 22.623972 imi_mug_run_2_treatment "trastuzumab" "mbc" "capecitabine"
5 Q0 9242384 566 22.61521 imi_mug_run_2_treatment "oestrogen" "oestrogens" "tamoxifen"
5 Q0 17308081 567 22.61521 imi_mug_run_2_treatment "various" "drug" "trastuzumab"
5 Q0 19707428 568 22.60564 imi_mug_run_2_treatment "capecitabine" "lapatinib" "taxane"
5 Q0 22908275 569 22.602968 imi_mug_run_2_treatment "mediated" "il-3"
5 Q0 27998284 570 22.595278 imi_mug_run_2_treatment "glucose" "avid"
5 Q0 15059917 571 22.579723 imi_mug_run_2_treatment "monoclonal antibody 2c4" "anti-erbb2 monoclonal antibody" "monolayer"
5 Q0 17847085 572 22.570154 imi_mug_run_2_treatment "herceptin" "therapeutics" "anti-erbb2 monoclonal antibody"
5 Q0 26071215 573 22.570154 imi_mug_run_2_treatment "hla-g" "silver" "color"
5 Q0 19459856 574 22.559792 imi_mug_run_2_treatment "mp-412" "various" "kinase inhibitor"
5 Q0 27662323 575 22.54121 imi_mug_run_2_treatment "level" "aim"
5 Q0 26955870 576 22.527351 imi_mug_run_2_treatment "various" "trastuzumab" "anti-erbb2 monoclonal antibody"
5 Q0 22460089 577 22.5166 imi_mug_run_2_treatment "mediated"
5 Q0 21311224 578 22.512032 imi_mug_run_2_treatment "interferon" "mediated" "her-2"
5 Q0 15480783 579 22.504349 imi_mug_run_2_treatment "level" "balance"
5 Q0 15923396 580 22.485306 imi_mug_run_2_treatment "herceptin" "level"
5 Q0 17013533 581 22.471045 imi_mug_run_2_treatment "aim"
5 Q0 24899264 582 22.45529 imi_mug_run_2_treatment "pooled"
5 Q0 28178722 583 22.45529 imi_mug_run_2_treatment "basis" "aim"
5 Q0 29193033 584 22.450302 imi_mug_run_2_treatment "drug" "epidermal growth factor"
5 Q0 25789534 585 22.436615 imi_mug_run_2_treatment "trastuzumab"
5 Q0 19183447 586 22.430637 imi_mug_run_2_treatment "antimicrobial" "agar"
5 Q0 23323159 587 22.422073 imi_mug_run_2_treatment "progesterone" "adjuvant"
5 Q0 18355957 588 22.417011 imi_mug_run_2_treatment "mediated" "genesis"
5 Q0 27965166 589 22.41442 imi_mug_run_2_treatment "drug" "polyethylene glycol"
5 Q0 20584310 590 22.410236 imi_mug_run_2_treatment "oxygen"
5 Q0 17122652 591 22.410168 imi_mug_run_2_treatment "formic acid" "lead"
5 Q0 16958676 592 22.405092 imi_mug_run_2_treatment "ethanol" "oxygen"
5 Q0 18700973 593 22.398489 imi_mug_run_2_treatment "glucose" "lactate" "level"
5 Q0 26057454 594 22.398312 imi_mug_run_2_treatment "adjuvant"
5 Q0 19458057 595 22.38674 imi_mug_run_2_treatment "gefitinib" "ag825" "erbb1 inhibitor"
5 Q0 12461170 596 22.38674 imi_mug_run_2_treatment "ile"
5 Q0 27633099 597 22.370285 imi_mug_run_2_treatment "lapatinib" "akt inhibitor mk2206" "mk2206"
5 Q0 15705882 598 22.3524 imi_mug_run_2_treatment "kinase inhibitor" "mediated" "program"
5 Q0 12517790 599 22.3524 imi_mug_run_2_treatment "kinase inhibitor" "osi-774"
5 Q0 14668544 600 22.345509 imi_mug_run_2_treatment "aim"
5 Q0 20847930 601 22.33136 imi_mug_run_2_treatment "trastuzumab" "lapatinib" "new drugs"
5 Q0 19285990 602 22.331188 imi_mug_run_2_treatment "fiber" "pix" "histidine"
5 Q0 28205231 603 22.322855 imi_mug_run_2_treatment "various" "plasma"
5 Q0 16607561 604 22.322247 imi_mug_run_2_treatment "level"
5 Q0 29318276 605 22.319263 imi_mug_run_2_treatment "estrogen" "trastuzumab"
5 Q0 23833684 606 22.312294 imi_mug_run_2_treatment "trastuzumab" "mediated" "herceptin"
5 Q0 11321488 607 22.269436 imi_mug_run_2_treatment "color" "formaldehyde"
5 Q0 19349372 608 22.268375 imi_mug_run_2_treatment "mediated" "vascular endothelial growth factor" "blockade"
5 Q0 23238628 609 22.25958 imi_mug_run_2_treatment "silver" "trastuzumab"
5 Q0 27939360 610 22.25674 imi_mug_run_2_treatment "alcohol" "alcohol's" "oxygen"
5 Q0 26254336 611 22.254532 imi_mug_run_2_treatment "enzymes" "antioxidant" "oxygen"
5 Q0 22855166 612 22.249811 imi_mug_run_2_treatment "medicine" "level"
5 Q0 29955792 613 22.234928 imi_mug_run_2_treatment "t-dm1" "tucatinib" "trastuzumab"
5 Q0 20811704 614 22.208412 imi_mug_run_2_treatment "various" "trastuzumab" "drug"
5 Q0 19293191 615 22.204172 imi_mug_run_2_treatment "epidermal growth factor" "therapeutic agents"
5 Q0 24285539 616 22.191692 imi_mug_run_2_treatment "tyrosine"
5 Q0 30094493 617 22.180567 imi_mug_run_2_treatment "aromatase inhibitors"
5 Q0 17717428 618 22.177032 imi_mug_run_2_treatment "aim"
5 Q0 12183061 619 22.173027 imi_mug_run_2_treatment "mediated" "therapeutic agent"
5 Q0 18818943 620 22.165497 imi_mug_run_2_treatment "trastuzumab"
5 Q0 8104440 621 22.15232 imi_mug_run_2_treatment "enzymes" "anticancer agents" "retinoic acid"
5 Q0 19226453 622 22.147816 imi_mug_run_2_treatment "tyrosine"
5 Q0 19826412 623 22.142881 imi_mug_run_2_treatment "tyr" "paclitaxel" "ras"
5 Q0 14523990 624 22.131441 imi_mug_run_2_treatment "growth hormone" "methylxanthine" "dexamethasone"
5 Q0 21821674 625 22.127312 imi_mug_run_2_treatment "estrogen" "suppressor"
5 Q0 19220462 626 22.114561 imi_mug_run_2_treatment "herceptin" "human antibody" "drugs"
5 Q0 21570197 627 22.094131 imi_mug_run_2_treatment "lapatinib" "capecitabine"
5 Q0 29967253 628 22.091986 imi_mug_run_2_treatment "various" "neratinib" "afatinib"
5 Q0 23861392 629 22.089577 imi_mug_run_2_treatment "estrogen" "mediated"
5 Q0 27531070 630 22.087292 imi_mug_run_2_treatment "thr" "mediated" "trametinib"
5 Q0 28514745 631 22.087292 imi_mug_run_2_treatment "human antibody" "trastuzumab" "mediated"
5 Q0 20371687 632 22.087057 imi_mug_run_2_treatment "level" "cyclophosphamide" "epirubicin"
5 Q0 15586221 633 22.067024 imi_mug_run_2_treatment "wortmannin"
5 Q0 9019162 634 22.050417 imi_mug_run_2_treatment "insulin" "cytotoxic" "mitogen"
5 Q0 15897883 635 22.015549 imi_mug_run_2_treatment "activin"
5 Q0 15371781 636 22.005798 imi_mug_run_2_treatment "anti-erbb2 monoclonal antibody"
5 Q0 7931839 637 21.985413 imi_mug_run_2_treatment "formalin"
5 Q0 15862149 638 21.965094 imi_mug_run_2_treatment "aim"
5 Q0 26489445 639 21.961102 imi_mug_run_2_treatment "formalin" "basis" "level"
5 Q0 15816643 640 21.96103 imi_mug_run_2_treatment "trastuzumab" "mbc" "bcnu"
5 Q0 11448910 641 21.955147 imi_mug_run_2_treatment "epidermal growth factor"
5 Q0 20824048 642 21.953947 imi_mug_run_2_treatment "estrogen" "prophylactic"
5 Q0 21647371 643 21.951918 imi_mug_run_2_treatment "matrix"
5 Q0 16784538 644 21.938377 imi_mug_run_2_treatment "various" "pooled"
5 Q0 19472407 645 21.934155 imi_mug_run_2_treatment "ly294002" "erlotinib" "pha665752"
5 Q0 16357148 646 21.92556 imi_mug_run_2_treatment "histone deacetylase inhibitors"
5 Q0 17938205 647 21.91454 imi_mug_run_2_treatment "level"
5 Q0 27666484 648 21.885971 imi_mug_run_2_treatment "trastuzumab" "saracatinib" "drug"
5 Q0 20060649 649 21.871384 imi_mug_run_2_treatment "drugs" "oestrogen" "parp inhibitors"
5 Q0 25435423 650 21.8641 imi_mug_run_2_treatment "trastuzumab" "cisplatinum" "gant61"
5 Q0 30005627 651 21.856361 imi_mug_run_2_treatment "lead"
5 Q0 25876877 652 21.85469 imi_mug_run_2_treatment "androgen" "lapatinib" "androgens"
5 Q0 21933912 653 21.85469 imi_mug_run_2_treatment "cddo" "chemopreventive agent"
5 Q0 17440093 654 21.848866 imi_mug_run_2_treatment "macrolide" "drugs" "therapeutic agents"
5 Q0 23686807 655 21.841228 imi_mug_run_2_treatment "plasma" "adjuvant" "aim"
5 Q0 27229930 656 21.825409 imi_mug_run_2_treatment "drugs"
5 Q0 12362975 657 21.821545 imi_mug_run_2_treatment "estrogen"
5 Q0 22864381 658 21.821545 imi_mug_run_2_treatment "glucose" "drug" "combinations"
5 Q0 19208461 659 21.820478 imi_mug_run_2_treatment "therapeutics"
5 Q0 15501954 660 21.81076 imi_mug_run_2_treatment "various" "mediated" "mtor inhibitor"
5 Q0 25865255 661 21.802155 imi_mug_run_2_treatment "ptm" "epidermal growth factor" "lead"
5 Q0 19876926 662 21.793259 imi_mug_run_2_treatment "agar" "mediated"
5 Q0 9337347 663 21.790758 imi_mug_run_2_treatment "epidermal growth factor" "program"
5 Q0 1359495 664 21.790758 imi_mug_run_2_treatment "enzymes"
5 Q0 22912742 665 21.790758 imi_mug_run_2_treatment "lapatinib"
5 Q0 21947749 666 21.788965 imi_mug_run_2_treatment "trastuzumab" "lapatinib" "drugs"
5 Q0 12214266 667 21.787083 imi_mug_run_2_treatment "gw572016" "tyrosine" "tyrosine kinase inhibitor"
5 Q0 16115903 668 21.781536 imi_mug_run_2_treatment "paclitaxel" "cyclophosphamide" "fluorouracil"
5 Q0 9649144 669 21.770271 imi_mug_run_2_treatment "epirubicin" "topo" "drugs"
5 Q0 18361882 670 21.749346 imi_mug_run_2_treatment "product"
5 Q0 19272639 671 21.746424 imi_mug_run_2_treatment "cisplatin" "cyclophosphamide" "paclitaxel"
5 Q0 20923638 672 21.73542 imi_mug_run_2_treatment "matrix"
5 Q0 24382582 673 21.719261 imi_mug_run_2_treatment "estrogen"
5 Q0 29181633 674 21.715565 imi_mug_run_2_treatment "aim"
5 Q0 25760308 675 21.710667 imi_mug_run_2_treatment "aim"
5 Q0 10469452 676 21.700151 imi_mug_run_2_treatment "level" "lead"
5 Q0 9009162 677 21.689651 imi_mug_run_2_treatment "tyrosine"
5 Q0 23028451 678 21.676823 imi_mug_run_2_treatment "various" "drug" "docetaxel"
5 Q0 9043760 679 21.667828 imi_mug_run_2_treatment "estrogen"
5 Q0 21498634 680 21.660217 imi_mug_run_2_treatment "trastuzumab"
5 Q0 18177484 681 21.65932 imi_mug_run_2_treatment "epidermal growth factor" "lead" "basis"
5 Q0 17431415 682 21.65932 imi_mug_run_2_treatment "various combinations" "color" "level"
5 Q0 19509242 683 21.658058 imi_mug_run_2_treatment "mediated" "trastuzumab" "epidermal growth factor"
5 Q0 19075277 684 21.645191 imi_mug_run_2_treatment "tamoxifen" "estrogen"
5 Q0 29089571 685 21.630253 imi_mug_run_2_treatment "fluorophore"
5 Q0 9685225 686 21.62982 imi_mug_run_2_treatment "agar"
5 Q0 26072398 687 21.628534 imi_mug_run_2_treatment "drug"
5 Q0 30008904 688 21.620369 imi_mug_run_2_treatment "trastuzumab" "oxaliplatin" "capecitabine"
5 Q0 21733823 689 21.609415 imi_mug_run_2_treatment "vaccines" "dna vaccinations" "dna vaccine"
5 Q0 25303361 690 21.60561 imi_mug_run_2_treatment "various" "lapatinib"
5 Q0 11426640 691 21.592941 imi_mug_run_2_treatment "paclitaxel" "trastuzumab" "imc-c225"
5 Q0 23842006 692 21.580664 imi_mug_run_2_treatment "various"
5 Q0 30352929 693 21.548962 imi_mug_run_2_treatment "basis"
5 Q0 26863927 694 21.547564 imi_mug_run_2_treatment "drugs" "investigational drugs" "trastuzumab"
5 Q0 18288481 695 21.545055 imi_mug_run_2_treatment "lead"
5 Q0 12730682 696 21.53793 imi_mug_run_2_treatment "matrix"
5 Q0 16685446 697 21.53793 imi_mug_run_2_treatment "sage" "mediated"
5 Q0 23154999 698 21.53793 imi_mug_run_2_treatment "mediated"
5 Q0 22562558 699 21.532478 imi_mug_run_2_treatment "trastuzumab" "hyaluronan" "drug"
5 Q0 10941162 700 21.526535 imi_mug_run_2_treatment "cisplatin" "taxol" "fluorouracil"
5 Q0 9885379 701 21.51466 imi_mug_run_2_treatment "ras"
5 Q0 17923870 702 21.506626 imi_mug_run_2_treatment "herceptin" "combinations" "immunoconjugates"
5 Q0 15950051 703 21.499352 imi_mug_run_2_treatment "various" "herceptin" "trastuzumab"
5 Q0 19801938 704 21.496092 imi_mug_run_2_treatment "aim"
5 Q0 21516080 705 21.486288 imi_mug_run_2_treatment "trastuzumab" "basis"
5 Q0 23288344 706 21.48293 imi_mug_run_2_treatment "various"
5 Q0 17546589 707 21.47747 imi_mug_run_2_treatment "various" "ras" "level"
5 Q0 22587495 708 21.47747 imi_mug_run_2_treatment "various" "epidermal growth factor"
5 Q0 8874330 709 21.474255 imi_mug_run_2_treatment "tamoxifen" "adjuvant" "level"
5 Q0 17100565 710 21.459604 imi_mug_run_2_treatment "various" "drug" "herceptin"
5 Q0 26706834 711 21.458954 imi_mug_run_2_treatment "her-2" "aim"
5 Q0 12149207 712 21.458796 imi_mug_run_2_treatment "various" "cytotoxic"
5 Q0 19509241 713 21.445906 imi_mug_run_2_treatment "chloroquine" "immunotoxin"
5 Q0 24530706 714 21.44014 imi_mug_run_2_treatment "mediated"
5 Q0 20622016 715 21.437649 imi_mug_run_2_treatment "various" "mediated" "ras"
5 Q0 30463015 716 21.43583 imi_mug_run_2_treatment "cytokines" "il-6"
5 Q0 20124187 717 21.434933 imi_mug_run_2_treatment "lapatinib" "mbc" "trastuzumab"
5 Q0 10541479 718 21.431501 imi_mug_run_2_treatment "lead" "aim"
5 Q0 17493932 719 21.428986 imi_mug_run_2_treatment "mediated" "hyaluronan"
5 Q0 16199884 720 21.418354 imi_mug_run_2_treatment "collagen" "mediated"
5 Q0 15690056 721 21.414093 imi_mug_run_2_treatment "lead"
5 Q0 22938721 722 21.404875 imi_mug_run_2_treatment "combinations"
5 Q0 15720812 723 21.399572 imi_mug_run_2_treatment "mediated"
5 Q0 16397255 724 21.381756 imi_mug_run_2_treatment "ag879" "tyrosine kinase inhibitor" "gw572016"
5 Q0 29755619 725 21.375423 imi_mug_run_2_treatment "cetuximab" "lapatinib"
5 Q0 27918780 726 21.373081 imi_mug_run_2_treatment "taxane" "trastuzumab" "taxanes"
5 Q0 17620428 727 21.359741 imi_mug_run_2_treatment "combinations" "mediated" "herceptin"
5 Q0 17867588 728 21.34872 imi_mug_run_2_treatment "herceptin"
5 Q0 22526592 729 21.34106 imi_mug_run_2_treatment "interferon" "mediated" "interleukin"
5 Q0 17721278 730 21.323723 imi_mug_run_2_treatment "tma"
5 Q0 11522658 731 21.310963 imi_mug_run_2_treatment "ag1478" "kinase inhibitor" "blockade"
5 Q0 23383112 732 21.310963 imi_mug_run_2_treatment "various" "mediated" "matrix"
5 Q0 17717635 733 21.308992 imi_mug_run_2_treatment "trastuzumab" "vascular endothelial growth factor"
5 Q0 17760256 734 21.29792 imi_mug_run_2_treatment "adjuvant"
5 Q0 22326466 735 21.28649 imi_mug_run_2_treatment "chemotherapeutic agent" "gemcitabine" "saha"
5 Q0 15377668 736 21.276733 imi_mug_run_2_treatment "mediated" "pd173074" "pki166"
5 Q0 15970791 737 21.274197 imi_mug_run_2_treatment "ile" "aim"
5 Q0 23915743 738 21.272182 imi_mug_run_2_treatment "drug"
5 Q0 9812623 739 21.266193 imi_mug_run_2_treatment "kappa-selenocarrageenan" "epidermal growth factor"
5 Q0 19567831 740 21.266193 imi_mug_run_2_treatment "various" "therapeutics" "trastuzumab"
5 Q0 17255277 741 21.25507 imi_mug_run_2_treatment "epirubicin" "tamoxifen"
5 Q0 26317614 742 21.25507 imi_mug_run_2_treatment "tamoxifen" "estrogenic" "lapatinib"
5 Q0 11929951 743 21.254217 imi_mug_run_2_treatment "ras" "agent"
5 Q0 24886178 744 21.25368 imi_mug_run_2_treatment "immune sera" "immune serum" "vaccine"
5 Q0 12586780 745 21.24647 imi_mug_run_2_treatment "tam" "kinase inhibitor" "tamoxifen"
5 Q0 28027945 746 21.236649 imi_mug_run_2_treatment "medicine"
5 Q0 22589551 747 21.236027 imi_mug_run_2_treatment "her-2"
5 Q0 26221378 748 21.236027 imi_mug_run_2_treatment "estrogen" "prothrombin"
5 Q0 22085636 749 21.232227 imi_mug_run_2_treatment "cancer drug" "drug" "drugs"
5 Q0 26892105 750 21.228428 imi_mug_run_2_treatment "progesterone" "aim"
5 Q0 19190626 751 21.195826 imi_mug_run_2_treatment "matrix" "herceptin"
5 Q0 25853295 752 21.184505 imi_mug_run_2_treatment "serine"
5 Q0 15994962 753 21.183777 imi_mug_run_2_treatment "combinations" "ag879" "kinase inhibitor"
5 Q0 15242530 754 21.168621 imi_mug_run_2_treatment "cytokines"
5 Q0 19487683 755 21.134262 imi_mug_run_2_treatment "losartan"
5 Q0 24005419 756 21.109509 imi_mug_run_2_treatment "various"
5 Q0 17705881 757 21.097446 imi_mug_run_2_treatment "interferon-gamma" "hub"
5 Q0 18777949 758 21.092064 imi_mug_run_2_treatment "combinations" "mediated" "adjuvant"
5 Q0 22585169 759 21.079659 imi_mug_run_2_treatment "mediated"
5 Q0 18594201 760 21.075626 imi_mug_run_2_treatment "herceptin" "lapatinib" "generic"
5 Q0 19435911 761 21.062675 imi_mug_run_2_treatment "insulin" "matrix"
5 Q0 12554767 762 21.061584 imi_mug_run_2_treatment "antiestrogens" "estradiol" "arginine"
5 Q0 19007432 763 21.057167 imi_mug_run_2_treatment "com" "trastuzumab" "bortezomib"
5 Q0 26001248 764 21.04731 imi_mug_run_2_treatment "basis"
5 Q0 23277357 765 21.023125 imi_mug_run_2_treatment "tyr" "tyrosine" "mediated"
5 Q0 18180774 766 21.011675 imi_mug_run_2_treatment "animals"
5 Q0 23361053 767 20.996786 imi_mug_run_2_treatment "ipa" "tamoxifen"
5 Q0 24311197 768 20.992289 imi_mug_run_2_treatment "level" "trastuzumab"
5 Q0 12297466 769 20.991556 imi_mug_run_2_treatment "agar"
5 Q0 27626067 770 20.978573 imi_mug_run_2_treatment "drugs" "fluorouracil" "leucovorin"
5 Q0 15567174 771 20.960049 imi_mug_run_2_treatment "sage" "annexin a1" "level"
5 Q0 21951604 772 20.94006 imi_mug_run_2_treatment "gefitinib" "combinations" "drugs"
5 Q0 9387273 773 20.930729 imi_mug_run_2_treatment "various"
5 Q0 29119846 774 20.93021 imi_mug_run_2_treatment "drugs" "epidermal growth factor"
5 Q0 21723941 775 20.927929 imi_mug_run_2_treatment "tocotrienols" "vitamin e" "tocotrienol"
5 Q0 28490348 776 20.927929 imi_mug_run_2_treatment "basis" "icc"
5 Q0 27002940 777 20.920834 imi_mug_run_2_treatment "ras" "basis"
5 Q0 26392111 778 20.920277 imi_mug_run_2_treatment "docetaxel" "wortmannin" "taxane"
5 Q0 8099725 779 20.916245 imi_mug_run_2_treatment "collagen" "product" "agar"
5 Q0 28916248 780 20.893528 imi_mug_run_2_treatment "vaccine" "asa" "vaccines"
5 Q0 25075564 781 20.867601 imi_mug_run_2_treatment "interferon" "cytokines"
5 Q0 19756737 782 20.85881 imi_mug_run_2_treatment "aim"
5 Q0 10698518 783 20.847527 imi_mug_run_2_treatment "oestrogen" "oestrogens" "tamoxifen"
5 Q0 20095796 784 20.845522 imi_mug_run_2_treatment "paclitaxel" "combinations" "lapatinib"
5 Q0 9079740 785 20.843826 imi_mug_run_2_treatment "epidermal growth factor" "monoclonal antibodies"
5 Q0 25668816 786 20.80718 imi_mug_run_2_treatment "blockade"
5 Q0 16142310 787 20.800407 imi_mug_run_2_treatment "estrogen" "estradiol"
5 Q0 29845222 788 20.784008 imi_mug_run_2_treatment "paeonol" "drugs" "basis"
5 Q0 20655838 789 20.777042 imi_mug_run_2_treatment "epidermal growth factor"
5 Q0 29131383 790 20.777042 imi_mug_run_2_treatment "tyrosine" "suppressor"
5 Q0 30067338 791 20.777042 imi_mug_run_2_treatment "tyrosine"
5 Q0 20514464 792 20.772923 imi_mug_run_2_treatment "androgen" "gw2974" "kinase inhibitor"
5 Q0 30250529 793 20.770088 imi_mug_run_2_treatment "collagen" "pooled"
5 Q0 8455947 794 20.766945 imi_mug_run_2_treatment "estrogens"
5 Q0 18008005 795 20.752037 imi_mug_run_2_treatment "mediated" "suppressor"
5 Q0 9310246 796 20.737959 imi_mug_run_2_treatment "genesis"
5 Q0 15236312 797 20.735386 imi_mug_run_2_treatment "color"
5 Q0 24853384 798 20.730375 imi_mug_run_2_treatment "interferon"
5 Q0 21481261 799 20.723362 imi_mug_run_2_treatment "plasma" "isolate"
5 Q0 26744522 800 20.695152 imi_mug_run_2_treatment "trastuzumab"
5 Q0 29396433 801 20.691301 imi_mug_run_2_treatment "zinc"
5 Q0 27078022 802 20.688763 imi_mug_run_2_treatment "lapatinib" "nervous system" "paclitaxel"
5 Q0 15958580 803 20.668114 imi_mug_run_2_treatment "monolayer" "vascular endothelial growth factor"
5 Q0 25373520 804 20.636173 imi_mug_run_2_treatment "therapeutic agent"
5 Q0 25865888 805 20.629925 imi_mug_run_2_treatment "kinase inhibitor" "lapatinib" "tyrosine"
5 Q0 15665568 806 20.6296 imi_mug_run_2_treatment "monoclonal antibodies"
5 Q0 21210970 807 20.621899 imi_mug_run_2_treatment "mediated" "lead"
5 Q0 25882375 808 20.620655 imi_mug_run_2_treatment "crizotinib"
5 Q0 25719557 809 20.604183 imi_mug_run_2_treatment "gefitinib" "erlotinib"
5 Q0 23451056 810 20.581089 imi_mug_run_2_treatment "mediated" "enzymes" "therapeutics"
5 Q0 15256466 811 20.579372 imi_mug_run_2_treatment "antiangiogenic" "epidermal growth factor" "agent"
5 Q0 19098003 812 20.579205 imi_mug_run_2_treatment "lead" "cancer drug" "drugs"
5 Q0 11791178 813 20.562057 imi_mug_run_2_treatment "ag879" "aim" "blockade"
5 Q0 26539793 814 20.557835 imi_mug_run_2_treatment "paclitaxel" "adjuvant" "trastuzumab"
5 Q0 15220474 815 20.553078 imi_mug_run_2_treatment "mediated" "herceptin"
5 Q0 29190909 816 20.54964 imi_mug_run_2_treatment "mediated"
5 Q0 17947490 817 20.54902 imi_mug_run_2_treatment "chemopreventive agent"
5 Q0 23333248 818 20.53074 imi_mug_run_2_treatment "aim"
5 Q0 23100016 819 20.51841 imi_mug_run_2_treatment "trastuzumab"
5 Q0 26986538 820 20.51552 imi_mug_run_2_treatment "trastuzumab"
5 Q0 19881546 821 20.511929 imi_mug_run_2_treatment "mediated"
5 Q0 10705918 822 20.506767 imi_mug_run_2_treatment "trastuzumab" "monoclonal antibodies"
5 Q0 18483270 823 20.50195 imi_mug_run_2_treatment "vaccine"
5 Q0 19133120 824 20.491604 imi_mug_run_2_treatment "level"
5 Q0 25070180 825 20.457527 imi_mug_run_2_treatment "lapatinib" "roscovitine" "kinase inhibitor"
5 Q0 27812689 826 20.452553 imi_mug_run_2_treatment "adjuvant" "cyclophosphamide" "paclitaxel"
5 Q0 27864121 827 20.44724 imi_mug_run_2_treatment "color"
5 Q0 23090500 828 20.443935 imi_mug_run_2_treatment "epidermal growth factor"
5 Q0 26285240 829 20.437746 imi_mug_run_2_treatment "favoring" "trastuzumab" "pertuzumab"
5 Q0 21403841 830 20.422922 imi_mug_run_2_treatment "mediated"
5 Q0 25184361 831 20.421432 imi_mug_run_2_treatment "various"
5 Q0 17288526 832 20.420502 imi_mug_run_2_treatment "mediated"
5 Q0 29932151 833 20.417496 imi_mug_run_2_treatment "cytotoxic drugs"
5 Q0 26100352 834 20.414562 imi_mug_run_2_treatment "estrogen" "aim"
5 Q0 14592414 835 20.41319 imi_mug_run_2_treatment "bsab" "bispecific antibody" "cytotoxic"
5 Q0 15017081 836 20.408998 imi_mug_run_2_treatment "antisense oligonucleotide"
5 Q0 22547270 837 20.379429 imi_mug_run_2_treatment "surfactant" "interleukin 1" "interleukin 6"
5 Q0 11156083 838 20.370056 imi_mug_run_2_treatment "mediated" "agent" "aim"
5 Q0 23160933 839 20.348845 imi_mug_run_2_treatment "trastuzumab" "salt"
5 Q0 20142587 840 20.348747 imi_mug_run_2_treatment "trastuzumab" "neratinib" "antidiarrheal agents"
5 Q0 25573952 841 20.342743 imi_mug_run_2_treatment "mediated" "program" "animals"
5 Q0 1968902 842 20.341946 imi_mug_run_2_treatment "various"
5 Q0 27872096 843 20.33969 imi_mug_run_2_treatment "trastuzumab" "blockade"
5 Q0 18079969 844 20.318726 imi_mug_run_2_treatment "ras"
5 Q0 18724389 845 20.318726 imi_mug_run_2_treatment "protein c" "mediated"
5 Q0 24269963 846 20.316462 imi_mug_run_2_treatment "combinations" "drugs" "drug"
5 Q0 25890497 847 20.315964 imi_mug_run_2_treatment "gemcitabine" "irinotecan" "sn-38"
5 Q0 21674850 848 20.282595 imi_mug_run_2_treatment "level"
5 Q0 21674799 849 20.26942 imi_mug_run_2_treatment "iron"
5 Q0 20521754 850 20.267744 imi_mug_run_2_treatment "adjuvant" "taxane" "trastuzumab"
5 Q0 20159766 851 20.252645 imi_mug_run_2_treatment "ag1478" "level"
5 Q0 12370757 852 20.246836 imi_mug_run_2_treatment "hme"
5 Q0 8752152 853 20.246836 imi_mug_run_2_treatment "level"
5 Q0 24449784 854 20.246689 imi_mug_run_2_treatment "platinum" "others"
5 Q0 8869284 855 20.244905 imi_mug_run_2_treatment "epidermal growth factor"
5 Q0 17535433 856 20.24421 imi_mug_run_2_treatment "level"
5 Q0 10569141 857 20.242413 imi_mug_run_2_treatment "ras"
5 Q0 30135398 858 20.242176 imi_mug_run_2_treatment "l-thyroxine" "tetrac" "hormone antagonist"
5 Q0 23710360 859 20.226515 imi_mug_run_2_treatment "ptm" "chymotrypsin" "protease"
5 Q0 21789172 860 20.221102 imi_mug_run_2_treatment "ast1306" "egfr inhibitor"
5 Q0 25081690 861 20.217548 imi_mug_run_2_treatment "alcohol" "combinations" "estrogen"
5 Q0 22767218 862 20.210686 imi_mug_run_2_treatment "tor" "bortezomib" "mediated"
5 Q0 19467222 863 20.201092 imi_mug_run_2_treatment "drugs" "epidermal growth factor" "trastuzumab"
5 Q0 23308242 864 20.200932 imi_mug_run_2_treatment "morphine" "opioid analgesics" "protein kinase inhibitors"
5 Q0 17234748 865 20.199627 imi_mug_run_2_treatment "herceptin"
5 Q0 22448335 866 20.19727 imi_mug_run_2_treatment "trastuzumab" "program" "lead"
5 Q0 15221962 867 20.189844 imi_mug_run_2_treatment "aim" "others"
5 Q0 23737949 868 20.17301 imi_mug_run_2_treatment "aim"
5 Q0 29438965 869 20.158903 imi_mug_run_2_treatment "ras" "aim"
5 Q0 22168360 870 20.141655 imi_mug_run_2_treatment "estradiol" "igf-1" "ici 182780"
5 Q0 23610600 871 20.140163 imi_mug_run_2_treatment "various" "sulfur"
5 Q0 20198662 872 20.122974 imi_mug_run_2_treatment "therapeutics"
5 Q0 17158753 873 20.122074 imi_mug_run_2_treatment "dtc" "serpinb5" "basis"
5 Q0 22404908 874 20.122074 imi_mug_run_2_treatment "mediated"
5 Q0 23267137 875 20.116768 imi_mug_run_2_treatment "artemisinin" "artemisinin dimer" "buffer"
5 Q0 11012094 876 20.103014 imi_mug_run_2_treatment "docetaxel" "endocrine therapy"
5 Q0 22729366 877 20.09882 imi_mug_run_2_treatment "lapatinib" "mbc" "bnp"
5 Q0 17059343 878 20.092602 imi_mug_run_2_treatment "estrogen" "tamoxifen" "aim"
5 Q0 18688028 879 20.09168 imi_mug_run_2_treatment "ag879" "kinase inhibitor" "leucine"
5 Q0 23213241 880 20.091646 imi_mug_run_2_treatment "cetuximab" "lapatinib" "kinase inhibitor"
5 Q0 25739959 881 20.091646 imi_mug_run_2_treatment "shh"
5 Q0 9721067 882 20.08593 imi_mug_run_2_treatment "soy" "testosterone" "genistein"
5 Q0 16652155 883 20.084396 imi_mug_run_2_treatment "various" "mediated"
5 Q0 16814944 884 20.082573 imi_mug_run_2_treatment "epidermal growth factor"
5 Q0 11263196 885 20.080326 imi_mug_run_2_treatment "drug"
5 Q0 27156933 886 20.031076 imi_mug_run_2_treatment "adjuvant" "trastuzumab"
5 Q0 18768663 887 20.028496 imi_mug_run_2_treatment "herceptin" "tamoxifen" "estrogen"
5 Q0 21590373 888 20.024082 imi_mug_run_2_treatment "mediated" "blockade"
5 Q0 11079160 889 20.023335 imi_mug_run_2_treatment "ethanol" "alcohol" "mediated"
5 Q0 27462779 890 20.023335 imi_mug_run_2_treatment "trastuzumab" "adjuvant"
5 Q0 24164280 891 20.023335 imi_mug_run_2_treatment "mediated"
5 Q0 21330148 892 20.023335 imi_mug_run_2_treatment "mbc" "bisphosphonates" "trastuzumab"
5 Q0 15856022 893 20.02299 imi_mug_run_2_treatment "drug" "herceptin" "tyrosine"
5 Q0 25986891 894 19.99324 imi_mug_run_2_treatment "pertuzumab" "ly294002" "level"
5 Q0 11422380 895 19.96672 imi_mug_run_2_treatment "mediated" "product"
5 Q0 30227250 896 19.96046 imi_mug_run_2_treatment "level"
5 Q0 21577028 897 19.95279 imi_mug_run_2_treatment "lapatinib" "capecitabine" "program"
5 Q0 22120673 898 19.943153 imi_mug_run_2_treatment "eipa" "collagen" "aim"
5 Q0 9585252 899 19.938583 imi_mug_run_2_treatment "tyrosine" "agent"
5 Q0 19138935 900 19.91756 imi_mug_run_2_treatment "blockade" "drugs" "animals"
5 Q0 19748849 901 19.906914 imi_mug_run_2_treatment "various" "ga733"
5 Q0 24215614 902 19.89349 imi_mug_run_2_treatment "sar256212" "trastuzumab" "mm-121"
5 Q0 23445612 903 19.891262 imi_mug_run_2_treatment "kinase inhibitor" "lapatinib" "drugs"
5 Q0 20406946 904 19.850893 imi_mug_run_2_treatment "drug" "lapatinib" "embelin"
5 Q0 16266989 905 19.84176 imi_mug_run_2_treatment "various" "therapeutics"
5 Q0 17259656 906 19.84019 imi_mug_run_2_treatment "linoleic acid" "conjugated linoleic acid" "liver"
5 Q0 20579853 907 19.828362 imi_mug_run_2_treatment "aim"
5 Q0 22722202 908 19.828354 imi_mug_run_2_treatment "oestrogen"
5 Q0 9342440 909 19.823448 imi_mug_run_2_treatment "fiber"
5 Q0 15967487 910 19.819042 imi_mug_run_2_treatment "monoclonal antibodies" "isolate"
5 Q0 25727212 911 19.812506 imi_mug_run_2_treatment "gold"
5 Q0 24886126 912 19.811909 imi_mug_run_2_treatment "various" "therapeutics" "therapeutic agents"
5 Q0 12746839 913 19.799736 imi_mug_run_2_treatment "androgens" "ly294002" "androgen"
5 Q0 19390941 914 19.799736 imi_mug_run_2_treatment "ors" "taxane"
5 Q0 15684311 915 19.781563 imi_mug_run_2_treatment "lapatinib" "various" "others"
5 Q0 9137481 916 19.778643 imi_mug_run_2_treatment "basis"
5 Q0 21731642 917 19.770773 imi_mug_run_2_treatment "mediated"
5 Q0 12859950 918 19.770773 imi_mug_run_2_treatment "tyrosine" "drugs" "favor"
5 Q0 23593223 919 19.770773 imi_mug_run_2_treatment "estrogen"
5 Q0 16045813 920 19.747812 imi_mug_run_2_treatment "mediated"
5 Q0 21406037 921 19.720438 imi_mug_run_2_treatment "drugs" "trastuzumab" "therapeutic agents"
5 Q0 14719064 922 19.71811 imi_mug_run_2_treatment "gastrin"
5 Q0 18372913 923 19.717518 imi_mug_run_2_treatment "protease" "proteases"
5 Q0 24587811 924 19.701979 imi_mug_run_2_treatment "various" "lapatinib" "fucoidan"
5 Q0 14570715 925 19.701422 imi_mug_run_2_treatment "estrogen"
5 Q0 23300358 926 19.696526 imi_mug_run_2_treatment "various" "suppressor"
5 Q0 25811908 927 19.679543 imi_mug_run_2_treatment "plasma" "zinc oxide" "oxygen"
5 Q0 25228389 928 19.670063 imi_mug_run_2_treatment "antineoplastic" "drugs"
5 Q0 21779217 929 19.652477 imi_mug_run_2_treatment "capecitabine" "lapatinib" "cyclophosphamide"
5 Q0 26837769 930 19.64418 imi_mug_run_2_treatment "igf2" "insulin-like growth factor 2"
5 Q0 7880720 931 19.643602 imi_mug_run_2_treatment "oestrogen"
5 Q0 16490596 932 19.636362 imi_mug_run_2_treatment "level"
5 Q0 19704002 933 19.636362 imi_mug_run_2_treatment "gefitinib" "erlotinib" "tyrosine"
5 Q0 20331976 934 19.629328 imi_mug_run_2_treatment "tyrosine"
5 Q0 19821025 935 19.614254 imi_mug_run_2_treatment "estrogen" "progesterone" "tyrosine"
5 Q0 12941816 936 19.609844 imi_mug_run_2_treatment "mediated"
5 Q0 22319204 937 19.609844 imi_mug_run_2_treatment "sklb1206" "gefitinib" "drug"
5 Q0 12490548 938 19.608562 imi_mug_run_2_treatment "therapeutics" "phosphorothioate oligonucleotide"
5 Q0 11739740 939 19.591888 imi_mug_run_2_treatment "nrg" "epidermal growth factor" "ras"
5 Q0 17092940 940 19.590467 imi_mug_run_2_treatment "mediated" "hyaluronan" "ag825"
5 Q0 16465429 941 19.583353 imi_mug_run_2_treatment "trastuzumab" "astatine" "benzoate"
5 Q0 19153829 942 19.578636 imi_mug_run_2_treatment "capecitabine" "lapatinib" "favor"
5 Q0 7688814 943 19.5682 imi_mug_run_2_treatment "aim" "monoclonal antibodies"
5 Q0 16299242 944 19.564978 imi_mug_run_2_treatment "drug" "gefitinib" "erlotinib"
5 Q0 12102554 945 19.556934 imi_mug_run_2_treatment "protective agent"
5 Q0 19525980 946 19.54865 imi_mug_run_2_treatment "mediated" "tyrosine"
5 Q0 12479367 947 19.548454 imi_mug_run_2_treatment "tamoxifen" "ly294002" "trastuzumab"
5 Q0 27165212 948 19.548368 imi_mug_run_2_treatment "level" "aim"
5 Q0 17334996 949 19.532715 imi_mug_run_2_treatment "level" "trastuzumab"
5 Q0 12709419 950 19.52875 imi_mug_run_2_treatment "drug" "drugs"
5 Q0 25354531 951 19.52766 imi_mug_run_2_treatment "therapeutics" "level"
5 Q0 18588872 952 19.519238 imi_mug_run_2_treatment "honokiol" "her-2" "drug"
5 Q0 28133304 953 19.517536 imi_mug_run_2_treatment "panitumumab" "ras" "bevacizumab"
5 Q0 11687975 954 19.515001 imi_mug_run_2_treatment "tamoxifen" "adjuvant" "alpha subunit of glycoprotein hormones"
5 Q0 7912926 955 19.506237 imi_mug_run_2_treatment "tyrosine"
5 Q0 29770537 956 19.506237 imi_mug_run_2_treatment "egg" "iodine"
5 Q0 10656732 957 19.47639 imi_mug_run_2_treatment "basis"
5 Q0 24100522 958 19.47639 imi_mug_run_2_treatment "estrogen" "progesterone" "aim"
5 Q0 17936675 959 19.476366 imi_mug_run_2_treatment "gw2974" "alcohol" "pge2"
5 Q0 17513611 960 19.469505 imi_mug_run_2_treatment "estrogen" "lapatinib" "mediated"
5 Q0 28338617 961 19.459684 imi_mug_run_2_treatment "trastuzumab" "gefitinib" "tyrosine kinase inhibitor"
5 Q0 25546926 962 19.446081 imi_mug_run_2_treatment "aim"
5 Q0 18159252 963 19.438887 imi_mug_run_2_treatment "mediated" "phorbol myristate acetate" "myristate"
5 Q0 16142439 964 19.437773 imi_mug_run_2_treatment "nordihydroguaiaretic acid" "igf-1" "ndga"
5 Q0 19778814 965 19.416468 imi_mug_run_2_treatment "level"
5 Q0 12138394 966 19.41393 imi_mug_run_2_treatment "trastuzumab" "monoclonal antibodies" "lead"
5 Q0 24281038 967 19.396587 imi_mug_run_2_treatment "serine" "tyrosine" "ras"
5 Q0 12755489 968 19.391592 imi_mug_run_2_treatment "trastuzumab" "her-2"
5 Q0 26621843 969 19.39149 imi_mug_run_2_treatment "lapatinib" "trastuzumab" "mediated"
5 Q0 28881779 970 19.38095 imi_mug_run_2_treatment "trastuzumab" "agent"
5 Q0 23389114 971 19.363512 imi_mug_run_2_treatment "sulforaphane"
5 Q0 22897846 972 19.36241 imi_mug_run_2_treatment "lead"
5 Q0 17599092 973 19.36162 imi_mug_run_2_treatment "vaccine" "vaccines" "interleukin-12"
5 Q0 9769953 974 19.356464 imi_mug_run_2_treatment "genesis"
5 Q0 15021895 975 19.353458 imi_mug_run_2_treatment "suppressor"
5 Q0 11030150 976 19.348173 imi_mug_run_2_treatment "hpv-16 e6" "vascular endothelial growth factor"
5 Q0 20145185 977 19.343405 imi_mug_run_2_treatment "azd8931" "gefitinib" "lapatinib"
5 Q0 16489071 978 19.338064 imi_mug_run_2_treatment "tamoxifen" "basis"
5 Q0 10840938 979 19.332449 imi_mug_run_2_treatment "aim"
5 Q0 7781111 980 19.32787 imi_mug_run_2_treatment "epidermal growth factor"
5 Q0 30126855 981 19.32787 imi_mug_run_2_treatment "level" "agent" "oil"
5 Q0 22589274 982 19.304749 imi_mug_run_2_treatment "gemcitabine" "hub" "trastuzumab"
5 Q0 18662380 983 19.299679 imi_mug_run_2_treatment "various"
5 Q0 11500850 984 19.290688 imi_mug_run_2_treatment "brdu" "mediated" "lead"
5 Q0 19188165 985 19.28758 imi_mug_run_2_treatment "interferon-gamma" "mediated" "cytotoxic"
5 Q0 24835218 986 19.272812 imi_mug_run_2_treatment "afatinib"
5 Q0 12060622 987 19.25364 imi_mug_run_2_treatment "cyclophosphamide" "epirubicin" "fluorouracil"
5 Q0 20036907 988 19.25364 imi_mug_run_2_treatment "trastuzumab" "aim"
5 Q0 1682035 989 19.23671 imi_mug_run_2_treatment "basis"
5 Q0 7912561 990 19.234518 imi_mug_run_2_treatment "combinations"
5 Q0 1679528 991 19.204742 imi_mug_run_2_treatment "epidermal growth factor"
5 Q0 14586404 992 19.165062 imi_mug_run_2_treatment "mediated" "tyrphostin"
5 Q0 21743497 993 19.161182 imi_mug_run_2_treatment "trastuzumab" "level"
5 Q0 17430582 994 19.152977 imi_mug_run_2_treatment "cyclophosphamide" "paclitaxel" "tamoxifen"
5 Q0 15748904 995 19.142672 imi_mug_run_2_treatment "various" "herceptin" "combinations"
5 Q0 19797898 996 19.137062 imi_mug_run_2_treatment "nrg" "vascular endothelial growth factor"
5 Q0 22315472 997 19.131348 imi_mug_run_2_treatment "ras" "agent" "dovitinib"
5 Q0 28978093 998 19.118671 imi_mug_run_2_treatment "lead" "level"
5 Q0 22705569 999 19.110893 imi_mug_run_2_treatment "lapatinib" "sham" "agent"
6 Q0 23244184 1 65.35606 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors" "aim"
6 Q0 29977749 2 64.507935 imi_mug_run_2_treatment "chemotherapy agents" "gefitinib" "platinum"
6 Q0 29607142 3 62.879883 imi_mug_run_2_treatment "level" "deoxyglucose"
6 Q0 21677478 4 62.49755 imi_mug_run_2_treatment "erlotinib" "gefitinib"
6 Q0 19572809 5 62.09809 imi_mug_run_2_treatment "drugs" "monoclonal antibodies"
6 Q0 22562326 6 61.641376 imi_mug_run_2_treatment "drugs"
6 Q0 23733083 7 61.262062 imi_mug_run_2_treatment "gefitinib" "erlotinib" "crizotinib"
6 Q0 29927769 8 61.080727 imi_mug_run_2_treatment "celastrol" "epidermal growth factor receptor tyrosine kinase inhibitor"
6 Q0 17671147 9 60.70454 imi_mug_run_2_treatment "erlotinib" "gefitinib" "hki-272"
6 Q0 30267319 10 60.421223 imi_mug_run_2_treatment "drug" "dacomitinib" "osimertinib"
6 Q0 17931092 11 60.380276 imi_mug_run_2_treatment "erlotinib"
6 Q0 28577943 12 60.363106 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
6 Q0 21660144 13 60.239456 imi_mug_run_2_treatment "gefitinib" "tyrosine kinase inhibitor" "egfr tyrosine kinase inhibitors"
6 Q0 14682117 14 60.078903 imi_mug_run_2_treatment "erlotinib" "angiogenesis inhibitor" "bevacizumab"
6 Q0 29493460 15 59.950645 imi_mug_run_2_treatment "various" "gefitinib" "drug"
6 Q0 29526180 16 59.71853 imi_mug_run_2_treatment "drug" "mediated" "gefitinib"
6 Q0 21196393 17 59.649807 imi_mug_run_2_treatment "adjuvant" "cetuximab" "gefitinib"
6 Q0 23664448 18 59.366295 imi_mug_run_2_treatment "afatinib" "gefitinib" "erlotinib"
6 Q0 16608981 19 59.325256 imi_mug_run_2_treatment "erlotinib" "gefitinib" "cytotoxic drugs"
6 Q0 27188576 20 59.157368 imi_mug_run_2_treatment "com" "monoclonal antibodies"
6 Q0 15991677 21 59.121967 imi_mug_run_2_treatment "drugs" "angiogenesis inhibitors" "inhibitors, angiogenesis"
6 Q0 29998228 22 58.83355 imi_mug_run_2_treatment "gefitinib" "erlotinib" "platinum"
6 Q0 23647298 23 58.786682 imi_mug_run_2_treatment "aim"
6 Q0 24777808 24 58.73859 imi_mug_run_2_treatment "gefitinib"
6 Q0 21314611 25 58.151817 imi_mug_run_2_treatment "antiestrogens" "antiestrogen" "estrogen"
6 Q0 17845978 26 57.93262 imi_mug_run_2_treatment "gemcitabine" "adjuvant" "vinorelbine"
6 Q0 24957682 27 57.80526 imi_mug_run_2_treatment "gefitinib" "akt inhibitor azd5363" "azd5363"
6 Q0 27770511 28 57.695015 imi_mug_run_2_treatment "lead"
6 Q0 18081540 29 57.631527 imi_mug_run_2_treatment "cetuximab"
6 Q0 15728811 30 57.576183 imi_mug_run_2_treatment "gefitinib"
6 Q0 18506667 31 57.531036 imi_mug_run_2_treatment "erlotinib" "bevacizumab" "sunitinib"
6 Q0 19227598 32 57.492043 imi_mug_run_2_treatment "egfr inhibitor"
6 Q0 9042264 33 57.458 imi_mug_run_2_treatment "oxygen"
6 Q0 19531624 34 57.445053 imi_mug_run_2_treatment "gefitinib"
6 Q0 12202783 35 57.42 imi_mug_run_2_treatment "iressa" "cisplatin" "zd1839"
6 Q0 29031620 36 57.357307 imi_mug_run_2_treatment "epidermal growth factor" "gefitinib" "erlotinib"
6 Q0 25923549 37 57.273506 imi_mug_run_2_treatment "azd9291" "egfr inhibitor" "egfr tyrosine kinase inhibitors"
6 Q0 30032836 38 57.228855 imi_mug_run_2_treatment "tyrosine kinase inhibitor"
6 Q0 15902597 39 57.202225 imi_mug_run_2_treatment "gefitinib" "iressa"
6 Q0 28641700 40 57.174446 imi_mug_run_2_treatment "drugs" "epidermal growth factor receptor tyrosine kinase inhibitor" "revolution"
6 Q0 22223435 41 57.019615 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
6 Q0 21463141 42 57.01725 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
6 Q0 23837762 43 56.93919 imi_mug_run_2_treatment "drugs" "egfr tyrosine kinase inhibitors" "monoclonal antibodies"
6 Q0 12375797 44 56.91131 imi_mug_run_2_treatment "combinations" "gemcitabine" "vinorelbine"
6 Q0 28217439 45 56.86473 imi_mug_run_2_treatment "drugs" "erlotinib" "lead"
6 Q0 23300028 46 56.860886 imi_mug_run_2_treatment "cetuximab" "monoclonal antibodies" "panitumumab"
6 Q0 25923550 47 56.82366 imi_mug_run_2_treatment "rociletinib" "egfr inhibitor" "mediated"
6 Q0 29899852 48 56.67744 imi_mug_run_2_treatment "erlotinib" "egfr tyrosine kinase inhibitors"
6 Q0 16563096 49 56.622807 imi_mug_run_2_treatment "drugs" "cisplatin" "fluorouracil"
6 Q0 29099567 50 56.61533 imi_mug_run_2_treatment "erlotinib"
6 Q0 27226511 51 56.606792 imi_mug_run_2_treatment "combinations" "drugs" "gefitinib"
6 Q0 21575523 52 56.55416 imi_mug_run_2_treatment "level" "duration"
6 Q0 27433281 53 56.45689 imi_mug_run_2_treatment "tyrosine"
6 Q0 21734175 54 56.293247 imi_mug_run_2_treatment "drug" "drugs" "gefitinib"
6 Q0 18020911 55 56.275753 imi_mug_run_2_treatment "various" "gefitinib" "erlotinib"
6 Q0 29157085 56 56.22111 imi_mug_run_2_treatment "afatinib"
6 Q0 15605116 57 56.211845 imi_mug_run_2_treatment "drug" "platinum" "gefitinib"
6 Q0 21109448 58 56.122074 imi_mug_run_2_treatment "cetuximab" "monoclonal antibodies" "carboplatin"
6 Q0 27978873 59 56.084095 imi_mug_run_2_treatment "gefitinib" "level"
6 Q0 15452456 60 56.07153 imi_mug_run_2_treatment "ras" "others"
6 Q0 25539612 61 56.0217 imi_mug_run_2_treatment "level"
6 Q0 25846096 62 56.020245 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
6 Q0 23723712 63 55.99256 imi_mug_run_2_treatment "combinations" "drugs" "gefitinib"
6 Q0 27748834 64 55.9126 imi_mug_run_2_treatment "trametinib" "pd0325901" "mek inhibitor"
6 Q0 23128522 65 55.901344 imi_mug_run_2_treatment "norcantharidin" "chemotherapeutic agent" "cisplatin"
6 Q0 30237726 66 55.89777 imi_mug_run_2_treatment "pembrolizumab" "gemcitabine" "egfr tyrosine kinase inhibitor"
6 Q0 20942631 67 55.890995 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors" "iressa" "gefitinib"
6 Q0 16628257 68 55.871952 imi_mug_run_2_treatment "erlotinib" "tyrosine kinase inhibitor" "monoclonal antibodies"
6 Q0 29455650 69 55.749485 imi_mug_run_2_treatment "various" "gefitinib" "erlotinib"
6 Q0 29477930 70 55.725468 imi_mug_run_2_treatment "combinations" "drug" "platinum"
6 Q0 21513367 71 55.69669 imi_mug_run_2_treatment "erlotinib" "platinum" "erlotinib 150 mg"
6 Q0 28838401 72 55.68821 imi_mug_run_2_treatment "nivolumab"
6 Q0 22263075 73 55.67487 imi_mug_run_2_treatment "bevacizumab" "gefitinib" "erlotinib"
6 Q0 25704901 74 55.65929 imi_mug_run_2_treatment "basis"
6 Q0 22087216 75 55.6417 imi_mug_run_2_treatment "mediated" "cytotoxic" "therapeutics"
6 Q0 21666560 76 55.633747 imi_mug_run_2_treatment "vaccines" "tor"
6 Q0 26567882 77 55.580566 imi_mug_run_2_treatment "various" "monoclonal antibodies" "drugs"
6 Q0 30232957 78 55.54023 imi_mug_run_2_treatment "nsaid" "nsaids" "drug"
6 Q0 27873136 79 55.525517 imi_mug_run_2_treatment "afatinib" "cisplatin" "tyrosine"
6 Q0 26227959 80 55.52372 imi_mug_run_2_treatment "therapeutics" "plasma"
6 Q0 22725255 81 55.517063 imi_mug_run_2_treatment "sorafenib" "anti-vegf" "bevacizumab"
6 Q0 24357744 82 55.516518 imi_mug_run_2_treatment "drug" "erlotinib" "egfr tyrosine kinase inhibitor"
6 Q0 25572790 83 55.512203 imi_mug_run_2_treatment "erlotinib" "monoclonal antibodies"
6 Q0 21905963 84 55.490967 imi_mug_run_2_treatment "gefitinib" "platinum" "egfr tyrosine kinase inhibitor"
6 Q0 26400330 85 55.486595 imi_mug_run_2_treatment "aim"
6 Q0 3038157 86 55.454845 imi_mug_run_2_treatment "epidermal growth factor"
6 Q0 19028612 87 55.406437 imi_mug_run_2_treatment "adjuvant" "cytostatic" "drugs"
6 Q0 15913841 88 55.355537 imi_mug_run_2_treatment "gefitinib" "epidermal growth factor receptor tyrosine kinase inhibitor"
6 Q0 24828666 89 55.346115 imi_mug_run_2_treatment "egfr inhibitor" "aim"
6 Q0 30404555 90 55.339928 imi_mug_run_2_treatment "duration" "level"
6 Q0 25995428 91 55.314873 imi_mug_run_2_treatment "agent"
6 Q0 21167447 92 55.306442 imi_mug_run_2_treatment "cetuximab" "gefitinib" "erlotinib"
6 Q0 29239135 93 55.303375 imi_mug_run_2_treatment "oxymatrine" "therapeutic agent"
6 Q0 16554105 94 55.276066 imi_mug_run_2_treatment "gefitinib" "tyrosine kinase inhibitor"
6 Q0 15217966 95 55.27465 imi_mug_run_2_treatment "cetuximab" "docetaxel" "c225"
6 Q0 28399187 96 55.22023 imi_mug_run_2_treatment "erlotinib" "chelerythrine" "chelerythrine chloride"
6 Q0 25278773 97 55.199753 imi_mug_run_2_treatment "afatinib" "mediated" "bibw2992"
6 Q0 16769595 98 55.186317 imi_mug_run_2_treatment "gefitinib" "erlotinib" "egfr inhibitor"
6 Q0 28188446 99 55.175133 imi_mug_run_2_treatment "gefitinib" "erlotinib" "egfr tyrosine kinase inhibitor"
6 Q0 29989451 100 55.146328 imi_mug_run_2_treatment "aim"
6 Q0 14610920 101 55.14081 imi_mug_run_2_treatment "drugs" "vaccines" "inhibitors, cyclooxygenase"
6 Q0 29528255 102 55.084274 imi_mug_run_2_treatment "gefitinib" "aim"
6 Q0 20477469 103 55.082558 imi_mug_run_2_treatment "gefitinib"
6 Q0 28116908 104 55.035477 imi_mug_run_2_treatment "osimertinib" "egfr tyrosine kinase inhibitors" "plasma"
6 Q0 18712184 105 55.032906 imi_mug_run_2_treatment "cetuximab" "gefitinib" "erlotinib"
6 Q0 19318309 106 55.019096 imi_mug_run_2_treatment "combinations"
6 Q0 30014952 107 54.999245 imi_mug_run_2_treatment "afatinib" "program" "gefitinib"
6 Q0 16316305 108 54.997044 imi_mug_run_2_treatment "various" "epidermal growth factor" "antiangiogenic agent"
6 Q0 17874972 109 54.99269 imi_mug_run_2_treatment "bevacizumab" "erlotinib" "drugs"
6 Q0 25797462 110 54.96141 imi_mug_run_2_treatment "human immunoglobulin g" "cisplatin" "gemcitabine"
6 Q0 20573926 111 54.9088 imi_mug_run_2_treatment "gefitinib" "carboplatin" "paclitaxel"
6 Q0 24222153 112 54.87506 imi_mug_run_2_treatment "erlotinib" "gefitinib"
6 Q0 25441176 113 54.871708 imi_mug_run_2_treatment "mediated" "ty21a"
6 Q0 30521113 114 54.86869 imi_mug_run_2_treatment "osimertinib" "gefitinib" "erlotinib"
6 Q0 16705311 115 54.844982 imi_mug_run_2_treatment "level"
6 Q0 29793222 116 54.80886 imi_mug_run_2_treatment "gefitinib" "iressa"
6 Q0 25580271 117 54.80215 imi_mug_run_2_treatment "necitumumab" "cisplatin" "gemcitabine"
6 Q0 21866438 118 54.801476 imi_mug_run_2_treatment "lead" "egfr tyrosine kinase inhibitors"
6 Q0 16806963 119 54.745003 imi_mug_run_2_treatment "cetuximab" "platinum"
6 Q0 15952926 120 54.743595 imi_mug_run_2_treatment "gefitinib" "combinations" "drug"
6 Q0 29738778 121 54.721855 imi_mug_run_2_treatment "shikonin" "gefitinib" "cck-8"
6 Q0 26392110 122 54.675697 imi_mug_run_2_treatment "various" "gefitinib"
6 Q0 22409867 123 54.63572 imi_mug_run_2_treatment "anti-vegf monoclonal antibody" "bevacizumab" "gefitinib"
6 Q0 28060728 124 54.623043 imi_mug_run_2_treatment "aim"
6 Q0 27402797 125 54.59263 imi_mug_run_2_treatment "adjuvant"
6 Q0 25482516 126 54.591995 imi_mug_run_2_treatment "gefitinib"
6 Q0 21764376 127 54.560764 imi_mug_run_2_treatment "gefitinib" "erlotinib" "egfr tyrosine kinase inhibitors"
6 Q0 24086949 128 54.52807 imi_mug_run_2_treatment "afatinib" "gefitinib" "erlotinib"
6 Q0 28979142 129 54.483395 imi_mug_run_2_treatment "drug" "erlotinib" "epidermal growth factor"
6 Q0 19349489 130 54.477287 imi_mug_run_2_treatment "ras" "gefitinib" "erlotinib"
6 Q0 23226726 131 54.457924 imi_mug_run_2_treatment "various" "egfr tyrosine kinase inhibitors"
6 Q0 19102716 132 54.451958 imi_mug_run_2_treatment "cetuximab" "gefitinib" "erlotinib"
6 Q0 27268079 133 54.450912 imi_mug_run_2_treatment "gefitinib" "fluorouracil" "epidermal growth factor"
6 Q0 18520299 134 54.44146 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
6 Q0 26446154 135 54.399162 imi_mug_run_2_treatment "gefitinib" "erlotinib" "medications"
6 Q0 21819274 136 54.38244 imi_mug_run_2_treatment "vandetanib" "therapeutic agent"
6 Q0 26961971 137 54.36171 imi_mug_run_2_treatment "platinum" "agent" "egfr tyrosine kinase inhibitors"
6 Q0 15952927 138 54.35707 imi_mug_run_2_treatment "erlotinib" "drug" "tarceva"
6 Q0 25862853 139 54.333893 imi_mug_run_2_treatment "afatinib" "drug"
6 Q0 21126404 140 54.333565 imi_mug_run_2_treatment "aim"
6 Q0 26936397 141 54.318245 imi_mug_run_2_treatment "erlotinib" "nsc305787"
6 Q0 14656386 142 54.288773 imi_mug_run_2_treatment "zd1839" "iressa" "mediated"
6 Q0 26885207 143 54.2675 imi_mug_run_2_treatment "gefitinib" "gefitinib 250 mg" "aim"
6 Q0 25399972 144 54.239277 imi_mug_run_2_treatment "level"
6 Q0 16011858 145 54.21632 imi_mug_run_2_treatment "gefitinib" "egfr tyrosine kinase inhibitors"
6 Q0 19366827 146 54.198853 imi_mug_run_2_treatment "monoclonal antibodies"
6 Q0 22119437 147 54.189705 imi_mug_run_2_treatment "mediated" "gefitinib" "erlotinib"
6 Q0 15118073 148 54.170334 imi_mug_run_2_treatment "tyrosine kinase inhibitor" "gefitinib" "lead"
6 Q0 22446631 149 54.123993 imi_mug_run_2_treatment "various" "gefitinib" "epidermal growth factor receptor tyrosine kinase inhibitor"
6 Q0 25629371 150 54.12382 imi_mug_run_2_treatment "afatinib"
6 Q0 27597244 151 54.114006 imi_mug_run_2_treatment "various" "proteasome inhibitor" "phenolic"
6 Q0 20426712 152 54.086063 imi_mug_run_2_treatment "gefitinib" "carboplatin" "paclitaxel"
6 Q0 26345914 153 54.074436 imi_mug_run_2_treatment "egfr inhibitor" "gefitinib" "agent"
6 Q0 27336608 154 54.067436 imi_mug_run_2_treatment "various" "ras" "cytotoxic"
6 Q0 21277552 155 54.061016 imi_mug_run_2_treatment "lead"
6 Q0 27739449 156 54.042133 imi_mug_run_2_treatment "docosahexaenoic acid"
6 Q0 25962919 157 54.03552 imi_mug_run_2_treatment "various" "cetuximab" "erlotinib"
6 Q0 20701554 158 54.02696 imi_mug_run_2_treatment "pemetrexed" "bevacizumab" "gefitinib"
6 Q0 27821604 159 54.001125 imi_mug_run_2_treatment "kinase inhibitor" "osimertinib" "tagrisso"
6 Q0 20040275 160 53.99695 imi_mug_run_2_treatment "medicine" "gefitinib" "carboplatin"
6 Q0 24565582 161 53.962746 imi_mug_run_2_treatment "pemetrexed" "erlotinib" "platinum"
6 Q0 29936901 162 53.961613 imi_mug_run_2_treatment "therapeutic vaccine" "cancer vaccine" "cancer vaccines"
6 Q0 24675568 163 53.95904 imi_mug_run_2_treatment "mediated" "egfr tyrosine kinase inhibitor" "il-6"
6 Q0 25956936 164 53.95836 imi_mug_run_2_treatment "shape" "ras"
6 Q0 18760859 165 53.90995 imi_mug_run_2_treatment "gefitinib" "erlotinib"
6 Q0 29173773 166 53.873573 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
6 Q0 23515752 167 53.86161 imi_mug_run_2_treatment "gefitinib" "histone deacetylase inhibitor" "tyrosine kinase inhibitor"
6 Q0 25302015 168 53.860886 imi_mug_run_2_treatment "chemotherapy agents"
6 Q0 28219203 169 53.843773 imi_mug_run_2_treatment "gefitinib" "afatinib" "azd9291"
6 Q0 29785875 170 53.843773 imi_mug_run_2_treatment "drugs"
6 Q0 27071706 171 53.8432 imi_mug_run_2_treatment "osimertinib" "pf-06747775" "egf816"
6 Q0 29234489 172 53.83326 imi_mug_run_2_treatment "verrucarin j" "platinum"
6 Q0 25512530 173 53.81608 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors" "basis"
6 Q0 25912735 174 53.7731 imi_mug_run_2_treatment "various" "egfr tyrosine kinase inhibitor" "level"
6 Q0 29061221 175 53.709198 imi_mug_run_2_treatment "drug" "level"
6 Q0 24349229 176 53.703064 imi_mug_run_2_treatment "mediated" "crizotinib"
6 Q0 22926905 177 53.672688 imi_mug_run_2_treatment "gefitinib" "drugs"
6 Q0 26950292 178 53.63212 imi_mug_run_2_treatment "antiangiogenic" "bevacizumab" "monoclonal antibodies"
6 Q0 15068324 179 53.611008 imi_mug_run_2_treatment "her-2" "adjuvant"
6 Q0 28915692 180 53.60443 imi_mug_run_2_treatment "erlotinib"
6 Q0 26184032 181 53.60047 imi_mug_run_2_treatment "drug" "gefitinib" "tyrosine kinase inhibitor"
6 Q0 29136465 182 53.587803 imi_mug_run_2_treatment "serine" "osimertinib"
6 Q0 17175059 183 53.55045 imi_mug_run_2_treatment "various" "interleukin-8" "mediated"
6 Q0 24102012 184 53.53767 imi_mug_run_2_treatment "cisplatin" "drug" "adjuvant"
6 Q0 28699260 185 53.526924 imi_mug_run_2_treatment "osimertinib"
6 Q0 26829230 186 53.510124 imi_mug_run_2_treatment "adjuvant" "duration"
6 Q0 26398757 187 53.462494 imi_mug_run_2_treatment "drugs" "gefitinib" "erlotinib"
6 Q0 25489257 188 53.42714 imi_mug_run_2_treatment "mediated" "lead"
6 Q0 25908039 189 53.408905 imi_mug_run_2_treatment "cisplatin" "etoposide" "basis"
6 Q0 20704815 190 53.403046 imi_mug_run_2_treatment "cetuximab" "drug" "enzymes"
6 Q0 26893752 191 53.39972 imi_mug_run_2_treatment "drug" "drugs" "medicine"
6 Q0 20616912 192 53.384857 imi_mug_run_2_treatment "cetuximab"
6 Q0 18030354 193 53.35029 imi_mug_run_2_treatment "mediators" "egfr tyrosine kinase inhibitor" "basis"
6 Q0 26379824 194 53.3351 imi_mug_run_2_treatment "drugs" "medication"
6 Q0 16115182 195 53.329086 imi_mug_run_2_treatment "drugs" "her-2" "gefitinib"
6 Q0 26302350 196 53.2917 imi_mug_run_2_treatment "epidermal growth factor receptor tyrosine kinase inhibitor"
6 Q0 22075159 197 53.28755 imi_mug_run_2_treatment "erlotinib" "drug" "suppressor"
6 Q0 26160838 198 53.262703 imi_mug_run_2_treatment "gefitinib" "mtor inhibitor" "aim"
6 Q0 29423594 199 53.261703 imi_mug_run_2_treatment "various" "osimertinib" "agent"
6 Q0 25704957 200 53.23987 imi_mug_run_2_treatment "gefitinib" "erlotinib" "afatinib"
6 Q0 28271729 201 53.215305 imi_mug_run_2_treatment "erlotinib" "blockade" "gefitinib"
6 Q0 27659294 202 53.2127 imi_mug_run_2_treatment "erlotinib" "agent" "egfr tyrosine kinase inhibitors"
6 Q0 27866095 203 53.18871 imi_mug_run_2_treatment "drug" "egfr tyrosine kinase inhibitors" "plasma"
6 Q0 19038728 204 53.170963 imi_mug_run_2_treatment "cisplatin" "lead" "vascular endothelial growth factor"
6 Q0 24307395 205 53.163662 imi_mug_run_2_treatment "kinase inhibitor" "basis"
6 Q0 15226769 206 53.148254 imi_mug_run_2_treatment "her-2"
6 Q0 29296194 207 53.146103 imi_mug_run_2_treatment "tumor infiltrating lymphocytes"
6 Q0 24113009 208 53.1428 imi_mug_run_2_treatment "drug"
6 Q0 24113007 209 53.132812 imi_mug_run_2_treatment "drugs" "gefitinib" "erlotinib"
6 Q0 22281074 210 53.132675 imi_mug_run_2_treatment "various" "gefitinib" "erlotinib"
6 Q0 28454365 211 53.128044 imi_mug_run_2_treatment "cytotoxic" "erlotinib" "tyrosine kinase inhibitor"
6 Q0 28871105 212 53.12056 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitor" "egfr inhibitor" "tyrosine kinase inhibitor"
6 Q0 19892771 213 53.105354 imi_mug_run_2_treatment "cetuximab" "gefitinib" "erlotinib"
6 Q0 25806269 214 53.07855 imi_mug_run_2_treatment "gefitinib" "erlotinib"
6 Q0 28210119 215 53.062866 imi_mug_run_2_treatment "nimotuzumab" "monoclonal antibodies" "egfr tyrosine kinase inhibitors"
6 Q0 27279498 216 53.052605 imi_mug_run_2_treatment "erlotinib" "drug"
6 Q0 23963360 217 53.036255 imi_mug_run_2_treatment "cetuximab" "erlotinib" "agent"
6 Q0 27431492 218 53.021606 imi_mug_run_2_treatment "gefitinib" "bcl-2 inhibitor"
6 Q0 30320506 219 53.015938 imi_mug_run_2_treatment "afatinib" "gefitinib" "aim"
6 Q0 30172273 220 53.006927 imi_mug_run_2_treatment "drugs" "medication"
6 Q0 23484645 221 52.96762 imi_mug_run_2_treatment "cetuximab" "vandetanib" "gefitinib"
6 Q0 21655159 222 52.965042 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors" "anti-neoplastic agents" "mediated"
6 Q0 22005472 223 52.946533 imi_mug_run_2_treatment "erlotinib" "egfr inhibitor"
6 Q0 19243280 224 52.94201 imi_mug_run_2_treatment "drug" "drugs" "epidermal growth factor"
6 Q0 20871269 225 52.93927 imi_mug_run_2_treatment "various" "gefitinib" "egfr tyrosine kinase inhibitors"
6 Q0 21849857 226 52.903095 imi_mug_run_2_treatment "medicine" "anti-vegf monoclonal antibody" "vascular endothelial growth factor"
6 Q0 26676152 227 52.888096 imi_mug_run_2_treatment "mediated" "erlotinib" "cyclopamine"
6 Q0 24252457 228 52.869137 imi_mug_run_2_treatment "radiosensitizers"
6 Q0 30092812 229 52.85867 imi_mug_run_2_treatment "favor" "aim"
6 Q0 27864022 230 52.84961 imi_mug_run_2_treatment "gefitinib" "shikonin"
6 Q0 25676406 231 52.825226 imi_mug_run_2_treatment "drugs" "epidermal growth factor" "bevacizumab"
6 Q0 17409862 232 52.81646 imi_mug_run_2_treatment "air"
6 Q0 30454543 233 52.81646 imi_mug_run_2_treatment "aim" "plasma"
6 Q0 22550402 234 52.808746 imi_mug_run_2_treatment "erlotinib" "agent" "erlotinib's"
6 Q0 18487906 235 52.792133 imi_mug_run_2_treatment "bevacizumab" "gefitinib" "erlotinib"
6 Q0 17521215 236 52.782284 imi_mug_run_2_treatment "erlotinib" "gefitinib"
6 Q0 16857814 237 52.725636 imi_mug_run_2_treatment "trastuzumab" "egfr tyrosine kinase inhibitor"
6 Q0 22928112 238 52.72085 imi_mug_run_2_treatment "ras"
6 Q0 27241841 239 52.693848 imi_mug_run_2_treatment "suppressor"
6 Q0 23909081 240 52.692577 imi_mug_run_2_treatment "plasma" "insulin" "level"
6 Q0 24161785 241 52.683895 imi_mug_run_2_treatment "ps-101"
6 Q0 27664271 242 52.68243 imi_mug_run_2_treatment "kinase inhibitor" "gefitinib" "erlotinib"
6 Q0 26961138 243 52.6761 imi_mug_run_2_treatment "afatinib" "various" "drugs"
6 Q0 24354593 244 52.656494 imi_mug_run_2_treatment "protein kinase inhibitors" "crizotinib" "dacomitinib"
6 Q0 30378264 245 52.655224 imi_mug_run_2_treatment "mediated" "egfr tyrosine kinase inhibitor"
6 Q0 29713183 246 52.642887 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
6 Q0 22003224 247 52.63748 imi_mug_run_2_treatment "morphine" "ors" "epidermal growth factor"
6 Q0 25806267 248 52.62283 imi_mug_run_2_treatment "medicine" "egfr tyrosine kinase inhibitor" "egfr tyrosine kinase inhibitors"
6 Q0 19351754 249 52.619423 imi_mug_run_2_treatment "gefitinib" "erlotinib" "plasma"
6 Q0 17760255 250 52.615997 imi_mug_run_2_treatment "iressa"
6 Q0 22333382 251 52.590473 imi_mug_run_2_treatment "gefitinib" "erlotinib"
6 Q0 29910646 252 52.53861 imi_mug_run_2_treatment "various" "plasma"
6 Q0 21554040 253 52.534786 imi_mug_run_2_treatment "afatinib" "gefitinib" "erlotinib"
6 Q0 24523812 254 52.50939 imi_mug_run_2_treatment "drug" "taxane" "others"
6 Q0 24039832 255 52.499626 imi_mug_run_2_treatment "level" "bevacizumab" "erlotinib"
6 Q0 20015198 256 52.499626 imi_mug_run_2_treatment "gefitinib" "erlotinib" "pooled"
6 Q0 16282720 257 52.49797 imi_mug_run_2_treatment "various" "gefitinib" "zd 1839"
6 Q0 25573345 258 52.47973 imi_mug_run_2_treatment "docetaxel"
6 Q0 16614231 259 52.47947 imi_mug_run_2_treatment "therapeutics" "monoclonal antibodies"
6 Q0 29461911 260 52.476677 imi_mug_run_2_treatment "adjuvant" "erlotinib"
6 Q0 26486077 261 52.46835 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
6 Q0 22321545 262 52.45586 imi_mug_run_2_treatment "basis"
6 Q0 26505339 263 52.443962 imi_mug_run_2_treatment "aim"
6 Q0 29761660 264 52.427887 imi_mug_run_2_treatment "mediated"
6 Q0 24314215 265 52.410423 imi_mug_run_2_treatment "ras" "ple"
6 Q0 27348572 266 52.4089 imi_mug_run_2_treatment "clot"
6 Q0 24258572 267 52.385635 imi_mug_run_2_treatment "kinase inhibitor"
6 Q0 16730855 268 52.377914 imi_mug_run_2_treatment "gefitinib" "leucine" "tyrosine"
6 Q0 26616848 269 52.36133 imi_mug_run_2_treatment "ras"
6 Q0 29215723 270 52.34449 imi_mug_run_2_treatment "gefitinib"
6 Q0 21924037 271 52.305702 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors" "aim"
6 Q0 24916999 272 52.2983 imi_mug_run_2_treatment "various" "mediators" "gefitinib"
6 Q0 20677568 273 52.296036 imi_mug_run_2_treatment "iressa" "gefitinib" "erlotinib"
6 Q0 25897257 274 52.28552 imi_mug_run_2_treatment "lead"
6 Q0 28668844 275 52.280537 imi_mug_run_2_treatment "afatinib" "level"
6 Q0 24807015 276 52.273808 imi_mug_run_2_treatment "gefitinib" "erlotinib" "egfr inhibitor"
6 Q0 26314834 277 52.245373 imi_mug_run_2_treatment "afatinib" "mediated" "tyrosine kinase inhibitor"
6 Q0 24398248 278 52.239902 imi_mug_run_2_treatment "formalin"
6 Q0 26370354 279 52.239902 imi_mug_run_2_treatment "drugs" "gefitinib" "erlotinib"
6 Q0 24054018 280 52.237854 imi_mug_run_2_treatment "cisplatin" "gemcitabine" "vinorelbine"
6 Q0 18483355 281 52.233467 imi_mug_run_2_treatment "gefitinib" "erlotinib" "egfr tyrosine kinase inhibitor"
6 Q0 26349474 282 52.21295 imi_mug_run_2_treatment "bevacizumab" "gefitinib" "erlotinib"
6 Q0 23769347 283 52.167328 imi_mug_run_2_treatment "drug"
6 Q0 29726094 284 52.159786 imi_mug_run_2_treatment "drug" "drugs" "platinum"
6 Q0 18036700 285 52.158394 imi_mug_run_2_treatment "platinum agents"
6 Q0 23514946 286 52.152348 imi_mug_run_2_treatment "tyrosine kinase inhibitor" "egfr tyrosine kinase inhibitors"
6 Q0 28891180 287 52.152084 imi_mug_run_2_treatment "epidermal growth factor"
6 Q0 29140105 288 52.12647 imi_mug_run_2_treatment "combinations" "durvalumab" "drugs"
6 Q0 25145405 289 52.073044 imi_mug_run_2_treatment "drug" "egfr tyrosine kinase inhibitors"
6 Q0 16080566 290 52.037643 imi_mug_run_2_treatment "trastuzumab"
6 Q0 20719167 291 52.037567 imi_mug_run_2_treatment "various" "cisplatin" "irinotecan"
6 Q0 28373815 292 52.035034 imi_mug_run_2_treatment "various" "erlotinib" "bevacizumab"
6 Q0 21196162 293 52.03402 imi_mug_run_2_treatment "monoclonal antibodies"
6 Q0 21216930 294 52.028065 imi_mug_run_2_treatment "siltuximab" "serine" "tyrosine"
6 Q0 29466812 295 52.00526 imi_mug_run_2_treatment "etoposide" "carboplatin" "osimertinib"
6 Q0 19707410 296 51.990532 imi_mug_run_2_treatment "various" "cetuximab" "drugs"
6 Q0 23402326 297 51.989563 imi_mug_run_2_treatment "gefitinib"
6 Q0 30349313 298 51.95905 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
6 Q0 20156777 299 51.956844 imi_mug_run_2_treatment "erlotinib" "gefitinib" "egfr tyrosine kinase inhibitors"
6 Q0 16857825 300 51.952934 imi_mug_run_2_treatment "zd6474" "gefitinib" "erlotinib"
6 Q0 26354527 301 51.948814 imi_mug_run_2_treatment "afatinib" "egfr tyrosine kinase inhibitor" "program"
6 Q0 28332047 302 51.94021 imi_mug_run_2_treatment "osimertinib"
6 Q0 24752335 303 51.93212 imi_mug_run_2_treatment "tyrosine kinase inhibitor"
6 Q0 23730419 304 51.93038 imi_mug_run_2_treatment "hts" "radiosensitizer"
6 Q0 19580206 305 51.91568 imi_mug_run_2_treatment "kinase inhibitor" "cetuximab" "erlotinib"
6 Q0 24344015 306 51.907433 imi_mug_run_2_treatment "agent" "erlotinib"
6 Q0 24406751 307 51.907433 imi_mug_run_2_treatment "docetaxel" "crizotinib" "afatinib"
6 Q0 20443070 308 51.891445 imi_mug_run_2_treatment "cisplatin" "drugs" "gemcitabine"
6 Q0 26450446 309 51.871174 imi_mug_run_2_treatment "azd9291" "gefitinib" "erlotinib"
6 Q0 23270410 310 51.86995 imi_mug_run_2_treatment "cetuximab"
6 Q0 27912836 311 51.860294 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors" "gefitinib" "erlotinib"
6 Q0 26958501 312 51.853725 imi_mug_run_2_treatment "epidermal growth factor receptor tyrosine kinase inhibitor" "bevacizumab"
6 Q0 18078086 313 51.849144 imi_mug_run_2_treatment "drug" "gemcitabine" "vinorelbine"
6 Q0 24759598 314 51.848156 imi_mug_run_2_treatment "epidermal growth factor receptor tyrosine kinase inhibitor" "aim"
6 Q0 19415121 315 51.844524 imi_mug_run_2_treatment "cisplatin" "docetaxel" "erlotinib"
6 Q0 21444946 316 51.833366 imi_mug_run_2_treatment "platinum" "egfr tyrosine kinase inhibitors"
6 Q0 29088904 317 51.80569 imi_mug_run_2_treatment "anti-angiogenic drugs" "egfr tyrosine kinase inhibitors"
6 Q0 23788917 318 51.80219 imi_mug_run_2_treatment "drugs" "erlotinib" "new drugs"
6 Q0 26888425 319 51.79575 imi_mug_run_2_treatment "aim" "crizotinib"
6 Q0 24179413 320 51.79575 imi_mug_run_2_treatment "antiangiogenic"
6 Q0 23524403 321 51.79575 imi_mug_run_2_treatment "ras" "level"
6 Q0 28110557 322 51.795013 imi_mug_run_2_treatment "aim"
6 Q0 22705678 323 51.793083 imi_mug_run_2_treatment "gefitinib" "erlotinib" "egfr tyrosine kinase inhibitors"
6 Q0 22805266 324 51.765747 imi_mug_run_2_treatment "drugs"
6 Q0 24439568 325 51.764793 imi_mug_run_2_treatment "product"
6 Q0 26435742 326 51.733646 imi_mug_run_2_treatment "new drugs" "aim"
6 Q0 22336239 327 51.722015 imi_mug_run_2_treatment "gefitinib" "erlotinib"
6 Q0 22114570 328 51.716343 imi_mug_run_2_treatment "gefitinib" "erlotinib" "corticosteroid"
6 Q0 18541260 329 51.701584 imi_mug_run_2_treatment "gefitinib" "erlotinib"
6 Q0 17285540 330 51.700848 imi_mug_run_2_treatment "ras" "gefitinib"
6 Q0 21959109 331 51.690243 imi_mug_run_2_treatment "anti-vegf" "vascular endothelial growth factor"
6 Q0 22971028 332 51.67504 imi_mug_run_2_treatment "erlotinib" "agent" "egfr tyrosine kinase inhibitors"
6 Q0 29631678 333 51.669254 imi_mug_run_2_treatment "gefitinib" "drug" "tyrosine kinase inhibitor"
6 Q0 24793378 334 51.657825 imi_mug_run_2_treatment "paclitaxel" "platinum" "aim"
6 Q0 21723791 335 51.637917 imi_mug_run_2_treatment "various" "vandetanib" "gefitinib"
6 Q0 26707566 336 51.62198 imi_mug_run_2_treatment "medicine" "aim"
6 Q0 27133754 337 51.618652 imi_mug_run_2_treatment "drugs"
6 Q0 30217489 338 51.6164 imi_mug_run_2_treatment "etoposide" "platinum"
6 Q0 22634180 339 51.612473 imi_mug_run_2_treatment "mediated" "egfr tyrosine kinase inhibitors"
6 Q0 21124044 340 51.607243 imi_mug_run_2_treatment "monoclonal antibodies"
6 Q0 19562083 341 51.581955 imi_mug_run_2_treatment "combinations" "cetuximab" "drugs"
6 Q0 28129709 342 51.581955 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors" "plasma"
6 Q0 29207630 343 51.58037 imi_mug_run_2_treatment "gefitinib" "u0126" "tyrosine kinase inhibitor"
6 Q0 28236980 344 51.565666 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
6 Q0 19010912 345 51.50903 imi_mug_run_2_treatment "ras"
6 Q0 29570930 346 51.502514 imi_mug_run_2_treatment "nicotine-derived nitrosamine ketone" "nnk" "crizotinib"
6 Q0 15492241 347 51.50077 imi_mug_run_2_treatment "gefitinib" "egfr inhibitor"
6 Q0 27491402 348 51.499466 imi_mug_run_2_treatment "gefitinib" "erlotinib" "new drugs"
6 Q0 12867061 349 51.49328 imi_mug_run_2_treatment "erlotinib" "agent" "cytotoxic"
6 Q0 22826274 350 51.49081 imi_mug_run_2_treatment "plasma"
6 Q0 17158592 351 51.490555 imi_mug_run_2_treatment "iressa" "gefitinib" "erlotinib"
6 Q0 29467275 352 51.475624 imi_mug_run_2_treatment "naquotinib" "osimertinib" "egfr tyrosine kinase inhibitor"
6 Q0 30172266 353 51.474785 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
6 Q0 28293073 354 51.465294 imi_mug_run_2_treatment "various" "drug" "pred"
6 Q0 29534579 355 51.45302 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
6 Q0 17409891 356 51.447784 imi_mug_run_2_treatment "level"
6 Q0 15492792 357 51.443924 imi_mug_run_2_treatment "gefitinib" "ras" "zd1839"
6 Q0 25328417 358 51.439674 imi_mug_run_2_treatment "tivantinib" "egfr tyrosine kinase inhibitor" "arq 197"
6 Q0 26977054 359 51.433784 imi_mug_run_2_treatment "gefitinib" "platinum" "egfr tyrosine kinase inhibitors"
6 Q0 29534625 360 51.430115 imi_mug_run_2_treatment "cetuximab"
6 Q0 27468240 361 51.40876 imi_mug_run_2_treatment "gefitinib" "erlotinib"
6 Q0 21320004 362 51.402294 imi_mug_run_2_treatment "bibw 2992" "drug" "drugs"
6 Q0 24720835 363 51.386566 imi_mug_run_2_treatment "aim"
6 Q0 27264264 364 51.373825 imi_mug_run_2_treatment "gefitinib" "cyclosporine a"
6 Q0 26517520 365 51.367977 imi_mug_run_2_treatment "gefitinib" "pdx" "egfr tyrosine kinase inhibitors"
6 Q0 18317074 366 51.367584 imi_mug_run_2_treatment "gefitinib" "erlotinib" "platinum"
6 Q0 29740718 367 51.365482 imi_mug_run_2_treatment "blockade" "agent"
6 Q0 26557922 368 51.35974 imi_mug_run_2_treatment "cisplatin" "etoposide"
6 Q0 24889366 369 51.34047 imi_mug_run_2_treatment "crizotinib" "cisplatin" "carboplatin"
6 Q0 25302168 370 51.31721 imi_mug_run_2_treatment "gefitinib" "erlotinib"
6 Q0 21885318 371 51.292984 imi_mug_run_2_treatment "combinations" "lead" "monoclonal antibodies"
6 Q0 25725115 372 51.276978 imi_mug_run_2_treatment "combinations" "egfr tyrosine kinase inhibitors" "monoclonal antibodies"
6 Q0 25806192 373 51.267002 imi_mug_run_2_treatment "cetuximab" "platinum" "favor"
6 Q0 17239298 374 51.2489 imi_mug_run_2_treatment "erlotinib"
6 Q0 24958518 375 51.2488 imi_mug_run_2_treatment "gefitinib" "erlotinib" "tyrosine kinase inhibitor"
6 Q0 26361996 376 51.24775 imi_mug_run_2_treatment "ras"
6 Q0 28611939 377 51.237576 imi_mug_run_2_treatment "drug"
6 Q0 22340408 378 51.227417 imi_mug_run_2_treatment "epidermal growth factor" "various"
6 Q0 29755953 379 51.215034 imi_mug_run_2_treatment "osimertinib" "gefitinib" "erlotinib"
6 Q0 25366755 380 51.208218 imi_mug_run_2_treatment "gefitinib" "erlotinib" "egfr inhibitor"
6 Q0 29151359 381 51.191486 imi_mug_run_2_treatment "osimertinib" "gefitinib" "erlotinib"
6 Q0 24210543 382 51.181465 imi_mug_run_2_treatment "adc"
6 Q0 26959310 383 51.17598 imi_mug_run_2_treatment "epidermal growth factor receptor tyrosine kinase inhibitor" "rociletinib" "osimertinib"
6 Q0 29344197 384 51.172142 imi_mug_run_2_treatment "aim"
6 Q0 25591975 385 51.165703 imi_mug_run_2_treatment "various" "gefitinib" "erlotinib"
6 Q0 19786660 386 51.156822 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
6 Q0 26958508 387 51.155987 imi_mug_run_2_treatment "erlotinib"
6 Q0 29184671 388 51.12934 imi_mug_run_2_treatment "plasma"
6 Q0 24649318 389 51.123184 imi_mug_run_2_treatment "erlotinib"
6 Q0 23628526 390 51.109425 imi_mug_run_2_treatment "various"
6 Q0 23423768 391 51.085617 imi_mug_run_2_treatment "adc"
6 Q0 23251849 392 51.078598 imi_mug_run_2_treatment "epidermal growth factor"
6 Q0 23676980 393 51.074894 imi_mug_run_2_treatment "icotinib hydrochloride" "aim"
6 Q0 20529262 394 51.063576 imi_mug_run_2_treatment "cetuximab" "drug" "complement inhibitor"
6 Q0 30510441 395 51.05433 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitor"
6 Q0 28367252 396 51.036427 imi_mug_run_2_treatment "angiogenesis inhibitors"
6 Q0 18428387 397 51.033768 imi_mug_run_2_treatment "medications"
6 Q0 23514942 398 51.01878 imi_mug_run_2_treatment "drug" "gefitinib" "epidermal growth factor receptor tyrosine kinase inhibitor"
6 Q0 25400829 399 51.01594 imi_mug_run_2_treatment "gefitinib" "epidermal growth factor receptor inhibitor"
6 Q0 22985911 400 51.008163 imi_mug_run_2_treatment "anastrozole" "gefitinib" "drug"
6 Q0 28513466 401 50.990253 imi_mug_run_2_treatment "combinations" "cytostatic agents" "cytostatics"
6 Q0 22610259 402 50.98214 imi_mug_run_2_treatment "plasma" "drug" "kinase inhibitor"
6 Q0 19098404 403 50.97088 imi_mug_run_2_treatment "gefitinib" "duration" "agent"
6 Q0 25676398 404 50.965702 imi_mug_run_2_treatment "crizotinib" "level"
6 Q0 19185949 405 50.964367 imi_mug_run_2_treatment "gefitinib"
6 Q0 17237005 406 50.961765 imi_mug_run_2_treatment "erlotinib" "cetuximab" "gefitinib"
6 Q0 29057232 407 50.959408 imi_mug_run_2_treatment "drug"
6 Q0 23683257 408 50.930733 imi_mug_run_2_treatment "platinum" "gefitinib" "erlotinib"
6 Q0 20002849 409 50.92869 imi_mug_run_2_treatment "gefitinib" "bevacizumab" "cetuximab"
6 Q0 14534727 410 50.927578 imi_mug_run_2_treatment "various" "product"
6 Q0 27090797 411 50.92408 imi_mug_run_2_treatment "sorafenib" "mediated" "kinase inhibitor"
6 Q0 24193010 412 50.909904 imi_mug_run_2_treatment "aim"
6 Q0 25953440 413 50.909904 imi_mug_run_2_treatment "gefitinib" "erlotinib" "gefitinib 250 mg"
6 Q0 27341162 414 50.909904 imi_mug_run_2_treatment "drugs" "k252a" "alkaloid"
6 Q0 17201173 415 50.906933 imi_mug_run_2_treatment "gefitinib"
6 Q0 27448564 416 50.903297 imi_mug_run_2_treatment "azd9291" "osimertinib" "tagrisso"
6 Q0 15813676 417 50.902233 imi_mug_run_2_treatment "gefitinib" "drug" "docetaxel"
6 Q0 18458038 418 50.894398 imi_mug_run_2_treatment "gefitinib" "gefitinib 250 mg" "egfr tyrosine kinase inhibitors"
6 Q0 28002980 419 50.894196 imi_mug_run_2_treatment "drugs" "plasma"
6 Q0 24023334 420 50.88113 imi_mug_run_2_treatment "epidermal growth factor"
6 Q0 25806231 421 50.872612 imi_mug_run_2_treatment "docetaxel"
6 Q0 25214559 422 50.871666 imi_mug_run_2_treatment "ibrutinib" "erlotinib" "drug"
6 Q0 26056478 423 50.869244 imi_mug_run_2_treatment "cetuximab" "afatinib" "gefitinib"
6 Q0 28210105 424 50.865036 imi_mug_run_2_treatment "drug" "gefitinib" "kinase inhibitor"
6 Q0 25486910 425 50.86456 imi_mug_run_2_treatment "erlotinib" "azacytidine" "sorafenib"
6 Q0 28089159 426 50.85314 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitor"
6 Q0 24113003 427 50.846554 imi_mug_run_2_treatment "aim"
6 Q0 25778308 428 50.830444 imi_mug_run_2_treatment "gefitinib" "lead"
6 Q0 19410716 429 50.821724 imi_mug_run_2_treatment "cetuximab" "cisplatin" "vinorelbine"
6 Q0 19362943 430 50.818295 imi_mug_run_2_treatment "monoclonal antibodies" "cetuximab" "agent"
6 Q0 29807405 431 50.817936 imi_mug_run_2_treatment "osimertinib" "therapeutics"
6 Q0 30355843 432 50.8094 imi_mug_run_2_treatment "aim"
6 Q0 21245935 433 50.796135 imi_mug_run_2_treatment "ras"
6 Q0 29344640 434 50.769657 imi_mug_run_2_treatment "cisplatin" "egfr inhibitor" "lapatinib"
6 Q0 23140355 435 50.762184 imi_mug_run_2_treatment "gefitinib" "erlotinib" "drugs"
6 Q0 26161893 436 50.747036 imi_mug_run_2_treatment "epidermal growth factor"
6 Q0 18645621 437 50.738823 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
6 Q0 24179385 438 50.734753 imi_mug_run_2_treatment "level" "plasma" "aim"
6 Q0 29246024 439 50.716488 imi_mug_run_2_treatment "various" "plasma"
6 Q0 18393776 440 50.716236 imi_mug_run_2_treatment "cetuximab" "gefitinib" "erlotinib"
6 Q0 21562939 441 50.70759 imi_mug_run_2_treatment "estrogen" "gefitinib"
6 Q0 24982409 442 50.70672 imi_mug_run_2_treatment "epidermal growth factor"
6 Q0 30171258 443 50.699787 imi_mug_run_2_treatment "osimertinib" "erlotinib" "mediated"
6 Q0 21959047 444 50.688118 imi_mug_run_2_treatment "cetuximab" "drugs" "epidermal growth factor"
6 Q0 20005069 445 50.672348 imi_mug_run_2_treatment "gefitinib" "tamoxifen" "drug"
6 Q0 22514499 446 50.658455 imi_mug_run_2_treatment "gefitinib" "erlotinib"
6 Q0 26497899 447 50.656914 imi_mug_run_2_treatment "various" "enzymes" "epidermal growth factor"
6 Q0 21702662 448 50.65442 imi_mug_run_2_treatment "erlotinib" "gefitinib"
6 Q0 24857124 449 50.65283 imi_mug_run_2_treatment "crizotinib" "gefitinib" "erlotinib"
6 Q0 29958099 450 50.642437 imi_mug_run_2_treatment "combinations" "durvalumab" "drugs"
6 Q0 19105704 451 50.62663 imi_mug_run_2_treatment "drug" "docetaxel" "iressa"
6 Q0 23493885 452 50.616413 imi_mug_run_2_treatment "aim" "monoclonal antibodies"
6 Q0 25514804 453 50.613106 imi_mug_run_2_treatment "afatinib" "duration"
6 Q0 19238632 454 50.61035 imi_mug_run_2_treatment "erlotinib" "su11274" "mediated"
6 Q0 24419415 455 50.597427 imi_mug_run_2_treatment "gefitinib" "carboplatin" "paclitaxel"
6 Q0 14565788 456 50.591507 imi_mug_run_2_treatment "gefitinib" "docetaxel" "platinum"
6 Q0 18520300 457 50.59044 imi_mug_run_2_treatment "gefitinib" "erlotinib" "xl647"
6 Q0 21165163 458 50.588745 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors" "therapeutics"
6 Q0 20942630 459 50.58773 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitor"
6 Q0 24790411 460 50.58484 imi_mug_run_2_treatment "afatinib" "drug" "program"
6 Q0 20740181 461 50.584133 imi_mug_run_2_treatment "erlotinib" "nervous system" "epidermal growth factor"
6 Q0 26820570 462 50.577457 imi_mug_run_2_treatment "drug" "guanosine" "gefitinib"
6 Q0 23592446 463 50.57713 imi_mug_run_2_treatment "gefitinib" "mediated" "cytotoxic"
6 Q0 18176089 464 50.575794 imi_mug_run_2_treatment "gefitinib" "egfr tyrosine kinase inhibitor"
6 Q0 28717762 465 50.574715 imi_mug_run_2_treatment "alcohol"
6 Q0 29844828 466 50.55613 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitor" "plasma"
6 Q0 28731495 467 50.544388 imi_mug_run_2_treatment "gefitinib" "erlotinib" "level"
6 Q0 18520298 468 50.535088 imi_mug_run_2_treatment "egfr inhibitor" "egfr tyrosine kinase inhibitors"
6 Q0 15610717 469 50.5342 imi_mug_run_2_treatment "combinations" "gefitinib" "erlotinib"
6 Q0 30425905 470 50.530178 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
6 Q0 24773774 471 50.524994 imi_mug_run_2_treatment "plasma" "erlotinib"
6 Q0 27389045 472 50.521034 imi_mug_run_2_treatment "aim"
6 Q0 30315932 473 50.50337 imi_mug_run_2_treatment "erlotinib" "gefitinib"
6 Q0 23064619 474 50.49878 imi_mug_run_2_treatment "aim"
6 Q0 16453093 475 50.47518 imi_mug_run_2_treatment "erlotinib" "drugs" "cetuximab"
6 Q0 25678473 476 50.456776 imi_mug_run_2_treatment "cisplatin" "afatinib" "lead"
6 Q0 14676101 477 50.45579 imi_mug_run_2_treatment "agent" "tk inhibitors" "drug combination"
6 Q0 23599349 478 50.44622 imi_mug_run_2_treatment "erlotinib" "gefitinib"
6 Q0 23507559 479 50.43435 imi_mug_run_2_treatment "enzymes" "gefitinib" "lipoic acid"
6 Q0 26439803 480 50.427048 imi_mug_run_2_treatment "egfr inhibitor"
6 Q0 24816813 481 50.42347 imi_mug_run_2_treatment "various" "mediated"
6 Q0 27760600 482 50.41876 imi_mug_run_2_treatment "platinum"
6 Q0 21865399 483 50.41434 imi_mug_run_2_treatment "erlotinib" "egfr tyrosine kinase inhibitors"
6 Q0 28881856 484 50.40232 imi_mug_run_2_treatment "antiangiogenic" "antiangiogenic agents" "bevacizumab"
6 Q0 24331409 485 50.397934 imi_mug_run_2_treatment "gly"
6 Q0 30453282 486 50.375637 imi_mug_run_2_treatment "suppressor" "plasma"
6 Q0 28521651 487 50.375137 imi_mug_run_2_treatment "liver"
6 Q0 22726919 488 50.369217 imi_mug_run_2_treatment "flt" "erlotinib" "afatinib"
6 Q0 28635227 489 50.353996 imi_mug_run_2_treatment "epidermal growth factor receptor tyrosine kinase inhibitor"
6 Q0 25364452 490 50.33394 imi_mug_run_2_treatment "erlotinib"
6 Q0 27565925 491 50.33281 imi_mug_run_2_treatment "bevacizumab" "erlotinib" "nervous system"
6 Q0 25855240 492 50.329323 imi_mug_run_2_treatment "afatinib" "therapeutics" "gefitinib"
6 Q0 22680928 493 50.306606 imi_mug_run_2_treatment "antimetabolite" "drugs" "ras"
6 Q0 28841389 494 50.302105 imi_mug_run_2_treatment "osimertinib" "plasma" "tyrosine kinase inhibitor"
6 Q0 27561797 495 50.302082 imi_mug_run_2_treatment "nervous system"
6 Q0 25538894 496 50.296936 imi_mug_run_2_treatment "gefitinib" "erlotinib" "afatinib"
6 Q0 15025409 497 50.295296 imi_mug_run_2_treatment "docetaxel" "osi-774" "egfr tyrosine kinase inhibitor"
6 Q0 18827604 498 50.293213 imi_mug_run_2_treatment "gefitinib" "egfr tyrosine kinase inhibitors"
6 Q0 15851406 499 50.256554 imi_mug_run_2_treatment "gefitinib" "egfr tk inhibitors" "basis"
6 Q0 16857823 500 50.251156 imi_mug_run_2_treatment "cetuximab" "platinum" "agent"
6 Q0 29110853 501 50.245155 imi_mug_run_2_treatment "cisplatin" "balance" "n-acetyl-l-cysteine"
6 Q0 25104233 502 50.24034 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitor"
6 Q0 20040267 503 50.22853 imi_mug_run_2_treatment "gefitinib" "erlotinib"
6 Q0 24750242 504 50.203255 imi_mug_run_2_treatment "gefitinib" "mediated"
6 Q0 23771519 505 50.202198 imi_mug_run_2_treatment "drugs"
6 Q0 28710768 506 50.18392 imi_mug_run_2_treatment "gefitinib" "panobinostat" "histone deacetylase inhibitor"
6 Q0 26730759 507 50.18367 imi_mug_run_2_treatment "drugs" "plasma"
6 Q0 29029422 508 50.18068 imi_mug_run_2_treatment "various" "serine"
6 Q0 30520383 509 50.170242 imi_mug_run_2_treatment "osimertinib"
6 Q0 20723379 510 50.166557 imi_mug_run_2_treatment "gefitinib" "erlotinib"
6 Q0 20486827 511 50.162277 imi_mug_run_2_treatment "cisplatin" "egfr tyrosine kinase inhibitors" "erlotinib"
6 Q0 25098682 512 50.1439 imi_mug_run_2_treatment "drugs"
6 Q0 30015158 513 50.14309 imi_mug_run_2_treatment "carboplatin" "mediated" "paclitaxel"
6 Q0 22627040 514 50.132385 imi_mug_run_2_treatment "erlotinib" "egfr tyrosine kinase inhibitors"
6 Q0 23576199 515 50.103626 imi_mug_run_2_treatment "medicine" "basis"
6 Q0 27212579 516 50.1027 imi_mug_run_2_treatment "gefitinib" "erlotinib" "afatinib"
6 Q0 15623594 517 50.095478 imi_mug_run_2_treatment "gefitinib"
6 Q0 27898252 518 50.072292 imi_mug_run_2_treatment "afatinib" "platinum" "gefitinib"
6 Q0 29673089 519 50.066597 imi_mug_run_2_treatment "gefitinib" "osimertinib" "azd9291"
6 Q0 26063687 520 50.060257 imi_mug_run_2_treatment "erlotinib" "drugs" "pemetrexed"
6 Q0 24799062 521 50.05877 imi_mug_run_2_treatment "dacomitinib" "kinase inhibitor"
6 Q0 26999786 522 50.04158 imi_mug_run_2_treatment "various" "egfr tyrosine kinase inhibitors"
6 Q0 18957054 523 50.02192 imi_mug_run_2_treatment "scorpion" "drugs" "egfr tyrosine kinase inhibitors"
6 Q0 15725915 524 50.02087 imi_mug_run_2_treatment "gefitinib"
6 Q0 19673930 525 50.013924 imi_mug_run_2_treatment "erlotinib" "oxygen" "hoechst 33342"
6 Q0 24669077 526 50.01069 imi_mug_run_2_treatment "aim"
6 Q0 27382309 527 50.004017 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors" "gefitinib" "erlotinib"
6 Q0 24611018 528 50.00372 imi_mug_run_2_treatment "erlotinib"
6 Q0 29425688 529 50.00372 imi_mug_run_2_treatment "osimertinib" "drugs" "egfr tyrosine kinase inhibitor"
6 Q0 29455656 530 49.972954 imi_mug_run_2_treatment "mediated"
6 Q0 23055691 531 49.95937 imi_mug_run_2_treatment "erlotinib" "egfr inhibitor" "afatinib"
6 Q0 26556242 532 49.959034 imi_mug_run_2_treatment "mediators" "erlotinib"
6 Q0 17681094 533 49.95788 imi_mug_run_2_treatment "epidermal growth factor"
6 Q0 26153330 534 49.955326 imi_mug_run_2_treatment "tyrosine kinase inhibitor"
6 Q0 27418143 535 49.934185 imi_mug_run_2_treatment "gefitinib" "egfr tyrosine kinase inhibitors"
6 Q0 28529902 536 49.92179 imi_mug_run_2_treatment "combinations" "pembrolizumab" "adjuvant"
6 Q0 21732753 537 49.920742 imi_mug_run_2_treatment "afatinib" "bibw 2992" "cisplatin"
6 Q0 24083690 538 49.91965 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
6 Q0 25714021 539 49.906845 imi_mug_run_2_treatment "afatinib" "gefitinib" "radiation sensitizer"
6 Q0 24853786 540 49.880444 imi_mug_run_2_treatment "afatinib" "gefitinib" "erlotinib"
6 Q0 23617344 541 49.8799 imi_mug_run_2_treatment "erlotinib" "drugs" "gefitinib"
6 Q0 20477246 542 49.87042 imi_mug_run_2_treatment "erlotinib" "drug" "level"
6 Q0 15946581 543 49.86422 imi_mug_run_2_treatment "erlotinib" "cetuximab" "gefitinib"
6 Q0 26706949 544 49.85863 imi_mug_run_2_treatment "icotinib hydrochloride" "drug" "gefitinib"
6 Q0 15332545 545 49.856384 imi_mug_run_2_treatment "agent" "gefitinib"
6 Q0 16877703 546 49.847878 imi_mug_run_2_treatment "gefitinib"
6 Q0 27835594 547 49.847878 imi_mug_run_2_treatment "navitoclax" "drug" "azd9291"
6 Q0 17405897 548 49.831486 imi_mug_run_2_treatment "ekb-569" "ci-1033" "gefitinib"
6 Q0 24662454 549 49.83004 imi_mug_run_2_treatment "cetuximab" "cisplatin" "vinorelbine"
6 Q0 24133589 550 49.829155 imi_mug_run_2_treatment "genesis"
6 Q0 23238037 551 49.787888 imi_mug_run_2_treatment "tma" "egfr tyrosine kinase inhibitors"
6 Q0 22328842 552 49.787212 imi_mug_run_2_treatment "erlotinib" "drugs" "tyrosine kinase inhibitor"
6 Q0 19427302 553 49.783134 imi_mug_run_2_treatment "gefitinib" "everolimus" "erlotinib"
6 Q0 24863259 554 49.760666 imi_mug_run_2_treatment "drugs" "tk inhibitors"
6 Q0 24435321 555 49.759403 imi_mug_run_2_treatment "afatinib" "cisplatin" "gemcitabine"
6 Q0 26775573 556 49.75734 imi_mug_run_2_treatment "crizotinib" "program" "gefitinib"
6 Q0 17711504 557 49.75591 imi_mug_run_2_treatment "gefitinib" "tk inhibitors" "drug"
6 Q0 28982900 558 49.752068 imi_mug_run_2_treatment "level"
6 Q0 29599365 559 49.752068 imi_mug_run_2_treatment "bevacizumab" "cisplatin" "pemetrexed"
6 Q0 22847157 560 49.719048 imi_mug_run_2_treatment "level"
6 Q0 23117577 561 49.715584 imi_mug_run_2_treatment "cisplatin" "chemotherapy agents"
6 Q0 22170031 562 49.707943 imi_mug_run_2_treatment "erlotinib"
6 Q0 29951305 563 49.698357 imi_mug_run_2_treatment "medicine"
6 Q0 29910643 564 49.689842 imi_mug_run_2_treatment "afatinib" "egfr inhibitor"
6 Q0 27396618 565 49.664806 imi_mug_run_2_treatment "erlotinib" "egfr tyrosine kinase inhibitor"
6 Q0 23962905 566 49.64955 imi_mug_run_2_treatment "gefitinib" "crizotinib" "kinase inhibitor"
6 Q0 22646768 567 49.648273 imi_mug_run_2_treatment "fulvestrant" "drug" "antiestrogen"
6 Q0 24195468 568 49.64554 imi_mug_run_2_treatment "kinase inhibitor" "cisplatin" "irinotecan"
6 Q0 24457318 569 49.641674 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitor" "egfr tyrosine kinase inhibitors"
6 Q0 29277186 570 49.63665 imi_mug_run_2_treatment "drugs" "mediated"
6 Q0 26295963 571 49.63038 imi_mug_run_2_treatment "vaccine" "cancer vaccine"
6 Q0 17233840 572 49.625587 imi_mug_run_2_treatment "docetaxel" "gefitinib" "erlotinib"
6 Q0 24954871 573 49.622444 imi_mug_run_2_treatment "egfr antagonist" "erlotinib" "aim"
6 Q0 15314969 574 49.619785 imi_mug_run_2_treatment "trastuzumab" "medication" "tarceva"
6 Q0 27630354 575 49.60559 imi_mug_run_2_treatment "epidermal growth factor receptor tyrosine kinase inhibitor" "aim"
6 Q0 23549019 576 49.595512 imi_mug_run_2_treatment "gefitinib" "tyrosine kinase inhibitor"
6 Q0 23154768 577 49.593124 imi_mug_run_2_treatment "silver" "kinase inhibitor"
6 Q0 21655094 578 49.5777 imi_mug_run_2_treatment "gefitinib" "erlotinib" "chloroquine"
6 Q0 19349493 579 49.575787 imi_mug_run_2_treatment "agent" "platinum" "pemetrexed"
6 Q0 25505694 580 49.57497 imi_mug_run_2_treatment "gefitinib" "erlotinib" "egfr tyrosine kinase inhibitors"
6 Q0 17686547 581 49.57183 imi_mug_run_2_treatment "gefitinib" "leucine" "erlotinib"
6 Q0 21066867 582 49.56471 imi_mug_run_2_treatment "docetaxel" "liver"
6 Q0 16140912 583 49.563805 imi_mug_run_2_treatment "gefitinib" "erlotinib" "plasma"
6 Q0 24636263 584 49.56248 imi_mug_run_2_treatment "various" "gefitinib" "erlotinib"
6 Q0 27466542 585 49.56248 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors" "aim" "afatinib"
6 Q0 19839922 586 49.56248 imi_mug_run_2_treatment "combinations" "erlotinib" "antifolate"
6 Q0 26202045 587 49.56028 imi_mug_run_2_treatment "various" "afatinib" "crizotinib"
6 Q0 26051700 588 49.553486 imi_mug_run_2_treatment "necitumumab" "human immunoglobulin" "cisplatin"
6 Q0 25750344 589 49.552784 imi_mug_run_2_treatment "cytotoxic" "fluorouracil" "aim"
6 Q0 26919236 590 49.545017 imi_mug_run_2_treatment "various" "level" "mediated"
6 Q0 22843912 591 49.53953 imi_mug_run_2_treatment "aim"
6 Q0 27381270 592 49.52677 imi_mug_run_2_treatment "epidermal growth factor"
6 Q0 25382203 593 49.525223 imi_mug_run_2_treatment "anticancer agents" "drugs" "imatinib"
6 Q0 27323821 594 49.510693 imi_mug_run_2_treatment "plasma"
6 Q0 23266614 595 49.509254 imi_mug_run_2_treatment "various" "cetuximab" "afatinib"
6 Q0 30079781 596 49.502266 imi_mug_run_2_treatment "osimertinib"
6 Q0 24440771 597 49.486515 imi_mug_run_2_treatment "gefitinib" "butanone" "mediated"
6 Q0 19173822 598 49.48011 imi_mug_run_2_treatment "level"
6 Q0 25806323 599 49.475018 imi_mug_run_2_treatment "azd9291" "egfr inhibitor"
6 Q0 28274536 600 49.466087 imi_mug_run_2_treatment "gefitinib" "egfr tyrosine kinase inhibitors" "afatinib"
6 Q0 28167215 601 49.45968 imi_mug_run_2_treatment "various" "medicine" "gefitinib"
6 Q0 16843002 602 49.45858 imi_mug_run_2_treatment "bevacizumab" "avastin" "erlotinib"
6 Q0 25532027 603 49.453636 imi_mug_run_2_treatment "interferon" "cytotoxic" "gefitinib"
6 Q0 28935493 604 49.45262 imi_mug_run_2_treatment "various"
6 Q0 24528028 605 49.451202 imi_mug_run_2_treatment "drug" "erlotinib"
6 Q0 27799795 606 49.451202 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
6 Q0 18243402 607 49.446857 imi_mug_run_2_treatment "gefitinib" "epidermal growth factor" "iressa"
6 Q0 25232221 608 49.435715 imi_mug_run_2_treatment "gefitinib"
6 Q0 30522170 609 49.42803 imi_mug_run_2_treatment "plasma" "egfr inhibitor" "egfr tyrosine kinase inhibitor"
6 Q0 30018881 610 49.424473 imi_mug_run_2_treatment "gefitinib" "erlotinib" "afatinib"
6 Q0 16009452 611 49.414776 imi_mug_run_2_treatment "gefitinib" "epidermal growth factor" "ly294002"
6 Q0 29526181 612 49.414143 imi_mug_run_2_treatment "drugs"
6 Q0 20678850 613 49.399063 imi_mug_run_2_treatment "erlotinib"
6 Q0 30429415 614 49.390972 imi_mug_run_2_treatment "gefitinib" "bevacizumab" "adenosine triphosphate"
6 Q0 21687596 615 49.389153 imi_mug_run_2_treatment "drugs" "gefitinib" "erlotinib"
6 Q0 29398601 616 49.38661 imi_mug_run_2_treatment "gefitinib" "pdx" "losmapimod"
6 Q0 21273611 617 49.385345 imi_mug_run_2_treatment "erlotinib"
6 Q0 14641989 618 49.375652 imi_mug_run_2_treatment "gefitinib" "mediated" "erlotinib"
6 Q0 20008850 619 49.375195 imi_mug_run_2_treatment "gefitinib" "erlotinib" "platinum"
6 Q0 16086866 620 49.37398 imi_mug_run_2_treatment "gefitinib"
6 Q0 24649300 621 49.371513 imi_mug_run_2_treatment "drugs" "cytotoxic" "gefitinib"
6 Q0 16863509 622 49.367016 imi_mug_run_2_treatment "gefitinib" "erlotinib"
6 Q0 17290067 623 49.36251 imi_mug_run_2_treatment "drugs" "egfr tk inhibitors" "basis"
6 Q0 22541616 624 49.358025 imi_mug_run_2_treatment "gefitinib" "erlotinib" "vascular endothelial growth factor"
6 Q0 22569624 625 49.350903 imi_mug_run_2_treatment "monoclonal antibodies"
6 Q0 28085233 626 49.35056 imi_mug_run_2_treatment "aim"
6 Q0 23493804 627 49.32901 imi_mug_run_2_treatment "docetaxel" "carboplatin" "epidermal growth factor"
6 Q0 27044261 628 49.318935 imi_mug_run_2_treatment "azd9291" "mediated" "agent"
6 Q0 25963689 629 49.31572 imi_mug_run_2_treatment "drugs" "mediated"
6 Q0 26000049 630 49.313732 imi_mug_run_2_treatment "adjuvant" "gefitinib" "erlotinib"
6 Q0 23708425 631 49.302307 imi_mug_run_2_treatment "hs-173" "drug" "egfr tyrosine kinase inhibitors"
6 Q0 21292812 632 49.301308 imi_mug_run_2_treatment "favor"
6 Q0 23021771 633 49.294937 imi_mug_run_2_treatment "gefitinib"
6 Q0 27072247 634 49.289753 imi_mug_run_2_treatment "level"
6 Q0 26882288 635 49.288116 imi_mug_run_2_treatment "drug" "mediated" "egfr tyrosine kinase inhibitors"
6 Q0 26308162 636 49.273388 imi_mug_run_2_treatment "gefitinib" "medicine" "erlotinib"
6 Q0 23088930 637 49.27067 imi_mug_run_2_treatment "drugs" "gefitinib" "erlotinib"
6 Q0 25832881 638 49.248024 imi_mug_run_2_treatment "adjuvant" "cisplatin" "cetuximab"
6 Q0 30174858 639 49.24375 imi_mug_run_2_treatment "aim"
6 Q0 30132854 640 49.242645 imi_mug_run_2_treatment "egfr inhibitor" "azd8931" "various"
6 Q0 23566546 641 49.236053 imi_mug_run_2_treatment "plasma" "cytokines" "il-10"
6 Q0 18596266 642 49.235844 imi_mug_run_2_treatment "drug" "plasma"
6 Q0 24197981 643 49.230347 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitor"
6 Q0 28391544 644 49.228943 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors" "drugs" "gefitinib"
6 Q0 24355409 645 49.22547 imi_mug_run_2_treatment "mediated" "gefitinib" "erlotinib"
6 Q0 28781309 646 49.221745 imi_mug_run_2_treatment "osimertinib" "trastuzumab"
6 Q0 26528697 647 49.218044 imi_mug_run_2_treatment "mediated"
6 Q0 16648046 648 49.215805 imi_mug_run_2_treatment "oestrogen" "adjuvant" "oestrogens"
6 Q0 17051834 649 49.207996 imi_mug_run_2_treatment "gefitinib"
6 Q0 29764507 650 49.19798 imi_mug_run_2_treatment "lactate" "adenosine triphosphate" "glucose"
6 Q0 26051236 651 49.196243 imi_mug_run_2_treatment "afatinib" "tyrosine kinase inhibitor"
6 Q0 22177532 652 49.191254 imi_mug_run_2_treatment "plasma" "aim"
6 Q0 26891293 653 49.18619 imi_mug_run_2_treatment "gefitinib" "level"
6 Q0 30153566 654 49.17863 imi_mug_run_2_treatment "antitumor agent" "mediated" "yuanhuadine"
6 Q0 21788562 655 49.173298 imi_mug_run_2_treatment "gefitinib" "aim"
6 Q0 16638863 656 49.171875 imi_mug_run_2_treatment "gefitinib" "ras"
6 Q0 16857820 657 49.156567 imi_mug_run_2_treatment "gefitinib" "erlotinib" "egfr tyrosine kinase inhibitors"
6 Q0 28880013 658 49.156387 imi_mug_run_2_treatment "azd9291" "osimertinib" "chloroquine"
6 Q0 15854414 659 49.155186 imi_mug_run_2_treatment "iressa" "gefitinib"
6 Q0 28822888 660 49.15203 imi_mug_run_2_treatment "apatinib" "gefitinib" "vascular endothelial growth factor"
6 Q0 15705135 661 49.150387 imi_mug_run_2_treatment "gefitinib" "agent" "aim"
6 Q0 28947971 662 49.149273 imi_mug_run_2_treatment "plasma" "medicine"
6 Q0 22207554 663 49.135944 imi_mug_run_2_treatment "level" "aim"
6 Q0 24736071 664 49.127647 imi_mug_run_2_treatment "sorafenib" "tyrosine" "aim"
6 Q0 29327061 665 49.12722 imi_mug_run_2_treatment "combinations" "drug" "nivolumab"
6 Q0 16857827 666 49.123096 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors" "drugs" "trastuzumab"
6 Q0 19707304 667 49.113167 imi_mug_run_2_treatment "erlotinib" "combinations" "drug"
6 Q0 20026433 668 49.10427 imi_mug_run_2_treatment "gefitinib" "erlotinib" "drugs"
6 Q0 27285768 669 49.07425 imi_mug_run_2_treatment "gefitinib" "drugs"
6 Q0 23237215 670 49.071075 imi_mug_run_2_treatment "kinase inhibitor" "tyrosine kinase inhibitor"
6 Q0 21688034 671 49.054596 imi_mug_run_2_treatment "erlotinib" "egfr tyrosine kinase inhibitor" "vascular endothelial growth factor"
6 Q0 23174717 672 49.05326 imi_mug_run_2_treatment "kinase inhibitor"
6 Q0 23911281 673 49.052437 imi_mug_run_2_treatment "gefitinib" "erlotinib" "egfr tyrosine kinase inhibitors"
6 Q0 26474873 674 49.046898 imi_mug_run_2_treatment "various" "gefitinib" "level"
6 Q0 25130967 675 49.03495 imi_mug_run_2_treatment "aim"
6 Q0 29227909 676 49.029266 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors" "aim"
6 Q0 25342043 677 49.01758 imi_mug_run_2_treatment "epidermal growth factor receptor tyrosine kinase inhibitor"
6 Q0 25716201 678 49.003647 imi_mug_run_2_treatment "egfr inhibitor" "level"
6 Q0 16002952 679 49.00229 imi_mug_run_2_treatment "gefitinib"
6 Q0 27621656 680 48.992573 imi_mug_run_2_treatment "necitumumab" "drug" "cisplatin"
6 Q0 28210147 681 48.991673 imi_mug_run_2_treatment "pemetrexed" "bevacizumab" "drug"
6 Q0 26891729 682 48.988754 imi_mug_run_2_treatment "gefitinib" "afatinib"
6 Q0 26575001 683 48.988754 imi_mug_run_2_treatment "erlotinib" "afatinib" "nervous system"
6 Q0 26554308 684 48.98079 imi_mug_run_2_treatment "igf-1"
6 Q0 24654822 685 48.97791 imi_mug_run_2_treatment "aim"
6 Q0 28210118 686 48.974434 imi_mug_run_2_treatment "afatinib" "anti-cancer agents" "agent"
6 Q0 26933807 687 48.958313 imi_mug_run_2_treatment "gefitinib" "erlotinib" "afatinib"
6 Q0 10071987 688 48.95547 imi_mug_run_2_treatment "ppads" "suramin" "mediated"
6 Q0 26235419 689 48.954678 imi_mug_run_2_treatment "medicine" "gefitinib" "erlotinib"
6 Q0 28299582 690 48.954678 imi_mug_run_2_treatment "afatinib" "afatinib 40 mg" "afatinib 20 mg"
6 Q0 25101332 691 48.945133 imi_mug_run_2_treatment "drug" "drugs" "basis"
6 Q0 30039345 692 48.92405 imi_mug_run_2_treatment "osimertinib" "kinase inhibitor"
6 Q0 22712795 693 48.923355 imi_mug_run_2_treatment "ras" "adjuvant" "anti-egfr monoclonal antibody"
6 Q0 28645631 694 48.913445 imi_mug_run_2_treatment "leucine"
6 Q0 14757534 695 48.896343 imi_mug_run_2_treatment "gefitinib" "drug" "iressa"
6 Q0 27250896 696 48.892376 imi_mug_run_2_treatment "favor" "vandetanib" "agent"
6 Q0 27738317 697 48.88508 imi_mug_run_2_treatment "pooled"
6 Q0 23226050 698 48.885014 imi_mug_run_2_treatment "gefitinib" "egfr tyrosine kinase inhibitor"
6 Q0 21715100 699 48.882088 imi_mug_run_2_treatment "combinations"
6 Q0 19292993 700 48.872135 imi_mug_run_2_treatment "drug" "ras"
6 Q0 21175241 701 48.87168 imi_mug_run_2_treatment "various" "gefitinib" "erlotinib"
6 Q0 18235413 702 48.868282 imi_mug_run_2_treatment "erlotinib" "gefitinib" "drugs"
6 Q0 24836053 703 48.865177 imi_mug_run_2_treatment "icotinib hydrochloride"
6 Q0 21757595 704 48.861378 imi_mug_run_2_treatment "drugs" "medicine" "pemetrexed"
6 Q0 28219202 705 48.857746 imi_mug_run_2_treatment "drugs" "gefitinib" "erlotinib"
6 Q0 22787411 706 48.850124 imi_mug_run_2_treatment "erlotinib" "platinum" "pemetrexed"
6 Q0 26483335 707 48.84823 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
6 Q0 26068305 708 48.84823 imi_mug_run_2_treatment "combinations" "investigational agents"
6 Q0 23929397 709 48.84746 imi_mug_run_2_treatment "tyrosine kinase inhibitor"
6 Q0 22942608 710 48.84515 imi_mug_run_2_treatment "drugs" "cytotoxic" "therapeutics"
6 Q0 30515972 711 48.842583 imi_mug_run_2_treatment "various"
6 Q0 27223439 712 48.841248 imi_mug_run_2_treatment "egfr inhibitor"
6 Q0 23726438 713 48.839462 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
6 Q0 30310681 714 48.827747 imi_mug_run_2_treatment "etoposide" "carboplatin" "gefitinib"
6 Q0 21406185 715 48.82264 imi_mug_run_2_treatment "gefitinib" "mediated" "wp1066"
6 Q0 18321238 716 48.816666 imi_mug_run_2_treatment "gefitinib" "adjuvant" "docetaxel"
6 Q0 23249107 717 48.815266 imi_mug_run_2_treatment "gefitinib" "erlotinib"
6 Q0 17094398 718 48.806477 imi_mug_run_2_treatment "gefitinib" "aim"
6 Q0 22870135 719 48.806477 imi_mug_run_2_treatment "erlotinib" "gemcitabine" "paclitaxel"
6 Q0 28152323 720 48.806477 imi_mug_run_2_treatment "gefitinib" "erlotinib"
6 Q0 21899495 721 48.792473 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitor"
6 Q0 30101528 722 48.791912 imi_mug_run_2_treatment "gefitinib" "erlotinib"
6 Q0 28724430 723 48.783646 imi_mug_run_2_treatment "cck-8" "level"
6 Q0 25714397 724 48.77879 imi_mug_run_2_treatment "erlotinib" "combinations" "adjuvant"
6 Q0 25967682 725 48.772663 imi_mug_run_2_treatment "erlotinib" "kinase inhibitor"
6 Q0 28479857 726 48.770977 imi_mug_run_2_treatment "plasma"
6 Q0 24246864 727 48.76123 imi_mug_run_2_treatment "gefitinib" "level"
6 Q0 25806155 728 48.740265 imi_mug_run_2_treatment "cetuximab" "cisplatin" "vinorelbine"
6 Q0 17505826 729 48.723507 imi_mug_run_2_treatment "gx15-070" "gefitinib" "bcl-2 inhibitor"
6 Q0 21687954 730 48.71966 imi_mug_run_2_treatment "adc" "level"
6 Q0 15182824 731 48.71808 imi_mug_run_2_treatment "gefitinib" "erlotinib" "drugs"
6 Q0 24331411 732 48.69782 imi_mug_run_2_treatment "mediated" "epidermal growth factor receptor tyrosine kinase inhibitor" "level"
6 Q0 22278730 733 48.689312 imi_mug_run_2_treatment "erlotinib" "cytotoxic" "tyrosine kinase inhibitor"
6 Q0 27347151 734 48.68788 imi_mug_run_2_treatment "bevacizumab" "afatinib"
6 Q0 25291948 735 48.68757 imi_mug_run_2_treatment "plasma"
6 Q0 27697601 736 48.68692 imi_mug_run_2_treatment "drug" "cisplatin" "chitosan"
6 Q0 21965761 737 48.676872 imi_mug_run_2_treatment "erlotinib" "gemcitabine" "carboplatin"
6 Q0 26933421 738 48.676697 imi_mug_run_2_treatment "rrx-001" "platinum" "immunotherapeutic agent"
6 Q0 20571071 739 48.66297 imi_mug_run_2_treatment "mediated" "bevacizumab" "vandetanib"
6 Q0 20035238 740 48.6629 imi_mug_run_2_treatment "erlotinib" "matrix"
6 Q0 25610713 741 48.659042 imi_mug_run_2_treatment "gefitinib 250 mg" "agent" "egfr tyrosine kinase inhibitor"
6 Q0 9930070 742 48.656784 imi_mug_run_2_treatment "aim"
6 Q0 24496038 743 48.65086 imi_mug_run_2_treatment "various" "sr48692" "gefitinib"
6 Q0 19371962 744 48.639275 imi_mug_run_2_treatment "glucose"
6 Q0 25719557 745 48.62355 imi_mug_run_2_treatment "gefitinib" "erlotinib"
6 Q0 29167003 746 48.61488 imi_mug_run_2_treatment "aim" "crizotinib"
6 Q0 25700797 747 48.611885 imi_mug_run_2_treatment "erlotinib" "egfr tyrosine kinase inhibitors"
6 Q0 28808573 748 48.609028 imi_mug_run_2_treatment "osimertinib" "nivolumab" "azd9291"
6 Q0 19159467 749 48.60805 imi_mug_run_2_treatment "cisplatin" "vinorelbine" "bevacizumab"
6 Q0 29095090 750 48.602688 imi_mug_run_2_treatment "osimertinib" "gefitinib" "erlotinib"
6 Q0 27533086 751 48.59558 imi_mug_run_2_treatment "crizotinib" "scorpion" "level"
6 Q0 27203390 752 48.59461 imi_mug_run_2_treatment "alcohol"
6 Q0 29909007 753 48.59319 imi_mug_run_2_treatment "erlotinib" "drug" "drugs"
6 Q0 25806181 754 48.592896 imi_mug_run_2_treatment "tyrosine" "egfr tyrosine kinase inhibitors"
6 Q0 16262567 755 48.592243 imi_mug_run_2_treatment "gefitinib" "erlotinib" "drugs"
6 Q0 17671149 756 48.59141 imi_mug_run_2_treatment "cetuximab" "agent"
6 Q0 24682085 757 48.5901 imi_mug_run_2_treatment "gefitinib" "docetaxel" "cytotoxic"
6 Q0 30210620 758 48.586586 imi_mug_run_2_treatment "estrogen"
6 Q0 27926478 759 48.57687 imi_mug_run_2_treatment "erlotinib"
6 Q0 20731903 760 48.572536 imi_mug_run_2_treatment "gefitinib" "erlotinib" "egfr tyrosine kinase inhibitors"
6 Q0 23376611 761 48.571903 imi_mug_run_2_treatment "carboplatin" "paclitaxel" "bevacizumab"
6 Q0 26958499 762 48.565018 imi_mug_run_2_treatment "drug" "agent" "epidermal growth factor receptor inhibitor"
6 Q0 27801728 763 48.563507 imi_mug_run_2_treatment "formalin" "egfr tyrosine kinase inhibitors"
6 Q0 26886284 764 48.55943 imi_mug_run_2_treatment "various" "monoclonal antibodies"
6 Q0 15733386 765 48.553978 imi_mug_run_2_treatment "cisplatin" "cytotoxic"
6 Q0 26096169 766 48.550007 imi_mug_run_2_treatment "various" "gefitinib" "erlotinib"
6 Q0 24326616 767 48.541946 imi_mug_run_2_treatment "carboplatin" "paclitaxel" "cetuximab"
6 Q0 29110716 768 48.536392 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitor" "aim"
6 Q0 25716471 769 48.529625 imi_mug_run_2_treatment "various" "trastuzumab" "cetuximab"
6 Q0 25477232 770 48.52237 imi_mug_run_2_treatment "taxane"
6 Q0 20530445 771 48.52228 imi_mug_run_2_treatment "aim"
6 Q0 28107191 772 48.521065 imi_mug_run_2_treatment "plasma"
6 Q0 16364841 773 48.51847 imi_mug_run_2_treatment "drugs" "gefitinib" "erlotinib"
6 Q0 22510346 774 48.50676 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
6 Q0 25302162 775 48.500534 imi_mug_run_2_treatment "gefitinib" "erlotinib" "crizotinib"
6 Q0 29341459 776 48.496555 imi_mug_run_2_treatment "cisplatin" "etoposide" "pemetrexed"
6 Q0 27721983 777 48.49063 imi_mug_run_2_treatment "erlotinib" "enzymes"
6 Q0 27229180 778 48.48864 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors" "pace" "osimertinib"
6 Q0 26943236 779 48.48581 imi_mug_run_2_treatment "osimertinib" "gefitinib" "erlotinib"
6 Q0 17845757 780 48.48214 imi_mug_run_2_treatment "phenol" "ethanol" "egfr inhibitor"
6 Q0 27057667 781 48.473877 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors" "level"
6 Q0 18154660 782 48.472576 imi_mug_run_2_treatment "level" "agent"
6 Q0 17187977 783 48.471226 imi_mug_run_2_treatment "biotin"
6 Q0 27385995 784 48.47078 imi_mug_run_2_treatment "gefitinib"
6 Q0 19731875 785 48.470055 imi_mug_run_2_treatment "bevacizumab" "erlotinib" "new drugs"
6 Q0 25960666 786 48.467415 imi_mug_run_2_treatment "erlotinib"
6 Q0 29434916 787 48.464348 imi_mug_run_2_treatment "adc" "gefitinib"
6 Q0 20085861 788 48.46407 imi_mug_run_2_treatment "erlotinib"
6 Q0 16869787 789 48.46113 imi_mug_run_2_treatment "erlotinib" "epidermal growth factor" "gefitinib"
6 Q0 27920137 790 48.454792 imi_mug_run_2_treatment "blockade"
6 Q0 20530444 791 48.44881 imi_mug_run_2_treatment "erlotinib"
6 Q0 22229045 792 48.44881 imi_mug_run_2_treatment "erlotinib" "medicine" "gefitinib"
6 Q0 20859451 793 48.44881 imi_mug_run_2_treatment "vandetanib" "agent" "zd6474"
6 Q0 16273252 794 48.445972 imi_mug_run_2_treatment "gefitinib" "kinase inhibitor" "platinum"
6 Q0 21047494 795 48.43951 imi_mug_run_2_treatment "carboplatin" "paclitaxel" "gefitinib"
6 Q0 28416959 796 48.435368 imi_mug_run_2_treatment "gefitinib" "erlotinib"
6 Q0 23239933 797 48.43201 imi_mug_run_2_treatment "gefitinib" "drugs"
6 Q0 29526937 798 48.428783 imi_mug_run_2_treatment "epidermal growth factor"
6 Q0 26490646 799 48.42241 imi_mug_run_2_treatment "erlotinib" "gefitinib" "egfr tyrosine kinase inhibitors"
6 Q0 25854394 800 48.417362 imi_mug_run_2_treatment "pemetrexed" "others"
6 Q0 20870923 801 48.412407 imi_mug_run_2_treatment "drug" "carboplatin" "paclitaxel"
6 Q0 28676222 802 48.406166 imi_mug_run_2_treatment "aim" "osimertinib" "gefitinib"
6 Q0 25450875 803 48.405235 imi_mug_run_2_treatment "gemcitabine" "taxane" "cytotoxic drugs"
6 Q0 23917487 804 48.402893 imi_mug_run_2_treatment "panitumumab" "investigational agent"
6 Q0 29363369 805 48.38834 imi_mug_run_2_treatment "various" "drugs"
6 Q0 29862230 806 48.383472 imi_mug_run_2_treatment "crizotinib" "alectinib" "medicines"
6 Q0 28880737 807 48.381874 imi_mug_run_2_treatment "osimertinib" "platinum" "program"
6 Q0 12057087 808 48.37779 imi_mug_run_2_treatment "docetaxel" "platinum" "agent"
6 Q0 18423126 809 48.37779 imi_mug_run_2_treatment "erlotinib" "drug" "program"
6 Q0 26325669 810 48.374237 imi_mug_run_2_treatment "ras" "erlotinib" "dasatinib"
6 Q0 27835586 811 48.35848 imi_mug_run_2_treatment "glucocorticoids" "drug" "drugs"
6 Q0 23469969 812 48.349205 imi_mug_run_2_treatment "erlotinib" "gefitinib" "platinum"
6 Q0 26515464 813 48.348747 imi_mug_run_2_treatment "osimertinib" "egfr tyrosine kinase inhibitors" "afatinib"
6 Q0 25263444 814 48.347626 imi_mug_run_2_treatment "mediated" "tyrosine" "ras"
6 Q0 26942444 815 48.34739 imi_mug_run_2_treatment "ci 4" "egfr tyrosine kinase inhibitors" "asc"
6 Q0 16538075 816 48.338654 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
6 Q0 18978556 817 48.337124 imi_mug_run_2_treatment "buffer" "erlotinib"
6 Q0 21059816 818 48.337124 imi_mug_run_2_treatment "basis" "duration"
6 Q0 28893372 819 48.336464 imi_mug_run_2_treatment "gefitinib"
6 Q0 23896512 820 48.33454 imi_mug_run_2_treatment "gefitinib" "erlotinib" "egfr tyrosine kinase inhibitors"
6 Q0 17363535 821 48.334507 imi_mug_run_2_treatment "retinoid" "bexarotene" "plasma"
6 Q0 25637458 822 48.333427 imi_mug_run_2_treatment "gefitinib"
6 Q0 28521301 823 48.32586 imi_mug_run_2_treatment "gefitinib" "afatinib" "erlotinib"
6 Q0 20092908 824 48.323563 imi_mug_run_2_treatment "kinase inhibitor" "pertuzumab" "pf00299804"
6 Q0 26967582 825 48.321457 imi_mug_run_2_treatment "erlotinib"
6 Q0 24378285 826 48.31761 imi_mug_run_2_treatment "plasma" "level" "cytokines"
6 Q0 23428780 827 48.315754 imi_mug_run_2_treatment "erlotinib" "pemetrexed" "aim"
6 Q0 29050366 828 48.31347 imi_mug_run_2_treatment "drugs"
6 Q0 28118631 829 48.312317 imi_mug_run_2_treatment "gefitinib" "erlotinib"
6 Q0 23249714 830 48.304886 imi_mug_run_2_treatment "level" "ly294002" "erlotinib"
6 Q0 15767641 831 48.30406 imi_mug_run_2_treatment "gefitinib" "erlotinib" "drugs"
6 Q0 25806189 832 48.301254 imi_mug_run_2_treatment "k252a" "su11274" "pha665752"
6 Q0 27866520 833 48.29915 imi_mug_run_2_treatment "plasma"
6 Q0 17285735 834 48.286827 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
6 Q0 29848736 835 48.286827 imi_mug_run_2_treatment "aim"
6 Q0 24944713 836 48.285454 imi_mug_run_2_treatment "various" "gefitinib" "egfr tyrosine kinase inhibitors"
6 Q0 29357971 837 48.260582 imi_mug_run_2_treatment "hcpt" "gefitinib"
6 Q0 23894143 838 48.25641 imi_mug_run_2_treatment "various" "niclosamide" "erlotinib"
6 Q0 26781399 839 48.255333 imi_mug_run_2_treatment "erlotinib" "drug" "docetaxel"
6 Q0 29121501 840 48.255203 imi_mug_run_2_treatment "onartuzumab" "tivantinib" "capmatinib"
6 Q0 25323938 841 48.251667 imi_mug_run_2_treatment "mk-2206" "mediated" "erlotinib"
6 Q0 29088281 842 48.248394 imi_mug_run_2_treatment "gefitinib" "combinations"
6 Q0 30263066 843 48.24048 imi_mug_run_2_treatment "gefitinib" "afatinib" "erlotinib"
6 Q0 21976946 844 48.238724 imi_mug_run_2_treatment "drug" "vandetanib" "protein tyrosine kinase inhibitor"
6 Q0 24150265 845 48.23153 imi_mug_run_2_treatment "aim"
6 Q0 18408761 846 48.22214 imi_mug_run_2_treatment "bibw2992" "erlotinib"
6 Q0 17548322 847 48.214294 imi_mug_run_2_treatment "gefitinib"
6 Q0 22302407 848 48.20661 imi_mug_run_2_treatment "aim"
6 Q0 23237220 849 48.204636 imi_mug_run_2_treatment "ppi" "kinase inhibitor" "epidermal growth factor"
6 Q0 27598680 850 48.20034 imi_mug_run_2_treatment "medicine" "matrix"
6 Q0 27688730 851 48.197453 imi_mug_run_2_treatment "gefitinib" "interferon" "aim"
6 Q0 24720523 852 48.197098 imi_mug_run_2_treatment "aim" "others"
6 Q0 25895031 853 48.179134 imi_mug_run_2_treatment "blockade"
6 Q0 27652204 854 48.169563 imi_mug_run_2_treatment "drugs" "eosin" "suppressor"
6 Q0 29571986 855 48.16585 imi_mug_run_2_treatment "osimertinib" "afatinib" "drug"
6 Q0 23306155 856 48.164665 imi_mug_run_2_treatment "mediated" "kinase inhibitor" "pd98059"
6 Q0 26929305 857 48.15757 imi_mug_run_2_treatment "afatinib" "gefitinib" "erlotinib"
6 Q0 27008036 858 48.14956 imi_mug_run_2_treatment "gold"
6 Q0 22989454 859 48.139618 imi_mug_run_2_treatment "gefitinib" "aim"
6 Q0 25810955 860 48.1345 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
6 Q0 20439190 861 48.12777 imi_mug_run_2_treatment "vascular endothelial growth factor"
6 Q0 28866043 862 48.1158 imi_mug_run_2_treatment "duration" "mediated"
6 Q0 25730907 863 48.109436 imi_mug_run_2_treatment "gefitinib" "cytotoxic"
6 Q0 30243717 864 48.086437 imi_mug_run_2_treatment "morusin" "erlotinib"
6 Q0 21372829 865 48.080666 imi_mug_run_2_treatment "aim"
6 Q0 19884551 866 48.069633 imi_mug_run_2_treatment "gefitinib" "gefitinib 250 mg" "duration"
6 Q0 16462182 867 48.059757 imi_mug_run_2_treatment "estrogen" "cisplatin"
6 Q0 16014883 868 48.05661 imi_mug_run_2_treatment "erlotinib" "agent"
6 Q0 28040594 869 48.04697 imi_mug_run_2_treatment "gefitinib" "egfr tyrosine kinase inhibitors" "lead"
6 Q0 23650389 870 48.04245 imi_mug_run_2_treatment "therapeutics" "lead"
6 Q0 20592359 871 48.0334 imi_mug_run_2_treatment "tyrosine kinase inhibitor"
6 Q0 27086595 872 48.0334 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitor" "basis"
6 Q0 30140655 873 48.018993 imi_mug_run_2_treatment "aim" "lead"
6 Q0 28708233 874 48.013878 imi_mug_run_2_treatment "osimertinib" "drugs" "gefitinib"
6 Q0 22978775 875 48.002235 imi_mug_run_2_treatment "gefitinib" "iressa"
6 Q0 23555954 876 47.989807 imi_mug_run_2_treatment "various" "drugs" "cetuximab"
6 Q0 28894381 877 47.980164 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitor"
6 Q0 23608109 878 47.971874 imi_mug_run_2_treatment "ras" "egfr tyrosine kinase inhibitors" "crizotinib"
6 Q0 30098066 879 47.96607 imi_mug_run_2_treatment "kinase inhibitor" "trametinib" "taselisib"
6 Q0 24947928 880 47.94976 imi_mug_run_2_treatment "cetuximab" "cisplatin"
6 Q0 21187458 881 47.949123 imi_mug_run_2_treatment "various" "gefitinib" "agent"
6 Q0 23154547 882 47.943085 imi_mug_run_2_treatment "formalin"
6 Q0 15448812 883 47.936554 imi_mug_run_2_treatment "gefitinib" "iressa" "chemotherapy agents"
6 Q0 24574860 884 47.935116 imi_mug_run_2_treatment "various" "erythropoietin" "ras"
6 Q0 30498734 885 47.93277 imi_mug_run_2_treatment "epidermal growth factor receptor tyrosine kinase inhibitor" "gefitinib" "egfr inhibitor"
6 Q0 18501093 886 47.93049 imi_mug_run_2_treatment "plasma"
6 Q0 18710625 887 47.927387 imi_mug_run_2_treatment "tma" "genesis"
6 Q0 21332242 888 47.92402 imi_mug_run_2_treatment "erlotinib" "drug" "drug's"
6 Q0 30419315 889 47.915077 imi_mug_run_2_treatment "drug" "egfr inhibitor"
6 Q0 25733926 890 47.909794 imi_mug_run_2_treatment "afatinib" "drugs" "gefitinib"
6 Q0 28579838 891 47.89923 imi_mug_run_2_treatment "erlotinib" "gefitinib" "afatinib"
6 Q0 20586711 892 47.897793 imi_mug_run_2_treatment "cytotoxic agent" "anti-egfr monoclonal antibody" "cetuximab"
6 Q0 30333876 893 47.884026 imi_mug_run_2_treatment "mediated"
6 Q0 23786931 894 47.88384 imi_mug_run_2_treatment "gefitinib" "epidermal growth factor receptor tyrosine kinase inhibitor" "aim"
6 Q0 24324054 895 47.883007 imi_mug_run_2_treatment "erlotinib" "aim" "blockade"
6 Q0 16472704 896 47.88125 imi_mug_run_2_treatment "bevacizumab" "carboplatin" "paclitaxel"
6 Q0 28454414 897 47.87818 imi_mug_run_2_treatment "plasma"
6 Q0 21426667 898 47.873 imi_mug_run_2_treatment "aim" "liver"
6 Q0 29416353 899 47.87042 imi_mug_run_2_treatment "various" "afatinib" "drug"
6 Q0 22762482 900 47.86634 imi_mug_run_2_treatment "various" "drugs" "gefitinib"
6 Q0 19240370 901 47.865067 imi_mug_run_2_treatment "su11274" "tyrphostin" "iressa"
6 Q0 17577030 902 47.862312 imi_mug_run_2_treatment "gefitinib" "erlotinib" "erlotinib 150 mg"
6 Q0 27447558 903 47.861332 imi_mug_run_2_treatment "gefitinib"
6 Q0 25494516 904 47.861115 imi_mug_run_2_treatment "drug" "egfr tyrosine kinase inhibitors"
6 Q0 28412028 905 47.85318 imi_mug_run_2_treatment "erlotinib" "cisplatin" "gemcitabine"
6 Q0 23707949 906 47.846725 imi_mug_run_2_treatment "gefitinib"
6 Q0 29253515 907 47.844746 imi_mug_run_2_treatment "igf-1" "gefitinib"
6 Q0 15788673 908 47.841743 imi_mug_run_2_treatment "gefitinib" "drug" "program"
6 Q0 20630828 909 47.83554 imi_mug_run_2_treatment "cetuximab" "gefitinib"
6 Q0 27109760 910 47.833057 imi_mug_run_2_treatment "gefitinib" "bisphosphonates" "drug"
6 Q0 23575415 911 47.8292 imi_mug_run_2_treatment "chloroquine" "erlotinib" "mediated"
6 Q0 24388704 912 47.814606 imi_mug_run_2_treatment "erlotinib"
6 Q0 22443647 913 47.803867 imi_mug_run_2_treatment "adjuvant" "drug" "bevacizumab"
6 Q0 27057666 914 47.80188 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors" "level"
6 Q0 25152277 915 47.796024 imi_mug_run_2_treatment "formalin" "isolate"
6 Q0 24229629 916 47.79385 imi_mug_run_2_treatment "tarceva" "crizotinib"
6 Q0 27816965 917 47.791145 imi_mug_run_2_treatment "gefitinib" "drugs"
6 Q0 29545967 918 47.782486 imi_mug_run_2_treatment "various" "radiosensitizer" "egfr tyrosine kinase inhibitor"
6 Q0 24041688 919 47.780674 imi_mug_run_2_treatment "egfr inhibitor"
6 Q0 28362115 920 47.78054 imi_mug_run_2_treatment "therapeutic agents" "aim"
6 Q0 21067263 921 47.778564 imi_mug_run_2_treatment "her-2"
6 Q0 19785057 922 47.770134 imi_mug_run_2_treatment "monoclonal antibodies" "bevacizumab" "platinum"
6 Q0 15875771 923 47.76079 imi_mug_run_2_treatment "combinations" "drug combinations" "drugs"
6 Q0 24606853 924 47.76066 imi_mug_run_2_treatment "gefitinib"
6 Q0 17634830 925 47.755806 imi_mug_run_2_treatment "erlotinib" "gefitinib" "lead"
6 Q0 22177492 926 47.755806 imi_mug_run_2_treatment "gefitinib"
6 Q0 29216508 927 47.755806 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitor"
6 Q0 27040849 928 47.75526 imi_mug_run_2_treatment "afatinib" "tyrosine kinase inhibitor"
6 Q0 24192124 929 47.750694 imi_mug_run_2_treatment "cetuximab" "erlotinib" "crizotinib"
6 Q0 19473721 930 47.748886 imi_mug_run_2_treatment "various" "gefitinib"
6 Q0 28476851 931 47.748886 imi_mug_run_2_treatment "plasma" "aim" "osimertinib"
6 Q0 25826078 932 47.748188 imi_mug_run_2_treatment "various" "erlotinib" "egfr inhibitor"
6 Q0 22085274 933 47.742332 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
6 Q0 19508832 934 47.74039 imi_mug_run_2_treatment "bevacizumab" "cetuximab" "erlotinib"
6 Q0 29858080 935 47.73521 imi_mug_run_2_treatment "various" "drug" "yuanhuadine"
6 Q0 18784157 936 47.73273 imi_mug_run_2_treatment "iressa" "erlotinib" "gefitinib"
6 Q0 23328701 937 47.72972 imi_mug_run_2_treatment "level"
6 Q0 14748652 938 47.72969 imi_mug_run_2_treatment "gefitinib" "iressa" "agent"
6 Q0 30501503 939 47.72969 imi_mug_run_2_treatment "necitumumab" "cisplatin" "medicine"
6 Q0 26706951 940 47.722134 imi_mug_run_2_treatment "epidermal growth factor receptor tyrosine kinase inhibitor"
6 Q0 30214557 941 47.715317 imi_mug_run_2_treatment "alectinib"
6 Q0 30293943 942 47.715317 imi_mug_run_2_treatment "drugs"
6 Q0 27398239 943 47.711906 imi_mug_run_2_treatment "ras" "drug" "monoclonal antibodies"
6 Q0 25029028 944 47.709152 imi_mug_run_2_treatment "enzymes" "phosphate"
6 Q0 26646697 945 47.693405 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
6 Q0 20423982 946 47.692997 imi_mug_run_2_treatment "drugs" "therapeutics" "gefitinib"
6 Q0 21645456 947 47.68993 imi_mug_run_2_treatment "tyrosine kinase inhibitor" "aim"
6 Q0 25992771 948 47.688465 imi_mug_run_2_treatment "blockade"
6 Q0 16843264 949 47.685608 imi_mug_run_2_treatment "mediated" "gefitinib" "incb3619"
6 Q0 29922072 950 47.676353 imi_mug_run_2_treatment "plasma" "osimertinib" "lead"
6 Q0 26415994 951 47.671406 imi_mug_run_2_treatment "medicine"
6 Q0 21116327 952 47.671406 imi_mug_run_2_treatment "nimotuzumab" "agent" "monoclonal antibodies"
6 Q0 26809532 953 47.66885 imi_mug_run_2_treatment "gefitinib" "afatinib"
6 Q0 27760604 954 47.66885 imi_mug_run_2_treatment "drugs"
6 Q0 23769345 955 47.663754 imi_mug_run_2_treatment "aim"
6 Q0 18579254 956 47.66152 imi_mug_run_2_treatment "various" "cancer drug" "anti-vegf"
6 Q0 25180058 957 47.66108 imi_mug_run_2_treatment "plasma"
6 Q0 27595749 958 47.65052 imi_mug_run_2_treatment "nivolumab" "cisplatin" "pemetrexed"
6 Q0 28838393 959 47.642624 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
6 Q0 25999733 960 47.63598 imi_mug_run_2_treatment "crizotinib" "various" "drugs"
6 Q0 16850125 961 47.634033 imi_mug_run_2_treatment "gefitinib" "erlotinib" "drugs"
6 Q0 22229252 962 47.62716 imi_mug_run_2_treatment "gefitinib" "erlotinib" "egfr tyrosine kinase inhibitors"
6 Q0 25668228 963 47.61209 imi_mug_run_2_treatment "drugs"
6 Q0 23972815 964 47.59914 imi_mug_run_2_treatment "lead" "egfr tyrosine kinase inhibitor" "egfr tyrosine kinase inhibitors"
6 Q0 29914238 965 47.59834 imi_mug_run_2_treatment "gefitinib" "erlotinib" "egfr tyrosine kinase inhibitor"
6 Q0 20631634 966 47.58572 imi_mug_run_2_treatment "epidermal growth factor"
6 Q0 2161199 967 47.58551 imi_mug_run_2_treatment "urokinase" "plasminogen activator" "epidermal growth factor"
6 Q0 24309006 968 47.583885 imi_mug_run_2_treatment "cisplatin" "docetaxel"
6 Q0 27739029 969 47.58232 imi_mug_run_2_treatment "cisplatin" "paclitaxel" "egfr inhibitor"
6 Q0 24205245 970 47.58192 imi_mug_run_2_treatment "lead"
6 Q0 22591345 971 47.58192 imi_mug_run_2_treatment "various" "plasma"
6 Q0 24959380 972 47.580544 imi_mug_run_2_treatment "ppa" "tma"
6 Q0 21785539 973 47.575874 imi_mug_run_2_treatment "erlotinib" "tarceva"
6 Q0 30309221 974 47.57297 imi_mug_run_2_treatment "capmatinib" "afatinib" "byl719"
6 Q0 23226067 975 47.569633 imi_mug_run_2_treatment "ras" "platinum" "egfr tyrosine kinase inhibitors"
6 Q0 30034635 976 47.563347 imi_mug_run_2_treatment "osimertinib" "essential drug" "egfr tyrosine kinase inhibitor"
6 Q0 29101033 977 47.552937 imi_mug_run_2_treatment "il-6" "gefitinib" "platinum"
6 Q0 16720916 978 47.551395 imi_mug_run_2_treatment "gefitinib" "iressa" "erlotinib"
6 Q0 17276470 979 47.548172 imi_mug_run_2_treatment "estrogens" "drug" "antiestrogens"
6 Q0 18559606 980 47.54765 imi_mug_run_2_treatment "erlotinib"
6 Q0 26664160 981 47.546677 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors" "aim"
6 Q0 20237869 982 47.545845 imi_mug_run_2_treatment "gefitinib" "cisplatin" "drug"
6 Q0 19519336 983 47.534286 imi_mug_run_2_treatment "bevacizumab" "erlotinib" "agent"
6 Q0 26958497 984 47.529705 imi_mug_run_2_treatment "azd9291" "platinum" "egfr tyrosine kinase inhibitor"
6 Q0 15988686 985 47.526997 imi_mug_run_2_treatment "combinations" "arsenal" "gefitinib"
6 Q0 15731348 986 47.521065 imi_mug_run_2_treatment "gefitinib" "iressa"
6 Q0 26816539 987 47.52088 imi_mug_run_2_treatment "epidermal growth factor"
6 Q0 21207017 988 47.50834 imi_mug_run_2_treatment "cetuximab" "platinum" "lead"
6 Q0 30049203 989 47.500908 imi_mug_run_2_treatment "agent" "egfr tyrosine kinase inhibitors"
6 Q0 27565905 990 47.495667 imi_mug_run_2_treatment "enzymes" "afatinib" "gefitinib"
6 Q0 23988622 991 47.49019 imi_mug_run_2_treatment "drugs" "plasma"
6 Q0 30147015 992 47.48636 imi_mug_run_2_treatment "drugs"
6 Q0 24246507 993 47.473736 imi_mug_run_2_treatment "ras"
6 Q0 19130057 994 47.465492 imi_mug_run_2_treatment "erlotinib" "cytotoxic" "agent"
6 Q0 24124611 995 47.464684 imi_mug_run_2_treatment "adjuvant" "anthocyanidin"
6 Q0 29575851 996 47.450687 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors" "aim"
6 Q0 26564313 997 47.443363 imi_mug_run_2_treatment "basis"
6 Q0 24594844 998 47.43859 imi_mug_run_2_treatment "tyrosine kinase inhibitor" "therapeutic agents" "bibw-2992"
6 Q0 24566025 999 47.43578 imi_mug_run_2_treatment "erlotinib" "crizotinib" "gefitinib"
7 Q0 29977749 1 84.32355 imi_mug_run_2_treatment "chemotherapy agents" "gefitinib" "platinum"
7 Q0 29927769 2 80.89633 imi_mug_run_2_treatment "celastrol" "epidermal growth factor receptor tyrosine kinase inhibitor"
7 Q0 27071706 3 75.45793 imi_mug_run_2_treatment "osimertinib" "pf-06747775" "egf816"
7 Q0 28188446 4 75.45214 imi_mug_run_2_treatment "gefitinib" "erlotinib" "egfr tyrosine kinase inhibitor"
7 Q0 19351754 5 75.11394 imi_mug_run_2_treatment "gefitinib" "erlotinib" "plasma"
7 Q0 17671147 6 74.62404 imi_mug_run_2_treatment "erlotinib" "gefitinib" "hki-272"
7 Q0 25923549 7 74.24777 imi_mug_run_2_treatment "azd9291" "egfr inhibitor" "egfr tyrosine kinase inhibitors"
7 Q0 28699260 8 73.96881 imi_mug_run_2_treatment "osimertinib"
7 Q0 27431492 9 73.821625 imi_mug_run_2_treatment "gefitinib" "bcl-2 inhibitor"
7 Q0 23769347 10 73.71475 imi_mug_run_2_treatment "drug"
7 Q0 30521113 11 73.48895 imi_mug_run_2_treatment "osimertinib" "gefitinib" "erlotinib"
7 Q0 25923550 12 73.3436 imi_mug_run_2_treatment "rociletinib" "egfr inhibitor" "mediated"
7 Q0 28002980 13 73.23842 imi_mug_run_2_treatment "drugs" "plasma"
7 Q0 26160838 14 72.897026 imi_mug_run_2_treatment "gefitinib" "mtor inhibitor" "aim"
7 Q0 25450875 15 72.352905 imi_mug_run_2_treatment "gemcitabine" "taxane" "cytotoxic drugs"
7 Q0 25532027 16 72.100876 imi_mug_run_2_treatment "interferon" "cytotoxic" "gefitinib"
7 Q0 27448564 17 71.78322 imi_mug_run_2_treatment "azd9291" "osimertinib" "tagrisso"
7 Q0 23266614 18 71.54033 imi_mug_run_2_treatment "various" "cetuximab" "afatinib"
7 Q0 23733083 19 71.47327 imi_mug_run_2_treatment "gefitinib" "erlotinib" "crizotinib"
7 Q0 23664448 20 71.27434 imi_mug_run_2_treatment "afatinib" "gefitinib" "erlotinib"
7 Q0 29423594 21 71.18185 imi_mug_run_2_treatment "various" "osimertinib" "agent"
7 Q0 29477930 22 71.01382 imi_mug_run_2_treatment "combinations" "drug" "platinum"
7 Q0 29031620 23 70.97392 imi_mug_run_2_treatment "epidermal growth factor" "gefitinib" "erlotinib"
7 Q0 29998228 24 70.863464 imi_mug_run_2_treatment "gefitinib" "erlotinib" "platinum"
7 Q0 29246024 25 70.59538 imi_mug_run_2_treatment "various" "plasma"
7 Q0 28866043 26 70.57961 imi_mug_run_2_treatment "duration" "mediated"
7 Q0 27044261 27 70.53204 imi_mug_run_2_treatment "azd9291" "mediated" "agent"
7 Q0 25714021 28 70.45891 imi_mug_run_2_treatment "afatinib" "gefitinib" "radiation sensitizer"
7 Q0 30237726 29 70.324936 imi_mug_run_2_treatment "pembrolizumab" "gemcitabine" "egfr tyrosine kinase inhibitor"
7 Q0 29909007 30 70.31238 imi_mug_run_2_treatment "erlotinib" "drug" "drugs"
7 Q0 26882288 31 70.24721 imi_mug_run_2_treatment "drug" "mediated" "egfr tyrosine kinase inhibitors"
7 Q0 27821604 32 70.23215 imi_mug_run_2_treatment "kinase inhibitor" "osimertinib" "tagrisso"
7 Q0 28479857 33 69.913025 imi_mug_run_2_treatment "plasma"
7 Q0 19238632 34 69.90771 imi_mug_run_2_treatment "erlotinib" "su11274" "mediated"
7 Q0 30079781 35 69.6335 imi_mug_run_2_treatment "osimertinib"
7 Q0 27721983 36 69.60255 imi_mug_run_2_treatment "erlotinib" "enzymes"
7 Q0 30034635 37 69.28253 imi_mug_run_2_treatment "osimertinib" "essential drug" "egfr tyrosine kinase inhibitor"
7 Q0 28476851 38 69.2314 imi_mug_run_2_treatment "plasma" "aim" "osimertinib"
7 Q0 30474188 39 69.225136 imi_mug_run_2_treatment "osimertinib"
7 Q0 26577492 40 69.07556 imi_mug_run_2_treatment "plasma" "egfr tyrosine kinase inhibitors"
7 Q0 29922072 41 68.65802 imi_mug_run_2_treatment "plasma" "osimertinib" "lead"
7 Q0 26235419 42 68.4712 imi_mug_run_2_treatment "medicine" "gefitinib" "erlotinib"
7 Q0 24919575 43 68.38696 imi_mug_run_2_treatment "afatinib" "dasatinib" "tyrosine"
7 Q0 26943236 44 68.30142 imi_mug_run_2_treatment "osimertinib" "gefitinib" "erlotinib"
7 Q0 28362115 45 68.30101 imi_mug_run_2_treatment "therapeutic agents" "aim"
7 Q0 23886554 46 68.28939 imi_mug_run_2_treatment "gefitinib" "egfr tyrosine kinase inhibitors" "plasma"
7 Q0 30015588 47 68.24434 imi_mug_run_2_treatment "duration"
7 Q0 24594844 48 68.23038 imi_mug_run_2_treatment "tyrosine kinase inhibitor" "therapeutic agents" "bibw-2992"
7 Q0 26450446 49 68.19284 imi_mug_run_2_treatment "azd9291" "gefitinib" "erlotinib"
7 Q0 20421816 50 67.8145 imi_mug_run_2_treatment "mediated" "inositol" "gefitinib"
7 Q0 28293073 51 67.78754 imi_mug_run_2_treatment "various" "drug" "pred"
7 Q0 27468240 52 67.66849 imi_mug_run_2_treatment "gefitinib" "erlotinib"
7 Q0 29455650 53 67.657524 imi_mug_run_2_treatment "various" "gefitinib" "erlotinib"
7 Q0 23493804 54 67.377625 imi_mug_run_2_treatment "docetaxel" "carboplatin" "epidermal growth factor"
7 Q0 30365094 55 67.30259 imi_mug_run_2_treatment "osimertinib" "azd9291"
7 Q0 25882755 56 67.16059 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors" "others"
7 Q0 23229345 57 67.15806 imi_mug_run_2_treatment "various" "drug" "kinase inhibitor"
7 Q0 27341162 58 67.094086 imi_mug_run_2_treatment "drugs" "k252a" "alkaloid"
7 Q0 25668228 59 66.94663 imi_mug_run_2_treatment "drugs"
7 Q0 28625653 60 66.87872 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
7 Q0 26052929 61 66.827324 imi_mug_run_2_treatment "afatinib" "gefitinib" "erlotinib"
7 Q0 25806291 62 66.74414 imi_mug_run_2_treatment "erlotinib" "drug" "agent"
7 Q0 26349474 63 66.59293 imi_mug_run_2_treatment "bevacizumab" "gefitinib" "erlotinib"
7 Q0 29807405 64 66.4045 imi_mug_run_2_treatment "osimertinib" "therapeutics"
7 Q0 21734175 65 66.362915 imi_mug_run_2_treatment "drug" "drugs" "gefitinib"
7 Q0 29910646 66 66.34661 imi_mug_run_2_treatment "various" "plasma"
7 Q0 28880737 67 66.28824 imi_mug_run_2_treatment "osimertinib" "platinum" "program"
7 Q0 26309190 68 66.26173 imi_mug_run_2_treatment "mediated" "erlotinib"
7 Q0 27177916 69 66.1179 imi_mug_run_2_treatment "osimertinib" "gefitinib" "erlotinib"
7 Q0 30392443 70 66.09721 imi_mug_run_2_treatment "osimertinib" "triumph" "plasma"
7 Q0 28635227 71 66.00156 imi_mug_run_2_treatment "epidermal growth factor receptor tyrosine kinase inhibitor"
7 Q0 29173769 72 65.979324 imi_mug_run_2_treatment "osimertinib" "erlotinib" "tyrosine kinase inhibitor"
7 Q0 29545967 73 65.93506 imi_mug_run_2_treatment "various" "radiosensitizer" "egfr tyrosine kinase inhibitor"
7 Q0 28302223 74 65.804306 imi_mug_run_2_treatment "lead" "epidermal growth factor receptor tyrosine kinase inhibitor" "osimertinib"
7 Q0 30358214 75 65.72916 imi_mug_run_2_treatment "azd9291" "tyrosine kinase inhibitor" "isolate"
7 Q0 28528303 76 65.69045 imi_mug_run_2_treatment "drugs" "egfr inhibitor" "ceritinib"
7 Q0 23515752 77 65.6664 imi_mug_run_2_treatment "gefitinib" "histone deacetylase inhibitor" "tyrosine kinase inhibitor"
7 Q0 25580271 78 65.468704 imi_mug_run_2_treatment "necitumumab" "cisplatin" "gemcitabine"
7 Q0 30522170 79 65.4608 imi_mug_run_2_treatment "plasma" "egfr inhibitor" "egfr tyrosine kinase inhibitor"
7 Q0 29363250 80 65.36622 imi_mug_run_2_treatment "osimertinib" "ci 4" "duration"
7 Q0 23244184 81 65.35606 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors" "aim"
7 Q0 28843359 82 65.34263 imi_mug_run_2_treatment "osimertinib" "plasma" "gefitinib"
7 Q0 29425688 83 65.29845 imi_mug_run_2_treatment "osimertinib" "drugs" "egfr tyrosine kinase inhibitor"
7 Q0 26517520 84 65.287476 imi_mug_run_2_treatment "gefitinib" "pdx" "egfr tyrosine kinase inhibitors"
7 Q0 29239135 85 65.285675 imi_mug_run_2_treatment "oxymatrine" "therapeutic agent"
7 Q0 26958499 86 65.168945 imi_mug_run_2_treatment "drug" "agent" "epidermal growth factor receptor inhibitor"
7 Q0 27259997 87 65.11327 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
7 Q0 22891040 88 64.94928 imi_mug_run_2_treatment "afatinib" "dacomitinib" "egfr tyrosine kinase inhibitors"
7 Q0 21233402 89 64.789795 imi_mug_run_2_treatment "erlotinib"
7 Q0 29496249 90 64.771324 imi_mug_run_2_treatment "osimertinib"
7 Q0 26959310 91 64.67475 imi_mug_run_2_treatment "epidermal growth factor receptor tyrosine kinase inhibitor" "rociletinib" "osimertinib"
7 Q0 30276451 92 64.66939 imi_mug_run_2_treatment "afatinib" "aim"
7 Q0 16730855 93 64.40783 imi_mug_run_2_treatment "gefitinib" "leucine" "tyrosine"
7 Q0 29761660 94 64.40223 imi_mug_run_2_treatment "mediated"
7 Q0 24790411 95 64.341125 imi_mug_run_2_treatment "afatinib" "drug" "program"
7 Q0 28577956 96 64.29691 imi_mug_run_2_treatment "platinum" "gefitinib" "erlotinib"
7 Q0 29292704 97 64.28888 imi_mug_run_2_treatment "drug" "therapeutics" "egfr tyrosine kinase inhibitors"
7 Q0 25384171 98 64.2185 imi_mug_run_2_treatment "xav939" "bibw2992" "egfr tyrosine kinase inhibitors"
7 Q0 25629371 99 64.19348 imi_mug_run_2_treatment "afatinib"
7 Q0 28723866 100 64.18476 imi_mug_run_2_treatment "drug" "kinase inhibitor" "plasma"
7 Q0 24623981 101 64.01437 imi_mug_run_2_treatment "kinase inhibitor"
7 Q0 28332047 102 63.970127 imi_mug_run_2_treatment "osimertinib"
7 Q0 16912157 103 63.953762 imi_mug_run_2_treatment "gefitinib"
7 Q0 28407039 104 63.841396 imi_mug_run_2_treatment "nivolumab" "egfr tyrosine kinase inhibitors" "blockade"
7 Q0 25939061 105 63.79073 imi_mug_run_2_treatment "azd9291" "mediated" "plasma"
7 Q0 20156777 106 63.761627 imi_mug_run_2_treatment "erlotinib" "gefitinib" "egfr tyrosine kinase inhibitors"
7 Q0 27821131 107 63.63273 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
7 Q0 26090892 108 63.62298 imi_mug_run_2_treatment "mediators"
7 Q0 29207630 109 63.554714 imi_mug_run_2_treatment "gefitinib" "u0126" "tyrosine kinase inhibitor"
7 Q0 25278773 110 63.55278 imi_mug_run_2_treatment "afatinib" "mediated" "bibw2992"
7 Q0 25806323 111 63.537243 imi_mug_run_2_treatment "azd9291" "egfr inhibitor"
7 Q0 28881618 112 63.478596 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors" "various" "pooled"
7 Q0 23723712 113 63.47648 imi_mug_run_2_treatment "combinations" "drugs" "gefitinib"
7 Q0 29754184 114 63.4354 imi_mug_run_2_treatment "osimertinib" "mediated" "egfr inhibitor"
7 Q0 30151614 115 63.420143 imi_mug_run_2_treatment "osimertinib" "erlotinib" "platinum"
7 Q0 27912836 116 63.40229 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors" "gefitinib" "erlotinib"
7 Q0 28841389 117 63.333923 imi_mug_run_2_treatment "osimertinib" "plasma" "tyrosine kinase inhibitor"
7 Q0 28454365 118 63.25376 imi_mug_run_2_treatment "cytotoxic" "erlotinib" "tyrosine kinase inhibitor"
7 Q0 22215752 119 63.253105 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitor" "egfr tyrosine kinase inhibitors" "matrix"
7 Q0 18078086 120 63.13226 imi_mug_run_2_treatment "drug" "gemcitabine" "vinorelbine"
7 Q0 24086949 121 62.919662 imi_mug_run_2_treatment "afatinib" "gefitinib" "erlotinib"
7 Q0 29070999 122 62.904617 imi_mug_run_2_treatment "osimertinib" "gefitinib"
7 Q0 29607142 123 62.879883 imi_mug_run_2_treatment "level" "deoxyglucose"
7 Q0 30039345 124 62.843544 imi_mug_run_2_treatment "osimertinib" "kinase inhibitor"
7 Q0 27268079 125 62.757767 imi_mug_run_2_treatment "gefitinib" "fluorouracil" "epidermal growth factor"
7 Q0 26354527 126 62.708782 imi_mug_run_2_treatment "afatinib" "egfr tyrosine kinase inhibitor" "program"
7 Q0 30337598 127 62.5719 imi_mug_run_2_treatment "duration" "medicine"
7 Q0 21677478 128 62.49755 imi_mug_run_2_treatment "erlotinib" "gefitinib"
7 Q0 29802850 129 62.46781 imi_mug_run_2_treatment "drug" "cetuximab" "gefitinib"
7 Q0 26314834 130 62.456573 imi_mug_run_2_treatment "afatinib" "mediated" "tyrosine kinase inhibitor"
7 Q0 26622796 131 62.447937 imi_mug_run_2_treatment "gefitinib" "level"
7 Q0 28422737 132 62.34846 imi_mug_run_2_treatment "various" "gefitinib" "mediated"
7 Q0 18760859 133 62.26297 imi_mug_run_2_treatment "gefitinib" "erlotinib"
7 Q0 24893891 134 62.188667 imi_mug_run_2_treatment "drug" "azd9291" "egfr tyrosine kinase inhibitors"
7 Q0 19572809 135 62.09809 imi_mug_run_2_treatment "drugs" "monoclonal antibodies"
7 Q0 26730759 136 62.091705 imi_mug_run_2_treatment "drugs" "plasma"
7 Q0 28884371 137 62.07554 imi_mug_run_2_treatment "osimertinib" "plasma"
7 Q0 28822888 138 62.074577 imi_mug_run_2_treatment "apatinib" "gefitinib" "vascular endothelial growth factor"
7 Q0 29061221 139 62.016052 imi_mug_run_2_treatment "drug" "level"
7 Q0 21635547 140 61.835796 imi_mug_run_2_treatment "level" "egfr tyrosine kinase inhibitor" "basis"
7 Q0 18458038 141 61.80547 imi_mug_run_2_treatment "gefitinib" "gefitinib 250 mg" "egfr tyrosine kinase inhibitors"
7 Q0 28848674 142 61.683113 imi_mug_run_2_treatment "osimertinib" "tyrosine kinase inhibitor"
7 Q0 22562326 143 61.641376 imi_mug_run_2_treatment "drugs"
7 Q0 25963689 144 61.56099 imi_mug_run_2_treatment "drugs" "mediated"
7 Q0 26202045 145 61.534626 imi_mug_run_2_treatment "various" "afatinib" "crizotinib"
7 Q0 28701107 146 61.503643 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors" "cytotoxic" "bevacizumab"
7 Q0 27959700 147 61.487198 imi_mug_run_2_treatment "osimertinib" "pemetrexed" "platinum"
7 Q0 30018881 148 61.454388 imi_mug_run_2_treatment "gefitinib" "erlotinib" "afatinib"
7 Q0 27655904 149 61.44093 imi_mug_run_2_treatment "bevacizumab" "platinum" "egfr tyrosine kinase inhibitors"
7 Q0 29110836 150 61.41816 imi_mug_run_2_treatment "gefitinib" "erlotinib" "afatinib"
7 Q0 29755953 151 61.38769 imi_mug_run_2_treatment "osimertinib" "gefitinib" "erlotinib"
7 Q0 22588155 152 61.38602 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
7 Q0 27999211 153 61.324688 imi_mug_run_2_treatment "gefitinib" "erlotinib"
7 Q0 28167215 154 61.264465 imi_mug_run_2_treatment "various" "medicine" "gefitinib"
7 Q0 29173773 155 61.205257 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
7 Q0 26622666 156 61.138725 imi_mug_run_2_treatment "gefitinib"
7 Q0 28221867 157 61.132652 imi_mug_run_2_treatment "corticosteroids" "osimertinib" "duration"
7 Q0 29190637 158 61.1149 imi_mug_run_2_treatment "osimertinib" "osimertinib 80 mg"
7 Q0 29571986 159 61.01682 imi_mug_run_2_treatment "osimertinib" "afatinib" "drug"
7 Q0 23466741 160 60.91223 imi_mug_run_2_treatment "erlotinib" "epidermal growth factor receptor tyrosine kinase inhibitor"
7 Q0 26961138 161 60.91073 imi_mug_run_2_treatment "afatinib" "various" "drugs"
7 Q0 26370161 162 60.905907 imi_mug_run_2_treatment "drug" "bevacizumab" "erlotinib"
7 Q0 26056478 163 60.851547 imi_mug_run_2_treatment "cetuximab" "afatinib" "gefitinib"
7 Q0 27660466 164 60.84508 imi_mug_run_2_treatment "osimertinib" "azd9291"
7 Q0 29526178 165 60.82739 imi_mug_run_2_treatment "epidermal growth factor receptor tyrosine kinase inhibitor"
7 Q0 28781309 166 60.60344 imi_mug_run_2_treatment "osimertinib" "trastuzumab"
7 Q0 20033049 167 60.592216 imi_mug_run_2_treatment "drug" "kinase inhibitor" "egfr inhibitor"
7 Q0 29095090 168 60.57703 imi_mug_run_2_treatment "osimertinib" "gefitinib" "erlotinib"
7 Q0 24916999 169 60.53293 imi_mug_run_2_treatment "various" "mediators" "gefitinib"
7 Q0 29848711 170 60.478294 imi_mug_run_2_treatment "osimertinib" "aim" "liver"
7 Q0 27384992 171 60.47573 imi_mug_run_2_treatment "erlotinib" "volasertib" "agent"
7 Q0 22899358 172 60.434765 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
7 Q0 30267319 173 60.421223 imi_mug_run_2_treatment "drug" "dacomitinib" "osimertinib"
7 Q0 29486953 174 60.418674 imi_mug_run_2_treatment "diphenyl" "azd9291"
7 Q0 28808573 175 60.41381 imi_mug_run_2_treatment "osimertinib" "nivolumab" "azd9291"
7 Q0 18978556 176 60.412655 imi_mug_run_2_treatment "buffer" "erlotinib"
7 Q0 24631288 177 60.387115 imi_mug_run_2_treatment "gefitinib" "erlotinib" "egfr tyrosine kinase inhibitors"
7 Q0 17931092 178 60.380276 imi_mug_run_2_treatment "erlotinib"
7 Q0 28577943 179 60.363106 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
7 Q0 25189483 180 60.28445 imi_mug_run_2_treatment "mediated" "gefitinib" "afatinib"
7 Q0 29341374 181 60.252747 imi_mug_run_2_treatment "gefitinib" "erlotinib" "tyrosine kinase inhibitor"
7 Q0 26898616 182 60.246315 imi_mug_run_2_treatment "platinum" "egfr tyrosine kinase inhibitors" "hm61713"
7 Q0 21660144 183 60.239456 imi_mug_run_2_treatment "gefitinib" "tyrosine kinase inhibitor" "egfr tyrosine kinase inhibitors"
7 Q0 28676222 184 60.210953 imi_mug_run_2_treatment "aim" "osimertinib" "gefitinib"
7 Q0 30464499 185 60.19402 imi_mug_run_2_treatment "tyrosine kinase inhibitor" "liver"
7 Q0 26400668 186 60.166702 imi_mug_run_2_treatment "drugs" "egfr tyrosine kinase inhibitors"
7 Q0 23788917 187 60.109043 imi_mug_run_2_treatment "drugs" "erlotinib" "new drugs"
7 Q0 18596266 188 60.105774 imi_mug_run_2_treatment "drug" "plasma"
7 Q0 27864022 189 60.080116 imi_mug_run_2_treatment "gefitinib" "shikonin"
7 Q0 14682117 190 60.078903 imi_mug_run_2_treatment "erlotinib" "angiogenesis inhibitor" "bevacizumab"
7 Q0 26528827 191 60.043983 imi_mug_run_2_treatment "sanguinarine" "methionine" "oxygen"
7 Q0 28708233 192 60.043793 imi_mug_run_2_treatment "osimertinib" "drugs" "gefitinib"
7 Q0 22821179 193 59.989223 imi_mug_run_2_treatment "cetuximab" "erlotinib" "epidermal growth factor"
7 Q0 29493460 194 59.950645 imi_mug_run_2_treatment "various" "gefitinib" "drug"
7 Q0 30114862 195 59.948326 imi_mug_run_2_treatment "aim"
7 Q0 28712979 196 59.897484 imi_mug_run_2_treatment "drug" "tyrosine kinase inhibitor" "co-1686"
7 Q0 19096299 197 59.85794 imi_mug_run_2_treatment "drug" "adenosine triphosphate" "egfr tyrosine kinase inhibitors"
7 Q0 24041688 198 59.856205 imi_mug_run_2_treatment "egfr inhibitor"
7 Q0 24636263 199 59.773678 imi_mug_run_2_treatment "various" "gefitinib" "erlotinib"
7 Q0 29526180 200 59.71853 imi_mug_run_2_treatment "drug" "mediated" "gefitinib"
7 Q0 25505694 201 59.700684 imi_mug_run_2_treatment "gefitinib" "erlotinib" "egfr tyrosine kinase inhibitors"
7 Q0 21196393 202 59.649807 imi_mug_run_2_treatment "adjuvant" "cetuximab" "gefitinib"
7 Q0 23527257 203 59.6101 imi_mug_run_2_treatment "various" "cetuximab" "afatinib"
7 Q0 23883584 204 59.61003 imi_mug_run_2_treatment "afatinib" "glucose" "bibw2992"
7 Q0 27542267 205 59.572945 imi_mug_run_2_treatment "plasma" "drugs" "mediated"
7 Q0 27910964 206 59.560787 imi_mug_run_2_treatment "osimertinib" "agent" "tyrosine kinase inhibitor"
7 Q0 29713646 207 59.54639 imi_mug_run_2_treatment "osimertinib"
7 Q0 30194196 208 59.54431 imi_mug_run_2_treatment "afatinib" "tyrosine kinase inhibitor" "aim"
7 Q0 28515244 209 59.516495 imi_mug_run_2_treatment "osimertinib" "plasma"
7 Q0 19381876 210 59.47809 imi_mug_run_2_treatment "tyrosine kinase inhibitor"
7 Q0 28778263 211 59.402176 imi_mug_run_2_treatment "mediated" "erlotinib" "osimertinib"
7 Q0 30457891 212 59.39531 imi_mug_run_2_treatment "osimertinib" "favor"
7 Q0 25338771 213 59.381386 imi_mug_run_2_treatment "plasma" "level" "egfr tyrosine kinase inhibitors"
7 Q0 20678850 214 59.381363 imi_mug_run_2_treatment "erlotinib"
7 Q0 28031840 215 59.37535 imi_mug_run_2_treatment "drug" "erlotinib"
7 Q0 29972716 216 59.374603 imi_mug_run_2_treatment "asp8273" "tyrosine kinase inhibitor" "duration"
7 Q0 28416959 217 59.34644 imi_mug_run_2_treatment "gefitinib" "erlotinib"
7 Q0 26958497 218 59.334488 imi_mug_run_2_treatment "azd9291" "platinum" "egfr tyrosine kinase inhibitor"
7 Q0 16608981 219 59.325256 imi_mug_run_2_treatment "erlotinib" "gefitinib" "cytotoxic drugs"
7 Q0 30268482 220 59.281418 imi_mug_run_2_treatment "gefitinib" "various" "pemetrexed"
7 Q0 25214559 221 59.26326 imi_mug_run_2_treatment "ibrutinib" "erlotinib" "drug"
7 Q0 22085274 222 59.240665 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
7 Q0 29581983 223 59.19384 imi_mug_run_2_treatment "epidermal growth factor receptor tyrosine kinase inhibitor"
7 Q0 27188576 224 59.157368 imi_mug_run_2_treatment "com" "monoclonal antibodies"
7 Q0 15991677 225 59.121967 imi_mug_run_2_treatment "drugs" "angiogenesis inhibitors" "inhibitors, angiogenesis"
7 Q0 24789720 226 59.08935 imi_mug_run_2_treatment "aim"
7 Q0 29191595 227 59.07376 imi_mug_run_2_treatment "dacomitinib"
7 Q0 29110841 228 59.067215 imi_mug_run_2_treatment "erlotinib" "adc" "etoposide"
7 Q0 29399354 229 59.01831 imi_mug_run_2_treatment "osimertinib" "erlotinib" "onartuzumab"
7 Q0 18632637 230 58.91311 imi_mug_run_2_treatment "cl-387,785" "kinase inhibitor" "mediated"
7 Q0 29221264 231 58.906937 imi_mug_run_2_treatment "gefitinib" "pemetrexed"
7 Q0 17974985 232 58.896675 imi_mug_run_2_treatment "cl-387,785" "gefitinib" "erlotinib"
7 Q0 23592446 233 58.883984 imi_mug_run_2_treatment "gefitinib" "mediated" "cytotoxic"
7 Q0 26068305 234 58.83053 imi_mug_run_2_treatment "combinations" "investigational agents"
7 Q0 18520300 235 58.82506 imi_mug_run_2_treatment "gefitinib" "erlotinib" "xl647"
7 Q0 24737599 236 58.82035 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors" "level" "matrix"
7 Q0 23647298 237 58.786682 imi_mug_run_2_treatment "aim"
7 Q0 28710746 238 58.786167 imi_mug_run_2_treatment "osimertinib" "platinum"
7 Q0 21865399 239 58.767365 imi_mug_run_2_treatment "erlotinib" "egfr tyrosine kinase inhibitors"
7 Q0 27811988 240 58.750347 imi_mug_run_2_treatment "duration"
7 Q0 24777808 241 58.73859 imi_mug_run_2_treatment "gefitinib"
7 Q0 29715155 242 58.734642 imi_mug_run_2_treatment "aim" "afatinib"
7 Q0 30336693 243 58.73139 imi_mug_run_2_treatment "afatinib" "osimertinib" "aim"
7 Q0 17510392 244 58.71011 imi_mug_run_2_treatment "basis"
7 Q0 20805561 245 58.706596 imi_mug_run_2_treatment "various" "drug"
7 Q0 28352759 246 58.697105 imi_mug_run_2_treatment "tace" "azd9291"
7 Q0 25302162 247 58.673195 imi_mug_run_2_treatment "gefitinib" "erlotinib" "crizotinib"
7 Q0 25682017 248 58.657417 imi_mug_run_2_treatment "level"
7 Q0 25973173 249 58.6178 imi_mug_run_2_treatment "gefitinib" "egfr inhibitor" "egfr tyrosine kinase inhibitor"
7 Q0 29151359 250 58.421993 imi_mug_run_2_treatment "osimertinib" "gefitinib" "erlotinib"
7 Q0 25760241 251 58.42125 imi_mug_run_2_treatment "cetuximab" "drug" "erlotinib"
7 Q0 29789021 252 58.40475 imi_mug_run_2_treatment "kinase inhibitor" "plasma"
7 Q0 25831463 253 58.3575 imi_mug_run_2_treatment "drug"
7 Q0 27784815 254 58.357048 imi_mug_run_2_treatment "osimertinib" "gefitinib" "erlotinib"
7 Q0 27528220 255 58.341606 imi_mug_run_2_treatment "drug" "egfr tyrosine kinase inhibitors"
7 Q0 27835594 256 58.271168 imi_mug_run_2_treatment "navitoclax" "drug" "azd9291"
7 Q0 29448920 257 58.17046 imi_mug_run_2_treatment "erlotinib" "mediated"
7 Q0 27486808 258 58.153576 imi_mug_run_2_treatment "osimertinib" "azd9291" "tagrisso"
7 Q0 21314611 259 58.151817 imi_mug_run_2_treatment "antiestrogens" "antiestrogen" "estrogen"
7 Q0 30156405 260 58.149155 imi_mug_run_2_treatment "plasma"
7 Q0 29848714 261 58.125946 imi_mug_run_2_treatment "aim"
7 Q0 22366308 262 58.087112 imi_mug_run_2_treatment "cl-387,785" "drug" "kinase inhibitor"
7 Q0 27660463 263 58.075687 imi_mug_run_2_treatment "gefitinib" "erlotinib" "afatinib"
7 Q0 24351833 264 58.059937 imi_mug_run_2_treatment "tyrosine kinase inhibitor"
7 Q0 25199820 265 58.040222 imi_mug_run_2_treatment "gefitinib" "chemotherapeutic agent" "melatonin"
7 Q0 27330954 266 58.01851 imi_mug_run_2_treatment "immunotherapeutic agent" "rrx-001" "carboplatin"
7 Q0 30171258 267 58.003937 imi_mug_run_2_treatment "osimertinib" "erlotinib" "mediated"
7 Q0 26775573 268 57.991962 imi_mug_run_2_treatment "crizotinib" "program" "gefitinib"
7 Q0 24857124 269 57.984512 imi_mug_run_2_treatment "crizotinib" "gefitinib" "erlotinib"
7 Q0 27381270 270 57.950058 imi_mug_run_2_treatment "epidermal growth factor"
7 Q0 17845978 271 57.93262 imi_mug_run_2_treatment "gemcitabine" "adjuvant" "vinorelbine"
7 Q0 29618075 272 57.931618 imi_mug_run_2_treatment "osimertinib"
7 Q0 27287717 273 57.926407 imi_mug_run_2_treatment "amlexanox" "mek inhibitor azd6244"
7 Q0 26973209 274 57.916157 imi_mug_run_2_treatment "various" "plasma" "mediated"
7 Q0 24957682 275 57.80526 imi_mug_run_2_treatment "gefitinib" "akt inhibitor azd5363" "azd5363"
7 Q0 20530710 276 57.76662 imi_mug_run_2_treatment "bibw2992" "gefitinib" "drugs"
7 Q0 27409677 277 57.761208 imi_mug_run_2_treatment "gefitinib"
7 Q0 30485437 278 57.753067 imi_mug_run_2_treatment "gefitinib" "erlotinib" "afatinib"
7 Q0 27131639 279 57.70881 imi_mug_run_2_treatment "drug" "pyrimidine derivatives" "wz4002"
7 Q0 27770511 280 57.695015 imi_mug_run_2_treatment "lead"
7 Q0 28745320 281 57.66791 imi_mug_run_2_treatment "level" "glycans" "tyrosine kinase inhibitor"
7 Q0 25855240 282 57.633472 imi_mug_run_2_treatment "afatinib" "therapeutics" "gefitinib"
7 Q0 18081540 283 57.631527 imi_mug_run_2_treatment "cetuximab"
7 Q0 28787267 284 57.61428 imi_mug_run_2_treatment "drugs" "fluorophore" "tyrosine kinase inhibitor"
7 Q0 15728811 285 57.576183 imi_mug_run_2_treatment "gefitinib"
7 Q0 18506667 286 57.531036 imi_mug_run_2_treatment "erlotinib" "bevacizumab" "sunitinib"
7 Q0 19227598 287 57.492043 imi_mug_run_2_treatment "egfr inhibitor"
7 Q0 9042264 288 57.458 imi_mug_run_2_treatment "oxygen"
7 Q0 20026433 289 57.4573 imi_mug_run_2_treatment "gefitinib" "erlotinib" "drugs"
7 Q0 25382705 290 57.453007 imi_mug_run_2_treatment "various" "saha" "bibw2992"
7 Q0 19531624 291 57.445053 imi_mug_run_2_treatment "gefitinib"
7 Q0 30237564 292 57.428886 imi_mug_run_2_treatment "gefitinib" "arsenic" "arsenic trioxide"
7 Q0 12202783 293 57.42 imi_mug_run_2_treatment "iressa" "cisplatin" "zd1839"
7 Q0 23911281 294 57.405464 imi_mug_run_2_treatment "gefitinib" "erlotinib" "egfr tyrosine kinase inhibitors"
7 Q0 19188161 295 57.233437 imi_mug_run_2_treatment "s-1" "fluorouracil" "gefitinib"
7 Q0 30032836 296 57.228855 imi_mug_run_2_treatment "tyrosine kinase inhibitor"
7 Q0 26451770 297 57.222946 imi_mug_run_2_treatment "gefitinib" "mediated"
7 Q0 15902597 298 57.202225 imi_mug_run_2_treatment "gefitinib" "iressa"
7 Q0 28641700 299 57.174446 imi_mug_run_2_treatment "drugs" "epidermal growth factor receptor tyrosine kinase inhibitor" "revolution"
7 Q0 28061471 300 57.111362 imi_mug_run_2_treatment "azd9291" "erlotinib"
7 Q0 21965761 301 57.10016 imi_mug_run_2_treatment "erlotinib" "gemcitabine" "carboplatin"
7 Q0 21899495 302 57.099327 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitor"
7 Q0 28219202 303 57.09237 imi_mug_run_2_treatment "drugs" "gefitinib" "erlotinib"
7 Q0 24662454 304 57.060547 imi_mug_run_2_treatment "cetuximab" "cisplatin" "vinorelbine"
7 Q0 25349236 305 57.03355 imi_mug_run_2_treatment "afatinib" "drugs" "gefitinib"
7 Q0 22223435 306 57.019615 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
7 Q0 21463141 307 57.01725 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
7 Q0 20008840 308 57.01522 imi_mug_run_2_treatment "cl-387,785" "mediated" "gefitinib"
7 Q0 17973572 309 57.00991 imi_mug_run_2_treatment "gefitinib" "cl-387,785" "erlotinib"
7 Q0 27145431 310 57.00781 imi_mug_run_2_treatment "liver"
7 Q0 26933421 311 56.98355 imi_mug_run_2_treatment "rrx-001" "platinum" "immunotherapeutic agent"
7 Q0 23837762 312 56.93919 imi_mug_run_2_treatment "drugs" "egfr tyrosine kinase inhibitors" "monoclonal antibodies"
7 Q0 12375797 313 56.91131 imi_mug_run_2_treatment "combinations" "gemcitabine" "vinorelbine"
7 Q0 26718140 314 56.87059 imi_mug_run_2_treatment "erlotinib" "gefitinib"
7 Q0 28217439 315 56.86473 imi_mug_run_2_treatment "drugs" "erlotinib" "lead"
7 Q0 23300028 316 56.860886 imi_mug_run_2_treatment "cetuximab" "monoclonal antibodies" "panitumumab"
7 Q0 29766737 317 56.82184 imi_mug_run_2_treatment "drug" "aim"
7 Q0 29505901 318 56.807465 imi_mug_run_2_treatment "plasma" "osimertinib"
7 Q0 27753039 319 56.708298 imi_mug_run_2_treatment "plasma" "egfr tyrosine kinase inhibitors"
7 Q0 26325669 320 56.68109 imi_mug_run_2_treatment "ras" "erlotinib" "dasatinib"
7 Q0 29899852 321 56.67744 imi_mug_run_2_treatment "erlotinib" "egfr tyrosine kinase inhibitors"
7 Q0 25323938 322 56.674957 imi_mug_run_2_treatment "mk-2206" "mediated" "erlotinib"
7 Q0 25936890 323 56.642887 imi_mug_run_2_treatment "drugs" "afatinib" "gefitinib"
7 Q0 30027579 324 56.63703 imi_mug_run_2_treatment "bevacizumab" "carboplatin" "pemetrexed"
7 Q0 16563096 325 56.622807 imi_mug_run_2_treatment "drugs" "cisplatin" "fluorouracil"
7 Q0 29099567 326 56.61533 imi_mug_run_2_treatment "erlotinib"
7 Q0 27226511 327 56.606792 imi_mug_run_2_treatment "combinations" "drugs" "gefitinib"
7 Q0 27866520 328 56.606007 imi_mug_run_2_treatment "plasma"
7 Q0 27755839 329 56.591824 imi_mug_run_2_treatment "drug" "mediated" "iressa"
7 Q0 21575523 330 56.55416 imi_mug_run_2_treatment "level" "duration"
7 Q0 30145586 331 56.48304 imi_mug_run_2_treatment "gefitinib" "tyrosine kinase inhibitor"
7 Q0 27433281 332 56.45689 imi_mug_run_2_treatment "tyrosine"
7 Q0 18408761 333 56.456764 imi_mug_run_2_treatment "bibw2992" "erlotinib"
7 Q0 28961841 334 56.452065 imi_mug_run_2_treatment "various" "osimertinib" "afatinib"
7 Q0 30512189 335 56.43054 imi_mug_run_2_treatment "osimertinib" "pooled" "azd9291"
7 Q0 27281561 336 56.426144 imi_mug_run_2_treatment "erlotinib" "plasma"
7 Q0 19351834 337 56.415382 imi_mug_run_2_treatment "erlotinib" "egfr inhibitor"
7 Q0 26446944 338 56.296303 imi_mug_run_2_treatment "stand-up"
7 Q0 26862733 339 56.28625 imi_mug_run_2_treatment "various" "afatinib" "egfr tyrosine kinase inhibitor"
7 Q0 18020911 340 56.275753 imi_mug_run_2_treatment "various" "gefitinib" "erlotinib"
7 Q0 29157085 341 56.22111 imi_mug_run_2_treatment "afatinib"
7 Q0 15605116 342 56.211845 imi_mug_run_2_treatment "drug" "platinum" "gefitinib"
7 Q0 30098066 343 56.20069 imi_mug_run_2_treatment "kinase inhibitor" "trametinib" "taselisib"
7 Q0 20630828 344 56.188564 imi_mug_run_2_treatment "cetuximab" "gefitinib"
7 Q0 24223798 345 56.175915 imi_mug_run_2_treatment "methionine" "gefitinib" "erlotinib"
7 Q0 19680293 346 56.156662 imi_mug_run_2_treatment "various" "gefitinib" "erlotinib"
7 Q0 21109448 347 56.122074 imi_mug_run_2_treatment "cetuximab" "monoclonal antibodies" "carboplatin"
7 Q0 27978873 348 56.084095 imi_mug_run_2_treatment "gefitinib" "level"
7 Q0 15452456 349 56.07153 imi_mug_run_2_treatment "ras" "others"
7 Q0 27595749 350 56.042118 imi_mug_run_2_treatment "nivolumab" "cisplatin" "pemetrexed"
7 Q0 30115389 351 56.022182 imi_mug_run_2_treatment "osimertinib"
7 Q0 25539612 352 56.0217 imi_mug_run_2_treatment "level"
7 Q0 25846096 353 56.020245 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
7 Q0 28426996 354 55.971104 imi_mug_run_2_treatment "azd9291"
7 Q0 29269665 355 55.96915 imi_mug_run_2_treatment "osimertinib"
7 Q0 27748834 356 55.9126 imi_mug_run_2_treatment "trametinib" "pd0325901" "mek inhibitor"
7 Q0 23128522 357 55.901344 imi_mug_run_2_treatment "norcantharidin" "chemotherapeutic agent" "cisplatin"
7 Q0 20942631 358 55.890995 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors" "iressa" "gefitinib"
7 Q0 16628257 359 55.871952 imi_mug_run_2_treatment "erlotinib" "tyrosine kinase inhibitor" "monoclonal antibodies"
7 Q0 23864840 360 55.855644 imi_mug_run_2_treatment "various" "igf-1" "egfr tyrosine kinase inhibitors"
7 Q0 23988622 361 55.843216 imi_mug_run_2_treatment "drugs" "plasma"
7 Q0 30192383 362 55.828636 imi_mug_run_2_treatment "bevacizumab" "afatinib" "abc"
7 Q0 28794368 363 55.811058 imi_mug_run_2_treatment "osimertinib" "erlotinib"
7 Q0 17020982 364 55.780586 imi_mug_run_2_treatment "gefitinib" "drug" "duration"
7 Q0 27573423 365 55.719227 imi_mug_run_2_treatment "egfr inhibitor" "pyrrolopyrimidine" "rociletinib"
7 Q0 21513367 366 55.69669 imi_mug_run_2_treatment "erlotinib" "platinum" "erlotinib 150 mg"
7 Q0 29915896 367 55.692898 imi_mug_run_2_treatment "osimertinib" "drug combinations" "egfr tyrosine kinase inhibitors"
7 Q0 29336166 368 55.69258 imi_mug_run_2_treatment "gefitinib" "erlotinib" "osimertinib"
7 Q0 18185470 369 55.691826 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors" "gefitinib" "erlotinib"
7 Q0 28838401 370 55.68821 imi_mug_run_2_treatment "nivolumab"
7 Q0 22263075 371 55.67487 imi_mug_run_2_treatment "bevacizumab" "gefitinib" "erlotinib"
7 Q0 23294134 372 55.670624 imi_mug_run_2_treatment "dacomitinib" "drugs" "tyrosine"
7 Q0 25057940 373 55.665768 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
7 Q0 25704901 374 55.65929 imi_mug_run_2_treatment "basis"
7 Q0 24033722 375 55.65899 imi_mug_run_2_treatment "gefitinib" "drug" "drugs"
7 Q0 26515464 376 55.652897 imi_mug_run_2_treatment "osimertinib" "egfr tyrosine kinase inhibitors" "afatinib"
7 Q0 18347147 377 55.643562 imi_mug_run_2_treatment "lapatinib" "cetuximab" "gefitinib"
7 Q0 22087216 378 55.6417 imi_mug_run_2_treatment "mediated" "cytotoxic" "therapeutics"
7 Q0 21666560 379 55.633747 imi_mug_run_2_treatment "vaccines" "tor"
7 Q0 29416630 380 55.63063 imi_mug_run_2_treatment "plasma" "aim"
7 Q0 24268810 381 55.622826 imi_mug_run_2_treatment "gefitinib" "fulvestrant" "mitogen"
7 Q0 21757251 382 55.587948 imi_mug_run_2_treatment "gefitinib"
7 Q0 26567882 383 55.580566 imi_mug_run_2_treatment "various" "monoclonal antibodies" "drugs"
7 Q0 23407556 384 55.541996 imi_mug_run_2_treatment "erlotinib"
7 Q0 30232957 385 55.54023 imi_mug_run_2_treatment "nsaid" "nsaids" "drug"
7 Q0 28408243 386 55.529877 imi_mug_run_2_treatment "bevacizumab" "erlotinib" "tyrosine kinase inhibitor"
7 Q0 27873136 387 55.525517 imi_mug_run_2_treatment "afatinib" "cisplatin" "tyrosine"
7 Q0 26227959 388 55.52372 imi_mug_run_2_treatment "therapeutics" "plasma"
7 Q0 22725255 389 55.517063 imi_mug_run_2_treatment "sorafenib" "anti-vegf" "bevacizumab"
7 Q0 24357744 390 55.516518 imi_mug_run_2_treatment "drug" "erlotinib" "egfr tyrosine kinase inhibitor"
7 Q0 30150444 391 55.513954 imi_mug_run_2_treatment "aim"
7 Q0 25572790 392 55.512203 imi_mug_run_2_treatment "erlotinib" "monoclonal antibodies"
7 Q0 25695284 393 55.503426 imi_mug_run_2_treatment "gefitinib" "erlotinib" "cisplatin"
7 Q0 25405807 394 55.49268 imi_mug_run_2_treatment "plasma"
7 Q0 21905963 395 55.490967 imi_mug_run_2_treatment "gefitinib" "platinum" "egfr tyrosine kinase inhibitor"
7 Q0 26400330 396 55.486595 imi_mug_run_2_treatment "aim"
7 Q0 22349823 397 55.48419 imi_mug_run_2_treatment "gefitinib" "drug" "basis"
7 Q0 29462255 398 55.464005 imi_mug_run_2_treatment "osimertinib"
7 Q0 3038157 399 55.454845 imi_mug_run_2_treatment "epidermal growth factor"
7 Q0 27980215 400 55.44082 imi_mug_run_2_treatment "plasma"
7 Q0 19028612 401 55.406437 imi_mug_run_2_treatment "adjuvant" "cytostatic" "drugs"
7 Q0 15913841 402 55.355537 imi_mug_run_2_treatment "gefitinib" "epidermal growth factor receptor tyrosine kinase inhibitor"
7 Q0 24828666 403 55.346115 imi_mug_run_2_treatment "egfr inhibitor" "aim"
7 Q0 30404555 404 55.339928 imi_mug_run_2_treatment "duration" "level"
7 Q0 27652204 405 55.337112 imi_mug_run_2_treatment "drugs" "eosin" "suppressor"
7 Q0 25995428 406 55.314873 imi_mug_run_2_treatment "agent"
7 Q0 21167447 407 55.306442 imi_mug_run_2_treatment "cetuximab" "gefitinib" "erlotinib"
7 Q0 28373750 408 55.30615 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
7 Q0 16554105 409 55.276066 imi_mug_run_2_treatment "gefitinib" "tyrosine kinase inhibitor"
7 Q0 15217966 410 55.27465 imi_mug_run_2_treatment "cetuximab" "docetaxel" "c225"
7 Q0 17699786 411 55.261215 imi_mug_run_2_treatment "gefitinib" "tyrosine kinase inhibitor" "balance"
7 Q0 27641462 412 55.240097 imi_mug_run_2_treatment "osimertinib" "tagrisso" "gefitinib"
7 Q0 25211582 413 55.2327 imi_mug_run_2_treatment "gefitinib" "erlotinib" "egfr tyrosine kinase inhibitors"
7 Q0 28399187 414 55.22023 imi_mug_run_2_treatment "erlotinib" "chelerythrine" "chelerythrine chloride"
7 Q0 29862229 415 55.206703 imi_mug_run_2_treatment "osimertinib" "platinum" "egfr tyrosine kinase inhibitors"
7 Q0 16769595 416 55.186317 imi_mug_run_2_treatment "gefitinib" "erlotinib" "egfr inhibitor"
7 Q0 29989451 417 55.146328 imi_mug_run_2_treatment "aim"
7 Q0 14610920 418 55.14081 imi_mug_run_2_treatment "drugs" "vaccines" "inhibitors, cyclooxygenase"
7 Q0 21644362 419 55.106865 imi_mug_run_2_treatment "gefitinib" "erlotinib"
7 Q0 29528255 420 55.084274 imi_mug_run_2_treatment "gefitinib" "aim"
7 Q0 20477469 421 55.082558 imi_mug_run_2_treatment "gefitinib"
7 Q0 24606853 422 55.06481 imi_mug_run_2_treatment "gefitinib"
7 Q0 28116908 423 55.035477 imi_mug_run_2_treatment "osimertinib" "egfr tyrosine kinase inhibitors" "plasma"
7 Q0 18712184 424 55.032906 imi_mug_run_2_treatment "cetuximab" "gefitinib" "erlotinib"
7 Q0 19318309 425 55.019096 imi_mug_run_2_treatment "combinations"
7 Q0 25296354 426 55.018692 imi_mug_run_2_treatment "gefitinib" "erlotinib" "egfr tyrosine kinase inhibitors"
7 Q0 21995722 427 55.01058 imi_mug_run_2_treatment "combinations" "therapeutics" "erlotinib"
7 Q0 30014952 428 54.999245 imi_mug_run_2_treatment "afatinib" "program" "gefitinib"
7 Q0 16316305 429 54.997044 imi_mug_run_2_treatment "various" "epidermal growth factor" "antiangiogenic agent"
7 Q0 25028470 430 54.997032 imi_mug_run_2_treatment "erlotinib" "quinacrine" "drug combination"
7 Q0 17874972 431 54.99269 imi_mug_run_2_treatment "bevacizumab" "erlotinib" "drugs"
7 Q0 25120654 432 54.976524 imi_mug_run_2_treatment "gefitinib"
7 Q0 25797462 433 54.96141 imi_mug_run_2_treatment "human immunoglobulin g" "cisplatin" "gemcitabine"
7 Q0 20573926 434 54.9088 imi_mug_run_2_treatment "gefitinib" "carboplatin" "paclitaxel"
7 Q0 21796416 435 54.90253 imi_mug_run_2_treatment "docetaxel" "various" "sunitinib"
7 Q0 27354477 436 54.898186 imi_mug_run_2_treatment "osimertinib" "plasma" "mediated"
7 Q0 24222153 437 54.87506 imi_mug_run_2_treatment "erlotinib" "gefitinib"
7 Q0 25441176 438 54.871708 imi_mug_run_2_treatment "mediated" "ty21a"
7 Q0 16705311 439 54.844982 imi_mug_run_2_treatment "level"
7 Q0 16906227 440 54.831528 imi_mug_run_2_treatment "gefitinib" "erlotinib"
7 Q0 29914238 441 54.828846 imi_mug_run_2_treatment "gefitinib" "erlotinib" "egfr tyrosine kinase inhibitor"
7 Q0 28838393 442 54.810173 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
7 Q0 29793222 443 54.80886 imi_mug_run_2_treatment "gefitinib" "iressa"
7 Q0 21866438 444 54.801476 imi_mug_run_2_treatment "lead" "egfr tyrosine kinase inhibitors"
7 Q0 26744526 445 54.793755 imi_mug_run_2_treatment "various" "erlotinib" "alw-ii-41-27"
7 Q0 30290647 446 54.773502 imi_mug_run_2_treatment "afatinib" "medicine" "gefitinib"
7 Q0 25564053 447 54.747448 imi_mug_run_2_treatment "cetuximab" "drugs" "aim"
7 Q0 16806963 448 54.745003 imi_mug_run_2_treatment "cetuximab" "platinum"
7 Q0 15952926 449 54.743595 imi_mug_run_2_treatment "gefitinib" "combinations" "drug"
7 Q0 26015938 450 54.74077 imi_mug_run_2_treatment "drugs" "gefitinib" "erlotinib"
7 Q0 28367058 451 54.72738 imi_mug_run_2_treatment "osimertinib" "egfr tyrosine kinase inhibitors" "duration"
7 Q0 29738778 452 54.721855 imi_mug_run_2_treatment "shikonin" "gefitinib" "cck-8"
7 Q0 29963252 453 54.716454 imi_mug_run_2_treatment "plasma" "osimertinib" "egfr tyrosine kinase inhibitor"
7 Q0 27801981 454 54.683838 imi_mug_run_2_treatment "gefitinib" "platinum"
7 Q0 26152224 455 54.676773 imi_mug_run_2_treatment "egfr inhibitor"
7 Q0 26392110 456 54.675697 imi_mug_run_2_treatment "various" "gefitinib"
7 Q0 20570926 457 54.655464 imi_mug_run_2_treatment "various" "gefitinib"
7 Q0 22409867 458 54.63572 imi_mug_run_2_treatment "anti-vegf monoclonal antibody" "bevacizumab" "gefitinib"
7 Q0 28060728 459 54.623043 imi_mug_run_2_treatment "aim"
7 Q0 20118985 460 54.612392 imi_mug_run_2_treatment "pf00299804" "gefitinib" "erlotinib"
7 Q0 29751135 461 54.60742 imi_mug_run_2_treatment "plasma"
7 Q0 25981922 462 54.60254 imi_mug_run_2_treatment "gefitinib" "medicine" "animals"
7 Q0 27402797 463 54.59263 imi_mug_run_2_treatment "adjuvant"
7 Q0 25482516 464 54.591995 imi_mug_run_2_treatment "gefitinib"
7 Q0 28974338 465 54.561005 imi_mug_run_2_treatment "f3t" "cytotoxic" "wz4002"
7 Q0 21764376 466 54.560764 imi_mug_run_2_treatment "gefitinib" "erlotinib" "egfr tyrosine kinase inhibitors"
7 Q0 17618013 467 54.55478 imi_mug_run_2_treatment "erlotinib" "gefitinib" "cisplatin"
7 Q0 28497422 468 54.55079 imi_mug_run_2_treatment "various" "plasma" "aim"
7 Q0 23588221 469 54.542267 imi_mug_run_2_treatment "gefitinib" "drug" "mediated"
7 Q0 28676213 470 54.53827 imi_mug_run_2_treatment "drug trials" "plasma"
7 Q0 29071523 471 54.512924 imi_mug_run_2_treatment "osimertinib" "epidermal growth factor" "therapeutics"
7 Q0 17726540 472 54.512226 imi_mug_run_2_treatment "drug" "kinase inhibitor" "animals"
7 Q0 20388064 473 54.507378 imi_mug_run_2_treatment "gefitinib" "erlotinib" "drugs"
7 Q0 28565936 474 54.491673 imi_mug_run_2_treatment "osimertinib" "platinum" "tyrosine kinase inhibitor"
7 Q0 28979142 475 54.483395 imi_mug_run_2_treatment "drug" "erlotinib" "epidermal growth factor"
7 Q0 27840244 476 54.479633 imi_mug_run_2_treatment "egfr inhibitor" "co-1686" "azd9291"
7 Q0 19349489 477 54.477287 imi_mug_run_2_treatment "ras" "gefitinib" "erlotinib"
7 Q0 23226726 478 54.457924 imi_mug_run_2_treatment "various" "egfr tyrosine kinase inhibitors"
7 Q0 19102716 479 54.451958 imi_mug_run_2_treatment "cetuximab" "gefitinib" "erlotinib"
7 Q0 21767894 480 54.447605 imi_mug_run_2_treatment "gefitinib" "erlotinib" "egfr tyrosine kinase inhibitor"
7 Q0 18520299 481 54.44146 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
7 Q0 26446154 482 54.399162 imi_mug_run_2_treatment "gefitinib" "erlotinib" "medications"
7 Q0 26749488 483 54.386932 imi_mug_run_2_treatment "hm61713" "kinase inhibitor" "azd9291"
7 Q0 21819274 484 54.38244 imi_mug_run_2_treatment "vandetanib" "therapeutic agent"
7 Q0 26961971 485 54.36171 imi_mug_run_2_treatment "platinum" "agent" "egfr tyrosine kinase inhibitors"
7 Q0 15952927 486 54.35707 imi_mug_run_2_treatment "erlotinib" "drug" "tarceva"
7 Q0 22016476 487 54.356342 imi_mug_run_2_treatment "her-2" "drugs" "gefitinib"
7 Q0 25862853 488 54.333893 imi_mug_run_2_treatment "afatinib" "drug"
7 Q0 21126404 489 54.333565 imi_mug_run_2_treatment "aim"
7 Q0 28786010 490 54.328205 imi_mug_run_2_treatment "duration" "beam" "egfr tyrosine kinase inhibitor"
7 Q0 27826531 491 54.31843 imi_mug_run_2_treatment "plasma"
7 Q0 26936397 492 54.318245 imi_mug_run_2_treatment "erlotinib" "nsc305787"
7 Q0 28104619 493 54.305847 imi_mug_run_2_treatment "osimertinib" "egfr tyrosine kinase inhibitors"
7 Q0 14656386 494 54.288773 imi_mug_run_2_treatment "zd1839" "iressa" "mediated"
7 Q0 28596108 495 54.27335 imi_mug_run_2_treatment "gefitinib" "erlotinib" "egfr tyrosine kinase inhibitors"
7 Q0 26885207 496 54.2675 imi_mug_run_2_treatment "gefitinib" "gefitinib 250 mg" "aim"
7 Q0 25399972 497 54.239277 imi_mug_run_2_treatment "level"
7 Q0 27821794 498 54.22925 imi_mug_run_2_treatment "osimertinib" "kinase inhibitor" "drugs"
7 Q0 16011858 499 54.21632 imi_mug_run_2_treatment "gefitinib" "egfr tyrosine kinase inhibitors"
7 Q0 19366827 500 54.198853 imi_mug_run_2_treatment "monoclonal antibodies"
7 Q0 22119437 501 54.189705 imi_mug_run_2_treatment "mediated" "gefitinib" "erlotinib"
7 Q0 15118073 502 54.170334 imi_mug_run_2_treatment "tyrosine kinase inhibitor" "gefitinib" "lead"
7 Q0 24510990 503 54.15106 imi_mug_run_2_treatment "aim"
7 Q0 22446631 504 54.123993 imi_mug_run_2_treatment "various" "gefitinib" "epidermal growth factor receptor tyrosine kinase inhibitor"
7 Q0 25027951 505 54.117775 imi_mug_run_2_treatment "dacomitinib" "afatinib" "drug combination"
7 Q0 27597244 506 54.114006 imi_mug_run_2_treatment "various" "proteasome inhibitor" "phenolic"
7 Q0 22433462 507 54.10005 imi_mug_run_2_treatment "erlotinib" "drugs" "therapeutics"
7 Q0 20426712 508 54.086063 imi_mug_run_2_treatment "gefitinib" "carboplatin" "paclitaxel"
7 Q0 26345914 509 54.074436 imi_mug_run_2_treatment "egfr inhibitor" "gefitinib" "agent"
7 Q0 27336608 510 54.067436 imi_mug_run_2_treatment "various" "ras" "cytotoxic"
7 Q0 21277552 511 54.061016 imi_mug_run_2_treatment "lead"
7 Q0 27739449 512 54.042133 imi_mug_run_2_treatment "docosahexaenoic acid"
7 Q0 29874151 513 54.039276 imi_mug_run_2_treatment "drug" "ptx" "azd9291"
7 Q0 25962919 514 54.03552 imi_mug_run_2_treatment "various" "cetuximab" "erlotinib"
7 Q0 20701554 515 54.02696 imi_mug_run_2_treatment "pemetrexed" "bevacizumab" "gefitinib"
7 Q0 20040275 516 53.99695 imi_mug_run_2_treatment "medicine" "gefitinib" "carboplatin"
7 Q0 24565582 517 53.962746 imi_mug_run_2_treatment "pemetrexed" "erlotinib" "platinum"
7 Q0 29936901 518 53.961613 imi_mug_run_2_treatment "therapeutic vaccine" "cancer vaccine" "cancer vaccines"
7 Q0 24675568 519 53.95904 imi_mug_run_2_treatment "mediated" "egfr tyrosine kinase inhibitor" "il-6"
7 Q0 25956936 520 53.95836 imi_mug_run_2_treatment "shape" "ras"
7 Q0 28378229 521 53.932686 imi_mug_run_2_treatment "anti-tumor agents" "therapeutics" "blockade"
7 Q0 29532998 522 53.90376 imi_mug_run_2_treatment "egfr inhibitor" "gefitinib"
7 Q0 25302015 523 53.860886 imi_mug_run_2_treatment "chemotherapy agents"
7 Q0 26396685 524 53.84855 imi_mug_run_2_treatment "gefitinib" "erlotinib"
7 Q0 28219203 525 53.843773 imi_mug_run_2_treatment "gefitinib" "afatinib" "azd9291"
7 Q0 29785875 526 53.843773 imi_mug_run_2_treatment "drugs"
7 Q0 29234489 527 53.83326 imi_mug_run_2_treatment "verrucarin j" "platinum"
7 Q0 25512530 528 53.81608 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors" "basis"
7 Q0 28565760 529 53.81031 imi_mug_run_2_treatment "drug" "gefitinib" "basis"
7 Q0 21953013 530 53.802826 imi_mug_run_2_treatment "mediated" "ras" "egfr tyrosine kinase inhibitors"
7 Q0 25912735 531 53.7731 imi_mug_run_2_treatment "various" "egfr tyrosine kinase inhibitor" "level"
7 Q0 22011666 532 53.773064 imi_mug_run_2_treatment "gefitinib" "erlotinib" "xl647"
7 Q0 29697876 533 53.760303 imi_mug_run_2_treatment "osimertinib" "platinum" "drugs"
7 Q0 23805327 534 53.74445 imi_mug_run_2_treatment "gefitinib" "level" "plasma"
7 Q0 30425968 535 53.719116 imi_mug_run_2_treatment "plasma"
7 Q0 24349229 536 53.703064 imi_mug_run_2_treatment "mediated" "crizotinib"
7 Q0 23769318 537 53.69346 imi_mug_run_2_treatment "chloroquine" "erlotinib" "crystal violet"
7 Q0 22926905 538 53.672688 imi_mug_run_2_treatment "gefitinib" "drugs"
7 Q0 25486409 539 53.669456 imi_mug_run_2_treatment "mediated" "gefitinib" "erlotinib"
7 Q0 29332537 540 53.667175 imi_mug_run_2_treatment "azd9291" "radiation sensitizer" "gefitinib"
7 Q0 28965727 541 53.642284 imi_mug_run_2_treatment "drug" "directed" "azd9291"
7 Q0 26950292 542 53.63212 imi_mug_run_2_treatment "antiangiogenic" "bevacizumab" "monoclonal antibodies"
7 Q0 19804422 543 53.626797 imi_mug_run_2_treatment "pha-665752" "gefitinib" "erlotinib"
7 Q0 15068324 544 53.611008 imi_mug_run_2_treatment "her-2" "adjuvant"
7 Q0 19884861 545 53.610268 imi_mug_run_2_treatment "plasma" "docetaxel" "erlotinib"
7 Q0 28915692 546 53.60443 imi_mug_run_2_treatment "erlotinib"
7 Q0 27840973 547 53.60408 imi_mug_run_2_treatment "various" "drugs" "gefitinib"
7 Q0 25271963 548 53.601692 imi_mug_run_2_treatment "lead" "azd9291" "egfr inhibitor"
7 Q0 26184032 549 53.60047 imi_mug_run_2_treatment "drug" "gefitinib" "tyrosine kinase inhibitor"
7 Q0 29136465 550 53.587803 imi_mug_run_2_treatment "serine" "osimertinib"
7 Q0 17175059 551 53.55045 imi_mug_run_2_treatment "various" "interleukin-8" "mediated"
7 Q0 24102012 552 53.53767 imi_mug_run_2_treatment "cisplatin" "drug" "adjuvant"
7 Q0 17616683 553 53.51551 imi_mug_run_2_treatment "bms-690514" "erlotinib" "egfr tyrosine kinase inhibitors"
7 Q0 26829230 554 53.510124 imi_mug_run_2_treatment "adjuvant" "duration"
7 Q0 25511613 555 53.509865 imi_mug_run_2_treatment "new drugs"
7 Q0 21428885 556 53.47628 imi_mug_run_2_treatment "her-2"
7 Q0 26398757 557 53.462494 imi_mug_run_2_treatment "drugs" "gefitinib" "erlotinib"
7 Q0 28000387 558 53.454487 imi_mug_run_2_treatment "plasma"
7 Q0 23816963 559 53.445568 imi_mug_run_2_treatment "gefitinib" "erlotinib" "afatinib"
7 Q0 25607753 560 53.43922 imi_mug_run_2_treatment "various" "gefitinib" "radiosensitizers"
7 Q0 27251290 561 53.429634 imi_mug_run_2_treatment "drug" "cetuximab" "agent"
7 Q0 25489257 562 53.42714 imi_mug_run_2_treatment "mediated" "lead"
7 Q0 28968167 563 53.41934 imi_mug_run_2_treatment "gefitinib" "cisplatin" "plasma"
7 Q0 25908039 564 53.408905 imi_mug_run_2_treatment "cisplatin" "etoposide" "basis"
7 Q0 28794650 565 53.407288 imi_mug_run_2_treatment "osimertinib" "drugs" "mediated"
7 Q0 20704815 566 53.403046 imi_mug_run_2_treatment "cetuximab" "drug" "enzymes"
7 Q0 26893752 567 53.39972 imi_mug_run_2_treatment "drug" "drugs" "medicine"
7 Q0 20616912 568 53.384857 imi_mug_run_2_treatment "cetuximab"
7 Q0 28456628 569 53.375534 imi_mug_run_2_treatment "drug" "staurosporine" "co-1686"
7 Q0 18030354 570 53.35029 imi_mug_run_2_treatment "mediators" "egfr tyrosine kinase inhibitor" "basis"
7 Q0 19381026 571 53.33928 imi_mug_run_2_treatment "various" "medicine"
7 Q0 26379824 572 53.3351 imi_mug_run_2_treatment "drugs" "medication"
7 Q0 16115182 573 53.329086 imi_mug_run_2_treatment "drugs" "her-2" "gefitinib"
7 Q0 26302350 574 53.2917 imi_mug_run_2_treatment "epidermal growth factor receptor tyrosine kinase inhibitor"
7 Q0 26282169 575 53.291084 imi_mug_run_2_treatment "gefitinib" "erlotinib"
7 Q0 22075159 576 53.28755 imi_mug_run_2_treatment "erlotinib" "drug" "suppressor"
7 Q0 29951342 577 53.271263 imi_mug_run_2_treatment "crizotinib" "osimertinib" "pemetrexed"
7 Q0 25704957 578 53.23987 imi_mug_run_2_treatment "gefitinib" "erlotinib" "afatinib"
7 Q0 28271729 579 53.215305 imi_mug_run_2_treatment "erlotinib" "blockade" "gefitinib"
7 Q0 27659294 580 53.2127 imi_mug_run_2_treatment "erlotinib" "agent" "egfr tyrosine kinase inhibitors"
7 Q0 21132006 581 53.197746 imi_mug_run_2_treatment "drug" "erlotinib" "pf00299804"
7 Q0 28272214 582 53.194977 imi_mug_run_2_treatment "gefitinib"
7 Q0 27866095 583 53.18871 imi_mug_run_2_treatment "drug" "egfr tyrosine kinase inhibitors" "plasma"
7 Q0 21531810 584 53.179733 imi_mug_run_2_treatment "gefitinib" "erlotinib" "egfr tyrosine kinase inhibitors"
7 Q0 19038728 585 53.170963 imi_mug_run_2_treatment "cisplatin" "lead" "vascular endothelial growth factor"
7 Q0 27843300 586 53.17087 imi_mug_run_2_treatment "agent" "herbal medicine"
7 Q0 24307395 587 53.163662 imi_mug_run_2_treatment "kinase inhibitor" "basis"
7 Q0 29556275 588 53.157578 imi_mug_run_2_treatment "plasma"
7 Q0 26825170 589 53.15434 imi_mug_run_2_treatment "egf816" "egfr inhibitor" "inc280"
7 Q0 28285688 590 53.15434 imi_mug_run_2_treatment "plasma" "egfr tyrosine kinase inhibitors"
7 Q0 15226769 591 53.148254 imi_mug_run_2_treatment "her-2"
7 Q0 29296194 592 53.146103 imi_mug_run_2_treatment "tumor infiltrating lymphocytes"
7 Q0 24113009 593 53.1428 imi_mug_run_2_treatment "drug"
7 Q0 24113007 594 53.132812 imi_mug_run_2_treatment "drugs" "gefitinib" "erlotinib"
7 Q0 22281074 595 53.132675 imi_mug_run_2_treatment "various" "gefitinib" "erlotinib"
7 Q0 28871105 596 53.12056 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitor" "egfr inhibitor" "tyrosine kinase inhibitor"
7 Q0 19892771 597 53.105354 imi_mug_run_2_treatment "cetuximab" "gefitinib" "erlotinib"
7 Q0 29067441 598 53.09716 imi_mug_run_2_treatment "plasma" "tyrosine kinase inhibitor"
7 Q0 26968843 599 53.093636 imi_mug_run_2_treatment "drugs" "egfr tyrosine kinase inhibitors" "crizotinib"
7 Q0 25806269 600 53.07855 imi_mug_run_2_treatment "gefitinib" "erlotinib"
7 Q0 28210119 601 53.062866 imi_mug_run_2_treatment "nimotuzumab" "monoclonal antibodies" "egfr tyrosine kinase inhibitors"
7 Q0 27279498 602 53.052605 imi_mug_run_2_treatment "erlotinib" "drug"
7 Q0 23963360 603 53.036255 imi_mug_run_2_treatment "cetuximab" "erlotinib" "agent"
7 Q0 23979197 604 53.024292 imi_mug_run_2_treatment "scorpion"
7 Q0 30320506 605 53.015938 imi_mug_run_2_treatment "afatinib" "gefitinib" "aim"
7 Q0 27239236 606 53.007107 imi_mug_run_2_treatment "crizotinib" "egfr tyrosine kinase inhibitors" "aim"
7 Q0 30172273 607 53.006927 imi_mug_run_2_treatment "drugs" "medication"
7 Q0 30017980 608 52.996964 imi_mug_run_2_treatment "drugs" "gefitinib" "erlotinib"
7 Q0 23484645 609 52.96762 imi_mug_run_2_treatment "cetuximab" "vandetanib" "gefitinib"
7 Q0 21655159 610 52.965042 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors" "anti-neoplastic agents" "mediated"
7 Q0 26789630 611 52.948547 imi_mug_run_2_treatment "erlotinib" "level"
7 Q0 22005472 612 52.946533 imi_mug_run_2_treatment "erlotinib" "egfr inhibitor"
7 Q0 29242281 613 52.945866 imi_mug_run_2_treatment "plasma" "osimertinib" "platinum"
7 Q0 26629323 614 52.943108 imi_mug_run_2_treatment "drug" "kinase inhibitor" "aim"
7 Q0 19243280 615 52.94201 imi_mug_run_2_treatment "drug" "drugs" "epidermal growth factor"
7 Q0 20871269 616 52.93927 imi_mug_run_2_treatment "various" "gefitinib" "egfr tyrosine kinase inhibitors"
7 Q0 28287083 617 52.920387 imi_mug_run_2_treatment "brigatinib" "osimertinib" "mediated"
7 Q0 21849857 618 52.903095 imi_mug_run_2_treatment "medicine" "anti-vegf monoclonal antibody" "vascular endothelial growth factor"
7 Q0 30194172 619 52.89101 imi_mug_run_2_treatment "osimertinib" "aim"
7 Q0 28899783 620 52.89088 imi_mug_run_2_treatment "gefitinib" "egfr inhibitor" "mediated"
7 Q0 26676152 621 52.888096 imi_mug_run_2_treatment "mediated" "erlotinib" "cyclopamine"
7 Q0 24252457 622 52.869137 imi_mug_run_2_treatment "radiosensitizers"
7 Q0 27747151 623 52.86199 imi_mug_run_2_treatment "gefitinib" "crizotinib" "alectinib"
7 Q0 30092812 624 52.85867 imi_mug_run_2_treatment "favor" "aim"
7 Q0 29930751 625 52.849773 imi_mug_run_2_treatment "osimertinib" "egfr tyrosine kinase inhibitors"
7 Q0 25676406 626 52.825226 imi_mug_run_2_treatment "drugs" "epidermal growth factor" "bevacizumab"
7 Q0 17409862 627 52.81646 imi_mug_run_2_treatment "air"
7 Q0 30454543 628 52.81646 imi_mug_run_2_treatment "aim" "plasma"
7 Q0 22550402 629 52.808746 imi_mug_run_2_treatment "erlotinib" "agent" "erlotinib's"
7 Q0 18487906 630 52.792133 imi_mug_run_2_treatment "bevacizumab" "gefitinib" "erlotinib"
7 Q0 17521215 631 52.782284 imi_mug_run_2_treatment "erlotinib" "gefitinib"
7 Q0 29907952 632 52.774853 imi_mug_run_2_treatment "osimertinib" "gefitinib" "erlotinib"
7 Q0 29245913 633 52.733665 imi_mug_run_2_treatment "various" "drug" "egfr tyrosine kinase inhibitors"
7 Q0 16857814 634 52.725636 imi_mug_run_2_treatment "trastuzumab" "egfr tyrosine kinase inhibitor"
7 Q0 22928112 635 52.72085 imi_mug_run_2_treatment "ras"
7 Q0 27241841 636 52.693848 imi_mug_run_2_treatment "suppressor"
7 Q0 23909081 637 52.692577 imi_mug_run_2_treatment "plasma" "insulin" "level"
7 Q0 26867973 638 52.68901 imi_mug_run_2_treatment "plasma"
7 Q0 24065731 639 52.685562 imi_mug_run_2_treatment "co-1686" "drug" "kinase inhibitor"
7 Q0 24161785 640 52.683895 imi_mug_run_2_treatment "ps-101"
7 Q0 27664271 641 52.68243 imi_mug_run_2_treatment "kinase inhibitor" "gefitinib" "erlotinib"
7 Q0 17913857 642 52.680782 imi_mug_run_2_treatment "cetuximab" "kinase inhibitor" "gefitinib"
7 Q0 24354593 643 52.656494 imi_mug_run_2_treatment "protein kinase inhibitors" "crizotinib" "dacomitinib"
7 Q0 30378264 644 52.655224 imi_mug_run_2_treatment "mediated" "egfr tyrosine kinase inhibitor"
7 Q0 28853575 645 52.64602 imi_mug_run_2_treatment "drug" "prompt"
7 Q0 29713183 646 52.642887 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
7 Q0 22003224 647 52.63748 imi_mug_run_2_treatment "morphine" "ors" "epidermal growth factor"
7 Q0 25806267 648 52.62283 imi_mug_run_2_treatment "medicine" "egfr tyrosine kinase inhibitor" "egfr tyrosine kinase inhibitors"
7 Q0 17760255 649 52.615997 imi_mug_run_2_treatment "iressa"
7 Q0 24738693 650 52.61114 imi_mug_run_2_treatment "gefitinib" "mediated" "her-2"
7 Q0 18992959 651 52.591022 imi_mug_run_2_treatment "gefitinib"
7 Q0 22333382 652 52.590473 imi_mug_run_2_treatment "gefitinib" "erlotinib"
7 Q0 28838405 653 52.578644 imi_mug_run_2_treatment "osimertinib" "tyrosine kinase inhibitor"
7 Q0 27843613 654 52.552288 imi_mug_run_2_treatment "drugs" "mediated"
7 Q0 21554040 655 52.534786 imi_mug_run_2_treatment "afatinib" "gefitinib" "erlotinib"
7 Q0 26629426 656 52.531624 imi_mug_run_2_treatment "oral antihyperglycemic" "rociletinib" "mediated"
7 Q0 18981003 657 52.522575 imi_mug_run_2_treatment "gefitinib" "erlotinib" "erlotinib 150 mg"
7 Q0 24523812 658 52.50939 imi_mug_run_2_treatment "drug" "taxane" "others"
7 Q0 24039832 659 52.499626 imi_mug_run_2_treatment "level" "bevacizumab" "erlotinib"
7 Q0 20015198 660 52.499626 imi_mug_run_2_treatment "gefitinib" "erlotinib" "pooled"
7 Q0 16282720 661 52.49797 imi_mug_run_2_treatment "various" "gefitinib" "zd 1839"
7 Q0 19589612 662 52.496536 imi_mug_run_2_treatment "gefitinib" "tyrosine kinase inhibitor"
7 Q0 25573345 663 52.47973 imi_mug_run_2_treatment "docetaxel"
7 Q0 16614231 664 52.47947 imi_mug_run_2_treatment "therapeutics" "monoclonal antibodies"
7 Q0 29461911 665 52.476677 imi_mug_run_2_treatment "adjuvant" "erlotinib"
7 Q0 24105277 666 52.476494 imi_mug_run_2_treatment "various"
7 Q0 29848710 667 52.472214 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors" "aim" "osimertinib"
7 Q0 27699048 668 52.47027 imi_mug_run_2_treatment "afatinib" "gefitinib" "erlotinib"
7 Q0 26486077 669 52.46835 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
7 Q0 25700775 670 52.460815 imi_mug_run_2_treatment "basis" "shape"
7 Q0 22321545 671 52.45586 imi_mug_run_2_treatment "basis"
7 Q0 30174832 672 52.45025 imi_mug_run_2_treatment "osimertinib" "plasma"
7 Q0 26505339 673 52.443962 imi_mug_run_2_treatment "aim"
7 Q0 28716641 674 52.43391 imi_mug_run_2_treatment "osimertinib"
7 Q0 28789446 675 52.433407 imi_mug_run_2_treatment "adenosine triphosphate"
7 Q0 27362807 676 52.428276 imi_mug_run_2_treatment "mediated" "gefitinib"
7 Q0 24314215 677 52.410423 imi_mug_run_2_treatment "ras" "ple"
7 Q0 27348572 678 52.4089 imi_mug_run_2_treatment "clot"
7 Q0 28806116 679 52.39352 imi_mug_run_2_treatment "crizotinib" "nivolumab" "pembrolizumab"
7 Q0 24258572 680 52.385635 imi_mug_run_2_treatment "kinase inhibitor"
7 Q0 28210165 681 52.369373 imi_mug_run_2_treatment "rociletinib" "gefitinib" "erlotinib"
7 Q0 26616848 682 52.36133 imi_mug_run_2_treatment "ras"
7 Q0 18413800 683 52.360283 imi_mug_run_2_treatment "erlotinib" "drug" "gefitinib"
7 Q0 29215723 684 52.34449 imi_mug_run_2_treatment "gefitinib"
7 Q0 21924037 685 52.305702 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors" "aim"
7 Q0 20677568 686 52.296036 imi_mug_run_2_treatment "iressa" "gefitinib" "erlotinib"
7 Q0 25897257 687 52.28552 imi_mug_run_2_treatment "lead"
7 Q0 28668844 688 52.280537 imi_mug_run_2_treatment "afatinib" "level"
7 Q0 24807015 689 52.273808 imi_mug_run_2_treatment "gefitinib" "erlotinib" "egfr inhibitor"
7 Q0 28287730 690 52.267677 imi_mug_run_2_treatment "erlotinib" "pyrrolopyrimidine" "pf-06747775"
7 Q0 24707260 691 52.25393 imi_mug_run_2_treatment "gefitinib"
7 Q0 24398248 692 52.239902 imi_mug_run_2_treatment "formalin"
7 Q0 26370354 693 52.239902 imi_mug_run_2_treatment "drugs" "gefitinib" "erlotinib"
7 Q0 24054018 694 52.237854 imi_mug_run_2_treatment "cisplatin" "gemcitabine" "vinorelbine"
7 Q0 29850136 695 52.23785 imi_mug_run_2_treatment "plasma" "pooled"
7 Q0 18483355 696 52.233467 imi_mug_run_2_treatment "gefitinib" "erlotinib" "egfr tyrosine kinase inhibitor"
7 Q0 27601920 697 52.194862 imi_mug_run_2_treatment "gefitinib" "pemetrexed" "s-1"
7 Q0 29726094 698 52.159786 imi_mug_run_2_treatment "drug" "drugs" "platinum"
7 Q0 18036700 699 52.158394 imi_mug_run_2_treatment "platinum agents"
7 Q0 23514946 700 52.152348 imi_mug_run_2_treatment "tyrosine kinase inhibitor" "egfr tyrosine kinase inhibitors"
7 Q0 28891180 701 52.152084 imi_mug_run_2_treatment "epidermal growth factor"
7 Q0 26999101 702 52.138714 imi_mug_run_2_treatment "digitoxin" "cardiac glycoside" "gefitinib"
7 Q0 28714692 703 52.131065 imi_mug_run_2_treatment "various" "protein kinase inhibitors" "level"
7 Q0 29140105 704 52.12647 imi_mug_run_2_treatment "combinations" "durvalumab" "drugs"
7 Q0 28623122 705 52.107582 imi_mug_run_2_treatment "nivolumab" "carboplatin" "gefitinib"
7 Q0 25145405 706 52.073044 imi_mug_run_2_treatment "drug" "egfr tyrosine kinase inhibitors"
7 Q0 24768581 707 52.067204 imi_mug_run_2_treatment "mediated" "aim"
7 Q0 16080566 708 52.037643 imi_mug_run_2_treatment "trastuzumab"
7 Q0 20719167 709 52.037567 imi_mug_run_2_treatment "various" "cisplatin" "irinotecan"
7 Q0 28373815 710 52.035034 imi_mug_run_2_treatment "various" "erlotinib" "bevacizumab"
7 Q0 21196162 711 52.03402 imi_mug_run_2_treatment "monoclonal antibodies"
7 Q0 21216930 712 52.028065 imi_mug_run_2_treatment "siltuximab" "serine" "tyrosine"
7 Q0 29466812 713 52.00526 imi_mug_run_2_treatment "etoposide" "carboplatin" "osimertinib"
7 Q0 27895763 714 51.995453 imi_mug_run_2_treatment "drug" "epirubicin" "paclitaxel"
7 Q0 17653080 715 51.991707 imi_mug_run_2_treatment "tyrosine" "gefitinib" "others"
7 Q0 23485129 716 51.991707 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors" "gefitinib" "erlotinib"
7 Q0 19707410 717 51.990532 imi_mug_run_2_treatment "various" "cetuximab" "drugs"
7 Q0 23402326 718 51.989563 imi_mug_run_2_treatment "gefitinib"
7 Q0 30349313 719 51.95905 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
7 Q0 24035188 720 51.958107 imi_mug_run_2_treatment "afatinib" "egfr tyrosine kinase inhibitors"
7 Q0 29524556 721 51.9539 imi_mug_run_2_treatment "osimertinib" "tyrosine kinase inhibitor"
7 Q0 16857825 722 51.952934 imi_mug_run_2_treatment "zd6474" "gefitinib" "erlotinib"
7 Q0 24752335 723 51.93212 imi_mug_run_2_treatment "tyrosine kinase inhibitor"
7 Q0 23730419 724 51.93038 imi_mug_run_2_treatment "hts" "radiosensitizer"
7 Q0 28337370 725 51.919315 imi_mug_run_2_treatment "gefitinib" "erlotinib" "adjuvant"
7 Q0 19580206 726 51.91568 imi_mug_run_2_treatment "kinase inhibitor" "cetuximab" "erlotinib"
7 Q0 24344015 727 51.907433 imi_mug_run_2_treatment "agent" "erlotinib"
7 Q0 24406751 728 51.907433 imi_mug_run_2_treatment "docetaxel" "crizotinib" "afatinib"
7 Q0 25934077 729 51.903885 imi_mug_run_2_treatment "rociletinib" "egfr inhibitor" "plasma"
7 Q0 20443070 730 51.891445 imi_mug_run_2_treatment "cisplatin" "drugs" "gemcitabine"
7 Q0 23270410 731 51.86995 imi_mug_run_2_treatment "cetuximab"
7 Q0 26958501 732 51.853725 imi_mug_run_2_treatment "epidermal growth factor receptor tyrosine kinase inhibitor" "bevacizumab"
7 Q0 24759598 733 51.848156 imi_mug_run_2_treatment "epidermal growth factor receptor tyrosine kinase inhibitor" "aim"
7 Q0 21135146 734 51.84672 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
7 Q0 19415121 735 51.844524 imi_mug_run_2_treatment "cisplatin" "docetaxel" "erlotinib"
7 Q0 21444946 736 51.833366 imi_mug_run_2_treatment "platinum" "egfr tyrosine kinase inhibitors"
7 Q0 29721209 737 51.82926 imi_mug_run_2_treatment "plasma" "drug" "tyrosine kinase inhibitor"
7 Q0 29088904 738 51.80569 imi_mug_run_2_treatment "anti-angiogenic drugs" "egfr tyrosine kinase inhibitors"
7 Q0 25975640 739 51.80138 imi_mug_run_2_treatment "drugs" "wz4002"
7 Q0 26888425 740 51.79575 imi_mug_run_2_treatment "aim" "crizotinib"
7 Q0 24179413 741 51.79575 imi_mug_run_2_treatment "antiangiogenic"
7 Q0 23524403 742 51.79575 imi_mug_run_2_treatment "ras" "level"
7 Q0 28110557 743 51.795013 imi_mug_run_2_treatment "aim"
7 Q0 22705678 744 51.793083 imi_mug_run_2_treatment "gefitinib" "erlotinib" "egfr tyrosine kinase inhibitors"
7 Q0 26153235 745 51.78547 imi_mug_run_2_treatment "platinum" "egfr tyrosine kinase inhibitors"
7 Q0 28630494 746 51.77867 imi_mug_run_2_treatment "drug" "egfr inhibitor" "basis"
7 Q0 22805266 747 51.765747 imi_mug_run_2_treatment "drugs"
7 Q0 24439568 748 51.764793 imi_mug_run_2_treatment "product"
7 Q0 26302343 749 51.757755 imi_mug_run_2_treatment "mediated" "basis" "aim"
7 Q0 27506489 750 51.742355 imi_mug_run_2_treatment "afatinib" "gefitinib" "erlotinib"
7 Q0 26435742 751 51.733646 imi_mug_run_2_treatment "new drugs" "aim"
7 Q0 22336239 752 51.722015 imi_mug_run_2_treatment "gefitinib" "erlotinib"
7 Q0 22114570 753 51.716343 imi_mug_run_2_treatment "gefitinib" "erlotinib" "corticosteroid"
7 Q0 18541260 754 51.701584 imi_mug_run_2_treatment "gefitinib" "erlotinib"
7 Q0 17285540 755 51.700848 imi_mug_run_2_treatment "ras" "gefitinib"
7 Q0 21959109 756 51.690243 imi_mug_run_2_treatment "anti-vegf" "vascular endothelial growth factor"
7 Q0 26424310 757 51.678978 imi_mug_run_2_treatment "erlotinib" "egfr tyrosine kinase inhibitor"
7 Q0 22971028 758 51.67504 imi_mug_run_2_treatment "erlotinib" "agent" "egfr tyrosine kinase inhibitors"
7 Q0 21053345 759 51.67337 imi_mug_run_2_treatment "gefitinib" "erlotinib" "tyrosine kinase inhibitor"
7 Q0 29631678 760 51.669254 imi_mug_run_2_treatment "gefitinib" "drug" "tyrosine kinase inhibitor"
7 Q0 24793378 761 51.657825 imi_mug_run_2_treatment "paclitaxel" "platinum" "aim"
7 Q0 25560642 762 51.655457 imi_mug_run_2_treatment "gefitinib" "aim"
7 Q0 21723791 763 51.637917 imi_mug_run_2_treatment "various" "vandetanib" "gefitinib"
7 Q0 26707566 764 51.62198 imi_mug_run_2_treatment "medicine" "aim"
7 Q0 27133754 765 51.618652 imi_mug_run_2_treatment "drugs"
7 Q0 30217489 766 51.6164 imi_mug_run_2_treatment "etoposide" "platinum"
7 Q0 22634180 767 51.612473 imi_mug_run_2_treatment "mediated" "egfr tyrosine kinase inhibitors"
7 Q0 21124044 768 51.607243 imi_mug_run_2_treatment "monoclonal antibodies"
7 Q0 22751098 769 51.58447 imi_mug_run_2_treatment "erlotinib"
7 Q0 19562083 770 51.581955 imi_mug_run_2_treatment "combinations" "cetuximab" "drugs"
7 Q0 28129709 771 51.581955 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors" "plasma"
7 Q0 28236980 772 51.565666 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
7 Q0 23668441 773 51.56159 imi_mug_run_2_treatment "furoxan"
7 Q0 19491268 774 51.55485 imi_mug_run_2_treatment "vandetanib" "agent" "tyrosine kinase inhibitor"
7 Q0 29325035 775 51.550354 imi_mug_run_2_treatment "plasma" "osimertinib"
7 Q0 26829280 776 51.548622 imi_mug_run_2_treatment "gefitinib" "aim"
7 Q0 28747773 777 51.525116 imi_mug_run_2_treatment "gefitinib" "erlotinib" "afatinib"
7 Q0 19010912 778 51.50903 imi_mug_run_2_treatment "ras"
7 Q0 24471765 779 51.503746 imi_mug_run_2_treatment "luteolin" "erlotinib" "drugs"
7 Q0 29570930 780 51.502514 imi_mug_run_2_treatment "nicotine-derived nitrosamine ketone" "nnk" "crizotinib"
7 Q0 15492241 781 51.50077 imi_mug_run_2_treatment "gefitinib" "egfr inhibitor"
7 Q0 27491402 782 51.499466 imi_mug_run_2_treatment "gefitinib" "erlotinib" "new drugs"
7 Q0 12867061 783 51.49328 imi_mug_run_2_treatment "erlotinib" "agent" "cytotoxic"
7 Q0 22826274 784 51.49081 imi_mug_run_2_treatment "plasma"
7 Q0 17158592 785 51.490555 imi_mug_run_2_treatment "iressa" "gefitinib" "erlotinib"
7 Q0 29467275 786 51.475624 imi_mug_run_2_treatment "naquotinib" "osimertinib" "egfr tyrosine kinase inhibitor"
7 Q0 30172266 787 51.474785 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
7 Q0 21421804 788 51.46975 imi_mug_run_2_treatment "oxygen" "ras"
7 Q0 29534579 789 51.45302 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
7 Q0 17613438 790 51.451363 imi_mug_run_2_treatment "erlotinib" "hki-272" "egfr tyrosine kinase inhibitor"
7 Q0 17409891 791 51.447784 imi_mug_run_2_treatment "level"
7 Q0 26036643 792 51.444542 imi_mug_run_2_treatment "trametinib" "egfr inhibitor" "egfr tyrosine kinase inhibitors"
7 Q0 15492792 793 51.443924 imi_mug_run_2_treatment "gefitinib" "ras" "zd1839"
7 Q0 25328417 794 51.439674 imi_mug_run_2_treatment "tivantinib" "egfr tyrosine kinase inhibitor" "arq 197"
7 Q0 29866661 795 51.435715 imi_mug_run_2_treatment "erlotinib" "osimertinib" "egfr tyrosine kinase inhibitors"
7 Q0 26977054 796 51.433784 imi_mug_run_2_treatment "gefitinib" "platinum" "egfr tyrosine kinase inhibitors"
7 Q0 29534625 797 51.430115 imi_mug_run_2_treatment "cetuximab"
7 Q0 25979928 798 51.420082 imi_mug_run_2_treatment "drugs" "afatinib" "gefitinib"
7 Q0 21444121 799 51.407486 imi_mug_run_2_treatment "drugs" "gefitinib"
7 Q0 22429575 800 51.404583 imi_mug_run_2_treatment "gefitinib" "docetaxel" "hoechst 33258"
7 Q0 21320004 801 51.402294 imi_mug_run_2_treatment "bibw 2992" "drug" "drugs"
7 Q0 24720835 802 51.386566 imi_mug_run_2_treatment "aim"
7 Q0 30073261 803 51.384964 imi_mug_run_2_treatment "osimertinib" "mediated" "plasma"
7 Q0 27264264 804 51.373825 imi_mug_run_2_treatment "gefitinib" "cyclosporine a"
7 Q0 18317074 805 51.367584 imi_mug_run_2_treatment "gefitinib" "erlotinib" "platinum"
7 Q0 29740718 806 51.365482 imi_mug_run_2_treatment "blockade" "agent"
7 Q0 26557922 807 51.35974 imi_mug_run_2_treatment "cisplatin" "etoposide"
7 Q0 24889366 808 51.34047 imi_mug_run_2_treatment "crizotinib" "cisplatin" "carboplatin"
7 Q0 25302168 809 51.31721 imi_mug_run_2_treatment "gefitinib" "erlotinib"
7 Q0 21885318 810 51.292984 imi_mug_run_2_treatment "combinations" "lead" "monoclonal antibodies"
7 Q0 25725115 811 51.276978 imi_mug_run_2_treatment "combinations" "egfr tyrosine kinase inhibitors" "monoclonal antibodies"
7 Q0 25806192 812 51.267002 imi_mug_run_2_treatment "cetuximab" "platinum" "favor"
7 Q0 17239298 813 51.2489 imi_mug_run_2_treatment "erlotinib"
7 Q0 24958518 814 51.2488 imi_mug_run_2_treatment "gefitinib" "erlotinib" "tyrosine kinase inhibitor"
7 Q0 26361996 815 51.24775 imi_mug_run_2_treatment "ras"
7 Q0 28611939 816 51.237576 imi_mug_run_2_treatment "drug"
7 Q0 22340408 817 51.227417 imi_mug_run_2_treatment "epidermal growth factor" "various"
7 Q0 20479403 818 51.21682 imi_mug_run_2_treatment "neratinib"
7 Q0 25366755 819 51.208218 imi_mug_run_2_treatment "gefitinib" "erlotinib" "egfr inhibitor"
7 Q0 24210543 820 51.181465 imi_mug_run_2_treatment "adc"
7 Q0 29344197 821 51.172142 imi_mug_run_2_treatment "aim"
7 Q0 25591975 822 51.165703 imi_mug_run_2_treatment "various" "gefitinib" "erlotinib"
7 Q0 23721103 823 51.15764 imi_mug_run_2_treatment "plasma" "saber" "gefitinib"
7 Q0 19786660 824 51.156822 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
7 Q0 26958508 825 51.155987 imi_mug_run_2_treatment "erlotinib"
7 Q0 26351321 826 51.14875 imi_mug_run_2_treatment "pha-665752" "elacridar" "level"
7 Q0 23863134 827 51.130424 imi_mug_run_2_treatment "ch5164840" "erlotinib" "lead"
7 Q0 29184671 828 51.12934 imi_mug_run_2_treatment "plasma"
7 Q0 24649318 829 51.123184 imi_mug_run_2_treatment "erlotinib"
7 Q0 23628526 830 51.109425 imi_mug_run_2_treatment "various"
7 Q0 23423768 831 51.085617 imi_mug_run_2_treatment "adc"
7 Q0 23251849 832 51.078598 imi_mug_run_2_treatment "epidermal growth factor"
7 Q0 23676980 833 51.074894 imi_mug_run_2_treatment "icotinib hydrochloride" "aim"
7 Q0 22339342 834 51.07219 imi_mug_run_2_treatment "oxo" "gefitinib" "erlotinib"
7 Q0 29393480 835 51.06644 imi_mug_run_2_treatment "gefitinib" "paclitaxel" "docetaxel"
7 Q0 20529262 836 51.063576 imi_mug_run_2_treatment "cetuximab" "drug" "complement inhibitor"
7 Q0 30510441 837 51.05433 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitor"
7 Q0 28367252 838 51.036427 imi_mug_run_2_treatment "angiogenesis inhibitors"
7 Q0 18428387 839 51.033768 imi_mug_run_2_treatment "medications"
7 Q0 23514942 840 51.01878 imi_mug_run_2_treatment "drug" "gefitinib" "epidermal growth factor receptor tyrosine kinase inhibitor"
7 Q0 25400829 841 51.01594 imi_mug_run_2_treatment "gefitinib" "epidermal growth factor receptor inhibitor"
7 Q0 22985911 842 51.008163 imi_mug_run_2_treatment "anastrozole" "gefitinib" "drug"
7 Q0 28513466 843 50.990253 imi_mug_run_2_treatment "combinations" "cytostatic agents" "cytostatics"
7 Q0 22610259 844 50.98214 imi_mug_run_2_treatment "plasma" "drug" "kinase inhibitor"
7 Q0 22957020 845 50.979523 imi_mug_run_2_treatment "drugs" "erlotinib" "mediated"
7 Q0 19098404 846 50.97088 imi_mug_run_2_treatment "gefitinib" "duration" "agent"
7 Q0 25676398 847 50.965702 imi_mug_run_2_treatment "crizotinib" "level"
7 Q0 19185949 848 50.964367 imi_mug_run_2_treatment "gefitinib"
7 Q0 17237005 849 50.961765 imi_mug_run_2_treatment "erlotinib" "cetuximab" "gefitinib"
7 Q0 29057232 850 50.959408 imi_mug_run_2_treatment "drug"
7 Q0 27597275 851 50.95487 imi_mug_run_2_treatment "metrics" "deoxyglucose" "egfr tyrosine kinase inhibitors"
7 Q0 18513582 852 50.947865 imi_mug_run_2_treatment "gefitinib" "erlotinib"
7 Q0 28061461 853 50.939842 imi_mug_run_2_treatment "plasma" "egfr tyrosine kinase inhibitors"
7 Q0 23683257 854 50.930733 imi_mug_run_2_treatment "platinum" "gefitinib" "erlotinib"
7 Q0 20002849 855 50.92869 imi_mug_run_2_treatment "gefitinib" "bevacizumab" "cetuximab"
7 Q0 14534727 856 50.927578 imi_mug_run_2_treatment "various" "product"
7 Q0 27090797 857 50.92408 imi_mug_run_2_treatment "sorafenib" "mediated" "kinase inhibitor"
7 Q0 24193010 858 50.909904 imi_mug_run_2_treatment "aim"
7 Q0 25953440 859 50.909904 imi_mug_run_2_treatment "gefitinib" "erlotinib" "gefitinib 250 mg"
7 Q0 17201173 860 50.906933 imi_mug_run_2_treatment "gefitinib"
7 Q0 15813676 861 50.902233 imi_mug_run_2_treatment "gefitinib" "drug" "docetaxel"
7 Q0 23144692 862 50.89443 imi_mug_run_2_treatment "gefitinib" "agonists"
7 Q0 24023334 863 50.88113 imi_mug_run_2_treatment "epidermal growth factor"
7 Q0 25806231 864 50.872612 imi_mug_run_2_treatment "docetaxel"
7 Q0 28210105 865 50.865036 imi_mug_run_2_treatment "drug" "gefitinib" "kinase inhibitor"
7 Q0 25486910 866 50.86456 imi_mug_run_2_treatment "erlotinib" "azacytidine" "sorafenib"
7 Q0 28089159 867 50.85314 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitor"
7 Q0 29404164 868 50.851795 imi_mug_run_2_treatment "gefitinib" "erlotinib" "epidermal growth factor receptor tyrosine kinase inhibitor"
7 Q0 24113003 869 50.846554 imi_mug_run_2_treatment "aim"
7 Q0 26187428 870 50.83545 imi_mug_run_2_treatment "afatinib"
7 Q0 25778308 871 50.830444 imi_mug_run_2_treatment "gefitinib" "lead"
7 Q0 27283993 872 50.828102 imi_mug_run_2_treatment "rociletinib" "egfr inhibitor" "crizotinib"
7 Q0 19410716 873 50.821724 imi_mug_run_2_treatment "cetuximab" "cisplatin" "vinorelbine"
7 Q0 19362943 874 50.818295 imi_mug_run_2_treatment "monoclonal antibodies" "cetuximab" "agent"
7 Q0 30355843 875 50.8094 imi_mug_run_2_treatment "aim"
7 Q0 21245935 876 50.796135 imi_mug_run_2_treatment "ras"
7 Q0 29344640 877 50.769657 imi_mug_run_2_treatment "cisplatin" "egfr inhibitor" "lapatinib"
7 Q0 17613432 878 50.769123 imi_mug_run_2_treatment "kinase inhibitor" "hki-272"
7 Q0 23140355 879 50.762184 imi_mug_run_2_treatment "gefitinib" "erlotinib" "drugs"
7 Q0 24517913 880 50.752663 imi_mug_run_2_treatment "tyrosine kinase inhibitor" "egfr tyrosine kinase inhibitors"
7 Q0 27885838 881 50.748795 imi_mug_run_2_treatment "osimertinib" "azd9291" "rociletinib"
7 Q0 26161893 882 50.747036 imi_mug_run_2_treatment "epidermal growth factor"
7 Q0 18645621 883 50.738823 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
7 Q0 24179385 884 50.734753 imi_mug_run_2_treatment "level" "plasma" "aim"
7 Q0 18393776 885 50.716236 imi_mug_run_2_treatment "cetuximab" "gefitinib" "erlotinib"
7 Q0 21562939 886 50.70759 imi_mug_run_2_treatment "estrogen" "gefitinib"
7 Q0 24982409 887 50.70672 imi_mug_run_2_treatment "epidermal growth factor"
7 Q0 30189719 888 50.704758 imi_mug_run_2_treatment "osimertinib" "drug" "duration"
7 Q0 28642172 889 50.6922 imi_mug_run_2_treatment "medicine" "egfr tyrosine kinase inhibitors"
7 Q0 21959047 890 50.688118 imi_mug_run_2_treatment "cetuximab" "drugs" "epidermal growth factor"
7 Q0 24053674 891 50.68194 imi_mug_run_2_treatment "gefitinib" "egfr inhibitor"
7 Q0 20005069 892 50.672348 imi_mug_run_2_treatment "gefitinib" "tamoxifen" "drug"
7 Q0 22514499 893 50.658455 imi_mug_run_2_treatment "gefitinib" "erlotinib"
7 Q0 26497899 894 50.656914 imi_mug_run_2_treatment "various" "enzymes" "epidermal growth factor"
7 Q0 21702662 895 50.65442 imi_mug_run_2_treatment "erlotinib" "gefitinib"
7 Q0 26508839 896 50.64456 imi_mug_run_2_treatment "dacomitinib" "gefitinib" "kinase inhibitor"
7 Q0 29958099 897 50.642437 imi_mug_run_2_treatment "combinations" "durvalumab" "drugs"
7 Q0 28982744 898 50.633698 imi_mug_run_2_treatment "level"
7 Q0 19105704 899 50.62663 imi_mug_run_2_treatment "drug" "docetaxel" "iressa"
7 Q0 23493885 900 50.616413 imi_mug_run_2_treatment "aim" "monoclonal antibodies"
7 Q0 25514804 901 50.613106 imi_mug_run_2_treatment "afatinib" "duration"
7 Q0 24419415 902 50.597427 imi_mug_run_2_treatment "gefitinib" "carboplatin" "paclitaxel"
7 Q0 25091415 903 50.59625 imi_mug_run_2_treatment "gefitinib" "drugs"
7 Q0 14565788 904 50.591507 imi_mug_run_2_treatment "gefitinib" "docetaxel" "platinum"
7 Q0 21165163 905 50.588745 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors" "therapeutics"
7 Q0 27496389 906 50.58806 imi_mug_run_2_treatment "drug"
7 Q0 20942630 907 50.58773 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitor"
7 Q0 20740181 908 50.584133 imi_mug_run_2_treatment "erlotinib" "nervous system" "epidermal growth factor"
7 Q0 26820570 909 50.577457 imi_mug_run_2_treatment "drug" "guanosine" "gefitinib"
7 Q0 18176089 910 50.575794 imi_mug_run_2_treatment "gefitinib" "egfr tyrosine kinase inhibitor"
7 Q0 28717762 911 50.574715 imi_mug_run_2_treatment "alcohol"
7 Q0 29844828 912 50.55613 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitor" "plasma"
7 Q0 28731495 913 50.544388 imi_mug_run_2_treatment "gefitinib" "erlotinib" "level"
7 Q0 18520298 914 50.535088 imi_mug_run_2_treatment "egfr inhibitor" "egfr tyrosine kinase inhibitors"
7 Q0 15610717 915 50.5342 imi_mug_run_2_treatment "combinations" "gefitinib" "erlotinib"
7 Q0 30425905 916 50.530178 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
7 Q0 25074459 917 50.52989 imi_mug_run_2_treatment "cetuximab" "afatinib" "gefitinib"
7 Q0 24773774 918 50.524994 imi_mug_run_2_treatment "plasma" "erlotinib"
7 Q0 27389045 919 50.521034 imi_mug_run_2_treatment "aim"
7 Q0 30315932 920 50.50337 imi_mug_run_2_treatment "erlotinib" "gefitinib"
7 Q0 23064619 921 50.49878 imi_mug_run_2_treatment "aim"
7 Q0 16453093 922 50.47518 imi_mug_run_2_treatment "erlotinib" "drugs" "cetuximab"
7 Q0 21775534 923 50.467167 imi_mug_run_2_treatment "combinations" "egfr tyrosine kinase inhibitors"
7 Q0 28854272 924 50.458862 imi_mug_run_2_treatment "afatinib" "ci 4" "gefitinib"
7 Q0 21732342 925 50.45799 imi_mug_run_2_treatment "erlotinib" "her-2" "tyrosine"
7 Q0 25678473 926 50.456776 imi_mug_run_2_treatment "cisplatin" "afatinib" "lead"
7 Q0 14676101 927 50.45579 imi_mug_run_2_treatment "agent" "tk inhibitors" "drug combination"
7 Q0 23599349 928 50.44622 imi_mug_run_2_treatment "erlotinib" "gefitinib"
7 Q0 24658966 929 50.43526 imi_mug_run_2_treatment "various" "staurosporine" "kinase inhibitor"
7 Q0 23507559 930 50.43435 imi_mug_run_2_treatment "enzymes" "gefitinib" "lipoic acid"
7 Q0 19888761 931 50.428352 imi_mug_run_2_treatment "tyrosine" "tyrosine kinase inhibitor" "therapeutic agents"
7 Q0 26439803 932 50.427048 imi_mug_run_2_treatment "egfr inhibitor"
7 Q0 24675505 933 50.423893 imi_mug_run_2_treatment "afatinib" "gefitinib" "erlotinib"
7 Q0 24816813 934 50.42347 imi_mug_run_2_treatment "various" "mediated"
7 Q0 27760600 935 50.41876 imi_mug_run_2_treatment "platinum"
7 Q0 29290257 936 50.40898 imi_mug_run_2_treatment "osimertinib" "mediated" "egfr tyrosine kinase inhibitors"
7 Q0 28881856 937 50.40232 imi_mug_run_2_treatment "antiangiogenic" "antiangiogenic agents" "bevacizumab"
7 Q0 24331409 938 50.397934 imi_mug_run_2_treatment "gly"
7 Q0 30453282 939 50.375637 imi_mug_run_2_treatment "suppressor" "plasma"
7 Q0 28521651 940 50.375137 imi_mug_run_2_treatment "liver"
7 Q0 22726919 941 50.369217 imi_mug_run_2_treatment "flt" "erlotinib" "afatinib"
7 Q0 19952121 942 50.36483 imi_mug_run_2_treatment "various" "erlotinib" "agent"
7 Q0 22052230 943 50.362213 imi_mug_run_2_treatment "level" "egfr tyrosine kinase inhibitor"
7 Q0 25364452 944 50.33394 imi_mug_run_2_treatment "erlotinib"
7 Q0 27565925 945 50.33281 imi_mug_run_2_treatment "bevacizumab" "erlotinib" "nervous system"
7 Q0 29852038 946 50.310852 imi_mug_run_2_treatment "gefitinib" "erlotinib" "osimertinib"
7 Q0 22680928 947 50.306606 imi_mug_run_2_treatment "antimetabolite" "drugs" "ras"
7 Q0 27561797 948 50.302082 imi_mug_run_2_treatment "nervous system"
7 Q0 25538894 949 50.296936 imi_mug_run_2_treatment "gefitinib" "erlotinib" "afatinib"
7 Q0 15025409 950 50.295296 imi_mug_run_2_treatment "docetaxel" "osi-774" "egfr tyrosine kinase inhibitor"
7 Q0 18827604 951 50.293213 imi_mug_run_2_treatment "gefitinib" "egfr tyrosine kinase inhibitors"
7 Q0 17082181 952 50.275955 imi_mug_run_2_treatment "cetuximab" "egfr tyrosine kinase inhibitors" "blockade"
7 Q0 27455248 953 50.26825 imi_mug_run_2_treatment "drugs"
7 Q0 29321093 954 50.26456 imi_mug_run_2_treatment "gefitinib" "erlotinib" "afatinib"
7 Q0 15851406 955 50.256554 imi_mug_run_2_treatment "gefitinib" "egfr tk inhibitors" "basis"
7 Q0 16857823 956 50.251156 imi_mug_run_2_treatment "cetuximab" "platinum" "agent"
7 Q0 26301867 957 50.245163 imi_mug_run_2_treatment "erlotinib" "everolimus" "su11274"
7 Q0 29110853 958 50.245155 imi_mug_run_2_treatment "cisplatin" "balance" "n-acetyl-l-cysteine"
7 Q0 25104233 959 50.24034 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitor"
7 Q0 20040267 960 50.22853 imi_mug_run_2_treatment "gefitinib" "erlotinib"
7 Q0 27770237 961 50.216137 imi_mug_run_2_treatment "plasma" "gefitinib"
7 Q0 26483331 962 50.209373 imi_mug_run_2_treatment "triptolide" "hoechst 33258" "gefitinib"
7 Q0 17335935 963 50.204544 imi_mug_run_2_treatment "gefitinib"
7 Q0 24750242 964 50.203255 imi_mug_run_2_treatment "gefitinib" "mediated"
7 Q0 23771519 965 50.202198 imi_mug_run_2_treatment "drugs"
7 Q0 25164010 966 50.19838 imi_mug_run_2_treatment "tyrosine" "mediated" "gefitinib"
7 Q0 28710768 967 50.18392 imi_mug_run_2_treatment "gefitinib" "panobinostat" "histone deacetylase inhibitor"
7 Q0 29029422 968 50.18068 imi_mug_run_2_treatment "various" "serine"
7 Q0 30520383 969 50.170242 imi_mug_run_2_treatment "osimertinib"
7 Q0 20723379 970 50.166557 imi_mug_run_2_treatment "gefitinib" "erlotinib"
7 Q0 20486827 971 50.162277 imi_mug_run_2_treatment "cisplatin" "egfr tyrosine kinase inhibitors" "erlotinib"
7 Q0 29101057 972 50.15513 imi_mug_run_2_treatment "osimertinib" "nervous system" "egfr tyrosine kinase inhibitor"
7 Q0 25098682 973 50.1439 imi_mug_run_2_treatment "drugs"
7 Q0 30015158 974 50.14309 imi_mug_run_2_treatment "carboplatin" "mediated" "paclitaxel"
7 Q0 22627040 975 50.132385 imi_mug_run_2_treatment "erlotinib" "egfr tyrosine kinase inhibitors"
7 Q0 29707292 976 50.10782 imi_mug_run_2_treatment "plasma" "egfr tyrosine kinase inhibitors" "egfr-tki"
7 Q0 23576199 977 50.103626 imi_mug_run_2_treatment "medicine" "basis"
7 Q0 27212579 978 50.1027 imi_mug_run_2_treatment "gefitinib" "erlotinib" "afatinib"
7 Q0 15623594 979 50.095478 imi_mug_run_2_treatment "gefitinib"
7 Q0 27898252 980 50.072292 imi_mug_run_2_treatment "afatinib" "platinum" "gefitinib"
7 Q0 27055085 981 50.068638 imi_mug_run_2_treatment "plasma" "kinase inhibitor"
7 Q0 29673089 982 50.066597 imi_mug_run_2_treatment "gefitinib" "osimertinib" "azd9291"
7 Q0 26063687 983 50.060257 imi_mug_run_2_treatment "erlotinib" "drugs" "pemetrexed"
7 Q0 24799062 984 50.05877 imi_mug_run_2_treatment "dacomitinib" "kinase inhibitor"
7 Q0 26999786 985 50.04158 imi_mug_run_2_treatment "various" "egfr tyrosine kinase inhibitors"
7 Q0 18957054 986 50.02192 imi_mug_run_2_treatment "scorpion" "drugs" "egfr tyrosine kinase inhibitors"
7 Q0 15725915 987 50.02087 imi_mug_run_2_treatment "gefitinib"
7 Q0 19673930 988 50.013924 imi_mug_run_2_treatment "erlotinib" "oxygen" "hoechst 33342"
7 Q0 24669077 989 50.01069 imi_mug_run_2_treatment "aim"
7 Q0 27382309 990 50.004017 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors" "gefitinib" "erlotinib"
7 Q0 24611018 991 50.00372 imi_mug_run_2_treatment "erlotinib"
7 Q0 23185274 992 49.996002 imi_mug_run_2_treatment "gefitinib" "v1801" "drug"
7 Q0 29097733 993 49.99489 imi_mug_run_2_treatment "drugs" "parp inhibitors"
7 Q0 28607578 994 49.974213 imi_mug_run_2_treatment "aim" "osimertinib" "gefitinib"
7 Q0 29455656 995 49.972954 imi_mug_run_2_treatment "mediated"
7 Q0 21430269 996 49.969044 imi_mug_run_2_treatment "drug" "egfr inhibitor" "egfr tyrosine kinase inhibitors"
7 Q0 23055691 997 49.95937 imi_mug_run_2_treatment "erlotinib" "egfr inhibitor" "afatinib"
7 Q0 26556242 998 49.959034 imi_mug_run_2_treatment "mediators" "erlotinib"
7 Q0 17681094 999 49.95788 imi_mug_run_2_treatment "epidermal growth factor"
8 Q0 17384684 1 72.10058 imi_mug_run_2_treatment "agar"
8 Q0 20542753 2 57.58276 imi_mug_run_2_treatment "various"
8 Q0 19663703 3 55.065487 imi_mug_run_2_treatment "isolate" "aim" "monoclonal antibodies"
8 Q0 11114733 4 48.661377 imi_mug_run_2_treatment "serine"
8 Q0 29226855 5 48.32985 imi_mug_run_2_treatment "cck-8"
8 Q0 27268915 6 47.944252 imi_mug_run_2_treatment "chemotherapeutic agent" "daidzein" "isoflavone"
8 Q0 28320388 7 47.77973 imi_mug_run_2_treatment "ppi" "hub"
8 Q0 26861974 8 47.300507 imi_mug_run_2_treatment "aim"
8 Q0 25326231 9 47.023396 imi_mug_run_2_treatment "experimental agent" "aim"
8 Q0 28507621 10 45.405502 imi_mug_run_2_treatment "aim"
8 Q0 25537218 11 45.338295 imi_mug_run_2_treatment "aim"
8 Q0 23657946 12 45.24755 imi_mug_run_2_treatment "drugs"
8 Q0 23019225 13 45.11975 imi_mug_run_2_treatment "enzymes"
8 Q0 17867592 14 44.562237 imi_mug_run_2_treatment "aim"
8 Q0 23272046 15 44.204582 imi_mug_run_2_treatment "others"
8 Q0 27586786 16 43.91667 imi_mug_run_2_treatment "basis"
8 Q0 19749790 17 43.723232 imi_mug_run_2_treatment "basis"
8 Q0 20822928 18 43.641148 imi_mug_run_2_treatment "various"
8 Q0 22820081 19 43.60862 imi_mug_run_2_treatment "ras" "hot spot"
8 Q0 24784839 20 43.59677 imi_mug_run_2_treatment "ganetespib" "resorcinol" "tyrosine kinase inhibitor"
8 Q0 19381019 21 43.560516 imi_mug_run_2_treatment "various"
8 Q0 28069289 22 43.491158 imi_mug_run_2_treatment "plasma"
8 Q0 16570285 23 43.476555 imi_mug_run_2_treatment "aim"
8 Q0 27091807 24 43.421066 imi_mug_run_2_treatment "adjuvant" "drugs"
8 Q0 23842048 25 43.126175 imi_mug_run_2_treatment "aim"
8 Q0 11466624 26 42.629257 imi_mug_run_2_treatment "various"
8 Q0 20824703 27 42.599983 imi_mug_run_2_treatment "aim"
8 Q0 24634132 28 42.167534 imi_mug_run_2_treatment "pooled"
8 Q0 27596295 29 41.615894 imi_mug_run_2_treatment "aim"
8 Q0 17290345 30 41.572872 imi_mug_run_2_treatment "tcc" "ras"
8 Q0 29525349 31 41.384026 imi_mug_run_2_treatment "kinase inhibitor"
8 Q0 22724020 32 41.278282 imi_mug_run_2_treatment "sam" "level"
8 Q0 28388658 33 40.90464 imi_mug_run_2_treatment "vemurafenib" "therapeutic agents" "trametinib"
8 Q0 25997541 34 40.401505 imi_mug_run_2_treatment "ras"
8 Q0 22295571 35 40.23899 imi_mug_run_2_treatment "aim"
8 Q0 16412606 36 40.121006 imi_mug_run_2_treatment "combinations" "tma" "monoclonal antibodies"
8 Q0 22417847 37 40.076683 imi_mug_run_2_treatment "ras" "combinations"
8 Q0 21683397 38 39.880707 imi_mug_run_2_treatment "pooled"
8 Q0 17803960 39 39.42282 imi_mug_run_2_treatment "mediated"
8 Q0 15690367 40 39.381172 imi_mug_run_2_treatment "level"
8 Q0 26901314 41 39.176308 imi_mug_run_2_treatment "pooled"
8 Q0 16278391 42 39.158676 imi_mug_run_2_treatment "aim"
8 Q0 19722178 43 39.141884 imi_mug_run_2_treatment "pah"
8 Q0 28855393 44 39.042084 imi_mug_run_2_treatment "level" "mediated" "lead"
8 Q0 19454613 45 38.88072 imi_mug_run_2_treatment "various"
8 Q0 27352265 46 38.869686 imi_mug_run_2_treatment "medications" "others"
8 Q0 26254388 47 38.7894 imi_mug_run_2_treatment "yeast" "aim"
8 Q0 25223521 48 38.749954 imi_mug_run_2_treatment "matrix" "plau"
8 Q0 17826665 49 38.636772 imi_mug_run_2_treatment "various" "others" "monoclonal antibodies"
8 Q0 27669755 50 38.61721 imi_mug_run_2_treatment "various"
8 Q0 24898159 51 38.395195 imi_mug_run_2_treatment "mediated" "level"
8 Q0 22422578 52 38.381355 imi_mug_run_2_treatment "kinase inhibitor"
8 Q0 21072204 53 38.273308 imi_mug_run_2_treatment "ras"
8 Q0 23991606 54 38.18972 imi_mug_run_2_treatment "tcc"
8 Q0 29463565 55 37.496445 imi_mug_run_2_treatment "pdx" "lead"
8 Q0 17085196 56 37.37515 imi_mug_run_2_treatment "yeast" "basis"
8 Q0 16338952 57 37.24168 imi_mug_run_2_treatment "agar" "su5402" "level"
8 Q0 30128829 58 36.980118 imi_mug_run_2_treatment "level" "blockade"
8 Q0 26542242 59 36.83847 imi_mug_run_2_treatment "aim"
8 Q0 15748888 60 36.517677 imi_mug_run_2_treatment "lead"
8 Q0 26617115 61 36.42882 imi_mug_run_2_treatment "medicine"
8 Q0 26869289 62 36.135674 imi_mug_run_2_treatment "tyrosine" "titanium dioxide" "lead"
8 Q0 11526491 63 36.042503 imi_mug_run_2_treatment "various"
8 Q0 20414420 64 35.936687 imi_mug_run_2_treatment "various"
8 Q0 21459758 65 35.73838 imi_mug_run_2_treatment "aim"
8 Q0 27846280 66 35.616463 imi_mug_run_2_treatment "level"
8 Q0 26364695 67 35.51 imi_mug_run_2_treatment "tcc"
8 Q0 28247712 68 35.434586 imi_mug_run_2_treatment "others"
8 Q0 25993148 69 35.424664 imi_mug_run_2_treatment "adjuvant" "cisplatin" "ras"
8 Q0 19843069 70 35.377254 imi_mug_run_2_treatment "mediated"
8 Q0 25654736 71 35.238197 imi_mug_run_2_treatment "level"
8 Q0 27271022 72 35.11959 imi_mug_run_2_treatment "new drugs"
8 Q0 24357085 73 35.03939 imi_mug_run_2_treatment "generic"
8 Q0 27447553 74 34.91691 imi_mug_run_2_treatment "zinc"
8 Q0 18231634 75 34.896416 imi_mug_run_2_treatment "aim"
8 Q0 27455559 76 34.809155 imi_mug_run_2_treatment "various" "phosphate" "basis"
8 Q0 23201384 77 34.750347 imi_mug_run_2_treatment "combinations"
8 Q0 20625299 78 34.711525 imi_mug_run_2_treatment "lead"
8 Q0 25589496 79 34.688828 imi_mug_run_2_treatment "debio 1347" "ch5183284"
8 Q0 24360661 80 34.6392 imi_mug_run_2_treatment "adjuvant" "cisplatin" "aim"
8 Q0 15701828 81 34.43476 imi_mug_run_2_treatment "monoclonal antibodies" "therapeutics"
8 Q0 26522772 82 34.39973 imi_mug_run_2_treatment "formalin" "lead" "aim"
8 Q0 28229968 83 34.335922 imi_mug_run_2_treatment "silibinin" "phenol" "cytotoxic"
8 Q0 18815930 84 34.224167 imi_mug_run_2_treatment "drug" "ras" "others"
8 Q0 19553819 85 34.19418 imi_mug_run_2_treatment "basis" "level"
8 Q0 18945538 86 34.16547 imi_mug_run_2_treatment "kinase inhibitor"
8 Q0 20187926 87 33.996376 imi_mug_run_2_treatment "aim"
8 Q0 17668422 88 33.920956 imi_mug_run_2_treatment "isolate" "level"
8 Q0 24199176 89 33.817497 imi_mug_run_2_treatment "lead"
8 Q0 30344944 90 33.712475 imi_mug_run_2_treatment "drug" "medicines" "trametinib"
8 Q0 23108201 91 33.649387 imi_mug_run_2_treatment "vitamin d" "plasma" "dihydroxyvitamin d"
8 Q0 18413799 92 33.6212 imi_mug_run_2_treatment "rgel" "immunotoxins" "immunotoxin"
8 Q0 24252684 93 33.491676 imi_mug_run_2_treatment "level"
8 Q0 24199183 94 33.48345 imi_mug_run_2_treatment "level"
8 Q0 25071007 95 33.112392 imi_mug_run_2_treatment "mediated"
8 Q0 17867603 96 33.071594 imi_mug_run_2_treatment "aim"
8 Q0 26853465 97 32.991386 imi_mug_run_2_treatment "enzymes" "chloroquine" "adjuvant"
8 Q0 27376138 98 32.94354 imi_mug_run_2_treatment "combinations" "drug" "therapeutics"
8 Q0 27356691 99 32.89187 imi_mug_run_2_treatment "ras" "aim"
8 Q0 29358619 100 32.610443 imi_mug_run_2_treatment "various" "khs101"
8 Q0 18923358 101 32.466084 imi_mug_run_2_treatment "ras" "genesis"
8 Q0 23232572 102 32.438118 imi_mug_run_2_treatment "various" "lead"
8 Q0 24121792 103 32.415688 imi_mug_run_2_treatment "tcc"
8 Q0 29673906 104 32.40412 imi_mug_run_2_treatment "medicine"
8 Q0 26041878 105 32.379562 imi_mug_run_2_treatment "pdx"
8 Q0 22873290 106 32.28522 imi_mug_run_2_treatment "tcc"
8 Q0 19955487 107 32.158623 imi_mug_run_2_treatment "pd173074" "urea" "tyrosine kinase inhibitor"
8 Q0 27611947 108 31.965427 imi_mug_run_2_treatment "combinations" "ras"
8 Q0 25284004 109 31.964493 imi_mug_run_2_treatment "dovitinib" "monoclonal antibodies"
8 Q0 29262532 110 31.884073 imi_mug_run_2_treatment "tandem"
8 Q0 27930669 111 31.677647 imi_mug_run_2_treatment "formaldehyde"
8 Q0 21792889 112 31.553635 imi_mug_run_2_treatment "tamoxifen" "fulvestrant" "lead"
8 Q0 17049235 113 31.462889 imi_mug_run_2_treatment "various" "drug"
8 Q0 27664399 114 31.36586 imi_mug_run_2_treatment "drug" "fluazuron" "drugs"
8 Q0 10918587 115 31.296955 imi_mug_run_2_treatment "glu"
8 Q0 19663734 116 30.955124 imi_mug_run_2_treatment "lead"
8 Q0 29573965 117 30.906418 imi_mug_run_2_treatment "ras" "lead"
8 Q0 22899908 118 30.800552 imi_mug_run_2_treatment "cytostatic" "cytotoxic" "ras"
8 Q0 22010395 119 30.76941 imi_mug_run_2_treatment "therapeutics" "ras"
8 Q0 27029060 120 30.638592 imi_mug_run_2_treatment "mpt0l145" "cisplatin" "therapeutic agent"
8 Q0 16474624 121 30.592434 imi_mug_run_2_treatment "tcc"
8 Q0 19789314 122 30.493074 imi_mug_run_2_treatment "agent" "aim"
8 Q0 22334592 123 30.48994 imi_mug_run_2_treatment "celastrol" "oxygen" "mediated"
8 Q0 15897885 124 30.425621 imi_mug_run_2_treatment "ras"
8 Q0 21173382 125 30.240662 imi_mug_run_2_treatment "histone deacetylase inhibitor" "demethylating agent"
8 Q0 25326864 126 30.20475 imi_mug_run_2_treatment "factor viii" "fgf-1"
8 Q0 25493074 127 30.126945 imi_mug_run_2_treatment "various" "aim"
8 Q0 28597078 128 30.046429 imi_mug_run_2_treatment "various" "others"
8 Q0 27267856 129 29.999086 imi_mug_run_2_treatment "trastuzumab" "dovitinib" "duration"
8 Q0 25311528 130 29.967205 imi_mug_run_2_treatment "tyrosine"
8 Q0 25431236 131 29.934559 imi_mug_run_2_treatment "basis"
8 Q0 26924873 132 29.738762 imi_mug_run_2_treatment "plasma"
8 Q0 26238783 133 29.66423 imi_mug_run_2_treatment "combinations" "favor"
8 Q0 25344675 134 29.511616 imi_mug_run_2_treatment "cisplatin"
8 Q0 20015323 135 29.490837 imi_mug_run_2_treatment "igf2"
8 Q0 25232488 136 29.226044 imi_mug_run_2_treatment "estrogens" "zinc" "anti-androgens"
8 Q0 21504385 137 29.218998 imi_mug_run_2_treatment "tma"
8 Q0 27835695 138 29.211815 imi_mug_run_2_treatment "oxygen" "deferoxamine mesilate" "salt"
8 Q0 27746284 139 29.131489 imi_mug_run_2_treatment "lead"
8 Q0 22285006 140 29.131273 imi_mug_run_2_treatment "therapeutics"
8 Q0 27998968 141 29.1297 imi_mug_run_2_treatment "drug"
8 Q0 27197067 142 28.982365 imi_mug_run_2_treatment "blockade" "immunol"
8 Q0 24626198 143 28.956396 imi_mug_run_2_treatment "ras" "mediated"
8 Q0 24519156 144 28.920353 imi_mug_run_2_treatment "level"
8 Q0 27885740 145 28.85352 imi_mug_run_2_treatment "gemcitabine" "adriamycin"
8 Q0 19901323 146 28.72665 imi_mug_run_2_treatment "drug" "tandem" "pervanadate"
8 Q0 23558953 147 28.56312 imi_mug_run_2_treatment "program"
8 Q0 30171455 148 28.561214 imi_mug_run_2_treatment "cisplatin"
8 Q0 24456664 149 28.537882 imi_mug_run_2_treatment "therapeutics"
8 Q0 26425723 150 28.512531 imi_mug_run_2_treatment "vaccine" "tyrosine kinase inhibitor"
8 Q0 23696246 151 28.364845 imi_mug_run_2_treatment "therapeutics" "dovitinib" "azd4547"
8 Q0 20439987 152 28.29869 imi_mug_run_2_treatment "nf449" "mediated" "ccl4"
8 Q0 11827956 153 28.287315 imi_mug_run_2_treatment "tyr" "yeast"
8 Q0 23744832 154 28.251822 imi_mug_run_2_treatment "combinations"
8 Q0 19821490 155 28.24612 imi_mug_run_2_treatment "basis"
8 Q0 21504907 156 28.061125 imi_mug_run_2_treatment "ras"
8 Q0 30267148 157 28.040272 imi_mug_run_2_treatment "various"
8 Q0 30061236 158 27.97383 imi_mug_run_2_treatment "aim"
8 Q0 25535896 159 27.64973 imi_mug_run_2_treatment "pd173074"
8 Q0 25801230 160 27.580677 imi_mug_run_2_treatment "aim"
8 Q0 20012924 161 27.523863 imi_mug_run_2_treatment "mediated" "level"
8 Q0 18794123 162 27.521225 imi_mug_run_2_treatment "ndga" "nordihydroguaiaretic acid"
8 Q0 24525232 163 27.512486 imi_mug_run_2_treatment "cisplatin" "methotrexate" "vinblastine"
8 Q0 23478169 164 27.430851 imi_mug_run_2_treatment "program" "matrix"
8 Q0 20234367 165 27.12762 imi_mug_run_2_treatment "mediated"
8 Q0 15105428 166 27.11547 imi_mug_run_2_treatment "tyr"
8 Q0 26078354 167 26.991304 imi_mug_run_2_treatment "arginine" "methyltransferase inhibitor"
8 Q0 26452803 168 26.989857 imi_mug_run_2_treatment "mce"
8 Q0 26547270 169 26.9053 imi_mug_run_2_treatment "shh"
8 Q0 16384584 170 26.555882 imi_mug_run_2_treatment "mediated" "lead"
8 Q0 27053219 171 26.49552 imi_mug_run_2_treatment "aim"
8 Q0 17697126 172 26.415462 imi_mug_run_2_treatment "mitogens" "genesis"
8 Q0 20651335 173 26.376652 imi_mug_run_2_treatment "bortezomib" "mediated"
8 Q0 22422829 174 26.291252 imi_mug_run_2_treatment "level"
8 Q0 26604796 175 26.26295 imi_mug_run_2_treatment "cisplatin" "nitrosourea" "mediated"
8 Q0 11975324 176 26.225471 imi_mug_run_2_treatment "favor"
8 Q0 26486077 177 26.10735 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
8 Q0 24250280 178 25.891644 imi_mug_run_2_treatment "combinations" "generic" "balance"
8 Q0 17673550 179 25.867119 imi_mug_run_2_treatment "alpha subunit"
8 Q0 25217465 180 25.78569 imi_mug_run_2_treatment "lead"
8 Q0 21119661 181 25.657553 imi_mug_run_2_treatment "su5402" "pd173074" "drugs"
8 Q0 26171066 182 25.195518 imi_mug_run_2_treatment "level" "aim"
8 Q0 21782482 183 25.150703 imi_mug_run_2_treatment "intravesical bcg"
8 Q0 29679612 184 24.99614 imi_mug_run_2_treatment "mediated"
8 Q0 24909170 185 24.98028 imi_mug_run_2_treatment "ponatinib"
8 Q0 24295726 186 24.885082 imi_mug_run_2_treatment "ras"
8 Q0 21936542 187 24.873363 imi_mug_run_2_treatment "nvp-bgj398" "piperazin" "urea"
8 Q0 29991799 188 24.757683 imi_mug_run_2_treatment "mediated"
8 Q0 27829236 189 24.529198 imi_mug_run_2_treatment "level"
8 Q0 29110841 190 24.412056 imi_mug_run_2_treatment "erlotinib" "adc" "etoposide"
8 Q0 23727984 191 24.40129 imi_mug_run_2_treatment "mediated"
8 Q0 16470587 192 24.332836 imi_mug_run_2_treatment "histidine" "matrix"
8 Q0 22926521 193 24.212543 imi_mug_run_2_treatment "tma"
8 Q0 25294908 194 24.13308 imi_mug_run_2_treatment "epidermal growth factor" "gefitinib"
8 Q0 29323298 195 23.903805 imi_mug_run_2_treatment "anabolic" "oxygen"
8 Q0 27345413 196 23.881716 imi_mug_run_2_treatment "blockade" "mediated" "ras"
8 Q0 28255359 197 23.805319 imi_mug_run_2_treatment "mediated"
8 Q0 27870574 198 23.643059 imi_mug_run_2_treatment "kinase inhibitor" "tyrosine kinase inhibitor" "basis"
8 Q0 21521775 199 23.637783 imi_mug_run_2_treatment "drugs" "dovitinib" "brdu"
8 Q0 26351323 200 23.533096 imi_mug_run_2_treatment "combinations" "azd5363" "agar"
8 Q0 26075305 201 23.421928 imi_mug_run_2_treatment "tyrosine"
8 Q0 28108151 202 23.221964 imi_mug_run_2_treatment "drug" "fgfr inhibitor azd4547" "pi3k inhibitor bkm120"
8 Q0 19404844 203 23.063734 imi_mug_run_2_treatment "aim"
8 Q0 26887047 204 23.022057 imi_mug_run_2_treatment "aim"
8 Q0 23298836 205 23.005543 imi_mug_run_2_treatment "drug" "tandem" "lead"
8 Q0 28427506 206 22.702183 imi_mug_run_2_treatment "cisplatin" "adjuvant" "ras"
8 Q0 28775129 207 22.561714 imi_mug_run_2_treatment "level"
8 Q0 26497743 208 22.351782 imi_mug_run_2_treatment "fgfr inhibitor azd4547" "platinum"
8 Q0 16965395 209 22.232311 imi_mug_run_2_treatment "epidermal growth factor"
8 Q0 29518612 210 22.168587 imi_mug_run_2_treatment "various" "alkaloid"
8 Q0 28340475 211 22.024025 imi_mug_run_2_treatment "drug" "irinotecan" "pd173074"
8 Q0 29299828 212 21.99321 imi_mug_run_2_treatment "level"
8 Q0 21577207 213 21.913177 imi_mug_run_2_treatment "drug" "pd173074" "mediated"
8 Q0 21383697 214 21.758482 imi_mug_run_2_treatment "mediated" "various" "epidermal growth factor"
8 Q0 22893791 215 21.672882 imi_mug_run_2_treatment "drugs" "estrogen"
8 Q0 26244699 216 21.655308 imi_mug_run_2_treatment "buffer"
8 Q0 22932667 217 21.455282 imi_mug_run_2_treatment "lead" "aim"
8 Q0 11294897 218 21.398136 imi_mug_run_2_treatment "tyrosine" "phenylalanine"
8 Q0 23661334 219 21.32193 imi_mug_run_2_treatment "pace"
8 Q0 18366975 220 21.16949 imi_mug_run_2_treatment "therapeutic agents"
8 Q0 24619956 221 20.899467 imi_mug_run_2_treatment "blockade" "sulindac sulfide amide"
8 Q0 22777346 222 20.79986 imi_mug_run_2_treatment "spg"
8 Q0 19458078 223 20.620964 imi_mug_run_2_treatment "level" "agar" "basis"
8 Q0 24588013 224 20.562088 imi_mug_run_2_treatment "various" "tandem" "therapeutics"
8 Q0 23185502 225 20.290127 imi_mug_run_2_treatment "pd173074" "level" "aim"
8 Q0 22730329 226 20.239721 imi_mug_run_2_treatment "ras" "drug" "vemurafenib"
8 Q0 16801131 227 20.202728 imi_mug_run_2_treatment "lead"
8 Q0 20406976 228 20.127285 imi_mug_run_2_treatment "level"
8 Q0 19243295 229 20.006664 imi_mug_run_2_treatment "pd173074" "therapeutic agents"
8 Q0 30343534 230 19.974514 imi_mug_run_2_treatment "selumetinib" "mediated" "pd173074"
8 Q0 17607666 231 19.873096 imi_mug_run_2_treatment "tma" "level"
8 Q0 26651075 232 19.747334 imi_mug_run_2_treatment "kinase inhibitor" "drugs"
8 Q0 21356388 233 19.720865 imi_mug_run_2_treatment "mediators" "fibroblast growth factor 1"
8 Q0 28169993 234 19.698423 imi_mug_run_2_treatment "enzymes" "medicine" "mediated"
8 Q0 27189274 235 19.69209 imi_mug_run_2_treatment "various"
8 Q0 23778488 236 19.688377 imi_mug_run_2_treatment "aim"
8 Q0 20601886 237 19.637106 imi_mug_run_2_treatment "natriuretic peptide" "therapeutic agents"
8 Q0 24467821 238 19.43289 imi_mug_run_2_treatment "anticancer agents" "cytotoxic" "agent"
8 Q0 27059373 239 19.22744 imi_mug_run_2_treatment "ras"
8 Q0 23926649 240 19.218233 imi_mug_run_2_treatment "lead"
8 Q0 29161613 241 19.211412 imi_mug_run_2_treatment "basis"
8 Q0 27933954 242 19.10073 imi_mug_run_2_treatment "various" "debio 1347" "ch5183284"
8 Q0 29588307 243 19.083616 imi_mug_run_2_treatment "mtor inhibitor" "temsirolimus" "investigational agent"
8 Q0 17949785 244 18.946571 imi_mug_run_2_treatment "histidine"
8 Q0 26318045 245 18.879484 imi_mug_run_2_treatment "various" "zinc" "mediated"
8 Q0 26574622 246 18.764082 imi_mug_run_2_treatment "ponatinib" "ap24534" "tyrosine kinase inhibitor"
8 Q0 20126581 247 18.745054 imi_mug_run_2_treatment "mbc" "tff" "pthrp"
8 Q0 27932416 248 18.558437 imi_mug_run_2_treatment "dovitinib"
8 Q0 25169980 249 18.459702 imi_mug_run_2_treatment "various" "enzymes" "debio 1347"
8 Q0 19165726 250 18.367645 imi_mug_run_2_treatment "various" "lead"
8 Q0 25807773 251 18.315058 imi_mug_run_2_treatment "bisulfite" "basis"
8 Q0 19694823 252 18.252544 imi_mug_run_2_treatment "various" "aim"
8 Q0 20334706 253 18.203522 imi_mug_run_2_treatment "ras" "genesis"
8 Q0 27245147 254 18.200474 imi_mug_run_2_treatment "dovitinib" "azd4547" "ponatinib"
8 Q0 26224133 255 18.153408 imi_mug_run_2_treatment "pazopanib" "regorafenib" "lenvatinib"
8 Q0 21655918 256 18.13224 imi_mug_run_2_treatment "kinase inhibitor" "foretinib" "kato"
8 Q0 29854313 257 18.11779 imi_mug_run_2_treatment "basis"
8 Q0 10366448 258 18.011852 imi_mug_run_2_treatment "various"
8 Q0 30267839 259 17.973995 imi_mug_run_2_treatment "various" "jnj-42756493"
8 Q0 22493262 260 17.922253 imi_mug_run_2_treatment "aristolochic acid"
8 Q0 29037125 261 17.798214 imi_mug_run_2_treatment "various" "il-10"
8 Q0 21726664 262 17.70267 imi_mug_run_2_treatment "medicine" "formalin"
8 Q0 27845189 263 17.690964 imi_mug_run_2_treatment "adc"
8 Q0 25477232 264 17.63551 imi_mug_run_2_treatment "taxane"
8 Q0 30060526 265 17.616447 imi_mug_run_2_treatment "combinations" "adc" "level"
8 Q0 28794627 266 17.578753 imi_mug_run_2_treatment "therapeutics" "azd4547"
8 Q0 28657667 267 17.270027 imi_mug_run_2_treatment "protein c" "aim"
8 Q0 27017984 268 17.219559 imi_mug_run_2_treatment "others" "lead"
8 Q0 27992319 269 17.061697 imi_mug_run_2_treatment "therapeutics" "monoclonal antibodies"
8 Q0 15655558 270 16.977654 imi_mug_run_2_treatment "paclitaxel" "human cap" "taxol"
8 Q0 28852916 271 16.921959 imi_mug_run_2_treatment "vbl" "mebendazole" "vinblastine"
8 Q0 29617662 272 16.895891 imi_mug_run_2_treatment "drug"
8 Q0 10023681 273 16.83736 imi_mug_run_2_treatment "level"
8 Q0 18156174 274 16.762026 imi_mug_run_2_treatment "epidermal growth factor" "tyr" "cyclic amp"
8 Q0 24608573 275 16.686192 imi_mug_run_2_treatment "therapeutics" "aim"
8 Q0 23573312 276 16.668142 imi_mug_run_2_treatment "ptx" "aim" "drugs"
8 Q0 22874768 277 16.616308 imi_mug_run_2_treatment "mediated" "lead"
8 Q0 23658459 278 16.59529 imi_mug_run_2_treatment "dovitinib" "silver" "basis"
8 Q0 22585860 279 16.576786 imi_mug_run_2_treatment "mediated" "opioid" "suppressor"
8 Q0 23466786 280 16.576786 imi_mug_run_2_treatment "blockade"
8 Q0 29110262 281 16.576786 imi_mug_run_2_treatment "aim"
8 Q0 24662823 282 16.551537 imi_mug_run_2_treatment "various" "drugs" "therapeutic antibody"
8 Q0 12066199 283 16.53959 imi_mug_run_2_treatment "cisplatin" "collagens" "angiogenesis inhibitors"
8 Q0 23880303 284 16.536566 imi_mug_run_2_treatment "therapeutics"
8 Q0 8099571 285 16.529276 imi_mug_run_2_treatment "estrogen" "progesterone"
8 Q0 28665395 286 16.499126 imi_mug_run_2_treatment "idelalisib" "cal-101"
8 Q0 25394791 287 16.286448 imi_mug_run_2_treatment "drug combinations" "drugs"
8 Q0 20811704 288 16.266338 imi_mug_run_2_treatment "various" "trastuzumab" "drug"
8 Q0 30275180 289 16.225937 imi_mug_run_2_treatment "ras" "basis"
8 Q0 23754791 290 15.841473 imi_mug_run_2_treatment "glycans" "glycan" "matrix"
8 Q0 16915569 291 15.810004 imi_mug_run_2_treatment "matrix"
8 Q0 27914362 292 15.805698 imi_mug_run_2_treatment "tyrosine"
8 Q0 29656465 293 15.798964 imi_mug_run_2_treatment "basis" "ssr128129e"
8 Q0 24946519 294 15.646807 imi_mug_run_2_treatment "drugs"
8 Q0 23107319 295 15.468476 imi_mug_run_2_treatment "various" "various combinations" "others"
8 Q0 26351897 296 15.464003 imi_mug_run_2_treatment "im-412" "mediated" "therapeutic agent"
8 Q0 27741505 297 15.460812 imi_mug_run_2_treatment "sunitinib" "sorafenib" "temsirolimus"
8 Q0 30171725 298 15.413128 imi_mug_run_2_treatment "nnk" "niacin" "nicotinamide adenine dinucleotide"
8 Q0 20595807 299 15.38843 imi_mug_run_2_treatment "cisplatin" "platinum" "aim"
8 Q0 29665843 300 15.166509 imi_mug_run_2_treatment "vandetanib"
8 Q0 29545752 301 15.163404 imi_mug_run_2_treatment "sam" "arginine" "s-adenosylmethionine"
8 Q0 25669975 302 15.158443 imi_mug_run_2_treatment "ras"
8 Q0 22553347 303 15.158443 imi_mug_run_2_treatment "drugs"
8 Q0 28475287 304 15.158443 imi_mug_run_2_treatment "cck-8" "level"
8 Q0 16115125 305 15.123094 imi_mug_run_2_treatment "id-1"
8 Q0 21078999 306 15.123094 imi_mug_run_2_treatment "ras"
8 Q0 29656442 307 15.0797825 imi_mug_run_2_treatment "lenvatinib" "dtc" "e7080"
8 Q0 24638926 308 15.050013 imi_mug_run_2_treatment "basis"
8 Q0 24405856 309 14.993427 imi_mug_run_2_treatment "masitinib" "drug" "imatinib"
8 Q0 28953502 310 14.993427 imi_mug_run_2_treatment "carboplatin" "paclitaxel" "al3818"
8 Q0 23679838 311 14.99155 imi_mug_run_2_treatment "various" "lead"
8 Q0 15561781 312 14.755762 imi_mug_run_2_treatment "androgen" "fgf-1" "mediated"
8 Q0 27095739 313 14.611155 imi_mug_run_2_treatment "drugs" "liver"
8 Q0 24520095 314 14.575084 imi_mug_run_2_treatment "sorafenib" "hdac inhibitor" "mediated"
8 Q0 27812884 315 14.566475 imi_mug_run_2_treatment "carboplatin" "paclitaxel" "alofanib"
8 Q0 27218826 316 14.531796 imi_mug_run_2_treatment "igf2"
8 Q0 24323028 317 14.494442 imi_mug_run_2_treatment "therapeutics"
8 Q0 23820017 318 14.490789 imi_mug_run_2_treatment "level"
8 Q0 20052764 319 14.485979 imi_mug_run_2_treatment "lead" "level"
8 Q0 28179005 320 14.218231 imi_mug_run_2_treatment "aim"
8 Q0 17103032 321 14.124829 imi_mug_run_2_treatment "arbutin"
8 Q0 21881272 322 14.124829 imi_mug_run_2_treatment "proteinase" "symmetry"
8 Q0 27231484 323 14.060141 imi_mug_run_2_treatment "drug" "drugs"
8 Q0 28824643 324 13.983608 imi_mug_run_2_treatment "collagen" "leucine"
8 Q0 26686047 325 13.977334 imi_mug_run_2_treatment "lead"
8 Q0 29546640 326 13.977334 imi_mug_run_2_treatment "hot spot" "aim"
8 Q0 28675510 327 13.932743 imi_mug_run_2_treatment "mpl"
8 Q0 25623536 328 13.922333 imi_mug_run_2_treatment "medicine" "lead"
8 Q0 25628921 329 13.843939 imi_mug_run_2_treatment "drug" "dovitinib" "tki258"
8 Q0 29045509 330 13.546862 imi_mug_run_2_treatment "drug" "adc" "cytotoxic agent"
8 Q0 26397152 331 13.427954 imi_mug_run_2_treatment "aristolochic acid"
8 Q0 24997326 332 13.120521 imi_mug_run_2_treatment "imatinib"
8 Q0 27438523 333 13.120521 imi_mug_run_2_treatment "basis"
8 Q0 21264207 334 13.120521 imi_mug_run_2_treatment "aim"
8 Q0 30075157 335 13.120521 imi_mug_run_2_treatment "thyroglobulin"
8 Q0 22342158 336 13.08054 imi_mug_run_2_treatment "monolayers" "animals"
8 Q0 16595896 337 13.08054 imi_mug_run_2_treatment "kojic acid" "agent"
8 Q0 25219510 338 13.073426 imi_mug_run_2_treatment "dovitinib" "ponatinib"
8 Q0 25053532 339 13.073426 imi_mug_run_2_treatment "ras"
8 Q0 22977516 340 13.073426 imi_mug_run_2_treatment "insulin" "trastuzumab" "various"
8 Q0 28359267 341 13.073426 imi_mug_run_2_treatment "level"
8 Q0 27283290 342 12.772409 imi_mug_run_2_treatment "vandetanib" "aim"
8 Q0 28619094 343 12.452126 imi_mug_run_2_treatment "aim"
8 Q0 28324520 344 12.225733 imi_mug_run_2_treatment "various" "level"
8 Q0 28102887 345 12.186842 imi_mug_run_2_treatment "nintedanib" "agent" "tyrosine kinase inhibitor"
8 Q0 26992226 346 12.176964 imi_mug_run_2_treatment "ap24534" "azd4547"
8 Q0 28029662 347 11.966917 imi_mug_run_2_treatment "drug" "pf-04691502" "cisplatin"
8 Q0 18172295 348 11.656279 imi_mug_run_2_treatment "various" "aza"
8 Q0 25589618 349 11.651808 imi_mug_run_2_treatment "ras" "aim"
8 Q0 27502722 350 11.651808 imi_mug_run_2_treatment "pmp"
8 Q0 26260906 351 11.627139 imi_mug_run_2_treatment "tandem" "mediated"
8 Q0 25950492 352 11.627139 imi_mug_run_2_treatment "drugs"
8 Q0 25633079 353 11.627139 imi_mug_run_2_treatment "platinum" "others"
8 Q0 25135958 354 11.627139 imi_mug_run_2_treatment "temozolomide"
8 Q0 30220708 355 11.627139 imi_mug_run_2_treatment "everolimus" "pazopanib" "tyrosine"
8 Q0 24370037 356 11.589813 imi_mug_run_2_treatment "level"
8 Q0 25267789 357 11.571498 imi_mug_run_2_treatment "duration"
8 Q0 24658394 358 11.555016 imi_mug_run_2_treatment "cancer drug"
8 Q0 25413587 359 11.548424 imi_mug_run_2_treatment "autologous"
8 Q0 21223544 360 11.540595 imi_mug_run_2_treatment "tonic"
8 Q0 14534538 361 11.535526 imi_mug_run_2_treatment "ras" "tyrosine" "ly294002"
8 Q0 7592624 362 11.535526 imi_mug_run_2_treatment "heparin" "mitogen" "product"
8 Q0 22325359 363 11.535526 imi_mug_run_2_treatment "mediated" "mediators" "ras"
8 Q0 26282654 364 11.535526 imi_mug_run_2_treatment "ras" "level"
8 Q0 27095246 365 11.535526 imi_mug_run_2_treatment "ras"
8 Q0 16010693 366 11.53 imi_mug_run_2_treatment "various"
8 Q0 24990767 367 11.53 imi_mug_run_2_treatment "protein amino acid"
8 Q0 27581340 368 11.53 imi_mug_run_2_treatment "nintedanib"
8 Q0 23288641 369 11.53 imi_mug_run_2_treatment "drugs" "lenalidomide" "bortezomib"
8 Q0 28523296 370 11.53 imi_mug_run_2_treatment "aristolochic acid" "chinese herbs" "genesis"
8 Q0 30116384 371 11.53 imi_mug_run_2_treatment "medicine"
8 Q0 21447618 372 11.5072975 imi_mug_run_2_treatment "drugs"
8 Q0 25546673 373 10.141882 imi_mug_run_2_treatment "favor"
8 Q0 21673064 374 10.120451 imi_mug_run_2_treatment "combinations" "fp-1039" "drugs"
8 Q0 25556475 375 10.120451 imi_mug_run_2_treatment "others"
8 Q0 29533868 376 10.120451 imi_mug_run_2_treatment "opc"
8 Q0 22067401 377 10.0760975 imi_mug_run_2_treatment "ras" "sorafenib" "vemurafenib"
8 Q0 21319186 378 10.040781 imi_mug_run_2_treatment "drug" "agar" "deferoxamine mesylate"
8 Q0 26324363 379 10.040781 imi_mug_run_2_treatment "jnj-42756493" "tyrosine kinase inhibitor"
8 Q0 28776571 380 10.040781 imi_mug_run_2_treatment "drug"
8 Q0 27756406 381 10.035784 imi_mug_run_2_treatment "ras" "liver"
8 Q0 28749946 382 9.797314 imi_mug_run_2_treatment "level" "others" "drugs"
9 Q0 16287112 1 69.546486 imi_mug_run_2_treatment "lead"
9 Q0 15087667 2 69.268585 imi_mug_run_2_treatment "sti-571"
9 Q0 18234489 3 67.29823 imi_mug_run_2_treatment "imatinib" "adjuvant" "sunitinib"
9 Q0 17229322 4 66.31554 imi_mug_run_2_treatment "combinations" "growth hormone" "insulin-like growth factor ii"
9 Q0 27258566 5 63.036552 imi_mug_run_2_treatment "imatinib" "kinase inhibitor" "aim"
9 Q0 20823768 6 62.67737 imi_mug_run_2_treatment "liver"
9 Q0 27753268 7 62.440834 imi_mug_run_2_treatment "adjuvant" "imatinib" "aim"
9 Q0 20096441 8 61.35874 imi_mug_run_2_treatment "liver"
9 Q0 20021947 9 60.645897 imi_mug_run_2_treatment "imatinib" "imatinib mesylate" "agent"
9 Q0 22307903 10 60.58287 imi_mug_run_2_treatment "air"
9 Q0 23084635 11 60.477863 imi_mug_run_2_treatment "imatinib mesylate"
9 Q0 16721136 12 60.394848 imi_mug_run_2_treatment "sti-571" "gleevec" "imatinib mesylate"
9 Q0 20967481 13 59.97602 imi_mug_run_2_treatment "adjuvant" "imatinib" "imatinib mesylate"
9 Q0 17018739 14 59.313824 imi_mug_run_2_treatment "imatinib" "adjuvant" "tyrosine kinase inhibitor"
9 Q0 19047911 15 59.202705 imi_mug_run_2_treatment "gat"
9 Q0 23106360 16 59.165215 imi_mug_run_2_treatment "tyrosine"
9 Q0 15045935 17 59.025272 imi_mug_run_2_treatment "drug" "imatinib" "imatinib mesylate"
9 Q0 18618605 18 58.9639 imi_mug_run_2_treatment "tandem"
9 Q0 23092343 19 58.772366 imi_mug_run_2_treatment "imatinib" "drugs"
9 Q0 10702394 20 58.636543 imi_mug_run_2_treatment "lys" "glu"
9 Q0 16630479 21 58.584267 imi_mug_run_2_treatment "icc"
9 Q0 17334345 22 58.57515 imi_mug_run_2_treatment "various" "vascular endothelial growth factor"
9 Q0 26631948 23 58.059658 imi_mug_run_2_treatment "tandem" "aim"
9 Q0 16850124 24 57.880524 imi_mug_run_2_treatment "imatinib mesylate" "drug" "imatinib"
9 Q0 25645799 25 57.80139 imi_mug_run_2_treatment "liver"
9 Q0 26658996 26 57.63873 imi_mug_run_2_treatment "imatinib"
9 Q0 24061512 27 57.59354 imi_mug_run_2_treatment "imatinib" "basis" "liver"
9 Q0 20674415 28 57.571617 imi_mug_run_2_treatment "others"
9 Q0 21621171 29 57.512505 imi_mug_run_2_treatment "imatinib" "pegylated liposomal doxorubicin"
9 Q0 17545799 30 57.501106 imi_mug_run_2_treatment "imatinib" "sunitinib" "drugs"
9 Q0 23840364 31 57.43771 imi_mug_run_2_treatment "sorafenib" "nilotinib" "imatinib mesylate"
9 Q0 26396737 32 57.423027 imi_mug_run_2_treatment "kinase inhibitor" "sunitinib" "imatinib"
9 Q0 15131046 33 57.268295 imi_mug_run_2_treatment "amino acid"
9 Q0 29969914 34 57.11464 imi_mug_run_2_treatment "imatinib" "adjuvant" "aim"
9 Q0 27777285 35 56.98015 imi_mug_run_2_treatment "cabozantinib" "imatinib" "pdx"
9 Q0 22454176 36 56.88135 imi_mug_run_2_treatment "imatinib"
9 Q0 19390946 37 56.744312 imi_mug_run_2_treatment "sunitinib" "imatinib" "drug"
9 Q0 21237497 38 56.684067 imi_mug_run_2_treatment "imatinib"
9 Q0 11378651 39 56.576637 imi_mug_run_2_treatment "sti571" "tyrosine kinase inhibitor" "mast cell growth factor"
9 Q0 14645423 40 56.498413 imi_mug_run_2_treatment "imatinib" "imatinib mesylate"
9 Q0 12960119 41 56.44838 imi_mug_run_2_treatment "hot spot" "tandem"
9 Q0 22943011 42 56.339348 imi_mug_run_2_treatment "level"
9 Q0 26819809 43 56.181953 imi_mug_run_2_treatment "imatinib"
9 Q0 17632543 44 56.15748 imi_mug_run_2_treatment "imatinib"
9 Q0 11021812 45 56.116676 imi_mug_run_2_treatment "lead" "balance"
9 Q0 12655446 46 55.991093 imi_mug_run_2_treatment "imatinib mesylate" "sti571"
9 Q0 15894928 47 55.958862 imi_mug_run_2_treatment "sti 571" "gleevec" "imatinib mesylate"
9 Q0 22815156 48 55.889008 imi_mug_run_2_treatment "imatinib"
9 Q0 23001300 49 55.844826 imi_mug_run_2_treatment "tyr" "imatinib mesylate"
9 Q0 15549490 50 55.633392 imi_mug_run_2_treatment "imatinib"
9 Q0 20499309 51 55.5457 imi_mug_run_2_treatment "imatinib" "ras"
9 Q0 23536354 52 55.465904 imi_mug_run_2_treatment "imatinib mesylate"
9 Q0 16773696 53 55.382523 imi_mug_run_2_treatment "glivec" "imatinib mesylate" "aim"
9 Q0 18443532 54 55.377785 imi_mug_run_2_treatment "adjuvant" "imatinib"
9 Q0 26240289 55 55.264496 imi_mug_run_2_treatment "imatinib"
9 Q0 30523507 56 55.254852 imi_mug_run_2_treatment "plx9486" "pdx" "imatinib"
9 Q0 9588894 57 55.19149 imi_mug_run_2_treatment "icc" "aim"
9 Q0 23459373 58 55.182602 imi_mug_run_2_treatment "imatinib" "nilotinib"
9 Q0 24379393 59 55.15058 imi_mug_run_2_treatment "various" "mediated" "matrix"
9 Q0 16776326 60 54.93121 imi_mug_run_2_treatment "tyrosine kinase inhibitor"
9 Q0 15112348 61 54.890022 imi_mug_run_2_treatment "aim"
9 Q0 29568401 62 54.885475 imi_mug_run_2_treatment "plasma" "aim"
9 Q0 19562456 63 54.87787 imi_mug_run_2_treatment "liver" "imatinib"
9 Q0 19830214 64 54.849472 imi_mug_run_2_treatment "lead"
9 Q0 16539879 65 54.849392 imi_mug_run_2_treatment "imatinib"
9 Q0 16481303 66 54.812572 imi_mug_run_2_treatment "imatinib" "liver"
9 Q0 21224658 67 54.746315 imi_mug_run_2_treatment "imatinib mesylate" "adjuvant" "imatinib"
9 Q0 27073655 68 54.734207 imi_mug_run_2_treatment "sunitinib" "imatinib" "kinase inhibitor"
9 Q0 22015552 69 54.71694 imi_mug_run_2_treatment "imatinib" "drug" "kinase inhibitor"
9 Q0 21181476 70 54.58348 imi_mug_run_2_treatment "imatinib" "imatinib mesylate" "sunitinib"
9 Q0 16610057 71 54.580284 imi_mug_run_2_treatment "imatinib mesylate" "glivec" "duration"
9 Q0 19961019 72 54.57506 imi_mug_run_2_treatment "imatinib"
9 Q0 17565683 73 54.503967 imi_mug_run_2_treatment "adjuvant" "imatinib"
9 Q0 26805679 74 54.4225 imi_mug_run_2_treatment "adjuvant"
9 Q0 30142229 75 54.356148 imi_mug_run_2_treatment "kinase inhibitor" "drug" "imatinib"
9 Q0 25504284 76 54.35491 imi_mug_run_2_treatment "imatinib"
9 Q0 26779618 77 54.170765 imi_mug_run_2_treatment "imatinib" "sunitinib"
9 Q0 11526490 78 54.09758 imi_mug_run_2_treatment "sti571" "tyrosine kinase inhibitor" "level"
9 Q0 18350628 79 53.9358 imi_mug_run_2_treatment "aim"
9 Q0 25735500 80 53.922325 imi_mug_run_2_treatment "plasma" "imatinib"
9 Q0 18724244 81 53.89335 imi_mug_run_2_treatment "tyrosine"
9 Q0 24583793 82 53.88025 imi_mug_run_2_treatment "imatinib" "tyrosine kinase inhibitor"
9 Q0 18416137 83 53.802017 imi_mug_run_2_treatment "aminoacids"
9 Q0 17253141 84 53.77169 imi_mug_run_2_treatment "aim"
9 Q0 23116579 85 53.72377 imi_mug_run_2_treatment "imatinib" "adjuvant"
9 Q0 17643098 86 53.66723 imi_mug_run_2_treatment "eosin" "aim"
9 Q0 14726714 87 53.666664 imi_mug_run_2_treatment "imatinib mesylate" "product"
9 Q0 18294292 88 53.600407 imi_mug_run_2_treatment "imatinib" "drug"
9 Q0 18488000 89 53.562782 imi_mug_run_2_treatment "lead"
9 Q0 15742474 90 53.555634 imi_mug_run_2_treatment "glutamine" "leucine"
9 Q0 19248971 91 53.43338 imi_mug_run_2_treatment "drug trials" "imatinib mesylate"
9 Q0 12190287 92 53.39772 imi_mug_run_2_treatment "glutamine"
9 Q0 19620409 93 53.370712 imi_mug_run_2_treatment "imatinib"
9 Q0 20878498 94 53.259293 imi_mug_run_2_treatment "kinase inhibitor" "imatinib mesylate"
9 Q0 24758502 95 53.257057 imi_mug_run_2_treatment "drugs" "imatinib"
9 Q0 15793646 96 53.244488 imi_mug_run_2_treatment "imatinib"
9 Q0 18246046 97 53.201202 imi_mug_run_2_treatment "imatinib"
9 Q0 18955458 98 53.175667 imi_mug_run_2_treatment "sunitinib" "imatinib"
9 Q0 24997326 99 53.063828 imi_mug_run_2_treatment "imatinib"
9 Q0 18636362 100 53.0343 imi_mug_run_2_treatment "tandem"
9 Q0 23326179 101 53.02412 imi_mug_run_2_treatment "adjuvant" "imatinib" "imatinib mesylate"
9 Q0 10835530 102 52.947353 imi_mug_run_2_treatment "arginine"
9 Q0 27263309 103 52.93347 imi_mug_run_2_treatment "various"
9 Q0 27163723 104 52.913254 imi_mug_run_2_treatment "adjuvant" "drugs" "imatinib"
9 Q0 20976730 105 52.907227 imi_mug_run_2_treatment "imatinib mesylate"
9 Q0 17498562 106 52.88998 imi_mug_run_2_treatment "lead" "level"
9 Q0 19248972 107 52.83454 imi_mug_run_2_treatment "imatinib mesylate"
9 Q0 18312355 108 52.827858 imi_mug_run_2_treatment "imatinib" "sunitinib" "tyrosine kinase inhibitor"
9 Q0 22164425 109 52.70603 imi_mug_run_2_treatment "fletcher's" "gleevec"
9 Q0 27178185 110 52.64717 imi_mug_run_2_treatment "plasma"
9 Q0 22489857 111 52.63624 imi_mug_run_2_treatment "liver"
9 Q0 16077968 112 52.59977 imi_mug_run_2_treatment "imatinib" "various"
9 Q0 20633291 113 52.535618 imi_mug_run_2_treatment "motesanib" "imatinib" "vascular endothelial growth factor"
9 Q0 26074249 114 52.526993 imi_mug_run_2_treatment "imatinib mesylate" "ile" "mct"
9 Q0 17867582 115 52.5198 imi_mug_run_2_treatment "imatinib" "su 11248" "tyrosine kinase inhibitor"
9 Q0 22229850 116 52.48253 imi_mug_run_2_treatment "imatinib mesylate" "drugs" "revolution"
9 Q0 17450496 117 52.452858 imi_mug_run_2_treatment "gleevec" "imatinib mesylate"
9 Q0 15309514 118 52.422398 imi_mug_run_2_treatment "imatinib mesylate" "agent" "tyrosine kinase inhibitor"
9 Q0 15921306 119 52.355434 imi_mug_run_2_treatment "lime" "imatinib" "aim"
9 Q0 23267143 120 52.35066 imi_mug_run_2_treatment "drugs" "imatinib" "sunitinib"
9 Q0 17699867 121 52.343925 imi_mug_run_2_treatment "imatinib" "sorafenib" "nilotinib"
9 Q0 18525340 122 52.333042 imi_mug_run_2_treatment "imatinib"
9 Q0 25294914 123 52.31432 imi_mug_run_2_treatment "imatinib" "adjuvant"
9 Q0 26170517 124 52.172436 imi_mug_run_2_treatment "level"
9 Q0 15507676 125 52.123714 imi_mug_run_2_treatment "kinase inhibitor" "gleevec" "imatinib mesylate"
9 Q0 16952044 126 52.000553 imi_mug_run_2_treatment "imatinib"
9 Q0 20690803 127 51.991108 imi_mug_run_2_treatment "imatinib" "sunitinib"
9 Q0 22454158 128 51.903694 imi_mug_run_2_treatment "sunitinib" "drugs" "imatinib"
9 Q0 22454169 129 51.86192 imi_mug_run_2_treatment "imatinib"
9 Q0 25222580 130 51.855583 imi_mug_run_2_treatment "imatinib" "aim"
9 Q0 16786129 131 51.841705 imi_mug_run_2_treatment "imatinib" "kinase inhibitor"
9 Q0 24159917 132 51.804134 imi_mug_run_2_treatment "adjuvant" "dioxin" "imatinib mesylate"
9 Q0 21386653 133 51.787964 imi_mug_run_2_treatment "imatinib mesylate"
9 Q0 21566429 134 51.675156 imi_mug_run_2_treatment "imatinib" "drug" "kinase inhibitor"
9 Q0 16624552 135 51.661846 imi_mug_run_2_treatment "imatinib" "drug"
9 Q0 11431711 136 51.616833 imi_mug_run_2_treatment "sti-571" "chemotherapeutic agent" "medicine"
9 Q0 22572723 137 51.551903 imi_mug_run_2_treatment "various" "imatinib" "adjuvant"
9 Q0 22150077 138 51.42849 imi_mug_run_2_treatment "imatinib" "imatinib 400 mg"
9 Q0 21932185 139 51.41146 imi_mug_run_2_treatment "drug" "imatinib"
9 Q0 21527063 140 51.308594 imi_mug_run_2_treatment "lead" "therapeutics" "sti-571"
9 Q0 23599150 141 51.267796 imi_mug_run_2_treatment "imatinib" "adjuvant"
9 Q0 16928224 142 51.245186 imi_mug_run_2_treatment "aim"
9 Q0 27430179 143 51.148132 imi_mug_run_2_treatment "basis"
9 Q0 20079191 144 51.0864 imi_mug_run_2_treatment "imatinib mesylate" "glivec" "shape"
9 Q0 15795882 145 51.085022 imi_mug_run_2_treatment "adjuvant"
9 Q0 24145645 146 51.077545 imi_mug_run_2_treatment "basis" "aim"
9 Q0 20806443 147 51.0574 imi_mug_run_2_treatment "imatinib" "aim"
9 Q0 21547131 148 51.04841 imi_mug_run_2_treatment "sunitinib" "imatinib" "imatinib mesylate"
9 Q0 27777718 149 50.94924 imi_mug_run_2_treatment "various" "mediated" "lead"
9 Q0 20489620 150 50.94835 imi_mug_run_2_treatment "plasma" "level" "imatinib"
9 Q0 21658742 151 50.921036 imi_mug_run_2_treatment "eosin"
9 Q0 16238204 152 50.83404 imi_mug_run_2_treatment "thyroxine"
9 Q0 19139121 153 50.814045 imi_mug_run_2_treatment "imatinib" "tae226"
9 Q0 27920660 154 50.80058 imi_mug_run_2_treatment "collagen"
9 Q0 22029680 155 50.74545 imi_mug_run_2_treatment "product"
9 Q0 11472565 156 50.71627 imi_mug_run_2_treatment "icc" "lead" "monoclonal antibodies"
9 Q0 25202087 157 50.71021 imi_mug_run_2_treatment "sunitinib" "imatinib" "imatinib mesylate"
9 Q0 26770446 158 50.678574 imi_mug_run_2_treatment "sunitinib" "reverse t3" "agent"
9 Q0 23606918 159 50.648243 imi_mug_run_2_treatment "imatinib"
9 Q0 24369323 160 50.6315 imi_mug_run_2_treatment "imatinib"
9 Q0 12355934 161 50.61968 imi_mug_run_2_treatment "imatinib mesylate" "drug" "sti 571"
9 Q0 20389135 162 50.5927 imi_mug_run_2_treatment "imatinib" "sunitinib" "drug"
9 Q0 28632504 163 50.56789 imi_mug_run_2_treatment "various"
9 Q0 15154382 164 50.55048 imi_mug_run_2_treatment "agent"
9 Q0 14675690 165 50.52037 imi_mug_run_2_treatment "imatinib mesylate"
9 Q0 19537128 166 50.405666 imi_mug_run_2_treatment "various" "gleevec" "imatinib mesylate"
9 Q0 16334774 167 50.34406 imi_mug_run_2_treatment "sti571" "medicine" "medicated"
9 Q0 20598160 168 50.254295 imi_mug_run_2_treatment "imatinib"
9 Q0 23579364 169 50.226173 imi_mug_run_2_treatment "tyrosine" "imatinib" "sunitinib"
9 Q0 19411681 170 50.224243 imi_mug_run_2_treatment "imatinib"
9 Q0 21475850 171 50.206783 imi_mug_run_2_treatment "imatinib" "tyrosine"
9 Q0 17532173 172 50.198364 imi_mug_run_2_treatment "various" "imatinib"
9 Q0 15897563 173 50.171333 imi_mug_run_2_treatment "imatinib mesylate" "imatinib" "tyrosine kinase inhibitor"
9 Q0 15007386 174 50.17042 imi_mug_run_2_treatment "kinase inhibitor" "sti571" "gleevec"
9 Q0 15365079 175 50.13414 imi_mug_run_2_treatment "kinase inhibitor" "imatinib"
9 Q0 15168243 176 50.09741 imi_mug_run_2_treatment "sti571" "imatinib mesylate" "drug"
9 Q0 15553717 177 50.043236 imi_mug_run_2_treatment "sti571" "imatinib mesylate" "gleevec"
9 Q0 15872385 178 49.986515 imi_mug_run_2_treatment "drug" "imatinib mesylate" "matrix"
9 Q0 12239933 179 49.95894 imi_mug_run_2_treatment "liver"
9 Q0 15723656 180 49.9559 imi_mug_run_2_treatment "sti571" "glivec"
9 Q0 19430004 181 49.94244 imi_mug_run_2_treatment "imatinib" "sunitinib" "adjuvant"
9 Q0 24760634 182 49.938103 imi_mug_run_2_treatment "imatinib" "sunitinib" "pazopanib"
9 Q0 21319869 183 49.91083 imi_mug_run_2_treatment "adjuvant" "drugs" "imatinib"
9 Q0 17943734 184 49.878433 imi_mug_run_2_treatment "imatinib"
9 Q0 30003531 185 49.84829 imi_mug_run_2_treatment "various"
9 Q0 23283817 186 49.831913 imi_mug_run_2_treatment "genesis"
9 Q0 12683877 187 49.812042 imi_mug_run_2_treatment "liver"
9 Q0 28074523 188 49.779827 imi_mug_run_2_treatment "imatinib"
9 Q0 19496720 189 49.7351 imi_mug_run_2_treatment "imatinib" "imatinib 400 mg" "sunitinib 50 mg"
9 Q0 15154005 190 49.717407 imi_mug_run_2_treatment "lys"
9 Q0 20124181 191 49.67334 imi_mug_run_2_treatment "imatinib" "level"
9 Q0 27217036 192 49.629776 imi_mug_run_2_treatment "various" "imatinib" "duration"
9 Q0 25481675 193 49.622364 imi_mug_run_2_treatment "imatinib"
9 Q0 27345285 194 49.579594 imi_mug_run_2_treatment "various" "imatinib" "imatinib mesylate"
9 Q0 21825009 195 49.55175 imi_mug_run_2_treatment "ipi-504" "imatinib" "sunitinib"
9 Q0 15742414 196 49.54077 imi_mug_run_2_treatment "aim"
9 Q0 20166214 197 49.51655 imi_mug_run_2_treatment "imatinib"
9 Q0 23639648 198 49.492744 imi_mug_run_2_treatment "tyrosine kinase inhibitor"
9 Q0 23859518 199 49.452213 imi_mug_run_2_treatment "drug" "imatinib"
9 Q0 25414046 200 49.449787 imi_mug_run_2_treatment "imatinib"
9 Q0 15682856 201 49.441856 imi_mug_run_2_treatment "adrenal hormone"
9 Q0 26596853 202 49.440277 imi_mug_run_2_treatment "imatinib"
9 Q0 12783584 203 49.341705 imi_mug_run_2_treatment "imatinib mesylate" "adjuvant" "gleevec"
9 Q0 14978967 204 49.33639 imi_mug_run_2_treatment "liver"
9 Q0 16203282 205 49.32892 imi_mug_run_2_treatment "various" "imatinib" "aim"
9 Q0 16061643 206 49.32285 imi_mug_run_2_treatment "icc" "color"
9 Q0 17090188 207 49.288734 imi_mug_run_2_treatment "imatinib" "tyrosine kinase inhibitor"
9 Q0 26772734 208 49.228012 imi_mug_run_2_treatment "sunitinib" "imatinib" "metrics"
9 Q0 17706113 209 49.223106 imi_mug_run_2_treatment "various"
9 Q0 22595603 210 49.21305 imi_mug_run_2_treatment "lead" "duration"
9 Q0 21600007 211 49.167213 imi_mug_run_2_treatment "imatinib mesylate" "imatinib"
9 Q0 15095270 212 49.157913 imi_mug_run_2_treatment "others"
9 Q0 22069173 213 49.103443 imi_mug_run_2_treatment "level"
9 Q0 18483389 214 49.067257 imi_mug_run_2_treatment "imatinib" "sunitinib" "dasatinib"
9 Q0 16776995 215 49.036877 imi_mug_run_2_treatment "tandem"
9 Q0 25264210 216 48.982056 imi_mug_run_2_treatment "collagen"
9 Q0 15095124 217 48.962494 imi_mug_run_2_treatment "imatinib" "adjuvant" "tyrosine"
9 Q0 18728705 218 48.927032 imi_mug_run_2_treatment "drug" "imatinib mesylate" "imatinib"
9 Q0 18286477 219 48.91015 imi_mug_run_2_treatment "adjuvant" "imatinib"
9 Q0 18314611 220 48.89913 imi_mug_run_2_treatment "imatinib" "tyrosine" "imatinib mesylate"
9 Q0 24833907 221 48.877724 imi_mug_run_2_treatment "protease" "fletcher" "aim"
9 Q0 18382354 222 48.842102 imi_mug_run_2_treatment "basis"
9 Q0 25606568 223 48.83512 imi_mug_run_2_treatment "lead"
9 Q0 17625442 224 48.83036 imi_mug_run_2_treatment "imatinib" "gleevec"
9 Q0 22124674 225 48.789474 imi_mug_run_2_treatment "imatinib mesylate"
9 Q0 21934616 226 48.788723 imi_mug_run_2_treatment "adjuvant" "imatinib"
9 Q0 16297706 227 48.747967 imi_mug_run_2_treatment "genesis"
9 Q0 22993368 228 48.711594 imi_mug_run_2_treatment "sunitinib" "adjuvant" "imatinib"
9 Q0 12704441 229 48.64418 imi_mug_run_2_treatment "imatinib" "glivec" "basis"
9 Q0 18085368 230 48.640835 imi_mug_run_2_treatment "imatinib" "imatinib mesylate" "liver"
9 Q0 12542597 231 48.607487 imi_mug_run_2_treatment "aim"
9 Q0 18045506 232 48.582024 imi_mug_run_2_treatment "imatinib mesylate"
9 Q0 25550846 233 48.58162 imi_mug_run_2_treatment "imatinib" "adjuvant" "tyrosine"
9 Q0 14632569 234 48.528923 imi_mug_run_2_treatment "liver"
9 Q0 16858179 235 48.512352 imi_mug_run_2_treatment "imatinib" "adjuvant" "imatinib mesylate"
9 Q0 12045714 236 48.422127 imi_mug_run_2_treatment "aim"
9 Q0 15387340 237 48.395077 imi_mug_run_2_treatment "ras" "aim"
9 Q0 21120166 238 48.39011 imi_mug_run_2_treatment "drug" "imatinib"
9 Q0 21605429 239 48.32055 imi_mug_run_2_treatment "aim" "others"
9 Q0 17072721 240 48.227333 imi_mug_run_2_treatment "sti571" "glivec" "imatinib mesylate"
9 Q0 12198577 241 48.226425 imi_mug_run_2_treatment "liver" "others"
9 Q0 25659388 242 48.22471 imi_mug_run_2_treatment "aim"
9 Q0 30101284 243 48.206795 imi_mug_run_2_treatment "imatinib" "sunitinib" "tyrosine kinase inhibitor"
9 Q0 20976851 244 48.194916 imi_mug_run_2_treatment "mediated" "aim"
9 Q0 15803185 245 48.194637 imi_mug_run_2_treatment "insulin"
9 Q0 15342366 246 48.186157 imi_mug_run_2_treatment "imatinib" "drug" "tyrosine kinase inhibitor"
9 Q0 17193822 247 48.171932 imi_mug_run_2_treatment "imatinib" "drug" "imatinib mesylate"
9 Q0 23382202 248 48.136654 imi_mug_run_2_treatment "imatinib" "mediated" "tyrosine kinase inhibitor"
9 Q0 29424982 249 48.136345 imi_mug_run_2_treatment "imatinib" "air"
9 Q0 15815732 250 48.068092 imi_mug_run_2_treatment "imatinib mesylate" "adjuvant" "drug"
9 Q0 26316776 251 48.062042 imi_mug_run_2_treatment "imatinib" "imatinib mesylate" "tyrosine kinase inhibitor"
9 Q0 23433424 252 48.058544 imi_mug_run_2_treatment "dtc" "imatinib mesylate"
9 Q0 17512858 253 48.04205 imi_mug_run_2_treatment "kinase inhibitor" "adjuvant" "mediated"
9 Q0 19096980 254 48.01926 imi_mug_run_2_treatment "imatinib" "tyrosine kinase inhibitor"
9 Q0 14515284 255 48.01461 imi_mug_run_2_treatment "imatinib" "adjuvant" "glucose"
9 Q0 18547614 256 47.987213 imi_mug_run_2_treatment "level"
9 Q0 26936919 257 47.98349 imi_mug_run_2_treatment "mediated" "pd325901" "liver"
9 Q0 22190996 258 47.966293 imi_mug_run_2_treatment "imatinib mesylate"
9 Q0 15930355 259 47.965237 imi_mug_run_2_treatment "imatinib" "drug" "tyrosine kinase inhibitor"
9 Q0 19770581 260 47.96193 imi_mug_run_2_treatment "egcg" "various" "imatinib"
9 Q0 17824795 261 47.96038 imi_mug_run_2_treatment "imatinib"
9 Q0 23112561 262 47.95504 imi_mug_run_2_treatment "imatinib mesylate"
9 Q0 19154263 263 47.9115 imi_mug_run_2_treatment "hot spot"
9 Q0 17921955 264 47.89378 imi_mug_run_2_treatment "gleevec" "imatinib"
9 Q0 14686698 265 47.88982 imi_mug_run_2_treatment "gleevec" "glivec" "imatinib"
9 Q0 20883053 266 47.86916 imi_mug_run_2_treatment "imatinib" "adjuvant" "tyrosine"
9 Q0 24855380 267 47.853676 imi_mug_run_2_treatment "imatinib" "sorafenib"
9 Q0 19646278 268 47.82286 imi_mug_run_2_treatment "imatinib" "everolimus" "therapeutic agents"
9 Q0 22713591 269 47.76093 imi_mug_run_2_treatment "imatinib"
9 Q0 15750270 270 47.758915 imi_mug_run_2_treatment "imatinib mesylate" "liver"
9 Q0 28163271 271 47.74536 imi_mug_run_2_treatment "liver"
9 Q0 21519258 272 47.739006 imi_mug_run_2_treatment "imatinib" "sunitinib" "aim"
9 Q0 14682111 273 47.732113 imi_mug_run_2_treatment "imatinib mesylate" "adjuvant" "gleevec"
9 Q0 19664491 274 47.722626 imi_mug_run_2_treatment "therapeutics"
9 Q0 25741171 275 47.68238 imi_mug_run_2_treatment "imatinib mesylate" "liver" "imatinib"
9 Q0 23894705 276 47.623825 imi_mug_run_2_treatment "imatinib"
9 Q0 24490049 277 47.62338 imi_mug_run_2_treatment "imatinib" "sorafenib" "kinase inhibitor"
9 Q0 16294026 278 47.614086 imi_mug_run_2_treatment "various" "imatinib" "imatinib mesylate"
9 Q0 18955451 279 47.596626 imi_mug_run_2_treatment "imatinib" "imatinib mesylate"
9 Q0 19386957 280 47.587452 imi_mug_run_2_treatment "new drugs"
9 Q0 17386236 281 47.577446 imi_mug_run_2_treatment "imatinib" "imatinib mesylate" "glivec"
9 Q0 17602353 282 47.575306 imi_mug_run_2_treatment "eosin"
9 Q0 25143820 283 47.407204 imi_mug_run_2_treatment "rms"
9 Q0 23456621 284 47.398804 imi_mug_run_2_treatment "sunitinib" "imatinib" "aim"
9 Q0 19319646 285 47.39241 imi_mug_run_2_treatment "liver"
9 Q0 25432174 286 47.362686 imi_mug_run_2_treatment "imatinib" "drug" "mediated"
9 Q0 23423603 287 47.340927 imi_mug_run_2_treatment "imatinib"
9 Q0 18701138 288 47.334423 imi_mug_run_2_treatment "biotin"
9 Q0 16622539 289 47.3291 imi_mug_run_2_treatment "sti-571" "imatinib mesilate"
9 Q0 16457143 290 47.3238 imi_mug_run_2_treatment "adjuvant"
9 Q0 19013895 291 47.31436 imi_mug_run_2_treatment "drug" "imatinib" "imatinib mesylate"
9 Q0 21970485 292 47.30282 imi_mug_run_2_treatment "imatinib mesylate" "sunitinib malate"
9 Q0 23489352 293 47.292118 imi_mug_run_2_treatment "tyrosine" "imatinib"
9 Q0 21171987 294 47.288963 imi_mug_run_2_treatment "pooled"
9 Q0 21888081 295 47.27148 imi_mug_run_2_treatment "imatinib"
9 Q0 22855636 296 47.244316 imi_mug_run_2_treatment "imatinib" "sunitinib"
9 Q0 24847623 297 47.18689 imi_mug_run_2_treatment "imatinib"
9 Q0 19307738 298 47.18445 imi_mug_run_2_treatment "imatinib" "imatinib mesylate"
9 Q0 23536336 299 47.172337 imi_mug_run_2_treatment "tyrosine kinase inhibitor"
9 Q0 11507701 300 47.106426 imi_mug_run_2_treatment "product" "aim"
9 Q0 28166823 301 47.097042 imi_mug_run_2_treatment "imatinib"
9 Q0 17701051 302 47.09102 imi_mug_run_2_treatment "imatinib" "adjuvant" "sunitinib"
9 Q0 15526368 303 47.02315 imi_mug_run_2_treatment "aim"
9 Q0 16143141 304 47.00759 imi_mug_run_2_treatment "drugs" "imatinib mesylate" "tyrosine kinase inhibitor"
9 Q0 24223922 305 46.982285 imi_mug_run_2_treatment "imatinib" "adjuvant" "ors"
9 Q0 18259950 306 46.81537 imi_mug_run_2_treatment "imatinib mesylate" "therapeutic agent"
9 Q0 24575748 307 46.805866 imi_mug_run_2_treatment "imatinib" "adjuvant"
9 Q0 12897659 308 46.787514 imi_mug_run_2_treatment "gleevec" "imatinib mesylate" "pharmaceuticals"
9 Q0 12522257 309 46.763783 imi_mug_run_2_treatment "gleevec"
9 Q0 11943343 310 46.757744 imi_mug_run_2_treatment "basis"
9 Q0 19222892 311 46.748447 imi_mug_run_2_treatment "imatinib mesylate" "gleevec" "lead"
9 Q0 17659849 312 46.722076 imi_mug_run_2_treatment "various" "imatinib" "macrophage colony stimulating factor"
9 Q0 27928806 313 46.71022 imi_mug_run_2_treatment "drug" "imatinib" "insulin-like growth factor 1"
9 Q0 22855655 314 46.70838 imi_mug_run_2_treatment "imatinib mesylate" "liver"
9 Q0 22281391 315 46.70277 imi_mug_run_2_treatment "adjuvant" "imatinib" "sunitinib"
9 Q0 19333543 316 46.696045 imi_mug_run_2_treatment "icc"
9 Q0 11300941 317 46.685905 imi_mug_run_2_treatment "various"
9 Q0 17729245 318 46.67762 imi_mug_run_2_treatment "imatinib" "sunitinib"
9 Q0 15976351 319 46.66117 imi_mug_run_2_treatment "imatinib" "basis"
9 Q0 15005250 320 46.641487 imi_mug_run_2_treatment "liver"
9 Q0 19186237 321 46.635624 imi_mug_run_2_treatment "imatinib mesylate"
9 Q0 21688472 322 46.627075 imi_mug_run_2_treatment "imatinib"
9 Q0 16740725 323 46.57677 imi_mug_run_2_treatment "flavopiridol" "imatinib mesylate" "tyrosine"
9 Q0 15537379 324 46.548637 imi_mug_run_2_treatment "imatinib" "tyrosine kinase inhibitor"
9 Q0 21737509 325 46.496445 imi_mug_run_2_treatment "imatinib" "ipi-493" "sterile water"
9 Q0 28488171 326 46.480865 imi_mug_run_2_treatment "imatinib" "aim"
9 Q0 23661933 327 46.476517 imi_mug_run_2_treatment "liver"
9 Q0 16126886 328 46.447037 imi_mug_run_2_treatment "lead"
9 Q0 21975443 329 46.43529 imi_mug_run_2_treatment "adjuvant" "imatinib" "imatinib 400 mg"
9 Q0 19509176 330 46.421616 imi_mug_run_2_treatment "panobinostat" "imatinib" "histone deacetylase inhibitors"
9 Q0 15236194 331 46.416237 imi_mug_run_2_treatment "imatinib" "drug" "tyrosine kinase inhibitor"
9 Q0 15968329 332 46.390163 imi_mug_run_2_treatment "hot spot" "tandem"
9 Q0 22202260 333 46.302235 imi_mug_run_2_treatment "imatinib" "sunitinib"
9 Q0 15161681 334 46.233536 imi_mug_run_2_treatment "various" "drug" "level"
9 Q0 28975117 335 46.167786 imi_mug_run_2_treatment "imatinib" "sunitinib" "pazopanib"
9 Q0 16136600 336 46.12213 imi_mug_run_2_treatment "imatinib" "agent" "adjuvant"
9 Q0 23585972 337 46.117485 imi_mug_run_2_treatment "imatinib mesylate" "adjuvant" "tyrosine kinase inhibitor"
9 Q0 16908864 338 46.10759 imi_mug_run_2_treatment "imatinib" "everolimus" "mtor inhibitor"
9 Q0 27928801 339 46.092514 imi_mug_run_2_treatment "imatinib" "adjuvant"
9 Q0 17623951 340 46.08847 imi_mug_run_2_treatment "kinase inhibitor"
9 Q0 28900071 341 46.06105 imi_mug_run_2_treatment "insulin" "medicine" "igfbp-3"
9 Q0 25239608 342 46.05126 imi_mug_run_2_treatment "drug" "imatinib" "sunitinib"
9 Q0 18042065 343 46.050644 imi_mug_run_2_treatment "imatinib"
9 Q0 25684950 344 46.010536 imi_mug_run_2_treatment "imatinib" "adjuvant" "aim"
9 Q0 12835984 345 45.964687 imi_mug_run_2_treatment "shape" "aim" "liver"
9 Q0 12817876 346 45.957916 imi_mug_run_2_treatment "sti571" "gleevec" "glivec"
9 Q0 17969814 347 45.90999 imi_mug_run_2_treatment "aim"
9 Q0 21116624 348 45.90164 imi_mug_run_2_treatment "sunitinib" "tyrosine kinase inhibitor" "imatinib"
9 Q0 19269008 349 45.88416 imi_mug_run_2_treatment "protease" "lead" "aim"
9 Q0 30292279 350 45.82546 imi_mug_run_2_treatment "level"
9 Q0 11002369 351 45.796597 imi_mug_run_2_treatment "schiff"
9 Q0 21099240 352 45.784447 imi_mug_run_2_treatment "imatinib"
9 Q0 18520229 353 45.778816 imi_mug_run_2_treatment "adjuvant" "imatinib"
9 Q0 16398673 354 45.753513 imi_mug_run_2_treatment "various" "icc" "imatinib mesylate"
9 Q0 14714258 355 45.732533 imi_mug_run_2_treatment "antral"
9 Q0 18525339 356 45.728245 imi_mug_run_2_treatment "imatinib" "adjuvant" "sunitinib"
9 Q0 28008275 357 45.713642 imi_mug_run_2_treatment "sunitinib" "imatinib"
9 Q0 16438868 358 45.71052 imi_mug_run_2_treatment "various" "eosin"
9 Q0 14606094 359 45.695488 imi_mug_run_2_treatment "aim"
9 Q0 17193819 360 45.683453 imi_mug_run_2_treatment "icc"
9 Q0 22202330 361 45.68311 imi_mug_run_2_treatment "imatinib"
9 Q0 29098070 362 45.669373 imi_mug_run_2_treatment "imatinib mesylate" "imatinib" "hot spot"
9 Q0 18477213 363 45.668175 imi_mug_run_2_treatment "aim"
9 Q0 12417503 364 45.66649 imi_mug_run_2_treatment "sti571" "agent"
9 Q0 20571340 365 45.55445 imi_mug_run_2_treatment "aim" "monoclonal antibodies"
9 Q0 15743318 366 45.53914 imi_mug_run_2_treatment "various"
9 Q0 15939196 367 45.529015 imi_mug_run_2_treatment "imatinib" "adjuvant" "imatinib mesylate"
9 Q0 20658364 368 45.52678 imi_mug_run_2_treatment "imatinib" "level"
9 Q0 20028860 369 45.49494 imi_mug_run_2_treatment "bortezomib" "imatinib" "mediated"
9 Q0 24925196 370 45.482903 imi_mug_run_2_treatment "imatinib" "sunitinib"
9 Q0 15492989 371 45.477882 imi_mug_run_2_treatment "sti571" "imatinib mesylate"
9 Q0 16242052 372 45.46861 imi_mug_run_2_treatment "imatinib" "sti571" "imatinib mesylate"
9 Q0 16638875 373 45.45863 imi_mug_run_2_treatment "imatinib" "su11248" "kinase inhibitor"
9 Q0 23053257 374 45.448814 imi_mug_run_2_treatment "imatinib" "adjuvant" "imatinib mesylate"
9 Q0 27771813 375 45.446053 imi_mug_run_2_treatment "imatinib"
9 Q0 27249382 376 45.426075 imi_mug_run_2_treatment "aim"
9 Q0 28096720 377 45.40629 imi_mug_run_2_treatment "adjuvant" "imatinib"
9 Q0 24423961 378 45.361656 imi_mug_run_2_treatment "liver" "imatinib"
9 Q0 11073817 379 45.343197 imi_mug_run_2_treatment "lys" "glu" "interleukin-3"
9 Q0 23307090 380 45.330906 imi_mug_run_2_treatment "tyrosine"
9 Q0 25832938 381 45.32091 imi_mug_run_2_treatment "imatinib" "drug"
9 Q0 28199021 382 45.309753 imi_mug_run_2_treatment "toceranib phosphate" "palladia"
9 Q0 20165865 383 45.304237 imi_mug_run_2_treatment "imatinib" "sunitinib" "therapeutics"
9 Q0 18777214 384 45.298813 imi_mug_run_2_treatment "factor viii-related antigen"
9 Q0 18729075 385 45.25871 imi_mug_run_2_treatment "ras" "basis" "aim"
9 Q0 23648119 386 45.257015 imi_mug_run_2_treatment "imatinib"
9 Q0 15043466 387 45.24782 imi_mug_run_2_treatment "sti571"
9 Q0 10824925 388 45.244232 imi_mug_run_2_treatment "antiserum"
9 Q0 30346846 389 45.228153 imi_mug_run_2_treatment "imatinib" "sunitinib" "aim"
9 Q0 16521203 390 45.22682 imi_mug_run_2_treatment "product"
9 Q0 25080996 391 45.220795 imi_mug_run_2_treatment "drugs" "new drugs" "aim"
9 Q0 11719439 392 45.217957 imi_mug_run_2_treatment "level"
9 Q0 28615132 393 45.18566 imi_mug_run_2_treatment "imatinib" "isoleucine"
9 Q0 26678977 394 45.179638 imi_mug_run_2_treatment "various"
9 Q0 17359292 395 45.179237 imi_mug_run_2_treatment "imatinib"
9 Q0 23536339 396 45.156376 imi_mug_run_2_treatment "sunitinib" "imatinib" "imatinib 400 mg"
9 Q0 30126859 397 45.153633 imi_mug_run_2_treatment "imatinib"
9 Q0 15223958 398 45.152946 imi_mug_run_2_treatment "imatinib"
9 Q0 21459336 399 45.14979 imi_mug_run_2_treatment "imatinib" "tyrosine kinase inhibitor"
9 Q0 28334365 400 45.14292 imi_mug_run_2_treatment "imatinib" "adjuvant" "duration"
9 Q0 22363143 401 45.13782 imi_mug_run_2_treatment "imatinib" "aim"
9 Q0 18479530 402 45.129665 imi_mug_run_2_treatment "sti-571" "adjuvant" "liver"
9 Q0 11706520 403 45.114014 imi_mug_run_2_treatment "icc"
9 Q0 16607775 404 45.086872 imi_mug_run_2_treatment "glivec" "imatinib mesylate" "product"
9 Q0 16240136 405 45.047165 imi_mug_run_2_treatment "adjuvant" "imatinib mesylate" "liver"
9 Q0 22952296 406 45.03111 imi_mug_run_2_treatment "imatinib" "vascular endothelial growth factor"
9 Q0 11127756 407 45.02099 imi_mug_run_2_treatment "alcohol"
9 Q0 12824897 408 45.01865 imi_mug_run_2_treatment "imatinib mesylate" "icc"
9 Q0 14717479 409 45.018013 imi_mug_run_2_treatment "imatinib mesylate" "tyrosine" "sti 571"
9 Q0 19011564 410 44.992012 imi_mug_run_2_treatment "mouse monoclonal antibody"
9 Q0 19239429 411 44.97969 imi_mug_run_2_treatment "drug"
9 Q0 19047110 412 44.978443 imi_mug_run_2_treatment "various" "imatinib"
9 Q0 23623056 413 44.96603 imi_mug_run_2_treatment "imatinib" "ras"
9 Q0 17874546 414 44.95383 imi_mug_run_2_treatment "liver"
9 Q0 21358619 415 44.928123 imi_mug_run_2_treatment "imatinib"
9 Q0 16723820 416 44.925377 imi_mug_run_2_treatment "gleevec" "imatinib mesylate"
9 Q0 21817899 417 44.918015 imi_mug_run_2_treatment "sunitinib" "imatinib" "vascular endothelial growth factor"
9 Q0 21456006 418 44.917713 imi_mug_run_2_treatment "imatinib" "sunitinib" "nilotinib"
9 Q0 21418861 419 44.83219 imi_mug_run_2_treatment "mediated"
9 Q0 15703627 420 44.826523 imi_mug_run_2_treatment "imatinib mesylate" "adjuvant" "agent"
9 Q0 22646775 421 44.824673 imi_mug_run_2_treatment "sunitinib" "imatinib" "sunitinib 37.5 mg"
9 Q0 19010506 422 44.822716 imi_mug_run_2_treatment "imatinib"
9 Q0 18542042 423 44.80326 imi_mug_run_2_treatment "imatinib" "sti571" "lead"
9 Q0 20047122 424 44.795288 imi_mug_run_2_treatment "drug" "imatinib" "sunitinib"
9 Q0 16551858 425 44.77398 imi_mug_run_2_treatment "imatinib" "glivec" "imatinib mesylate"
9 Q0 15010069 426 44.77004 imi_mug_run_2_treatment "imatinib" "lys" "imatinib mesylate"
9 Q0 12898363 427 44.769466 imi_mug_run_2_treatment "sti571" "tyrosine kinase inhibitor"
9 Q0 22764137 428 44.769283 imi_mug_run_2_treatment "suberoylanilide hydroxamic acid" "histone deacetylase inhibitor" "imatinib"
9 Q0 15188667 429 44.753002 imi_mug_run_2_treatment "imatinib" "adjuvant" "imatinib mesylate"
9 Q0 19335275 430 44.747654 imi_mug_run_2_treatment "imatinib" "sunitinib" "drug"
9 Q0 19802531 431 44.742893 imi_mug_run_2_treatment "tyrosine" "agent"
9 Q0 25525851 432 44.739273 imi_mug_run_2_treatment "imatinib" "prednisone"
9 Q0 16357454 433 44.735622 imi_mug_run_2_treatment "imatinib" "tyrosine kinase inhibitor"
9 Q0 15150562 434 44.70662 imi_mug_run_2_treatment "imatinib"
9 Q0 19617878 435 44.69056 imi_mug_run_2_treatment "imatinib" "tyrosine kinase inhibitor"
9 Q0 20662443 436 44.608448 imi_mug_run_2_treatment "aim"
9 Q0 18234488 437 44.607635 imi_mug_run_2_treatment "imatinib"
9 Q0 15018116 438 44.54161 imi_mug_run_2_treatment "various" "onion"
9 Q0 19148515 439 44.52916 imi_mug_run_2_treatment "mediated" "therapeutics"
9 Q0 15269295 440 44.518623 imi_mug_run_2_treatment "hot spot"
9 Q0 26191287 441 44.51373 imi_mug_run_2_treatment "product"
9 Q0 24635438 442 44.513565 imi_mug_run_2_treatment "imatinib mesylate" "cytostatic" "imatinib"
9 Q0 30488756 443 44.505375 imi_mug_run_2_treatment "kinase inhibitor" "mediated" "imatinib"
9 Q0 15480031 444 44.441193 imi_mug_run_2_treatment "various"
9 Q0 17573273 445 44.407955 imi_mug_run_2_treatment "sunitinib malate" "drug"
9 Q0 16521182 446 44.362595 imi_mug_run_2_treatment "sti571" "vascular endothelial growth factor" "glivec"
9 Q0 21873989 447 44.358517 imi_mug_run_2_treatment "imatinib" "immunosuppressive" "imatinib mesylate"
9 Q0 20442644 448 44.355396 imi_mug_run_2_treatment "adjuvant" "imatinib mesylate"
9 Q0 20231287 449 44.355026 imi_mug_run_2_treatment "imatinib"
9 Q0 24872712 450 44.340675 imi_mug_run_2_treatment "imatinib" "drug" "adjuvant"
9 Q0 15022111 451 44.33801 imi_mug_run_2_treatment "various" "gleevec" "imatinib"
9 Q0 23943029 452 44.329475 imi_mug_run_2_treatment "fluorophore"
9 Q0 16982758 453 44.31868 imi_mug_run_2_treatment "imatinib" "mediated"
9 Q0 18488160 454 44.286217 imi_mug_run_2_treatment "imatinib"
9 Q0 28710566 455 44.22867 imi_mug_run_2_treatment "imatinib" "adjuvant"
9 Q0 29245294 456 44.225044 imi_mug_run_2_treatment "imatinib" "imatinib mesylate"
9 Q0 27864688 457 44.22396 imi_mug_run_2_treatment "aim"
9 Q0 15656032 458 44.195988 imi_mug_run_2_treatment "imatinib" "adjuvant" "product"
9 Q0 17452978 459 44.19274 imi_mug_run_2_treatment "mediated" "pkc412" "imatinib"
9 Q0 29423012 460 44.18991 imi_mug_run_2_treatment "imatinib" "mediated"
9 Q0 25427437 461 44.17694 imi_mug_run_2_treatment "various" "imatinib"
9 Q0 15069768 462 44.17527 imi_mug_run_2_treatment "various" "icc" "sti571"
9 Q0 17363589 463 44.133633 imi_mug_run_2_treatment "imatinib" "imatinib mesylate" "mediated"
9 Q0 20346150 464 44.1301 imi_mug_run_2_treatment "maspin" "medicine"
9 Q0 23860199 465 44.11596 imi_mug_run_2_treatment "imatinib mesylate" "adjuvant" "imatinib"
9 Q0 16785193 466 44.062336 imi_mug_run_2_treatment "imatinib"
9 Q0 16996566 467 44.06029 imi_mug_run_2_treatment "eosin"
9 Q0 26298631 468 44.058887 imi_mug_run_2_treatment "icc"
9 Q0 26907871 469 44.01921 imi_mug_run_2_treatment "imatinib" "drugs" "ifosfamide"
9 Q0 12411997 470 44.005173 imi_mug_run_2_treatment "liver"
9 Q0 17437861 471 44.001587 imi_mug_run_2_treatment "imatinib" "sunitinib"
9 Q0 20043176 472 43.998764 imi_mug_run_2_treatment "imatinib"
9 Q0 12181401 473 43.982796 imi_mug_run_2_treatment "imatinib" "drug" "imatinib mesylate"
9 Q0 11831069 474 43.914062 imi_mug_run_2_treatment "glivec" "various" "imatinib"
9 Q0 24154923 475 43.90284 imi_mug_run_2_treatment "imatinib mesylate"
9 Q0 17546049 476 43.8963 imi_mug_run_2_treatment "imatinib" "inositol"
9 Q0 28984483 477 43.854675 imi_mug_run_2_treatment "imatinib" "lead"
9 Q0 12744097 478 43.798317 imi_mug_run_2_treatment "generic" "tyrosine kinase inhibitor"
9 Q0 16258521 479 43.79808 imi_mug_run_2_treatment "lysine" "tyrosine"
9 Q0 29093181 480 43.786465 imi_mug_run_2_treatment "various" "blu-285" "drugs"
9 Q0 11914627 481 43.776943 imi_mug_run_2_treatment "sti-571" "biotin" "tyrosine"
9 Q0 21362052 482 43.718998 imi_mug_run_2_treatment "imatinib" "interferon-alpha" "cladribine"
9 Q0 29187943 483 43.705105 imi_mug_run_2_treatment "basis"
9 Q0 22728491 484 43.693405 imi_mug_run_2_treatment "imatinib mesylate"
9 Q0 29489686 485 43.68703 imi_mug_run_2_treatment "polidocanol"
9 Q0 27846844 486 43.68399 imi_mug_run_2_treatment "genesis"
9 Q0 18290694 487 43.632565 imi_mug_run_2_treatment "adjuvant" "fletcher" "imatinib"
9 Q0 29866822 488 43.630726 imi_mug_run_2_treatment "others"
9 Q0 14560152 489 43.548935 imi_mug_run_2_treatment "eosin"
9 Q0 12739051 490 43.46614 imi_mug_run_2_treatment "imatinib" "tyrosine" "sti571"
9 Q0 16359540 491 43.44507 imi_mug_run_2_treatment "revolution"
9 Q0 15270663 492 43.42055 imi_mug_run_2_treatment "imatinib" "adjuvant" "gleevec"
9 Q0 18672547 493 43.40245 imi_mug_run_2_treatment "imatinib mesylate"
9 Q0 26722383 494 43.39456 imi_mug_run_2_treatment "various" "imatinib" "nilotinib"
9 Q0 18413817 495 43.36927 imi_mug_run_2_treatment "imatinib"
9 Q0 23057997 496 43.35714 imi_mug_run_2_treatment "basis"
9 Q0 23820134 497 43.331318 imi_mug_run_2_treatment "imatinib"
9 Q0 26184165 498 43.2976 imi_mug_run_2_treatment "drug" "medicine" "imatinib"
9 Q0 26893362 499 43.29501 imi_mug_run_2_treatment "mediated" "imatinib"
9 Q0 24867041 500 43.29441 imi_mug_run_2_treatment "antral"
9 Q0 25052916 501 43.292446 imi_mug_run_2_treatment "imatinib"
9 Q0 24749828 502 43.290215 imi_mug_run_2_treatment "imatinib" "tyrosine kinase inhibitor"
9 Q0 22932406 503 43.28457 imi_mug_run_2_treatment "imatinib mesylate" "sunitinib"
9 Q0 12475434 504 43.28251 imi_mug_run_2_treatment "eosin"
9 Q0 27842558 505 43.27848 imi_mug_run_2_treatment "melana"
9 Q0 27178821 506 43.275173 imi_mug_run_2_treatment "aim"
9 Q0 18239881 507 43.26664 imi_mug_run_2_treatment "imatinib"
9 Q0 16634209 508 43.26618 imi_mug_run_2_treatment "gleevec" "aim"
9 Q0 24507750 509 43.266006 imi_mug_run_2_treatment "drugs" "pdx" "imatinib"
9 Q0 28487491 510 43.24833 imi_mug_run_2_treatment "regorafenib" "imatinib" "sunitinib"
9 Q0 17178293 511 43.246933 imi_mug_run_2_treatment "imatinib" "adjuvant" "agent"
9 Q0 15967901 512 43.22777 imi_mug_run_2_treatment "ras"
9 Q0 28259173 513 43.212402 imi_mug_run_2_treatment "kinase inhibitor"
9 Q0 18671247 514 43.20112 imi_mug_run_2_treatment "ras" "imatinib" "lead"
9 Q0 16596277 515 43.19332 imi_mug_run_2_treatment "sti571" "glucose" "protein synthesis inhibitor"
9 Q0 15326474 516 43.19185 imi_mug_run_2_treatment "imatinib"
9 Q0 16552495 517 43.166584 imi_mug_run_2_treatment "adjuvant" "basis"
9 Q0 23087800 518 43.127563 imi_mug_run_2_treatment "generic"
9 Q0 22736916 519 43.119343 imi_mug_run_2_treatment "mediated" "biotin" "aim"
9 Q0 16865518 520 43.086292 imi_mug_run_2_treatment "imatinib" "imatinib mesylate"
9 Q0 30015051 521 43.07107 imi_mug_run_2_treatment "histidine" "phenylalanine" "tyrosine"
9 Q0 21115932 522 43.058266 imi_mug_run_2_treatment "imatinib"
9 Q0 20469993 523 43.047688 imi_mug_run_2_treatment "imatinib mesylate"
9 Q0 18219926 524 43.043316 imi_mug_run_2_treatment "drug" "glivec" "imatinib"
9 Q0 10864354 525 43.020664 imi_mug_run_2_treatment "eosin"
9 Q0 12094370 526 42.984196 imi_mug_run_2_treatment "sti-571"
9 Q0 12075401 527 42.984196 imi_mug_run_2_treatment "sti-571"
9 Q0 12651205 528 42.97735 imi_mug_run_2_treatment "sti571" "tyrosine kinase inhibitor"
9 Q0 19294538 529 42.97457 imi_mug_run_2_treatment "imatinib" "sunitinib"
9 Q0 19469547 530 42.942696 imi_mug_run_2_treatment "imatinib"
9 Q0 22083669 531 42.91837 imi_mug_run_2_treatment "imatinib" "nilotinib" "tyr"
9 Q0 10934966 532 42.894627 imi_mug_run_2_treatment "icc" "liver"
9 Q0 15452163 533 42.84908 imi_mug_run_2_treatment "aim"
9 Q0 19164557 534 42.84797 imi_mug_run_2_treatment "sunitinib" "imatinib" "imatinib mesylate"
9 Q0 21613800 535 42.833458 imi_mug_run_2_treatment "product" "level"
9 Q0 18381383 536 42.81976 imi_mug_run_2_treatment "various" "imatinib"
9 Q0 18575421 537 42.815147 imi_mug_run_2_treatment "various"
9 Q0 21599631 538 42.813377 imi_mug_run_2_treatment "imatinib" "drugs" "anti-angiogenic agents"
9 Q0 22535506 539 42.81021 imi_mug_run_2_treatment "adjuvant" "imatinib" "tyrosine kinase inhibitor"
9 Q0 11074645 540 42.800785 imi_mug_run_2_treatment "icc"
9 Q0 16534250 541 42.79579 imi_mug_run_2_treatment "imatinib" "amn107" "agent"
9 Q0 28098915 542 42.78773 imi_mug_run_2_treatment "imatinib"
9 Q0 23224721 543 42.75561 imi_mug_run_2_treatment "imatinib" "imatinib mesylate"
9 Q0 30403169 544 42.745506 imi_mug_run_2_treatment "drug" "drugs" "imatinib"
9 Q0 18648736 545 42.732964 imi_mug_run_2_treatment "various" "imatinib" "imatinib mesylate"
9 Q0 20660757 546 42.717888 imi_mug_run_2_treatment "antimalarial" "imatinib" "antimalarials"
9 Q0 18041915 547 42.715332 imi_mug_run_2_treatment "sti-571" "gleevec" "imatinib"
9 Q0 19417561 548 42.708874 imi_mug_run_2_treatment "imatinib"
9 Q0 27628557 549 42.707603 imi_mug_run_2_treatment "imatinib" "imatinib mesylate"
9 Q0 21054898 550 42.687214 imi_mug_run_2_treatment "gleevec" "imatinib mesylate"
9 Q0 22202277 551 42.680717 imi_mug_run_2_treatment "imatinib 400 mg"
9 Q0 17396139 552 42.651833 imi_mug_run_2_treatment "imatinib" "rad001" "drugs"
9 Q0 27446428 553 42.627983 imi_mug_run_2_treatment "aim"
9 Q0 22645636 554 42.61782 imi_mug_run_2_treatment "lys" "glu" "imatinib"
9 Q0 12727838 555 42.592636 imi_mug_run_2_treatment "matrix"
9 Q0 12894500 556 42.586765 imi_mug_run_2_treatment "tyr" "ly294002" "ag490"
9 Q0 18757323 557 42.563354 imi_mug_run_2_treatment "various" "basis" "icc"
9 Q0 14699510 558 42.53179 imi_mug_run_2_treatment "tyrosine"
9 Q0 21717788 559 42.509525 imi_mug_run_2_treatment "imatinib" "adjuvant" "sunitinib"
9 Q0 17211292 560 42.46084 imi_mug_run_2_treatment "imatinib mesylate" "tyrosine kinase inhibitor" "liver"
9 Q0 19283922 561 42.458153 imi_mug_run_2_treatment "imatinib" "adjuvant" "drugs"
9 Q0 23268086 562 42.431038 imi_mug_run_2_treatment "imatinib"
9 Q0 22542728 563 42.423 imi_mug_run_2_treatment "imatinib" "avid" "liver"
9 Q0 24128084 564 42.390434 imi_mug_run_2_treatment "tandem"
9 Q0 21461555 565 42.3807 imi_mug_run_2_treatment "various"
9 Q0 16052979 566 42.3693 imi_mug_run_2_treatment "imatinib mesylate" "tyrosine kinase inhibitor"
9 Q0 27011036 567 42.34175 imi_mug_run_2_treatment "liver"
9 Q0 18521245 568 42.30273 imi_mug_run_2_treatment "product"
9 Q0 30159192 569 42.302513 imi_mug_run_2_treatment "imatinib mesylate"
9 Q0 30101875 570 42.277782 imi_mug_run_2_treatment "imatinib" "fletcher's" "others"
9 Q0 28685593 571 42.26378 imi_mug_run_2_treatment "sunitinib" "imatinib" "aim"
9 Q0 29885053 572 42.245556 imi_mug_run_2_treatment "imatinib" "kinase inhibitor" "imatinib mesylate"
9 Q0 26990482 573 42.23679 imi_mug_run_2_treatment "various" "nilotinib" "imatinib"
9 Q0 25722316 574 42.23088 imi_mug_run_2_treatment "liver"
9 Q0 25182956 575 42.22668 imi_mug_run_2_treatment "imatinib" "ras" "lead"
9 Q0 24638003 576 42.188538 imi_mug_run_2_treatment "imatinib" "adjuvant"
9 Q0 20009472 577 42.16488 imi_mug_run_2_treatment "imatinib" "imatinib mesilate"
9 Q0 15750190 578 42.155937 imi_mug_run_2_treatment "imatinib mesylate" "imatinib" "agent"
9 Q0 19737953 579 42.143124 imi_mug_run_2_treatment "sunitinib" "imatinib" "plasma"
9 Q0 22069175 580 42.135414 imi_mug_run_2_treatment "imatinib" "tyrosine"
9 Q0 15471430 581 42.13082 imi_mug_run_2_treatment "gold"
9 Q0 27687311 582 42.118652 imi_mug_run_2_treatment "various" "imatinib" "regorafenib"
9 Q0 16291174 583 42.116943 imi_mug_run_2_treatment "imatinib" "imatinib mesylate" "product"
9 Q0 15898909 584 42.106087 imi_mug_run_2_treatment "basis"
9 Q0 23621836 585 42.103836 imi_mug_run_2_treatment "tyrosine" "imatinib mesylate"
9 Q0 19561230 586 42.059746 imi_mug_run_2_treatment "imatinib"
9 Q0 15946589 587 42.055134 imi_mug_run_2_treatment "imatinib" "drugs" "sti571"
9 Q0 15966213 588 42.04841 imi_mug_run_2_treatment "imatinib" "drug"
9 Q0 28970330 589 42.04281 imi_mug_run_2_treatment "imatinib"
9 Q0 22454172 590 42.035126 imi_mug_run_2_treatment "imatinib"
9 Q0 26098203 591 42.009907 imi_mug_run_2_treatment "drugs" "imatinib mesylate" "new drugs"
9 Q0 29760538 592 41.984665 imi_mug_run_2_treatment "adjuvant" "imatinib" "medicine"
9 Q0 27864817 593 41.972294 imi_mug_run_2_treatment "nilotinib" "imatinib"
9 Q0 15822120 594 41.97209 imi_mug_run_2_treatment "imatinib"
9 Q0 22379899 595 41.970623 imi_mug_run_2_treatment "adjuvant"
9 Q0 19917964 596 41.968006 imi_mug_run_2_treatment "imatinib" "imatinib mesylate"
9 Q0 16445822 597 41.935284 imi_mug_run_2_treatment "imatinib" "tyrosine kinase inhibitor"
9 Q0 22714264 598 41.9329 imi_mug_run_2_treatment "at13387" "imatinib" "hsp70"
9 Q0 21586885 599 41.931526 imi_mug_run_2_treatment "imatinib mesylate" "imatinib"
9 Q0 24935368 600 41.922493 imi_mug_run_2_treatment "various" "proteases"
9 Q0 19968734 601 41.92101 imi_mug_run_2_treatment "imatinib" "drug" "adjuvant"
9 Q0 29341147 602 41.917137 imi_mug_run_2_treatment "imatinib"
9 Q0 16231822 603 41.913544 imi_mug_run_2_treatment "st1571"
9 Q0 12672043 604 41.90588 imi_mug_run_2_treatment "imatinib" "various"
9 Q0 28645742 605 41.903667 imi_mug_run_2_treatment "liver" "imatinib"
9 Q0 17101067 606 41.888454 imi_mug_run_2_treatment "level"
9 Q0 24947094 607 41.877502 imi_mug_run_2_treatment "aim"
9 Q0 16778826 608 41.873104 imi_mug_run_2_treatment "imatinib mesylate" "kinase inhibitor" "mediated"
9 Q0 18411643 609 41.845978 imi_mug_run_2_treatment "aim"
9 Q0 12938260 610 41.844723 imi_mug_run_2_treatment "drug" "glivec" "sti571"
9 Q0 26396718 611 41.818142 imi_mug_run_2_treatment "liver"
9 Q0 29552659 612 41.80613 imi_mug_run_2_treatment "imatinib mesylate"
9 Q0 21953054 613 41.803665 imi_mug_run_2_treatment "others"
9 Q0 20575602 614 41.782158 imi_mug_run_2_treatment "imatinib"
9 Q0 21160808 615 41.78189 imi_mug_run_2_treatment "lysine" "glutamic acid" "eosin"
9 Q0 23576565 616 41.77382 imi_mug_run_2_treatment "calcium" "antiangiogenic" "imatinib"
9 Q0 21641899 617 41.77282 imi_mug_run_2_treatment "imatinib mesylate"
9 Q0 23746188 618 41.77282 imi_mug_run_2_treatment "imatinib" "aim"
9 Q0 28900984 619 41.76255 imi_mug_run_2_treatment "imatinib mesylate" "blockade"
9 Q0 12057170 620 41.744404 imi_mug_run_2_treatment "combinations" "product" "liver"
9 Q0 23637977 621 41.737392 imi_mug_run_2_treatment "dioxin" "adjuvant" "ors"
9 Q0 21104107 622 41.734337 imi_mug_run_2_treatment "sunitinib" "imatinib"
9 Q0 21140148 623 41.720078 imi_mug_run_2_treatment "plasma" "level" "imatinib"
9 Q0 12424067 624 41.71672 imi_mug_run_2_treatment "imatinib mesylate" "drug" "level"
9 Q0 22426502 625 41.714245 imi_mug_run_2_treatment "psychotropic medication"
9 Q0 10199467 626 41.71234 imi_mug_run_2_treatment "icc" "formalin"
9 Q0 25865047 627 41.68814 imi_mug_run_2_treatment "icc" "crenolanib" "imatinib"
9 Q0 22934279 628 41.6821 imi_mug_run_2_treatment "interferon" "imatinib" "peginterferon"
9 Q0 15928335 629 41.665504 imi_mug_run_2_treatment "imatinib" "drug" "kinase inhibitor"
9 Q0 29175467 630 41.664806 imi_mug_run_2_treatment "imatinib" "radiochemical" "tyrosine kinase inhibitor"
9 Q0 17827398 631 41.622337 imi_mug_run_2_treatment "imatinib" "aim"
9 Q0 25674291 632 41.618156 imi_mug_run_2_treatment "cisplatin"
9 Q0 12360044 633 41.617188 imi_mug_run_2_treatment "biotin" "sti571" "gleevec"
9 Q0 27097112 634 41.58689 imi_mug_run_2_treatment "imatinib" "aim"
9 Q0 16699280 635 41.582336 imi_mug_run_2_treatment "imatinib mesylate" "tyrosine" "glivec"
9 Q0 22866129 636 41.580685 imi_mug_run_2_treatment "imatinib"
9 Q0 30237583 637 41.5802 imi_mug_run_2_treatment "imatinib" "aim"
9 Q0 20011313 638 41.579197 imi_mug_run_2_treatment "imatinib mesylate" "tyrosine kinase inhibitor"
9 Q0 25741840 639 41.547802 imi_mug_run_2_treatment "imatinib" "adjuvant" "water"
9 Q0 26839131 640 41.54387 imi_mug_run_2_treatment "various" "basis"
9 Q0 17419150 641 41.538963 imi_mug_run_2_treatment "imatinib" "drug" "pkc412"
9 Q0 24674454 642 41.53439 imi_mug_run_2_treatment "imatinib"
9 Q0 22189238 643 41.527817 imi_mug_run_2_treatment "melan-a" "imatinib mesylate"
9 Q0 23755839 644 41.51518 imi_mug_run_2_treatment "imatinib"
9 Q0 22652566 645 41.500355 imi_mug_run_2_treatment "imatinib" "drug" "sunitinib"
9 Q0 28314314 646 41.475536 imi_mug_run_2_treatment "aim"
9 Q0 21277730 647 41.44997 imi_mug_run_2_treatment "imatinib" "adjuvant" "tcc"
9 Q0 25375091 648 41.447166 imi_mug_run_2_treatment "mediated" "imatinib" "mtor inhibitor"
9 Q0 25313780 649 41.43193 imi_mug_run_2_treatment "imatinib" "adjuvant"
9 Q0 12053473 650 41.418724 imi_mug_run_2_treatment "basis" "aim" "liver"
9 Q0 20799000 651 41.40488 imi_mug_run_2_treatment "imatinib" "basis"
9 Q0 16629079 652 41.396103 imi_mug_run_2_treatment "imatinib" "gleevec" "product"
9 Q0 12689667 653 41.396103 imi_mug_run_2_treatment "lead"
9 Q0 15966241 654 41.376724 imi_mug_run_2_treatment "eosin"
9 Q0 21355183 655 41.332222 imi_mug_run_2_treatment "imatinib"
9 Q0 27965460 656 41.328102 imi_mug_run_2_treatment "imatinib" "drug" "mediated"
9 Q0 25781619 657 41.303917 imi_mug_run_2_treatment "glucose" "imatinib" "deoxyglucose"
9 Q0 30098596 658 41.299973 imi_mug_run_2_treatment "adjuvant" "imatinib mesylate"
9 Q0 21863513 659 41.28315 imi_mug_run_2_treatment "imatinib" "adjuvant" "sunitinib"
9 Q0 22866155 660 41.2569 imi_mug_run_2_treatment "drug" "new drugs" "level"
9 Q0 24783183 661 41.215145 imi_mug_run_2_treatment "sunitinib" "imatinib"
9 Q0 15796874 662 41.214157 imi_mug_run_2_treatment "fletcher's"
9 Q0 25717425 663 41.211914 imi_mug_run_2_treatment "lead"
9 Q0 16842246 664 41.197662 imi_mug_run_2_treatment "imatinib" "basis"
9 Q0 12354362 665 41.18623 imi_mug_run_2_treatment "imatinib" "imatinib mesylate"
9 Q0 15024716 666 41.1839 imi_mug_run_2_treatment "drug" "imatinib mesylate" "sti-571"
9 Q0 22333644 667 41.164146 imi_mug_run_2_treatment "imatinib mesilate"
9 Q0 21302230 668 41.164146 imi_mug_run_2_treatment "imatinib mesylate"
9 Q0 24451814 669 41.1562 imi_mug_run_2_treatment "imatinib" "adjuvant" "ssg"
9 Q0 23133091 670 41.15012 imi_mug_run_2_treatment "imatinib mesylate" "tyrosine kinase inhibitor"
9 Q0 12781070 671 41.146423 imi_mug_run_2_treatment "imatinib" "drug" "imatinib mesylate"
9 Q0 25737303 672 41.11349 imi_mug_run_2_treatment "bortezomib" "proteasome inhibitor" "dasatinib"
9 Q0 10504550 673 41.061256 imi_mug_run_2_treatment "leu"
9 Q0 17147087 674 41.03355 imi_mug_run_2_treatment "imatinib" "tyrosine kinase inhibitor"
9 Q0 12610329 675 41.02507 imi_mug_run_2_treatment "imatinib" "sti 571" "tyrosine kinase inhibitor"
9 Q0 23196876 676 41.02497 imi_mug_run_2_treatment "imatinib" "tyrosine kinase inhibitor" "auy922"
9 Q0 29220298 677 40.98205 imi_mug_run_2_treatment "imatinib" "sunitinib" "tyrosine kinase inhibitor"
9 Q0 25473890 678 40.93831 imi_mug_run_2_treatment "various" "imatinib"
9 Q0 9916914 679 40.909832 imi_mug_run_2_treatment "monoclonal antibodies"
9 Q0 23743927 680 40.8981 imi_mug_run_2_treatment "tet" "succinate" "enzymes"
9 Q0 11751374 681 40.86055 imi_mug_run_2_treatment "sti571" "tyrosine kinase inhibitor" "lead"
9 Q0 18628470 682 40.84835 imi_mug_run_2_treatment "imatinib"
9 Q0 18496660 683 40.847004 imi_mug_run_2_treatment "mediated"
9 Q0 21064103 684 40.84413 imi_mug_run_2_treatment "tma" "aim"
9 Q0 28027118 685 40.82426 imi_mug_run_2_treatment "imatinib" "adjuvant"
9 Q0 23936759 686 40.787254 imi_mug_run_2_treatment "gleevec" "imatinib mesylate"
9 Q0 27123077 687 40.73578 imi_mug_run_2_treatment "imatinib"
9 Q0 24129766 688 40.722225 imi_mug_run_2_treatment "aim"
9 Q0 19593621 689 40.720497 imi_mug_run_2_treatment "imatinib mesylate" "liver"
9 Q0 17024483 690 40.719128 imi_mug_run_2_treatment "imatinib mesylate"
9 Q0 12228211 691 40.71663 imi_mug_run_2_treatment "aim"
9 Q0 17419245 692 40.711582 imi_mug_run_2_treatment "aim"
9 Q0 28462214 693 40.70659 imi_mug_run_2_treatment "imatinib" "imatinib mesylate"
9 Q0 30280421 694 40.693386 imi_mug_run_2_treatment "various"
9 Q0 18080227 695 40.689472 imi_mug_run_2_treatment "eosin" "product"
9 Q0 22009637 696 40.68578 imi_mug_run_2_treatment "immunosuppressive"
9 Q0 28988501 697 40.674305 imi_mug_run_2_treatment "drug" "sts" "imatinib"
9 Q0 18830121 698 40.666897 imi_mug_run_2_treatment "imatinib" "imatinib mesylate" "sunitinib"
9 Q0 16954519 699 40.651993 imi_mug_run_2_treatment "imatinib"
9 Q0 26848617 700 40.645576 imi_mug_run_2_treatment "imatinib"
9 Q0 16167230 701 40.6438 imi_mug_run_2_treatment "eosin"
9 Q0 25120810 702 40.641808 imi_mug_run_2_treatment "imatinib"
9 Q0 15689683 703 40.63114 imi_mug_run_2_treatment "imatinib" "therapeutic agent"
9 Q0 19491525 704 40.596226 imi_mug_run_2_treatment "diuretics" "oxygen"
9 Q0 26617916 705 40.569946 imi_mug_run_2_treatment "imatinib mesylate"
9 Q0 20180084 706 40.568962 imi_mug_run_2_treatment "imatinib"
9 Q0 12627712 707 40.568535 imi_mug_run_2_treatment "basis" "liver"
9 Q0 17255767 708 40.48945 imi_mug_run_2_treatment "aim"
9 Q0 30128077 709 40.476067 imi_mug_run_2_treatment "drug" "therapeutic agents"
9 Q0 26297068 710 40.472908 imi_mug_run_2_treatment "others"
9 Q0 20725786 711 40.454185 imi_mug_run_2_treatment "various" "imatinib"
9 Q0 17032555 712 40.443848 imi_mug_run_2_treatment "imatinib" "adjuvant" "sunitinib"
9 Q0 19360154 713 40.428642 imi_mug_run_2_treatment "imatinib" "drug" "sunitinib"
9 Q0 23036227 714 40.427765 imi_mug_run_2_treatment "various" "imatinib" "sunitinib"
9 Q0 10937062 715 40.423958 imi_mug_run_2_treatment "icc"
9 Q0 19949796 716 40.393497 imi_mug_run_2_treatment "drug" "glivec" "imatinib"
9 Q0 20533592 717 40.386543 imi_mug_run_2_treatment "various" "imatinib" "sunitinib"
9 Q0 25926077 718 40.3846 imi_mug_run_2_treatment "agent" "imatinib" "sunitinib"
9 Q0 17253167 719 40.36026 imi_mug_run_2_treatment "various" "eosin"
9 Q0 17591808 720 40.350517 imi_mug_run_2_treatment "imatinib mesylate" "kinase inhibitor" "tyrosine"
9 Q0 19084944 721 40.3392 imi_mug_run_2_treatment "gat"
9 Q0 28535771 722 40.31843 imi_mug_run_2_treatment "lead"
9 Q0 28915565 723 40.31149 imi_mug_run_2_treatment "aim"
9 Q0 17064855 724 40.304142 imi_mug_run_2_treatment "tyrosine" "sti571" "gleevec"
9 Q0 21284869 725 40.293198 imi_mug_run_2_treatment "aim" "fletcher's"
9 Q0 25970686 726 40.281933 imi_mug_run_2_treatment "imatinib"
9 Q0 30392567 727 40.2753 imi_mug_run_2_treatment "cck-8" "mediated"
9 Q0 11213830 728 40.269684 imi_mug_run_2_treatment "various" "mast cell growth factor"
9 Q0 19260254 729 40.23227 imi_mug_run_2_treatment "medication" "imatinib mesylate" "tyrosine kinase inhibitor"
9 Q0 26587973 730 40.208168 imi_mug_run_2_treatment "imatinib" "drug"
9 Q0 26672673 731 40.183002 imi_mug_run_2_treatment "imatinib" "adjuvant" "drugs"
9 Q0 22472152 732 40.155636 imi_mug_run_2_treatment "imatinib" "imatinib mesylate" "fletcher"
9 Q0 15070666 733 40.107727 imi_mug_run_2_treatment "imatinib" "imatinib mesylate" "vascular endothelial growth factor"
9 Q0 24392185 734 40.09875 imi_mug_run_2_treatment "imatinib"
9 Q0 26112683 735 40.08011 imi_mug_run_2_treatment "adjuvant" "imatinib"
9 Q0 15542802 736 40.078583 imi_mug_run_2_treatment "various" "imatinib" "imatinib mesylate"
9 Q0 26730087 737 40.071426 imi_mug_run_2_treatment "aim"
9 Q0 18629782 738 40.067604 imi_mug_run_2_treatment "imatinib" "adjuvant" "drugs"
9 Q0 12354363 739 40.056683 imi_mug_run_2_treatment "imatinib" "imatinib mesylate" "tyrosine kinase inhibitor"
9 Q0 17195905 740 40.048138 imi_mug_run_2_treatment "imatinib" "imatinib mesylate"
9 Q0 23456969 741 40.047974 imi_mug_run_2_treatment "liver"
9 Q0 12918066 742 40.03437 imi_mug_run_2_treatment "lys" "adjuvant" "lysine"
9 Q0 20081808 743 40.03125 imi_mug_run_2_treatment "various"
9 Q0 23935374 744 40.02802 imi_mug_run_2_treatment "imatinib" "adjuvant" "tyrosine kinase inhibitor"
9 Q0 21394667 745 40.018845 imi_mug_run_2_treatment "sunitinib" "imatinib" "liver"
9 Q0 12856366 746 40.004448 imi_mug_run_2_treatment "basis" "liver"
9 Q0 20551067 747 39.99988 imi_mug_run_2_treatment "imatinib" "drug" "fty720"
9 Q0 29394756 748 39.98388 imi_mug_run_2_treatment "imatinib"
9 Q0 27077705 749 39.981846 imi_mug_run_2_treatment "drug" "kinase inhibitor" "chmfl-kit-110"
9 Q0 16402362 750 39.981773 imi_mug_run_2_treatment "fibrinogen"
9 Q0 16910417 751 39.980034 imi_mug_run_2_treatment "imatinib mesylate" "duration"
9 Q0 16327443 752 39.95968 imi_mug_run_2_treatment "icc" "tyrosine"
9 Q0 22114577 753 39.95027 imi_mug_run_2_treatment "imatinib" "drug" "imatinib mesylate"
9 Q0 25836719 754 39.9469 imi_mug_run_2_treatment "crizotinib" "cabozantinib" "imatinib"
9 Q0 28478525 755 39.90459 imi_mug_run_2_treatment "imatinib" "sunitinib" "regorafenib"
9 Q0 28541695 756 39.900642 imi_mug_run_2_treatment "various" "imatinib" "liver"
9 Q0 24678982 757 39.841606 imi_mug_run_2_treatment "level"
9 Q0 22110419 758 39.841503 imi_mug_run_2_treatment "imatinib mesylate"
9 Q0 12649674 759 39.820988 imi_mug_run_2_treatment "sti-571"
9 Q0 28549261 760 39.801815 imi_mug_run_2_treatment "imatinib"
9 Q0 15693434 761 39.788963 imi_mug_run_2_treatment "gleevec" "imatinib mesylate" "basis"
9 Q0 16143881 762 39.77751 imi_mug_run_2_treatment "imatinib" "imatinib mesylate" "tyrosine kinase inhibitor"
9 Q0 25741136 763 39.759075 imi_mug_run_2_treatment "imatinib" "lead"
9 Q0 22228977 764 39.75604 imi_mug_run_2_treatment "imatinib"
9 Q0 26049274 765 39.748238 imi_mug_run_2_treatment "interferon" "drug" "imatinib"
9 Q0 24361761 766 39.74376 imi_mug_run_2_treatment "drug" "tyrosine kinase inhibitor" "imatinib"
9 Q0 17427641 767 39.736668 imi_mug_run_2_treatment "medication" "imatinib"
9 Q0 17256558 768 39.706417 imi_mug_run_2_treatment "imatinib" "adjuvant" "glivec"
9 Q0 18183595 769 39.69359 imi_mug_run_2_treatment "imatinib"
9 Q0 15283152 770 39.67161 imi_mug_run_2_treatment "drug" "imatinib" "imatinib mesylate"
9 Q0 17673922 771 39.662834 imi_mug_run_2_treatment "aim"
9 Q0 17458563 772 39.640903 imi_mug_run_2_treatment "imatinib" "level"
9 Q0 12600228 773 39.627872 imi_mug_run_2_treatment "enzymes" "tyrosine" "imatinib mesylate"
9 Q0 23852704 774 39.62179 imi_mug_run_2_treatment "trastuzumab" "aim"
9 Q0 19861442 775 39.610527 imi_mug_run_2_treatment "sunitinib" "imatinib" "drug"
9 Q0 25940166 776 39.543076 imi_mug_run_2_treatment "drugs"
9 Q0 11213513 777 39.537296 imi_mug_run_2_treatment "product"
9 Q0 19935059 778 39.51315 imi_mug_run_2_treatment "antral" "liver"
9 Q0 21410049 779 39.508488 imi_mug_run_2_treatment "aim"
9 Q0 26034378 780 39.492973 imi_mug_run_2_treatment "imatinib"
9 Q0 22593460 781 39.447224 imi_mug_run_2_treatment "imatinib mesylate"
9 Q0 16732863 782 39.43988 imi_mug_run_2_treatment "glivec" "imatinib"
9 Q0 20535017 783 39.435394 imi_mug_run_2_treatment "imatinib" "agent" "tyrosine kinase inhibitor"
9 Q0 17145623 784 39.434113 imi_mug_run_2_treatment "gleevec" "imatinib"
9 Q0 30181783 785 39.431564 imi_mug_run_2_treatment "imatinib" "sunitinib" "regorafenib"
9 Q0 21874433 786 39.4218 imi_mug_run_2_treatment "imatinib mesylate"
9 Q0 15145718 787 39.41684 imi_mug_run_2_treatment "imatinib"
9 Q0 26743300 788 39.414867 imi_mug_run_2_treatment "maspin"
9 Q0 21483516 789 39.414867 imi_mug_run_2_treatment "imatinib" "imatinib mesylate" "duration"
9 Q0 27793025 790 39.412186 imi_mug_run_2_treatment "icc" "imatinib" "mediated"
9 Q0 12483251 791 39.40744 imi_mug_run_2_treatment "somatostatin"
9 Q0 19894031 792 39.40295 imi_mug_run_2_treatment "imatinib" "imatinib mesylate" "lead"
9 Q0 12528772 793 39.385124 imi_mug_run_2_treatment "sti571" "glivec" "imatinib"
9 Q0 20361266 794 39.375362 imi_mug_run_2_treatment "imatinib mesylate" "sunitinib malate"
9 Q0 24451815 795 39.37066 imi_mug_run_2_treatment "tyrosine kinase inhibitor"
9 Q0 18521081 796 39.314983 imi_mug_run_2_treatment "imatinib" "kinase inhibitor" "mediated"
9 Q0 22381410 797 39.280914 imi_mug_run_2_treatment "smd" "imatinib mesylate"
9 Q0 16969663 798 39.26981 imi_mug_run_2_treatment "level"
9 Q0 19542718 799 39.266075 imi_mug_run_2_treatment "imatinib" "imatinib mesilate"
9 Q0 19690756 800 39.26145 imi_mug_run_2_treatment "imatinib"
9 Q0 15796875 801 39.256317 imi_mug_run_2_treatment "various"
9 Q0 16625094 802 39.242516 imi_mug_run_2_treatment "various" "imatinib"
9 Q0 11977548 803 39.241257 imi_mug_run_2_treatment "sti571" "tyrosine kinase inhibitor"
9 Q0 15101081 804 39.241257 imi_mug_run_2_treatment "imatinib mesylate" "liver"
9 Q0 28398518 805 39.225235 imi_mug_run_2_treatment "drug" "agent"
9 Q0 15545668 806 39.219646 imi_mug_run_2_treatment "imatinib mesylate"
9 Q0 25293993 807 39.214886 imi_mug_run_2_treatment "sti571" "tyrosine kinase inhibitor"
9 Q0 24743291 808 39.2138 imi_mug_run_2_treatment "imatinib mesylate"
9 Q0 16537295 809 39.205112 imi_mug_run_2_treatment "liver"
9 Q0 22800481 810 39.205112 imi_mug_run_2_treatment "imatinib"
9 Q0 21566432 811 39.20064 imi_mug_run_2_treatment "imatinib" "imatinib mesylate" "sunitinib"
9 Q0 15991300 812 39.196632 imi_mug_run_2_treatment "aim"
9 Q0 16570044 813 39.17512 imi_mug_run_2_treatment "aim"
9 Q0 10782882 814 39.168304 imi_mug_run_2_treatment "icc" "aim"
9 Q0 23592754 815 39.147 imi_mug_run_2_treatment "imatinib mesylate" "kinase inhibitor"
9 Q0 17385949 816 39.146336 imi_mug_run_2_treatment "imatinib" "drug" "adjuvant"
9 Q0 28222971 817 39.146336 imi_mug_run_2_treatment "aim"
9 Q0 16579858 818 39.143166 imi_mug_run_2_treatment "mcts" "tandem"
9 Q0 17802947 819 39.138943 imi_mug_run_2_treatment "tyrosine" "imatinib mesylate" "shape"
9 Q0 19706776 820 39.12422 imi_mug_run_2_treatment "imatinib" "saha" "lbh589"
9 Q0 19675092 821 39.10313 imi_mug_run_2_treatment "sunitinib" "imatinib" "sunitinib malate"
9 Q0 27633918 822 39.10294 imi_mug_run_2_treatment "various" "antineoplastic" "nh2"
9 Q0 22294424 823 39.077538 imi_mug_run_2_treatment "imatinib mesylate"
9 Q0 16952848 824 39.066654 imi_mug_run_2_treatment "drug" "imatinib" "others"
9 Q0 28203166 825 39.064117 imi_mug_run_2_treatment "imatinib"
9 Q0 18230576 826 39.04319 imi_mug_run_2_treatment "imatinib" "drug" "sunitinib"
9 Q0 15853160 827 38.99893 imi_mug_run_2_treatment "drug" "imatinib" "imatinib mesylate"
9 Q0 11727254 828 38.985573 imi_mug_run_2_treatment "various"
9 Q0 19636292 829 38.984707 imi_mug_run_2_treatment "various" "imatinib" "drugs"
9 Q0 18785120 830 38.977818 imi_mug_run_2_treatment "level"
9 Q0 18235442 831 38.961243 imi_mug_run_2_treatment "drug" "imatinib" "drugs"
9 Q0 19139124 832 38.961117 imi_mug_run_2_treatment "sorafenib" "imatinib" "sunitinib"
9 Q0 12094373 833 38.960884 imi_mug_run_2_treatment "various" "sti-571"
9 Q0 12094371 834 38.947277 imi_mug_run_2_treatment "sti-571" "tyrosine"
9 Q0 21772112 835 38.938736 imi_mug_run_2_treatment "imatinib" "medicine" "imatinib 400 mg"
9 Q0 17295594 836 38.935062 imi_mug_run_2_treatment "imatinib mesylate"
9 Q0 15838387 837 38.910164 imi_mug_run_2_treatment "liver"
9 Q0 23751846 838 38.902767 imi_mug_run_2_treatment "kinase inhibitor" "adjuvant"
9 Q0 18235121 839 38.884514 imi_mug_run_2_treatment "imatinib mesylate" "drug" "imatinib"
9 Q0 17968300 840 38.86799 imi_mug_run_2_treatment "imatinib"
9 Q0 26805230 841 38.867485 imi_mug_run_2_treatment "imatinib"
9 Q0 22584344 842 38.867485 imi_mug_run_2_treatment "imatinib mesylate"
9 Q0 15161707 843 38.85756 imi_mug_run_2_treatment "sti571"
9 Q0 24778033 844 38.83941 imi_mug_run_2_treatment "level"
9 Q0 17986244 845 38.815475 imi_mug_run_2_treatment "lead"
9 Q0 17607922 846 38.80088 imi_mug_run_2_treatment "imatinib" "sunitinib" "tyrosine kinase inhibitor"
9 Q0 16498290 847 38.796257 imi_mug_run_2_treatment "imatinib"
9 Q0 15244191 848 38.795753 imi_mug_run_2_treatment "various"
9 Q0 23348204 849 38.78631 imi_mug_run_2_treatment "imatinib" "level" "hot spot"
9 Q0 23041331 850 38.77599 imi_mug_run_2_treatment "lysozyme" "drug" "imatinib"
9 Q0 9797363 851 38.759644 imi_mug_run_2_treatment "lys" "il-3" "aim"
9 Q0 25831232 852 38.759644 imi_mug_run_2_treatment "ras" "imatinib"
9 Q0 11035578 853 38.751896 imi_mug_run_2_treatment "icc" "liver" "monoclonal antibodies"
9 Q0 28192400 854 38.751255 imi_mug_run_2_treatment "imatinib" "drug" "tyrosine"
9 Q0 15221987 855 38.742657 imi_mug_run_2_treatment "adjuvant" "imatinib mesylate"
9 Q0 16795978 856 38.736908 imi_mug_run_2_treatment "imatinib mesilate"
9 Q0 20023271 857 38.719776 imi_mug_run_2_treatment "imatinib"
9 Q0 20952281 858 38.716145 imi_mug_run_2_treatment "hot spot"
9 Q0 20927104 859 38.70785 imi_mug_run_2_treatment "program" "icc" "imatinib"
9 Q0 16397744 860 38.691814 imi_mug_run_2_treatment "basis"
9 Q0 22577569 861 38.675232 imi_mug_run_2_treatment "drug" "drugs" "imatinib"
9 Q0 24606551 862 38.672928 imi_mug_run_2_treatment "imatinib"
9 Q0 21177210 863 38.668983 imi_mug_run_2_treatment "glivec" "imatinib mesylate" "liver"
9 Q0 20946519 864 38.667557 imi_mug_run_2_treatment "tma"
9 Q0 16966028 865 38.664196 imi_mug_run_2_treatment "imatinib mesylate" "aim"
9 Q0 23295309 866 38.66286 imi_mug_run_2_treatment "level"
9 Q0 23468260 867 38.661762 imi_mug_run_2_treatment "basis" "aim" "monoclonal antibodies"
9 Q0 26805228 868 38.65128 imi_mug_run_2_treatment "s-1" "imatinib"
9 Q0 22739667 869 38.644142 imi_mug_run_2_treatment "imatinib" "duration" "adjuvant"
9 Q0 18334877 870 38.641388 imi_mug_run_2_treatment "cytokines" "tnf-alpha" "level"
9 Q0 17222247 871 38.641228 imi_mug_run_2_treatment "icc" "imatinib"
9 Q0 17629038 872 38.5812 imi_mug_run_2_treatment "imatinib mesylate"
9 Q0 19225718 873 38.580948 imi_mug_run_2_treatment "drugs" "flt" "therapeutics"
9 Q0 14695343 874 38.57391 imi_mug_run_2_treatment "imatinib mesylate" "sti571" "gleevec"
9 Q0 16555155 875 38.554783 imi_mug_run_2_treatment "others"
9 Q0 26989528 876 38.546364 imi_mug_run_2_treatment "basis"
9 Q0 25621782 877 38.511757 imi_mug_run_2_treatment "therapeutic agents"
9 Q0 24394052 878 38.489418 imi_mug_run_2_treatment "imatinib" "basis" "aim"
9 Q0 29998023 879 38.489044 imi_mug_run_2_treatment "kinase inhibitor" "imatinib"
9 Q0 29206199 880 38.486153 imi_mug_run_2_treatment "dsb" "abc" "imatinib"
9 Q0 22439647 881 38.47646 imi_mug_run_2_treatment "imatinib" "sunitinib" "antiangiogenic"
9 Q0 30224936 882 38.44673 imi_mug_run_2_treatment "sunitinib" "imatinib" "chemotherapeutic agent"
9 Q0 23873383 883 38.445354 imi_mug_run_2_treatment "therapeutics"
9 Q0 15668652 884 38.43125 imi_mug_run_2_treatment "imatinib" "sti 571" "imatinib mesylate"
9 Q0 16952042 885 38.429165 imi_mug_run_2_treatment "basis"
9 Q0 12759750 886 38.42534 imi_mug_run_2_treatment "various" "sti-571" "imatinib mesylate"
9 Q0 26521201 887 38.410797 imi_mug_run_2_treatment "icc"
9 Q0 23404343 888 38.410435 imi_mug_run_2_treatment "liver"
9 Q0 12912938 889 38.40628 imi_mug_run_2_treatment "imatinib mesylate"
9 Q0 19771279 890 38.38737 imi_mug_run_2_treatment "imatinib" "imatinib 400 mg" "basis"
9 Q0 28621321 891 38.37524 imi_mug_run_2_treatment "tandem"
9 Q0 15613856 892 38.37423 imi_mug_run_2_treatment "adjuvant" "gleevec"
9 Q0 11215292 893 38.356857 imi_mug_run_2_treatment "aim"
9 Q0 19737946 894 38.330833 imi_mug_run_2_treatment "imatinib" "sunitinib" "drug"
9 Q0 25205505 895 38.3175 imi_mug_run_2_treatment "sss"
9 Q0 29421913 896 38.297516 imi_mug_run_2_treatment "aim"
9 Q0 17438095 897 38.29158 imi_mug_run_2_treatment "imatinib" "basis"
9 Q0 24886695 898 38.284145 imi_mug_run_2_treatment "directed" "succinate" "insulin-like growth factor 1"
9 Q0 16916320 899 38.27554 imi_mug_run_2_treatment "su11248" "mediated" "ly294002"
9 Q0 23833252 900 38.25278 imi_mug_run_2_treatment "aim"
9 Q0 21279555 901 38.233307 imi_mug_run_2_treatment "imatinib" "kinase inhibitor" "gleevec"
9 Q0 15289315 902 38.227062 imi_mug_run_2_treatment "imatinib mesylate"
9 Q0 24343490 903 38.219986 imi_mug_run_2_treatment "adjuvant" "imatinib" "aim"
9 Q0 21435173 904 38.209244 imi_mug_run_2_treatment "various" "icc" "aza"
9 Q0 15788212 905 38.206715 imi_mug_run_2_treatment "liver"
9 Q0 16550875 906 38.199604 imi_mug_run_2_treatment "basis"
9 Q0 17588358 907 38.199604 imi_mug_run_2_treatment "sunitinib" "drug" "tyrosine kinase inhibitor"
9 Q0 21136920 908 38.19432 imi_mug_run_2_treatment "enzymes" "glycans"
9 Q0 26276366 909 38.170624 imi_mug_run_2_treatment "imatinib"
9 Q0 19900103 910 38.15177 imi_mug_run_2_treatment "aim"
9 Q0 12888812 911 38.151714 imi_mug_run_2_treatment "imatinib" "adjuvant" "tyrosine kinase inhibitor"
9 Q0 25731247 912 38.15049 imi_mug_run_2_treatment "imatinib" "sunitinib" "regorafenib"
9 Q0 26854374 913 38.138016 imi_mug_run_2_treatment "plasma"
9 Q0 22399613 914 38.134907 imi_mug_run_2_treatment "various"
9 Q0 17022716 915 38.13153 imi_mug_run_2_treatment "imatinib"
9 Q0 20683002 916 38.13056 imi_mug_run_2_treatment "oligo" "liver"
9 Q0 25934947 917 38.10472 imi_mug_run_2_treatment "combinations" "drug" "imatinib"
9 Q0 16155822 918 38.091305 imi_mug_run_2_treatment "sti571" "drug" "imatinib mesylate"
9 Q0 15215166 919 38.088448 imi_mug_run_2_treatment "antiserum" "imatinib mesylate" "lead"
9 Q0 18039140 920 38.08239 imi_mug_run_2_treatment "kinase inhibitor" "therapeutics" "imatinib"
9 Q0 18409663 921 38.08239 imi_mug_run_2_treatment "imatinib" "tyrosine kinase inhibitor" "adjuvant"
9 Q0 16908071 922 38.081753 imi_mug_run_2_treatment "tandem" "imatinib mesylate" "kinase inhibitor"
9 Q0 22453568 923 38.065983 imi_mug_run_2_treatment "imatinib" "adjuvant"
9 Q0 21505157 924 38.048737 imi_mug_run_2_treatment "lead"
9 Q0 15633227 925 38.04557 imi_mug_run_2_treatment "drug" "sti-571" "imatinib mesylate"
9 Q0 18422477 926 38.037193 imi_mug_run_2_treatment "imatinib mesilate" "imatinib" "adjuvant"
9 Q0 24970355 927 38.010914 imi_mug_run_2_treatment "level"
9 Q0 11865845 928 37.997368 imi_mug_run_2_treatment "sti571" "lead"
9 Q0 23550446 929 37.95539 imi_mug_run_2_treatment "imatinib"
9 Q0 25621775 930 37.947124 imi_mug_run_2_treatment "imatinib" "adjuvant" "drug"
9 Q0 12375034 931 37.911983 imi_mug_run_2_treatment "biotin" "mediated"
9 Q0 24052432 932 37.91054 imi_mug_run_2_treatment "liver" "air" "food"
9 Q0 21286759 933 37.899605 imi_mug_run_2_treatment "program"
9 Q0 26720290 934 37.849197 imi_mug_run_2_treatment "imatinib"
9 Q0 14651144 935 37.84373 imi_mug_run_2_treatment "chemotherapy agents" "sti-571" "agent"
9 Q0 18074824 936 37.828873 imi_mug_run_2_treatment "combinations" "liver"
9 Q0 18615679 937 37.828434 imi_mug_run_2_treatment "imatinib" "ras"
9 Q0 16144917 938 37.814453 imi_mug_run_2_treatment "imatinib" "vascular endothelial growth factor" "antiangiogenic"
9 Q0 19144598 939 37.810047 imi_mug_run_2_treatment "imatinib" "genesis"
9 Q0 27375917 940 37.79914 imi_mug_run_2_treatment "tyrosine kinase inhibitor"
9 Q0 23239909 941 37.788864 imi_mug_run_2_treatment "imatinib" "imatinib mesylate"
9 Q0 26905135 942 37.787613 imi_mug_run_2_treatment "various"
9 Q0 11914617 943 37.78188 imi_mug_run_2_treatment "lead"
9 Q0 16273186 944 37.77889 imi_mug_run_2_treatment "melan-a"
9 Q0 16166919 945 37.772873 imi_mug_run_2_treatment "drug" "imatinib mesilate" "tyrosine kinase inhibitor"
9 Q0 29100343 946 37.77054 imi_mug_run_2_treatment "pdx" "imatinib" "sunitinib"
9 Q0 11861291 947 37.76198 imi_mug_run_2_treatment "enzymes" "sti571" "drugs"
9 Q0 19176456 948 37.75821 imi_mug_run_2_treatment "imatinib" "ile" "thr"
9 Q0 17878015 949 37.75751 imi_mug_run_2_treatment "tyrosine kinase inhibitor"
9 Q0 25810235 950 37.75629 imi_mug_run_2_treatment "imatinib" "prednisolone" "agent"
9 Q0 25469264 951 37.75419 imi_mug_run_2_treatment "fletcher's" "duration"
9 Q0 21462307 952 37.75109 imi_mug_run_2_treatment "imatinib" "imatinib mesylate"
9 Q0 17674545 953 37.74799 imi_mug_run_2_treatment "various" "imatinib" "glivec"
9 Q0 23198834 954 37.74291 imi_mug_run_2_treatment "imatinib" "drugs" "imatinib mesylate"
9 Q0 16328663 955 37.74034 imi_mug_run_2_treatment "level"
9 Q0 21524289 956 37.73609 imi_mug_run_2_treatment "imatinib"
9 Q0 15875730 957 37.73571 imi_mug_run_2_treatment "kinase inhibitor" "tyrosine kinase inhibitor" "basis"
9 Q0 17454792 958 37.735603 imi_mug_run_2_treatment "imatinib mesylate" "glivec" "imatinib"
9 Q0 18690842 959 37.734726 imi_mug_run_2_treatment "imatinib" "kinase inhibitor" "mediators"
9 Q0 11246625 960 37.727413 imi_mug_run_2_treatment "parathyroid"
9 Q0 18708242 961 37.717175 imi_mug_run_2_treatment "asc"
9 Q0 17261983 962 37.716137 imi_mug_run_2_treatment "aim"
9 Q0 18294396 963 37.712185 imi_mug_run_2_treatment "generic"
9 Q0 25316817 964 37.704075 imi_mug_run_2_treatment "combinations" "imatinib" "agent"
9 Q0 21427092 965 37.69552 imi_mug_run_2_treatment "fletcher's"
9 Q0 12692842 966 37.68422 imi_mug_run_2_treatment "level" "aim"
9 Q0 15709888 967 37.682682 imi_mug_run_2_treatment "imatinib mesylate" "tyrosine" "imatinib"
9 Q0 24790651 968 37.682682 imi_mug_run_2_treatment "imatinib" "sunitinib" "regorafenib"
9 Q0 20736294 969 37.65703 imi_mug_run_2_treatment "imatinib" "dasatinib"
9 Q0 19476525 970 37.65006 imi_mug_run_2_treatment "imatinib" "sunitinib" "liver"
9 Q0 25564173 971 37.643845 imi_mug_run_2_treatment "basis" "aim"
9 Q0 15953881 972 37.640057 imi_mug_run_2_treatment "imatinib" "androgen" "imatinib mesylate"
9 Q0 20651610 973 37.639977 imi_mug_run_2_treatment "imatinib"
9 Q0 24444465 974 37.63716 imi_mug_run_2_treatment "imatinib"
9 Q0 23969726 975 37.621597 imi_mug_run_2_treatment "imatinib" "aim"
9 Q0 17923802 976 37.5813 imi_mug_run_2_treatment "insulin" "imatinib" "imatinib mesylate"
9 Q0 19213398 977 37.580013 imi_mug_run_2_treatment "imatinib"
9 Q0 17465451 978 37.558987 imi_mug_run_2_treatment "aim"
9 Q0 28280629 979 37.54858 imi_mug_run_2_treatment "duration" "imatinib" "imatinib mesylate"
9 Q0 14657591 980 37.52719 imi_mug_run_2_treatment "various" "glivec"
9 Q0 18394167 981 37.52625 imi_mug_run_2_treatment "imatinib mesylate"
9 Q0 18030576 982 37.52597 imi_mug_run_2_treatment "imatinib" "imatinib mesylate" "tyrosine kinase inhibitor"
9 Q0 22017446 983 37.51377 imi_mug_run_2_treatment "imatinib"
9 Q0 17633880 984 37.483913 imi_mug_run_2_treatment "gleevec" "imatinib" "adjuvant"
9 Q0 11688571 985 37.472633 imi_mug_run_2_treatment "liver"
9 Q0 26130666 986 37.4713 imi_mug_run_2_treatment "imatinib"
9 Q0 18684030 987 37.452705 imi_mug_run_2_treatment "melan-a"
9 Q0 30103756 988 37.448032 imi_mug_run_2_treatment "imatinib"
9 Q0 23205104 989 37.422962 imi_mug_run_2_treatment "nitrocellulose"
9 Q0 19536093 990 37.420425 imi_mug_run_2_treatment "imatinib" "aim"
9 Q0 15547773 991 37.40673 imi_mug_run_2_treatment "imatinib mesylate" "lead" "tyrosine"
9 Q0 20470368 992 37.393875 imi_mug_run_2_treatment "imatinib"
9 Q0 17227921 993 37.39334 imi_mug_run_2_treatment "aim"
9 Q0 24298573 994 37.384575 imi_mug_run_2_treatment "insulin" "igf1" "insulin-like growth factor 1"
9 Q0 17625429 995 37.357044 imi_mug_run_2_treatment "imatinib"
9 Q0 14639002 996 37.34682 imi_mug_run_2_treatment "drug" "sti571" "imatinib mesylate"
9 Q0 28231736 997 37.336994 imi_mug_run_2_treatment "mediated" "skf-96365" "blockade"
9 Q0 25905001 998 37.32658 imi_mug_run_2_treatment "regorafenib" "program" "imatinib"
9 Q0 20126584 999 37.322685 imi_mug_run_2_treatment "imatinib mesylate" "liver"
10 Q0 19671763 1 84.880646 imi_mug_run_2_treatment "dasatinib" "imatinib" "sorafenib"
10 Q0 26973244 2 71.242294 imi_mug_run_2_treatment "crest"
10 Q0 17372901 3 71.03503 imi_mug_run_2_treatment "imatinib" "kinase inhibitor" "dasatinib"
10 Q0 25841461 4 70.81969 imi_mug_run_2_treatment "various" "combinations" "drugs"
10 Q0 22513068 5 68.6502 imi_mug_run_2_treatment "eosin" "formalin"
10 Q0 19047099 6 67.999435 imi_mug_run_2_treatment "imatinib" "drug" "mediators"
10 Q0 22261812 7 65.14603 imi_mug_run_2_treatment "sunitinib" "kinase inhibitor" "duration"
10 Q0 21069551 8 64.35649 imi_mug_run_2_treatment "kinase inhibitor" "imatinib" "tyrosine kinase inhibitor"
10 Q0 25003536 9 64.17052 imi_mug_run_2_treatment "imatinib" "imatinib mesylate" "animals"
10 Q0 28421416 10 62.81755 imi_mug_run_2_treatment "imatinib"
10 Q0 16908931 11 62.68057 imi_mug_run_2_treatment "imatinib"
10 Q0 19035443 12 61.840576 imi_mug_run_2_treatment "sunitinib" "imatinib"
10 Q0 19996579 13 61.83245 imi_mug_run_2_treatment "imatinib" "sunitinib" "dasatinib"
10 Q0 19802003 14 61.707226 imi_mug_run_2_treatment "ras" "inositol" "imatinib"
10 Q0 18980976 15 61.339725 imi_mug_run_2_treatment "imatinib"
10 Q0 26399561 16 61.069492 imi_mug_run_2_treatment "aim"
10 Q0 22453014 17 60.85692 imi_mug_run_2_treatment "imatinib"
10 Q0 21680547 18 60.6867 imi_mug_run_2_treatment "various" "aim"
10 Q0 21595858 19 60.504757 imi_mug_run_2_treatment "agar"
10 Q0 20372153 20 60.4899 imi_mug_run_2_treatment "imatinib" "sorafenib"
10 Q0 21642685 21 60.259727 imi_mug_run_2_treatment "imatinib mesylate"
10 Q0 28334439 22 59.895496 imi_mug_run_2_treatment "dasatinib" "imatinib" "tyrosine kinase inhibitor"
10 Q0 28296713 23 58.363026 imi_mug_run_2_treatment "lead"
10 Q0 18066592 24 57.97705 imi_mug_run_2_treatment "various"
10 Q0 21478825 25 57.74408 imi_mug_run_2_treatment "imatinib"
10 Q0 23299198 26 56.909164 imi_mug_run_2_treatment "imatinib" "agent" "basis"
10 Q0 28327988 27 56.74356 imi_mug_run_2_treatment "nilotinib" "dtic" "imatinib"
10 Q0 25917463 28 56.702072 imi_mug_run_2_treatment "mms" "formalin" "aim"
10 Q0 23582185 29 56.466835 imi_mug_run_2_treatment "imatinib" "nilotinib" "dasatinib"
10 Q0 18936790 30 56.23575 imi_mug_run_2_treatment "sorafenib" "temozolomide" "vascular endothelial growth factor"
10 Q0 20457136 31 55.92398 imi_mug_run_2_treatment "therapeutics"
10 Q0 23664541 32 55.797825 imi_mug_run_2_treatment "level"
10 Q0 25178104 33 55.54882 imi_mug_run_2_treatment "agent"
10 Q0 25841460 34 55.313393 imi_mug_run_2_treatment "drug" "drugs" "ras"
10 Q0 27322141 35 55.23359 imi_mug_run_2_treatment "monolayers" "imatinib" "nilotinib"
10 Q0 23775962 36 55.00022 imi_mug_run_2_treatment "imatinib" "imatinib 400 mg"
10 Q0 22068222 37 54.714893 imi_mug_run_2_treatment "nilotinib"
10 Q0 29035277 38 54.515144 imi_mug_run_2_treatment "serine"
10 Q0 23860532 39 54.23878 imi_mug_run_2_treatment "isolate" "aim"
10 Q0 19652585 40 53.875237 imi_mug_run_2_treatment "imatinib" "tumor infiltrating lymphocytes"
10 Q0 21971089 41 53.491028 imi_mug_run_2_treatment "mms"
10 Q0 29746316 42 52.9196 imi_mug_run_2_treatment "ors"
10 Q0 25042176 43 52.56786 imi_mug_run_2_treatment "imatinib"
10 Q0 21750866 44 52.53369 imi_mug_run_2_treatment "ras"
10 Q0 26424760 45 52.28119 imi_mug_run_2_treatment "nilotinib" "duration"
10 Q0 19283671 46 52.10009 imi_mug_run_2_treatment "basis" "imatinib mesylate"
10 Q0 7687762 47 51.927162 imi_mug_run_2_treatment "mast cell growth factor"
10 Q0 30242244 48 51.90867 imi_mug_run_2_treatment "drug" "tyrosine" "duration"
10 Q0 29187493 49 51.812614 imi_mug_run_2_treatment "aim" "nervous system"
10 Q0 21495997 50 51.78251 imi_mug_run_2_treatment "imatinib"
10 Q0 28868012 51 51.645176 imi_mug_run_2_treatment "imatinib"
10 Q0 26710785 52 51.294304 imi_mug_run_2_treatment "level" "aim" "vemurafenib"
10 Q0 19847190 53 51.08812 imi_mug_run_2_treatment "drugs"
10 Q0 20571149 54 51.01486 imi_mug_run_2_treatment "various"
10 Q0 28380455 55 50.043686 imi_mug_run_2_treatment "ras" "level"
10 Q0 29137292 56 49.878654 imi_mug_run_2_treatment "imatinib" "tyrosine kinase inhibitor"
10 Q0 21825314 57 49.808456 imi_mug_run_2_treatment "melan a"
10 Q0 21848624 58 49.659733 imi_mug_run_2_treatment "various"
10 Q0 15223779 59 49.32637 imi_mug_run_2_treatment "sti571" "tyrosine" "tyrosine kinase inhibitor"
10 Q0 24295410 60 49.281784 imi_mug_run_2_treatment "sunitinib" "liver"
10 Q0 25695690 61 49.20076 imi_mug_run_2_treatment "imatinib" "nilotinib" "agent"
10 Q0 28026870 62 48.66104 imi_mug_run_2_treatment "platinum"
10 Q0 16741525 63 48.33034 imi_mug_run_2_treatment "drugs"
10 Q0 26264378 64 48.099236 imi_mug_run_2_treatment "sunitinib" "medication" "basis"
10 Q0 27864904 65 48.038586 imi_mug_run_2_treatment "adjuvant"
10 Q0 25797573 66 47.75774 imi_mug_run_2_treatment "ras" "liver"
10 Q0 19118061 67 47.357105 imi_mug_run_2_treatment "imatinib mesylate" "imatinib"
10 Q0 25317746 68 47.353806 imi_mug_run_2_treatment "imatinib" "dasatinib" "others"
10 Q0 26725706 69 47.131622 imi_mug_run_2_treatment "masitinib" "tyrosine kinase inhibitor"
10 Q0 23069279 70 46.788166 imi_mug_run_2_treatment "lead"
10 Q0 22500535 71 46.445118 imi_mug_run_2_treatment "nilotinib" "imatinib" "agent"
10 Q0 20360932 72 46.262283 imi_mug_run_2_treatment "mediators" "imatinib"
10 Q0 23940219 73 46.202873 imi_mug_run_2_treatment "diphencyprone" "level" "melan a"
10 Q0 15145934 74 46.13189 imi_mug_run_2_treatment "mediated" "sti571" "glivec"
10 Q0 22791410 75 46.10535 imi_mug_run_2_treatment "ras"
10 Q0 25766129 76 45.992004 imi_mug_run_2_treatment "ssm"
10 Q0 28092366 77 45.972244 imi_mug_run_2_treatment "mediated"
10 Q0 22736149 78 45.92049 imi_mug_run_2_treatment "biotin" "mms" "imatinib"
10 Q0 25834362 79 45.71772 imi_mug_run_2_treatment "liver"
10 Q0 28843487 80 45.70234 imi_mug_run_2_treatment "nilotinib"
10 Q0 24628300 81 45.223274 imi_mug_run_2_treatment "color"
10 Q0 16034302 82 45.13906 imi_mug_run_2_treatment "level" "imatinib mesylate" "formalin"
10 Q0 22281663 83 45.06312 imi_mug_run_2_treatment "mart-1" "isolate" "level"
10 Q0 27739435 84 45.036728 imi_mug_run_2_treatment "therapeutics"
10 Q0 8957075 85 44.958252 imi_mug_run_2_treatment "mediated"
10 Q0 28072717 86 44.94203 imi_mug_run_2_treatment "ipilimumab" "duration" "aim"
10 Q0 20425130 87 44.914677 imi_mug_run_2_treatment "imatinib"
10 Q0 28443572 88 44.899456 imi_mug_run_2_treatment "adjuvant" "melan a" "melan-a"
10 Q0 23246970 89 44.730988 imi_mug_run_2_treatment "imatinib mesylate"
10 Q0 26484880 90 44.67678 imi_mug_run_2_treatment "ras" "basis"
10 Q0 26990482 91 44.379135 imi_mug_run_2_treatment "various" "nilotinib" "imatinib"
10 Q0 9365536 92 43.7837 imi_mug_run_2_treatment "mediated"
10 Q0 21454057 93 43.755333 imi_mug_run_2_treatment "level"
10 Q0 22193299 94 43.67442 imi_mug_run_2_treatment "various"
10 Q0 27153441 95 43.638832 imi_mug_run_2_treatment "kinase inhibitor"
10 Q0 17214848 96 43.434166 imi_mug_run_2_treatment "basic fibroblast growth factor"
10 Q0 28410286 97 43.391014 imi_mug_run_2_treatment "imatinib" "nilotinib" "ipilimumab"
10 Q0 14634801 98 43.377064 imi_mug_run_2_treatment "vascular endothelial growth factor"
10 Q0 14513377 99 43.123886 imi_mug_run_2_treatment "tma" "imatinib mesylate"
10 Q0 18632627 100 43.03002 imi_mug_run_2_treatment "imatinib"
10 Q0 21523734 101 42.85401 imi_mug_run_2_treatment "dasatinib"
10 Q0 22154054 102 42.7432 imi_mug_run_2_treatment "imatinib"
10 Q0 25609545 103 42.72162 imi_mug_run_2_treatment "smd" "imatinib" "glucose"
10 Q0 21119596 104 42.600082 imi_mug_run_2_treatment "messenger"
10 Q0 19158841 105 42.40914 imi_mug_run_2_treatment "level"
10 Q0 22643209 106 42.243057 imi_mug_run_2_treatment "imatinib"
10 Q0 23773742 107 42.10879 imi_mug_run_2_treatment "adjuvant" "ssm"
10 Q0 25179409 108 41.782364 imi_mug_run_2_treatment "medicine"
10 Q0 7496598 109 41.617786 imi_mug_run_2_treatment "hmba" "sodium butyrate"
10 Q0 22355509 110 41.25449 imi_mug_run_2_treatment "carmustine" "dacarbazine" "tamoxifen"
10 Q0 17492934 111 41.08821 imi_mug_run_2_treatment "ras" "therapeutic agents"
10 Q0 9171936 112 40.944637 imi_mug_run_2_treatment "steel factor"
10 Q0 16034306 113 40.799286 imi_mug_run_2_treatment "gleevec" "imatinib" "imatinib mesylate"
10 Q0 20927104 114 40.758545 imi_mug_run_2_treatment "program" "icc" "imatinib"
10 Q0 24276025 115 40.63993 imi_mug_run_2_treatment "aim"
10 Q0 29273148 116 40.516777 imi_mug_run_2_treatment "nilotinib"
10 Q0 22350184 117 40.51223 imi_mug_run_2_treatment "dacarbazine" "ipilimumab" "drug"
10 Q0 24531699 118 40.400604 imi_mug_run_2_treatment "imatinib" "tyrosine kinase inhibitor" "vemurafenib"
10 Q0 17645464 119 40.394157 imi_mug_run_2_treatment "aim"
10 Q0 21887372 120 40.218708 imi_mug_run_2_treatment "ras"
10 Q0 24921944 121 40.160763 imi_mug_run_2_treatment "chemotherapy agents" "cisplatin" "dacarbazine"
10 Q0 27771229 122 40.056 imi_mug_run_2_treatment "ras" "genesis"
10 Q0 30236595 123 40.035095 imi_mug_run_2_treatment "metric" "metrics" "blockade"
10 Q0 9856895 124 40.028645 imi_mug_run_2_treatment "mates"
10 Q0 24802725 125 39.972084 imi_mug_run_2_treatment "aim"
10 Q0 22094233 126 39.772987 imi_mug_run_2_treatment "aim"
10 Q0 25324906 127 39.68863 imi_mug_run_2_treatment "nitrosoureas" "dacarbazine" "imatinib"
10 Q0 26282084 128 39.51013 imi_mug_run_2_treatment "genesis"
10 Q0 11596105 129 39.47942 imi_mug_run_2_treatment "level"
10 Q0 21690468 130 39.252514 imi_mug_run_2_treatment "imatinib" "imatinib 400 mg" "imatinib mesylate"
10 Q0 16236162 131 39.17684 imi_mug_run_2_treatment "imatinib mesylate"
10 Q0 19788535 132 39.162834 imi_mug_run_2_treatment "basis"
10 Q0 23127174 133 39.06521 imi_mug_run_2_treatment "imatinib" "lead" "pkc412"
10 Q0 18486988 134 38.938053 imi_mug_run_2_treatment "imatinib"
10 Q0 17361263 135 38.91682 imi_mug_run_2_treatment "liver"
10 Q0 26217117 136 38.91469 imi_mug_run_2_treatment "combinations" "mek inhibitor" "trametinib"
10 Q0 24969998 137 38.86183 imi_mug_run_2_treatment "antiangiogenic"
10 Q0 26275246 138 38.408203 imi_mug_run_2_treatment "various"
10 Q0 22261672 139 38.40129 imi_mug_run_2_treatment "drugs"
10 Q0 24413374 140 38.27719 imi_mug_run_2_treatment "vemurafenib" "ipilimumab" "new drugs"
10 Q0 30028779 141 37.965607 imi_mug_run_2_treatment "adjuvant"
10 Q0 17028924 142 37.914173 imi_mug_run_2_treatment "various" "cytokines"
10 Q0 24051699 143 37.89318 imi_mug_run_2_treatment "melana" "basis"
10 Q0 29600692 144 37.664185 imi_mug_run_2_treatment "various" "others" "imatinib"
10 Q0 30385465 145 37.640236 imi_mug_run_2_treatment "drugs"
10 Q0 24652072 146 37.637848 imi_mug_run_2_treatment "imatinib mesylate" "drug" "cytokines"
10 Q0 16441409 147 37.478043 imi_mug_run_2_treatment "various"
10 Q0 21051014 148 37.439255 imi_mug_run_2_treatment "drugs" "tyrosine" "plx4032"
10 Q0 27536065 149 37.22553 imi_mug_run_2_treatment "drug" "lead" "mediated"
10 Q0 29147422 150 37.112022 imi_mug_run_2_treatment "imatinib"
10 Q0 7507133 151 37.08181 imi_mug_run_2_treatment "various" "toluidine blue"
10 Q0 24127596 152 37.025013 imi_mug_run_2_treatment "basis" "isolate"
10 Q0 22112480 153 37.00748 imi_mug_run_2_treatment "mitogen"
10 Q0 15846297 154 36.94355 imi_mug_run_2_treatment "imatinib"
10 Q0 24341237 155 36.918697 imi_mug_run_2_treatment "drugs" "immunosuppressive" "imatinib"
10 Q0 15990777 156 36.76893 imi_mug_run_2_treatment "pollen"
10 Q0 24603591 157 36.746014 imi_mug_run_2_treatment "aim"
10 Q0 15009722 158 36.70057 imi_mug_run_2_treatment "imatinib mesylate" "phosphate" "level"
10 Q0 15906230 159 36.635887 imi_mug_run_2_treatment "therapeutic agent"
10 Q0 22351689 160 36.61509 imi_mug_run_2_treatment "raf265"
10 Q0 22394203 161 36.503017 imi_mug_run_2_treatment "various" "sorafenib" "drug"
10 Q0 25539369 162 36.471893 imi_mug_run_2_treatment "adjuvant"
10 Q0 20651610 163 36.443066 imi_mug_run_2_treatment "imatinib"
10 Q0 27188223 164 36.43775 imi_mug_run_2_treatment "com" "new drugs" "trametinib"
10 Q0 30086074 165 36.41324 imi_mug_run_2_treatment "various" "pdx" "drugs"
10 Q0 20525481 166 36.40567 imi_mug_run_2_treatment "cytostatic" "cytotoxic" "imatinib"
10 Q0 25841455 167 36.400238 imi_mug_run_2_treatment "ras"
10 Q0 25544564 168 36.397823 imi_mug_run_2_treatment "mediated"
10 Q0 25632386 169 36.36042 imi_mug_run_2_treatment "trametinib" "vemurafenib" "dabrafenib"
10 Q0 19126397 170 36.168182 imi_mug_run_2_treatment "various"
10 Q0 22493355 171 36.101097 imi_mug_run_2_treatment "ras" "kinase inhibitor"
10 Q0 18835628 172 36.101055 imi_mug_run_2_treatment "eosin"
10 Q0 28277830 173 36.039963 imi_mug_run_2_treatment "masitinib" "binimetinib" "mek inhibitor"
10 Q0 20595514 174 36.014732 imi_mug_run_2_treatment "isoleucine" "nitrosurea" "phenylalanine"
10 Q0 23114504 175 35.94388 imi_mug_run_2_treatment "sunitinib" "sunitinib malate" "tyrosine kinase inhibitor"
10 Q0 11865845 176 35.93186 imi_mug_run_2_treatment "sti571" "lead"
10 Q0 21349766 177 35.824852 imi_mug_run_2_treatment "mitogen"
10 Q0 24855380 178 35.798134 imi_mug_run_2_treatment "imatinib" "sorafenib"
10 Q0 26709572 179 35.58522 imi_mug_run_2_treatment "level"
10 Q0 29066909 180 35.57655 imi_mug_run_2_treatment "apatinib" "tmz" "temozolomide"
10 Q0 24050392 181 35.50428 imi_mug_run_2_treatment "drug" "sunitinib" "immunomodulator"
10 Q0 26277063 182 35.437725 imi_mug_run_2_treatment "liver"
10 Q0 26825879 183 35.315388 imi_mug_run_2_treatment "therapeutic agents"
10 Q0 16767900 184 35.272938 imi_mug_run_2_treatment "various" "tyrosine" "imatinib mesylate"
10 Q0 25357015 185 35.250454 imi_mug_run_2_treatment "various"
10 Q0 18728664 186 35.233463 imi_mug_run_2_treatment "imatinib" "tyrosine" "imatinib mesylate"
10 Q0 30075827 187 35.233463 imi_mug_run_2_treatment "imatinib" "therapeutic agent" "level"
10 Q0 16567968 188 35.18931 imi_mug_run_2_treatment "sti571" "antineoplastic" "aim"
10 Q0 18684030 189 35.18931 imi_mug_run_2_treatment "melan-a"
10 Q0 15173918 190 35.14073 imi_mug_run_2_treatment "vascular endothelial growth factor" "aim"
10 Q0 26266759 191 35.13205 imi_mug_run_2_treatment "liver"
10 Q0 24463461 192 35.12114 imi_mug_run_2_treatment "aim"
10 Q0 18078058 193 35.033806 imi_mug_run_2_treatment "drug" "glivec"
10 Q0 28494469 194 34.99417 imi_mug_run_2_treatment "aim"
10 Q0 17658483 195 34.852318 imi_mug_run_2_treatment "imidazole" "sulfonamide" "agent"
10 Q0 8541720 196 34.81289 imi_mug_run_2_treatment "dopa"
10 Q0 23158148 197 34.793663 imi_mug_run_2_treatment "lactose" "aim"
10 Q0 20975605 198 34.714466 imi_mug_run_2_treatment "paclitaxel" "imatinib" "vatalanib"
10 Q0 23644159 199 34.667057 imi_mug_run_2_treatment "cytokines" "buffers" "interferon-gamma"
10 Q0 1378316 200 34.647697 imi_mug_run_2_treatment "methylcellulose" "kato" "interleukin-3"
10 Q0 15846140 201 34.62506 imi_mug_run_2_treatment "lovastatin" "statins" "ethidium bromide"
10 Q0 24950457 202 34.543644 imi_mug_run_2_treatment "amuvatinib" "cytotoxic" "kinase inhibitor"
10 Q0 27020391 203 34.535904 imi_mug_run_2_treatment "aim"
10 Q0 28880927 204 34.51806 imi_mug_run_2_treatment "nitric oxide" "level"
10 Q0 21244632 205 34.493504 imi_mug_run_2_treatment "kinase inhibitor" "drugs" "imatinib"
10 Q0 1384954 206 34.481705 imi_mug_run_2_treatment "basis"
10 Q0 24489649 207 34.470398 imi_mug_run_2_treatment "igf-1" "cd271" "cytokines"
10 Q0 22798288 208 34.43444 imi_mug_run_2_treatment "mek inhibitor" "tak-733"
10 Q0 23958542 209 34.417404 imi_mug_run_2_treatment "cd271" "level"
10 Q0 17058169 210 34.31825 imi_mug_run_2_treatment "aim"
10 Q0 26206557 211 34.274826 imi_mug_run_2_treatment "protease" "dextran sodium sulfate" "program"
10 Q0 20545949 212 34.24549 imi_mug_run_2_treatment "interferon" "imatinib mesylate" "dacarbazine"
10 Q0 18776719 213 34.125324 imi_mug_run_2_treatment "plasma" "level"
10 Q0 18485676 214 34.112415 imi_mug_run_2_treatment "imatinib mesylate" "drug" "dacarbazine"
10 Q0 25131236 215 34.11026 imi_mug_run_2_treatment "tacrolimus" "topical tacrolimus" "level"
10 Q0 23102192 216 34.074623 imi_mug_run_2_treatment "kinase inhibitor" "vemurafenib" "medicines"
10 Q0 27502704 217 34.064617 imi_mug_run_2_treatment "imatinib" "paclitaxel"
10 Q0 24962553 218 34.05294 imi_mug_run_2_treatment "drugs" "ipilimumab" "blockade"
10 Q0 21235437 219 34.047928 imi_mug_run_2_treatment "dacarbazine" "ipilimumab" "new drugs"
10 Q0 21148330 220 34.03578 imi_mug_run_2_treatment "various" "animals"
10 Q0 21188111 221 34.033848 imi_mug_run_2_treatment "adjuvant" "interferon alpha-2b" "interleukin-2"
10 Q0 27602499 222 33.87152 imi_mug_run_2_treatment "animals"
10 Q0 9609630 223 33.846146 imi_mug_run_2_treatment "paraformaldehyde" "c-kit ligand" "mast cell growth factor"
10 Q0 23559126 224 33.826027 imi_mug_run_2_treatment "cyclic amp" "soybean" "blockade"
10 Q0 20482674 225 33.687298 imi_mug_run_2_treatment "tma" "mart-1" "lead"
10 Q0 1372524 226 33.686813 imi_mug_run_2_treatment "mast cell growth factor"
10 Q0 16753594 227 33.674324 imi_mug_run_2_treatment "melana" "lead"
10 Q0 23476798 228 33.616146 imi_mug_run_2_treatment "interferon" "adjuvant"
10 Q0 25435369 229 33.56447 imi_mug_run_2_treatment "tyrosine" "ras"
10 Q0 16565971 230 33.5277 imi_mug_run_2_treatment "imatinib" "imatinib mesylate" "agent"
10 Q0 27258816 231 33.499733 imi_mug_run_2_treatment "ptc" "imatinib"
10 Q0 19079179 232 33.47834 imi_mug_run_2_treatment "retinoic acid"
10 Q0 18454155 233 33.32151 imi_mug_run_2_treatment "adjuvant" "cpg oligodeoxynucleotide" "interleukin-6"
10 Q0 8978830 234 33.27499 imi_mug_run_2_treatment "nh2"
10 Q0 23762150 235 33.18524 imi_mug_run_2_treatment "resveratrol" "sti571" "melanocyte-stimulating hormone"
10 Q0 27466810 236 33.14392 imi_mug_run_2_treatment "medicine"
10 Q0 18281615 237 33.14331 imi_mug_run_2_treatment "tandem" "imatinib mesylate"
10 Q0 19013892 238 33.12918 imi_mug_run_2_treatment "drugs" "ras"
10 Q0 28130756 239 33.048553 imi_mug_run_2_treatment "asa" "formalin"
10 Q0 24880943 240 32.943306 imi_mug_run_2_treatment "mek inhibitor" "trametinib" "vemurafenib"
10 Q0 28858076 241 32.910423 imi_mug_run_2_treatment "level"
10 Q0 1381702 242 32.853546 imi_mug_run_2_treatment "product" "monoclonal antibodies"
10 Q0 9440696 243 32.75216 imi_mug_run_2_treatment "serine" "steel factor"
10 Q0 1711559 244 32.752007 imi_mug_run_2_treatment "protease" "c-kit ligand"
10 Q0 10721491 245 32.70832 imi_mug_run_2_treatment "her-2"
10 Q0 22635005 246 32.70832 imi_mug_run_2_treatment "mediators" "hsp70"
10 Q0 24281418 247 32.663204 imi_mug_run_2_treatment "dasatinib" "melphalan" "kinase inhibitor"
10 Q0 11310795 248 32.596363 imi_mug_run_2_treatment "balance"
10 Q0 30222690 249 32.57733 imi_mug_run_2_treatment "drug" "vemurafenib"
10 Q0 25363723 250 32.4688 imi_mug_run_2_treatment "autologous"
10 Q0 22987942 251 32.444542 imi_mug_run_2_treatment "combinations" "kinase inhibitor" "protein kinase inhibitors"
10 Q0 22231762 252 32.380394 imi_mug_run_2_treatment "combinations"
10 Q0 6845797 253 32.368134 imi_mug_run_2_treatment "dacarbazine"
10 Q0 14604954 254 32.33157 imi_mug_run_2_treatment "methylcellulose"
10 Q0 23796270 255 32.31114 imi_mug_run_2_treatment "product" "basis"
10 Q0 18941208 256 32.2142 imi_mug_run_2_treatment "cytokines" "allogeneic"
10 Q0 22594895 257 32.174625 imi_mug_run_2_treatment "various" "agent"
10 Q0 26942004 258 32.080482 imi_mug_run_2_treatment "zeaxanthin"
10 Q0 18510589 259 32.039307 imi_mug_run_2_treatment "imatinib"
10 Q0 7847808 260 32.030228 imi_mug_run_2_treatment "tyrosine"
10 Q0 26277786 261 31.958027 imi_mug_run_2_treatment "anti-angiogenic agents"
10 Q0 21670085 262 31.958027 imi_mug_run_2_treatment "lead" "basis"
10 Q0 14507401 263 31.925058 imi_mug_run_2_treatment "tyrosine" "sti-571" "gleevec"
10 Q0 16983347 264 31.834524 imi_mug_run_2_treatment "imatinib" "mediated" "agonist"
10 Q0 8652271 265 31.796265 imi_mug_run_2_treatment "genistein" "htca" "tyrosine kinase inhibitor"
10 Q0 24458518 266 31.771431 imi_mug_run_2_treatment "hot spot"
10 Q0 26225944 267 31.750843 imi_mug_run_2_treatment "aim"
10 Q0 22811327 268 31.697033 imi_mug_run_2_treatment "new medications" "vemurafenib"
10 Q0 27386120 269 31.685415 imi_mug_run_2_treatment "melan a"
10 Q0 25145549 270 31.623451 imi_mug_run_2_treatment "various" "ipilimumab" "vemurafenib"
10 Q0 23584343 271 31.617184 imi_mug_run_2_treatment "interferon alfa-2b" "imatinib" "ipilimumab"
10 Q0 16630177 272 31.505608 imi_mug_run_2_treatment "gleevec" "tyrosine" "anti-tumor drugs"
10 Q0 21946018 273 31.47686 imi_mug_run_2_treatment "tma"
10 Q0 1371080 274 31.414848 imi_mug_run_2_treatment "mast cell growth factor" "il-3" "interleukin-3"
10 Q0 27923592 275 31.394653 imi_mug_run_2_treatment "gna" "braf inhibitor"
10 Q0 23614295 276 31.338041 imi_mug_run_2_treatment "various" "dha" "docosahexaenoic acid"
10 Q0 28484715 277 31.327488 imi_mug_run_2_treatment "plasma"
10 Q0 18706273 278 31.317696 imi_mug_run_2_treatment "adjuvant"
10 Q0 24770508 279 31.311409 imi_mug_run_2_treatment "interferon" "drug" "ipilimumab"
10 Q0 26384656 280 31.243507 imi_mug_run_2_treatment "methylated"
10 Q0 28114255 281 31.223057 imi_mug_run_2_treatment "drug" "mek inhibitor" "glembatumumab"
10 Q0 22157936 282 31.211477 imi_mug_run_2_treatment "cd271"
10 Q0 7683919 283 31.180202 imi_mug_run_2_treatment "cytokines"
10 Q0 25450268 284 31.145111 imi_mug_run_2_treatment "dok"
10 Q0 2370914 285 31.089426 imi_mug_run_2_treatment "product"
10 Q0 7509778 286 31.028553 imi_mug_run_2_treatment "interferon" "cytokines" "il-12"
10 Q0 23438383 287 30.996399 imi_mug_run_2_treatment "agent" "braf inhibitor" "vemurafenib"
10 Q0 3373261 288 30.989277 imi_mug_run_2_treatment "monoclonal antibody 96.5"
10 Q0 29946185 289 30.867546 imi_mug_run_2_treatment "level" "nivolumab"
10 Q0 23694694 290 30.8563 imi_mug_run_2_treatment "aim"
10 Q0 26618350 291 30.855816 imi_mug_run_2_treatment "imatinib" "ipilimumab" "sorafenib"
10 Q0 21421113 292 30.733557 imi_mug_run_2_treatment "melanoma vaccines" "imatinib" "plx4032"
10 Q0 23420410 293 30.73119 imi_mug_run_2_treatment "braf inhibitor" "imatinib" "mek inhibitor"
10 Q0 18042149 294 30.650715 imi_mug_run_2_treatment "ras" "lead" "genesis"
10 Q0 7679484 295 30.634712 imi_mug_run_2_treatment "protease" "animals"
10 Q0 27137746 296 30.616978 imi_mug_run_2_treatment "combinations" "drugs" "therapeutics"
10 Q0 27056438 297 30.616978 imi_mug_run_2_treatment "melan-a"
10 Q0 23516515 298 30.608074 imi_mug_run_2_treatment "imatinib" "animals" "carbachol"
10 Q0 22411186 299 30.549671 imi_mug_run_2_treatment "biotin" "lead" "autologous"
10 Q0 25066030 300 30.452145 imi_mug_run_2_treatment "immunoglobulin g" "vaccine"
10 Q0 7512881 301 30.340942 imi_mug_run_2_treatment "interferons" "retinoids" "mediators"
10 Q0 11095400 302 30.225735 imi_mug_run_2_treatment "tyrosine" "igf1" "phosphate"
10 Q0 26106605 303 30.210606 imi_mug_run_2_treatment "mediated" "level"
10 Q0 19264211 304 30.094091 imi_mug_run_2_treatment "various"
10 Q0 24132921 305 30.086418 imi_mug_run_2_treatment "imatinib" "crenolanib" "tyrosine kinase inhibitor"
10 Q0 30430626 306 29.98779 imi_mug_run_2_treatment "local anesthetics" "vemurafenib" "local anesthetic"
10 Q0 25585249 307 29.841232 imi_mug_run_2_treatment "drugs"
10 Q0 18615679 308 29.809052 imi_mug_run_2_treatment "imatinib" "ras"
10 Q0 2575589 309 29.77411 imi_mug_run_2_treatment "melanoma growth stimulatory activity" "product"
10 Q0 24928310 310 29.747662 imi_mug_run_2_treatment "various combinations" "dacarbazine" "angiogenesis inhibitors"
10 Q0 26076063 311 29.747662 imi_mug_run_2_treatment "collagen" "matrix"
10 Q0 24133630 312 29.74393 imi_mug_run_2_treatment "vemurafenib" "monolayer" "braf inhibitor"
10 Q0 10571724 313 29.729576 imi_mug_run_2_treatment "cyclic adenosine monophosphate" "level"
10 Q0 9558107 314 29.683197 imi_mug_run_2_treatment "protease" "proteases" "il-4"
10 Q0 20128875 315 29.675114 imi_mug_run_2_treatment "lead"
10 Q0 29350287 316 29.67332 imi_mug_run_2_treatment "suppressor"
10 Q0 23752084 317 29.6706 imi_mug_run_2_treatment "ras"
10 Q0 22336523 318 29.66364 imi_mug_run_2_treatment "adjuvant" "glucose" "aim"
10 Q0 22876817 319 29.66364 imi_mug_run_2_treatment "combinations" "adjuvant" "basis"
10 Q0 27218826 320 29.572512 imi_mug_run_2_treatment "igf2"
10 Q0 12036934 321 29.408882 imi_mug_run_2_treatment "mediated"
10 Q0 24866436 322 29.370972 imi_mug_run_2_treatment "lnd" "aim" "others"
10 Q0 25119183 323 29.248781 imi_mug_run_2_treatment "inosine" "paclitaxel" "vascular endothelial growth factor"
10 Q0 26872428 324 29.248781 imi_mug_run_2_treatment "various" "mediated"
10 Q0 8988878 325 29.2453 imi_mug_run_2_treatment "mediated"
10 Q0 20465595 326 29.238722 imi_mug_run_2_treatment "therapeutics"
10 Q0 26546509 327 29.224194 imi_mug_run_2_treatment "imatinib" "tyrosine kinase inhibitor" "aim"
10 Q0 22007305 328 29.186222 imi_mug_run_2_treatment "plx 4032"
10 Q0 26084293 329 29.16169 imi_mug_run_2_treatment "trametinib" "afatinib"
10 Q0 18983236 330 29.153545 imi_mug_run_2_treatment "favor" "aim"
10 Q0 22127285 331 29.122026 imi_mug_run_2_treatment "dacarbazine" "dasatinib" "dasatinib 70 mg"
10 Q0 19491215 332 29.10907 imi_mug_run_2_treatment "combinations" "drug" "cd271"
10 Q0 25413220 333 29.100393 imi_mug_run_2_treatment "ras" "mediated"
10 Q0 23528057 334 29.096691 imi_mug_run_2_treatment "aim"
10 Q0 21826607 335 29.050163 imi_mug_run_2_treatment "ras" "lead"
10 Q0 26693896 336 29.036758 imi_mug_run_2_treatment "drug"
10 Q0 21820868 337 29.036758 imi_mug_run_2_treatment "polysaccharide" "ethanol" "water"
10 Q0 25597784 338 29.036758 imi_mug_run_2_treatment "combinations" "trametinib" "dabrafenib"
10 Q0 23248252 339 29.036758 imi_mug_run_2_treatment "combinations" "adjuvant" "cytotoxic"
10 Q0 19351826 340 29.030003 imi_mug_run_2_treatment "therapeutics" "agent" "lead"
10 Q0 14506642 341 29.00875 imi_mug_run_2_treatment "acetone" "melan a"
10 Q0 23923085 342 28.822317 imi_mug_run_2_treatment "melan a" "melan-a"
10 Q0 17235240 343 28.790386 imi_mug_run_2_treatment "level"
10 Q0 25592261 344 28.7397 imi_mug_run_2_treatment "imatinib" "mcts" "tyrosine"
10 Q0 25389459 345 28.712467 imi_mug_run_2_treatment "level"
10 Q0 25750332 346 28.712467 imi_mug_run_2_treatment "interferon-alpha" "melan-a"
10 Q0 24055054 347 28.60966 imi_mug_run_2_treatment "trametinib" "dabrafenib" "mek inhibitor"
10 Q0 25832654 348 28.407354 imi_mug_run_2_treatment "blockade"
10 Q0 8587759 349 28.394146 imi_mug_run_2_treatment "radiopharmaceutical" "aim"
10 Q0 7683922 350 28.378674 imi_mug_run_2_treatment "liver" "berberine" "heparin"
10 Q0 23890154 351 28.369835 imi_mug_run_2_treatment "hot spot"
10 Q0 29061773 352 28.369835 imi_mug_run_2_treatment "drug combination" "mapk inhibitors"
10 Q0 25654738 353 28.281017 imi_mug_run_2_treatment "combinations" "basis" "favor"
10 Q0 29512974 354 28.281017 imi_mug_run_2_treatment "mms" "ssm"
10 Q0 27147111 355 28.267029 imi_mug_run_2_treatment "melan a"
10 Q0 21395123 356 28.267029 imi_mug_run_2_treatment "drugs" "cytostatics" "medication"
10 Q0 29989578 357 28.267029 imi_mug_run_2_treatment "tyrosine" "vemurafenib" "drugs"
10 Q0 29434838 358 28.241226 imi_mug_run_2_treatment "level" "mediated"
10 Q0 30348504 359 28.22673 imi_mug_run_2_treatment "ras"
10 Q0 21320293 360 28.223389 imi_mug_run_2_treatment "tyrosine" "ras" "others"
10 Q0 25376477 361 28.187702 imi_mug_run_2_treatment "braf inhibitor" "mek inhibitor"
10 Q0 12464156 362 28.169226 imi_mug_run_2_treatment "various" "vaccines" "melanoma vaccines"
10 Q0 12789289 363 28.166615 imi_mug_run_2_treatment "proteases"
10 Q0 29483938 364 28.159695 imi_mug_run_2_treatment "ginsenoside"
10 Q0 14663357 365 28.15807 imi_mug_run_2_treatment "melan-a"
10 Q0 18417445 366 28.129913 imi_mug_run_2_treatment "blockade"
10 Q0 26970965 367 28.111172 imi_mug_run_2_treatment "mek inhibitor"
10 Q0 20406483 368 27.992207 imi_mug_run_2_treatment "interferon" "immune modulators"
10 Q0 11981876 369 27.876776 imi_mug_run_2_treatment "various" "aim"
10 Q0 28939173 370 27.869719 imi_mug_run_2_treatment "mediators" "ras" "level"
10 Q0 22825838 371 27.805882 imi_mug_run_2_treatment "hyaluronan" "matrix" "collagen"
10 Q0 28079159 372 27.740635 imi_mug_run_2_treatment "proteinases" "mediators" "matrix"
10 Q0 20110797 373 27.639015 imi_mug_run_2_treatment "various"
10 Q0 22101159 374 27.626377 imi_mug_run_2_treatment "mediated"
10 Q0 24456774 375 27.60788 imi_mug_run_2_treatment "dacarbazine" "melan-a"
10 Q0 20350535 376 27.57491 imi_mug_run_2_treatment "drug" "sorafenib" "agent"
10 Q0 12579529 377 27.56865 imi_mug_run_2_treatment "interferons"
10 Q0 25341882 378 27.56427 imi_mug_run_2_treatment "various" "air" "berberine"
10 Q0 21900792 379 27.555304 imi_mug_run_2_treatment "isolate"
10 Q0 27352784 380 27.54942 imi_mug_run_2_treatment "various" "buffer"
10 Q0 28092667 381 27.512218 imi_mug_run_2_treatment "pmm" "trametinib" "vemurafenib"
10 Q0 23601357 382 27.506742 imi_mug_run_2_treatment "agent"
10 Q0 29662561 383 27.506151 imi_mug_run_2_treatment "dtpa" "chelators" "dota"
10 Q0 18423269 384 27.481594 imi_mug_run_2_treatment "bisphosphonates" "pamidronate" "bps"
10 Q0 25210511 385 27.460266 imi_mug_run_2_treatment "air" "sham"
10 Q0 28638878 386 27.43826 imi_mug_run_2_treatment "fucoidan" "polysaccharide" "agent"
10 Q0 10928178 387 27.403198 imi_mug_run_2_treatment "level" "aim"
10 Q0 24971399 388 27.403198 imi_mug_run_2_treatment "various" "cytotoxic" "therapeutic agents"
10 Q0 29663897 389 27.374779 imi_mug_run_2_treatment "radiopharmaceutical" "agent" "dovitinib"
10 Q0 18421059 390 27.371689 imi_mug_run_2_treatment "imatinib mesylate"
10 Q0 1380168 391 27.303402 imi_mug_run_2_treatment "duration"
10 Q0 19660804 392 27.25512 imi_mug_run_2_treatment "mediated" "proteases" "ragweed"
10 Q0 24367142 393 27.24363 imi_mug_run_2_treatment "various"
10 Q0 17903613 394 27.218689 imi_mug_run_2_treatment "agonists" "ras" "therapeutics"
10 Q0 25746038 395 27.20434 imi_mug_run_2_treatment "various"
10 Q0 19320733 396 27.166023 imi_mug_run_2_treatment "mlana"
10 Q0 3038312 397 27.146225 imi_mug_run_2_treatment "level"
10 Q0 18813822 398 27.145428 imi_mug_run_2_treatment "eosin"
10 Q0 28210865 399 27.145428 imi_mug_run_2_treatment "blockade"
10 Q0 17222061 400 26.994938 imi_mug_run_2_treatment "animals" "level" "antioxidant"
10 Q0 29371009 401 26.99059 imi_mug_run_2_treatment "adjuvant" "aim"
10 Q0 25755683 402 26.982124 imi_mug_run_2_treatment "interleukin-2" "blockade"
10 Q0 11824794 403 26.955963 imi_mug_run_2_treatment "water" "interleukin-8"
10 Q0 28428884 404 26.952415 imi_mug_run_2_treatment "imatinib" "ipilimumab" "blockade"
10 Q0 30373548 405 26.935307 imi_mug_run_2_treatment "ras"
10 Q0 16969355 406 26.909668 imi_mug_run_2_treatment "midostaurin" "midostaurin's" "n-benzoyl-staurosporine"
10 Q0 30400750 407 26.909668 imi_mug_run_2_treatment "ipilimumab" "level"
10 Q0 22743761 408 26.88923 imi_mug_run_2_treatment "vemurafenib" "ipilimumab" "imatinib"
10 Q0 16419059 409 26.885927 imi_mug_run_2_treatment "level"
10 Q0 24909096 410 26.852745 imi_mug_run_2_treatment "inosine" "adenosine" "brdu"
10 Q0 20862309 411 26.774143 imi_mug_run_2_treatment "color"
10 Q0 19375057 412 26.75824 imi_mug_run_2_treatment "serine" "basis"
10 Q0 22189238 413 26.749434 imi_mug_run_2_treatment "melan-a" "imatinib mesylate"
10 Q0 15285706 414 26.72511 imi_mug_run_2_treatment "vaccines" "vaccine" "aids vaccines"
10 Q0 29512873 415 26.723886 imi_mug_run_2_treatment "anti-pdl1"
10 Q0 14563910 416 26.709547 imi_mug_run_2_treatment "anonymous"
10 Q0 18931652 417 26.694204 imi_mug_run_2_treatment "eosin"
10 Q0 23982913 418 26.687914 imi_mug_run_2_treatment "tyr" "suppressor"
10 Q0 17527083 419 26.666996 imi_mug_run_2_treatment "aim"
10 Q0 19563533 420 26.537434 imi_mug_run_2_treatment "various" "statins" "statin"
10 Q0 30075775 421 26.526073 imi_mug_run_2_treatment "stimulant" "amd" "il-6"
10 Q0 27703510 422 26.510056 imi_mug_run_2_treatment "various" "air" "ginsenoside rb1"
10 Q0 1370529 423 26.495687 imi_mug_run_2_treatment "agonists" "cytokines" "anti-ige"
10 Q0 29568965 424 26.473328 imi_mug_run_2_treatment "various"
10 Q0 29843107 425 26.443188 imi_mug_run_2_treatment "ipilimumab" "blockade" "nivolumab"
10 Q0 20055910 426 26.441822 imi_mug_run_2_treatment "ras"
10 Q0 27053954 427 26.421412 imi_mug_run_2_treatment "various" "kinase inhibitor" "anthraquinone compounds"
10 Q0 7509212 428 26.40054 imi_mug_run_2_treatment "various" "protease" "recombinant stem cell factor"
10 Q0 27499153 429 26.387695 imi_mug_run_2_treatment "melan-a" "eosin"
10 Q0 25543407 430 26.348698 imi_mug_run_2_treatment "eosin"
10 Q0 11163669 431 26.294445 imi_mug_run_2_treatment "adjuvant" "hepatitis b surface antigen" "tetanus toxoid"
10 Q0 24194964 432 26.286312 imi_mug_run_2_treatment "oxygen" "vascular endothelial growth factor" "others"
10 Q0 12538879 433 26.209183 imi_mug_run_2_treatment "genesis"
10 Q0 14502781 434 26.165577 imi_mug_run_2_treatment "trastuzumab" "level" "herceptin"
10 Q0 23437250 435 26.140848 imi_mug_run_2_treatment "antineoplastic" "tyr"
10 Q0 24258993 436 26.13195 imi_mug_run_2_treatment "lapatinib"
10 Q0 25677969 437 26.121952 imi_mug_run_2_treatment "various"
10 Q0 18223323 438 26.105536 imi_mug_run_2_treatment "antiserum" "monoclonal antibodies"
10 Q0 21147226 439 26.098448 imi_mug_run_2_treatment "maspin" "id-1"
10 Q0 25202118 440 26.091862 imi_mug_run_2_treatment "igf1" "insulin-like growth factor 1" "aim"
10 Q0 24842760 441 26.041176 imi_mug_run_2_treatment "aim"
10 Q0 1372640 442 25.996014 imi_mug_run_2_treatment "heparin" "protease" "proteases"
10 Q0 17611626 443 25.907387 imi_mug_run_2_treatment "msg" "tyr" "lead"
10 Q0 2970963 444 25.826157 imi_mug_run_2_treatment "melanoma growth stimulatory activity" "level"
10 Q0 29708815 445 25.820324 imi_mug_run_2_treatment "kinase inhibitor" "ly294002" "everolimus"
10 Q0 29492214 446 25.64996 imi_mug_run_2_treatment "aim"
10 Q0 29951919 447 25.64683 imi_mug_run_2_treatment "interferon" "dacarbazine" "imiquimod"
10 Q0 21994611 448 25.565374 imi_mug_run_2_treatment "vaccine" "aids vaccine" "various"
10 Q0 17965534 449 25.554935 imi_mug_run_2_treatment "interferon" "liver" "cisplatin"
10 Q0 11112213 450 25.552515 imi_mug_run_2_treatment "mart-1"
10 Q0 18034402 451 25.512833 imi_mug_run_2_treatment "liver" "ruthenium-106"
10 Q0 22395615 452 25.459988 imi_mug_run_2_treatment "b-raf inhibitor" "mediated" "vemurafenib"
10 Q0 19543533 453 25.415205 imi_mug_run_2_treatment "plasma"
10 Q0 28464776 454 25.409855 imi_mug_run_2_treatment "nitric oxide" "duration" "antioxidants"
10 Q0 2927944 455 25.355396 imi_mug_run_2_treatment "isolate"
10 Q0 9148038 456 25.352848 imi_mug_run_2_treatment "toluidine blue"
10 Q0 23284752 457 25.338371 imi_mug_run_2_treatment "various" "melanoma vaccination" "autologous"
10 Q0 26026122 458 25.329193 imi_mug_run_2_treatment "il-6" "il-10" "interleukins"
10 Q0 22052279 459 25.319036 imi_mug_run_2_treatment "imatinib" "sti 571" "gleevec"
10 Q0 11893939 460 25.298145 imi_mug_run_2_treatment "aim"
10 Q0 20740142 461 25.29448 imi_mug_run_2_treatment "melan-a"
10 Q0 19188183 462 25.264688 imi_mug_run_2_treatment "sorafenib" "carboplatin" "paclitaxel"
10 Q0 11592072 463 25.234644 imi_mug_run_2_treatment "cytokines" "interleukin" "phosphate"
10 Q0 16001072 464 25.23176 imi_mug_run_2_treatment "genesis"
10 Q0 29212027 465 25.226307 imi_mug_run_2_treatment "glucose" "glutamine" "serine"
10 Q0 16917210 466 25.179993 imi_mug_run_2_treatment "imatinib mesylate" "cytotoxic drugs" "cisplatin"
10 Q0 25073704 467 25.167023 imi_mug_run_2_treatment "etv" "vemurafenib" "dabrafenib"
10 Q0 16328119 468 25.131767 imi_mug_run_2_treatment "asa" "hemorrhoidal"
10 Q0 2267994 469 25.126736 imi_mug_run_2_treatment "estrogen" "charcoal" "estradiol"
10 Q0 10487831 470 25.120966 imi_mug_run_2_treatment "mediated"
10 Q0 24345920 471 25.062366 imi_mug_run_2_treatment "mek inhibitor"
10 Q0 1445804 472 25.049805 imi_mug_run_2_treatment "tyrosine" "mast cell growth factor"
10 Q0 20653773 473 25.003553 imi_mug_run_2_treatment "kinase inhibitor"
10 Q0 16792758 474 24.998959 imi_mug_run_2_treatment "ing1" "suppressor"
10 Q0 23000456 475 24.982174 imi_mug_run_2_treatment "agonists" "forskolin" "agonist"
10 Q0 27256045 476 24.958355 imi_mug_run_2_treatment "onion"
10 Q0 1382993 477 24.952303 imi_mug_run_2_treatment "il-3" "mast cell growth factor" "interleukin"
10 Q0 26965315 478 24.941175 imi_mug_run_2_treatment "level"
10 Q0 21770473 479 24.903648 imi_mug_run_2_treatment "enzymes" "b-raf inhibitor" "denileukin diftitox"
10 Q0 22688822 480 24.882664 imi_mug_run_2_treatment "interleukin-4" "live vaccine" "basis"
10 Q0 21203884 481 24.875967 imi_mug_run_2_treatment "vaccines" "aids vaccine" "cytotoxic"
10 Q0 16720908 482 24.844723 imi_mug_run_2_treatment "tyr" "tyrosine" "aim"
10 Q0 30400954 483 24.843414 imi_mug_run_2_treatment "vitexin" "chinese herb" "various"
10 Q0 17202834 484 24.833065 imi_mug_run_2_treatment "trp-2" "artificial antigen" "autologous"
10 Q0 25595173 485 24.7762 imi_mug_run_2_treatment "interferon"
10 Q0 25163722 486 24.7762 imi_mug_run_2_treatment "melan a"
10 Q0 1674672 487 24.724983 imi_mug_run_2_treatment "cytotoxic" "lead" "chromium"
10 Q0 20200520 488 24.716984 imi_mug_run_2_treatment "cytokines" "interleukin"
10 Q0 25746036 489 24.700708 imi_mug_run_2_treatment "isolate" "aim"
10 Q0 29503569 490 24.694504 imi_mug_run_2_treatment "ubenimex" "drug" "ethidium bromide"
10 Q0 27571875 491 24.685661 imi_mug_run_2_treatment "dacarbazine" "carboplatin" "paclitaxel"
10 Q0 2358975 492 24.658794 imi_mug_run_2_treatment "level" "iga"
10 Q0 22241959 493 24.657724 imi_mug_run_2_treatment "plx4032" "drugs" "uo126"
10 Q0 30221692 494 24.641922 imi_mug_run_2_treatment "cantharidin" "agent"
10 Q0 11106324 495 24.634718 imi_mug_run_2_treatment "mart-1"
10 Q0 30066877 496 24.581291 imi_mug_run_2_treatment "unbs5162"
10 Q0 16224241 497 24.558056 imi_mug_run_2_treatment "citrulline" "amifostine" "sugar"
10 Q0 17975509 498 24.556244 imi_mug_run_2_treatment "matrix"
10 Q0 11115581 499 24.535255 imi_mug_run_2_treatment "plasma" "mart-1"
10 Q0 24405856 500 24.518143 imi_mug_run_2_treatment "masitinib" "drug" "imatinib"
10 Q0 23377457 501 24.501553 imi_mug_run_2_treatment "drugs"
10 Q0 10808130 502 24.495415 imi_mug_run_2_treatment "matrix"
10 Q0 18563430 503 24.48775 imi_mug_run_2_treatment "various"
10 Q0 29935949 504 24.457108 imi_mug_run_2_treatment "collagen" "sp600125"
10 Q0 23599644 505 24.427425 imi_mug_run_2_treatment "icc" "sodium taurocholate" "sham"
10 Q0 20160028 506 24.425903 imi_mug_run_2_treatment "mediated" "genesis"
10 Q0 1873853 507 24.364449 imi_mug_run_2_treatment "tyrosine" "lead" "basic fibroblast growth factor"
10 Q0 30198403 508 24.335537 imi_mug_run_2_treatment "vascular endothelial growth factor" "eosin"
10 Q0 24137243 509 24.297974 imi_mug_run_2_treatment "anti-inflammatory" "berberine" "prostaglandin e2"
10 Q0 19368660 510 24.28647 imi_mug_run_2_treatment "icc" "level"
10 Q0 23840625 511 24.28647 imi_mug_run_2_treatment "icc" "aim" "fcm"
10 Q0 8510410 512 24.281216 imi_mug_run_2_treatment "cytokines" "tnf-alpha"
10 Q0 20675596 513 24.270168 imi_mug_run_2_treatment "adjuvant" "vaccines" "mediated"
10 Q0 10612858 514 24.259418 imi_mug_run_2_treatment "digoxigenin" "aim"
10 Q0 19211118 515 24.251606 imi_mug_run_2_treatment "icc"
10 Q0 26933137 516 24.251606 imi_mug_run_2_treatment "mediators"
10 Q0 2302716 517 24.251133 imi_mug_run_2_treatment "antimetabolite" "fibroblast interferon" "methotrexate"
10 Q0 26701415 518 24.24202 imi_mug_run_2_treatment "ras"
10 Q0 29187473 519 24.238895 imi_mug_run_2_treatment "interferon-alpha" "dacarbazine"
10 Q0 23938462 520 24.201267 imi_mug_run_2_treatment "pge2" "h2o2" "mediators"
10 Q0 28914674 521 24.189697 imi_mug_run_2_treatment "blockade"
10 Q0 8011699 522 24.17609 imi_mug_run_2_treatment "growth inhibitors" "oncostatin m" "lead"
10 Q0 22719918 523 24.17609 imi_mug_run_2_treatment "mitogen" "interleukin-8"
10 Q0 3135310 524 24.173107 imi_mug_run_2_treatment "mediated"
10 Q0 23001925 525 24.143631 imi_mug_run_2_treatment "level"
10 Q0 17371436 526 24.143173 imi_mug_run_2_treatment "lead" "program"
10 Q0 10769680 527 24.125519 imi_mug_run_2_treatment "estrogen" "tyrosine" "insect"
10 Q0 28077651 528 24.118721 imi_mug_run_2_treatment "interferon" "antiviral" "lys"
10 Q0 15252307 529 24.10148 imi_mug_run_2_treatment "melan-a"
10 Q0 24659394 530 24.098545 imi_mug_run_2_treatment "paclitaxel" "drugs" "monodansylcadaverine"
10 Q0 21905615 531 24.091125 imi_mug_run_2_treatment "interferon alpha" "drug" "ras"
10 Q0 23670576 532 24.08733 imi_mug_run_2_treatment "dacarbazine" "endostar" "endostatin"
10 Q0 10885678 533 24.084185 imi_mug_run_2_treatment "trp-2"
10 Q0 12373144 534 24.078682 imi_mug_run_2_treatment "lysozyme" "biotin"
10 Q0 18312383 535 24.062084 imi_mug_run_2_treatment "aim" "autologous"
10 Q0 23576709 536 24.061312 imi_mug_run_2_treatment "drug" "program"
10 Q0 27776349 537 24.059254 imi_mug_run_2_treatment "basis"
10 Q0 8314354 538 24.046822 imi_mug_run_2_treatment "il-10" "immunosuppressive" "mediated"
10 Q0 14647751 539 24.042099 imi_mug_run_2_treatment "eosin"
10 Q0 11174200 540 23.999908 imi_mug_run_2_treatment "recombinant human stem cell factor"
10 Q0 29607663 541 23.999908 imi_mug_run_2_treatment "therapeutic agent"
10 Q0 11092036 542 23.971579 imi_mug_run_2_treatment "various" "melana"
10 Q0 21572085 543 23.954744 imi_mug_run_2_treatment "aim"
10 Q0 10223723 544 23.936386 imi_mug_run_2_treatment "tandem" "level"
10 Q0 16609060 545 23.872593 imi_mug_run_2_treatment "combinations" "agent" "dacarbazine"
10 Q0 16485879 546 23.871033 imi_mug_run_2_treatment "imatinib mesylate" "gleevec" "imatinib"
10 Q0 10417512 547 23.852987 imi_mug_run_2_treatment "melana" "mart-1"
10 Q0 20040059 548 23.724178 imi_mug_run_2_treatment "icc" "phenol red"
10 Q0 25023876 549 23.701775 imi_mug_run_2_treatment "aim"
10 Q0 9256124 550 23.673954 imi_mug_run_2_treatment "level" "aim"
10 Q0 9377644 551 23.654285 imi_mug_run_2_treatment "level" "animals"
10 Q0 24194775 552 23.628315 imi_mug_run_2_treatment "melan-a"
10 Q0 28217853 553 23.621798 imi_mug_run_2_treatment "formalin"
10 Q0 10353744 554 23.61634 imi_mug_run_2_treatment "basis"
10 Q0 16366422 555 23.612411 imi_mug_run_2_treatment "aim"
10 Q0 23223133 556 23.612411 imi_mug_run_2_treatment "fluorocytosine" "fluorouracil" "yeast"
10 Q0 21949374 557 23.607433 imi_mug_run_2_treatment "mediated" "prolyl-hydroxylase inhibitors"
10 Q0 11198476 558 23.607311 imi_mug_run_2_treatment "various" "aim"
10 Q0 10209510 559 23.593328 imi_mug_run_2_treatment "various" "granulocytes"
10 Q0 26801070 560 23.586058 imi_mug_run_2_treatment "formalin"
10 Q0 14751520 561 23.531666 imi_mug_run_2_treatment "antiangiogenic"
10 Q0 25362585 562 23.522911 imi_mug_run_2_treatment "enzymes" "tyr" "mediated"
10 Q0 19065103 563 23.520336 imi_mug_run_2_treatment "aim"
10 Q0 8578201 564 23.428776 imi_mug_run_2_treatment "matrix"
10 Q0 23833299 565 23.394182 imi_mug_run_2_treatment "dabrafenib" "dacarbazine" "gsk2118436"
10 Q0 30199578 566 23.37289 imi_mug_run_2_treatment "imatinib"
10 Q0 10766187 567 23.368746 imi_mug_run_2_treatment "ssm"
10 Q0 11139316 568 23.346472 imi_mug_run_2_treatment "level"
10 Q0 9303551 569 23.31446 imi_mug_run_2_treatment "il-3" "il-4"
10 Q0 10632661 570 23.307999 imi_mug_run_2_treatment "sulphate sodium" "dextran"
10 Q0 10739303 571 23.242325 imi_mug_run_2_treatment "agonists" "melatonin" "s-20098"
10 Q0 23447565 572 23.197657 imi_mug_run_2_treatment "drug" "lead" "obatoclax"
10 Q0 28624295 573 23.175486 imi_mug_run_2_treatment "various" "sugar" "animals"
10 Q0 24684112 574 23.17305 imi_mug_run_2_treatment "duration" "dopamine" "level"
10 Q0 23908683 575 23.168478 imi_mug_run_2_treatment "various"
10 Q0 27145040 576 23.168322 imi_mug_run_2_treatment "various" "ors"
10 Q0 18985043 577 23.14471 imi_mug_run_2_treatment "ras" "product"
10 Q0 15225766 578 23.132332 imi_mug_run_2_treatment "vitamin d" "various" "dihydroxyvitamin d"
10 Q0 21352258 579 23.062946 imi_mug_run_2_treatment "cetuximab"
10 Q0 29138111 580 23.053036 imi_mug_run_2_treatment "immunosuppressive"
10 Q0 10543339 581 23.040386 imi_mug_run_2_treatment "pma" "calcium" "prostaglandins"
10 Q0 9534991 582 23.019604 imi_mug_run_2_treatment "plasma" "lead" "level"
10 Q0 16273654 583 22.880358 imi_mug_run_2_treatment "l-arginine" "plasma" "sham"
10 Q0 23064375 584 22.87318 imi_mug_run_2_treatment "mediated" "diallyl trisulfide" "garlic"
10 Q0 23453134 585 22.856808 imi_mug_run_2_treatment "agonist" "blockade"
10 Q0 7544650 586 22.855747 imi_mug_run_2_treatment "egg" "protease"
10 Q0 25112824 587 22.808718 imi_mug_run_2_treatment "ifx" "infliximab" "aim"
10 Q0 25574741 588 22.789194 imi_mug_run_2_treatment "level" "sulfate" "monoclonal antibodies"
10 Q0 8640069 589 22.772741 imi_mug_run_2_treatment "level"
10 Q0 9461344 590 22.772741 imi_mug_run_2_treatment "enzymes" "bisulfite"
10 Q0 27418645 591 22.772741 imi_mug_run_2_treatment "mediated"
10 Q0 29408204 592 22.772741 imi_mug_run_2_treatment "various" "program"
10 Q0 24812408 593 22.768925 imi_mug_run_2_treatment "vemurafenib" "drug" "cytokines"
10 Q0 3365686 594 22.756538 imi_mug_run_2_treatment "various" "mediated"
10 Q0 12107840 595 22.749277 imi_mug_run_2_treatment "adjuvant" "interferon"
10 Q0 9596274 596 22.742584 imi_mug_run_2_treatment "various"
10 Q0 17255954 597 22.725124 imi_mug_run_2_treatment "kinase inhibitor" "tyr"
10 Q0 21159146 598 22.720547 imi_mug_run_2_treatment "imatinib"
10 Q0 12702540 599 22.718443 imi_mug_run_2_treatment "imatinib mesylate"
10 Q0 17327598 600 22.684374 imi_mug_run_2_treatment "imatinib"
10 Q0 22442756 601 22.663078 imi_mug_run_2_treatment "vascular endothelial growth factor"
10 Q0 24265155 602 22.58186 imi_mug_run_2_treatment "braf inhibitor" "drug" "ras"
10 Q0 24127407 603 22.55832 imi_mug_run_2_treatment "various"
10 Q0 10655201 604 22.459497 imi_mug_run_2_treatment "level"
10 Q0 10628399 605 22.446386 imi_mug_run_2_treatment "matrix"
10 Q0 12528772 606 22.441847 imi_mug_run_2_treatment "sti571" "glivec" "imatinib"
10 Q0 15671530 607 22.373898 imi_mug_run_2_treatment "vascular endothelial growth factor" "aim"
10 Q0 22323255 608 22.371225 imi_mug_run_2_treatment "various" "fmm"
10 Q0 15951821 609 22.370287 imi_mug_run_2_treatment "ras"
10 Q0 3652042 610 22.367317 imi_mug_run_2_treatment "monoclonal antibodies" "antiserum" "cytotoxic"
10 Q0 19679545 611 22.367317 imi_mug_run_2_treatment "various"
10 Q0 24618605 612 22.330112 imi_mug_run_2_treatment "liver" "basis"
10 Q0 2935400 613 22.324642 imi_mug_run_2_treatment "xenon"
10 Q0 16517174 614 22.313896 imi_mug_run_2_treatment "product" "aim"
10 Q0 25746039 615 22.311134 imi_mug_run_2_treatment "dacarbazine" "bevacizumab" "duration"
10 Q0 27251777 616 22.298164 imi_mug_run_2_treatment "ras"
10 Q0 21430779 617 22.291914 imi_mug_run_2_treatment "lysine" "genesis"
10 Q0 28885200 618 22.291914 imi_mug_run_2_treatment "il-1ra" "interleukin-1 receptor antagonist"
10 Q0 26936398 619 22.290186 imi_mug_run_2_treatment "gsk126"
10 Q0 3567893 620 22.288042 imi_mug_run_2_treatment "drug" "methotrexate" "drugs"
10 Q0 19818222 621 22.233597 imi_mug_run_2_treatment "biotin" "formaldehyde" "ganglioside"
10 Q0 30320917 622 22.225948 imi_mug_run_2_treatment "h101" "mediated"
10 Q0 21479383 623 22.2236 imi_mug_run_2_treatment "hmm" "bisulfite"
10 Q0 15870711 624 22.221994 imi_mug_run_2_treatment "imatinib mesylate" "drug" "various"
10 Q0 26403583 625 22.221994 imi_mug_run_2_treatment "cbn" "aim"
10 Q0 11164190 626 22.217703 imi_mug_run_2_treatment "collagen" "matrix"
10 Q0 19500876 627 22.217703 imi_mug_run_2_treatment "kinase inhibitor"
10 Q0 18803327 628 22.214336 imi_mug_run_2_treatment "aza"
10 Q0 21435845 629 22.178988 imi_mug_run_2_treatment "docetaxel" "aim"
10 Q0 19617296 630 22.178988 imi_mug_run_2_treatment "combinations" "drugs" "ras"
10 Q0 26907635 631 22.178988 imi_mug_run_2_treatment "methylated"
10 Q0 29736211 632 22.178988 imi_mug_run_2_treatment "ras" "vemurafenib" "trametinib"
10 Q0 22843987 633 22.173813 imi_mug_run_2_treatment "cytotoxic" "h101"
10 Q0 28786531 634 22.173813 imi_mug_run_2_treatment "plasma"
10 Q0 27640074 635 22.159252 imi_mug_run_2_treatment "dopamine" "tyr"
10 Q0 23814474 636 22.159252 imi_mug_run_2_treatment "lead" "vascular endothelial growth factor"
10 Q0 10574469 637 22.150791 imi_mug_run_2_treatment "ebrotidine" "drug" "agent"
10 Q0 21964182 638 22.115917 imi_mug_run_2_treatment "cytotoxic" "amonafide" "mitonafide"
10 Q0 11929499 639 22.090223 imi_mug_run_2_treatment "tgf-beta1" "protease" "proteases"
10 Q0 15613856 640 22.075666 imi_mug_run_2_treatment "adjuvant" "gleevec"
10 Q0 20624645 641 22.029549 imi_mug_run_2_treatment "mediated" "il-4" "blockade"
10 Q0 20232784 642 22.007423 imi_mug_run_2_treatment "cetuximab"
10 Q0 19800285 643 21.999807 imi_mug_run_2_treatment "acetic acid" "aim"
10 Q0 11479879 644 21.995552 imi_mug_run_2_treatment "icc"
10 Q0 21160808 645 21.995552 imi_mug_run_2_treatment "lysine" "glutamic acid" "eosin"
10 Q0 30499815 646 21.994104 imi_mug_run_2_treatment "mart-1" "chromagen"
10 Q0 29057919 647 21.992998 imi_mug_run_2_treatment "biotin" "new drugs"
10 Q0 23574530 648 21.95273 imi_mug_run_2_treatment "aim"
10 Q0 19635938 649 21.922258 imi_mug_run_2_treatment "serine" "lead" "color"
10 Q0 21439677 650 21.910679 imi_mug_run_2_treatment "aim"
10 Q0 19419947 651 21.886955 imi_mug_run_2_treatment "aim"
10 Q0 12460203 652 21.859516 imi_mug_run_2_treatment "aim" "melan a"
10 Q0 9368607 653 21.84861 imi_mug_run_2_treatment "protease" "interleukin-9" "interleukin"
10 Q0 12725137 654 21.84861 imi_mug_run_2_treatment "il-10" "buffer" "mediators"
10 Q0 16378305 655 21.84861 imi_mug_run_2_treatment "epidermal growth factor" "ursodeoxycholic acid" "antral"
10 Q0 23621218 656 21.826473 imi_mug_run_2_treatment "aim"
10 Q0 12796512 657 21.807743 imi_mug_run_2_treatment "protease" "mediated"
10 Q0 30453554 658 21.807743 imi_mug_run_2_treatment "various" "anti-inflammatory" "dichloromethane"
10 Q0 26995715 659 21.794964 imi_mug_run_2_treatment "sugar"
10 Q0 20025023 660 21.774588 imi_mug_run_2_treatment "icc" "carbachol"
10 Q0 26290260 661 21.766163 imi_mug_run_2_treatment "aim"
10 Q0 16482632 662 21.751905 imi_mug_run_2_treatment "iga" "product" "aim"
10 Q0 9888908 663 21.731632 imi_mug_run_2_treatment "zidovudine"
10 Q0 10192188 664 21.731186 imi_mug_run_2_treatment "indomethacin" "protease" "nitric oxide"
10 Q0 15661888 665 21.700714 imi_mug_run_2_treatment "agonist"
10 Q0 22290633 666 21.700714 imi_mug_run_2_treatment "icc" "electrolytes" "water"
10 Q0 25796615 667 21.70036 imi_mug_run_2_treatment "tyr"
10 Q0 2691957 668 21.692303 imi_mug_run_2_treatment "ras"
10 Q0 10417513 669 21.668474 imi_mug_run_2_treatment "various" "melana" "aim"
10 Q0 6492144 670 21.654617 imi_mug_run_2_treatment "various"
10 Q0 17907487 671 21.616352 imi_mug_run_2_treatment "phenol" "sodium" "ethanol"
10 Q0 28229253 672 21.610966 imi_mug_run_2_treatment "adjuvant" "mitogen" "liver"
10 Q0 24269414 673 21.60611 imi_mug_run_2_treatment "adjuvant"
10 Q0 15250936 674 21.533403 imi_mug_run_2_treatment "l-dopa"
10 Q0 16179865 675 21.533403 imi_mug_run_2_treatment "drug" "chloroquine" "cytostatic drugs"
10 Q0 29278418 676 21.533403 imi_mug_run_2_treatment "methylated"
10 Q0 23100363 677 21.530693 imi_mug_run_2_treatment "nervous system"
10 Q0 9060833 678 21.51387 imi_mug_run_2_treatment "basis"
10 Q0 8608953 679 21.51387 imi_mug_run_2_treatment "il-6" "tgf-beta1" "keratinocyte growth factor"
10 Q0 9918881 680 21.484882 imi_mug_run_2_treatment "rh1"
10 Q0 20143236 681 21.46772 imi_mug_run_2_treatment "adjuvant"
10 Q0 11581571 682 21.462029 imi_mug_run_2_treatment "tnf-alpha" "aspirin" "indomethacin"
10 Q0 8344785 683 21.461962 imi_mug_run_2_treatment "liver"
10 Q0 17001621 684 21.461962 imi_mug_run_2_treatment "bps"
10 Q0 17581615 685 21.458685 imi_mug_run_2_treatment "mediated"
10 Q0 3422521 686 21.44875 imi_mug_run_2_treatment "monolayer"
10 Q0 20975103 687 21.44875 imi_mug_run_2_treatment "combinations"
10 Q0 7511820 688 21.44727 imi_mug_run_2_treatment "autologous"
10 Q0 10719365 689 21.44727 imi_mug_run_2_treatment "lead"
10 Q0 11783112 690 21.44727 imi_mug_run_2_treatment "collagen" "matrix"
10 Q0 11604998 691 21.4161 imi_mug_run_2_treatment "product" "ethidium bromide" "intercept"
10 Q0 30001235 692 21.408096 imi_mug_run_2_treatment "aim"
10 Q0 17263886 693 21.379385 imi_mug_run_2_treatment "mediated"
10 Q0 24846719 694 21.360548 imi_mug_run_2_treatment "level" "prostaglandin e2"
10 Q0 27666934 695 21.227549 imi_mug_run_2_treatment "mediated"
10 Q0 10096249 696 21.201378 imi_mug_run_2_treatment "cytokines" "tnf-alpha" "il-6"
10 Q0 1454829 697 21.182596 imi_mug_run_2_treatment "crest"
10 Q0 22706087 698 21.182596 imi_mug_run_2_treatment "immunosuppressive"
10 Q0 21513164 699 21.180782 imi_mug_run_2_treatment "color" "tyrp" "basis"
10 Q0 27926791 700 21.149244 imi_mug_run_2_treatment "casein" "melan-a" "aim"
10 Q0 26265689 701 21.143559 imi_mug_run_2_treatment "diastase" "lead" "schiff"
10 Q0 25452114 702 21.128828 imi_mug_run_2_treatment "trametinib" "dabrafenib" "mapk inhibitors"
10 Q0 8104462 703 21.128727 imi_mug_run_2_treatment "scatter factor" "level"
10 Q0 24778276 704 21.128727 imi_mug_run_2_treatment "various" "ipilimumab" "blockade"
10 Q0 24835696 705 21.128727 imi_mug_run_2_treatment "pdt" "photosensitizer" "protoporphyrin ix"
10 Q0 14599476 706 21.11898 imi_mug_run_2_treatment "zinc" "hp-beta-cd" "hydroxypropyl-beta-cyclodextrin"
10 Q0 9103444 707 21.113342 imi_mug_run_2_treatment "autologous" "cytotoxic" "mart-1"
10 Q0 20701798 708 21.112389 imi_mug_run_2_treatment "serine" "mediated" "level"
10 Q0 9502368 709 21.100372 imi_mug_run_2_treatment "level"
10 Q0 18790768 710 21.090286 imi_mug_run_2_treatment "braf inhibitor" "drug"
10 Q0 17585022 711 21.08075 imi_mug_run_2_treatment "maltase-glucoamylase" "starch" "dextrin"
10 Q0 25815401 712 21.061625 imi_mug_run_2_treatment "formalin" "aim"
10 Q0 11453099 713 21.056726 imi_mug_run_2_treatment "aspirin" "sb 203580" "tnf-alpha"
10 Q0 10544199 714 21.048609 imi_mug_run_2_treatment "mediated" "interleukin 12" "blockade"
10 Q0 11857020 715 21.029589 imi_mug_run_2_treatment "level"
10 Q0 19805372 716 21.015348 imi_mug_run_2_treatment "mediated" "autologous"
10 Q0 29202777 717 21.001863 imi_mug_run_2_treatment "pdx" "vemurafenib" "aim"
10 Q0 15467608 718 20.912153 imi_mug_run_2_treatment "epidermal growth factor"
10 Q0 12962699 719 20.912153 imi_mug_run_2_treatment "mediators"
10 Q0 17641583 720 20.902283 imi_mug_run_2_treatment "sotradecol" "agent" "aim"
10 Q0 18847349 721 20.902283 imi_mug_run_2_treatment "monoclonal antibodies" "iga"
10 Q0 22065909 722 20.902283 imi_mug_run_2_treatment "matrix"
10 Q0 17958893 723 20.901531 imi_mug_run_2_treatment "enzymes" "various" "level"
10 Q0 15975819 724 20.901531 imi_mug_run_2_treatment "tgf-beta1" "interleukin" "interleukin-8"
10 Q0 15490151 725 20.875528 imi_mug_run_2_treatment "pertechnetate"
10 Q0 26245469 726 20.875528 imi_mug_run_2_treatment "zirconia"
10 Q0 21533447 727 20.852642 imi_mug_run_2_treatment "ras" "monoclonal antibodies"
10 Q0 9820483 728 20.850418 imi_mug_run_2_treatment "il-3" "bmc" "il-10"
10 Q0 18059223 729 20.812263 imi_mug_run_2_treatment "various" "mediators"
10 Q0 20234825 730 20.802923 imi_mug_run_2_treatment "lead"
10 Q0 16580503 731 20.736216 imi_mug_run_2_treatment "capsaicin" "sham"
10 Q0 26307133 732 20.602802 imi_mug_run_2_treatment "sorafenib" "carboplatin" "paclitaxel"
10 Q0 3180053 733 20.59846 imi_mug_run_2_treatment "drug" "colchicine" "deoxyglucose"
10 Q0 10473072 734 20.59846 imi_mug_run_2_treatment "product"
10 Q0 11327313 735 20.594479 imi_mug_run_2_treatment "tnf-alpha" "aspirin" "anti-inflammatory"
10 Q0 3594442 736 20.550175 imi_mug_run_2_treatment "animals" "quinacrine" "liver"
10 Q0 11591221 737 20.524055 imi_mug_run_2_treatment "medicine"
10 Q0 20346344 738 20.523472 imi_mug_run_2_treatment "oxygen" "mediated"
10 Q0 30099299 739 20.519817 imi_mug_run_2_treatment "melanocyte stimulating hormone" "tyr" "glycyrrhiza uralensis"
10 Q0 24857113 740 20.492622 imi_mug_run_2_treatment "chemotherapy agents"
10 Q0 26810733 741 20.492622 imi_mug_run_2_treatment "vemurafenib" "mek inhibitor" "braf inhibitor"
10 Q0 15902326 742 20.473965 imi_mug_run_2_treatment "cisplatin" "taxane" "herceptin"
10 Q0 18551246 743 20.471718 imi_mug_run_2_treatment "imatinib mesylate" "agent" "duration"
10 Q0 10210150 744 20.448528 imi_mug_run_2_treatment "sucralfate" "indomethacin" "tnf-alpha"
10 Q0 8700511 745 20.440058 imi_mug_run_2_treatment "mediated"
10 Q0 9598804 746 20.404716 imi_mug_run_2_treatment "kinase inhibitor" "level" "genesis"
10 Q0 20072649 747 20.378159 imi_mug_run_2_treatment "blockade"
10 Q0 9287392 748 20.378159 imi_mug_run_2_treatment "adjuvant" "mediated" "vaccines, dna"
10 Q0 22850419 749 20.378159 imi_mug_run_2_treatment "iga"
10 Q0 24518077 750 20.372618 imi_mug_run_2_treatment "ruthenium 106" "ruthenium-106" "duration"
10 Q0 20360961 751 20.369272 imi_mug_run_2_treatment "iga" "edta" "protease inhibitors"
10 Q0 29568946 752 20.366257 imi_mug_run_2_treatment "gefitinib" "vascular endothelial growth factor"
10 Q0 9625038 753 20.3592 imi_mug_run_2_treatment "tris" "origen" "product"
10 Q0 10479054 754 20.3592 imi_mug_run_2_treatment "hla-g" "cytotoxic" "favor"
10 Q0 16462768 755 20.3592 imi_mug_run_2_treatment "agar" "level"
10 Q0 26983079 756 20.3592 imi_mug_run_2_treatment "vemurafenib" "animals"
10 Q0 20406486 757 20.3592 imi_mug_run_2_treatment "plx4032" "rg7204"
10 Q0 30226396 758 20.3592 imi_mug_run_2_treatment "immunosuppressive"
10 Q0 15630577 759 20.358358 imi_mug_run_2_treatment "sucrose" "product"
10 Q0 10890374 760 20.357462 imi_mug_run_2_treatment "tyrosinase-related protein-2" "trp-2"
10 Q0 21273047 761 20.314539 imi_mug_run_2_treatment "level"
10 Q0 17057190 762 20.206554 imi_mug_run_2_treatment "iga"
10 Q0 7737912 763 20.206554 imi_mug_run_2_treatment "level" "lead"
10 Q0 19344006 764 20.206554 imi_mug_run_2_treatment "various" "antisera"
10 Q0 16365061 765 20.197868 imi_mug_run_2_treatment "water" "fructooligosaccharides" "edta"
10 Q0 18031362 766 20.197868 imi_mug_run_2_treatment "aim" "shape"
10 Q0 17991916 767 20.197868 imi_mug_run_2_treatment "interleukin-6"
10 Q0 26283536 768 20.197868 imi_mug_run_2_treatment "mediated"
10 Q0 22438643 769 20.197868 imi_mug_run_2_treatment "level" "iga" "aim"
10 Q0 18794610 770 20.197218 imi_mug_run_2_treatment "basis"
10 Q0 17331035 771 20.197218 imi_mug_run_2_treatment "plasma" "animals" "alpha-defensins"
10 Q0 8128982 772 20.197218 imi_mug_run_2_treatment "interleukin-3"
10 Q0 8512895 773 20.17566 imi_mug_run_2_treatment "enzymes" "gastrin" "biotin"
10 Q0 11966525 774 20.17566 imi_mug_run_2_treatment "tnf-alpha" "proteasome inhibitor" "brdu"
10 Q0 25083083 775 20.17566 imi_mug_run_2_treatment "il-10" "interferon" "mediated"
10 Q0 19621633 776 20.17566 imi_mug_run_2_treatment "vaccine" "cesium chloride" "basis"
10 Q0 24082733 777 20.15637 imi_mug_run_2_treatment "various" "immunoglobulin a" "level"
10 Q0 18597157 778 20.076525 imi_mug_run_2_treatment "omeprazole" "sucralfate" "anti-ulcer agents"
10 Q0 15887981 779 20.007833 imi_mug_run_2_treatment "aim" "eosin" "formalin"
10 Q0 29344493 780 20.002586 imi_mug_run_2_treatment "iodine-125" "aim"
10 Q0 20110059 781 19.97924 imi_mug_run_2_treatment "interferon" "alpha interferon" "program"
10 Q0 30097108 782 19.97924 imi_mug_run_2_treatment "flowers" "antioxidant" "drug"
10 Q0 23981604 783 19.975937 imi_mug_run_2_treatment "various" "interferon" "cck-8"
10 Q0 27934878 784 19.975937 imi_mug_run_2_treatment "lead"
10 Q0 2144741 785 19.955885 imi_mug_run_2_treatment "pala" "drug" "mtx"
10 Q0 16780866 786 19.94915 imi_mug_run_2_treatment "combinations" "isolate"
10 Q0 18304866 787 19.946152 imi_mug_run_2_treatment "enzymes" "polyacrylamide gels"
10 Q0 10762636 788 19.848701 imi_mug_run_2_treatment "cisplatin" "drugs" "antitumor agents"
10 Q0 8302587 789 19.835766 imi_mug_run_2_treatment "mediated" "level"
10 Q0 10360670 790 19.834377 imi_mug_run_2_treatment "mart-1"
10 Q0 24317392 791 19.74059 imi_mug_run_2_treatment "imatinib"
10 Q0 19799079 792 19.71674 imi_mug_run_2_treatment "vaccines" "mip-1 alpha" "vaccine"
10 Q0 7698025 793 19.671549 imi_mug_run_2_treatment "gamma-interferon"
10 Q0 27698849 794 19.671549 imi_mug_run_2_treatment "color" "basis"
10 Q0 10894834 795 19.670223 imi_mug_run_2_treatment "dnp" "product"
10 Q0 2567607 796 19.664448 imi_mug_run_2_treatment "cytotoxic drugs" "agent" "level"
10 Q0 21041732 797 19.639877 imi_mug_run_2_treatment "agonists" "mediated" "mediators"
10 Q0 8790222 798 19.638668 imi_mug_run_2_treatment "sulfur colloid" "antimony trisulfide" "radiopharmaceutical"
10 Q0 24258979 799 19.592402 imi_mug_run_2_treatment "braf inhibitor"
10 Q0 21280901 800 19.58922 imi_mug_run_2_treatment "fiber"
10 Q0 29507054 801 19.58922 imi_mug_run_2_treatment "combinations" "pdx" "dinaciclib"
10 Q0 17253167 802 19.585257 imi_mug_run_2_treatment "various" "eosin"
10 Q0 29353412 803 19.574352 imi_mug_run_2_treatment "mediated" "tyr" "pge2"
10 Q0 11078808 804 19.536648 imi_mug_run_2_treatment "animals" "swine skin"
10 Q0 26101714 805 19.520773 imi_mug_run_2_treatment "vemurafenib" "mek inhibitor" "drug combinations"
10 Q0 27490749 806 19.51432 imi_mug_run_2_treatment "drugs"
10 Q0 23319739 807 19.449112 imi_mug_run_2_treatment "il-4" "il-6" "proteases"
10 Q0 15900576 808 19.4387 imi_mug_run_2_treatment "various"
10 Q0 24316261 809 19.4387 imi_mug_run_2_treatment "isolate" "biogenic amines"
10 Q0 19675452 810 19.43779 imi_mug_run_2_treatment "antral"
10 Q0 28693143 811 19.43779 imi_mug_run_2_treatment "aim"
10 Q0 14696423 812 19.42087 imi_mug_run_2_treatment "level"
10 Q0 8671643 813 19.420212 imi_mug_run_2_treatment "protease" "mediated" "cytokines"
10 Q0 28159380 814 19.411617 imi_mug_run_2_treatment "prompt"
10 Q0 18347007 815 19.409992 imi_mug_run_2_treatment "sunitinib" "mbc" "taxane"
10 Q0 23378560 816 19.409992 imi_mug_run_2_treatment "aim"
10 Q0 29729162 817 19.409992 imi_mug_run_2_treatment "level" "gastrin" "aim"
10 Q0 28495150 818 19.394293 imi_mug_run_2_treatment "combinations" "basis"
10 Q0 26720798 819 19.38084 imi_mug_run_2_treatment "various" "icc" "sham"
10 Q0 28566079 820 19.38084 imi_mug_run_2_treatment "il-12" "il-10" "various"
10 Q0 19633643 821 19.35989 imi_mug_run_2_treatment "level" "aim"
10 Q0 17488338 822 19.325407 imi_mug_run_2_treatment "various" "calcium chloride" "level"
10 Q0 26516964 823 19.300138 imi_mug_run_2_treatment "eosin"
10 Q0 11814456 824 19.287256 imi_mug_run_2_treatment "edta"
10 Q0 21606571 825 19.27047 imi_mug_run_2_treatment "animals" "imatinib mesylate" "cyclosporin a"
10 Q0 12850372 826 19.266623 imi_mug_run_2_treatment "dim"
10 Q0 19861964 827 19.261581 imi_mug_run_2_treatment "arry-142886" "azd6244" "aim"
10 Q0 24588073 828 19.257973 imi_mug_run_2_treatment "vemurafenib"
10 Q0 13129437 829 19.138556 imi_mug_run_2_treatment "il-1ra" "interleukin-1" "interleukin 1 receptor antagonist"
10 Q0 17196780 830 19.06727 imi_mug_run_2_treatment "pronto" "eosin" "agent"
10 Q0 11251559 831 19.036394 imi_mug_run_2_treatment "mart-1" "melana" "adjuvant"
10 Q0 8471837 832 19.012892 imi_mug_run_2_treatment "various" "level"
10 Q0 6332522 833 18.96488 imi_mug_run_2_treatment "iga"
10 Q0 22972819 834 18.95088 imi_mug_run_2_treatment "vaccines"
10 Q0 8618015 835 18.93705 imi_mug_run_2_treatment "mediated"
10 Q0 1512051 836 18.913044 imi_mug_run_2_treatment "committed" "lead" "cytokines"
10 Q0 8394038 837 18.912245 imi_mug_run_2_treatment "phenol" "ethidium bromide" "product"
10 Q0 16227821 838 18.905333 imi_mug_run_2_treatment "autologous" "immunosuppressive"
10 Q0 26762460 839 18.905333 imi_mug_run_2_treatment "cytokines" "interleukins" "il-4"
10 Q0 19372776 840 18.905333 imi_mug_run_2_treatment "microbicide"
10 Q0 14988918 841 18.890137 imi_mug_run_2_treatment "level" "animals"
10 Q0 17535228 842 18.877234 imi_mug_run_2_treatment "kinase inhibitor"
10 Q0 11892684 843 18.871716 imi_mug_run_2_treatment "adjuvant" "vaccines"
10 Q0 21925513 844 18.868446 imi_mug_run_2_treatment "protease" "mediators" "animals"
10 Q0 11321515 845 18.846643 imi_mug_run_2_treatment "nsaids" "aspirin" "anti-inflammatory"
10 Q0 8960099 846 18.842924 imi_mug_run_2_treatment "others"
10 Q0 23795354 847 18.743675 imi_mug_run_2_treatment "aim"
10 Q0 1330099 848 18.740799 imi_mug_run_2_treatment "ras"
10 Q0 27111917 849 18.73872 imi_mug_run_2_treatment "asa"
10 Q0 14500367 850 18.72737 imi_mug_run_2_treatment "ras" "basis" "genesis"
10 Q0 16274626 851 18.72737 imi_mug_run_2_treatment "trp-2" "mediated"
10 Q0 22157614 852 18.703989 imi_mug_run_2_treatment "basis"
10 Q0 17690212 853 18.666239 imi_mug_run_2_treatment "lead"
10 Q0 19710399 854 18.666239 imi_mug_run_2_treatment "various" "formalin" "level"
10 Q0 24265152 855 18.665714 imi_mug_run_2_treatment "braf inhibitor"
10 Q0 28708099 856 18.665714 imi_mug_run_2_treatment "drug" "vemurafenib" "braf inhibitor"
10 Q0 16001163 857 18.654835 imi_mug_run_2_treatment "mart-1"
10 Q0 11476540 858 18.605038 imi_mug_run_2_treatment "phosphate" "level"
10 Q0 30206025 859 18.492634 imi_mug_run_2_treatment "metric" "calypso" "level"
10 Q0 6383433 860 18.49179 imi_mug_run_2_treatment "level"
10 Q0 8735018 861 18.479164 imi_mug_run_2_treatment "product" "ethidium bromide" "polyacrylamide gels"
10 Q0 15466707 862 18.47647 imi_mug_run_2_treatment "polysaccharide" "polysaccharides"
10 Q0 1812623 863 18.466183 imi_mug_run_2_treatment "guanidine"
10 Q0 30214446 864 18.427612 imi_mug_run_2_treatment "various" "melan-a" "blockade"
10 Q0 22131883 865 18.371666 imi_mug_run_2_treatment "level"
10 Q0 23116250 866 18.371666 imi_mug_run_2_treatment "vemurafenib" "drug" "dacarbazine"
10 Q0 10464712 867 18.364277 imi_mug_run_2_treatment "tgf-beta 1" "il-10" "immunosuppressive"
10 Q0 11953125 868 18.357807 imi_mug_run_2_treatment "silver"
10 Q0 19040570 869 18.357807 imi_mug_run_2_treatment "antral" "ulex europaeus"
10 Q0 19414559 870 18.318268 imi_mug_run_2_treatment "plasma" "vaccine" "microbicide"
10 Q0 24958904 871 18.316692 imi_mug_run_2_treatment "poly ic" "influenza vaccines" "polyinosinic-polycytidylic acid"
10 Q0 22731835 872 18.243336 imi_mug_run_2_treatment "aim"
10 Q0 18809698 873 18.214134 imi_mug_run_2_treatment "adjuvant"
10 Q0 16890795 874 18.204971 imi_mug_run_2_treatment "sorafenib" "kinase inhibitor" "protein kinase inhibitors"
10 Q0 25613753 875 18.204971 imi_mug_run_2_treatment "andrographolide" "anti-inflammatory" "diphenyl"
10 Q0 18312439 876 18.202751 imi_mug_run_2_treatment "various"
10 Q0 25834314 877 18.199482 imi_mug_run_2_treatment "aim"
10 Q0 9626047 878 18.195816 imi_mug_run_2_treatment "ganglioside" "level"
10 Q0 26496938 879 18.183758 imi_mug_run_2_treatment "nerve growth factor"
10 Q0 16729170 880 18.146 imi_mug_run_2_treatment "aim" "genesis"
10 Q0 20140953 881 18.143946 imi_mug_run_2_treatment "interferon" "formalin"
10 Q0 2884996 882 18.143677 imi_mug_run_2_treatment "l-dopa" "dopa" "phenylalanine"
10 Q0 22613960 883 18.143677 imi_mug_run_2_treatment "calcium" "drugs" "glibenclamide"
10 Q0 28486310 884 18.143677 imi_mug_run_2_treatment "iodine-125"
10 Q0 27990727 885 18.140823 imi_mug_run_2_treatment "mediated" "human chorionic gonadotropin"
10 Q0 25952101 886 18.131401 imi_mug_run_2_treatment "aim"
10 Q0 24529162 887 18.117607 imi_mug_run_2_treatment "lead"
10 Q0 27566656 888 18.056923 imi_mug_run_2_treatment "various" "drugs" "fluorophore"
10 Q0 2340496 889 18.05271 imi_mug_run_2_treatment "retinoic acid" "agar" "mediated"
10 Q0 8095141 890 18.041576 imi_mug_run_2_treatment "trifluoperazine" "verapamil"
10 Q0 19414304 891 18.041576 imi_mug_run_2_treatment "aim"
10 Q0 24258992 892 18.041576 imi_mug_run_2_treatment "various" "adjuvant"
10 Q0 19623896 893 18.02465 imi_mug_run_2_treatment "aim" "bovine uterus"
10 Q0 23382631 894 18.011787 imi_mug_run_2_treatment "level" "duration" "aim"
10 Q0 30092155 895 17.994972 imi_mug_run_2_treatment "level"
10 Q0 10379477 896 17.91232 imi_mug_run_2_treatment "level" "aim" "food"
10 Q0 19118416 897 17.91232 imi_mug_run_2_treatment "betadine" "swine colon" "animals"
10 Q0 22474475 898 17.91232 imi_mug_run_2_treatment "pantoprazole" "egg" "mediated"
10 Q0 25784212 899 17.91232 imi_mug_run_2_treatment "ras"
10 Q0 29521926 900 17.91232 imi_mug_run_2_treatment "basis"
10 Q0 21294907 901 17.90452 imi_mug_run_2_treatment "calcium" "atropine" "verapamil"
10 Q0 20203509 902 17.90452 imi_mug_run_2_treatment "prostaglandins" "mediators" "antihistamines"
10 Q0 23905145 903 17.90452 imi_mug_run_2_treatment "iron" "parenteral iron"
10 Q0 29635244 904 17.90452 imi_mug_run_2_treatment "level" "fluorouracil" "mediated"
10 Q0 11773216 905 17.904238 imi_mug_run_2_treatment "level"
10 Q0 21262211 906 17.895628 imi_mug_run_2_treatment "aim"
10 Q0 11341798 907 17.885056 imi_mug_run_2_treatment "sodium" "fructose" "glucose"
10 Q0 11911346 908 17.885056 imi_mug_run_2_treatment "gastrin"
10 Q0 11111847 909 17.868607 imi_mug_run_2_treatment "icc" "mediated"
10 Q0 7512032 910 17.868607 imi_mug_run_2_treatment "il-12" "interleukin-4" "mast cell growth factor"
10 Q0 23534980 911 17.813686 imi_mug_run_2_treatment "tnf-alpha" "various" "melphalan"
10 Q0 9520947 912 17.80722 imi_mug_run_2_treatment "others" "basis"
10 Q0 19628634 913 17.702269 imi_mug_run_2_treatment "proton pump inhibitor" "anti-inflammatory" "drug"
10 Q0 28446532 914 17.701775 imi_mug_run_2_treatment "favor"
10 Q0 8339262 915 17.701742 imi_mug_run_2_treatment "autologous"
10 Q0 27688612 916 17.648535 imi_mug_run_2_treatment "aim"
10 Q0 17594688 917 17.613567 imi_mug_run_2_treatment "aim"
10 Q0 21981974 918 17.592745 imi_mug_run_2_treatment "enzymes" "serine"
10 Q0 24969466 919 17.561125 imi_mug_run_2_treatment "plasma" "medicine" "vemurafenib"
10 Q0 11517302 920 17.556551 imi_mug_run_2_treatment "level" "vaccine" "vaccines"
10 Q0 25600339 921 17.534378 imi_mug_run_2_treatment "agent" "braf inhibitor"
10 Q0 16806278 922 17.506653 imi_mug_run_2_treatment "heparin" "resveratrol" "porcine heparin"
10 Q0 17168979 923 17.506653 imi_mug_run_2_treatment "melanoma growth stimulatory activity"
10 Q0 19542718 924 17.506653 imi_mug_run_2_treatment "imatinib" "imatinib mesilate"
10 Q0 23176005 925 17.506653 imi_mug_run_2_treatment "gleevec" "imatinib" "tyrosine kinase inhibitor"
10 Q0 23583561 926 17.506653 imi_mug_run_2_treatment "sensory organs"
10 Q0 26921540 927 17.506653 imi_mug_run_2_treatment "formalin"
10 Q0 23901197 928 17.476686 imi_mug_run_2_treatment "betaine" "dmso" "dimethyl sulfoxide"
10 Q0 15572665 929 17.474339 imi_mug_run_2_treatment "mediated"
10 Q0 15743179 930 17.474339 imi_mug_run_2_treatment "lc-6" "level" "others"
10 Q0 17245318 931 17.474339 imi_mug_run_2_treatment "drug" "sti571" "gleevec"
10 Q0 17094949 932 17.474339 imi_mug_run_2_treatment "pervanadate" "mediated" "epidermal growth factor"
10 Q0 8510874 933 17.474339 imi_mug_run_2_treatment "monoclonal antibodies"
10 Q0 10982396 934 17.474339 imi_mug_run_2_treatment "agent" "acetate" "nocodazole"
10 Q0 26370527 935 17.474339 imi_mug_run_2_treatment "ras" "propolis" "tyr"
10 Q0 21977985 936 17.474339 imi_mug_run_2_treatment "vascular endothelial growth factor" "melan a"
10 Q0 30032643 937 17.472382 imi_mug_run_2_treatment "lenvatinib" "various" "drug"
10 Q0 8598336 938 17.441467 imi_mug_run_2_treatment "biotin"
10 Q0 15053044 939 17.441467 imi_mug_run_2_treatment "level"
10 Q0 18162323 940 17.441467 imi_mug_run_2_treatment "level" "plasma"
10 Q0 19027198 941 17.441467 imi_mug_run_2_treatment "anti-inflammatory" "ethanol" "carrageenan"
10 Q0 17979879 942 17.441467 imi_mug_run_2_treatment "drug combinations" "basis"
10 Q0 27459381 943 17.441467 imi_mug_run_2_treatment "sunitinib" "sorafenib" "aim"
10 Q0 22841617 944 17.441467 imi_mug_run_2_treatment "cytotoxic" "tyrosine" "basis"
10 Q0 23833303 945 17.441467 imi_mug_run_2_treatment "various" "ssd" "tandem"
10 Q0 19809274 946 17.441467 imi_mug_run_2_treatment "tyr" "fontana-masson stain"
10 Q0 30269470 947 17.441467 imi_mug_run_2_treatment "melan a"
10 Q0 27115155 948 17.437567 imi_mug_run_2_treatment "product"
10 Q0 29906747 949 17.421518 imi_mug_run_2_treatment "honey bee" "ethanol" "isolate"
10 Q0 8901575 950 17.355835 imi_mug_run_2_treatment "product" "melan-a"
10 Q0 2167156 951 17.352938 imi_mug_run_2_treatment "collagenase" "gelatin" "phorbol myristate acetate"
10 Q0 15163005 952 17.352938 imi_mug_run_2_treatment "eosin"
10 Q0 16261157 953 17.352938 imi_mug_run_2_treatment "level" "aim" "others"
10 Q0 10690896 954 17.329132 imi_mug_run_2_treatment "stimulant" "tandem"
10 Q0 20520718 955 17.329132 imi_mug_run_2_treatment "therapeutics"
10 Q0 21278735 956 17.279545 imi_mug_run_2_treatment "antiparasitic" "interleukin 13"
10 Q0 15122588 957 17.256275 imi_mug_run_2_treatment "fmm"
10 Q0 16438868 958 17.251102 imi_mug_run_2_treatment "various" "eosin"
10 Q0 9678250 959 17.251102 imi_mug_run_2_treatment "pga"
10 Q0 18194500 960 17.251102 imi_mug_run_2_treatment "lead" "aim"
10 Q0 18575421 961 17.251102 imi_mug_run_2_treatment "various"
10 Q0 25138665 962 17.251102 imi_mug_run_2_treatment "cytotoxic" "cytokines" "lymphotoxin"
10 Q0 22020746 963 17.251102 imi_mug_run_2_treatment "cck-8" "fcm"
10 Q0 26823734 964 17.251102 imi_mug_run_2_treatment "il-10" "il-6" "il-4"
10 Q0 22293262 965 17.251102 imi_mug_run_2_treatment "various" "aim"
10 Q0 18033835 966 17.251102 imi_mug_run_2_treatment "betadine"
10 Q0 27900093 967 17.251102 imi_mug_run_2_treatment "adjuvant" "imatinib mesylate" "air"
10 Q0 11078608 968 17.242641 imi_mug_run_2_treatment "cytotoxic"
10 Q0 15542237 969 17.242641 imi_mug_run_2_treatment "scorpion venom" "scg" "level"
10 Q0 17502183 970 17.242641 imi_mug_run_2_treatment "icc" "bicarbonate" "eosin"
10 Q0 10521992 971 17.242641 imi_mug_run_2_treatment "prednisolone"
10 Q0 26192434 972 17.242641 imi_mug_run_2_treatment "various" "liver" "basis"
10 Q0 21853268 973 17.242641 imi_mug_run_2_treatment "mediated" "level"
10 Q0 21410049 974 17.242641 imi_mug_run_2_treatment "aim"
10 Q0 25210522 975 17.242641 imi_mug_run_2_treatment "level" "aim"
10 Q0 20228932 976 17.242641 imi_mug_run_2_treatment "il-3" "ganglioside" "protease"
10 Q0 28580832 977 17.242641 imi_mug_run_2_treatment "plasma"
10 Q0 29110332 978 17.242641 imi_mug_run_2_treatment "level" "mannose-binding lectin"
10 Q0 11909697 979 17.242168 imi_mug_run_2_treatment "enzymes" "antioxidant" "vitamins"
10 Q0 14660743 980 17.242168 imi_mug_run_2_treatment "allergen" "alum" "mediators"
10 Q0 10389693 981 17.242168 imi_mug_run_2_treatment "antral" "proton pump inhibitor" "rabeprazole"
10 Q0 25512686 982 17.242168 imi_mug_run_2_treatment "casein"
10 Q0 21951672 983 17.242168 imi_mug_run_2_treatment "liver"
10 Q0 26488471 984 17.242168 imi_mug_run_2_treatment "serine" "cck"
10 Q0 27638345 985 17.242168 imi_mug_run_2_treatment "nilotinib"
10 Q0 23911613 986 17.242168 imi_mug_run_2_treatment "drug" "infliximab" "human igg"
10 Q0 12239933 987 17.242168 imi_mug_run_2_treatment "liver"
10 Q0 27317811 988 17.242168 imi_mug_run_2_treatment "lead" "shape"
10 Q0 28935400 989 17.22079 imi_mug_run_2_treatment "adjuvant" "sunitinib"
10 Q0 17309750 990 17.220367 imi_mug_run_2_treatment "aim"
10 Q0 15985723 991 17.220367 imi_mug_run_2_treatment "ethanol" "iga" "immunoglobulin a"
10 Q0 18648178 992 17.220367 imi_mug_run_2_treatment "basis"
10 Q0 16123204 993 17.220367 imi_mug_run_2_treatment "icc" "bumetanide" "aim"
10 Q0 16344990 994 17.220367 imi_mug_run_2_treatment "cortisol" "leucine" "glucocorticoids"
10 Q0 24169385 995 17.220367 imi_mug_run_2_treatment "duration" "genesis"
10 Q0 22257551 996 17.220367 imi_mug_run_2_treatment "various" "glucose" "incretin hormone"
10 Q0 21224053 997 17.220367 imi_mug_run_2_treatment "dextran sodium sulfate"
10 Q0 20405350 998 17.220367 imi_mug_run_2_treatment "mediated"
10 Q0 20151281 999 17.220367 imi_mug_run_2_treatment "level"
11 Q0 22745105 1 73.44092 imi_mug_run_2_treatment "imatinib" "drug" "crenolanib"
11 Q0 30506540 2 68.75058 imi_mug_run_2_treatment "imatinib" "adjuvant"
11 Q0 16638875 3 66.49172 imi_mug_run_2_treatment "imatinib" "su11248" "kinase inhibitor"
11 Q0 22783407 4 66.1933 imi_mug_run_2_treatment "imatinib" "sti571" "glivec"
11 Q0 20096441 5 64.80199 imi_mug_run_2_treatment "liver"
11 Q0 26130666 6 64.56987 imi_mug_run_2_treatment "imatinib"
11 Q0 18794084 7 64.27777 imi_mug_run_2_treatment "imatinib" "dasatinib" "ipi-504"
11 Q0 15894928 8 63.977406 imi_mug_run_2_treatment "sti 571" "gleevec" "imatinib mesylate"
11 Q0 27258566 9 63.929478 imi_mug_run_2_treatment "imatinib" "kinase inhibitor" "aim"
11 Q0 28284172 10 63.831116 imi_mug_run_2_treatment "imatinib"
11 Q0 15087667 11 63.77083 imi_mug_run_2_treatment "sti-571"
11 Q0 17087936 12 63.562813 imi_mug_run_2_treatment "imatinib" "nilotinib" "pkc412"
11 Q0 30101875 13 63.092026 imi_mug_run_2_treatment "imatinib" "fletcher's" "others"
11 Q0 29510530 14 62.292732 imi_mug_run_2_treatment "imatinib" "crenolanib"
11 Q0 25735500 15 62.236107 imi_mug_run_2_treatment "plasma" "imatinib"
11 Q0 26658996 16 61.18513 imi_mug_run_2_treatment "imatinib"
11 Q0 15928335 17 60.91096 imi_mug_run_2_treatment "imatinib" "drug" "kinase inhibitor"
11 Q0 22943011 18 59.8414 imi_mug_run_2_treatment "level"
11 Q0 27163723 19 59.694664 imi_mug_run_2_treatment "adjuvant" "drugs" "imatinib"
11 Q0 23106360 20 59.378723 imi_mug_run_2_treatment "tyrosine"
11 Q0 26396737 21 59.360085 imi_mug_run_2_treatment "kinase inhibitor" "sunitinib" "imatinib"
11 Q0 18416137 22 58.728348 imi_mug_run_2_treatment "aminoacids"
11 Q0 12522257 23 58.07118 imi_mug_run_2_treatment "gleevec"
11 Q0 22718859 24 57.793938 imi_mug_run_2_treatment "imatinib" "tyrosine kinase inhibitor"
11 Q0 28031906 25 57.698914 imi_mug_run_2_treatment "regorafenib" "imatinib"
11 Q0 27349873 26 57.62565 imi_mug_run_2_treatment "drug" "imatinib"
11 Q0 29220298 27 57.611317 imi_mug_run_2_treatment "imatinib" "sunitinib" "tyrosine kinase inhibitor"
11 Q0 21934616 28 57.48558 imi_mug_run_2_treatment "adjuvant" "imatinib"
11 Q0 17253141 29 57.254765 imi_mug_run_2_treatment "aim"
11 Q0 21566429 30 57.04084 imi_mug_run_2_treatment "imatinib" "drug" "kinase inhibitor"
11 Q0 22645636 31 56.77195 imi_mug_run_2_treatment "lys" "glu" "imatinib"
11 Q0 17018739 32 56.498566 imi_mug_run_2_treatment "imatinib" "adjuvant" "tyrosine kinase inhibitor"
11 Q0 24997326 33 56.109276 imi_mug_run_2_treatment "imatinib"
11 Q0 25222580 34 56.02027 imi_mug_run_2_treatment "imatinib" "aim"
11 Q0 16630479 35 55.82145 imi_mug_run_2_treatment "icc"
11 Q0 18636362 36 55.66603 imi_mug_run_2_treatment "tandem"
11 Q0 29093181 37 55.518627 imi_mug_run_2_treatment "various" "blu-285" "drugs"
11 Q0 15685537 38 55.46814 imi_mug_run_2_treatment "imatinib" "drug" "kinase inhibitor"
11 Q0 23092343 39 54.640324 imi_mug_run_2_treatment "imatinib" "drugs"
11 Q0 30003531 40 54.558247 imi_mug_run_2_treatment "various"
11 Q0 24858723 41 54.083004 imi_mug_run_2_treatment "adjuvant" "imatinib" "tyrosine kinase inhibitor"
11 Q0 14699510 42 53.74356 imi_mug_run_2_treatment "tyrosine"
11 Q0 20823768 43 53.55076 imi_mug_run_2_treatment "liver"
11 Q0 28632504 44 53.424583 imi_mug_run_2_treatment "various"
11 Q0 17512858 45 52.777714 imi_mug_run_2_treatment "kinase inhibitor" "adjuvant" "mediated"
11 Q0 24758502 46 52.477863 imi_mug_run_2_treatment "drugs" "imatinib"
11 Q0 22124674 47 52.387417 imi_mug_run_2_treatment "imatinib mesylate"
11 Q0 24266839 48 52.360886 imi_mug_run_2_treatment "various" "basis"
11 Q0 24635438 49 52.252686 imi_mug_run_2_treatment "imatinib mesylate" "cytostatic" "imatinib"
11 Q0 24124608 50 52.014698 imi_mug_run_2_treatment "imatinib"
11 Q0 17565683 51 51.91152 imi_mug_run_2_treatment "adjuvant" "imatinib"
11 Q0 18618605 52 51.676155 imi_mug_run_2_treatment "tandem"
11 Q0 25593916 53 51.452988 imi_mug_run_2_treatment "ras"
11 Q0 15223958 54 51.30549 imi_mug_run_2_treatment "imatinib"
11 Q0 21461555 55 51.1294 imi_mug_run_2_treatment "various"
11 Q0 17729245 56 50.949844 imi_mug_run_2_treatment "imatinib" "sunitinib"
11 Q0 25143820 57 50.809174 imi_mug_run_2_treatment "rms"
11 Q0 19900103 58 50.73719 imi_mug_run_2_treatment "aim"
11 Q0 24159917 59 50.679916 imi_mug_run_2_treatment "adjuvant" "dioxin" "imatinib mesylate"
11 Q0 30101284 60 50.278404 imi_mug_run_2_treatment "imatinib" "sunitinib" "tyrosine kinase inhibitor"
11 Q0 25970686 61 50.273567 imi_mug_run_2_treatment "imatinib"
11 Q0 23489352 62 50.153656 imi_mug_run_2_treatment "tyrosine" "imatinib"
11 Q0 16776995 63 50.146954 imi_mug_run_2_treatment "tandem"
11 Q0 22855636 64 50.134796 imi_mug_run_2_treatment "imatinib" "sunitinib"
11 Q0 25427437 65 50.123096 imi_mug_run_2_treatment "various" "imatinib"
11 Q0 24145645 66 49.62311 imi_mug_run_2_treatment "basis" "aim"
11 Q0 16398673 67 49.57706 imi_mug_run_2_treatment "various" "icc" "imatinib mesylate"
11 Q0 23536336 68 49.43946 imi_mug_run_2_treatment "tyrosine kinase inhibitor"
11 Q0 26191287 69 49.34003 imi_mug_run_2_treatment "product"
11 Q0 16136600 70 48.99509 imi_mug_run_2_treatment "imatinib" "agent" "adjuvant"
11 Q0 22743760 71 48.97928 imi_mug_run_2_treatment "adjuvant" "imatinib" "basis"
11 Q0 22799337 72 48.951355 imi_mug_run_2_treatment "nvp"
11 Q0 20047122 73 48.859512 imi_mug_run_2_treatment "drug" "imatinib" "sunitinib"
11 Q0 20499309 74 48.850395 imi_mug_run_2_treatment "imatinib" "ras"
11 Q0 25975287 75 48.687096 imi_mug_run_2_treatment "inf" "aim"
11 Q0 21970485 76 48.57718 imi_mug_run_2_treatment "imatinib mesylate" "sunitinib malate"
11 Q0 25368123 77 48.46676 imi_mug_run_2_treatment "level"
11 Q0 28932084 78 48.422836 imi_mug_run_2_treatment "imatinib" "aim"
11 Q0 21817899 79 48.420067 imi_mug_run_2_treatment "sunitinib" "imatinib" "vascular endothelial growth factor"
11 Q0 15742414 80 48.36402 imi_mug_run_2_treatment "aim"
11 Q0 20941986 81 48.34334 imi_mug_run_2_treatment "adjuvant" "imatinib mesylate"
11 Q0 22229850 82 48.184532 imi_mug_run_2_treatment "imatinib mesylate" "drugs" "revolution"
11 Q0 17673922 83 48.022697 imi_mug_run_2_treatment "aim"
11 Q0 15365079 84 48.00896 imi_mug_run_2_treatment "kinase inhibitor" "imatinib"
11 Q0 15872385 85 47.99222 imi_mug_run_2_treatment "drug" "imatinib mesylate" "matrix"
11 Q0 15188667 86 47.764748 imi_mug_run_2_treatment "imatinib" "adjuvant" "imatinib mesylate"
11 Q0 28535771 87 47.757927 imi_mug_run_2_treatment "lead"
11 Q0 19047911 88 47.566826 imi_mug_run_2_treatment "gat"
11 Q0 21953054 89 47.55462 imi_mug_run_2_treatment "others"
11 Q0 20489620 90 47.48271 imi_mug_run_2_treatment "plasma" "level" "imatinib"
11 Q0 20660757 91 47.42744 imi_mug_run_2_treatment "antimalarial" "imatinib" "antimalarials"
11 Q0 14645423 92 47.298847 imi_mug_run_2_treatment "imatinib" "imatinib mesylate"
11 Q0 18360281 93 47.278282 imi_mug_run_2_treatment "various"
11 Q0 18671247 94 47.235634 imi_mug_run_2_treatment "ras" "imatinib" "lead"
11 Q0 24867041 95 47.23095 imi_mug_run_2_treatment "antral"
11 Q0 18312355 96 47.230804 imi_mug_run_2_treatment "imatinib" "sunitinib" "tyrosine kinase inhibitor"
11 Q0 27178185 97 47.219036 imi_mug_run_2_treatment "plasma"
11 Q0 19968734 98 47.150352 imi_mug_run_2_treatment "imatinib" "drug" "adjuvant"
11 Q0 29885053 99 46.968773 imi_mug_run_2_treatment "imatinib" "kinase inhibitor" "imatinib mesylate"
11 Q0 26098203 100 46.824627 imi_mug_run_2_treatment "drugs" "imatinib mesylate" "new drugs"
11 Q0 26184165 101 46.73435 imi_mug_run_2_treatment "drug" "medicine" "imatinib"
11 Q0 18483389 102 46.69847 imi_mug_run_2_treatment "imatinib" "sunitinib" "dasatinib"
11 Q0 20021947 103 46.66595 imi_mug_run_2_treatment "imatinib" "imatinib mesylate" "agent"
11 Q0 21717788 104 46.628067 imi_mug_run_2_treatment "imatinib" "adjuvant" "sunitinib"
11 Q0 26622437 105 46.536396 imi_mug_run_2_treatment "imatinib" "tyrosine kinase inhibitor" "aim"
11 Q0 20469993 106 46.53039 imi_mug_run_2_treatment "imatinib mesylate"
11 Q0 25481675 107 46.49542 imi_mug_run_2_treatment "imatinib"
11 Q0 23623056 108 46.23221 imi_mug_run_2_treatment "imatinib" "ras"
11 Q0 17363589 109 46.205242 imi_mug_run_2_treatment "imatinib" "imatinib mesylate" "mediated"
11 Q0 26297068 110 46.17427 imi_mug_run_2_treatment "others"
11 Q0 25831232 111 46.129723 imi_mug_run_2_treatment "ras" "imatinib"
11 Q0 28768491 112 45.965324 imi_mug_run_2_treatment "imatinib" "imatinib mesylate" "sunitinib"
11 Q0 22015552 113 45.864044 imi_mug_run_2_treatment "imatinib" "drug" "kinase inhibitor"
11 Q0 22952296 114 45.658325 imi_mug_run_2_treatment "imatinib" "vascular endothelial growth factor"
11 Q0 24129766 115 45.45789 imi_mug_run_2_treatment "aim"
11 Q0 26678977 116 45.365482 imi_mug_run_2_treatment "various"
11 Q0 24369323 117 45.355713 imi_mug_run_2_treatment "imatinib"
11 Q0 25659388 118 45.33017 imi_mug_run_2_treatment "aim"
11 Q0 23833252 119 45.33017 imi_mug_run_2_treatment "aim"
11 Q0 21459336 120 45.270256 imi_mug_run_2_treatment "imatinib" "tyrosine kinase inhibitor"
11 Q0 23326179 121 45.25802 imi_mug_run_2_treatment "adjuvant" "imatinib" "imatinib mesylate"
11 Q0 16143881 122 45.257412 imi_mug_run_2_treatment "imatinib" "imatinib mesylate" "tyrosine kinase inhibitor"
11 Q0 23746188 123 45.236202 imi_mug_run_2_treatment "imatinib" "aim"
11 Q0 23036227 124 45.16343 imi_mug_run_2_treatment "various" "imatinib" "sunitinib"
11 Q0 19949796 125 45.041008 imi_mug_run_2_treatment "drug" "glivec" "imatinib"
11 Q0 20946519 126 44.903427 imi_mug_run_2_treatment "tma"
11 Q0 29866822 127 44.887955 imi_mug_run_2_treatment "others"
11 Q0 20598160 128 44.842728 imi_mug_run_2_treatment "imatinib"
11 Q0 26848617 129 44.81304 imi_mug_run_2_treatment "imatinib"
11 Q0 21863513 130 44.73938 imi_mug_run_2_treatment "imatinib" "adjuvant" "sunitinib"
11 Q0 21505157 131 44.719975 imi_mug_run_2_treatment "lead"
11 Q0 27011036 132 44.64182 imi_mug_run_2_treatment "liver"
11 Q0 20165865 133 44.623615 imi_mug_run_2_treatment "imatinib" "sunitinib" "therapeutics"
11 Q0 21140148 134 44.593037 imi_mug_run_2_treatment "plasma" "level" "imatinib"
11 Q0 16291174 135 44.576706 imi_mug_run_2_treatment "imatinib" "imatinib mesylate" "product"
11 Q0 25865047 136 44.571953 imi_mug_run_2_treatment "icc" "crenolanib" "imatinib"
11 Q0 24451815 137 44.47836 imi_mug_run_2_treatment "tyrosine kinase inhibitor"
11 Q0 28027118 138 44.401775 imi_mug_run_2_treatment "imatinib" "adjuvant"
11 Q0 19333543 139 44.28814 imi_mug_run_2_treatment "icc"
11 Q0 17625442 140 44.20221 imi_mug_run_2_treatment "imatinib" "gleevec"
11 Q0 16402362 141 44.122555 imi_mug_run_2_treatment "fibrinogen"
11 Q0 15154005 142 44.073692 imi_mug_run_2_treatment "lys"
11 Q0 23307090 143 44.071167 imi_mug_run_2_treatment "tyrosine"
11 Q0 15215166 144 44.003864 imi_mug_run_2_treatment "antiserum" "imatinib mesylate" "lead"
11 Q0 19047110 145 43.937496 imi_mug_run_2_treatment "various" "imatinib"
11 Q0 23833305 146 43.921135 imi_mug_run_2_treatment "plasma"
11 Q0 15289315 147 43.865944 imi_mug_run_2_treatment "imatinib mesylate"
11 Q0 25741136 148 43.854782 imi_mug_run_2_treatment "imatinib" "lead"
11 Q0 15946589 149 43.844574 imi_mug_run_2_treatment "imatinib" "drugs" "sti571"
11 Q0 21613800 150 43.769817 imi_mug_run_2_treatment "product" "level"
11 Q0 17532173 151 43.748352 imi_mug_run_2_treatment "various" "imatinib"
11 Q0 23935374 152 43.60553 imi_mug_run_2_treatment "imatinib" "adjuvant" "tyrosine kinase inhibitor"
11 Q0 16359540 153 43.565533 imi_mug_run_2_treatment "revolution"
11 Q0 20028860 154 43.481293 imi_mug_run_2_treatment "bortezomib" "imatinib" "mediated"
11 Q0 17193822 155 43.451416 imi_mug_run_2_treatment "imatinib" "drug" "imatinib mesylate"
11 Q0 25473890 156 43.42508 imi_mug_run_2_treatment "various" "imatinib"
11 Q0 17452978 157 43.42361 imi_mug_run_2_treatment "mediated" "pkc412" "imatinib"
11 Q0 18628470 158 43.37152 imi_mug_run_2_treatment "imatinib"
11 Q0 25717425 159 43.28481 imi_mug_run_2_treatment "lead"
11 Q0 21434524 160 43.277794 imi_mug_run_2_treatment "imatinib" "mediated"
11 Q0 17438095 161 43.144268 imi_mug_run_2_treatment "imatinib" "basis"
11 Q0 20126584 162 43.13207 imi_mug_run_2_treatment "imatinib mesylate" "liver"
11 Q0 16773696 163 43.03641 imi_mug_run_2_treatment "glivec" "imatinib mesylate" "aim"
11 Q0 18777214 164 42.992916 imi_mug_run_2_treatment "factor viii-related antigen"
11 Q0 16052979 165 42.99189 imi_mug_run_2_treatment "imatinib mesylate" "tyrosine kinase inhibitor"
11 Q0 23295309 166 42.92234 imi_mug_run_2_treatment "level"
11 Q0 30383140 167 42.92215 imi_mug_run_2_treatment "adjuvant" "imatinib" "imatinib mesylate"
11 Q0 22764137 168 42.885284 imi_mug_run_2_treatment "suberoylanilide hydroxamic acid" "histone deacetylase inhibitor" "imatinib"
11 Q0 15968329 169 42.798683 imi_mug_run_2_treatment "hot spot" "tandem"
11 Q0 27625077 170 42.76526 imi_mug_run_2_treatment "aim"
11 Q0 16203282 171 42.72867 imi_mug_run_2_treatment "various" "imatinib" "aim"
11 Q0 25674291 172 42.71434 imi_mug_run_2_treatment "cisplatin"
11 Q0 16785193 173 42.641106 imi_mug_run_2_treatment "imatinib"
11 Q0 26672673 174 42.611847 imi_mug_run_2_treatment "imatinib" "adjuvant" "drugs"
11 Q0 24361761 175 42.60076 imi_mug_run_2_treatment "drug" "tyrosine kinase inhibitor" "imatinib"
11 Q0 29760538 176 42.598103 imi_mug_run_2_treatment "adjuvant" "imatinib" "medicine"
11 Q0 16610057 177 42.54808 imi_mug_run_2_treatment "imatinib mesylate" "glivec" "duration"
11 Q0 17623951 178 42.508736 imi_mug_run_2_treatment "kinase inhibitor"
11 Q0 18690842 179 42.485588 imi_mug_run_2_treatment "imatinib" "kinase inhibitor" "mediators"
11 Q0 23198834 180 42.444656 imi_mug_run_2_treatment "imatinib" "drugs" "imatinib mesylate"
11 Q0 19935059 181 42.402107 imi_mug_run_2_treatment "antral" "liver"
11 Q0 20470368 182 42.34755 imi_mug_run_2_treatment "imatinib"
11 Q0 16778826 183 42.34411 imi_mug_run_2_treatment "imatinib mesylate" "kinase inhibitor" "mediated"
11 Q0 20023271 184 42.097435 imi_mug_run_2_treatment "imatinib"
11 Q0 15930355 185 42.086323 imi_mug_run_2_treatment "imatinib" "drug" "tyrosine kinase inhibitor"
11 Q0 20081808 186 42.031105 imi_mug_run_2_treatment "various"
11 Q0 19585585 187 41.919693 imi_mug_run_2_treatment "lead" "level"
11 Q0 23873383 188 41.882103 imi_mug_run_2_treatment "therapeutics"
11 Q0 27753268 189 41.852417 imi_mug_run_2_treatment "adjuvant" "imatinib" "aim"
11 Q0 17591808 190 41.842392 imi_mug_run_2_treatment "imatinib mesylate" "kinase inhibitor" "tyrosine"
11 Q0 24783183 191 41.84236 imi_mug_run_2_treatment "sunitinib" "imatinib"
11 Q0 28488171 192 41.717407 imi_mug_run_2_treatment "imatinib" "aim"
11 Q0 18955458 193 41.625305 imi_mug_run_2_treatment "sunitinib" "imatinib"
11 Q0 16287112 194 41.60849 imi_mug_run_2_treatment "lead"
11 Q0 16258521 195 41.58834 imi_mug_run_2_treatment "lysine" "tyrosine"
11 Q0 27263309 196 41.563797 imi_mug_run_2_treatment "various"
11 Q0 17255767 197 41.521397 imi_mug_run_2_treatment "aim"
11 Q0 15492989 198 41.404472 imi_mug_run_2_treatment "sti571" "imatinib mesylate"
11 Q0 25934947 199 41.362843 imi_mug_run_2_treatment "combinations" "drug" "imatinib"
11 Q0 27472829 200 41.36187 imi_mug_run_2_treatment "aim"
11 Q0 24384849 201 41.30121 imi_mug_run_2_treatment "imatinib" "sunitinib" "regorafenib"
11 Q0 28988501 202 41.296894 imi_mug_run_2_treatment "drug" "sts" "imatinib"
11 Q0 24405315 203 41.278774 imi_mug_run_2_treatment "regorafenib" "imatinib" "kinase inhibitor"
11 Q0 27256045 204 41.239468 imi_mug_run_2_treatment "onion"
11 Q0 26415883 205 41.172897 imi_mug_run_2_treatment "bisulfite"
11 Q0 23637977 206 41.08052 imi_mug_run_2_treatment "dioxin" "adjuvant" "ors"
11 Q0 22017446 207 40.996475 imi_mug_run_2_treatment "imatinib"
11 Q0 19011564 208 40.994335 imi_mug_run_2_treatment "mouse monoclonal antibody"
11 Q0 24298573 209 40.886627 imi_mug_run_2_treatment "insulin" "igf1" "insulin-like growth factor 1"
11 Q0 29227120 210 40.837418 imi_mug_run_2_treatment "imatinib mesylate"
11 Q0 25080996 211 40.82652 imi_mug_run_2_treatment "drugs" "new drugs" "aim"
11 Q0 24886695 212 40.784813 imi_mug_run_2_treatment "directed" "succinate" "insulin-like growth factor 1"
11 Q0 17193819 213 40.778667 imi_mug_run_2_treatment "icc"
11 Q0 17090188 214 40.769035 imi_mug_run_2_treatment "imatinib" "tyrosine kinase inhibitor"
11 Q0 21286759 215 40.618187 imi_mug_run_2_treatment "program"
11 Q0 17824795 216 40.574574 imi_mug_run_2_treatment "imatinib"
11 Q0 18537751 217 40.565895 imi_mug_run_2_treatment "imatinib" "drug" "imatinib mesylate"
11 Q0 15613856 218 40.53855 imi_mug_run_2_treatment "adjuvant" "gleevec"
11 Q0 15095270 219 40.46321 imi_mug_run_2_treatment "others"
11 Q0 20845009 220 40.451546 imi_mug_run_2_treatment "adjuvant"
11 Q0 22363143 221 40.449326 imi_mug_run_2_treatment "imatinib" "aim"
11 Q0 15452163 222 40.365257 imi_mug_run_2_treatment "aim"
11 Q0 24760637 223 40.30486 imi_mug_run_2_treatment "imatinib" "sunitinib"
11 Q0 23702733 224 40.231945 imi_mug_run_2_treatment "imatinib" "aim"
11 Q0 19144598 225 40.21971 imi_mug_run_2_treatment "imatinib" "genesis"
11 Q0 19417561 226 40.174145 imi_mug_run_2_treatment "imatinib"
11 Q0 20385106 227 40.167114 imi_mug_run_2_treatment "imatinib" "kinase inhibitor" "gleevec"
11 Q0 24802226 228 40.156673 imi_mug_run_2_treatment "various" "adjuvant" "imatinib"
11 Q0 15750190 229 40.14229 imi_mug_run_2_treatment "imatinib mesylate" "imatinib" "agent"
11 Q0 15712189 230 40.138584 imi_mug_run_2_treatment "imatinib mesylate" "liver"
11 Q0 19509155 231 40.110657 imi_mug_run_2_treatment "imatinib"
11 Q0 22988538 232 40.1075 imi_mug_run_2_treatment "fletcher"
11 Q0 22577569 233 40.10666 imi_mug_run_2_treatment "drug" "drugs" "imatinib"
11 Q0 19561230 234 40.06898 imi_mug_run_2_treatment "imatinib"
11 Q0 17566086 235 40.062355 imi_mug_run_2_treatment "lead"
11 Q0 30488756 236 40.01581 imi_mug_run_2_treatment "kinase inhibitor" "mediated" "imatinib"
11 Q0 24040448 237 39.879253 imi_mug_run_2_treatment "kinase inhibitor" "aim"
11 Q0 19690756 238 39.840816 imi_mug_run_2_treatment "imatinib"
11 Q0 18521081 239 39.815025 imi_mug_run_2_treatment "imatinib" "kinase inhibitor" "mediated"
11 Q0 27178821 240 39.813 imi_mug_run_2_treatment "aim"
11 Q0 21566432 241 39.797337 imi_mug_run_2_treatment "imatinib" "imatinib mesylate" "sunitinib"
11 Q0 19366796 242 39.7194 imi_mug_run_2_treatment "various" "sunitinib" "mediated"
11 Q0 27864688 243 39.649803 imi_mug_run_2_treatment "aim"
11 Q0 19448595 244 39.64646 imi_mug_run_2_treatment "hot spot"
11 Q0 25504284 245 39.64001 imi_mug_run_2_treatment "imatinib"
11 Q0 24444465 246 39.44324 imi_mug_run_2_treatment "imatinib"
11 Q0 21605429 247 39.35586 imi_mug_run_2_treatment "aim" "others"
11 Q0 22994537 248 39.336323 imi_mug_run_2_treatment "adjuvant" "imatinib" "duration"
11 Q0 26511941 249 39.320747 imi_mug_run_2_treatment "various"
11 Q0 23730622 250 39.320747 imi_mug_run_2_treatment "kinase inhibitor"
11 Q0 28478525 251 39.29615 imi_mug_run_2_treatment "imatinib" "sunitinib" "regorafenib"
11 Q0 26772734 252 39.26393 imi_mug_run_2_treatment "sunitinib" "imatinib" "metrics"
11 Q0 18510377 253 39.245285 imi_mug_run_2_treatment "imatinib mesylate" "tyrosine kinase inhibitor"
11 Q0 22739667 254 39.240837 imi_mug_run_2_treatment "imatinib" "duration" "adjuvant"
11 Q0 15815732 255 39.23965 imi_mug_run_2_treatment "imatinib mesylate" "adjuvant" "drug"
11 Q0 23859518 256 39.23965 imi_mug_run_2_treatment "drug" "imatinib"
11 Q0 29110548 257 39.226273 imi_mug_run_2_treatment "drugs"
11 Q0 22454176 258 39.213444 imi_mug_run_2_treatment "imatinib"
11 Q0 29682621 259 39.177994 imi_mug_run_2_treatment "imatinib" "sunitinib" "tyrosine kinase inhibitor"
11 Q0 22150077 260 39.1734 imi_mug_run_2_treatment "imatinib" "imatinib 400 mg"
11 Q0 16166437 261 39.163452 imi_mug_run_2_treatment "level" "aim"
11 Q0 25182956 262 39.159798 imi_mug_run_2_treatment "imatinib" "ras" "lead"
11 Q0 24755645 263 39.128475 imi_mug_run_2_treatment "imatinib mesylate"
11 Q0 25905001 264 39.09221 imi_mug_run_2_treatment "regorafenib" "program" "imatinib"
11 Q0 15326474 265 39.077175 imi_mug_run_2_treatment "imatinib"
11 Q0 27793025 266 39.05841 imi_mug_run_2_treatment "icc" "imatinib" "mediated"
11 Q0 18525340 267 39.027683 imi_mug_run_2_treatment "imatinib"
11 Q0 30126859 268 39.025597 imi_mug_run_2_treatment "imatinib"
11 Q0 23576565 269 39.017666 imi_mug_run_2_treatment "calcium" "antiangiogenic" "imatinib"
11 Q0 20008851 270 39.01699 imi_mug_run_2_treatment "drug" "drugs" "imatinib"
11 Q0 18369405 271 39.005283 imi_mug_run_2_treatment "imatinib" "tyrosine"
11 Q0 21387320 272 38.972694 imi_mug_run_2_treatment "adjuvant" "aim"
11 Q0 23283817 273 38.972336 imi_mug_run_2_treatment "genesis"
11 Q0 19307738 274 38.95141 imi_mug_run_2_treatment "imatinib" "imatinib mesylate"
11 Q0 28098915 275 38.9457 imi_mug_run_2_treatment "imatinib"
11 Q0 24790651 276 38.93991 imi_mug_run_2_treatment "imatinib" "sunitinib" "regorafenib"
11 Q0 18488160 277 38.91789 imi_mug_run_2_treatment "imatinib"
11 Q0 22665524 278 38.80708 imi_mug_run_2_treatment "sorafenib" "various" "imatinib"
11 Q0 27600498 279 38.806824 imi_mug_run_2_treatment "various" "adjuvant" "imatinib"
11 Q0 20442644 280 38.797413 imi_mug_run_2_treatment "adjuvant" "imatinib mesylate"
11 Q0 19508837 281 38.781796 imi_mug_run_2_treatment "others"
11 Q0 17921955 282 38.706097 imi_mug_run_2_treatment "gleevec" "imatinib"
11 Q0 17200708 283 38.67884 imi_mug_run_2_treatment "basis"
11 Q0 22009637 284 38.643414 imi_mug_run_2_treatment "immunosuppressive"
11 Q0 25205505 285 38.609592 imi_mug_run_2_treatment "sss"
11 Q0 17527083 286 38.528877 imi_mug_run_2_treatment "aim"
11 Q0 20025481 287 38.48096 imi_mug_run_2_treatment "imatinib"
11 Q0 29719410 288 38.47322 imi_mug_run_2_treatment "aim"
11 Q0 22453568 289 38.352123 imi_mug_run_2_treatment "imatinib" "adjuvant"
11 Q0 17330260 290 38.33687 imi_mug_run_2_treatment "imatinib mesylate"
11 Q0 19606013 291 38.325653 imi_mug_run_2_treatment "drugs"
11 Q0 26214687 292 38.324802 imi_mug_run_2_treatment "pba" "mediated" "bisulfite"
11 Q0 21116624 293 38.279205 imi_mug_run_2_treatment "sunitinib" "tyrosine kinase inhibitor" "imatinib"
11 Q0 23717541 294 38.279205 imi_mug_run_2_treatment "basis"
11 Q0 24847623 295 38.220432 imi_mug_run_2_treatment "imatinib"
11 Q0 18350628 296 38.12311 imi_mug_run_2_treatment "aim"
11 Q0 17087943 297 38.116196 imi_mug_run_2_treatment "aim"
11 Q0 23536353 298 38.10359 imi_mug_run_2_treatment "drug" "imatinib" "sunitinib"
11 Q0 25621775 299 38.0966 imi_mug_run_2_treatment "imatinib" "adjuvant" "drug"
11 Q0 24727986 300 37.94251 imi_mug_run_2_treatment "imatinib" "adjuvant" "drugs"
11 Q0 15822120 301 37.937206 imi_mug_run_2_treatment "imatinib"
11 Q0 22593460 302 37.89715 imi_mug_run_2_treatment "imatinib mesylate"
11 Q0 27097112 303 37.831272 imi_mug_run_2_treatment "imatinib" "aim"
11 Q0 23696920 304 37.776863 imi_mug_run_2_treatment "icc"
11 Q0 28398518 305 37.770607 imi_mug_run_2_treatment "drug" "agent"
11 Q0 21868553 306 37.692623 imi_mug_run_2_treatment "aim"
11 Q0 23423603 307 37.667934 imi_mug_run_2_treatment "imatinib"
11 Q0 27928806 308 37.667934 imi_mug_run_2_treatment "drug" "imatinib" "insulin-like growth factor 1"
11 Q0 21364741 309 37.593052 imi_mug_run_2_treatment "icc" "animals"
11 Q0 22282465 310 37.591984 imi_mug_run_2_treatment "imatinib" "ras"
11 Q0 27446428 311 37.518784 imi_mug_run_2_treatment "aim"
11 Q0 27974047 312 37.493034 imi_mug_run_2_treatment "ras"
11 Q0 21462307 313 37.357178 imi_mug_run_2_treatment "imatinib" "imatinib mesylate"
11 Q0 16954519 314 37.34304 imi_mug_run_2_treatment "imatinib"
11 Q0 26056505 315 37.25054 imi_mug_run_2_treatment "adjuvant" "imatinib" "tyrosine kinase inhibitor"
11 Q0 19006610 316 37.13851 imi_mug_run_2_treatment "imatinib" "imatinib mesylate" "sunitinib"
11 Q0 15864317 317 37.136765 imi_mug_run_2_treatment "tma"
11 Q0 24133624 318 37.083244 imi_mug_run_2_treatment "igf1" "igf2"
11 Q0 27686810 319 37.054104 imi_mug_run_2_treatment "various"
11 Q0 21358619 320 37.0377 imi_mug_run_2_treatment "imatinib"
11 Q0 17209131 321 37.009354 imi_mug_run_2_treatment "icc" "aim"
11 Q0 21479127 322 36.900574 imi_mug_run_2_treatment "imatinib"
11 Q0 16900856 323 36.86888 imi_mug_run_2_treatment "imatinib" "adjuvant" "sunitinib"
11 Q0 20690803 324 36.849014 imi_mug_run_2_treatment "imatinib" "sunitinib"
11 Q0 17200352 325 36.82036 imi_mug_run_2_treatment "imatinib"
11 Q0 18785120 326 36.725792 imi_mug_run_2_treatment "level"
11 Q0 24990162 327 36.64147 imi_mug_run_2_treatment "imatinib" "sunitinib" "regorafenib"
11 Q0 18314611 328 36.60282 imi_mug_run_2_treatment "imatinib" "tyrosine" "imatinib mesylate"
11 Q0 19020900 329 36.594627 imi_mug_run_2_treatment "ras"
11 Q0 27633918 330 36.57706 imi_mug_run_2_treatment "various" "antineoplastic" "nh2"
11 Q0 25294914 331 36.57263 imi_mug_run_2_treatment "imatinib" "adjuvant"
11 Q0 27443349 332 36.57068 imi_mug_run_2_treatment "drugs"
11 Q0 20947481 333 36.55018 imi_mug_run_2_treatment "kinase inhibitor" "imatinib" "imatinib mesylate"
11 Q0 24618081 334 36.332867 imi_mug_run_2_treatment "various" "tyrosine"
11 Q0 26187774 335 36.31958 imi_mug_run_2_treatment "imatinib" "drug" "sunitinib"
11 Q0 30221743 336 36.190105 imi_mug_run_2_treatment "hub" "ppi"
11 Q0 17171690 337 36.11817 imi_mug_run_2_treatment "level"
11 Q0 27370604 338 36.1 imi_mug_run_2_treatment "imatinib mesylate" "mk-2206" "drug combination"
11 Q0 22996768 339 36.02256 imi_mug_run_2_treatment "drug" "drugs" "imatinib"
11 Q0 18271923 340 35.86863 imi_mug_run_2_treatment "methylated"
11 Q0 29183145 341 35.815224 imi_mug_run_2_treatment "drugs" "imatinib" "histone deacetylase inhibitors"
11 Q0 16498290 342 35.80959 imi_mug_run_2_treatment "imatinib"
11 Q0 19335275 343 35.74933 imi_mug_run_2_treatment "imatinib" "sunitinib" "drug"
11 Q0 23041331 344 35.744293 imi_mug_run_2_treatment "lysozyme" "drug" "imatinib"
11 Q0 21136920 345 35.741417 imi_mug_run_2_treatment "enzymes" "glycans"
11 Q0 23479771 346 35.737495 imi_mug_run_2_treatment "imatinib"
11 Q0 27375917 347 35.737495 imi_mug_run_2_treatment "tyrosine kinase inhibitor"
11 Q0 16624552 348 35.729717 imi_mug_run_2_treatment "imatinib" "drug"
11 Q0 19411681 349 35.729717 imi_mug_run_2_treatment "imatinib"
11 Q0 28222971 350 35.729717 imi_mug_run_2_treatment "aim"
11 Q0 20512492 351 35.709908 imi_mug_run_2_treatment "imatinib" "sunitinib" "adjuvant"
11 Q0 25659413 352 35.709908 imi_mug_run_2_treatment "insulin"
11 Q0 18615679 353 35.67084 imi_mug_run_2_treatment "imatinib" "ras"
11 Q0 18223323 354 35.67084 imi_mug_run_2_treatment "antiserum" "monoclonal antibodies"
11 Q0 25836719 355 35.66444 imi_mug_run_2_treatment "crizotinib" "cabozantinib" "imatinib"
11 Q0 20108043 356 35.66444 imi_mug_run_2_treatment "sti-571" "gleevec" "imatinib mesylate"
11 Q0 22442907 357 35.629623 imi_mug_run_2_treatment "imatinib"
11 Q0 17437861 358 35.61772 imi_mug_run_2_treatment "imatinib" "sunitinib"
11 Q0 19706776 359 35.61772 imi_mug_run_2_treatment "imatinib" "saha" "lbh589"
11 Q0 21279555 360 35.550957 imi_mug_run_2_treatment "imatinib" "kinase inhibitor" "gleevec"
11 Q0 23752188 361 35.524105 imi_mug_run_2_treatment "imatinib" "imatinib mesylate" "tyrosine kinase inhibitor"
11 Q0 21171987 362 35.519012 imi_mug_run_2_treatment "pooled"
11 Q0 25221952 363 35.470154 imi_mug_run_2_treatment "nilotinib" "tyrosine kinase inhibitor" "imatinib"
11 Q0 20043176 364 35.452515 imi_mug_run_2_treatment "imatinib"
11 Q0 30117724 365 35.361145 imi_mug_run_2_treatment "icc"
11 Q0 29143894 366 35.269947 imi_mug_run_2_treatment "drug" "imatinib"
11 Q0 20032375 367 35.26485 imi_mug_run_2_treatment "various" "tk inhibitors" "aim"
11 Q0 20473908 368 35.260273 imi_mug_run_2_treatment "imatinib"
11 Q0 26447534 369 35.259686 imi_mug_run_2_treatment "aim"
11 Q0 21224473 370 35.208725 imi_mug_run_2_treatment "imatinib"
11 Q0 23755839 371 35.15398 imi_mug_run_2_treatment "imatinib"
11 Q0 23584476 372 34.918884 imi_mug_run_2_treatment "various" "imatinib" "mediated"
11 Q0 22866155 373 34.896713 imi_mug_run_2_treatment "drug" "new drugs" "level"
11 Q0 20621681 374 34.78953 imi_mug_run_2_treatment "icc" "imatinib" "drug"
11 Q0 18190445 375 34.623207 imi_mug_run_2_treatment "imatinib mesylate"
11 Q0 17875769 376 34.52509 imi_mug_run_2_treatment "imatinib" "glucose" "imatinib mesylate"
11 Q0 15545668 377 34.501457 imi_mug_run_2_treatment "imatinib mesylate"
11 Q0 18246046 378 34.49594 imi_mug_run_2_treatment "imatinib"
11 Q0 21160808 379 34.456474 imi_mug_run_2_treatment "lysine" "glutamic acid" "eosin"
11 Q0 18063877 380 34.341293 imi_mug_run_2_treatment "imatinib mesylate" "deoxyglucose" "imatinib"
11 Q0 29312652 381 34.31189 imi_mug_run_2_treatment "imatinib" "plasma" "sunitinib"
11 Q0 28710566 382 34.30716 imi_mug_run_2_treatment "imatinib" "adjuvant"
11 Q0 25120810 383 34.23455 imi_mug_run_2_treatment "imatinib"
11 Q0 15010069 384 34.203896 imi_mug_run_2_treatment "imatinib" "lys" "imatinib mesylate"
11 Q0 18183595 385 34.09994 imi_mug_run_2_treatment "imatinib"
11 Q0 23942094 386 34.09404 imi_mug_run_2_treatment "aim"
11 Q0 19771279 387 34.089375 imi_mug_run_2_treatment "imatinib" "imatinib 400 mg" "basis"
11 Q0 21385119 388 33.934746 imi_mug_run_2_treatment "aim" "drugs"
11 Q0 23621836 389 33.927746 imi_mug_run_2_treatment "tyrosine" "imatinib mesylate"
11 Q0 17632543 390 33.887558 imi_mug_run_2_treatment "imatinib"
11 Q0 15838387 391 33.84986 imi_mug_run_2_treatment "liver"
11 Q0 22381410 392 33.78309 imi_mug_run_2_treatment "smd" "imatinib mesylate"
11 Q0 18381383 393 33.7322 imi_mug_run_2_treatment "various" "imatinib"
11 Q0 22955521 394 33.666424 imi_mug_run_2_treatment "lead"
11 Q0 27928801 395 33.647198 imi_mug_run_2_treatment "imatinib" "adjuvant"
11 Q0 29710216 396 33.615273 imi_mug_run_2_treatment "imatinib" "dasatinib" "iron"
11 Q0 25394969 397 33.612953 imi_mug_run_2_treatment "various" "others"
11 Q0 27777072 398 33.55069 imi_mug_run_2_treatment "imatinib" "pd0325901" "mek inhibitor"
11 Q0 20978145 399 33.51844 imi_mug_run_2_treatment "bisulfite"
11 Q0 23599150 400 33.510376 imi_mug_run_2_treatment "imatinib" "adjuvant"
11 Q0 24833907 401 33.509808 imi_mug_run_2_treatment "protease" "fletcher" "aim"
11 Q0 23743927 402 33.45102 imi_mug_run_2_treatment "tet" "succinate" "enzymes"
11 Q0 17914114 403 33.445553 imi_mug_run_2_treatment "aim"
11 Q0 26276366 404 33.445553 imi_mug_run_2_treatment "imatinib"
11 Q0 23722018 405 33.445553 imi_mug_run_2_treatment "kinase inhibitor" "eosin" "imatinib mesylate"
11 Q0 23648119 406 33.42372 imi_mug_run_2_treatment "imatinib"
11 Q0 22399613 407 33.400494 imi_mug_run_2_treatment "various"
11 Q0 21192792 408 33.36016 imi_mug_run_2_treatment "everolimus" "imatinib" "nilotinib"
11 Q0 21326036 409 33.334618 imi_mug_run_2_treatment "aim"
11 Q0 28356974 410 33.32459 imi_mug_run_2_treatment "matrix"
11 Q0 21358303 411 33.28581 imi_mug_run_2_treatment "liver" "eosin" "imatinib"
11 Q0 22430048 412 33.243683 imi_mug_run_2_treatment "nilotinib" "imatinib" "sunitinib"
11 Q0 23282968 413 33.23261 imi_mug_run_2_treatment "mouse monoclonal antibody"
11 Q0 22804613 414 33.152103 imi_mug_run_2_treatment "imatinib" "aim"
11 Q0 17145623 415 33.0977 imi_mug_run_2_treatment "gleevec" "imatinib"
11 Q0 27156227 416 33.02159 imi_mug_run_2_treatment "imatinib" "onalespib" "sunitinib"
11 Q0 18973210 417 33.018764 imi_mug_run_2_treatment "imatinib" "drugs"
11 Q0 21663639 418 32.981277 imi_mug_run_2_treatment "antral"
11 Q0 17455099 419 32.97924 imi_mug_run_2_treatment "collagen"
11 Q0 17827398 420 32.90571 imi_mug_run_2_treatment "imatinib" "aim"
11 Q0 20834236 421 32.89535 imi_mug_run_2_treatment "aim"
11 Q0 24375257 422 32.840096 imi_mug_run_2_treatment "adjuvant" "imatinib"
11 Q0 26599335 423 32.799896 imi_mug_run_2_treatment "regorafenib" "various" "irinotecan"
11 Q0 19648886 424 32.772423 imi_mug_run_2_treatment "mediated"
11 Q0 25339426 425 32.741436 imi_mug_run_2_treatment "somatostatin" "imatinib"
11 Q0 19064982 426 32.688927 imi_mug_run_2_treatment "sunitinib" "imatinib" "tyrosine kinase inhibitor"
11 Q0 15146165 427 32.314964 imi_mug_run_2_treatment "formaldehyde"
11 Q0 20548289 428 32.300102 imi_mug_run_2_treatment "mediated"
11 Q0 28334365 429 32.297043 imi_mug_run_2_treatment "imatinib" "adjuvant" "duration"
11 Q0 22174597 430 32.25082 imi_mug_run_2_treatment "imatinib" "imatinib mesylate" "tyrosine kinase inhibitor"
11 Q0 29985958 431 32.237095 imi_mug_run_2_treatment "mediated" "imatinib" "sunitinib"
11 Q0 20730857 432 32.215515 imi_mug_run_2_treatment "adjuvant"
11 Q0 17208434 433 32.145645 imi_mug_run_2_treatment "imatinib" "sunitinib" "flavopiridol"
11 Q0 16397744 434 32.145016 imi_mug_run_2_treatment "basis"
11 Q0 20927104 435 32.145016 imi_mug_run_2_treatment "program" "icc" "imatinib"
11 Q0 22167411 436 32.145016 imi_mug_run_2_treatment "basis" "imatinib"
11 Q0 27366945 437 32.145016 imi_mug_run_2_treatment "imatinib"
11 Q0 18520229 438 32.13848 imi_mug_run_2_treatment "adjuvant" "imatinib"
11 Q0 25673643 439 32.13848 imi_mug_run_2_treatment "imatinib" "mediated"
11 Q0 17195905 440 32.03696 imi_mug_run_2_treatment "imatinib" "imatinib mesylate"
11 Q0 22555179 441 31.986864 imi_mug_run_2_treatment "imatinib"
11 Q0 24342289 442 31.976818 imi_mug_run_2_treatment "kinase inhibitor" "basis"
11 Q0 24307908 443 31.953579 imi_mug_run_2_treatment "basis"
11 Q0 19614767 444 31.84462 imi_mug_run_2_treatment "ras" "imatinib" "aim"
11 Q0 22439647 445 31.838177 imi_mug_run_2_treatment "imatinib" "sunitinib" "antiangiogenic"
11 Q0 25653733 446 31.714306 imi_mug_run_2_treatment "basis"
11 Q0 28481328 447 31.558514 imi_mug_run_2_treatment "imatinib"
11 Q0 30389923 448 31.517654 imi_mug_run_2_treatment "mannose"
11 Q0 24952730 449 31.514387 imi_mug_run_2_treatment "drugs" "sunitinib" "investigational agents"
11 Q0 19326424 450 31.421253 imi_mug_run_2_treatment "sunitinib" "imatinib" "duration"
11 Q0 28351781 451 31.363777 imi_mug_run_2_treatment "imatinib" "sunitinib" "regorafenib"
11 Q0 17384206 452 31.286026 imi_mug_run_2_treatment "kinase inhibitor" "imatinib mesylate"
11 Q0 17715395 453 31.213078 imi_mug_run_2_treatment "tyrosine" "pdgf-bb" "gleevec"
11 Q0 17197927 454 31.102718 imi_mug_run_2_treatment "icc"
11 Q0 15221957 455 31.07598 imi_mug_run_2_treatment "various" "imatinib"
11 Q0 25755961 456 31.019217 imi_mug_run_2_treatment "various"
11 Q0 29868467 457 30.901522 imi_mug_run_2_treatment "imatinib" "adjuvant" "drugs"
11 Q0 27928797 458 30.676935 imi_mug_run_2_treatment "imatinib" "sunitinib" "liver"
11 Q0 23497641 459 30.673082 imi_mug_run_2_treatment "imatinib"
11 Q0 19424610 460 30.662289 imi_mug_run_2_treatment "aim"
11 Q0 28314314 461 30.611996 imi_mug_run_2_treatment "aim"
11 Q0 28133332 462 30.611996 imi_mug_run_2_treatment "imatinib" "sunitinib" "ts-1"
11 Q0 28831081 463 30.584032 imi_mug_run_2_treatment "balance"
11 Q0 28196207 464 30.363716 imi_mug_run_2_treatment "imatinib" "drug" "imatinib mesylate"
11 Q0 19176456 465 30.304403 imi_mug_run_2_treatment "imatinib" "ile" "thr"
11 Q0 23291969 466 30.257912 imi_mug_run_2_treatment "imatinib"
11 Q0 21435173 467 30.2328 imi_mug_run_2_treatment "various" "icc" "aza"
11 Q0 20180814 468 30.2328 imi_mug_run_2_treatment "imatinib"
11 Q0 22770876 469 30.2328 imi_mug_run_2_treatment "insulin" "igf2" "sts"
11 Q0 16441423 470 30.231949 imi_mug_run_2_treatment "imatinib" "liver"
11 Q0 22968735 471 30.194931 imi_mug_run_2_treatment "imatinib" "adjuvant" "ras"
11 Q0 28487491 472 30.159636 imi_mug_run_2_treatment "regorafenib" "imatinib" "sunitinib"
11 Q0 25239601 473 30.036915 imi_mug_run_2_treatment "ras" "tyrosine" "aim"
11 Q0 26521201 474 29.983007 imi_mug_run_2_treatment "icc"
11 Q0 21475850 475 29.927765 imi_mug_run_2_treatment "imatinib" "tyrosine"
11 Q0 27118626 476 29.914032 imi_mug_run_2_treatment "imatinib" "ras"
11 Q0 23242283 477 29.907114 imi_mug_run_2_treatment "color"
11 Q0 28187274 478 29.794992 imi_mug_run_2_treatment "lartruvo"
11 Q0 27582545 479 29.601524 imi_mug_run_2_treatment "dasatinib" "medicine"
11 Q0 30224936 480 29.531637 imi_mug_run_2_treatment "sunitinib" "imatinib" "chemotherapeutic agent"
11 Q0 19432672 481 29.455719 imi_mug_run_2_treatment "basis"
11 Q0 22294526 482 29.408833 imi_mug_run_2_treatment "sorafenib"
11 Q0 28288036 483 29.383827 imi_mug_run_2_treatment "basis"
11 Q0 15781488 484 29.381693 imi_mug_run_2_treatment "imatinib" "adjuvant"
11 Q0 24489888 485 29.232048 imi_mug_run_2_treatment "u0126" "mek inhibitor"
11 Q0 21904406 486 29.117176 imi_mug_run_2_treatment "lead"
11 Q0 24638003 487 29.107382 imi_mug_run_2_treatment "imatinib" "adjuvant"
11 Q0 28744850 488 29.092216 imi_mug_run_2_treatment "basis"
11 Q0 16160481 489 29.071312 imi_mug_run_2_treatment "liver"
11 Q0 29599305 490 29.052776 imi_mug_run_2_treatment "aim"
11 Q0 17189383 491 28.702002 imi_mug_run_2_treatment "genesis"
11 Q0 22855146 492 28.515844 imi_mug_run_2_treatment "fletcher" "imatinib" "glivec"
11 Q0 28212550 493 28.378696 imi_mug_run_2_treatment "various" "level"
11 Q0 22960170 494 28.299896 imi_mug_run_2_treatment "kinase inhibitor" "imatinib" "sorafenib"
11 Q0 21191613 495 28.075119 imi_mug_run_2_treatment "imatinib mesylate" "glivec" "imatinib"
11 Q0 21132034 496 27.997889 imi_mug_run_2_treatment "drugs" "aim"
11 Q0 24294389 497 27.97353 imi_mug_run_2_treatment "icc"
11 Q0 21757001 498 27.932102 imi_mug_run_2_treatment "lys" "glu" "imatinib"
11 Q0 27358721 499 27.884634 imi_mug_run_2_treatment "insulin" "terminator" "imatinib"
11 Q0 22793864 500 27.881535 imi_mug_run_2_treatment "imatinib" "others"
11 Q0 19060840 501 27.837719 imi_mug_run_2_treatment "imatinib" "others"
11 Q0 22351694 502 27.703636 imi_mug_run_2_treatment "kinase inhibitor" "adjuvant" "fletcher"
11 Q0 23889148 503 27.703636 imi_mug_run_2_treatment "various" "aim"
11 Q0 22281667 504 27.703392 imi_mug_run_2_treatment "mct" "fletcher's" "mcts"
11 Q0 22065192 505 27.673428 imi_mug_run_2_treatment "imatinib" "sunitinib" "sorafenib"
11 Q0 21104107 506 27.626827 imi_mug_run_2_treatment "sunitinib" "imatinib"
11 Q0 28049691 507 27.566391 imi_mug_run_2_treatment "collagen" "favoring" "balance"
11 Q0 18437171 508 27.430874 imi_mug_run_2_treatment "imatinib" "icc"
11 Q0 29310833 509 27.38687 imi_mug_run_2_treatment "imatinib"
11 Q0 22076173 510 27.308165 imi_mug_run_2_treatment "cisplatin" "liver"
11 Q0 16865565 511 27.267467 imi_mug_run_2_treatment "imatinib"
11 Q0 16625094 512 27.241058 imi_mug_run_2_treatment "various" "imatinib"
11 Q0 28609680 513 27.233421 imi_mug_run_2_treatment "sti571" "imatinib" "crenolanib"
11 Q0 28253727 514 27.1746 imi_mug_run_2_treatment "aim"
11 Q0 23621172 515 27.061012 imi_mug_run_2_treatment "various" "osm" "oncostatin m"
11 Q0 26555092 516 26.948076 imi_mug_run_2_treatment "factor x" "succinate"
11 Q0 17316415 517 26.908981 imi_mug_run_2_treatment "monoclonal antibodies"
11 Q0 23074200 518 26.856272 imi_mug_run_2_treatment "various" "level"
11 Q0 19859843 519 26.756048 imi_mug_run_2_treatment "cisplatin"
11 Q0 23348204 520 26.75197 imi_mug_run_2_treatment "imatinib" "level" "hot spot"
11 Q0 22262331 521 26.6334 imi_mug_run_2_treatment "imatinib" "drug" "adjuvant"
11 Q0 20354820 522 26.4597 imi_mug_run_2_treatment "cisplatin"
11 Q0 22722648 523 26.383064 imi_mug_run_2_treatment "imatinib mesylate"
11 Q0 22355509 524 26.362593 imi_mug_run_2_treatment "carmustine" "dacarbazine" "tamoxifen"
11 Q0 19222333 525 26.159346 imi_mug_run_2_treatment "epidermal growth factor" "fletcher's"
11 Q0 23564025 526 25.870766 imi_mug_run_2_treatment "calcitonin" "insulin" "somatostatin"
11 Q0 18778561 527 25.864605 imi_mug_run_2_treatment "imatinib" "sunitinib" "tyrosine"
11 Q0 19620796 528 25.864605 imi_mug_run_2_treatment "imatinib" "sunitinib" "tyrosine kinase inhibitor"
11 Q0 29451912 529 25.76717 imi_mug_run_2_treatment "imatinib" "adjuvant"
11 Q0 20453818 530 25.63839 imi_mug_run_2_treatment "imatinib"
11 Q0 22323597 531 25.617908 imi_mug_run_2_treatment "color"
11 Q0 23573327 532 25.569874 imi_mug_run_2_treatment "various" "cisplatin" "psk"
11 Q0 19182535 533 25.511948 imi_mug_run_2_treatment "imatinib"
11 Q0 23989401 534 25.252344 imi_mug_run_2_treatment "coagulation factors" "cladribine" "recombinant factor viia"
11 Q0 22394371 535 25.235271 imi_mug_run_2_treatment "hot spot"
11 Q0 22411791 536 25.21762 imi_mug_run_2_treatment "various" "pdgf-bb" "mediated"
11 Q0 19563658 537 25.214876 imi_mug_run_2_treatment "drugs"
11 Q0 21364689 538 25.212337 imi_mug_run_2_treatment "drug" "therapeutic agents"
11 Q0 19246520 539 25.074898 imi_mug_run_2_treatment "ras" "mtor inhibitor"
11 Q0 23330018 540 25.064095 imi_mug_run_2_treatment "various"
11 Q0 28557709 541 25.002705 imi_mug_run_2_treatment "imatinib" "abc" "aim"
11 Q0 19705153 542 24.86811 imi_mug_run_2_treatment "kinase inhibitor" "suppressor"
11 Q0 20588273 543 24.840237 imi_mug_run_2_treatment "adjuvant" "imatinib"
11 Q0 23550446 544 24.78417 imi_mug_run_2_treatment "imatinib"
11 Q0 23211371 545 24.72432 imi_mug_run_2_treatment "axitinib" "bms-754807"
11 Q0 27477693 546 24.683964 imi_mug_run_2_treatment "kinase inhibitor" "sunitinib" "mek inhibitor"
11 Q0 28885361 547 24.67753 imi_mug_run_2_treatment "imatinib" "corticosteroid" "vitamin b12"
11 Q0 22160160 548 24.602564 imi_mug_run_2_treatment "kinase inhibitor"
11 Q0 23573331 549 24.542124 imi_mug_run_2_treatment "pas"
11 Q0 16505440 550 24.529648 imi_mug_run_2_treatment "imatinib" "pdgf-bb" "agent"
11 Q0 17667967 551 24.465881 imi_mug_run_2_treatment "sti571" "imatinib mesylate" "protein tyrosine kinase inhibitors"
11 Q0 28342264 552 24.426004 imi_mug_run_2_treatment "level" "blockade"
11 Q0 15933471 553 24.134502 imi_mug_run_2_treatment "methotrexate" "imatinib" "drugs"
11 Q0 16781490 554 24.027676 imi_mug_run_2_treatment "interferon-alpha" "drugs" "imatinib mesylate"
11 Q0 30289069 555 23.9907 imi_mug_run_2_treatment "drug" "imatinib"
11 Q0 28528977 556 23.970417 imi_mug_run_2_treatment "imatinib" "imatinib mesylate"
11 Q0 15299092 557 23.735428 imi_mug_run_2_treatment "estrogen" "prostaglandin e2" "ras"
11 Q0 30126369 558 23.657663 imi_mug_run_2_treatment "trabectedin" "drugs"
11 Q0 20606738 559 23.641884 imi_mug_run_2_treatment "icc"
11 Q0 29312807 560 23.618755 imi_mug_run_2_treatment "cck-8" "edu"
11 Q0 25132955 561 23.39062 imi_mug_run_2_treatment "regorafenib" "imatinib" "sunitinib"
11 Q0 17163160 562 23.332222 imi_mug_run_2_treatment "imatinib" "imatinib mesylate"
11 Q0 20685895 563 23.296917 imi_mug_run_2_treatment "dasatinib" "imatinib"
11 Q0 17883045 564 23.092424 imi_mug_run_2_treatment "imatinib" "basis"
11 Q0 16266874 565 23.078697 imi_mug_run_2_treatment "imatinib" "adjuvant"
11 Q0 27371698 566 23.064503 imi_mug_run_2_treatment "regorafenib" "kinase inhibitor" "imatinib"
11 Q0 29932244 567 22.936874 imi_mug_run_2_treatment "sts"
11 Q0 24405942 568 22.863657 imi_mug_run_2_treatment "tyrosine"
11 Q0 29416434 569 22.80177 imi_mug_run_2_treatment "sorafenib" "imatinib" "sunitinib"
11 Q0 24750504 570 22.77752 imi_mug_run_2_treatment "crizotinib"
11 Q0 24405856 571 22.360386 imi_mug_run_2_treatment "masitinib" "drug" "imatinib"
11 Q0 19580708 572 22.341413 imi_mug_run_2_treatment "drug" "imatinib" "product"
11 Q0 24638008 573 22.28846 imi_mug_run_2_treatment "imatinib"
11 Q0 22787122 574 22.131023 imi_mug_run_2_treatment "drug combination" "everolimus" "imatinib mesylate"
11 Q0 21125679 575 22.063934 imi_mug_run_2_treatment "drug" "imatinib" "imatinib mesylate"
11 Q0 26796526 576 21.979961 imi_mug_run_2_treatment "imatinib"
11 Q0 24480986 577 21.657253 imi_mug_run_2_treatment "plasma"
11 Q0 21997692 578 21.59005 imi_mug_run_2_treatment "basis"
11 Q0 23605780 579 21.391617 imi_mug_run_2_treatment "imatinib" "aim"
11 Q0 26942271 580 21.391617 imi_mug_run_2_treatment "imatinib"
11 Q0 19723893 581 21.299316 imi_mug_run_2_treatment "imatinib" "level"
11 Q0 22516345 582 21.299316 imi_mug_run_2_treatment "imatinib" "insulin-like growth factor 1" "kinase inhibitor"
11 Q0 23696939 583 21.268856 imi_mug_run_2_treatment "cisplatin"
11 Q0 24038753 584 20.96916 imi_mug_run_2_treatment "matrix" "fibrin" "triiodothyronine"
11 Q0 30060824 585 20.779215 imi_mug_run_2_treatment "pazopanib" "drugs" "temozolomide"
11 Q0 30318721 586 20.709488 imi_mug_run_2_treatment "sorafenib" "sorafenib 200 mg"
11 Q0 23411939 587 20.66849 imi_mug_run_2_treatment "various" "cisplatin" "liver"
11 Q0 19262599 588 20.397785 imi_mug_run_2_treatment "tet"
11 Q0 17785554 589 20.36378 imi_mug_run_2_treatment "nonsteroidal anti-inflammatory drug" "anti-inflammatory" "pdgfb"
11 Q0 23696935 590 20.077766 imi_mug_run_2_treatment "various"
11 Q0 26155363 591 20.062586 imi_mug_run_2_treatment "endopeptidase" "phosphate" "level"
11 Q0 24674454 592 19.899471 imi_mug_run_2_treatment "imatinib"
11 Q0 23356981 593 19.865173 imi_mug_run_2_treatment "triiodothyronine"
11 Q0 24356634 594 19.7493 imi_mug_run_2_treatment "pazopanib" "imatinib" "sunitinib"
11 Q0 21839357 595 19.739473 imi_mug_run_2_treatment "factor viii"
11 Q0 26709572 596 19.62062 imi_mug_run_2_treatment "level"
11 Q0 29512900 597 19.57763 imi_mug_run_2_treatment "dasatinib" "crizotinib" "drug combination"
11 Q0 29932922 598 19.568668 imi_mug_run_2_treatment "pdgfb" "shape"
11 Q0 15166033 599 19.523726 imi_mug_run_2_treatment "drug" "imatinib" "tyrosine"
11 Q0 26457233 600 19.467545 imi_mug_run_2_treatment "imatinib"
11 Q0 21478825 601 19.391378 imi_mug_run_2_treatment "imatinib"
11 Q0 22076171 602 19.205862 imi_mug_run_2_treatment "pas"
11 Q0 16251422 603 19.155918 imi_mug_run_2_treatment "level"
11 Q0 22400077 604 19.130638 imi_mug_run_2_treatment "estrogen"
11 Q0 24503937 605 19.056734 imi_mug_run_2_treatment "mediated"
11 Q0 23696937 606 19.013412 imi_mug_run_2_treatment "various"
11 Q0 15831234 607 18.851557 imi_mug_run_2_treatment "level" "agent"
11 Q0 29016808 608 18.841785 imi_mug_run_2_treatment "methylated" "level"
11 Q0 29369502 609 18.800522 imi_mug_run_2_treatment "shh" "aim"
11 Q0 22949944 610 18.78598 imi_mug_run_2_treatment "various" "cisplatin"
11 Q0 29641993 611 18.78598 imi_mug_run_2_treatment "aim"
11 Q0 17108337 612 18.756718 imi_mug_run_2_treatment "antral" "pdgfb"
11 Q0 26744442 613 18.744343 imi_mug_run_2_treatment "basis"
11 Q0 20552546 614 18.715733 imi_mug_run_2_treatment "factor viii-related antigen"
11 Q0 26687836 615 18.594563 imi_mug_run_2_treatment "imatinib"
11 Q0 29239034 616 18.594563 imi_mug_run_2_treatment "imatinib"
11 Q0 21064103 617 18.594563 imi_mug_run_2_treatment "tma" "aim"
11 Q0 20490332 618 18.571453 imi_mug_run_2_treatment "gleevec"
11 Q0 20090503 619 18.479877 imi_mug_run_2_treatment "collagen" "fiber"
11 Q0 25683249 620 18.180744 imi_mug_run_2_treatment "animals" "opc"
11 Q0 18332873 621 18.111267 imi_mug_run_2_treatment "product"
11 Q0 26718692 622 18.111267 imi_mug_run_2_treatment "drug" "cyclophosphamide" "etoposide"
11 Q0 30446580 623 18.079498 imi_mug_run_2_treatment "sunitinib" "nivolumab"
11 Q0 22606444 624 17.995594 imi_mug_run_2_treatment "drug" "imatinib" "imatinib mesylate"
11 Q0 22348015 625 17.957853 imi_mug_run_2_treatment "nilotinib" "imatinib" "drug"
11 Q0 26320507 626 17.919931 imi_mug_run_2_treatment "aza" "drugs" "dna methylation inhibitor"
11 Q0 20385747 627 17.763731 imi_mug_run_2_treatment "drug" "bms-754807" "imatinib"
11 Q0 18004179 628 17.633387 imi_mug_run_2_treatment "corticosteroids" "hydroxyurea" "imatinib"
11 Q0 17298867 629 17.55168 imi_mug_run_2_treatment "imatinib"
11 Q0 19966015 630 17.55168 imi_mug_run_2_treatment "various" "estrogen" "anti-estrogens"
11 Q0 28852847 631 17.503275 imi_mug_run_2_treatment "lead"
11 Q0 22831984 632 17.483456 imi_mug_run_2_treatment "adjuvant" "imatinib" "ssg"
11 Q0 29964125 633 17.434906 imi_mug_run_2_treatment "imatinib" "sunitinib" "crenolanib"
11 Q0 18339881 634 17.422028 imi_mug_run_2_treatment "insulin-like growth factor binding protein 3"
11 Q0 18281533 635 17.232666 imi_mug_run_2_treatment "level" "aim"
11 Q0 22440051 636 17.13176 imi_mug_run_2_treatment "lead"
11 Q0 21319518 637 17.13176 imi_mug_run_2_treatment "eosin" "imatinib"
11 Q0 25525250 638 17.097866 imi_mug_run_2_treatment "lysine"
11 Q0 23134683 639 17.011496 imi_mug_run_2_treatment "ulex europaeus"
11 Q0 27781423 640 17.001942 imi_mug_run_2_treatment "formaldehyde"
11 Q0 15469929 641 16.674665 imi_mug_run_2_treatment "gold" "sage" "tgfb1"
11 Q0 26464733 642 16.374826 imi_mug_run_2_treatment "tyrosine kinase inhibitor"
11 Q0 20924728 643 16.369194 imi_mug_run_2_treatment "factor viii-related antigen"
11 Q0 22000015 644 16.244047 imi_mug_run_2_treatment "mediated"
11 Q0 28698100 645 16.244047 imi_mug_run_2_treatment "asc"
11 Q0 22670180 646 16.184118 imi_mug_run_2_treatment "cdx"
11 Q0 28824643 647 16.182808 imi_mug_run_2_treatment "collagen" "leucine"
11 Q0 30472185 648 16.127415 imi_mug_run_2_treatment "tam"
11 Q0 27013922 649 15.927719 imi_mug_run_2_treatment "rms"
11 Q0 24714777 650 15.913647 imi_mug_run_2_treatment "basis"
11 Q0 17615082 651 15.838602 imi_mug_run_2_treatment "therapeutics" "suppressor"
11 Q0 25333264 652 15.56078 imi_mug_run_2_treatment "various" "others"
11 Q0 21254299 653 15.53982 imi_mug_run_2_treatment "ing1"
11 Q0 12112531 654 15.479723 imi_mug_run_2_treatment "level"
11 Q0 17372901 655 15.469271 imi_mug_run_2_treatment "imatinib" "kinase inhibitor" "dasatinib"
11 Q0 20943952 656 15.469271 imi_mug_run_2_treatment "cyt" "kinase inhibitor" "lead"
11 Q0 22100984 657 15.469271 imi_mug_run_2_treatment "imatinib" "pha-739358" "aurora kinase inhibitor"
11 Q0 22747609 658 15.469271 imi_mug_run_2_treatment "opc" "basis"
11 Q0 22474082 659 15.335974 imi_mug_run_2_treatment "plasma" "imatinib" "glucose"
11 Q0 24405801 660 15.314914 imi_mug_run_2_treatment "bmc"
11 Q0 26474454 661 15.219778 imi_mug_run_2_treatment "sunitinib" "level"
11 Q0 23412337 662 15.199681 imi_mug_run_2_treatment "level"
11 Q0 20739887 663 15.199681 imi_mug_run_2_treatment "kinase inhibitor"
11 Q0 26630576 664 15.1831045 imi_mug_run_2_treatment "docetaxel"
11 Q0 28675510 665 15.116127 imi_mug_run_2_treatment "mpl"
11 Q0 27251041 666 14.666542 imi_mug_run_2_treatment "ras"
11 Q0 26337765 667 14.6393385 imi_mug_run_2_treatment "drug" "level" "medicine"
11 Q0 20224732 668 14.624344 imi_mug_run_2_treatment "cisplatin"
11 Q0 28836293 669 14.615313 imi_mug_run_2_treatment "pdgfb"
11 Q0 30155964 670 14.615313 imi_mug_run_2_treatment "melan a"
11 Q0 26625196 671 14.594643 imi_mug_run_2_treatment "angiopoietin-2"
11 Q0 17465254 672 14.542868 imi_mug_run_2_treatment "imatinib mesylate" "drugs"
11 Q0 23064464 673 14.52438 imi_mug_run_2_treatment "blockade"
11 Q0 24333442 674 14.4868 imi_mug_run_2_treatment "calcium" "indatraline" "drugs"
11 Q0 27771229 675 14.400506 imi_mug_run_2_treatment "ras" "genesis"
11 Q0 16768285 676 14.1615925 imi_mug_run_2_treatment "corticosteroids" "interferon alpha" "hydroxycarbamide"
11 Q0 25621091 677 14.134376 imi_mug_run_2_treatment "antihistamines" "hydroxycarbamide" "methotrexate"
11 Q0 26710785 678 13.87819 imi_mug_run_2_treatment "level" "aim" "vemurafenib"
11 Q0 24123310 679 13.776332 imi_mug_run_2_treatment "aim"
11 Q0 21713766 680 13.764442 imi_mug_run_2_treatment "ras"
11 Q0 19967449 681 13.718464 imi_mug_run_2_treatment "tma"
11 Q0 25887408 682 13.718464 imi_mug_run_2_treatment "ptc" "ftc"
11 Q0 29084603 683 13.701242 imi_mug_run_2_treatment "drug"
11 Q0 26298629 684 13.692367 imi_mug_run_2_treatment "tyrosine" "new drugs"
11 Q0 21196210 685 13.692367 imi_mug_run_2_treatment "basis"
11 Q0 26536461 686 13.677135 imi_mug_run_2_treatment "drug" "mta" "mediated"
11 Q0 27502722 687 13.677135 imi_mug_run_2_treatment "pmp"
11 Q0 28423517 688 13.677135 imi_mug_run_2_treatment "sunitinib" "tyrosine kinase inhibitor"
11 Q0 24335104 689 13.646904 imi_mug_run_2_treatment "various" "bortezomib" "dexamethasone"
11 Q0 24229683 690 13.646904 imi_mug_run_2_treatment "platinum"
11 Q0 23830351 691 13.608135 imi_mug_run_2_treatment "medicine" "tff"
11 Q0 28449808 692 13.34267 imi_mug_run_2_treatment "various"
11 Q0 19304958 693 13.112549 imi_mug_run_2_treatment "ras" "others"
11 Q0 22295151 694 13.088532 imi_mug_run_2_treatment "tcc"
11 Q0 26727948 695 13.088532 imi_mug_run_2_treatment "therapeutics"
11 Q0 30173533 696 13.088532 imi_mug_run_2_treatment "sts" "combinations" "viral vaccines"
11 Q0 22400079 697 13.0753355 imi_mug_run_2_treatment "allogeneic"
11 Q0 30470871 698 13.067408 imi_mug_run_2_treatment "level"
11 Q0 23696938 699 12.845025 imi_mug_run_2_treatment "pmp" "surfactant" "cdx"
11 Q0 29945573 700 12.562328 imi_mug_run_2_treatment "lead" "hot spot"
11 Q0 27639803 701 12.497423 imi_mug_run_2_treatment "drugs" "therapeutic agents"
11 Q0 25398061 702 12.30274 imi_mug_run_2_treatment "corticosteroids" "duration"
11 Q0 27662660 703 12.104113 imi_mug_run_2_treatment "liver"
11 Q0 30107230 704 12.104113 imi_mug_run_2_treatment "hub" "ppi" "tac"
11 Q0 14655756 705 12.090689 imi_mug_run_2_treatment "inositol" "level"
11 Q0 25861023 706 12.090689 imi_mug_run_2_treatment "favor" "duration" "aim"
11 Q0 25754088 707 12.090689 imi_mug_run_2_treatment "program" "suppressor"
11 Q0 25070369 708 12.02111 imi_mug_run_2_treatment "enzymes" "insulin"
11 Q0 19860179 709 12.02111 imi_mug_run_2_treatment "p23"
11 Q0 27255222 710 12.02111 imi_mug_run_2_treatment "erlotinib" "tyrosine kinase inhibitor"
11 Q0 28657476 711 12.02111 imi_mug_run_2_treatment "aim"
11 Q0 19140237 712 11.99697 imi_mug_run_2_treatment "aim"
11 Q0 25026175 713 11.99697 imi_mug_run_2_treatment "formalin"
11 Q0 22821383 714 11.99697 imi_mug_run_2_treatment "program"
11 Q0 28401334 715 11.99697 imi_mug_run_2_treatment "various"
11 Q0 27538133 716 11.982479 imi_mug_run_2_treatment "sunitinib"
11 Q0 25978031 717 11.981403 imi_mug_run_2_treatment "gefitinib" "drug" "drugs"
11 Q0 26626801 718 11.981403 imi_mug_run_2_treatment "aim"
11 Q0 25736685 719 11.981403 imi_mug_run_2_treatment "cytostatic" "mek inhibitor"
11 Q0 22661233 720 11.981403 imi_mug_run_2_treatment "mediated"
11 Q0 20068183 721 11.981403 imi_mug_run_2_treatment "basis"
11 Q0 20197733 722 11.981403 imi_mug_run_2_treatment "imatinib" "imatinib mesylate"
11 Q0 28501860 723 11.981403 imi_mug_run_2_treatment "cytotoxic" "imatinib"
11 Q0 11351043 724 11.973316 imi_mug_run_2_treatment "various" "level"
11 Q0 16166280 725 11.973316 imi_mug_run_2_treatment "lead"
11 Q0 26945107 726 11.973316 imi_mug_run_2_treatment "pdgf-bb" "platelet-derived growth factor-bb"
11 Q0 28133136 727 11.973316 imi_mug_run_2_treatment "cetuximab"
11 Q0 10761702 728 11.950262 imi_mug_run_2_treatment "level"
11 Q0 19861461 729 11.950262 imi_mug_run_2_treatment "adjuvant" "temozolomide"
11 Q0 19965620 730 11.950262 imi_mug_run_2_treatment "cytotoxic" "imatinib"
11 Q0 28359267 731 11.950262 imi_mug_run_2_treatment "level"
11 Q0 30302546 732 11.950262 imi_mug_run_2_treatment "aim"
11 Q0 29263494 733 11.93067 imi_mug_run_2_treatment "sunitinib"
11 Q0 25943888 734 11.29771 imi_mug_run_2_treatment "therapeutics"
11 Q0 28069272 735 11.244803 imi_mug_run_2_treatment "aim"
11 Q0 21160925 736 10.463445 imi_mug_run_2_treatment "basis"
11 Q0 19857474 737 10.463445 imi_mug_run_2_treatment "various"
11 Q0 26884818 738 10.463445 imi_mug_run_2_treatment "estrogen" "progesterone" "level"
11 Q0 29465505 739 10.463445 imi_mug_run_2_treatment "various"
11 Q0 29668342 740 10.463445 imi_mug_run_2_treatment "medicine" "plasma"
11 Q0 21429632 741 10.428766 imi_mug_run_2_treatment "growth inhibitor" "level" "others"
11 Q0 27220763 742 10.428766 imi_mug_run_2_treatment "mbc"
11 Q0 30085274 743 10.421768 imi_mug_run_2_treatment "ras" "mek inhibitor"
11 Q0 30067438 744 10.421768 imi_mug_run_2_treatment "mbc" "anti-inflammatory"
11 Q0 16787167 745 10.401583 imi_mug_run_2_treatment "cytokines" "epidermal growth factor" "tgfbeta1"
11 Q0 23529017 746 10.401583 imi_mug_run_2_treatment "mediated" "epidermal growth factor" "liver"
11 Q0 26769141 747 10.401583 imi_mug_run_2_treatment "bisulfite" "suppressor"
11 Q0 20300772 748 10.157967 imi_mug_run_2_treatment "folliculin"
11 Q0 25716962 749 8.67037 imi_mug_run_2_treatment "tumor necrosis factor-beta" "aim"
11 Q0 21084243 750 8.67037 imi_mug_run_2_treatment "abc"
12 Q0 25028698 1 96.372406 imi_mug_run_2_treatment "crizotinib" "kinase inhibitor"
12 Q0 12661011 2 92.37466 imi_mug_run_2_treatment "tpm"
12 Q0 28787324 3 83.78117 imi_mug_run_2_treatment "crizotinib"
12 Q0 28535796 4 78.46637 imi_mug_run_2_treatment "crizotinib"
12 Q0 29925295 5 76.09593 imi_mug_run_2_treatment "crizotinib"
12 Q0 20979472 6 72.8649 imi_mug_run_2_treatment "crizotinib" "mediated" "others"
12 Q0 28504207 7 71.992325 imi_mug_run_2_treatment "therapeutics"
12 Q0 18701132 8 71.86958 imi_mug_run_2_treatment "liver"
12 Q0 25682942 9 71.483444 imi_mug_run_2_treatment "therapeutics"
12 Q0 12787312 10 71.01137 imi_mug_run_2_treatment "various"
12 Q0 30015720 11 66.70781 imi_mug_run_2_treatment "aim"
12 Q0 28977547 12 66.394806 imi_mug_run_2_treatment "alectinib"
12 Q0 16161041 13 65.7473 imi_mug_run_2_treatment "various" "product"
12 Q0 10934142 14 65.39925 imi_mug_run_2_treatment "tpm"
12 Q0 29336647 15 64.97002 imi_mug_run_2_treatment "tyrosine kinase inhibitor"
12 Q0 21164297 16 64.73324 imi_mug_run_2_treatment "liver"
12 Q0 24034896 17 64.45384 imi_mug_run_2_treatment "ras"
12 Q0 13679433 18 64.07642 imi_mug_run_2_treatment "level"
12 Q0 28415158 19 63.63875 imi_mug_run_2_treatment "various" "liver"
12 Q0 25208985 20 63.364445 imi_mug_run_2_treatment "various"
12 Q0 28409069 21 63.149208 imi_mug_run_2_treatment "crizotinib"
12 Q0 29268561 22 62.81556 imi_mug_run_2_treatment "drug"
12 Q0 21030459 23 62.360397 imi_mug_run_2_treatment "kinase inhibitor" "crizotinib" "mediated"
12 Q0 27721769 24 61.822983 imi_mug_run_2_treatment "vascular endothelial growth factor"
12 Q0 17090200 25 61.35739 imi_mug_run_2_treatment "liver"
12 Q0 12112524 26 61.260193 imi_mug_run_2_treatment "product"
12 Q0 24583837 27 60.942257 imi_mug_run_2_treatment "crizotinib" "liver"
12 Q0 30449794 28 60.04934 imi_mug_run_2_treatment "crizotinib"
12 Q0 28705706 29 59.549583 imi_mug_run_2_treatment "favoring"
12 Q0 16831032 30 59.331825 imi_mug_run_2_treatment "p23" "zonal"
12 Q0 21430068 31 59.27135 imi_mug_run_2_treatment "various" "crizotinib"
12 Q0 23345154 32 59.08241 imi_mug_run_2_treatment "shape"
12 Q0 27155927 33 58.8079 imi_mug_run_2_treatment "allogeneic"
12 Q0 27846861 34 58.664543 imi_mug_run_2_treatment "various"
12 Q0 25045570 35 58.560703 imi_mug_run_2_treatment "liver" "crizotinib"
12 Q0 22658521 36 58.015007 imi_mug_run_2_treatment "glycine"
12 Q0 28490045 37 57.94776 imi_mug_run_2_treatment "aim"
12 Q0 19680189 38 57.210747 imi_mug_run_2_treatment "various" "adjuvant"
12 Q0 26793530 39 56.77546 imi_mug_run_2_treatment "basis"
12 Q0 26647767 40 56.08642 imi_mug_run_2_treatment "aim"
12 Q0 16623783 41 56.00604 imi_mug_run_2_treatment "aim" "others"
12 Q0 20730898 42 55.837425 imi_mug_run_2_treatment "liver"
12 Q0 20857269 43 55.58412 imi_mug_run_2_treatment "various" "duration"
12 Q0 21918650 44 55.431625 imi_mug_run_2_treatment "favor"
12 Q0 22664824 45 55.18225 imi_mug_run_2_treatment "crizotinib" "drugs"
12 Q0 29872693 46 55.058556 imi_mug_run_2_treatment "crizotinib" "kinase inhibitor" "ceritinib"
12 Q0 25731575 47 54.75547 imi_mug_run_2_treatment "various"
12 Q0 26178751 48 54.64338 imi_mug_run_2_treatment "shape"
12 Q0 17643094 49 54.60527 imi_mug_run_2_treatment "collagen"
12 Q0 24100523 50 54.54235 imi_mug_run_2_treatment "eosin" "aim"
12 Q0 29758320 51 54.390984 imi_mug_run_2_treatment "various" "crizotinib"
12 Q0 26823889 52 54.295578 imi_mug_run_2_treatment "crizotinib" "shape"
12 Q0 26062823 53 54.171753 imi_mug_run_2_treatment "pazopanib" "crizotinib" "vegf inhibitor"
12 Q0 20450762 54 54.09798 imi_mug_run_2_treatment "shape"
12 Q0 29739898 55 53.89989 imi_mug_run_2_treatment "therapeutics"
12 Q0 26356188 56 53.852066 imi_mug_run_2_treatment "liver"
12 Q0 20058697 57 53.657158 imi_mug_run_2_treatment "drug" "cisplatin" "etoposide"
12 Q0 27259007 58 53.392883 imi_mug_run_2_treatment "various" "tyrosine"
12 Q0 24875859 59 53.35537 imi_mug_run_2_treatment "crizotinib"
12 Q0 25744866 60 53.315727 imi_mug_run_2_treatment "crizotinib"
12 Q0 25628846 61 52.16194 imi_mug_run_2_treatment "human chorionic gonadotropin"
12 Q0 28713152 62 51.857468 imi_mug_run_2_treatment "drug"
12 Q0 19718789 63 51.556465 imi_mug_run_2_treatment "various" "liver"
12 Q0 11406658 64 51.12576 imi_mug_run_2_treatment "formalin" "monoclonal antibodies"
12 Q0 27565932 65 51.11552 imi_mug_run_2_treatment "ceritinib"
12 Q0 27742657 66 50.722115 imi_mug_run_2_treatment "crizotinib" "ceritinib"
12 Q0 26469330 67 50.58069 imi_mug_run_2_treatment "various" "basis"
12 Q0 23761833 68 50.08551 imi_mug_run_2_treatment "nsaid" "various" "corticosteroids"
12 Q0 25624890 69 49.951866 imi_mug_run_2_treatment "biotin"
12 Q0 11284039 70 49.884655 imi_mug_run_2_treatment "prenatal"
12 Q0 24602144 71 49.704365 imi_mug_run_2_treatment "level"
12 Q0 29617048 72 49.43474 imi_mug_run_2_treatment "aim"
12 Q0 26076149 73 49.358227 imi_mug_run_2_treatment "liver"
12 Q0 16651537 74 49.110733 imi_mug_run_2_treatment "p23"
12 Q0 25766836 75 48.90411 imi_mug_run_2_treatment "crizotinib" "level"
12 Q0 12218210 76 48.289165 imi_mug_run_2_treatment "formalin"
12 Q0 21459633 77 47.88769 imi_mug_run_2_treatment "aim"
12 Q0 17938159 78 47.785805 imi_mug_run_2_treatment "generic"
12 Q0 15897859 79 47.77939 imi_mug_run_2_treatment "various"
12 Q0 17660712 80 47.770226 imi_mug_run_2_treatment "tyrosine kinase inhibitor"
12 Q0 25596129 81 47.678413 imi_mug_run_2_treatment "various"
12 Q0 25763286 82 46.654053 imi_mug_run_2_treatment "zonal"
12 Q0 19787794 83 46.466305 imi_mug_run_2_treatment "plasma"
12 Q0 22353270 84 46.429882 imi_mug_run_2_treatment "lead"
12 Q0 16226988 85 46.17771 imi_mug_run_2_treatment "formalin"
12 Q0 26808369 86 46.08478 imi_mug_run_2_treatment "crizotinib"
12 Q0 24715763 87 45.87951 imi_mug_run_2_treatment "tyrosine" "crizotinib"
12 Q0 11395553 88 45.786156 imi_mug_run_2_treatment "aim" "liver" "genesis"
12 Q0 11280613 89 45.45543 imi_mug_run_2_treatment "genesis" "liver" "nervous system"
12 Q0 29805657 90 45.328552 imi_mug_run_2_treatment "blockade"
12 Q0 23239810 91 45.12716 imi_mug_run_2_treatment "crizotinib" "egfr inhibitor"
12 Q0 22920921 92 45.105988 imi_mug_run_2_treatment "crizotinib"
12 Q0 29871358 93 44.939552 imi_mug_run_2_treatment "others"
12 Q0 25979929 94 44.796333 imi_mug_run_2_treatment "medicine" "crizotinib" "others"
12 Q0 21669196 95 44.425194 imi_mug_run_2_treatment "iga"
12 Q0 22614325 96 44.34619 imi_mug_run_2_treatment "various" "crizotinib"
12 Q0 22852078 97 44.28666 imi_mug_run_2_treatment "tyrosine"
12 Q0 16160478 98 44.201027 imi_mug_run_2_treatment "various"
12 Q0 26477709 99 44.093346 imi_mug_run_2_treatment "liver"
12 Q0 28731868 100 44.035686 imi_mug_run_2_treatment "eosin" "crizotinib"
12 Q0 23927068 101 44.004997 imi_mug_run_2_treatment "lead" "level"
12 Q0 29888269 102 43.557358 imi_mug_run_2_treatment "shape"
12 Q0 26276782 103 43.367138 imi_mug_run_2_treatment "various"
12 Q0 15095281 104 43.262413 imi_mug_run_2_treatment "mediated"
12 Q0 11561161 105 42.83441 imi_mug_run_2_treatment "nervous system"
12 Q0 26100036 106 42.761444 imi_mug_run_2_treatment "prompt" "aim" "others"
12 Q0 23350604 107 42.585625 imi_mug_run_2_treatment "aim" "lead"
12 Q0 11172201 108 42.207108 imi_mug_run_2_treatment "biotin"
12 Q0 26191301 109 42.186947 imi_mug_run_2_treatment "prompt"
12 Q0 17694547 110 41.75795 imi_mug_run_2_treatment "genesis" "pleiotrophin" "prompt"
12 Q0 27013922 111 41.642555 imi_mug_run_2_treatment "rms"
12 Q0 22808292 112 41.53302 imi_mug_run_2_treatment "medicine"
12 Q0 12232572 113 41.490135 imi_mug_run_2_treatment "collagen"
12 Q0 22034911 114 41.47987 imi_mug_run_2_treatment "crizotinib" "crizotinib's"
12 Q0 12920229 115 41.22549 imi_mug_run_2_treatment "basis" "liver"
12 Q0 16451066 116 40.881935 imi_mug_run_2_treatment "pyridone"
12 Q0 19052027 117 40.716297 imi_mug_run_2_treatment "pmp"
12 Q0 29081033 118 40.647354 imi_mug_run_2_treatment "sts" "crizotinib"
12 Q0 29877921 119 40.621487 imi_mug_run_2_treatment "color"
12 Q0 30116888 120 40.486115 imi_mug_run_2_treatment "medicine" "level"
12 Q0 22998583 121 40.465794 imi_mug_run_2_treatment "drugs" "aim"
12 Q0 15330992 122 40.36687 imi_mug_run_2_treatment "various" "collagen"
12 Q0 15991185 123 40.16941 imi_mug_run_2_treatment "anti-inflammatory" "nonsteroidal anti-inflammatory drug" "nonsteroidal anti-inflammatory drugs"
12 Q0 29876333 124 39.99279 imi_mug_run_2_treatment "celecoxib"
12 Q0 23201355 125 39.96952 imi_mug_run_2_treatment "various" "crizotinib" "drugs"
12 Q0 29097878 126 39.83186 imi_mug_run_2_treatment "liver"
12 Q0 21076462 127 39.770027 imi_mug_run_2_treatment "prompt"
12 Q0 22084642 128 39.748318 imi_mug_run_2_treatment "crizotinib" "tyrosine" "mediated"
12 Q0 21288922 129 39.54975 imi_mug_run_2_treatment "tyrosine" "mediated" "crizotinib"
12 Q0 24814936 130 39.52259 imi_mug_run_2_treatment "allogeneic"
12 Q0 25120743 131 39.449028 imi_mug_run_2_treatment "aim"
12 Q0 24943745 132 39.342377 imi_mug_run_2_treatment "eosin" "aim"
12 Q0 27271275 133 38.971275 imi_mug_run_2_treatment "various"
12 Q0 25795305 134 38.776363 imi_mug_run_2_treatment "aim" "crizotinib"
12 Q0 25683346 135 38.661537 imi_mug_run_2_treatment "various"
12 Q0 29455642 136 38.639137 imi_mug_run_2_treatment "crizotinib" "ceritinib" "alectinib"
12 Q0 26020125 137 38.361816 imi_mug_run_2_treatment "ceritinib" "alectinib" "crizotinib"
12 Q0 20961208 138 38.279552 imi_mug_run_2_treatment "drugs" "therapeutic agents" "pace"
12 Q0 28787259 139 38.235863 imi_mug_run_2_treatment "crizotinib" "drug"
12 Q0 24736082 140 37.951916 imi_mug_run_2_treatment "p23"
12 Q0 26998073 141 37.7225 imi_mug_run_2_treatment "anti-inflammatory"
12 Q0 12917640 142 37.691383 imi_mug_run_2_treatment "product"
12 Q0 27450657 143 37.548096 imi_mug_run_2_treatment "basis"
12 Q0 22536569 144 37.488464 imi_mug_run_2_treatment "crizotinib"
12 Q0 24496003 145 37.43265 imi_mug_run_2_treatment "crizotinib" "pdx" "aim"
12 Q0 17611412 146 37.195 imi_mug_run_2_treatment "lead" "nervous system" "level"
12 Q0 22912387 147 37.073254 imi_mug_run_2_treatment "cytotoxic" "duration" "crizotinib"
12 Q0 19737969 148 37.022827 imi_mug_run_2_treatment "mediated"
12 Q0 23719267 149 36.98875 imi_mug_run_2_treatment "lead" "crizotinib"
12 Q0 19383809 150 36.65765 imi_mug_run_2_treatment "dextran"
12 Q0 30168888 151 36.61889 imi_mug_run_2_treatment "tma"
12 Q0 27141355 152 36.265488 imi_mug_run_2_treatment "crizotinib"
12 Q0 24388371 153 35.790146 imi_mug_run_2_treatment "basis"
12 Q0 10552961 154 35.561527 imi_mug_run_2_treatment "product"
12 Q0 22252991 155 35.509056 imi_mug_run_2_treatment "drugs"
12 Q0 14692518 156 35.354176 imi_mug_run_2_treatment "nervous system" "cytotoxic"
12 Q0 19275511 157 35.346504 imi_mug_run_2_treatment "pleiotrophin" "genesis"
12 Q0 29290262 158 35.274563 imi_mug_run_2_treatment "crizotinib" "product" "ceritinib"
12 Q0 28884746 159 35.20813 imi_mug_run_2_treatment "level"
12 Q0 15887977 160 35.17329 imi_mug_run_2_treatment "aim"
12 Q0 27052813 161 35.149696 imi_mug_run_2_treatment "azathioprine" "cyclophosphamide"
12 Q0 29747676 162 35.05556 imi_mug_run_2_treatment "melan a"
12 Q0 26590817 163 35.01502 imi_mug_run_2_treatment "various"
12 Q0 26295973 164 34.98685 imi_mug_run_2_treatment "glutamine" "phosphate" "crizotinib"
12 Q0 15188137 165 34.54922 imi_mug_run_2_treatment "various" "level"
12 Q0 23999969 166 34.52788 imi_mug_run_2_treatment "various" "lead" "level"
12 Q0 23301645 167 34.48117 imi_mug_run_2_treatment "various" "crizotinib" "mediated"
12 Q0 22655265 168 34.19635 imi_mug_run_2_treatment "drug"
12 Q0 23876410 169 34.13671 imi_mug_run_2_treatment "aim"
12 Q0 29327718 170 34.052704 imi_mug_run_2_treatment "others"
12 Q0 18320074 171 33.935932 imi_mug_run_2_treatment "level"
12 Q0 27926526 172 33.86416 imi_mug_run_2_treatment "plasma" "crizotinib"
12 Q0 12816858 173 33.845577 imi_mug_run_2_treatment "immunoglobulin a" "level"
12 Q0 19322071 174 33.82215 imi_mug_run_2_treatment "pio" "program"
12 Q0 27836576 175 33.75694 imi_mug_run_2_treatment "crizotinib" "tamoxifen" "protein c gene"
12 Q0 11395396 176 33.750473 imi_mug_run_2_treatment "level"
12 Q0 30518629 177 33.703197 imi_mug_run_2_treatment "kinase inhibitor" "lorlatinib"
12 Q0 24942490 178 33.629734 imi_mug_run_2_treatment "aim"
12 Q0 27469327 179 33.615345 imi_mug_run_2_treatment "p23" "crizotinib"
12 Q0 23598171 180 33.604927 imi_mug_run_2_treatment "crizotinib" "various"
12 Q0 19170230 181 33.508804 imi_mug_run_2_treatment "various" "p23" "others"
12 Q0 26973203 182 33.412167 imi_mug_run_2_treatment "crizotinib" "ci 4" "aim"
12 Q0 20979473 183 33.406734 imi_mug_run_2_treatment "others"
12 Q0 21258415 184 33.041466 imi_mug_run_2_treatment "ipi-504" "agent"
12 Q0 30010043 185 32.750618 imi_mug_run_2_treatment "crizotinib" "tyrosine kinase inhibitor"
12 Q0 24899136 186 32.7238 imi_mug_run_2_treatment "air"
12 Q0 28806414 187 32.65413 imi_mug_run_2_treatment "vitamin e" "tocopherol" "crizotinib"
12 Q0 23443800 188 32.488083 imi_mug_run_2_treatment "pf02341066" "crizotinib" "radiation sensitizer"
12 Q0 30274779 189 32.44411 imi_mug_run_2_treatment "protac" "ceritinib"
12 Q0 22791881 190 32.3836 imi_mug_run_2_treatment "e10a"
12 Q0 30236141 191 32.33617 imi_mug_run_2_treatment "plasma"
12 Q0 26848800 192 32.336143 imi_mug_run_2_treatment "sunitinib"
12 Q0 26901483 193 32.298363 imi_mug_run_2_treatment "ras"
12 Q0 22249260 194 32.187416 imi_mug_run_2_treatment "agar" "mediated"
12 Q0 21656749 195 32.15843 imi_mug_run_2_treatment "various"
12 Q0 26867942 196 32.112106 imi_mug_run_2_treatment "adjuvant"
12 Q0 26468446 197 32.081078 imi_mug_run_2_treatment "drug" "crizotinib" "drugs"
12 Q0 24750504 198 31.983694 imi_mug_run_2_treatment "crizotinib"
12 Q0 25170107 199 31.819668 imi_mug_run_2_treatment "abc" "crizotinib" "ceritinib"
12 Q0 26813592 200 31.74086 imi_mug_run_2_treatment "crizotinib" "aim"
12 Q0 26805736 201 31.72026 imi_mug_run_2_treatment "ras" "basis" "aim"
12 Q0 18394993 202 31.695187 imi_mug_run_2_treatment "topo" "mediated" "animals"
12 Q0 30125543 203 31.693335 imi_mug_run_2_treatment "various" "thyroglobulin" "goitrogen"
12 Q0 23246132 204 31.654932 imi_mug_run_2_treatment "crizotinib"
12 Q0 28185914 205 31.48185 imi_mug_run_2_treatment "lead"
12 Q0 24475247 206 31.478575 imi_mug_run_2_treatment "experimental drug" "crizotinib"
12 Q0 29957732 207 31.346062 imi_mug_run_2_treatment "aim"
12 Q0 23951022 208 31.316631 imi_mug_run_2_treatment "product" "tyrosine kinase inhibitor" "crizotinib"
12 Q0 22483782 209 31.31646 imi_mug_run_2_treatment "level"
12 Q0 26438251 210 31.315147 imi_mug_run_2_treatment "various" "crizotinib"
12 Q0 27496196 211 31.282825 imi_mug_run_2_treatment "crizotinib" "her-2" "tyrosine kinase inhibitor"
12 Q0 24947326 212 31.17011 imi_mug_run_2_treatment "various" "tamoxifen" "crest"
12 Q0 23669222 213 31.162706 imi_mug_run_2_treatment "crizotinib"
12 Q0 24613930 214 31.094936 imi_mug_run_2_treatment "thyroid-stimulating hormone" "crizotinib"
12 Q0 26993609 215 30.95303 imi_mug_run_2_treatment "crizotinib"
12 Q0 29046432 216 30.93712 imi_mug_run_2_treatment "interferon" "mediated" "therapeutics"
12 Q0 27803410 217 30.863756 imi_mug_run_2_treatment "crizotinib"
12 Q0 26517679 218 30.84091 imi_mug_run_2_treatment "crizotinib" "agent"
12 Q0 26018086 219 30.80476 imi_mug_run_2_treatment "drug" "crizotinib" "ceritinib"
12 Q0 30150445 220 30.802774 imi_mug_run_2_treatment "alectinib"
12 Q0 19656549 221 30.782719 imi_mug_run_2_treatment "corticosteroid" "eosin" "aim"
12 Q0 23625156 222 30.76207 imi_mug_run_2_treatment "adc"
12 Q0 24476492 223 30.751354 imi_mug_run_2_treatment "crizotinib" "therapeutics" "pace"
12 Q0 23696342 224 30.751354 imi_mug_run_2_treatment "various" "drug" "mediators"
12 Q0 28449809 225 30.618706 imi_mug_run_2_treatment "medicine" "crizotinib"
12 Q0 24887559 226 30.617514 imi_mug_run_2_treatment "crizotinib" "alectinib" "ch5424802"
12 Q0 11877285 227 30.616016 imi_mug_run_2_treatment "interferon-gamma" "mediated" "cytotoxic"
12 Q0 20393185 228 30.59925 imi_mug_run_2_treatment "tyrosine"
12 Q0 29373100 229 30.556702 imi_mug_run_2_treatment "lorlatinib"
12 Q0 19286999 230 30.519526 imi_mug_run_2_treatment "suppressor"
12 Q0 18685609 231 30.434635 imi_mug_run_2_treatment "dex" "dexamethasone" "product"
12 Q0 21245935 232 30.385544 imi_mug_run_2_treatment "ras"
12 Q0 19064915 233 30.356066 imi_mug_run_2_treatment "animals"
12 Q0 30225407 234 30.34296 imi_mug_run_2_treatment "crizotinib" "kinase inhibitor" "plasma"
12 Q0 29669701 235 30.30526 imi_mug_run_2_treatment "drug" "crizotinib" "tyrosine kinase inhibitor"
12 Q0 24935562 236 30.215206 imi_mug_run_2_treatment "level"
12 Q0 15921012 237 30.208227 imi_mug_run_2_treatment "iga" "proteinase"
12 Q0 29352732 238 30.160168 imi_mug_run_2_treatment "crizotinib" "crizotinib 250 mg"
12 Q0 22743654 239 30.14713 imi_mug_run_2_treatment "various" "crizotinib"
12 Q0 25921060 240 30.108444 imi_mug_run_2_treatment "interferon"
12 Q0 26347798 241 30.089296 imi_mug_run_2_treatment "level" "serine"
12 Q0 21715655 242 30.079334 imi_mug_run_2_treatment "cytokines"
12 Q0 12937132 243 30.071241 imi_mug_run_2_treatment "p23" "agent" "color"
12 Q0 23889739 244 29.953028 imi_mug_run_2_treatment "level"
12 Q0 25144242 245 29.952059 imi_mug_run_2_treatment "alectinib" "ch5424802" "mediated"
12 Q0 29079636 246 29.925068 imi_mug_run_2_treatment "crizotinib" "alectinib"
12 Q0 28368455 247 29.81838 imi_mug_run_2_treatment "plasma" "medicine" "entrectinib"
12 Q0 20179225 248 29.81506 imi_mug_run_2_treatment "level" "monoclonal antibodies"
12 Q0 20952506 249 29.781214 imi_mug_run_2_treatment "kinase inhibitor" "carboplatin" "paclitaxel"
12 Q0 22235099 250 29.627415 imi_mug_run_2_treatment "crizotinib"
12 Q0 18845790 251 29.621857 imi_mug_run_2_treatment "enzymes" "mediated" "methotrexate"
12 Q0 26172300 252 29.617323 imi_mug_run_2_treatment "crizotinib" "entrectinib"
12 Q0 27769042 253 29.552456 imi_mug_run_2_treatment "various" "crizotinib"
12 Q0 21519259 254 29.433342 imi_mug_run_2_treatment "combinations" "drugs" "agent"
12 Q0 23484153 255 29.432648 imi_mug_run_2_treatment "aim"
12 Q0 25205428 256 29.371527 imi_mug_run_2_treatment "drug" "crizotinib" "plasma"
12 Q0 23434628 257 29.37064 imi_mug_run_2_treatment "crizotinib" "kinase inhibitor" "duration"
12 Q0 27564104 258 29.332602 imi_mug_run_2_treatment "crizotinib" "plasma" "mediated"
12 Q0 26487585 259 29.30662 imi_mug_run_2_treatment "alectinib" "level"
12 Q0 27565911 260 29.228985 imi_mug_run_2_treatment "mediated" "crizotinib" "ceritinib"
12 Q0 25193384 261 29.215923 imi_mug_run_2_treatment "ras" "bevacizumab"
12 Q0 26715170 262 29.184502 imi_mug_run_2_treatment "melana"
12 Q0 18989780 263 29.12399 imi_mug_run_2_treatment "anti-inflammatory" "dextran sulfate sodium" "messengers"
12 Q0 27009859 264 29.069216 imi_mug_run_2_treatment "new drugs"
12 Q0 29444468 265 28.993427 imi_mug_run_2_treatment "crizotinib" "tocopherol" "vitamin e"
12 Q0 26301689 266 28.91246 imi_mug_run_2_treatment "ras" "duration"
12 Q0 21059859 267 28.888975 imi_mug_run_2_treatment "serine"
12 Q0 30466405 268 28.84688 imi_mug_run_2_treatment "level" "color"
12 Q0 25592111 269 28.845661 imi_mug_run_2_treatment "crizotinib" "tyrosine kinase inhibitor"
12 Q0 29635259 270 28.845186 imi_mug_run_2_treatment "melana"
12 Q0 26933125 271 28.835651 imi_mug_run_2_treatment "ceritinib"
12 Q0 9763551 272 28.809475 imi_mug_run_2_treatment "product"
12 Q0 12213716 273 28.763113 imi_mug_run_2_treatment "coumermycin"
12 Q0 17513510 274 28.702412 imi_mug_run_2_treatment "biotin"
12 Q0 24102046 275 28.661911 imi_mug_run_2_treatment "therapeutics" "pf-02341066" "program"
12 Q0 25806308 276 28.65623 imi_mug_run_2_treatment "crizotinib" "revolution"
12 Q0 24296758 277 28.620468 imi_mug_run_2_treatment "color"
12 Q0 26168728 278 28.62008 imi_mug_run_2_treatment "crizotinib" "various"
12 Q0 20424160 279 28.569061 imi_mug_run_2_treatment "tyr" "tyrosine" "various combinations"
12 Q0 25251827 280 28.559635 imi_mug_run_2_treatment "clb"
12 Q0 16469875 281 28.518639 imi_mug_run_2_treatment "level"
12 Q0 27354483 282 28.450872 imi_mug_run_2_treatment "crizotinib" "kinase inhibitor" "duration"
12 Q0 26654768 283 28.378857 imi_mug_run_2_treatment "ras"
12 Q0 29209562 284 28.314428 imi_mug_run_2_treatment "vaccine" "anti-inflammatory" "collagen"
12 Q0 24346090 285 28.282143 imi_mug_run_2_treatment "level"
12 Q0 20009909 286 28.255762 imi_mug_run_2_treatment "pf02341066"
12 Q0 27045755 287 28.187849 imi_mug_run_2_treatment "crizotinib" "product"
12 Q0 27565908 288 28.171982 imi_mug_run_2_treatment "crizotinib" "kinase inhibitor"
12 Q0 27613526 289 28.13998 imi_mug_run_2_treatment "pdx" "crizotinib" "product"
12 Q0 26888425 290 28.119556 imi_mug_run_2_treatment "aim" "crizotinib"
12 Q0 26849637 291 28.09488 imi_mug_run_2_treatment "various" "crizotinib" "alectinib"
12 Q0 28601386 292 28.034176 imi_mug_run_2_treatment "crizotinib" "plasma"
12 Q0 29775614 293 28.028505 imi_mug_run_2_treatment "level"
12 Q0 25581823 294 27.97247 imi_mug_run_2_treatment "various" "crizotinib" "alectinib"
12 Q0 25653133 295 27.969482 imi_mug_run_2_treatment "crizotinib" "plasma"
12 Q0 21471522 296 27.939917 imi_mug_run_2_treatment "pf-2341066" "blockade"
12 Q0 25197351 297 27.931517 imi_mug_run_2_treatment "cytokines" "interleukin-2"
12 Q0 19393833 298 27.899443 imi_mug_run_2_treatment "immunosuppressive" "cytokines" "il-10"
12 Q0 10942417 299 27.845814 imi_mug_run_2_treatment "plasma"
12 Q0 16189272 300 27.845814 imi_mug_run_2_treatment "mediated"
12 Q0 28189201 301 27.789848 imi_mug_run_2_treatment "crizotinib"
12 Q0 30350109 302 27.780613 imi_mug_run_2_treatment "various" "crizotinib" "others"
12 Q0 18394551 303 27.694744 imi_mug_run_2_treatment "lead"
12 Q0 29642597 304 27.68246 imi_mug_run_2_treatment "others" "plasma"
12 Q0 24667260 305 27.572914 imi_mug_run_2_treatment "aim"
12 Q0 26416997 306 27.569677 imi_mug_run_2_treatment "various"
12 Q0 24742568 307 27.568226 imi_mug_run_2_treatment "adc"
12 Q0 18322000 308 27.486366 imi_mug_run_2_treatment "anti-inflammatory" "il-12" "interleukin"
12 Q0 28174489 309 27.437195 imi_mug_run_2_treatment "crizotinib"
12 Q0 23743932 310 27.361568 imi_mug_run_2_treatment "basis"
12 Q0 29376144 311 27.344467 imi_mug_run_2_treatment "plasma" "mediators" "lorlatinib"
12 Q0 27137772 312 27.332756 imi_mug_run_2_treatment "crizotinib" "others"
12 Q0 27245569 313 27.316826 imi_mug_run_2_treatment "crizotinib" "drug" "duration"
12 Q0 26622190 314 27.301779 imi_mug_run_2_treatment "crizotinib" "drug" "ceritinib"
12 Q0 24717232 315 27.196884 imi_mug_run_2_treatment "prompt"
12 Q0 29571990 316 27.177912 imi_mug_run_2_treatment "crizotinib" "duration" "others"
12 Q0 23904459 317 27.138544 imi_mug_run_2_treatment "adc"
12 Q0 29907598 318 27.13591 imi_mug_run_2_treatment "various" "ceritinib" "catecholamine"
12 Q0 23931927 319 27.013132 imi_mug_run_2_treatment "crizotinib"
12 Q0 23669200 320 26.976318 imi_mug_run_2_treatment "basis"
12 Q0 23139213 321 26.91947 imi_mug_run_2_treatment "various" "clb"
12 Q0 9376569 322 26.881971 imi_mug_run_2_treatment "fluorouracil" "mediated" "liver"
12 Q0 24166094 323 26.864912 imi_mug_run_2_treatment "crizotinib"
12 Q0 29930762 324 26.856373 imi_mug_run_2_treatment "drug" "ganetespib" "crizotinib"
12 Q0 26464158 325 26.851095 imi_mug_run_2_treatment "alectinib" "various" "crizotinib"
12 Q0 25950466 326 26.84187 imi_mug_run_2_treatment "various" "cytotoxic" "mediated"
12 Q0 21154129 327 26.814817 imi_mug_run_2_treatment "crizotinib" "drug"
12 Q0 30429055 328 26.81341 imi_mug_run_2_treatment "crizotinib"
12 Q0 22282074 329 26.73988 imi_mug_run_2_treatment "crizotinib"
12 Q0 24255633 330 26.693792 imi_mug_run_2_treatment "color"
12 Q0 26923554 331 26.662258 imi_mug_run_2_treatment "ceritinib" "krca-386" "crizotinib"
12 Q0 9736036 332 26.608942 imi_mug_run_2_treatment "buffer" "ethylenediaminetetraacetic acid"
12 Q0 25017418 333 26.572111 imi_mug_run_2_treatment "tma"
12 Q0 30326973 334 26.521807 imi_mug_run_2_treatment "mtp"
12 Q0 12177545 335 26.507757 imi_mug_run_2_treatment "cytokines" "anti-inflammatory" "il-1ra"
12 Q0 20576349 336 26.505297 imi_mug_run_2_treatment "atra" "trans retinoic acid" "lead"
12 Q0 21921848 337 26.476574 imi_mug_run_2_treatment "color"
12 Q0 28683775 338 26.474451 imi_mug_run_2_treatment "alectinib" "cisplatin" "vinorelbine"
12 Q0 10381534 339 26.452383 imi_mug_run_2_treatment "p23" "product"
12 Q0 28321808 340 26.37637 imi_mug_run_2_treatment "cisplatin" "vinorelbine"
12 Q0 26964870 341 26.328228 imi_mug_run_2_treatment "therapeutic agents" "crizotinib" "asp3026"
12 Q0 16101126 342 26.296024 imi_mug_run_2_treatment "tyrosine kinase inhibitor"
12 Q0 28359267 343 26.296024 imi_mug_run_2_treatment "level"
12 Q0 29637735 344 26.279821 imi_mug_run_2_treatment "various" "alectinib"
12 Q0 28696381 345 26.277645 imi_mug_run_2_treatment "crizotinib"
12 Q0 26964537 346 26.272476 imi_mug_run_2_treatment "eosin"
12 Q0 27554841 347 26.263252 imi_mug_run_2_treatment "crizotinib"
12 Q0 26053561 348 26.237913 imi_mug_run_2_treatment "alemtuzumab" "brentuximab"
12 Q0 23700294 349 26.18573 imi_mug_run_2_treatment "ch5424802" "drug" "af802"
12 Q0 27130468 350 26.147799 imi_mug_run_2_treatment "crizotinib" "alectinib" "ras"
12 Q0 7655001 351 26.125065 imi_mug_run_2_treatment "basis"
12 Q0 26519123 352 26.069204 imi_mug_run_2_treatment "crizotinib" "pemetrexed" "platinum"
12 Q0 20223922 353 26.058857 imi_mug_run_2_treatment "tyrosine"
12 Q0 23267434 354 26.047682 imi_mug_run_2_treatment "pleiotrophin" "nervous system"
12 Q0 21518927 355 26.034883 imi_mug_run_2_treatment "program"
12 Q0 28431340 356 26.029922 imi_mug_run_2_treatment "lorlatinib" "pf-06463922"
12 Q0 26544515 357 25.979523 imi_mug_run_2_treatment "platelets" "crizotinib" "plasma"
12 Q0 29629521 358 25.972801 imi_mug_run_2_treatment "crizotinib" "ceritinib"
12 Q0 21948233 359 25.961468 imi_mug_run_2_treatment "crizotinib" "pf02341066" "duration"
12 Q0 19171422 360 25.95887 imi_mug_run_2_treatment "sage" "tma"
12 Q0 26364603 361 25.94544 imi_mug_run_2_treatment "nh2"
12 Q0 29744229 362 25.94542 imi_mug_run_2_treatment "alectinib"
12 Q0 25733882 363 25.92311 imi_mug_run_2_treatment "crizotinib" "pf-06463922" "pf-02341066"
12 Q0 21062932 364 25.915628 imi_mug_run_2_treatment "basis"
12 Q0 26698910 365 25.901524 imi_mug_run_2_treatment "crizotinib" "lorlatinib" "tyrosine"
12 Q0 18469826 366 25.823492 imi_mug_run_2_treatment "interferon-gamma" "mediated" "dna vaccination"
12 Q0 24736079 367 25.787731 imi_mug_run_2_treatment "crizotinib" "ch5424802" "ro5424802"
12 Q0 23028547 368 25.78151 imi_mug_run_2_treatment "cytokines" "il12"
12 Q0 25828520 369 25.769367 imi_mug_run_2_treatment "vaccines"
12 Q0 29732013 370 25.733414 imi_mug_run_2_treatment "ceritinib" "drugs" "lead"
12 Q0 22743652 371 25.666279 imi_mug_run_2_treatment "crizotinib"
12 Q0 26654422 372 25.65421 imi_mug_run_2_treatment "crizotinib" "ceritinib" "pf-06463922"
12 Q0 26419961 373 25.652763 imi_mug_run_2_treatment "vaccine" "combinations" "immunosuppressive"
12 Q0 29596910 374 25.625443 imi_mug_run_2_treatment "interferon gamma"
12 Q0 21804922 375 25.590437 imi_mug_run_2_treatment "lead" "agonist"
12 Q0 29495603 376 25.587341 imi_mug_run_2_treatment "crizotinib"
12 Q0 22323827 377 25.582369 imi_mug_run_2_treatment "therapeutics" "crizotinib"
12 Q0 26747894 378 25.575802 imi_mug_run_2_treatment "drug" "magic bullet"
12 Q0 26220634 379 25.57055 imi_mug_run_2_treatment "neurolenin b" "dichloromethane"
12 Q0 17922009 380 25.541893 imi_mug_run_2_treatment "dna methyltransferase inhibitor"
12 Q0 12202671 381 25.53378 imi_mug_run_2_treatment "ras" "lead"
12 Q0 26585927 382 25.53086 imi_mug_run_2_treatment "crizotinib"
12 Q0 23386065 383 25.52545 imi_mug_run_2_treatment "drug" "duration" "crizotinib"
12 Q0 27131066 384 25.461954 imi_mug_run_2_treatment "lead" "hot spot"
12 Q0 25312988 385 25.431662 imi_mug_run_2_treatment "prompt"
12 Q0 22042699 386 25.429188 imi_mug_run_2_treatment "mediated" "lead" "blockade"
12 Q0 22414602 387 25.426872 imi_mug_run_2_treatment "suppressor"
12 Q0 21791641 388 25.420061 imi_mug_run_2_treatment "crizotinib" "mediated"
12 Q0 9990069 389 25.375702 imi_mug_run_2_treatment "antiangiogenic" "agent" "animals"
12 Q0 21474455 390 25.3378 imi_mug_run_2_treatment "drugs"
12 Q0 24811913 391 25.32352 imi_mug_run_2_treatment "vandetanib" "crizotinib"
12 Q0 24795343 392 25.321903 imi_mug_run_2_treatment "cytokines" "dodecyl sulfate" "monoclonal antibodies"
12 Q0 24915814 393 25.308691 imi_mug_run_2_treatment "scorpion"
12 Q0 18089725 394 25.2935 imi_mug_run_2_treatment "pf-2341066" "mediated" "mediators"
12 Q0 26312204 395 25.287628 imi_mug_run_2_treatment "tyrosine kinase inhibitor" "crizotinib"
12 Q0 29801706 396 25.286808 imi_mug_run_2_treatment "crizotinib" "therapeutics"
12 Q0 16434370 397 25.271677 imi_mug_run_2_treatment "interferon" "cytotoxic" "cancer vaccination"
12 Q0 28969070 398 25.250729 imi_mug_run_2_treatment "formalin" "monoclonal antibodies"
12 Q0 25989870 399 25.205645 imi_mug_run_2_treatment "liver"
12 Q0 27438512 400 25.199879 imi_mug_run_2_treatment "various"
12 Q0 25351246 401 25.15659 imi_mug_run_2_treatment "crizotinib"
12 Q0 28455243 402 25.12087 imi_mug_run_2_treatment "alectinib" "mediated" "therapeutic agent"
12 Q0 24443522 403 25.096668 imi_mug_run_2_treatment "crizotinib" "egfr tyrosine kinase inhibitors"
12 Q0 20043120 404 25.087524 imi_mug_run_2_treatment "vaccines" "mediated"
12 Q0 24722153 405 25.052517 imi_mug_run_2_treatment "medicine" "basis"
12 Q0 26422230 406 25.04873 imi_mug_run_2_treatment "lead" "aim"
12 Q0 21432020 407 25.008793 imi_mug_run_2_treatment "vaccines" "cancer vaccines"
12 Q0 22705117 408 24.998272 imi_mug_run_2_treatment "gcg"
12 Q0 29400604 409 24.985327 imi_mug_run_2_treatment "lorlatinib" "plasma" "ceritinib"
12 Q0 26554404 410 24.940966 imi_mug_run_2_treatment "crizotinib" "pf-06463922" "agent"
12 Q0 29984766 411 24.911491 imi_mug_run_2_treatment "alectinib"
12 Q0 29723525 412 24.902477 imi_mug_run_2_treatment "mediated" "drugs" "cytokines"
12 Q0 25650807 413 24.882324 imi_mug_run_2_treatment "com"
12 Q0 23714556 414 24.876522 imi_mug_run_2_treatment "drug" "gemcitabine" "paclitaxel"
12 Q0 26775590 415 24.86137 imi_mug_run_2_treatment "crizotinib"
12 Q0 15886631 416 24.83439 imi_mug_run_2_treatment "basis" "allogeneic" "beta-galactosidase"
12 Q0 26751586 417 24.773876 imi_mug_run_2_treatment "alectinib" "agent" "crizotinib"
12 Q0 29374774 418 24.756584 imi_mug_run_2_treatment "various"
12 Q0 29755689 419 24.740446 imi_mug_run_2_treatment "crizotinib"
12 Q0 27507192 420 24.725313 imi_mug_run_2_treatment "ceritinib" "crizotinib"
12 Q0 25228534 421 24.719336 imi_mug_run_2_treatment "ceritinib" "crizotinib" "alectinib"
12 Q0 28285684 422 24.708582 imi_mug_run_2_treatment "crizotinib" "lorlatinib" "ceritinib"
12 Q0 24384233 423 24.688768 imi_mug_run_2_treatment "lymphotoxin" "cytokines"
12 Q0 25652313 424 24.685974 imi_mug_run_2_treatment "mediated" "crest"
12 Q0 23360421 425 24.685974 imi_mug_run_2_treatment "mediated"
12 Q0 28534251 426 24.685602 imi_mug_run_2_treatment "crizotinib" "agent" "others"
12 Q0 16982741 427 24.683537 imi_mug_run_2_treatment "mediated" "level"
12 Q0 26299615 428 24.66863 imi_mug_run_2_treatment "x-396" "various" "combinations"
12 Q0 17332315 429 24.636517 imi_mug_run_2_treatment "interleukin-4"
12 Q0 24940496 430 24.63028 imi_mug_run_2_treatment "crizotinib" "pemetrexed"
12 Q0 21778999 431 24.62355 imi_mug_run_2_treatment "vascular endothelial growth factor" "level"
12 Q0 18451166 432 24.616726 imi_mug_run_2_treatment "various" "lead"
12 Q0 28629361 433 24.54052 imi_mug_run_2_treatment "various" "immunomodulator" "mediated"
12 Q0 27483357 434 24.538383 imi_mug_run_2_treatment "pf-06463922" "crizotinib" "agent"
12 Q0 15790089 435 24.53666 imi_mug_run_2_treatment "nsaids" "nsaid" "anti-inflammatory"
12 Q0 8090750 436 24.516712 imi_mug_run_2_treatment "animals"
12 Q0 20054852 437 24.511288 imi_mug_run_2_treatment "allogeneic"
12 Q0 12016425 438 24.505848 imi_mug_run_2_treatment "interferon gamma" "interferon alpha" "interferon beta-1a"
12 Q0 27240347 439 24.494947 imi_mug_run_2_treatment "various" "cancer vaccines"
12 Q0 29151286 440 24.471443 imi_mug_run_2_treatment "mediated" "liver"
12 Q0 27003761 441 24.470007 imi_mug_run_2_treatment "entrectinib" "tyrosine" "program"
12 Q0 27598116 442 24.45368 imi_mug_run_2_treatment "acetate" "botanical" "interleukin-6"
12 Q0 30233266 443 24.448648 imi_mug_run_2_treatment "alectinib" "brigatinib"
12 Q0 30422774 444 24.425842 imi_mug_run_2_treatment "avid" "air"
12 Q0 25789835 445 24.40971 imi_mug_run_2_treatment "crizotinib"
12 Q0 24419060 446 24.404217 imi_mug_run_2_treatment "crizotinib" "paclitaxel" "pemetrexed"
12 Q0 30214557 447 24.391052 imi_mug_run_2_treatment "alectinib"
12 Q0 22907376 448 24.350943 imi_mug_run_2_treatment "il12" "cytokines"
12 Q0 22622656 449 24.345394 imi_mug_run_2_treatment "polyethylene glycol" "balance"
12 Q0 25312989 450 24.337784 imi_mug_run_2_treatment "egfr inhibitor"
12 Q0 15993950 451 24.3336 imi_mug_run_2_treatment "vaccine" "vaccines" "tumor vaccine"
12 Q0 29569804 452 24.329035 imi_mug_run_2_treatment "mediated"
12 Q0 12691610 453 24.324064 imi_mug_run_2_treatment "drugs"
12 Q0 26454342 454 24.30943 imi_mug_run_2_treatment "crizotinib" "duration"
12 Q0 24058440 455 24.291866 imi_mug_run_2_treatment "vaccines" "cancer vaccines"
12 Q0 28676342 456 24.271862 imi_mug_run_2_treatment "interferon-gamma"
12 Q0 23198539 457 24.24607 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
12 Q0 27401149 458 24.236444 imi_mug_run_2_treatment "aim"
12 Q0 28903995 459 24.234962 imi_mug_run_2_treatment "crizotinib"
12 Q0 24722154 460 24.192091 imi_mug_run_2_treatment "color" "crizotinib"
12 Q0 16434897 461 24.183056 imi_mug_run_2_treatment "various" "granulocytes"
12 Q0 17163160 462 24.182259 imi_mug_run_2_treatment "imatinib" "imatinib mesylate"
12 Q0 28990926 463 24.171139 imi_mug_run_2_treatment "mediated"
12 Q0 12646647 464 24.166233 imi_mug_run_2_treatment "vaccine" "vaccines" "animals"
12 Q0 26603857 465 24.144638 imi_mug_run_2_treatment "crizotinib"
12 Q0 22640922 466 24.117643 imi_mug_run_2_treatment "agonists" "alkaloid" "anti-inflammatory"
12 Q0 19176057 467 24.10292 imi_mug_run_2_treatment "il-3"
12 Q0 16164218 468 24.096283 imi_mug_run_2_treatment "biologics" "infliximab" "etanercept"
12 Q0 24900237 469 24.086662 imi_mug_run_2_treatment "lead"
12 Q0 26850068 470 24.085342 imi_mug_run_2_treatment "erlotinib" "crizotinib" "liver"
12 Q0 28850922 471 24.075119 imi_mug_run_2_treatment "drug" "kinase inhibitor" "compound 18"
12 Q0 25997961 472 24.072485 imi_mug_run_2_treatment "mediated"
12 Q0 23237551 473 24.067268 imi_mug_run_2_treatment "lead"
12 Q0 22365399 474 23.98077 imi_mug_run_2_treatment "tyrosine"
12 Q0 28766541 475 23.978607 imi_mug_run_2_treatment "crizotinib" "drug" "favor"
12 Q0 17213658 476 23.976564 imi_mug_run_2_treatment "interferon-gamma" "vaccine" "mediated"
12 Q0 27662658 477 23.97388 imi_mug_run_2_treatment "temsirolimus" "crizotinib" "drugs"
12 Q0 22334442 478 23.971853 imi_mug_run_2_treatment "various" "suppressor"
12 Q0 26001149 479 23.964394 imi_mug_run_2_treatment "ceritinib" "crizotinib" "nervous system"
12 Q0 21989914 480 23.9605 imi_mug_run_2_treatment "mediated"
12 Q0 23064464 481 23.95411 imi_mug_run_2_treatment "blockade"
12 Q0 25891416 482 23.950903 imi_mug_run_2_treatment "cytotoxic" "mediated" "aim"
12 Q0 9563116 483 23.948391 imi_mug_run_2_treatment "ketorolac" "anti-inflammatory" "nonsteroidal anti-inflammatory drugs"
12 Q0 29190913 484 23.914246 imi_mug_run_2_treatment "vaccine"
12 Q0 30290287 485 23.90918 imi_mug_run_2_treatment "crizotinib" "duration" "palbociclib"
12 Q0 21156280 486 23.906414 imi_mug_run_2_treatment "crizotinib" "medicine"
12 Q0 28385505 487 23.906414 imi_mug_run_2_treatment "imidazole" "diaminopyrimidines" "piperazine"
12 Q0 26667344 488 23.881573 imi_mug_run_2_treatment "crizotinib"
12 Q0 11467623 489 23.870863 imi_mug_run_2_treatment "various" "infliximab" "medications"
12 Q0 28676215 490 23.865522 imi_mug_run_2_treatment "ceritinib" "crizotinib" "alectinib"
12 Q0 25947665 491 23.860569 imi_mug_run_2_treatment "vaccines"
12 Q0 29683819 492 23.787086 imi_mug_run_2_treatment "various"
12 Q0 28103968 493 23.778276 imi_mug_run_2_treatment "aim"
12 Q0 21945349 494 23.770372 imi_mug_run_2_treatment "mediated" "crizotinib"
12 Q0 27430882 495 23.759586 imi_mug_run_2_treatment "plasma"
12 Q0 28415793 496 23.757156 imi_mug_run_2_treatment "therapeutics"
12 Q0 27393517 497 23.737585 imi_mug_run_2_treatment "crizotinib"
12 Q0 29844868 498 23.727386 imi_mug_run_2_treatment "crizotinib" "ceritinib" "alectinib"
12 Q0 18219758 499 23.717783 imi_mug_run_2_treatment "autologous" "vaccine" "cancer vaccines"
12 Q0 25899913 500 23.717775 imi_mug_run_2_treatment "crizotinib" "docetaxel"
12 Q0 8174122 501 23.693624 imi_mug_run_2_treatment "drug" "animals" "mediated"
12 Q0 30090893 502 23.688904 imi_mug_run_2_treatment "il-12" "hyaluronic acid" "anti-inflammatory"
12 Q0 22594847 503 23.682394 imi_mug_run_2_treatment "crizotinib" "product" "tyrosine kinase inhibitor"
12 Q0 29067644 504 23.67568 imi_mug_run_2_treatment "rms" "dasatinib" "kinase inhibitor"
12 Q0 22129595 505 23.660242 imi_mug_run_2_treatment "crizotinib" "plasma"
12 Q0 29130105 506 23.643543 imi_mug_run_2_treatment "hot spot"
12 Q0 17325480 507 23.634361 imi_mug_run_2_treatment "various" "basis"
12 Q0 2462422 508 23.620173 imi_mug_run_2_treatment "anti-inflammatory" "platelets"
12 Q0 28285695 509 23.613556 imi_mug_run_2_treatment "crizotinib" "pemetrexed" "pace"
12 Q0 19177199 510 23.577286 imi_mug_run_2_treatment "pleiotrophin" "various" "mediated"
12 Q0 16287709 511 23.573875 imi_mug_run_2_treatment "cytokines"
12 Q0 23254764 512 23.550957 imi_mug_run_2_treatment "pf-02341066" "crizotinib" "agent"
12 Q0 27413147 513 23.536484 imi_mug_run_2_treatment "cytokines" "drug" "anti-inflammatory"
12 Q0 23449277 514 23.534874 imi_mug_run_2_treatment "aim" "crizotinib"
12 Q0 25349124 515 23.51662 imi_mug_run_2_treatment "oxo" "crizotinib" "pf06463922"
12 Q0 24787965 516 23.499004 imi_mug_run_2_treatment "various" "crizotinib"
12 Q0 21632243 517 23.472929 imi_mug_run_2_treatment "methanesulfonamide" "diaminopyrimidines"
12 Q0 27472693 518 23.468704 imi_mug_run_2_treatment "crizotinib" "agent" "tyrosine kinase inhibitor"
12 Q0 22155737 519 23.448933 imi_mug_run_2_treatment "pf-2341066" "mediated"
12 Q0 11850821 520 23.44106 imi_mug_run_2_treatment "mediated"
12 Q0 29978950 521 23.44106 imi_mug_run_2_treatment "crizotinib"
12 Q0 29436187 522 23.405582 imi_mug_run_2_treatment "pemetrexed"
12 Q0 28147314 523 23.39087 imi_mug_run_2_treatment "various" "cancer drug" "antiangiogenic"
12 Q0 23344087 524 23.376387 imi_mug_run_2_treatment "crizotinib" "duration"
12 Q0 28338501 525 23.366262 imi_mug_run_2_treatment "level"
12 Q0 25797883 526 23.359108 imi_mug_run_2_treatment "calcium" "mediated" "oxygen"
12 Q0 21862980 527 23.33234 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
12 Q0 30008296 528 23.303701 imi_mug_run_2_treatment "pembrolizumab" "alectinib" "cddp"
12 Q0 23328551 529 23.27784 imi_mug_run_2_treatment "crizotinib"
12 Q0 30499816 530 23.210316 imi_mug_run_2_treatment "basis" "crizotinib"
12 Q0 27646667 531 23.189272 imi_mug_run_2_treatment "gemcitabine" "cisplatin" "crizotinib"
12 Q0 20414428 532 23.184086 imi_mug_run_2_treatment "interleukin-4" "vaccine" "interferon-gamma"
12 Q0 23837018 533 23.169422 imi_mug_run_2_treatment "aim"
12 Q0 22394598 534 23.159956 imi_mug_run_2_treatment "mediators" "glycyrrhizin"
12 Q0 29856687 535 23.159073 imi_mug_run_2_treatment "egfr inhibitor" "combinations" "gefitinib"
12 Q0 28607809 536 23.154705 imi_mug_run_2_treatment "crizotinib"
12 Q0 30077013 537 23.154198 imi_mug_run_2_treatment "plasma"
12 Q0 12122009 538 23.14912 imi_mug_run_2_treatment "pleiotrophin" "monoclonal antibodies"
12 Q0 30251885 539 23.147863 imi_mug_run_2_treatment "drugs" "crizotinib" "others"
12 Q0 18648902 540 23.134827 imi_mug_run_2_treatment "various"
12 Q0 22595051 541 23.132614 imi_mug_run_2_treatment "cancer vaccines" "immunosuppressive" "mediated"
12 Q0 23923083 542 23.12484 imi_mug_run_2_treatment "methotrexate"
12 Q0 23543207 543 23.11191 imi_mug_run_2_treatment "ras"
12 Q0 29318404 544 23.099892 imi_mug_run_2_treatment "bevacizumab" "pemetrexed" "tyrosine kinase inhibitor"
12 Q0 25687751 545 23.085524 imi_mug_run_2_treatment "drugs" "biologics" "monoclonal antibodies"
12 Q0 23814019 546 23.05526 imi_mug_run_2_treatment "mediated" "lactate"
12 Q0 16886121 547 23.052084 imi_mug_run_2_treatment "vaccine" "vaccines" "interleukin-4"
12 Q0 12498004 548 23.01321 imi_mug_run_2_treatment "thalidomide" "infliximab" "etanercept"
12 Q0 26829053 549 23.011118 imi_mug_run_2_treatment "crizotinib"
12 Q0 12517951 550 23.003807 imi_mug_run_2_treatment "protein c"
12 Q0 30355843 551 22.990578 imi_mug_run_2_treatment "aim"
12 Q0 24885608 552 22.983103 imi_mug_run_2_treatment "crizotinib" "kinase inhibitor" "ras"
12 Q0 27056568 553 22.98163 imi_mug_run_2_treatment "adc"
12 Q0 16191376 554 22.980042 imi_mug_run_2_treatment "tumor vaccine" "vaccine" "fcm"
12 Q0 27385213 555 22.965693 imi_mug_run_2_treatment "rms" "committed"
12 Q0 17974271 556 22.928812 imi_mug_run_2_treatment "vaccine" "interleukin-4" "polyethylene glycol"
12 Q0 29455675 557 22.926907 imi_mug_run_2_treatment "various" "crizotinib" "aim"
12 Q0 22203728 558 22.921951 imi_mug_run_2_treatment "cep-28122"
12 Q0 26152804 559 22.882736 imi_mug_run_2_treatment "adc" "crizotinib"
12 Q0 18714045 560 22.875023 imi_mug_run_2_treatment "vaccine" "vaccines" "human igm"
12 Q0 22987955 561 22.849731 imi_mug_run_2_treatment "gemcitabine" "sunitinib" "pazopanib"
12 Q0 24618813 562 22.818737 imi_mug_run_2_treatment "cm-118" "blockade" "cm-118's"
12 Q0 27225694 563 22.814276 imi_mug_run_2_treatment "blockade"
12 Q0 24223939 564 22.802128 imi_mug_run_2_treatment "drug" "gonadotrophin"
12 Q0 3356752 565 22.7986 imi_mug_run_2_treatment "ouabain" "drug" "alanosine"
12 Q0 22543535 566 22.796268 imi_mug_run_2_treatment "corticosteroids" "anti-inflammatory" "nonsteroidal anti-inflammatory drug"
12 Q0 24633422 567 22.794662 imi_mug_run_2_treatment "ptc" "therapeutic agents" "crizotinib"
12 Q0 28452858 568 22.772951 imi_mug_run_2_treatment "level"
12 Q0 26338968 569 22.765343 imi_mug_run_2_treatment "crizotinib" "kinase inhibitor" "chloroquine"
12 Q0 23536384 570 22.765343 imi_mug_run_2_treatment "crizotinib"
12 Q0 26536196 571 22.76371 imi_mug_run_2_treatment "crizotinib"
12 Q0 2793245 572 22.762884 imi_mug_run_2_treatment "phosphate"
12 Q0 18537561 573 22.76041 imi_mug_run_2_treatment "therapeutics" "new drugs" "liver"
12 Q0 24712007 574 22.756962 imi_mug_run_2_treatment "sunitinib" "imatinib" "taxanes"
12 Q0 16315876 575 22.754183 imi_mug_run_2_treatment "vaccine"
12 Q0 29654269 576 22.752645 imi_mug_run_2_treatment "ras"
12 Q0 30372870 577 22.744053 imi_mug_run_2_treatment "drugs" "cck-8" "level"
12 Q0 15989471 578 22.736778 imi_mug_run_2_treatment "tnf-alpha" "antitumor antibody" "antineoplastic"
12 Q0 23684749 579 22.732761 imi_mug_run_2_treatment "hot spot"
12 Q0 14656879 580 22.723564 imi_mug_run_2_treatment "mediated"
12 Q0 26045865 581 22.714241 imi_mug_run_2_treatment "crizotinib"
12 Q0 22968692 582 22.696373 imi_mug_run_2_treatment "crizotinib"
12 Q0 20979469 583 22.691912 imi_mug_run_2_treatment "crizotinib" "drug" "others"
12 Q0 25228590 584 22.68821 imi_mug_run_2_treatment "crizotinib" "mtor inhibitor"
12 Q0 25529354 585 22.678246 imi_mug_run_2_treatment "crizotinib"
12 Q0 18447686 586 22.674686 imi_mug_run_2_treatment "level"
12 Q0 25813151 587 22.668337 imi_mug_run_2_treatment "basis" "aim"
12 Q0 26638437 588 22.66334 imi_mug_run_2_treatment "drugs"
12 Q0 17502870 589 22.658682 imi_mug_run_2_treatment "etanercept"
12 Q0 26415994 590 22.646597 imi_mug_run_2_treatment "medicine"
12 Q0 26568007 591 22.622484 imi_mug_run_2_treatment "tyrosine kinase inhibitor" "crizotinib"
12 Q0 28771164 592 22.622484 imi_mug_run_2_treatment "phosphate"
12 Q0 29449735 593 22.622484 imi_mug_run_2_treatment "cisplatin" "pemetrexed" "nivolumab"
12 Q0 26597476 594 22.617207 imi_mug_run_2_treatment "crizotinib" "ceritinib" "sur"
12 Q0 27058664 595 22.588966 imi_mug_run_2_treatment "vinorelbine"
12 Q0 24885803 596 22.583511 imi_mug_run_2_treatment "crizotinib"
12 Q0 18343068 597 22.5821 imi_mug_run_2_treatment "collagen"
12 Q0 28597670 598 22.560654 imi_mug_run_2_treatment "aim"
12 Q0 28668524 599 22.552073 imi_mug_run_2_treatment "dex" "il-6" "dexmedetomidine"
12 Q0 25676398 600 22.528217 imi_mug_run_2_treatment "crizotinib" "level"
12 Q0 26958511 601 22.528217 imi_mug_run_2_treatment "drug" "crizotinib" "tyrosine kinase inhibitor"
12 Q0 16928325 602 22.512829 imi_mug_run_2_treatment "vaccine"
12 Q0 25707471 603 22.508814 imi_mug_run_2_treatment "anti-inflammatory" "drugs" "basic fibroblast growth factor"
12 Q0 24670165 604 22.508259 imi_mug_run_2_treatment "ceritinib" "various" "crizotinib"
12 Q0 28356514 605 22.50783 imi_mug_run_2_treatment "various" "cytokines" "ruxolitinib"
12 Q0 18197808 606 22.453949 imi_mug_run_2_treatment "vaccines" "vaccine" "autologous"
12 Q0 24885982 607 22.441439 imi_mug_run_2_treatment "crizotinib"
12 Q0 23567620 608 22.434492 imi_mug_run_2_treatment "blockade"
12 Q0 25576649 609 22.434492 imi_mug_run_2_treatment "various" "tyrosine kinase inhibitor" "crizotinib"
12 Q0 25073473 610 22.43078 imi_mug_run_2_treatment "pf06463922" "oxo" "animals"
12 Q0 26703575 611 22.42614 imi_mug_run_2_treatment "lead"
12 Q0 24466232 612 22.425312 imi_mug_run_2_treatment "various" "product"
12 Q0 21233844 613 22.41924 imi_mug_run_2_treatment "cannabinoid" "marijuana" "cannabinoids"
12 Q0 15448029 614 22.39914 imi_mug_run_2_treatment "cancer vaccines" "vaccines" "mediated"
12 Q0 24885886 615 22.395937 imi_mug_run_2_treatment "ras"
12 Q0 9274957 616 22.378246 imi_mug_run_2_treatment "p23"
12 Q0 9616164 617 22.37732 imi_mug_run_2_treatment "lead"
12 Q0 29855693 618 22.375132 imi_mug_run_2_treatment "rms" "pdx" "crizotinib"
12 Q0 24128285 619 22.374826 imi_mug_run_2_treatment "endostatin" "cck-8" "antiangiogenic"
12 Q0 20433995 620 22.370594 imi_mug_run_2_treatment "ttf-ngr" "fibrin"
12 Q0 22474449 621 22.358646 imi_mug_run_2_treatment "iga" "crizotinib"
12 Q0 29300322 622 22.338205 imi_mug_run_2_treatment "crizotinib" "drug" "aim"
12 Q0 16627963 623 22.331799 imi_mug_run_2_treatment "glycans" "matrix"
12 Q0 23708071 624 22.324501 imi_mug_run_2_treatment "insulin" "combinations" "radiosensitizers"
12 Q0 16457153 625 22.314613 imi_mug_run_2_treatment "mediated" "il-12" "vaccines"
12 Q0 8582236 626 22.284294 imi_mug_run_2_treatment "pkh 26" "color" "aim"
12 Q0 16483188 627 22.283134 imi_mug_run_2_treatment "cytokines" "recombinant human il-2"
12 Q0 22769420 628 22.282001 imi_mug_run_2_treatment "matrix"
12 Q0 19578737 629 22.270351 imi_mug_run_2_treatment "meth" "bmc" "il-12"
12 Q0 12658768 630 22.257725 imi_mug_run_2_treatment "tumor vaccine" "cancer vaccines"
12 Q0 24633193 631 22.251347 imi_mug_run_2_treatment "mdc" "cytotoxic"
12 Q0 22565853 632 22.250399 imi_mug_run_2_treatment "il-1ra" "cytokines" "anti-inflammatory"
12 Q0 23891424 633 22.250072 imi_mug_run_2_treatment "interferon" "il-12" "vaccine"
12 Q0 29883838 634 22.22527 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors" "osimertinib" "formalin"
12 Q0 17909857 635 22.211727 imi_mug_run_2_treatment "vaccine" "immunosuppressive" "cancer vaccines"
12 Q0 28514730 636 22.207497 imi_mug_run_2_treatment "crizotinib" "plasma"
12 Q0 17974270 637 22.20519 imi_mug_run_2_treatment "tgf-beta1" "mediated" "enzyme digestion"
12 Q0 26939704 638 22.183323 imi_mug_run_2_treatment "entrectinib" "drug" "drug's"
12 Q0 22176433 639 22.17972 imi_mug_run_2_treatment "level" "collagen"
12 Q0 12015071 640 22.170628 imi_mug_run_2_treatment "vaccine" "cancer vaccines" "tumor vaccine"
12 Q0 30489320 641 22.169521 imi_mug_run_2_treatment "basis" "matrix"
12 Q0 10096292 642 22.166649 imi_mug_run_2_treatment "interferon" "vaccine" "vaccines"
12 Q0 22546342 643 22.16399 imi_mug_run_2_treatment "mycophenolate mofetil"
12 Q0 12574367 644 22.151958 imi_mug_run_2_treatment "prophylactic" "vaccine" "tumor vaccines"
12 Q0 23242316 645 22.151958 imi_mug_run_2_treatment "cytotoxic" "cytokines" "agonist"
12 Q0 22989574 646 22.14625 imi_mug_run_2_treatment "crizotinib" "medicine"
12 Q0 22842996 647 22.13894 imi_mug_run_2_treatment "lead"
12 Q0 29595984 648 22.121704 imi_mug_run_2_treatment "various" "ceritinib" "crizotinib"
12 Q0 21725211 649 22.119663 imi_mug_run_2_treatment "mediated"
12 Q0 24146199 650 22.109955 imi_mug_run_2_treatment "hpv16 e7" "interferon-gamma" "therapeutic agent"
12 Q0 19908319 651 22.106392 imi_mug_run_2_treatment "agonists" "vaccines" "il-12"
12 Q0 23599149 652 22.1044 imi_mug_run_2_treatment "program"
12 Q0 19788747 653 22.093546 imi_mug_run_2_treatment "cytotoxic"
12 Q0 17572011 654 22.081394 imi_mug_run_2_treatment "tnf-alpha" "cytokines"
12 Q0 30497270 655 22.06623 imi_mug_run_2_treatment "hot spot" "melan a"
12 Q0 27162697 656 22.05753 imi_mug_run_2_treatment "gefitinib" "alectinib"
12 Q0 15930317 657 22.04579 imi_mug_run_2_treatment "adjuvant" "interleukin-12" "dendritic cell vaccine"
12 Q0 23897781 658 22.04216 imi_mug_run_2_treatment "blockade" "rms"
12 Q0 24500009 659 22.031754 imi_mug_run_2_treatment "pma" "acetate" "anti-inflammatory"
12 Q0 24633252 660 22.01904 imi_mug_run_2_treatment "ghb" "cytokines" "interleukin-6"
12 Q0 8402682 661 22.016636 imi_mug_run_2_treatment "antisera" "vaccines" "monoclonal antibodies"
12 Q0 29517860 662 22.013638 imi_mug_run_2_treatment "product" "tyrosine kinase inhibitor" "crizotinib"
12 Q0 28837676 663 22.007944 imi_mug_run_2_treatment "mediated" "nervous system"
12 Q0 28335413 664 21.975208 imi_mug_run_2_treatment "drug" "adjuvant" "anti-inflammatory"
12 Q0 27235139 665 21.968967 imi_mug_run_2_treatment "anti-inflammatory" "ras" "interleukin"
12 Q0 27769623 666 21.965286 imi_mug_run_2_treatment "blockade"
12 Q0 26990744 667 21.95862 imi_mug_run_2_treatment "crizotinib" "platinum"
12 Q0 21281497 668 21.935585 imi_mug_run_2_treatment "mediated" "cytotoxic" "citrate"
12 Q0 24736067 669 21.91837 imi_mug_run_2_treatment "color" "basis" "crizotinib"
12 Q0 15553669 670 21.909304 imi_mug_run_2_treatment "vaccine" "pge2" "immunosuppressive"
12 Q0 28605874 671 21.900076 imi_mug_run_2_treatment "cytokines" "interleukin"
12 Q0 7660686 672 21.899254 imi_mug_run_2_treatment "anti-inflammatory" "prostanoids" "mediators"
12 Q0 29515255 673 21.898092 imi_mug_run_2_treatment "crizotinib" "level"
12 Q0 21364672 674 21.876297 imi_mug_run_2_treatment "mediated" "trail-r2" "plasma"
12 Q0 27171666 675 21.862022 imi_mug_run_2_treatment "formalin"
12 Q0 29177672 676 21.843996 imi_mug_run_2_treatment "vaccine" "tumor vaccine" "heat shock protein 70"
12 Q0 21898241 677 21.827976 imi_mug_run_2_treatment "vaccine" "hsp70" "tumor vaccine"
12 Q0 9426830 678 21.816238 imi_mug_run_2_treatment "ro 45-2081" "therapeutics"
12 Q0 23475129 679 21.79017 imi_mug_run_2_treatment "vaccines" "cancer vaccines"
12 Q0 28363519 680 21.780876 imi_mug_run_2_treatment "biotin" "mediated" "therapeutic agents"
12 Q0 30449809 681 21.774403 imi_mug_run_2_treatment "insulin" "ceritinib" "glucose"
12 Q0 30510251 682 21.757881 imi_mug_run_2_treatment "mediators"
12 Q0 22777145 683 21.7522 imi_mug_run_2_treatment "sham" "cytokines" "interleukin"
12 Q0 18558334 684 21.736713 imi_mug_run_2_treatment "drug" "mediated" "cytotoxic"
12 Q0 23523007 685 21.728266 imi_mug_run_2_treatment "icc"
12 Q0 26968843 686 21.724455 imi_mug_run_2_treatment "drugs" "egfr tyrosine kinase inhibitors" "crizotinib"
12 Q0 22932403 687 21.723896 imi_mug_run_2_treatment "color"
12 Q0 12133269 688 21.716003 imi_mug_run_2_treatment "interleukin-2" "animals" "antineoplastic"
12 Q0 21890002 689 21.708015 imi_mug_run_2_treatment "anti-inflammatory" "dhc" "carrageenan"
12 Q0 25674293 690 21.691357 imi_mug_run_2_treatment "cytotoxic"
12 Q0 29097733 691 21.687897 imi_mug_run_2_treatment "drugs" "parp inhibitors"
12 Q0 25997964 692 21.656261 imi_mug_run_2_treatment "coagulant" "agent" "product"
12 Q0 21847362 693 21.644815 imi_mug_run_2_treatment "various" "mediators"
12 Q0 21945963 694 21.639309 imi_mug_run_2_treatment "vaccine" "adjuvant" "vaccines"
12 Q0 19528090 695 21.639305 imi_mug_run_2_treatment "animals"
12 Q0 17131471 696 21.638805 imi_mug_run_2_treatment "heat shock protein 70" "hsp70" "aim"
12 Q0 17053806 697 21.634678 imi_mug_run_2_treatment "proteases" "urokinase plasminogen activator" "mediated"
12 Q0 12747760 698 21.624992 imi_mug_run_2_treatment "polyethylene glycol" "vaccines" "il-12"
12 Q0 25829459 699 21.618263 imi_mug_run_2_treatment "prompt"
12 Q0 28459464 700 21.618263 imi_mug_run_2_treatment "vpa" "mediated" "valproic acid"
12 Q0 9820528 701 21.613174 imi_mug_run_2_treatment "vaccine" "vaccines" "polyethylene glycol"
12 Q0 27251414 702 21.60102 imi_mug_run_2_treatment "gelonin" "rgel" "pft"
12 Q0 29638111 703 21.592852 imi_mug_run_2_treatment "amd"
12 Q0 15720226 704 21.575386 imi_mug_run_2_treatment "anti-inflammatory" "glucose" "mediators"
12 Q0 23891510 705 21.537186 imi_mug_run_2_treatment "drugs" "aim"
12 Q0 30049331 706 21.504932 imi_mug_run_2_treatment "protease" "serine"
12 Q0 28104537 707 21.486176 imi_mug_run_2_treatment "bevacizumab" "platinum" "tyrosine kinase inhibitor"
12 Q0 19363438 708 21.481709 imi_mug_run_2_treatment "cytotoxic"
12 Q0 9661877 709 21.476894 imi_mug_run_2_treatment "immunoglobulin g" "animals"
12 Q0 27283964 710 21.465923 imi_mug_run_2_treatment "plasma"
12 Q0 26668594 711 21.457771 imi_mug_run_2_treatment "various" "color" "cm-dil"
12 Q0 19251467 712 21.456299 imi_mug_run_2_treatment "tnf-alpha" "cytokines" "pentoxifylline"
12 Q0 16271073 713 21.453724 imi_mug_run_2_treatment "sb-431542" "cytokines"
12 Q0 1922108 714 21.439777 imi_mug_run_2_treatment "immunotoxin" "cytotoxic" "level"
12 Q0 15642197 715 21.437075 imi_mug_run_2_treatment "yeast" "mediated" "epidermal growth factor"
12 Q0 29524063 716 21.43188 imi_mug_run_2_treatment "alectinib" "tyrosine kinase inhibitor"
12 Q0 23114745 717 21.427166 imi_mug_run_2_treatment "cisplatin" "etoposide" "oxaliplatin"
12 Q0 23157740 718 21.42449 imi_mug_run_2_treatment "level"
12 Q0 27561692 719 21.424425 imi_mug_run_2_treatment "basis"
12 Q0 22351377 720 21.400883 imi_mug_run_2_treatment "alcohol" "air"
12 Q0 29662531 721 21.382362 imi_mug_run_2_treatment "crizotinib" "prompt"
12 Q0 19735074 722 21.352272 imi_mug_run_2_treatment "various" "dextran sodium sulfate" "cytotoxic"
12 Q0 28296581 723 21.30512 imi_mug_run_2_treatment "alectinib" "kinase inhibitor" "medication"
12 Q0 23578105 724 21.298122 imi_mug_run_2_treatment "rms"
12 Q0 24513263 725 21.289268 imi_mug_run_2_treatment "others"
12 Q0 30095326 726 21.286938 imi_mug_run_2_treatment "crizotinib"
12 Q0 26709646 727 21.285048 imi_mug_run_2_treatment "suppressor"
12 Q0 25682925 728 21.2796 imi_mug_run_2_treatment "egfr inhibitor"
12 Q0 30066208 729 21.272835 imi_mug_run_2_treatment "lorlatinib" "prompt" "crizotinib"
12 Q0 17509395 730 21.263746 imi_mug_run_2_treatment "level"
12 Q0 18687171 731 21.257092 imi_mug_run_2_treatment "tnf-alpha" "mediators" "eosin"
12 Q0 27912826 732 21.247383 imi_mug_run_2_treatment "lead" "crizotinib" "ceritinib"
12 Q0 30429043 733 21.246098 imi_mug_run_2_treatment "cpis"
12 Q0 9160678 734 21.244503 imi_mug_run_2_treatment "plasma" "antithrombin iii" "prothrombin"
12 Q0 15872130 735 21.239944 imi_mug_run_2_treatment "ketorolac" "nsaid" "celecoxib"
12 Q0 24406431 736 21.23681 imi_mug_run_2_treatment "rms"
12 Q0 27197808 737 21.219868 imi_mug_run_2_treatment "crizotinib" "ceritinib"
12 Q0 22184391 738 21.21108 imi_mug_run_2_treatment "rms" "aim"
12 Q0 17009594 739 21.200254 imi_mug_run_2_treatment "hsp70" "tumor vaccine"
12 Q0 18767954 740 21.191143 imi_mug_run_2_treatment "vaccines" "vaccine"
12 Q0 15044960 741 21.189198 imi_mug_run_2_treatment "gly" "therapeutic agents"
12 Q0 25672264 742 21.183262 imi_mug_run_2_treatment "liver" "urokinase" "mediated"
12 Q0 22614968 743 21.1781 imi_mug_run_2_treatment "combinations" "drugs" "cetuximab"
12 Q0 25270523 744 21.17467 imi_mug_run_2_treatment "crizotinib"
12 Q0 27009091 745 21.173573 imi_mug_run_2_treatment "tyr" "drug" "cep-37440"
12 Q0 21933375 746 21.157785 imi_mug_run_2_treatment "mediated" "polyethylene glycol" "isolate"
12 Q0 17575687 747 21.154663 imi_mug_run_2_treatment "interleukin"
12 Q0 9669388 748 21.151348 imi_mug_run_2_treatment "salt"
12 Q0 29112931 749 21.146236 imi_mug_run_2_treatment "vaccines" "vaccine" "gonadotrophin releasing hormone"
12 Q0 382866 750 21.13801 imi_mug_run_2_treatment "lymphokines" "mitogen" "mediated"
12 Q0 11929818 751 21.137964 imi_mug_run_2_treatment "drug" "oxygen" "beta-galactosidase"
12 Q0 22286581 752 21.136524 imi_mug_run_2_treatment "blockade"
12 Q0 27764830 753 21.13599 imi_mug_run_2_treatment "pazopanib" "crizotinib" "vegf inhibitor"
12 Q0 21829174 754 21.134182 imi_mug_run_2_treatment "vascular endothelial growth factor"
12 Q0 18157011 755 21.133045 imi_mug_run_2_treatment "various" "mediated"
12 Q0 9816154 756 21.114227 imi_mug_run_2_treatment "various" "ch14.18" "recombinant human interleukin-2"
12 Q0 29370427 757 21.109823 imi_mug_run_2_treatment "ras"
12 Q0 12799209 758 21.1013 imi_mug_run_2_treatment "tnf-alpha" "mediators" "il-1ra"
12 Q0 24815447 759 21.092844 imi_mug_run_2_treatment "aim"
12 Q0 12573106 760 21.09138 imi_mug_run_2_treatment "interferon gamma" "cytokines" "cytotoxic"
12 Q0 29186933 761 21.083982 imi_mug_run_2_treatment "rms" "lead"
12 Q0 25534130 762 21.081264 imi_mug_run_2_treatment "metmab"
12 Q0 10562982 763 21.071056 imi_mug_run_2_treatment "nonsteroidal anti-inflammatory drug" "ketorolac" "anti-inflammatory"
12 Q0 17671198 764 21.069374 imi_mug_run_2_treatment "drugs" "plasminogen" "yeast"
12 Q0 29777599 765 21.069134 imi_mug_run_2_treatment "level" "tyrosine kinase inhibitor" "color"
12 Q0 16210694 766 21.051722 imi_mug_run_2_treatment "tnf-alpha"
12 Q0 10699932 767 21.05068 imi_mug_run_2_treatment "carboxypeptidase g2" "cytotoxic drug" "liver"
12 Q0 19380798 768 21.038202 imi_mug_run_2_treatment "mediators"
12 Q0 28666189 769 21.01548 imi_mug_run_2_treatment "crizotinib" "various" "topotecan"
12 Q0 9448920 770 21.013065 imi_mug_run_2_treatment "interferon" "interferon-gamma" "interferons"
12 Q0 22474390 771 21.010637 imi_mug_run_2_treatment "dexamethasone"
12 Q0 22320267 772 21.005892 imi_mug_run_2_treatment "mediated" "heat shock protein 70" "hsp70"
12 Q0 15225428 773 21.000126 imi_mug_run_2_treatment "vaccine" "hcpt" "vaccines"
12 Q0 26488716 774 20.9975 imi_mug_run_2_treatment "level"
12 Q0 12827309 775 20.97437 imi_mug_run_2_treatment "mediated" "t-cell growth factor"
12 Q0 26463662 776 20.973576 imi_mug_run_2_treatment "interferon alpha"
12 Q0 29741717 777 20.972849 imi_mug_run_2_treatment "corticosteroids" "influenza" "antiviral"
12 Q0 23768240 778 20.964975 imi_mug_run_2_treatment "vaccine" "il-12" "anti-cd25 monoclonal antibody"
12 Q0 23379731 779 20.956272 imi_mug_run_2_treatment "n-acetylcysteine" "antioxidants" "nitric oxide"
12 Q0 24788185 780 20.954317 imi_mug_run_2_treatment "il-1ra" "anti-inflammatory agents" "mediators"
12 Q0 18617319 781 20.953857 imi_mug_run_2_treatment "drug" "nsaids" "nsaid"
12 Q0 25852061 782 20.91039 imi_mug_run_2_treatment "antiviral" "mediated"
12 Q0 30041728 783 20.899124 imi_mug_run_2_treatment "polyethylene glycol" "il-12p70" "cytotoxic"
12 Q0 19633684 784 20.844608 imi_mug_run_2_treatment "yeast" "monolayer" "pleiotrophin"
12 Q0 19393834 785 20.823982 imi_mug_run_2_treatment "anticancer agents" "drugs" "medicine"
12 Q0 18181164 786 20.81892 imi_mug_run_2_treatment "com"
12 Q0 19691112 787 20.817083 imi_mug_run_2_treatment "product"
12 Q0 20415409 788 20.797585 imi_mug_run_2_treatment "prostaglandins" "anti-inflammatory" "nonsteroidal anti-inflammatory drugs"
12 Q0 15621573 789 20.79729 imi_mug_run_2_treatment "tnf-alpha" "mediated" "animals"
12 Q0 26045672 790 20.796787 imi_mug_run_2_treatment "drug" "aim"
12 Q0 20528452 791 20.79346 imi_mug_run_2_treatment "drug" "doxil" "aim"
12 Q0 11775545 792 20.781025 imi_mug_run_2_treatment "vaccine"
12 Q0 24069821 793 20.771984 imi_mug_run_2_treatment "aim"
12 Q0 29199679 794 20.765165 imi_mug_run_2_treatment "basis" "formalin" "color"
12 Q0 20065063 795 20.757095 imi_mug_run_2_treatment "drugs" "basic fibroblast growth factor"
12 Q0 19304513 796 20.755802 imi_mug_run_2_treatment "tnf-alpha" "mediated" "therapeutic agent"
12 Q0 24810493 797 20.749752 imi_mug_run_2_treatment "carboplatin" "paclitaxel" "s-1"
12 Q0 20138246 798 20.738735 imi_mug_run_2_treatment "cytotoxic" "drugs" "mediated"
12 Q0 8886831 799 20.738533 imi_mug_run_2_treatment "gamma interferon"
12 Q0 26474502 800 20.735023 imi_mug_run_2_treatment "tyrosine"
12 Q0 12941833 801 20.731365 imi_mug_run_2_treatment "agent"
12 Q0 11278720 802 20.731174 imi_mug_run_2_treatment "pleiotrophin" "mediated" "nervous system"
12 Q0 17077015 803 20.718786 imi_mug_run_2_treatment "aim" "fcm"
12 Q0 19232460 804 20.717316 imi_mug_run_2_treatment "drug" "oxygen"
12 Q0 16823838 805 20.716476 imi_mug_run_2_treatment "il12" "interleukin-12" "mediated"
12 Q0 23291127 806 20.705666 imi_mug_run_2_treatment "adjuvant" "vaccine"
12 Q0 12673560 807 20.698124 imi_mug_run_2_treatment "antiviral" "immunosuppressive"
12 Q0 15661883 808 20.691162 imi_mug_run_2_treatment "various"
12 Q0 25193856 809 20.689915 imi_mug_run_2_treatment "various" "drug" "crizotinib"
12 Q0 25732197 810 20.68748 imi_mug_run_2_treatment "crizotinib" "drug" "drugs"
12 Q0 15956253 811 20.659119 imi_mug_run_2_treatment "endostatin" "antitumor agent"
12 Q0 27738759 812 20.651705 imi_mug_run_2_treatment "basis"
12 Q0 25614375 813 20.64885 imi_mug_run_2_treatment "aim"
12 Q0 28638480 814 20.647293 imi_mug_run_2_treatment "vaccine" "chitosan" "interferon"
12 Q0 21282338 815 20.636902 imi_mug_run_2_treatment "mediated"
12 Q0 7527617 816 20.623098 imi_mug_run_2_treatment "product" "p23"
12 Q0 28118634 817 20.623081 imi_mug_run_2_treatment "crizotinib"
12 Q0 18250039 818 20.622326 imi_mug_run_2_treatment "vaccine" "il-10" "interferon-gamma"
12 Q0 12924105 819 20.61543 imi_mug_run_2_treatment "various" "drugs" "interleukin-1 receptor antagonist"
12 Q0 18997619 820 20.607803 imi_mug_run_2_treatment "aim"
12 Q0 28653985 821 20.605556 imi_mug_run_2_treatment "drug"
12 Q0 24006371 822 20.600725 imi_mug_run_2_treatment "human serum albumin"
12 Q0 11714836 823 20.597239 imi_mug_run_2_treatment "various" "defensin" "defensins"
12 Q0 29137103 824 20.595453 imi_mug_run_2_treatment "crizotinib" "ceritinib"
12 Q0 16120577 825 20.58842 imi_mug_run_2_treatment "epidermal growth factor" "cytotoxic" "insect"
12 Q0 24819411 826 20.584166 imi_mug_run_2_treatment "cytotoxic" "autologous" "il-12p70"
12 Q0 27682212 827 20.580778 imi_mug_run_2_treatment "crizotinib" "drug" "drugs"
12 Q0 6324459 828 20.576752 imi_mug_run_2_treatment "glucocorticoids" "monolayer"
12 Q0 24232092 829 20.576193 imi_mug_run_2_treatment "adjuvant" "mediated" "aim"
12 Q0 19060369 830 20.575148 imi_mug_run_2_treatment "cytotoxic" "vaccine" "abc"
12 Q0 10448117 831 20.573284 imi_mug_run_2_treatment "com"
12 Q0 29336268 832 20.56995 imi_mug_run_2_treatment "drug" "mediated"
12 Q0 27291760 833 20.563164 imi_mug_run_2_treatment "vascular endothelial growth factor"
12 Q0 18941404 834 20.56292 imi_mug_run_2_treatment "pmp"
12 Q0 21901167 835 20.562748 imi_mug_run_2_treatment "kinase inhibitor"
12 Q0 16397252 836 20.55671 imi_mug_run_2_treatment "endostatin" "flucytosine" "fluorouracil"
12 Q0 21999838 837 20.535778 imi_mug_run_2_treatment "dmpc" "drugs" "various"
12 Q0 9073530 838 20.535137 imi_mug_run_2_treatment "mediators" "tenefuse"
12 Q0 25240321 839 20.529175 imi_mug_run_2_treatment "anti-inflammatory" "therapeutics"
12 Q0 29500915 840 20.525084 imi_mug_run_2_treatment "yeast" "various combinations"
12 Q0 17618576 841 20.511894 imi_mug_run_2_treatment "vaccine" "aim"
12 Q0 19954169 842 20.507137 imi_mug_run_2_treatment "drug" "drugs" "anti-inflammatory"
12 Q0 17380443 843 20.505856 imi_mug_run_2_treatment "factor viii" "lysozyme"
12 Q0 10851456 844 20.502192 imi_mug_run_2_treatment "cytotoxic"
12 Q0 26648752 845 20.49335 imi_mug_run_2_treatment "temozolomide" "crizotinib" "blockade"
12 Q0 21926464 846 20.48881 imi_mug_run_2_treatment "cytokines" "il-6" "mediated"
12 Q0 26507578 847 20.447117 imi_mug_run_2_treatment "various" "cancer vaccines" "vaccines"
12 Q0 21311755 848 20.423935 imi_mug_run_2_treatment "interferon" "cytotoxic" "agent"
12 Q0 23162075 849 20.397032 imi_mug_run_2_treatment "mediated"
12 Q0 12359759 850 20.386175 imi_mug_run_2_treatment "mediated" "melanoma vaccine" "vaccines"
12 Q0 11261231 851 20.379879 imi_mug_run_2_treatment "monoclonal antibodies" "mediated" "polyethylene glycol"
12 Q0 15312683 852 20.379204 imi_mug_run_2_treatment "interferon-gamma"
12 Q0 19006426 853 20.37133 imi_mug_run_2_treatment "basis"
12 Q0 21425149 854 20.369263 imi_mug_run_2_treatment "various"
12 Q0 26766993 855 20.365805 imi_mug_run_2_treatment "medicine"
12 Q0 29547712 856 20.35635 imi_mug_run_2_treatment "drug" "anti-inflammatory" "leflunomide"
12 Q0 28551309 857 20.34645 imi_mug_run_2_treatment "fusion toxin" "yeast" "ontak"
12 Q0 7097396 858 20.336506 imi_mug_run_2_treatment "phosphate"
12 Q0 12139943 859 20.319633 imi_mug_run_2_treatment "various" "adjuvant" "interferon-gamma"
12 Q0 28153506 860 20.305014 imi_mug_run_2_treatment "collagen" "melan a"
12 Q0 22491823 861 20.302292 imi_mug_run_2_treatment "cytokines" "interleukin"
12 Q0 22079273 862 20.301306 imi_mug_run_2_treatment "lead"
12 Q0 18463688 863 20.299349 imi_mug_run_2_treatment "mediated" "therapeutic agent"
12 Q0 15285878 864 20.296747 imi_mug_run_2_treatment "vaccines" "vaccine" "mediated"
12 Q0 29775683 865 20.290134 imi_mug_run_2_treatment "aim"
12 Q0 23428543 866 20.282188 imi_mug_run_2_treatment "gdnf" "anti-inflammatory agent" "agent"
12 Q0 18360705 867 20.272827 imi_mug_run_2_treatment "vaccine" "tumor vaccine" "agent"
12 Q0 24260079 868 20.272827 imi_mug_run_2_treatment "vaccine" "polyethylene glycol" "tumor vaccine"
12 Q0 24276620 869 20.272827 imi_mug_run_2_treatment "interleukin-2 fusion protein" "interleukin-2" "cytokines"
12 Q0 7568219 870 20.271961 imi_mug_run_2_treatment "interferon gamma" "cytokines" "monoclonal antibodies"
12 Q0 12712444 871 20.261406 imi_mug_run_2_treatment "vaccine" "cytotoxic"
12 Q0 30222966 872 20.260403 imi_mug_run_2_treatment "lys"
12 Q0 21216716 873 20.256073 imi_mug_run_2_treatment "shape" "flair" "level"
12 Q0 17482260 874 20.252666 imi_mug_run_2_treatment "il-1ra" "cytokines" "anti-inflammatory"
12 Q0 18755367 875 20.23952 imi_mug_run_2_treatment "drug" "biologics" "infliximab"
12 Q0 24020521 876 20.22939 imi_mug_run_2_treatment "mannose"
12 Q0 20957039 877 20.191008 imi_mug_run_2_treatment "mediated"
12 Q0 6491605 878 20.18632 imi_mug_run_2_treatment "polyethylene glycol"
12 Q0 21298913 879 20.186195 imi_mug_run_2_treatment "aim"
12 Q0 11792173 880 20.168747 imi_mug_run_2_treatment "agent"
12 Q0 21061145 881 20.167719 imi_mug_run_2_treatment "colloidal gold" "platelets" "liver"
12 Q0 26735175 882 20.166847 imi_mug_run_2_treatment "entrectinib" "chloroquine" "cytostatic"
12 Q0 21278610 883 20.166847 imi_mug_run_2_treatment "gold" "color"
12 Q0 2504990 884 20.15784 imi_mug_run_2_treatment "interleukin-6" "mediators" "cytotoxic"
12 Q0 21585384 885 20.1567 imi_mug_run_2_treatment "dichloromethane" "anti-inflammatory" "quercetin"
12 Q0 25656847 886 20.15599 imi_mug_run_2_treatment "gefitinib" "egfr inhibitor"
12 Q0 12810649 887 20.143177 imi_mug_run_2_treatment "il-12" "tnf-alpha" "combinations"
12 Q0 24088074 888 20.134012 imi_mug_run_2_treatment "vaccines" "vaccine" "autologous"
12 Q0 12429175 889 20.128506 imi_mug_run_2_treatment "vaccine" "cytotoxic" "cell stimulant"
12 Q0 25782870 890 20.119188 imi_mug_run_2_treatment "normal saline"
12 Q0 27696251 891 20.11893 imi_mug_run_2_treatment "ras"
12 Q0 25467796 892 20.11118 imi_mug_run_2_treatment "vaccines" "il-12" "prophylactic"
12 Q0 11090045 893 20.105328 imi_mug_run_2_treatment "vaccines"
12 Q0 21424118 894 20.091349 imi_mug_run_2_treatment "tumor vaccine" "atv" "vaccine"
12 Q0 12385005 895 20.086296 imi_mug_run_2_treatment "immunoconjugates" "vascular endothelial growth factor" "vascular permeability factor"
12 Q0 16671943 896 20.080875 imi_mug_run_2_treatment "various" "cpg-odn" "stimulant"
12 Q0 29554661 897 20.076576 imi_mug_run_2_treatment "insulin" "cytokines" "interleukin"
12 Q0 11274143 898 20.076138 imi_mug_run_2_treatment "cytokines" "mediated"
12 Q0 9862706 899 20.069763 imi_mug_run_2_treatment "histidine" "mediated"
12 Q0 21777658 900 20.063364 imi_mug_run_2_treatment "mediators" "drug" "erythritol"
12 Q0 26845116 901 20.050835 imi_mug_run_2_treatment "formalin" "basis"
12 Q0 9726441 902 20.050074 imi_mug_run_2_treatment "interleukin-2" "animals"
12 Q0 30210625 903 20.048864 imi_mug_run_2_treatment "vandetanib" "kinase inhibitor" "sorafenib"
12 Q0 26064415 904 20.03957 imi_mug_run_2_treatment "vaccine" "defensin" "anti-cd8 monoclonal antibody"
12 Q0 24386191 905 20.035618 imi_mug_run_2_treatment "lead" "tyrosine" "air"
12 Q0 15668131 906 20.033981 imi_mug_run_2_treatment "protease" "proteases" "saporin"
12 Q0 29296786 907 20.023584 imi_mug_run_2_treatment "hirudin" "protein c" "therapeutics"
12 Q0 19799815 908 20.021988 imi_mug_run_2_treatment "vaccine" "polyethylene glycol" "cytotoxic"
12 Q0 25380501 909 20.019005 imi_mug_run_2_treatment "drug" "various" "nsaids"
12 Q0 7510148 910 20.012547 imi_mug_run_2_treatment "lead"
12 Q0 28843358 911 20.011557 imi_mug_run_2_treatment "tyrosine kinase inhibitor" "level"
12 Q0 30069765 912 20.000965 imi_mug_run_2_treatment "drug" "larotrectinib" "loxo-101"
12 Q0 20594011 913 19.980293 imi_mug_run_2_treatment "various"
12 Q0 29205057 914 19.972424 imi_mug_run_2_treatment "aim"
12 Q0 21150773 915 19.970535 imi_mug_run_2_treatment "antiangiogenic" "basic fibroblast growth factor" "vascular endothelial growth factor"
12 Q0 23637254 916 19.953636 imi_mug_run_2_treatment "medicine"
12 Q0 15889213 917 19.95283 imi_mug_run_2_treatment "interferon gamma" "vaccines" "tumor vaccine"
12 Q0 27148422 918 19.949053 imi_mug_run_2_treatment "crizotinib"
12 Q0 16027141 919 19.946823 imi_mug_run_2_treatment "il-4"
12 Q0 11091128 920 19.946743 imi_mug_run_2_treatment "nsaids" "enzymes" "anti-inflammatory"
12 Q0 26974841 921 19.939392 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
12 Q0 28414205 922 19.937569 imi_mug_run_2_treatment "various" "gelonin" "drug"
12 Q0 19713601 923 19.936798 imi_mug_run_2_treatment "liver" "tace" "agent"
12 Q0 2869497 924 19.929455 imi_mug_run_2_treatment "allogeneic"
12 Q0 20339532 925 19.921333 imi_mug_run_2_treatment "normal saline" "il-10" "il-4"
12 Q0 22804236 926 19.91648 imi_mug_run_2_treatment "therapeutics" "level"
12 Q0 20948444 927 19.912134 imi_mug_run_2_treatment "mediated" "lead" "agonist"
12 Q0 15184663 928 19.907803 imi_mug_run_2_treatment "mediated"
12 Q0 1500863 929 19.904892 imi_mug_run_2_treatment "glycosaminoglycan" "hyaluronate"
12 Q0 27713158 930 19.897682 imi_mug_run_2_treatment "various"
12 Q0 26557908 931 19.884787 imi_mug_run_2_treatment "scorpion"
12 Q0 22564207 932 19.876057 imi_mug_run_2_treatment "crizotinib"
12 Q0 17883948 933 19.865702 imi_mug_run_2_treatment "mediated" "aim"
12 Q0 29909991 934 19.857788 imi_mug_run_2_treatment "enzymes" "combinations" "mediated"
12 Q0 28061367 935 19.850222 imi_mug_run_2_treatment "nmf" "matrix"
12 Q0 12459375 936 19.841066 imi_mug_run_2_treatment "therapeutics" "pharmaceuticals" "animals"
12 Q0 6687920 937 19.837934 imi_mug_run_2_treatment "various" "wheat germ"
12 Q0 1955380 938 19.83397 imi_mug_run_2_treatment "heparin" "monoclonal antibodies" "mediated"
12 Q0 21833532 939 19.832378 imi_mug_run_2_treatment "anti-inflammatory" "nitric oxide" "cytokines"
12 Q0 26165403 940 19.820856 imi_mug_run_2_treatment "interleukin" "il-6"
12 Q0 29109791 941 19.820786 imi_mug_run_2_treatment "combinations" "gold" "crizotinib"
12 Q0 18006780 942 19.817791 imi_mug_run_2_treatment "vaccine" "defensin" "vascular endothelial growth factor"
12 Q0 16305489 943 19.814617 imi_mug_run_2_treatment "ras" "gleevec" "imatinib mesylate"
12 Q0 29617662 944 19.814617 imi_mug_run_2_treatment "drug"
12 Q0 9917092 945 19.809538 imi_mug_run_2_treatment "tnf-alpha" "mediated" "beta-galactosidase"
12 Q0 25350699 946 19.804033 imi_mug_run_2_treatment "fusion toxin" "protease" "polyethylene glycol"
12 Q0 1685442 947 19.783648 imi_mug_run_2_treatment "ras"
12 Q0 9137087 948 19.772837 imi_mug_run_2_treatment "interferon-gamma" "interleukin" "lymphokines"
12 Q0 22484425 949 19.77135 imi_mug_run_2_treatment "nbt-272"
12 Q0 21084243 950 19.769485 imi_mug_run_2_treatment "abc"
12 Q0 17502862 951 19.769226 imi_mug_run_2_treatment "various" "infliximab" "etanercept"
12 Q0 19913113 952 19.766624 imi_mug_run_2_treatment "vaccine" "human chorionic gonadotropin" "cancer vaccines"
12 Q0 14990955 953 19.761503 imi_mug_run_2_treatment "combinations" "cytotoxic"
12 Q0 15579093 954 19.760109 imi_mug_run_2_treatment "biologics" "cytokines" "anti-inflammatory"
12 Q0 24432909 955 19.751064 imi_mug_run_2_treatment "crizotinib"
12 Q0 28606241 956 19.722485 imi_mug_run_2_treatment "level" "interferon" "il-4"
12 Q0 16255717 957 19.722143 imi_mug_run_2_treatment "npp" "edta" "glycerol"
12 Q0 26273361 958 19.718649 imi_mug_run_2_treatment "gefitinib" "egfr tyrosine kinase inhibitor"
12 Q0 16189700 959 19.705507 imi_mug_run_2_treatment "cytotoxic"
12 Q0 10514417 960 19.679403 imi_mug_run_2_treatment "interferon-gamma" "hefi-1"
12 Q0 14657946 961 19.67867 imi_mug_run_2_treatment "boc-d-fmk" "caspase inhibitors"
12 Q0 18559727 962 19.669294 imi_mug_run_2_treatment "adjuvant" "monoclonal antibodies" "il-12"
12 Q0 25629635 963 19.65667 imi_mug_run_2_treatment "aim"
12 Q0 15383204 964 19.655514 imi_mug_run_2_treatment "glucose"
12 Q0 621440 965 19.648212 imi_mug_run_2_treatment "ether" "basis"
12 Q0 16580737 966 19.641865 imi_mug_run_2_treatment "tumor vaccine" "hsp70" "vaccine"
12 Q0 30505716 967 19.639814 imi_mug_run_2_treatment "medicine" "pembrolizumab"
12 Q0 20377831 968 19.633244 imi_mug_run_2_treatment "lead"
12 Q0 11223071 969 19.630163 imi_mug_run_2_treatment "il12" "cytokines" "interleukin-12"
12 Q0 8403983 970 19.629177 imi_mug_run_2_treatment "basis" "lead"
12 Q0 27144064 971 19.626068 imi_mug_run_2_treatment "ras"
12 Q0 14562200 972 19.625647 imi_mug_run_2_treatment "cytokines" "therapeutic agents" "investigational agents"
12 Q0 25058391 973 19.620415 imi_mug_run_2_treatment "tyrosine kinase inhibitor" "crizotinib"
12 Q0 21972109 974 19.620415 imi_mug_run_2_treatment "prompt"
12 Q0 26000970 975 19.61743 imi_mug_run_2_treatment "various"
12 Q0 27063727 976 19.610802 imi_mug_run_2_treatment "therapeutic agent"
12 Q0 19535344 977 19.603907 imi_mug_run_2_treatment "flavopiridol" "cdk inhibitor" "cyclin-dependent kinase inhibitor"
12 Q0 26463022 978 19.59474 imi_mug_run_2_treatment "aim"
12 Q0 20935477 979 19.583616 imi_mug_run_2_treatment "mediated"
12 Q0 26898615 980 19.57854 imi_mug_run_2_treatment "ras" "crizotinib" "lead"
12 Q0 16121986 981 19.578434 imi_mug_run_2_treatment "vaccines" "tumor inoculation" "tumor vaccines"
12 Q0 16103750 982 19.571999 imi_mug_run_2_treatment "various"
12 Q0 16619287 983 19.570717 imi_mug_run_2_treatment "mediated" "cytotoxic" "autologous"
12 Q0 26044863 984 19.567663 imi_mug_run_2_treatment "various" "protease" "product"
12 Q0 18033820 985 19.564034 imi_mug_run_2_treatment "enzymes" "yeast" "monoclonal antibodies"
12 Q0 20406889 986 19.563879 imi_mug_run_2_treatment "various" "osteogenic protein-1"
12 Q0 15993840 987 19.560759 imi_mug_run_2_treatment "therapeutics" "gly" "epidermal growth factor"
12 Q0 17056519 988 19.559782 imi_mug_run_2_treatment "tumor vaccine" "heat shock protein 70" "hsp70"
12 Q0 28342334 989 19.557728 imi_mug_run_2_treatment "crizotinib" "dedicated"
12 Q0 23615728 990 19.540169 imi_mug_run_2_treatment "crizotinib" "verapamil" "hoechst 33342"
12 Q0 30323631 991 19.53894 imi_mug_run_2_treatment "sb431542"
12 Q0 9137837 992 19.533754 imi_mug_run_2_treatment "level"
12 Q0 24075124 993 19.532305 imi_mug_run_2_treatment "denosumab"
12 Q0 25882777 994 19.530159 imi_mug_run_2_treatment "alectinib" "tmz" "temozolomide"
12 Q0 27468968 995 19.530159 imi_mug_run_2_treatment "basis"
12 Q0 15949286 996 19.524742 imi_mug_run_2_treatment "vaccine" "vaccines" "cytotoxic"
12 Q0 26337721 997 19.518177 imi_mug_run_2_treatment "adjuvant" "shape"
12 Q0 11004679 998 19.51374 imi_mug_run_2_treatment "cytotoxic" "product" "fusion toxin"
12 Q0 25720988 999 19.512138 imi_mug_run_2_treatment "her-2" "designated"
13 Q0 29361925 1 77.26057 imi_mug_run_2_treatment "crizotinib" "lorlatinib" "cisplatin"
13 Q0 23418494 2 76.76194 imi_mug_run_2_treatment "kinase inhibitor" "therapeutic agents" "crizotinib"
13 Q0 29517860 3 61.391785 imi_mug_run_2_treatment "product" "tyrosine kinase inhibitor" "crizotinib"
13 Q0 27094798 4 60.004417 imi_mug_run_2_treatment "pemetrexed" "basis"
13 Q0 25234288 5 59.250095 imi_mug_run_2_treatment "crizotinib"
13 Q0 24462463 6 58.129654 imi_mug_run_2_treatment "aim"
13 Q0 25851827 7 57.4685 imi_mug_run_2_treatment "product" "tyrosine kinase inhibitor" "crizotinib"
13 Q0 28465216 8 55.109303 imi_mug_run_2_treatment "crizotinib" "drugs" "tyrosine"
13 Q0 26273395 9 54.079872 imi_mug_run_2_treatment "aim"
13 Q0 29268402 10 53.998863 imi_mug_run_2_treatment "crizotinib"
13 Q0 25985019 11 53.785744 imi_mug_run_2_treatment "ras"
13 Q0 28971587 12 53.686844 imi_mug_run_2_treatment "crizotinib"
13 Q0 26964870 13 53.272514 imi_mug_run_2_treatment "therapeutic agents" "crizotinib" "asp3026"
13 Q0 27561802 14 53.235252 imi_mug_run_2_treatment "crizotinib"
13 Q0 23788756 15 52.643063 imi_mug_run_2_treatment "lead"
13 Q0 30443294 16 52.047817 imi_mug_run_2_treatment "crizotinib"
13 Q0 24186139 17 51.649166 imi_mug_run_2_treatment "plasma"
13 Q0 26207220 18 51.105705 imi_mug_run_2_treatment "pooled"
13 Q0 23719267 19 49.566772 imi_mug_run_2_treatment "lead" "crizotinib"
13 Q0 23514723 20 48.9517 imi_mug_run_2_treatment "formalin"
13 Q0 25806222 21 48.86953 imi_mug_run_2_treatment "various" "crizotinib"
13 Q0 26973202 22 48.72538 imi_mug_run_2_treatment "adc" "vandetanib" "crizotinib"
13 Q0 25058391 23 48.696697 imi_mug_run_2_treatment "tyrosine kinase inhibitor" "crizotinib"
13 Q0 27040858 24 48.5449 imi_mug_run_2_treatment "crizotinib"
13 Q0 25667280 25 48.44638 imi_mug_run_2_treatment "crizotinib" "pemetrexed" "platinum"
13 Q0 25868855 26 48.39746 imi_mug_run_2_treatment "crizotinib"
13 Q0 25742289 27 48.36377 imi_mug_run_2_treatment "adc" "crizotinib"
13 Q0 26705279 28 48.247475 imi_mug_run_2_treatment "formalin"
13 Q0 30464529 29 48.087524 imi_mug_run_2_treatment "crizotinib"
13 Q0 30095326 30 48.0614 imi_mug_run_2_treatment "crizotinib"
13 Q0 24218589 31 47.795105 imi_mug_run_2_treatment "foretinib" "crizotinib"
13 Q0 23400546 32 46.976585 imi_mug_run_2_treatment "sodium phosphate" "crizotinib"
13 Q0 27738759 33 46.936707 imi_mug_run_2_treatment "basis"
13 Q0 28104537 34 46.252457 imi_mug_run_2_treatment "bevacizumab" "platinum" "tyrosine kinase inhibitor"
13 Q0 28914263 35 46.12891 imi_mug_run_2_treatment "agent"
13 Q0 27401242 36 45.905006 imi_mug_run_2_treatment "crizotinib" "lorlatinib" "tyrosine kinase inhibitor"
13 Q0 29883837 37 45.608143 imi_mug_run_2_treatment "pemetrexed"
13 Q0 27544536 38 45.46366 imi_mug_run_2_treatment "pemetrexed" "level" "crizotinib"
13 Q0 27237027 39 45.33085 imi_mug_run_2_treatment "cdx" "crizotinib" "product"
13 Q0 30107055 40 44.90692 imi_mug_run_2_treatment "various"
13 Q0 26992220 41 44.80899 imi_mug_run_2_treatment "formalin"
13 Q0 29874982 42 44.14021 imi_mug_run_2_treatment "aim"
13 Q0 30083883 43 44.023964 imi_mug_run_2_treatment "crizotinib"
13 Q0 28869223 44 43.9351 imi_mug_run_2_treatment "crizotinib"
13 Q0 27237034 45 43.77547 imi_mug_run_2_treatment "crizotinib"
13 Q0 23052255 46 43.647446 imi_mug_run_2_treatment "tyrosine"
13 Q0 25908037 47 43.36625 imi_mug_run_2_treatment "crizotinib" "oxygen" "tyrosine"
13 Q0 27575422 48 43.057972 imi_mug_run_2_treatment "pemetrexed" "program"
13 Q0 22975805 49 42.725292 imi_mug_run_2_treatment "tyrosine" "lead" "basis"
13 Q0 24469055 50 42.059822 imi_mug_run_2_treatment "ras"
13 Q0 24456475 51 42.024323 imi_mug_run_2_treatment "aim" "crizotinib"
13 Q0 26258422 52 41.97325 imi_mug_run_2_treatment "lead" "aim" "crizotinib"
13 Q0 23887156 53 41.849648 imi_mug_run_2_treatment "tyrosine kinase inhibitor" "crizotinib"
13 Q0 24345493 54 41.825657 imi_mug_run_2_treatment "lead" "crizotinib"
13 Q0 22919003 55 41.51805 imi_mug_run_2_treatment "various" "tma" "drug"
13 Q0 28468034 56 41.36285 imi_mug_run_2_treatment "air" "stas"
13 Q0 27342566 57 41.255352 imi_mug_run_2_treatment "mediated"
13 Q0 24296758 58 40.97128 imi_mug_run_2_treatment "color"
13 Q0 24349229 59 40.767803 imi_mug_run_2_treatment "mediated" "crizotinib"
13 Q0 28538401 60 40.444828 imi_mug_run_2_treatment "crizotinib"
13 Q0 25226429 61 40.378662 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
13 Q0 28888985 62 40.28109 imi_mug_run_2_treatment "aim"
13 Q0 24418728 63 40.247345 imi_mug_run_2_treatment "crizotinib"
13 Q0 27065847 64 40.226936 imi_mug_run_2_treatment "crizotinib"
13 Q0 28103968 65 40.216583 imi_mug_run_2_treatment "aim"
13 Q0 23724914 66 40.19916 imi_mug_run_2_treatment "crizotinib" "arginine" "glycine"
13 Q0 30053332 67 39.97473 imi_mug_run_2_treatment "crizotinib" "cabozantinib" "combinations"
13 Q0 26767038 68 39.974594 imi_mug_run_2_treatment "crizotinib" "kinase inhibitor" "program"
13 Q0 25753527 69 39.945435 imi_mug_run_2_treatment "level"
13 Q0 26438251 70 39.78917 imi_mug_run_2_treatment "various" "crizotinib"
13 Q0 25264305 71 39.75655 imi_mug_run_2_treatment "crizotinib" "tyrosine kinase inhibitor" "duration"
13 Q0 29517858 72 39.658577 imi_mug_run_2_treatment "drugs"
13 Q0 27535289 73 39.35011 imi_mug_run_2_treatment "crizotinib"
13 Q0 29704675 74 39.324352 imi_mug_run_2_treatment "crizotinib"
13 Q0 29571998 75 39.32365 imi_mug_run_2_treatment "vandetanib" "cabozantinib"
13 Q0 30029601 76 39.27207 imi_mug_run_2_treatment "crizotinib" "drug" "methylprednisolone"
13 Q0 26673800 77 38.958954 imi_mug_run_2_treatment "crizotinib" "cabozantinib"
13 Q0 27611848 78 38.913403 imi_mug_run_2_treatment "pemetrexed" "crizotinib"
13 Q0 24503571 79 38.768116 imi_mug_run_2_treatment "basis"
13 Q0 27486332 80 38.755714 imi_mug_run_2_treatment "adjuvant"
13 Q0 30150445 81 38.75342 imi_mug_run_2_treatment "alectinib"
13 Q0 29039585 82 38.68958 imi_mug_run_2_treatment "gefitinib" "erlotinib" "aim"
13 Q0 24380695 83 38.65117 imi_mug_run_2_treatment "crizotinib" "others"
13 Q0 26845116 84 38.636387 imi_mug_run_2_treatment "formalin" "basis"
13 Q0 26098749 85 38.492065 imi_mug_run_2_treatment "ras"
13 Q0 23157740 86 38.462147 imi_mug_run_2_treatment "level"
13 Q0 29290262 87 38.43136 imi_mug_run_2_treatment "crizotinib" "product" "ceritinib"
13 Q0 28177518 88 38.393017 imi_mug_run_2_treatment "medicine"
13 Q0 26152804 89 38.31517 imi_mug_run_2_treatment "adc" "crizotinib"
13 Q0 25733882 90 38.2987 imi_mug_run_2_treatment "crizotinib" "pf-06463922" "pf-02341066"
13 Q0 25760072 91 38.02693 imi_mug_run_2_treatment "aim"
13 Q0 29738763 92 38.005157 imi_mug_run_2_treatment "various" "crizotinib" "drug"
13 Q0 24992173 93 37.968956 imi_mug_run_2_treatment "crizotinib"
13 Q0 29451745 94 37.899834 imi_mug_run_2_treatment "icc"
13 Q0 25629635 95 37.867325 imi_mug_run_2_treatment "aim"
13 Q0 26791794 96 37.822815 imi_mug_run_2_treatment "crizotinib" "ceritinib"
13 Q0 28818606 97 37.797234 imi_mug_run_2_treatment "crizotinib" "medicines"
13 Q0 24736082 98 37.782406 imi_mug_run_2_treatment "p23"
13 Q0 26134228 99 37.77745 imi_mug_run_2_treatment "agar" "mediated"
13 Q0 30475455 100 37.714382 imi_mug_run_2_treatment "aim"
13 Q0 23558310 101 37.52484 imi_mug_run_2_treatment "crizotinib" "gemcitabine" "carboplatin"
13 Q0 28903995 102 37.40064 imi_mug_run_2_treatment "crizotinib"
13 Q0 28676214 103 37.348156 imi_mug_run_2_treatment "various" "penta"
13 Q0 23154560 104 37.206955 imi_mug_run_2_treatment "vandetanib"
13 Q0 28342334 105 37.136948 imi_mug_run_2_treatment "crizotinib" "dedicated"
13 Q0 28845578 106 36.997616 imi_mug_run_2_treatment "crizotinib" "kinase inhibitor"
13 Q0 27738334 107 36.806335 imi_mug_run_2_treatment "pemetrexed" "crizotinib"
13 Q0 25351743 108 36.795498 imi_mug_run_2_treatment "crizotinib" "cabozantinib" "drug"
13 Q0 26366094 109 36.790714 imi_mug_run_2_treatment "gefitinib" "erlotinib" "crizotinib"
13 Q0 29251734 110 36.65941 imi_mug_run_2_treatment "color"
13 Q0 27794403 111 36.544746 imi_mug_run_2_treatment "level" "platinum"
13 Q0 25429229 112 36.50286 imi_mug_run_2_treatment "mica" "basis"
13 Q0 26237499 113 36.42172 imi_mug_run_2_treatment "sorafenib" "platinum"
13 Q0 22215748 114 36.24143 imi_mug_run_2_treatment "crizotinib" "tyrosine kinase inhibitor"
13 Q0 28843358 115 36.070423 imi_mug_run_2_treatment "tyrosine kinase inhibitor" "level"
13 Q0 24700479 116 36.0658 imi_mug_run_2_treatment "medicine" "therapeutics"
13 Q0 28821955 117 35.95291 imi_mug_run_2_treatment "level"
13 Q0 24935562 118 35.660854 imi_mug_run_2_treatment "level"
13 Q0 24519667 119 35.623592 imi_mug_run_2_treatment "viral vector" "cytotoxic"
13 Q0 26486077 120 35.412983 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
13 Q0 26703797 121 35.36909 imi_mug_run_2_treatment "drugs" "crizotinib"
13 Q0 26958511 122 35.360306 imi_mug_run_2_treatment "drug" "crizotinib" "tyrosine kinase inhibitor"
13 Q0 24361161 123 35.33504 imi_mug_run_2_treatment "product"
13 Q0 28146588 124 35.220184 imi_mug_run_2_treatment "silver" "level"
13 Q0 25170107 125 35.129757 imi_mug_run_2_treatment "abc" "crizotinib" "ceritinib"
13 Q0 28237354 126 35.12919 imi_mug_run_2_treatment "crizotinib" "animals"
13 Q0 29167001 127 35.078506 imi_mug_run_2_treatment "pemetrexed" "platinum" "aim"
13 Q0 29333528 128 34.973236 imi_mug_run_2_treatment "crizotinib"
13 Q0 28717217 129 34.93911 imi_mug_run_2_treatment "crizotinib" "cabozantinib" "mediated"
13 Q0 26331813 130 34.84803 imi_mug_run_2_treatment "adc" "others"
13 Q0 28415793 131 34.73587 imi_mug_run_2_treatment "therapeutics"
13 Q0 26124082 132 34.719444 imi_mug_run_2_treatment "level"
13 Q0 25294908 133 34.617252 imi_mug_run_2_treatment "epidermal growth factor" "gefitinib"
13 Q0 27606884 134 34.365147 imi_mug_run_2_treatment "crizotinib"
13 Q0 25064355 135 34.35743 imi_mug_run_2_treatment "vandetanib" "tyrosine kinase inhibitor"
13 Q0 27496196 136 34.327152 imi_mug_run_2_treatment "crizotinib" "her-2" "tyrosine kinase inhibitor"
13 Q0 29371790 137 34.22107 imi_mug_run_2_treatment "crizotinib" "agent" "crizotinib 250 mg"
13 Q0 25505733 138 34.169323 imi_mug_run_2_treatment "medicine" "ras"
13 Q0 29290255 139 34.04903 imi_mug_run_2_treatment "erlotinib" "egfr inhibitor"
13 Q0 27670699 140 34.006947 imi_mug_run_2_treatment "adc" "selumetinib"
13 Q0 29600239 141 33.934605 imi_mug_run_2_treatment "crizotinib" "cdx" "aim"
13 Q0 30059431 142 33.735233 imi_mug_run_2_treatment "alectinib" "kinase inhibitor"
13 Q0 29692481 143 33.727615 imi_mug_run_2_treatment "aim"
13 Q0 25344360 144 33.698013 imi_mug_run_2_treatment "crizotinib"
13 Q0 23405175 145 33.6906 imi_mug_run_2_treatment "level" "lead"
13 Q0 27200298 146 33.643394 imi_mug_run_2_treatment "therapeutics"
13 Q0 26372962 147 33.631676 imi_mug_run_2_treatment "various" "crizotinib" "foretinib"
13 Q0 30015159 148 33.549675 imi_mug_run_2_treatment "agar"
13 Q0 26711128 149 33.527378 imi_mug_run_2_treatment "ras"
13 Q0 23647298 150 33.423477 imi_mug_run_2_treatment "aim"
13 Q0 27179848 151 33.37675 imi_mug_run_2_treatment "crizotinib"
13 Q0 25688157 152 33.3402 imi_mug_run_2_treatment "crizotinib" "egfr tyrosine kinase inhibitors" "foretinib"
13 Q0 28838404 153 33.228764 imi_mug_run_2_treatment "gold" "crizotinib"
13 Q0 27997009 154 33.2174 imi_mug_run_2_treatment "aim" "others"
13 Q0 30108778 155 33.066658 imi_mug_run_2_treatment "mitoxantrone" "drug"
13 Q0 30060526 156 33.010902 imi_mug_run_2_treatment "combinations" "adc" "level"
13 Q0 25691052 157 32.7865 imi_mug_run_2_treatment "ras" "drugs" "kinase inhibitor"
13 Q0 25676401 158 32.782356 imi_mug_run_2_treatment "crizotinib"
13 Q0 29364576 159 32.756805 imi_mug_run_2_treatment "ras"
13 Q0 28280984 160 32.66815 imi_mug_run_2_treatment "drugs" "blockade"
13 Q0 27068398 161 32.61184 imi_mug_run_2_treatment "crizotinib" "ras" "ponatinib"
13 Q0 30133144 162 32.602745 imi_mug_run_2_treatment "alectinib"
13 Q0 26437441 163 32.56533 imi_mug_run_2_treatment "drugs" "dsb"
13 Q0 29372517 164 32.516815 imi_mug_run_2_treatment "aim"
13 Q0 27017063 165 32.44153 imi_mug_run_2_treatment "agent" "egfr tyrosine kinase inhibitors" "aim"
13 Q0 25846554 166 32.2767 imi_mug_run_2_treatment "crizotinib"
13 Q0 24920890 167 32.190796 imi_mug_run_2_treatment "srif" "collagen"
13 Q0 28743163 168 32.17195 imi_mug_run_2_treatment "icc" "color"
13 Q0 30268483 169 32.04913 imi_mug_run_2_treatment "erlotinib" "blockade"
13 Q0 28759046 170 32.04548 imi_mug_run_2_treatment "mediated" "level"
13 Q0 25796500 171 32.023884 imi_mug_run_2_treatment "suppressor"
13 Q0 21798574 172 32.023884 imi_mug_run_2_treatment "cisplatin" "drug"
13 Q0 24469108 173 31.974617 imi_mug_run_2_treatment "agar"
13 Q0 23181703 174 31.963715 imi_mug_run_2_treatment "erlotinib" "platinum"
13 Q0 29327716 175 31.935518 imi_mug_run_2_treatment "level" "drugs" "crizotinib"
13 Q0 29227119 176 31.893505 imi_mug_run_2_treatment "aim"
13 Q0 22327624 177 31.867893 imi_mug_run_2_treatment "vandetanib" "tyrosine kinase inhibitor"
13 Q0 23661334 178 31.864862 imi_mug_run_2_treatment "pace"
13 Q0 30410351 179 31.717869 imi_mug_run_2_treatment "crizotinib" "tyrosine kinase inhibitor"
13 Q0 27370605 180 31.716742 imi_mug_run_2_treatment "cabozantinib" "drugs" "crizotinib"
13 Q0 27009821 181 31.703102 imi_mug_run_2_treatment "crizotinib" "aim"
13 Q0 25349307 182 31.62033 imi_mug_run_2_treatment "alectinib" "antitumor agents" "crizotinib"
13 Q0 29771657 183 31.607569 imi_mug_run_2_treatment "ras" "aim"
13 Q0 30144837 184 31.585188 imi_mug_run_2_treatment "gefitinib" "erlotinib" "agent"
13 Q0 29961337 185 31.574516 imi_mug_run_2_treatment "drug" "crizotinib"
13 Q0 22617245 186 31.44965 imi_mug_run_2_treatment "crizotinib" "imatinib" "erlotinib"
13 Q0 28346673 187 31.440083 imi_mug_run_2_treatment "crizotinib"
13 Q0 23991695 188 31.405766 imi_mug_run_2_treatment "tyrosine" "vandetanib" "xl184"
13 Q0 22140546 189 31.36999 imi_mug_run_2_treatment "tyrosine kinase inhibitor"
13 Q0 22483782 190 31.367317 imi_mug_run_2_treatment "level"
13 Q0 27328934 191 31.30809 imi_mug_run_2_treatment "crizotinib" "duration" "crizotinib 250 mg"
13 Q0 23070242 192 31.279133 imi_mug_run_2_treatment "kinase inhibitor" "drugs"
13 Q0 28332047 193 31.234411 imi_mug_run_2_treatment "osimertinib"
13 Q0 27535395 194 30.949848 imi_mug_run_2_treatment "lead"
13 Q0 30049378 195 30.911724 imi_mug_run_2_treatment "crizotinib"
13 Q0 23919423 196 30.875881 imi_mug_run_2_treatment "drug combination"
13 Q0 24163741 197 30.871563 imi_mug_run_2_treatment "adc" "lead" "revolution"
13 Q0 22915320 198 30.747292 imi_mug_run_2_treatment "level"
13 Q0 27056998 199 30.703054 imi_mug_run_2_treatment "pemetrexed"
13 Q0 19383809 200 30.689869 imi_mug_run_2_treatment "dextran"
13 Q0 26837769 201 30.68533 imi_mug_run_2_treatment "igf2" "insulin-like growth factor 2"
13 Q0 23664446 202 30.604506 imi_mug_run_2_treatment "kinase inhibitor" "crizotinib"
13 Q0 27080983 203 30.590115 imi_mug_run_2_treatment "aim"
13 Q0 25208991 204 30.539165 imi_mug_run_2_treatment "color"
13 Q0 26813592 205 30.52163 imi_mug_run_2_treatment "crizotinib" "aim"
13 Q0 2555985 206 30.485676 imi_mug_run_2_treatment "immunotoxin" "cytotoxic" "abc"
13 Q0 26379824 207 30.375381 imi_mug_run_2_treatment "drugs" "medication"
13 Q0 22500682 208 30.355791 imi_mug_run_2_treatment "kinase inhibitor" "crizotinib" "pace"
13 Q0 20731934 209 30.333103 imi_mug_run_2_treatment "aim"
13 Q0 29187012 210 30.291199 imi_mug_run_2_treatment "crizotinib" "ceritinib" "alectinib"
13 Q0 26893862 211 30.28595 imi_mug_run_2_treatment "drugs" "carboplatin" "agent"
13 Q0 25905642 212 30.269135 imi_mug_run_2_treatment "tma"
13 Q0 28619094 213 30.267445 imi_mug_run_2_treatment "aim"
13 Q0 24510538 214 30.255447 imi_mug_run_2_treatment "various" "mediated" "cytotoxic"
13 Q0 29801706 215 30.116528 imi_mug_run_2_treatment "crizotinib" "therapeutics"
13 Q0 26901483 216 30.08915 imi_mug_run_2_treatment "ras"
13 Q0 29981925 217 29.945683 imi_mug_run_2_treatment "crizotinib" "others"
13 Q0 26268749 218 29.931643 imi_mug_run_2_treatment "crizotinib"
13 Q0 29549897 219 29.931108 imi_mug_run_2_treatment "various" "tma"
13 Q0 29335598 220 29.840805 imi_mug_run_2_treatment "pemetrexed"
13 Q0 30293943 221 29.722687 imi_mug_run_2_treatment "drugs"
13 Q0 23489560 222 29.464394 imi_mug_run_2_treatment "various" "drugs"
13 Q0 27480287 223 29.42746 imi_mug_run_2_treatment "ceritinib" "crizotinib" "food"
13 Q0 28063177 224 29.387901 imi_mug_run_2_treatment "adc" "afatinib"
13 Q0 27756333 225 29.328722 imi_mug_run_2_treatment "pemetrexed" "platinum" "crizotinib"
13 Q0 28502721 226 29.31586 imi_mug_run_2_treatment "crizotinib"
13 Q0 29128428 227 29.31075 imi_mug_run_2_treatment "drug"
13 Q0 21428883 228 29.242294 imi_mug_run_2_treatment "various" "erlotinib" "tyrosine"
13 Q0 28520527 229 29.238762 imi_mug_run_2_treatment "ceritinib" "duration" "crizotinib"
13 Q0 30326973 230 29.15001 imi_mug_run_2_treatment "mtp"
13 Q0 26703339 231 29.104376 imi_mug_run_2_treatment "crizotinib"
13 Q0 27613526 232 29.10008 imi_mug_run_2_treatment "pdx" "crizotinib" "product"
13 Q0 21129606 233 29.034382 imi_mug_run_2_treatment "drugs" "egfr tyrosine kinase inhibitors"
13 Q0 23932363 234 28.97127 imi_mug_run_2_treatment "color"
13 Q0 28318251 235 28.942402 imi_mug_run_2_treatment "basis" "crizotinib" "pf-06463922"
13 Q0 23769348 236 28.90828 imi_mug_run_2_treatment "crizotinib" "drug" "epidermal growth factor receptor tyrosine kinase inhibitor"
13 Q0 27987587 237 28.902174 imi_mug_run_2_treatment "crizotinib"
13 Q0 26775573 238 28.820183 imi_mug_run_2_treatment "crizotinib" "program" "gefitinib"
13 Q0 26802023 239 28.807415 imi_mug_run_2_treatment "crizotinib"
13 Q0 24388371 240 28.806755 imi_mug_run_2_treatment "basis"
13 Q0 28362192 241 28.771078 imi_mug_run_2_treatment "crizotinib"
13 Q0 28851076 242 28.693472 imi_mug_run_2_treatment "cisplatin" "level"
13 Q0 26301689 243 28.638891 imi_mug_run_2_treatment "ras" "duration"
13 Q0 27298405 244 28.631641 imi_mug_run_2_treatment "avid"
13 Q0 29596029 245 28.59582 imi_mug_run_2_treatment "crizotinib" "duration"
13 Q0 19706765 246 28.571905 imi_mug_run_2_treatment "interleukin-6"
13 Q0 23301645 247 28.499073 imi_mug_run_2_treatment "various" "crizotinib" "mediated"
13 Q0 20593550 248 28.496777 imi_mug_run_2_treatment "erlotinib" "platinum" "vascular endothelial growth factor trap"
13 Q0 26268359 249 28.493734 imi_mug_run_2_treatment "ras" "formalin"
13 Q0 27438512 250 28.463425 imi_mug_run_2_treatment "various"
13 Q0 25785456 251 28.36409 imi_mug_run_2_treatment "crizotinib"
13 Q0 28321808 252 28.358753 imi_mug_run_2_treatment "cisplatin" "vinorelbine"
13 Q0 24997577 253 28.244907 imi_mug_run_2_treatment "crizotinib"
13 Q0 6362852 254 28.19654 imi_mug_run_2_treatment "monoclonal antibodies" "dodecyl sulfate"
13 Q0 28898463 255 28.195644 imi_mug_run_2_treatment "calcium" "tyrosine kinase inhibitor" "basis"
13 Q0 23625156 256 28.140694 imi_mug_run_2_treatment "adc"
13 Q0 27418132 257 28.066341 imi_mug_run_2_treatment "crizotinib" "kinase inhibitor" "food"
13 Q0 27877008 258 28.006525 imi_mug_run_2_treatment "crizotinib"
13 Q0 29587667 259 27.93528 imi_mug_run_2_treatment "pemetrexed" "drugs" "aim"
13 Q0 22987962 260 27.81517 imi_mug_run_2_treatment "product"
13 Q0 22594847 261 27.710941 imi_mug_run_2_treatment "crizotinib" "product" "tyrosine kinase inhibitor"
13 Q0 30131091 262 27.708406 imi_mug_run_2_treatment "cabozantinib" "osimertinib"
13 Q0 23841470 263 27.660482 imi_mug_run_2_treatment "platinum" "prompt"
13 Q0 25364439 264 27.54342 imi_mug_run_2_treatment "crizotinib" "tyrosine kinase inhibitor" "level"
13 Q0 28555282 265 27.525578 imi_mug_run_2_treatment "sucrose"
13 Q0 27467545 266 27.525064 imi_mug_run_2_treatment "adc" "aim"
13 Q0 29401004 267 27.464476 imi_mug_run_2_treatment "amp"
13 Q0 27686809 268 27.426294 imi_mug_run_2_treatment "gefitinib" "erlotinib" "drugs"
13 Q0 27144064 269 27.353971 imi_mug_run_2_treatment "ras"
13 Q0 24899136 270 27.32316 imi_mug_run_2_treatment "air"
13 Q0 19155514 271 27.317413 imi_mug_run_2_treatment "aim" "brdu" "cytokines"
13 Q0 19734849 272 27.31289 imi_mug_run_2_treatment "level"
13 Q0 30230541 273 27.238422 imi_mug_run_2_treatment "gefitinib" "osimertinib"
13 Q0 12665627 274 27.181335 imi_mug_run_2_treatment "calcium phosphate" "biotin" "mediated"
13 Q0 24872405 275 27.143326 imi_mug_run_2_treatment "crizotinib" "drug" "prednisolone"
13 Q0 15010834 276 27.129107 imi_mug_run_2_treatment "gcv" "ganciclovir" "mediated"
13 Q0 25534130 277 27.084156 imi_mug_run_2_treatment "metmab"
13 Q0 25588859 278 27.07993 imi_mug_run_2_treatment "crizotinib"
13 Q0 25567908 279 27.050144 imi_mug_run_2_treatment "agent"
13 Q0 30218431 280 27.038471 imi_mug_run_2_treatment "crizotinib" "duration" "aim"
13 Q0 30050303 281 27.012024 imi_mug_run_2_treatment "tyrosine kinase inhibitor" "entrectinib" "drug"
13 Q0 28840016 282 27.007656 imi_mug_run_2_treatment "adc"
13 Q0 27969452 283 26.98272 imi_mug_run_2_treatment "crizotinib"
13 Q0 8334453 284 26.90349 imi_mug_run_2_treatment "therapeutics"
13 Q0 1598801 285 26.841124 imi_mug_run_2_treatment "proteinase" "iodogen"
13 Q0 29325035 286 26.819544 imi_mug_run_2_treatment "plasma" "osimertinib"
13 Q0 28018791 287 26.638376 imi_mug_run_2_treatment "ceritinib" "crizotinib"
13 Q0 27797842 288 26.63084 imi_mug_run_2_treatment "drug" "crizotinib" "ceritinib"
13 Q0 26939704 289 26.607607 imi_mug_run_2_treatment "entrectinib" "drug" "drug's"
13 Q0 27045755 290 26.579147 imi_mug_run_2_treatment "crizotinib" "product"
13 Q0 1718742 291 26.563707 imi_mug_run_2_treatment "tyrosine"
13 Q0 25558789 292 26.563707 imi_mug_run_2_treatment "crizotinib" "tyrosine kinase inhibitor"
13 Q0 29541220 293 26.47003 imi_mug_run_2_treatment "aim"
13 Q0 27769042 294 26.456095 imi_mug_run_2_treatment "various" "crizotinib"
13 Q0 28065467 295 26.43695 imi_mug_run_2_treatment "various" "adc"
13 Q0 28683775 296 26.42121 imi_mug_run_2_treatment "alectinib" "cisplatin" "vinorelbine"
13 Q0 20624322 297 26.407331 imi_mug_run_2_treatment "lead"
13 Q0 27863497 298 26.400513 imi_mug_run_2_treatment "crizotinib"
13 Q0 21562939 299 26.396849 imi_mug_run_2_treatment "estrogen" "gefitinib"
13 Q0 24667260 300 26.396627 imi_mug_run_2_treatment "aim"
13 Q0 25806218 301 26.348457 imi_mug_run_2_treatment "crizotinib"
13 Q0 1834175 302 26.344337 imi_mug_run_2_treatment "calcium" "surfactant" "lung surfactant"
13 Q0 27494860 303 26.343971 imi_mug_run_2_treatment "apatinib" "mediated" "aim"
13 Q0 25477232 304 26.339375 imi_mug_run_2_treatment "taxane"
13 Q0 22707299 305 26.30424 imi_mug_run_2_treatment "aim"
13 Q0 16201231 306 26.187069 imi_mug_run_2_treatment "calcium"
13 Q0 24742568 307 26.180735 imi_mug_run_2_treatment "adc"
13 Q0 23731739 308 26.179653 imi_mug_run_2_treatment "erlotinib" "crizotinib"
13 Q0 25230898 309 26.15698 imi_mug_run_2_treatment "crizotinib"
13 Q0 22980554 310 26.154884 imi_mug_run_2_treatment "crizotinib" "kinase inhibitor" "vinorelbine"
13 Q0 18242762 311 26.154213 imi_mug_run_2_treatment "ras"
13 Q0 29074098 312 26.125143 imi_mug_run_2_treatment "lorlatinib" "crizotinib" "tyrosine kinase inhibitor"
13 Q0 26457764 313 25.951305 imi_mug_run_2_treatment "various" "entrectinib" "agent"
13 Q0 24940496 314 25.902645 imi_mug_run_2_treatment "crizotinib" "pemetrexed"
13 Q0 29469073 315 25.867294 imi_mug_run_2_treatment "crizotinib"
13 Q0 23578175 316 25.692469 imi_mug_run_2_treatment "vandetanib"
13 Q0 26666609 317 25.679695 imi_mug_run_2_treatment "crizotinib"
13 Q0 23052178 318 25.648657 imi_mug_run_2_treatment "azathioprine" "crizotinib"
13 Q0 21656749 319 25.642155 imi_mug_run_2_treatment "various"
13 Q0 6090307 320 25.47537 imi_mug_run_2_treatment "monoclonal antibodies"
13 Q0 29460035 321 25.457634 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors" "crizotinib"
13 Q0 23904459 322 25.308615 imi_mug_run_2_treatment "adc"
13 Q0 6091874 323 25.153736 imi_mug_run_2_treatment "monoclonal antibodies" "sodium dodecyl sulfate"
13 Q0 27496134 324 25.098455 imi_mug_run_2_treatment "vandetanib" "ponatinib" "lenvatinib"
13 Q0 11975760 325 25.081444 imi_mug_run_2_treatment "interleukin" "animals"
13 Q0 23688269 326 25.07214 imi_mug_run_2_treatment "ras"
13 Q0 22898526 327 25.023865 imi_mug_run_2_treatment "air" "duration" "autologous"
13 Q0 23264847 328 25.011366 imi_mug_run_2_treatment "various" "therapeutics" "drugs"
13 Q0 29261000 329 25.002892 imi_mug_run_2_treatment "apatinib" "docetaxel" "kinase inhibitor"
13 Q0 28381877 330 24.998957 imi_mug_run_2_treatment "level"
13 Q0 30155324 331 24.953587 imi_mug_run_2_treatment "crizotinib" "drug" "tyrosine kinase inhibitor"
13 Q0 26076869 332 24.922585 imi_mug_run_2_treatment "new drugs" "others" "monoclonal antibodies"
13 Q0 23790969 333 24.835613 imi_mug_run_2_treatment "crizotinib" "tyrosine kinase inhibitor"
13 Q0 29066671 334 24.833359 imi_mug_run_2_treatment "oligo" "others"
13 Q0 28829490 335 24.792002 imi_mug_run_2_treatment "crizotinib"
13 Q0 25581823 336 24.771723 imi_mug_run_2_treatment "various" "crizotinib" "alectinib"
13 Q0 23794492 337 24.751778 imi_mug_run_2_treatment "adc" "therapeutics" "aim"
13 Q0 22351502 338 24.732159 imi_mug_run_2_treatment "gemcitabin" "carboplatin" "cetuximab"
13 Q0 24946519 339 24.65701 imi_mug_run_2_treatment "drugs"
13 Q0 25995428 340 24.642841 imi_mug_run_2_treatment "agent"
13 Q0 26893860 341 24.607288 imi_mug_run_2_treatment "pas" "ras"
13 Q0 23930754 342 24.598858 imi_mug_run_2_treatment "duration" "aim"
13 Q0 24323028 343 24.556211 imi_mug_run_2_treatment "therapeutics"
13 Q0 26689248 344 24.536205 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
13 Q0 19064915 345 24.481382 imi_mug_run_2_treatment "animals"
13 Q0 27403614 346 24.471977 imi_mug_run_2_treatment "medicine"
13 Q0 22989574 347 24.45383 imi_mug_run_2_treatment "crizotinib" "medicine"
13 Q0 25436805 348 24.434746 imi_mug_run_2_treatment "cabozantinib" "prompt"
13 Q0 30262706 349 24.421528 imi_mug_run_2_treatment "calcium phosphate" "hot spot"
13 Q0 24623980 350 24.363775 imi_mug_run_2_treatment "kinase inhibitor" "basis" "crizotinib"
13 Q0 24156959 351 24.351265 imi_mug_run_2_treatment "crizotinib"
13 Q0 24327273 352 24.313887 imi_mug_run_2_treatment "crizotinib" "docetaxel" "pemetrexed"
13 Q0 25047660 353 24.287483 imi_mug_run_2_treatment "basis"
13 Q0 24857785 354 24.258545 imi_mug_run_2_treatment "gefitinib" "erlotinib"
13 Q0 28818608 355 24.182526 imi_mug_run_2_treatment "serine" "lead" "egfr tyrosine kinase inhibitors"
13 Q0 23637631 356 24.180527 imi_mug_run_2_treatment "level"
13 Q0 27535394 357 24.145536 imi_mug_run_2_treatment "crizotinib" "platinum" "cisplatin"
13 Q0 11050472 358 24.128807 imi_mug_run_2_treatment "mabs" "proteinase" "monoclonal antibodies"
13 Q0 16551617 359 24.02298 imi_mug_run_2_treatment "drug" "superoxide dismutase"
13 Q0 29526181 360 24.008158 imi_mug_run_2_treatment "drugs"
13 Q0 28786099 361 23.986217 imi_mug_run_2_treatment "drug" "egfr inhibitor"
13 Q0 6276266 362 23.972864 imi_mug_run_2_treatment "various" "iododeoxyuridine" "others"
13 Q0 26391251 363 23.965433 imi_mug_run_2_treatment "adc" "basis"
13 Q0 25757678 364 23.926855 imi_mug_run_2_treatment "crizotinib" "crizotinib's"
13 Q0 24229629 365 23.853994 imi_mug_run_2_treatment "tarceva" "crizotinib"
13 Q0 25999733 366 23.789455 imi_mug_run_2_treatment "crizotinib" "various" "drugs"
13 Q0 27873490 367 23.715046 imi_mug_run_2_treatment "vandetanib" "kinase inhibitor" "sunitinib"
13 Q0 2540427 368 23.692938 imi_mug_run_2_treatment "various" "ras"
13 Q0 27150058 369 23.670689 imi_mug_run_2_treatment "vandetanib"
13 Q0 28167572 370 23.64748 imi_mug_run_2_treatment "crizotinib" "alectinib" "interleukin-3"
13 Q0 7488637 371 23.644054 imi_mug_run_2_treatment "lung surfactant" "mediated" "anx"
13 Q0 25237908 372 23.62693 imi_mug_run_2_treatment "various"
13 Q0 30010043 373 23.554935 imi_mug_run_2_treatment "crizotinib" "tyrosine kinase inhibitor"
13 Q0 23918070 374 23.47971 imi_mug_run_2_treatment "docetaxel" "favor" "gefitinib"
13 Q0 28911147 375 23.433777 imi_mug_run_2_treatment "ptc"
13 Q0 7972041 376 23.418201 imi_mug_run_2_treatment "animals"
13 Q0 27413712 377 23.349092 imi_mug_run_2_treatment "crizotinib" "ch5424802" "ro5424802"
13 Q0 24420742 378 23.346024 imi_mug_run_2_treatment "basis"
13 Q0 24810493 379 23.336174 imi_mug_run_2_treatment "carboplatin" "paclitaxel" "s-1"
13 Q0 18166835 380 23.313183 imi_mug_run_2_treatment "product"
13 Q0 26191258 381 23.30273 imi_mug_run_2_treatment "monoclonal antibodies"
13 Q0 24292963 382 23.253622 imi_mug_run_2_treatment "various" "ras"
13 Q0 23533264 383 23.22128 imi_mug_run_2_treatment "cabozantinib"
13 Q0 25806314 384 23.203465 imi_mug_run_2_treatment "antiangiogenic"
13 Q0 25708242 385 23.139313 imi_mug_run_2_treatment "aim"
13 Q0 25989941 386 23.13322 imi_mug_run_2_treatment "adc"
13 Q0 25695223 387 23.072662 imi_mug_run_2_treatment "erlotinib" "crizotinib" "epidermal growth factor"
13 Q0 27499265 388 23.022974 imi_mug_run_2_treatment "ipa" "phb" "prohibitin"
13 Q0 22350957 389 22.996187 imi_mug_run_2_treatment "lead"
13 Q0 25806349 390 22.99614 imi_mug_run_2_treatment "nedaplatin" "agent" "abraxane"
13 Q0 23328547 391 22.984066 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
13 Q0 22696596 392 22.96968 imi_mug_run_2_treatment "matrix"
13 Q0 25131476 393 22.95731 imi_mug_run_2_treatment "eosin" "color"
13 Q0 28296772 394 22.917423 imi_mug_run_2_treatment "various" "liver"
13 Q0 25122427 395 22.881905 imi_mug_run_2_treatment "vandetanib" "ponatinib" "blockade"
13 Q0 11286831 396 22.876404 imi_mug_run_2_treatment "deoxyglucose"
13 Q0 21029578 397 22.876085 imi_mug_run_2_treatment "agar" "polyethylene glycol" "cancer vaccines"
13 Q0 21549910 398 22.87201 imi_mug_run_2_treatment "gefitinib" "erlotinib" "emla"
13 Q0 28082048 399 22.810032 imi_mug_run_2_treatment "cabozantinib" "platinum" "pembrolizumab"
13 Q0 28231386 400 22.798971 imi_mug_run_2_treatment "tma" "aim"
13 Q0 28073897 401 22.766144 imi_mug_run_2_treatment "formalin"
13 Q0 28950338 402 22.737476 imi_mug_run_2_treatment "kinase inhibitor" "afatinib" "program"
13 Q0 15578922 403 22.651358 imi_mug_run_2_treatment "drugs" "gonadotropin releasing hormone" "gnrh analog"
13 Q0 21757253 404 22.63306 imi_mug_run_2_treatment "drug" "pf02341066" "crizotinib"
13 Q0 25614375 405 22.622698 imi_mug_run_2_treatment "aim"
13 Q0 27969474 406 22.563927 imi_mug_run_2_treatment "gefitinib"
13 Q0 2413999 407 22.557796 imi_mug_run_2_treatment "various" "proteases" "mouse monoclonal antibody"
13 Q0 24279718 408 22.536427 imi_mug_run_2_treatment "crizotinib" "drug" "kinase inhibitor"
13 Q0 24354593 409 22.535984 imi_mug_run_2_treatment "protein kinase inhibitors" "crizotinib" "dacomitinib"
13 Q0 20923647 410 22.531937 imi_mug_run_2_treatment "mediated" "lung surfactant" "shape"
13 Q0 24744988 411 22.529076 imi_mug_run_2_treatment "cdx" "drug" "crizotinib"
13 Q0 30074936 412 22.5086 imi_mug_run_2_treatment "alectinib" "apatinib" "drug"
13 Q0 19352325 413 22.49413 imi_mug_run_2_treatment "therapeutics" "aim" "balance"
13 Q0 26200282 414 22.454983 imi_mug_run_2_treatment "crizotinib"
13 Q0 21921848 415 22.453007 imi_mug_run_2_treatment "color"
13 Q0 26045672 416 22.358133 imi_mug_run_2_treatment "drug" "aim"
13 Q0 21475478 417 22.323814 imi_mug_run_2_treatment "glucose"
13 Q0 26842788 418 22.31791 imi_mug_run_2_treatment "platinum" "aim"
13 Q0 24727987 419 22.271957 imi_mug_run_2_treatment "drugs"
13 Q0 1706786 420 22.226295 imi_mug_run_2_treatment "various" "biotin"
13 Q0 20952506 421 22.203592 imi_mug_run_2_treatment "kinase inhibitor" "carboplatin" "paclitaxel"
13 Q0 29085074 422 22.137753 imi_mug_run_2_treatment "bdnf" "nervous system" "rxdx-101"
13 Q0 23507588 423 22.115494 imi_mug_run_2_treatment "gefitinib" "erlotinib" "platinum"
13 Q0 25982012 424 22.098686 imi_mug_run_2_treatment "vandetanib" "everolimus" "kinase inhibitor"
13 Q0 23664537 425 22.002926 imi_mug_run_2_treatment "formalin"
13 Q0 26377589 426 22.001028 imi_mug_run_2_treatment "cabozantinib" "vandetanib" "sunitinib"
13 Q0 24857124 427 21.961267 imi_mug_run_2_treatment "crizotinib" "gefitinib" "erlotinib"
13 Q0 22980976 428 21.927965 imi_mug_run_2_treatment "enzymes"
13 Q0 29057233 429 21.927965 imi_mug_run_2_treatment "therapeutics" "revolution"
13 Q0 26527886 430 21.91217 imi_mug_run_2_treatment "various" "aim" "suppressor"
13 Q0 25708035 431 21.904337 imi_mug_run_2_treatment "corrective" "symmetry"
13 Q0 24140933 432 21.88995 imi_mug_run_2_treatment "crizotinib" "liver"
13 Q0 28410289 433 21.827732 imi_mug_run_2_treatment "sestamibi" "aim"
13 Q0 26620497 434 21.819742 imi_mug_run_2_treatment "crizotinib" "afatinib" "drug"
13 Q0 27080225 435 21.797112 imi_mug_run_2_treatment "amino acid" "liver"
13 Q0 25087901 436 21.789732 imi_mug_run_2_treatment "crizotinib"
13 Q0 29935846 437 21.789732 imi_mug_run_2_treatment "crizotinib" "osimertinib"
13 Q0 15739095 438 21.788906 imi_mug_run_2_treatment "mediated" "ginseng"
13 Q0 12876301 439 21.76306 imi_mug_run_2_treatment "androgen" "luteinizing hormone-releasing hormone" "thioredoxin"
13 Q0 26462554 440 21.757755 imi_mug_run_2_treatment "aim"
13 Q0 29101158 441 21.663113 imi_mug_run_2_treatment "lorlatinib"
13 Q0 28609321 442 21.65548 imi_mug_run_2_treatment "symmetry" "aim"
13 Q0 8153308 443 21.641352 imi_mug_run_2_treatment "glucose"
13 Q0 30105645 444 21.634811 imi_mug_run_2_treatment "blockade"
13 Q0 26667344 445 21.6142 imi_mug_run_2_treatment "crizotinib"
13 Q0 18687171 446 21.607092 imi_mug_run_2_treatment "tnf-alpha" "mediators" "eosin"
13 Q0 29130105 447 21.6069 imi_mug_run_2_treatment "hot spot"
13 Q0 29958730 448 21.60545 imi_mug_run_2_treatment "aim"
13 Q0 6684641 449 21.574516 imi_mug_run_2_treatment "various" "plasminogen activator"
13 Q0 29877554 450 21.554512 imi_mug_run_2_treatment "drugs"
13 Q0 17765009 451 21.529804 imi_mug_run_2_treatment "diacylglycerol" "mediated" "lung surfactant"
13 Q0 18320074 452 21.51918 imi_mug_run_2_treatment "level"
13 Q0 20433995 453 21.506306 imi_mug_run_2_treatment "ttf-ngr" "fibrin"
13 Q0 2474040 454 21.505302 imi_mug_run_2_treatment "ethanol" "ns-1"
13 Q0 18537561 455 21.503025 imi_mug_run_2_treatment "therapeutics" "new drugs" "liver"
13 Q0 12131730 456 21.455702 imi_mug_run_2_treatment "various" "autologous"
13 Q0 29130101 457 21.434477 imi_mug_run_2_treatment "agent"
13 Q0 21232014 458 21.418087 imi_mug_run_2_treatment "oxygen" "dehydroascorbic acid" "mediated"
13 Q0 25394854 459 21.405273 imi_mug_run_2_treatment "cisplatin" "drug" "drugs"
13 Q0 29697418 460 21.372215 imi_mug_run_2_treatment "various"
13 Q0 26798590 461 21.340828 imi_mug_run_2_treatment "alectinib"
13 Q0 11422498 462 21.306921 imi_mug_run_2_treatment "product"
13 Q0 25665893 463 21.2929 imi_mug_run_2_treatment "pemetrexed" "bevacizumab" "platinum"
13 Q0 29910649 464 21.2929 imi_mug_run_2_treatment "crizotinib" "alectinib" "osimertinib"
13 Q0 28391773 465 21.289623 imi_mug_run_2_treatment "adjuvant"
13 Q0 26045865 466 21.231041 imi_mug_run_2_treatment "crizotinib"
13 Q0 24565585 467 21.228228 imi_mug_run_2_treatment "drugs"
13 Q0 29199691 468 21.21912 imi_mug_run_2_treatment "crizotinib"
13 Q0 27401797 469 21.202131 imi_mug_run_2_treatment "drug" "lorlatinib"
13 Q0 28960893 470 21.17416 imi_mug_run_2_treatment "crizotinib" "tyrosine kinase inhibitor" "lead"
13 Q0 28677170 471 21.159332 imi_mug_run_2_treatment "methylated"
13 Q0 24346098 472 21.139336 imi_mug_run_2_treatment "vinorelbine" "pemetrexed" "cetuximab"
13 Q0 29114473 473 21.127201 imi_mug_run_2_treatment "various"
13 Q0 17521235 474 21.111996 imi_mug_run_2_treatment "surfactant" "liver"
13 Q0 18726295 475 21.059406 imi_mug_run_2_treatment "recombinant human gm-csf" "normal saline"
13 Q0 8033110 476 21.04054 imi_mug_run_2_treatment "nitrosobis(2-oxopropyl)amine" "product"
13 Q0 18650784 477 21.029049 imi_mug_run_2_treatment "antithrombin" "etanercept" "mediated"
13 Q0 19112200 478 21.028664 imi_mug_run_2_treatment "glucose"
13 Q0 20705596 479 21.00573 imi_mug_run_2_treatment "dex" "dexamethasone" "hydroxyproline"
13 Q0 21499238 480 20.99481 imi_mug_run_2_treatment "serine"
13 Q0 26530085 481 20.956928 imi_mug_run_2_treatment "aim"
13 Q0 27573756 482 20.885 imi_mug_run_2_treatment "crizotinib" "tyrosine kinase inhibitor"
13 Q0 27447897 483 20.8811 imi_mug_run_2_treatment "basis"
13 Q0 7046915 484 20.828684 imi_mug_run_2_treatment "monoclonal antibodies"
13 Q0 21220230 485 20.820965 imi_mug_run_2_treatment "adjuvant" "gemcitabine" "imatinib"
13 Q0 29199697 486 20.820965 imi_mug_run_2_treatment "color" "crizotinib" "ceritinib"
13 Q0 21102267 487 20.803465 imi_mug_run_2_treatment "gefitinib"
13 Q0 23584301 488 20.80061 imi_mug_run_2_treatment "vandetanib"
13 Q0 28000627 489 20.798496 imi_mug_run_2_treatment "drugs"
13 Q0 30225407 490 20.78984 imi_mug_run_2_treatment "crizotinib" "kinase inhibitor" "plasma"
13 Q0 22655265 491 20.786194 imi_mug_run_2_treatment "drug"
13 Q0 29703539 492 20.781979 imi_mug_run_2_treatment "alectinib"
13 Q0 30368418 493 20.781979 imi_mug_run_2_treatment "crizotinib"
13 Q0 26291023 494 20.781738 imi_mug_run_2_treatment "sunitinib"
13 Q0 28605874 495 20.748009 imi_mug_run_2_treatment "cytokines" "interleukin"
13 Q0 24346091 496 20.734865 imi_mug_run_2_treatment "ras"
13 Q0 26144315 497 20.721394 imi_mug_run_2_treatment "pf-06463922"
13 Q0 28955006 498 20.708797 imi_mug_run_2_treatment "alectinib" "lead" "step 2"
13 Q0 2422274 499 20.687855 imi_mug_run_2_treatment "basis" "human igm"
13 Q0 6207911 500 20.68685 imi_mug_run_2_treatment "monoclonal antibodies" "liver" "animals"
13 Q0 30391211 501 20.669191 imi_mug_run_2_treatment "various"
13 Q0 29057232 502 20.659245 imi_mug_run_2_treatment "drug"
13 Q0 30282874 503 20.659245 imi_mug_run_2_treatment "drugs" "pembrolizumab"
13 Q0 24417083 504 20.647858 imi_mug_run_2_treatment "basis"
13 Q0 28638113 505 20.629993 imi_mug_run_2_treatment "hot spot"
13 Q0 27007084 506 20.616367 imi_mug_run_2_treatment "adc"
13 Q0 24346090 507 20.50819 imi_mug_run_2_treatment "level"
13 Q0 17575687 508 20.496754 imi_mug_run_2_treatment "interleukin"
13 Q0 28174383 509 20.431274 imi_mug_run_2_treatment "cddp" "cisplatin" "s-1"
13 Q0 26778816 510 20.299786 imi_mug_run_2_treatment "favor"
13 Q0 17295648 511 20.282166 imi_mug_run_2_treatment "collagen" "product"
13 Q0 24165158 512 20.25241 imi_mug_run_2_treatment "nps-1034" "drug" "gefitinib"
13 Q0 10449441 513 20.242416 imi_mug_run_2_treatment "blockade"
13 Q0 26139353 514 20.240433 imi_mug_run_2_treatment "vaccine" "polyethylene glycol" "mediators"
13 Q0 24942367 515 20.233557 imi_mug_run_2_treatment "diacylglycerol"
13 Q0 25795230 516 20.21793 imi_mug_run_2_treatment "nnk" "i3c" "chemopreventive agents"
13 Q0 23385859 517 20.209538 imi_mug_run_2_treatment "crizotinib" "tyrosine kinase inhibitor" "basis"
13 Q0 23408463 518 20.163828 imi_mug_run_2_treatment "buffer" "sodium dodecyl sulfate"
13 Q0 8232306 519 20.160252 imi_mug_run_2_treatment "surfactant" "hgh" "dex"
13 Q0 14566261 520 20.139742 imi_mug_run_2_treatment "beta-galactosidase"
13 Q0 23922677 521 20.115273 imi_mug_run_2_treatment "crizotinib"
13 Q0 26564313 522 20.114607 imi_mug_run_2_treatment "basis"
13 Q0 16315876 523 20.104856 imi_mug_run_2_treatment "vaccine"
13 Q0 24654596 524 20.08213 imi_mug_run_2_treatment "therapeutics" "lead"
13 Q0 11067765 525 20.064388 imi_mug_run_2_treatment "various" "surfactant"
13 Q0 26720421 526 20.039583 imi_mug_run_2_treatment "agent"
13 Q0 26215190 527 20.00452 imi_mug_run_2_treatment "drugs" "adjuvant" "others"
13 Q0 24564548 528 20.00304 imi_mug_run_2_treatment "drug"
13 Q0 22571236 529 20.000948 imi_mug_run_2_treatment "surfactant" "lung surfactant"
13 Q0 29198084 530 19.975042 imi_mug_run_2_treatment "drugs" "her-2" "agent"
13 Q0 23198539 531 19.95612 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
13 Q0 21500543 532 19.948523 imi_mug_run_2_treatment "cesium chloride" "mediated" "cytotoxic"
13 Q0 19737969 533 19.942383 imi_mug_run_2_treatment "mediated"
13 Q0 29666465 534 19.911957 imi_mug_run_2_treatment "various" "interleukins"
13 Q0 24128285 535 19.889812 imi_mug_run_2_treatment "endostatin" "cck-8" "antiangiogenic"
13 Q0 3052807 536 19.889097 imi_mug_run_2_treatment "various" "ethanol"
13 Q0 25824206 537 19.8819 imi_mug_run_2_treatment "basis" "beam"
13 Q0 25322323 538 19.873386 imi_mug_run_2_treatment "crizotinib" "drugs" "tyrosine"
13 Q0 23612660 539 19.872108 imi_mug_run_2_treatment "crizotinib"
13 Q0 19342415 540 19.838093 imi_mug_run_2_treatment "protein c" "antiinflammatory" "fibrin"
13 Q0 30011388 541 19.835106 imi_mug_run_2_treatment "oxygen" "pooled"
13 Q0 28024693 542 19.80119 imi_mug_run_2_treatment "mediated" "crizotinib" "cabozantinib"
13 Q0 8396567 543 19.782097 imi_mug_run_2_treatment "various" "monoclonal antibodies"
13 Q0 29991799 544 19.774286 imi_mug_run_2_treatment "mediated"
13 Q0 23325296 545 19.767506 imi_mug_run_2_treatment "crizotinib"
13 Q0 25302162 546 19.752005 imi_mug_run_2_treatment "gefitinib" "erlotinib" "crizotinib"
13 Q0 23850495 547 19.745317 imi_mug_run_2_treatment "product"
13 Q0 9000570 548 19.736553 imi_mug_run_2_treatment "cytotoxic" "chloroquine" "mediated"
13 Q0 23856031 549 19.700375 imi_mug_run_2_treatment "lenvatinib" "tyrosine kinase inhibitor" "e7080"
13 Q0 15744675 550 19.698753 imi_mug_run_2_treatment "collagen"
13 Q0 27378174 551 19.666424 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitor" "basis" "crizotinib"
13 Q0 17557235 552 19.660301 imi_mug_run_2_treatment "ns-1" "basis" "liver"
13 Q0 17268330 553 19.658066 imi_mug_run_2_treatment "glucose" "radiopharmaceutical"
13 Q0 25971657 554 19.646948 imi_mug_run_2_treatment "alectinib" "drugs" "crizotinib"
13 Q0 27541546 555 19.636105 imi_mug_run_2_treatment "alcohol"
13 Q0 25671264 556 19.635445 imi_mug_run_2_treatment "crizotinib"
13 Q0 25671265 557 19.635445 imi_mug_run_2_treatment "crizotinib"
13 Q0 24496003 558 19.635246 imi_mug_run_2_treatment "crizotinib" "pdx" "aim"
13 Q0 30017832 559 19.627571 imi_mug_run_2_treatment "vandetanib" "cabozantinib" "everolimus"
13 Q0 17569023 560 19.626112 imi_mug_run_2_treatment "various" "aim"
13 Q0 25351503 561 19.59889 imi_mug_run_2_treatment "eacs" "lead"
13 Q0 25414704 562 19.579197 imi_mug_run_2_treatment "various" "human serum albumin" "thioredoxin"
13 Q0 22497683 563 19.56613 imi_mug_run_2_treatment "liver" "basis"
13 Q0 29076877 564 19.564133 imi_mug_run_2_treatment "hot spot"
13 Q0 8168066 565 19.55606 imi_mug_run_2_treatment "basis"
13 Q0 22321727 566 19.527483 imi_mug_run_2_treatment "mediated"
13 Q0 29576302 567 19.526306 imi_mug_run_2_treatment "crizotinib"
13 Q0 12917640 568 19.506817 imi_mug_run_2_treatment "product"
13 Q0 24914066 569 19.461208 imi_mug_run_2_treatment "vaccine" "rsv vaccine"
13 Q0 29424404 570 19.445435 imi_mug_run_2_treatment "rose" "prompt" "aim"
13 Q0 30069759 571 19.437798 imi_mug_run_2_treatment "crizotinib" "drug" "liver"
13 Q0 15140052 572 19.43692 imi_mug_run_2_treatment "interferon-gamma" "polyethylene glycol" "interleukin-2"
13 Q0 25453465 573 19.417082 imi_mug_run_2_treatment "matrix"
13 Q0 27277016 574 19.41143 imi_mug_run_2_treatment "basis"
13 Q0 10699932 575 19.38499 imi_mug_run_2_treatment "carboxypeptidase g2" "cytotoxic drug" "liver"
13 Q0 30108712 576 19.359327 imi_mug_run_2_treatment "kinase inhibitor"
13 Q0 25257380 577 19.348042 imi_mug_run_2_treatment "asc"
13 Q0 22811080 578 19.33028 imi_mug_run_2_treatment "various" "monoclonal antibodies"
13 Q0 27259007 579 19.328026 imi_mug_run_2_treatment "various" "tyrosine"
13 Q0 27213588 580 19.322197 imi_mug_run_2_treatment "factor i" "lead" "animals"
13 Q0 2859687 581 19.292545 imi_mug_run_2_treatment "glucose" "genesis"
13 Q0 21620911 582 19.286083 imi_mug_run_2_treatment "human serum albumin" "thioredoxin" "anti-inflammatory"
13 Q0 25413260 583 19.214315 imi_mug_run_2_treatment "crizotinib" "tyrosine kinase inhibitor"
13 Q0 19968500 584 19.210926 imi_mug_run_2_treatment "shepherdin"
13 Q0 28806116 585 19.19775 imi_mug_run_2_treatment "crizotinib" "nivolumab" "pembrolizumab"
13 Q0 8526861 586 19.19514 imi_mug_run_2_treatment "amp" "tyrosine"
13 Q0 26986751 587 19.184036 imi_mug_run_2_treatment "mediated" "cytotoxic" "therapeutics"
13 Q0 30344944 588 19.178856 imi_mug_run_2_treatment "drug" "medicines" "trametinib"
13 Q0 12527889 589 19.175678 imi_mug_run_2_treatment "various" "retinoid" "retinoic acid"
13 Q0 22989458 590 19.167183 imi_mug_run_2_treatment "drugs"
13 Q0 27180141 591 19.14523 imi_mug_run_2_treatment "platelets"
13 Q0 9386063 592 19.137276 imi_mug_run_2_treatment "basis"
13 Q0 29434222 593 19.12854 imi_mug_run_2_treatment "vandetanib" "drug" "kinase inhibitor"
13 Q0 15994877 594 19.119875 imi_mug_run_2_treatment "product"
13 Q0 21503656 595 19.113068 imi_mug_run_2_treatment "drugs"
13 Q0 21384194 596 19.113068 imi_mug_run_2_treatment "enzymes"
13 Q0 9556216 597 19.109892 imi_mug_run_2_treatment "drug" "cytotoxic" "sugar"
13 Q0 24362875 598 19.100266 imi_mug_run_2_treatment "crizotinib"
13 Q0 7748077 599 19.100218 imi_mug_run_2_treatment "monoclonal antibodies"
13 Q0 25073473 600 19.092619 imi_mug_run_2_treatment "pf06463922" "oxo" "animals"
13 Q0 21542273 601 19.085978 imi_mug_run_2_treatment "lead"
13 Q0 1848084 602 19.075481 imi_mug_run_2_treatment "dexamethasone" "liver" "level"
13 Q0 19345122 603 19.07456 imi_mug_run_2_treatment "aim"
13 Q0 25541622 604 19.05876 imi_mug_run_2_treatment "crizotinib" "liver"
13 Q0 27760592 605 19.056498 imi_mug_run_2_treatment "drugs" "aim"
13 Q0 25884512 606 19.023317 imi_mug_run_2_treatment "drugs"
13 Q0 25373695 607 19.021461 imi_mug_run_2_treatment "medicine" "aim"
13 Q0 25963689 608 19.00562 imi_mug_run_2_treatment "drugs" "mediated"
13 Q0 28077299 609 18.99949 imi_mug_run_2_treatment "various" "crizotinib" "drug"
13 Q0 22787408 610 18.94804 imi_mug_run_2_treatment "revolution"
13 Q0 28529902 611 18.922539 imi_mug_run_2_treatment "combinations" "pembrolizumab" "adjuvant"
13 Q0 20880464 612 18.915936 imi_mug_run_2_treatment "azaguanine" "guanidine" "cancer vaccine"
13 Q0 9518624 613 18.914936 imi_mug_run_2_treatment "lung surfactant" "monolayer" "monolayers"
13 Q0 30195801 614 18.912683 imi_mug_run_2_treatment "basic fibroblast growth factor"
13 Q0 10400765 615 18.905287 imi_mug_run_2_treatment "level" "limited use"
13 Q0 24982409 616 18.903227 imi_mug_run_2_treatment "epidermal growth factor"
13 Q0 15210944 617 18.892315 imi_mug_run_2_treatment "erythropoietin" "mediated"
13 Q0 25173427 618 18.883884 imi_mug_run_2_treatment "crizotinib" "tyrosine kinase inhibitor"
13 Q0 21432019 619 18.882887 imi_mug_run_2_treatment "liver"
13 Q0 28623478 620 18.878553 imi_mug_run_2_treatment "shape"
13 Q0 9486078 621 18.872368 imi_mug_run_2_treatment "beam"
13 Q0 23246132 622 18.87225 imi_mug_run_2_treatment "crizotinib"
13 Q0 19170230 623 18.84982 imi_mug_run_2_treatment "various" "p23" "others"
13 Q0 24566025 624 18.834805 imi_mug_run_2_treatment "erlotinib" "crizotinib" "gefitinib"
13 Q0 7857967 625 18.832943 imi_mug_run_2_treatment "dids" "surfactant" "mediated"
13 Q0 16365579 626 18.830608 imi_mug_run_2_treatment "clot"
13 Q0 24889366 627 18.82288 imi_mug_run_2_treatment "crizotinib" "cisplatin" "carboplatin"
13 Q0 22968077 628 18.82191 imi_mug_run_2_treatment "bafilomycin a1" "blockade"
13 Q0 12940078 629 18.818869 imi_mug_run_2_treatment "glucose"
13 Q0 21911013 630 18.811981 imi_mug_run_2_treatment "lung surfactant" "surfactant" "h89"
13 Q0 6327024 631 18.810125 imi_mug_run_2_treatment "ouabain" "monoclonal antibodies"
13 Q0 22476664 632 18.788464 imi_mug_run_2_treatment "liver"
13 Q0 17618868 633 18.778906 imi_mug_run_2_treatment "cyclic adenosine monophosphate" "lead"
13 Q0 30195415 634 18.777729 imi_mug_run_2_treatment "metric"
13 Q0 28881856 635 18.770863 imi_mug_run_2_treatment "antiangiogenic" "antiangiogenic agents" "bevacizumab"
13 Q0 26136951 636 18.769463 imi_mug_run_2_treatment "drug"
13 Q0 24942490 637 18.751543 imi_mug_run_2_treatment "aim"
13 Q0 11605006 638 18.74678 imi_mug_run_2_treatment "suppressor"
13 Q0 25299566 639 18.741383 imi_mug_run_2_treatment "crizotinib" "testosterone" "tyrosine kinase inhibitor"
13 Q0 27997006 640 18.741383 imi_mug_run_2_treatment "nivolumab" "chemotherapy agents" "docetaxel"
13 Q0 23406861 641 18.725426 imi_mug_run_2_treatment "asa"
13 Q0 7801727 642 18.725016 imi_mug_run_2_treatment "polysaccharide"
13 Q0 15107827 643 18.707508 imi_mug_run_2_treatment "dega" "serine"
13 Q0 29564764 644 18.70719 imi_mug_run_2_treatment "various"
13 Q0 28675026 645 18.677105 imi_mug_run_2_treatment "everolimus" "crizotinib" "ras"
13 Q0 20098007 646 18.670494 imi_mug_run_2_treatment "liver"
13 Q0 16181004 647 18.621826 imi_mug_run_2_treatment "erythropoietin" "mediated"
13 Q0 30505716 648 18.594658 imi_mug_run_2_treatment "medicine" "pembrolizumab"
13 Q0 10518547 649 18.57603 imi_mug_run_2_treatment "aim"
13 Q0 27101025 650 18.569424 imi_mug_run_2_treatment "matrix"
13 Q0 28763691 651 18.558537 imi_mug_run_2_treatment "angiogenesis inhibitors"
13 Q0 29713646 652 18.542873 imi_mug_run_2_treatment "osimertinib"
13 Q0 30413378 653 18.541754 imi_mug_run_2_treatment "lorlatinib" "crizotinib" "kinase inhibitor"
13 Q0 19032370 654 18.540234 imi_mug_run_2_treatment "various"
13 Q0 26898613 655 18.540234 imi_mug_run_2_treatment "sorafenib" "kinase inhibitor"
13 Q0 25531467 656 18.519783 imi_mug_run_2_treatment "genesis"
13 Q0 2369584 657 18.498304 imi_mug_run_2_treatment "surfactant" "lung surfactant" "phosphatidylcholine"
13 Q0 30389658 658 18.4936 imi_mug_run_2_treatment "drug"
13 Q0 15232107 659 18.485622 imi_mug_run_2_treatment "beta-galactosidase" "liver"
13 Q0 21731703 660 18.438766 imi_mug_run_2_treatment "level" "r1881" "androgen"
13 Q0 26392858 661 18.42063 imi_mug_run_2_treatment "eosin"
13 Q0 26292034 662 18.40934 imi_mug_run_2_treatment "air"
13 Q0 28125528 663 18.396217 imi_mug_run_2_treatment "animals" "liver"
13 Q0 20673487 664 18.394638 imi_mug_run_2_treatment "aim"
13 Q0 10974460 665 18.389137 imi_mug_run_2_treatment "liver"
13 Q0 14519080 666 18.377436 imi_mug_run_2_treatment "cytotoxic" "gemcitabine" "targeted toxins"
13 Q0 9607495 667 18.368568 imi_mug_run_2_treatment "liver"
13 Q0 25650807 668 18.368568 imi_mug_run_2_treatment "com"
13 Q0 11273779 669 18.363192 imi_mug_run_2_treatment "isoleucine" "level"
13 Q0 21767331 670 18.359203 imi_mug_run_2_treatment "crizotinib" "tyrosine kinase inhibitor"
13 Q0 23279859 671 18.34726 imi_mug_run_2_treatment "das181"
13 Q0 28932542 672 18.343313 imi_mug_run_2_treatment "icc"
13 Q0 25625428 673 18.343014 imi_mug_run_2_treatment "kinase inhibitor" "vandetanib" "sunitinib"
13 Q0 26933125 674 18.336548 imi_mug_run_2_treatment "ceritinib"
13 Q0 25817339 675 18.315693 imi_mug_run_2_treatment "drug" "level" "cytokines"
13 Q0 23576200 676 18.313972 imi_mug_run_2_treatment "various" "crizotinib"
13 Q0 18931051 677 18.238462 imi_mug_run_2_treatment "pah" "genesis"
13 Q0 15744557 678 18.220629 imi_mug_run_2_treatment "mediated"
13 Q0 27507537 679 18.203602 imi_mug_run_2_treatment "ss1p" "immunotoxin" "cytotoxic"
13 Q0 25182378 680 18.19875 imi_mug_run_2_treatment "protease" "mediated" "cytotoxic"
13 Q0 22749186 681 18.194836 imi_mug_run_2_treatment "various" "iodine" "sodium"
13 Q0 29776229 682 18.193712 imi_mug_run_2_treatment "formalin" "crizotinib"
13 Q0 25386659 683 18.179718 imi_mug_run_2_treatment "crizotinib"
13 Q0 29652780 684 18.171095 imi_mug_run_2_treatment "lead" "duration"
13 Q0 24389446 685 18.15916 imi_mug_run_2_treatment "crizotinib"
13 Q0 26001147 686 18.156765 imi_mug_run_2_treatment "crizotinib"
13 Q0 30366769 687 18.156765 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitor"
13 Q0 6928631 688 18.147808 imi_mug_run_2_treatment "polyethylene glycol"
13 Q0 29774128 689 18.135414 imi_mug_run_2_treatment "drugs" "crizotinib" "ceritinib"
13 Q0 27836576 690 18.102654 imi_mug_run_2_treatment "crizotinib" "tamoxifen" "protein c gene"
13 Q0 10217560 691 18.102114 imi_mug_run_2_treatment "basis"
13 Q0 9186494 692 18.102114 imi_mug_run_2_treatment "phenothiazines" "anx" "promethazine"
13 Q0 21248471 693 18.095068 imi_mug_run_2_treatment "oxygen" "cytotoxic"
13 Q0 25884597 694 18.094282 imi_mug_run_2_treatment "various" "hsvtk" "gcv"
13 Q0 23187307 695 18.075998 imi_mug_run_2_treatment "phenylalanine" "polysaccharide" "suppressor"
13 Q0 21862980 696 18.063824 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
13 Q0 23199019 697 18.048252 imi_mug_run_2_treatment "bevacizumab" "mediators" "vegf trap"
13 Q0 2265408 698 18.044619 imi_mug_run_2_treatment "agar"
13 Q0 28210164 699 18.044104 imi_mug_run_2_treatment "crizotinib" "various" "medicines"
13 Q0 22620005 700 18.044104 imi_mug_run_2_treatment "gefitinib" "erlotinib" "egfr tyrosine kinase inhibitors"
13 Q0 29067878 701 18.028313 imi_mug_run_2_treatment "lorlatinib" "drug" "program"
13 Q0 24304249 702 18.008589 imi_mug_run_2_treatment "insulin" "exubera" "duration"
13 Q0 23018874 703 17.999538 imi_mug_run_2_treatment "tma" "color" "others"
13 Q0 14697159 704 17.999533 imi_mug_run_2_treatment "program"
13 Q0 11260639 705 17.993904 imi_mug_run_2_treatment "various"
13 Q0 28544061 706 17.99381 imi_mug_run_2_treatment "aim"
13 Q0 30034277 707 17.983683 imi_mug_run_2_treatment "level" "medicine"
13 Q0 16483559 708 17.979507 imi_mug_run_2_treatment "various" "staurosporine" "etoh"
13 Q0 27666544 709 17.978214 imi_mug_run_2_treatment "dna methyltransferase inhibitor" "aim"
13 Q0 9799345 710 17.962841 imi_mug_run_2_treatment "glucose"
13 Q0 21148224 711 17.955793 imi_mug_run_2_treatment "antiviral" "drug" "antiviral drug"
13 Q0 10811133 712 17.919535 imi_mug_run_2_treatment "ibmx"
13 Q0 18293042 713 17.91898 imi_mug_run_2_treatment "glucose"
13 Q0 21245935 714 17.91898 imi_mug_run_2_treatment "ras"
13 Q0 17970092 715 17.915688 imi_mug_run_2_treatment "various" "urokinase" "therapeutic agent"
13 Q0 18270032 716 17.907322 imi_mug_run_2_treatment "rms" "program" "level"
13 Q0 6488314 717 17.896244 imi_mug_run_2_treatment "animals" "favoring"
13 Q0 22427111 718 17.883232 imi_mug_run_2_treatment "antiviral" "therapeutic agents"
13 Q0 28401019 719 17.864574 imi_mug_run_2_treatment "various" "resveratrol" "endostatin"
13 Q0 25384085 720 17.859093 imi_mug_run_2_treatment "amp" "basis"
13 Q0 26221682 721 17.852516 imi_mug_run_2_treatment "level"
13 Q0 25941796 722 17.849737 imi_mug_run_2_treatment "crizotinib" "agent" "lead"
13 Q0 15531757 723 17.797161 imi_mug_run_2_treatment "beta-adrenergic agonists" "mediators" "air"
13 Q0 29534405 724 17.778522 imi_mug_run_2_treatment "crizotinib" "drug combination" "platinum"
13 Q0 30339388 725 17.774055 imi_mug_run_2_treatment "anti-rsv" "fusion inhibitors" "fusion inhibitor"
13 Q0 8718659 726 17.772255 imi_mug_run_2_treatment "growth hormone"
13 Q0 26452381 727 17.767118 imi_mug_run_2_treatment "product"
13 Q0 22912387 728 17.766907 imi_mug_run_2_treatment "cytotoxic" "duration" "crizotinib"
13 Q0 9808136 729 17.764105 imi_mug_run_2_treatment "acyclovir" "liver"
13 Q0 3116897 730 17.738316 imi_mug_run_2_treatment "dexamethasone" "glucose" "cytostatic"
13 Q0 7361376 731 17.737898 imi_mug_run_2_treatment "liver"
13 Q0 6324459 732 17.721153 imi_mug_run_2_treatment "glucocorticoids" "monolayer"
13 Q0 21182087 733 17.700535 imi_mug_run_2_treatment "calcium" "il-4" "blockade"
13 Q0 19640857 734 17.687065 imi_mug_run_2_treatment "aim"
13 Q0 24138719 735 17.68636 imi_mug_run_2_treatment "anti-angiogenic drugs" "anti-angiogenic agents"
13 Q0 30025476 736 17.68636 imi_mug_run_2_treatment "necitumumab" "cisplatin" "gemcitabine"
13 Q0 28245430 737 17.675316 imi_mug_run_2_treatment "kinase inhibitor" "liver" "fer"
13 Q0 22864469 738 17.652351 imi_mug_run_2_treatment "imp321" "gemcitabine" "agonist"
13 Q0 16125870 739 17.635841 imi_mug_run_2_treatment "glucose" "deoxyglucose"
13 Q0 24115920 740 17.632162 imi_mug_run_2_treatment "various" "surfactant" "lung surfactant"
13 Q0 24878018 741 17.603897 imi_mug_run_2_treatment "crizotinib"
13 Q0 21288922 742 17.588547 imi_mug_run_2_treatment "tyrosine" "mediated" "crizotinib"
13 Q0 27563823 743 17.573055 imi_mug_run_2_treatment "tomato"
13 Q0 27842052 744 17.569326 imi_mug_run_2_treatment "platinum" "therapeutic agent"
13 Q0 23256924 745 17.563189 imi_mug_run_2_treatment "various" "ptds" "tandem"
13 Q0 1856594 746 17.5506 imi_mug_run_2_treatment "yeast" "lucifer yellow"
13 Q0 11317024 747 17.548893 imi_mug_run_2_treatment "radiopharmaceuticals"
13 Q0 24315414 748 17.548397 imi_mug_run_2_treatment "mediated"
13 Q0 2163206 749 17.515224 imi_mug_run_2_treatment "lung surfactant" "agonists" "various"
13 Q0 26753004 750 17.507965 imi_mug_run_2_treatment "crizotinib" "cep-28122" "ch5424802"
13 Q0 29487011 751 17.507965 imi_mug_run_2_treatment "adc" "basis"
13 Q0 22849528 752 17.493654 imi_mug_run_2_treatment "oxygen"
13 Q0 9269316 753 17.489773 imi_mug_run_2_treatment "annexin i" "hydroxyproline" "collagen"
13 Q0 24192513 754 17.479427 imi_mug_run_2_treatment "crizotinib" "kinase inhibitor"
13 Q0 15709972 755 17.466084 imi_mug_run_2_treatment "surfactant" "air" "lung surfactant"
13 Q0 28378229 756 17.40633 imi_mug_run_2_treatment "anti-tumor agents" "therapeutics" "blockade"
13 Q0 29516752 757 17.39254 imi_mug_run_2_treatment "combinations"
13 Q0 19109379 758 17.387966 imi_mug_run_2_treatment "monoclonal antibodies" "vaccines" "therapeutics"
13 Q0 3743347 759 17.387579 imi_mug_run_2_treatment "enzymes"
13 Q0 10851514 760 17.350014 imi_mug_run_2_treatment "animals"
13 Q0 29488330 761 17.340996 imi_mug_run_2_treatment "crizotinib" "nervous system"
13 Q0 29996478 762 17.339693 imi_mug_run_2_treatment "liver"
13 Q0 7241666 763 17.338589 imi_mug_run_2_treatment "drug" "product"
13 Q0 7270426 764 17.328325 imi_mug_run_2_treatment "sodium" "animals"
13 Q0 28607809 765 17.320335 imi_mug_run_2_treatment "crizotinib"
13 Q0 15618585 766 17.320097 imi_mug_run_2_treatment "aim"
13 Q0 17037722 767 17.318214 imi_mug_run_2_treatment "antiserum" "vaccine"
13 Q0 19769957 768 17.314213 imi_mug_run_2_treatment "prenatal"
13 Q0 26321050 769 17.312477 imi_mug_run_2_treatment "respiratory system"
13 Q0 11866984 770 17.310991 imi_mug_run_2_treatment "formalin"
13 Q0 28296173 771 17.30578 imi_mug_run_2_treatment "lysine" "level"
13 Q0 3290332 772 17.264782 imi_mug_run_2_treatment "gold" "level" "monoclonal antibodies"
13 Q0 26000049 773 17.245277 imi_mug_run_2_treatment "adjuvant" "gefitinib" "erlotinib"
13 Q0 7493342 774 17.225626 imi_mug_run_2_treatment "immu-4"
13 Q0 27926526 775 17.225626 imi_mug_run_2_treatment "plasma" "crizotinib"
13 Q0 27246873 776 17.223228 imi_mug_run_2_treatment "immunosuppressive" "il-12" "cytokines"
13 Q0 21892161 777 17.21905 imi_mug_run_2_treatment "mediated" "lead"
13 Q0 22791881 778 17.21493 imi_mug_run_2_treatment "e10a"
13 Q0 25153496 779 17.2086 imi_mug_run_2_treatment "drug" "basis" "crizotinib"
13 Q0 18474293 780 17.207241 imi_mug_run_2_treatment "level"
13 Q0 26063431 781 17.198652 imi_mug_run_2_treatment "vaccine" "matrix"
13 Q0 30519133 782 17.180025 imi_mug_run_2_treatment "alectinib" "crizotinib"
13 Q0 3777448 783 17.173168 imi_mug_run_2_treatment "lead" "animals"
13 Q0 20179225 784 17.14582 imi_mug_run_2_treatment "level" "monoclonal antibodies"
13 Q0 14568982 785 17.14181 imi_mug_run_2_treatment "antiinflammatory"
13 Q0 29451020 786 17.132912 imi_mug_run_2_treatment "brigatinib" "crizotinib" "ceritinib"
13 Q0 2847384 787 17.124306 imi_mug_run_2_treatment "abc" "liver"
13 Q0 16242781 788 17.116276 imi_mug_run_2_treatment "adjuvant" "vaccine" "prophylactic"
13 Q0 29682161 789 17.101793 imi_mug_run_2_treatment "anti-inflammatory" "antioxidant"
13 Q0 26134262 790 17.08989 imi_mug_run_2_treatment "various" "drugs" "therapeutic agents"
13 Q0 18519321 791 17.083687 imi_mug_run_2_treatment "level"
13 Q0 27282352 792 17.080692 imi_mug_run_2_treatment "thyroglobulin"
13 Q0 12663329 793 17.079601 imi_mug_run_2_treatment "surfactant" "lung surfactant" "beta-escin"
13 Q0 21769425 794 17.049423 imi_mug_run_2_treatment "interferon" "enzymes" "drug"
13 Q0 21103621 795 17.048159 imi_mug_run_2_treatment "combinations" "cytotoxic drugs"
13 Q0 15186480 796 17.03827 imi_mug_run_2_treatment "lead" "protein c gene"
13 Q0 25594902 797 17.036793 imi_mug_run_2_treatment "medicine" "drugs" "cytotoxic drugs"
13 Q0 29175207 798 17.036793 imi_mug_run_2_treatment "cisplatin" "drug"
13 Q0 17135359 799 17.02881 imi_mug_run_2_treatment "tnf-alpha" "interleukin"
13 Q0 23364427 800 17.026455 imi_mug_run_2_treatment "animals"
13 Q0 8009365 801 17.002445 imi_mug_run_2_treatment "various"
13 Q0 25101240 802 17.001507 imi_mug_run_2_treatment "crizotinib" "medication"
13 Q0 3699933 803 16.99758 imi_mug_run_2_treatment "hmt" "polyethylene glycol"
13 Q0 29337216 804 16.99672 imi_mug_run_2_treatment "ciprofloxacin" "drug" "cpfx"
13 Q0 28967088 805 16.991915 imi_mug_run_2_treatment "adjuvant" "trastuzumab" "her-2"
13 Q0 19284887 806 16.986856 imi_mug_run_2_treatment "aim"
13 Q0 27902399 807 16.948261 imi_mug_run_2_treatment "mediated" "hyaluronoglucosaminidase"
13 Q0 21178721 808 16.930464 imi_mug_run_2_treatment "gemcitabine" "platinum" "crizotinib"
13 Q0 19465903 809 16.928333 imi_mug_run_2_treatment "androgen" "spink1"
13 Q0 12232604 810 16.926525 imi_mug_run_2_treatment "beta-galactosidase"
13 Q0 17276053 811 16.923439 imi_mug_run_2_treatment "various"
13 Q0 1312699 812 16.920418 imi_mug_run_2_treatment "product"
13 Q0 1651427 813 16.911259 imi_mug_run_2_treatment "octadecyl rhodamine b chloride"
13 Q0 11369547 814 16.911259 imi_mug_run_2_treatment "surfactant"
13 Q0 29629426 815 16.910719 imi_mug_run_2_treatment "various"
13 Q0 19667264 816 16.90492 imi_mug_run_2_treatment "platinum" "egfr tyrosine kinase inhibitors" "basis"
13 Q0 1668890 817 16.876926 imi_mug_run_2_treatment "ras" "product"
13 Q0 22912388 818 16.855083 imi_mug_run_2_treatment "crizotinib"
13 Q0 20813423 819 16.853075 imi_mug_run_2_treatment "level"
13 Q0 22185353 820 16.853075 imi_mug_run_2_treatment "various" "interleukin"
13 Q0 28640357 821 16.845606 imi_mug_run_2_treatment "calcium" "eacs"
13 Q0 9843922 822 16.838745 imi_mug_run_2_treatment "tnf-alpha"
13 Q0 4644630 823 16.833189 imi_mug_run_2_treatment "immune sera" "buffer" "glycerol"
13 Q0 17311257 824 16.804558 imi_mug_run_2_treatment "various"
13 Q0 9343723 825 16.800793 imi_mug_run_2_treatment "color"
13 Q0 25374843 826 16.800793 imi_mug_run_2_treatment "immunosuppressive" "vaccines" "therapeutics"
13 Q0 11959831 827 16.799149 imi_mug_run_2_treatment "zinc"
13 Q0 27122312 828 16.799149 imi_mug_run_2_treatment "drugs" "crizotinib" "ceritinib"
13 Q0 15746946 829 16.797888 imi_mug_run_2_treatment "cyclophosphamide" "mediated"
13 Q0 30205166 830 16.79676 imi_mug_run_2_treatment "crizotinib" "level" "kinase inhibitor"
13 Q0 2999485 831 16.796228 imi_mug_run_2_treatment "monoclonal antibodies" "anti-tumor agents" "mediated"
13 Q0 10923012 832 16.793955 imi_mug_run_2_treatment "blockade"
13 Q0 26623046 833 16.783924 imi_mug_run_2_treatment "aim"
13 Q0 18021435 834 16.78106 imi_mug_run_2_treatment "level"
13 Q0 9311563 835 16.780052 imi_mug_run_2_treatment "mediated" "matrix"
13 Q0 15930019 836 16.780052 imi_mug_run_2_treatment "radiopharmaceutical" "radiopharmaceuticals" "basis"
13 Q0 25982285 837 16.780052 imi_mug_run_2_treatment "adc" "tgfb1"
13 Q0 10729773 838 16.76589 imi_mug_run_2_treatment "animals" "urokinase" "symmetry"
13 Q0 27145121 839 16.74974 imi_mug_run_2_treatment "surfactant" "air" "lung surfactant"
13 Q0 30038711 840 16.7432 imi_mug_run_2_treatment "pdx" "ponatinib" "chemotherapeutic agent"
13 Q0 22622656 841 16.732246 imi_mug_run_2_treatment "polyethylene glycol" "balance"
13 Q0 11956209 842 16.710993 imi_mug_run_2_treatment "surfactant" "antiviral"
13 Q0 28911956 843 16.705929 imi_mug_run_2_treatment "crizotinib"
13 Q0 30212301 844 16.705929 imi_mug_run_2_treatment "crizotinib"
13 Q0 30327756 845 16.705929 imi_mug_run_2_treatment "crizotinib"
13 Q0 23712942 846 16.702717 imi_mug_run_2_treatment "level" "liver" "animals"
13 Q0 21914348 847 16.700392 imi_mug_run_2_treatment "liver"
13 Q0 23415663 848 16.690863 imi_mug_run_2_treatment "various"
13 Q0 15772951 849 16.680826 imi_mug_run_2_treatment "glucose"
13 Q0 25953441 850 16.666235 imi_mug_run_2_treatment "crizotinib" "chemotherapy agents" "drugs"
13 Q0 7046919 851 16.663227 imi_mug_run_2_treatment "monoclonal antibodies" "various"
13 Q0 17303001 852 16.657465 imi_mug_run_2_treatment "collagen" "aim"
13 Q0 19406588 853 16.657465 imi_mug_run_2_treatment "various"
13 Q0 10438964 854 16.655981 imi_mug_run_2_treatment "fas ligand"
13 Q0 9680139 855 16.655981 imi_mug_run_2_treatment "cytokines" "il-4" "animals"
13 Q0 17038662 856 16.655981 imi_mug_run_2_treatment "drugs" "mediated" "cytotoxic"
13 Q0 10746551 857 16.651754 imi_mug_run_2_treatment "various" "vaccines" "therapeutic vaccine"
13 Q0 25842168 858 16.650677 imi_mug_run_2_treatment "aim"
13 Q0 23533265 859 16.650677 imi_mug_run_2_treatment "ganetespib" "crizotinib" "blockade"
13 Q0 29494220 860 16.650677 imi_mug_run_2_treatment "bisulfite"
13 Q0 23226067 861 16.648323 imi_mug_run_2_treatment "ras" "platinum" "egfr tyrosine kinase inhibitors"
13 Q0 9490659 862 16.642609 imi_mug_run_2_treatment "rolipram" "blockade"
13 Q0 24556908 863 16.641968 imi_mug_run_2_treatment "crizotinib" "drug" "chloroquine"
13 Q0 12243806 864 16.635502 imi_mug_run_2_treatment "metrics"
13 Q0 24242010 865 16.63394 imi_mug_run_2_treatment "mediated" "cytokines" "il-6"
13 Q0 30422774 866 16.627617 imi_mug_run_2_treatment "avid" "air"
13 Q0 20639175 867 16.618862 imi_mug_run_2_treatment "air"
13 Q0 29312796 868 16.618862 imi_mug_run_2_treatment "drug" "ptx" "ambroxol"
13 Q0 25704901 869 16.617413 imi_mug_run_2_treatment "basis"
13 Q0 8637912 870 16.616943 imi_mug_run_2_treatment "androgen" "mediated"
13 Q0 9125879 871 16.60099 imi_mug_run_2_treatment "color"
13 Q0 25636466 872 16.599913 imi_mug_run_2_treatment "various" "tet" "drug"
13 Q0 6307921 873 16.59948 imi_mug_run_2_treatment "ionophore" "mannose"
13 Q0 18632217 874 16.593254 imi_mug_run_2_treatment "glucose"
13 Q0 28952794 875 16.58545 imi_mug_run_2_treatment "level"
13 Q0 29064653 876 16.583752 imi_mug_run_2_treatment "various" "aim"
13 Q0 25546157 877 16.577217 imi_mug_run_2_treatment "product" "tyrosine kinase inhibitor"
13 Q0 26930653 878 16.559282 imi_mug_run_2_treatment "monolayer" "mediated" "mediators"
13 Q0 16640800 879 16.554743 imi_mug_run_2_treatment "antiangiogenic agents" "bevacizumab" "vascular endothelial growth factor trap"
13 Q0 10092662 880 16.551252 imi_mug_run_2_treatment "recombinant human deoxyribonuclease i" "papain" "salt"
13 Q0 20105618 881 16.540955 imi_mug_run_2_treatment "alerted" "liver"
13 Q0 23629446 882 16.536236 imi_mug_run_2_treatment "color" "matrix"
13 Q0 20815983 883 16.507847 imi_mug_run_2_treatment "ifa" "histidine" "aim"
13 Q0 27575447 884 16.501068 imi_mug_run_2_treatment "hemin" "oxygen" "carbon monoxide-releasing molecule-2"
13 Q0 23561899 885 16.47966 imi_mug_run_2_treatment "crizotinib" "therapeutics"
13 Q0 27261479 886 16.47966 imi_mug_run_2_treatment "lead"
13 Q0 22435662 887 16.477974 imi_mug_run_2_treatment "drugs" "crizotinib" "gefitinib"
13 Q0 26917690 888 16.475002 imi_mug_run_2_treatment "ceritinib"
13 Q0 15652670 889 16.462482 imi_mug_run_2_treatment "macrophage colony-stimulating factor" "dna vaccine" "plasmid dna vaccines"
13 Q0 25888090 890 16.436811 imi_mug_run_2_treatment "crizotinib" "ceritinib" "pf-06463922"
13 Q0 22669629 891 16.42804 imi_mug_run_2_treatment "antivirals" "vaccines" "monolayers"
13 Q0 14501933 892 16.417244 imi_mug_run_2_treatment "oxygen" "level"
13 Q0 26568289 893 16.392035 imi_mug_run_2_treatment "crizotinib" "alectinib" "ceritinib"
13 Q0 26766993 894 16.383884 imi_mug_run_2_treatment "medicine"
13 Q0 19269006 895 16.380852 imi_mug_run_2_treatment "product"
13 Q0 30071258 896 16.372398 imi_mug_run_2_treatment "crizotinib" "ceritinib" "drug"
13 Q0 24041791 897 16.36734 imi_mug_run_2_treatment "choline" "toxoid" "vaccine"
13 Q0 29161788 898 16.36734 imi_mug_run_2_treatment "liver"
13 Q0 11059280 899 16.362783 imi_mug_run_2_treatment "pma" "interleukin-11" "product"
13 Q0 27513518 900 16.358559 imi_mug_run_2_treatment "irgd" "drug" "cytotoxic"
13 Q0 22340310 901 16.358393 imi_mug_run_2_treatment "aim"
13 Q0 22891268 902 16.352036 imi_mug_run_2_treatment "crizotinib"
13 Q0 24455775 903 16.339314 imi_mug_run_2_treatment "cytokines" "il-4" "anti-inflammatory"
13 Q0 22581115 904 16.337332 imi_mug_run_2_treatment "shh" "il-12" "interleukin"
13 Q0 28185914 905 16.301006 imi_mug_run_2_treatment "lead"
13 Q0 16087377 906 16.291931 imi_mug_run_2_treatment "glucose"
13 Q0 19910420 907 16.284977 imi_mug_run_2_treatment "aim"
13 Q0 12935923 908 16.282436 imi_mug_run_2_treatment "basis"
13 Q0 12634566 909 16.272816 imi_mug_run_2_treatment "crest"
13 Q0 18219758 910 16.264858 imi_mug_run_2_treatment "autologous" "vaccine" "cancer vaccines"
13 Q0 23674412 911 16.262867 imi_mug_run_2_treatment "color" "shape"
13 Q0 7923880 912 16.26154 imi_mug_run_2_treatment "tnf-alpha" "interferon-gamma"
13 Q0 16822578 913 16.256407 imi_mug_run_2_treatment "deoxyglucose"
13 Q0 19921709 914 16.254286 imi_mug_run_2_treatment "androgen"
13 Q0 3002616 915 16.253134 imi_mug_run_2_treatment "monoclonal antibodies" "gm1" "ganglioside"
13 Q0 11792173 916 16.252651 imi_mug_run_2_treatment "agent"
13 Q0 24912636 917 16.230381 imi_mug_run_2_treatment "hyp" "xuebijing" "collagen"
13 Q0 6247283 918 16.22887 imi_mug_run_2_treatment "yeast" "level" "animals"
13 Q0 29277178 919 16.21811 imi_mug_run_2_treatment "various" "level"
13 Q0 28838394 920 16.21811 imi_mug_run_2_treatment "ci 4" "gefitinib" "egfr tyrosine kinase inhibitor"
13 Q0 29172833 921 16.21811 imi_mug_run_2_treatment "various" "ras"
13 Q0 11513464 922 16.213747 imi_mug_run_2_treatment "iron"
13 Q0 22330583 923 16.207632 imi_mug_run_2_treatment "animals"
13 Q0 27591391 924 16.207216 imi_mug_run_2_treatment "diastase" "schiff"
13 Q0 29178078 925 16.200928 imi_mug_run_2_treatment "various" "oxygen"
13 Q0 9000125 926 16.199427 imi_mug_run_2_treatment "keratinocyte growth factor"
13 Q0 9823972 927 16.199427 imi_mug_run_2_treatment "human antibody" "monoclonal antibodies"
13 Q0 2583749 928 16.191069 imi_mug_run_2_treatment "c-73" "vaccine" "mediated"
13 Q0 22406361 929 16.191069 imi_mug_run_2_treatment "antibody human" "liver"
13 Q0 29672325 930 16.185162 imi_mug_run_2_treatment "various"
13 Q0 18976148 931 16.178238 imi_mug_run_2_treatment "blade"
13 Q0 10437919 932 16.173176 imi_mug_run_2_treatment "melanocyte-stimulating hormone" "melanocyte stimulating hormone"
13 Q0 12368202 933 16.172634 imi_mug_run_2_treatment "il-4" "collagen" "egg"
13 Q0 15924723 934 16.16788 imi_mug_run_2_treatment "anti-inflammatory"
13 Q0 12931325 935 16.164885 imi_mug_run_2_treatment "beam"
13 Q0 21514433 936 16.164665 imi_mug_run_2_treatment "cytokines"
13 Q0 26964537 937 16.164665 imi_mug_run_2_treatment "eosin"
13 Q0 24567430 938 16.148634 imi_mug_run_2_treatment "crizotinib" "drug" "program"
13 Q0 9534958 939 16.145727 imi_mug_run_2_treatment "monoclonal antibodies"
13 Q0 9421477 940 16.14447 imi_mug_run_2_treatment "estradiol" "pd098059" "ras"
13 Q0 30236141 941 16.14084 imi_mug_run_2_treatment "plasma"
13 Q0 15888025 942 16.138956 imi_mug_run_2_treatment "experimental gene therapy"
13 Q0 26973216 943 16.138645 imi_mug_run_2_treatment "crizotinib" "others"
13 Q0 23484153 944 16.138645 imi_mug_run_2_treatment "aim"
13 Q0 26519258 945 16.130253 imi_mug_run_2_treatment "heparin" "keratinocyte growth factor" "sulfate"
13 Q0 29764594 946 16.130253 imi_mug_run_2_treatment "drugs"
13 Q0 2010302 947 16.129417 imi_mug_run_2_treatment "various" "radiolabeled antibodies"
13 Q0 30401947 948 16.125912 imi_mug_run_2_treatment "ras" "level"
13 Q0 25863938 949 16.11615 imi_mug_run_2_treatment "sham" "superoxide dismutase" "cytokines"
13 Q0 23201355 950 16.114899 imi_mug_run_2_treatment "various" "crizotinib" "drugs"
13 Q0 18083107 951 16.093277 imi_mug_run_2_treatment "drug" "tyrosine" "therapeutics"
13 Q0 22084642 952 16.093277 imi_mug_run_2_treatment "crizotinib" "tyrosine" "mediated"
13 Q0 30361052 953 16.093277 imi_mug_run_2_treatment "epidermal growth factor"
13 Q0 12883632 954 16.09118 imi_mug_run_2_treatment "urokinase-type plasminogen activator" "plasminogen activator" "product"
13 Q0 16481075 955 16.090206 imi_mug_run_2_treatment "anti-cd3" "nitric oxide" "cytotoxic"
13 Q0 7678969 956 16.087833 imi_mug_run_2_treatment "hgh" "human growth hormone" "liver"
13 Q0 17187076 957 16.087448 imi_mug_run_2_treatment "basis" "glucan" "glycans"
13 Q0 19185385 958 16.087448 imi_mug_run_2_treatment "gefitinib" "mediated"
13 Q0 23371030 959 16.086111 imi_mug_run_2_treatment "medicine" "generic"
13 Q0 25535896 960 16.085468 imi_mug_run_2_treatment "pd173074"
13 Q0 16988814 961 16.079464 imi_mug_run_2_treatment "various" "angiotensin"
13 Q0 26888425 962 16.079464 imi_mug_run_2_treatment "aim" "crizotinib"
13 Q0 27250896 963 16.079464 imi_mug_run_2_treatment "favor" "vandetanib" "agent"
13 Q0 22777145 964 16.068806 imi_mug_run_2_treatment "sham" "cytokines" "interleukin"
13 Q0 8835843 965 16.062239 imi_mug_run_2_treatment "tgf-beta 1" "collagen" "protease"
13 Q0 26899759 966 16.05983 imi_mug_run_2_treatment "crizotinib" "dacomitinib" "epidermal growth factor receptor inhibitor"
13 Q0 15573293 967 16.057854 imi_mug_run_2_treatment "combinations" "program" "liver"
13 Q0 26073862 968 16.053032 imi_mug_run_2_treatment "drugs" "aim" "crizotinib"
13 Q0 27220787 969 16.048838 imi_mug_run_2_treatment "adjuvant" "drugs" "angiogenesis inhibitors"
13 Q0 27102076 970 16.046537 imi_mug_run_2_treatment "various" "mediated" "erlotinib"
13 Q0 23742148 971 16.041323 imi_mug_run_2_treatment "mediated" "matrix"
13 Q0 16158944 972 16.02948 imi_mug_run_2_treatment "endostatin" "angiostatin" "agent"
13 Q0 28720835 973 16.028896 imi_mug_run_2_treatment "mediated"
13 Q0 18594010 974 16.018848 imi_mug_run_2_treatment "kinase inhibitor" "cl-387,785"
13 Q0 29057231 975 16.014648 imi_mug_run_2_treatment "favor" "product"
13 Q0 24191684 976 16.01293 imi_mug_run_2_treatment "vaccines" "tumor vaccines" "il-10"
13 Q0 18221150 977 16.00483 imi_mug_run_2_treatment "various" "guanosine" "ribavirin"
13 Q0 8613701 978 16.002419 imi_mug_run_2_treatment "animals"
13 Q0 26565381 979 16.002419 imi_mug_run_2_treatment "entrectinib" "amp" "nervous system"
13 Q0 6624688 980 15.995104 imi_mug_run_2_treatment "collagen"
13 Q0 21244786 981 15.994049 imi_mug_run_2_treatment "vaccine" "ifa" "prophylactic"
13 Q0 1576323 982 15.983024 imi_mug_run_2_treatment "various" "ok-432" "il-6"
13 Q0 27636353 983 15.981649 imi_mug_run_2_treatment "tyrosine kinase inhibitor" "dasatinib"
13 Q0 25780911 984 15.976846 imi_mug_run_2_treatment "lead" "level"
13 Q0 27513955 985 15.9683275 imi_mug_run_2_treatment "bcma" "mediated"
13 Q0 20031962 986 15.963899 imi_mug_run_2_treatment "various" "gefitinib" "platinum"
13 Q0 7192863 987 15.914304 imi_mug_run_2_treatment "polyethylene glycol"
13 Q0 24574860 988 15.908047 imi_mug_run_2_treatment "various" "erythropoietin" "ras"
13 Q0 11450996 989 15.896307 imi_mug_run_2_treatment "various" "color"
13 Q0 14610621 990 15.889368 imi_mug_run_2_treatment "therapeutics" "suppressor"
13 Q0 23463584 991 15.889225 imi_mug_run_2_treatment "interferon" "interferon-gamma"
13 Q0 23891510 992 15.870589 imi_mug_run_2_treatment "drugs" "aim"
13 Q0 23438759 993 15.857546 imi_mug_run_2_treatment "drugs" "medicine"
13 Q0 1933866 994 15.844856 imi_mug_run_2_treatment "mct" "mediated" "dexamethasone"
13 Q0 24756793 995 15.844606 imi_mug_run_2_treatment "crizotinib" "drug"
13 Q0 28449509 996 15.842266 imi_mug_run_2_treatment "crizotinib"
13 Q0 28065229 997 15.838497 imi_mug_run_2_treatment "premier" "plasma"
13 Q0 25339762 998 15.831181 imi_mug_run_2_treatment "vaccine" "aid vaccine"
13 Q0 26541285 999 15.82695 imi_mug_run_2_treatment "animals" "vaccine" "anti-rsv"
14 Q0 18523027 1 66.690384 imi_mug_run_2_treatment "alcohol" "gly" "glu"
14 Q0 15760919 2 64.77721 imi_mug_run_2_treatment "lead"
14 Q0 12612901 3 64.77591 imi_mug_run_2_treatment "ras"
14 Q0 17465465 4 64.32471 imi_mug_run_2_treatment "fluorouracil" "genesis"
14 Q0 18615680 5 64.18638 imi_mug_run_2_treatment "mint"
14 Q0 21213371 6 63.178886 imi_mug_run_2_treatment "level"
14 Q0 15000146 7 58.88225 imi_mug_run_2_treatment "lead" "level"
14 Q0 18843035 8 58.618988 imi_mug_run_2_treatment "folate" "vitamin b" "b vitamins"
14 Q0 10072435 9 57.736866 imi_mug_run_2_treatment "basis" "genesis"
14 Q0 12203784 10 57.62609 imi_mug_run_2_treatment "bisulfite"
14 Q0 17186090 11 57.49234 imi_mug_run_2_treatment "aim"
14 Q0 19669908 12 56.358223 imi_mug_run_2_treatment "mint"
14 Q0 17476321 13 55.71792 imi_mug_run_2_treatment "bisulfite"
14 Q0 16204034 14 55.68324 imi_mug_run_2_treatment "mediated" "yeast" "basis"
14 Q0 21102416 15 55.27076 imi_mug_run_2_treatment "level"
14 Q0 18832519 16 54.625294 imi_mug_run_2_treatment "igf2"
14 Q0 17909015 17 53.925438 imi_mug_run_2_treatment "methylated" "histone deacetylase inhibitors"
14 Q0 23374646 18 53.901833 imi_mug_run_2_treatment "aim"
14 Q0 20640893 19 53.794174 imi_mug_run_2_treatment "level"
14 Q0 19127559 20 53.767643 imi_mug_run_2_treatment "various" "glutamic acid" "bisulfite"
14 Q0 23414134 21 53.144062 imi_mug_run_2_treatment "various" "ras"
14 Q0 16784982 22 52.64563 imi_mug_run_2_treatment "bisulfite"
14 Q0 19109866 23 52.54704 imi_mug_run_2_treatment "water" "aim"
14 Q0 15354418 24 52.53959 imi_mug_run_2_treatment "epidermal growth factor" "cytokines" "interleukin"
14 Q0 11535541 25 52.194748 imi_mug_run_2_treatment "level" "others"
14 Q0 26512054 26 52.027863 imi_mug_run_2_treatment "aim"
14 Q0 24448331 27 51.90843 imi_mug_run_2_treatment "medicine" "aim"
14 Q0 21766496 28 51.222534 imi_mug_run_2_treatment "bisulfite" "aim"
14 Q0 12867608 29 50.786057 imi_mug_run_2_treatment "fluorouracil"
14 Q0 15826579 30 50.67763 imi_mug_run_2_treatment "leucovorin" "suppressor"
14 Q0 11438476 31 50.59085 imi_mug_run_2_treatment "cytotoxic"
14 Q0 23963522 32 50.583115 imi_mug_run_2_treatment "aim"
14 Q0 14767526 33 50.545567 imi_mug_run_2_treatment "lead"
14 Q0 30443012 34 50.464912 imi_mug_run_2_treatment "pembrolizumab"
14 Q0 8968080 35 50.410233 imi_mug_run_2_treatment "ras"
14 Q0 28874631 36 50.325844 imi_mug_run_2_treatment "aim"
14 Q0 19582761 37 50.17605 imi_mug_run_2_treatment "mint"
14 Q0 22067334 38 50.144623 imi_mug_run_2_treatment "various"
14 Q0 18594535 39 50.11783 imi_mug_run_2_treatment "lead"
14 Q0 15017620 40 50.094086 imi_mug_run_2_treatment "bisulfite"
14 Q0 10615123 41 49.97702 imi_mug_run_2_treatment "yeast"
14 Q0 22792460 42 49.95685 imi_mug_run_2_treatment "adjuvant" "fluorouracil"
14 Q0 16033773 43 49.956375 imi_mug_run_2_treatment "methylated"
14 Q0 18767147 44 49.910137 imi_mug_run_2_treatment "mint"
14 Q0 12057899 45 49.696114 imi_mug_run_2_treatment "rii" "basis"
14 Q0 22878509 46 49.691147 imi_mug_run_2_treatment "level" "cfr"
14 Q0 17085649 47 49.579643 imi_mug_run_2_treatment "level" "aim"
14 Q0 19855373 48 49.526215 imi_mug_run_2_treatment "level"
14 Q0 17545526 49 49.312298 imi_mug_run_2_treatment "aim"
14 Q0 16569647 50 49.229042 imi_mug_run_2_treatment "enzymes"
14 Q0 19127118 51 49.19171 imi_mug_run_2_treatment "methylated" "bisulfite"
14 Q0 23878352 52 49.186596 imi_mug_run_2_treatment "level"
14 Q0 19581844 53 49.112595 imi_mug_run_2_treatment "various"
14 Q0 18556776 54 48.91113 imi_mug_run_2_treatment "lead"
14 Q0 23034738 55 48.89892 imi_mug_run_2_treatment "adjuvant" "fluorouracil" "leucovorin"
14 Q0 21114775 56 48.862473 imi_mug_run_2_treatment "aim"
14 Q0 17513808 57 48.631912 imi_mug_run_2_treatment "bisulfite"
14 Q0 12067992 58 48.604164 imi_mug_run_2_treatment "product"
14 Q0 10190329 59 48.58468 imi_mug_run_2_treatment "basis"
14 Q0 12124320 60 48.488907 imi_mug_run_2_treatment "sodium bisulfite"
14 Q0 26836800 61 48.105453 imi_mug_run_2_treatment "aim"
14 Q0 11290569 62 48.039246 imi_mug_run_2_treatment "ras" "others"
14 Q0 21651356 63 47.900837 imi_mug_run_2_treatment "fluorouracil" "irinotecan"
14 Q0 17087932 64 47.823208 imi_mug_run_2_treatment "aim"
14 Q0 16230380 65 47.77037 imi_mug_run_2_treatment "legacy"
14 Q0 19117505 66 47.75377 imi_mug_run_2_treatment "methylated"
14 Q0 12626904 67 47.658607 imi_mug_run_2_treatment "basis" "aim"
14 Q0 20978114 68 47.578316 imi_mug_run_2_treatment "histidine" "leucine"
14 Q0 11935297 69 47.51672 imi_mug_run_2_treatment "bisulfite"
14 Q0 10680334 70 47.492603 imi_mug_run_2_treatment "basis"
14 Q0 20967208 71 47.419827 imi_mug_run_2_treatment "basis"
14 Q0 22353804 72 47.338917 imi_mug_run_2_treatment "level"
14 Q0 23155252 73 47.21791 imi_mug_run_2_treatment "bisulfite" "level" "aim"
14 Q0 24705641 74 47.09363 imi_mug_run_2_treatment "aim"
14 Q0 16951683 75 47.057003 imi_mug_run_2_treatment "level"
14 Q0 22977561 76 47.037148 imi_mug_run_2_treatment "aim"
14 Q0 22987381 77 47.02835 imi_mug_run_2_treatment "methylated" "aim"
14 Q0 24396821 78 46.751472 imi_mug_run_2_treatment "arginine" "glutamine"
14 Q0 12430186 79 46.72419 imi_mug_run_2_treatment "lead"
14 Q0 17923762 80 46.70409 imi_mug_run_2_treatment "level"
14 Q0 7696368 81 46.687912 imi_mug_run_2_treatment "alkylating agents"
14 Q0 11729109 82 46.672203 imi_mug_run_2_treatment "bisulfite"
14 Q0 18718023 83 46.649986 imi_mug_run_2_treatment "fluorouracil"
14 Q0 26775578 84 46.58181 imi_mug_run_2_treatment "level"
14 Q0 19761686 85 46.57999 imi_mug_run_2_treatment "level"
14 Q0 19033568 86 46.470974 imi_mug_run_2_treatment "level"
14 Q0 24027018 87 46.36382 imi_mug_run_2_treatment "aim"
14 Q0 14760069 88 46.324184 imi_mug_run_2_treatment "aim"
14 Q0 15386381 89 46.29945 imi_mug_run_2_treatment "agent"
14 Q0 20682997 90 46.299274 imi_mug_run_2_treatment "aim"
14 Q0 10861474 91 46.297256 imi_mug_run_2_treatment "combinations" "level"
14 Q0 16143123 92 46.248627 imi_mug_run_2_treatment "mint"
14 Q0 22368298 93 46.24461 imi_mug_run_2_treatment "ci 4"
14 Q0 20033812 94 45.995575 imi_mug_run_2_treatment "adjuvant" "oxaliplatin" "leucovorin"
14 Q0 20011542 95 45.91075 imi_mug_run_2_treatment "activin" "aza"
14 Q0 10822375 96 45.906887 imi_mug_run_2_treatment "alkylator" "genesis"
14 Q0 26884349 97 45.872852 imi_mug_run_2_treatment "various" "methylated"
14 Q0 17148775 98 45.8545 imi_mug_run_2_treatment "sodium bisulfite"
14 Q0 22933939 99 45.731304 imi_mug_run_2_treatment "adjuvant"
14 Q0 17987798 100 45.60666 imi_mug_run_2_treatment "various" "aim"
14 Q0 11440966 101 45.435184 imi_mug_run_2_treatment "level"
14 Q0 27977020 102 45.426598 imi_mug_run_2_treatment "level"
14 Q0 11857087 103 45.347305 imi_mug_run_2_treatment "methylate" "methylated"
14 Q0 22144422 104 45.318726 imi_mug_run_2_treatment "basis"
14 Q0 19444104 105 45.30924 imi_mug_run_2_treatment "fluorouracil" "leucovorin" "oxaliplatin"
14 Q0 19470733 106 45.210316 imi_mug_run_2_treatment "igf2" "level"
14 Q0 18446350 107 45.19994 imi_mug_run_2_treatment "aim"
14 Q0 11577009 108 45.17224 imi_mug_run_2_treatment "duration"
14 Q0 18769787 109 45.153896 imi_mug_run_2_treatment "aim"
14 Q0 27051466 110 45.076363 imi_mug_run_2_treatment "adjuvant" "fluorouracil" "leucovorin"
14 Q0 19273709 111 45.00721 imi_mug_run_2_treatment "irinotecan" "leucovorin" "fluorouracil"
14 Q0 16951227 112 44.994904 imi_mug_run_2_treatment "level"
14 Q0 23277013 113 44.882694 imi_mug_run_2_treatment "ras"
14 Q0 20200425 114 44.8119 imi_mug_run_2_treatment "prostaglandin e2" "product" "igf2"
14 Q0 23716983 115 44.805756 imi_mug_run_2_treatment "duration" "aim"
14 Q0 8967715 116 44.78237 imi_mug_run_2_treatment "yeast"
14 Q0 11606497 117 44.777397 imi_mug_run_2_treatment "level"
14 Q0 17278092 118 44.641754 imi_mug_run_2_treatment "methylated"
14 Q0 20717847 119 44.576317 imi_mug_run_2_treatment "lead"
14 Q0 26552419 120 44.551952 imi_mug_run_2_treatment "nrg"
14 Q0 21712435 121 44.38858 imi_mug_run_2_treatment "oligo"
14 Q0 11984524 122 44.330166 imi_mug_run_2_treatment "bisulfite" "mediated" "lead"
14 Q0 20507057 123 44.29139 imi_mug_run_2_treatment "inositol" "aim" "glucose"
14 Q0 17270239 124 44.285885 imi_mug_run_2_treatment "igf2"
14 Q0 16361538 125 44.240448 imi_mug_run_2_treatment "bisulfite" "level" "aim"
14 Q0 26307088 126 44.23923 imi_mug_run_2_treatment "suppressor" "methylated" "lead"
14 Q0 18084616 127 44.215313 imi_mug_run_2_treatment "insulin-like growth factor binding protein 3" "igf2"
14 Q0 10213220 128 44.130535 imi_mug_run_2_treatment "lead"
14 Q0 21037082 129 44.101974 imi_mug_run_2_treatment "igf2"
14 Q0 18834886 130 44.06243 imi_mug_run_2_treatment "mediated" "suberoylanilide hydroxamic acid"
14 Q0 28533824 131 44.01059 imi_mug_run_2_treatment "level" "others"
14 Q0 12861059 132 43.976044 imi_mug_run_2_treatment "basis"
14 Q0 10507723 133 43.776928 imi_mug_run_2_treatment "yeast"
14 Q0 23653048 134 43.763012 imi_mug_run_2_treatment "irinotecan" "poly(adp-ribose) polymerase inhibitor" "sn-38"
14 Q0 28471193 135 43.743122 imi_mug_run_2_treatment "drugs" "aim"
14 Q0 17347588 136 43.729202 imi_mug_run_2_treatment "dextran sodium sulfate" "aim"
14 Q0 7797042 137 43.6675 imi_mug_run_2_treatment "aim"
14 Q0 22498935 138 43.665985 imi_mug_run_2_treatment "aim"
14 Q0 16268414 139 43.661106 imi_mug_run_2_treatment "aim"
14 Q0 27422471 140 43.653168 imi_mug_run_2_treatment "asc"
14 Q0 17636402 141 43.634132 imi_mug_run_2_treatment "linoleic acid"
14 Q0 19949897 142 43.61583 imi_mug_run_2_treatment "oxaliplatin" "fluorouracil" "capecitabine"
14 Q0 21875327 143 43.61421 imi_mug_run_2_treatment "alcohol" "folate"
14 Q0 16952549 144 43.576317 imi_mug_run_2_treatment "somatostatin" "level"
14 Q0 17203532 145 43.509327 imi_mug_run_2_treatment "prophylactic" "aim"
14 Q0 20516444 146 43.50397 imi_mug_run_2_treatment "fluorouracil"
14 Q0 19843671 147 43.44407 imi_mug_run_2_treatment "folate" "enzymes"
14 Q0 14504054 148 43.413612 imi_mug_run_2_treatment "various"
14 Q0 18069769 149 43.39972 imi_mug_run_2_treatment "aim"
14 Q0 10495421 150 43.39621 imi_mug_run_2_treatment "bisulfite"
14 Q0 22156611 151 43.39587 imi_mug_run_2_treatment "adjuvant" "autologous tumor cell vaccine" "aim"
14 Q0 29496087 152 43.388832 imi_mug_run_2_treatment "fluorouracil"
14 Q0 28961932 153 43.363693 imi_mug_run_2_treatment "edu" "com"
14 Q0 23754140 154 43.34606 imi_mug_run_2_treatment "adjuvant"
14 Q0 11309634 155 43.34513 imi_mug_run_2_treatment "fluorouracil" "tgf-beta1" "various combinations"
14 Q0 9136829 156 43.23178 imi_mug_run_2_treatment "level" "aim"
14 Q0 17591800 157 43.085297 imi_mug_run_2_treatment "level" "aim"
14 Q0 26005817 158 43.08225 imi_mug_run_2_treatment "aim"
14 Q0 26185136 159 43.07816 imi_mug_run_2_treatment "level"
14 Q0 18922929 160 43.03073 imi_mug_run_2_treatment "level"
14 Q0 24456667 161 42.9712 imi_mug_run_2_treatment "level"
14 Q0 22276605 162 42.825638 imi_mug_run_2_treatment "aim"
14 Q0 19672700 163 42.802452 imi_mug_run_2_treatment "level"
14 Q0 14696396 164 42.80224 imi_mug_run_2_treatment "various"
14 Q0 23648460 165 42.75979 imi_mug_run_2_treatment "level"
14 Q0 7889482 166 42.737404 imi_mug_run_2_treatment "various"
14 Q0 11159189 167 42.731033 imi_mug_run_2_treatment "eosin"
14 Q0 9691992 168 42.617523 imi_mug_run_2_treatment "arginine" "leucine" "urea"
14 Q0 20552889 169 42.614742 imi_mug_run_2_treatment "level"
14 Q0 16555243 170 42.607048 imi_mug_run_2_treatment "ras"
14 Q0 16322221 171 42.604813 imi_mug_run_2_treatment "animals"
14 Q0 17950328 172 42.41689 imi_mug_run_2_treatment "lead"
14 Q0 19404924 173 42.392128 imi_mug_run_2_treatment "various" "level"
14 Q0 21853109 174 42.369198 imi_mug_run_2_treatment "lysine" "suppressor"
14 Q0 16630478 175 42.307304 imi_mug_run_2_treatment "gat"
14 Q0 28512763 176 42.27459 imi_mug_run_2_treatment "aim" "animals"
14 Q0 17309645 177 42.206226 imi_mug_run_2_treatment "bisulfite" "aim"
14 Q0 15059896 178 42.188496 imi_mug_run_2_treatment "genesis"
14 Q0 27391152 179 42.169216 imi_mug_run_2_treatment "level"
14 Q0 19825961 180 42.165443 imi_mug_run_2_treatment "igf2"
14 Q0 21687703 181 42.161446 imi_mug_run_2_treatment "methylated" "level"
14 Q0 17474983 182 42.153618 imi_mug_run_2_treatment "igf2"
14 Q0 9699680 183 42.1444 imi_mug_run_2_treatment "others"
14 Q0 14975808 184 42.134727 imi_mug_run_2_treatment "fluorouracil" "leucovorin" "adjuvant"
14 Q0 11251526 185 42.12262 imi_mug_run_2_treatment "genesis"
14 Q0 24748501 186 42.082382 imi_mug_run_2_treatment "oxaliplatin" "docetaxel"
14 Q0 15583832 187 42.069786 imi_mug_run_2_treatment "level"
14 Q0 15289847 188 41.98378 imi_mug_run_2_treatment "aim"
14 Q0 21989661 189 41.942974 imi_mug_run_2_treatment "aim"
14 Q0 7585508 190 41.940628 imi_mug_run_2_treatment "ras" "level"
14 Q0 25529563 191 41.937202 imi_mug_run_2_treatment "dextran sodium sulfate"
14 Q0 19147861 192 41.88331 imi_mug_run_2_treatment "level" "suppressor"
14 Q0 14551292 193 41.878902 imi_mug_run_2_treatment "bisulfite" "methylated" "mint"
14 Q0 29659608 194 41.84342 imi_mug_run_2_treatment "various" "bisulfite"
14 Q0 22022465 195 41.82343 imi_mug_run_2_treatment "bisulfite" "aim"
14 Q0 20064828 196 41.81835 imi_mug_run_2_treatment "estrogen" "duration"
14 Q0 28293308 197 41.79249 imi_mug_run_2_treatment "aim"
14 Q0 10812001 198 41.78579 imi_mug_run_2_treatment "estrogen" "lead"
14 Q0 15714592 199 41.74404 imi_mug_run_2_treatment "maspin" "serpin"
14 Q0 11221863 200 41.727882 imi_mug_run_2_treatment "level" "ras"
14 Q0 18084250 201 41.673172 imi_mug_run_2_treatment "glycosaminoglycan" "igf2"
14 Q0 12700670 202 41.645992 imi_mug_run_2_treatment "various" "methylated"
14 Q0 12591727 203 41.582333 imi_mug_run_2_treatment "basis"
14 Q0 19694828 204 41.545776 imi_mug_run_2_treatment "genesis"
14 Q0 23195666 205 41.542564 imi_mug_run_2_treatment "fluorouracil" "adjuvant"
14 Q0 22349300 206 41.489136 imi_mug_run_2_treatment "cdx"
14 Q0 24418929 207 41.478523 imi_mug_run_2_treatment "liver"
14 Q0 17985359 208 41.473503 imi_mug_run_2_treatment "rii" "suppressor"
14 Q0 22810696 209 41.455814 imi_mug_run_2_treatment "drug" "igf2"
14 Q0 16708352 210 41.43662 imi_mug_run_2_treatment "level" "aim"
14 Q0 25704535 211 41.368217 imi_mug_run_2_treatment "basis" "canakinumab" "aim"
14 Q0 26172297 212 41.354492 imi_mug_run_2_treatment "various" "level"
14 Q0 10469448 213 41.34547 imi_mug_run_2_treatment "lead"
14 Q0 21454688 214 41.34014 imi_mug_run_2_treatment "mediated" "basis"
14 Q0 23702729 215 41.318092 imi_mug_run_2_treatment "sucrose"
14 Q0 25701956 216 41.318047 imi_mug_run_2_treatment "various"
14 Q0 15331927 217 41.315052 imi_mug_run_2_treatment "level"
14 Q0 19797108 218 41.30123 imi_mug_run_2_treatment "basis"
14 Q0 20093385 219 41.273155 imi_mug_run_2_treatment "bisulfite" "sodium bisulfite" "level"
14 Q0 14646573 220 41.267033 imi_mug_run_2_treatment "aim"
14 Q0 18366060 221 41.207767 imi_mug_run_2_treatment "level" "igf2"
14 Q0 17868408 222 41.173164 imi_mug_run_2_treatment "basis" "aim"
14 Q0 19479271 223 41.057663 imi_mug_run_2_treatment "glycine" "isoleucine" "leucine"
14 Q0 22302899 224 41.05236 imi_mug_run_2_treatment "drugs" "therapeutics"
14 Q0 20210238 225 40.98079 imi_mug_run_2_treatment "aim"
14 Q0 7761852 226 40.965446 imi_mug_run_2_treatment "rii" "mediated"
14 Q0 26224509 227 40.93402 imi_mug_run_2_treatment "aim"
14 Q0 28103454 228 40.884224 imi_mug_run_2_treatment "prophylactic" "lead"
14 Q0 10688097 229 40.87845 imi_mug_run_2_treatment "tcc"
14 Q0 11148689 230 40.836037 imi_mug_run_2_treatment "lead"
14 Q0 26031544 231 40.833073 imi_mug_run_2_treatment "fluorouracil" "adjuvant"
14 Q0 27938333 232 40.81942 imi_mug_run_2_treatment "pmp" "various"
14 Q0 15199545 233 40.80244 imi_mug_run_2_treatment "zinc" "folate" "selenium"
14 Q0 12915601 234 40.755127 imi_mug_run_2_treatment "basis"
14 Q0 10845276 235 40.74469 imi_mug_run_2_treatment "genesis"
14 Q0 29187431 236 40.73199 imi_mug_run_2_treatment "aim"
14 Q0 23734346 237 40.6793 imi_mug_run_2_treatment "ras"
14 Q0 19966864 238 40.65473 imi_mug_run_2_treatment "igf2"
14 Q0 14762775 239 40.64743 imi_mug_run_2_treatment "fluorouracil"
14 Q0 14732695 240 40.619247 imi_mug_run_2_treatment "mediated"
14 Q0 7567931 241 40.536514 imi_mug_run_2_treatment "ras"
14 Q0 16332476 242 40.535202 imi_mug_run_2_treatment "aim"
14 Q0 14724942 243 40.515114 imi_mug_run_2_treatment "basis"
14 Q0 18936738 244 40.490322 imi_mug_run_2_treatment "various" "bisulfite"
14 Q0 24530564 245 40.437206 imi_mug_run_2_treatment "level" "bisulfite"
14 Q0 12481012 246 40.37319 imi_mug_run_2_treatment "level" "bisulfite"
14 Q0 24643686 247 40.36989 imi_mug_run_2_treatment "product"
14 Q0 24625416 248 40.334663 imi_mug_run_2_treatment "basis"
14 Q0 15734969 249 40.308052 imi_mug_run_2_treatment "vitamin c" "vitamin e" "beta-carotene"
14 Q0 14654551 250 40.265564 imi_mug_run_2_treatment "eacs"
14 Q0 25043185 251 40.250057 imi_mug_run_2_treatment "lysine" "dna methyltransferase inhibitor"
14 Q0 17054581 252 40.24574 imi_mug_run_2_treatment "prophylactic"
14 Q0 16879751 253 40.238625 imi_mug_run_2_treatment "platinum" "cisplatin" "bisulfite"
14 Q0 10637515 254 40.22326 imi_mug_run_2_treatment "lead"
14 Q0 15340260 255 40.21334 imi_mug_run_2_treatment "bisulfite" "level"
14 Q0 10793088 256 40.17583 imi_mug_run_2_treatment "basis"
14 Q0 21140203 257 40.134453 imi_mug_run_2_treatment "igf2"
14 Q0 19002263 258 40.12532 imi_mug_run_2_treatment "igf2" "lead"
14 Q0 22915242 259 40.114944 imi_mug_run_2_treatment "sucrose"
14 Q0 12926109 260 40.111214 imi_mug_run_2_treatment "others"
14 Q0 21498722 261 40.058765 imi_mug_run_2_treatment "aim"
14 Q0 9772075 262 40.03687 imi_mug_run_2_treatment "prompt" "aim"
14 Q0 28224663 263 40.02169 imi_mug_run_2_treatment "dsb"
14 Q0 16675565 264 40.018303 imi_mug_run_2_treatment "fluorouracil"
14 Q0 29341452 265 39.939068 imi_mug_run_2_treatment "various"
14 Q0 19690386 266 39.937737 imi_mug_run_2_treatment "various"
14 Q0 10535979 267 39.93645 imi_mug_run_2_treatment "calcitonin"
14 Q0 10564582 268 39.92905 imi_mug_run_2_treatment "various"
14 Q0 17504984 269 39.89473 imi_mug_run_2_treatment "level"
14 Q0 17117178 270 39.893787 imi_mug_run_2_treatment "level"
14 Q0 24806665 271 39.883827 imi_mug_run_2_treatment "level"
14 Q0 14737099 272 39.88024 imi_mug_run_2_treatment "emetine" "mediated" "drugs"
14 Q0 28533942 273 39.87457 imi_mug_run_2_treatment "hla-a24" "cytotoxic"
14 Q0 20924129 274 39.837967 imi_mug_run_2_treatment "prompt"
14 Q0 12097272 275 39.77324 imi_mug_run_2_treatment "agent" "suppressor"
14 Q0 22006538 276 39.77215 imi_mug_run_2_treatment "various" "hme" "bisulfite"
14 Q0 16403224 277 39.76973 imi_mug_run_2_treatment "serine" "ras" "aim"
14 Q0 17991344 278 39.74842 imi_mug_run_2_treatment "adjuvant" "fluorouracil" "leucovorin"
14 Q0 15118616 279 39.743324 imi_mug_run_2_treatment "ras" "basis" "lead"
14 Q0 9181230 280 39.699074 imi_mug_run_2_treatment "urea"
14 Q0 9823339 281 39.683273 imi_mug_run_2_treatment "basis"
14 Q0 25632919 282 39.660885 imi_mug_run_2_treatment "igf2"
14 Q0 16077070 283 39.633755 imi_mug_run_2_treatment "methylated"
14 Q0 17695437 284 39.577507 imi_mug_run_2_treatment "oxaliplatin" "fluorouracil" "aim"
14 Q0 18003927 285 39.55406 imi_mug_run_2_treatment "basis"
14 Q0 9927040 286 39.52519 imi_mug_run_2_treatment "rii" "blockade"
14 Q0 23328702 287 39.524963 imi_mug_run_2_treatment "folic acid" "vitamin b12" "folate"
14 Q0 21140452 288 39.46513 imi_mug_run_2_treatment "pooled"
14 Q0 16981189 289 39.461582 imi_mug_run_2_treatment "aim" "methylene" "thf"
14 Q0 20142816 290 39.40184 imi_mug_run_2_treatment "fluorouracil" "irinotecan"
14 Q0 22252522 291 39.3486 imi_mug_run_2_treatment "azacitidine"
14 Q0 16162019 292 39.348434 imi_mug_run_2_treatment "fluorouracil" "adjuvant" "folinic acid"
14 Q0 10665647 293 39.299927 imi_mug_run_2_treatment "hot spot"
14 Q0 20026115 294 39.242767 imi_mug_run_2_treatment "tgf-beta1"
14 Q0 20135198 295 39.16072 imi_mug_run_2_treatment "aim"
14 Q0 21209843 296 39.131424 imi_mug_run_2_treatment "mediated" "vaccine"
14 Q0 10573010 297 39.130394 imi_mug_run_2_treatment "aminoacid"
14 Q0 16675157 298 39.118206 imi_mug_run_2_treatment "various"
14 Q0 20489114 299 39.11417 imi_mug_run_2_treatment "aim"
14 Q0 19165625 300 39.11252 imi_mug_run_2_treatment "immunosuppressive"
14 Q0 11477566 301 39.111725 imi_mug_run_2_treatment "alcohol"
14 Q0 11251970 302 39.10665 imi_mug_run_2_treatment "aim"
14 Q0 20473920 303 39.083862 imi_mug_run_2_treatment "cyclin-dependent kinase inhibitor" "igf2"
14 Q0 25841496 304 39.069138 imi_mug_run_2_treatment "adjuvant" "fluorouracil" "oxaliplatin"
14 Q0 21238786 305 39.06494 imi_mug_run_2_treatment "ras"
14 Q0 11240745 306 39.053493 imi_mug_run_2_treatment "rii"
14 Q0 26895074 307 39.029247 imi_mug_run_2_treatment "basis"
14 Q0 15494688 308 39.005375 imi_mug_run_2_treatment "aim"
14 Q0 21758003 309 38.997406 imi_mug_run_2_treatment "genistein"
14 Q0 15897597 310 38.957813 imi_mug_run_2_treatment "various" "tum" "autologous"
14 Q0 21615788 311 38.943764 imi_mug_run_2_treatment "aim"
14 Q0 25356998 312 38.93751 imi_mug_run_2_treatment "lead"
14 Q0 17372756 313 38.888847 imi_mug_run_2_treatment "igf2" "fluorouracil" "leucovorin"
14 Q0 10675010 314 38.87195 imi_mug_run_2_treatment "ras" "lead" "others"
14 Q0 20833970 315 38.86606 imi_mug_run_2_treatment "proteases"
14 Q0 21507361 316 38.864403 imi_mug_run_2_treatment "thr" "lead"
14 Q0 10411935 317 38.860283 imi_mug_run_2_treatment "methylated"
14 Q0 26722606 318 38.85304 imi_mug_run_2_treatment "level" "dextran sodium sulfate"
14 Q0 24177031 319 38.848003 imi_mug_run_2_treatment "methylated" "bile acid"
14 Q0 17724798 320 38.843792 imi_mug_run_2_treatment "aim"
14 Q0 8880570 321 38.822487 imi_mug_run_2_treatment "product"
14 Q0 16143142 322 38.78415 imi_mug_run_2_treatment "level" "aim"
14 Q0 17086168 323 38.76682 imi_mug_run_2_treatment "various" "cyclin-dependent kinase inhibitor" "mediated"
14 Q0 26309352 324 38.74484 imi_mug_run_2_treatment "others"
14 Q0 16361634 325 38.74469 imi_mug_run_2_treatment "others"
14 Q0 9269998 326 38.74223 imi_mug_run_2_treatment "angiogenesis inhibitor" "igf2" "insulin-like growth factor ii"
14 Q0 24286815 327 38.74166 imi_mug_run_2_treatment "level" "aim"
14 Q0 9624418 328 38.739708 imi_mug_run_2_treatment "aim"
14 Q0 19430421 329 38.69687 imi_mug_run_2_treatment "igf2"
14 Q0 21621406 330 38.69388 imi_mug_run_2_treatment "aim"
14 Q0 11120331 331 38.693306 imi_mug_run_2_treatment "androgens"
14 Q0 11579115 332 38.66112 imi_mug_run_2_treatment "aim"
14 Q0 17339237 333 38.651573 imi_mug_run_2_treatment "igf2" "aim"
14 Q0 24408015 334 38.642445 imi_mug_run_2_treatment "enzyme digestion"
14 Q0 23684749 335 38.626663 imi_mug_run_2_treatment "hot spot"
14 Q0 21190186 336 38.61506 imi_mug_run_2_treatment "level"
14 Q0 15138486 337 38.601562 imi_mug_run_2_treatment "level"
14 Q0 25918287 338 38.59133 imi_mug_run_2_treatment "combinations" "oxaliplatin" "fluoropyrimidines"
14 Q0 16724012 339 38.563473 imi_mug_run_2_treatment "tcc" "gcg"
14 Q0 16103455 340 38.54578 imi_mug_run_2_treatment "folate"
14 Q0 18039421 341 38.543655 imi_mug_run_2_treatment "adjuvant"
14 Q0 27377375 342 38.50242 imi_mug_run_2_treatment "aza" "methyltransferase inhibitor" "level"
14 Q0 26510091 343 38.49627 imi_mug_run_2_treatment "level"
14 Q0 12588445 344 38.474266 imi_mug_run_2_treatment "bisulfite" "methylated"
14 Q0 26710839 345 38.46666 imi_mug_run_2_treatment "aim"
14 Q0 11078760 346 38.41398 imi_mug_run_2_treatment "anti-inflammatory" "nonsteroidal anti-inflammatory drugs" "aspirin"
14 Q0 8521394 347 38.400852 imi_mug_run_2_treatment "lead"
14 Q0 30387329 348 38.38861 imi_mug_run_2_treatment "zonal"
14 Q0 17123889 349 38.363564 imi_mug_run_2_treatment "level"
14 Q0 10329502 350 38.34305 imi_mug_run_2_treatment "product"
14 Q0 16042583 351 38.3356 imi_mug_run_2_treatment "lead"
14 Q0 20420946 352 38.33091 imi_mug_run_2_treatment "lead"
14 Q0 7657390 353 38.32865 imi_mug_run_2_treatment "various"
14 Q0 16982745 354 38.322716 imi_mug_run_2_treatment "level"
14 Q0 20233473 355 38.294727 imi_mug_run_2_treatment "level"
14 Q0 29511481 356 38.249157 imi_mug_run_2_treatment "various" "aim"
14 Q0 20215533 357 38.23563 imi_mug_run_2_treatment "cfr" "aim"
14 Q0 19300472 358 38.22309 imi_mug_run_2_treatment "gcv" "ganciclovir" "hydroxyurea"
14 Q0 27445647 359 38.19081 imi_mug_run_2_treatment "methylated"
14 Q0 13680299 360 38.12546 imi_mug_run_2_treatment "various" "product"
14 Q0 9500192 361 38.11271 imi_mug_run_2_treatment "various"
14 Q0 26647925 362 38.092422 imi_mug_run_2_treatment "level"
14 Q0 16285940 363 38.063354 imi_mug_run_2_treatment "bisulfite"
14 Q0 9558484 364 38.060165 imi_mug_run_2_treatment "beta-galactosidase"
14 Q0 23943026 365 38.047195 imi_mug_run_2_treatment "adjuvant" "aim"
14 Q0 15555207 366 38.036057 imi_mug_run_2_treatment "adjuvant"
14 Q0 17443689 367 38.020676 imi_mug_run_2_treatment "azacytidine" "suppressor" "mediated"
14 Q0 12438215 368 38.0144 imi_mug_run_2_treatment "tgf-beta1" "lead"
14 Q0 20305446 369 37.980457 imi_mug_run_2_treatment "various"
14 Q0 8527861 370 37.960773 imi_mug_run_2_treatment "yeast"
14 Q0 23788674 371 37.956398 imi_mug_run_2_treatment "duration"
14 Q0 10992275 372 37.93116 imi_mug_run_2_treatment "estrogen" "lead"
14 Q0 10220498 373 37.918983 imi_mug_run_2_treatment "ras" "methylated" "level"
14 Q0 19789368 374 37.901398 imi_mug_run_2_treatment "various" "vitamin d" "ras"
14 Q0 25167802 375 37.899242 imi_mug_run_2_treatment "sur" "igf2" "liver"
14 Q0 11232644 376 37.894836 imi_mug_run_2_treatment "aim" "suppressor"
14 Q0 11904375 377 37.88607 imi_mug_run_2_treatment "various" "enzymes" "azacytidine"
14 Q0 18162445 378 37.85505 imi_mug_run_2_treatment "cisplatin" "etoposide" "therapeutic agents"
14 Q0 16319691 379 37.843735 imi_mug_run_2_treatment "aim"
14 Q0 15782118 380 37.824436 imi_mug_run_2_treatment "ras"
14 Q0 23636450 381 37.81399 imi_mug_run_2_treatment "oxaliplatin" "platinum compounds" "poly(adp-ribose) polymerase inhibitors"
14 Q0 21455990 382 37.77997 imi_mug_run_2_treatment "shh"
14 Q0 20824433 383 37.776062 imi_mug_run_2_treatment "adjuvant" "fluorouracil"
14 Q0 24376999 384 37.764294 imi_mug_run_2_treatment "aim"
14 Q0 20387074 385 37.72351 imi_mug_run_2_treatment "fluorouracil" "therapeutic agent" "level"
14 Q0 15312538 386 37.69552 imi_mug_run_2_treatment "hmt" "level" "silver"
14 Q0 19469003 387 37.660904 imi_mug_run_2_treatment "lead" "aim"
14 Q0 25331470 388 37.627075 imi_mug_run_2_treatment "phenol"
14 Q0 12177776 389 37.62102 imi_mug_run_2_treatment "aim"
14 Q0 24360395 390 37.615173 imi_mug_run_2_treatment "various"
14 Q0 27853901 391 37.543396 imi_mug_run_2_treatment "adjuvant" "fluorouracil" "oxaliplatin"
14 Q0 12970888 392 37.54249 imi_mug_run_2_treatment "dna methyltransferase inhibitor" "level" "aim"
14 Q0 15175889 393 37.53939 imi_mug_run_2_treatment "level" "aim"
14 Q0 27718135 394 37.524963 imi_mug_run_2_treatment "agent"
14 Q0 18981723 395 37.488537 imi_mug_run_2_treatment "dna methylation inhibitor"
14 Q0 17716371 396 37.47103 imi_mug_run_2_treatment "various"
14 Q0 21422910 397 37.457207 imi_mug_run_2_treatment "various" "fluorouracil" "level"
14 Q0 11966533 398 37.386745 imi_mug_run_2_treatment "aim"
14 Q0 12475895 399 37.370586 imi_mug_run_2_treatment "level"
14 Q0 30173350 400 37.369152 imi_mug_run_2_treatment "cytotoxic drugs"
14 Q0 23089493 401 37.367115 imi_mug_run_2_treatment "aim"
14 Q0 15872200 402 37.343113 imi_mug_run_2_treatment "lead"
14 Q0 21879275 403 37.305115 imi_mug_run_2_treatment "lead"
14 Q0 15856472 404 37.302826 imi_mug_run_2_treatment "bisulfite" "genesis"
14 Q0 19686745 405 37.253716 imi_mug_run_2_treatment "suppressor" "lactase" "mediated"
14 Q0 29055842 406 37.239944 imi_mug_run_2_treatment "ras" "liver"
14 Q0 15713240 407 37.227863 imi_mug_run_2_treatment "lead"
14 Q0 16142001 408 37.226116 imi_mug_run_2_treatment "aim"
14 Q0 16407376 409 37.220177 imi_mug_run_2_treatment "aim"
14 Q0 10471384 410 37.18694 imi_mug_run_2_treatment "bisulfite" "methylated"
14 Q0 26249337 411 37.131912 imi_mug_run_2_treatment "aim"
14 Q0 16528606 412 37.12227 imi_mug_run_2_treatment "ras"
14 Q0 23354634 413 37.119957 imi_mug_run_2_treatment "aim"
14 Q0 20492682 414 37.1177 imi_mug_run_2_treatment "various" "aim"
14 Q0 26604793 415 37.11635 imi_mug_run_2_treatment "various"
14 Q0 17139886 416 37.10971 imi_mug_run_2_treatment "lead" "aim"
14 Q0 11358834 417 37.10624 imi_mug_run_2_treatment "lead"
14 Q0 19152022 418 37.106056 imi_mug_run_2_treatment "aim"
14 Q0 10077143 419 37.104404 imi_mug_run_2_treatment "basis" "aim"
14 Q0 11093935 420 37.094826 imi_mug_run_2_treatment "azacytidine" "bisulfite" "agent"
14 Q0 17031233 421 37.087574 imi_mug_run_2_treatment "mediators"
14 Q0 21342487 422 37.086884 imi_mug_run_2_treatment "enzymes" "drug" "level"
14 Q0 14755154 423 37.083084 imi_mug_run_2_treatment "various" "ras"
14 Q0 9200151 424 37.080208 imi_mug_run_2_treatment "alcohol" "calcium" "vitamin b12"
14 Q0 15118395 425 37.061043 imi_mug_run_2_treatment "aim"
14 Q0 16110022 426 37.056282 imi_mug_run_2_treatment "adjuvant" "fluorouracil"
14 Q0 20043265 427 37.039825 imi_mug_run_2_treatment "antineoplastic" "aim"
14 Q0 12436451 428 37.02859 imi_mug_run_2_treatment "others"
14 Q0 15133479 429 37.01561 imi_mug_run_2_treatment "level"
14 Q0 22526901 430 37.005768 imi_mug_run_2_treatment "fluorouracil"
14 Q0 12373605 431 36.983788 imi_mug_run_2_treatment "basis"
14 Q0 18096441 432 36.975594 imi_mug_run_2_treatment "aim"
14 Q0 25033682 433 36.967705 imi_mug_run_2_treatment "prophylactic"
14 Q0 10416598 434 36.963806 imi_mug_run_2_treatment "tgf-beta1"
14 Q0 30303141 435 36.93948 imi_mug_run_2_treatment "various"
14 Q0 17979506 436 36.93367 imi_mug_run_2_treatment "sodium bisulfite"
14 Q0 18517279 437 36.931145 imi_mug_run_2_treatment "level"
14 Q0 11325821 438 36.88572 imi_mug_run_2_treatment "methylated" "lead"
14 Q0 9212728 439 36.85878 imi_mug_run_2_treatment "rii"
14 Q0 12684669 440 36.83784 imi_mug_run_2_treatment "beta-galactosidase"
14 Q0 22274583 441 36.822933 imi_mug_run_2_treatment "aim"
14 Q0 25420937 442 36.81202 imi_mug_run_2_treatment "adjuvant"
14 Q0 27167203 443 36.775963 imi_mug_run_2_treatment "egcg" "epigallocatechin-3-gallate" "polyphenols"
14 Q0 16426447 444 36.77149 imi_mug_run_2_treatment "various"
14 Q0 16929496 445 36.75192 imi_mug_run_2_treatment "various"
14 Q0 17671175 446 36.722237 imi_mug_run_2_treatment "level" "others"
14 Q0 19662090 447 36.720573 imi_mug_run_2_treatment "oncostatin m" "mediated"
14 Q0 19107235 448 36.712246 imi_mug_run_2_treatment "lead" "igf2"
14 Q0 19833818 449 36.695038 imi_mug_run_2_treatment "oxaliplatin" "fluorouracil" "leucovorin"
14 Q0 21206982 450 36.651592 imi_mug_run_2_treatment "level"
14 Q0 17921385 451 36.625427 imi_mug_run_2_treatment "vitamin b-12" "folate" "plasma"
14 Q0 19480245 452 36.60298 imi_mug_run_2_treatment "aim"
14 Q0 10362807 453 36.58168 imi_mug_run_2_treatment "level" "aim"
14 Q0 9683789 454 36.580093 imi_mug_run_2_treatment "cisplatin" "thioguanine" "agent"
14 Q0 22278153 455 36.558884 imi_mug_run_2_treatment "aim"
14 Q0 17192059 456 36.558327 imi_mug_run_2_treatment "fluorouracil" "mediated"
14 Q0 10496533 457 36.548306 imi_mug_run_2_treatment "aim"
14 Q0 17022696 458 36.53123 imi_mug_run_2_treatment "aim"
14 Q0 17982118 459 36.500187 imi_mug_run_2_treatment "cfr"
14 Q0 15921009 460 36.498955 imi_mug_run_2_treatment "various" "aim"
14 Q0 27114419 461 36.481964 imi_mug_run_2_treatment "aim"
14 Q0 10719371 462 36.47172 imi_mug_run_2_treatment "antral"
14 Q0 15483016 463 36.468468 imi_mug_run_2_treatment "aim"
14 Q0 12172579 464 36.467644 imi_mug_run_2_treatment "lead" "aim"
14 Q0 24316944 465 36.458107 imi_mug_run_2_treatment "aim"
14 Q0 28848075 466 36.453987 imi_mug_run_2_treatment "level"
14 Q0 15161007 467 36.44542 imi_mug_run_2_treatment "level"
14 Q0 18641409 468 36.415165 imi_mug_run_2_treatment "various"
14 Q0 18537129 469 36.392178 imi_mug_run_2_treatment "lycopene" "tomato" "kinase inhibitor"
14 Q0 12454837 470 36.390232 imi_mug_run_2_treatment "lead"
14 Q0 28440661 471 36.368076 imi_mug_run_2_treatment "eacs"
14 Q0 26247523 472 36.322792 imi_mug_run_2_treatment "fluorouracil" "others"
14 Q0 21556654 473 36.320007 imi_mug_run_2_treatment "level"
14 Q0 8824498 474 36.31744 imi_mug_run_2_treatment "basis"
14 Q0 29304767 475 36.303555 imi_mug_run_2_treatment "methylate"
14 Q0 26609171 476 36.290962 imi_mug_run_2_treatment "dca" "deoxycholic acid" "bile acid"
14 Q0 10716966 477 36.289143 imi_mug_run_2_treatment "cytotoxic" "favor" "agent"
14 Q0 20653064 478 36.265465 imi_mug_run_2_treatment "kinase inhibitor" "level" "aim"
14 Q0 30009279 479 36.262375 imi_mug_run_2_treatment "irinotecan"
14 Q0 18792805 480 36.24488 imi_mug_run_2_treatment "mediated"
14 Q0 29547900 481 36.230576 imi_mug_run_2_treatment "curcumin" "mediated" "dextran sulfate sodium"
14 Q0 8622897 482 36.189995 imi_mug_run_2_treatment "oligo"
14 Q0 18782444 483 36.1864 imi_mug_run_2_treatment "bisulfite" "lead"
14 Q0 11054716 484 36.16946 imi_mug_run_2_treatment "level"
14 Q0 24323032 485 36.168705 imi_mug_run_2_treatment "various" "combinations" "level"
14 Q0 16542391 486 36.15533 imi_mug_run_2_treatment "program" "level" "aim"
14 Q0 16613332 487 36.147102 imi_mug_run_2_treatment "aim"
14 Q0 19363658 488 36.136597 imi_mug_run_2_treatment "sham"
14 Q0 22958290 489 36.126015 imi_mug_run_2_treatment "tma"
14 Q0 14654793 490 36.12449 imi_mug_run_2_treatment "lead"
14 Q0 25360631 491 36.117275 imi_mug_run_2_treatment "oxaliplatin"
14 Q0 9713355 492 36.089626 imi_mug_run_2_treatment "rii" "lead"
14 Q0 21821115 493 36.086617 imi_mug_run_2_treatment "enzymes" "level"
14 Q0 22382314 494 36.075848 imi_mug_run_2_treatment "drug" "histone deacetylase inhibitor" "phosphate"
14 Q0 19789347 495 36.072517 imi_mug_run_2_treatment "mediators" "ras" "tet"
14 Q0 11821788 496 36.055984 imi_mug_run_2_treatment "various" "mediated"
14 Q0 14726683 497 36.04659 imi_mug_run_2_treatment "bisulfite" "dna methyltransferase inhibitor"
14 Q0 16769811 498 36.045067 imi_mug_run_2_treatment "mediated"
14 Q0 25366420 499 36.04377 imi_mug_run_2_treatment "various" "drug" "hme"
14 Q0 16078859 500 36.03087 imi_mug_run_2_treatment "drug" "cancer drug" "therapeutic agents"
14 Q0 11996796 501 36.03021 imi_mug_run_2_treatment "others"
14 Q0 17394133 502 36.014454 imi_mug_run_2_treatment "collagens"
14 Q0 23175808 503 36.011326 imi_mug_run_2_treatment "level"
14 Q0 19063841 504 36.00656 imi_mug_run_2_treatment "polyphenols" "tgf-beta1"
14 Q0 28418886 505 36.005234 imi_mug_run_2_treatment "valproate" "methylated"
14 Q0 21949851 506 36.000095 imi_mug_run_2_treatment "tgfb1"
14 Q0 24324066 507 35.984814 imi_mug_run_2_treatment "egcg" "polyphenol"
14 Q0 14750212 508 35.948654 imi_mug_run_2_treatment "chemopreventive agents" "aspirin" "calcium chloride"
14 Q0 22300984 509 35.923542 imi_mug_run_2_treatment "glucose"
14 Q0 16675567 510 35.9102 imi_mug_run_2_treatment "others"
14 Q0 29896277 511 35.90711 imi_mug_run_2_treatment "pooled"
14 Q0 11733373 512 35.903385 imi_mug_run_2_treatment "others"
14 Q0 11901802 513 35.876286 imi_mug_run_2_treatment "basis"
14 Q0 19934290 514 35.859688 imi_mug_run_2_treatment "fluorouracil" "irinotecan" "ras"
14 Q0 25117503 515 35.853966 imi_mug_run_2_treatment "tumor infiltrating lymphocytes"
14 Q0 10521294 516 35.847775 imi_mug_run_2_treatment "basis"
14 Q0 20691710 517 35.84768 imi_mug_run_2_treatment "lead"
14 Q0 15571801 518 35.84709 imi_mug_run_2_treatment "lead"
14 Q0 26967246 519 35.839134 imi_mug_run_2_treatment "fluorouracil" "agent" "parp inhibitors"
14 Q0 17454879 520 35.83524 imi_mug_run_2_treatment "level"
14 Q0 16012936 521 35.815197 imi_mug_run_2_treatment "level"
14 Q0 19639184 522 35.812958 imi_mug_run_2_treatment "saha" "vpa" "histone deacetylase inhibitor"
14 Q0 15945244 523 35.80461 imi_mug_run_2_treatment "aminoacids" "suppressor"
14 Q0 21679278 524 35.7912 imi_mug_run_2_treatment "irinotecan"
14 Q0 8690195 525 35.752464 imi_mug_run_2_treatment "liver"
14 Q0 20591884 526 35.7349 imi_mug_run_2_treatment "ci 4" "aim"
14 Q0 18773212 527 35.706673 imi_mug_run_2_treatment "chemotherapeutic agent" "fluorouracil" "aim"
14 Q0 9823804 528 35.696636 imi_mug_run_2_treatment "formalin" "aim" "shape"
14 Q0 21271382 529 35.689514 imi_mug_run_2_treatment "bisulfite"
14 Q0 28830689 530 35.689404 imi_mug_run_2_treatment "level"
14 Q0 29929473 531 35.688637 imi_mug_run_2_treatment "prophylactic"
14 Q0 11437928 532 35.6856 imi_mug_run_2_treatment "aim"
14 Q0 19881948 533 35.675438 imi_mug_run_2_treatment "therapeutics"
14 Q0 7479796 534 35.632313 imi_mug_run_2_treatment "yeast" "lead"
14 Q0 15930362 535 35.62403 imi_mug_run_2_treatment "vascular endothelial growth factor" "fluorouracil"
14 Q0 28234922 536 35.619453 imi_mug_run_2_treatment "various"
14 Q0 20354000 537 35.613415 imi_mug_run_2_treatment "il-6" "mediated" "interleukin-6"
14 Q0 29976631 538 35.613033 imi_mug_run_2_treatment "aim"
14 Q0 28059100 539 35.602882 imi_mug_run_2_treatment "program" "others"
14 Q0 26181448 540 35.588318 imi_mug_run_2_treatment "fluorouracil"
14 Q0 21184144 541 35.587204 imi_mug_run_2_treatment "level" "lysine" "serine"
14 Q0 17621591 542 35.585968 imi_mug_run_2_treatment "igf2"
14 Q0 28878284 543 35.571053 imi_mug_run_2_treatment "dextran sodium sulfate"
14 Q0 30272331 544 35.5642 imi_mug_run_2_treatment "lithium chloride" "aim"
14 Q0 11776835 545 35.52253 imi_mug_run_2_treatment "polyacrylamide gel" "silver" "genesis"
14 Q0 25939752 546 35.51237 imi_mug_run_2_treatment "agent"
14 Q0 24533778 547 35.507793 imi_mug_run_2_treatment "mediated" "level" "suppressor"
14 Q0 26918725 548 35.504547 imi_mug_run_2_treatment "favoring" "drug" "cytotoxic"
14 Q0 24944470 549 35.49671 imi_mug_run_2_treatment "adjuvant"
14 Q0 16448675 550 35.49302 imi_mug_run_2_treatment "insulin" "igf1"
14 Q0 23783552 551 35.481125 imi_mug_run_2_treatment "sodium bisulfite" "liver"
14 Q0 28411881 552 35.47461 imi_mug_run_2_treatment "level"
14 Q0 11303196 553 35.458836 imi_mug_run_2_treatment "polyacrylamide gels" "basis"
14 Q0 20096102 554 35.456245 imi_mug_run_2_treatment "sn-38" "drugs" "irinotecan"
14 Q0 11584201 555 35.45269 imi_mug_run_2_treatment "basis"
14 Q0 28431273 556 35.450745 imi_mug_run_2_treatment "aim"
14 Q0 26880610 557 35.4433 imi_mug_run_2_treatment "blockade" "medicine"
14 Q0 8960367 558 35.420364 imi_mug_run_2_treatment "pcc"
14 Q0 16106779 559 35.414078 imi_mug_run_2_treatment "fluorouracil" "leukovorin" "genesis"
14 Q0 14647464 560 35.408432 imi_mug_run_2_treatment "tcc"
14 Q0 14631366 561 35.381535 imi_mug_run_2_treatment "various"
14 Q0 19737982 562 35.372757 imi_mug_run_2_treatment "mediators"
14 Q0 16108056 563 35.371544 imi_mug_run_2_treatment "rii"
14 Q0 30429213 564 35.351494 imi_mug_run_2_treatment "various" "cytotoxic"
14 Q0 29933315 565 35.35 imi_mug_run_2_treatment "tumor infiltrating lymphocytes"
14 Q0 11535705 566 35.333046 imi_mug_run_2_treatment "product"
14 Q0 30464574 567 35.316803 imi_mug_run_2_treatment "capecitabine" "adjuvant" "aim"
14 Q0 25798424 568 35.31432 imi_mug_run_2_treatment "various"
14 Q0 22711178 569 35.31264 imi_mug_run_2_treatment "aim"
14 Q0 15563510 570 35.276783 imi_mug_run_2_treatment "aim"
14 Q0 25477755 571 35.24746 imi_mug_run_2_treatment "ras" "aim"
14 Q0 30311169 572 35.231766 imi_mug_run_2_treatment "mediated" "product" "aim"
14 Q0 17334979 573 35.23133 imi_mug_run_2_treatment "methylated"
14 Q0 20836393 574 35.218155 imi_mug_run_2_treatment "level" "bisulfite" "aim"
14 Q0 11343776 575 35.21557 imi_mug_run_2_treatment "various"
14 Q0 12964042 576 35.207752 imi_mug_run_2_treatment "various" "level"
14 Q0 15342696 577 35.206947 imi_mug_run_2_treatment "ras"
14 Q0 29205508 578 35.200737 imi_mug_run_2_treatment "level"
14 Q0 11052472 579 35.192024 imi_mug_run_2_treatment "aim"
14 Q0 21677822 580 35.19073 imi_mug_run_2_treatment "bile acid"
14 Q0 21157981 581 35.184113 imi_mug_run_2_treatment "polyacrylamide gel" "aim"
14 Q0 22769569 582 35.142216 imi_mug_run_2_treatment "enzymes" "adjuvant" "tegafur"
14 Q0 30376427 583 35.12832 imi_mug_run_2_treatment "basis"
14 Q0 26171582 584 35.10208 imi_mug_run_2_treatment "ipa" "level"
14 Q0 11196149 585 35.08133 imi_mug_run_2_treatment "estrogen" "estrogens" "oral contraceptives"
14 Q0 25902909 586 35.08109 imi_mug_run_2_treatment "aim"
14 Q0 28133101 587 35.080364 imi_mug_run_2_treatment "level"
14 Q0 30399198 588 35.07749 imi_mug_run_2_treatment "adjuvant" "aim"
14 Q0 16952542 589 35.077446 imi_mug_run_2_treatment "fluorouracil"
14 Q0 17461458 590 35.07469 imi_mug_run_2_treatment "aim"
14 Q0 19505918 591 35.072563 imi_mug_run_2_treatment "cyclin-dependent kinase inhibitor"
14 Q0 21036707 592 35.064465 imi_mug_run_2_treatment "ethidium bromide" "licorice" "agent"
14 Q0 17047040 593 35.05249 imi_mug_run_2_treatment "mediated"
14 Q0 20077021 594 35.04951 imi_mug_run_2_treatment "adjuvant" "fluoropyrimidine"
14 Q0 15375009 595 35.032314 imi_mug_run_2_treatment "liver"
14 Q0 26095997 596 35.010235 imi_mug_run_2_treatment "aim"
14 Q0 22565205 597 34.998817 imi_mug_run_2_treatment "glycan" "glycans" "level"
14 Q0 30185207 598 34.98989 imi_mug_run_2_treatment "various" "trametinib" "drug"
14 Q0 16157203 599 34.96012 imi_mug_run_2_treatment "suppressor" "lead"
14 Q0 22243995 600 34.958817 imi_mug_run_2_treatment "bisulfite" "sodium bisulfite" "formalin"
14 Q0 23804521 601 34.95802 imi_mug_run_2_treatment "genesis"
14 Q0 11120891 602 34.956547 imi_mug_run_2_treatment "igf2" "insulin-like growth factor ii"
14 Q0 11522655 603 34.91811 imi_mug_run_2_treatment "mediated" "animals"
14 Q0 23451280 604 34.901985 imi_mug_run_2_treatment "dnase"
14 Q0 28367107 605 34.87198 imi_mug_run_2_treatment "fluorouracil" "blockade" "genesis"
14 Q0 16490738 606 34.871223 imi_mug_run_2_treatment "aim"
14 Q0 9671741 607 34.86639 imi_mug_run_2_treatment "azacytidine" "agent"
14 Q0 22039417 608 34.865967 imi_mug_run_2_treatment "fructose" "liver" "aza"
14 Q0 20802524 609 34.853596 imi_mug_run_2_treatment "bisulfite" "kinase inhibitor" "mediated"
14 Q0 10714217 610 34.844963 imi_mug_run_2_treatment "nsaids" "aspirin" "sulindac"
14 Q0 20211485 611 34.844578 imi_mug_run_2_treatment "bisulfite"
14 Q0 10393852 612 34.839897 imi_mug_run_2_treatment "level"
14 Q0 10786688 613 34.794746 imi_mug_run_2_treatment "yeast" "basis"
14 Q0 7705951 614 34.763767 imi_mug_run_2_treatment "trans-retinoic acid" "level"
14 Q0 24577941 615 34.724056 imi_mug_run_2_treatment "sn-38" "olaparib" "mediated"
14 Q0 17267619 616 34.723248 imi_mug_run_2_treatment "aim"
14 Q0 17108209 617 34.722897 imi_mug_run_2_treatment "basis" "plasma"
14 Q0 18425817 618 34.713387 imi_mug_run_2_treatment "mediated" "ras" "tgf-beta1"
14 Q0 22359293 619 34.710808 imi_mug_run_2_treatment "various" "lead" "drugs"
14 Q0 24048684 620 34.707535 imi_mug_run_2_treatment "basis" "level"
14 Q0 12555992 621 34.69558 imi_mug_run_2_treatment "aim"
14 Q0 18584349 622 34.670803 imi_mug_run_2_treatment "plasma" "vitamin b12" "methylene"
14 Q0 26862732 623 34.658943 imi_mug_run_2_treatment "aim"
14 Q0 28458789 624 34.642967 imi_mug_run_2_treatment "fluorouracil" "leucovorin" "oxaliplatin"
14 Q0 21298366 625 34.63925 imi_mug_run_2_treatment "agent"
14 Q0 28278514 626 34.638374 imi_mug_run_2_treatment "adjuvant" "oxaliplatin" "fluoropyrimidine"
14 Q0 18339680 627 34.620876 imi_mug_run_2_treatment "alcohol" "folate" "vitamins"
14 Q0 9691137 628 34.608006 imi_mug_run_2_treatment "beta galactosidase"
14 Q0 12470902 629 34.60488 imi_mug_run_2_treatment "lead"
14 Q0 24594804 630 34.603374 imi_mug_run_2_treatment "ors"
14 Q0 17187355 631 34.594776 imi_mug_run_2_treatment "tumor infiltrating lymphocytes"
14 Q0 16762487 632 34.588547 imi_mug_run_2_treatment "aim"
14 Q0 25190725 633 34.577934 imi_mug_run_2_treatment "level"
14 Q0 19686742 634 34.57576 imi_mug_run_2_treatment "igf2"
14 Q0 29473436 635 34.565582 imi_mug_run_2_treatment "agent" "nivolumab"
14 Q0 17044039 636 34.5608 imi_mug_run_2_treatment "various"
14 Q0 25743829 637 34.556202 imi_mug_run_2_treatment "fluorouracil"
14 Q0 26538087 638 34.55256 imi_mug_run_2_treatment "various" "hme"
14 Q0 16163424 639 34.552177 imi_mug_run_2_treatment "aim"
14 Q0 14695993 640 34.541252 imi_mug_run_2_treatment "ras"
14 Q0 17101318 641 34.49418 imi_mug_run_2_treatment "methylated"
14 Q0 24127781 642 34.485523 imi_mug_run_2_treatment "adjuvant" "lead"
14 Q0 19672874 643 34.401882 imi_mug_run_2_treatment "aim"
14 Q0 22198706 644 34.388138 imi_mug_run_2_treatment "basis"
14 Q0 23226285 645 34.379963 imi_mug_run_2_treatment "ors" "aim"
14 Q0 22244828 646 34.35818 imi_mug_run_2_treatment "level"
14 Q0 26305882 647 34.349903 imi_mug_run_2_treatment "enzymes"
14 Q0 17007286 648 34.336525 imi_mug_run_2_treatment "aim"
14 Q0 29181059 649 34.329033 imi_mug_run_2_treatment "aim"
14 Q0 18640693 650 34.313015 imi_mug_run_2_treatment "basis"
14 Q0 17109103 651 34.300808 imi_mug_run_2_treatment "chemotherapeutic agent" "fluorouracil" "irinotecan"
14 Q0 24466191 652 34.295845 imi_mug_run_2_treatment "combinations" "level" "igf2"
14 Q0 15334673 653 34.27984 imi_mug_run_2_treatment "level" "aim"
14 Q0 9639521 654 34.27576 imi_mug_run_2_treatment "rii" "lead"
14 Q0 7615195 655 34.272873 imi_mug_run_2_treatment "aim"
14 Q0 23209772 656 34.26034 imi_mug_run_2_treatment "aim"
14 Q0 24389200 657 34.257458 imi_mug_run_2_treatment "level"
14 Q0 19723919 658 34.244255 imi_mug_run_2_treatment "cyclin-dependent kinase inhibitor"
14 Q0 25172634 659 34.2403 imi_mug_run_2_treatment "nicotinamide" "oxygen"
14 Q0 29615301 660 34.23784 imi_mug_run_2_treatment "alcohol"
14 Q0 21484480 661 34.23539 imi_mug_run_2_treatment "various" "adjuvant" "cytotoxic drugs"
14 Q0 10369701 662 34.234467 imi_mug_run_2_treatment "basis"
14 Q0 28341242 663 34.229797 imi_mug_run_2_treatment "oxaliplatin" "adjuvant" "fluorouracil"
14 Q0 13679870 664 34.22951 imi_mug_run_2_treatment "suppressor"
14 Q0 15216397 665 34.22132 imi_mug_run_2_treatment "biotin" "eosin"
14 Q0 17086209 666 34.22116 imi_mug_run_2_treatment "caffeine" "mediated" "emetine"
14 Q0 28467774 667 34.21341 imi_mug_run_2_treatment "anti-inflammatory" "interleukin"
14 Q0 16551870 668 34.21196 imi_mug_run_2_treatment "sn-38" "irinotecan" "histone deacetylase inhibitor"
14 Q0 20507599 669 34.208813 imi_mug_run_2_treatment "tumor infiltrating lymphocytes" "level"
14 Q0 18618713 670 34.189125 imi_mug_run_2_treatment "various" "lead"
14 Q0 11272898 671 34.171177 imi_mug_run_2_treatment "polyacrylamide gel"
14 Q0 15583795 672 34.159676 imi_mug_run_2_treatment "tamoxifen"
14 Q0 19093176 673 34.145126 imi_mug_run_2_treatment "fluorouracil" "methylene" "others"
14 Q0 30519050 674 34.140152 imi_mug_run_2_treatment "irinotecan" "bevacizumab" "cetuximab"
14 Q0 30121380 675 34.138763 imi_mug_run_2_treatment "dextran sodium sulfate"
14 Q0 22028395 676 34.137985 imi_mug_run_2_treatment "e-10"
14 Q0 11161395 677 34.1312 imi_mug_run_2_treatment "tcc"
14 Q0 12829793 678 34.119366 imi_mug_run_2_treatment "sodium" "drug" "azacytidine"
14 Q0 11852345 679 34.11754 imi_mug_run_2_treatment "various"
14 Q0 23792451 680 34.117485 imi_mug_run_2_treatment "aspirin" "bisphosphonate" "various"
14 Q0 20124488 681 34.117218 imi_mug_run_2_treatment "anti-inflammatory" "nonsteroidal anti-inflammatory drug" "aspirin"
14 Q0 8645585 682 34.10147 imi_mug_run_2_treatment "genesis"
14 Q0 25853800 683 34.080414 imi_mug_run_2_treatment "tet"
14 Q0 19165197 684 34.07114 imi_mug_run_2_treatment "aim"
14 Q0 20492385 685 34.0639 imi_mug_run_2_treatment "aim"
14 Q0 27430658 686 34.058846 imi_mug_run_2_treatment "level"
14 Q0 16322293 687 34.058094 imi_mug_run_2_treatment "fluorouracil" "aim"
14 Q0 28327908 688 34.051643 imi_mug_run_2_treatment "vitamin d" "adjuvant" "plasma"
14 Q0 25919688 689 34.04561 imi_mug_run_2_treatment "bisulfite"
14 Q0 17250665 690 34.04122 imi_mug_run_2_treatment "program"
14 Q0 19424571 691 34.037872 imi_mug_run_2_treatment "aim"
14 Q0 20473912 692 34.030254 imi_mug_run_2_treatment "basis"
14 Q0 24267189 693 34.029037 imi_mug_run_2_treatment "basis"
14 Q0 21717218 694 34.026634 imi_mug_run_2_treatment "formaldehyde" "aim"
14 Q0 20966546 695 34.026634 imi_mug_run_2_treatment "formaldehyde" "aim"
14 Q0 11506498 696 34.0266 imi_mug_run_2_treatment "lead"
14 Q0 15492759 697 34.02575 imi_mug_run_2_treatment "others"
14 Q0 17965620 698 34.02398 imi_mug_run_2_treatment "bisulfite" "com"
14 Q0 28643016 699 33.982807 imi_mug_run_2_treatment "aim"
14 Q0 28957395 700 33.976997 imi_mug_run_2_treatment "various" "adjuvant" "aim"
14 Q0 21115903 701 33.95543 imi_mug_run_2_treatment "novasoy" "genistein" "level"
14 Q0 18310315 702 33.94906 imi_mug_run_2_treatment "aim"
14 Q0 22740977 703 33.94565 imi_mug_run_2_treatment "aim"
14 Q0 20937028 704 33.939346 imi_mug_run_2_treatment "alcohol" "animal fats"
14 Q0 9850084 705 33.92388 imi_mug_run_2_treatment "calca" "igf2"
14 Q0 21706001 706 33.919636 imi_mug_run_2_treatment "matrix"
14 Q0 14521608 707 33.88435 imi_mug_run_2_treatment "aspirin" "sodium salicylate" "drugs"
14 Q0 24603996 708 33.88022 imi_mug_run_2_treatment "aim"
14 Q0 21738611 709 33.878746 imi_mug_run_2_treatment "b vitamins" "alcohol" "folate"
14 Q0 16099019 710 33.877964 imi_mug_run_2_treatment "acetate" "progestins" "combination oral contraceptive"
14 Q0 10082584 711 33.86008 imi_mug_run_2_treatment "yeast"
14 Q0 17962810 712 33.845913 imi_mug_run_2_treatment "level"
14 Q0 22085384 713 33.844723 imi_mug_run_2_treatment "adjuvant" "fluorouracil" "oxaliplatin"
14 Q0 25766089 714 33.79597 imi_mug_run_2_treatment "sts"
14 Q0 15217933 715 33.792416 imi_mug_run_2_treatment "ras" "basis"
14 Q0 14572584 716 33.781837 imi_mug_run_2_treatment "program" "aim"
14 Q0 18673531 717 33.78032 imi_mug_run_2_treatment "bisulfite" "histone deacetylase inhibitor" "cyclosporine a"
14 Q0 17317101 718 33.760513 imi_mug_run_2_treatment "ras" "mediated"
14 Q0 20028768 719 33.759537 imi_mug_run_2_treatment "aim"
14 Q0 28352680 720 33.746616 imi_mug_run_2_treatment "various" "penta"
14 Q0 23411922 721 33.742027 imi_mug_run_2_treatment "aim"
14 Q0 16395674 722 33.739822 imi_mug_run_2_treatment "histidine" "bisulfite"
14 Q0 26805315 723 33.736137 imi_mug_run_2_treatment "sps"
14 Q0 20501503 724 33.73598 imi_mug_run_2_treatment "fluorouracil" "pooled"
14 Q0 11389062 725 33.71833 imi_mug_run_2_treatment "basis"
14 Q0 21557332 726 33.717415 imi_mug_run_2_treatment "suppressor"
14 Q0 24330717 727 33.711838 imi_mug_run_2_treatment "liver" "level" "bisulfite"
14 Q0 12048675 728 33.69228 imi_mug_run_2_treatment "atra" "retinoid" "beta-galactosidase"
14 Q0 21417908 729 33.682487 imi_mug_run_2_treatment "fluorouracil"
14 Q0 25841497 730 33.679523 imi_mug_run_2_treatment "drug" "oxaliplatin" "capecitabine"
14 Q0 12559075 731 33.672165 imi_mug_run_2_treatment "various" "rii"
14 Q0 25836926 732 33.668594 imi_mug_run_2_treatment "fluorouracil" "mediated" "interleukin-6"
14 Q0 19412426 733 33.652847 imi_mug_run_2_treatment "various"
14 Q0 11905459 734 33.646854 imi_mug_run_2_treatment "suppressor"
14 Q0 22719182 735 33.643085 imi_mug_run_2_treatment "various" "level"
14 Q0 16819508 736 33.627808 imi_mug_run_2_treatment "basis"
14 Q0 10374688 737 33.625103 imi_mug_run_2_treatment "various"
14 Q0 29654889 738 33.62423 imi_mug_run_2_treatment "level"
14 Q0 29930328 739 33.622154 imi_mug_run_2_treatment "anti-inflammatory" "steroidal anti-inflammatory drugs" "folate"
14 Q0 11245440 740 33.607784 imi_mug_run_2_treatment "hydrogen peroxide" "drugs" "mediated"
14 Q0 8952554 741 33.602818 imi_mug_run_2_treatment "rii" "aim"
14 Q0 17397030 742 33.584526 imi_mug_run_2_treatment "agent"
14 Q0 29451183 743 33.5795 imi_mug_run_2_treatment "fluorouracil" "mapk inhibitors" "level"
14 Q0 18823011 744 33.56295 imi_mug_run_2_treatment "mediated"
14 Q0 21213373 745 33.555687 imi_mug_run_2_treatment "level"
14 Q0 9250815 746 33.554947 imi_mug_run_2_treatment "lead"
14 Q0 21526302 747 33.521675 imi_mug_run_2_treatment "aim"
14 Q0 18983468 748 33.515835 imi_mug_run_2_treatment "igf2" "aim"
14 Q0 22287190 749 33.501087 imi_mug_run_2_treatment "level"
14 Q0 18451690 750 33.500793 imi_mug_run_2_treatment "aim"
14 Q0 29725538 751 33.492855 imi_mug_run_2_treatment "fluorouracil" "leucovorin" "oxaliplatin"
14 Q0 12584437 752 33.492374 imi_mug_run_2_treatment "color"
14 Q0 17026563 753 33.489567 imi_mug_run_2_treatment "fluorouracil"
14 Q0 9882509 754 33.48709 imi_mug_run_2_treatment "drugs" "cisplatin" "temozolomide"
14 Q0 17512720 755 33.472534 imi_mug_run_2_treatment "aim"
14 Q0 7707417 756 33.468655 imi_mug_run_2_treatment "folate" "methionine" "combinations"
14 Q0 12679904 757 33.468227 imi_mug_run_2_treatment "aim"
14 Q0 9122232 758 33.458878 imi_mug_run_2_treatment "various" "azacytidine" "agent"
14 Q0 15170669 759 33.454247 imi_mug_run_2_treatment "level"
14 Q0 18516290 760 33.450485 imi_mug_run_2_treatment "igf2" "level"
14 Q0 11859205 761 33.449654 imi_mug_run_2_treatment "aim"
14 Q0 22147942 762 33.44467 imi_mug_run_2_treatment "irinotecan" "fluorouracil" "leucovorin"
14 Q0 10585582 763 33.44445 imi_mug_run_2_treatment "level"
14 Q0 16815967 764 33.429565 imi_mug_run_2_treatment "mediated" "lead"
14 Q0 19549920 765 33.427517 imi_mug_run_2_treatment "insulin-like growth factor ii" "level"
14 Q0 9255561 766 33.427402 imi_mug_run_2_treatment "various"
14 Q0 10598412 767 33.42291 imi_mug_run_2_treatment "aim"
14 Q0 29337063 768 33.419384 imi_mug_run_2_treatment "various" "mediated"
14 Q0 18830122 769 33.416794 imi_mug_run_2_treatment "fluorouracil"
14 Q0 23258531 770 33.412525 imi_mug_run_2_treatment "various"
14 Q0 25576161 771 33.40575 imi_mug_run_2_treatment "bisulfite" "aim"
14 Q0 18225536 772 33.357853 imi_mug_run_2_treatment "piroxicam" "drug" "anti-inflammatory"
14 Q0 19638594 773 33.355114 imi_mug_run_2_treatment "histone deacetylase inhibitor" "alpha subunit" "suberoylanilide hydroxamic acid"
14 Q0 17075118 774 33.35463 imi_mug_run_2_treatment "adjuvant" "leucovorin"
14 Q0 21998335 775 33.35463 imi_mug_run_2_treatment "adjuvant" "oxaliplatin" "fluorouracil"
14 Q0 20526097 776 33.349228 imi_mug_run_2_treatment "adjuvant" "oxaliplatin" "fluoropyrimidine"
14 Q0 16177963 777 33.344093 imi_mug_run_2_treatment "level"
14 Q0 20594200 778 33.344093 imi_mug_run_2_treatment "aim" "anti-vegf" "vascular endothelial growth factor"
14 Q0 24108782 779 33.342175 imi_mug_run_2_treatment "folate" "insulin-like growth factor ii" "plasma"
14 Q0 30400781 780 33.333595 imi_mug_run_2_treatment "tma"
14 Q0 12820718 781 33.331726 imi_mug_run_2_treatment "lead"
14 Q0 10080156 782 33.328342 imi_mug_run_2_treatment "basis" "liver"
14 Q0 20488783 783 33.326584 imi_mug_run_2_treatment "basis"
14 Q0 24166914 784 33.323483 imi_mug_run_2_treatment "adjuvant"
14 Q0 28537083 785 33.313774 imi_mug_run_2_treatment "tumor infiltrating lymphocytes"
14 Q0 9679977 786 33.298935 imi_mug_run_2_treatment "rii"
14 Q0 26619098 787 33.292942 imi_mug_run_2_treatment "combinations" "level" "others"
14 Q0 23855266 788 33.289787 imi_mug_run_2_treatment "hydroxycinnamaldehyde"
14 Q0 17625441 789 33.282097 imi_mug_run_2_treatment "various" "aim"
14 Q0 23282306 790 33.281082 imi_mug_run_2_treatment "ras" "level"
14 Q0 15616773 791 33.270924 imi_mug_run_2_treatment "various" "gat"
14 Q0 8069848 792 33.26782 imi_mug_run_2_treatment "polyacrylamide gels"
14 Q0 8196422 793 33.262123 imi_mug_run_2_treatment "basis"
14 Q0 18541613 794 33.260075 imi_mug_run_2_treatment "bisulfite"
14 Q0 26637399 795 33.25479 imi_mug_run_2_treatment "mediated" "level"
14 Q0 10488714 796 33.248302 imi_mug_run_2_treatment "aim"
14 Q0 24052409 797 33.246708 imi_mug_run_2_treatment "chemotherapeutic agent" "fluorouracil" "mediated"
14 Q0 15257543 798 33.237713 imi_mug_run_2_treatment "various" "adjuvant" "fluouracil"
14 Q0 24100870 799 33.23181 imi_mug_run_2_treatment "aim"
14 Q0 9066723 800 33.229992 imi_mug_run_2_treatment "serine"
14 Q0 11370176 801 33.22088 imi_mug_run_2_treatment "various"
14 Q0 19248199 802 33.20577 imi_mug_run_2_treatment "aim"
14 Q0 15701853 803 33.205368 imi_mug_run_2_treatment "bisulfite" "aim"
14 Q0 17914562 804 33.19973 imi_mug_run_2_treatment "level"
14 Q0 25322805 805 33.189972 imi_mug_run_2_treatment "interleukin" "aim" "il-6"
14 Q0 20082476 806 33.18325 imi_mug_run_2_treatment "aim"
14 Q0 10344734 807 33.17031 imi_mug_run_2_treatment "enzymes" "methylated" "isolate"
14 Q0 19441164 808 33.16969 imi_mug_run_2_treatment "maspin" "level"
14 Q0 21042749 809 33.163677 imi_mug_run_2_treatment "level"
14 Q0 15842591 810 33.162292 imi_mug_run_2_treatment "aim"
14 Q0 30045022 811 33.14897 imi_mug_run_2_treatment "andrographolide" "tsp-2" "angiogenesis inhibitor"
14 Q0 29901158 812 33.13506 imi_mug_run_2_treatment "level"
14 Q0 22228973 813 33.13019 imi_mug_run_2_treatment "bisulfite" "sodium bisulfite" "aim"
14 Q0 24769599 814 33.124916 imi_mug_run_2_treatment "basis" "lead"
14 Q0 15236168 815 33.101887 imi_mug_run_2_treatment "prophylactic" "aim"
14 Q0 23905898 816 33.101482 imi_mug_run_2_treatment "aim"
14 Q0 17436407 817 33.08293 imi_mug_run_2_treatment "aim"
14 Q0 9233784 818 33.079247 imi_mug_run_2_treatment "various" "rii"
14 Q0 9648558 819 33.07733 imi_mug_run_2_treatment "alkylator" "bromodeoxyuridine"
14 Q0 26794448 820 33.075462 imi_mug_run_2_treatment "aza" "sam"
14 Q0 11369138 821 33.073444 imi_mug_run_2_treatment "histidine" "leucine" "basis"
14 Q0 28762328 822 33.06876 imi_mug_run_2_treatment "emodin" "emodin's" "chinese herbs"
14 Q0 29925347 823 33.062332 imi_mug_run_2_treatment "lysine" "mediated"
14 Q0 18835263 824 33.059746 imi_mug_run_2_treatment "methylated"
14 Q0 30119911 825 33.05967 imi_mug_run_2_treatment "drugs"
14 Q0 12066197 826 33.058174 imi_mug_run_2_treatment "level"
14 Q0 21571909 827 33.053825 imi_mug_run_2_treatment "genistein" "mediated" "agent"
14 Q0 12640532 828 33.019943 imi_mug_run_2_treatment "level"
14 Q0 21830274 829 33.019375 imi_mug_run_2_treatment "gdnf" "methylated" "aim"
14 Q0 20952593 830 33.00826 imi_mug_run_2_treatment "mint"
14 Q0 17195906 831 33.008064 imi_mug_run_2_treatment "various" "cpt-11" "irinotecan"
14 Q0 21753893 832 32.99134 imi_mug_run_2_treatment "antioxidant" "antioxidants" "folic acid"
14 Q0 23671654 833 32.98771 imi_mug_run_2_treatment "metric"
14 Q0 24047059 834 32.9799 imi_mug_run_2_treatment "duration" "others"
14 Q0 23243217 835 32.977856 imi_mug_run_2_treatment "liver"
14 Q0 16203774 836 32.977177 imi_mug_run_2_treatment "basis" "program"
14 Q0 19156137 837 32.977135 imi_mug_run_2_treatment "suppressor" "mediated"
14 Q0 24130681 838 32.973984 imi_mug_run_2_treatment "american ginseng" "anti-inflammatory"
14 Q0 21976543 839 32.971718 imi_mug_run_2_treatment "level" "pooled"
14 Q0 15963980 840 32.967247 imi_mug_run_2_treatment "level" "aim"
14 Q0 18551179 841 32.965656 imi_mug_run_2_treatment "mediated"
14 Q0 23958088 842 32.957085 imi_mug_run_2_treatment "aim"
14 Q0 26885089 843 32.95421 imi_mug_run_2_treatment "phenol"
14 Q0 29120224 844 32.949112 imi_mug_run_2_treatment "drug" "level" "pembrolizumab"
14 Q0 21237486 845 32.946705 imi_mug_run_2_treatment "agent" "s-adenosylmethionine"
14 Q0 19078953 846 32.94564 imi_mug_run_2_treatment "enzymes" "arginine"
14 Q0 12713593 847 32.924923 imi_mug_run_2_treatment "various" "basis"
14 Q0 16399437 848 32.907017 imi_mug_run_2_treatment "leucovorin" "fluorouracil" "oxaliplatin"
14 Q0 21617854 849 32.89605 imi_mug_run_2_treatment "methylated" "cytokines"
14 Q0 24097071 850 32.891605 imi_mug_run_2_treatment "various" "interleukin 6"
14 Q0 20205967 851 32.88874 imi_mug_run_2_treatment "folate" "alcohol"
14 Q0 17408908 852 32.88578 imi_mug_run_2_treatment "aim"
14 Q0 8608549 853 32.868828 imi_mug_run_2_treatment "ras" "food"
14 Q0 12378627 854 32.868156 imi_mug_run_2_treatment "fluorouracil" "cddp" "cisplatin"
14 Q0 28622390 855 32.864346 imi_mug_run_2_treatment "others"
14 Q0 28676214 856 32.86396 imi_mug_run_2_treatment "various" "penta"
14 Q0 10575566 857 32.855988 imi_mug_run_2_treatment "tamoxifen" "basis"
14 Q0 24065530 858 32.85001 imi_mug_run_2_treatment "dextran sodium sulphate" "aim" "animals"
14 Q0 26298904 859 32.839752 imi_mug_run_2_treatment "lead"
14 Q0 20544289 860 32.834576 imi_mug_run_2_treatment "folate" "folic acid" "water"
14 Q0 10963127 861 32.8291 imi_mug_run_2_treatment "lead" "igf2" "others"
14 Q0 11403917 862 32.82449 imi_mug_run_2_treatment "level"
14 Q0 25735954 863 32.797283 imi_mug_run_2_treatment "anti-inflammatory agents" "mediated" "methylated"
14 Q0 24941850 864 32.79314 imi_mug_run_2_treatment "medication" "fluorouracil"
14 Q0 19828464 865 32.78723 imi_mug_run_2_treatment "alcohol" "level" "folate"
14 Q0 27471558 866 32.777992 imi_mug_run_2_treatment "mediated"
14 Q0 20127035 867 32.769775 imi_mug_run_2_treatment "sam" "aim"
14 Q0 14965712 868 32.76261 imi_mug_run_2_treatment "mbc"
14 Q0 11974557 869 32.758026 imi_mug_run_2_treatment "estrogen"
14 Q0 14643031 870 32.752594 imi_mug_run_2_treatment "asc" "methylated"
14 Q0 26697194 871 32.748974 imi_mug_run_2_treatment "biotin"
14 Q0 27228287 872 32.742897 imi_mug_run_2_treatment "os1"
14 Q0 16639607 873 32.7379 imi_mug_run_2_treatment "various"
14 Q0 9770509 874 32.719143 imi_mug_run_2_treatment "hydrogen peroxide" "basis"
14 Q0 12496760 875 32.71437 imi_mug_run_2_treatment "enzymes"
14 Q0 12939742 876 32.714245 imi_mug_run_2_treatment "vascular endothelial growth factor" "level"
14 Q0 22870149 877 32.710857 imi_mug_run_2_treatment "various" "level"
14 Q0 28241740 878 32.70319 imi_mug_run_2_treatment "hinokitiol" "level" "anti-inflammatory"
15 Q0 27795727 1 64.926056 imi_mug_run_2_treatment "gat" "level" "aim"
15 Q0 24768329 2 62.855164 imi_mug_run_2_treatment "platinum"
15 Q0 26622666 3 59.94051 imi_mug_run_2_treatment "gefitinib"
15 Q0 25380065 4 56.65926 imi_mug_run_2_treatment "level"
15 Q0 26855149 5 55.958805 imi_mug_run_2_treatment "pdx" "mediators"
15 Q0 23208496 6 55.316017 imi_mug_run_2_treatment "mediated"
15 Q0 29151304 7 54.94699 imi_mug_run_2_treatment "aim"
15 Q0 29447458 8 54.71457 imi_mug_run_2_treatment "liver"
15 Q0 27439864 9 53.608955 imi_mug_run_2_treatment "jak inhibitors"
15 Q0 24700479 10 52.759384 imi_mug_run_2_treatment "medicine" "therapeutics"
15 Q0 22210048 11 52.72634 imi_mug_run_2_treatment "enzymes"
15 Q0 25359494 12 52.645412 imi_mug_run_2_treatment "angiopoietin 2" "animals"
15 Q0 26622749 13 51.638615 imi_mug_run_2_treatment "combinations"
15 Q0 28451792 14 51.539528 imi_mug_run_2_treatment "blockade" "pembrolizumab" "mediated"
15 Q0 30522449 15 50.839535 imi_mug_run_2_treatment "matrix"
15 Q0 25170638 16 49.750977 imi_mug_run_2_treatment "aim"
15 Q0 27068338 17 49.408638 imi_mug_run_2_treatment "ras" "lead" "mek inhibitor"
15 Q0 29781772 18 49.40095 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
15 Q0 29415661 19 48.678772 imi_mug_run_2_treatment "various" "level" "hot spot"
15 Q0 27738759 20 48.33265 imi_mug_run_2_treatment "basis"
15 Q0 24577055 21 48.22512 imi_mug_run_2_treatment "interleukin-8" "basis" "level"
15 Q0 25129367 22 48.12589 imi_mug_run_2_treatment "erlotinib" "kinase inhibitor" "tarceva"
15 Q0 29727601 23 48.04016 imi_mug_run_2_treatment "trametinib" "mediated" "mek inhibitor"
15 Q0 30072189 24 47.986645 imi_mug_run_2_treatment "others"
15 Q0 27597273 25 47.89344 imi_mug_run_2_treatment "medicine" "plasma"
15 Q0 28894382 26 47.86405 imi_mug_run_2_treatment "apatinib"
15 Q0 18794081 27 47.766777 imi_mug_run_2_treatment "gefitinib" "erlotinib"
15 Q0 23792647 28 47.665565 imi_mug_run_2_treatment "various" "paclitaxel" "cink4"
15 Q0 23943799 29 47.657097 imi_mug_run_2_treatment "level" "mediated"
15 Q0 23157740 30 47.44297 imi_mug_run_2_treatment "level"
15 Q0 24694341 31 47.208954 imi_mug_run_2_treatment "ras"
15 Q0 23224736 32 47.182312 imi_mug_run_2_treatment "mediated"
15 Q0 18932251 33 47.14808 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitor"
15 Q0 26045124 34 46.881348 imi_mug_run_2_treatment "various"
15 Q0 26542681 35 46.53871 imi_mug_run_2_treatment "ras" "therapeutics" "program"
15 Q0 26273395 36 46.44953 imi_mug_run_2_treatment "aim"
15 Q0 22876814 37 46.26276 imi_mug_run_2_treatment "various" "liver"
15 Q0 26667343 38 46.21145 imi_mug_run_2_treatment "various"
15 Q0 19681124 39 46.0271 imi_mug_run_2_treatment "drugs"
15 Q0 26744530 40 45.948513 imi_mug_run_2_treatment "cytokines" "basis"
15 Q0 23143308 41 45.897415 imi_mug_run_2_treatment "mediated" "urethane"
15 Q0 25695224 42 45.827045 imi_mug_run_2_treatment "epidermal growth factor receptor tyrosine kinase inhibitor"
15 Q0 28400509 43 45.786743 imi_mug_run_2_treatment "cerulenin" "glucose"
15 Q0 24442099 44 45.71618 imi_mug_run_2_treatment "aim"
15 Q0 22761399 45 45.675373 imi_mug_run_2_treatment "various" "ipa" "glycans"
15 Q0 30171261 46 45.65733 imi_mug_run_2_treatment "drug combinations" "drugs"
15 Q0 26415993 47 45.567493 imi_mug_run_2_treatment "taxanes" "platinum" "pemetrexed"
15 Q0 19270482 48 45.475227 imi_mug_run_2_treatment "formalin"
15 Q0 22157931 49 45.423203 imi_mug_run_2_treatment "kinase inhibitor" "isolate"
15 Q0 21779443 50 45.405563 imi_mug_run_2_treatment "others"
15 Q0 20381121 51 45.37753 imi_mug_run_2_treatment "aim"
15 Q0 24469055 52 45.301846 imi_mug_run_2_treatment "ras"
15 Q0 24576404 53 45.174187 imi_mug_run_2_treatment "various"
15 Q0 21543344 54 45.076458 imi_mug_run_2_treatment "mediated" "interleukin"
15 Q0 24998203 55 44.858673 imi_mug_run_2_treatment "serine"
15 Q0 30013628 56 44.807396 imi_mug_run_2_treatment "aim"
15 Q0 24762440 57 44.731834 imi_mug_run_2_treatment "mediators" "animals"
15 Q0 26232258 58 44.701065 imi_mug_run_2_treatment "vanadium pentoxide" "gat" "program"
15 Q0 25328676 59 44.559364 imi_mug_run_2_treatment "edta" "medicine"
15 Q0 25941815 60 44.494637 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
15 Q0 19855375 61 44.36071 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
15 Q0 22158040 62 44.25878 imi_mug_run_2_treatment "level" "suppressor"
15 Q0 18090579 63 44.23263 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
15 Q0 21874163 64 44.181786 imi_mug_run_2_treatment "bortezomib" "drug"
15 Q0 28051122 65 44.07466 imi_mug_run_2_treatment "liver"
15 Q0 23598351 66 43.988056 imi_mug_run_2_treatment "caerulein" "suppressor"
15 Q0 27199349 67 43.9691 imi_mug_run_2_treatment "cisplatin"
15 Q0 18303429 68 43.924194 imi_mug_run_2_treatment "kinase inhibitor" "egfr tyrosine kinase inhibitors"
15 Q0 30291816 69 43.87217 imi_mug_run_2_treatment "aim"
15 Q0 21107288 70 43.824142 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
15 Q0 19881948 71 43.75169 imi_mug_run_2_treatment "therapeutics"
15 Q0 22729835 72 43.694378 imi_mug_run_2_treatment "tma" "aim"
15 Q0 30089720 73 43.649254 imi_mug_run_2_treatment "adc" "urethane" "blockade"
15 Q0 27106232 74 43.643517 imi_mug_run_2_treatment "pd98059" "mek inhibitor" "balance"
15 Q0 20101149 75 43.617977 imi_mug_run_2_treatment "bht" "new drugs"
15 Q0 23604119 76 43.554207 imi_mug_run_2_treatment "mediated" "suppressor" "urethane"
15 Q0 27514406 77 43.51693 imi_mug_run_2_treatment "cisplatin" "etoposide"
15 Q0 29658845 78 43.437786 imi_mug_run_2_treatment "level" "nivolumab" "ipilimumab"
15 Q0 24511003 79 43.372025 imi_mug_run_2_treatment "aim"
15 Q0 26486077 80 43.2874 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
15 Q0 25833149 81 43.136505 imi_mug_run_2_treatment "adc" "aim"
15 Q0 12755843 82 43.07058 imi_mug_run_2_treatment "aim"
15 Q0 8694568 83 42.94464 imi_mug_run_2_treatment "level"
15 Q0 20028932 84 42.91638 imi_mug_run_2_treatment "gefitinib"
15 Q0 26055897 85 42.881126 imi_mug_run_2_treatment "ras" "tk inhibitors" "egfr tk inhibitors"
15 Q0 24982195 86 42.862396 imi_mug_run_2_treatment "brain-derived neurotrophic factor"
15 Q0 25429229 87 42.83976 imi_mug_run_2_treatment "mica" "basis"
15 Q0 28685219 88 42.78762 imi_mug_run_2_treatment "aim"
15 Q0 16618742 89 42.71443 imi_mug_run_2_treatment "ras"
15 Q0 30505580 90 42.65345 imi_mug_run_2_treatment "level"
15 Q0 29487705 91 42.574257 imi_mug_run_2_treatment "tumor infiltrating lymphocytes"
15 Q0 24782938 92 42.57329 imi_mug_run_2_treatment "cdx"
15 Q0 22399565 93 42.51544 imi_mug_run_2_treatment "mediated"
15 Q0 28474808 94 42.515083 imi_mug_run_2_treatment "mediated"
15 Q0 29808009 95 42.402504 imi_mug_run_2_treatment "ras" "blockade"
15 Q0 21896780 96 42.386414 imi_mug_run_2_treatment "basis"
15 Q0 30268834 97 42.285637 imi_mug_run_2_treatment "drugs" "cytarabine" "enzastaurin"
15 Q0 24681874 98 42.2732 imi_mug_run_2_treatment "aim"
15 Q0 24255704 99 42.269505 imi_mug_run_2_treatment "mediated" "ras"
15 Q0 24169260 100 42.17717 imi_mug_run_2_treatment "suppressor"
15 Q0 29951597 101 42.078693 imi_mug_run_2_treatment "blockade"
15 Q0 9332768 102 41.99697 imi_mug_run_2_treatment "arginine" "glycine"
15 Q0 22975805 103 41.996784 imi_mug_run_2_treatment "tyrosine" "lead" "basis"
15 Q0 18635814 104 41.993023 imi_mug_run_2_treatment "urethane" "ras"
15 Q0 23938291 105 41.991665 imi_mug_run_2_treatment "sam"
15 Q0 23595221 106 41.98285 imi_mug_run_2_treatment "various" "aim"
15 Q0 20023657 107 41.94156 imi_mug_run_2_treatment "egfr inhibitor" "animals"
15 Q0 29731394 108 41.89784 imi_mug_run_2_treatment "nivolumab" "ipilimumab"
15 Q0 26554912 109 41.784607 imi_mug_run_2_treatment "oxygen" "mediated"
15 Q0 17487277 110 41.624268 imi_mug_run_2_treatment "ras" "product"
15 Q0 26709701 111 41.59372 imi_mug_run_2_treatment "proteasome inhibitor" "ixazomib" "glucose"
15 Q0 27010960 112 41.525383 imi_mug_run_2_treatment "ras" "drugs"
15 Q0 27998968 113 41.51574 imi_mug_run_2_treatment "drug"
15 Q0 18334834 114 41.512318 imi_mug_run_2_treatment "gefitinib" "mediated"
15 Q0 24586805 115 41.498634 imi_mug_run_2_treatment "pdx" "kinase inhibitor" "bkm120"
15 Q0 21943394 116 41.366787 imi_mug_run_2_treatment "anti-egfr monoclonal antibody" "cetuximab" "gefitinib"
15 Q0 26663872 117 41.317833 imi_mug_run_2_treatment "epidermal growth factor" "lead"
15 Q0 26555914 118 41.288063 imi_mug_run_2_treatment "level"
15 Q0 27245608 119 41.2502 imi_mug_run_2_treatment "drug combinations"
15 Q0 25851923 120 41.243988 imi_mug_run_2_treatment "various"
15 Q0 29441110 121 41.22277 imi_mug_run_2_treatment "gat"
15 Q0 26977885 122 41.216927 imi_mug_run_2_treatment "mediated" "blockade"
15 Q0 19740513 123 41.172375 imi_mug_run_2_treatment "level" "aim"
15 Q0 26515557 124 41.152122 imi_mug_run_2_treatment "monoclonal antibodies"
15 Q0 23204236 125 41.145103 imi_mug_run_2_treatment "ras"
15 Q0 27133754 126 41.096684 imi_mug_run_2_treatment "drugs"
15 Q0 29422640 127 41.081406 imi_mug_run_2_treatment "others"
15 Q0 25813151 128 41.069885 imi_mug_run_2_treatment "basis" "aim"
15 Q0 29191600 129 41.069305 imi_mug_run_2_treatment "mitogen"
15 Q0 26084335 130 40.97647 imi_mug_run_2_treatment "cancer drug" "pdx"
15 Q0 22613842 131 40.95833 imi_mug_run_2_treatment "ras" "others" "matrix"
15 Q0 23645403 132 40.91043 imi_mug_run_2_treatment "level" "matrix"
15 Q0 29112457 133 40.897594 imi_mug_run_2_treatment "various" "mediated" "ras"
15 Q0 16721785 134 40.89402 imi_mug_run_2_treatment "ras"
15 Q0 22022614 135 40.871944 imi_mug_run_2_treatment "urethane" "mediated"
15 Q0 21187500 136 40.85897 imi_mug_run_2_treatment "aim" "gefitinib" "erlotinib"
15 Q0 29223537 137 40.806484 imi_mug_run_2_treatment "cisplatin" "blockade"
15 Q0 23285300 138 40.79499 imi_mug_run_2_treatment "suppressor"
15 Q0 28971587 139 40.756073 imi_mug_run_2_treatment "crizotinib"
15 Q0 24054548 140 40.738598 imi_mug_run_2_treatment "basis"
15 Q0 24466154 141 40.73639 imi_mug_run_2_treatment "level"
15 Q0 29658609 142 40.69411 imi_mug_run_2_treatment "abt-263" "trametinib" "mek inhibitor"
15 Q0 27685632 143 40.683643 imi_mug_run_2_treatment "kinase inhibitor"
15 Q0 23208128 144 40.67358 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
15 Q0 25926041 145 40.661293 imi_mug_run_2_treatment "ras" "therapeutics"
15 Q0 14566258 146 40.64075 imi_mug_run_2_treatment "celecoxib" "animals"
15 Q0 26268359 147 40.529602 imi_mug_run_2_treatment "ras" "formalin"
15 Q0 24938684 148 40.486156 imi_mug_run_2_treatment "aim"
15 Q0 27580131 149 40.464172 imi_mug_run_2_treatment "various"
15 Q0 3041218 150 40.330177 imi_mug_run_2_treatment "ras"
15 Q0 26125448 151 40.330143 imi_mug_run_2_treatment "docetaxel" "selumetinib" "arry-142886"
15 Q0 25044103 152 40.271088 imi_mug_run_2_treatment "vaccine" "interferon-gamma" "yeast"
15 Q0 24463346 153 40.23039 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitor"
15 Q0 30297358 154 40.226852 imi_mug_run_2_treatment "sam" "mediated" "basis"
15 Q0 21847063 155 40.21232 imi_mug_run_2_treatment "salirasib" "drug trials" "ras"
15 Q0 29137294 156 40.21041 imi_mug_run_2_treatment "vaccine" "cytokines" "adjuvant"
15 Q0 27337801 157 40.1876 imi_mug_run_2_treatment "plasma"
15 Q0 18509000 158 40.117573 imi_mug_run_2_treatment "estradiol" "estrogen"
15 Q0 7606952 159 40.10778 imi_mug_run_2_treatment "level"
15 Q0 23629442 160 40.04609 imi_mug_run_2_treatment "various" "cdx" "lead"
15 Q0 28949084 161 40.03745 imi_mug_run_2_treatment "aim"
15 Q0 19794967 162 39.948124 imi_mug_run_2_treatment "gefitinib" "erlotinib"
15 Q0 29440631 163 39.939976 imi_mug_run_2_treatment "deltarasin" "n-acetylcysteine" "oxygen"
15 Q0 23919423 164 39.881874 imi_mug_run_2_treatment "drug combination"
15 Q0 24439569 165 39.87159 imi_mug_run_2_treatment "platinum" "liver"
15 Q0 26700152 166 39.868473 imi_mug_run_2_treatment "enzymes" "antioxidants" "animals"
15 Q0 28676214 167 39.734985 imi_mug_run_2_treatment "various" "penta"
15 Q0 22684718 168 39.70176 imi_mug_run_2_treatment "pd-0325901" "pf-04691502" "agent"
15 Q0 27062566 169 39.659523 imi_mug_run_2_treatment "liver"
15 Q0 26068980 170 39.656773 imi_mug_run_2_treatment "aim"
15 Q0 25281617 171 39.637135 imi_mug_run_2_treatment "various" "cddp"
15 Q0 18299280 172 39.609142 imi_mug_run_2_treatment "ors" "adc"
15 Q0 29504894 173 39.576942 imi_mug_run_2_treatment "ras"
15 Q0 26968843 174 39.445637 imi_mug_run_2_treatment "drugs" "egfr tyrosine kinase inhibitors" "crizotinib"
15 Q0 19369630 175 39.41475 imi_mug_run_2_treatment "ras"
15 Q0 29247171 176 39.399757 imi_mug_run_2_treatment "color"
15 Q0 30505716 177 39.296722 imi_mug_run_2_treatment "medicine" "pembrolizumab"
15 Q0 28024695 178 39.29628 imi_mug_run_2_treatment "immune modulators"
15 Q0 29455666 179 39.25968 imi_mug_run_2_treatment "combinations" "aim"
15 Q0 28232723 180 39.241013 imi_mug_run_2_treatment "nadh" "mediated"
15 Q0 17349581 181 39.240124 imi_mug_run_2_treatment "shape"
15 Q0 20676804 182 39.203438 imi_mug_run_2_treatment "aim"
15 Q0 21471965 183 39.201218 imi_mug_run_2_treatment "mediated" "suppressor"
15 Q0 28373435 184 39.18978 imi_mug_run_2_treatment "aim"
15 Q0 17671710 185 39.18123 imi_mug_run_2_treatment "glycine"
15 Q0 27338794 186 39.176365 imi_mug_run_2_treatment "trametinib" "combinations" "mek inhibitor"
15 Q0 28539837 187 39.151802 imi_mug_run_2_treatment "adc" "igf1" "insulin-like growth factor 1"
15 Q0 28306189 188 39.13855 imi_mug_run_2_treatment "ras" "erlotinib" "egfr inhibitor"
15 Q0 26677401 189 39.115444 imi_mug_run_2_treatment "aim"
15 Q0 28879441 190 39.089054 imi_mug_run_2_treatment "interleukin-6" "il-6"
15 Q0 17510423 191 39.08902 imi_mug_run_2_treatment "ci-1040" "mek inhibitor"
15 Q0 24462463 192 38.997177 imi_mug_run_2_treatment "aim"
15 Q0 23625632 193 38.987885 imi_mug_run_2_treatment "adc"
15 Q0 28967920 194 38.97782 imi_mug_run_2_treatment "antioxidant" "lead"
15 Q0 30048458 195 38.962677 imi_mug_run_2_treatment "adc"
15 Q0 7329207 196 38.83366 imi_mug_run_2_treatment "phosphatidylcholine"
15 Q0 29728140 197 38.833347 imi_mug_run_2_treatment "aim"
15 Q0 21102258 198 38.829636 imi_mug_run_2_treatment "various" "drugs" "others"
15 Q0 21825899 199 38.822006 imi_mug_run_2_treatment "liver"
15 Q0 27843638 200 38.76345 imi_mug_run_2_treatment "drug combinations"
15 Q0 30334450 201 38.761948 imi_mug_run_2_treatment "adca"
15 Q0 28872477 202 38.759014 imi_mug_run_2_treatment "prompt" "liver"
15 Q0 11176288 203 38.695908 imi_mug_run_2_treatment "vascular endothelial growth factor"
15 Q0 22528563 204 38.680847 imi_mug_run_2_treatment "aim"
15 Q0 24489653 205 38.662464 imi_mug_run_2_treatment "ras"
15 Q0 21455588 206 38.645393 imi_mug_run_2_treatment "aim"
15 Q0 18367224 207 38.64093 imi_mug_run_2_treatment "lead"
15 Q0 29390348 208 38.620487 imi_mug_run_2_treatment "icc" "liver"
15 Q0 23916545 209 38.61579 imi_mug_run_2_treatment "matrix"
15 Q0 21839537 210 38.54219 imi_mug_run_2_treatment "basis" "duration" "aim"
15 Q0 20660313 211 38.484993 imi_mug_run_2_treatment "oxygen"
15 Q0 26880715 212 38.47309 imi_mug_run_2_treatment "immune modulators"
15 Q0 27565922 213 38.46507 imi_mug_run_2_treatment "hot spot" "aim"
15 Q0 18632602 214 38.45823 imi_mug_run_2_treatment "azd6244" "lysine" "mek inhibitor"
15 Q0 22446020 215 38.452377 imi_mug_run_2_treatment "scorpion" "product" "aim"
15 Q0 27094798 216 38.435425 imi_mug_run_2_treatment "pemetrexed" "basis"
15 Q0 23401440 217 38.431286 imi_mug_run_2_treatment "monoclonal antibodies" "therapeutics" "basis"
15 Q0 29948972 218 38.425285 imi_mug_run_2_treatment "platinum" "taxanes" "gemcitabine"
15 Q0 25226429 219 38.396126 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
15 Q0 28574510 220 38.356724 imi_mug_run_2_treatment "collagen" "interleukin-6"
15 Q0 24040454 221 38.353767 imi_mug_run_2_treatment "salt"
15 Q0 28422979 222 38.346985 imi_mug_run_2_treatment "cit" "glucose"
15 Q0 28843358 223 38.337814 imi_mug_run_2_treatment "tyrosine kinase inhibitor" "level"
15 Q0 24186144 224 38.301422 imi_mug_run_2_treatment "various"
15 Q0 30034242 225 38.297653 imi_mug_run_2_treatment "drugs"
15 Q0 27020204 226 38.294933 imi_mug_run_2_treatment "ras"
15 Q0 26807202 227 38.28412 imi_mug_run_2_treatment "retinol" "trans-retinoic acid" "mediated"
15 Q0 26646269 228 38.28055 imi_mug_run_2_treatment "various"
15 Q0 25303301 229 38.264652 imi_mug_run_2_treatment "ras"
15 Q0 18757405 230 38.247116 imi_mug_run_2_treatment "mediated"
15 Q0 26861459 231 38.223343 imi_mug_run_2_treatment "suppressor"
15 Q0 29662194 232 38.204178 imi_mug_run_2_treatment "liver"
15 Q0 29844707 233 38.188873 imi_mug_run_2_treatment "temsirolimus" "everolimus"
15 Q0 29656749 234 38.154686 imi_mug_run_2_treatment "various"
15 Q0 26359571 235 38.15363 imi_mug_run_2_treatment "various"
15 Q0 19261348 236 38.14167 imi_mug_run_2_treatment "adc" "aim"
15 Q0 26657862 237 38.133408 imi_mug_run_2_treatment "ras" "mediated"
15 Q0 19887599 238 38.12971 imi_mug_run_2_treatment "growth inhibitors"
15 Q0 23775406 239 38.073605 imi_mug_run_2_treatment "various"
15 Q0 22200795 240 38.06729 imi_mug_run_2_treatment "sage"
15 Q0 26029525 241 38.04491 imi_mug_run_2_treatment "erlotinib"
15 Q0 28012926 242 38.02896 imi_mug_run_2_treatment "various"
15 Q0 30315364 243 37.99464 imi_mug_run_2_treatment "level"
15 Q0 26378065 244 37.980198 imi_mug_run_2_treatment "amp" "level"
15 Q0 25347573 245 37.954624 imi_mug_run_2_treatment "fst" "level"
15 Q0 29147353 246 37.923058 imi_mug_run_2_treatment "das" "medicine"
15 Q0 20921461 247 37.921738 imi_mug_run_2_treatment "monoclonal antibodies" "epidermal growth factor" "ras"
15 Q0 27753661 248 37.90152 imi_mug_run_2_treatment "cdx"
15 Q0 29517858 249 37.900993 imi_mug_run_2_treatment "drugs"
15 Q0 22670180 250 37.887093 imi_mug_run_2_treatment "cdx"
15 Q0 26268750 251 37.883934 imi_mug_run_2_treatment "level"
15 Q0 21607772 252 37.87105 imi_mug_run_2_treatment "drugs"
15 Q0 19644015 253 37.84308 imi_mug_run_2_treatment "drugs"
15 Q0 24955208 254 37.83928 imi_mug_run_2_treatment "aim"
15 Q0 25103784 255 37.82621 imi_mug_run_2_treatment "various"
15 Q0 21385341 256 37.816788 imi_mug_run_2_treatment "lead" "aim"
15 Q0 24317514 257 37.81588 imi_mug_run_2_treatment "uridine" "mediated"
15 Q0 21920623 258 37.805656 imi_mug_run_2_treatment "estrogen" "favor" "level"
15 Q0 28554329 259 37.804928 imi_mug_run_2_treatment "blockade"
15 Q0 19787214 260 37.796425 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
15 Q0 27040858 261 37.785366 imi_mug_run_2_treatment "crizotinib"
15 Q0 30095461 262 37.768238 imi_mug_run_2_treatment "aim"
15 Q0 8609053 263 37.74974 imi_mug_run_2_treatment "monolayers" "monoclonal antibodies"
15 Q0 23627488 264 37.72737 imi_mug_run_2_treatment "sunitinib" "axitinib" "pf-00337210"
15 Q0 23995859 265 37.71384 imi_mug_run_2_treatment "aim"
15 Q0 25734337 266 37.6855 imi_mug_run_2_treatment "mediated"
15 Q0 29572010 267 37.67671 imi_mug_run_2_treatment "various" "liver"
15 Q0 26851185 268 37.671604 imi_mug_run_2_treatment "blockade"
15 Q0 28881604 269 37.626427 imi_mug_run_2_treatment "aim"
15 Q0 29855376 270 37.551506 imi_mug_run_2_treatment "urethane"
15 Q0 28403077 271 37.529022 imi_mug_run_2_treatment "various"
15 Q0 30317654 272 37.51822 imi_mug_run_2_treatment "flavopiridol" "flavopiridol's" "cytotoxic"
15 Q0 26223682 273 37.514984 imi_mug_run_2_treatment "nnk"
15 Q0 16840834 274 37.507225 imi_mug_run_2_treatment "acth" "plasma" "cortisol"
15 Q0 26714748 275 37.499313 imi_mug_run_2_treatment "drug" "aim"
15 Q0 20952731 276 37.479736 imi_mug_run_2_treatment "digoxigenin" "mediated"
15 Q0 30514684 277 37.46647 imi_mug_run_2_treatment "level"
15 Q0 26185140 278 37.46465 imi_mug_run_2_treatment "various" "tandem" "epidermal growth factor"
15 Q0 20716403 279 37.461174 imi_mug_run_2_treatment "vascular endothelial growth factor"
15 Q0 23392229 280 37.458282 imi_mug_run_2_treatment "adjuvant" "egfr tyrosine kinase inhibitors" "aim"
15 Q0 23817662 281 37.449406 imi_mug_run_2_treatment "erlotinib" "gefitinib" "aim"
15 Q0 26616848 282 37.432438 imi_mug_run_2_treatment "ras"
15 Q0 25114235 283 37.39571 imi_mug_run_2_treatment "cisplatin" "mediated" "therapeutics"
15 Q0 23788756 284 37.350754 imi_mug_run_2_treatment "lead"
15 Q0 28453411 285 37.316475 imi_mug_run_2_treatment "pooled"
15 Q0 7522947 286 37.303905 imi_mug_run_2_treatment "factor viii"
15 Q0 26544866 287 37.286182 imi_mug_run_2_treatment "aim"
15 Q0 28665451 288 37.28456 imi_mug_run_2_treatment "ras" "bevacizumab" "panitumumab"
15 Q0 9626466 289 37.279137 imi_mug_run_2_treatment "various" "vascular endothelial growth factor" "anti-vegf"
15 Q0 22129856 290 37.251408 imi_mug_run_2_treatment "tma"
15 Q0 20108024 291 37.245556 imi_mug_run_2_treatment "gefitinib" "erlotinib" "egfr tyrosine kinase inhibitors"
15 Q0 29926551 292 37.241676 imi_mug_run_2_treatment "silver" "egfr tyrosine kinase inhibitor"
15 Q0 1503402 293 37.21253 imi_mug_run_2_treatment "liver"
15 Q0 26463718 294 37.19329 imi_mug_run_2_treatment "leucine" "thr" "ras"
15 Q0 21151896 295 37.18674 imi_mug_run_2_treatment "level"
15 Q0 2718768 296 37.177334 imi_mug_run_2_treatment "human chorionic gonadotropin"
15 Q0 24367082 297 37.14075 imi_mug_run_2_treatment "ras"
15 Q0 28679956 298 37.138565 imi_mug_run_2_treatment "pioglitazone" "drug" "drugs"
15 Q0 27329725 299 37.12324 imi_mug_run_2_treatment "paclitaxel" "ras"
15 Q0 15696205 300 37.107918 imi_mug_run_2_treatment "gefitinib" "erlotinib" "drug"
15 Q0 23425899 301 37.09868 imi_mug_run_2_treatment "gefitinib" "aim"
15 Q0 30420048 302 37.08348 imi_mug_run_2_treatment "aim"
15 Q0 27069542 303 37.060978 imi_mug_run_2_treatment "estrogen"
15 Q0 23917487 304 37.012108 imi_mug_run_2_treatment "panitumumab" "investigational agent"
15 Q0 18030469 305 36.97734 imi_mug_run_2_treatment "plasma" "erlotinib" "urethane"
15 Q0 25588859 306 36.96566 imi_mug_run_2_treatment "crizotinib"
15 Q0 29945706 307 36.941967 imi_mug_run_2_treatment "level" "aim"
15 Q0 25603869 308 36.934906 imi_mug_run_2_treatment "aim"
15 Q0 30483865 309 36.929928 imi_mug_run_2_treatment "aim"
15 Q0 1320564 310 36.921776 imi_mug_run_2_treatment "cytokines"
15 Q0 25339352 311 36.9217 imi_mug_run_2_treatment "cisplatin" "mediated"
15 Q0 25843002 312 36.92068 imi_mug_run_2_treatment "trail-r2"
15 Q0 27032467 313 36.85937 imi_mug_run_2_treatment "others"
15 Q0 30178907 314 36.849392 imi_mug_run_2_treatment "aim"
15 Q0 29610476 315 36.845184 imi_mug_run_2_treatment "combinations" "mediated"
15 Q0 25535726 316 36.843876 imi_mug_run_2_treatment "liver"
15 Q0 30233846 317 36.83833 imi_mug_run_2_treatment "tma" "blockade" "pooled"
15 Q0 27335109 318 36.834526 imi_mug_run_2_treatment "pulmonary surfactant" "mediated" "phosphatidylcholines"
15 Q0 28338535 319 36.83264 imi_mug_run_2_treatment "fludeoxyglucose" "aim" "others"
15 Q0 26098749 320 36.828144 imi_mug_run_2_treatment "ras"
15 Q0 23565506 321 36.820732 imi_mug_run_2_treatment "bromodeoxyuridine"
15 Q0 27640882 322 36.82064 imi_mug_run_2_treatment "plasma" "combinations" "kinase inhibitor"
15 Q0 29218652 323 36.800247 imi_mug_run_2_treatment "suppressor"
15 Q0 30089582 324 36.75745 imi_mug_run_2_treatment "air" "stas"
15 Q0 24323028 325 36.73179 imi_mug_run_2_treatment "therapeutics"
15 Q0 23305175 326 36.68498 imi_mug_run_2_treatment "vascular endothelial growth factor" "cytokines"
15 Q0 11861397 327 36.683216 imi_mug_run_2_treatment "various"
15 Q0 30217639 328 36.67646 imi_mug_run_2_treatment "amino acid" "taxane" "platinum"
15 Q0 28950283 329 36.66663 imi_mug_run_2_treatment "aim"
15 Q0 21610106 330 36.62593 imi_mug_run_2_treatment "mediated"
15 Q0 30132854 331 36.61518 imi_mug_run_2_treatment "egfr inhibitor" "azd8931" "various"
15 Q0 20840813 332 36.60546 imi_mug_run_2_treatment "aim"
15 Q0 12399135 333 36.597958 imi_mug_run_2_treatment "level"
15 Q0 28677069 334 36.564175 imi_mug_run_2_treatment "metrics"
15 Q0 22590557 335 36.559723 imi_mug_run_2_treatment "cisplatin" "vinorelbine" "gefitinib"
15 Q0 25175030 336 36.55699 imi_mug_run_2_treatment "mediated"
15 Q0 22482404 337 36.545635 imi_mug_run_2_treatment "level" "aim"
15 Q0 26986073 338 36.525906 imi_mug_run_2_treatment "various" "mediated"
15 Q0 29676606 339 36.48188 imi_mug_run_2_treatment "plasma"
15 Q0 21191700 340 36.47816 imi_mug_run_2_treatment "gly" "leu" "phe"
15 Q0 8620411 341 36.459843 imi_mug_run_2_treatment "various" "serine protease inhibitor"
15 Q0 30069034 342 36.455715 imi_mug_run_2_treatment "drug" "cisplatin"
15 Q0 24793789 343 36.445057 imi_mug_run_2_treatment "mediated" "agar"
15 Q0 27157618 344 36.436455 imi_mug_run_2_treatment "heparin" "level" "sulfate"
15 Q0 21266922 345 36.422943 imi_mug_run_2_treatment "various" "adc" "aim"
15 Q0 26559081 346 36.411465 imi_mug_run_2_treatment "potassium" "aim"
15 Q0 27446565 347 36.40707 imi_mug_run_2_treatment "eosin"
15 Q0 8996154 348 36.40166 imi_mug_run_2_treatment "mesna" "etoposide" "ifosfamide"
15 Q0 29151932 349 36.378113 imi_mug_run_2_treatment "aim"
15 Q0 22460425 350 36.371666 imi_mug_run_2_treatment "basis"
15 Q0 22866100 351 36.350117 imi_mug_run_2_treatment "vascular endothelial growth factor"
15 Q0 22666783 352 36.32106 imi_mug_run_2_treatment "therapeutics" "aim"
15 Q0 30150445 353 36.295036 imi_mug_run_2_treatment "alectinib"
15 Q0 25193910 354 36.28323 imi_mug_run_2_treatment "corticosteroids" "cyclophosphamide"
15 Q0 25363767 355 36.26055 imi_mug_run_2_treatment "urethane" "nitrosourea" "lead"
15 Q0 20972333 356 36.235878 imi_mug_run_2_treatment "ras" "others"
15 Q0 24449404 357 36.2341 imi_mug_run_2_treatment "adc" "antioxidant" "product"
15 Q0 27262438 358 36.22735 imi_mug_run_2_treatment "various" "mediated"
15 Q0 15296034 359 36.222057 imi_mug_run_2_treatment "calcitonin" "thyroglobulin"
15 Q0 27922010 360 36.216175 imi_mug_run_2_treatment "drugs" "drug" "ras"
15 Q0 29858021 361 36.211803 imi_mug_run_2_treatment "tumor infiltrating lymphocytes"
15 Q0 22310466 362 36.201683 imi_mug_run_2_treatment "level"
15 Q0 26567140 363 36.18757 imi_mug_run_2_treatment "mediated"
15 Q0 27496865 364 36.185925 imi_mug_run_2_treatment "drugs" "cetuximab" "erlotinib"
15 Q0 15976377 365 36.169533 imi_mug_run_2_treatment "mediators" "matrix"
15 Q0 22080568 366 36.160973 imi_mug_run_2_treatment "adc"
15 Q0 26136941 367 36.14453 imi_mug_run_2_treatment "aim"
15 Q0 24336155 368 36.13509 imi_mug_run_2_treatment "ethanol" "air"
15 Q0 29343688 369 36.110226 imi_mug_run_2_treatment "sorafenib" "drug"
15 Q0 8865130 370 36.090225 imi_mug_run_2_treatment "level"
15 Q0 24030743 371 36.08882 imi_mug_run_2_treatment "eosin"
15 Q0 26272233 372 36.084953 imi_mug_run_2_treatment "plasma"
15 Q0 15623594 373 36.07968 imi_mug_run_2_treatment "gefitinib"
15 Q0 25820700 374 36.056667 imi_mug_run_2_treatment "aim"
15 Q0 22070055 375 36.05084 imi_mug_run_2_treatment "urethane" "agent" "animals"
15 Q0 20020061 376 36.03499 imi_mug_run_2_treatment "adjuvant" "fluorouracil" "level"
15 Q0 24378644 377 36.033405 imi_mug_run_2_treatment "therapeutics"
15 Q0 22618808 378 36.03195 imi_mug_run_2_treatment "nitric oxide"
15 Q0 29844447 379 36.025284 imi_mug_run_2_treatment "homoharringtonine" "translation inhibitor" "narciclasine"
15 Q0 24994038 380 36.00822 imi_mug_run_2_treatment "basis"
15 Q0 29367106 381 35.998363 imi_mug_run_2_treatment "various"
15 Q0 25077772 382 35.996464 imi_mug_run_2_treatment "dna vaccine" "immunotherapeutic agent"
15 Q0 27775074 383 35.98326 imi_mug_run_2_treatment "cytostatic"
15 Q0 26045824 384 35.982918 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
15 Q0 21707848 385 35.95748 imi_mug_run_2_treatment "thyroglobulin"
15 Q0 18487919 386 35.95529 imi_mug_run_2_treatment "ifosfamide"
15 Q0 23991331 387 35.91949 imi_mug_run_2_treatment "amylase"
15 Q0 28869500 388 35.917374 imi_mug_run_2_treatment "ras"
15 Q0 20959066 389 35.91285 imi_mug_run_2_treatment "various" "aim"
15 Q0 29371589 390 35.895927 imi_mug_run_2_treatment "adc"
15 Q0 21502435 391 35.887493 imi_mug_run_2_treatment "kinase inhibitor"
15 Q0 24137407 392 35.887035 imi_mug_run_2_treatment "various" "nsaid"
15 Q0 29588349 393 35.88541 imi_mug_run_2_treatment "various" "urethane"
15 Q0 30457021 394 35.8834 imi_mug_run_2_treatment "cisplatin"
15 Q0 27467545 395 35.84192 imi_mug_run_2_treatment "adc" "aim"
15 Q0 24386371 396 35.84043 imi_mug_run_2_treatment "mediated"
15 Q0 29773717 397 35.836967 imi_mug_run_2_treatment "blockade" "nivolumab"
15 Q0 24461128 398 35.830208 imi_mug_run_2_treatment "bosutinib"
15 Q0 9298890 399 35.81951 imi_mug_run_2_treatment "level" "schiff"
15 Q0 26297253 400 35.8144 imi_mug_run_2_treatment "various" "aim"
15 Q0 29764596 401 35.8125 imi_mug_run_2_treatment "anlotinib"
15 Q0 24691991 402 35.79663 imi_mug_run_2_treatment "arsenic trioxide" "mediated"
15 Q0 24952473 403 35.796234 imi_mug_run_2_treatment "enzymes" "glutamine"
15 Q0 27573925 404 35.788525 imi_mug_run_2_treatment "aim"
15 Q0 25076248 405 35.781715 imi_mug_run_2_treatment "aim"
15 Q0 18469798 406 35.764977 imi_mug_run_2_treatment "ras" "suppressor"
15 Q0 24569458 407 35.757126 imi_mug_run_2_treatment "sorafenib"
15 Q0 30096292 408 35.742836 imi_mug_run_2_treatment "iad"
15 Q0 29544586 409 35.728176 imi_mug_run_2_treatment "combinations"
15 Q0 25896422 410 35.7205 imi_mug_run_2_treatment "cck-8" "mediated"
15 Q0 24768118 411 35.71466 imi_mug_run_2_treatment "aim"
15 Q0 26929424 412 35.71426 imi_mug_run_2_treatment "combinations" "drugs" "ras"
15 Q0 26459797 413 35.70879 imi_mug_run_2_treatment "level"
15 Q0 28219204 414 35.673946 imi_mug_run_2_treatment "level"
15 Q0 23122493 415 35.668438 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
15 Q0 23181744 416 35.664196 imi_mug_run_2_treatment "cisplatin" "zol"
15 Q0 25294902 417 35.660038 imi_mug_run_2_treatment "various" "lead"
15 Q0 23064619 418 35.63257 imi_mug_run_2_treatment "aim"
15 Q0 30465536 419 35.614613 imi_mug_run_2_treatment "combinations" "eosin"
15 Q0 21665177 420 35.60192 imi_mug_run_2_treatment "cetuximab"
15 Q0 22135231 421 35.597183 imi_mug_run_2_treatment "various" "ras" "erlotinib"
15 Q0 228572 422 35.5919 imi_mug_run_2_treatment "prophylactic"
15 Q0 21732141 423 35.590145 imi_mug_run_2_treatment "level"
15 Q0 25286762 424 35.585747 imi_mug_run_2_treatment "lipid emulsion"
15 Q0 29474642 425 35.574688 imi_mug_run_2_treatment "cisplatin" "cystine" "drug"
15 Q0 20972324 426 35.562202 imi_mug_run_2_treatment "ras"
15 Q0 9875778 427 35.56181 imi_mug_run_2_treatment "melphalan" "sham" "level"
15 Q0 515543 428 35.54578 imi_mug_run_2_treatment "liver"
15 Q0 27153497 429 35.54578 imi_mug_run_2_treatment "insulin" "glucose" "liver"
15 Q0 19556853 430 35.541245 imi_mug_run_2_treatment "monoclonal antibodies" "mediated" "peroxiredoxin"
15 Q0 10189882 431 35.53466 imi_mug_run_2_treatment "various"
15 Q0 8468822 432 35.53011 imi_mug_run_2_treatment "calcium"
15 Q0 26403398 433 35.5118 imi_mug_run_2_treatment "mediated"
15 Q0 30032819 434 35.503975 imi_mug_run_2_treatment "level"
15 Q0 25560643 435 35.495857 imi_mug_run_2_treatment "aim"
15 Q0 28167572 436 35.495007 imi_mug_run_2_treatment "crizotinib" "alectinib" "interleukin-3"
15 Q0 21807965 437 35.4656 imi_mug_run_2_treatment "level"
15 Q0 25721211 438 35.46167 imi_mug_run_2_treatment "cisplatin" "various" "cddp"
15 Q0 28544512 439 35.457386 imi_mug_run_2_treatment "interferon"
15 Q0 25128483 440 35.43103 imi_mug_run_2_treatment "cisplatin" "various" "cddp"
15 Q0 28746919 441 35.43103 imi_mug_run_2_treatment "mediated"
15 Q0 28177518 442 35.418526 imi_mug_run_2_treatment "medicine"
15 Q0 27911940 443 35.416916 imi_mug_run_2_treatment "urethane" "combinations"
15 Q0 25995644 444 35.415226 imi_mug_run_2_treatment "various" "aim"
15 Q0 24496383 445 35.39886 imi_mug_run_2_treatment "mediated"
15 Q0 30087612 446 35.396446 imi_mug_run_2_treatment "temsirolimus" "cisplatin" "gemcitabine"
15 Q0 23364532 447 35.396374 imi_mug_run_2_treatment "mediators" "program"
15 Q0 25978653 448 35.38074 imi_mug_run_2_treatment "mediated"
15 Q0 28639892 449 35.37724 imi_mug_run_2_treatment "diphenyl"
15 Q0 26917231 450 35.35305 imi_mug_run_2_treatment "basis"
15 Q0 24260500 451 35.34171 imi_mug_run_2_treatment "il-6" "interleukin-6" "blockade"
15 Q0 25499173 452 35.326767 imi_mug_run_2_treatment "epidermal growth factor receptor tyrosine kinase inhibitor" "liver"
15 Q0 26381283 453 35.315815 imi_mug_run_2_treatment "adc" "crizotinib" "erlotinib"
15 Q0 27588131 454 35.303787 imi_mug_run_2_treatment "choline" "phosphocholine"
15 Q0 25054035 455 35.29755 imi_mug_run_2_treatment "drugs"
15 Q0 28821955 456 35.271137 imi_mug_run_2_treatment "level"
15 Q0 1362113 457 35.23233 imi_mug_run_2_treatment "various" "level"
15 Q0 27402308 458 35.22789 imi_mug_run_2_treatment "aim"
15 Q0 26631572 459 35.2265 imi_mug_run_2_treatment "collagen"
15 Q0 29850577 460 35.201477 imi_mug_run_2_treatment "various"
15 Q0 27247934 461 35.197186 imi_mug_run_2_treatment "aim" "pooled"
15 Q0 24922005 462 35.17559 imi_mug_run_2_treatment "siltuximab" "il-6" "erlotinib"
15 Q0 30333887 463 35.15967 imi_mug_run_2_treatment "level"
15 Q0 29637735 464 35.14018 imi_mug_run_2_treatment "various" "alectinib"
15 Q0 11920479 465 35.118 imi_mug_run_2_treatment "vascular endothelial growth factor" "basic fibroblast growth factor"
15 Q0 25748236 466 35.116364 imi_mug_run_2_treatment "various" "pdx" "therapeutics"
15 Q0 27462019 467 35.113434 imi_mug_run_2_treatment "cck-8"
15 Q0 22282307 468 35.108257 imi_mug_run_2_treatment "monoclonal antibodies"
15 Q0 27987592 469 35.106068 imi_mug_run_2_treatment "aim" "monoclonal antibodies"
15 Q0 24374738 470 35.101807 imi_mug_run_2_treatment "gefitinib"
15 Q0 26501265 471 35.0997 imi_mug_run_2_treatment "level" "mediated" "vascular endothelial growth factor"
15 Q0 26842935 472 35.09584 imi_mug_run_2_treatment "ras" "mediated" "aurora kinase inhibitor"
15 Q0 18413809 473 35.090363 imi_mug_run_2_treatment "pha-665752" "ras"
15 Q0 26102513 474 35.082108 imi_mug_run_2_treatment "adc"
15 Q0 27437773 475 35.080353 imi_mug_run_2_treatment "program"
15 Q0 25743147 476 35.07158 imi_mug_run_2_treatment "capecitabine"
15 Q0 23226801 477 35.05697 imi_mug_run_2_treatment "somatostatin" "interleukin-6"
15 Q0 25202344 478 35.048595 imi_mug_run_2_treatment "formalin" "aim"
15 Q0 28114446 479 35.036167 imi_mug_run_2_treatment "ras" "lead"
15 Q0 21457162 480 35.034206 imi_mug_run_2_treatment "level"
15 Q0 29925636 481 35.027084 imi_mug_run_2_treatment "ras"
15 Q0 19826477 482 35.005302 imi_mug_run_2_treatment "ras" "level"
15 Q0 29026990 483 35.000713 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitor"
15 Q0 26767003 484 34.999866 imi_mug_run_2_treatment "level"
15 Q0 24519667 485 34.990673 imi_mug_run_2_treatment "viral vector" "cytotoxic"
15 Q0 27575421 486 34.983143 imi_mug_run_2_treatment "adc"
15 Q0 28068363 487 34.971634 imi_mug_run_2_treatment "shape"
15 Q0 25796148 488 34.96918 imi_mug_run_2_treatment "activin"
15 Q0 25629635 489 34.959076 imi_mug_run_2_treatment "aim"
15 Q0 24998965 490 34.95284 imi_mug_run_2_treatment "basis"
15 Q0 21129303 491 34.946472 imi_mug_run_2_treatment "gefitinib" "level" "epidermal growth factor receptor tyrosine kinase inhibitor"
15 Q0 29856861 492 34.945995 imi_mug_run_2_treatment "duration"
15 Q0 27017063 493 34.945984 imi_mug_run_2_treatment "agent" "egfr tyrosine kinase inhibitors" "aim"
15 Q0 26676638 494 34.942703 imi_mug_run_2_treatment "immunosuppressive" "cytokines" "interleukin"
15 Q0 18758463 495 34.942425 imi_mug_run_2_treatment "ras"
15 Q0 27342566 496 34.937782 imi_mug_run_2_treatment "mediated"
15 Q0 30107055 497 34.937782 imi_mug_run_2_treatment "various"
15 Q0 28331820 498 34.93547 imi_mug_run_2_treatment "ppa"
15 Q0 27842505 499 34.927155 imi_mug_run_2_treatment "platinum"
15 Q0 19107609 500 34.924828 imi_mug_run_2_treatment "medicine" "genesis"
15 Q0 28334878 501 34.918343 imi_mug_run_2_treatment "inositol"
15 Q0 25734833 502 34.906826 imi_mug_run_2_treatment "gemcitabine" "aim"
15 Q0 21729655 503 34.90465 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors" "aim"
15 Q0 20014400 504 34.903343 imi_mug_run_2_treatment "basis" "aim"
15 Q0 21400670 505 34.9007 imi_mug_run_2_treatment "aim"
15 Q0 8207892 506 34.887882 imi_mug_run_2_treatment "level"
15 Q0 29676621 507 34.884285 imi_mug_run_2_treatment "serine" "ras" "suppressor"
15 Q0 26301689 508 34.883125 imi_mug_run_2_treatment "ras" "duration"
15 Q0 24692715 509 34.876045 imi_mug_run_2_treatment "aim"
15 Q0 29169410 510 34.876045 imi_mug_run_2_treatment "various"
15 Q0 27713162 511 34.847095 imi_mug_run_2_treatment "erlotinib" "drug" "everolimus"
15 Q0 28810596 512 34.842205 imi_mug_run_2_treatment "various" "level" "aim"
15 Q0 24725383 513 34.842167 imi_mug_run_2_treatment "aim"
15 Q0 29232915 514 34.841488 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitor" "prompt"
15 Q0 22883546 515 34.830124 imi_mug_run_2_treatment "glucose"
15 Q0 24140068 516 34.828197 imi_mug_run_2_treatment "interleukin"
15 Q0 29212235 517 34.82477 imi_mug_run_2_treatment "product"
15 Q0 26177377 518 34.82052 imi_mug_run_2_treatment "thyroglobulin" "cisplatinum" "bevacizumab"
15 Q0 12942568 519 34.817036 imi_mug_run_2_treatment "suppressor"
15 Q0 19847165 520 34.81517 imi_mug_run_2_treatment "drugs"
15 Q0 23098378 521 34.798016 imi_mug_run_2_treatment "lead"
15 Q0 24427341 522 34.797462 imi_mug_run_2_treatment "suppressor"
15 Q0 140093 523 34.784477 imi_mug_run_2_treatment "enzymes" "agar"
15 Q0 27667466 524 34.779243 imi_mug_run_2_treatment "cisplatin" "gemcitabine"
15 Q0 25222473 525 34.77445 imi_mug_run_2_treatment "mitomycins"
15 Q0 22171490 526 34.77195 imi_mug_run_2_treatment "surfactant"
15 Q0 29361925 527 34.7684 imi_mug_run_2_treatment "crizotinib" "lorlatinib" "cisplatin"
15 Q0 28004467 528 34.76788 imi_mug_run_2_treatment "aim" "shape"
15 Q0 28423676 529 34.732555 imi_mug_run_2_treatment "various" "mediated" "level"
15 Q0 29719560 530 34.72446 imi_mug_run_2_treatment "aim"
15 Q0 26832408 531 34.723946 imi_mug_run_2_treatment "trametinib" "fluvastatin" "drugs"
15 Q0 26329363 532 34.721558 imi_mug_run_2_treatment "stimulant"
15 Q0 23444212 533 34.713943 imi_mug_run_2_treatment "dim"
15 Q0 29454587 534 34.694588 imi_mug_run_2_treatment "aim"
15 Q0 8008739 535 34.688377 imi_mug_run_2_treatment "wheat germ" "dodecyl sulfate" "ricinus communis"
15 Q0 7928630 536 34.67564 imi_mug_run_2_treatment "ndp" "diphosphate" "others"
15 Q0 17342326 537 34.6712 imi_mug_run_2_treatment "methylcellulose"
15 Q0 26204223 538 34.657963 imi_mug_run_2_treatment "paclitaxel"
15 Q0 30093964 539 34.642746 imi_mug_run_2_treatment "aim"
15 Q0 28927126 540 34.640656 imi_mug_run_2_treatment "enzymes" "mediated" "plasma"
15 Q0 24815469 541 34.640503 imi_mug_run_2_treatment "various" "cisplatin"
15 Q0 23593434 542 34.64016 imi_mug_run_2_treatment "level"
15 Q0 29715131 543 34.640038 imi_mug_run_2_treatment "maspin" "aim" "suppressor"
15 Q0 29781848 544 34.63825 imi_mug_run_2_treatment "lead" "aim"
15 Q0 19381893 545 34.62726 imi_mug_run_2_treatment "coomassie blue" "matrix"
15 Q0 27072586 546 34.62341 imi_mug_run_2_treatment "mediated"
15 Q0 28720066 547 34.620106 imi_mug_run_2_treatment "drugs"
15 Q0 17686824 548 34.619255 imi_mug_run_2_treatment "anti-inflammatory" "cytokines"
15 Q0 20080496 549 34.60976 imi_mug_run_2_treatment "aim" "animals"
15 Q0 22613331 550 34.60773 imi_mug_run_2_treatment "aim"
15 Q0 30501603 551 34.60402 imi_mug_run_2_treatment "cisplatin" "drug"
15 Q0 22461368 552 34.597218 imi_mug_run_2_treatment "activated protein c"
15 Q0 23743567 553 34.592396 imi_mug_run_2_treatment "mediated" "il-10" "interleukin-10"
15 Q0 28145884 554 34.58437 imi_mug_run_2_treatment "level"
15 Q0 23494387 555 34.57897 imi_mug_run_2_treatment "lead"
15 Q0 23357462 556 34.575626 imi_mug_run_2_treatment "hub"
15 Q0 29285248 557 34.569016 imi_mug_run_2_treatment "lysine"
15 Q0 29027312 558 34.563473 imi_mug_run_2_treatment "basis"
15 Q0 23453624 559 34.562286 imi_mug_run_2_treatment "adm" "ras"
15 Q0 30220105 560 34.55713 imi_mug_run_2_treatment "drug" "agent" "blockade"
15 Q0 27077967 561 34.556465 imi_mug_run_2_treatment "gefitinib" "kinase inhibitor" "tgf-beta-1"
15 Q0 28146588 562 34.5538 imi_mug_run_2_treatment "silver" "level"
15 Q0 26766588 563 34.54349 imi_mug_run_2_treatment "program"
15 Q0 19121086 564 34.538246 imi_mug_run_2_treatment "others"
15 Q0 27993377 565 34.531357 imi_mug_run_2_treatment "duration"
15 Q0 22966403 566 34.510124 imi_mug_run_2_treatment "proteinase"
15 Q0 12096622 567 34.49869 imi_mug_run_2_treatment "various" "isolate" "liver"
15 Q0 21671464 568 34.493286 imi_mug_run_2_treatment "level"
15 Q0 27056568 569 34.49122 imi_mug_run_2_treatment "adc"
15 Q0 22528516 570 34.487972 imi_mug_run_2_treatment "aim"
15 Q0 24128716 571 34.487328 imi_mug_run_2_treatment "arsenic" "level"
15 Q0 29564165 572 34.44493 imi_mug_run_2_treatment "medicine's" "gemcitabine"
15 Q0 23599802 573 34.439293 imi_mug_run_2_treatment "aim"
15 Q0 28932588 574 34.43061 imi_mug_run_2_treatment "epidermal growth factor"
15 Q0 7092452 575 34.428734 imi_mug_run_2_treatment "adrenocorticotropic hormone" "acth" "corticosterone"
15 Q0 16528673 576 34.427868 imi_mug_run_2_treatment "various" "aim"
15 Q0 25278450 577 34.42522 imi_mug_run_2_treatment "lead"
15 Q0 24917165 578 34.424446 imi_mug_run_2_treatment "glucose"
15 Q0 29541220 579 34.423767 imi_mug_run_2_treatment "aim"
15 Q0 17030461 580 34.403255 imi_mug_run_2_treatment "aim"
15 Q0 21954021 581 34.395985 imi_mug_run_2_treatment "drugs" "metric"
15 Q0 27346245 582 34.395332 imi_mug_run_2_treatment "formalin"
15 Q0 24805982 583 34.39311 imi_mug_run_2_treatment "various"
15 Q0 27595477 584 34.390663 imi_mug_run_2_treatment "basis"
15 Q0 23539445 585 34.388367 imi_mug_run_2_treatment "mediated"
15 Q0 25628349 586 34.386253 imi_mug_run_2_treatment "glucose"
15 Q0 24859971 587 34.385292 imi_mug_run_2_treatment "drug" "drugs" "hub"
15 Q0 3048648 588 34.381004 imi_mug_run_2_treatment "ras"
15 Q0 25546673 589 34.373386 imi_mug_run_2_treatment "favor"
15 Q0 23206831 590 34.37326 imi_mug_run_2_treatment "level"
15 Q0 25030993 591 34.370766 imi_mug_run_2_treatment "level"
15 Q0 27358292 592 34.366207 imi_mug_run_2_treatment "oxygen" "level"
15 Q0 21937081 593 34.36517 imi_mug_run_2_treatment "aim"
15 Q0 26642845 594 34.363705 imi_mug_run_2_treatment "various" "air" "stas"
15 Q0 26168791 595 34.358402 imi_mug_run_2_treatment "various"
15 Q0 27990560 596 34.356762 imi_mug_run_2_treatment "pooled"
15 Q0 30122949 597 34.34871 imi_mug_run_2_treatment "docetaxel" "flt" "nintedanib"
15 Q0 29880877 598 34.347084 imi_mug_run_2_treatment "protease"
15 Q0 29312735 599 34.345894 imi_mug_run_2_treatment "adjuvant" "aim"
15 Q0 28141826 600 34.34212 imi_mug_run_2_treatment "therapeutics"
15 Q0 17967182 601 34.31712 imi_mug_run_2_treatment "plasma"
15 Q0 24486245 602 34.31372 imi_mug_run_2_treatment "estrogens" "level"
15 Q0 26356712 603 34.303535 imi_mug_run_2_treatment "adjuvant" "imatinib mesylate" "imatinib"
15 Q0 9660914 604 34.292217 imi_mug_run_2_treatment "others"
15 Q0 24503571 605 34.28796 imi_mug_run_2_treatment "basis"
15 Q0 1984945 606 34.286793 imi_mug_run_2_treatment "liver"
15 Q0 28349831 607 34.27501 imi_mug_run_2_treatment "various" "level"
15 Q0 20880465 608 34.269005 imi_mug_run_2_treatment "interferon gamma" "tnf-alpha"
15 Q0 28819306 609 34.2643 imi_mug_run_2_treatment "level" "epidermal growth factor"
15 Q0 24972691 610 34.26326 imi_mug_run_2_treatment "shikonin" "agent"
15 Q0 24513263 611 34.263237 imi_mug_run_2_treatment "others"
15 Q0 9083332 612 34.261913 imi_mug_run_2_treatment "various"
15 Q0 17653092 613 34.25975 imi_mug_run_2_treatment "mediated"
15 Q0 17889960 614 34.258884 imi_mug_run_2_treatment "lead"
15 Q0 25336976 615 34.255444 imi_mug_run_2_treatment "various"
15 Q0 30165371 616 34.238365 imi_mug_run_2_treatment "agent" "blockade"
15 Q0 22795503 617 34.23516 imi_mug_run_2_treatment "product"
15 Q0 21040633 618 34.23351 imi_mug_run_2_treatment "viron" "liver"
15 Q0 29173768 619 34.222992 imi_mug_run_2_treatment "level"
15 Q0 26896556 620 34.22152 imi_mug_run_2_treatment "mediated" "gefitinib" "egfr inhibitor"
15 Q0 24721325 621 34.20586 imi_mug_run_2_treatment "cck-8"
15 Q0 29415746 622 34.202404 imi_mug_run_2_treatment "methotrexate" "prednisone" "intravenous immunoglobulin"
15 Q0 25197384 623 34.20043 imi_mug_run_2_treatment "lead"
15 Q0 21523732 624 34.17002 imi_mug_run_2_treatment "copper" "mediated"
15 Q0 29927028 625 34.163982 imi_mug_run_2_treatment "plasma"
15 Q0 1322788 626 34.1617 imi_mug_run_2_treatment "level"
15 Q0 18948947 627 34.158184 imi_mug_run_2_treatment "basis"
15 Q0 22139708 628 34.139206 imi_mug_run_2_treatment "docetaxel" "various" "mediated"
15 Q0 26468015 629 34.137615 imi_mug_run_2_treatment "various" "mediated" "chemotherapeutic agent"
15 Q0 25944163 630 34.136505 imi_mug_run_2_treatment "granulocytes"
15 Q0 12918063 631 34.12063 imi_mug_run_2_treatment "tpi"
15 Q0 26264617 632 34.11344 imi_mug_run_2_treatment "il-12" "il-10" "immunosuppressive"
15 Q0 28435290 633 34.107803 imi_mug_run_2_treatment "adjuvant"
15 Q0 8634783 634 34.07746 imi_mug_run_2_treatment "ras"
15 Q0 22767360 635 34.076004 imi_mug_run_2_treatment "various"
15 Q0 24051307 636 34.071404 imi_mug_run_2_treatment "calcineurin inhibitor"
15 Q0 26903162 637 34.06857 imi_mug_run_2_treatment "aim"
15 Q0 28407465 638 34.05629 imi_mug_run_2_treatment "gemcitabine" "pemetrexed" "singlet"
15 Q0 24654231 639 34.054314 imi_mug_run_2_treatment "mediated"
15 Q0 28377352 640 34.047447 imi_mug_run_2_treatment "level"
15 Q0 20675343 641 34.037056 imi_mug_run_2_treatment "therapeutic agent"
15 Q0 26647728 642 34.03267 imi_mug_run_2_treatment "basis"
15 Q0 21074889 643 34.02688 imi_mug_run_2_treatment "plasma" "adc" "cisplatin"
15 Q0 23239811 644 34.02578 imi_mug_run_2_treatment "level"
15 Q0 25291939 645 34.024597 imi_mug_run_2_treatment "level" "egfr tyrosine kinase inhibitor" "egfr tyrosine kinase inhibitors"
15 Q0 26483334 646 34.012543 imi_mug_run_2_treatment "tyrosine kinase inhibitor" "aim"
15 Q0 21075310 647 34.01052 imi_mug_run_2_treatment "mediated"
15 Q0 30106864 648 34.003506 imi_mug_run_2_treatment "sur"
15 Q0 20445465 649 34.00115 imi_mug_run_2_treatment "various" "basis"
15 Q0 21655907 650 33.990654 imi_mug_run_2_treatment "drugs"
15 Q0 28938613 651 33.982063 imi_mug_run_2_treatment "ras" "leucine" "egfr tyrosine kinase inhibitors"
15 Q0 24377518 652 33.97685 imi_mug_run_2_treatment "various" "oligo"
15 Q0 25936704 653 33.97502 imi_mug_run_2_treatment "shape" "her-2" "vascular endothelial growth factor"
15 Q0 28289710 654 33.969223 imi_mug_run_2_treatment "collagen"
15 Q0 19582164 655 33.94751 imi_mug_run_2_treatment "il-12" "il-6" "cytokines"
15 Q0 18620727 656 33.93707 imi_mug_run_2_treatment "sex hormones" "level"
15 Q0 29806739 657 33.931732 imi_mug_run_2_treatment "aim"
15 Q0 22542705 658 33.92696 imi_mug_run_2_treatment "aim"
15 Q0 24086497 659 33.90539 imi_mug_run_2_treatment "il-6" "coagulation factor"
15 Q0 20738912 660 33.893707 imi_mug_run_2_treatment "aim"
15 Q0 22799351 661 33.893166 imi_mug_run_2_treatment "basis" "genesis"
15 Q0 30332938 662 33.887848 imi_mug_run_2_treatment "glycan" "level"
15 Q0 19362747 663 33.878376 imi_mug_run_2_treatment "adc" "others"
15 Q0 27997009 664 33.872475 imi_mug_run_2_treatment "aim" "others"
15 Q0 12488755 665 33.871277 imi_mug_run_2_treatment "air"
15 Q0 18669174 666 33.864967 imi_mug_run_2_treatment "tandem" "ras" "monoclonal antibodies"
15 Q0 29120087 667 33.86172 imi_mug_run_2_treatment "drug"
15 Q0 21247966 668 33.853325 imi_mug_run_2_treatment "carboplatin" "paclitaxel"
15 Q0 28952911 669 33.8496 imi_mug_run_2_treatment "ras" "duration"
15 Q0 27007150 670 33.847797 imi_mug_run_2_treatment "perifosine"
15 Q0 27239180 671 33.846596 imi_mug_run_2_treatment "bevacizumab" "oxaliplatin" "liver"
15 Q0 20941554 672 33.818867 imi_mug_run_2_treatment "level" "vascular endothelial growth factor"
15 Q0 30426188 673 33.814964 imi_mug_run_2_treatment "aim"
15 Q0 22552406 674 33.811554 imi_mug_run_2_treatment "cisplatin" "various"
15 Q0 24959282 675 33.795666 imi_mug_run_2_treatment "nicotinamide adenine dinucleotide"
15 Q0 22824148 676 33.79262 imi_mug_run_2_treatment "aim"
15 Q0 11950910 677 33.791885 imi_mug_run_2_treatment "level"
15 Q0 22481253 678 33.787777 imi_mug_run_2_treatment "fcm"
15 Q0 29748019 679 33.78204 imi_mug_run_2_treatment "erlotinib"
15 Q0 25087094 680 33.77511 imi_mug_run_2_treatment "vitamin d" "cisplatin" "drug"
15 Q0 3545444 681 33.772385 imi_mug_run_2_treatment "various" "monoclonal antibodies" "level"
15 Q0 24556579 682 33.761475 imi_mug_run_2_treatment "glycyrrhizin" "agent"
15 Q0 26469326 683 33.759586 imi_mug_run_2_treatment "cdx" "aim"
15 Q0 29057889 684 33.749977 imi_mug_run_2_treatment "program"
15 Q0 22833420 685 33.74914 imi_mug_run_2_treatment "drugs"
15 Q0 29168346 686 33.74078 imi_mug_run_2_treatment "mediated"
15 Q0 30171333 687 33.740616 imi_mug_run_2_treatment "liver"
15 Q0 29526175 688 33.723873 imi_mug_run_2_treatment "aim"
15 Q0 27237029 689 33.716522 imi_mug_run_2_treatment "level"
15 Q0 22918072 690 33.71554 imi_mug_run_2_treatment "fiber" "haq" "aim"
15 Q0 28629842 691 33.710144 imi_mug_run_2_treatment "aim"
15 Q0 21252716 692 33.688217 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors" "pemetrexed" "bevacizumab"
15 Q0 27782156 693 33.683353 imi_mug_run_2_treatment "methylated"
15 Q0 7686360 694 33.6829 imi_mug_run_2_treatment "level" "monoclonal antibodies"
15 Q0 29199670 695 33.67429 imi_mug_run_2_treatment "duration"
15 Q0 26774193 696 33.67204 imi_mug_run_2_treatment "adc"
15 Q0 26789109 697 33.671806 imi_mug_run_2_treatment "adc" "gefitinib" "erlotinib"
15 Q0 26356813 698 33.66493 imi_mug_run_2_treatment "level" "matrix"
15 Q0 21447735 699 33.659096 imi_mug_run_2_treatment "mediated"
15 Q0 25418354 700 33.657963 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
15 Q0 30282880 701 33.65396 imi_mug_run_2_treatment "various"
15 Q0 24282590 702 33.65052 imi_mug_run_2_treatment "plasma"
15 Q0 26469914 703 33.631344 imi_mug_run_2_treatment "afatinib" "gefitinib" "erlotinib"
15 Q0 25174355 704 33.62397 imi_mug_run_2_treatment "arsenic trioxide" "mediated"
15 Q0 28164517 705 33.619503 imi_mug_run_2_treatment "various" "nicotinamide adenine dinucleotide"
15 Q0 21633846 706 33.618744 imi_mug_run_2_treatment "aim"
15 Q0 27139190 707 33.6101 imi_mug_run_2_treatment "mediators"
15 Q0 28982179 708 33.609467 imi_mug_run_2_treatment "trametinib" "mek inhibitor" "azd5363"
15 Q0 18844936 709 33.601543 imi_mug_run_2_treatment "hot spot" "tca"
15 Q0 25499851 710 33.601543 imi_mug_run_2_treatment "cisplatin" "mediated" "curcumin"
15 Q0 21556796 711 33.601334 imi_mug_run_2_treatment "level" "aim"
15 Q0 7700050 712 33.59961 imi_mug_run_2_treatment "surfactant"
15 Q0 21619686 713 33.599197 imi_mug_run_2_treatment "level"
15 Q0 20878108 714 33.573364 imi_mug_run_2_treatment "diphenyl"
15 Q0 29166433 715 33.567387 imi_mug_run_2_treatment "insulin"
15 Q0 22263102 716 33.565937 imi_mug_run_2_treatment "erlotinib"
15 Q0 25982011 717 33.560017 imi_mug_run_2_treatment "adc" "pas"
15 Q0 30403196 718 33.55871 imi_mug_run_2_treatment "shape"
15 Q0 25004243 719 33.555702 imi_mug_run_2_treatment "adc" "hub"
15 Q0 18676835 720 33.554455 imi_mug_run_2_treatment "mediated" "collagen"
15 Q0 26903158 721 33.536892 imi_mug_run_2_treatment "aim"
15 Q0 24811831 722 33.519936 imi_mug_run_2_treatment "adc"
15 Q0 20719150 723 33.515434 imi_mug_run_2_treatment "aim" "il-6"
15 Q0 17785952 724 33.510136 imi_mug_run_2_treatment "plasminogen activator"
15 Q0 23443411 725 33.510136 imi_mug_run_2_treatment "level" "aim"
15 Q0 26322380 726 33.503586 imi_mug_run_2_treatment "glycan" "glycans" "level"
15 Q0 17310850 727 33.48687 imi_mug_run_2_treatment "activin" "insulin-like growth factor binding protein 3"
15 Q0 25286755 728 33.467495 imi_mug_run_2_treatment "mouse monoclonal antibody"
15 Q0 15063225 729 33.46113 imi_mug_run_2_treatment "level"
15 Q0 26061649 730 33.460144 imi_mug_run_2_treatment "defensin"
15 Q0 28843361 731 33.45207 imi_mug_run_2_treatment "basis"
15 Q0 27336603 732 33.442413 imi_mug_run_2_treatment "liver"
15 Q0 23414265 733 33.439587 imi_mug_run_2_treatment "thyroglobulin"
15 Q0 24060722 734 33.428696 imi_mug_run_2_treatment "melan a"
15 Q0 1753506 735 33.422596 imi_mug_run_2_treatment "silver"
15 Q0 21598249 736 33.419353 imi_mug_run_2_treatment "gefitinib" "aim"
15 Q0 25934296 737 33.413326 imi_mug_run_2_treatment "dehydrogenase inhibitor" "level"
15 Q0 19223748 738 33.40859 imi_mug_run_2_treatment "carboplatin" "irinotecan"
15 Q0 27299180 739 33.40859 imi_mug_run_2_treatment "mdc"
15 Q0 21306997 740 33.404617 imi_mug_run_2_treatment "drugs"
15 Q0 26759016 741 33.4034 imi_mug_run_2_treatment "various" "animals"
15 Q0 22729036 742 33.394844 imi_mug_run_2_treatment "antifolate" "folate"
15 Q0 25739030 743 33.394653 imi_mug_run_2_treatment "shape" "metrics"
15 Q0 28701723 744 33.383553 imi_mug_run_2_treatment "aim"
15 Q0 24470024 745 33.36386 imi_mug_run_2_treatment "mediated"
15 Q0 18801198 746 33.359493 imi_mug_run_2_treatment "surfactant"
15 Q0 27349355 747 33.355297 imi_mug_run_2_treatment "formalin" "isolate" "aim"
15 Q0 30268473 748 33.353718 imi_mug_run_2_treatment "stas" "basis"
15 Q0 17121895 749 33.349457 imi_mug_run_2_treatment "carboplatin" "docetaxel" "plasma"
15 Q0 23268088 750 33.340153 imi_mug_run_2_treatment "level"
15 Q0 23911772 751 33.330704 imi_mug_run_2_treatment "various" "basis"
15 Q0 29805502 752 33.324715 imi_mug_run_2_treatment "various"
15 Q0 26673119 753 33.3221 imi_mug_run_2_treatment "nivolumab"
15 Q0 23892093 754 33.315483 imi_mug_run_2_treatment "docetaxel" "various" "lead"
15 Q0 24679953 755 33.313137 imi_mug_run_2_treatment "shape"
15 Q0 29484434 756 33.310898 imi_mug_run_2_treatment "celastrol"
15 Q0 28445137 757 33.30877 imi_mug_run_2_treatment "level" "plasma" "dedicated"
15 Q0 29167001 758 33.307972 imi_mug_run_2_treatment "pemetrexed" "platinum" "aim"
15 Q0 26934441 759 33.30533 imi_mug_run_2_treatment "various"
15 Q0 28246207 760 33.278053 imi_mug_run_2_treatment "simtuzumab" "fluorouracil" "leucovorin"
15 Q0 30008907 761 33.275463 imi_mug_run_2_treatment "various" "level" "vascular endothelial growth factor"
15 Q0 15798092 762 33.267838 imi_mug_run_2_treatment "interleukin-4" "cytokines" "interleukin-6"
15 Q0 29561699 763 33.250565 imi_mug_run_2_treatment "afatinib"
15 Q0 26693065 764 33.246887 imi_mug_run_2_treatment "mediated"
15 Q0 24743582 765 33.246086 imi_mug_run_2_treatment "urethane"
15 Q0 29443542 766 33.242645 imi_mug_run_2_treatment "hub"
15 Q0 25975687 767 33.24221 imi_mug_run_2_treatment "adc"
15 Q0 28810144 768 33.241425 imi_mug_run_2_treatment "ras"
15 Q0 27829148 769 33.230827 imi_mug_run_2_treatment "platelets"
15 Q0 23226501 770 33.229996 imi_mug_run_2_treatment "suppressor" "animals"
15 Q0 30103827 771 33.227592 imi_mug_run_2_treatment "mediated"
15 Q0 28623644 772 33.220104 imi_mug_run_2_treatment "colloidal gold"
15 Q0 26285240 773 33.21824 imi_mug_run_2_treatment "favoring" "trastuzumab" "pertuzumab"
15 Q0 27623992 774 33.20229 imi_mug_run_2_treatment "androgen"
15 Q0 24789104 775 33.194645 imi_mug_run_2_treatment "il-6" "metformin" "blockade"
15 Q0 17449174 776 33.185947 imi_mug_run_2_treatment "plasma"
15 Q0 29221141 777 33.17209 imi_mug_run_2_treatment "plasma" "mediators" "isolating"
15 Q0 26816547 778 33.161938 imi_mug_run_2_treatment "shape" "level"
15 Q0 18241651 779 33.158035 imi_mug_run_2_treatment "matrine" "anti-tumor drugs" "spca"
15 Q0 26056182 780 33.147568 imi_mug_run_2_treatment "matrix"
15 Q0 11326972 781 33.142223 imi_mug_run_2_treatment "anti-egfr monoclonal antibody" "epidermal growth factor"
15 Q0 28544031 782 33.14074 imi_mug_run_2_treatment "protease"
15 Q0 24533074 783 33.139847 imi_mug_run_2_treatment "various"
15 Q0 21106155 784 33.1389 imi_mug_run_2_treatment "lead"
15 Q0 26416458 785 33.13809 imi_mug_run_2_treatment "platinum" "aim"
15 Q0 27266347 786 33.132607 imi_mug_run_2_treatment "interleukin-8" "blade"
15 Q0 26101637 787 33.131065 imi_mug_run_2_treatment "various"
15 Q0 26445613 788 33.129654 imi_mug_run_2_treatment "gefitinib"
15 Q0 29427136 789 33.129375 imi_mug_run_2_treatment "liver"
15 Q0 24079724 790 33.12577 imi_mug_run_2_treatment "rose" "air"
15 Q0 18245014 791 33.11403 imi_mug_run_2_treatment "corticosteroids"
15 Q0 19576624 792 33.109375 imi_mug_run_2_treatment "mediators" "program"
15 Q0 30008873 793 33.102455 imi_mug_run_2_treatment "aim"
15 Q0 29541384 794 33.09677 imi_mug_run_2_treatment "various"
15 Q0 25776025 795 33.06634 imi_mug_run_2_treatment "surfactant"
15 Q0 29469192 796 33.058884 imi_mug_run_2_treatment "aim"
15 Q0 15965285 797 33.04311 imi_mug_run_2_treatment "zoledronic acid"
15 Q0 30499220 798 33.033867 imi_mug_run_2_treatment "various"
15 Q0 24857785 799 33.031685 imi_mug_run_2_treatment "gefitinib" "erlotinib"
15 Q0 25994008 800 33.022923 imi_mug_run_2_treatment "level"
15 Q0 17036361 801 33.016354 imi_mug_run_2_treatment "deoxyglucose"
15 Q0 9738975 802 33.00894 imi_mug_run_2_treatment "nitric oxide" "yeast"
15 Q0 18391747 803 33.006393 imi_mug_run_2_treatment "various"
15 Q0 7882350 804 33.005013 imi_mug_run_2_treatment "ras"
15 Q0 21351266 805 33.004223 imi_mug_run_2_treatment "aim"
15 Q0 25446096 806 32.991817 imi_mug_run_2_treatment "level"
15 Q0 14681207 807 32.989777 imi_mug_run_2_treatment "mediated"
15 Q0 27733346 808 32.985565 imi_mug_run_2_treatment "cis-diamminedichloroplatinum" "cisplatin"
15 Q0 26520779 809 32.98391 imi_mug_run_2_treatment "various" "drugs" "ras"
15 Q0 9615796 810 32.97503 imi_mug_run_2_treatment "vascular endothelial growth factor" "level"
15 Q0 24460299 811 32.971996 imi_mug_run_2_treatment "dapi"
15 Q0 29984766 812 32.968884 imi_mug_run_2_treatment "alectinib"
15 Q0 19358724 813 32.966545 imi_mug_run_2_treatment "drugs"
15 Q0 24799473 814 32.95522 imi_mug_run_2_treatment "adjuvant"
15 Q0 17313031 815 32.94208 imi_mug_run_2_treatment "gefitinib"
15 Q0 21503575 816 32.940495 imi_mug_run_2_treatment "various" "mediated" "tma"
15 Q0 20369711 817 32.93963 imi_mug_run_2_treatment "liver"
15 Q0 16767555 818 32.93705 imi_mug_run_2_treatment "pma"
15 Q0 25197873 819 32.936848 imi_mug_run_2_treatment "pdx" "lead"
15 Q0 20139980 820 32.912598 imi_mug_run_2_treatment "dok"
15 Q0 28532538 821 32.906155 imi_mug_run_2_treatment "lead"
15 Q0 21172159 822 32.898613 imi_mug_run_2_treatment "aim"
15 Q0 12044784 823 32.891197 imi_mug_run_2_treatment "acetylsalicylic acid" "collagen" "product"
15 Q0 24297623 824 32.89016 imi_mug_run_2_treatment "gefitinib" "erlotinib"
15 Q0 24570539 825 32.88606 imi_mug_run_2_treatment "gefitinib"
15 Q0 28118634 826 32.88509 imi_mug_run_2_treatment "crizotinib"
15 Q0 27722820 827 32.865677 imi_mug_run_2_treatment "mediated"
15 Q0 29587953 828 32.865158 imi_mug_run_2_treatment "drugs" "aim"
15 Q0 20723342 829 32.857445 imi_mug_run_2_treatment "il-6" "liver"
15 Q0 29722145 830 32.85609 imi_mug_run_2_treatment "ccl4"
15 Q0 18801593 831 32.85014 imi_mug_run_2_treatment "platinum" "protease"
15 Q0 28935011 832 32.845375 imi_mug_run_2_treatment "level"
15 Q0 3221828 833 32.845272 imi_mug_run_2_treatment "genesis"
15 Q0 25664625 834 32.828114 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
15 Q0 22327624 835 32.8205 imi_mug_run_2_treatment "vandetanib" "tyrosine kinase inhibitor"
15 Q0 24751107 836 32.816826 imi_mug_run_2_treatment "lcr" "air"
15 Q0 26209642 837 32.806454 imi_mug_run_2_treatment "docetaxel" "erlotinib" "platinum"
15 Q0 26471868 838 32.80515 imi_mug_run_2_treatment "drug"
15 Q0 29622074 839 32.79255 imi_mug_run_2_treatment "level"
15 Q0 2249588 840 32.79109 imi_mug_run_2_treatment "liver"
15 Q0 28698100 841 32.786713 imi_mug_run_2_treatment "asc"
15 Q0 29147258 842 32.786537 imi_mug_run_2_treatment "methotrexate"
15 Q0 27870944 843 32.786446 imi_mug_run_2_treatment "plasma" "basis" "hot spot"
15 Q0 26141216 844 32.76522 imi_mug_run_2_treatment "various"
15 Q0 19068768 845 32.74808 imi_mug_run_2_treatment "gemcitabine" "carboplatin" "paclitaxel"
15 Q0 26397133 846 32.746853 imi_mug_run_2_treatment "nnk" "butanone" "aim"
15 Q0 9872650 847 32.744698 imi_mug_run_2_treatment "aim"
15 Q0 24920890 848 32.73278 imi_mug_run_2_treatment "srif" "collagen"
15 Q0 25097032 849 32.73227 imi_mug_run_2_treatment "erlotinib"
15 Q0 28005074 850 32.73171 imi_mug_run_2_treatment "various"
15 Q0 28231733 851 32.72855 imi_mug_run_2_treatment "basis"
15 Q0 28554746 852 32.72664 imi_mug_run_2_treatment "prompt"
15 Q0 26428847 853 32.72207 imi_mug_run_2_treatment "dim" "blockade" "mediated"
15 Q0 24668305 854 32.72113 imi_mug_run_2_treatment "sgi-110" "entinostat" "decitabine"
15 Q0 18349398 855 32.71659 imi_mug_run_2_treatment "erlotinib" "erlotinib 150 mg"
15 Q0 24457240 856 32.696136 imi_mug_run_2_treatment "various" "level" "aim"
15 Q0 22460125 857 32.69428 imi_mug_run_2_treatment "docetaxel" "mediated" "paclitaxel"
15 Q0 21205527 858 32.69428 imi_mug_run_2_treatment "gln" "oil" "aim"
15 Q0 23721095 859 32.693577 imi_mug_run_2_treatment "mediated"
15 Q0 26782587 860 32.69287 imi_mug_run_2_treatment "blockade" "vascular endothelial growth factor" "aim"
15 Q0 11750712 861 32.68546 imi_mug_run_2_treatment "vitamin e" "carotenoids" "fats"
15 Q0 23540296 862 32.675087 imi_mug_run_2_treatment "others"
15 Q0 23584293 863 32.673386 imi_mug_run_2_treatment "adc"
15 Q0 28481029 864 32.668133 imi_mug_run_2_treatment "cisplatin"
16 Q0 29228520 1 87.09874 imi_mug_run_2_treatment "ptc"
16 Q0 20473281 2 84.457825 imi_mug_run_2_treatment "mediated"
16 Q0 23981603 3 83.378784 imi_mug_run_2_treatment "vascular endothelial growth factor"
16 Q0 28789361 4 80.60559 imi_mug_run_2_treatment "ptc" "aim"
16 Q0 21167555 5 80.363304 imi_mug_run_2_treatment "enzyme digestion"
16 Q0 29254799 6 78.76122 imi_mug_run_2_treatment "ptc" "mouse monoclonal antibody" "radioactive iodine"
16 Q0 26884113 7 78.17883 imi_mug_run_2_treatment "iodine"
16 Q0 25400776 8 77.95674 imi_mug_run_2_treatment "aim"
16 Q0 24228637 9 77.54396 imi_mug_run_2_treatment "ptc"
16 Q0 26403329 10 77.45877 imi_mug_run_2_treatment "aim"
16 Q0 29264486 11 77.11037 imi_mug_run_2_treatment "iodine"
16 Q0 20410389 12 76.713715 imi_mug_run_2_treatment "shape"
16 Q0 16533790 13 75.936905 imi_mug_run_2_treatment "bay 43-9006" "aim"
16 Q0 23161556 14 75.51681 imi_mug_run_2_treatment "various"
16 Q0 22767446 15 75.50203 imi_mug_run_2_treatment "ptc"
16 Q0 27625138 16 75.47545 imi_mug_run_2_treatment "ptc" "medicine" "genesis"
16 Q0 24839220 17 75.14189 imi_mug_run_2_treatment "aim" "ptc"
16 Q0 24828987 18 74.7805 imi_mug_run_2_treatment "ptc"
16 Q0 16268813 19 74.75215 imi_mug_run_2_treatment "ptc" "aim"
16 Q0 16983703 20 74.636284 imi_mug_run_2_treatment "product" "others"
16 Q0 23157614 21 74.398895 imi_mug_run_2_treatment "ptc" "aim"
16 Q0 24396464 22 74.10726 imi_mug_run_2_treatment "ptc" "aim"
16 Q0 29088832 23 74.10305 imi_mug_run_2_treatment "ptc"
16 Q0 24746198 24 73.7428 imi_mug_run_2_treatment "ptc"
16 Q0 24612623 25 73.64799 imi_mug_run_2_treatment "ptc"
16 Q0 27568671 26 73.584564 imi_mug_run_2_treatment "formalin"
16 Q0 26631873 27 73.50145 imi_mug_run_2_treatment "ptc"
16 Q0 30009773 28 73.4527 imi_mug_run_2_treatment "ptc"
16 Q0 27179656 29 73.13779 imi_mug_run_2_treatment "aim"
16 Q0 24382015 30 72.93485 imi_mug_run_2_treatment "calcitriol" "ptc" "vitamin d"
16 Q0 24679337 31 72.73265 imi_mug_run_2_treatment "thyroglobulin" "ptc" "level"
16 Q0 21249150 32 72.68344 imi_mug_run_2_treatment "ptc" "ras"
16 Q0 25623974 33 72.66412 imi_mug_run_2_treatment "ptc"
16 Q0 23837025 34 72.60263 imi_mug_run_2_treatment "ptc"
16 Q0 17542667 35 72.173386 imi_mug_run_2_treatment "ptc"
16 Q0 25337709 36 72.16235 imi_mug_run_2_treatment "ptc"
16 Q0 23163107 37 72.12542 imi_mug_run_2_treatment "mediated" "aim"
16 Q0 22997209 38 72.09796 imi_mug_run_2_treatment "ptc"
16 Q0 23725167 39 72.01359 imi_mug_run_2_treatment "ptc" "genesis"
16 Q0 22549934 40 71.92674 imi_mug_run_2_treatment "drug" "aim"
16 Q0 26795218 41 71.85971 imi_mug_run_2_treatment "ptc"
16 Q0 24354346 42 71.83931 imi_mug_run_2_treatment "ptc"
16 Q0 22524468 43 71.81563 imi_mug_run_2_treatment "ptc" "shape" "aim"
16 Q0 18310287 44 71.6004 imi_mug_run_2_treatment "ptc"
16 Q0 25266729 45 71.51047 imi_mug_run_2_treatment "ptc"
16 Q0 25013423 46 71.50476 imi_mug_run_2_treatment "thyroglobulin"
16 Q0 26448939 47 71.48735 imi_mug_run_2_treatment "ptc"
16 Q0 19534623 48 71.46403 imi_mug_run_2_treatment "ptc" "aim"
16 Q0 26823846 49 71.35457 imi_mug_run_2_treatment "ptc"
16 Q0 19574281 50 71.318985 imi_mug_run_2_treatment "ptc" "aim"
16 Q0 22592144 51 71.31606 imi_mug_run_2_treatment "ptc" "therapeutics"
16 Q0 26838744 52 71.31465 imi_mug_run_2_treatment "ptc"
16 Q0 23158172 53 71.112915 imi_mug_run_2_treatment "ptc"
16 Q0 29132392 54 71.08631 imi_mug_run_2_treatment "ptc"
16 Q0 27544995 55 70.901245 imi_mug_run_2_treatment "ptc" "radioactive iodine"
16 Q0 27064992 56 70.632675 imi_mug_run_2_treatment "ptc" "aim"
16 Q0 25468810 57 70.40006 imi_mug_run_2_treatment "ptc" "tma" "aim"
16 Q0 21221869 58 70.35084 imi_mug_run_2_treatment "thyroglobulin" "insulin-like growth factor ii"
16 Q0 29560564 59 70.35056 imi_mug_run_2_treatment "ptc"
16 Q0 23544999 60 70.345474 imi_mug_run_2_treatment "ptc" "kinase inhibitor"
16 Q0 29768105 61 70.15645 imi_mug_run_2_treatment "ptc" "aim"
16 Q0 22105775 62 70.107086 imi_mug_run_2_treatment "ptc"
16 Q0 19169486 63 70.01609 imi_mug_run_2_treatment "iodine" "ptc" "level"
16 Q0 20230995 64 70.013885 imi_mug_run_2_treatment "various" "ptc" "ras"
16 Q0 26191315 65 69.99539 imi_mug_run_2_treatment "leu"
16 Q0 25961545 66 69.96077 imi_mug_run_2_treatment "iodine" "ptc" "drugs"
16 Q0 20837233 67 69.93502 imi_mug_run_2_treatment "ptc"
16 Q0 23482591 68 69.88388 imi_mug_run_2_treatment "ptc"
16 Q0 21803329 69 69.733 imi_mug_run_2_treatment "ptc"
16 Q0 26454140 70 69.71243 imi_mug_run_2_treatment "prompt"
16 Q0 25755776 71 69.70085 imi_mug_run_2_treatment "ptc"
16 Q0 28329426 72 69.63008 imi_mug_run_2_treatment "ptc" "avid"
16 Q0 26780618 73 69.45684 imi_mug_run_2_treatment "thyroglobulin" "ptc" "radioactive iodine"
16 Q0 17363500 74 69.01306 imi_mug_run_2_treatment "ras" "raf kinase inhibitor"
16 Q0 17641411 75 68.97069 imi_mug_run_2_treatment "ptc"
16 Q0 17693984 76 68.94559 imi_mug_run_2_treatment "ptc" "ras" "aim"
16 Q0 22863493 77 68.72111 imi_mug_run_2_treatment "serine"
16 Q0 24604709 78 68.712364 imi_mug_run_2_treatment "ptc"
16 Q0 17006850 79 68.62585 imi_mug_run_2_treatment "ptc"
16 Q0 23931769 80 68.52727 imi_mug_run_2_treatment "ptc"
16 Q0 22170714 81 68.51373 imi_mug_run_2_treatment "ptc"
16 Q0 23370668 82 68.50254 imi_mug_run_2_treatment "ptc" "others"
16 Q0 24549591 83 68.432846 imi_mug_run_2_treatment "ptc" "eosin"
16 Q0 21875464 84 68.31946 imi_mug_run_2_treatment "ptc"
16 Q0 26020381 85 68.210724 imi_mug_run_2_treatment "ptc"
16 Q0 28342873 86 68.135704 imi_mug_run_2_treatment "ptc" "level"
16 Q0 21512141 87 68.11369 imi_mug_run_2_treatment "ptc"
16 Q0 24389984 88 68.0348 imi_mug_run_2_treatment "ptc" "ors"
16 Q0 26914762 89 67.87875 imi_mug_run_2_treatment "ptc"
16 Q0 17201587 90 67.75561 imi_mug_run_2_treatment "various" "ptc" "ras"
16 Q0 23970782 91 67.73126 imi_mug_run_2_treatment "ptc" "thyroglobulin"
16 Q0 19156774 92 67.63811 imi_mug_run_2_treatment "ptc"
16 Q0 30219154 93 67.34921 imi_mug_run_2_treatment "ptc"
16 Q0 21879273 94 67.29576 imi_mug_run_2_treatment "ptc"
16 Q0 23746767 95 67.240326 imi_mug_run_2_treatment "ptc"
16 Q0 24987354 96 67.15816 imi_mug_run_2_treatment "ptc" "vemurafenib" "radioactive iodine"
16 Q0 29199726 97 67.125916 imi_mug_run_2_treatment "ptc" "aim"
16 Q0 22858857 98 67.0438 imi_mug_run_2_treatment "ptc"
16 Q0 23179992 99 66.97594 imi_mug_run_2_treatment "ptc" "various"
16 Q0 26598713 100 66.89395 imi_mug_run_2_treatment "ptc"
16 Q0 17387744 101 66.88964 imi_mug_run_2_treatment "ftc" "ptc"
16 Q0 23806056 102 66.86717 imi_mug_run_2_treatment "ptc" "ras" "aim"
16 Q0 29271794 103 66.840996 imi_mug_run_2_treatment "braf inhibitor"
16 Q0 27863429 104 66.79688 imi_mug_run_2_treatment "ptc" "agent"
16 Q0 23109980 105 66.7809 imi_mug_run_2_treatment "ptc"
16 Q0 18283163 106 66.58888 imi_mug_run_2_treatment "ptc"
16 Q0 17727338 107 66.52344 imi_mug_run_2_treatment "ptc"
16 Q0 18682506 108 66.4854 imi_mug_run_2_treatment "ptc" "vascular endothelial growth factor"
16 Q0 17972530 109 66.475555 imi_mug_run_2_treatment "ptc"
16 Q0 26569424 110 66.343475 imi_mug_run_2_treatment "ras" "level"
16 Q0 25837167 111 66.22055 imi_mug_run_2_treatment "plasma" "ptc"
16 Q0 26125698 112 66.20187 imi_mug_run_2_treatment "ptc" "aim"
16 Q0 17186541 113 66.16775 imi_mug_run_2_treatment "ptc" "ras"
16 Q0 21937738 114 66.03548 imi_mug_run_2_treatment "ptc"
16 Q0 17298986 115 66.01352 imi_mug_run_2_treatment "ptc" "formalin"
16 Q0 26885200 116 65.75555 imi_mug_run_2_treatment "ptc"
16 Q0 29651624 117 65.75555 imi_mug_run_2_treatment "ptc"
16 Q0 29388401 118 65.73586 imi_mug_run_2_treatment "ptc" "aim"
16 Q0 27184112 119 65.7148 imi_mug_run_2_treatment "ptc"
16 Q0 28423545 120 65.692314 imi_mug_run_2_treatment "pdtc" "ptc" "ras"
16 Q0 24955518 121 65.52925 imi_mug_run_2_treatment "ptc" "enzymes" "immunosuppressive"
16 Q0 16299399 122 65.51437 imi_mug_run_2_treatment "ptc" "ras"
16 Q0 27460442 123 65.38942 imi_mug_run_2_treatment "vemurafenib" "radioactive iodine" "kinase inhibitor"
16 Q0 26230187 124 65.23224 imi_mug_run_2_treatment "ptc" "glutamic acid"
16 Q0 19475551 125 65.21334 imi_mug_run_2_treatment "ptc"
16 Q0 23625203 126 65.208824 imi_mug_run_2_treatment "ras" "aim"
16 Q0 24039206 127 65.201225 imi_mug_run_2_treatment "ptc"
16 Q0 22181337 128 65.1583 imi_mug_run_2_treatment "ptc"
16 Q0 23469793 129 65.14548 imi_mug_run_2_treatment "ptc"
16 Q0 24721322 130 65.09023 imi_mug_run_2_treatment "aim" "ptc" "radioactive iodine"
16 Q0 21707687 131 65.037506 imi_mug_run_2_treatment "shape"
16 Q0 29941398 132 65.02366 imi_mug_run_2_treatment "ptc"
16 Q0 22870129 133 64.98302 imi_mug_run_2_treatment "ptc"
16 Q0 26041461 134 64.79432 imi_mug_run_2_treatment "ptc"
16 Q0 29033690 135 64.792595 imi_mug_run_2_treatment "plx4032" "vemurafenib" "cytostatic"
16 Q0 22376167 136 64.72956 imi_mug_run_2_treatment "ptc" "lead"
16 Q0 24677749 137 64.6712 imi_mug_run_2_treatment "ptc"
16 Q0 18070147 138 64.65875 imi_mug_run_2_treatment "ras" "ptc"
16 Q0 23203004 139 64.56281 imi_mug_run_2_treatment "ptc"
16 Q0 23416953 140 64.51083 imi_mug_run_2_treatment "ptc" "lead"
16 Q0 20607744 141 64.22879 imi_mug_run_2_treatment "ptc"
16 Q0 24909403 142 64.183586 imi_mug_run_2_treatment "ptc" "level"
16 Q0 24570209 143 64.181984 imi_mug_run_2_treatment "ptc" "aim"
16 Q0 19355825 144 64.17081 imi_mug_run_2_treatment "various" "ptc" "aim"
16 Q0 27911099 145 64.12207 imi_mug_run_2_treatment "shape"
16 Q0 16601293 146 63.985073 imi_mug_run_2_treatment "ptc" "mediated"
16 Q0 24252159 147 63.96272 imi_mug_run_2_treatment "ptc" "product"
16 Q0 21862261 148 63.884216 imi_mug_run_2_treatment "various" "ptc"
16 Q0 15902486 149 63.817345 imi_mug_run_2_treatment "ptc"
16 Q0 20012784 150 63.713238 imi_mug_run_2_treatment "ptc" "ras"
16 Q0 23132790 151 63.659946 imi_mug_run_2_treatment "pdtc" "ptc"
16 Q0 22451557 152 63.65899 imi_mug_run_2_treatment "basis" "aim"
16 Q0 18426810 153 63.628075 imi_mug_run_2_treatment "ptc"
16 Q0 21653734 154 63.58784 imi_mug_run_2_treatment "drugs" "mediated" "pdgfb"
16 Q0 29451347 155 63.57654 imi_mug_run_2_treatment "thyroglobulin" "ptc"
16 Q0 17685465 156 63.454716 imi_mug_run_2_treatment "ptc"
16 Q0 25975689 157 63.45366 imi_mug_run_2_treatment "ptc"
16 Q0 24711431 158 63.45346 imi_mug_run_2_treatment "ptc" "lead" "pd0325901"
16 Q0 22691412 159 63.344887 imi_mug_run_2_treatment "ptc"
16 Q0 19626635 160 63.342262 imi_mug_run_2_treatment "ptc"
16 Q0 17374713 161 63.28427 imi_mug_run_2_treatment "ptc" "agar" "aim"
16 Q0 24071017 162 63.26504 imi_mug_run_2_treatment "various" "monoclonal antibodies" "others"
16 Q0 24503805 163 63.110996 imi_mug_run_2_treatment "sunitinib" "antiangiogenic" "sunitinib 50 mg"
16 Q0 14508525 164 63.095383 imi_mug_run_2_treatment "ras"
16 Q0 17785355 165 63.067818 imi_mug_run_2_treatment "ptc"
16 Q0 17956956 166 62.98919 imi_mug_run_2_treatment "ncs" "ras" "ptc"
16 Q0 22993650 167 62.95121 imi_mug_run_2_treatment "ptc"
16 Q0 25957797 168 62.929688 imi_mug_run_2_treatment "ptc" "aim"
16 Q0 22190222 169 62.87606 imi_mug_run_2_treatment "ptc" "aim"
16 Q0 26733165 170 62.792328 imi_mug_run_2_treatment "ptc" "aim"
16 Q0 28808756 171 62.77626 imi_mug_run_2_treatment "ptc" "deoxyglucose" "level"
16 Q0 22649416 172 62.77303 imi_mug_run_2_treatment "ptc" "sorafenib" "vemurafenib"
16 Q0 22535974 173 62.71067 imi_mug_run_2_treatment "ptc"
16 Q0 22508706 174 62.6983 imi_mug_run_2_treatment "terminator" "ptc"
16 Q0 26693224 175 62.608696 imi_mug_run_2_treatment "aim"
16 Q0 25870252 176 62.596176 imi_mug_run_2_treatment "ptc"
16 Q0 23788690 177 62.51987 imi_mug_run_2_treatment "ptc" "plasma" "basis"
16 Q0 25262966 178 62.485687 imi_mug_run_2_treatment "aim"
16 Q0 21239517 179 62.461014 imi_mug_run_2_treatment "ptc"
16 Q0 25482468 180 62.45459 imi_mug_run_2_treatment "ptc"
16 Q0 27138882 181 62.44837 imi_mug_run_2_treatment "ptc" "radioactive iodine"
16 Q0 28687736 182 62.426544 imi_mug_run_2_treatment "ptc"
16 Q0 20854070 183 62.417374 imi_mug_run_2_treatment "ptc"
16 Q0 21136722 184 62.39095 imi_mug_run_2_treatment "enzymes" "ptc" "ras"
16 Q0 21725210 185 62.36558 imi_mug_run_2_treatment "sunitinib" "ptc" "tyrosine kinase inhibitor"
16 Q0 25489262 186 62.34479 imi_mug_run_2_treatment "ptc"
16 Q0 19903742 187 62.270508 imi_mug_run_2_treatment "ras" "ptc" "level"
16 Q0 23489023 188 62.265022 imi_mug_run_2_treatment "vemurafenib" "ptc" "duration"
16 Q0 26501867 189 62.248783 imi_mug_run_2_treatment "ptc" "il-12" "interleukin-12"
16 Q0 30254191 190 62.23582 imi_mug_run_2_treatment "mediators" "il-6" "ptc"
16 Q0 22887810 191 62.221127 imi_mug_run_2_treatment "ptc"
16 Q0 16606457 192 62.202553 imi_mug_run_2_treatment "ptc"
16 Q0 22426956 193 62.155678 imi_mug_run_2_treatment "ptc" "lead"
16 Q0 16013975 194 62.14521 imi_mug_run_2_treatment "ras"
16 Q0 17721188 195 62.13108 imi_mug_run_2_treatment "bso" "ras" "ptc"
16 Q0 17199737 196 62.112957 imi_mug_run_2_treatment "ptc"
16 Q0 18676742 197 61.866085 imi_mug_run_2_treatment "ptc"
16 Q0 26384552 198 61.770096 imi_mug_run_2_treatment "bht" "suppressor"
16 Q0 29144823 199 61.749413 imi_mug_run_2_treatment "ptc" "dtc" "ci 4"
16 Q0 25014730 200 61.708035 imi_mug_run_2_treatment "glutamic acid"
16 Q0 25012490 201 61.675972 imi_mug_run_2_treatment "ptc"
16 Q0 16918957 202 61.64585 imi_mug_run_2_treatment "ptc" "aim"
16 Q0 22156467 203 61.63083 imi_mug_run_2_treatment "ptc"
16 Q0 27581851 204 61.61491 imi_mug_run_2_treatment "duet" "ptc"
16 Q0 19207009 205 61.57625 imi_mug_run_2_treatment "thyrotropin" "prohibitin" "phb"
16 Q0 21948220 206 61.504013 imi_mug_run_2_treatment "ptc"
16 Q0 25285888 207 61.391464 imi_mug_run_2_treatment "dabrafenib" "braf inhibitor" "amylase"
16 Q0 29566452 208 61.35785 imi_mug_run_2_treatment "ptc" "plasma"
16 Q0 24745617 209 61.33947 imi_mug_run_2_treatment "ptc" "formalin"
16 Q0 29566402 210 61.328102 imi_mug_run_2_treatment "ptc" "aim"
16 Q0 19370505 211 61.295788 imi_mug_run_2_treatment "ptc" "aim"
16 Q0 24798740 212 61.293262 imi_mug_run_2_treatment "ras" "ptc" "mitogen"
16 Q0 27127178 213 61.28352 imi_mug_run_2_treatment "vemurafenib" "ptc" "combinations"
16 Q0 25194426 214 61.277397 imi_mug_run_2_treatment "aim"
16 Q0 22358007 215 61.23156 imi_mug_run_2_treatment "combinations" "shape" "ptc"
16 Q0 25085839 216 61.205215 imi_mug_run_2_treatment "plasminogen activator" "ptc" "u0126"
16 Q0 18383861 217 61.187763 imi_mug_run_2_treatment "ptc" "ras" "aim"
16 Q0 26622769 218 61.17479 imi_mug_run_2_treatment "ptc" "aim"
16 Q0 25213729 219 61.17099 imi_mug_run_2_treatment "ptc"
16 Q0 28314770 220 61.06852 imi_mug_run_2_treatment "ptc" "aim"
16 Q0 29158933 221 61.051468 imi_mug_run_2_treatment "ptc" "carboplatin" "paclitaxel"
16 Q0 25549723 222 61.043884 imi_mug_run_2_treatment "iodine" "dabrafenib" "ptc"
16 Q0 22998776 223 61.00223 imi_mug_run_2_treatment "thyroid stimulating hormone" "radioactive iodine"
16 Q0 18697864 224 60.967327 imi_mug_run_2_treatment "ptc"
16 Q0 24770869 225 60.92782 imi_mug_run_2_treatment "various" "ptc" "lead"
16 Q0 23469895 226 60.92372 imi_mug_run_2_treatment "ptc"
16 Q0 30294355 227 60.919224 imi_mug_run_2_treatment "ptc"
16 Q0 26477313 228 60.790176 imi_mug_run_2_treatment "ptc" "ly294002" "balance"
16 Q0 21498916 229 60.7317 imi_mug_run_2_treatment "ptc" "ras" "aim"
16 Q0 22752848 230 60.724365 imi_mug_run_2_treatment "ptc" "sorafenib" "braf inhibitor"
16 Q0 17714762 231 60.711586 imi_mug_run_2_treatment "various"
16 Q0 24297791 232 60.687218 imi_mug_run_2_treatment "tumor infiltrating lymphocytes" "hla-g"
16 Q0 22488961 233 60.59884 imi_mug_run_2_treatment "ptc"
16 Q0 23571588 234 60.551804 imi_mug_run_2_treatment "ptc"
16 Q0 24780046 235 60.542004 imi_mug_run_2_treatment "ptc"
16 Q0 22136270 236 60.538822 imi_mug_run_2_treatment "ptc" "ftc"
16 Q0 26960768 237 60.502758 imi_mug_run_2_treatment "aim"
16 Q0 16772349 238 60.481216 imi_mug_run_2_treatment "ptc" "vascular endothelial growth factor" "level"
16 Q0 26438153 239 60.476147 imi_mug_run_2_treatment "ptc" "mouse monoclonal antibody"
16 Q0 26871894 240 60.297546 imi_mug_run_2_treatment "ptc" "ors"
16 Q0 25332244 241 60.23454 imi_mug_run_2_treatment "various" "ptc"
16 Q0 23533235 242 60.229614 imi_mug_run_2_treatment "ptc"
16 Q0 26148673 243 60.221096 imi_mug_run_2_treatment "ptc"
16 Q0 28718951 244 60.183884 imi_mug_run_2_treatment "ptc" "aim"
16 Q0 18337114 245 60.11402 imi_mug_run_2_treatment "serine"
16 Q0 22500044 246 60.111572 imi_mug_run_2_treatment "ptc"
16 Q0 30396219 247 60.068863 imi_mug_run_2_treatment "ptc" "thyroglobulin" "retinoic acid"
16 Q0 27904709 248 60.055695 imi_mug_run_2_treatment "ptc"
16 Q0 27543599 249 59.97465 imi_mug_run_2_treatment "ptc" "various"
16 Q0 29240540 250 59.951946 imi_mug_run_2_treatment "ptc"
16 Q0 30070937 251 59.951946 imi_mug_run_2_treatment "ptc"
16 Q0 22732794 252 59.918587 imi_mug_run_2_treatment "aim" "ptc" "various"
16 Q0 29927436 253 59.901146 imi_mug_run_2_treatment "various" "ptc" "eosin"
16 Q0 30361900 254 59.845493 imi_mug_run_2_treatment "ptc"
16 Q0 21358618 255 59.827328 imi_mug_run_2_treatment "estrogen" "others"
16 Q0 17317846 256 59.79814 imi_mug_run_2_treatment "ptc" "u0126" "mek inhibitor"
16 Q0 27101676 257 59.779526 imi_mug_run_2_treatment "prophylactic" "ptc"
16 Q0 25648502 258 59.772724 imi_mug_run_2_treatment "ras"
16 Q0 25312294 259 59.732426 imi_mug_run_2_treatment "ptc" "aim"
16 Q0 19880792 260 59.705723 imi_mug_run_2_treatment "plx4032" "adenosine triphosphate" "cytostatic"
16 Q0 14743508 261 59.70288 imi_mug_run_2_treatment "ptc"
16 Q0 27571181 262 59.61217 imi_mug_run_2_treatment "ptc" "aim"
16 Q0 21730105 263 59.58361 imi_mug_run_2_treatment "ptc" "aim"
16 Q0 15126572 264 59.545677 imi_mug_run_2_treatment "aim"
16 Q0 23924149 265 59.493305 imi_mug_run_2_treatment "thyrotropin"
16 Q0 19147753 266 59.465515 imi_mug_run_2_treatment "ptc" "ras" "others"
16 Q0 24626334 267 59.46306 imi_mug_run_2_treatment "ptc"
16 Q0 22451620 268 59.45853 imi_mug_run_2_treatment "agent" "radioactive iodine"
16 Q0 26636651 269 59.44202 imi_mug_run_2_treatment "vemurafenib" "ptc" "mcl1 inhibitor"
16 Q0 16452550 270 59.416115 imi_mug_run_2_treatment "ptc"
16 Q0 20631031 271 59.407776 imi_mug_run_2_treatment "ptc"
16 Q0 25937618 272 59.33837 imi_mug_run_2_treatment "ptc"
16 Q0 24417277 273 59.297935 imi_mug_run_2_treatment "ptc" "level" "aim"
16 Q0 23946802 274 59.211433 imi_mug_run_2_treatment "ptc"
16 Q0 27143921 275 59.12314 imi_mug_run_2_treatment "ptc" "level"
16 Q0 21900390 276 59.08101 imi_mug_run_2_treatment "iodine" "sorafenib" "ptc"
16 Q0 12907632 277 59.038673 imi_mug_run_2_treatment "ras" "ptc"
16 Q0 19504446 278 58.970444 imi_mug_run_2_treatment "ptc"
16 Q0 30148098 279 58.909782 imi_mug_run_2_treatment "ptc" "ras" "isolate"
16 Q0 29179638 280 58.78541 imi_mug_run_2_treatment "ptc" "ras" "radioactive iodine"
16 Q0 18462259 281 58.776955 imi_mug_run_2_treatment "basis"
16 Q0 26892809 282 58.715046 imi_mug_run_2_treatment "ptc" "ftc" "vemurafenib"
16 Q0 17824790 283 58.653133 imi_mug_run_2_treatment "ptc"
16 Q0 26273300 284 58.605865 imi_mug_run_2_treatment "ptc"
16 Q0 16647954 285 58.552452 imi_mug_run_2_treatment "ptc"
16 Q0 15356020 286 58.54117 imi_mug_run_2_treatment "ptc"
16 Q0 28459034 287 58.409687 imi_mug_run_2_treatment "ptc"
16 Q0 20640859 288 58.408943 imi_mug_run_2_treatment "ptc"
16 Q0 23594689 289 58.3704 imi_mug_run_2_treatment "various"
16 Q0 27318915 290 58.347847 imi_mug_run_2_treatment "ptc" "prophylactic"
16 Q0 27865374 291 58.344177 imi_mug_run_2_treatment "ptc" "radioactive iodine" "basis"
16 Q0 22105174 292 58.339725 imi_mug_run_2_treatment "mapk inhibitors"
16 Q0 19493635 293 58.271046 imi_mug_run_2_treatment "ptc"
16 Q0 20526288 294 58.23647 imi_mug_run_2_treatment "ras"
16 Q0 28467685 295 58.2059 imi_mug_run_2_treatment "ptc" "methylene blue" "respiratory system"
16 Q0 26240026 296 58.156574 imi_mug_run_2_treatment "ptc" "icc"
16 Q0 16021577 297 58.07026 imi_mug_run_2_treatment "ptc" "lysine"
16 Q0 27146414 298 58.055115 imi_mug_run_2_treatment "ptc"
16 Q0 23775351 299 58.01036 imi_mug_run_2_treatment "lead"
16 Q0 21220306 300 58.002903 imi_mug_run_2_treatment "mediated" "mek inhibitor"
16 Q0 26584635 301 58.001503 imi_mug_run_2_treatment "program"
16 Q0 24295207 302 57.988716 imi_mug_run_2_treatment "combinations" "therapeutics" "ptc"
16 Q0 24588959 303 57.984932 imi_mug_run_2_treatment "ptc" "level" "calca"
16 Q0 21134544 304 57.954132 imi_mug_run_2_treatment "ptc" "radioactive iodine"
16 Q0 23066120 305 57.863037 imi_mug_run_2_treatment "ptc" "level" "aim"
16 Q0 22362717 306 57.83984 imi_mug_run_2_treatment "ptc" "liver"
16 Q0 27713418 307 57.775578 imi_mug_run_2_treatment "various" "ptc" "radioactive iodine"
16 Q0 27145091 308 57.653862 imi_mug_run_2_treatment "ptc"
16 Q0 22941165 309 57.63099 imi_mug_run_2_treatment "ptc"
16 Q0 22335197 310 57.597652 imi_mug_run_2_treatment "ptc"
16 Q0 23931930 311 57.448395 imi_mug_run_2_treatment "iodine" "ptc" "aim"
16 Q0 24858900 312 57.429897 imi_mug_run_2_treatment "calcitonin" "plasma" "ptc"
16 Q0 19066305 313 57.38269 imi_mug_run_2_treatment "ptc"
16 Q0 26513490 314 57.34329 imi_mug_run_2_treatment "ptc" "glucose"
16 Q0 24052184 315 57.22062 imi_mug_run_2_treatment "ptc"
16 Q0 20652698 316 57.197353 imi_mug_run_2_treatment "ptc" "ftc"
16 Q0 26223933 317 57.142647 imi_mug_run_2_treatment "ptc"
16 Q0 28423638 318 56.912052 imi_mug_run_2_treatment "iodine" "mek inhibitor" "glucose"
16 Q0 22823995 319 56.909492 imi_mug_run_2_treatment "ptc" "mediated" "sb203580"
16 Q0 28552827 320 56.89437 imi_mug_run_2_treatment "ptc"
16 Q0 24748129 321 56.87767 imi_mug_run_2_treatment "ptc" "aim"
16 Q0 24267957 322 56.872757 imi_mug_run_2_treatment "ptc" "aim"
16 Q0 29611028 323 56.869568 imi_mug_run_2_treatment "ptc"
16 Q0 24217901 324 56.835403 imi_mug_run_2_treatment "ptc" "adjuvant" "ras"
16 Q0 18058267 325 56.824337 imi_mug_run_2_treatment "ptc"
16 Q0 24417340 326 56.762623 imi_mug_run_2_treatment "ptc"
16 Q0 23323158 327 56.708786 imi_mug_run_2_treatment "pas"
16 Q0 27071483 328 56.67996 imi_mug_run_2_treatment "ptc"
16 Q0 25879531 329 56.60256 imi_mug_run_2_treatment "kinase inhibitor" "various" "sorafenib"
16 Q0 23253715 330 56.58407 imi_mug_run_2_treatment "ptc"
16 Q0 23528368 331 56.58407 imi_mug_run_2_treatment "various" "ptc"
16 Q0 21526955 332 56.54799 imi_mug_run_2_treatment "ras"
16 Q0 23893334 333 56.54398 imi_mug_run_2_treatment "ptc" "mediated"
16 Q0 18235983 334 56.521317 imi_mug_run_2_treatment "ptc" "ftc"
16 Q0 27866718 335 56.492226 imi_mug_run_2_treatment "ras" "radioactive iodine"
16 Q0 29484992 336 56.383476 imi_mug_run_2_treatment "ptc" "plasma"
16 Q0 17054470 337 56.335464 imi_mug_run_2_treatment "ptc" "ftc" "aim"
16 Q0 26676331 338 56.266964 imi_mug_run_2_treatment "ptc"
16 Q0 23580256 339 56.253384 imi_mug_run_2_treatment "ptc" "tcvs"
16 Q0 26362194 340 56.21397 imi_mug_run_2_treatment "pcso"
16 Q0 26910217 341 56.1987 imi_mug_run_2_treatment "ras" "ptc"
16 Q0 25577570 342 56.166702 imi_mug_run_2_treatment "ras" "aim"
16 Q0 29541194 343 56.083447 imi_mug_run_2_treatment "ptc" "aim"
16 Q0 24893893 344 56.074818 imi_mug_run_2_treatment "thyroglobulin"
16 Q0 29099711 345 56.045208 imi_mug_run_2_treatment "ptc" "aim"
16 Q0 28281551 346 56.034447 imi_mug_run_2_treatment "ras"
16 Q0 29582677 347 56.030922 imi_mug_run_2_treatment "ras" "ptc"
16 Q0 23482475 348 55.89367 imi_mug_run_2_treatment "ptc"
16 Q0 26422023 349 55.85229 imi_mug_run_2_treatment "various" "ptc"
16 Q0 20459574 350 55.79945 imi_mug_run_2_treatment "ptc"
16 Q0 17199440 351 55.73212 imi_mug_run_2_treatment "combinations" "thyroglobulin" "drugs"
16 Q0 25076938 352 55.723064 imi_mug_run_2_treatment "celastrol"
16 Q0 23055546 353 55.719223 imi_mug_run_2_treatment "ptc"
16 Q0 26625260 354 55.718113 imi_mug_run_2_treatment "ptc" "ras"
16 Q0 17488796 355 55.696915 imi_mug_run_2_treatment "iodine" "thyroglobulin" "sodium"
16 Q0 25156883 356 55.69255 imi_mug_run_2_treatment "ptc" "basis" "shape"
16 Q0 26521063 357 55.66181 imi_mug_run_2_treatment "ptc" "aim"
16 Q0 29396809 358 55.65986 imi_mug_run_2_treatment "ras" "aim"
16 Q0 26296380 359 55.650757 imi_mug_run_2_treatment "aim"
16 Q0 23818056 360 55.648613 imi_mug_run_2_treatment "sorafenib" "nexavar"
16 Q0 21903858 361 55.53746 imi_mug_run_2_treatment "ptc" "tissue inhibitor of metalloproteinases" "sorafenib"
16 Q0 23235345 362 55.520454 imi_mug_run_2_treatment "nervous system"
16 Q0 25583906 363 55.504753 imi_mug_run_2_treatment "aim"
16 Q0 25325273 364 55.443176 imi_mug_run_2_treatment "various" "ptc"
16 Q0 26943032 365 55.423386 imi_mug_run_2_treatment "ptc"
16 Q0 12970315 366 55.405605 imi_mug_run_2_treatment "kinase inhibitor" "u0126" "hot spot"
16 Q0 23966419 367 55.36853 imi_mug_run_2_treatment "ptc" "ras"
16 Q0 26080065 368 55.344677 imi_mug_run_2_treatment "ptc"
16 Q0 23717622 369 55.268574 imi_mug_run_2_treatment "aim"
16 Q0 23998804 370 55.133186 imi_mug_run_2_treatment "iodine" "mediated" "sodium iodide"
16 Q0 26751190 371 55.040054 imi_mug_run_2_treatment "saha" "sodium" "plx4032"
16 Q0 26456083 372 55.029373 imi_mug_run_2_treatment "plx4032" "braf inhibitor" "mediated"
16 Q0 26338373 373 55.020523 imi_mug_run_2_treatment "ptc" "iodine" "radioactive iodine"
16 Q0 22515292 374 54.990273 imi_mug_run_2_treatment "ptc" "aim"
16 Q0 16181547 375 54.961414 imi_mug_run_2_treatment "ptc"
16 Q0 30226444 376 54.924557 imi_mug_run_2_treatment "ras" "various" "level"
16 Q0 28293988 377 54.92135 imi_mug_run_2_treatment "ras" "ptc"
16 Q0 28507274 378 54.823025 imi_mug_run_2_treatment "ptc"
16 Q0 24879726 379 54.822746 imi_mug_run_2_treatment "ptc" "parathyroid hormone" "parathyroid"
16 Q0 26649796 380 54.768738 imi_mug_run_2_treatment "ftc" "ptc" "ras"
16 Q0 19738460 381 54.766777 imi_mug_run_2_treatment "terminator"
16 Q0 24094449 382 54.765472 imi_mug_run_2_treatment "ptc" "level"
16 Q0 21479404 383 54.752354 imi_mug_run_2_treatment "mediated" "cyclic amp"
16 Q0 15515191 384 54.747448 imi_mug_run_2_treatment "ptc" "aim"
16 Q0 25543402 385 54.74019 imi_mug_run_2_treatment "ptc" "ftc"
16 Q0 24417615 386 54.61486 imi_mug_run_2_treatment "ptc"
16 Q0 19724843 387 54.564117 imi_mug_run_2_treatment "ptc"
16 Q0 24255086 388 54.524887 imi_mug_run_2_treatment "ptc"
16 Q0 19415957 389 54.46429 imi_mug_run_2_treatment "others"
16 Q0 28680105 390 54.428387 imi_mug_run_2_treatment "ptc"
16 Q0 26885238 391 54.42526 imi_mug_run_2_treatment "prophylactic"
16 Q0 16551863 392 54.423744 imi_mug_run_2_treatment "ras" "growth inhibitors"
16 Q0 20518413 393 54.406796 imi_mug_run_2_treatment "ptc"
16 Q0 26279992 394 54.39443 imi_mug_run_2_treatment "aim"
16 Q0 21049459 395 54.33303 imi_mug_run_2_treatment "ptc" "dtc"
16 Q0 23657056 396 54.324986 imi_mug_run_2_treatment "thyrotropin" "methimazole"
16 Q0 24787545 397 54.31765 imi_mug_run_2_treatment "ptc" "basis" "aim"
16 Q0 25083484 398 54.304947 imi_mug_run_2_treatment "ptc" "prophylactic"
16 Q0 25024077 399 54.27623 imi_mug_run_2_treatment "ptc"
16 Q0 17878251 400 54.24995 imi_mug_run_2_treatment "azd6244" "cytostatic" "drug"
16 Q0 24947099 401 54.22612 imi_mug_run_2_treatment "formalin" "aim"
16 Q0 22319199 402 54.196854 imi_mug_run_2_treatment "cep-32496" "braf inhibitor" "sorafenib"
16 Q0 24030686 403 54.160202 imi_mug_run_2_treatment "ptc"
16 Q0 29723601 404 54.148975 imi_mug_run_2_treatment "ras"
16 Q0 23000762 405 54.145073 imi_mug_run_2_treatment "ras"
16 Q0 24124924 406 54.128365 imi_mug_run_2_treatment "ptc" "mediated"
16 Q0 25616949 407 54.09423 imi_mug_run_2_treatment "shape"
16 Q0 17044028 408 54.089172 imi_mug_run_2_treatment "ptc"
16 Q0 17638058 409 54.066753 imi_mug_run_2_treatment "ptc" "ras" "ftc"
16 Q0 29391807 410 54.066586 imi_mug_run_2_treatment "ptc"
16 Q0 25019383 411 54.066273 imi_mug_run_2_treatment "dtc" "ras" "igf-1"
16 Q0 19898969 412 54.01159 imi_mug_run_2_treatment "ras"
16 Q0 27447554 413 54.00293 imi_mug_run_2_treatment "ptc"
16 Q0 26885073 414 53.97144 imi_mug_run_2_treatment "ptc"
16 Q0 21447745 415 53.910103 imi_mug_run_2_treatment "ptc" "therapeutics" "plx4032"
16 Q0 25916409 416 53.863678 imi_mug_run_2_treatment "ptc" "aim"
16 Q0 23585181 417 53.803604 imi_mug_run_2_treatment "ptc" "aim"
16 Q0 21568726 418 53.79962 imi_mug_run_2_treatment "ptc" "lavage fluids"
16 Q0 27621653 419 53.745384 imi_mug_run_2_treatment "dabrafenib" "braf inhibitor"
16 Q0 20647301 420 53.723343 imi_mug_run_2_treatment "glucose" "aim" "ptc"
16 Q0 24243688 421 53.72 imi_mug_run_2_treatment "saha" "lysine" "plx4032"
16 Q0 23435375 422 53.713135 imi_mug_run_2_treatment "mediated" "u0126" "mek inhibitor"
16 Q0 18226854 423 53.661407 imi_mug_run_2_treatment "ptc" "ras"
16 Q0 25520863 424 53.65422 imi_mug_run_2_treatment "ptc" "aim"
16 Q0 24897065 425 53.65087 imi_mug_run_2_treatment "monoclonal antibodies"
16 Q0 24301760 426 53.609573 imi_mug_run_2_treatment "ptc"
16 Q0 24783006 427 53.60726 imi_mug_run_2_treatment "ptc"
16 Q0 27875244 428 53.53828 imi_mug_run_2_treatment "ras" "duet" "ptc"
16 Q0 18628356 429 53.49098 imi_mug_run_2_treatment "ptc"
16 Q0 21882184 430 53.489967 imi_mug_run_2_treatment "ors" "ptc" "lead"
16 Q0 24989827 431 53.428493 imi_mug_run_2_treatment "ptc"
16 Q0 25771987 432 53.410557 imi_mug_run_2_treatment "ras"
16 Q0 16434896 433 53.407356 imi_mug_run_2_treatment "ras"
16 Q0 19878585 434 53.389854 imi_mug_run_2_treatment "sorafenib" "kinase inhibitor" "brdu"
16 Q0 16708643 435 53.387196 imi_mug_run_2_treatment "various" "ras" "glutamic acid"
16 Q0 21147872 436 53.33448 imi_mug_run_2_treatment "adjuvant"
16 Q0 21716161 437 53.328697 imi_mug_run_2_treatment "ptc" "aim"
16 Q0 17464312 438 53.318245 imi_mug_run_2_treatment "ptc" "ras"
16 Q0 26572991 439 53.309135 imi_mug_run_2_treatment "ptc" "aim"
16 Q0 20042852 440 53.22604 imi_mug_run_2_treatment "medicine" "others"
16 Q0 22702340 441 53.199234 imi_mug_run_2_treatment "urokinase plasminogen activator" "urokinase" "ptc"
16 Q0 26014474 442 53.15023 imi_mug_run_2_treatment "level"
16 Q0 23343222 443 53.11147 imi_mug_run_2_treatment "ptc" "color"
16 Q0 29435002 444 53.10769 imi_mug_run_2_treatment "ras" "ptc"
16 Q0 16189702 445 53.04776 imi_mug_run_2_treatment "enzymes" "ras"
16 Q0 23534744 446 53.038475 imi_mug_run_2_treatment "ptc" "aim"
16 Q0 27387551 447 53.024815 imi_mug_run_2_treatment "dtc" "ptc" "hot spot"
16 Q0 28974264 448 53.019974 imi_mug_run_2_treatment "ptc" "blockade"
16 Q0 15880523 449 53.017216 imi_mug_run_2_treatment "ptc" "tcc" "serine"
16 Q0 22431868 450 53.00846 imi_mug_run_2_treatment "ras"
16 Q0 22118425 451 53.004887 imi_mug_run_2_treatment "ptc"
16 Q0 24362526 452 52.983948 imi_mug_run_2_treatment "drugs"
16 Q0 15095090 453 52.977226 imi_mug_run_2_treatment "ptc"
16 Q0 25317411 454 52.96236 imi_mug_run_2_treatment "ptc" "radioactive iodine" "aim"
16 Q0 24548081 455 52.90011 imi_mug_run_2_treatment "ptc" "aim"
16 Q0 25712893 456 52.85447 imi_mug_run_2_treatment "ptc"
16 Q0 16784981 457 52.80589 imi_mug_run_2_treatment "ptc" "ras"
16 Q0 30449496 458 52.760696 imi_mug_run_2_treatment "ptc" "ras" "ftc"
16 Q0 17355635 459 52.756325 imi_mug_run_2_treatment "ptc" "various" "aim"
16 Q0 15859312 460 52.697792 imi_mug_run_2_treatment "ptc"
16 Q0 26231782 461 52.538353 imi_mug_run_2_treatment "ptc"
16 Q0 22770943 462 52.50527 imi_mug_run_2_treatment "ptc"
16 Q0 16219715 463 52.42787 imi_mug_run_2_treatment "ras" "fta" "ftc"
16 Q0 24777145 464 52.387062 imi_mug_run_2_treatment "ptc"
16 Q0 26889698 465 52.29152 imi_mug_run_2_treatment "iodine" "ptc" "aim"
16 Q0 16143028 466 52.2268 imi_mug_run_2_treatment "ptc"
16 Q0 29368294 467 52.219807 imi_mug_run_2_treatment "ptc" "lead"
16 Q0 27656301 468 52.19303 imi_mug_run_2_treatment "ptc" "posterior pituitary"
16 Q0 15456136 469 52.041824 imi_mug_run_2_treatment "ptc"
16 Q0 26961557 470 52.0283 imi_mug_run_2_treatment "ptc" "thyroglobulin"
16 Q0 24848709 471 52.028194 imi_mug_run_2_treatment "ptc" "various"
16 Q0 23729178 472 51.986084 imi_mug_run_2_treatment "dasatinib" "ptc" "su6656"
16 Q0 17520704 473 51.926956 imi_mug_run_2_treatment "ptc"
16 Q0 24402044 474 51.899887 imi_mug_run_2_treatment "ptc" "prophylactic"
16 Q0 28425764 475 51.88947 imi_mug_run_2_treatment "dabrafenib" "trametinib 2 mg"
16 Q0 22930785 476 51.865025 imi_mug_run_2_treatment "various" "prophylactic" "ptc"
16 Q0 27037835 477 51.8238 imi_mug_run_2_treatment "ptc" "color" "aim"
16 Q0 23607002 478 51.807938 imi_mug_run_2_treatment "ptc" "radioactive iodine" "sorafenib"
16 Q0 26818109 479 51.76265 imi_mug_run_2_treatment "ptc" "pdtc" "collagen"
16 Q0 19958951 480 51.729362 imi_mug_run_2_treatment "ptc"
16 Q0 20186005 481 51.720833 imi_mug_run_2_treatment "ptc" "ras" "lead"
16 Q0 27843810 482 51.70649 imi_mug_run_2_treatment "ptc" "aim"
16 Q0 24559275 483 51.695934 imi_mug_run_2_treatment "ptc" "basis"
16 Q0 24247620 484 51.65142 imi_mug_run_2_treatment "ptc"
16 Q0 29165667 485 51.610073 imi_mug_run_2_treatment "ptc"
16 Q0 27936049 486 51.51624 imi_mug_run_2_treatment "ptc" "alpha subunit" "vascular endothelial growth factor"
16 Q0 21274720 487 51.48003 imi_mug_run_2_treatment "various"
16 Q0 28358874 488 51.473923 imi_mug_run_2_treatment "various" "ptc"
16 Q0 26268700 489 51.448784 imi_mug_run_2_treatment "prophylactic" "ptc"
16 Q0 28521635 490 51.437393 imi_mug_run_2_treatment "ptc" "aim"
16 Q0 22745248 491 51.432686 imi_mug_run_2_treatment "ptc" "aim"
16 Q0 26320103 492 51.425346 imi_mug_run_2_treatment "ptc" "ras"
16 Q0 16487015 493 51.40557 imi_mug_run_2_treatment "others"
16 Q0 23845288 494 51.38835 imi_mug_run_2_treatment "various" "ptc"
16 Q0 26957611 495 51.377365 imi_mug_run_2_treatment "braf inhibitor"
16 Q0 20824810 496 51.372437 imi_mug_run_2_treatment "radioactive iodine"
16 Q0 23323230 497 51.31956 imi_mug_run_2_treatment "ptc" "level"
16 Q0 21594703 498 51.298244 imi_mug_run_2_treatment "ptc"
16 Q0 26950846 499 51.26472 imi_mug_run_2_treatment "ptc" "prophylactic"
16 Q0 18437172 500 51.26097 imi_mug_run_2_treatment "ptc" "ras"
16 Q0 28004221 501 51.2589 imi_mug_run_2_treatment "oxygen" "radioactive iodine"
16 Q0 26189429 502 51.21699 imi_mug_run_2_treatment "vemurafenib"
16 Q0 24375266 503 51.216152 imi_mug_run_2_treatment "iodine"
16 Q0 25911848 504 51.210155 imi_mug_run_2_treatment "hot spot" "ras" "formalin"
16 Q0 22563563 505 51.201847 imi_mug_run_2_treatment "ptc" "glutamic acid"
16 Q0 17195637 506 51.18113 imi_mug_run_2_treatment "ptc"
16 Q0 16555627 507 51.16478 imi_mug_run_2_treatment "ras" "drugs" "lead"
16 Q0 23987486 508 51.09995 imi_mug_run_2_treatment "ptc" "radioactive iodine"
16 Q0 30187175 509 51.07321 imi_mug_run_2_treatment "tca" "lead"
16 Q0 23200790 510 51.06313 imi_mug_run_2_treatment "thyroglobulin" "lead"
16 Q0 25427145 511 51.06266 imi_mug_run_2_treatment "ptc"
16 Q0 19534622 512 51.03001 imi_mug_run_2_treatment "estrogen" "thyroglobulin"
16 Q0 30265861 513 51.017307 imi_mug_run_2_treatment "ptc" "ras"
16 Q0 26498373 514 50.996754 imi_mug_run_2_treatment "trametinib" "dabrafenib"
16 Q0 24337906 515 50.970646 imi_mug_run_2_treatment "ptc"
16 Q0 28049366 516 50.962513 imi_mug_run_2_treatment "ptc" "ras" "aim"
16 Q0 20187782 517 50.946705 imi_mug_run_2_treatment "shape"
16 Q0 26941858 518 50.89316 imi_mug_run_2_treatment "ptc" "avid" "deoxyglucose"
16 Q0 21190444 519 50.818794 imi_mug_run_2_treatment "basis"
16 Q0 29868127 520 50.803604 imi_mug_run_2_treatment "timp3 protein" "level" "ptc"
16 Q0 28181854 521 50.78311 imi_mug_run_2_treatment "ptc" "duet" "aim"
16 Q0 27264674 522 50.773308 imi_mug_run_2_treatment "ras" "ptc" "iodine"
16 Q0 25755913 523 50.701107 imi_mug_run_2_treatment "ptc"
16 Q0 24639117 524 50.66555 imi_mug_run_2_treatment "ptc" "glutamic acid"
16 Q0 25882744 525 50.634598 imi_mug_run_2_treatment "ptc"
16 Q0 15781663 526 50.60877 imi_mug_run_2_treatment "thyrotropin" "ptc" "cyclic amp"
16 Q0 20025539 527 50.59458 imi_mug_run_2_treatment "ptc"
16 Q0 23857250 528 50.49676 imi_mug_run_2_treatment "ptc" "mediated" "raf kinase inhibitor"
16 Q0 22535643 529 50.451942 imi_mug_run_2_treatment "ptc" "level"
16 Q0 25784606 530 50.431152 imi_mug_run_2_treatment "various" "ptc"
16 Q0 23600282 531 50.41476 imi_mug_run_2_treatment "aim"
16 Q0 26828826 532 50.41468 imi_mug_run_2_treatment "mek inhibitor" "pd0325901" "basis"
16 Q0 28666074 533 50.385006 imi_mug_run_2_treatment "ptc"
16 Q0 15947103 534 50.359802 imi_mug_run_2_treatment "ptc"
16 Q0 20498063 535 50.354286 imi_mug_run_2_treatment "ptc"
16 Q0 29767243 536 50.346207 imi_mug_run_2_treatment "ptc"
16 Q0 25013418 537 50.32704 imi_mug_run_2_treatment "ptc"
16 Q0 24367375 538 50.279724 imi_mug_run_2_treatment "methylated"
16 Q0 20924280 539 50.19925 imi_mug_run_2_treatment "ptc"
16 Q0 17854396 540 50.13931 imi_mug_run_2_treatment "thyroglobulin" "iodine" "ptc"
16 Q0 21796448 541 50.131973 imi_mug_run_2_treatment "ptc" "ras"
16 Q0 21179278 542 50.113907 imi_mug_run_2_treatment "ptc"
16 Q0 24617711 543 50.10434 imi_mug_run_2_treatment "various" "ftc" "iodine"
16 Q0 25487587 544 50.10257 imi_mug_run_2_treatment "ptc"
16 Q0 23844038 545 50.093304 imi_mug_run_2_treatment "dabrafenib" "braf inhibitor" "mek inhibitor"
16 Q0 27180965 546 50.042824 imi_mug_run_2_treatment "various" "ras" "drugs"
16 Q0 26323637 547 49.987568 imi_mug_run_2_treatment "ptc"
16 Q0 20629554 548 49.979313 imi_mug_run_2_treatment "ptc"
16 Q0 19370421 549 49.957394 imi_mug_run_2_treatment "ptc" "isoleucine" "leucine"
16 Q0 28805135 550 49.938442 imi_mug_run_2_treatment "dabrafenib" "trametinib" "radioactive iodine"
16 Q0 21795305 551 49.915283 imi_mug_run_2_treatment "mediated"
16 Q0 25109485 552 49.88914 imi_mug_run_2_treatment "ras" "ftc"
16 Q0 26863344 553 49.829292 imi_mug_run_2_treatment "ptc"
16 Q0 28875621 554 49.801464 imi_mug_run_2_treatment "various" "ptc"
16 Q0 29895015 555 49.747055 imi_mug_run_2_treatment "ptc" "ras"
16 Q0 19152441 556 49.66613 imi_mug_run_2_treatment "ptc"
16 Q0 24673746 557 49.657494 imi_mug_run_2_treatment "various" "plx4032" "drug's"
16 Q0 24927793 558 49.65467 imi_mug_run_2_treatment "methylated" "aim"
16 Q0 26823860 559 49.57084 imi_mug_run_2_treatment "ras" "ptc"
16 Q0 26030480 560 49.564198 imi_mug_run_2_treatment "ptc"
16 Q0 28535653 561 49.55997 imi_mug_run_2_treatment "ptc"
16 Q0 26835544 562 49.533745 imi_mug_run_2_treatment "ptc"
16 Q0 22081104 563 49.528507 imi_mug_run_2_treatment "ftc" "ptc" "ras"
16 Q0 18393366 564 49.49993 imi_mug_run_2_treatment "ptc"
16 Q0 29067516 565 49.445496 imi_mug_run_2_treatment "ptc" "iodine"
16 Q0 24150898 566 49.430466 imi_mug_run_2_treatment "ptc"
16 Q0 23062653 567 49.386192 imi_mug_run_2_treatment "ptc"
16 Q0 25111330 568 49.293854 imi_mug_run_2_treatment "aim"
16 Q0 20951315 569 49.26292 imi_mug_run_2_treatment "ptc" "favor" "lead"
16 Q0 16007166 570 49.246223 imi_mug_run_2_treatment "ptc" "ras"
16 Q0 16786134 571 49.230225 imi_mug_run_2_treatment "ptc"
16 Q0 25444226 572 49.09922 imi_mug_run_2_treatment "ptc" "prophylactic"
16 Q0 23192464 573 49.08986 imi_mug_run_2_treatment "ptc"
16 Q0 17381488 574 49.053627 imi_mug_run_2_treatment "ftc"
16 Q0 30090725 575 49.027298 imi_mug_run_2_treatment "iodine" "ras" "radioactive iodine"
16 Q0 24367234 576 49.02232 imi_mug_run_2_treatment "ptc"
16 Q0 19883729 577 49.014454 imi_mug_run_2_treatment "various" "ptc"
16 Q0 15472223 578 48.95793 imi_mug_run_2_treatment "ptc"
16 Q0 26112458 579 48.95302 imi_mug_run_2_treatment "sorafenib" "antiangiogenic" "serine"
16 Q0 20950194 580 48.944206 imi_mug_run_2_treatment "ptc"
16 Q0 27516030 581 48.91881 imi_mug_run_2_treatment "ptc" "thyroglobulin" "ras"
16 Q0 17308360 582 48.73404 imi_mug_run_2_treatment "ptc" "level"
16 Q0 29083503 583 48.711346 imi_mug_run_2_treatment "ptc"
16 Q0 30414980 584 48.604965 imi_mug_run_2_treatment "ptc" "glutamic acid"
16 Q0 16818623 585 48.60356 imi_mug_run_2_treatment "ptc" "oligos" "mediated"
16 Q0 21431280 586 48.582527 imi_mug_run_2_treatment "blade" "ptc"
16 Q0 29037127 587 48.566547 imi_mug_run_2_treatment "ras"
16 Q0 21134562 588 48.49398 imi_mug_run_2_treatment "mek inhibitor" "aim"
16 Q0 27484771 589 48.456062 imi_mug_run_2_treatment "glucose" "lactate" "favoring"
16 Q0 23484549 590 48.452377 imi_mug_run_2_treatment "combinations"
16 Q0 19850689 591 48.38861 imi_mug_run_2_treatment "thyroglobulin" "ptc"
16 Q0 17179987 592 48.364056 imi_mug_run_2_treatment "mediators"
16 Q0 27873522 593 48.337494 imi_mug_run_2_treatment "ras" "ptc"
16 Q0 20714830 594 48.324207 imi_mug_run_2_treatment "ras" "ptc"
16 Q0 28609009 595 48.32144 imi_mug_run_2_treatment "ptc" "ras"
16 Q0 26733501 596 48.291466 imi_mug_run_2_treatment "ptc" "ras"
16 Q0 22661970 597 48.28177 imi_mug_run_2_treatment "ptc"
16 Q0 26825960 598 48.277386 imi_mug_run_2_treatment "shh" "ptc" "cyclopamine"
16 Q0 15584614 599 48.235096 imi_mug_run_2_treatment "tyrosine" "ras"
16 Q0 26912807 600 48.231594 imi_mug_run_2_treatment "ras" "ptc" "aim"
16 Q0 24863948 601 48.224728 imi_mug_run_2_treatment "ptc" "aim"
16 Q0 16715702 602 48.18186 imi_mug_run_2_treatment "ptc" "tca"
16 Q0 28362711 603 48.10951 imi_mug_run_2_treatment "others"
16 Q0 17960500 604 48.10262 imi_mug_run_2_treatment "ptc" "ras"
16 Q0 24838814 605 48.102005 imi_mug_run_2_treatment "ptc" "prophylactic"
16 Q0 27372303 606 48.07494 imi_mug_run_2_treatment "ras" "pdtc"
16 Q0 26152656 607 48.06041 imi_mug_run_2_treatment "ptc" "aim"
16 Q0 17709622 608 48.01874 imi_mug_run_2_treatment "pd98059" "u0126" "ptc"
16 Q0 22442268 609 48.01219 imi_mug_run_2_treatment "sunitinib" "ptc" "ras"
16 Q0 27119842 610 48.002148 imi_mug_run_2_treatment "ptc"
16 Q0 29229408 611 47.97641 imi_mug_run_2_treatment "ptc"
16 Q0 26120069 612 47.939316 imi_mug_run_2_treatment "ptc" "prophylactic"
16 Q0 22150560 613 47.89274 imi_mug_run_2_treatment "ras" "ptc"
16 Q0 20447069 614 47.89034 imi_mug_run_2_treatment "ptc"
16 Q0 27410688 615 47.882095 imi_mug_run_2_treatment "level" "ptc"
16 Q0 26715280 616 47.878735 imi_mug_run_2_treatment "ptc" "tma"
16 Q0 25353071 617 47.809998 imi_mug_run_2_treatment "vemurafenib" "ptc" "drug"
16 Q0 26242638 618 47.753784 imi_mug_run_2_treatment "ras"
16 Q0 30069716 619 47.75274 imi_mug_run_2_treatment "braf inhibitor"
16 Q0 26152183 620 47.73893 imi_mug_run_2_treatment "braf inhibitor" "level" "vemurafenib"
16 Q0 30337961 621 47.7337 imi_mug_run_2_treatment "ptc" "sodium" "iodine"
16 Q0 28112041 622 47.69693 imi_mug_run_2_treatment "ptc"
16 Q0 12670889 623 47.696716 imi_mug_run_2_treatment "ras" "ptc" "tandem"
16 Q0 25983754 624 47.678776 imi_mug_run_2_treatment "ptc"
16 Q0 17415708 625 47.6428 imi_mug_run_2_treatment "ptc"
16 Q0 26314551 626 47.601437 imi_mug_run_2_treatment "drug" "sorafenib" "trametinib"
16 Q0 23543667 627 47.588867 imi_mug_run_2_treatment "hot spot"
16 Q0 24197448 628 47.535614 imi_mug_run_2_treatment "ptc" "matrix"
16 Q0 26980298 629 47.523643 imi_mug_run_2_treatment "ras"
16 Q0 30518486 630 47.48465 imi_mug_run_2_treatment "ptc" "level" "aim"
16 Q0 28231576 631 47.434914 imi_mug_run_2_treatment "ras"
16 Q0 27880942 632 47.42299 imi_mug_run_2_treatment "braf inhibitor" "plx4032" "mediated"
16 Q0 29117154 633 47.42076 imi_mug_run_2_treatment "ptc" "pdtc" "pyrrolidine dithiocarbamate"
16 Q0 28646474 634 47.35933 imi_mug_run_2_treatment "ptc"
16 Q0 15947100 635 47.35428 imi_mug_run_2_treatment "ptc"
16 Q0 15735849 636 47.317993 imi_mug_run_2_treatment "agent"
16 Q0 29239036 637 47.315968 imi_mug_run_2_treatment "ras"
16 Q0 23079204 638 47.311478 imi_mug_run_2_treatment "ras"
16 Q0 23650027 639 47.290783 imi_mug_run_2_treatment "various"
16 Q0 22202162 640 47.286385 imi_mug_run_2_treatment "animals"
16 Q0 25309777 641 47.285053 imi_mug_run_2_treatment "ras" "sunitinib" "sorafenib"
16 Q0 22471241 642 47.250923 imi_mug_run_2_treatment "ptc"
16 Q0 19493000 643 47.21573 imi_mug_run_2_treatment "ptc"
16 Q0 21385081 644 47.132633 imi_mug_run_2_treatment "ptc" "formalin" "vascular endothelial growth factor"
16 Q0 23797723 645 47.10301 imi_mug_run_2_treatment "various" "ptc" "ras"
16 Q0 27542980 646 47.10301 imi_mug_run_2_treatment "ptc"
16 Q0 18353179 647 47.05314 imi_mug_run_2_treatment "ptc"
16 Q0 27314338 648 47.051003 imi_mug_run_2_treatment "ptc" "ras"
16 Q0 21441079 649 47.0416 imi_mug_run_2_treatment "ptc"
16 Q0 17535994 650 47.041298 imi_mug_run_2_treatment "ptc"
16 Q0 22855362 651 47.039463 imi_mug_run_2_treatment "ptc"
16 Q0 23162534 652 47.035072 imi_mug_run_2_treatment "ptc" "ftc"
16 Q0 16365291 653 47.0284 imi_mug_run_2_treatment "ptc" "ras"
16 Q0 23075900 654 47.00801 imi_mug_run_2_treatment "ptc"
16 Q0 27350555 655 47.003433 imi_mug_run_2_treatment "vemurafenib" "braf inhibitor"
16 Q0 16199894 656 46.9934 imi_mug_run_2_treatment "ras"
16 Q0 28072975 657 46.97206 imi_mug_run_2_treatment "mediated"
16 Q0 25789503 658 46.952713 imi_mug_run_2_treatment "drugs" "thyroid-stimulating hormone" "ras"
16 Q0 23128507 659 46.92726 imi_mug_run_2_treatment "ptc" "ras" "basis"
16 Q0 26339365 660 46.906406 imi_mug_run_2_treatment "ptc"
16 Q0 20470206 661 46.894634 imi_mug_run_2_treatment "sulindac" "ptc" "antiinflammatory"
16 Q0 18310288 662 46.865936 imi_mug_run_2_treatment "ras" "aim"
16 Q0 25202067 663 46.86591 imi_mug_run_2_treatment "proteasome inhibitor" "plx4032" "aim"
16 Q0 24978326 664 46.846855 imi_mug_run_2_treatment "ptc" "iodine" "avid"
16 Q0 29663854 665 46.842335 imi_mug_run_2_treatment "fluoruracil" "favoring"
16 Q0 18491251 666 46.817505 imi_mug_run_2_treatment "calcitonin" "alcohol"
16 Q0 22527019 667 46.80731 imi_mug_run_2_treatment "ptc" "ras"
16 Q0 22925390 668 46.78464 imi_mug_run_2_treatment "ftc" "ptc"
16 Q0 24633422 669 46.70886 imi_mug_run_2_treatment "ptc" "therapeutic agents" "crizotinib"
16 Q0 25053682 670 46.70304 imi_mug_run_2_treatment "aim"
16 Q0 18382358 671 46.624355 imi_mug_run_2_treatment "ptc"
16 Q0 22895275 672 46.620594 imi_mug_run_2_treatment "ftc" "ptc"
16 Q0 19393416 673 46.615143 imi_mug_run_2_treatment "ptc"
16 Q0 30210710 674 46.61123 imi_mug_run_2_treatment "ptc" "aim"
16 Q0 25123949 675 46.545208 imi_mug_run_2_treatment "aim"
16 Q0 19414674 676 46.530632 imi_mug_run_2_treatment "ptc"
16 Q0 15998781 677 46.446915 imi_mug_run_2_treatment "ptc" "tandem"
16 Q0 27896649 678 46.445377 imi_mug_run_2_treatment "thyroglobulin" "ptc" "antisera"
16 Q0 26884114 679 46.39971 imi_mug_run_2_treatment "aim"
16 Q0 22558328 680 46.395023 imi_mug_run_2_treatment "ptc" "aim"
16 Q0 30132406 681 46.373966 imi_mug_run_2_treatment "thyrotropin" "animals"
16 Q0 26384551 682 46.33532 imi_mug_run_2_treatment "u0126" "collagen" "drugs"
16 Q0 17210745 683 46.332283 imi_mug_run_2_treatment "ptc" "ftc" "aim"
16 Q0 26749005 684 46.30156 imi_mug_run_2_treatment "collagen"
16 Q0 30005075 685 46.287193 imi_mug_run_2_treatment "cytokines" "level" "ptc"
16 Q0 29969659 686 46.273296 imi_mug_run_2_treatment "plx4032" "cytostatic" "agent"
16 Q0 29232305 687 46.255302 imi_mug_run_2_treatment "braf inhibitor" "glutamic acid" "new drugs"
16 Q0 23716027 688 46.24881 imi_mug_run_2_treatment "ptc" "aim"
16 Q0 24123003 689 46.222435 imi_mug_run_2_treatment "matrix"
16 Q0 30052723 690 46.218746 imi_mug_run_2_treatment "ras"
16 Q0 24449679 691 46.217094 imi_mug_run_2_treatment "ptc" "isoleucine" "aim"
16 Q0 30361901 692 46.190342 imi_mug_run_2_treatment "ptc" "ras" "basis"
16 Q0 19500021 693 46.17167 imi_mug_run_2_treatment "ptc" "ci-1040" "ras"
16 Q0 16402937 694 46.15603 imi_mug_run_2_treatment "ras" "ftc" "ptc"
16 Q0 29439609 695 46.152195 imi_mug_run_2_treatment "ras"
16 Q0 25467940 696 46.121986 imi_mug_run_2_treatment "vemurafenib" "dabrafenib" "radioactive iodine"
16 Q0 29549631 697 46.07663 imi_mug_run_2_treatment "ptc" "dtc" "aim"
16 Q0 26680454 698 46.071808 imi_mug_run_2_treatment "drug"
16 Q0 21733000 699 46.070385 imi_mug_run_2_treatment "calcitonin"
16 Q0 22820660 700 46.02049 imi_mug_run_2_treatment "lead" "aim"
16 Q0 24450682 701 46.008476 imi_mug_run_2_treatment "shape"
16 Q0 29616135 702 45.958168 imi_mug_run_2_treatment "plx4032" "egfr inhibitor" "mitogen"
16 Q0 28585075 703 45.95331 imi_mug_run_2_treatment "ptc" "thyroglobulin"
16 Q0 16753739 704 45.9466 imi_mug_run_2_treatment "ptc" "aim"
16 Q0 29701552 705 45.945625 imi_mug_run_2_treatment "dabrafenib"
16 Q0 16181240 706 45.92912 imi_mug_run_2_treatment "various" "ras" "ptc"
16 Q0 27750022 707 45.92572 imi_mug_run_2_treatment "ptc"
16 Q0 22575864 708 45.91829 imi_mug_run_2_treatment "mitogen"
16 Q0 29635968 709 45.916466 imi_mug_run_2_treatment "ras" "klk" "kallikreins"
16 Q0 19107232 710 45.908634 imi_mug_run_2_treatment "ptc"
16 Q0 24004175 711 45.823936 imi_mug_run_2_treatment "ptc" "level"
16 Q0 22156468 712 45.799683 imi_mug_run_2_treatment "ptc"
16 Q0 29239040 713 45.797905 imi_mug_run_2_treatment "ptc"
16 Q0 15272920 714 45.794273 imi_mug_run_2_treatment "ptc"
16 Q0 23192956 715 45.709404 imi_mug_run_2_treatment "ptc" "glutamic acid"
16 Q0 30294871 716 45.70372 imi_mug_run_2_treatment "ptc" "aim"
16 Q0 25501013 717 45.70335 imi_mug_run_2_treatment "ptc"
16 Q0 23496275 718 45.697403 imi_mug_run_2_treatment "ptc" "lead"
16 Q0 29948935 719 45.695446 imi_mug_run_2_treatment "ptc" "pdtc" "ras"
16 Q0 26510840 720 45.65707 imi_mug_run_2_treatment "ras"
16 Q0 20926530 721 45.64556 imi_mug_run_2_treatment "sorafenib" "staurosporine" "u0126"
16 Q0 26054797 722 45.616417 imi_mug_run_2_treatment "ptc"
16 Q0 28928829 723 45.572018 imi_mug_run_2_treatment "ptc" "basis"
16 Q0 26662608 724 45.532627 imi_mug_run_2_treatment "serine" "eosin"
16 Q0 26581891 725 45.469772 imi_mug_run_2_treatment "aim"
16 Q0 30146440 726 45.46947 imi_mug_run_2_treatment "adjuvant" "ras"
16 Q0 22973979 727 45.464565 imi_mug_run_2_treatment "ptc"
16 Q0 24255689 728 45.449265 imi_mug_run_2_treatment "ptc" "glutamic acid"
16 Q0 16254036 729 45.42323 imi_mug_run_2_treatment "ras" "mediated" "others"
16 Q0 29316976 730 45.41983 imi_mug_run_2_treatment "ptc"
16 Q0 21383698 731 45.39272 imi_mug_run_2_treatment "ptc" "pdtc" "animals"
16 Q0 15001635 732 45.37485 imi_mug_run_2_treatment "ptc"
16 Q0 20001715 733 45.35282 imi_mug_run_2_treatment "thyrotropin" "ptc" "cyclic adenosine monophosphate"
16 Q0 26392228 734 45.322983 imi_mug_run_2_treatment "mediated" "su6656" "program"
16 Q0 22930660 735 45.277294 imi_mug_run_2_treatment "ptc" "gat" "ras"
16 Q0 25456905 736 45.27204 imi_mug_run_2_treatment "various" "ptc"
16 Q0 26146959 737 45.217484 imi_mug_run_2_treatment "ptc" "mediated" "ftc"
16 Q0 29785019 738 45.185165 imi_mug_run_2_treatment "calcitonin" "estrogen" "thyroglobulin"
16 Q0 28009980 739 45.173817 imi_mug_run_2_treatment "ptc"
16 Q0 20097316 740 45.16723 imi_mug_run_2_treatment "various" "ras"
16 Q0 25469237 741 45.1599 imi_mug_run_2_treatment "ptc" "ftc"
16 Q0 19380355 742 45.097874 imi_mug_run_2_treatment "ci-1040" "ptc" "pd184352"
16 Q0 28549037 743 45.097626 imi_mug_run_2_treatment "formalin" "basis" "aim"
16 Q0 22522845 744 45.093796 imi_mug_run_2_treatment "level"
16 Q0 15687339 745 45.06325 imi_mug_run_2_treatment "ptc" "level"
16 Q0 29881305 746 45.00923 imi_mug_run_2_treatment "ptc" "cancer vaccine"
16 Q0 27574774 747 44.97974 imi_mug_run_2_treatment "radioactive iodine"
16 Q0 23372702 748 44.95254 imi_mug_run_2_treatment "ptc" "tam" "kinase inhibitor"
16 Q0 17940185 749 44.945724 imi_mug_run_2_treatment "ptc" "mitogen" "vascular endothelial growth factor"
16 Q0 19893009 750 44.929607 imi_mug_run_2_treatment "iron" "various" "water"
16 Q0 25627462 751 44.88149 imi_mug_run_2_treatment "ptc" "ras"
16 Q0 24272599 752 44.857853 imi_mug_run_2_treatment "ptc"
16 Q0 24042420 753 44.826004 imi_mug_run_2_treatment "ptc"
16 Q0 26727717 754 44.805283 imi_mug_run_2_treatment "ptc"
16 Q0 23595984 755 44.783447 imi_mug_run_2_treatment "ptc" "thyroglobulin"
16 Q0 25814520 756 44.723343 imi_mug_run_2_treatment "pdtc" "dtc" "glucose"
16 Q0 21088998 757 44.71941 imi_mug_run_2_treatment "ras"
16 Q0 22457234 758 44.706516 imi_mug_run_2_treatment "ptc"
16 Q0 15294323 759 44.679367 imi_mug_run_2_treatment "ras"
16 Q0 17429154 760 44.56026 imi_mug_run_2_treatment "ptc"
16 Q0 21765995 761 44.49697 imi_mug_run_2_treatment "ptc" "ras"
16 Q0 30352402 762 44.48202 imi_mug_run_2_treatment "ptc"
16 Q0 19956384 763 44.4193 imi_mug_run_2_treatment "ras" "ptc"
16 Q0 30509240 764 44.41413 imi_mug_run_2_treatment "ptc" "aim"
16 Q0 23544172 765 44.404907 imi_mug_run_2_treatment "ptc" "mediated" "ras"
16 Q0 27753098 766 44.402462 imi_mug_run_2_treatment "glycosphingolipid" "vaccine"
16 Q0 23766237 767 44.35144 imi_mug_run_2_treatment "ptc" "pdtc" "ftc"
16 Q0 27824297 768 44.335747 imi_mug_run_2_treatment "dtc" "ptc"
16 Q0 15547711 769 44.324615 imi_mug_run_2_treatment "ptc"
16 Q0 30466862 770 44.251823 imi_mug_run_2_treatment "ptc"
16 Q0 23783103 771 44.24755 imi_mug_run_2_treatment "ptc"
16 Q0 29762246 772 44.243275 imi_mug_run_2_treatment "ptc"
16 Q0 28636673 773 44.239395 imi_mug_run_2_treatment "ptc" "asa"
16 Q0 19356676 774 44.23522 imi_mug_run_2_treatment "ptc"
16 Q0 22503804 775 44.222054 imi_mug_run_2_treatment "ras" "radioactive iodine"
16 Q0 29976183 776 44.217655 imi_mug_run_2_treatment "ptc" "ptc's"
16 Q0 26648183 777 44.182022 imi_mug_run_2_treatment "ptc" "pooled"
16 Q0 25863487 778 44.180008 imi_mug_run_2_treatment "ptc"
16 Q0 19190105 779 44.17216 imi_mug_run_2_treatment "ptc" "iodine"
16 Q0 22241789 780 44.14631 imi_mug_run_2_treatment "selumetinib" "iodine" "arry-142886"
16 Q0 22419100 781 44.14483 imi_mug_run_2_treatment "ptc"
16 Q0 23559083 782 44.135666 imi_mug_run_2_treatment "gefitinib" "epidermal growth factor" "egfr tyrosine kinase inhibitor"
16 Q0 26347145 783 44.097275 imi_mug_run_2_treatment "paclitaxel" "pazopanib" "vemurafenib"
16 Q0 23349472 784 44.091732 imi_mug_run_2_treatment "pdtc" "radioactive iodine"
16 Q0 23969188 785 44.062202 imi_mug_run_2_treatment "ptc" "prophylactic"
16 Q0 26784937 786 44.059753 imi_mug_run_2_treatment "ptc" "glutamic acid"
16 Q0 26187369 787 44.01376 imi_mug_run_2_treatment "aim"
16 Q0 26137119 788 43.98528 imi_mug_run_2_treatment "ptc" "aim"
16 Q0 26932895 789 43.93929 imi_mug_run_2_treatment "therapeutics" "level" "others"
16 Q0 23116250 790 43.93233 imi_mug_run_2_treatment "vemurafenib" "drug" "dacarbazine"
16 Q0 22494995 791 43.9135 imi_mug_run_2_treatment "ptc"
16 Q0 15613458 792 43.897697 imi_mug_run_2_treatment "various" "crest"
16 Q0 17131411 793 43.894444 imi_mug_run_2_treatment "ptc" "ras"
16 Q0 25556681 794 43.81253 imi_mug_run_2_treatment "aim"
16 Q0 24442520 795 43.796906 imi_mug_run_2_treatment "glutamine" "aim"
16 Q0 22090271 796 43.777946 imi_mug_run_2_treatment "plx4032" "azd6244" "perifosine"
16 Q0 17302867 797 43.75296 imi_mug_run_2_treatment "various" "ras"
16 Q0 27401113 798 43.72162 imi_mug_run_2_treatment "ptc" "sodium" "level"
16 Q0 25920006 799 43.70771 imi_mug_run_2_treatment "pooled"
16 Q0 24696132 800 43.70457 imi_mug_run_2_treatment "ptc"
16 Q0 27793009 801 43.70121 imi_mug_run_2_treatment "ptc" "ras" "excel"
16 Q0 16117812 802 43.663853 imi_mug_run_2_treatment "aim"
16 Q0 22682753 803 43.659668 imi_mug_run_2_treatment "ptc" "gly" "ras"
16 Q0 25868389 804 43.63412 imi_mug_run_2_treatment "ptc"
16 Q0 26716505 805 43.634075 imi_mug_run_2_treatment "ptc"
16 Q0 15681856 806 43.604904 imi_mug_run_2_treatment "ras"
16 Q0 22870901 807 43.59865 imi_mug_run_2_treatment "ptc" "tam"
16 Q0 27416738 808 43.5911 imi_mug_run_2_treatment "aim"
16 Q0 21521301 809 43.565617 imi_mug_run_2_treatment "dtc" "ptc"
16 Q0 28093480 810 43.50249 imi_mug_run_2_treatment "various"
16 Q0 23883275 811 43.459656 imi_mug_run_2_treatment "ptc"
16 Q0 23636013 812 43.4483 imi_mug_run_2_treatment "combinations" "ptc"
16 Q0 30075157 813 43.43911 imi_mug_run_2_treatment "thyroglobulin"
16 Q0 22932786 814 43.406464 imi_mug_run_2_treatment "ptc"
16 Q0 22504197 815 43.395927 imi_mug_run_2_treatment "ptc"
16 Q0 22233555 816 43.372593 imi_mug_run_2_treatment "lead" "new drugs"
16 Q0 28659720 817 43.362087 imi_mug_run_2_treatment "ras"
16 Q0 22985488 818 43.337727 imi_mug_run_2_treatment "isoleucine" "ras" "radioactive iodine"
16 Q0 25063326 819 43.331654 imi_mug_run_2_treatment "pdx" "vemurafenib" "matrix"
16 Q0 26456124 820 43.30092 imi_mug_run_2_treatment "drugs"
16 Q0 30126001 821 43.296303 imi_mug_run_2_treatment "various" "ptc" "bromodeoxyuridine"
16 Q0 26750533 822 43.25569 imi_mug_run_2_treatment "ptc" "aim"
16 Q0 27058903 823 43.254665 imi_mug_run_2_treatment "mitogen" "mediators" "ras"
16 Q0 29805692 824 43.243378 imi_mug_run_2_treatment "ras" "basis"
16 Q0 21609347 825 43.234818 imi_mug_run_2_treatment "ptc"
16 Q0 28383817 826 43.201485 imi_mug_run_2_treatment "therapeutic agents" "aim"
16 Q0 28031237 827 43.16653 imi_mug_run_2_treatment "ptc" "aim"
16 Q0 15980887 828 43.15999 imi_mug_run_2_treatment "ptc"
16 Q0 27618325 829 43.136078 imi_mug_run_2_treatment "calcitonin" "ras" "antiangiogenic"
16 Q0 20369307 830 43.113304 imi_mug_run_2_treatment "ptc"
16 Q0 24955024 831 43.095642 imi_mug_run_2_treatment "ras" "ptc"
16 Q0 26604858 832 43.057602 imi_mug_run_2_treatment "ptc" "ras"
16 Q0 28258306 833 43.05352 imi_mug_run_2_treatment "ptc" "iodine" "plasma"
16 Q0 28575350 834 42.97774 imi_mug_run_2_treatment "sitagliptin" "aim"
16 Q0 20587665 835 42.960236 imi_mug_run_2_treatment "pd0325901" "ptc" "drug"
16 Q0 18098337 836 42.95717 imi_mug_run_2_treatment "brdu"
16 Q0 21537871 837 42.939777 imi_mug_run_2_treatment "various" "ptc" "ras"
16 Q0 29209896 838 42.923996 imi_mug_run_2_treatment "enzymes" "ptc" "thyroid-stimulating hormone"
16 Q0 21185263 839 42.915134 imi_mug_run_2_treatment "plx4032" "ras" "rg7204"
16 Q0 23477374 840 42.89528 imi_mug_run_2_treatment "ras"
16 Q0 25448848 841 42.8946 imi_mug_run_2_treatment "ras"
16 Q0 16149875 842 42.85882 imi_mug_run_2_treatment "ras" "eosin" "level"
16 Q0 24591770 843 42.804184 imi_mug_run_2_treatment "ras" "level" "aim"
16 Q0 18948674 844 42.783188 imi_mug_run_2_treatment "ptc" "ras"
16 Q0 27682157 845 42.7676 imi_mug_run_2_treatment "aim"
16 Q0 27494611 846 42.742645 imi_mug_run_2_treatment "ras" "ptc" "ftc"
16 Q0 26285789 847 42.740158 imi_mug_run_2_treatment "ptc" "pdtc" "ras"
16 Q0 17900235 848 42.72564 imi_mug_run_2_treatment "ras" "ptc"
16 Q0 22549559 849 42.682484 imi_mug_run_2_treatment "calcium" "vitamin d" "ptc"
16 Q0 14996725 850 42.671867 imi_mug_run_2_treatment "ptc" "ras"
16 Q0 30034553 851 42.66449 imi_mug_run_2_treatment "ptc" "aim"
16 Q0 23993207 852 42.619312 imi_mug_run_2_treatment "ptc"
16 Q0 26711586 853 42.602524 imi_mug_run_2_treatment "aim"
16 Q0 20460314 854 42.58431 imi_mug_run_2_treatment "ptc"
16 Q0 15899815 855 42.50391 imi_mug_run_2_treatment "ptc" "iodine" "thyroglobulin"
16 Q0 16676402 856 42.501266 imi_mug_run_2_treatment "potassium" "ptc" "matrix"
16 Q0 21403618 857 42.41797 imi_mug_run_2_treatment "ptc" "aim"
16 Q0 28840946 858 42.366623 imi_mug_run_2_treatment "glu"
16 Q0 16896265 859 42.30308 imi_mug_run_2_treatment "ptc" "ras"
16 Q0 17227125 860 42.300373 imi_mug_run_2_treatment "ptc" "pdgfb" "level"
16 Q0 27775641 861 42.283344 imi_mug_run_2_treatment "ptc" "dedicated"
16 Q0 23488912 862 42.282997 imi_mug_run_2_treatment "ptc"
16 Q0 15761501 863 42.254875 imi_mug_run_2_treatment "ras" "program"
16 Q0 21175381 864 42.244278 imi_mug_run_2_treatment "ptc" "adjuvant"
16 Q0 19627734 865 42.13241 imi_mug_run_2_treatment "various" "ras" "ptc"
16 Q0 17848408 866 42.11633 imi_mug_run_2_treatment "various" "bortezomib" "velcade"
16 Q0 18458053 867 42.097466 imi_mug_run_2_treatment "plx4032" "blockade"
16 Q0 24222120 868 42.059742 imi_mug_run_2_treatment "ptc" "peptidase inhibitor" "serpin"
16 Q0 16444351 869 41.99747 imi_mug_run_2_treatment "ftc" "ptc" "product"
16 Q0 26003825 870 41.996895 imi_mug_run_2_treatment "thyroglobulin" "ptc" "sodium"
16 Q0 29626249 871 41.90359 imi_mug_run_2_treatment "various" "combinations" "ras"
16 Q0 28974238 872 41.89328 imi_mug_run_2_treatment "ptc" "monoclonal antibodies"
16 Q0 16501605 873 41.891567 imi_mug_run_2_treatment "enzymes" "ptc"
16 Q0 27688081 874 41.88984 imi_mug_run_2_treatment "ptc" "radioactive iodine"
16 Q0 29890543 875 41.888935 imi_mug_run_2_treatment "ptc" "ras" "igf1"
16 Q0 24810336 876 41.876442 imi_mug_run_2_treatment "ptc"
16 Q0 25148236 877 41.846695 imi_mug_run_2_treatment "ras"
16 Q0 27462868 878 41.83602 imi_mug_run_2_treatment "ptc" "u0126" "mek inhibitor"
16 Q0 26971368 879 41.81362 imi_mug_run_2_treatment "dtc" "ras" "ptc"
16 Q0 24838325 880 41.784065 imi_mug_run_2_treatment "various" "adrenocorticotropic hormone" "acth"
16 Q0 23513230 881 41.749344 imi_mug_run_2_treatment "ptc" "icc" "aim"
16 Q0 16174717 882 41.74373 imi_mug_run_2_treatment "ptc"
16 Q0 25244593 883 41.741383 imi_mug_run_2_treatment "ras" "lead"
16 Q0 26904701 884 41.67925 imi_mug_run_2_treatment "ptc" "radioactive iodine" "vemurafenib"
16 Q0 29476382 885 41.64219 imi_mug_run_2_treatment "various"
16 Q0 29072975 886 41.63437 imi_mug_run_2_treatment "dabrafenib" "trametinib" "duration"
16 Q0 16867191 887 41.633434 imi_mug_run_2_treatment "ptc" "others"
16 Q0 29070763 888 41.627243 imi_mug_run_2_treatment "ptc" "lnd" "prophylactic"
16 Q0 25229773 889 41.588966 imi_mug_run_2_treatment "level"
16 Q0 15181070 890 41.581295 imi_mug_run_2_treatment "ptc" "various"
16 Q0 15876153 891 41.57852 imi_mug_run_2_treatment "ptc" "ras"
16 Q0 25592597 892 41.57039 imi_mug_run_2_treatment "ppa" "medicine"
16 Q0 25333496 893 41.56506 imi_mug_run_2_treatment "ras" "ptc"
16 Q0 15630448 894 41.556343 imi_mug_run_2_treatment "various"
16 Q0 18088233 895 41.55008 imi_mug_run_2_treatment "ptc" "ras"
16 Q0 24261392 896 41.534874 imi_mug_run_2_treatment "shape"
16 Q0 25714871 897 41.53051 imi_mug_run_2_treatment "cetuximab" "ras"
16 Q0 29320776 898 41.525948 imi_mug_run_2_treatment "various"
16 Q0 24955023 899 41.52134 imi_mug_run_2_treatment "ptc" "mediated" "vascular endothelial growth factor"
16 Q0 26568156 900 41.516132 imi_mug_run_2_treatment "aim" "ptc"
16 Q0 25922907 901 41.45995 imi_mug_run_2_treatment "basis"
16 Q0 18473997 902 41.447826 imi_mug_run_2_treatment "ras" "glycine" "sorafenib"
16 Q0 26902827 903 41.388012 imi_mug_run_2_treatment "ras" "therapeutics"
16 Q0 24619974 904 41.36336 imi_mug_run_2_treatment "glutamic acid" "others"
16 Q0 28331529 905 41.361847 imi_mug_run_2_treatment "ptc"
16 Q0 23690767 906 41.36121 imi_mug_run_2_treatment "ptc"
16 Q0 22728346 907 41.35679 imi_mug_run_2_treatment "ptc" "messengers" "basis"
16 Q0 22435913 908 41.341446 imi_mug_run_2_treatment "sorafenib" "ptc" "radioactive iodine"
16 Q0 23414134 909 41.332573 imi_mug_run_2_treatment "various" "ras"
16 Q0 23186006 910 41.328682 imi_mug_run_2_treatment "ptc" "prophylactic"
16 Q0 20564403 911 41.32165 imi_mug_run_2_treatment "ras" "ptc" "lead"
16 Q0 28160058 912 41.307686 imi_mug_run_2_treatment "ptc"
16 Q0 20406109 913 41.3017 imi_mug_run_2_treatment "ptc" "basis"
16 Q0 30036146 914 41.214584 imi_mug_run_2_treatment "vemurafenib" "ras" "ptc"
16 Q0 17097223 915 41.20247 imi_mug_run_2_treatment "ras"
16 Q0 15273715 916 41.172626 imi_mug_run_2_treatment "ptc" "ras"
16 Q0 23887306 917 41.154396 imi_mug_run_2_treatment "level" "aim"
16 Q0 19861538 918 41.146706 imi_mug_run_2_treatment "ptc" "sodium"
16 Q0 18000091 919 41.108307 imi_mug_run_2_treatment "various" "ras" "ptc"
16 Q0 19913280 920 41.088535 imi_mug_run_2_treatment "ras"
16 Q0 18470905 921 41.08171 imi_mug_run_2_treatment "ptc"
16 Q0 30333891 922 41.08 imi_mug_run_2_treatment "various" "ptc" "mediated"
16 Q0 30100099 923 41.049404 imi_mug_run_2_treatment "ptc" "shape"
16 Q0 26065894 924 41.019558 imi_mug_run_2_treatment "ras" "ptc" "mediated"
16 Q0 24468978 925 41.017548 imi_mug_run_2_treatment "dtc" "ras" "prophylactic"
16 Q0 25201000 926 41.016705 imi_mug_run_2_treatment "vitamin d" "ptc" "vitamin d3"
16 Q0 15102681 927 40.99559 imi_mug_run_2_treatment "ptc"
16 Q0 18202121 928 40.963085 imi_mug_run_2_treatment "sodium" "adenosine" "thyroid-stimulating hormone"
16 Q0 19040996 929 40.95582 imi_mug_run_2_treatment "ptc" "mitogen"
16 Q0 24405857 930 40.9357 imi_mug_run_2_treatment "dtc" "therapeutic agents"
16 Q0 27538953 931 40.926014 imi_mug_run_2_treatment "ptc"
16 Q0 17210721 932 40.89623 imi_mug_run_2_treatment "mediated" "ptc" "tyr"
16 Q0 26917553 933 40.89623 imi_mug_run_2_treatment "radioactive iodine" "ptc" "medicine"
16 Q0 26941397 934 40.86316 imi_mug_run_2_treatment "ptc"
16 Q0 25803323 935 40.86316 imi_mug_run_2_treatment "enzymes" "ptc" "adjuvant"
16 Q0 23754825 936 40.858997 imi_mug_run_2_treatment "ptc"
16 Q0 24152792 937 40.751434 imi_mug_run_2_treatment "therapeutics"
16 Q0 22514085 938 40.720673 imi_mug_run_2_treatment "ptc" "ptc's"
16 Q0 23933154 939 40.711967 imi_mug_run_2_treatment "ras"
16 Q0 26461266 940 40.71044 imi_mug_run_2_treatment "ptc"
16 Q0 28323937 941 40.709164 imi_mug_run_2_treatment "ptc"
16 Q0 26575115 942 40.685654 imi_mug_run_2_treatment "dtc" "aim"
16 Q0 27454941 943 40.677967 imi_mug_run_2_treatment "lead"
16 Q0 28030816 944 40.616444 imi_mug_run_2_treatment "ptc"
16 Q0 30145748 945 40.61223 imi_mug_run_2_treatment "ptc" "radioactive iodine" "level"
16 Q0 27717284 946 40.591278 imi_mug_run_2_treatment "ptc"
16 Q0 28534687 947 40.545803 imi_mug_run_2_treatment "ptc" "various" "radioactive iodine"
16 Q0 24702198 948 40.512196 imi_mug_run_2_treatment "ptc" "ras"
16 Q0 19147513 949 40.48814 imi_mug_run_2_treatment "ptc"
16 Q0 20009493 950 40.46858 imi_mug_run_2_treatment "ptc" "aim"
16 Q0 22007921 951 40.46604 imi_mug_run_2_treatment "ptc" "mediated" "ras"
16 Q0 18676765 952 40.454727 imi_mug_run_2_treatment "sorafenib" "ptc" "bay 43-9006"
16 Q0 23264400 953 40.440384 imi_mug_run_2_treatment "ptc"
16 Q0 22654560 954 40.3732 imi_mug_run_2_treatment "pdtc" "ptc" "ftc"
16 Q0 24529329 955 40.369358 imi_mug_run_2_treatment "level"
16 Q0 20735442 956 40.360874 imi_mug_run_2_treatment "glycine" "ras" "product"
16 Q0 16728576 957 40.338776 imi_mug_run_2_treatment "icc" "pcc"
16 Q0 24756795 958 40.30473 imi_mug_run_2_treatment "combinations" "drug" "vemurafenib"
16 Q0 30069761 959 40.30473 imi_mug_run_2_treatment "combinations" "drug" "vemurafenib"
16 Q0 21449767 960 40.273533 imi_mug_run_2_treatment "ptc" "glutamic acid" "bisulfite"
16 Q0 28488545 961 40.223186 imi_mug_run_2_treatment "various" "glutamic acid" "aim"
16 Q0 17891237 962 40.218475 imi_mug_run_2_treatment "iodine" "ptc" "favor"
16 Q0 20637346 963 40.19462 imi_mug_run_2_treatment "ptc" "lead"
16 Q0 24295088 964 40.151 imi_mug_run_2_treatment "ptc"
16 Q0 24717435 965 40.115086 imi_mug_run_2_treatment "copper" "chelators"
16 Q0 29737325 966 40.04457 imi_mug_run_2_treatment "azd6244" "combinations" "drug"
16 Q0 27423883 967 40.037056 imi_mug_run_2_treatment "ras" "mitogen"
16 Q0 26959890 968 40.02936 imi_mug_run_2_treatment "mediated" "ras" "vemurafenib"
16 Q0 29427554 969 40.014782 imi_mug_run_2_treatment "ptc" "radioactive iodine"
16 Q0 29144541 970 40.008034 imi_mug_run_2_treatment "ptc" "ras"
16 Q0 20702649 971 39.985344 imi_mug_run_2_treatment "ptc" "ras"
16 Q0 22471242 972 39.974644 imi_mug_run_2_treatment "ptc" "radioactive iodine"
16 Q0 27459529 973 39.965763 imi_mug_run_2_treatment "ptc"
16 Q0 22249628 974 39.946537 imi_mug_run_2_treatment "ptc"
16 Q0 20718682 975 39.94232 imi_mug_run_2_treatment "l-thyroxine" "lithium" "prompt"
16 Q0 30481266 976 39.91896 imi_mug_run_2_treatment "vemurafenib" "com" "isolate"
16 Q0 26461378 977 39.906307 imi_mug_run_2_treatment "various" "quercetin"
16 Q0 18055323 978 39.778835 imi_mug_run_2_treatment "ptc" "ras" "ftc"
16 Q0 24009630 979 39.74135 imi_mug_run_2_treatment "vemurafenib" "formalin"
16 Q0 25785246 980 39.705933 imi_mug_run_2_treatment "ras" "revolution"
16 Q0 16728573 981 39.675674 imi_mug_run_2_treatment "ptc" "aim"
16 Q0 19055826 982 39.674416 imi_mug_run_2_treatment "various" "ptc"
16 Q0 20345340 983 39.640114 imi_mug_run_2_treatment "ptc"
16 Q0 23327964 984 39.614414 imi_mug_run_2_treatment "level" "ptc"
16 Q0 18644254 985 39.608524 imi_mug_run_2_treatment "ras"
16 Q0 21070478 986 39.5403 imi_mug_run_2_treatment "ptc"
16 Q0 28124274 987 39.528122 imi_mug_run_2_treatment "estrogen" "ptc" "sex hormones"
16 Q0 27535135 988 39.514328 imi_mug_run_2_treatment "ptc" "ras" "aim"
16 Q0 15689324 989 39.506958 imi_mug_run_2_treatment "ptc" "ras"
16 Q0 26297257 990 39.451897 imi_mug_run_2_treatment "heparin" "various" "ptc"
16 Q0 23404751 991 39.40933 imi_mug_run_2_treatment "ptc" "ras" "lead"
16 Q0 27261210 992 39.383347 imi_mug_run_2_treatment "basis"
16 Q0 28699414 993 39.361797 imi_mug_run_2_treatment "level"
16 Q0 26177218 994 39.355507 imi_mug_run_2_treatment "ptc" "aim"
16 Q0 20001716 995 39.347515 imi_mug_run_2_treatment "ras"
16 Q0 28687160 996 39.333755 imi_mug_run_2_treatment "ptc"
16 Q0 27867864 997 39.247833 imi_mug_run_2_treatment "ptc" "others"
16 Q0 27802204 998 39.210827 imi_mug_run_2_treatment "ptc"
16 Q0 15186612 999 39.20736 imi_mug_run_2_treatment "ras" "lead"
17 Q0 26927556 1 56.33547 imi_mug_run_2_treatment "level"
17 Q0 26381180 2 55.39219 imi_mug_run_2_treatment "monoclonal antibodies"
17 Q0 29625108 3 54.324467 imi_mug_run_2_treatment "temozolomide" "aim"
17 Q0 23011765 4 54.31353 imi_mug_run_2_treatment "edu" "mediated"
17 Q0 24473683 5 54.154808 imi_mug_run_2_treatment "histidine" "level"
17 Q0 24668804 6 53.864105 imi_mug_run_2_treatment "product"
17 Q0 26860959 7 53.700188 imi_mug_run_2_treatment "mediators" "level"
17 Q0 22445362 8 52.825558 imi_mug_run_2_treatment "mouse monoclonal antibody" "arginine" "histidine"
17 Q0 21352804 9 51.292236 imi_mug_run_2_treatment "arginine"
17 Q0 23934769 10 50.483627 imi_mug_run_2_treatment "mouse monoclonal antibody" "basis"
17 Q0 29453678 11 50.313843 imi_mug_run_2_treatment "agent" "agi-5198"
17 Q0 20560678 12 50.294014 imi_mug_run_2_treatment "temozolomide" "aim"
17 Q0 29662659 13 49.838627 imi_mug_run_2_treatment "mediated" "vwf"
17 Q0 29115585 14 48.85352 imi_mug_run_2_treatment "mediators" "tma" "level"
17 Q0 23619925 15 48.825806 imi_mug_run_2_treatment "suppressor"
17 Q0 19818334 16 48.157555 imi_mug_run_2_treatment "monoclonal antibodies"
17 Q0 29057925 17 47.50106 imi_mug_run_2_treatment "mediated" "threonine"
17 Q0 22385787 18 46.094353 imi_mug_run_2_treatment "various"
17 Q0 21088844 19 45.666637 imi_mug_run_2_treatment "basis"
17 Q0 27275230 20 45.27571 imi_mug_run_2_treatment "mouse monoclonal antibody"
17 Q0 24077277 21 44.78978 imi_mug_run_2_treatment "kinase inhibitor"
17 Q0 20127344 22 44.61631 imi_mug_run_2_treatment "alpha-ketoglutarate" "phosphate" "mediated"
17 Q0 27478330 23 44.432102 imi_mug_run_2_treatment "combinations" "various" "basis"
17 Q0 27088883 24 43.97937 imi_mug_run_2_treatment "temozolomide"
17 Q0 23115158 25 43.861027 imi_mug_run_2_treatment "various" "temozolomide" "agar"
17 Q0 27466707 26 43.78595 imi_mug_run_2_treatment "pharmaceuticals" "ag-120"
17 Q0 25083393 27 43.471626 imi_mug_run_2_treatment "temozolomide"
17 Q0 22904127 28 43.26889 imi_mug_run_2_treatment "various" "das" "duration"
17 Q0 20171178 29 42.77066 imi_mug_run_2_treatment "ftc"
17 Q0 24922649 30 42.0593 imi_mug_run_2_treatment "brdu"
17 Q0 29016871 31 41.37108 imi_mug_run_2_treatment "medicine"
17 Q0 23451042 32 40.813408 imi_mug_run_2_treatment "level"
17 Q0 22113362 33 40.49144 imi_mug_run_2_treatment "histidine"
17 Q0 26498130 34 40.245552 imi_mug_run_2_treatment "crizotinib"
17 Q0 28214089 35 40.237793 imi_mug_run_2_treatment "flair"
17 Q0 28073027 36 40.129696 imi_mug_run_2_treatment "antiepileptic drugs" "prophylactic"
17 Q0 23370430 37 40.080524 imi_mug_run_2_treatment "favor"
17 Q0 26405082 38 39.689125 imi_mug_run_2_treatment "adc"
17 Q0 25415071 39 39.63038 imi_mug_run_2_treatment "angiogenesis inhibitor" "angiogenesis inhibitors" "bevacizumab"
17 Q0 29031038 40 39.581223 imi_mug_run_2_treatment "methylated"
17 Q0 25277177 41 39.270218 imi_mug_run_2_treatment "gefitinib" "egfr inhibitor" "rembrandt"
17 Q0 25225364 42 39.267494 imi_mug_run_2_treatment "glucose" "glutamine"
17 Q0 29423539 43 38.93267 imi_mug_run_2_treatment "temozolomide"
17 Q0 30203362 44 38.855713 imi_mug_run_2_treatment "bisulfite"
17 Q0 25427834 45 38.840267 imi_mug_run_2_treatment "basis"
17 Q0 29016947 46 37.940964 imi_mug_run_2_treatment "avid"
17 Q0 24089051 47 37.542877 imi_mug_run_2_treatment "temozolomide"
17 Q0 26935296 48 37.388866 imi_mug_run_2_treatment "temozolomide" "adjuvant" "aim"
17 Q0 27904447 49 37.369934 imi_mug_run_2_treatment "temozolomide" "aim"
17 Q0 23361281 50 36.905342 imi_mug_run_2_treatment "tma" "biotin"
17 Q0 23438035 51 36.733543 imi_mug_run_2_treatment "level"
17 Q0 28665384 52 36.721165 imi_mug_run_2_treatment "various"
17 Q0 29138945 53 36.621887 imi_mug_run_2_treatment "others"
17 Q0 26045167 54 36.40227 imi_mug_run_2_treatment "dca" "dichloroacetate" "glucose"
17 Q0 23988086 55 36.360855 imi_mug_run_2_treatment "sam" "aim"
17 Q0 24305712 56 35.7404 imi_mug_run_2_treatment "flair" "tmz" "temozolomide"
17 Q0 25732040 57 35.34076 imi_mug_run_2_treatment "adjuvant" "temozolomide" "imatinib"
17 Q0 26725094 58 35.28509 imi_mug_run_2_treatment "aim"
17 Q0 19903171 59 35.175575 imi_mug_run_2_treatment "various" "favor" "mouse monoclonal antibody"
17 Q0 28122345 60 34.897617 imi_mug_run_2_treatment "tmz" "glycine" "histidine"
17 Q0 26194445 61 34.81555 imi_mug_run_2_treatment "complete adjuvant"
17 Q0 28345125 62 34.62455 imi_mug_run_2_treatment "thioredoxin" "aim"
17 Q0 23429602 63 34.439934 imi_mug_run_2_treatment "aim"
17 Q0 22291938 64 34.38493 imi_mug_run_2_treatment "tmz"
17 Q0 19755387 65 34.36199 imi_mug_run_2_treatment "level"
17 Q0 29404978 66 34.142796 imi_mug_run_2_treatment "cystine"
17 Q0 22034964 67 34.13228 imi_mug_run_2_treatment "temozolomide"
17 Q0 27409829 68 33.63304 imi_mug_run_2_treatment "methylated"
17 Q0 26025143 69 33.45186 imi_mug_run_2_treatment "tmz" "temozolomide" "adjuvant"
17 Q0 22040412 70 33.263664 imi_mug_run_2_treatment "amino acid"
17 Q0 29169920 71 33.254906 imi_mug_run_2_treatment "rembrandt"
17 Q0 30074469 72 33.163177 imi_mug_run_2_treatment "various" "interleukin"
17 Q0 24375041 73 33.14125 imi_mug_run_2_treatment "aim"
17 Q0 24706357 74 33.0577 imi_mug_run_2_treatment "others"
17 Q0 29844869 75 32.97153 imi_mug_run_2_treatment "level"
17 Q0 22298889 76 32.94203 imi_mug_run_2_treatment "antiangiogenic"
17 Q0 22270850 77 32.88377 imi_mug_run_2_treatment "lead"
17 Q0 24019001 78 32.88018 imi_mug_run_2_treatment "agent" "lead"
17 Q0 28302331 79 32.633133 imi_mug_run_2_treatment "temozolomide" "adjuvant"
17 Q0 24129546 80 32.511093 imi_mug_run_2_treatment "vascular endothelial growth factor"
17 Q0 27626306 81 32.478447 imi_mug_run_2_treatment "bevacizumab" "antiangiogenic"
17 Q0 28571041 82 32.384464 imi_mug_run_2_treatment "drug" "oxygen" "temozolomide"
17 Q0 26366972 83 32.384407 imi_mug_run_2_treatment "aminolevulinic acid" "tyrosine" "aim"
17 Q0 29372493 84 32.357895 imi_mug_run_2_treatment "sodium" "electrolyte" "level"
17 Q0 28507382 85 32.06095 imi_mug_run_2_treatment "basis" "genesis"
17 Q0 26373279 86 31.935595 imi_mug_run_2_treatment "tmz" "temozolomide"
17 Q0 25650121 87 31.912592 imi_mug_run_2_treatment "various"
17 Q0 22752663 88 31.750795 imi_mug_run_2_treatment "temozolomide" "tmz"
17 Q0 28195901 89 31.71467 imi_mug_run_2_treatment "amt" "tryptophan"
17 Q0 24876103 90 31.567444 imi_mug_run_2_treatment "level"
17 Q0 28564604 91 31.561535 imi_mug_run_2_treatment "acetate" "glucose" "oxygen"
17 Q0 23595628 92 31.479767 imi_mug_run_2_treatment "phosphate"
17 Q0 27406953 93 31.326134 imi_mug_run_2_treatment "arginine" "histidine"
17 Q0 22752145 94 31.123936 imi_mug_run_2_treatment "cetuximab"
17 Q0 30152087 95 31.03093 imi_mug_run_2_treatment "lgg"
17 Q0 28467784 96 30.991062 imi_mug_run_2_treatment "lactate" "acetate" "tca"
17 Q0 27834733 97 30.93433 imi_mug_run_2_treatment "mediated" "mek inhibitor" "level"
17 Q0 30073642 98 30.792356 imi_mug_run_2_treatment "various" "atezolizumab" "immunosuppressive"
17 Q0 19378339 99 30.745869 imi_mug_run_2_treatment "various" "aim" "liver"
17 Q0 22865003 100 30.699112 imi_mug_run_2_treatment "aim"
17 Q0 28353033 101 30.653414 imi_mug_run_2_treatment "buffer" "edta" "tris"
17 Q0 22281465 102 30.558712 imi_mug_run_2_treatment "various" "temozolomide"
17 Q0 23541771 103 30.557547 imi_mug_run_2_treatment "oxygen"
17 Q0 21885076 104 30.410912 imi_mug_run_2_treatment "therapeutics"
17 Q0 26404554 105 30.38467 imi_mug_run_2_treatment "temozolomide"
17 Q0 29251609 106 29.889912 imi_mug_run_2_treatment "product" "aim"
17 Q0 26323991 107 29.724297 imi_mug_run_2_treatment "collagen"
17 Q0 26852708 108 29.607147 imi_mug_run_2_treatment "temozolomide" "cisplatin" "semustine"
17 Q0 26503470 109 29.596197 imi_mug_run_2_treatment "tmz" "temozolomide"
17 Q0 20504876 110 29.58943 imi_mug_run_2_treatment "various" "mediated" "endostatin"
17 Q0 23291739 111 29.50876 imi_mug_run_2_treatment "sts"
17 Q0 24614622 112 29.465405 imi_mug_run_2_treatment "rembrandt"
17 Q0 25950388 113 29.460316 imi_mug_run_2_treatment "various"
17 Q0 26591624 114 29.389076 imi_mug_run_2_treatment "adjuvant" "antisera" "temozolomide"
17 Q0 21045145 115 29.33892 imi_mug_run_2_treatment "glutamine"
17 Q0 26911558 116 29.25344 imi_mug_run_2_treatment "temozolomide" "others"
17 Q0 22046342 117 29.214012 imi_mug_run_2_treatment "kinase inhibitor"
17 Q0 25943888 118 29.20714 imi_mug_run_2_treatment "therapeutics"
17 Q0 26124478 119 29.195606 imi_mug_run_2_treatment "bevacizumab" "temozolomide" "avastin"
17 Q0 19805672 120 29.191456 imi_mug_run_2_treatment "temozolomide"
17 Q0 24158110 121 28.92632 imi_mug_run_2_treatment "aim"
17 Q0 21442241 122 28.900055 imi_mug_run_2_treatment "basis"
17 Q0 29937336 123 28.783329 imi_mug_run_2_treatment "temozolomide" "adjuvant" "tmz"
17 Q0 27260389 124 28.594238 imi_mug_run_2_treatment "tmz" "temozolomide"
17 Q0 22199315 125 28.53071 imi_mug_run_2_treatment "bevacizumab" "cetuximab" "sunitinib"
17 Q0 29718366 126 28.502974 imi_mug_run_2_treatment "oxygen" "level"
17 Q0 29618055 127 28.47649 imi_mug_run_2_treatment "temozolomide" "bevacizumab"
17 Q0 29302887 128 28.189688 imi_mug_run_2_treatment "lead"
17 Q0 27437179 129 28.09645 imi_mug_run_2_treatment "lactate" "temozolomide" "tmz"
17 Q0 28039367 130 27.928482 imi_mug_run_2_treatment "abt-414" "temozolomide" "drug"
17 Q0 26366867 131 27.885584 imi_mug_run_2_treatment "formalin"
17 Q0 26092597 132 27.777767 imi_mug_run_2_treatment "level" "aim"
17 Q0 24662514 133 27.776573 imi_mug_run_2_treatment "rembrandt"
17 Q0 28672945 134 27.68559 imi_mug_run_2_treatment "temozolomide" "drug"
17 Q0 26616112 135 27.591478 imi_mug_run_2_treatment "various" "super oxide dismutase"
17 Q0 21382095 136 27.44865 imi_mug_run_2_treatment "level" "aim"
17 Q0 29016996 137 27.42071 imi_mug_run_2_treatment "tyrosine"
17 Q0 27923049 138 27.372627 imi_mug_run_2_treatment "lgg"
17 Q0 29434344 139 27.344015 imi_mug_run_2_treatment "adjuvant" "level"
17 Q0 26506620 140 27.23684 imi_mug_run_2_treatment "glucose" "favor"
17 Q0 28214639 141 26.749771 imi_mug_run_2_treatment "interferon-beta" "etoposide" "carboplatin"
17 Q0 26934681 142 26.745243 imi_mug_run_2_treatment "sts"
17 Q0 25714433 143 26.674282 imi_mug_run_2_treatment "chondroitin sulfate"
17 Q0 30386738 144 26.541513 imi_mug_run_2_treatment "enzymes" "basis"
17 Q0 29599982 145 26.514736 imi_mug_run_2_treatment "various" "eosin"
17 Q0 20692206 146 26.301355 imi_mug_run_2_treatment "enzymes" "alpha-ketoglutarate"
17 Q0 21955197 147 26.217537 imi_mug_run_2_treatment "enzymes" "therapeutics"
17 Q0 24765187 148 26.18809 imi_mug_run_2_treatment "temozolomide" "tumor vaccination" "bevacizumab"
17 Q0 30156013 149 26.10913 imi_mug_run_2_treatment "icc" "various" "agi-5198"
17 Q0 29108308 150 26.08753 imi_mug_run_2_treatment "drug" "bevacizumab" "agent"
17 Q0 28984190 151 25.95634 imi_mug_run_2_treatment "level"
17 Q0 29147863 152 25.928967 imi_mug_run_2_treatment "aim"
17 Q0 25976245 153 25.887907 imi_mug_run_2_treatment "combinations"
17 Q0 28945795 154 25.793495 imi_mug_run_2_treatment "level"
17 Q0 21555372 155 25.793495 imi_mug_run_2_treatment "others"
17 Q0 22568967 156 25.766014 imi_mug_run_2_treatment "various"
17 Q0 30472185 157 25.653086 imi_mug_run_2_treatment "tam"
17 Q0 27764705 158 25.616077 imi_mug_run_2_treatment "tmz" "temozolomide" "adjuvant"
17 Q0 24451717 159 25.549505 imi_mug_run_2_treatment "vascular endothelial growth factor"
17 Q0 26018396 160 25.443703 imi_mug_run_2_treatment "aed" "antiepileptic drug" "temozolomide"
17 Q0 25754088 161 25.227463 imi_mug_run_2_treatment "program" "suppressor"
17 Q0 28161760 162 25.227463 imi_mug_run_2_treatment "program"
17 Q0 25586680 163 25.220493 imi_mug_run_2_treatment "enzymes"
17 Q0 26960561 164 25.127056 imi_mug_run_2_treatment "adjuvant" "favor" "agent"
17 Q0 23530875 165 25.123262 imi_mug_run_2_treatment "temozolomide" "tmz"
17 Q0 25727226 166 25.032925 imi_mug_run_2_treatment "therapeutics"
17 Q0 21996744 167 24.962732 imi_mug_run_2_treatment "lead"
17 Q0 26224161 168 24.645374 imi_mug_run_2_treatment "level" "macrophage colony-stimulating factor"
17 Q0 23711013 169 24.518312 imi_mug_run_2_treatment "temozolomide" "balance"
17 Q0 28759950 170 24.415771 imi_mug_run_2_treatment "various" "aim"
17 Q0 25944688 171 24.351032 imi_mug_run_2_treatment "sts" "magea3"
17 Q0 30401645 172 24.139973 imi_mug_run_2_treatment "matrix"
17 Q0 29668342 173 24.081772 imi_mug_run_2_treatment "medicine" "plasma"
17 Q0 20661018 174 23.966434 imi_mug_run_2_treatment "various"
17 Q0 29628799 175 23.953066 imi_mug_run_2_treatment "temozolomide" "tmz" "agent"
17 Q0 23184331 176 23.939142 imi_mug_run_2_treatment "glycine"
17 Q0 20862485 177 23.74477 imi_mug_run_2_treatment "anti-angiogenic agents" "agent"
17 Q0 20817192 178 23.726013 imi_mug_run_2_treatment "others"
17 Q0 29704527 179 23.719444 imi_mug_run_2_treatment "tacrine" "drug" "tmz"
17 Q0 20589679 180 23.712154 imi_mug_run_2_treatment "hydroxyurea" "imatinib" "tyrosine kinase inhibitor"
17 Q0 20972461 181 23.506897 imi_mug_run_2_treatment "enzymes"
17 Q0 29393185 182 23.366203 imi_mug_run_2_treatment "temozolomide" "pcv"
17 Q0 26945349 183 23.12357 imi_mug_run_2_treatment "combinations" "pooled"
17 Q0 26423801 184 23.115364 imi_mug_run_2_treatment "temozolomide" "tmz" "methylated"
17 Q0 22238332 185 23.021774 imi_mug_run_2_treatment "arginine" "glutamine"
17 Q0 27253461 186 22.828989 imi_mug_run_2_treatment "agent"
17 Q0 30347300 187 22.770866 imi_mug_run_2_treatment "aim"
17 Q0 28110346 188 22.734165 imi_mug_run_2_treatment "meth"
17 Q0 27604789 189 22.721842 imi_mug_run_2_treatment "metrics"
17 Q0 24473978 190 22.695322 imi_mug_run_2_treatment "temozolomide" "methylated"
17 Q0 24997139 191 22.673567 imi_mug_run_2_treatment "oxygen" "phosphate"
17 Q0 29439493 192 22.600927 imi_mug_run_2_treatment "enzymes" "lysine" "lead"
17 Q0 25184684 193 22.576912 imi_mug_run_2_treatment "pdx" "bromodeoxyuridine"
17 Q0 25562199 194 22.495275 imi_mug_run_2_treatment "level"
17 Q0 23762372 195 22.495275 imi_mug_run_2_treatment "level" "aim"
17 Q0 24312360 196 22.379227 imi_mug_run_2_treatment "serine" "level"
17 Q0 25821160 197 22.331505 imi_mug_run_2_treatment "aim"
17 Q0 25429835 198 22.331505 imi_mug_run_2_treatment "aim"
17 Q0 28654422 199 22.331505 imi_mug_run_2_treatment "various" "aim"
17 Q0 25869098 200 22.307243 imi_mug_run_2_treatment "various" "tmz" "temozolomide"
17 Q0 23096413 201 22.022484 imi_mug_run_2_treatment "cystine"
17 Q0 28375741 202 21.970058 imi_mug_run_2_treatment "nicotinamide adenine dinucleotide" "therapeutics"
17 Q0 21641335 203 21.916702 imi_mug_run_2_treatment "lead" "level"
17 Q0 25909875 204 21.867437 imi_mug_run_2_treatment "aim"
17 Q0 19915015 205 21.803608 imi_mug_run_2_treatment "enzymes"
17 Q0 22570067 206 21.803608 imi_mug_run_2_treatment "alkylating agents" "level"
17 Q0 29844871 207 21.780163 imi_mug_run_2_treatment "level"
17 Q0 26902851 208 21.77149 imi_mug_run_2_treatment "drug" "kinase inhibitor" "lomustine"
17 Q0 20869088 209 21.63373 imi_mug_run_2_treatment "adjuvant"
17 Q0 27370400 210 21.47979 imi_mug_run_2_treatment "blockade"
17 Q0 24057326 211 21.45541 imi_mug_run_2_treatment "pas"
17 Q0 29730791 212 21.438557 imi_mug_run_2_treatment "various" "shh"
17 Q0 29218546 213 21.388548 imi_mug_run_2_treatment "aim"
17 Q0 29454261 214 21.34626 imi_mug_run_2_treatment "lead"
17 Q0 25609060 215 21.096909 imi_mug_run_2_treatment "jnj-42756493"
17 Q0 28339588 216 21.080814 imi_mug_run_2_treatment "rembrandt"
17 Q0 28401334 217 21.074451 imi_mug_run_2_treatment "various"
17 Q0 27713134 218 21.049316 imi_mug_run_2_treatment "level"
17 Q0 25233099 219 20.988853 imi_mug_run_2_treatment "temozolomide"
17 Q0 30236994 220 20.988853 imi_mug_run_2_treatment "temozolomide"
17 Q0 30038703 221 20.974184 imi_mug_run_2_treatment "various"
17 Q0 28631186 222 20.776333 imi_mug_run_2_treatment "basis"
17 Q0 28481241 223 20.612524 imi_mug_run_2_treatment "galunisertib" "lomustine" "kinase inhibitor"
17 Q0 24328866 224 20.315355 imi_mug_run_2_treatment "anticonvulsant" "valproic acid"
17 Q0 20124482 225 20.310259 imi_mug_run_2_treatment "suppressor"
17 Q0 29703472 226 20.310259 imi_mug_run_2_treatment "coagulant" "protease" "mediators"
17 Q0 29170066 227 20.310259 imi_mug_run_2_treatment "combinations" "alkylating agent"
17 Q0 21472719 228 20.269173 imi_mug_run_2_treatment "tmz" "interferon" "temozolomide"
17 Q0 26493382 229 20.2647 imi_mug_run_2_treatment "various"
17 Q0 23243055 230 20.259615 imi_mug_run_2_treatment "bevacizumab" "temozolomide" "iplex"
17 Q0 27573687 231 20.223503 imi_mug_run_2_treatment "others"
17 Q0 26885285 232 20.208126 imi_mug_run_2_treatment "aim"
17 Q0 22990979 233 20.17182 imi_mug_run_2_treatment "temozolomide"
17 Q0 29767813 234 20.17182 imi_mug_run_2_treatment "level" "pooled"
17 Q0 27230974 235 20.102001 imi_mug_run_2_treatment "tmz" "temozolomide"
17 Q0 28980701 236 20.102001 imi_mug_run_2_treatment "suppressor"
17 Q0 22309944 237 20.07899 imi_mug_run_2_treatment "enzymes"
17 Q0 21914791 238 19.982878 imi_mug_run_2_treatment "temozolomide"
17 Q0 23801749 239 19.982878 imi_mug_run_2_treatment "various" "tet"
17 Q0 27278882 240 19.976961 imi_mug_run_2_treatment "combinations" "lead"
17 Q0 23432648 241 19.916943 imi_mug_run_2_treatment "enzymes"
17 Q0 24264532 242 19.895428 imi_mug_run_2_treatment "sts"
17 Q0 29063957 243 19.895428 imi_mug_run_2_treatment "various"
17 Q0 26033547 244 19.82845 imi_mug_run_2_treatment "level" "aim"
17 Q0 21107199 245 19.82845 imi_mug_run_2_treatment "various"
17 Q0 30404651 246 19.82845 imi_mug_run_2_treatment "glutamine"
17 Q0 26839018 247 19.777836 imi_mug_run_2_treatment "genesis"
17 Q0 29255149 248 19.65018 imi_mug_run_2_treatment "level" "flair" "adc"
17 Q0 26212701 249 19.462904 imi_mug_run_2_treatment "favor" "bevacizumab" "vascular endothelial growth factor"
17 Q0 27923831 250 19.455687 imi_mug_run_2_treatment "mediated" "antioxidants"
17 Q0 22249618 251 18.102901 imi_mug_run_2_treatment "temozolomide"
17 Q0 26354927 252 18.089325 imi_mug_run_2_treatment "pcv" "procarbazine" "aim"
17 Q0 25468223 253 18.074915 imi_mug_run_2_treatment "various" "temozolomide"
17 Q0 29730475 254 18.04435 imi_mug_run_2_treatment "iron"
17 Q0 24670968 255 18.034391 imi_mug_run_2_treatment "genesis"
17 Q0 30295979 256 17.967154 imi_mug_run_2_treatment "phosphate"
17 Q0 24410805 257 17.965794 imi_mug_run_2_treatment "various" "tma"
17 Q0 28472509 258 17.82118 imi_mug_run_2_treatment "tmz" "temozolomide" "autologous"
17 Q0 21378543 259 17.783592 imi_mug_run_2_treatment "level"
17 Q0 27649069 260 17.783592 imi_mug_run_2_treatment "basis"
17 Q0 26603354 261 16.990192 imi_mug_run_2_treatment "temozolomide"
17 Q0 24582303 262 16.790388 imi_mug_run_2_treatment "temozolomide" "bevacizumab"
17 Q0 22960273 263 16.72848 imi_mug_run_2_treatment "sts"
17 Q0 26370624 264 16.58228 imi_mug_run_2_treatment "various"
17 Q0 20304625 265 16.58228 imi_mug_run_2_treatment "revival"
17 Q0 26253473 266 16.550884 imi_mug_run_2_treatment "various" "medication"
17 Q0 22930388 267 16.550884 imi_mug_run_2_treatment "meth"
17 Q0 26660517 268 16.550884 imi_mug_run_2_treatment "therapeutics" "quinone" "arq 501"
17 Q0 25192052 269 16.494572 imi_mug_run_2_treatment "ras"
17 Q0 26967252 270 16.494572 imi_mug_run_2_treatment "plasma" "arginine" "cystamine"
17 Q0 26190651 271 16.494572 imi_mug_run_2_treatment "various" "glucose" "mediated"
17 Q0 22829908 272 16.494572 imi_mug_run_2_treatment "enzymes" "tet"
17 Q0 25135958 273 16.494572 imi_mug_run_2_treatment "temozolomide"
17 Q0 25054200 274 16.494572 imi_mug_run_2_treatment "edu"
17 Q0 28574255 275 16.494572 imi_mug_run_2_treatment "gold" "shape"
17 Q0 24607494 276 16.47933 imi_mug_run_2_treatment "rembrandt" "aim"
17 Q0 24549719 277 16.47933 imi_mug_run_2_treatment "lithium chloride" "lead"
17 Q0 24114272 278 16.47933 imi_mug_run_2_treatment "therapeutics"
17 Q0 22098029 279 16.47933 imi_mug_run_2_treatment "drugs"
17 Q0 26927648 280 16.47933 imi_mug_run_2_treatment "prisma"
17 Q0 29610069 281 16.47933 imi_mug_run_2_treatment "level" "nervous system"
17 Q0 27025857 282 14.433321 imi_mug_run_2_treatment "tmz" "temozolomide"
17 Q0 28432586 283 14.433321 imi_mug_run_2_treatment "aim"
17 Q0 27781423 284 14.417507 imi_mug_run_2_treatment "formaldehyde"
17 Q0 28371827 285 14.417507 imi_mug_run_2_treatment "basis"
17 Q0 21829728 286 14.406328 imi_mug_run_2_treatment "tmz" "temozolomide" "agent"
17 Q0 23104868 287 14.357143 imi_mug_run_2_treatment "lgg"
17 Q0 23095825 288 14.357143 imi_mug_run_2_treatment "temozolomide" "procarbazine" "vincristine"
17 Q0 27158275 289 14.357143 imi_mug_run_2_treatment "level" "alkylating drugs" "temozolomide"
17 Q0 26699864 290 11.967728 imi_mug_run_2_treatment "lgg"
18 Q0 25985019 1 70.89055 imi_mug_run_2_treatment "ras"
18 Q0 29962848 2 50.13412 imi_mug_run_2_treatment "trametinib" "vemurafenib" "dabrafenib"
18 Q0 26711128 3 47.94904 imi_mug_run_2_treatment "ras"
18 Q0 24035431 4 46.894516 imi_mug_run_2_treatment "vemurafenib"
18 Q0 19369630 5 46.596893 imi_mug_run_2_treatment "ras"
18 Q0 26273372 6 45.21338 imi_mug_run_2_treatment "plasma" "adc"
18 Q0 27738759 7 43.803642 imi_mug_run_2_treatment "basis"
18 Q0 17332367 8 43.06984 imi_mug_run_2_treatment "various" "level"
18 Q0 29151304 9 42.98853 imi_mug_run_2_treatment "aim"
18 Q0 26102513 10 42.001484 imi_mug_run_2_treatment "adc"
18 Q0 30019008 11 41.12422 imi_mug_run_2_treatment "tyrosine"
18 Q0 29167001 12 40.774315 imi_mug_run_2_treatment "pemetrexed" "platinum" "aim"
18 Q0 22975805 13 40.53982 imi_mug_run_2_treatment "tyrosine" "lead" "basis"
18 Q0 24469055 14 39.72284 imi_mug_run_2_treatment "ras"
18 Q0 29517858 15 39.658577 imi_mug_run_2_treatment "drugs"
18 Q0 25466451 16 39.371807 imi_mug_run_2_treatment "braf inhibitor" "vemurafenib" "dabrafenib"
18 Q0 22969966 17 39.337265 imi_mug_run_2_treatment "tyrosine"
18 Q0 29036262 18 39.090733 imi_mug_run_2_treatment "vemurafenib" "drugs"
18 Q0 27017063 19 38.98538 imi_mug_run_2_treatment "agent" "egfr tyrosine kinase inhibitors" "aim"
18 Q0 26200454 20 38.934776 imi_mug_run_2_treatment "sorafenib" "vemurafenib" "dabrafenib"
18 Q0 24503571 21 38.768116 imi_mug_run_2_treatment "basis"
18 Q0 30150445 22 38.75342 imi_mug_run_2_treatment "alectinib"
18 Q0 27094798 23 38.474564 imi_mug_run_2_treatment "pemetrexed" "basis"
18 Q0 23157740 24 38.462147 imi_mug_run_2_treatment "level"
18 Q0 27342566 25 38.42441 imi_mug_run_2_treatment "mediated"
18 Q0 30107055 26 38.42441 imi_mug_run_2_treatment "various"
18 Q0 25226429 27 38.29382 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
18 Q0 25806238 28 38.14676 imi_mug_run_2_treatment "dabrafenib" "drugs" "ras"
18 Q0 24736082 29 37.782406 imi_mug_run_2_treatment "p23"
18 Q0 26134228 30 37.77745 imi_mug_run_2_treatment "agar" "mediated"
18 Q0 22707299 31 37.324608 imi_mug_run_2_treatment "aim"
18 Q0 23154560 32 37.206955 imi_mug_run_2_treatment "vandetanib"
18 Q0 24888229 33 36.965424 imi_mug_run_2_treatment "vemurafenib" "vemurafenib's" "braf inhibitor"
18 Q0 26237499 34 36.94061 imi_mug_run_2_treatment "sorafenib" "platinum"
18 Q0 28203297 35 36.930298 imi_mug_run_2_treatment "drugs"
18 Q0 24462463 36 36.802025 imi_mug_run_2_treatment "aim"
18 Q0 26366094 37 36.790714 imi_mug_run_2_treatment "gefitinib" "erlotinib" "crizotinib"
18 Q0 29039585 38 36.655415 imi_mug_run_2_treatment "gefitinib" "erlotinib" "aim"
18 Q0 27794403 39 36.544746 imi_mug_run_2_treatment "level" "platinum"
18 Q0 26845116 40 36.45092 imi_mug_run_2_treatment "formalin" "basis"
18 Q0 16721785 41 36.440247 imi_mug_run_2_treatment "ras"
18 Q0 28848703 42 36.19435 imi_mug_run_2_treatment "lead"
18 Q0 30095461 43 36.03944 imi_mug_run_2_treatment "aim"
18 Q0 30334450 44 35.959694 imi_mug_run_2_treatment "adca"
18 Q0 29467863 45 35.691216 imi_mug_run_2_treatment "drugs" "dabrafenib"
18 Q0 24935562 46 35.660854 imi_mug_run_2_treatment "level"
18 Q0 24519667 47 35.623592 imi_mug_run_2_treatment "viral vector" "cytotoxic"
18 Q0 17510423 48 35.48134 imi_mug_run_2_treatment "ci-1040" "mek inhibitor"
18 Q0 26098749 49 35.431297 imi_mug_run_2_treatment "ras"
18 Q0 24361161 50 35.33504 imi_mug_run_2_treatment "product"
18 Q0 29137260 51 35.249207 imi_mug_run_2_treatment "ppa"
18 Q0 20381121 52 35.203083 imi_mug_run_2_treatment "aim"
18 Q0 25170107 53 35.129757 imi_mug_run_2_treatment "abc" "crizotinib" "ceritinib"
18 Q0 25629635 54 34.734257 imi_mug_run_2_treatment "aim"
18 Q0 25294908 55 34.617252 imi_mug_run_2_treatment "epidermal growth factor" "gefitinib"
18 Q0 25234288 56 34.594063 imi_mug_run_2_treatment "crizotinib"
18 Q0 22407457 57 34.45737 imi_mug_run_2_treatment "ras"
18 Q0 25054035 58 34.382683 imi_mug_run_2_treatment "drugs"
18 Q0 25429229 59 34.37399 imi_mug_run_2_treatment "mica" "basis"
18 Q0 25064355 60 34.35743 imi_mug_run_2_treatment "vandetanib" "tyrosine kinase inhibitor"
18 Q0 27496196 61 34.327152 imi_mug_run_2_treatment "crizotinib" "her-2" "tyrosine kinase inhibitor"
18 Q0 25126481 62 34.28877 imi_mug_run_2_treatment "agar" "collagen"
18 Q0 17299132 63 34.20828 imi_mug_run_2_treatment "mediated"
18 Q0 29290255 64 34.04903 imi_mug_run_2_treatment "erlotinib" "egfr inhibitor"
18 Q0 27670699 65 34.006947 imi_mug_run_2_treatment "adc" "selumetinib"
18 Q0 24700479 66 33.93693 imi_mug_run_2_treatment "medicine" "therapeutics"
18 Q0 29600239 67 33.934605 imi_mug_run_2_treatment "crizotinib" "cdx" "aim"
18 Q0 29850361 68 33.83777 imi_mug_run_2_treatment "vemurafenib" "braf inhibitor" "drugs"
18 Q0 29692481 69 33.727615 imi_mug_run_2_treatment "aim"
18 Q0 23405175 70 33.6906 imi_mug_run_2_treatment "level" "lead"
18 Q0 30060710 71 33.67827 imi_mug_run_2_treatment "trametinib" "dabrafenib" "drug"
18 Q0 29517860 72 33.6551 imi_mug_run_2_treatment "product" "tyrosine kinase inhibitor" "crizotinib"
18 Q0 27561802 73 33.566715 imi_mug_run_2_treatment "crizotinib"
18 Q0 30015159 74 33.549675 imi_mug_run_2_treatment "agar"
18 Q0 29361925 75 33.486782 imi_mug_run_2_treatment "crizotinib" "lorlatinib" "cisplatin"
18 Q0 26486077 76 33.227512 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
18 Q0 23392229 77 33.2097 imi_mug_run_2_treatment "adjuvant" "egfr tyrosine kinase inhibitors" "aim"
18 Q0 25676401 78 32.782356 imi_mug_run_2_treatment "crizotinib"
18 Q0 26301799 79 32.705902 imi_mug_run_2_treatment "braf inhibitor" "ras" "trametinib"
18 Q0 25941815 80 32.703854 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
18 Q0 28821955 81 32.602768 imi_mug_run_2_treatment "level"
18 Q0 30133144 82 32.602745 imi_mug_run_2_treatment "alectinib"
18 Q0 28971587 83 32.596798 imi_mug_run_2_treatment "crizotinib"
18 Q0 27080364 84 32.509228 imi_mug_run_2_treatment "dabrafenib" "vemurafenib" "braf inhibitor"
18 Q0 25851827 85 32.49415 imi_mug_run_2_treatment "product" "tyrosine kinase inhibitor" "crizotinib"
18 Q0 21151896 86 32.42392 imi_mug_run_2_treatment "level"
18 Q0 27922010 87 32.2331 imi_mug_run_2_treatment "drugs" "drug" "ras"
18 Q0 30214735 88 32.184845 imi_mug_run_2_treatment "vemurafenib" "plasma" "braf inhibitor"
18 Q0 27769042 89 32.1698 imi_mug_run_2_treatment "various" "crizotinib"
18 Q0 16029927 90 32.16885 imi_mug_run_2_treatment "ras" "mediated"
18 Q0 30225212 91 32.123856 imi_mug_run_2_treatment "others"
18 Q0 30268483 92 32.04913 imi_mug_run_2_treatment "erlotinib" "blockade"
18 Q0 25796500 93 32.023884 imi_mug_run_2_treatment "suppressor"
18 Q0 21798574 94 32.023884 imi_mug_run_2_treatment "cisplatin" "drug"
18 Q0 14724583 95 31.983639 imi_mug_run_2_treatment "ras"
18 Q0 24469108 96 31.974617 imi_mug_run_2_treatment "agar"
18 Q0 23181703 97 31.963715 imi_mug_run_2_treatment "erlotinib" "platinum"
18 Q0 29327716 98 31.935518 imi_mug_run_2_treatment "level" "drugs" "crizotinib"
18 Q0 22327624 99 31.867893 imi_mug_run_2_treatment "vandetanib" "tyrosine kinase inhibitor"
18 Q0 23661334 100 31.864862 imi_mug_run_2_treatment "pace"
18 Q0 25760072 101 31.8256 imi_mug_run_2_treatment "aim"
18 Q0 21102258 102 31.662357 imi_mug_run_2_treatment "various" "drugs" "others"
18 Q0 24768118 103 31.639204 imi_mug_run_2_treatment "aim"
18 Q0 29771657 104 31.607569 imi_mug_run_2_treatment "ras" "aim"
18 Q0 28135039 105 31.583338 imi_mug_run_2_treatment "drugs"
18 Q0 25273224 106 31.435635 imi_mug_run_2_treatment "ras"
18 Q0 23418494 107 31.419973 imi_mug_run_2_treatment "kinase inhibitor" "therapeutic agents" "crizotinib"
18 Q0 26703797 108 31.409472 imi_mug_run_2_treatment "drugs" "crizotinib"
18 Q0 12460918 109 31.405924 imi_mug_run_2_treatment "ras" "mediated"
18 Q0 23991695 110 31.405766 imi_mug_run_2_treatment "tyrosine" "vandetanib" "xl184"
18 Q0 22483782 111 31.367317 imi_mug_run_2_treatment "level"
18 Q0 29948972 112 31.289461 imi_mug_run_2_treatment "platinum" "taxanes" "gemcitabine"
18 Q0 21457162 113 31.273525 imi_mug_run_2_treatment "level"
18 Q0 27753661 114 31.23058 imi_mug_run_2_treatment "cdx"
18 Q0 19079609 115 31.132221 imi_mug_run_2_treatment "androgen" "lead"
18 Q0 23098378 116 30.943125 imi_mug_run_2_treatment "lead"
18 Q0 30060526 117 30.92606 imi_mug_run_2_treatment "combinations" "adc" "level"
18 Q0 26862733 118 30.923035 imi_mug_run_2_treatment "various" "afatinib" "egfr tyrosine kinase inhibitor"
18 Q0 23647298 119 30.896137 imi_mug_run_2_treatment "aim"
18 Q0 23919423 120 30.875881 imi_mug_run_2_treatment "drug combination"
18 Q0 26892442 121 30.849209 imi_mug_run_2_treatment "various"
18 Q0 18987552 122 30.839672 imi_mug_run_2_treatment "ras"
18 Q0 29268402 123 30.798195 imi_mug_run_2_treatment "crizotinib"
18 Q0 29364576 124 30.722641 imi_mug_run_2_treatment "ras"
18 Q0 28572536 125 30.69813 imi_mug_run_2_treatment "medication" "plasma"
18 Q0 19383809 126 30.689869 imi_mug_run_2_treatment "dextran"
18 Q0 26837769 127 30.68533 imi_mug_run_2_treatment "igf2" "insulin-like growth factor 2"
18 Q0 29290262 128 30.660925 imi_mug_run_2_treatment "crizotinib" "product" "ceritinib"
18 Q0 27200298 129 30.648758 imi_mug_run_2_treatment "therapeutics"
18 Q0 29571998 130 30.63864 imi_mug_run_2_treatment "vandetanib" "cabozantinib"
18 Q0 23664446 131 30.604506 imi_mug_run_2_treatment "kinase inhibitor" "crizotinib"
18 Q0 28280984 132 30.539282 imi_mug_run_2_treatment "drugs" "blockade"
18 Q0 26813592 133 30.52163 imi_mug_run_2_treatment "crizotinib" "aim"
18 Q0 2555985 134 30.485676 imi_mug_run_2_treatment "immunotoxin" "cytotoxic" "abc"
18 Q0 23052255 135 30.359188 imi_mug_run_2_treatment "tyrosine"
18 Q0 20731934 136 30.333103 imi_mug_run_2_treatment "aim"
18 Q0 25556681 137 30.32289 imi_mug_run_2_treatment "aim"
18 Q0 25851923 138 30.298046 imi_mug_run_2_treatment "various"
18 Q0 26893862 139 30.28595 imi_mug_run_2_treatment "drugs" "carboplatin" "agent"
18 Q0 24510538 140 30.255447 imi_mug_run_2_treatment "various" "mediated" "cytotoxic"
18 Q0 22135231 141 30.248722 imi_mug_run_2_treatment "various" "ras" "erlotinib"
18 Q0 26964870 142 30.159523 imi_mug_run_2_treatment "therapeutic agents" "crizotinib" "asp3026"
18 Q0 28078189 143 30.153206 imi_mug_run_2_treatment "dabrafenib" "agent" "trametinib"
18 Q0 25894280 144 30.102459 imi_mug_run_2_treatment "crest"
18 Q0 26901483 145 30.08915 imi_mug_run_2_treatment "ras"
18 Q0 29616327 146 29.941809 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors" "gefitinib" "erlotinib"
18 Q0 26268749 147 29.931643 imi_mug_run_2_treatment "crizotinib"
18 Q0 29549897 148 29.931108 imi_mug_run_2_treatment "various" "tma"
18 Q0 29335598 149 29.840805 imi_mug_run_2_treatment "pemetrexed"
18 Q0 18632602 150 29.683132 imi_mug_run_2_treatment "azd6244" "lysine" "mek inhibitor"
18 Q0 25546673 151 29.627172 imi_mug_run_2_treatment "favor"
18 Q0 23489560 152 29.464394 imi_mug_run_2_treatment "various" "drugs"
18 Q0 27480287 153 29.42746 imi_mug_run_2_treatment "ceritinib" "crizotinib" "food"
18 Q0 27116958 154 29.42709 imi_mug_run_2_treatment "ras"
18 Q0 21943394 155 29.42587 imi_mug_run_2_treatment "anti-egfr monoclonal antibody" "cetuximab" "gefitinib"
18 Q0 27756333 156 29.328722 imi_mug_run_2_treatment "pemetrexed" "platinum" "crizotinib"
18 Q0 27575422 157 29.318836 imi_mug_run_2_treatment "pemetrexed" "program"
18 Q0 26775573 158 29.303257 imi_mug_run_2_treatment "crizotinib" "program" "gefitinib"
18 Q0 27180965 159 29.257284 imi_mug_run_2_treatment "various" "ras" "drugs"
18 Q0 21428883 160 29.242294 imi_mug_run_2_treatment "various" "erlotinib" "tyrosine"
18 Q0 26998077 161 29.16494 imi_mug_run_2_treatment "epidermal growth factor"
18 Q0 30326973 162 29.15001 imi_mug_run_2_treatment "mtp"
18 Q0 26703339 163 29.104376 imi_mug_run_2_treatment "crizotinib"
18 Q0 27613526 164 29.10008 imi_mug_run_2_treatment "pdx" "crizotinib" "product"
18 Q0 26207220 165 29.090345 imi_mug_run_2_treatment "pooled"
18 Q0 21129606 166 29.034382 imi_mug_run_2_treatment "drugs" "egfr tyrosine kinase inhibitors"
18 Q0 29227119 167 29.029083 imi_mug_run_2_treatment "aim"
18 Q0 21479466 168 29.027292 imi_mug_run_2_treatment "ras"
18 Q0 28947956 169 28.998478 imi_mug_run_2_treatment "trametinib" "dabrafenib" "basis"
18 Q0 23932363 170 28.97127 imi_mug_run_2_treatment "color"
18 Q0 27454941 171 28.847563 imi_mug_run_2_treatment "lead"
18 Q0 24163741 172 28.837399 imi_mug_run_2_treatment "adc" "lead" "revolution"
18 Q0 24388371 173 28.806755 imi_mug_run_2_treatment "basis"
18 Q0 28362192 174 28.771078 imi_mug_run_2_treatment "crizotinib"
18 Q0 24511003 175 28.77046 imi_mug_run_2_treatment "aim"
18 Q0 27080983 176 28.737091 imi_mug_run_2_treatment "aim"
18 Q0 26045855 177 28.712017 imi_mug_run_2_treatment "vemurafenib" "agent"
18 Q0 28851076 178 28.693472 imi_mug_run_2_treatment "cisplatin" "level"
18 Q0 29320776 179 28.687624 imi_mug_run_2_treatment "various"
18 Q0 29454261 180 28.678448 imi_mug_run_2_treatment "lead"
18 Q0 22522845 181 28.66991 imi_mug_run_2_treatment "level"
18 Q0 26301689 182 28.638891 imi_mug_run_2_treatment "ras" "duration"
18 Q0 29449740 183 28.6016 imi_mug_run_2_treatment "vinca alkaloid" "vinorelbine"
18 Q0 19706765 184 28.571905 imi_mug_run_2_treatment "interleukin-6"
18 Q0 26711930 185 28.509747 imi_mug_run_2_treatment "program"
18 Q0 23301645 186 28.499073 imi_mug_run_2_treatment "various" "crizotinib" "mediated"
18 Q0 20593550 187 28.496777 imi_mug_run_2_treatment "erlotinib" "platinum" "vascular endothelial growth factor trap"
18 Q0 26268359 188 28.493734 imi_mug_run_2_treatment "ras" "formalin"
18 Q0 25695537 189 28.48869 imi_mug_run_2_treatment "panitumumab" "cetuximab" "liver"
18 Q0 26527886 190 28.45602 imi_mug_run_2_treatment "various" "aim" "suppressor"
18 Q0 23744164 191 28.441551 imi_mug_run_2_treatment "afatinib" "nervous system"
18 Q0 30464529 192 28.432404 imi_mug_run_2_treatment "crizotinib"
18 Q0 24342286 193 28.36749 imi_mug_run_2_treatment "drugs"
18 Q0 25785456 194 28.36409 imi_mug_run_2_treatment "crizotinib"
18 Q0 28321808 195 28.358753 imi_mug_run_2_treatment "cisplatin" "vinorelbine"
18 Q0 27870944 196 28.354454 imi_mug_run_2_treatment "plasma" "basis" "hot spot"
18 Q0 23817662 197 28.337172 imi_mug_run_2_treatment "erlotinib" "gefitinib" "aim"
18 Q0 26973202 198 28.255959 imi_mug_run_2_treatment "adc" "vandetanib" "crizotinib"
18 Q0 22140546 199 28.236923 imi_mug_run_2_treatment "tyrosine kinase inhibitor"
18 Q0 6362852 200 28.19654 imi_mug_run_2_treatment "monoclonal antibodies" "dodecyl sulfate"
18 Q0 25328676 201 28.151922 imi_mug_run_2_treatment "edta" "medicine"
18 Q0 23625156 202 28.140694 imi_mug_run_2_treatment "adc"
18 Q0 27418132 203 28.066341 imi_mug_run_2_treatment "crizotinib" "kinase inhibitor" "food"
18 Q0 26045672 204 28.053942 imi_mug_run_2_treatment "drug" "aim"
18 Q0 27877008 205 28.006525 imi_mug_run_2_treatment "crizotinib"
18 Q0 25837167 206 27.954117 imi_mug_run_2_treatment "plasma" "ptc"
18 Q0 24946815 207 27.925756 imi_mug_run_2_treatment "vemurafenib" "mediated" "ras"
18 Q0 27040858 208 27.740822 imi_mug_run_2_treatment "crizotinib"
18 Q0 23515407 209 27.732296 imi_mug_run_2_treatment "trametinib" "selumetinib"
18 Q0 30131091 210 27.708406 imi_mug_run_2_treatment "cabozantinib" "osimertinib"
18 Q0 24550319 211 27.66489 imi_mug_run_2_treatment "mediated" "braf inhibitor"
18 Q0 22743296 212 27.663422 imi_mug_run_2_treatment "vemurafenib"
18 Q0 24594201 213 27.58097 imi_mug_run_2_treatment "various"
18 Q0 25706985 214 27.57379 imi_mug_run_2_treatment "vemurafenib" "trametinib" "erlotinib"
18 Q0 27467545 215 27.525064 imi_mug_run_2_treatment "adc" "aim"
18 Q0 23558310 216 27.516325 imi_mug_run_2_treatment "crizotinib" "gemcitabine" "carboplatin"
18 Q0 29511884 217 27.511269 imi_mug_run_2_treatment "aim"
18 Q0 22649091 218 27.456055 imi_mug_run_2_treatment "dasatinib" "mitogen" "tyrosine kinase inhibitor"
18 Q0 27760604 219 27.433035 imi_mug_run_2_treatment "drugs"
18 Q0 24369052 220 27.431925 imi_mug_run_2_treatment "hla-g" "aim"
18 Q0 26992220 221 27.361378 imi_mug_run_2_treatment "formalin"
18 Q0 24899136 222 27.32316 imi_mug_run_2_treatment "air"
18 Q0 19155514 223 27.317413 imi_mug_run_2_treatment "aim" "brdu" "cytokines"
18 Q0 19734849 224 27.31289 imi_mug_run_2_treatment "level"
18 Q0 24346091 225 27.278717 imi_mug_run_2_treatment "ras"
18 Q0 29662630 226 27.2248 imi_mug_run_2_treatment "dabrafenib" "trametinib" "agent"
18 Q0 28638113 227 27.20661 imi_mug_run_2_treatment "hot spot"
18 Q0 23833300 228 27.202656 imi_mug_run_2_treatment "platinum"
18 Q0 12665627 229 27.181335 imi_mug_run_2_treatment "calcium phosphate" "biotin" "mediated"
18 Q0 28538219 230 27.15268 imi_mug_run_2_treatment "aim"
18 Q0 29348459 231 27.15168 imi_mug_run_2_treatment "egfr inhibitor" "mek inhibitor" "tonic"
18 Q0 24872405 232 27.143326 imi_mug_run_2_treatment "crizotinib" "drug" "prednisolone"
18 Q0 15010834 233 27.129107 imi_mug_run_2_treatment "gcv" "ganciclovir" "mediated"
18 Q0 25588859 234 27.07993 imi_mug_run_2_treatment "crizotinib"
18 Q0 30218431 235 27.038471 imi_mug_run_2_treatment "crizotinib" "duration" "aim"
18 Q0 24589553 236 26.95636 imi_mug_run_2_treatment "blockade"
18 Q0 20855837 237 26.95618 imi_mug_run_2_treatment "drugs"
18 Q0 25450274 238 26.918335 imi_mug_run_2_treatment "aim"
18 Q0 8334453 239 26.90349 imi_mug_run_2_treatment "therapeutics"
18 Q0 27388325 240 26.853876 imi_mug_run_2_treatment "sorafenib" "drug" "kinase inhibitor"
18 Q0 1598801 241 26.841124 imi_mug_run_2_treatment "proteinase" "iodogen"
18 Q0 26314551 242 26.813326 imi_mug_run_2_treatment "drug" "sorafenib" "trametinib"
18 Q0 29142786 243 26.775867 imi_mug_run_2_treatment "dabrafenib" "pembrolizumab" "pemetrexed"
18 Q0 30095326 244 26.768724 imi_mug_run_2_treatment "crizotinib"
18 Q0 27606884 245 26.767092 imi_mug_run_2_treatment "crizotinib"
18 Q0 28422723 246 26.653616 imi_mug_run_2_treatment "various"
18 Q0 28018791 247 26.638376 imi_mug_run_2_treatment "ceritinib" "crizotinib"
18 Q0 27045755 248 26.579147 imi_mug_run_2_treatment "crizotinib" "product"
18 Q0 29114471 249 26.536001 imi_mug_run_2_treatment "lead"
18 Q0 22446020 250 26.532238 imi_mug_run_2_treatment "scorpion" "product" "aim"
18 Q0 29541220 251 26.47003 imi_mug_run_2_treatment "aim"
18 Q0 22511580 252 26.462423 imi_mug_run_2_treatment "mediated"
18 Q0 27298405 253 26.44617 imi_mug_run_2_treatment "avid"
18 Q0 28683775 254 26.42121 imi_mug_run_2_treatment "alectinib" "cisplatin" "vinorelbine"
18 Q0 20624322 255 26.407331 imi_mug_run_2_treatment "lead"
18 Q0 27863497 256 26.400513 imi_mug_run_2_treatment "crizotinib"
18 Q0 21562939 257 26.396849 imi_mug_run_2_treatment "estrogen" "gefitinib"
18 Q0 24667260 258 26.396627 imi_mug_run_2_treatment "aim"
18 Q0 17487277 259 26.352917 imi_mug_run_2_treatment "ras" "product"
18 Q0 1834175 260 26.344337 imi_mug_run_2_treatment "calcium" "surfactant" "lung surfactant"
18 Q0 27494860 261 26.343971 imi_mug_run_2_treatment "apatinib" "mediated" "aim"
18 Q0 29516752 262 26.336119 imi_mug_run_2_treatment "combinations"
18 Q0 24979348 263 26.3232 imi_mug_run_2_treatment "ors"
18 Q0 28383426 264 26.3088 imi_mug_run_2_treatment "ors"
18 Q0 26498038 265 26.291824 imi_mug_run_2_treatment "ras" "mek inhibitor" "trametinib"
18 Q0 24758501 266 26.278164 imi_mug_run_2_treatment "aim"
18 Q0 29595366 267 26.221237 imi_mug_run_2_treatment "trametinib" "dabrafenib" "medicines"
18 Q0 16201231 268 26.187069 imi_mug_run_2_treatment "calcium"
18 Q0 24742568 269 26.180735 imi_mug_run_2_treatment "adc"
18 Q0 23731739 270 26.179653 imi_mug_run_2_treatment "erlotinib" "crizotinib"
18 Q0 22980554 271 26.154884 imi_mug_run_2_treatment "crizotinib" "kinase inhibitor" "vinorelbine"
18 Q0 18242762 272 26.154213 imi_mug_run_2_treatment "ras"
18 Q0 30503528 273 26.11454 imi_mug_run_2_treatment "drug" "trastuzumab" "arsenal"
18 Q0 18757405 274 26.057041 imi_mug_run_2_treatment "mediated"
18 Q0 26136882 275 26.034761 imi_mug_run_2_treatment "vemurafenib"
18 Q0 24908142 276 25.993341 imi_mug_run_2_treatment "lead" "level"
18 Q0 26705279 277 25.951576 imi_mug_run_2_treatment "formalin"
18 Q0 25965817 278 25.935692 imi_mug_run_2_treatment "various" "agent"
18 Q0 26331813 279 25.93443 imi_mug_run_2_treatment "adc" "others"
18 Q0 24940496 280 25.902645 imi_mug_run_2_treatment "crizotinib" "pemetrexed"
18 Q0 26861459 281 25.861736 imi_mug_run_2_treatment "suppressor"
18 Q0 28252478 282 25.771198 imi_mug_run_2_treatment "vemurafenib" "dabrafenib" "drugs"
18 Q0 17204027 283 25.767584 imi_mug_run_2_treatment "level"
18 Q0 25667280 284 25.739756 imi_mug_run_2_treatment "crizotinib" "pemetrexed" "platinum"
18 Q0 23578175 285 25.692469 imi_mug_run_2_treatment "vandetanib"
18 Q0 28659148 286 25.68745 imi_mug_run_2_treatment "plx8394" "col-1" "dabrafenib"
18 Q0 26666609 287 25.679695 imi_mug_run_2_treatment "crizotinib"
18 Q0 18397470 288 25.671581 imi_mug_run_2_treatment "ras" "leucine" "mitogen"
18 Q0 29401004 289 25.649801 imi_mug_run_2_treatment "amp"
18 Q0 23052178 290 25.648657 imi_mug_run_2_treatment "azathioprine" "crizotinib"
18 Q0 21656749 291 25.642155 imi_mug_run_2_treatment "various"
18 Q0 27923066 292 25.614756 imi_mug_run_2_treatment "ras"
18 Q0 25704901 293 25.600353 imi_mug_run_2_treatment "basis"
18 Q0 6090307 294 25.47537 imi_mug_run_2_treatment "monoclonal antibodies"
18 Q0 30505580 295 25.455542 imi_mug_run_2_treatment "level"
18 Q0 19010912 296 25.399601 imi_mug_run_2_treatment "ras"
18 Q0 23841470 297 25.323498 imi_mug_run_2_treatment "platinum" "prompt"
18 Q0 30268473 298 25.31491 imi_mug_run_2_treatment "stas" "basis"
18 Q0 23719267 299 25.31358 imi_mug_run_2_treatment "lead" "crizotinib"
18 Q0 23904459 300 25.308615 imi_mug_run_2_treatment "adc"
18 Q0 27026619 301 25.23212 imi_mug_run_2_treatment "various" "therapeutics" "drug"
18 Q0 18644254 302 25.230274 imi_mug_run_2_treatment "ras"
18 Q0 26124082 303 25.222717 imi_mug_run_2_treatment "level"
18 Q0 30230541 304 25.204258 imi_mug_run_2_treatment "gefitinib" "osimertinib"
18 Q0 23763264 305 25.199207 imi_mug_run_2_treatment "aim"
18 Q0 6091874 306 25.153736 imi_mug_run_2_treatment "monoclonal antibodies" "sodium dodecyl sulfate"
18 Q0 19440799 307 25.15335 imi_mug_run_2_treatment "hot spot"
18 Q0 27496134 308 25.098455 imi_mug_run_2_treatment "vandetanib" "ponatinib" "lenvatinib"
18 Q0 11975760 309 25.081444 imi_mug_run_2_treatment "interleukin" "animals"
18 Q0 27438512 310 25.076042 imi_mug_run_2_treatment "various"
18 Q0 23688269 311 25.07214 imi_mug_run_2_treatment "ras"
18 Q0 22898526 312 25.023865 imi_mug_run_2_treatment "air" "duration" "autologous"
18 Q0 28671973 313 25.023506 imi_mug_run_2_treatment "tumor infiltrating lymphocytes" "aim"
18 Q0 28381877 314 24.998957 imi_mug_run_2_treatment "level"
18 Q0 25868855 315 24.989372 imi_mug_run_2_treatment "crizotinib"
18 Q0 22987962 316 24.958477 imi_mug_run_2_treatment "product"
18 Q0 28103968 317 24.91888 imi_mug_run_2_treatment "aim"
18 Q0 28811946 318 24.872522 imi_mug_run_2_treatment "vemurafenib" "panitumumab" "cetuximab"
18 Q0 23055340 319 24.83566 imi_mug_run_2_treatment "basis" "aim"
18 Q0 27009213 320 24.797434 imi_mug_run_2_treatment "basis" "braf inhibitor"
18 Q0 25581823 321 24.771723 imi_mug_run_2_treatment "various" "crizotinib" "alectinib"
18 Q0 23794492 322 24.751778 imi_mug_run_2_treatment "adc" "therapeutics" "aim"
18 Q0 19881948 323 24.743341 imi_mug_run_2_treatment "therapeutics"
18 Q0 22351502 324 24.732159 imi_mug_run_2_treatment "gemcitabin" "carboplatin" "cetuximab"
18 Q0 26391251 325 24.697977 imi_mug_run_2_treatment "adc" "basis"
18 Q0 23355004 326 24.658678 imi_mug_run_2_treatment "ras" "aim"
18 Q0 24164966 327 24.657951 imi_mug_run_2_treatment "kinase inhibitor" "urea" "ras"
18 Q0 17001163 328 24.652836 imi_mug_run_2_treatment "adc"
18 Q0 27565922 329 24.64322 imi_mug_run_2_treatment "hot spot" "aim"
18 Q0 26893860 330 24.607288 imi_mug_run_2_treatment "pas" "ras"
18 Q0 25742289 331 24.556236 imi_mug_run_2_treatment "adc" "crizotinib"
18 Q0 24323028 332 24.556211 imi_mug_run_2_treatment "therapeutics"
18 Q0 25710585 333 24.49532 imi_mug_run_2_treatment "tma" "aim"
18 Q0 19064915 334 24.481382 imi_mug_run_2_treatment "animals"
18 Q0 26784937 335 24.452955 imi_mug_run_2_treatment "ptc" "glutamic acid"
18 Q0 28619094 336 24.445923 imi_mug_run_2_treatment "aim"
18 Q0 25436805 337 24.434746 imi_mug_run_2_treatment "cabozantinib" "prompt"
18 Q0 28065467 338 24.402786 imi_mug_run_2_treatment "various" "adc"
18 Q0 24362353 339 24.39413 imi_mug_run_2_treatment "antioxidant" "glutamine" "mediated"
18 Q0 29974407 340 24.377537 imi_mug_run_2_treatment "hme" "aim"
18 Q0 24623980 341 24.363775 imi_mug_run_2_treatment "kinase inhibitor" "basis" "crizotinib"
18 Q0 24456475 342 24.352148 imi_mug_run_2_treatment "aim" "crizotinib"
18 Q0 24156959 343 24.351265 imi_mug_run_2_treatment "crizotinib"
18 Q0 22740923 344 24.32603 imi_mug_run_2_treatment "various" "drug" "basis"
18 Q0 24327273 345 24.313887 imi_mug_run_2_treatment "crizotinib" "docetaxel" "pemetrexed"
18 Q0 25047660 346 24.287483 imi_mug_run_2_treatment "basis"
18 Q0 22773810 347 24.28649 imi_mug_run_2_treatment "various" "drug" "mediators"
18 Q0 25583765 348 24.255785 imi_mug_run_2_treatment "braf inhibitor" "dabrafenib"
18 Q0 25567908 349 24.219204 imi_mug_run_2_treatment "agent"
18 Q0 28818608 350 24.182526 imi_mug_run_2_treatment "serine" "lead" "egfr tyrosine kinase inhibitors"
18 Q0 26588428 351 24.17501 imi_mug_run_2_treatment "others"
18 Q0 25806231 352 24.156311 imi_mug_run_2_treatment "docetaxel"
18 Q0 25902737 353 24.153088 imi_mug_run_2_treatment "cetuximab" "gefitinib" "erlotinib"
18 Q0 11050472 354 24.128807 imi_mug_run_2_treatment "mabs" "proteinase" "monoclonal antibodies"
18 Q0 24296758 355 24.119328 imi_mug_run_2_treatment "color"
18 Q0 30442523 356 24.111277 imi_mug_run_2_treatment "aim"
18 Q0 21818706 357 24.09387 imi_mug_run_2_treatment "ras" "plx4032" "gsk2118436"
18 Q0 29193645 358 24.058088 imi_mug_run_2_treatment "trametinib" "serine peptidase inhibitor" "spink1"
18 Q0 27682157 359 24.05752 imi_mug_run_2_treatment "aim"
18 Q0 27732995 360 24.040699 imi_mug_run_2_treatment "platinum" "vascular endothelial growth factor"
18 Q0 16551617 361 24.02298 imi_mug_run_2_treatment "drug" "superoxide dismutase"
18 Q0 27573925 362 24.015614 imi_mug_run_2_treatment "aim"
18 Q0 6276266 363 23.972864 imi_mug_run_2_treatment "various" "iododeoxyuridine" "others"
18 Q0 24218589 364 23.929815 imi_mug_run_2_treatment "foretinib" "crizotinib"
18 Q0 28810144 365 23.875923 imi_mug_run_2_treatment "ras"
18 Q0 17956344 366 23.856365 imi_mug_run_2_treatment "mediated"
18 Q0 24229629 367 23.853994 imi_mug_run_2_treatment "tarceva" "crizotinib"
18 Q0 23723294 368 23.821999 imi_mug_run_2_treatment "adc"
18 Q0 22791881 369 23.791546 imi_mug_run_2_treatment "e10a"
18 Q0 24955706 370 23.738262 imi_mug_run_2_treatment "various" "agent" "vemurafenib"
18 Q0 23514723 371 23.731691 imi_mug_run_2_treatment "formalin"
18 Q0 27873490 372 23.715046 imi_mug_run_2_treatment "vandetanib" "kinase inhibitor" "sunitinib"
18 Q0 2540427 373 23.692938 imi_mug_run_2_treatment "various" "ras"
18 Q0 27150058 374 23.670689 imi_mug_run_2_treatment "vandetanib"
18 Q0 28167572 375 23.64748 imi_mug_run_2_treatment "crizotinib" "alectinib" "interleukin-3"
18 Q0 7488637 376 23.644054 imi_mug_run_2_treatment "lung surfactant" "mediated" "anx"
18 Q0 25237908 377 23.62693 imi_mug_run_2_treatment "various"
18 Q0 27742540 378 23.59446 imi_mug_run_2_treatment "antiangiogenic agents" "pooled"
18 Q0 28487464 379 23.570032 imi_mug_run_2_treatment "lead" "basis"
18 Q0 30010043 380 23.554935 imi_mug_run_2_treatment "crizotinib" "tyrosine kinase inhibitor"
18 Q0 22202162 381 23.52179 imi_mug_run_2_treatment "animals"
18 Q0 16231326 382 23.4962 imi_mug_run_2_treatment "ras" "tk inhibitors"
18 Q0 29029440 383 23.486252 imi_mug_run_2_treatment "others"
18 Q0 26190239 384 23.483143 imi_mug_run_2_treatment "ras" "cytotoxic" "duration"
18 Q0 30121391 385 23.46739 imi_mug_run_2_treatment "various" "adc"
18 Q0 18343945 386 23.453709 imi_mug_run_2_treatment "various" "ras"
18 Q0 27080216 387 23.45037 imi_mug_run_2_treatment "dabrafenib"
18 Q0 28911147 388 23.433777 imi_mug_run_2_treatment "ptc"
18 Q0 7972041 389 23.418201 imi_mug_run_2_treatment "animals"
18 Q0 26732095 390 23.33284 imi_mug_run_2_treatment "ly3009120" "vemurafenib" "braf inhibitor"
18 Q0 27300552 391 23.33215 imi_mug_run_2_treatment "ras"
18 Q0 27258560 392 23.324831 imi_mug_run_2_treatment "aim"
18 Q0 18166835 393 23.313183 imi_mug_run_2_treatment "product"
18 Q0 30055110 394 23.276012 imi_mug_run_2_treatment "alcohol" "air"
18 Q0 25562798 395 23.255516 imi_mug_run_2_treatment "vemurafenib" "therapeutics" "dacarbazine"
18 Q0 24292963 396 23.253622 imi_mug_run_2_treatment "various" "ras"
18 Q0 27621653 397 23.25135 imi_mug_run_2_treatment "dabrafenib" "braf inhibitor"
18 Q0 29729495 398 23.24017 imi_mug_run_2_treatment "drugs" "mek inhibitor" "trametinib"
18 Q0 27132476 399 23.237207 imi_mug_run_2_treatment "various"
18 Q0 23533264 400 23.22128 imi_mug_run_2_treatment "cabozantinib"
18 Q0 23264847 401 23.196692 imi_mug_run_2_treatment "various" "therapeutics" "drugs"
18 Q0 16931592 402 23.192738 imi_mug_run_2_treatment "hot spot" "polyacrylamide gel" "ras"
18 Q0 29540830 403 23.161888 imi_mug_run_2_treatment "ras" "lead"
18 Q0 25708242 404 23.139313 imi_mug_run_2_treatment "aim"
18 Q0 26287849 405 23.095448 imi_mug_run_2_treatment "various" "vemurafenib" "cetuximab"
18 Q0 24500884 406 23.094707 imi_mug_run_2_treatment "adca" "hot spot" "aim"
18 Q0 29036791 407 23.078682 imi_mug_run_2_treatment "adc" "cancer vaccine"
18 Q0 16906516 408 23.076637 imi_mug_run_2_treatment "ras" "level" "aim"
18 Q0 25695223 409 23.072662 imi_mug_run_2_treatment "erlotinib" "crizotinib" "epidermal growth factor"
18 Q0 24152792 410 23.024925 imi_mug_run_2_treatment "therapeutics"
18 Q0 22964644 411 23.003267 imi_mug_run_2_treatment "mediated"
18 Q0 22350957 412 22.996187 imi_mug_run_2_treatment "lead"
18 Q0 25806349 413 22.99614 imi_mug_run_2_treatment "nedaplatin" "agent" "abraxane"
18 Q0 25131476 414 22.95731 imi_mug_run_2_treatment "eosin" "color"
18 Q0 24560515 415 22.951885 imi_mug_run_2_treatment "adjuvant"
18 Q0 23733758 416 22.926352 imi_mug_run_2_treatment "vemurafenib"
18 Q0 28296772 417 22.917423 imi_mug_run_2_treatment "various" "liver"
18 Q0 25361007 418 22.91218 imi_mug_run_2_treatment "ras" "combinations" "drug"
18 Q0 26414886 419 22.91218 imi_mug_run_2_treatment "kinase inhibitor" "vemurafenib" "dabrafenib"
18 Q0 25014730 420 22.905247 imi_mug_run_2_treatment "glutamic acid"
18 Q0 25122427 421 22.881905 imi_mug_run_2_treatment "vandetanib" "ponatinib" "blockade"
18 Q0 29631033 422 22.877636 imi_mug_run_2_treatment "trametinib" "dabrafenib"
18 Q0 11286831 423 22.876404 imi_mug_run_2_treatment "deoxyglucose"
18 Q0 21029578 424 22.876085 imi_mug_run_2_treatment "agar" "polyethylene glycol" "cancer vaccines"
18 Q0 21549910 425 22.87201 imi_mug_run_2_treatment "gefitinib" "erlotinib" "emla"
18 Q0 21297586 426 22.870432 imi_mug_run_2_treatment "level"
18 Q0 23606169 427 22.837454 imi_mug_run_2_treatment "ptc" "panitumumab" "cetuximab"
18 Q0 28082048 428 22.810032 imi_mug_run_2_treatment "cabozantinib" "platinum" "pembrolizumab"
18 Q0 28231386 429 22.798971 imi_mug_run_2_treatment "tma" "aim"
18 Q0 28950338 430 22.737476 imi_mug_run_2_treatment "kinase inhibitor" "afatinib" "program"
18 Q0 26664139 431 22.662596 imi_mug_run_2_treatment "trametinib" "dabrafenib"
18 Q0 15578922 432 22.651358 imi_mug_run_2_treatment "drugs" "gonadotropin releasing hormone" "gnrh analog"
18 Q0 29261000 433 22.639965 imi_mug_run_2_treatment "apatinib" "docetaxel" "kinase inhibitor"
18 Q0 21757253 434 22.63306 imi_mug_run_2_treatment "drug" "pf02341066" "crizotinib"
18 Q0 27001432 435 22.622898 imi_mug_run_2_treatment "aim"
18 Q0 17201587 436 22.594395 imi_mug_run_2_treatment "various" "ptc" "ras"
18 Q0 2413999 437 22.557796 imi_mug_run_2_treatment "various" "proteases" "mouse monoclonal antibody"
18 Q0 24279718 438 22.536427 imi_mug_run_2_treatment "crizotinib" "drug" "kinase inhibitor"
18 Q0 20923647 439 22.531937 imi_mug_run_2_treatment "mediated" "lung surfactant" "shape"
18 Q0 30074936 440 22.5086 imi_mug_run_2_treatment "alectinib" "apatinib" "drug"
18 Q0 19352325 441 22.49413 imi_mug_run_2_treatment "therapeutics" "aim" "balance"
18 Q0 23988776 442 22.47444 imi_mug_run_2_treatment "adc" "adjuvant"
18 Q0 27382093 443 22.464693 imi_mug_run_2_treatment "vinblastine" "lead" "liver"
18 Q0 25351955 444 22.456326 imi_mug_run_2_treatment "agonists" "cytokines" "vemurafenib"
18 Q0 21921848 445 22.453007 imi_mug_run_2_treatment "color"
18 Q0 21220306 446 22.443737 imi_mug_run_2_treatment "mediated" "mek inhibitor"
18 Q0 22892241 447 22.424656 imi_mug_run_2_treatment "ras" "mediated"
18 Q0 25636897 448 22.405369 imi_mug_run_2_treatment "fluorouracil" "leucovorin" "oxaliplatin"
18 Q0 24687927 449 22.393854 imi_mug_run_2_treatment "adjuvant" "cetuximab" "pooled"
18 Q0 28783719 450 22.388699 imi_mug_run_2_treatment "ras" "mediated"
18 Q0 27403614 451 22.343107 imi_mug_run_2_treatment "medicine"
18 Q0 21475478 452 22.323814 imi_mug_run_2_treatment "glucose"
18 Q0 22871572 453 22.263973 imi_mug_run_2_treatment "mediated" "igf2"
18 Q0 28465216 454 22.237833 imi_mug_run_2_treatment "crizotinib" "drugs" "tyrosine"
18 Q0 23930754 455 22.235931 imi_mug_run_2_treatment "duration" "aim"
18 Q0 1706786 456 22.226295 imi_mug_run_2_treatment "various" "biotin"
18 Q0 24857785 457 22.22438 imi_mug_run_2_treatment "gefitinib" "erlotinib"
18 Q0 26714964 458 22.219015 imi_mug_run_2_treatment "liver"
18 Q0 20952506 459 22.203592 imi_mug_run_2_treatment "kinase inhibitor" "carboplatin" "paclitaxel"
18 Q0 24946519 460 22.129671 imi_mug_run_2_treatment "drugs"
18 Q0 25982012 461 22.098686 imi_mug_run_2_treatment "vandetanib" "everolimus" "kinase inhibitor"
18 Q0 26076869 462 22.089643 imi_mug_run_2_treatment "new drugs" "others" "monoclonal antibodies"
18 Q0 26521063 463 22.08654 imi_mug_run_2_treatment "ptc" "aim"
18 Q0 27520705 464 22.05497 imi_mug_run_2_treatment "bcl-2 inhibitor" "abt-199"
18 Q0 30354850 465 22.026606 imi_mug_run_2_treatment "interferon" "natriuretic peptide" "adenosine deaminase"
18 Q0 24743704 466 22.006111 imi_mug_run_2_treatment "drug" "drugs"
18 Q0 23664537 467 22.002926 imi_mug_run_2_treatment "formalin"
18 Q0 26377589 468 22.001028 imi_mug_run_2_treatment "cabozantinib" "vandetanib" "sunitinib"
18 Q0 24844134 469 21.958494 imi_mug_run_2_treatment "kinases inhibitor" "monoclonal antibodies"
18 Q0 26359417 470 21.954037 imi_mug_run_2_treatment "aim"
18 Q0 27075779 471 21.931953 imi_mug_run_2_treatment "mek inhibitor"
18 Q0 27121209 472 21.90778 imi_mug_run_2_treatment "gefitinib" "egfr tyrosine kinase inhibitor"
18 Q0 28031175 473 21.907143 imi_mug_run_2_treatment "cetuximab" "ras" "adjuvant"
18 Q0 25708035 474 21.904337 imi_mug_run_2_treatment "corrective" "symmetry"
18 Q0 24489653 475 21.87962 imi_mug_run_2_treatment "ras"
18 Q0 24071017 476 21.863058 imi_mug_run_2_treatment "various" "monoclonal antibodies" "others"
18 Q0 28410289 477 21.827732 imi_mug_run_2_treatment "sestamibi" "aim"
18 Q0 24823994 478 21.824139 imi_mug_run_2_treatment "ras"
18 Q0 27080225 479 21.797112 imi_mug_run_2_treatment "amino acid" "liver"
18 Q0 27056568 480 21.792362 imi_mug_run_2_treatment "adc"
18 Q0 15739095 481 21.788906 imi_mug_run_2_treatment "mediated" "ginseng"
18 Q0 25940438 482 21.771057 imi_mug_run_2_treatment "n-acetyl-l-cysteine" "cisplatin" "fluouracil"
18 Q0 12876301 483 21.76306 imi_mug_run_2_treatment "androgen" "luteinizing hormone-releasing hormone" "thioredoxin"
18 Q0 26462554 484 21.757755 imi_mug_run_2_treatment "aim"
18 Q0 28502721 485 21.756197 imi_mug_run_2_treatment "crizotinib"
18 Q0 29128428 486 21.751085 imi_mug_run_2_treatment "drug"
18 Q0 28609321 487 21.65548 imi_mug_run_2_treatment "symmetry" "aim"
18 Q0 8153308 488 21.641352 imi_mug_run_2_treatment "glucose"
18 Q0 18687171 489 21.607092 imi_mug_run_2_treatment "tnf-alpha" "mediators" "eosin"
18 Q0 29380640 490 21.59093 imi_mug_run_2_treatment "ras" "irinotecan" "oxaliplatin"
18 Q0 27490749 491 21.582123 imi_mug_run_2_treatment "drugs"
18 Q0 6684641 492 21.574516 imi_mug_run_2_treatment "various" "plasminogen activator"
18 Q0 26366702 493 21.531614 imi_mug_run_2_treatment "plasma" "basis"
18 Q0 17765009 494 21.529804 imi_mug_run_2_treatment "diacylglycerol" "mediated" "lung surfactant"
18 Q0 18320074 495 21.51918 imi_mug_run_2_treatment "level"
18 Q0 20433995 496 21.506306 imi_mug_run_2_treatment "ttf-ngr" "fibrin"
18 Q0 2474040 497 21.505302 imi_mug_run_2_treatment "ethanol" "ns-1"
18 Q0 18537561 498 21.503025 imi_mug_run_2_treatment "therapeutics" "new drugs" "liver"
18 Q0 27283860 499 21.50215 imi_mug_run_2_treatment "trametinib" "dabrafenib" "platinum"
18 Q0 17047397 500 21.490885 imi_mug_run_2_treatment "mediated" "ras"
18 Q0 16397024 501 21.489351 imi_mug_run_2_treatment "ras" "mediated"
18 Q0 22628411 502 21.480516 imi_mug_run_2_treatment "ras" "drug combinations" "genesis"
18 Q0 23154547 503 21.480026 imi_mug_run_2_treatment "formalin"
18 Q0 19190079 504 21.475769 imi_mug_run_2_treatment "ras" "tyr"
18 Q0 28145866 505 21.475702 imi_mug_run_2_treatment "ras" "oxygen"
18 Q0 12131730 506 21.455702 imi_mug_run_2_treatment "various" "autologous"
18 Q0 29662327 507 21.445713 imi_mug_run_2_treatment "trametinib" "dabrafenib" "ras"
18 Q0 25995428 508 21.440762 imi_mug_run_2_treatment "agent"
18 Q0 29130101 509 21.434477 imi_mug_run_2_treatment "agent"
18 Q0 24997135 510 21.420372 imi_mug_run_2_treatment "pas" "lead"
18 Q0 21232014 511 21.418087 imi_mug_run_2_treatment "oxygen" "dehydroascorbic acid" "mediated"
18 Q0 29057232 512 21.414375 imi_mug_run_2_treatment "drug"
18 Q0 23287985 513 21.413294 imi_mug_run_2_treatment "hot spot" "vemurafenib"
18 Q0 28786099 514 21.405575 imi_mug_run_2_treatment "drug" "egfr inhibitor"
18 Q0 25394854 515 21.405273 imi_mug_run_2_treatment "cisplatin" "drug" "drugs"
18 Q0 30171333 516 21.404778 imi_mug_run_2_treatment "liver"
18 Q0 28245430 517 21.403358 imi_mug_run_2_treatment "kinase inhibitor" "liver" "fer"
18 Q0 28085233 518 21.392206 imi_mug_run_2_treatment "aim"
18 Q0 26798590 519 21.340828 imi_mug_run_2_treatment "alectinib"
18 Q0 11422498 520 21.306921 imi_mug_run_2_treatment "product"
18 Q0 28391773 521 21.289623 imi_mug_run_2_treatment "adjuvant"
18 Q0 29199691 522 21.21912 imi_mug_run_2_treatment "crizotinib"
18 Q0 29259073 523 21.189968 imi_mug_run_2_treatment "ras" "panitumumab" "monoclonal antibodies"
18 Q0 28738329 524 21.171505 imi_mug_run_2_treatment "shh"
18 Q0 23715079 525 21.165607 imi_mug_run_2_treatment "vemurafenib" "liver"
18 Q0 28677170 526 21.159332 imi_mug_run_2_treatment "methylated"
18 Q0 22433711 527 21.1577 imi_mug_run_2_treatment "paclitaxel" "sorafenib" "drugs"
18 Q0 29427662 528 21.157433 imi_mug_run_2_treatment "various" "level"
18 Q0 27535394 529 21.156773 imi_mug_run_2_treatment "crizotinib" "platinum" "cisplatin"
18 Q0 24346098 530 21.139336 imi_mug_run_2_treatment "vinorelbine" "pemetrexed" "cetuximab"
18 Q0 25725450 531 21.129025 imi_mug_run_2_treatment "vemurafenib" "drug" "cd271"
18 Q0 17521235 532 21.111996 imi_mug_run_2_treatment "surfactant" "liver"
18 Q0 27215271 533 21.100578 imi_mug_run_2_treatment "aim"
18 Q0 27007084 534 21.099442 imi_mug_run_2_treatment "adc"
18 Q0 23328547 535 21.08182 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
18 Q0 25807485 536 21.073639 imi_mug_run_2_treatment "kinase inhibitor" "drug" "vemurafenib"
18 Q0 18726295 537 21.059406 imi_mug_run_2_treatment "recombinant human gm-csf" "normal saline"
18 Q0 22319199 538 21.046192 imi_mug_run_2_treatment "cep-32496" "braf inhibitor" "sorafenib"
18 Q0 23499205 539 21.044493 imi_mug_run_2_treatment "nitrocellulose" "anti-egfr monoclonal antibody" "cetuximab"
18 Q0 23876834 540 21.044493 imi_mug_run_2_treatment "drugs" "investigational drugs" "generic"
18 Q0 26786320 541 21.044493 imi_mug_run_2_treatment "sorafenib" "drugs" "kinase inhibitor"
18 Q0 8033110 542 21.04054 imi_mug_run_2_treatment "nitrosobis(2-oxopropyl)amine" "product"
18 Q0 18650784 543 21.029049 imi_mug_run_2_treatment "antithrombin" "etanercept" "mediated"
18 Q0 19112200 544 21.028664 imi_mug_run_2_treatment "glucose"
18 Q0 26181322 545 21.01719 imi_mug_run_2_treatment "ras"
18 Q0 29164615 546 21.007988 imi_mug_run_2_treatment "various"
18 Q0 20705596 547 21.00573 imi_mug_run_2_treatment "dex" "dexamethasone" "hydroxyproline"
18 Q0 21499238 548 20.99481 imi_mug_run_2_treatment "serine"
18 Q0 18594528 549 20.98466 imi_mug_run_2_treatment "suppressor"
18 Q0 28115307 550 20.98466 imi_mug_run_2_treatment "isolate"
18 Q0 27196768 551 20.958195 imi_mug_run_2_treatment "gsk2118436" "mediated" "ras"
18 Q0 28415793 552 20.92472 imi_mug_run_2_treatment "therapeutics"
18 Q0 27573756 553 20.885 imi_mug_run_2_treatment "crizotinib" "tyrosine kinase inhibitor"
18 Q0 27073482 554 20.882273 imi_mug_run_2_treatment "various"
18 Q0 27447897 555 20.8811 imi_mug_run_2_treatment "basis"
18 Q0 7046915 556 20.828684 imi_mug_run_2_treatment "monoclonal antibodies"
18 Q0 21220230 557 20.820965 imi_mug_run_2_treatment "adjuvant" "gemcitabine" "imatinib"
18 Q0 29199697 558 20.820965 imi_mug_run_2_treatment "color" "crizotinib" "ceritinib"
18 Q0 25886136 559 20.812363 imi_mug_run_2_treatment "ras"
18 Q0 21102267 560 20.803465 imi_mug_run_2_treatment "gefitinib"
18 Q0 23584301 561 20.80061 imi_mug_run_2_treatment "vandetanib"
18 Q0 30049378 562 20.80061 imi_mug_run_2_treatment "crizotinib"
18 Q0 28000627 563 20.798496 imi_mug_run_2_treatment "drugs"
18 Q0 30225407 564 20.78984 imi_mug_run_2_treatment "crizotinib" "kinase inhibitor" "plasma"
18 Q0 22655265 565 20.786194 imi_mug_run_2_treatment "drug"
18 Q0 26811072 566 20.784061 imi_mug_run_2_treatment "ras" "aim"
18 Q0 29703539 567 20.781979 imi_mug_run_2_treatment "alectinib"
18 Q0 30368418 568 20.781979 imi_mug_run_2_treatment "crizotinib"
18 Q0 26291023 569 20.781738 imi_mug_run_2_treatment "sunitinib"
18 Q0 29526181 570 20.770468 imi_mug_run_2_treatment "drugs"
18 Q0 24420742 571 20.76538 imi_mug_run_2_treatment "basis"
18 Q0 23481512 572 20.762955 imi_mug_run_2_treatment "epirubicin" "adjuvant" "cisplatin"
18 Q0 28605874 573 20.748009 imi_mug_run_2_treatment "cytokines" "interleukin"
18 Q0 24158231 574 20.742123 imi_mug_run_2_treatment "eosin"
18 Q0 23792567 575 20.735735 imi_mug_run_2_treatment "dulanermin" "agonists" "cetuximab"
18 Q0 27350555 576 20.731575 imi_mug_run_2_treatment "vemurafenib" "braf inhibitor"
18 Q0 24380695 577 20.72946 imi_mug_run_2_treatment "crizotinib" "others"
18 Q0 28955006 578 20.708797 imi_mug_run_2_treatment "alectinib" "lead" "step 2"
18 Q0 2422274 579 20.687855 imi_mug_run_2_treatment "basis" "human igm"
18 Q0 18676837 580 20.687103 imi_mug_run_2_treatment "azd6244" "arry 142886"
18 Q0 6207911 581 20.68685 imi_mug_run_2_treatment "monoclonal antibodies" "liver" "animals"
18 Q0 25745045 582 20.667088 imi_mug_run_2_treatment "duration"
18 Q0 24417083 583 20.647858 imi_mug_run_2_treatment "basis"
18 Q0 29587667 584 20.601183 imi_mug_run_2_treatment "pemetrexed" "drugs" "aim"
18 Q0 29909991 585 20.57148 imi_mug_run_2_treatment "enzymes" "combinations" "mediated"
18 Q0 26801070 586 20.54203 imi_mug_run_2_treatment "formalin"
18 Q0 27076591 587 20.531954 imi_mug_run_2_treatment "kinase inhibitor" "lead"
18 Q0 24346090 588 20.50819 imi_mug_run_2_treatment "level"
18 Q0 17575687 589 20.496754 imi_mug_run_2_treatment "interleukin"
18 Q0 24934810 590 20.45765 imi_mug_run_2_treatment "tamoxifen" "ras"
18 Q0 30348712 591 20.453428 imi_mug_run_2_treatment "kinase inhibitor" "aim"
18 Q0 29368620 592 20.43751 imi_mug_run_2_treatment "aim"
18 Q0 28174383 593 20.431274 imi_mug_run_2_treatment "cddp" "cisplatin" "s-1"
18 Q0 22245873 594 20.418175 imi_mug_run_2_treatment "calcineurin inhibitors" "aim"
18 Q0 15367885 595 20.386408 imi_mug_run_2_treatment "ras" "liver"
18 Q0 27207893 596 20.37555 imi_mug_run_2_treatment "dabrafenib" "agent" "mek inhibitor"
18 Q0 28639239 597 20.333858 imi_mug_run_2_treatment "others"
18 Q0 17295648 598 20.282166 imi_mug_run_2_treatment "collagen" "product"
18 Q0 23400546 599 20.245403 imi_mug_run_2_treatment "sodium phosphate" "crizotinib"
18 Q0 10449441 600 20.242416 imi_mug_run_2_treatment "blockade"
18 Q0 26139353 601 20.240433 imi_mug_run_2_treatment "vaccine" "polyethylene glycol" "mediators"
18 Q0 24533074 602 20.235981 imi_mug_run_2_treatment "various"
18 Q0 24942367 603 20.233557 imi_mug_run_2_treatment "diacylglycerol"
18 Q0 25470237 604 20.227552 imi_mug_run_2_treatment "pdx" "therapeutics"
18 Q0 29129434 605 20.211315 imi_mug_run_2_treatment "aim"
18 Q0 21943101 606 20.210972 imi_mug_run_2_treatment "ras" "mediated" "botulinum toxin"
18 Q0 23408463 607 20.163828 imi_mug_run_2_treatment "buffer" "sodium dodecyl sulfate"
18 Q0 8232306 608 20.160252 imi_mug_run_2_treatment "surfactant" "hgh" "dex"
18 Q0 24727987 609 20.143087 imi_mug_run_2_treatment "drugs"
18 Q0 14566261 610 20.139742 imi_mug_run_2_treatment "beta-galactosidase"
18 Q0 23792568 611 20.122082 imi_mug_run_2_treatment "cetuximab" "sorafenib" "regorafenib"
18 Q0 29167892 612 20.11876 imi_mug_run_2_treatment "ras" "cetuximab" "adjuvant"
18 Q0 23922677 613 20.115273 imi_mug_run_2_treatment "crizotinib"
18 Q0 25101332 614 20.109056 imi_mug_run_2_treatment "drug" "drugs" "basis"
18 Q0 16315876 615 20.104856 imi_mug_run_2_treatment "vaccine"
18 Q0 26915300 616 20.08446 imi_mug_run_2_treatment "ras"
18 Q0 24654596 617 20.08213 imi_mug_run_2_treatment "therapeutics" "lead"
18 Q0 29052598 618 20.07965 imi_mug_run_2_treatment "ras" "monoclonal antibodies"
18 Q0 11067765 619 20.064388 imi_mug_run_2_treatment "various" "surfactant"
18 Q0 28421339 620 20.05791 imi_mug_run_2_treatment "duration"
18 Q0 29198034 621 20.05791 imi_mug_run_2_treatment "level"
18 Q0 24564548 622 20.00304 imi_mug_run_2_treatment "drug"
18 Q0 30513023 623 20.002071 imi_mug_run_2_treatment "trametinib" "combinations" "dabrafenib"
18 Q0 22571236 624 20.000948 imi_mug_run_2_treatment "surfactant" "lung surfactant"
18 Q0 30244853 625 19.969925 imi_mug_run_2_treatment "pemetrexed"
18 Q0 23362162 626 19.95617 imi_mug_run_2_treatment "various" "tyrosine kinase inhibitor" "aim"
18 Q0 23198539 627 19.95612 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
18 Q0 21500543 628 19.948523 imi_mug_run_2_treatment "cesium chloride" "mediated" "cytotoxic"
18 Q0 19737969 629 19.942383 imi_mug_run_2_treatment "mediated"
18 Q0 28558851 630 19.929811 imi_mug_run_2_treatment "crizotinib" "alectinib"
18 Q0 24128285 631 19.889812 imi_mug_run_2_treatment "endostatin" "cck-8" "antiangiogenic"
18 Q0 3052807 632 19.889097 imi_mug_run_2_treatment "various" "ethanol"
18 Q0 25824206 633 19.8819 imi_mug_run_2_treatment "basis" "beam"
18 Q0 21738740 634 19.877346 imi_mug_run_2_treatment "combinations" "agent" "level"
18 Q0 23612660 635 19.872108 imi_mug_run_2_treatment "crizotinib"
18 Q0 25013125 636 19.849186 imi_mug_run_2_treatment "plasma"
18 Q0 19342415 637 19.838093 imi_mug_run_2_treatment "protein c" "antiinflammatory" "fibrin"
18 Q0 27821319 638 19.821873 imi_mug_run_2_treatment "sorafenib" "anti-angiogenic agents" "agent"
18 Q0 26918352 639 19.820726 imi_mug_run_2_treatment "vemurafenib" "braf inhibitor"
18 Q0 26373952 640 19.820726 imi_mug_run_2_treatment "aim"
18 Q0 25153497 641 19.81923 imi_mug_run_2_treatment "drugs" "hydrogel"
18 Q0 8396567 642 19.782097 imi_mug_run_2_treatment "various" "monoclonal antibodies"
18 Q0 29991799 643 19.774286 imi_mug_run_2_treatment "mediated"
18 Q0 23325296 644 19.767506 imi_mug_run_2_treatment "crizotinib"
18 Q0 23850495 645 19.745317 imi_mug_run_2_treatment "product"
18 Q0 26581482 646 19.744762 imi_mug_run_2_treatment "epidermal growth factor" "plasma"
18 Q0 23930206 647 19.742771 imi_mug_run_2_treatment "her-2" "aim"
18 Q0 23629727 648 19.740656 imi_mug_run_2_treatment "sorafenib" "ras" "everolimus"
18 Q0 9000570 649 19.736553 imi_mug_run_2_treatment "cytotoxic" "chloroquine" "mediated"
18 Q0 17487504 650 19.735653 imi_mug_run_2_treatment "sti571" "gleevec" "drug"
18 Q0 27759578 651 19.735653 imi_mug_run_2_treatment "vemurafenib" "dabrafenib" "others"
18 Q0 21277552 652 19.720818 imi_mug_run_2_treatment "lead"
18 Q0 23856031 653 19.700375 imi_mug_run_2_treatment "lenvatinib" "tyrosine kinase inhibitor" "e7080"
18 Q0 15744675 654 19.698753 imi_mug_run_2_treatment "collagen"
18 Q0 17557235 655 19.660301 imi_mug_run_2_treatment "ns-1" "basis" "liver"
18 Q0 17268330 656 19.658066 imi_mug_run_2_treatment "glucose" "radiopharmaceutical"
18 Q0 25971657 657 19.646948 imi_mug_run_2_treatment "alectinib" "drugs" "crizotinib"
18 Q0 24496003 658 19.635246 imi_mug_run_2_treatment "crizotinib" "pdx" "aim"
18 Q0 17569023 659 19.626112 imi_mug_run_2_treatment "various" "aim"
18 Q0 29097733 660 19.60981 imi_mug_run_2_treatment "drugs" "parp inhibitors"
18 Q0 25351503 661 19.59889 imi_mug_run_2_treatment "eacs" "lead"
18 Q0 25414704 662 19.579197 imi_mug_run_2_treatment "various" "human serum albumin" "thioredoxin"
18 Q0 14601056 663 19.577492 imi_mug_run_2_treatment "ras"
18 Q0 22497683 664 19.56613 imi_mug_run_2_treatment "liver" "basis"
18 Q0 29076877 665 19.564133 imi_mug_run_2_treatment "hot spot"
18 Q0 8168066 666 19.55606 imi_mug_run_2_treatment "basis"
18 Q0 29130105 667 19.550169 imi_mug_run_2_treatment "hot spot"
18 Q0 24113009 668 19.536459 imi_mug_run_2_treatment "drug"
18 Q0 23245516 669 19.530895 imi_mug_run_2_treatment "drugs"
18 Q0 22321727 670 19.527483 imi_mug_run_2_treatment "mediated"
18 Q0 23791006 671 19.512743 imi_mug_run_2_treatment "various"
18 Q0 12917640 672 19.506817 imi_mug_run_2_treatment "product"
18 Q0 22761469 673 19.493319 imi_mug_run_2_treatment "adc"
18 Q0 26623721 674 19.47731 imi_mug_run_2_treatment "dasatinib" "kinase inhibitor" "drugs"
18 Q0 24914066 675 19.461208 imi_mug_run_2_treatment "vaccine" "rsv vaccine"
18 Q0 25723114 676 19.445847 imi_mug_run_2_treatment "stas" "adc" "air"
18 Q0 15140052 677 19.43692 imi_mug_run_2_treatment "interferon-gamma" "polyethylene glycol" "interleukin-2"
18 Q0 25453465 678 19.417082 imi_mug_run_2_treatment "matrix"
18 Q0 27277016 679 19.41143 imi_mug_run_2_treatment "basis"
18 Q0 10699932 680 19.38499 imi_mug_run_2_treatment "carboxypeptidase g2" "cytotoxic drug" "liver"
18 Q0 29877554 681 19.369041 imi_mug_run_2_treatment "drugs"
18 Q0 30108712 682 19.359327 imi_mug_run_2_treatment "kinase inhibitor"
18 Q0 29854313 683 19.356012 imi_mug_run_2_treatment "basis"
18 Q0 21125676 684 19.335701 imi_mug_run_2_treatment "ras" "drug"
18 Q0 22811080 685 19.33028 imi_mug_run_2_treatment "various" "monoclonal antibodies"
18 Q0 27213588 686 19.322197 imi_mug_run_2_treatment "factor i" "lead" "animals"
18 Q0 2859687 687 19.292545 imi_mug_run_2_treatment "glucose" "genesis"
18 Q0 21620911 688 19.286083 imi_mug_run_2_treatment "human serum albumin" "thioredoxin" "anti-inflammatory"
18 Q0 22525302 689 19.243345 imi_mug_run_2_treatment "ras" "aim" "crizotinib"
18 Q0 19472407 690 19.223255 imi_mug_run_2_treatment "ly294002" "erlotinib" "pha665752"
18 Q0 19968500 691 19.210926 imi_mug_run_2_treatment "shepherdin"
18 Q0 27237027 692 19.209055 imi_mug_run_2_treatment "cdx" "crizotinib" "product"
18 Q0 8526861 693 19.19514 imi_mug_run_2_treatment "amp" "tyrosine"
18 Q0 26986751 694 19.184036 imi_mug_run_2_treatment "mediated" "cytotoxic" "therapeutics"
18 Q0 30344944 695 19.178856 imi_mug_run_2_treatment "drug" "medicines" "trametinib"
18 Q0 12527889 696 19.175678 imi_mug_run_2_treatment "various" "retinoid" "retinoic acid"
18 Q0 22989458 697 19.167183 imi_mug_run_2_treatment "drugs"
18 Q0 22942608 698 19.160423 imi_mug_run_2_treatment "drugs" "cytotoxic" "therapeutics"
18 Q0 26968843 699 19.15751 imi_mug_run_2_treatment "drugs" "egfr tyrosine kinase inhibitors" "crizotinib"
18 Q0 21791485 700 19.142542 imi_mug_run_2_treatment "igf2"
18 Q0 9386063 701 19.137276 imi_mug_run_2_treatment "basis"
18 Q0 29434222 702 19.12854 imi_mug_run_2_treatment "vandetanib" "drug" "kinase inhibitor"
18 Q0 15994877 703 19.119875 imi_mug_run_2_treatment "product"
18 Q0 17075123 704 19.117535 imi_mug_run_2_treatment "gefitinib" "iressa"
18 Q0 21503656 705 19.113068 imi_mug_run_2_treatment "drugs"
18 Q0 21384194 706 19.113068 imi_mug_run_2_treatment "enzymes"
18 Q0 21239505 707 19.112513 imi_mug_run_2_treatment "liver"
18 Q0 9556216 708 19.109892 imi_mug_run_2_treatment "drug" "cytotoxic" "sugar"
18 Q0 24362875 709 19.100266 imi_mug_run_2_treatment "crizotinib"
18 Q0 7748077 710 19.100218 imi_mug_run_2_treatment "monoclonal antibodies"
18 Q0 21542273 711 19.085978 imi_mug_run_2_treatment "lead"
18 Q0 22594847 712 19.075848 imi_mug_run_2_treatment "crizotinib" "product" "tyrosine kinase inhibitor"
18 Q0 1848084 713 19.075481 imi_mug_run_2_treatment "dexamethasone" "liver" "level"
18 Q0 19345122 714 19.07456 imi_mug_run_2_treatment "aim"
18 Q0 16118624 715 19.058945 imi_mug_run_2_treatment "various"
18 Q0 25541622 716 19.05876 imi_mug_run_2_treatment "crizotinib" "liver"
18 Q0 27760592 717 19.056498 imi_mug_run_2_treatment "drugs" "aim"
18 Q0 23599689 718 19.054169 imi_mug_run_2_treatment "vaccines" "vascular endothelial growth factor"
18 Q0 30105645 719 19.054169 imi_mug_run_2_treatment "blockade"
18 Q0 25814520 720 19.051195 imi_mug_run_2_treatment "pdtc" "dtc" "glucose"
18 Q0 21463141 721 19.031975 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
18 Q0 25884512 722 19.023317 imi_mug_run_2_treatment "drugs"
18 Q0 25963689 723 19.00562 imi_mug_run_2_treatment "drugs" "mediated"
18 Q0 28077299 724 18.99949 imi_mug_run_2_treatment "various" "crizotinib" "drug"
18 Q0 29703606 725 18.997759 imi_mug_run_2_treatment "panitumumab" "ras" "oxaliplatin"
18 Q0 22787408 726 18.94804 imi_mug_run_2_treatment "revolution"
18 Q0 30466862 727 18.935028 imi_mug_run_2_treatment "ptc"
18 Q0 20880464 728 18.915936 imi_mug_run_2_treatment "azaguanine" "guanidine" "cancer vaccine"
18 Q0 9518624 729 18.914936 imi_mug_run_2_treatment "lung surfactant" "monolayer" "monolayers"
18 Q0 30195801 730 18.912683 imi_mug_run_2_treatment "basic fibroblast growth factor"
18 Q0 10400765 731 18.905287 imi_mug_run_2_treatment "level" "limited use"
18 Q0 24982409 732 18.903227 imi_mug_run_2_treatment "epidermal growth factor"
18 Q0 15210944 733 18.892315 imi_mug_run_2_treatment "erythropoietin" "mediated"
18 Q0 25173427 734 18.883884 imi_mug_run_2_treatment "crizotinib" "tyrosine kinase inhibitor"
18 Q0 21432019 735 18.882887 imi_mug_run_2_treatment "liver"
18 Q0 28623478 736 18.878553 imi_mug_run_2_treatment "shape"
18 Q0 9486078 737 18.872368 imi_mug_run_2_treatment "beam"
18 Q0 23246132 738 18.87225 imi_mug_run_2_treatment "crizotinib"
18 Q0 19170230 739 18.84982 imi_mug_run_2_treatment "various" "p23" "others"
18 Q0 7857967 740 18.832943 imi_mug_run_2_treatment "dids" "surfactant" "mediated"
18 Q0 25647260 741 18.830662 imi_mug_run_2_treatment "various"
18 Q0 16365579 742 18.830608 imi_mug_run_2_treatment "clot"
18 Q0 22968077 743 18.82191 imi_mug_run_2_treatment "bafilomycin a1" "blockade"
18 Q0 12940078 744 18.818869 imi_mug_run_2_treatment "glucose"
18 Q0 30198802 745 18.81345 imi_mug_run_2_treatment "dabrafenib" "trametinib" "mek inhibitor"
18 Q0 21911013 746 18.811981 imi_mug_run_2_treatment "lung surfactant" "surfactant" "h89"
18 Q0 6327024 747 18.810125 imi_mug_run_2_treatment "ouabain" "monoclonal antibodies"
18 Q0 28776576 748 18.809692 imi_mug_run_2_treatment "ras"
18 Q0 22476664 749 18.788464 imi_mug_run_2_treatment "liver"
18 Q0 17618868 750 18.778906 imi_mug_run_2_treatment "cyclic adenosine monophosphate" "lead"
18 Q0 30195415 751 18.777729 imi_mug_run_2_treatment "metric"
18 Q0 26136951 752 18.769463 imi_mug_run_2_treatment "drug"
18 Q0 24942490 753 18.751543 imi_mug_run_2_treatment "aim"
18 Q0 11605006 754 18.74678 imi_mug_run_2_treatment "suppressor"
18 Q0 23406861 755 18.725426 imi_mug_run_2_treatment "asa"
18 Q0 7801727 756 18.725016 imi_mug_run_2_treatment "polysaccharide"
18 Q0 29437753 757 18.718155 imi_mug_run_2_treatment "plasma" "level" "hot spot"
18 Q0 26553611 758 18.717758 imi_mug_run_2_treatment "temozolomide" "gemcitabine" "irinotecan"
18 Q0 15107827 759 18.707508 imi_mug_run_2_treatment "dega" "serine"
18 Q0 29564764 760 18.70719 imi_mug_run_2_treatment "various"
18 Q0 15613458 761 18.69762 imi_mug_run_2_treatment "various" "crest"
18 Q0 27686809 762 18.696974 imi_mug_run_2_treatment "gefitinib" "erlotinib" "drugs"
18 Q0 28675026 763 18.677105 imi_mug_run_2_treatment "everolimus" "crizotinib" "ras"
18 Q0 26080731 764 18.671638 imi_mug_run_2_treatment "vemurafenib" "kinase inhibitor" "duration"
18 Q0 20098007 765 18.670494 imi_mug_run_2_treatment "liver"
18 Q0 24797764 766 18.65872 imi_mug_run_2_treatment "agent" "aim"
18 Q0 24893893 767 18.6503 imi_mug_run_2_treatment "thyroglobulin"
18 Q0 26448190 768 18.628365 imi_mug_run_2_treatment "melan a"
18 Q0 16181004 769 18.621826 imi_mug_run_2_treatment "erythropoietin" "mediated"
18 Q0 30032849 770 18.594004 imi_mug_run_2_treatment "plasma"
18 Q0 10518547 771 18.57603 imi_mug_run_2_treatment "aim"
18 Q0 26854464 772 18.5744 imi_mug_run_2_treatment "lead"
18 Q0 27101025 773 18.569424 imi_mug_run_2_treatment "matrix"
18 Q0 25759539 774 18.543245 imi_mug_run_2_treatment "aim"
18 Q0 29713646 775 18.542873 imi_mug_run_2_treatment "osimertinib"
18 Q0 19032370 776 18.540234 imi_mug_run_2_treatment "various"
18 Q0 26898613 777 18.540234 imi_mug_run_2_treatment "sorafenib" "kinase inhibitor"
18 Q0 25531467 778 18.519783 imi_mug_run_2_treatment "genesis"
18 Q0 2369584 779 18.498304 imi_mug_run_2_treatment "surfactant" "lung surfactant" "phosphatidylcholine"
18 Q0 18382358 780 18.494146 imi_mug_run_2_treatment "ptc"
18 Q0 15232107 781 18.485622 imi_mug_run_2_treatment "beta-galactosidase" "liver"
18 Q0 21731703 782 18.438766 imi_mug_run_2_treatment "level" "r1881" "androgen"
18 Q0 26842788 783 18.436798 imi_mug_run_2_treatment "platinum" "aim"
18 Q0 26392858 784 18.42063 imi_mug_run_2_treatment "eosin"
18 Q0 26292034 785 18.40934 imi_mug_run_2_treatment "air"
18 Q0 28125528 786 18.396217 imi_mug_run_2_treatment "animals" "liver"
18 Q0 20673487 787 18.394638 imi_mug_run_2_treatment "aim"
18 Q0 10974460 788 18.389137 imi_mug_run_2_treatment "liver"
18 Q0 14519080 789 18.377436 imi_mug_run_2_treatment "cytotoxic" "gemcitabine" "targeted toxins"
18 Q0 24565585 790 18.371534 imi_mug_run_2_treatment "drugs"
18 Q0 9607495 791 18.368568 imi_mug_run_2_treatment "liver"
18 Q0 25650807 792 18.368568 imi_mug_run_2_treatment "com"
18 Q0 11273779 793 18.363192 imi_mug_run_2_treatment "isoleucine" "level"
18 Q0 21767331 794 18.359203 imi_mug_run_2_treatment "crizotinib" "tyrosine kinase inhibitor"
18 Q0 20526349 795 18.353958 imi_mug_run_2_treatment "lead"
18 Q0 23279859 796 18.34726 imi_mug_run_2_treatment "das181"
18 Q0 26720421 797 18.343946 imi_mug_run_2_treatment "agent"
18 Q0 27009821 798 18.343822 imi_mug_run_2_treatment "crizotinib" "aim"
18 Q0 28932542 799 18.343313 imi_mug_run_2_treatment "icc"
18 Q0 26338658 800 18.343288 imi_mug_run_2_treatment "ras"
18 Q0 25625428 801 18.343014 imi_mug_run_2_treatment "kinase inhibitor" "vandetanib" "sunitinib"
18 Q0 26933125 802 18.336548 imi_mug_run_2_treatment "ceritinib"
18 Q0 25817339 803 18.315693 imi_mug_run_2_treatment "drug" "level" "cytokines"
18 Q0 23576200 804 18.313972 imi_mug_run_2_treatment "various" "crizotinib"
18 Q0 25878335 805 18.304234 imi_mug_run_2_treatment "drugs" "therapeutic agents" "level"
18 Q0 22321987 806 18.268448 imi_mug_run_2_treatment "kinase inhibitor" "medicine" "crizotinib"
18 Q0 29451347 807 18.251987 imi_mug_run_2_treatment "thyroglobulin" "ptc"
18 Q0 18931051 808 18.238462 imi_mug_run_2_treatment "pah" "genesis"
18 Q0 22833083 809 18.222454 imi_mug_run_2_treatment "lead"
18 Q0 21273060 810 18.222422 imi_mug_run_2_treatment "cetuximab"
18 Q0 15744557 811 18.220629 imi_mug_run_2_treatment "mediated"
18 Q0 26778816 812 18.214941 imi_mug_run_2_treatment "favor"
18 Q0 27507537 813 18.203602 imi_mug_run_2_treatment "ss1p" "immunotoxin" "cytotoxic"
18 Q0 25182378 814 18.19875 imi_mug_run_2_treatment "protease" "mediated" "cytotoxic"
18 Q0 22749186 815 18.194836 imi_mug_run_2_treatment "various" "iodine" "sodium"
18 Q0 29776229 816 18.193712 imi_mug_run_2_treatment "formalin" "crizotinib"
18 Q0 20536315 817 18.189672 imi_mug_run_2_treatment "various" "ras" "aim"
18 Q0 27001591 818 18.18081 imi_mug_run_2_treatment "calcium" "vitamin d" "angiotensin-converting enzyme inhibitor"
18 Q0 24756795 819 18.159494 imi_mug_run_2_treatment "combinations" "drug" "vemurafenib"
18 Q0 30069761 820 18.159494 imi_mug_run_2_treatment "combinations" "drug" "vemurafenib"
18 Q0 24389446 821 18.15916 imi_mug_run_2_treatment "crizotinib"
18 Q0 26001147 822 18.156765 imi_mug_run_2_treatment "crizotinib"
18 Q0 27969452 823 18.156765 imi_mug_run_2_treatment "crizotinib"
18 Q0 30366769 824 18.156765 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitor"
18 Q0 6928631 825 18.147808 imi_mug_run_2_treatment "polyethylene glycol"
18 Q0 26768652 826 18.118927 imi_mug_run_2_treatment "cetuximab" "adjuvant" "fluorouracil"
18 Q0 27836576 827 18.102654 imi_mug_run_2_treatment "crizotinib" "tamoxifen" "protein c gene"
18 Q0 10217560 828 18.102114 imi_mug_run_2_treatment "basis"
18 Q0 9186494 829 18.102114 imi_mug_run_2_treatment "phenothiazines" "anx" "promethazine"
18 Q0 17122504 830 18.097954 imi_mug_run_2_treatment "stas" "tca" "aim"
18 Q0 26437441 831 18.095068 imi_mug_run_2_treatment "drugs" "dsb"
18 Q0 21248471 832 18.095068 imi_mug_run_2_treatment "oxygen" "cytotoxic"
18 Q0 25884597 833 18.094282 imi_mug_run_2_treatment "various" "hsvtk" "gcv"
18 Q0 30035653 834 18.086672 imi_mug_run_2_treatment "liver" "ras" "duration"
18 Q0 23187307 835 18.075998 imi_mug_run_2_treatment "phenylalanine" "polysaccharide" "suppressor"
18 Q0 21862980 836 18.063824 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
18 Q0 25165098 837 18.056152 imi_mug_run_2_treatment "liver"
18 Q0 23199019 838 18.048252 imi_mug_run_2_treatment "bevacizumab" "mediators" "vegf trap"
18 Q0 2265408 839 18.044619 imi_mug_run_2_treatment "agar"
18 Q0 22620005 840 18.044104 imi_mug_run_2_treatment "gefitinib" "erlotinib" "egfr tyrosine kinase inhibitors"
18 Q0 24304249 841 18.008589 imi_mug_run_2_treatment "insulin" "exubera" "duration"
18 Q0 23018874 842 17.999538 imi_mug_run_2_treatment "tma" "color" "others"
18 Q0 14697159 843 17.999533 imi_mug_run_2_treatment "program"
18 Q0 20686774 844 17.99812 imi_mug_run_2_treatment "ras"
18 Q0 11260639 845 17.993904 imi_mug_run_2_treatment "various"
18 Q0 24856126 846 17.989616 imi_mug_run_2_treatment "aim"
18 Q0 25473756 847 17.989616 imi_mug_run_2_treatment "ras"
18 Q0 30034277 848 17.983683 imi_mug_run_2_treatment "level" "medicine"
18 Q0 16483559 849 17.979507 imi_mug_run_2_treatment "various" "staurosporine" "etoh"
18 Q0 27666544 850 17.978214 imi_mug_run_2_treatment "dna methyltransferase inhibitor" "aim"
18 Q0 29973561 851 17.972126 imi_mug_run_2_treatment "various"
18 Q0 25477108 852 17.963129 imi_mug_run_2_treatment "neratinib" "dabrafenib" "temsirolimus"
18 Q0 9799345 853 17.962841 imi_mug_run_2_treatment "glucose"
18 Q0 21148224 854 17.955793 imi_mug_run_2_treatment "antiviral" "drug" "antiviral drug"
18 Q0 25378536 855 17.951374 imi_mug_run_2_treatment "ras" "level"
18 Q0 26376781 856 17.951374 imi_mug_run_2_treatment "liver"
18 Q0 10811133 857 17.919535 imi_mug_run_2_treatment "ibmx"
18 Q0 18293042 858 17.91898 imi_mug_run_2_treatment "glucose"
18 Q0 21245935 859 17.91898 imi_mug_run_2_treatment "ras"
18 Q0 17970092 860 17.915688 imi_mug_run_2_treatment "various" "urokinase" "therapeutic agent"
18 Q0 19826477 861 17.914762 imi_mug_run_2_treatment "ras" "level"
18 Q0 18270032 862 17.907322 imi_mug_run_2_treatment "rms" "program" "level"
18 Q0 28133295 863 17.905615 imi_mug_run_2_treatment "panitumumab" "ras" "bevacizumab"
18 Q0 6488314 864 17.896244 imi_mug_run_2_treatment "animals" "favoring"
18 Q0 30293943 865 17.890707 imi_mug_run_2_treatment "drugs"
18 Q0 23881668 866 17.885561 imi_mug_run_2_treatment "dabrafenib" "kinase inhibitor" "trametinib"
18 Q0 22427111 867 17.883232 imi_mug_run_2_treatment "antiviral" "therapeutic agents"
18 Q0 28888985 868 17.87698 imi_mug_run_2_treatment "aim"
18 Q0 28401019 869 17.864574 imi_mug_run_2_treatment "various" "resveratrol" "endostatin"
18 Q0 19353596 870 17.856075 imi_mug_run_2_treatment "aim"
18 Q0 26221682 871 17.852516 imi_mug_run_2_treatment "level"
18 Q0 25941796 872 17.849737 imi_mug_run_2_treatment "crizotinib" "agent" "lead"
18 Q0 25130969 873 17.839262 imi_mug_run_2_treatment "drug" "drugs"
18 Q0 24997156 874 17.831295 imi_mug_run_2_treatment "ras"
18 Q0 23370426 875 17.827114 imi_mug_run_2_treatment "various"
18 Q0 29666465 876 17.827114 imi_mug_run_2_treatment "various" "interleukins"
18 Q0 26215190 877 17.819052 imi_mug_run_2_treatment "drugs" "adjuvant" "others"
18 Q0 30053332 878 17.802 imi_mug_run_2_treatment "crizotinib" "cabozantinib" "combinations"
18 Q0 23015072 879 17.799904 imi_mug_run_2_treatment "panitumumab" "cetuximab" "lead"
18 Q0 22362717 880 17.799904 imi_mug_run_2_treatment "ptc" "liver"
18 Q0 15531757 881 17.797161 imi_mug_run_2_treatment "beta-adrenergic agonists" "mediators" "air"
18 Q0 22435913 882 17.791618 imi_mug_run_2_treatment "sorafenib" "ptc" "radioactive iodine"
18 Q0 29599344 883 17.784885 imi_mug_run_2_treatment "mpl" "aim"
18 Q0 29534405 884 17.778522 imi_mug_run_2_treatment "crizotinib" "drug combination" "platinum"
18 Q0 30339388 885 17.774055 imi_mug_run_2_treatment "anti-rsv" "fusion inhibitors" "fusion inhibitor"
18 Q0 8718659 886 17.772255 imi_mug_run_2_treatment "growth hormone"
18 Q0 26452381 887 17.767118 imi_mug_run_2_treatment "product"
18 Q0 22912387 888 17.766907 imi_mug_run_2_treatment "cytotoxic" "duration" "crizotinib"
18 Q0 9808136 889 17.764105 imi_mug_run_2_treatment "acyclovir" "liver"
18 Q0 30320628 890 17.747355 imi_mug_run_2_treatment "medication" "immunosuppressants" "immunosuppressive"
18 Q0 3116897 891 17.738316 imi_mug_run_2_treatment "dexamethasone" "glucose" "cytostatic"
18 Q0 7361376 892 17.737898 imi_mug_run_2_treatment "liver"
18 Q0 27223439 893 17.733154 imi_mug_run_2_treatment "egfr inhibitor"
18 Q0 30275180 894 17.733154 imi_mug_run_2_treatment "ras" "basis"
18 Q0 28709170 895 17.732544 imi_mug_run_2_treatment "methotrexate"
18 Q0 24429876 896 17.729126 imi_mug_run_2_treatment "plasma" "erlotinib"
18 Q0 6324459 897 17.721153 imi_mug_run_2_treatment "glucocorticoids" "monolayer"
18 Q0 21182087 898 17.700535 imi_mug_run_2_treatment "calcium" "il-4" "blockade"
18 Q0 21849857 899 17.690548 imi_mug_run_2_treatment "medicine" "anti-vegf monoclonal antibody" "vascular endothelial growth factor"
18 Q0 19640857 900 17.687065 imi_mug_run_2_treatment "aim"
18 Q0 24633422 901 17.668606 imi_mug_run_2_treatment "ptc" "therapeutic agents" "crizotinib"
18 Q0 22864469 902 17.652351 imi_mug_run_2_treatment "imp321" "gemcitabine" "agonist"
18 Q0 16125870 903 17.635841 imi_mug_run_2_treatment "glucose" "deoxyglucose"
18 Q0 24115920 904 17.632162 imi_mug_run_2_treatment "various" "surfactant" "lung surfactant"
18 Q0 24878018 905 17.603897 imi_mug_run_2_treatment "crizotinib"
18 Q0 21288922 906 17.588547 imi_mug_run_2_treatment "tyrosine" "mediated" "crizotinib"
18 Q0 27563823 907 17.573055 imi_mug_run_2_treatment "tomato"
18 Q0 23256924 908 17.563189 imi_mug_run_2_treatment "various" "ptds" "tandem"
18 Q0 1856594 909 17.5506 imi_mug_run_2_treatment "yeast" "lucifer yellow"
18 Q0 11317024 910 17.548893 imi_mug_run_2_treatment "radiopharmaceuticals"
18 Q0 24315414 911 17.548397 imi_mug_run_2_treatment "mediated"
18 Q0 27174587 912 17.532143 imi_mug_run_2_treatment "drugs"
18 Q0 26077004 913 17.52045 imi_mug_run_2_treatment "aim"
18 Q0 2163206 914 17.515224 imi_mug_run_2_treatment "lung surfactant" "agonists" "various"
18 Q0 25000258 915 17.511368 imi_mug_run_2_treatment "canertinib"
18 Q0 22594466 916 17.510664 imi_mug_run_2_treatment "dabrafenib" "dacarbazine" "braf inhibitor"
18 Q0 30192303 917 17.509426 imi_mug_run_2_treatment "vemurafenib" "braf inhibitor"
18 Q0 29576302 918 17.508415 imi_mug_run_2_treatment "crizotinib"
18 Q0 26697197 919 17.504227 imi_mug_run_2_treatment "liver"
18 Q0 22849528 920 17.493654 imi_mug_run_2_treatment "oxygen"
18 Q0 9269316 921 17.489773 imi_mug_run_2_treatment "annexin i" "hydroxyproline" "collagen"
18 Q0 15709972 922 17.466084 imi_mug_run_2_treatment "surfactant" "air" "lung surfactant"
18 Q0 29784736 923 17.427975 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitor" "alectinib" "osimertinib"
18 Q0 19109379 924 17.387966 imi_mug_run_2_treatment "monoclonal antibodies" "vaccines" "therapeutics"
18 Q0 3743347 925 17.387579 imi_mug_run_2_treatment "enzymes"
18 Q0 10851514 926 17.350014 imi_mug_run_2_treatment "animals"
18 Q0 27041411 927 17.344936 imi_mug_run_2_treatment "diphosphate" "erlotinib"
18 Q0 28584208 928 17.341364 imi_mug_run_2_treatment "epidermal growth factor receptor tyrosine kinase inhibitor" "matrix"
18 Q0 29488330 929 17.340996 imi_mug_run_2_treatment "crizotinib" "nervous system"
18 Q0 29996478 930 17.339693 imi_mug_run_2_treatment "liver"
18 Q0 7241666 931 17.338589 imi_mug_run_2_treatment "drug" "product"
18 Q0 18223333 932 17.337767 imi_mug_run_2_treatment "duration"
18 Q0 27124490 933 17.337767 imi_mug_run_2_treatment "duration"
18 Q0 29034239 934 17.33562 imi_mug_run_2_treatment "cisplatinum" "docetaxel" "capecitabine"
18 Q0 7270426 935 17.328325 imi_mug_run_2_treatment "sodium" "animals"
18 Q0 22287190 936 17.328127 imi_mug_run_2_treatment "level"
18 Q0 28607809 937 17.320335 imi_mug_run_2_treatment "crizotinib"
18 Q0 15618585 938 17.320097 imi_mug_run_2_treatment "aim"
18 Q0 17037722 939 17.318214 imi_mug_run_2_treatment "antiserum" "vaccine"
18 Q0 19769957 940 17.314213 imi_mug_run_2_treatment "prenatal"
18 Q0 26321050 941 17.312477 imi_mug_run_2_treatment "respiratory system"
18 Q0 11866984 942 17.310991 imi_mug_run_2_treatment "formalin"
18 Q0 27834212 943 17.308369 imi_mug_run_2_treatment "plx8394" "vemurafenib" "mediated"
18 Q0 28296173 944 17.30578 imi_mug_run_2_treatment "lysine" "level"
18 Q0 26325103 945 17.300724 imi_mug_run_2_treatment "ras"
18 Q0 28829490 946 17.275906 imi_mug_run_2_treatment "crizotinib"
18 Q0 3290332 947 17.264782 imi_mug_run_2_treatment "gold" "level" "monoclonal antibodies"
18 Q0 29469219 948 17.233912 imi_mug_run_2_treatment "aim"
18 Q0 7493342 949 17.225626 imi_mug_run_2_treatment "immu-4"
18 Q0 27926526 950 17.225626 imi_mug_run_2_treatment "plasma" "crizotinib"
18 Q0 25302162 951 17.224667 imi_mug_run_2_treatment "gefitinib" "erlotinib" "crizotinib"
18 Q0 26890862 952 17.224667 imi_mug_run_2_treatment "therapeutic agents" "docetaxel"
18 Q0 27246873 953 17.223228 imi_mug_run_2_treatment "immunosuppressive" "il-12" "cytokines"
18 Q0 21892161 954 17.21905 imi_mug_run_2_treatment "mediated" "lead"
18 Q0 25153496 955 17.2086 imi_mug_run_2_treatment "drug" "basis" "crizotinib"
18 Q0 18474293 956 17.207241 imi_mug_run_2_treatment "level"
18 Q0 26063431 957 17.198652 imi_mug_run_2_treatment "vaccine" "matrix"
18 Q0 30519133 958 17.180025 imi_mug_run_2_treatment "alectinib" "crizotinib"
18 Q0 3777448 959 17.173168 imi_mug_run_2_treatment "lead" "animals"
18 Q0 22981500 960 17.157734 imi_mug_run_2_treatment "dabrafenib"
18 Q0 20179225 961 17.14582 imi_mug_run_2_treatment "level" "monoclonal antibodies"
18 Q0 14568982 962 17.14181 imi_mug_run_2_treatment "antiinflammatory"
18 Q0 29451020 963 17.132912 imi_mug_run_2_treatment "brigatinib" "crizotinib" "ceritinib"
18 Q0 2847384 964 17.124306 imi_mug_run_2_treatment "abc" "liver"
18 Q0 16242781 965 17.116276 imi_mug_run_2_treatment "adjuvant" "vaccine" "prophylactic"
18 Q0 29915896 966 17.107864 imi_mug_run_2_treatment "osimertinib" "drug combinations" "egfr tyrosine kinase inhibitors"
18 Q0 29682161 967 17.101793 imi_mug_run_2_treatment "anti-inflammatory" "antioxidant"
18 Q0 18519321 968 17.083687 imi_mug_run_2_treatment "level"
18 Q0 27282352 969 17.080692 imi_mug_run_2_treatment "thyroglobulin"
18 Q0 12663329 970 17.079601 imi_mug_run_2_treatment "surfactant" "lung surfactant" "beta-escin"
18 Q0 25349307 971 17.067177 imi_mug_run_2_treatment "alectinib" "antitumor agents" "crizotinib"
18 Q0 23470965 972 17.064877 imi_mug_run_2_treatment "various" "gefitinib" "erlotinib"
18 Q0 24418728 973 17.062904 imi_mug_run_2_treatment "crizotinib"
18 Q0 21769425 974 17.049423 imi_mug_run_2_treatment "interferon" "enzymes" "drug"
18 Q0 21103621 975 17.048159 imi_mug_run_2_treatment "combinations" "cytotoxic drugs"
18 Q0 15186480 976 17.03827 imi_mug_run_2_treatment "lead" "protein c gene"
18 Q0 25594902 977 17.036793 imi_mug_run_2_treatment "medicine" "drugs" "cytotoxic drugs"
18 Q0 29175207 978 17.036793 imi_mug_run_2_treatment "cisplatin" "drug"
19 Q0 15493579 1 51.49521 imi_mug_run_2_treatment "ras"
19 Q0 9712416 2 43.02873 imi_mug_run_2_treatment "level"
19 Q0 12942124 3 42.90079 imi_mug_run_2_treatment "lead"
19 Q0 7904177 4 40.284645 imi_mug_run_2_treatment "product"
19 Q0 12527905 5 40.138477 imi_mug_run_2_treatment "estrogens" "estradiol" "tamoxifen"
19 Q0 15741050 6 40.043648 imi_mug_run_2_treatment "various" "rutin" "quercetin"
19 Q0 16770086 7 39.999496 imi_mug_run_2_treatment "level" "aim" "liver"
19 Q0 20811704 8 39.41757 imi_mug_run_2_treatment "various" "trastuzumab" "drug"
19 Q0 1351679 9 39.377186 imi_mug_run_2_treatment "level"
19 Q0 7656779 10 39.18447 imi_mug_run_2_treatment "level"
19 Q0 24186136 11 38.834923 imi_mug_run_2_treatment "product"
19 Q0 22482406 12 38.79184 imi_mug_run_2_treatment "aim"
19 Q0 19945923 13 38.600315 imi_mug_run_2_treatment "tandem" "level"
19 Q0 11153605 14 38.394665 imi_mug_run_2_treatment "aim"
19 Q0 9892105 15 38.286003 imi_mug_run_2_treatment "gastrin"
19 Q0 8096076 16 38.127094 imi_mug_run_2_treatment "m-amsa" "mitoxantrone" "topoisomerase inhibitors"
19 Q0 10474685 17 38.07692 imi_mug_run_2_treatment "digoxigenin" "aim"
19 Q0 26314265 18 37.253254 imi_mug_run_2_treatment "combinations" "level"
19 Q0 30210703 19 37.013138 imi_mug_run_2_treatment "lead"
19 Q0 19331129 20 37.00727 imi_mug_run_2_treatment "combinations" "color"
19 Q0 25509354 21 36.84101 imi_mug_run_2_treatment "various"
19 Q0 22899293 22 36.776752 imi_mug_run_2_treatment "level" "monoclonal antibodies"
19 Q0 19797898 23 36.5857 imi_mug_run_2_treatment "nrg" "vascular endothelial growth factor"
19 Q0 29044505 24 36.352646 imi_mug_run_2_treatment "various" "adjuvant"
19 Q0 19876926 25 36.329933 imi_mug_run_2_treatment "agar" "mediated"
19 Q0 29352243 26 36.3143 imi_mug_run_2_treatment "tyrphostin" "mediated" "as1411"
19 Q0 8585979 27 36.197426 imi_mug_run_2_treatment "ras"
19 Q0 11786427 28 35.978214 imi_mug_run_2_treatment "androgen" "level" "trastuzumab"
19 Q0 20056314 29 35.932693 imi_mug_run_2_treatment "chloroquine"
19 Q0 18787015 30 35.885067 imi_mug_run_2_treatment "her-2"
19 Q0 18719096 31 35.66262 imi_mug_run_2_treatment "kinase inhibitor" "ras" "lapatinib"
19 Q0 25820598 32 35.538376 imi_mug_run_2_treatment "basis"
19 Q0 21787752 33 35.447678 imi_mug_run_2_treatment "agar"
19 Q0 18661347 34 35.19973 imi_mug_run_2_treatment "hyaluronan" "mediated"
19 Q0 27416801 35 35.09845 imi_mug_run_2_treatment "alcohol"
19 Q0 15300811 36 34.984818 imi_mug_run_2_treatment "mbc" "basis"
19 Q0 9499914 37 34.83501 imi_mug_run_2_treatment "drugs" "product" "lead"
19 Q0 17369913 38 34.59585 imi_mug_run_2_treatment "estrogen"
19 Q0 16601278 39 34.299633 imi_mug_run_2_treatment "various" "drug" "herceptin"
19 Q0 15994962 40 34.28772 imi_mug_run_2_treatment "combinations" "ag879" "kinase inhibitor"
19 Q0 28160563 41 34.25401 imi_mug_run_2_treatment "cisplatin" "fluorouracil"
19 Q0 10469452 42 34.18198 imi_mug_run_2_treatment "level" "lead"
19 Q0 15511476 43 34.1358 imi_mug_run_2_treatment "trastuzumab" "level"
19 Q0 16607561 44 34.13283 imi_mug_run_2_treatment "level"
19 Q0 26435392 45 34.10345 imi_mug_run_2_treatment "mediated"
19 Q0 20518902 46 34.10085 imi_mug_run_2_treatment "basis"
19 Q0 27652326 47 34.036854 imi_mug_run_2_treatment "matrix"
19 Q0 15000146 48 34.030457 imi_mug_run_2_treatment "lead" "level"
19 Q0 26071215 49 33.977108 imi_mug_run_2_treatment "hla-g" "silver" "color"
19 Q0 15476264 50 33.894787 imi_mug_run_2_treatment "level"
19 Q0 7912163 51 33.864334 imi_mug_run_2_treatment "drug" "tamoxifen" "adjuvant"
19 Q0 27926948 52 33.813534 imi_mug_run_2_treatment "level"
19 Q0 30123134 53 33.756935 imi_mug_run_2_treatment "drug" "drugs" "atra"
19 Q0 8104440 54 33.729004 imi_mug_run_2_treatment "enzymes" "anticancer agents" "retinoic acid"
19 Q0 28504299 55 33.727432 imi_mug_run_2_treatment "adjuvant" "oxaliplatin" "aim"
19 Q0 30463996 56 33.684757 imi_mug_run_2_treatment "afatinib" "trastuzumab" "kinase inhibitor"
19 Q0 19616374 57 33.67281 imi_mug_run_2_treatment "fluorouracil" "resveratrol" "drug"
19 Q0 8664033 58 33.67221 imi_mug_run_2_treatment "plasma"
19 Q0 19881546 59 33.5924 imi_mug_run_2_treatment "mediated"
19 Q0 15640503 60 33.54808 imi_mug_run_2_treatment "fluorouracil"
19 Q0 9885379 61 33.497353 imi_mug_run_2_treatment "ras"
19 Q0 24120871 62 33.476883 imi_mug_run_2_treatment "adjuvant" "trastuzumab"
19 Q0 12727839 63 33.470848 imi_mug_run_2_treatment "level"
19 Q0 11410482 64 33.30918 imi_mug_run_2_treatment "topo" "enzymes" "alkylator"
19 Q0 18326857 65 33.296364 imi_mug_run_2_treatment "hyaluronan" "matrix"
19 Q0 27864121 66 33.263363 imi_mug_run_2_treatment "color"
19 Q0 24970817 67 33.18293 imi_mug_run_2_treatment "ly294002"
19 Q0 12362975 68 33.150425 imi_mug_run_2_treatment "estrogen"
19 Q0 22157714 69 33.131203 imi_mug_run_2_treatment "dextran sulfate sodium"
19 Q0 19331154 70 33.09967 imi_mug_run_2_treatment "epidermal growth factor" "basis"
19 Q0 17001161 71 33.0846 imi_mug_run_2_treatment "mbc"
19 Q0 28504690 72 32.99398 imi_mug_run_2_treatment "cisplatin" "drugs" "fluorouracil"
19 Q0 19424877 73 32.87158 imi_mug_run_2_treatment "aspirin" "hoechst 33258" "agent"
19 Q0 16397255 74 32.849205 imi_mug_run_2_treatment "ag879" "tyrosine kinase inhibitor" "gw572016"
19 Q0 20201928 75 32.832787 imi_mug_run_2_treatment "ag825" "ethanol" "human plasma"
19 Q0 15743507 76 32.811783 imi_mug_run_2_treatment "aim"
19 Q0 18855989 77 32.805557 imi_mug_run_2_treatment "lmd" "level" "aim"
19 Q0 12631589 78 32.771763 imi_mug_run_2_treatment "her-2"
19 Q0 26244165 79 32.669548 imi_mug_run_2_treatment "trastuzumab"
19 Q0 19272639 80 32.638836 imi_mug_run_2_treatment "cisplatin" "cyclophosphamide" "paclitaxel"
19 Q0 23720052 81 32.629925 imi_mug_run_2_treatment "mediated"
19 Q0 21034468 82 32.59589 imi_mug_run_2_treatment "mediated" "ethanol" "antioxidant"
19 Q0 11156524 83 32.59446 imi_mug_run_2_treatment "various" "mediated" "lead"
19 Q0 25414785 84 32.529575 imi_mug_run_2_treatment "sodium chloride"
19 Q0 7509020 85 32.514503 imi_mug_run_2_treatment "gastrin"
19 Q0 11321488 86 32.510593 imi_mug_run_2_treatment "color" "formaldehyde"
19 Q0 10066072 87 32.44404 imi_mug_run_2_treatment "tamoxifen" "antiestrogen" "adjuvant"
19 Q0 21749294 88 32.38041 imi_mug_run_2_treatment "various" "agent"
19 Q0 12571082 89 32.338943 imi_mug_run_2_treatment "conjugated linoleic acid"
19 Q0 7742600 90 32.330757 imi_mug_run_2_treatment "lead"
19 Q0 16414259 91 32.309486 imi_mug_run_2_treatment "tyrosine" "aim"
19 Q0 18339869 92 32.27791 imi_mug_run_2_treatment "mediated"
19 Q0 27791982 93 32.27021 imi_mug_run_2_treatment "lapatinib"
19 Q0 11791178 94 32.15889 imi_mug_run_2_treatment "ag879" "aim" "blockade"
19 Q0 10607920 95 32.15291 imi_mug_run_2_treatment "drug" "mediated" "lead"
19 Q0 18594210 96 32.147152 imi_mug_run_2_treatment "trastuzumab" "adjuvant" "agar"
19 Q0 20371687 97 32.04071 imi_mug_run_2_treatment "level" "cyclophosphamide" "epirubicin"
19 Q0 2229991 98 32.03667 imi_mug_run_2_treatment "ras"
19 Q0 26755150 99 32.0335 imi_mug_run_2_treatment "gold"
19 Q0 29844865 100 31.910095 imi_mug_run_2_treatment "aim"
19 Q0 15480783 101 31.829552 imi_mug_run_2_treatment "level" "balance"
19 Q0 23334330 102 31.8169 imi_mug_run_2_treatment "level"
19 Q0 17570480 103 31.806572 imi_mug_run_2_treatment "her-2"
19 Q0 26449765 104 31.69283 imi_mug_run_2_treatment "trastuzumab" "cetuximab" "lapatinib"
19 Q0 25789534 105 31.593555 imi_mug_run_2_treatment "trastuzumab"
19 Q0 27542246 106 31.531305 imi_mug_run_2_treatment "mediated" "various" "drugs"
19 Q0 30070702 107 31.502497 imi_mug_run_2_treatment "mtx" "dsb" "methotrexate"
19 Q0 24934366 108 31.405407 imi_mug_run_2_treatment "mediated" "aim"
19 Q0 23553339 109 31.395073 imi_mug_run_2_treatment "aim"
19 Q0 8695221 110 31.385017 imi_mug_run_2_treatment "oestrogen" "toremifene" "level"
19 Q0 19787624 111 31.374798 imi_mug_run_2_treatment "interleukin-2" "tnf-alpha" "cytokines"
19 Q0 19214513 112 31.3586 imi_mug_run_2_treatment "trastuzumab" "color"
19 Q0 11205461 113 31.348291 imi_mug_run_2_treatment "tamoxifen" "adjuvant" "aim"
19 Q0 18361882 114 31.298685 imi_mug_run_2_treatment "product"
19 Q0 24492513 115 31.254059 imi_mug_run_2_treatment "trastuzumab"
19 Q0 26489445 116 31.216064 imi_mug_run_2_treatment "formalin" "basis" "level"
19 Q0 29089858 117 31.17229 imi_mug_run_2_treatment "cisplatin" "fluorouracil"
19 Q0 17100565 118 31.169518 imi_mug_run_2_treatment "various" "drug" "herceptin"
19 Q0 22684906 119 31.114164 imi_mug_run_2_treatment "eosin" "lead"
19 Q0 17311002 120 31.111658 imi_mug_run_2_treatment "hki-272" "kinase inhibitor" "drugs"
19 Q0 20553228 121 31.06131 imi_mug_run_2_treatment "combinations" "nsaid" "food"
19 Q0 20029639 122 31.047226 imi_mug_run_2_treatment "basis"
19 Q0 30030278 123 31.019402 imi_mug_run_2_treatment "ado-trastuzumab emtansine"
19 Q0 18382352 124 30.980518 imi_mug_run_2_treatment "silver"
19 Q0 11575440 125 30.97536 imi_mug_run_2_treatment "product"
19 Q0 11746979 126 30.963516 imi_mug_run_2_treatment "level"
19 Q0 16153159 127 30.93705 imi_mug_run_2_treatment "lead" "level"
19 Q0 18948375 128 30.870346 imi_mug_run_2_treatment "cytokines"
19 Q0 1352298 129 30.84053 imi_mug_run_2_treatment "aim"
19 Q0 28133304 130 30.831215 imi_mug_run_2_treatment "panitumumab" "ras" "bevacizumab"
19 Q0 12853564 131 30.81245 imi_mug_run_2_treatment "basis"
19 Q0 21113617 132 30.78095 imi_mug_run_2_treatment "aim"
19 Q0 14669907 133 30.71901 imi_mug_run_2_treatment "chemotherapeutic agent" "agent"
19 Q0 23328479 134 30.664364 imi_mug_run_2_treatment "phosphate"
19 Q0 28027945 135 30.527546 imi_mug_run_2_treatment "medicine"
19 Q0 25124601 136 30.526802 imi_mug_run_2_treatment "rice" "plasminogen activator"
19 Q0 17431415 137 30.507154 imi_mug_run_2_treatment "various combinations" "color" "level"
19 Q0 19226453 138 30.503857 imi_mug_run_2_treatment "tyrosine"
19 Q0 11398198 139 30.467188 imi_mug_run_2_treatment "messenger"
19 Q0 22810696 140 30.453972 imi_mug_run_2_treatment "drug" "igf2"
19 Q0 17013533 141 30.429598 imi_mug_run_2_treatment "aim"
19 Q0 7763285 142 30.40876 imi_mug_run_2_treatment "fluorouracil" "fdump" "fluoropyrimidine"
19 Q0 1680817 143 30.39886 imi_mug_run_2_treatment "anti-estrogens" "tamoxifen" "toremifene"
19 Q0 27596216 144 30.340338 imi_mug_run_2_treatment "drugs" "her-2" "lead"
19 Q0 9310246 145 30.329332 imi_mug_run_2_treatment "genesis"
19 Q0 11984589 146 30.305021 imi_mug_run_2_treatment "herceptin" "trastuzumab"
19 Q0 21900593 147 30.27322 imi_mug_run_2_treatment "cetuximab" "therapeutic antibody"
19 Q0 15498639 148 30.204803 imi_mug_run_2_treatment "level"
19 Q0 14632727 149 30.20202 imi_mug_run_2_treatment "her-2" "drugs"
19 Q0 30442682 150 30.189583 imi_mug_run_2_treatment "drug" "bispecific antibodies" "therapeutics"
19 Q0 28784859 151 30.182545 imi_mug_run_2_treatment "various" "trastuzumab"
19 Q0 15107620 152 30.154331 imi_mug_run_2_treatment "therapeutics"
19 Q0 18454306 153 30.081854 imi_mug_run_2_treatment "duet" "pharmaceuticals"
19 Q0 29941010 154 30.05308 imi_mug_run_2_treatment "lapatinib" "trastuzumab" "aim"
19 Q0 10344734 155 29.977814 imi_mug_run_2_treatment "enzymes" "methylated" "isolate"
19 Q0 15300809 156 29.967632 imi_mug_run_2_treatment "anti-cancer agents" "biotin"
19 Q0 11920778 157 29.962181 imi_mug_run_2_treatment "adjuvant" "duration"
19 Q0 19778814 158 29.952652 imi_mug_run_2_treatment "level"
19 Q0 11360601 159 29.943539 imi_mug_run_2_treatment "oligo"
19 Q0 24861025 160 29.910782 imi_mug_run_2_treatment "trastuzumab" "therapeutics" "tyrosine"
19 Q0 11304576 161 29.90588 imi_mug_run_2_treatment "level"
19 Q0 2253224 162 29.897346 imi_mug_run_2_treatment "ras"
19 Q0 12917629 163 29.868565 imi_mug_run_2_treatment "mediated" "ethanol" "hydrogen peroxide"
19 Q0 19228734 164 29.859123 imi_mug_run_2_treatment "mediated" "level" "taxol"
19 Q0 19513620 165 29.83176 imi_mug_run_2_treatment "cisplatin" "herceptin" "ag825"
19 Q0 22975353 166 29.766802 imi_mug_run_2_treatment "pala" "water"
19 Q0 3282475 167 29.763683 imi_mug_run_2_treatment "ras" "level"
19 Q0 15329759 168 29.754292 imi_mug_run_2_treatment "various" "herceptin"
19 Q0 19360355 169 29.716347 imi_mug_run_2_treatment "various" "zinc"
19 Q0 24311197 170 29.706533 imi_mug_run_2_treatment "level" "trastuzumab"
19 Q0 18701712 171 29.693413 imi_mug_run_2_treatment "mediated" "mediators" "balance"
19 Q0 26164760 172 29.641115 imi_mug_run_2_treatment "vcr" "drug" "vincristine"
19 Q0 10430778 173 29.630177 imi_mug_run_2_treatment "therapeutic agents" "level"
19 Q0 20087350 174 29.625685 imi_mug_run_2_treatment "liver"
19 Q0 15695389 175 29.61721 imi_mug_run_2_treatment "herceptin" "trastuzumab" "level"
19 Q0 12553037 176 29.591953 imi_mug_run_2_treatment "estrogen" "estradiol" "therapeutic agents"
19 Q0 23517721 177 29.578323 imi_mug_run_2_treatment "hyaluronan" "phenol" "enzymes"
19 Q0 22070864 178 29.577347 imi_mug_run_2_treatment "ginseng" "metronidazole" "dextran sulfate sodium"
19 Q0 28099468 179 29.567902 imi_mug_run_2_treatment "suppressor"
19 Q0 23739740 180 29.548294 imi_mug_run_2_treatment "laminarin" "brown algae" "laminaria digitata"
19 Q0 11737892 181 29.543587 imi_mug_run_2_treatment "cytotoxic" "her-2"
19 Q0 7477377 182 29.517933 imi_mug_run_2_treatment "acetylcholine" "crest"
19 Q0 27765041 183 29.498096 imi_mug_run_2_treatment "mediated"
19 Q0 25743022 184 29.447626 imi_mug_run_2_treatment "aim"
19 Q0 12420218 185 29.447266 imi_mug_run_2_treatment "product" "lead"
19 Q0 26899482 186 29.395899 imi_mug_run_2_treatment "gat" "matrix"
19 Q0 22200761 187 29.389044 imi_mug_run_2_treatment "mediated"
19 Q0 19077306 188 29.373093 imi_mug_run_2_treatment "proteasome inhibitor" "thr" "mediated"
19 Q0 23552733 189 29.37147 imi_mug_run_2_treatment "trastuzumab" "level" "pertuzumab"
19 Q0 30005627 190 29.321796 imi_mug_run_2_treatment "lead"
19 Q0 17721278 191 29.282278 imi_mug_run_2_treatment "tma"
19 Q0 9572489 192 29.251038 imi_mug_run_2_treatment "taxotere" "taxol" "thioridazine"
19 Q0 16309427 193 29.247162 imi_mug_run_2_treatment "ras"
19 Q0 20331626 194 29.234821 imi_mug_run_2_treatment "herceptin" "agent" "level"
19 Q0 17704139 195 29.219038 imi_mug_run_2_treatment "various" "androgen" "mediated"
19 Q0 15743501 196 29.218761 imi_mug_run_2_treatment "level"
19 Q0 15457249 197 29.212273 imi_mug_run_2_treatment "enzymes"
19 Q0 24798404 198 29.201422 imi_mug_run_2_treatment "oxygen" "ag825"
19 Q0 27077364 199 29.18885 imi_mug_run_2_treatment "lead" "program"
19 Q0 26439168 200 29.178268 imi_mug_run_2_treatment "suppressor"
19 Q0 16286993 201 29.166931 imi_mug_run_2_treatment "biotin" "abc" "aim"
19 Q0 28415602 202 29.156792 imi_mug_run_2_treatment "lapatinib" "tyrosine kinase inhibitor" "lead"
19 Q0 20649976 203 29.148224 imi_mug_run_2_treatment "cannabinoid" "cannabinoids" "marijuana"
19 Q0 23238628 204 29.142015 imi_mug_run_2_treatment "silver" "trastuzumab"
19 Q0 24685132 205 29.138542 imi_mug_run_2_treatment "drugs"
19 Q0 27363335 206 29.135586 imi_mug_run_2_treatment "combinations" "trastuzumab" "pertuzumab"
19 Q0 26980732 207 29.13129 imi_mug_run_2_treatment "panitumumab" "agent"
19 Q0 21673090 208 29.110577 imi_mug_run_2_treatment "lapatinib" "tyrosine" "proteasome inhibitors"
19 Q0 21516080 209 29.10958 imi_mug_run_2_treatment "trastuzumab" "basis"
19 Q0 16007155 210 29.100754 imi_mug_run_2_treatment "mtx" "methotrexate"
19 Q0 29285258 211 29.080536 imi_mug_run_2_treatment "trastuzumab" "matrix"
19 Q0 15059917 212 29.078642 imi_mug_run_2_treatment "monoclonal antibody 2c4" "anti-erbb2 monoclonal antibody" "monolayer"
19 Q0 14743203 213 29.067348 imi_mug_run_2_treatment "herceptin" "trastuzumab"
19 Q0 8816893 214 29.057125 imi_mug_run_2_treatment "liver"
19 Q0 27048593 215 29.051956 imi_mug_run_2_treatment "forchlorfenuron" "basis" "level"
19 Q0 24937171 216 29.022057 imi_mug_run_2_treatment "ras" "androgen"
19 Q0 27332557 217 29.010384 imi_mug_run_2_treatment "combinations" "drug" "ras"
19 Q0 15911106 218 28.970623 imi_mug_run_2_treatment "troglitazone"
19 Q0 20542996 219 28.969915 imi_mug_run_2_treatment "lapatinib" "trastuzumab" "nervous system"
19 Q0 26936914 220 28.959595 imi_mug_run_2_treatment "abiraterone" "leuprolide" "lapatinib"
19 Q0 8949986 221 28.94212 imi_mug_run_2_treatment "combinations" "cisplatin" "cytotoxic"
19 Q0 27065318 222 28.937449 imi_mug_run_2_treatment "trastuzumab" "level"
19 Q0 21782788 223 28.911497 imi_mug_run_2_treatment "ag1478" "egfr inhibitor" "mediated"
19 Q0 18769124 224 28.863436 imi_mug_run_2_treatment "trastuzumab" "drug" "herceptin"
19 Q0 12457032 225 28.834713 imi_mug_run_2_treatment "zinc"
19 Q0 23788961 226 28.812622 imi_mug_run_2_treatment "aim" "product"
19 Q0 26645663 227 28.808805 imi_mug_run_2_treatment "therapeutic agents"
19 Q0 26261492 228 28.807926 imi_mug_run_2_treatment "kinase inhibitor" "herceptin" "lapatinib"
19 Q0 24835103 229 28.73717 imi_mug_run_2_treatment "trastuzumab" "monoclonal antibodies"
19 Q0 17409443 230 28.708906 imi_mug_run_2_treatment "tocopheryl succinate" "vitamin e succinate"
19 Q0 7903175 231 28.661972 imi_mug_run_2_treatment "estrogen"
19 Q0 27170298 232 28.656612 imi_mug_run_2_treatment "human serum albumin" "tandem"
19 Q0 29279289 233 28.65572 imi_mug_run_2_treatment "icc" "ras"
19 Q0 20498641 234 28.639336 imi_mug_run_2_treatment "paclitaxel" "mediated"
19 Q0 16490596 235 28.630299 imi_mug_run_2_treatment "level"
19 Q0 15580295 236 28.625694 imi_mug_run_2_treatment "mediated" "lactate" "animals"
19 Q0 7584099 237 28.577982 imi_mug_run_2_treatment "monoclonal antibodies"
19 Q0 15678850 238 28.576931 imi_mug_run_2_treatment "antiserum"
19 Q0 26936618 239 28.57294 imi_mug_run_2_treatment "cerulenin" "mediated" "deoxyglucose"
19 Q0 23153426 240 28.54446 imi_mug_run_2_treatment "adjuvant" "ras" "formalin"
19 Q0 21088503 241 28.544336 imi_mug_run_2_treatment "celastrol" "trastuzumab" "therapeutics"
19 Q0 22914212 242 28.53479 imi_mug_run_2_treatment "epidermal growth factor" "level"
19 Q0 11343776 243 28.532934 imi_mug_run_2_treatment "various"
19 Q0 27447172 244 28.506573 imi_mug_run_2_treatment "mediated"
19 Q0 20936496 245 28.504118 imi_mug_run_2_treatment "enzymes" "herceptin" "antioxidant"
19 Q0 25003657 246 28.50287 imi_mug_run_2_treatment "various" "cytotoxic" "peptide t"
19 Q0 16585203 247 28.501076 imi_mug_run_2_treatment "therapeutics" "basis"
19 Q0 19949897 248 28.493364 imi_mug_run_2_treatment "oxaliplatin" "fluorouracil" "capecitabine"
19 Q0 21710689 249 28.488958 imi_mug_run_2_treatment "heat shock protein 70"
19 Q0 26285240 250 28.488659 imi_mug_run_2_treatment "favoring" "trastuzumab" "pertuzumab"
19 Q0 15753384 251 28.474445 imi_mug_run_2_treatment "mediated" "protease" "lead"
19 Q0 8752152 252 28.400948 imi_mug_run_2_treatment "level"
19 Q0 18409049 253 28.3925 imi_mug_run_2_treatment "h-89" "tam" "tamoxifen"
19 Q0 27345410 254 28.381685 imi_mug_run_2_treatment "azacytidine"
19 Q0 26977021 255 28.373127 imi_mug_run_2_treatment "hsp70" "mediated" "drug"
19 Q0 25081321 256 28.364985 imi_mug_run_2_treatment "drug" "ibrutinib" "pi3k/mtor inhibitor bez235"
19 Q0 10918198 257 28.35086 imi_mug_run_2_treatment "basis" "pooled"
19 Q0 17938205 258 28.315987 imi_mug_run_2_treatment "level"
19 Q0 16882699 259 28.315422 imi_mug_run_2_treatment "level" "herceptin" "trastuzumab"
19 Q0 24122876 260 28.310373 imi_mug_run_2_treatment "glutamine" "mediated"
19 Q0 10408862 261 28.301617 imi_mug_run_2_treatment "icc"
19 Q0 16452223 262 28.29923 imi_mug_run_2_treatment "lapatinib" "proteosome inhibitor" "mediated"
19 Q0 12894578 263 28.287937 imi_mug_run_2_treatment "oestrogen"
19 Q0 23661506 264 28.251305 imi_mug_run_2_treatment "level"
19 Q0 27029001 265 28.240856 imi_mug_run_2_treatment "mediated"
19 Q0 16375577 266 28.232683 imi_mug_run_2_treatment "level"
19 Q0 26496221 267 28.218372 imi_mug_run_2_treatment "drugs" "gold" "mediated"
19 Q0 9875670 268 28.214302 imi_mug_run_2_treatment "dna immunization" "cancer vaccine" "genetic immunization"
19 Q0 25596742 269 28.202276 imi_mug_run_2_treatment "mediated" "kinase inhibitor" "lapatinib"
19 Q0 15687687 270 28.196136 imi_mug_run_2_treatment "therapeutic agents"
19 Q0 8099571 271 28.193832 imi_mug_run_2_treatment "estrogen" "progesterone"
19 Q0 20379846 272 28.18869 imi_mug_run_2_treatment "tamoxifen" "mediated" "proteasome inhibitors"
19 Q0 29715459 273 28.187809 imi_mug_run_2_treatment "paclitaxel" "mediated" "level"
19 Q0 25238247 274 28.14801 imi_mug_run_2_treatment "lapatinib" "blockade"
19 Q0 29394766 275 28.140846 imi_mug_run_2_treatment "ras" "liver"
19 Q0 10681823 276 28.136099 imi_mug_run_2_treatment "col-1"
19 Q0 16003726 277 28.123554 imi_mug_run_2_treatment "gefitinib"
19 Q0 16091755 278 28.114338 imi_mug_run_2_treatment "lapatinib" "trastuzumab"
19 Q0 28306722 279 28.111572 imi_mug_run_2_treatment "matrix" "aim" "shape"
19 Q0 16679780 280 28.103277 imi_mug_run_2_treatment "aim"
19 Q0 24888777 281 28.098423 imi_mug_run_2_treatment "trastuzumab" "cyclophosphamide" "epirubicin"
19 Q0 17942920 282 28.089062 imi_mug_run_2_treatment "kinase inhibitor" "herceptin" "trastuzumab"
19 Q0 9087165 283 28.07571 imi_mug_run_2_treatment "agar" "collagen"
19 Q0 17266042 284 28.066257 imi_mug_run_2_treatment "tamoxifen" "mediated"
19 Q0 21419042 285 28.0616 imi_mug_run_2_treatment "mediated" "aim"
19 Q0 20124457 286 28.04892 imi_mug_run_2_treatment "lapatinib" "calcium" "drug"
19 Q0 18765569 287 28.036928 imi_mug_run_2_treatment "epidermal growth factor"
19 Q0 28442738 288 28.025166 imi_mug_run_2_treatment "mediated"
19 Q0 9408753 289 28.017082 imi_mug_run_2_treatment "level"
19 Q0 24492292 290 28.003387 imi_mug_run_2_treatment "trastuzumab" "saracatinib" "drug"
19 Q0 23943608 291 27.985056 imi_mug_run_2_treatment "trastuzumab" "lapatinib" "combination drug"
19 Q0 15093533 292 27.977703 imi_mug_run_2_treatment "mediated" "herceptin" "trastuzumab"
19 Q0 29686309 293 27.975945 imi_mug_run_2_treatment "various" "mediated"
19 Q0 30094493 294 27.964779 imi_mug_run_2_treatment "aromatase inhibitors"
19 Q0 9206112 295 27.956463 imi_mug_run_2_treatment "drug" "adm" "adriamycine"
19 Q0 20961995 296 27.940231 imi_mug_run_2_treatment "estrogen"
19 Q0 21127496 297 27.92588 imi_mug_run_2_treatment "tocopheryl succinate" "recombinant tnf-related apoptosis-inducing ligand" "aim"
19 Q0 26999718 298 27.924747 imi_mug_run_2_treatment "trastuzumab" "pertuzumab" "mediated"
19 Q0 20068093 299 27.904446 imi_mug_run_2_treatment "balance"
19 Q0 17148775 300 27.904367 imi_mug_run_2_treatment "sodium bisulfite"
19 Q0 23900832 301 27.888615 imi_mug_run_2_treatment "ile"
19 Q0 16901783 302 27.861656 imi_mug_run_2_treatment "mediated"
19 Q0 10878580 303 27.86127 imi_mug_run_2_treatment "mediated" "taxol" "lead"
19 Q0 23460348 304 27.859467 imi_mug_run_2_treatment "trastuzumab"
19 Q0 15987433 305 27.825844 imi_mug_run_2_treatment "aim"
19 Q0 12918107 306 27.807781 imi_mug_run_2_treatment "aim"
19 Q0 16947083 307 27.763645 imi_mug_run_2_treatment "drugs"
19 Q0 28300085 308 27.758041 imi_mug_run_2_treatment "mediated"
19 Q0 16784538 309 27.709263 imi_mug_run_2_treatment "various" "pooled"
19 Q0 7584078 310 27.69915 imi_mug_run_2_treatment "fluorocytosine" "fluorouracil" "cytotoxic"
19 Q0 16407820 311 27.686665 imi_mug_run_2_treatment "mediated" "plasminogen activator" "agent"
19 Q0 1980125 312 27.661476 imi_mug_run_2_treatment "level"
19 Q0 25333815 313 27.645294 imi_mug_run_2_treatment "various" "tor" "mediated"
19 Q0 18316590 314 27.636946 imi_mug_run_2_treatment "level"
19 Q0 11175365 315 27.60274 imi_mug_run_2_treatment "tcc" "therapeutics" "level"
19 Q0 19668225 316 27.597536 imi_mug_run_2_treatment "deoxyglucose" "mediated" "level"
19 Q0 22393464 317 27.5958 imi_mug_run_2_treatment "agonist" "others"
19 Q0 29792724 318 27.5958 imi_mug_run_2_treatment "trastuzumab" "therapeutic antibody" "level"
19 Q0 26716506 319 27.581493 imi_mug_run_2_treatment "trastuzumab" "therapeutic agents"
19 Q0 10499598 320 27.58088 imi_mug_run_2_treatment "erb-38" "immunotoxin" "liver"
19 Q0 24247619 321 27.578297 imi_mug_run_2_treatment "phb" "prohibitin" "aim"
19 Q0 23318431 322 27.577156 imi_mug_run_2_treatment "antioxidants" "oxygen" "tyrosine"
19 Q0 25537274 323 27.57275 imi_mug_run_2_treatment "mtx" "methotrexate"
19 Q0 30520849 324 27.541225 imi_mug_run_2_treatment "trastuzumab" "bispecific antibody" "cytotoxic"
19 Q0 22674190 325 27.512081 imi_mug_run_2_treatment "herceptin" "kinase inhibitor" "pertuzumab"
19 Q0 27203740 326 27.483131 imi_mug_run_2_treatment "herceptin"
19 Q0 9696394 327 27.478836 imi_mug_run_2_treatment "level" "tyrosine" "tyrosine kinase inhibitor"
19 Q0 22589274 328 27.475637 imi_mug_run_2_treatment "gemcitabine" "hub" "trastuzumab"
19 Q0 7904515 329 27.474108 imi_mug_run_2_treatment "her-2"
19 Q0 26471763 330 27.473972 imi_mug_run_2_treatment "suppressor"
19 Q0 15252840 331 27.457607 imi_mug_run_2_treatment "others"
19 Q0 24367169 332 27.456467 imi_mug_run_2_treatment "lapatinib" "various" "drug"
19 Q0 9337347 333 27.447563 imi_mug_run_2_treatment "epidermal growth factor" "program"
19 Q0 24463007 334 27.41851 imi_mug_run_2_treatment "tamoxifen" "endocrine therapy" "selective estrogen receptor modulator"
19 Q0 20033812 335 27.396015 imi_mug_run_2_treatment "adjuvant" "oxaliplatin" "leucovorin"
19 Q0 22464443 336 27.383366 imi_mug_run_2_treatment "mediators"
19 Q0 23915743 337 27.378656 imi_mug_run_2_treatment "drug"
19 Q0 25719557 338 27.36809 imi_mug_run_2_treatment "gefitinib" "erlotinib"
19 Q0 27102434 339 27.363537 imi_mug_run_2_treatment "calcium" "lead" "monoclonal antibodies"
19 Q0 9135021 340 27.354134 imi_mug_run_2_treatment "fluorouracil" "levamisole" "level"
19 Q0 25047501 341 27.351871 imi_mug_run_2_treatment "kato" "monolayer"
19 Q0 7954425 342 27.350618 imi_mug_run_2_treatment "various" "immunostimulant" "levamisole"
19 Q0 22969966 343 27.3377 imi_mug_run_2_treatment "tyrosine"
19 Q0 9614437 344 27.333052 imi_mug_run_2_treatment "basis"
19 Q0 23851309 345 27.324951 imi_mug_run_2_treatment "trastuzumab"
19 Q0 24322659 346 27.313145 imi_mug_run_2_treatment "metformin" "mediated"
19 Q0 24046294 347 27.293457 imi_mug_run_2_treatment "immunoglobulin g" "bispecific antibody" "pertuzumab"
19 Q0 23271292 348 27.285103 imi_mug_run_2_treatment "herceptin" "dsb"
19 Q0 23089982 349 27.26324 imi_mug_run_2_treatment "lapatinib" "drug" "kinase inhibitor"
19 Q0 22046346 350 27.259361 imi_mug_run_2_treatment "kinase inhibitor" "lapatinib" "cl-387785"
19 Q0 19208461 351 27.222921 imi_mug_run_2_treatment "therapeutics"
19 Q0 14696118 352 27.219164 imi_mug_run_2_treatment "her-2" "blockade"
19 Q0 25590338 353 27.206211 imi_mug_run_2_treatment "lapatinib" "trastuzumab" "mediated"
19 Q0 17699716 354 27.176228 imi_mug_run_2_treatment "mtor inhibitor"
19 Q0 15557752 355 27.138767 imi_mug_run_2_treatment "aim"
19 Q0 23770845 356 27.138353 imi_mug_run_2_treatment "gw9662" "level"
19 Q0 15609325 357 27.134209 imi_mug_run_2_treatment "com" "antiangiogenic" "aim"
19 Q0 20579853 358 27.131348 imi_mug_run_2_treatment "aim"
19 Q0 28096336 359 27.130484 imi_mug_run_2_treatment "program" "balance"
19 Q0 22248472 360 27.122173 imi_mug_run_2_treatment "bispecific antibody" "human serum albumin" "trastuzumab"
19 Q0 27474152 361 27.1129 imi_mug_run_2_treatment "therapeutics" "lapatinib"
19 Q0 15385631 362 27.097633 imi_mug_run_2_treatment "trastuzumab" "herceptin" "balance"
19 Q0 25566992 363 27.094517 imi_mug_run_2_treatment "iff" "mediated" "matrix"
19 Q0 20331976 364 27.084166 imi_mug_run_2_treatment "tyrosine"
19 Q0 20197472 365 27.069443 imi_mug_run_2_treatment "trastuzumab" "lapatinib" "mediated"
19 Q0 12584562 366 27.061892 imi_mug_run_2_treatment "mediated"
19 Q0 23612964 367 27.061892 imi_mug_run_2_treatment "tyrosine" "lapatinib"
19 Q0 25791465 368 27.061028 imi_mug_run_2_treatment "matrix"
19 Q0 20711231 369 27.023031 imi_mug_run_2_treatment "mediated" "ras" "drug"
19 Q0 19435870 370 27.020203 imi_mug_run_2_treatment "nonsteroidal anti-inflammatory drug" "anti-inflammatory" "drug"
19 Q0 18255351 371 27.004559 imi_mug_run_2_treatment "hgh" "growth hormone" "human growth hormone"
19 Q0 25229241 372 27.004086 imi_mug_run_2_treatment "product"
19 Q0 24668895 373 26.997196 imi_mug_run_2_treatment "liver" "aim"
19 Q0 12970889 374 26.99194 imi_mug_run_2_treatment "aim"
19 Q0 11062025 375 26.962532 imi_mug_run_2_treatment "drugs" "various" "fluorouracil"
19 Q0 20814902 376 26.934319 imi_mug_run_2_treatment "various"
19 Q0 27879270 377 26.928299 imi_mug_run_2_treatment "antiestrogen" "drug" "antiestrogens"
19 Q0 18936791 378 26.917881 imi_mug_run_2_treatment "trastuzumab" "tyrosine kinase inhibitor" "lapatinib"
19 Q0 24970802 379 26.913738 imi_mug_run_2_treatment "silibinin" "mediated" "various"
19 Q0 12115729 380 26.903315 imi_mug_run_2_treatment "mediated" "level"
19 Q0 16958676 381 26.853645 imi_mug_run_2_treatment "ethanol" "oxygen"
19 Q0 24121271 382 26.837893 imi_mug_run_2_treatment "program"
19 Q0 28032729 383 26.810238 imi_mug_run_2_treatment "quercetin" "fluorouracil"
19 Q0 22505344 384 26.802269 imi_mug_run_2_treatment "androgen" "trastuzumab" "pertuzumab"
19 Q0 23519125 385 26.7695 imi_mug_run_2_treatment "saha" "hdac inhibitor" "panobinostat"
19 Q0 17687647 386 26.74168 imi_mug_run_2_treatment "ile" "isoleucine"
19 Q0 16963728 387 26.738754 imi_mug_run_2_treatment "urokinase-type plasminogen activator" "plasminogen activator" "plau"
19 Q0 21384344 388 26.723583 imi_mug_run_2_treatment "mediated"
19 Q0 29409051 389 26.723497 imi_mug_run_2_treatment "lapatinib" "plasma" "oxaliplatin"
19 Q0 24935174 390 26.714346 imi_mug_run_2_treatment "therapeutics" "azd6244"
19 Q0 7912561 391 26.709175 imi_mug_run_2_treatment "combinations"
19 Q0 7960236 392 26.706726 imi_mug_run_2_treatment "various"
19 Q0 1682035 393 26.704803 imi_mug_run_2_treatment "basis"
19 Q0 16488535 394 26.700176 imi_mug_run_2_treatment "resveratrol" "estrogen"
19 Q0 24709902 395 26.671637 imi_mug_run_2_treatment "nervous system"
19 Q0 11956082 396 26.671036 imi_mug_run_2_treatment "combinations" "flavopiridol" "herceptin"
19 Q0 16772118 397 26.653807 imi_mug_run_2_treatment "color"
19 Q0 24566388 398 26.649212 imi_mug_run_2_treatment "mediated"
19 Q0 10738122 399 26.642832 imi_mug_run_2_treatment "progesterone" "cyclophosphamide" "oestrogen"
19 Q0 17717428 400 26.633598 imi_mug_run_2_treatment "aim"
19 Q0 22789781 401 26.598358 imi_mug_run_2_treatment "trastuzumab" "cetuximab" "bsab"
19 Q0 19826412 402 26.591434 imi_mug_run_2_treatment "tyr" "paclitaxel" "ras"
19 Q0 21613411 403 26.581728 imi_mug_run_2_treatment "androgen" "dihydrotestosterone" "tcc"
19 Q0 12477051 404 26.570044 imi_mug_run_2_treatment "hdac inhibitor" "sodium butyrate" "histone deacetylase inhibitors"
19 Q0 23971878 405 26.551949 imi_mug_run_2_treatment "lapatinib" "oxygen" "mediated"
19 Q0 20429623 406 26.549103 imi_mug_run_2_treatment "estrogen"
19 Q0 8077048 407 26.541264 imi_mug_run_2_treatment "urokinase" "plasmin" "plasminogen"
19 Q0 17452776 408 26.538082 imi_mug_run_2_treatment "aim"
19 Q0 19826038 409 26.513802 imi_mug_run_2_treatment "sndx-275" "hdac inhibitor sndx-275" "therapeutic agent"
19 Q0 16319978 410 26.507948 imi_mug_run_2_treatment "estrogen" "plasma"
19 Q0 21497990 411 26.507948 imi_mug_run_2_treatment "combinations" "sndx-275" "hdac inhibitor"
19 Q0 24551203 412 26.49501 imi_mug_run_2_treatment "psoralen" "mediated" "methoxypsoralen"
19 Q0 7954259 413 26.472984 imi_mug_run_2_treatment "adjuvant" "product"
19 Q0 20847831 414 26.465067 imi_mug_run_2_treatment "lapatinib" "estrogen" "tamoxifen"
19 Q0 21086124 415 26.454746 imi_mug_run_2_treatment "trastuzumab" "paclitaxel" "herceptin"
19 Q0 14726656 416 26.449015 imi_mug_run_2_treatment "liver"
19 Q0 12748185 417 26.446482 imi_mug_run_2_treatment "color" "tyrosine"
19 Q0 19262900 418 26.443436 imi_mug_run_2_treatment "color"
19 Q0 27597738 419 26.425488 imi_mug_run_2_treatment "neratinib" "lapatinib" "mediated"
19 Q0 14697248 420 26.399506 imi_mug_run_2_treatment "pd98059" "trastuzumab"
19 Q0 14982856 421 26.37847 imi_mug_run_2_treatment "mediated"
19 Q0 23232401 422 26.369093 imi_mug_run_2_treatment "therapeutics" "trastuzumab"
19 Q0 24723567 423 26.365732 imi_mug_run_2_treatment "basis"
19 Q0 11156523 424 26.365118 imi_mug_run_2_treatment "cdk inhibitor"
19 Q0 25986173 425 26.35294 imi_mug_run_2_treatment "ras"
19 Q0 27863425 426 26.345541 imi_mug_run_2_treatment "wortmannin" "mediated"
19 Q0 29907770 427 26.322937 imi_mug_run_2_treatment "glucose" "lactate" "level"
19 Q0 20060649 428 26.319935 imi_mug_run_2_treatment "drugs" "oestrogen" "parp inhibitors"
19 Q0 22461520 429 26.295076 imi_mug_run_2_treatment "ly294002" "androgen" "wortmannin"
19 Q0 24384723 430 26.293945 imi_mug_run_2_treatment "lapatinib" "mediated" "epidermal growth factor receptor inhibitor"
19 Q0 12755489 431 26.286304 imi_mug_run_2_treatment "trastuzumab" "her-2"
19 Q0 12553494 432 26.285664 imi_mug_run_2_treatment "trastuzumab" "aim"
19 Q0 10474684 433 26.259785 imi_mug_run_2_treatment "sam" "aim"
19 Q0 16818618 434 26.249971 imi_mug_run_2_treatment "hki-272" "kinase inhibitor" "interleukin-3"
19 Q0 16672071 435 26.24665 imi_mug_run_2_treatment "enzymes"
19 Q0 12527944 436 26.240273 imi_mug_run_2_treatment "edta" "ethidium bromide"
19 Q0 12384528 437 26.22792 imi_mug_run_2_treatment "tyr" "herceptin" "taxol"
19 Q0 7913873 438 26.207518 imi_mug_run_2_treatment "various"
19 Q0 30385370 439 26.203434 imi_mug_run_2_treatment "aim"
19 Q0 1355483 440 26.201777 imi_mug_run_2_treatment "drug" "cytotoxic drugs" "basis"
19 Q0 22591714 441 26.167807 imi_mug_run_2_treatment "kinase inhibitor" "mediated" "product"
19 Q0 17214955 442 26.159904 imi_mug_run_2_treatment "level" "u73122"
19 Q0 19561085 443 26.146591 imi_mug_run_2_treatment "various" "mediated"
19 Q0 26933086 444 26.134401 imi_mug_run_2_treatment "mediated"
19 Q0 24839254 445 26.108557 imi_mug_run_2_treatment "bile acid" "tace" "taurochenodeoxycholic acid"
19 Q0 24615340 446 26.098902 imi_mug_run_2_treatment "drugs" "mediated" "ink-128"
19 Q0 25225290 447 26.086414 imi_mug_run_2_treatment "pma" "kinase inhibitor" "hub"
19 Q0 29163776 448 26.078657 imi_mug_run_2_treatment "drug" "mediated"
19 Q0 30008904 449 26.06892 imi_mug_run_2_treatment "trastuzumab" "oxaliplatin" "capecitabine"
19 Q0 1373318 450 26.051174 imi_mug_run_2_treatment "drugs"
19 Q0 10098763 451 26.03041 imi_mug_run_2_treatment "endocrine therapy" "tamoxifen"
19 Q0 18777950 452 26.029625 imi_mug_run_2_treatment "trastuzumab" "adjuvant" "lapatinib"
19 Q0 19298655 453 26.029274 imi_mug_run_2_treatment "fats" "oxygen" "gw9662"
19 Q0 19821025 454 26.015701 imi_mug_run_2_treatment "estrogen" "progesterone" "tyrosine"
19 Q0 26863927 455 26.002773 imi_mug_run_2_treatment "drugs" "investigational drugs" "trastuzumab"
19 Q0 14739033 456 25.992672 imi_mug_run_2_treatment "nrg" "blockade"
19 Q0 11279343 457 25.988703 imi_mug_run_2_treatment "level"
19 Q0 29755687 458 25.98378 imi_mug_run_2_treatment "ras"
19 Q0 17234750 459 25.982494 imi_mug_run_2_treatment "mdf"
19 Q0 17525746 460 25.968378 imi_mug_run_2_treatment "trastuzumab" "tyrosine" "herceptin"
19 Q0 8758793 461 25.936333 imi_mug_run_2_treatment "cisplatinum" "drugs" "fluorouracil"
19 Q0 30304546 462 25.925282 imi_mug_run_2_treatment "adjuvant" "afatinib"
19 Q0 19372587 463 25.91585 imi_mug_run_2_treatment "taxol" "mediated"
19 Q0 20622016 464 25.898294 imi_mug_run_2_treatment "various" "mediated" "ras"
19 Q0 24280377 465 25.888788 imi_mug_run_2_treatment "mediated"
19 Q0 20335174 466 25.880608 imi_mug_run_2_treatment "agar" "tyrosol"
19 Q0 10567214 467 25.868387 imi_mug_run_2_treatment "monoclonal antibodies"
19 Q0 23007710 468 25.868317 imi_mug_run_2_treatment "lapatinib" "gemcitabine" "agent"
19 Q0 12792823 469 25.85831 imi_mug_run_2_treatment "ndp"
19 Q0 18922900 470 25.855198 imi_mug_run_2_treatment "mediated"
19 Q0 24971884 471 25.855198 imi_mug_run_2_treatment "lapatinib" "tyrosine kinase inhibitor" "lead"
19 Q0 12937837 472 25.852907 imi_mug_run_2_treatment "adc"
19 Q0 17288526 473 25.821157 imi_mug_run_2_treatment "mediated"
19 Q0 9604788 474 25.81612 imi_mug_run_2_treatment "various"
19 Q0 15489929 475 25.804037 imi_mug_run_2_treatment "level"
19 Q0 25973297 476 25.796919 imi_mug_run_2_treatment "various" "anti-cancer agents" "drugs"
19 Q0 19005469 477 25.796404 imi_mug_run_2_treatment "tamoxifen" "cancer drug" "oestrogen"
19 Q0 23474764 478 25.793362 imi_mug_run_2_treatment "mediated"
19 Q0 27063727 479 25.78213 imi_mug_run_2_treatment "therapeutic agent"
19 Q0 25723113 480 25.778027 imi_mug_run_2_treatment "estrogen" "basis"
19 Q0 17392524 481 25.773336 imi_mug_run_2_treatment "bortezomib" "azd6244" "therapeutics"
19 Q0 18516291 482 25.76052 imi_mug_run_2_treatment "flutamide" "testosterone" "antiandrogen"
19 Q0 26955870 483 25.754946 imi_mug_run_2_treatment "various" "trastuzumab" "anti-erbb2 monoclonal antibody"
19 Q0 19697624 484 25.74493 imi_mug_run_2_treatment "aim"
19 Q0 22331080 485 25.730421 imi_mug_run_2_treatment "vaccine" "therapeutic vaccine" "cancer vaccine"
19 Q0 14580688 486 25.72488 imi_mug_run_2_treatment "level"
19 Q0 19318561 487 25.694256 imi_mug_run_2_treatment "androgen" "sdm" "kinase inhibitor"
19 Q0 22266114 488 25.677008 imi_mug_run_2_treatment "glucose" "mediated" "drugs"
19 Q0 1359495 489 25.673405 imi_mug_run_2_treatment "enzymes"
19 Q0 19221498 490 25.671688 imi_mug_run_2_treatment "metformin" "drug" "level"
19 Q0 1652174 491 25.64983 imi_mug_run_2_treatment "basis"
19 Q0 26391955 492 25.618607 imi_mug_run_2_treatment "tyrosine"
19 Q0 2052000 493 25.617836 imi_mug_run_2_treatment "various" "basis"
19 Q0 21876697 494 25.616419 imi_mug_run_2_treatment "trastuzumab"
19 Q0 28422721 495 25.613844 imi_mug_run_2_treatment "androgen"
19 Q0 22448335 496 25.59971 imi_mug_run_2_treatment "trastuzumab" "program" "lead"
19 Q0 23856074 497 25.59863 imi_mug_run_2_treatment "bxl0124" "vitamin d analog"
19 Q0 23792450 498 25.574232 imi_mug_run_2_treatment "herceptin" "level"
19 Q0 21686266 499 25.545868 imi_mug_run_2_treatment "ras" "mediated" "others"
19 Q0 20626753 500 25.534119 imi_mug_run_2_treatment "liver" "mediated"
19 Q0 24668364 501 25.519825 imi_mug_run_2_treatment "trastuzumab" "cetuximab"
19 Q0 17304506 502 25.513828 imi_mug_run_2_treatment "various" "level" "ly294002"
19 Q0 25215939 503 25.495163 imi_mug_run_2_treatment "androgen" "tyrosine" "epidermal growth factor"
19 Q0 27564098 504 25.487696 imi_mug_run_2_treatment "trastuzumab" "human antibody" "pertuzumab"
19 Q0 11571643 505 25.466972 imi_mug_run_2_treatment "anti-cancer agents" "drug" "taxol"
19 Q0 21867536 506 25.46624 imi_mug_run_2_treatment "mediated" "trastuzumab"
19 Q0 9769953 507 25.452084 imi_mug_run_2_treatment "genesis"
19 Q0 20103628 508 25.451202 imi_mug_run_2_treatment "trastuzumab" "cancer drug" "mediated"
19 Q0 26301495 509 25.447105 imi_mug_run_2_treatment "trastuzumab"
19 Q0 16537704 510 25.444515 imi_mug_run_2_treatment "centuries"
19 Q0 23419522 511 25.428616 imi_mug_run_2_treatment "level"
19 Q0 11953857 512 25.42736 imi_mug_run_2_treatment "epidermal growth factor"
19 Q0 23644215 513 25.425138 imi_mug_run_2_treatment "drug" "curcumin" "fluorouracil"
19 Q0 17176074 514 25.423943 imi_mug_run_2_treatment "herceptin" "level"
19 Q0 19906305 515 25.40282 imi_mug_run_2_treatment "serine"
19 Q0 22952421 516 25.396847 imi_mug_run_2_treatment "mediated"
19 Q0 12032832 517 25.388985 imi_mug_run_2_treatment "various"
19 Q0 20051960 518 25.372417 imi_mug_run_2_treatment "trastuzumab" "cytotoxic"
19 Q0 15868442 519 25.365402 imi_mug_run_2_treatment "tamoxifen"
19 Q0 18795950 520 25.361336 imi_mug_run_2_treatment "herceptin"
19 Q0 18729063 521 25.359814 imi_mug_run_2_treatment "drugs" "vaccines"
19 Q0 29636108 522 25.353088 imi_mug_run_2_treatment "various" "others"
19 Q0 23852390 523 25.34791 imi_mug_run_2_treatment "mtor inhibitor"
19 Q0 9337349 524 25.347393 imi_mug_run_2_treatment "chemotherapeutic agent" "drug" "acetone"
19 Q0 18560559 525 25.340439 imi_mug_run_2_treatment "coload1" "mediated" "agent"
19 Q0 15324690 526 25.325481 imi_mug_run_2_treatment "trastuzumab"
19 Q0 22070017 527 25.320986 imi_mug_run_2_treatment "trastuzumab" "cetuximab" "level"
19 Q0 28947957 528 25.317806 imi_mug_run_2_treatment "trastuzumab"
19 Q0 10861310 529 25.30838 imi_mug_run_2_treatment "various" "drug" "combinations"
19 Q0 24733427 530 25.295784 imi_mug_run_2_treatment "various"
19 Q0 27606947 531 25.289696 imi_mug_run_2_treatment "aim"
19 Q0 11706391 532 25.289505 imi_mug_run_2_treatment "paclitaxel" "trastuzumab" "mediated"
19 Q0 21503962 533 25.287222 imi_mug_run_2_treatment "kinase inhibitor" "proteasome inhibitor" "mp-412"
19 Q0 27853901 534 25.284115 imi_mug_run_2_treatment "adjuvant" "fluorouracil" "oxaliplatin"
19 Q0 23912956 535 25.264484 imi_mug_run_2_treatment "pdgfb" "epidermal growth factor" "product"
19 Q0 12907618 536 25.24388 imi_mug_run_2_treatment "kinase inhibitor" "tarceva" "egfr inhibitor"
19 Q0 8455947 537 25.232382 imi_mug_run_2_treatment "estrogens"
19 Q0 18458039 538 25.231571 imi_mug_run_2_treatment "lapatinib"
19 Q0 27940449 539 25.21797 imi_mug_run_2_treatment "mbc" "endocrine therapy"
19 Q0 18661526 540 25.207922 imi_mug_run_2_treatment "fluorouracil"
19 Q0 17243161 541 25.207233 imi_mug_run_2_treatment "trastuzumab" "combinations"
19 Q0 23146892 542 25.204742 imi_mug_run_2_treatment "oxygen"
19 Q0 19190117 543 25.17945 imi_mug_run_2_treatment "mtx" "methotrexate" "drug"
19 Q0 18588872 544 25.17809 imi_mug_run_2_treatment "honokiol" "her-2" "drug"
19 Q0 18931700 545 25.173738 imi_mug_run_2_treatment "mediated"
19 Q0 7605658 546 25.173265 imi_mug_run_2_treatment "level"
19 Q0 26631035 547 25.172369 imi_mug_run_2_treatment "various" "celecoxib" "drugs"
19 Q0 16904607 548 25.164825 imi_mug_run_2_treatment "guo"
19 Q0 22977516 549 25.157635 imi_mug_run_2_treatment "insulin" "trastuzumab" "various"
19 Q0 11689293 550 25.123665 imi_mug_run_2_treatment "adjuvant" "level" "tamoxifen"
19 Q0 12234993 551 25.118366 imi_mug_run_2_treatment "pki-166" "androgen" "tyrosine kinase inhibitor"
19 Q0 17146442 552 25.104574 imi_mug_run_2_treatment "agar" "mediated" "ag825"
19 Q0 29139039 553 25.103859 imi_mug_run_2_treatment "various" "adc"
19 Q0 23474757 554 25.091236 imi_mug_run_2_treatment "lapatinib" "agent"
19 Q0 24168763 555 25.081623 imi_mug_run_2_treatment "mediated" "sar256212" "paclitaxel"
19 Q0 16834533 556 25.07936 imi_mug_run_2_treatment "drug" "ps-341" "dtp"
19 Q0 24692179 557 25.078289 imi_mug_run_2_treatment "mediated" "lapatinib" "egfr inhibitor"
19 Q0 26719032 558 25.076262 imi_mug_run_2_treatment "calcium" "tandem" "yeast"
19 Q0 25882375 559 25.075863 imi_mug_run_2_treatment "crizotinib"
19 Q0 21499233 560 25.074133 imi_mug_run_2_treatment "trastuzumab" "adjuvant" "product"
19 Q0 25738885 561 25.070538 imi_mug_run_2_treatment "various" "copper" "disulfiram"
19 Q0 7880720 562 25.044258 imi_mug_run_2_treatment "oestrogen"
19 Q0 25520867 563 25.038294 imi_mug_run_2_treatment "mediated" "ras"
19 Q0 7667291 564 25.023285 imi_mug_run_2_treatment "various" "therapeutics" "color"
19 Q0 8176843 565 25.009726 imi_mug_run_2_treatment "ras"
19 Q0 15632176 566 24.966452 imi_mug_run_2_treatment "hyaluronan"
19 Q0 21559673 567 24.964582 imi_mug_run_2_treatment "sulindac" "ras" "phitc"
19 Q0 19718021 568 24.950294 imi_mug_run_2_treatment "epidermal growth factor"
19 Q0 26964772 569 24.950294 imi_mug_run_2_treatment "afatinib" "plasma"
19 Q0 18258606 570 24.93253 imi_mug_run_2_treatment "mediated" "ag825" "ag1478"
19 Q0 17145873 571 24.92295 imi_mug_run_2_treatment "mediated"
19 Q0 20179677 572 24.922424 imi_mug_run_2_treatment "autologous" "interferon-gamma" "herceptin"
19 Q0 11796827 573 24.905457 imi_mug_run_2_treatment "her-2"
19 Q0 10022814 574 24.897036 imi_mug_run_2_treatment "oligos" "ras"
19 Q0 14749494 575 24.894424 imi_mug_run_2_treatment "drug" "nrg" "herceptin"
19 Q0 1355402 576 24.877583 imi_mug_run_2_treatment "product"
19 Q0 10738256 577 24.833061 imi_mug_run_2_treatment "animals" "monoclonal antibodies"
19 Q0 20043086 578 24.81094 imi_mug_run_2_treatment "plasminogen activator"
19 Q0 10706127 579 24.810379 imi_mug_run_2_treatment "color" "level" "aim"
19 Q0 21862872 580 24.805336 imi_mug_run_2_treatment "metformin" "trastuzumab" "dasatinib"
19 Q0 18083065 581 24.80449 imi_mug_run_2_treatment "letrozole" "tamoxifen" "drug"
19 Q0 30425522 582 24.803959 imi_mug_run_2_treatment "afatinib" "glycine"
19 Q0 26810187 583 24.803455 imi_mug_run_2_treatment "her-2" "trastuzumab" "adjuvant"
19 Q0 24465712 584 24.794949 imi_mug_run_2_treatment "curcumin" "tyrosine" "lead"
19 Q0 12451999 585 24.793888 imi_mug_run_2_treatment "icc" "elder"
19 Q0 18454161 586 24.79168 imi_mug_run_2_treatment "trastuzumab" "herceptin" "anhydrotetracycline"
19 Q0 18724389 587 24.784163 imi_mug_run_2_treatment "protein c" "mediated"
19 Q0 15582575 588 24.770039 imi_mug_run_2_treatment "vitamin e" "oxygen" "superoxide dismutase"
19 Q0 21533396 589 24.769247 imi_mug_run_2_treatment "animals" "dfmo" "piroxicam"
19 Q0 22544433 590 24.756577 imi_mug_run_2_treatment "adjuvant" "antiangiogenic" "anti-vegf"
19 Q0 22190871 591 24.75389 imi_mug_run_2_treatment "lapatinib" "kinase inhibitor" "program"
19 Q0 17224938 592 24.753391 imi_mug_run_2_treatment "aim"
19 Q0 23529353 593 24.747684 imi_mug_run_2_treatment "epidermal growth factor" "ras" "trastuzumab"
19 Q0 20051871 594 24.742668 imi_mug_run_2_treatment "gen-1" "genistein" "estradiol"
19 Q0 11827067 595 24.735147 imi_mug_run_2_treatment "liver"
19 Q0 19409371 596 24.7228 imi_mug_run_2_treatment "various" "trastuzumab" "drugs"
19 Q0 15545967 597 24.718662 imi_mug_run_2_treatment "trastuzumab" "platinum"
19 Q0 25792810 598 24.706612 imi_mug_run_2_treatment "emodin" "oxygen" "n-acetylcysteine"
19 Q0 17164260 599 24.703285 imi_mug_run_2_treatment "various" "oestrogen"
19 Q0 3837853 600 24.698492 imi_mug_run_2_treatment "level"
19 Q0 1285215 601 24.691454 imi_mug_run_2_treatment "product"
19 Q0 12016390 602 24.680557 imi_mug_run_2_treatment "various"
19 Q0 19072471 603 24.677582 imi_mug_run_2_treatment "letrozole" "adjuvant" "tamoxifen"
19 Q0 17999753 604 24.676289 imi_mug_run_2_treatment "hydroxyurea"
19 Q0 12530026 605 24.664516 imi_mug_run_2_treatment "others"
19 Q0 12174876 606 24.66078 imi_mug_run_2_treatment "cisplatin" "drugs" "emodin"
19 Q0 26692570 607 24.657532 imi_mug_run_2_treatment "isoproterenol" "agonist" "antineoplastic drugs"
19 Q0 27931797 608 24.655357 imi_mug_run_2_treatment "acetate" "mediated"
19 Q0 17963298 609 24.638199 imi_mug_run_2_treatment "ors" "aim"
19 Q0 27906677 610 24.631218 imi_mug_run_2_treatment "regorafenib" "drug combinations" "flt"
19 Q0 8403199 611 24.629324 imi_mug_run_2_treatment "gat" "ras"
19 Q0 19411062 612 24.6265 imi_mug_run_2_treatment "trastuzumab" "blockade"
19 Q0 16682622 613 24.622898 imi_mug_run_2_treatment "lapatinib" "tyrosine" "mediated"
19 Q0 12115478 614 24.615072 imi_mug_run_2_treatment "herceptin" "level" "matrix"
19 Q0 26358791 615 24.60285 imi_mug_run_2_treatment "trastuzumab" "fulvestrant" "pertuzumab"
19 Q0 9652761 616 24.598507 imi_mug_run_2_treatment "enzyme digestion"
19 Q0 17003495 617 24.595455 imi_mug_run_2_treatment "prostaglandin"
19 Q0 25660204 618 24.591259 imi_mug_run_2_treatment "drug" "trastuzumab" "agent"
19 Q0 26217940 619 24.578884 imi_mug_run_2_treatment "drugs"
19 Q0 1346333 620 24.569632 imi_mug_run_2_treatment "level" "cisplatin" "alkylating agents"
19 Q0 12460931 621 24.567959 imi_mug_run_2_treatment "water" "food"
19 Q0 28938602 622 24.55099 imi_mug_run_2_treatment "mediated" "lapatinib" "ly294002"
19 Q0 7585656 623 24.543736 imi_mug_run_2_treatment "adjuvant" "level"
19 Q0 20847829 624 24.535135 imi_mug_run_2_treatment "trastuzumab"
19 Q0 22190870 625 24.528181 imi_mug_run_2_treatment "trastuzumab" "herceptin" "others"
19 Q0 22778627 626 24.523151 imi_mug_run_2_treatment "ether"
19 Q0 20458558 627 24.485033 imi_mug_run_2_treatment "tamoxifen"
19 Q0 15856022 628 24.483637 imi_mug_run_2_treatment "drug" "herceptin" "tyrosine"
19 Q0 24747692 629 24.481422 imi_mug_run_2_treatment "drugs" "mediated"
19 Q0 8605112 630 24.47797 imi_mug_run_2_treatment "various"
19 Q0 16857791 631 24.476122 imi_mug_run_2_treatment "trastuzumab"
19 Q0 19751177 632 24.474329 imi_mug_run_2_treatment "trastuzumab" "pertuzumab" "monoclonal antibodies"
19 Q0 27462779 633 24.471886 imi_mug_run_2_treatment "trastuzumab" "adjuvant"
19 Q0 28885562 634 24.439579 imi_mug_run_2_treatment "cytotoxic"
19 Q0 19424599 635 24.439304 imi_mug_run_2_treatment "docetaxel" "drug" "mediated"
19 Q0 12888924 636 24.426142 imi_mug_run_2_treatment "others"
19 Q0 27109096 637 24.42294 imi_mug_run_2_treatment "mediated" "lapatinib"
19 Q0 12099646 638 24.422691 imi_mug_run_2_treatment "various"
19 Q0 20012671 639 24.42228 imi_mug_run_2_treatment "basis"
19 Q0 16254685 640 24.41442 imi_mug_run_2_treatment "serine" "suppressor"
19 Q0 30107476 641 24.395676 imi_mug_run_2_treatment "various" "mediated"
19 Q0 15862947 642 24.392849 imi_mug_run_2_treatment "estrogen"
19 Q0 19861407 643 24.392849 imi_mug_run_2_treatment "estrogen" "estradiol" "estrogenic compounds"
19 Q0 9585252 644 24.387136 imi_mug_run_2_treatment "tyrosine" "agent"
19 Q0 20304052 645 24.37811 imi_mug_run_2_treatment "vitamin d analog" "bxl0124" "vitamin d"
19 Q0 12366664 646 24.37463 imi_mug_run_2_treatment "various"
19 Q0 24421342 647 24.372242 imi_mug_run_2_treatment "trastuzumab" "immunotoxins"
19 Q0 25636205 648 24.372173 imi_mug_run_2_treatment "platinum"
19 Q0 12574167 649 24.354933 imi_mug_run_2_treatment "mediated" "hsp70"
19 Q0 17189388 650 24.35371 imi_mug_run_2_treatment "taxol" "drugs" "monoclonal antibodies"
19 Q0 23658725 651 24.345123 imi_mug_run_2_treatment "suppressor"
19 Q0 25070180 652 24.340174 imi_mug_run_2_treatment "lapatinib" "roscovitine" "kinase inhibitor"
19 Q0 16061662 653 24.340076 imi_mug_run_2_treatment "herceptin" "tyrosine" "epidermal growth factor"
19 Q0 15665275 654 24.339952 imi_mug_run_2_treatment "lapatinib" "antiestrogen" "estrogen"
19 Q0 10485493 655 24.336264 imi_mug_run_2_treatment "mediated" "hyaluronan"
19 Q0 11038295 656 24.323322 imi_mug_run_2_treatment "cytotoxic" "fluorouracil"
19 Q0 16266989 657 24.307196 imi_mug_run_2_treatment "various" "therapeutics"
19 Q0 21403841 658 24.29497 imi_mug_run_2_treatment "mediated"
19 Q0 7688814 659 24.287678 imi_mug_run_2_treatment "aim" "monoclonal antibodies"
19 Q0 10760817 660 24.284325 imi_mug_run_2_treatment "tcc" "thr"
19 Q0 18039470 661 24.280552 imi_mug_run_2_treatment "herceptin"
19 Q0 17911008 662 24.2793 imi_mug_run_2_treatment "trastuzumab" "hyaluronan" "mediated"
19 Q0 21136925 663 24.2793 imi_mug_run_2_treatment "trastuzumab" "aim" "others"
19 Q0 20160030 664 24.27489 imi_mug_run_2_treatment "level"
19 Q0 19390941 665 24.260384 imi_mug_run_2_treatment "ors" "taxane"
19 Q0 18490651 666 24.234144 imi_mug_run_2_treatment "trastuzumab" "lapatinib" "drug"
19 Q0 22387177 667 24.215204 imi_mug_run_2_treatment "various" "enzymes" "docetaxel"
19 Q0 17879382 668 24.208847 imi_mug_run_2_treatment "ptx" "antitumor agent" "paclitaxel"
19 Q0 24466191 669 24.203176 imi_mug_run_2_treatment "combinations" "level" "igf2"
19 Q0 20679487 670 24.195091 imi_mug_run_2_treatment "thr" "epidermal growth factor" "ras"
19 Q0 18644987 671 24.187607 imi_mug_run_2_treatment "hdac inhibitor" "st71"
19 Q0 21406037 672 24.168991 imi_mug_run_2_treatment "drugs" "trastuzumab" "therapeutic agents"
19 Q0 28453704 673 24.167871 imi_mug_run_2_treatment "trastuzumab" "level"
19 Q0 25396002 674 24.162806 imi_mug_run_2_treatment "aim"
19 Q0 24961464 675 24.155602 imi_mug_run_2_treatment "parathyroid hormone" "cytokines" "il-6"
19 Q0 27002940 676 24.148428 imi_mug_run_2_treatment "ras" "basis"
19 Q0 17283152 677 24.129448 imi_mug_run_2_treatment "trastuzumab" "lapatinib"
19 Q0 23445612 678 24.108654 imi_mug_run_2_treatment "kinase inhibitor" "lapatinib" "drugs"
19 Q0 22892392 679 24.09871 imi_mug_run_2_treatment "lapatinib" "tamoxifen" "antioestrogen"
19 Q0 20056944 680 24.088776 imi_mug_run_2_treatment "drugs" "epidermal growth factor"
19 Q0 16510594 681 24.07203 imi_mug_run_2_treatment "ras" "level" "mediated"
19 Q0 12941816 682 24.066408 imi_mug_run_2_treatment "mediated"
19 Q0 29799521 683 24.065796 imi_mug_run_2_treatment "lapatinib" "mediated"
19 Q0 27900589 684 24.061443 imi_mug_run_2_treatment "trastuzumab" "leucine" "her2 monoclonal antibody"
19 Q0 19046792 685 24.058584 imi_mug_run_2_treatment "mediators" "level"
19 Q0 16467098 686 24.057236 imi_mug_run_2_treatment "etoposide" "herceptin" "taxol"
19 Q0 25306619 687 24.042473 imi_mug_run_2_treatment "formalin"
19 Q0 16299242 688 24.025621 imi_mug_run_2_treatment "drug" "gefitinib" "erlotinib"
19 Q0 17626164 689 24.01687 imi_mug_run_2_treatment "various"
19 Q0 17572496 690 24.011477 imi_mug_run_2_treatment "cytostatic" "aim" "matrix"
19 Q0 15017656 691 24.011179 imi_mug_run_2_treatment "ras"
19 Q0 23447672 692 24.00389 imi_mug_run_2_treatment "mediated"
19 Q0 11330837 693 23.999578 imi_mug_run_2_treatment "serine"
19 Q0 15305385 694 23.994976 imi_mug_run_2_treatment "capecitabine" "fluorouracil" "fluoropyrimidine"
19 Q0 16585198 695 23.993717 imi_mug_run_2_treatment "mediated" "favor" "basis"
19 Q0 24304688 696 23.989937 imi_mug_run_2_treatment "various" "glutamine"
19 Q0 22217347 697 23.986242 imi_mug_run_2_treatment "various"
19 Q0 9625302 698 23.979315 imi_mug_run_2_treatment "level" "cytotoxic" "basis"
19 Q0 28781955 699 23.968245 imi_mug_run_2_treatment "ras" "sch772984" "agar"
19 Q0 2876925 700 23.963018 imi_mug_run_2_treatment "ras" "nitrocellulose"
19 Q0 15236312 701 23.96298 imi_mug_run_2_treatment "color"
19 Q0 18202008 702 23.943144 imi_mug_run_2_treatment "trastuzumab" "embelin" "mediated"
19 Q0 24452693 703 23.942463 imi_mug_run_2_treatment "tcn" "triciribine" "trastuzumab"
19 Q0 21323863 704 23.907639 imi_mug_run_2_treatment "human igg"
19 Q0 17416003 705 23.907011 imi_mug_run_2_treatment "tam" "tamoxifen" "level"
19 Q0 10537329 706 23.898775 imi_mug_run_2_treatment "basis"
19 Q0 11162510 707 23.895826 imi_mug_run_2_treatment "mediated" "herceptin" "therapeutics"
19 Q0 28243898 708 23.892876 imi_mug_run_2_treatment "lead"
19 Q0 18618485 709 23.867416 imi_mug_run_2_treatment "quercetin" "egcg" "epigallocatechin-3-gallate"
19 Q0 10411935 710 23.85804 imi_mug_run_2_treatment "methylated"
19 Q0 19690388 711 23.856977 imi_mug_run_2_treatment "egfr inhibitor" "blockade"
19 Q0 21210970 712 23.85448 imi_mug_run_2_treatment "mediated" "lead"
19 Q0 14614020 713 23.841484 imi_mug_run_2_treatment "tcc" "product"
19 Q0 18980964 714 23.83796 imi_mug_run_2_treatment "lapatinib" "trastuzumab" "herceptin"
19 Q0 25633808 715 23.83796 imi_mug_run_2_treatment "trastuzumab" "pertuzumab" "level"
19 Q0 28817097 716 23.826624 imi_mug_run_2_treatment "monoclonal antibodies"
19 Q0 24165569 717 23.826176 imi_mug_run_2_treatment "erythropoietin"
19 Q0 9380415 718 23.816294 imi_mug_run_2_treatment "basis"
19 Q0 4028026 719 23.807186 imi_mug_run_2_treatment "enzymes" "level" "liver"
19 Q0 30248295 720 23.795486 imi_mug_run_2_treatment "formalin" "aim"
19 Q0 20825649 721 23.793444 imi_mug_run_2_treatment "mediated" "therapeutics"
19 Q0 22022496 722 23.787277 imi_mug_run_2_treatment "estrogen" "progesterone" "therapeutic agents"
19 Q0 2487147 723 23.782896 imi_mug_run_2_treatment "insulin" "hydrocortisone" "epidermal growth factor"
19 Q0 26441531 724 23.770159 imi_mug_run_2_treatment "gdnf" "neurotrophic factor" "basis"
19 Q0 1352878 725 23.753677 imi_mug_run_2_treatment "immunotoxins" "cytotoxic" "immunotoxin"
19 Q0 15142456 726 23.744362 imi_mug_run_2_treatment "epidermal growth factor"
19 Q0 21288302 727 23.7407 imi_mug_run_2_treatment "herceptin" "immunoconjugates" "cytotoxic"
19 Q0 14633703 728 23.726606 imi_mug_run_2_treatment "serine" "mediated" "zd1839"
19 Q0 29894706 729 23.722801 imi_mug_run_2_treatment "mediated"
19 Q0 17426253 730 23.721287 imi_mug_run_2_treatment "various" "tyrosine" "epidermal growth factor"
19 Q0 23585570 731 23.714909 imi_mug_run_2_treatment "mediated" "oxygen" "matrix"
19 Q0 23327903 732 23.714045 imi_mug_run_2_treatment "aim"
19 Q0 11571533 733 23.713884 imi_mug_run_2_treatment "protamine"
19 Q0 9702495 734 23.712326 imi_mug_run_2_treatment "alcohol" "biotin" "phenolic"
19 Q0 17290345 735 23.704987 imi_mug_run_2_treatment "tcc" "ras"
19 Q0 10521789 736 23.699066 imi_mug_run_2_treatment "tyrosine" "level"
19 Q0 16029927 737 23.696953 imi_mug_run_2_treatment "ras" "mediated"
19 Q0 30098331 738 23.69402 imi_mug_run_2_treatment "mediated" "pma" "hsp70"
19 Q0 15682468 739 23.689161 imi_mug_run_2_treatment "aim"
19 Q0 21559015 740 23.676561 imi_mug_run_2_treatment "trastuzumab" "immunoconjugate"
19 Q0 12790321 741 23.675425 imi_mug_run_2_treatment "plasminogen activator" "epidermal growth factor"
19 Q0 8726462 742 23.64618 imi_mug_run_2_treatment "tyrosine" "nh2" "mediated"
19 Q0 17329190 743 23.64584 imi_mug_run_2_treatment "oestrogen"
19 Q0 11709727 744 23.63768 imi_mug_run_2_treatment "ly294002" "wortmannin" "mediated"
19 Q0 25866362 745 23.623167 imi_mug_run_2_treatment "curcumin" "drug"
19 Q0 12060608 746 23.608627 imi_mug_run_2_treatment "combinations" "therapeutics" "isolate"
19 Q0 16818711 747 23.603321 imi_mug_run_2_treatment "cetuximab" "gefitinib" "iressa"
19 Q0 9436045 748 23.596592 imi_mug_run_2_treatment "digoxigenin" "chaps"
19 Q0 25970488 749 23.589828 imi_mug_run_2_treatment "dha" "urokinase plasminogen activator" "docosahexaenoic acid"
19 Q0 15156151 750 23.571877 imi_mug_run_2_treatment "tyr" "fibres"
19 Q0 17888033 751 23.557209 imi_mug_run_2_treatment "various" "gefitinib" "mp-412"
19 Q0 16041691 752 23.555252 imi_mug_run_2_treatment "level"
19 Q0 16258537 753 23.543869 imi_mug_run_2_treatment "bispecific antibody"
19 Q0 10101454 754 23.536133 imi_mug_run_2_treatment "liver"
19 Q0 22425775 755 23.52934 imi_mug_run_2_treatment "endocrine therapy" "tamoxifen" "antagonist g"
19 Q0 22851698 756 23.514517 imi_mug_run_2_treatment "mediated" "monolayer" "tyrosine"
19 Q0 11484982 757 23.50608 imi_mug_run_2_treatment "level"
19 Q0 11745477 758 23.505505 imi_mug_run_2_treatment "various" "zd1839" "iressa"
19 Q0 26667234 759 23.505257 imi_mug_run_2_treatment "plasma"
19 Q0 20712882 760 23.499355 imi_mug_run_2_treatment "various"
19 Q0 22373082 761 23.498432 imi_mug_run_2_treatment "mediated" "animals"
19 Q0 29434871 762 23.487734 imi_mug_run_2_treatment "thr" "cddp" "mediated"
19 Q0 12866575 763 23.477509 imi_mug_run_2_treatment "estrogen"
19 Q0 17043217 764 23.474518 imi_mug_run_2_treatment "agonists" "mediated" "agonist"
19 Q0 12376557 765 23.464342 imi_mug_run_2_treatment "various" "gm1" "anti-erbb2 monoclonal antibody"
19 Q0 21637380 766 23.444965 imi_mug_run_2_treatment "mediated" "trastuzumab" "therapeutic antibody"
19 Q0 17477367 767 23.432583 imi_mug_run_2_treatment "oxygen"
19 Q0 20658094 768 23.430336 imi_mug_run_2_treatment "lead"
19 Q0 22424291 769 23.427197 imi_mug_run_2_treatment "vcr" "cisplatin" "cck-8"
19 Q0 19707333 770 23.424147 imi_mug_run_2_treatment "trastuzumab" "lapatinib" "adjuvant"
19 Q0 11351242 771 23.419575 imi_mug_run_2_treatment "various" "aim" "sulfate"
19 Q0 10854209 772 23.41934 imi_mug_run_2_treatment "level"
19 Q0 29169184 773 23.41866 imi_mug_run_2_treatment "drugs"
19 Q0 17334996 774 23.404762 imi_mug_run_2_treatment "level" "trastuzumab"
19 Q0 22527098 775 23.4047 imi_mug_run_2_treatment "therapeutic agents"
19 Q0 19331811 776 23.391449 imi_mug_run_2_treatment "pki166" "monoclonal antibodies"
19 Q0 19956838 777 23.39007 imi_mug_run_2_treatment "various" "drug" "insulin"
19 Q0 28133136 778 23.390009 imi_mug_run_2_treatment "cetuximab"
19 Q0 19967068 779 23.38538 imi_mug_run_2_treatment "tyrphostin" "ag879" "ag825"
19 Q0 29143776 780 23.381603 imi_mug_run_2_treatment "glycan" "enzymes" "mediated"
19 Q0 14613025 781 23.377151 imi_mug_run_2_treatment "mediated"
19 Q0 22102915 782 23.3708 imi_mug_run_2_treatment "aim"
19 Q0 11706392 783 23.356216 imi_mug_run_2_treatment "trastuzumab" "therapeutics" "antineoplastic drug"
19 Q0 22899247 784 23.353573 imi_mug_run_2_treatment "product" "lead"
19 Q0 10233167 785 23.349571 imi_mug_run_2_treatment "epidermal growth factor"
19 Q0 16956305 786 23.342522 imi_mug_run_2_treatment "trastuzumab" "drug" "bevacizumab"
19 Q0 25186909 787 23.339443 imi_mug_run_2_treatment "tandem" "genesis"
19 Q0 9872321 788 23.322844 imi_mug_run_2_treatment "cytotoxic" "fas ligand"
19 Q0 17604714 789 23.311619 imi_mug_run_2_treatment "drug" "herceptin" "her-2"
19 Q0 8709940 790 23.304882 imi_mug_run_2_treatment "various"
19 Q0 2162845 791 23.301498 imi_mug_run_2_treatment "sulfate" "glycosaminoglycan" "product"
19 Q0 15027118 792 23.299324 imi_mug_run_2_treatment "irinotecan" "mediated" "level"
19 Q0 18519692 793 23.291386 imi_mug_run_2_treatment "combinations" "fluorouracil" "tandem"
19 Q0 8841466 794 23.288696 imi_mug_run_2_treatment "fats" "diglyceride" "ras"
19 Q0 18039657 795 23.286007 imi_mug_run_2_treatment "gly" "mediated"
19 Q0 14760776 796 23.285877 imi_mug_run_2_treatment "aim"
19 Q0 16450376 797 23.274776 imi_mug_run_2_treatment "ethanol" "mediated" "antioxidants"
19 Q0 26155288 798 23.242529 imi_mug_run_2_treatment "rhg-csf" "normal saline"
19 Q0 25350844 799 23.22711 imi_mug_run_2_treatment "lapatinib" "drug"
19 Q0 9815855 800 23.223602 imi_mug_run_2_treatment "tamoxifen" "endocrine therapy"
19 Q0 22553354 801 23.21911 imi_mug_run_2_treatment "cannabinoid" "betulinic acid" "agent"
19 Q0 26859680 802 23.206244 imi_mug_run_2_treatment "trastuzumab" "chemotherapeutic agent" "drug"
19 Q0 30456437 803 23.198717 imi_mug_run_2_treatment "mbc" "aromatase inhibitor"
19 Q0 22056878 804 23.191427 imi_mug_run_2_treatment "atra" "combinations" "lapatinib"
19 Q0 18624900 805 23.188402 imi_mug_run_2_treatment "lead" "aim" "genesis"
19 Q0 18662380 806 23.186468 imi_mug_run_2_treatment "various"
19 Q0 18777951 807 23.185375 imi_mug_run_2_treatment "trastuzumab" "adjuvant" "monoclonal antibodies"
19 Q0 19017630 808 23.178764 imi_mug_run_2_treatment "blockade" "trastuzumab" "oxygen"
19 Q0 28125512 809 23.173582 imi_mug_run_2_treatment "trastuzumab" "matrix" "pertuzumab"
19 Q0 20406983 810 23.154411 imi_mug_run_2_treatment "ps341" "proteasome inhibitor" "bortezomib"
19 Q0 7946596 811 23.153496 imi_mug_run_2_treatment "product"
19 Q0 22292935 812 23.138002 imi_mug_run_2_treatment "level"
19 Q0 10535875 813 23.131363 imi_mug_run_2_treatment "various" "aim"
19 Q0 2218496 814 23.131363 imi_mug_run_2_treatment "product"
19 Q0 19822081 815 23.131363 imi_mug_run_2_treatment "vaccines"
19 Q0 9590694 816 23.121635 imi_mug_run_2_treatment "interleukin-6" "il-6"
19 Q0 24817309 817 23.121635 imi_mug_run_2_treatment "mediated"
19 Q0 29854313 818 23.11336 imi_mug_run_2_treatment "basis"
19 Q0 20565902 819 23.111288 imi_mug_run_2_treatment "calphostin" "epidermal growth factor" "pd98059"
19 Q0 10604729 820 23.090775 imi_mug_run_2_treatment "p23" "level"
19 Q0 23279575 821 23.089964 imi_mug_run_2_treatment "drugs"
19 Q0 21887346 822 23.083885 imi_mug_run_2_treatment "mediated"
19 Q0 10657973 823 23.082397 imi_mug_run_2_treatment "calcium"
19 Q0 20133707 824 23.071514 imi_mug_run_2_treatment "mediated"
19 Q0 12044528 825 23.062094 imi_mug_run_2_treatment "various"
19 Q0 23420759 826 23.058994 imi_mug_run_2_treatment "level" "trastuzumab"
19 Q0 28178681 827 23.039219 imi_mug_run_2_treatment "ras"
19 Q0 11454671 828 23.028114 imi_mug_run_2_treatment "urokinase" "urokinase-type plasminogen activator" "various"
19 Q0 29665843 829 23.027445 imi_mug_run_2_treatment "vandetanib"
19 Q0 16384610 830 23.026897 imi_mug_run_2_treatment "drug" "trastuzumab" "cytostatic"
19 Q0 15761964 831 23.024866 imi_mug_run_2_treatment "level" "aim"
19 Q0 7910405 832 23.022484 imi_mug_run_2_treatment "interferon gamma" "cytotoxic"
19 Q0 14639104 833 23.00944 imi_mug_run_2_treatment "ras" "program"
19 Q0 27171333 834 23.009174 imi_mug_run_2_treatment "gemcitabine" "trastuzumab" "pertuzumab"
19 Q0 23647160 835 22.998526 imi_mug_run_2_treatment "serpin b5" "serpinb5" "phosphate"
19 Q0 22879877 836 22.991825 imi_mug_run_2_treatment "sts" "level"
19 Q0 12239347 837 22.98979 imi_mug_run_2_treatment "mediated"
19 Q0 20332114 838 22.983326 imi_mug_run_2_treatment "mediated"
19 Q0 10318765 839 22.978485 imi_mug_run_2_treatment "epidermal growth factor" "anti-erbb2 monoclonal antibody" "tyrosine kinase inhibitor"
19 Q0 19301121 840 22.97789 imi_mug_run_2_treatment "drug" "trastuzumab" "herceptin"
19 Q0 7872717 841 22.96615 imi_mug_run_2_treatment "level"
19 Q0 17675364 842 22.96031 imi_mug_run_2_treatment "level" "mediated"
19 Q0 25089830 843 22.9459 imi_mug_run_2_treatment "various" "human serum albumin" "drug"
19 Q0 26994385 844 22.944122 imi_mug_run_2_treatment "product" "lead"
19 Q0 8172796 845 22.942274 imi_mug_run_2_treatment "enzymes" "enzyme inhibitors" "cytotoxic"
19 Q0 11417997 846 22.941624 imi_mug_run_2_treatment "genesis"
19 Q0 26001389 847 22.937443 imi_mug_run_2_treatment "mediated" "trastuzumab" "cetuximab"
19 Q0 24818668 848 22.937443 imi_mug_run_2_treatment "various" "mediated"
19 Q0 20007845 849 22.935093 imi_mug_run_2_treatment "scorpion" "cetuximab"
19 Q0 10645007 850 22.923153 imi_mug_run_2_treatment "oestrogen" "estrogenic"
19 Q0 27830833 851 22.915644 imi_mug_run_2_treatment "noscapine" "alkaloid" "opium poppy"
19 Q0 18829572 852 22.909603 imi_mug_run_2_treatment "ras" "agar"
19 Q0 27284958 853 22.908184 imi_mug_run_2_treatment "mbc"
19 Q0 26167451 854 22.906597 imi_mug_run_2_treatment "lead"
19 Q0 18841159 855 22.906504 imi_mug_run_2_treatment "epidermal growth factor" "therapeutics" "therapeutic agent"
19 Q0 1682162 856 22.894745 imi_mug_run_2_treatment "cytotoxic drugs" "level"
19 Q0 16253756 857 22.892628 imi_mug_run_2_treatment "suppressor"
19 Q0 30448735 858 22.89215 imi_mug_run_2_treatment "drug" "everolimus" "bevacizumab"
19 Q0 20336784 859 22.886747 imi_mug_run_2_treatment "taxane" "platinum"
19 Q0 17636013 860 22.886198 imi_mug_run_2_treatment "glucose" "mediated"
19 Q0 20607690 861 22.883707 imi_mug_run_2_treatment "lapatinib" "ag879" "erbb1 inhibitor"
19 Q0 20625818 862 22.867645 imi_mug_run_2_treatment "mbc" "level" "matrix"
19 Q0 16187281 863 22.863308 imi_mug_run_2_treatment "mediated" "ras"
19 Q0 23254686 864 22.848742 imi_mug_run_2_treatment "level" "cancer vaccines"
19 Q0 25246633 865 22.847643 imi_mug_run_2_treatment "trastuzumab" "drug" "program"
19 Q0 12503030 866 22.820244 imi_mug_run_2_treatment "trastuzumab" "herceptin" "hsp70"
19 Q0 23321163 867 22.81915 imi_mug_run_2_treatment "oestrogen" "isoflavone" "soybean"
19 Q0 26762307 868 22.818657 imi_mug_run_2_treatment "drugs" "lead" "liver"
19 Q0 21220473 869 22.81105 imi_mug_run_2_treatment "trastuzumab"
19 Q0 25853036 870 22.800182 imi_mug_run_2_treatment "immunotoxin" "immunotoxins" "therapeutics"
19 Q0 9927200 871 22.799545 imi_mug_run_2_treatment "level"
19 Q0 9735325 872 22.790304 imi_mug_run_2_treatment "agar" "tyrphostin ag 825" "ras"
19 Q0 17177846 873 22.790066 imi_mug_run_2_treatment "drug" "fdurd" "arabinofuranosylcytosine"
19 Q0 20695903 874 22.788706 imi_mug_run_2_treatment "mediated" "matrix"
19 Q0 19472191 875 22.778343 imi_mug_run_2_treatment "ras" "yeast"
19 Q0 12049736 876 22.77655 imi_mug_run_2_treatment "taxol" "tyrosine" "mediated"
19 Q0 24205104 877 22.774673 imi_mug_run_2_treatment "various" "pha-665752" "lapatinib"
19 Q0 1704999 878 22.770601 imi_mug_run_2_treatment "adriamycin" "fluorouracil" "level"
19 Q0 28819847 879 22.76664 imi_mug_run_2_treatment "isolate"
19 Q0 2685334 880 22.762255 imi_mug_run_2_treatment "various" "aim"
19 Q0 19372580 881 22.749023 imi_mug_run_2_treatment "level"
19 Q0 28637868 882 22.743107 imi_mug_run_2_treatment "tamoxifen" "level"
19 Q0 24987437 883 22.727676 imi_mug_run_2_treatment "estrogen" "chinese herbs" "aim"
19 Q0 19294521 884 22.7268 imi_mug_run_2_treatment "androgen" "mediated"
19 Q0 15255019 885 22.726482 imi_mug_run_2_treatment "aim"
19 Q0 17148612 886 22.719904 imi_mug_run_2_treatment "herceptin"
19 Q0 28805349 887 22.719904 imi_mug_run_2_treatment "brdu" "therapeutic agents"
19 Q0 22461643 888 22.716955 imi_mug_run_2_treatment "trastuzumab" "tyrosine kinase inhibitor" "lapatinib"
19 Q0 20847929 889 22.715965 imi_mug_run_2_treatment "lapatinib" "adjuvant" "tyrosine kinase inhibitor"
19 Q0 11194458 890 22.710838 imi_mug_run_2_treatment "estrogen"
19 Q0 27356767 891 22.708008 imi_mug_run_2_treatment "epidermal growth factor" "level"
19 Q0 20651047 892 22.707878 imi_mug_run_2_treatment "drugs"
19 Q0 8529465 893 22.688713 imi_mug_run_2_treatment "ras"
19 Q0 24982406 894 22.681242 imi_mug_run_2_treatment "aim"
19 Q0 28791631 895 22.678152 imi_mug_run_2_treatment "various" "tyrosine" "epidermal growth factor"
19 Q0 10462557 896 22.67792 imi_mug_run_2_treatment "digoxigenin"
19 Q0 8692139 897 22.666384 imi_mug_run_2_treatment "ras"
19 Q0 18462377 898 22.656202 imi_mug_run_2_treatment "therapeutics" "erlotinib" "erbb1 inhibitor"
19 Q0 24715245 899 22.635988 imi_mug_run_2_treatment "sts"
19 Q0 16489002 900 22.629807 imi_mug_run_2_treatment "vascular endothelial growth factor" "mediated" "antiangiogenic"
19 Q0 8825138 901 22.626484 imi_mug_run_2_treatment "estrogen" "level"
19 Q0 18506690 902 22.626179 imi_mug_run_2_treatment "aim"
19 Q0 12053195 903 22.624247 imi_mug_run_2_treatment "human antibody" "mtx"
19 Q0 25383500 904 22.623972 imi_mug_run_2_treatment "trastuzumab" "mbc" "capecitabine"
19 Q0 9242384 905 22.61521 imi_mug_run_2_treatment "oestrogen" "oestrogens" "tamoxifen"
19 Q0 17308081 906 22.61521 imi_mug_run_2_treatment "various" "drug" "trastuzumab"
19 Q0 8449929 907 22.607006 imi_mug_run_2_treatment "level"
19 Q0 19707428 908 22.60564 imi_mug_run_2_treatment "capecitabine" "lapatinib" "taxane"
19 Q0 22908275 909 22.602968 imi_mug_run_2_treatment "mediated" "il-3"
19 Q0 27998284 910 22.595278 imi_mug_run_2_treatment "glucose" "avid"
19 Q0 17847085 911 22.570154 imi_mug_run_2_treatment "herceptin" "therapeutics" "anti-erbb2 monoclonal antibody"
19 Q0 18593999 912 22.565083 imi_mug_run_2_treatment "gemcitabine" "fluorouracil" "immunosuppressive"
19 Q0 19459856 913 22.559792 imi_mug_run_2_treatment "mp-412" "various" "kinase inhibitor"
19 Q0 28775770 914 22.55012 imi_mug_run_2_treatment "level"
19 Q0 15778089 915 22.5453 imi_mug_run_2_treatment "glucose" "oxygen" "cytotoxic"
19 Q0 12871052 916 22.541725 imi_mug_run_2_treatment "various" "drug" "herceptin"
19 Q0 27662323 917 22.54121 imi_mug_run_2_treatment "level" "aim"
19 Q0 17157792 918 22.528423 imi_mug_run_2_treatment "level"
19 Q0 8450216 919 22.526798 imi_mug_run_2_treatment "il-1ra" "level" "il-6"
19 Q0 29641976 920 22.523764 imi_mug_run_2_treatment "aim"
19 Q0 29259703 921 22.517967 imi_mug_run_2_treatment "aspirin" "nsaids" "drugs"
19 Q0 22460089 922 22.5166 imi_mug_run_2_treatment "mediated"
19 Q0 21311224 923 22.512032 imi_mug_run_2_treatment "interferon" "mediated" "her-2"
19 Q0 23157824 924 22.509787 imi_mug_run_2_treatment "gat" "ras"
19 Q0 2227545 925 22.487116 imi_mug_run_2_treatment "platinol"
19 Q0 15923396 926 22.485306 imi_mug_run_2_treatment "herceptin" "level"
19 Q0 26018088 927 22.467743 imi_mug_run_2_treatment "aspirin" "prostaglandin e2" "prostaglandin"
19 Q0 8286193 928 22.46305 imi_mug_run_2_treatment "insulin" "level"
19 Q0 24899264 929 22.45529 imi_mug_run_2_treatment "pooled"
19 Q0 28178722 930 22.45529 imi_mug_run_2_treatment "basis" "aim"
19 Q0 29193033 931 22.450302 imi_mug_run_2_treatment "drug" "epidermal growth factor"
19 Q0 9331100 932 22.437576 imi_mug_run_2_treatment "aim"
19 Q0 19183447 933 22.430637 imi_mug_run_2_treatment "antimicrobial" "agar"
19 Q0 23323159 934 22.422073 imi_mug_run_2_treatment "progesterone" "adjuvant"
19 Q0 25436757 935 22.417545 imi_mug_run_2_treatment "methotrexate" "cytotoxic drugs"
19 Q0 18355957 936 22.417011 imi_mug_run_2_treatment "mediated" "genesis"
19 Q0 27965166 937 22.41442 imi_mug_run_2_treatment "drug" "polyethylene glycol"
19 Q0 25934693 938 22.410896 imi_mug_run_2_treatment "mediated"
19 Q0 20584310 939 22.410236 imi_mug_run_2_treatment "oxygen"
19 Q0 17122652 940 22.410168 imi_mug_run_2_treatment "formic acid" "lead"
19 Q0 18700973 941 22.398489 imi_mug_run_2_treatment "glucose" "lactate" "level"
19 Q0 26057454 942 22.398312 imi_mug_run_2_treatment "adjuvant"
19 Q0 10531414 943 22.387165 imi_mug_run_2_treatment "fdurd" "drug" "antifolates"
19 Q0 19458057 944 22.38674 imi_mug_run_2_treatment "gefitinib" "ag825" "erbb1 inhibitor"
19 Q0 12461170 945 22.38674 imi_mug_run_2_treatment "ile"
19 Q0 10029066 946 22.381836 imi_mug_run_2_treatment "metastat" "level"
19 Q0 11498399 947 22.381445 imi_mug_run_2_treatment "her-2" "cytotoxic drugs"
19 Q0 27633099 948 22.370285 imi_mug_run_2_treatment "lapatinib" "akt inhibitor mk2206" "mk2206"
19 Q0 29938395 949 22.356388 imi_mug_run_2_treatment "vinorelbine" "everolimus" "trastuzumab"
19 Q0 15705882 950 22.3524 imi_mug_run_2_treatment "kinase inhibitor" "mediated" "program"
19 Q0 12517790 951 22.3524 imi_mug_run_2_treatment "kinase inhibitor" "osi-774"
19 Q0 11371225 952 22.349771 imi_mug_run_2_treatment "level"
19 Q0 20847930 953 22.33136 imi_mug_run_2_treatment "trastuzumab" "lapatinib" "new drugs"
19 Q0 19285990 954 22.331188 imi_mug_run_2_treatment "fiber" "pix" "histidine"
19 Q0 17925876 955 22.323288 imi_mug_run_2_treatment "liver" "phosphorus"
19 Q0 28205231 956 22.322855 imi_mug_run_2_treatment "various" "plasma"
19 Q0 29318276 957 22.319263 imi_mug_run_2_treatment "estrogen" "trastuzumab"
19 Q0 23833684 958 22.312294 imi_mug_run_2_treatment "trastuzumab" "mediated" "herceptin"
19 Q0 24782652 959 22.308819 imi_mug_run_2_treatment "phosphate" "liver"
19 Q0 27223437 960 22.274176 imi_mug_run_2_treatment "various" "mbc"
19 Q0 19349372 961 22.268375 imi_mug_run_2_treatment "mediated" "vascular endothelial growth factor" "blockade"
19 Q0 27939360 962 22.25674 imi_mug_run_2_treatment "alcohol" "alcohol's" "oxygen"
19 Q0 26254336 963 22.254532 imi_mug_run_2_treatment "enzymes" "antioxidant" "oxygen"
19 Q0 22855166 964 22.249811 imi_mug_run_2_treatment "medicine" "level"
19 Q0 23595612 965 22.243666 imi_mug_run_2_treatment "various"
19 Q0 22128285 966 22.242441 imi_mug_run_2_treatment "metmab" "tivantinib"
19 Q0 29955792 967 22.234928 imi_mug_run_2_treatment "t-dm1" "tucatinib" "trastuzumab"
19 Q0 12209585 968 22.23186 imi_mug_run_2_treatment "vascular endothelial growth factor" "basis" "antisense oligonucleotide"
19 Q0 23273921 969 22.229912 imi_mug_run_2_treatment "fty720" "phosphate" "il-6"
19 Q0 25068025 970 22.221878 imi_mug_run_2_treatment "lead"
19 Q0 27811012 971 22.211918 imi_mug_run_2_treatment "lapatinib"
19 Q0 19293191 972 22.204172 imi_mug_run_2_treatment "epidermal growth factor" "therapeutic agents"
19 Q0 23690216 973 22.200047 imi_mug_run_2_treatment "level"
19 Q0 16909123 974 22.198122 imi_mug_run_2_treatment "mediated" "fti-277" "ras"
19 Q0 2993214 975 22.195515 imi_mug_run_2_treatment "ras"
19 Q0 12183061 976 22.173027 imi_mug_run_2_treatment "mediated" "therapeutic agent"
19 Q0 1504374 977 22.159256 imi_mug_run_2_treatment "drugs" "cytotoxic" "lead"
19 Q0 11008201 978 22.1511 imi_mug_run_2_treatment "various"
19 Q0 25135188 979 22.136465 imi_mug_run_2_treatment "aim"
19 Q0 14523990 980 22.131441 imi_mug_run_2_treatment "growth hormone" "methylxanthine" "dexamethasone"
19 Q0 21821674 981 22.127312 imi_mug_run_2_treatment "estrogen" "suppressor"
19 Q0 19220462 982 22.114561 imi_mug_run_2_treatment "herceptin" "human antibody" "drugs"
19 Q0 21570197 983 22.094131 imi_mug_run_2_treatment "lapatinib" "capecitabine"
19 Q0 29967253 984 22.091986 imi_mug_run_2_treatment "various" "neratinib" "afatinib"
19 Q0 11696979 985 22.091755 imi_mug_run_2_treatment "mediated"
19 Q0 23861392 986 22.089577 imi_mug_run_2_treatment "estrogen" "mediated"
19 Q0 27531070 987 22.087292 imi_mug_run_2_treatment "thr" "mediated" "trametinib"
19 Q0 28514745 988 22.087292 imi_mug_run_2_treatment "human antibody" "trastuzumab" "mediated"
19 Q0 2821605 989 22.082996 imi_mug_run_2_treatment "level"
19 Q0 24615865 990 22.071772 imi_mug_run_2_treatment "level"
19 Q0 15586221 991 22.067024 imi_mug_run_2_treatment "wortmannin"
19 Q0 17417639 992 22.06633 imi_mug_run_2_treatment "adjuvant"
19 Q0 10409446 993 22.060047 imi_mug_run_2_treatment "level"
19 Q0 29387480 994 22.054462 imi_mug_run_2_treatment "ras" "trastuzumab" "blockade"
19 Q0 9019162 995 22.050417 imi_mug_run_2_treatment "insulin" "cytotoxic" "mitogen"
19 Q0 24267189 996 22.049635 imi_mug_run_2_treatment "basis"
19 Q0 15897883 997 22.015549 imi_mug_run_2_treatment "activin"
19 Q0 28782986 998 22.008356 imi_mug_run_2_treatment "silver"
19 Q0 15371781 999 22.005798 imi_mug_run_2_treatment "anti-erbb2 monoclonal antibody"
20 Q0 12622420 1 51.14227 imi_mug_run_2_treatment "basis"
20 Q0 21508395 2 43.817482 imi_mug_run_2_treatment "iniparib" "parp inhibitor" "gemcitabine"
20 Q0 18855126 3 42.919197 imi_mug_run_2_treatment "program"
20 Q0 28291774 4 42.793087 imi_mug_run_2_treatment "platinum" "parp inhibitor"
20 Q0 23456555 5 42.33114 imi_mug_run_2_treatment "aim"
20 Q0 28630313 6 42.149582 imi_mug_run_2_treatment "tempol" "antioxidant" "nitrite"
20 Q0 24268522 7 40.97824 imi_mug_run_2_treatment "suppressor"
20 Q0 26180923 8 40.58002 imi_mug_run_2_treatment "cisplatin" "gemcitabine" "drugs"
20 Q0 28078281 9 39.990635 imi_mug_run_2_treatment "parp inhibitors" "drugs" "sugar"
20 Q0 23187834 10 39.969288 imi_mug_run_2_treatment "lead"
20 Q0 19690177 11 39.15054 imi_mug_run_2_treatment "level"
20 Q0 14726700 12 38.96671 imi_mug_run_2_treatment "basis"
20 Q0 10793087 13 38.959198 imi_mug_run_2_treatment "mediated"
20 Q0 9438603 14 38.87878 imi_mug_run_2_treatment "lead"
20 Q0 11888897 15 38.286366 imi_mug_run_2_treatment "animals"
20 Q0 21455033 16 38.205475 imi_mug_run_2_treatment "basis"
20 Q0 22934697 17 38.15558 imi_mug_run_2_treatment "mediated"
20 Q0 22162228 18 38.13114 imi_mug_run_2_treatment "basis"
20 Q0 21289082 19 37.946754 imi_mug_run_2_treatment "gemcitabine" "drugs"
20 Q0 10436789 20 37.924774 imi_mug_run_2_treatment "basis"
20 Q0 15217503 21 37.789177 imi_mug_run_2_treatment "glycine" "serine"
20 Q0 16973716 22 37.632843 imi_mug_run_2_treatment "basis"
20 Q0 20623197 23 37.61146 imi_mug_run_2_treatment "program" "lead"
20 Q0 16632103 24 37.530743 imi_mug_run_2_treatment "various"
20 Q0 24737347 25 37.33123 imi_mug_run_2_treatment "program"
20 Q0 8950667 26 37.308617 imi_mug_run_2_treatment "ras" "basis" "food"
20 Q0 15796958 27 37.104805 imi_mug_run_2_treatment "others"
20 Q0 23474559 28 37.100357 imi_mug_run_2_treatment "platinum" "abt-888" "veliparib"
20 Q0 11385254 29 36.9807 imi_mug_run_2_treatment "various"
20 Q0 19264984 30 36.963814 imi_mug_run_2_treatment "lead"
20 Q0 14749618 31 36.775166 imi_mug_run_2_treatment "basis"
20 Q0 17023981 32 36.70092 imi_mug_run_2_treatment "lead"
20 Q0 15173085 33 36.57427 imi_mug_run_2_treatment "level"
20 Q0 19072437 34 36.473785 imi_mug_run_2_treatment "basis"
20 Q0 18787609 35 36.4524 imi_mug_run_2_treatment "tma"
20 Q0 16243825 36 36.284595 imi_mug_run_2_treatment "various" "chlorambucil" "cisplatin"
20 Q0 19433978 37 36.202972 imi_mug_run_2_treatment "enzymes" "camptothecin" "oxaliplatin"
20 Q0 10667595 38 36.142593 imi_mug_run_2_treatment "various"
20 Q0 28205231 39 36.09801 imi_mug_run_2_treatment "various" "plasma"
20 Q0 16888680 40 36.02337 imi_mug_run_2_treatment "various"
20 Q0 12670518 41 35.79389 imi_mug_run_2_treatment "vitamin c" "salt" "fiber"
20 Q0 22493542 42 35.720898 imi_mug_run_2_treatment "drugs"
20 Q0 18469443 43 35.585686 imi_mug_run_2_treatment "gemcitabine" "capecitabine"
20 Q0 25076338 44 35.52885 imi_mug_run_2_treatment "platinum"
20 Q0 19140568 45 35.435272 imi_mug_run_2_treatment "asa"
20 Q0 27511924 46 35.29789 imi_mug_run_2_treatment "poly(adp-ribose) polymerase inhibitors"
20 Q0 12094699 47 35.082935 imi_mug_run_2_treatment "ras" "lead"
20 Q0 26658419 48 34.987625 imi_mug_run_2_treatment "basis"
20 Q0 26511885 49 34.968517 imi_mug_run_2_treatment "platinum" "parp inhibitors"
20 Q0 19826425 50 34.86653 imi_mug_run_2_treatment "aim" "liver"
20 Q0 26585231 51 34.85053 imi_mug_run_2_treatment "azd1775" "gemcitabine" "wee1 inhibitor azd1775"
20 Q0 9438601 52 34.82692 imi_mug_run_2_treatment "cytokines" "level" "blockade"
20 Q0 14966099 53 34.787117 imi_mug_run_2_treatment "basis"
20 Q0 12750283 54 34.735935 imi_mug_run_2_treatment "mitomycin" "therapeutic agents"
20 Q0 21613821 55 34.619537 imi_mug_run_2_treatment "cisplatin" "gemcitabine" "agent"
20 Q0 11879560 56 34.446014 imi_mug_run_2_treatment "mbc"
20 Q0 17312386 57 34.439842 imi_mug_run_2_treatment "basis"
20 Q0 16162302 58 34.436028 imi_mug_run_2_treatment "basis"
20 Q0 25719666 59 34.326706 imi_mug_run_2_treatment "platinum"
20 Q0 15172125 60 33.89438 imi_mug_run_2_treatment "level"
20 Q0 14981540 61 33.862087 imi_mug_run_2_treatment "suppressor" "animals"
20 Q0 11490843 62 33.82439 imi_mug_run_2_treatment "ras"
20 Q0 8673090 63 33.754616 imi_mug_run_2_treatment "product" "lead"
20 Q0 20423983 64 33.670204 imi_mug_run_2_treatment "mediated"
20 Q0 16648548 65 33.481773 imi_mug_run_2_treatment "drugs" "lead" "level"
20 Q0 8988179 66 33.445793 imi_mug_run_2_treatment "lead"
20 Q0 29309945 67 33.28981 imi_mug_run_2_treatment "platinum"
20 Q0 9134530 68 33.249695 imi_mug_run_2_treatment "lead"
20 Q0 12718618 69 33.09828 imi_mug_run_2_treatment "ras" "level"
20 Q0 30113427 70 33.09828 imi_mug_run_2_treatment "combinations" "spink1"
20 Q0 8881452 71 33.04077 imi_mug_run_2_treatment "parathyroid"
20 Q0 23948969 72 32.972687 imi_mug_run_2_treatment "program"
20 Q0 11207041 73 32.94073 imi_mug_run_2_treatment "various"
20 Q0 28033382 74 32.86452 imi_mug_run_2_treatment "olaparib" "parp inhibitor" "azd-2281"
20 Q0 24622079 75 32.82196 imi_mug_run_2_treatment "lead"
20 Q0 20878484 76 32.76849 imi_mug_run_2_treatment "lead"
20 Q0 22212556 77 32.4186 imi_mug_run_2_treatment "matrix"
20 Q0 26691940 78 32.374374 imi_mug_run_2_treatment "various"
20 Q0 26691938 79 32.268448 imi_mug_run_2_treatment "basis"
20 Q0 22187320 80 32.16458 imi_mug_run_2_treatment "ci 4"
20 Q0 28288110 81 32.009827 imi_mug_run_2_treatment "parp inhibitors"
20 Q0 16964288 82 31.976486 imi_mug_run_2_treatment "lead"
20 Q0 17148771 83 31.954422 imi_mug_run_2_treatment "various"
20 Q0 22368299 84 31.90625 imi_mug_run_2_treatment "basis"
20 Q0 23213974 85 31.845161 imi_mug_run_2_treatment "folate" "epidermal growth factor" "favor"
20 Q0 26439702 86 31.682732 imi_mug_run_2_treatment "ras"
20 Q0 15277238 87 31.643415 imi_mug_run_2_treatment "agent"
20 Q0 9665145 88 31.565786 imi_mug_run_2_treatment "mitoxantrone" "drugs" "amsacrine"
20 Q0 21135251 89 31.401678 imi_mug_run_2_treatment "basis" "drugs" "gemcitabine"
20 Q0 12120230 90 31.272654 imi_mug_run_2_treatment "lead"
20 Q0 27530658 91 31.21149 imi_mug_run_2_treatment "dsb"
20 Q0 30407325 92 31.13508 imi_mug_run_2_treatment "olaparib" "parp inhibitor"
20 Q0 27603373 93 30.996128 imi_mug_run_2_treatment "androgen"
20 Q0 25853369 94 30.98188 imi_mug_run_2_treatment "program"
20 Q0 18264087 95 30.914064 imi_mug_run_2_treatment "cisplatin" "mediated" "platinum"
20 Q0 17113724 96 30.823362 imi_mug_run_2_treatment "mbc"
20 Q0 15112280 97 30.56546 imi_mug_run_2_treatment "monolayer"
20 Q0 12126570 98 30.489395 imi_mug_run_2_treatment "aim"
20 Q0 9383000 99 30.426666 imi_mug_run_2_treatment "aim"
20 Q0 16261408 100 30.251238 imi_mug_run_2_treatment "thr"
20 Q0 29777302 101 30.044285 imi_mug_run_2_treatment "antimetabolite" "platinum" "drugs"
20 Q0 9560268 102 30.013802 imi_mug_run_2_treatment "mms" "methyl methanesulfonate"
20 Q0 28858227 103 30.001625 imi_mug_run_2_treatment "mediators" "suppressor"
20 Q0 16129371 104 29.987577 imi_mug_run_2_treatment "various" "adjuvant"
20 Q0 26360800 105 29.82093 imi_mug_run_2_treatment "aim"
20 Q0 17031113 106 29.745735 imi_mug_run_2_treatment "shape"
20 Q0 18264088 107 29.644302 imi_mug_run_2_treatment "parp inhibitor" "carboplatin" "basis"
20 Q0 25864590 108 29.590815 imi_mug_run_2_treatment "bmn 673" "cisplatin" "veliparib"
20 Q0 29309780 109 29.585793 imi_mug_run_2_treatment "pas"
20 Q0 28375947 110 29.579176 imi_mug_run_2_treatment "aim"
20 Q0 17520196 111 29.561972 imi_mug_run_2_treatment "basis"
20 Q0 29725535 112 29.555674 imi_mug_run_2_treatment "cisplatin" "agent"
20 Q0 24756831 113 29.468548 imi_mug_run_2_treatment "basis" "program" "aim"
20 Q0 18204050 114 29.4683 imi_mug_run_2_treatment "mediated"
20 Q0 27535760 115 29.428999 imi_mug_run_2_treatment "yeast" "level" "aim"
20 Q0 9443984 116 29.282082 imi_mug_run_2_treatment "lead"
20 Q0 22920214 117 29.28091 imi_mug_run_2_treatment "various" "aim"
20 Q0 26727920 118 29.202965 imi_mug_run_2_treatment "lead" "program"
20 Q0 18439106 119 29.142069 imi_mug_run_2_treatment "mbc"
20 Q0 21222048 120 29.047344 imi_mug_run_2_treatment "various"
20 Q0 27630665 121 29.035358 imi_mug_run_2_treatment "program"
20 Q0 10570174 122 29.022545 imi_mug_run_2_treatment "product"
20 Q0 26111274 123 28.964529 imi_mug_run_2_treatment "ors" "pooled"
20 Q0 30051098 124 28.93283 imi_mug_run_2_treatment "rucaparib" "lead"
20 Q0 21183737 125 28.891197 imi_mug_run_2_treatment "ag014699" "drug" "cytotoxic"
20 Q0 24084722 126 28.871687 imi_mug_run_2_treatment "lead"
20 Q0 25798433 127 28.799603 imi_mug_run_2_treatment "adjuvant"
20 Q0 27065665 128 28.723423 imi_mug_run_2_treatment "level" "aim"
20 Q0 11694875 129 28.683033 imi_mug_run_2_treatment "various" "suppressor"
20 Q0 14651845 130 28.64729 imi_mug_run_2_treatment "product"
20 Q0 10690392 131 28.618893 imi_mug_run_2_treatment "aim"
20 Q0 9579822 132 28.516712 imi_mug_run_2_treatment "glycine"
20 Q0 15734731 133 28.50578 imi_mug_run_2_treatment "mediated" "hdac inhibitor"
20 Q0 29767749 134 28.49662 imi_mug_run_2_treatment "level"
20 Q0 27499891 135 28.455456 imi_mug_run_2_treatment "adjuvant" "aim"
20 Q0 29506471 136 28.400175 imi_mug_run_2_treatment "program"
20 Q0 11734330 137 28.39711 imi_mug_run_2_treatment "basis"
20 Q0 19066131 138 28.385542 imi_mug_run_2_treatment "cls" "ors"
20 Q0 26600777 139 28.36588 imi_mug_run_2_treatment "oxaliplatin" "gemox regimen" "gemcitabine"
20 Q0 20927582 140 28.323261 imi_mug_run_2_treatment "mbc"
20 Q0 15589605 141 28.277796 imi_mug_run_2_treatment "tamoxifen"
20 Q0 25112434 142 28.231937 imi_mug_run_2_treatment "adjuvant" "endocrine therapy"
20 Q0 21514447 143 28.176928 imi_mug_run_2_treatment "tma"
20 Q0 25348552 144 28.158043 imi_mug_run_2_treatment "ors" "prisma"
20 Q0 11072151 145 28.147942 imi_mug_run_2_treatment "various"
20 Q0 14555518 146 28.126173 imi_mug_run_2_treatment "mbc" "sex hormone"
20 Q0 10972993 147 28.118427 imi_mug_run_2_treatment "androgen"
20 Q0 25192939 148 28.096928 imi_mug_run_2_treatment "program"
20 Q0 15197194 149 28.078451 imi_mug_run_2_treatment "tamoxifen"
20 Q0 27656835 150 28.067749 imi_mug_run_2_treatment "yeast" "level" "aim"
20 Q0 17143532 151 28.02103 imi_mug_run_2_treatment "mediated"
20 Q0 21708937 152 28.02103 imi_mug_run_2_treatment "igf2"
20 Q0 20798986 153 28.020498 imi_mug_run_2_treatment "estrogen" "aim" "matrix"
20 Q0 19030985 154 28.002438 imi_mug_run_2_treatment "lead"
20 Q0 22429936 155 27.976154 imi_mug_run_2_treatment "aim"
20 Q0 12527904 156 27.962763 imi_mug_run_2_treatment "mediated" "yeast"
20 Q0 26696390 157 27.958025 imi_mug_run_2_treatment "gemcitabine" "cisplatin" "ci 4"
20 Q0 12927042 158 27.957952 imi_mug_run_2_treatment "duration" "product"
20 Q0 21161372 159 27.944769 imi_mug_run_2_treatment "quad"
20 Q0 28676659 160 27.872377 imi_mug_run_2_treatment "docetaxel" "drug" "taxane"
20 Q0 9497246 161 27.86137 imi_mug_run_2_treatment "others"
20 Q0 16537453 162 27.847763 imi_mug_run_2_treatment "lead"
20 Q0 18618591 163 27.841793 imi_mug_run_2_treatment "mediated"
20 Q0 15986445 164 27.81358 imi_mug_run_2_treatment "ors"
20 Q0 23613489 165 27.7988 imi_mug_run_2_treatment "ppi" "modus"
20 Q0 11710890 166 27.778343 imi_mug_run_2_treatment "adjuvant" "tamoxifen"
20 Q0 23085856 167 27.769348 imi_mug_run_2_treatment "ras"
20 Q0 26446551 168 27.758522 imi_mug_run_2_treatment "plasma" "alpha 1-antitrypsin"
20 Q0 28608931 169 27.703983 imi_mug_run_2_treatment "platinum" "carboplatin" "taxane"
20 Q0 15548363 170 27.676569 imi_mug_run_2_treatment "mbc"
20 Q0 8700550 171 27.598845 imi_mug_run_2_treatment "antioxidant" "protease" "lead"
20 Q0 27000661 172 27.593315 imi_mug_run_2_treatment "estrogens" "anti-androgens" "androgen"
20 Q0 26320393 173 27.57491 imi_mug_run_2_treatment "serine" "aim"
20 Q0 22351618 174 27.550047 imi_mug_run_2_treatment "lead"
20 Q0 16331614 175 27.533249 imi_mug_run_2_treatment "tamoxifen"
20 Q0 10449599 176 27.5068 imi_mug_run_2_treatment "others"
20 Q0 21557934 177 27.482286 imi_mug_run_2_treatment "methylated"
20 Q0 27114589 178 27.481045 imi_mug_run_2_treatment "program" "aim"
20 Q0 24764694 179 27.430164 imi_mug_run_2_treatment "lead"
20 Q0 12464649 180 27.429981 imi_mug_run_2_treatment "oral contraceptives" "contraceptive" "ors"
20 Q0 30286473 181 27.40648 imi_mug_run_2_treatment "parp inhibitors"
20 Q0 22274543 182 27.382673 imi_mug_run_2_treatment "aim"
20 Q0 23803109 183 27.369968 imi_mug_run_2_treatment "lead" "aim"
20 Q0 15317758 184 27.315548 imi_mug_run_2_treatment "basis"
20 Q0 23257159 185 27.274723 imi_mug_run_2_treatment "various" "lead"
20 Q0 15805113 186 27.27366 imi_mug_run_2_treatment "mediated"
20 Q0 17196508 187 27.259563 imi_mug_run_2_treatment "oral contraceptives"
20 Q0 12242698 188 27.259436 imi_mug_run_2_treatment "various"
20 Q0 11972384 189 27.249866 imi_mug_run_2_treatment "aim"
20 Q0 28410213 190 27.2448 imi_mug_run_2_treatment "aim" "pooled"
20 Q0 27914478 191 27.224606 imi_mug_run_2_treatment "aim"
20 Q0 22684231 192 27.215115 imi_mug_run_2_treatment "program"
20 Q0 17592676 193 27.203697 imi_mug_run_2_treatment "aim"
20 Q0 15564800 194 27.176577 imi_mug_run_2_treatment "serine"
20 Q0 17408542 195 27.175522 imi_mug_run_2_treatment "prophylactic"
20 Q0 12543786 196 27.172348 imi_mug_run_2_treatment "level"
20 Q0 12938098 197 27.165365 imi_mug_run_2_treatment "lead"
20 Q0 17466083 198 27.164778 imi_mug_run_2_treatment "lead"
20 Q0 29158857 199 27.147272 imi_mug_run_2_treatment "radium"
20 Q0 18275599 200 27.10226 imi_mug_run_2_treatment "ck-17"
20 Q0 29707112 201 27.092978 imi_mug_run_2_treatment "level" "favor" "lead"
20 Q0 17661168 202 27.022686 imi_mug_run_2_treatment "mbc"
20 Q0 26745123 203 27.014 imi_mug_run_2_treatment "lead"
20 Q0 17351952 204 26.992573 imi_mug_run_2_treatment "prophylactic"
20 Q0 11003560 205 26.956701 imi_mug_run_2_treatment "basis"
20 Q0 26843614 206 26.949541 imi_mug_run_2_treatment "mediated" "drugs" "trail-r2"
20 Q0 11196174 207 26.943762 imi_mug_run_2_treatment "wortmannin" "dsb"
20 Q0 11062481 208 26.933697 imi_mug_run_2_treatment "prenatal"
20 Q0 26576347 209 26.911228 imi_mug_run_2_treatment "aim"
20 Q0 15550590 210 26.908596 imi_mug_run_2_treatment "level"
20 Q0 11130383 211 26.871956 imi_mug_run_2_treatment "tamoxifen"
20 Q0 22923021 212 26.869844 imi_mug_run_2_treatment "aim"
20 Q0 23918944 213 26.814112 imi_mug_run_2_treatment "tamoxifen" "adjuvant"
20 Q0 19584259 214 26.798393 imi_mug_run_2_treatment "nh2" "genesis"
20 Q0 17503080 215 26.797153 imi_mug_run_2_treatment "aim"
20 Q0 12070551 216 26.779598 imi_mug_run_2_treatment "aim"
20 Q0 23009828 217 26.751415 imi_mug_run_2_treatment "basis"
20 Q0 11307153 218 26.71592 imi_mug_run_2_treatment "various"
20 Q0 18445692 219 26.7117 imi_mug_run_2_treatment "aim"
20 Q0 18429825 220 26.69443 imi_mug_run_2_treatment "mediated"
20 Q0 21990299 221 26.690454 imi_mug_run_2_treatment "platinum" "duration"
20 Q0 24974076 222 26.686518 imi_mug_run_2_treatment "cisplatin" "anti-cancer agents" "mediated"
20 Q0 27033093 223 26.669832 imi_mug_run_2_treatment "aim"
20 Q0 21373873 224 26.669832 imi_mug_run_2_treatment "program"
20 Q0 24742220 225 26.668804 imi_mug_run_2_treatment "aim"
20 Q0 20729832 226 26.65831 imi_mug_run_2_treatment "mediated" "lead" "isolating"
20 Q0 23562522 227 26.578342 imi_mug_run_2_treatment "tamoxifen" "prophylactic"
20 Q0 10805950 228 26.566423 imi_mug_run_2_treatment "estrogen"
20 Q0 22085629 229 26.558756 imi_mug_run_2_treatment "aim"
20 Q0 9500439 230 26.549376 imi_mug_run_2_treatment "tandem"
20 Q0 21593217 231 26.537834 imi_mug_run_2_treatment "lead"
20 Q0 23847380 232 26.521015 imi_mug_run_2_treatment "parp inhibitor" "olaparib"
20 Q0 17289874 233 26.515438 imi_mug_run_2_treatment "aza"
20 Q0 12618335 234 26.515245 imi_mug_run_2_treatment "ftc"
20 Q0 22405187 235 26.500107 imi_mug_run_2_treatment "duration"
20 Q0 22293751 236 26.496471 imi_mug_run_2_treatment "hydroxyurea" "aphidicolin"
20 Q0 18279628 237 26.494808 imi_mug_run_2_treatment "program"
20 Q0 25556971 238 26.492014 imi_mug_run_2_treatment "pooled"
20 Q0 10464631 239 26.484365 imi_mug_run_2_treatment "various"
20 Q0 9619832 240 26.48172 imi_mug_run_2_treatment "various" "adriamycin" "topoisomerase i inhibitor"
20 Q0 19609323 241 26.478113 imi_mug_run_2_treatment "basis"
20 Q0 22053997 242 26.47237 imi_mug_run_2_treatment "estrogen"
20 Q0 18523885 243 26.47121 imi_mug_run_2_treatment "tgfb1"
20 Q0 24312913 244 26.450481 imi_mug_run_2_treatment "various"
20 Q0 20383589 245 26.449503 imi_mug_run_2_treatment "touchdown"
20 Q0 16261400 246 26.428772 imi_mug_run_2_treatment "aim"
20 Q0 23853209 247 26.428772 imi_mug_run_2_treatment "ors"
20 Q0 16170354 248 26.425869 imi_mug_run_2_treatment "ptc" "mediated"
20 Q0 25879355 249 26.422016 imi_mug_run_2_treatment "level"
20 Q0 14984974 250 26.409718 imi_mug_run_2_treatment "prophylactic"
20 Q0 27528622 251 26.399288 imi_mug_run_2_treatment "basis"
20 Q0 22217331 252 26.387714 imi_mug_run_2_treatment "equol" "s-equol" "oestrogen"
20 Q0 19877752 253 26.366707 imi_mug_run_2_treatment "aim"
20 Q0 22176776 254 26.366707 imi_mug_run_2_treatment "platinum"
20 Q0 25632310 255 26.366203 imi_mug_run_2_treatment "mbc" "lead"
20 Q0 25838448 256 26.366203 imi_mug_run_2_treatment "combinations"
20 Q0 18483851 257 26.34387 imi_mug_run_2_treatment "contraceptive"
20 Q0 12124354 258 26.341438 imi_mug_run_2_treatment "methylated"
20 Q0 8875189 259 26.332685 imi_mug_run_2_treatment "basis"
20 Q0 26026974 260 26.312735 imi_mug_run_2_treatment "mbc"
20 Q0 25975955 261 26.312027 imi_mug_run_2_treatment "ci 4"
20 Q0 17021353 262 26.311317 imi_mug_run_2_treatment "oral contraceptives" "contraceptive" "duration"
20 Q0 15545966 263 26.306595 imi_mug_run_2_treatment "contraceptive" "oral contraceptives"
20 Q0 22262156 264 26.285305 imi_mug_run_2_treatment "various"
20 Q0 15557797 265 26.265306 imi_mug_run_2_treatment "aim"
20 Q0 10733923 266 26.261578 imi_mug_run_2_treatment "various"
20 Q0 19102642 267 26.258163 imi_mug_run_2_treatment "tamoxifen"
20 Q0 11597317 268 26.256647 imi_mug_run_2_treatment "mediated"
20 Q0 19654294 269 26.243982 imi_mug_run_2_treatment "cisplatin" "ag14361" "poly(adp-ribose) polymerase inhibitor"
20 Q0 21850394 270 26.232765 imi_mug_run_2_treatment "aim"
20 Q0 12680164 271 26.213686 imi_mug_run_2_treatment "estrogen"
20 Q0 24265793 272 26.19814 imi_mug_run_2_treatment "mediated"
20 Q0 11192759 273 26.193584 imi_mug_run_2_treatment "program"
20 Q0 14718789 274 26.184105 imi_mug_run_2_treatment "prophylactic"
20 Q0 17063271 275 26.182137 imi_mug_run_2_treatment "aim"
20 Q0 18451181 276 26.141178 imi_mug_run_2_treatment "dbd" "favor" "others"
20 Q0 12555988 277 26.096405 imi_mug_run_2_treatment "various"
20 Q0 19564533 278 26.093138 imi_mug_run_2_treatment "cyclophosphamide" "fluorouracil" "methotrexate"
20 Q0 20216074 279 26.085993 imi_mug_run_2_treatment "various"
20 Q0 15107617 280 26.073816 imi_mug_run_2_treatment "aim"
20 Q0 15654225 281 26.072626 imi_mug_run_2_treatment "combinations"
20 Q0 29545922 282 26.071316 imi_mug_run_2_treatment "pimasertib" "evofosfamide" "olaparib"
20 Q0 18657973 283 26.044367 imi_mug_run_2_treatment "liver"
20 Q0 11239959 284 26.02746 imi_mug_run_2_treatment "lead" "level"
20 Q0 14681210 285 26.02746 imi_mug_run_2_treatment "suppressor"
20 Q0 26187060 286 26.02746 imi_mug_run_2_treatment "various" "others"
20 Q0 9537231 287 26.013006 imi_mug_run_2_treatment "estrogen"
20 Q0 9150153 288 26.010567 imi_mug_run_2_treatment "basis"
20 Q0 24156927 289 26.004719 imi_mug_run_2_treatment "product"
20 Q0 19150414 290 25.991884 imi_mug_run_2_treatment "various" "basis"
20 Q0 28802188 291 25.97537 imi_mug_run_2_treatment "aim"
20 Q0 28067867 292 25.968374 imi_mug_run_2_treatment "suppressor"
20 Q0 19263514 293 25.945251 imi_mug_run_2_treatment "prophylactic" "aim"
20 Q0 30380096 294 25.941492 imi_mug_run_2_treatment "ors" "aim"
20 Q0 9288771 295 25.932123 imi_mug_run_2_treatment "contraceptive" "oral contraceptive"
20 Q0 20359158 296 25.906353 imi_mug_run_2_treatment "basis"
20 Q0 24870022 297 25.892937 imi_mug_run_2_treatment "mediated" "suppressor"
20 Q0 16141007 298 25.864368 imi_mug_run_2_treatment "basis"
20 Q0 9605646 299 25.864368 imi_mug_run_2_treatment "antiestrogenic"
20 Q0 19843326 300 25.858212 imi_mug_run_2_treatment "igf1"
20 Q0 24711893 301 25.854961 imi_mug_run_2_treatment "aim"
20 Q0 25053764 302 25.850033 imi_mug_run_2_treatment "lead" "basis"
20 Q0 29101607 303 25.849463 imi_mug_run_2_treatment "program"
20 Q0 18060494 304 25.848307 imi_mug_run_2_treatment "program"
20 Q0 16434590 305 25.837315 imi_mug_run_2_treatment "glutamine"
20 Q0 15276185 306 25.82906 imi_mug_run_2_treatment "shape"
20 Q0 24293293 307 25.82019 imi_mug_run_2_treatment "level"
20 Q0 27537391 308 25.815495 imi_mug_run_2_treatment "various"
20 Q0 20625817 309 25.803764 imi_mug_run_2_treatment "cancer drug" "drugs" "mitomycin"
20 Q0 30221688 310 25.799778 imi_mug_run_2_treatment "sage"
20 Q0 11474660 311 25.791567 imi_mug_run_2_treatment "oral contraceptives" "contraceptive"
20 Q0 17686574 312 25.790802 imi_mug_run_2_treatment "mediated"
20 Q0 10560359 313 25.789541 imi_mug_run_2_treatment "aim"
20 Q0 18167127 314 25.772354 imi_mug_run_2_treatment "matrix" "collagens" "suppressor"
20 Q0 25072261 315 25.76974 imi_mug_run_2_treatment "platinum"
20 Q0 10445022 316 25.765186 imi_mug_run_2_treatment "animals"
20 Q0 12845657 317 25.753227 imi_mug_run_2_treatment "aim"
20 Q0 18349832 318 25.73613 imi_mug_run_2_treatment "program"
20 Q0 28418854 319 25.722988 imi_mug_run_2_treatment "various" "basis"
20 Q0 21425892 320 25.697502 imi_mug_run_2_treatment "tamoxifen"
20 Q0 23657012 321 25.684763 imi_mug_run_2_treatment "mediated" "lead"
20 Q0 20010525 322 25.680979 imi_mug_run_2_treatment "aim"
20 Q0 15382059 323 25.658123 imi_mug_run_2_treatment "tamoxifen"
20 Q0 21671020 324 25.648106 imi_mug_run_2_treatment "dsb"
20 Q0 18819001 325 25.646118 imi_mug_run_2_treatment "mbc" "estrogen"
20 Q0 20400477 326 25.643955 imi_mug_run_2_treatment "lead"
20 Q0 10354832 327 25.634176 imi_mug_run_2_treatment "basis"
20 Q0 30275862 328 25.61362 imi_mug_run_2_treatment "mediated"
20 Q0 9811893 329 25.606293 imi_mug_run_2_treatment "suppressor"
20 Q0 14680495 330 25.605902 imi_mug_run_2_treatment "adjuvant"
20 Q0 25849179 331 25.599356 imi_mug_run_2_treatment "mediated"
20 Q0 27797936 332 25.596008 imi_mug_run_2_treatment "blockade" "il-6" "interleukin 6"
20 Q0 15265971 333 25.57285 imi_mug_run_2_treatment "duration" "ors" "basis"
20 Q0 15987451 334 25.568707 imi_mug_run_2_treatment "oestrogen" "aim"
20 Q0 26310895 335 25.558983 imi_mug_run_2_treatment "parp inhibitor" "anticancer agents" "lysine"
20 Q0 14722926 336 25.54669 imi_mug_run_2_treatment "amino acid" "generic" "mediated"
20 Q0 20871615 337 25.54425 imi_mug_run_2_treatment "parp inhibitors"
20 Q0 26489468 338 25.539177 imi_mug_run_2_treatment "parp inhibitor" "tandem"
20 Q0 16162645 339 25.538185 imi_mug_run_2_treatment "folic acid"
20 Q0 25154392 340 25.53355 imi_mug_run_2_treatment "pdx"
20 Q0 16754685 341 25.53056 imi_mug_run_2_treatment "mediated" "sulfate" "matrix"
20 Q0 20877358 342 25.524107 imi_mug_run_2_treatment "docetaxel" "basis" "aim"
20 Q0 18546071 343 25.521143 imi_mug_run_2_treatment "various"
20 Q0 22348646 344 25.515263 imi_mug_run_2_treatment "lead"
20 Q0 10665701 345 25.512478 imi_mug_run_2_treatment "combinations" "tamoxifen" "prophylactic"
20 Q0 29045505 346 25.462105 imi_mug_run_2_treatment "parp inhibitor"
20 Q0 17570734 347 25.4511 imi_mug_run_2_treatment "prophylactic"
20 Q0 17011978 348 25.422699 imi_mug_run_2_treatment "lead" "level" "aim"
20 Q0 29021639 349 25.416172 imi_mug_run_2_treatment "basis"
20 Q0 20134318 350 25.415585 imi_mug_run_2_treatment "aim"
20 Q0 23047548 351 25.413223 imi_mug_run_2_treatment "platinum" "parp inhibitors"
20 Q0 18694767 352 25.413115 imi_mug_run_2_treatment "basis" "aim"
20 Q0 11191790 353 25.409706 imi_mug_run_2_treatment "level"
20 Q0 12228710 354 25.405964 imi_mug_run_2_treatment "mediated" "oligo" "dsb"
20 Q0 10718491 355 25.405113 imi_mug_run_2_treatment "oral contraceptives"
20 Q0 12193279 356 25.397564 imi_mug_run_2_treatment "monoclonal antibodies"
20 Q0 19787003 357 25.369005 imi_mug_run_2_treatment "hormone analog"
20 Q0 22187435 358 25.352808 imi_mug_run_2_treatment "replication inhibitors"
20 Q0 22158906 359 25.34935 imi_mug_run_2_treatment "mediated" "level"
20 Q0 18820000 360 25.336248 imi_mug_run_2_treatment "parp inhibitor" "ag14361" "cytotoxic"
20 Q0 22340495 361 25.331589 imi_mug_run_2_treatment "lead" "level"
20 Q0 15944772 362 25.329794 imi_mug_run_2_treatment "aim"
20 Q0 28066861 363 25.322645 imi_mug_run_2_treatment "trastuzumab"
20 Q0 10676562 364 25.312775 imi_mug_run_2_treatment "level"
20 Q0 14600353 365 25.266964 imi_mug_run_2_treatment "various" "basis"
20 Q0 11257103 366 25.261736 imi_mug_run_2_treatment "estrogen" "mediated" "lead"
20 Q0 9625424 367 25.2373 imi_mug_run_2_treatment "mediated"
20 Q0 12727514 368 25.236378 imi_mug_run_2_treatment "basis"
20 Q0 14517958 369 25.23234 imi_mug_run_2_treatment "basis"
20 Q0 18489799 370 25.218931 imi_mug_run_2_treatment "level"
20 Q0 19896100 371 25.213112 imi_mug_run_2_treatment "ras"
20 Q0 16648044 372 25.207146 imi_mug_run_2_treatment "contraceptive"
20 Q0 16234515 373 25.18985 imi_mug_run_2_treatment "contraceptive" "ors"
20 Q0 16939956 374 25.18985 imi_mug_run_2_treatment "level"
20 Q0 21190077 375 25.18985 imi_mug_run_2_treatment "aim"
20 Q0 16736282 376 25.156616 imi_mug_run_2_treatment "cisplatinum" "drugs" "platinum"
20 Q0 27498558 377 25.15572 imi_mug_run_2_treatment "olaparib" "mediated"
20 Q0 28914618 378 25.151 imi_mug_run_2_treatment "prophylactic" "parp inhibitors"
20 Q0 11605067 379 25.120422 imi_mug_run_2_treatment "monoclonal antibodies"
20 Q0 9537232 380 25.091484 imi_mug_run_2_treatment "level"
20 Q0 20585617 381 25.08005 imi_mug_run_2_treatment "suppressor" "animals"
20 Q0 24343917 382 25.071957 imi_mug_run_2_treatment "basis"
20 Q0 8589730 383 25.059402 imi_mug_run_2_treatment "basis"
20 Q0 19047179 384 25.059402 imi_mug_run_2_treatment "mediated" "cisplatin" "therapeutics"
20 Q0 25366685 385 25.050117 imi_mug_run_2_treatment "olaparib" "poly (adp-ribose) polymerase inhibitor" "gemcitabine"
20 Q0 12721241 386 25.048225 imi_mug_run_2_treatment "prophylactic"
20 Q0 15930293 387 25.045202 imi_mug_run_2_treatment "mediated"
20 Q0 29387975 388 25.01153 imi_mug_run_2_treatment "various"
20 Q0 18288683 389 25.008364 imi_mug_run_2_treatment "basis"
20 Q0 16912212 390 24.995636 imi_mug_run_2_treatment "combinations"
20 Q0 29335925 391 24.989466 imi_mug_run_2_treatment "mbc" "aim"
20 Q0 20380699 392 24.982975 imi_mug_run_2_treatment "aim"
20 Q0 23593081 393 24.979546 imi_mug_run_2_treatment "aim"
20 Q0 9622070 394 24.978296 imi_mug_run_2_treatment "favor"
20 Q0 12967658 395 24.97516 imi_mug_run_2_treatment "yeast"
20 Q0 16507150 396 24.949448 imi_mug_run_2_treatment "aim"
20 Q0 25043256 397 24.937206 imi_mug_run_2_treatment "interferon" "mediated" "therapeutic agents"
20 Q0 17216544 398 24.922031 imi_mug_run_2_treatment "basis"
20 Q0 22331464 399 24.920685 imi_mug_run_2_treatment "antioxidant" "oxygen" "level"
20 Q0 18284688 400 24.90884 imi_mug_run_2_treatment "matrix"
20 Q0 12756300 401 24.893738 imi_mug_run_2_treatment "androgen" "mediated"
20 Q0 12849591 402 24.88763 imi_mug_run_2_treatment "basis"
20 Q0 19796187 403 24.88763 imi_mug_run_2_treatment "various"
20 Q0 12165866 404 24.885767 imi_mug_run_2_treatment "dbd"
20 Q0 20711702 405 24.87587 imi_mug_run_2_treatment "program" "aim"
20 Q0 24389956 406 24.844006 imi_mug_run_2_treatment "prophylactic" "level" "aim"
20 Q0 9168997 407 24.841625 imi_mug_run_2_treatment "level" "nocodazole" "mediated"
20 Q0 11377596 408 24.833488 imi_mug_run_2_treatment "contraceptive" "oral contraceptive"
20 Q0 22752604 409 24.825294 imi_mug_run_2_treatment "com"
20 Q0 19574032 410 24.823143 imi_mug_run_2_treatment "platinum" "basis"
20 Q0 20890790 411 24.821678 imi_mug_run_2_treatment "program"
20 Q0 25666348 412 24.777655 imi_mug_run_2_treatment "lead"
20 Q0 26724258 413 24.768269 imi_mug_run_2_treatment "platinum"
20 Q0 11668223 414 24.768082 imi_mug_run_2_treatment "oral contraceptives" "contraceptive"
20 Q0 10531007 415 24.745476 imi_mug_run_2_treatment "kinase inhibitor" "suppressor"
20 Q0 28487881 416 24.715343 imi_mug_run_2_treatment "medicine" "platinum"
20 Q0 18451254 417 24.674057 imi_mug_run_2_treatment "prophylactic"
20 Q0 12690474 418 24.667809 imi_mug_run_2_treatment "prophylactic"
20 Q0 19016568 419 24.667212 imi_mug_run_2_treatment "roscovitine" "mediated" "oestradiol"
20 Q0 24951267 420 24.665823 imi_mug_run_2_treatment "tamoxifen" "duration"
20 Q0 17453335 421 24.659176 imi_mug_run_2_treatment "level"
20 Q0 10652564 422 24.6543 imi_mug_run_2_treatment "level"
20 Q0 27433848 423 24.6543 imi_mug_run_2_treatment "cls" "ehna"
20 Q0 11463009 424 24.632671 imi_mug_run_2_treatment "basis"
20 Q0 22739995 425 24.632671 imi_mug_run_2_treatment "ci 4"
20 Q0 24454456 426 24.62614 imi_mug_run_2_treatment "various"
20 Q0 18158280 427 24.619188 imi_mug_run_2_treatment "mbc"
20 Q0 29961768 428 24.617601 imi_mug_run_2_treatment "platinum"
20 Q0 23319376 429 24.582323 imi_mug_run_2_treatment "ras" "insulin-like growth factor binding protein 3"
20 Q0 22825375 430 24.578617 imi_mug_run_2_treatment "therapeutics" "parp inhibitors"
20 Q0 9126738 431 24.57819 imi_mug_run_2_treatment "mediated" "suppressor"
20 Q0 20135345 432 24.572748 imi_mug_run_2_treatment "ors"
20 Q0 12083779 433 24.570484 imi_mug_run_2_treatment "various"
20 Q0 9150152 434 24.5509 imi_mug_run_2_treatment "product"
20 Q0 23980083 435 24.53763 imi_mug_run_2_treatment "tamoxifen"
20 Q0 23108138 436 24.529102 imi_mug_run_2_treatment "dbd"
20 Q0 24448238 437 24.529102 imi_mug_run_2_treatment "mediated"
20 Q0 12483515 438 24.513384 imi_mug_run_2_treatment "mediated"
20 Q0 20614180 439 24.51139 imi_mug_run_2_treatment "aim"
20 Q0 11352856 440 24.504742 imi_mug_run_2_treatment "basis"
20 Q0 15059511 441 24.489136 imi_mug_run_2_treatment "leu"
20 Q0 28467918 442 24.488077 imi_mug_run_2_treatment "trabectedin" "mbc" "alkylators"
20 Q0 8616762 443 24.474073 imi_mug_run_2_treatment "basis"
20 Q0 21761396 444 24.474073 imi_mug_run_2_treatment "taxane"
20 Q0 16448223 445 24.472553 imi_mug_run_2_treatment "basis" "hpv-16 e6"
20 Q0 10197592 446 24.462517 imi_mug_run_2_treatment "product"
20 Q0 26349355 447 24.461327 imi_mug_run_2_treatment "tamoxifen"
20 Q0 15381448 448 24.450363 imi_mug_run_2_treatment "estrogen" "estrogens" "adjuvant"
20 Q0 21441901 449 24.449276 imi_mug_run_2_treatment "various"
20 Q0 12459499 450 24.436302 imi_mug_run_2_treatment "prolactin"
20 Q0 20135344 451 24.4304 imi_mug_run_2_treatment "tamoxifen" "adjuvant"
20 Q0 15308204 452 24.410582 imi_mug_run_2_treatment "ustilago maydis"
20 Q0 21221768 453 24.40976 imi_mug_run_2_treatment "various"
20 Q0 25692405 454 24.402727 imi_mug_run_2_treatment "suppressor" "animals"
20 Q0 14645421 455 24.398666 imi_mug_run_2_treatment "tamoxifen" "adjuvant"
20 Q0 25975349 456 24.397617 imi_mug_run_2_treatment "parp inhibitors" "parp inhibitor" "olaparib"
20 Q0 29802810 457 24.397617 imi_mug_run_2_treatment "level"
20 Q0 19619314 458 24.39732 imi_mug_run_2_treatment "various" "estrogen"
20 Q0 24862760 459 24.394379 imi_mug_run_2_treatment "mediated"
20 Q0 26641009 460 24.389324 imi_mug_run_2_treatment "cytotoxic"
20 Q0 20356927 461 24.388721 imi_mug_run_2_treatment "suppressor"
20 Q0 15734957 462 24.371593 imi_mug_run_2_treatment "contraceptive" "oral contraceptive" "oral contraceptives"
20 Q0 24485656 463 24.345812 imi_mug_run_2_treatment "hydroxyurea" "mediated" "dsb"
20 Q0 22218796 464 24.30984 imi_mug_run_2_treatment "others"
20 Q0 20810544 465 24.273346 imi_mug_run_2_treatment "prompt"
20 Q0 20617377 466 24.267078 imi_mug_run_2_treatment "basis"
20 Q0 16764716 467 24.26398 imi_mug_run_2_treatment "mbc"
20 Q0 23071527 468 24.263445 imi_mug_run_2_treatment "mediated"
20 Q0 14506147 469 24.255924 imi_mug_run_2_treatment "her-2"
20 Q0 27426853 470 24.224724 imi_mug_run_2_treatment "prophylactic"
20 Q0 28893223 471 24.221596 imi_mug_run_2_treatment "mbc" "methylated" "aim"
20 Q0 11698567 472 24.211824 imi_mug_run_2_treatment "basis"
20 Q0 19088722 473 24.210049 imi_mug_run_2_treatment "tamoxifen"
20 Q0 22339411 474 24.209286 imi_mug_run_2_treatment "daidzein" "genistein" "budesonide"
20 Q0 10638982 475 24.19227 imi_mug_run_2_treatment "enzymes"
20 Q0 11207349 476 24.179268 imi_mug_run_2_treatment "basis"
20 Q0 16434996 477 24.170244 imi_mug_run_2_treatment "i3c" "genistein" "indole-3-carbinol"
20 Q0 12215251 478 24.162783 imi_mug_run_2_treatment "aim"
20 Q0 24237098 479 24.159815 imi_mug_run_2_treatment "medication"
20 Q0 20429623 480 24.13795 imi_mug_run_2_treatment "estrogen"
20 Q0 29565421 481 24.13795 imi_mug_run_2_treatment "medicine"
20 Q0 12215246 482 24.13559 imi_mug_run_2_treatment "others"
20 Q0 22564871 483 24.123299 imi_mug_run_2_treatment "various" "basis" "duration"
20 Q0 11250682 484 24.116419 imi_mug_run_2_treatment "lead"
20 Q0 9119389 485 24.115273 imi_mug_run_2_treatment "level"
20 Q0 21939546 486 24.114906 imi_mug_run_2_treatment "level"
20 Q0 28183138 487 24.113035 imi_mug_run_2_treatment "platinum" "adjuvant"
20 Q0 23696131 488 24.110617 imi_mug_run_2_treatment "mitoxantrone" "gemcitabine" "parp inhibitors"
20 Q0 30407790 489 24.107218 imi_mug_run_2_treatment "drug" "drugs" "gemcitabine"
20 Q0 26698676 490 24.102808 imi_mug_run_2_treatment "fertility medication" "gonadotropin"
20 Q0 26022977 491 24.102571 imi_mug_run_2_treatment "tamoxifen" "adjuvant" "pooled"
20 Q0 9207100 492 24.088345 imi_mug_run_2_treatment "yeast"
20 Q0 10837032 493 24.088345 imi_mug_run_2_treatment "basis"
20 Q0 26452665 494 24.075193 imi_mug_run_2_treatment "platinum" "parp inhibitors"
20 Q0 25682074 495 24.075193 imi_mug_run_2_treatment "progesterone" "oestrogen"
20 Q0 22901131 496 24.060337 imi_mug_run_2_treatment "methylated"
20 Q0 29240602 497 24.056355 imi_mug_run_2_treatment "aim"
20 Q0 27941124 498 24.043594 imi_mug_run_2_treatment "dsb"
20 Q0 25282148 499 24.031857 imi_mug_run_2_treatment "mediated" "product"
20 Q0 21097693 500 24.022346 imi_mug_run_2_treatment "olaparib" "experimental drug" "carboplatin"
20 Q0 21918854 501 24.001266 imi_mug_run_2_treatment "aim"
20 Q0 27060914 502 24.001266 imi_mug_run_2_treatment "taxanes"
20 Q0 26691937 503 23.996252 imi_mug_run_2_treatment "basis" "parp inhibitors"
20 Q0 21166701 504 23.991608 imi_mug_run_2_treatment "androgen" "progesterone" "oestrogen"
20 Q0 21228333 505 23.988308 imi_mug_run_2_treatment "ci 4"
20 Q0 9679765 506 23.978493 imi_mug_run_2_treatment "camptothecin" "etoposide" "nitrogen mustard"
20 Q0 22579622 507 23.97491 imi_mug_run_2_treatment "mediated" "level"
20 Q0 11801872 508 23.954647 imi_mug_run_2_treatment "oral contraceptives"
20 Q0 26997744 509 23.940886 imi_mug_run_2_treatment "favor"
20 Q0 28184943 510 23.93996 imi_mug_run_2_treatment "gentle" "level" "aim"
20 Q0 21327470 511 23.92981 imi_mug_run_2_treatment "product"
20 Q0 11251181 512 23.929184 imi_mug_run_2_treatment "aim"
20 Q0 26052455 513 23.92078 imi_mug_run_2_treatment "hub"
20 Q0 29330845 514 23.91916 imi_mug_run_2_treatment "aim"
20 Q0 16962648 515 23.91124 imi_mug_run_2_treatment "tamoxifen" "prophylactic"
20 Q0 29138730 516 23.908096 imi_mug_run_2_treatment "level"
20 Q0 28431939 517 23.905128 imi_mug_run_2_treatment "hdac inhibitor" "paclitaxel"
20 Q0 19027287 518 23.900452 imi_mug_run_2_treatment "adjuvant"
20 Q0 28575672 519 23.896414 imi_mug_run_2_treatment "formaldehyde" "alcohol"
20 Q0 27616351 520 23.893188 imi_mug_run_2_treatment "mk-1775" "mitotic inhibitor" "gemcitabine"
20 Q0 8787076 521 23.884647 imi_mug_run_2_treatment "lead" "basis"
20 Q0 18182601 522 23.883703 imi_mug_run_2_treatment "basis"
20 Q0 21665305 523 23.882347 imi_mug_run_2_treatment "dsb"
20 Q0 15026330 524 23.878233 imi_mug_run_2_treatment "animals"
20 Q0 19707196 525 23.869871 imi_mug_run_2_treatment "mediated"
20 Q0 25743105 526 23.866232 imi_mug_run_2_treatment "cisplatinum"
20 Q0 27272846 527 23.863317 imi_mug_run_2_treatment "vitamin d" "level" "aim"
20 Q0 19214744 528 23.860909 imi_mug_run_2_treatment "program"
20 Q0 21945869 529 23.854607 imi_mug_run_2_treatment "platinum agents"
20 Q0 15516847 530 23.851992 imi_mug_run_2_treatment "combinations"
20 Q0 11861370 531 23.839184 imi_mug_run_2_treatment "various"
20 Q0 9148160 532 23.812077 imi_mug_run_2_treatment "basis"
20 Q0 11447276 533 23.80961 imi_mug_run_2_treatment "mediated"
20 Q0 29700634 534 23.801962 imi_mug_run_2_treatment "aim"
20 Q0 12591928 535 23.791977 imi_mug_run_2_treatment "adriamycin"
20 Q0 21667031 536 23.788046 imi_mug_run_2_treatment "aim"
20 Q0 12410562 537 23.78802 imi_mug_run_2_treatment "etoposide" "mitogen" "agent"
20 Q0 20729858 538 23.782402 imi_mug_run_2_treatment "mediated"
20 Q0 17822314 539 23.77475 imi_mug_run_2_treatment "estrogen" "various" "aim"
20 Q0 17767707 540 23.77316 imi_mug_run_2_treatment "mbc" "level"
20 Q0 8917547 541 23.764229 imi_mug_run_2_treatment "glucocorticoids"
20 Q0 25497410 542 23.747581 imi_mug_run_2_treatment "lead"
20 Q0 10373512 543 23.741772 imi_mug_run_2_treatment "yeast" "product"
20 Q0 23958087 544 23.720299 imi_mug_run_2_treatment "aim"
20 Q0 25808098 545 23.720259 imi_mug_run_2_treatment "lead" "aim"
20 Q0 9002670 546 23.707373 imi_mug_run_2_treatment "matrix"
20 Q0 10399947 547 23.703075 imi_mug_run_2_treatment "basis"
20 Q0 29492181 548 23.698265 imi_mug_run_2_treatment "various"
20 Q0 8895509 549 23.688152 imi_mug_run_2_treatment "antiestrogens" "progesterone" "estrogen"
20 Q0 21731065 550 23.673069 imi_mug_run_2_treatment "product"
20 Q0 28376189 551 23.664635 imi_mug_run_2_treatment "aim"
20 Q0 17686308 552 23.664429 imi_mug_run_2_treatment "phenol"
20 Q0 11039575 553 23.664429 imi_mug_run_2_treatment "others"
20 Q0 17624601 554 23.660458 imi_mug_run_2_treatment "adjuvant" "therapeutics" "poly(adp-ribose) polymerase inhibitors"
20 Q0 20361264 555 23.65908 imi_mug_run_2_treatment "ras" "suppressor"
20 Q0 10090881 556 23.658691 imi_mug_run_2_treatment "anonymous"
20 Q0 21499684 557 23.654264 imi_mug_run_2_treatment "contraceptive" "oral contraceptives"
20 Q0 27721065 558 23.634912 imi_mug_run_2_treatment "flt"
20 Q0 18307534 559 23.6322 imi_mug_run_2_treatment "various" "adriamycin" "yeast"
20 Q0 27195161 560 23.631142 imi_mug_run_2_treatment "pertuzumab"
20 Q0 26577449 561 23.627733 imi_mug_run_2_treatment "aim"
20 Q0 19110958 562 23.61748 imi_mug_run_2_treatment "medicine"
20 Q0 24473064 563 23.61748 imi_mug_run_2_treatment "dsb"
20 Q0 18723021 564 23.61483 imi_mug_run_2_treatment "brdu"
20 Q0 15280181 565 23.608997 imi_mug_run_2_treatment "lead" "others"
20 Q0 30430339 566 23.603718 imi_mug_run_2_treatment "genesis"
20 Q0 29339979 567 23.59739 imi_mug_run_2_treatment "aim"
20 Q0 16510331 568 23.578688 imi_mug_run_2_treatment "prophylactic"
20 Q0 10652533 569 23.572655 imi_mug_run_2_treatment "lead"
20 Q0 12838319 570 23.566063 imi_mug_run_2_treatment "resveratrol" "oestrogen"
20 Q0 28929593 571 23.566 imi_mug_run_2_treatment "taxane" "basis"
20 Q0 17513806 572 23.56424 imi_mug_run_2_treatment "level"
20 Q0 10749118 573 23.550686 imi_mug_run_2_treatment "vincristine"
20 Q0 16687415 574 23.536533 imi_mug_run_2_treatment "cisplatin" "mediated"
20 Q0 16683254 575 23.525639 imi_mug_run_2_treatment "program"
20 Q0 19200354 576 23.505924 imi_mug_run_2_treatment "aim"
20 Q0 23271408 577 23.497612 imi_mug_run_2_treatment "level" "aim"
20 Q0 19944633 578 23.497612 imi_mug_run_2_treatment "lysine"
20 Q0 16998501 579 23.491556 imi_mug_run_2_treatment "various"
20 Q0 23519070 580 23.490711 imi_mug_run_2_treatment "various combinations"
20 Q0 16616110 581 23.453667 imi_mug_run_2_treatment "basis"
20 Q0 9700175 582 23.451927 imi_mug_run_2_treatment "contraceptive" "oral contraceptives"
20 Q0 10558858 583 23.433155 imi_mug_run_2_treatment "suppressor"
20 Q0 26202431 584 23.432074 imi_mug_run_2_treatment "mediated" "lead"
20 Q0 19012002 585 23.421196 imi_mug_run_2_treatment "her-2"
20 Q0 25103822 586 23.42085 imi_mug_run_2_treatment "ors"
20 Q0 26347108 587 23.415854 imi_mug_run_2_treatment "aim"
20 Q0 16825437 588 23.415741 imi_mug_run_2_treatment "aim"
20 Q0 22072316 589 23.412743 imi_mug_run_2_treatment "touchdown" "product" "program"
20 Q0 27708239 590 23.412186 imi_mug_run_2_treatment "olaparib" "liver"
20 Q0 17292821 591 23.37783 imi_mug_run_2_treatment "lead"
20 Q0 18781154 592 23.375868 imi_mug_run_2_treatment "various"
20 Q0 24627042 593 23.374939 imi_mug_run_2_treatment "fluorouracil" "drugs" "dsb"
20 Q0 12619154 594 23.36274 imi_mug_run_2_treatment "agent" "level" "animals"
20 Q0 16521688 595 23.355423 imi_mug_run_2_treatment "contraceptive"
20 Q0 15343273 596 23.33878 imi_mug_run_2_treatment "lead"
20 Q0 17307353 597 23.336952 imi_mug_run_2_treatment "oestrogen" "prophylactic" "aim"
20 Q0 11306454 598 23.332073 imi_mug_run_2_treatment "mediated" "product"
20 Q0 20202217 599 23.329222 imi_mug_run_2_treatment "product"
20 Q0 20399636 600 23.320187 imi_mug_run_2_treatment "estrogen"
20 Q0 19698031 601 23.305729 imi_mug_run_2_treatment "aim"
20 Q0 26109557 602 23.300476 imi_mug_run_2_treatment "suppressor"
20 Q0 30111871 603 23.283096 imi_mug_run_2_treatment "platinum"
20 Q0 25716084 604 23.276104 imi_mug_run_2_treatment "various"
20 Q0 9133444 605 23.265285 imi_mug_run_2_treatment "progesterone" "sex hormones" "estradiol"
20 Q0 29202657 606 23.259304 imi_mug_run_2_treatment "oxaliplatin" "cdx" "capecitabine"
20 Q0 17515904 607 23.243944 imi_mug_run_2_treatment "mediated"
20 Q0 11850397 608 23.243944 imi_mug_run_2_treatment "animals"
20 Q0 25482078 609 23.243221 imi_mug_run_2_treatment "contraceptive"
20 Q0 17476307 610 23.234228 imi_mug_run_2_treatment "lead" "nervous system"
20 Q0 21409565 611 23.23287 imi_mug_run_2_treatment "level"
20 Q0 12125210 612 23.231483 imi_mug_run_2_treatment "program"
20 Q0 11170890 613 23.22444 imi_mug_run_2_treatment "basis"
20 Q0 19442290 614 23.221447 imi_mug_run_2_treatment "phytoestrogen" "phytoestrogens" "isoflavone"
20 Q0 21565612 615 23.218699 imi_mug_run_2_treatment "hydroxyurea" "fiber"
20 Q0 29386125 616 23.218699 imi_mug_run_2_treatment "mediated" "prevent"
20 Q0 9634504 617 23.215107 imi_mug_run_2_treatment "anonymous"
20 Q0 11332051 618 23.212166 imi_mug_run_2_treatment "contraceptives"
20 Q0 9774970 619 23.207706 imi_mug_run_2_treatment "hydroxyurea"
20 Q0 9824164 620 23.20361 imi_mug_run_2_treatment "mediated"
20 Q0 17634833 621 23.200745 imi_mug_run_2_treatment "combinations"
20 Q0 11173152 622 23.196785 imi_mug_run_2_treatment "estrogen"
20 Q0 15642173 623 23.193367 imi_mug_run_2_treatment "aim"
20 Q0 15318925 624 23.186111 imi_mug_run_2_treatment "lead"
20 Q0 11102977 625 23.185318 imi_mug_run_2_treatment "favor"
20 Q0 20233478 626 23.179785 imi_mug_run_2_treatment "oral contraceptives" "oestrogen"
20 Q0 23080033 627 23.175694 imi_mug_run_2_treatment "prophylactic" "basis"
20 Q0 15937124 628 23.144556 imi_mug_run_2_treatment "lead"
20 Q0 30181190 629 23.143412 imi_mug_run_2_treatment "prophylactic"
20 Q0 24052750 630 23.142126 imi_mug_run_2_treatment "aim"
20 Q0 25091037 631 23.137516 imi_mug_run_2_treatment "therapeutic agents"
20 Q0 21978880 632 23.136044 imi_mug_run_2_treatment "methylated" "aim"
20 Q0 18544963 633 23.134617 imi_mug_run_2_treatment "estrogen"
20 Q0 10921314 634 23.134384 imi_mug_run_2_treatment "basis"
20 Q0 19644536 635 23.12349 imi_mug_run_2_treatment "alkylator" "megestrol" "tamoxifen"
20 Q0 20653694 636 23.121878 imi_mug_run_2_treatment "program" "level"
20 Q0 16998497 637 23.114922 imi_mug_run_2_treatment "oral contraceptives"
20 Q0 16417652 638 23.114077 imi_mug_run_2_treatment "various" "level"
20 Q0 17428325 639 23.100857 imi_mug_run_2_treatment "aim"
20 Q0 9585613 640 23.096249 imi_mug_run_2_treatment "tandem"
20 Q0 16085232 641 23.069416 imi_mug_run_2_treatment "oral contraceptives" "contraceptive" "prophylactic"
21 Q0 16638875 1 67.60765 imi_mug_run_2_treatment "imatinib" "su11248" "kinase inhibitor"
21 Q0 17699867 2 65.16024 imi_mug_run_2_treatment "imatinib" "sorafenib" "nilotinib"
21 Q0 20021947 3 61.238125 imi_mug_run_2_treatment "imatinib" "imatinib mesylate" "agent"
21 Q0 16721136 4 60.394848 imi_mug_run_2_treatment "sti-571" "gleevec" "imatinib mesylate"
21 Q0 17363509 5 59.753525 imi_mug_run_2_treatment "imatinib" "drug" "kinase inhibitor"
21 Q0 15045935 6 59.025272 imi_mug_run_2_treatment "drug" "imatinib" "imatinib mesylate"
21 Q0 15087667 7 57.65933 imi_mug_run_2_treatment "sti-571"
21 Q0 26658996 8 57.63873 imi_mug_run_2_treatment "imatinib"
21 Q0 20096441 9 56.481377 imi_mug_run_2_treatment "liver"
21 Q0 22943011 10 56.339348 imi_mug_run_2_treatment "level"
21 Q0 26819809 11 56.181953 imi_mug_run_2_treatment "imatinib"
21 Q0 18234489 12 56.07042 imi_mug_run_2_treatment "imatinib" "adjuvant" "sunitinib"
21 Q0 23536354 13 55.465904 imi_mug_run_2_treatment "imatinib mesylate"
21 Q0 9588894 14 55.19149 imi_mug_run_2_treatment "icc" "aim"
21 Q0 24379393 15 55.15058 imi_mug_run_2_treatment "various" "mediated" "matrix"
21 Q0 23084635 16 55.02302 imi_mug_run_2_treatment "imatinib mesylate"
21 Q0 16776326 17 54.93121 imi_mug_run_2_treatment "tyrosine kinase inhibitor"
21 Q0 16539879 18 54.849392 imi_mug_run_2_treatment "imatinib"
21 Q0 16481303 19 54.812572 imi_mug_run_2_treatment "imatinib" "liver"
21 Q0 21224658 20 54.746315 imi_mug_run_2_treatment "imatinib mesylate" "adjuvant" "imatinib"
21 Q0 27073655 21 54.734207 imi_mug_run_2_treatment "sunitinib" "imatinib" "kinase inhibitor"
21 Q0 17018739 22 54.439484 imi_mug_run_2_treatment "imatinib" "adjuvant" "tyrosine kinase inhibitor"
21 Q0 20633291 23 54.39473 imi_mug_run_2_treatment "motesanib" "imatinib" "vascular endothelial growth factor"
21 Q0 23092343 24 53.89747 imi_mug_run_2_treatment "imatinib" "drugs"
21 Q0 24583793 25 53.88025 imi_mug_run_2_treatment "imatinib" "tyrosine kinase inhibitor"
21 Q0 17253141 26 53.77169 imi_mug_run_2_treatment "aim"
21 Q0 23116579 27 53.72377 imi_mug_run_2_treatment "imatinib" "adjuvant"
21 Q0 17643098 28 53.66723 imi_mug_run_2_treatment "eosin" "aim"
21 Q0 14726714 29 53.666664 imi_mug_run_2_treatment "imatinib mesylate" "product"
21 Q0 15685537 30 53.527794 imi_mug_run_2_treatment "imatinib" "drug" "kinase inhibitor"
21 Q0 19248971 31 53.43338 imi_mug_run_2_treatment "drug trials" "imatinib mesylate"
21 Q0 20967481 32 53.39569 imi_mug_run_2_treatment "adjuvant" "imatinib" "imatinib mesylate"
21 Q0 20674415 33 53.32071 imi_mug_run_2_treatment "others"
21 Q0 20878498 34 53.259293 imi_mug_run_2_treatment "kinase inhibitor" "imatinib mesylate"
21 Q0 16850124 35 53.00316 imi_mug_run_2_treatment "imatinib mesylate" "drug" "imatinib"
21 Q0 19248972 36 52.83454 imi_mug_run_2_treatment "imatinib mesylate"
21 Q0 18443532 37 52.69508 imi_mug_run_2_treatment "adjuvant" "imatinib"
21 Q0 22489857 38 52.63624 imi_mug_run_2_treatment "liver"
21 Q0 25239608 39 52.57591 imi_mug_run_2_treatment "drug" "imatinib" "sunitinib"
21 Q0 17450496 40 52.452858 imi_mug_run_2_treatment "gleevec" "imatinib mesylate"
21 Q0 15309514 41 52.422398 imi_mug_run_2_treatment "imatinib mesylate" "agent" "tyrosine kinase inhibitor"
21 Q0 15921306 42 52.355434 imi_mug_run_2_treatment "lime" "imatinib" "aim"
21 Q0 25645799 43 51.88877 imi_mug_run_2_treatment "liver"
21 Q0 21386653 44 51.787964 imi_mug_run_2_treatment "imatinib mesylate"
21 Q0 21566429 45 51.675156 imi_mug_run_2_treatment "imatinib" "drug" "kinase inhibitor"
21 Q0 19047911 46 51.64125 imi_mug_run_2_treatment "gat"
21 Q0 11431711 47 51.616833 imi_mug_run_2_treatment "sti-571" "chemotherapeutic agent" "medicine"
21 Q0 21932185 48 51.41146 imi_mug_run_2_treatment "drug" "imatinib"
21 Q0 21527063 49 51.308594 imi_mug_run_2_treatment "lead" "therapeutics" "sti-571"
21 Q0 27777718 50 50.94924 imi_mug_run_2_treatment "various" "mediated" "lead"
21 Q0 21658742 51 50.921036 imi_mug_run_2_treatment "eosin"
21 Q0 16238204 52 50.83404 imi_mug_run_2_treatment "thyroxine"
21 Q0 27920660 53 50.80058 imi_mug_run_2_treatment "collagen"
21 Q0 22029680 54 50.74545 imi_mug_run_2_treatment "product"
21 Q0 26770446 55 50.678574 imi_mug_run_2_treatment "sunitinib" "reverse t3" "agent"
21 Q0 12355934 56 50.61968 imi_mug_run_2_treatment "imatinib mesylate" "drug" "sti 571"
21 Q0 28632504 57 50.56789 imi_mug_run_2_treatment "various"
21 Q0 15154382 58 50.55048 imi_mug_run_2_treatment "agent"
21 Q0 14675690 59 50.52037 imi_mug_run_2_treatment "imatinib mesylate"
21 Q0 19537128 60 50.405666 imi_mug_run_2_treatment "various" "gleevec" "imatinib mesylate"
21 Q0 16334774 61 50.34406 imi_mug_run_2_treatment "sti571" "medicine" "medicated"
21 Q0 23579364 62 50.226173 imi_mug_run_2_treatment "tyrosine" "imatinib" "sunitinib"
21 Q0 15168243 63 50.09741 imi_mug_run_2_treatment "sti571" "imatinib mesylate" "drug"
21 Q0 12655446 64 50.078472 imi_mug_run_2_treatment "imatinib mesylate" "sti571"
21 Q0 15894928 65 50.049297 imi_mug_run_2_treatment "sti 571" "gleevec" "imatinib mesylate"
21 Q0 19830214 66 49.97457 imi_mug_run_2_treatment "lead"
21 Q0 12239933 67 49.95894 imi_mug_run_2_treatment "liver"
21 Q0 30003531 68 49.84829 imi_mug_run_2_treatment "various"
21 Q0 12683877 69 49.812042 imi_mug_run_2_treatment "liver"
21 Q0 19961019 70 49.70072 imi_mug_run_2_treatment "imatinib"
21 Q0 27345285 71 49.579594 imi_mug_run_2_treatment "various" "imatinib" "imatinib mesylate"
21 Q0 23639648 72 49.492744 imi_mug_run_2_treatment "tyrosine kinase inhibitor"
21 Q0 25414046 73 49.449787 imi_mug_run_2_treatment "imatinib"
21 Q0 15682856 74 49.441856 imi_mug_run_2_treatment "adrenal hormone"
21 Q0 26596853 75 49.440277 imi_mug_run_2_treatment "imatinib"
21 Q0 16630479 76 49.418003 imi_mug_run_2_treatment "icc"
21 Q0 14978967 77 49.33639 imi_mug_run_2_treatment "liver"
21 Q0 16061643 78 49.32285 imi_mug_run_2_treatment "icc" "color"
21 Q0 21600007 79 49.167213 imi_mug_run_2_treatment "imatinib mesylate" "imatinib"
21 Q0 22069173 80 49.103443 imi_mug_run_2_treatment "level"
21 Q0 22355224 81 49.027893 imi_mug_run_2_treatment "imatinib" "sunitinib" "aim"
21 Q0 25264210 82 48.982056 imi_mug_run_2_treatment "collagen"
21 Q0 17229322 83 48.95697 imi_mug_run_2_treatment "combinations" "growth hormone" "insulin-like growth factor ii"
21 Q0 18728705 84 48.927032 imi_mug_run_2_treatment "drug" "imatinib mesylate" "imatinib"
21 Q0 18286477 85 48.91015 imi_mug_run_2_treatment "adjuvant" "imatinib"
21 Q0 21621171 86 48.86483 imi_mug_run_2_treatment "imatinib" "pegylated liposomal doxorubicin"
21 Q0 25606568 87 48.83512 imi_mug_run_2_treatment "lead"
21 Q0 22124674 88 48.789474 imi_mug_run_2_treatment "imatinib mesylate"
21 Q0 24145645 89 48.7425 imi_mug_run_2_treatment "basis" "aim"
21 Q0 27258566 90 48.71321 imi_mug_run_2_treatment "imatinib" "kinase inhibitor" "aim"
21 Q0 21237497 91 48.68844 imi_mug_run_2_treatment "imatinib"
21 Q0 18045506 92 48.582024 imi_mug_run_2_treatment "imatinib mesylate"
21 Q0 20499309 93 48.557205 imi_mug_run_2_treatment "imatinib" "ras"
21 Q0 14632569 94 48.528923 imi_mug_run_2_treatment "liver"
21 Q0 16858179 95 48.512352 imi_mug_run_2_treatment "imatinib" "adjuvant" "imatinib mesylate"
21 Q0 27753268 96 48.444244 imi_mug_run_2_treatment "adjuvant" "imatinib" "aim"
21 Q0 29969914 97 48.442966 imi_mug_run_2_treatment "imatinib" "adjuvant" "aim"
21 Q0 15387340 98 48.395077 imi_mug_run_2_treatment "ras" "aim"
21 Q0 21120166 99 48.39011 imi_mug_run_2_treatment "drug" "imatinib"
21 Q0 24758502 100 48.382156 imi_mug_run_2_treatment "drugs" "imatinib"
21 Q0 30101284 101 48.206795 imi_mug_run_2_treatment "imatinib" "sunitinib" "tyrosine kinase inhibitor"
21 Q0 20976851 102 48.194916 imi_mug_run_2_treatment "mediated" "aim"
21 Q0 15803185 103 48.194637 imi_mug_run_2_treatment "insulin"
21 Q0 17565683 104 48.19009 imi_mug_run_2_treatment "adjuvant" "imatinib"
21 Q0 23382202 105 48.136654 imi_mug_run_2_treatment "imatinib" "mediated" "tyrosine kinase inhibitor"
21 Q0 23433424 106 48.058544 imi_mug_run_2_treatment "dtc" "imatinib mesylate"
21 Q0 17512858 107 48.04205 imi_mug_run_2_treatment "kinase inhibitor" "adjuvant" "mediated"
21 Q0 19096980 108 48.01926 imi_mug_run_2_treatment "imatinib" "tyrosine kinase inhibitor"
21 Q0 19770581 109 47.96193 imi_mug_run_2_treatment "egcg" "various" "imatinib"
21 Q0 23112561 110 47.95504 imi_mug_run_2_treatment "imatinib mesylate"
21 Q0 14686698 111 47.88982 imi_mug_run_2_treatment "gleevec" "glivec" "imatinib"
21 Q0 17334345 112 47.8836 imi_mug_run_2_treatment "various" "vascular endothelial growth factor"
21 Q0 20823768 113 47.87478 imi_mug_run_2_treatment "liver"
21 Q0 17545799 114 47.826168 imi_mug_run_2_treatment "imatinib" "sunitinib" "drugs"
21 Q0 19646278 115 47.82286 imi_mug_run_2_treatment "imatinib" "everolimus" "therapeutic agents"
21 Q0 27178185 116 47.77283 imi_mug_run_2_treatment "plasma"
21 Q0 28163271 117 47.74536 imi_mug_run_2_treatment "liver"
21 Q0 21519258 118 47.739006 imi_mug_run_2_treatment "imatinib" "sunitinib" "aim"
21 Q0 19664491 119 47.722626 imi_mug_run_2_treatment "therapeutics"
21 Q0 23894705 120 47.623825 imi_mug_run_2_treatment "imatinib"
21 Q0 22229850 121 47.605164 imi_mug_run_2_treatment "imatinib mesylate" "drugs" "revolution"
21 Q0 26240289 122 47.599827 imi_mug_run_2_treatment "imatinib"
21 Q0 17386236 123 47.577446 imi_mug_run_2_treatment "imatinib" "imatinib mesylate" "glivec"
21 Q0 26805679 124 47.434864 imi_mug_run_2_treatment "adjuvant"
21 Q0 25432174 125 47.362686 imi_mug_run_2_treatment "imatinib" "drug" "mediated"
21 Q0 18701138 126 47.334423 imi_mug_run_2_treatment "biotin"
21 Q0 16457143 127 47.3238 imi_mug_run_2_treatment "adjuvant"
21 Q0 21970485 128 47.30282 imi_mug_run_2_treatment "imatinib mesylate" "sunitinib malate"
21 Q0 15872385 129 47.2994 imi_mug_run_2_treatment "drug" "imatinib mesylate" "matrix"
21 Q0 23489352 130 47.292118 imi_mug_run_2_treatment "tyrosine" "imatinib"
21 Q0 22855636 131 47.244316 imi_mug_run_2_treatment "imatinib" "sunitinib"
21 Q0 23536336 132 47.172337 imi_mug_run_2_treatment "tyrosine kinase inhibitor"
21 Q0 11526490 133 47.12442 imi_mug_run_2_treatment "sti571" "tyrosine kinase inhibitor" "level"
21 Q0 27777285 134 47.09925 imi_mug_run_2_treatment "cabozantinib" "imatinib" "pdx"
21 Q0 28166823 135 47.097042 imi_mug_run_2_treatment "imatinib"
21 Q0 23840364 136 47.076057 imi_mug_run_2_treatment "sorafenib" "nilotinib" "imatinib mesylate"
21 Q0 25735500 137 46.933826 imi_mug_run_2_treatment "plasma" "imatinib"
21 Q0 19390946 138 46.864082 imi_mug_run_2_treatment "sunitinib" "imatinib" "drug"
21 Q0 15742414 139 46.85191 imi_mug_run_2_treatment "aim"
21 Q0 12897659 140 46.787514 imi_mug_run_2_treatment "gleevec" "imatinib mesylate" "pharmaceuticals"
21 Q0 12522257 141 46.763783 imi_mug_run_2_treatment "gleevec"
21 Q0 11943343 142 46.757744 imi_mug_run_2_treatment "basis"
21 Q0 19222892 143 46.748447 imi_mug_run_2_treatment "imatinib mesylate" "gleevec" "lead"
21 Q0 22855655 144 46.70838 imi_mug_run_2_treatment "imatinib mesylate" "liver"
21 Q0 22281391 145 46.70277 imi_mug_run_2_treatment "adjuvant" "imatinib" "sunitinib"
21 Q0 11300941 146 46.685905 imi_mug_run_2_treatment "various"
21 Q0 17729245 147 46.67762 imi_mug_run_2_treatment "imatinib" "sunitinib"
21 Q0 10835530 148 46.646484 imi_mug_run_2_treatment "arginine"
21 Q0 15005250 149 46.641487 imi_mug_run_2_treatment "liver"
21 Q0 19186237 150 46.635624 imi_mug_run_2_treatment "imatinib mesylate"
21 Q0 21688472 151 46.627075 imi_mug_run_2_treatment "imatinib"
21 Q0 16740725 152 46.57677 imi_mug_run_2_treatment "flavopiridol" "imatinib mesylate" "tyrosine"
21 Q0 15537379 153 46.548637 imi_mug_run_2_treatment "imatinib" "tyrosine kinase inhibitor"
21 Q0 23267143 154 46.44181 imi_mug_run_2_treatment "drugs" "imatinib" "sunitinib"
21 Q0 21975443 155 46.43529 imi_mug_run_2_treatment "adjuvant" "imatinib" "imatinib 400 mg"
21 Q0 22202260 156 46.302235 imi_mug_run_2_treatment "imatinib" "sunitinib"
21 Q0 27430179 157 46.27323 imi_mug_run_2_treatment "basis"
21 Q0 19620409 158 46.13022 imi_mug_run_2_treatment "imatinib"
21 Q0 16136600 159 46.12213 imi_mug_run_2_treatment "imatinib" "agent" "adjuvant"
21 Q0 23585972 160 46.117485 imi_mug_run_2_treatment "imatinib mesylate" "adjuvant" "tyrosine kinase inhibitor"
21 Q0 17325667 161 46.114292 imi_mug_run_2_treatment "kinase inhibitor" "tyrosine" "docetaxel"
21 Q0 16908864 162 46.10759 imi_mug_run_2_treatment "imatinib" "everolimus" "mtor inhibitor"
21 Q0 22015552 163 46.063995 imi_mug_run_2_treatment "imatinib" "drug" "kinase inhibitor"
21 Q0 17969814 164 45.90999 imi_mug_run_2_treatment "aim"
21 Q0 10702394 165 45.870037 imi_mug_run_2_treatment "lys" "glu"
21 Q0 11472565 166 45.83891 imi_mug_run_2_treatment "icc" "lead" "monoclonal antibodies"
21 Q0 11002369 167 45.796597 imi_mug_run_2_treatment "schiff"
21 Q0 18618605 168 45.788166 imi_mug_run_2_treatment "tandem"
21 Q0 21099240 169 45.784447 imi_mug_run_2_treatment "imatinib"
21 Q0 16398673 170 45.753513 imi_mug_run_2_treatment "various" "icc" "imatinib mesylate"
21 Q0 18525339 171 45.728245 imi_mug_run_2_treatment "imatinib" "adjuvant" "sunitinib"
21 Q0 11378651 172 45.721455 imi_mug_run_2_treatment "sti571" "tyrosine kinase inhibitor" "mast cell growth factor"
21 Q0 16438868 173 45.71052 imi_mug_run_2_treatment "various" "eosin"
21 Q0 17193819 174 45.683453 imi_mug_run_2_treatment "icc"
21 Q0 22202330 175 45.68311 imi_mug_run_2_treatment "imatinib"
21 Q0 12417503 176 45.66649 imi_mug_run_2_treatment "sti571" "agent"
21 Q0 16077968 177 45.611275 imi_mug_run_2_treatment "imatinib" "various"
21 Q0 12198577 178 45.543716 imi_mug_run_2_treatment "liver" "others"
21 Q0 15743318 179 45.53914 imi_mug_run_2_treatment "various"
21 Q0 15939196 180 45.529015 imi_mug_run_2_treatment "imatinib" "adjuvant" "imatinib mesylate"
21 Q0 20658364 181 45.52678 imi_mug_run_2_treatment "imatinib" "level"
21 Q0 20028860 182 45.49494 imi_mug_run_2_treatment "bortezomib" "imatinib" "mediated"
21 Q0 24159917 183 45.486263 imi_mug_run_2_treatment "adjuvant" "dioxin" "imatinib mesylate"
21 Q0 24925196 184 45.482903 imi_mug_run_2_treatment "imatinib" "sunitinib"
21 Q0 27249382 185 45.426075 imi_mug_run_2_treatment "aim"
21 Q0 24423961 186 45.361656 imi_mug_run_2_treatment "liver" "imatinib"
21 Q0 11073817 187 45.343197 imi_mug_run_2_treatment "lys" "glu" "interleukin-3"
21 Q0 14515284 188 45.328167 imi_mug_run_2_treatment "imatinib" "adjuvant" "glucose"
21 Q0 20165865 189 45.304237 imi_mug_run_2_treatment "imatinib" "sunitinib" "therapeutics"
21 Q0 26779618 190 45.258835 imi_mug_run_2_treatment "imatinib" "sunitinib"
21 Q0 16521203 191 45.22682 imi_mug_run_2_treatment "product"
21 Q0 25080996 192 45.220795 imi_mug_run_2_treatment "drugs" "new drugs" "aim"
21 Q0 11719439 193 45.217957 imi_mug_run_2_treatment "level"
21 Q0 21459336 194 45.14979 imi_mug_run_2_treatment "imatinib" "tyrosine kinase inhibitor"
21 Q0 18479530 195 45.129665 imi_mug_run_2_treatment "sti-571" "adjuvant" "liver"
21 Q0 11706520 196 45.114014 imi_mug_run_2_treatment "icc"
21 Q0 16607775 197 45.086872 imi_mug_run_2_treatment "glivec" "imatinib mesylate" "product"
21 Q0 16240136 198 45.047165 imi_mug_run_2_treatment "adjuvant" "imatinib mesylate" "liver"
21 Q0 22952296 199 45.03111 imi_mug_run_2_treatment "imatinib" "vascular endothelial growth factor"
21 Q0 12824897 200 45.01865 imi_mug_run_2_treatment "imatinib mesylate" "icc"
21 Q0 14717479 201 45.018013 imi_mug_run_2_treatment "imatinib mesylate" "tyrosine" "sti 571"
21 Q0 19239429 202 44.97969 imi_mug_run_2_treatment "drug"
21 Q0 19047110 203 44.978443 imi_mug_run_2_treatment "various" "imatinib"
21 Q0 23623056 204 44.96603 imi_mug_run_2_treatment "imatinib" "ras"
21 Q0 17874546 205 44.95383 imi_mug_run_2_treatment "liver"
21 Q0 12190287 206 44.950546 imi_mug_run_2_treatment "glutamine"
21 Q0 16723820 207 44.925377 imi_mug_run_2_treatment "gleevec" "imatinib mesylate"
21 Q0 21817899 208 44.918015 imi_mug_run_2_treatment "sunitinib" "imatinib" "vascular endothelial growth factor"
21 Q0 21418861 209 44.83219 imi_mug_run_2_treatment "mediated"
21 Q0 15703627 210 44.826523 imi_mug_run_2_treatment "imatinib mesylate" "adjuvant" "agent"
21 Q0 19010506 211 44.822716 imi_mug_run_2_treatment "imatinib"
21 Q0 18542042 212 44.80326 imi_mug_run_2_treatment "imatinib" "sti571" "lead"
21 Q0 20047122 213 44.795288 imi_mug_run_2_treatment "drug" "imatinib" "sunitinib"
21 Q0 12898363 214 44.769466 imi_mug_run_2_treatment "sti571" "tyrosine kinase inhibitor"
21 Q0 22764137 215 44.769283 imi_mug_run_2_treatment "suberoylanilide hydroxamic acid" "histone deacetylase inhibitor" "imatinib"
21 Q0 15188667 216 44.753002 imi_mug_run_2_treatment "imatinib" "adjuvant" "imatinib mesylate"
21 Q0 19802531 217 44.742893 imi_mug_run_2_treatment "tyrosine" "agent"
21 Q0 25525851 218 44.739273 imi_mug_run_2_treatment "imatinib" "prednisone"
21 Q0 16357454 219 44.735622 imi_mug_run_2_treatment "imatinib" "tyrosine kinase inhibitor"
21 Q0 23606918 220 44.735622 imi_mug_run_2_treatment "imatinib"
21 Q0 25143820 221 44.72076 imi_mug_run_2_treatment "rms"
21 Q0 15150562 222 44.70662 imi_mug_run_2_treatment "imatinib"
21 Q0 26396737 223 44.704453 imi_mug_run_2_treatment "kinase inhibitor" "sunitinib" "imatinib"
21 Q0 30142229 224 44.68131 imi_mug_run_2_treatment "kinase inhibitor" "drug" "imatinib"
21 Q0 16622539 225 44.646393 imi_mug_run_2_treatment "sti-571" "imatinib mesilate"
21 Q0 20662443 226 44.608448 imi_mug_run_2_treatment "aim"
21 Q0 16751810 227 44.589016 imi_mug_run_2_treatment "drug" "imatinib" "level"
21 Q0 23106360 228 44.56594 imi_mug_run_2_treatment "tyrosine"
21 Q0 19148515 229 44.52916 imi_mug_run_2_treatment "mediated" "therapeutics"
21 Q0 30488756 230 44.505375 imi_mug_run_2_treatment "kinase inhibitor" "mediated" "imatinib"
21 Q0 23326179 231 44.47751 imi_mug_run_2_treatment "adjuvant" "imatinib" "imatinib mesylate"
21 Q0 15480031 232 44.441193 imi_mug_run_2_treatment "various"
21 Q0 17573273 233 44.407955 imi_mug_run_2_treatment "sunitinib malate" "drug"
21 Q0 21873989 234 44.358517 imi_mug_run_2_treatment "imatinib" "immunosuppressive" "imatinib mesylate"
21 Q0 20231287 235 44.355026 imi_mug_run_2_treatment "imatinib"
21 Q0 24872712 236 44.340675 imi_mug_run_2_treatment "imatinib" "drug" "adjuvant"
21 Q0 15022111 237 44.33801 imi_mug_run_2_treatment "various" "gleevec" "imatinib"
21 Q0 23943029 238 44.329475 imi_mug_run_2_treatment "fluorophore"
21 Q0 16982758 239 44.31868 imi_mug_run_2_treatment "imatinib" "mediated"
21 Q0 25504284 240 44.29025 imi_mug_run_2_treatment "imatinib"
21 Q0 15656032 241 44.195988 imi_mug_run_2_treatment "imatinib" "adjuvant" "product"
21 Q0 17452978 242 44.19274 imi_mug_run_2_treatment "mediated" "pkc412" "imatinib"
21 Q0 29423012 243 44.18991 imi_mug_run_2_treatment "imatinib" "mediated"
21 Q0 25427437 244 44.17694 imi_mug_run_2_treatment "various" "imatinib"
21 Q0 15069768 245 44.17527 imi_mug_run_2_treatment "various" "icc" "sti571"
21 Q0 17363589 246 44.133633 imi_mug_run_2_treatment "imatinib" "imatinib mesylate" "mediated"
21 Q0 15095124 247 44.087597 imi_mug_run_2_treatment "imatinib" "adjuvant" "tyrosine"
21 Q0 15723656 248 44.046333 imi_mug_run_2_treatment "sti571" "glivec"
21 Q0 12411997 249 44.005173 imi_mug_run_2_treatment "liver"
21 Q0 16287112 250 44.003414 imi_mug_run_2_treatment "lead"
21 Q0 12181401 251 43.982796 imi_mug_run_2_treatment "imatinib" "drug" "imatinib mesylate"
21 Q0 18294292 252 43.92547 imi_mug_run_2_treatment "imatinib" "drug"
21 Q0 24154923 253 43.90284 imi_mug_run_2_treatment "imatinib mesylate"
21 Q0 17546049 254 43.8963 imi_mug_run_2_treatment "imatinib" "inositol"
21 Q0 28984483 255 43.854675 imi_mug_run_2_treatment "imatinib" "lead"
21 Q0 12744097 256 43.798317 imi_mug_run_2_treatment "generic" "tyrosine kinase inhibitor"
21 Q0 23661933 257 43.78765 imi_mug_run_2_treatment "liver"
21 Q0 29093181 258 43.786465 imi_mug_run_2_treatment "various" "blu-285" "drugs"
21 Q0 11914627 259 43.776943 imi_mug_run_2_treatment "sti-571" "biotin" "tyrosine"
21 Q0 18547614 260 43.744038 imi_mug_run_2_treatment "level"
21 Q0 21181476 261 43.727924 imi_mug_run_2_treatment "imatinib" "imatinib mesylate" "sunitinib"
21 Q0 29187943 262 43.705105 imi_mug_run_2_treatment "basis"
21 Q0 27846844 263 43.68399 imi_mug_run_2_treatment "genesis"
21 Q0 15095270 264 43.67166 imi_mug_run_2_treatment "others"
21 Q0 19562456 265 43.636684 imi_mug_run_2_treatment "liver" "imatinib"
21 Q0 18290694 266 43.632565 imi_mug_run_2_treatment "adjuvant" "fletcher" "imatinib"
21 Q0 29866822 267 43.630726 imi_mug_run_2_treatment "others"
21 Q0 15365079 268 43.56344 imi_mug_run_2_treatment "kinase inhibitor" "imatinib"
21 Q0 30523507 269 43.555836 imi_mug_run_2_treatment "plx9486" "pdx" "imatinib"
21 Q0 22932406 270 43.541496 imi_mug_run_2_treatment "imatinib mesylate" "sunitinib"
21 Q0 12739051 271 43.46614 imi_mug_run_2_treatment "imatinib" "tyrosine" "sti571"
21 Q0 16359540 272 43.44507 imi_mug_run_2_treatment "revolution"
21 Q0 12783584 273 43.44507 imi_mug_run_2_treatment "imatinib mesylate" "adjuvant" "gleevec"
21 Q0 15270663 274 43.42055 imi_mug_run_2_treatment "imatinib" "adjuvant" "gleevec"
21 Q0 18672547 275 43.40245 imi_mug_run_2_treatment "imatinib mesylate"
21 Q0 15112348 276 43.399513 imi_mug_run_2_treatment "aim"
21 Q0 14714258 277 43.39422 imi_mug_run_2_treatment "antral"
21 Q0 20489620 278 43.387005 imi_mug_run_2_treatment "plasma" "level" "imatinib"
21 Q0 26074249 279 43.362236 imi_mug_run_2_treatment "imatinib mesylate" "ile" "mct"
21 Q0 23057997 280 43.35714 imi_mug_run_2_treatment "basis"
21 Q0 17943734 281 43.298103 imi_mug_run_2_treatment "imatinib"
21 Q0 26184165 282 43.2976 imi_mug_run_2_treatment "drug" "medicine" "imatinib"
21 Q0 26893362 283 43.29501 imi_mug_run_2_treatment "mediated" "imatinib"
21 Q0 24867041 284 43.29441 imi_mug_run_2_treatment "antral"
21 Q0 25052916 285 43.292446 imi_mug_run_2_treatment "imatinib"
21 Q0 24749828 286 43.290215 imi_mug_run_2_treatment "imatinib" "tyrosine kinase inhibitor"
21 Q0 19139121 287 43.28872 imi_mug_run_2_treatment "imatinib" "tae226"
21 Q0 12475434 288 43.28251 imi_mug_run_2_treatment "eosin"
21 Q0 27842558 289 43.27848 imi_mug_run_2_treatment "melana"
21 Q0 18239881 290 43.26664 imi_mug_run_2_treatment "imatinib"
21 Q0 17178293 291 43.246933 imi_mug_run_2_treatment "imatinib" "adjuvant" "agent"
21 Q0 15967901 292 43.22777 imi_mug_run_2_treatment "ras"
21 Q0 20571340 293 43.219406 imi_mug_run_2_treatment "aim" "monoclonal antibodies"
21 Q0 28259173 294 43.212402 imi_mug_run_2_treatment "kinase inhibitor"
21 Q0 18671247 295 43.20112 imi_mug_run_2_treatment "ras" "imatinib" "lead"
21 Q0 16596277 296 43.19332 imi_mug_run_2_treatment "sti571" "glucose" "protein synthesis inhibitor"
21 Q0 15526368 297 43.174915 imi_mug_run_2_treatment "aim"
21 Q0 23087800 298 43.127563 imi_mug_run_2_treatment "generic"
21 Q0 22736916 299 43.119343 imi_mug_run_2_treatment "mediated" "biotin" "aim"
21 Q0 30015051 300 43.07107 imi_mug_run_2_treatment "histidine" "phenylalanine" "tyrosine"
21 Q0 20469993 301 43.047688 imi_mug_run_2_treatment "imatinib mesylate"
21 Q0 19154263 302 43.04714 imi_mug_run_2_treatment "hot spot"
21 Q0 18219926 303 43.043316 imi_mug_run_2_treatment "drug" "glivec" "imatinib"
21 Q0 10864354 304 43.020664 imi_mug_run_2_treatment "eosin"
21 Q0 12094370 305 42.984196 imi_mug_run_2_treatment "sti-571"
21 Q0 12075401 306 42.984196 imi_mug_run_2_treatment "sti-571"
21 Q0 16773696 307 42.972267 imi_mug_run_2_treatment "glivec" "imatinib mesylate" "aim"
21 Q0 16952044 308 42.956993 imi_mug_run_2_treatment "imatinib"
21 Q0 18382354 309 42.945465 imi_mug_run_2_treatment "basis"
21 Q0 19469547 310 42.942696 imi_mug_run_2_treatment "imatinib"
21 Q0 17625442 311 42.92785 imi_mug_run_2_treatment "imatinib" "gleevec"
21 Q0 10934966 312 42.894627 imi_mug_run_2_treatment "icc" "liver"
21 Q0 19164557 313 42.84797 imi_mug_run_2_treatment "sunitinib" "imatinib" "imatinib mesylate"
21 Q0 21613800 314 42.833458 imi_mug_run_2_treatment "product" "level"
21 Q0 18575421 315 42.815147 imi_mug_run_2_treatment "various"
21 Q0 21599631 316 42.813377 imi_mug_run_2_treatment "imatinib" "drugs" "anti-angiogenic agents"
21 Q0 22535506 317 42.81021 imi_mug_run_2_treatment "adjuvant" "imatinib" "tyrosine kinase inhibitor"
21 Q0 11074645 318 42.800785 imi_mug_run_2_treatment "icc"
21 Q0 28074523 319 42.799706 imi_mug_run_2_treatment "imatinib"
21 Q0 23001300 320 42.79913 imi_mug_run_2_treatment "tyr" "imatinib mesylate"
21 Q0 16534250 321 42.79579 imi_mug_run_2_treatment "imatinib" "amn107" "agent"
21 Q0 23224721 322 42.75561 imi_mug_run_2_treatment "imatinib" "imatinib mesylate"
21 Q0 22454158 323 42.737507 imi_mug_run_2_treatment "sunitinib" "drugs" "imatinib"
21 Q0 18648736 324 42.732964 imi_mug_run_2_treatment "various" "imatinib" "imatinib mesylate"
21 Q0 20660757 325 42.717888 imi_mug_run_2_treatment "antimalarial" "imatinib" "antimalarials"
21 Q0 18041915 326 42.715332 imi_mug_run_2_treatment "sti-571" "gleevec" "imatinib"
21 Q0 19417561 327 42.708874 imi_mug_run_2_treatment "imatinib"
21 Q0 27628557 328 42.707603 imi_mug_run_2_treatment "imatinib" "imatinib mesylate"
21 Q0 21054898 329 42.687214 imi_mug_run_2_treatment "gleevec" "imatinib mesylate"
21 Q0 22202277 330 42.680717 imi_mug_run_2_treatment "imatinib 400 mg"
21 Q0 17396139 331 42.651833 imi_mug_run_2_treatment "imatinib" "rad001" "drugs"
21 Q0 15553717 332 42.59625 imi_mug_run_2_treatment "sti571" "imatinib mesylate" "gleevec"
21 Q0 12727838 333 42.592636 imi_mug_run_2_treatment "matrix"
21 Q0 18757323 334 42.563354 imi_mug_run_2_treatment "various" "basis" "icc"
21 Q0 15043466 335 42.563354 imi_mug_run_2_treatment "sti571"
21 Q0 21825009 336 42.559616 imi_mug_run_2_treatment "ipi-504" "imatinib" "sunitinib"
21 Q0 27163723 337 42.539658 imi_mug_run_2_treatment "adjuvant" "drugs" "imatinib"
21 Q0 14699510 338 42.53179 imi_mug_run_2_treatment "tyrosine"
21 Q0 15549490 339 42.529545 imi_mug_run_2_treatment "imatinib"
21 Q0 21717788 340 42.509525 imi_mug_run_2_treatment "imatinib" "adjuvant" "sunitinib"
21 Q0 26678977 341 42.492523 imi_mug_run_2_treatment "various"
21 Q0 17706113 342 42.487007 imi_mug_run_2_treatment "various"
21 Q0 19283922 343 42.458153 imi_mug_run_2_treatment "imatinib" "adjuvant" "drugs"
21 Q0 19013895 344 42.449997 imi_mug_run_2_treatment "drug" "imatinib" "imatinib mesylate"
21 Q0 23268086 345 42.431038 imi_mug_run_2_treatment "imatinib"
21 Q0 22542728 346 42.423 imi_mug_run_2_treatment "imatinib" "avid" "liver"
21 Q0 16052979 347 42.3693 imi_mug_run_2_treatment "imatinib mesylate" "tyrosine kinase inhibitor"
21 Q0 19011564 348 42.30755 imi_mug_run_2_treatment "mouse monoclonal antibody"
21 Q0 18521245 349 42.30273 imi_mug_run_2_treatment "product"
21 Q0 30159192 350 42.302513 imi_mug_run_2_treatment "imatinib mesylate"
21 Q0 29885053 351 42.245556 imi_mug_run_2_treatment "imatinib" "kinase inhibitor" "imatinib mesylate"
21 Q0 25722316 352 42.23088 imi_mug_run_2_treatment "liver"
21 Q0 25182956 353 42.22668 imi_mug_run_2_treatment "imatinib" "ras" "lead"
21 Q0 18488000 354 42.20764 imi_mug_run_2_treatment "lead"
21 Q0 14645423 355 42.175076 imi_mug_run_2_treatment "imatinib" "imatinib mesylate"
21 Q0 15750190 356 42.155937 imi_mug_run_2_treatment "imatinib mesylate" "imatinib" "agent"
21 Q0 19737953 357 42.143124 imi_mug_run_2_treatment "sunitinib" "imatinib" "plasma"
21 Q0 22069175 358 42.135414 imi_mug_run_2_treatment "imatinib" "tyrosine"
21 Q0 15471430 359 42.13082 imi_mug_run_2_treatment "gold"
21 Q0 18483389 360 42.094097 imi_mug_run_2_treatment "imatinib" "sunitinib" "dasatinib"
21 Q0 18724244 361 42.080765 imi_mug_run_2_treatment "tyrosine"
21 Q0 16610057 362 42.070473 imi_mug_run_2_treatment "imatinib mesylate" "glivec" "duration"
21 Q0 15946589 363 42.055134 imi_mug_run_2_treatment "imatinib" "drugs" "sti571"
21 Q0 15966213 364 42.04841 imi_mug_run_2_treatment "imatinib" "drug"
21 Q0 26098203 365 42.009907 imi_mug_run_2_treatment "drugs" "imatinib mesylate" "new drugs"
21 Q0 29760538 366 41.984665 imi_mug_run_2_treatment "adjuvant" "imatinib" "medicine"
21 Q0 27864817 367 41.972294 imi_mug_run_2_treatment "nilotinib" "imatinib"
21 Q0 15822120 368 41.97209 imi_mug_run_2_treatment "imatinib"
21 Q0 22379899 369 41.970623 imi_mug_run_2_treatment "adjuvant"
21 Q0 19917964 370 41.968006 imi_mug_run_2_treatment "imatinib" "imatinib mesylate"
21 Q0 22714264 371 41.9329 imi_mug_run_2_treatment "at13387" "imatinib" "hsp70"
21 Q0 21586885 372 41.931526 imi_mug_run_2_treatment "imatinib mesylate" "imatinib"
21 Q0 24575748 373 41.931526 imi_mug_run_2_treatment "imatinib" "adjuvant"
21 Q0 19968734 374 41.92101 imi_mug_run_2_treatment "imatinib" "drug" "adjuvant"
21 Q0 16231822 375 41.913544 imi_mug_run_2_treatment "st1571"
21 Q0 12672043 376 41.90588 imi_mug_run_2_treatment "imatinib" "various"
21 Q0 17101067 377 41.888454 imi_mug_run_2_treatment "level"
21 Q0 12938260 378 41.844723 imi_mug_run_2_treatment "drug" "glivec" "sti571"
21 Q0 17659849 379 41.84472 imi_mug_run_2_treatment "various" "imatinib" "macrophage colony stimulating factor"
21 Q0 14682111 380 41.822548 imi_mug_run_2_treatment "imatinib mesylate" "adjuvant" "gleevec"
21 Q0 26396718 381 41.818142 imi_mug_run_2_treatment "liver"
21 Q0 29552659 382 41.80613 imi_mug_run_2_treatment "imatinib mesylate"
21 Q0 20575602 383 41.782158 imi_mug_run_2_treatment "imatinib"
21 Q0 23576565 384 41.77382 imi_mug_run_2_treatment "calcium" "antiangiogenic" "imatinib"
21 Q0 21641899 385 41.77282 imi_mug_run_2_treatment "imatinib mesylate"
21 Q0 25741171 386 41.77282 imi_mug_run_2_treatment "imatinib mesylate" "liver" "imatinib"
21 Q0 23746188 387 41.77282 imi_mug_run_2_treatment "imatinib" "aim"
21 Q0 22815156 388 41.770664 imi_mug_run_2_treatment "imatinib"
21 Q0 28900984 389 41.76255 imi_mug_run_2_treatment "imatinib mesylate" "blockade"
21 Q0 12057170 390 41.744404 imi_mug_run_2_treatment "combinations" "product" "liver"
21 Q0 21140148 391 41.720078 imi_mug_run_2_treatment "plasma" "level" "imatinib"
21 Q0 12424067 392 41.71672 imi_mug_run_2_treatment "imatinib mesylate" "drug" "level"
21 Q0 10199467 393 41.71234 imi_mug_run_2_treatment "icc" "formalin"
21 Q0 25865047 394 41.68814 imi_mug_run_2_treatment "icc" "crenolanib" "imatinib"
21 Q0 27263309 395 41.663204 imi_mug_run_2_treatment "various"
21 Q0 22866129 396 41.580685 imi_mug_run_2_treatment "imatinib"
21 Q0 20011313 397 41.579197 imi_mug_run_2_treatment "imatinib mesylate" "tyrosine kinase inhibitor"
21 Q0 26839131 398 41.54387 imi_mug_run_2_treatment "various" "basis"
21 Q0 17419150 399 41.538963 imi_mug_run_2_treatment "imatinib" "drug" "pkc412"
21 Q0 22189238 400 41.527817 imi_mug_run_2_treatment "melan-a" "imatinib mesylate"
21 Q0 22652566 401 41.500355 imi_mug_run_2_treatment "imatinib" "drug" "sunitinib"
21 Q0 19319646 402 41.489895 imi_mug_run_2_treatment "liver"
21 Q0 15131046 403 41.47288 imi_mug_run_2_treatment "amino acid"
21 Q0 21277730 404 41.44997 imi_mug_run_2_treatment "imatinib" "adjuvant" "tcc"
21 Q0 25375091 405 41.447166 imi_mug_run_2_treatment "mediated" "imatinib" "mtor inhibitor"
21 Q0 25313780 406 41.43193 imi_mug_run_2_treatment "imatinib" "adjuvant"
21 Q0 12053473 407 41.418724 imi_mug_run_2_treatment "basis" "aim" "liver"
21 Q0 20799000 408 41.40488 imi_mug_run_2_treatment "imatinib" "basis"
21 Q0 16629079 409 41.396103 imi_mug_run_2_treatment "imatinib" "gleevec" "product"
21 Q0 12689667 410 41.396103 imi_mug_run_2_treatment "lead"
21 Q0 21355183 411 41.332222 imi_mug_run_2_treatment "imatinib"
21 Q0 27965460 412 41.328102 imi_mug_run_2_treatment "imatinib" "drug" "mediated"
21 Q0 24507750 413 41.31823 imi_mug_run_2_treatment "drugs" "pdx" "imatinib"
21 Q0 25781619 414 41.303917 imi_mug_run_2_treatment "glucose" "imatinib" "deoxyglucose"
21 Q0 30098596 415 41.299973 imi_mug_run_2_treatment "adjuvant" "imatinib mesylate"
21 Q0 18416137 416 41.2865 imi_mug_run_2_treatment "aminoacids"
21 Q0 24847623 417 41.27732 imi_mug_run_2_treatment "imatinib"
21 Q0 11831069 418 41.2252 imi_mug_run_2_treatment "glivec" "various" "imatinib"
21 Q0 24783183 419 41.215145 imi_mug_run_2_treatment "sunitinib" "imatinib"
21 Q0 15796874 420 41.214157 imi_mug_run_2_treatment "fletcher's"
21 Q0 25717425 421 41.211914 imi_mug_run_2_treatment "lead"
21 Q0 28900071 422 41.191875 imi_mug_run_2_treatment "insulin" "medicine" "igfbp-3"
21 Q0 12354362 423 41.18623 imi_mug_run_2_treatment "imatinib" "imatinib mesylate"
21 Q0 22333644 424 41.164146 imi_mug_run_2_treatment "imatinib mesilate"
21 Q0 21302230 425 41.164146 imi_mug_run_2_treatment "imatinib mesylate"
21 Q0 24451814 426 41.1562 imi_mug_run_2_treatment "imatinib" "adjuvant" "ssg"
21 Q0 23133091 427 41.15012 imi_mug_run_2_treatment "imatinib mesylate" "tyrosine kinase inhibitor"
21 Q0 12781070 428 41.146423 imi_mug_run_2_treatment "imatinib" "drug" "imatinib mesylate"
21 Q0 25684950 429 41.141365 imi_mug_run_2_treatment "imatinib" "adjuvant" "aim"
21 Q0 25737303 430 41.11349 imi_mug_run_2_treatment "bortezomib" "proteasome inhibitor" "dasatinib"
21 Q0 16143141 431 41.09497 imi_mug_run_2_treatment "drugs" "imatinib mesylate" "tyrosine kinase inhibitor"
21 Q0 15750270 432 41.09397 imi_mug_run_2_treatment "imatinib mesylate" "liver"
21 Q0 12704441 433 41.084114 imi_mug_run_2_treatment "imatinib" "glivec" "basis"
21 Q0 15742474 434 41.082783 imi_mug_run_2_treatment "glutamine" "leucine"
21 Q0 20976730 435 41.0807 imi_mug_run_2_treatment "imatinib mesylate"
21 Q0 17147087 436 41.03355 imi_mug_run_2_treatment "imatinib" "tyrosine kinase inhibitor"
21 Q0 23196876 437 41.02497 imi_mug_run_2_treatment "imatinib" "tyrosine kinase inhibitor" "auy922"
21 Q0 15930355 438 40.985115 imi_mug_run_2_treatment "imatinib" "drug" "tyrosine kinase inhibitor"
21 Q0 29220298 439 40.98205 imi_mug_run_2_treatment "imatinib" "sunitinib" "tyrosine kinase inhibitor"
21 Q0 25473890 440 40.93831 imi_mug_run_2_treatment "various" "imatinib"
21 Q0 30126859 441 40.919563 imi_mug_run_2_treatment "imatinib"
21 Q0 15223958 442 40.918877 imi_mug_run_2_treatment "imatinib"
21 Q0 19386957 443 40.91346 imi_mug_run_2_treatment "new drugs"
21 Q0 9916914 444 40.909832 imi_mug_run_2_treatment "monoclonal antibodies"
21 Q0 11751374 445 40.86055 imi_mug_run_2_treatment "sti571" "tyrosine kinase inhibitor" "lead"
21 Q0 18496660 446 40.847004 imi_mug_run_2_treatment "mediated"
21 Q0 16552495 447 40.828266 imi_mug_run_2_treatment "adjuvant" "basis"
21 Q0 28027118 448 40.82426 imi_mug_run_2_treatment "imatinib" "adjuvant"
21 Q0 18477213 449 40.79081 imi_mug_run_2_treatment "aim"
21 Q0 23936759 450 40.787254 imi_mug_run_2_treatment "gleevec" "imatinib mesylate"
21 Q0 17867582 451 40.769352 imi_mug_run_2_treatment "imatinib" "su 11248" "tyrosine kinase inhibitor"
21 Q0 27123077 452 40.73578 imi_mug_run_2_treatment "imatinib"
21 Q0 24129766 453 40.722225 imi_mug_run_2_treatment "aim"
21 Q0 22307903 454 40.722008 imi_mug_run_2_treatment "air"
21 Q0 19593621 455 40.720497 imi_mug_run_2_treatment "imatinib mesylate" "liver"
21 Q0 17419245 456 40.711582 imi_mug_run_2_treatment "aim"
21 Q0 30280421 457 40.693386 imi_mug_run_2_treatment "various"
21 Q0 18080227 458 40.689472 imi_mug_run_2_treatment "eosin" "product"
21 Q0 28988501 459 40.674305 imi_mug_run_2_treatment "drug" "sts" "imatinib"
21 Q0 18085368 460 40.650475 imi_mug_run_2_treatment "imatinib" "imatinib mesylate" "liver"
21 Q0 17632543 461 40.6488 imi_mug_run_2_treatment "imatinib"
21 Q0 16167230 462 40.6438 imi_mug_run_2_treatment "eosin"
21 Q0 15689683 463 40.63114 imi_mug_run_2_treatment "imatinib" "therapeutic agent"
21 Q0 19491525 464 40.596226 imi_mug_run_2_treatment "diuretics" "oxygen"
21 Q0 29424982 465 40.587513 imi_mug_run_2_treatment "imatinib" "air"
21 Q0 19496720 466 40.57309 imi_mug_run_2_treatment "imatinib" "imatinib 400 mg" "sunitinib 50 mg"
21 Q0 24997326 467 40.57164 imi_mug_run_2_treatment "imatinib"
21 Q0 26617916 468 40.569946 imi_mug_run_2_treatment "imatinib mesylate"
21 Q0 20180084 469 40.568962 imi_mug_run_2_treatment "imatinib"
21 Q0 16551858 470 40.531273 imi_mug_run_2_treatment "imatinib" "glivec" "imatinib mesylate"
21 Q0 17255767 471 40.48945 imi_mug_run_2_treatment "aim"
21 Q0 30128077 472 40.476067 imi_mug_run_2_treatment "drug" "therapeutic agents"
21 Q0 26297068 473 40.472908 imi_mug_run_2_treatment "others"
21 Q0 20725786 474 40.454185 imi_mug_run_2_treatment "various" "imatinib"
21 Q0 17032555 475 40.443848 imi_mug_run_2_treatment "imatinib" "adjuvant" "sunitinib"
21 Q0 19360154 476 40.428642 imi_mug_run_2_treatment "imatinib" "drug" "sunitinib"
21 Q0 23036227 477 40.427765 imi_mug_run_2_treatment "various" "imatinib" "sunitinib"
21 Q0 10937062 478 40.423958 imi_mug_run_2_treatment "icc"
21 Q0 19949796 479 40.393497 imi_mug_run_2_treatment "drug" "glivec" "imatinib"
21 Q0 27011036 480 40.3908 imi_mug_run_2_treatment "liver"
21 Q0 20533592 481 40.386543 imi_mug_run_2_treatment "various" "imatinib" "sunitinib"
21 Q0 25926077 482 40.3846 imi_mug_run_2_treatment "agent" "imatinib" "sunitinib"
21 Q0 17253167 483 40.36026 imi_mug_run_2_treatment "various" "eosin"
21 Q0 18955458 484 40.35797 imi_mug_run_2_treatment "sunitinib" "imatinib"
21 Q0 17591808 485 40.350517 imi_mug_run_2_treatment "imatinib mesylate" "kinase inhibitor" "tyrosine"
21 Q0 18636362 486 40.345478 imi_mug_run_2_treatment "tandem"
21 Q0 18312355 487 40.321358 imi_mug_run_2_treatment "imatinib" "sunitinib" "tyrosine kinase inhibitor"
21 Q0 28535771 488 40.31843 imi_mug_run_2_treatment "lead"
21 Q0 28915565 489 40.31149 imi_mug_run_2_treatment "aim"
21 Q0 17064855 490 40.304142 imi_mug_run_2_treatment "tyrosine" "sti571" "gleevec"
21 Q0 22572723 491 40.304142 imi_mug_run_2_treatment "various" "imatinib" "adjuvant"
21 Q0 17359292 492 40.301872 imi_mug_run_2_treatment "imatinib"
21 Q0 21284869 493 40.293198 imi_mug_run_2_treatment "aim" "fletcher's"
21 Q0 30392567 494 40.2753 imi_mug_run_2_treatment "cck-8" "mediated"
21 Q0 17072721 495 40.245647 imi_mug_run_2_treatment "sti571" "glivec" "imatinib mesylate"
21 Q0 19260254 496 40.23227 imi_mug_run_2_treatment "medication" "imatinib mesylate" "tyrosine kinase inhibitor"
21 Q0 20079191 497 40.23026 imi_mug_run_2_treatment "imatinib mesylate" "glivec" "shape"
21 Q0 26587973 498 40.208168 imi_mug_run_2_treatment "imatinib" "drug"
21 Q0 26672673 499 40.183002 imi_mug_run_2_treatment "imatinib" "adjuvant" "drugs"
21 Q0 28488171 500 40.166985 imi_mug_run_2_treatment "imatinib" "aim"
21 Q0 22993368 501 40.129456 imi_mug_run_2_treatment "sunitinib" "adjuvant" "imatinib"
21 Q0 15236194 502 40.109104 imi_mug_run_2_treatment "imatinib" "drug" "tyrosine kinase inhibitor"
21 Q0 15070666 503 40.107727 imi_mug_run_2_treatment "imatinib" "imatinib mesylate" "vascular endothelial growth factor"
21 Q0 24392185 504 40.09875 imi_mug_run_2_treatment "imatinib"
21 Q0 26112683 505 40.08011 imi_mug_run_2_treatment "adjuvant" "imatinib"
21 Q0 26730087 506 40.071426 imi_mug_run_2_treatment "aim"
21 Q0 18629782 507 40.067604 imi_mug_run_2_treatment "imatinib" "adjuvant" "drugs"
21 Q0 12354363 508 40.056683 imi_mug_run_2_treatment "imatinib" "imatinib mesylate" "tyrosine kinase inhibitor"
21 Q0 30403169 509 40.056644 imi_mug_run_2_treatment "drug" "drugs" "imatinib"
21 Q0 20081808 510 40.03125 imi_mug_run_2_treatment "various"
21 Q0 23935374 511 40.02802 imi_mug_run_2_treatment "imatinib" "adjuvant" "tyrosine kinase inhibitor"
21 Q0 22728491 512 40.012386 imi_mug_run_2_treatment "imatinib mesylate"
21 Q0 20551067 513 39.99988 imi_mug_run_2_treatment "imatinib" "drug" "fty720"
21 Q0 15976351 514 39.989548 imi_mug_run_2_treatment "imatinib" "basis"
21 Q0 29394756 515 39.98388 imi_mug_run_2_treatment "imatinib"
21 Q0 29245294 516 39.981873 imi_mug_run_2_treatment "imatinib" "imatinib mesylate"
21 Q0 27077705 517 39.981846 imi_mug_run_2_treatment "drug" "kinase inhibitor" "chmfl-kit-110"
21 Q0 16402362 518 39.981773 imi_mug_run_2_treatment "fibrinogen"
21 Q0 16910417 519 39.980034 imi_mug_run_2_treatment "imatinib mesylate" "duration"
21 Q0 17824795 520 39.97869 imi_mug_run_2_treatment "imatinib"
21 Q0 25836719 521 39.9469 imi_mug_run_2_treatment "crizotinib" "cabozantinib" "imatinib"
21 Q0 28478525 522 39.90459 imi_mug_run_2_treatment "imatinib" "sunitinib" "regorafenib"
21 Q0 28541695 523 39.900642 imi_mug_run_2_treatment "various" "imatinib" "liver"
21 Q0 25202087 524 39.872177 imi_mug_run_2_treatment "sunitinib" "imatinib" "imatinib mesylate"
21 Q0 24678982 525 39.841606 imi_mug_run_2_treatment "level"
21 Q0 20166214 526 39.841606 imi_mug_run_2_treatment "imatinib"
21 Q0 22454169 527 39.841606 imi_mug_run_2_treatment "imatinib"
21 Q0 22110419 528 39.841503 imi_mug_run_2_treatment "imatinib mesylate"
21 Q0 16865518 529 39.83416 imi_mug_run_2_treatment "imatinib" "imatinib mesylate"
21 Q0 12649674 530 39.820988 imi_mug_run_2_treatment "sti-571"
21 Q0 28549261 531 39.801815 imi_mug_run_2_treatment "imatinib"
21 Q0 15693434 532 39.788963 imi_mug_run_2_treatment "gleevec" "imatinib mesylate" "basis"
21 Q0 22454176 533 39.781174 imi_mug_run_2_treatment "imatinib"
21 Q0 16143881 534 39.77751 imi_mug_run_2_treatment "imatinib" "imatinib mesylate" "tyrosine kinase inhibitor"
21 Q0 17211292 535 39.776367 imi_mug_run_2_treatment "imatinib mesylate" "tyrosine kinase inhibitor" "liver"
21 Q0 17498562 536 39.773262 imi_mug_run_2_treatment "lead" "level"
21 Q0 16126886 537 39.76384 imi_mug_run_2_treatment "lead"
21 Q0 25741136 538 39.759075 imi_mug_run_2_treatment "imatinib" "lead"
21 Q0 26049274 539 39.748238 imi_mug_run_2_treatment "interferon" "drug" "imatinib"
21 Q0 24361761 540 39.74376 imi_mug_run_2_treatment "drug" "tyrosine kinase inhibitor" "imatinib"
21 Q0 17427641 541 39.736668 imi_mug_run_2_treatment "medication" "imatinib"
21 Q0 17256558 542 39.706417 imi_mug_run_2_treatment "imatinib" "adjuvant" "glivec"
21 Q0 18183595 543 39.69359 imi_mug_run_2_treatment "imatinib"
21 Q0 21461555 544 39.69359 imi_mug_run_2_treatment "various"
21 Q0 15283152 545 39.67161 imi_mug_run_2_treatment "drug" "imatinib" "imatinib mesylate"
21 Q0 15161681 546 39.662834 imi_mug_run_2_treatment "various" "drug" "level"
21 Q0 17673922 547 39.662834 imi_mug_run_2_treatment "aim"
21 Q0 18525340 548 39.662098 imi_mug_run_2_treatment "imatinib"
21 Q0 21934616 549 39.637943 imi_mug_run_2_treatment "adjuvant" "imatinib"
21 Q0 23852704 550 39.62179 imi_mug_run_2_treatment "trastuzumab" "aim"
21 Q0 27446428 551 39.600483 imi_mug_run_2_treatment "aim"
21 Q0 25940166 552 39.543076 imi_mug_run_2_treatment "drugs"
21 Q0 16778826 553 39.536472 imi_mug_run_2_treatment "imatinib mesylate" "kinase inhibitor" "mediated"
21 Q0 27771813 554 39.533432 imi_mug_run_2_treatment "imatinib"
21 Q0 19935059 555 39.51315 imi_mug_run_2_treatment "antral" "liver"
21 Q0 21410049 556 39.508488 imi_mug_run_2_treatment "aim"
21 Q0 16521182 557 39.49823 imi_mug_run_2_treatment "sti571" "vascular endothelial growth factor" "glivec"
21 Q0 26034378 558 39.492973 imi_mug_run_2_treatment "imatinib"
21 Q0 20442644 559 39.478035 imi_mug_run_2_treatment "adjuvant" "imatinib mesylate"
21 Q0 20009472 560 39.476017 imi_mug_run_2_treatment "imatinib" "imatinib mesilate"
21 Q0 16732863 561 39.43988 imi_mug_run_2_treatment "glivec" "imatinib"
21 Q0 20535017 562 39.435394 imi_mug_run_2_treatment "imatinib" "agent" "tyrosine kinase inhibitor"
21 Q0 26631948 563 39.433846 imi_mug_run_2_treatment "tandem" "aim"
21 Q0 30181783 564 39.431564 imi_mug_run_2_treatment "imatinib" "sunitinib" "regorafenib"
21 Q0 16291174 565 39.430496 imi_mug_run_2_treatment "imatinib" "imatinib mesylate" "product"
21 Q0 23307090 566 39.42206 imi_mug_run_2_treatment "tyrosine"
21 Q0 15145718 567 39.41684 imi_mug_run_2_treatment "imatinib"
21 Q0 26743300 568 39.414867 imi_mug_run_2_treatment "maspin"
21 Q0 21483516 569 39.414867 imi_mug_run_2_treatment "imatinib" "imatinib mesylate" "duration"
21 Q0 27793025 570 39.412186 imi_mug_run_2_treatment "icc" "imatinib" "mediated"
21 Q0 12483251 571 39.40744 imi_mug_run_2_treatment "somatostatin"
21 Q0 20361266 572 39.375362 imi_mug_run_2_treatment "imatinib mesylate" "sunitinib malate"
21 Q0 24451815 573 39.37066 imi_mug_run_2_treatment "tyrosine kinase inhibitor"
21 Q0 28710566 574 39.359497 imi_mug_run_2_treatment "imatinib" "adjuvant"
21 Q0 15897563 575 39.331573 imi_mug_run_2_treatment "imatinib mesylate" "imatinib" "tyrosine kinase inhibitor"
21 Q0 29175467 576 39.326492 imi_mug_run_2_treatment "imatinib" "radiochemical" "tyrosine kinase inhibitor"
21 Q0 21116624 577 39.320152 imi_mug_run_2_treatment "sunitinib" "tyrosine kinase inhibitor" "imatinib"
21 Q0 18521081 578 39.314983 imi_mug_run_2_treatment "imatinib" "kinase inhibitor" "mediated"
21 Q0 19542718 579 39.266075 imi_mug_run_2_treatment "imatinib" "imatinib mesilate"
21 Q0 19690756 580 39.26145 imi_mug_run_2_treatment "imatinib"
21 Q0 20598160 581 39.251747 imi_mug_run_2_treatment "imatinib"
21 Q0 11977548 582 39.241257 imi_mug_run_2_treatment "sti571" "tyrosine kinase inhibitor"
21 Q0 15101081 583 39.241257 imi_mug_run_2_treatment "imatinib mesylate" "liver"
21 Q0 16928224 584 39.231388 imi_mug_run_2_treatment "aim"
21 Q0 28398518 585 39.225235 imi_mug_run_2_treatment "drug" "agent"
21 Q0 24743291 586 39.2138 imi_mug_run_2_treatment "imatinib mesylate"
21 Q0 16537295 587 39.205112 imi_mug_run_2_treatment "liver"
21 Q0 22800481 588 39.205112 imi_mug_run_2_treatment "imatinib"
21 Q0 21566432 589 39.20064 imi_mug_run_2_treatment "imatinib" "imatinib mesylate" "sunitinib"
21 Q0 15991300 590 39.196632 imi_mug_run_2_treatment "aim"
21 Q0 26298631 591 39.184547 imi_mug_run_2_treatment "icc"
21 Q0 16996566 592 39.18293 imi_mug_run_2_treatment "eosin"
21 Q0 28975117 593 39.175655 imi_mug_run_2_treatment "imatinib" "sunitinib" "pazopanib"
21 Q0 16570044 594 39.17512 imi_mug_run_2_treatment "aim"
21 Q0 10782882 595 39.168304 imi_mug_run_2_treatment "icc" "aim"
21 Q0 23592754 596 39.147 imi_mug_run_2_treatment "imatinib mesylate" "kinase inhibitor"
21 Q0 17802947 597 39.138943 imi_mug_run_2_treatment "tyrosine" "imatinib mesylate" "shape"
21 Q0 19333543 598 39.13459 imi_mug_run_2_treatment "icc"
21 Q0 17437861 599 39.12422 imi_mug_run_2_treatment "imatinib" "sunitinib"
21 Q0 19706776 600 39.12422 imi_mug_run_2_treatment "imatinib" "saha" "lbh589"
21 Q0 27633918 601 39.10294 imi_mug_run_2_treatment "various" "antineoplastic" "nh2"
21 Q0 19430004 602 39.0863 imi_mug_run_2_treatment "imatinib" "sunitinib" "adjuvant"
21 Q0 16952848 603 39.066654 imi_mug_run_2_treatment "drug" "imatinib" "others"
21 Q0 21319869 604 39.055645 imi_mug_run_2_treatment "adjuvant" "drugs" "imatinib"
21 Q0 24369323 605 39.02224 imi_mug_run_2_treatment "imatinib"
21 Q0 15853160 606 38.99893 imi_mug_run_2_treatment "drug" "imatinib" "imatinib mesylate"
21 Q0 18235442 607 38.961243 imi_mug_run_2_treatment "drug" "imatinib" "drugs"
21 Q0 19139124 608 38.961117 imi_mug_run_2_treatment "sorafenib" "imatinib" "sunitinib"
21 Q0 12094373 609 38.960884 imi_mug_run_2_treatment "various" "sti-571"
21 Q0 12094371 610 38.947277 imi_mug_run_2_treatment "sti-571" "tyrosine"
21 Q0 21772112 611 38.938736 imi_mug_run_2_treatment "imatinib" "medicine" "imatinib 400 mg"
21 Q0 17295594 612 38.935062 imi_mug_run_2_treatment "imatinib mesylate"
21 Q0 25674291 613 38.93171 imi_mug_run_2_treatment "cisplatin"
21 Q0 23751846 614 38.902767 imi_mug_run_2_treatment "kinase inhibitor" "adjuvant"
21 Q0 16699280 615 38.895893 imi_mug_run_2_treatment "imatinib mesylate" "tyrosine" "glivec"
21 Q0 26805230 616 38.867485 imi_mug_run_2_treatment "imatinib"
21 Q0 22584344 617 38.867485 imi_mug_run_2_treatment "imatinib mesylate"
21 Q0 17986244 618 38.815475 imi_mug_run_2_treatment "lead"
21 Q0 23423603 619 38.815426 imi_mug_run_2_treatment "imatinib"
21 Q0 16498290 620 38.796257 imi_mug_run_2_treatment "imatinib"
21 Q0 23041331 621 38.77599 imi_mug_run_2_treatment "lysozyme" "drug" "imatinib"
21 Q0 9797363 622 38.759644 imi_mug_run_2_treatment "lys" "il-3" "aim"
21 Q0 25831232 623 38.759644 imi_mug_run_2_treatment "ras" "imatinib"
21 Q0 11035578 624 38.751896 imi_mug_run_2_treatment "icc" "liver" "monoclonal antibodies"
21 Q0 28192400 625 38.751255 imi_mug_run_2_treatment "imatinib" "drug" "tyrosine"
21 Q0 15221987 626 38.742657 imi_mug_run_2_treatment "adjuvant" "imatinib mesylate"
21 Q0 16795978 627 38.736908 imi_mug_run_2_treatment "imatinib mesilate"
21 Q0 24760634 628 38.71314 imi_mug_run_2_treatment "imatinib" "sunitinib" "pazopanib"
21 Q0 17532173 629 38.70785 imi_mug_run_2_treatment "various" "imatinib"
21 Q0 14606094 630 38.70785 imi_mug_run_2_treatment "aim"
21 Q0 20927104 631 38.70785 imi_mug_run_2_treatment "program" "icc" "imatinib"
21 Q0 16397744 632 38.691814 imi_mug_run_2_treatment "basis"
21 Q0 21177210 633 38.668983 imi_mug_run_2_treatment "glivec" "imatinib mesylate" "liver"
21 Q0 20946519 634 38.667557 imi_mug_run_2_treatment "tma"
21 Q0 16966028 635 38.664196 imi_mug_run_2_treatment "imatinib mesylate" "aim"
21 Q0 23295309 636 38.66286 imi_mug_run_2_treatment "level"
21 Q0 23468260 637 38.661762 imi_mug_run_2_treatment "basis" "aim" "monoclonal antibodies"
21 Q0 26805228 638 38.65128 imi_mug_run_2_treatment "s-1" "imatinib"
21 Q0 22739667 639 38.644142 imi_mug_run_2_treatment "imatinib" "duration" "adjuvant"
21 Q0 18334877 640 38.641388 imi_mug_run_2_treatment "cytokines" "tnf-alpha" "level"
21 Q0 17222247 641 38.641228 imi_mug_run_2_treatment "icc" "imatinib"
21 Q0 25832938 642 38.641228 imi_mug_run_2_treatment "imatinib" "drug"
21 Q0 15507676 643 38.62304 imi_mug_run_2_treatment "kinase inhibitor" "gleevec" "imatinib mesylate"
21 Q0 21358619 644 38.613495 imi_mug_run_2_treatment "imatinib"
21 Q0 21888081 645 38.605614 imi_mug_run_2_treatment "imatinib"
21 Q0 12360044 646 38.59167 imi_mug_run_2_treatment "biotin" "sti571" "gleevec"
21 Q0 18381383 647 38.585686 imi_mug_run_2_treatment "various" "imatinib"
21 Q0 25659388 648 38.56708 imi_mug_run_2_treatment "aim"
21 Q0 26989528 649 38.546364 imi_mug_run_2_treatment "basis"
21 Q0 21547131 650 38.545013 imi_mug_run_2_treatment "sunitinib" "imatinib" "imatinib mesylate"
21 Q0 24855380 651 38.53023 imi_mug_run_2_treatment "imatinib" "sorafenib"
21 Q0 17623951 652 38.527126 imi_mug_run_2_treatment "kinase inhibitor"
21 Q0 18628470 653 38.513306 imi_mug_run_2_treatment "imatinib"
21 Q0 25621782 654 38.511757 imi_mug_run_2_treatment "therapeutic agents"
21 Q0 15342366 655 38.51122 imi_mug_run_2_treatment "imatinib" "drug" "tyrosine kinase inhibitor"
21 Q0 16842246 656 38.51122 imi_mug_run_2_treatment "imatinib" "basis"
21 Q0 16786129 657 38.494682 imi_mug_run_2_treatment "imatinib" "kinase inhibitor"
21 Q0 18413817 658 38.49437 imi_mug_run_2_treatment "imatinib"
21 Q0 15007386 659 38.492138 imi_mug_run_2_treatment "kinase inhibitor" "sti571" "gleevec"
21 Q0 24394052 660 38.489418 imi_mug_run_2_treatment "imatinib" "basis" "aim"
21 Q0 29998023 661 38.489044 imi_mug_run_2_treatment "kinase inhibitor" "imatinib"
21 Q0 29206199 662 38.486153 imi_mug_run_2_treatment "dsb" "abc" "imatinib"
21 Q0 27527414 663 38.473923 imi_mug_run_2_treatment "enzymes" "tyrosine" "imatinib"
21 Q0 23873383 664 38.445354 imi_mug_run_2_treatment "therapeutics"
21 Q0 15668652 665 38.43125 imi_mug_run_2_treatment "imatinib" "sti 571" "imatinib mesylate"
21 Q0 16952042 666 38.429165 imi_mug_run_2_treatment "basis"
21 Q0 12759750 667 38.42534 imi_mug_run_2_treatment "various" "sti-571" "imatinib mesylate"
21 Q0 15795882 668 38.414097 imi_mug_run_2_treatment "adjuvant"
21 Q0 10504550 669 38.378548 imi_mug_run_2_treatment "leu"
21 Q0 11215292 670 38.356857 imi_mug_run_2_treatment "aim"
21 Q0 19737946 671 38.330833 imi_mug_run_2_treatment "imatinib" "sunitinib" "drug"
21 Q0 26848617 672 38.308945 imi_mug_run_2_treatment "imatinib"
21 Q0 29421913 673 38.297516 imi_mug_run_2_treatment "aim"
21 Q0 17438095 674 38.29158 imi_mug_run_2_treatment "imatinib" "basis"
21 Q0 24886695 675 38.284145 imi_mug_run_2_treatment "directed" "succinate" "insulin-like growth factor 1"
21 Q0 24490049 676 38.275177 imi_mug_run_2_treatment "imatinib" "sorafenib" "kinase inhibitor"
21 Q0 23833252 677 38.25278 imi_mug_run_2_treatment "aim"
21 Q0 16624552 678 38.244213 imi_mug_run_2_treatment "imatinib" "drug"
21 Q0 15289315 679 38.227062 imi_mug_run_2_treatment "imatinib mesylate"
21 Q0 24343490 680 38.219986 imi_mug_run_2_treatment "adjuvant" "imatinib" "aim"
21 Q0 21435173 681 38.209244 imi_mug_run_2_treatment "various" "icc" "aza"
21 Q0 29568401 682 38.207123 imi_mug_run_2_treatment "plasma" "aim"
21 Q0 15788212 683 38.206715 imi_mug_run_2_treatment "liver"
21 Q0 16550875 684 38.199604 imi_mug_run_2_treatment "basis"
21 Q0 17588358 685 38.199604 imi_mug_run_2_treatment "sunitinib" "drug" "tyrosine kinase inhibitor"
21 Q0 21136920 686 38.19432 imi_mug_run_2_treatment "enzymes" "glycans"
21 Q0 20883053 687 38.19432 imi_mug_run_2_treatment "imatinib" "adjuvant" "tyrosine"
21 Q0 19900103 688 38.15177 imi_mug_run_2_treatment "aim"
21 Q0 18246046 689 38.14868 imi_mug_run_2_treatment "imatinib"
21 Q0 26854374 690 38.138016 imi_mug_run_2_treatment "plasma"
21 Q0 17022716 691 38.13153 imi_mug_run_2_treatment "imatinib"
21 Q0 26907871 692 38.122574 imi_mug_run_2_treatment "imatinib" "drugs" "ifosfamide"
21 Q0 25934947 693 38.10472 imi_mug_run_2_treatment "combinations" "drug" "imatinib"
21 Q0 12600228 694 38.102512 imi_mug_run_2_treatment "enzymes" "tyrosine" "imatinib mesylate"
21 Q0 16155822 695 38.091305 imi_mug_run_2_treatment "sti571" "drug" "imatinib mesylate"
21 Q0 15215166 696 38.088448 imi_mug_run_2_treatment "antiserum" "imatinib mesylate" "lead"
21 Q0 18039140 697 38.08239 imi_mug_run_2_treatment "kinase inhibitor" "therapeutics" "imatinib"
21 Q0 18409663 698 38.08239 imi_mug_run_2_treatment "imatinib" "tyrosine kinase inhibitor" "adjuvant"
21 Q0 16203282 699 38.081158 imi_mug_run_2_treatment "various" "imatinib" "aim"
21 Q0 11021812 700 38.072598 imi_mug_run_2_treatment "lead" "balance"
21 Q0 22453568 701 38.065983 imi_mug_run_2_treatment "imatinib" "adjuvant"
21 Q0 25741840 702 38.06487 imi_mug_run_2_treatment "imatinib" "adjuvant" "water"
21 Q0 21505157 703 38.048737 imi_mug_run_2_treatment "lead"
21 Q0 22083669 704 38.04403 imi_mug_run_2_treatment "imatinib" "nilotinib" "tyr"
21 Q0 30101875 705 38.039547 imi_mug_run_2_treatment "imatinib" "fletcher's" "others"
21 Q0 18422477 706 38.037193 imi_mug_run_2_treatment "imatinib mesilate" "imatinib" "adjuvant"
21 Q0 11127756 707 38.02886 imi_mug_run_2_treatment "alcohol"
21 Q0 11865845 708 37.997368 imi_mug_run_2_treatment "sti571" "lead"
21 Q0 21456006 709 37.944553 imi_mug_run_2_treatment "imatinib" "sunitinib" "nilotinib"
21 Q0 12375034 710 37.911983 imi_mug_run_2_treatment "biotin" "mediated"
21 Q0 15154005 711 37.89088 imi_mug_run_2_treatment "lys"
21 Q0 26170517 712 37.881332 imi_mug_run_2_treatment "level"
21 Q0 14651144 713 37.84373 imi_mug_run_2_treatment "chemotherapy agents" "sti-571" "agent"
21 Q0 18074824 714 37.828873 imi_mug_run_2_treatment "combinations" "liver"
21 Q0 20389135 715 37.82619 imi_mug_run_2_treatment "imatinib" "sunitinib" "drug"
21 Q0 22472152 716 37.81519 imi_mug_run_2_treatment "imatinib" "imatinib mesylate" "fletcher"
21 Q0 16144917 717 37.814453 imi_mug_run_2_treatment "imatinib" "vascular endothelial growth factor" "antiangiogenic"
21 Q0 19144598 718 37.810047 imi_mug_run_2_treatment "imatinib" "genesis"
21 Q0 23239909 719 37.788864 imi_mug_run_2_treatment "imatinib" "imatinib mesylate"
21 Q0 26905135 720 37.787613 imi_mug_run_2_treatment "various"
21 Q0 16273186 721 37.77889 imi_mug_run_2_treatment "melan-a"
21 Q0 16166919 722 37.772873 imi_mug_run_2_treatment "drug" "imatinib mesilate" "tyrosine kinase inhibitor"
21 Q0 11861291 723 37.76198 imi_mug_run_2_treatment "enzymes" "sti571" "drugs"
21 Q0 19176456 724 37.75821 imi_mug_run_2_treatment "imatinib" "ile" "thr"
21 Q0 17878015 725 37.75751 imi_mug_run_2_treatment "tyrosine kinase inhibitor"
21 Q0 25810235 726 37.75629 imi_mug_run_2_treatment "imatinib" "prednisolone" "agent"
21 Q0 21462307 727 37.75109 imi_mug_run_2_treatment "imatinib" "imatinib mesylate"
21 Q0 23198834 728 37.74291 imi_mug_run_2_treatment "imatinib" "drugs" "imatinib mesylate"
21 Q0 16328663 729 37.74034 imi_mug_run_2_treatment "level"
21 Q0 21524289 730 37.73609 imi_mug_run_2_treatment "imatinib"
21 Q0 17454792 731 37.735603 imi_mug_run_2_treatment "imatinib mesylate" "glivec" "imatinib"
21 Q0 18690842 732 37.734726 imi_mug_run_2_treatment "imatinib" "kinase inhibitor" "mediators"
21 Q0 12894500 733 37.7224 imi_mug_run_2_treatment "tyr" "ly294002" "ag490"
21 Q0 17261983 734 37.716137 imi_mug_run_2_treatment "aim"
21 Q0 18294396 735 37.712185 imi_mug_run_2_treatment "generic"
21 Q0 25316817 736 37.704075 imi_mug_run_2_treatment "combinations" "imatinib" "agent"
21 Q0 21427092 737 37.69552 imi_mug_run_2_treatment "fletcher's"
21 Q0 19509176 738 37.69552 imi_mug_run_2_treatment "panobinostat" "imatinib" "histone deacetylase inhibitors"
21 Q0 15709888 739 37.682682 imi_mug_run_2_treatment "imatinib mesylate" "tyrosine" "imatinib"
21 Q0 24790651 740 37.682682 imi_mug_run_2_treatment "imatinib" "sunitinib" "regorafenib"
21 Q0 22190996 741 37.678223 imi_mug_run_2_treatment "imatinib mesylate"
21 Q0 20736294 742 37.65703 imi_mug_run_2_treatment "imatinib" "dasatinib"
21 Q0 19476525 743 37.65006 imi_mug_run_2_treatment "imatinib" "sunitinib" "liver"
21 Q0 15024716 744 37.64692 imi_mug_run_2_treatment "drug" "imatinib mesylate" "sti-571"
21 Q0 15953881 745 37.640057 imi_mug_run_2_treatment "imatinib" "androgen" "imatinib mesylate"
21 Q0 20651610 746 37.639977 imi_mug_run_2_treatment "imatinib"
21 Q0 23969726 747 37.621597 imi_mug_run_2_treatment "imatinib" "aim"
21 Q0 12045714 748 37.5985 imi_mug_run_2_treatment "aim"
21 Q0 17923802 749 37.5813 imi_mug_run_2_treatment "insulin" "imatinib" "imatinib mesylate"
21 Q0 19213398 750 37.580013 imi_mug_run_2_treatment "imatinib"
21 Q0 22363143 751 37.576366 imi_mug_run_2_treatment "imatinib" "aim"
21 Q0 14657591 752 37.52719 imi_mug_run_2_treatment "various" "glivec"
21 Q0 18394167 753 37.52625 imi_mug_run_2_treatment "imatinib mesylate"
21 Q0 18030576 754 37.52597 imi_mug_run_2_treatment "imatinib" "imatinib mesylate" "tyrosine kinase inhibitor"
21 Q0 22017446 755 37.51377 imi_mug_run_2_treatment "imatinib"
21 Q0 19307738 756 37.50961 imi_mug_run_2_treatment "imatinib" "imatinib mesylate"
21 Q0 23637977 757 37.503323 imi_mug_run_2_treatment "dioxin" "adjuvant" "ors"
21 Q0 17633880 758 37.483913 imi_mug_run_2_treatment "gleevec" "imatinib" "adjuvant"
21 Q0 17193822 759 37.478764 imi_mug_run_2_treatment "imatinib" "drug" "imatinib mesylate"
21 Q0 16294026 760 37.43551 imi_mug_run_2_treatment "various" "imatinib" "imatinib mesylate"
21 Q0 23205104 761 37.422962 imi_mug_run_2_treatment "nitrocellulose"
21 Q0 23283817 762 37.421913 imi_mug_run_2_treatment "genesis"
21 Q0 20470368 763 37.393875 imi_mug_run_2_treatment "imatinib"
21 Q0 15542802 764 37.39147 imi_mug_run_2_treatment "various" "imatinib" "imatinib mesylate"
21 Q0 24298573 765 37.384575 imi_mug_run_2_treatment "insulin" "igf1" "insulin-like growth factor 1"
21 Q0 17625429 766 37.357044 imi_mug_run_2_treatment "imatinib"
21 Q0 28231736 767 37.336994 imi_mug_run_2_treatment "mediated" "skf-96365" "blockade"
21 Q0 22453014 768 37.31792 imi_mug_run_2_treatment "imatinib"
21 Q0 15492989 769 37.308765 imi_mug_run_2_treatment "sti571" "imatinib mesylate"
21 Q0 21364741 770 37.299862 imi_mug_run_2_treatment "icc" "animals"
21 Q0 27440273 771 37.280716 imi_mug_run_2_treatment "mediated"
21 Q0 20385106 772 37.278156 imi_mug_run_2_treatment "imatinib" "kinase inhibitor" "gleevec"
21 Q0 24384849 773 37.266693 imi_mug_run_2_treatment "imatinib" "sunitinib" "regorafenib"
21 Q0 18393778 774 37.263775 imi_mug_run_2_treatment "imatinib mesylate" "drug" "adjuvant"
21 Q0 18487970 775 37.254745 imi_mug_run_2_treatment "drugs" "level"
21 Q0 21490839 776 37.254745 imi_mug_run_2_treatment "imatinib"
21 Q0 15815732 777 37.212532 imi_mug_run_2_treatment "imatinib mesylate" "adjuvant" "drug"
21 Q0 14686005 778 37.208004 imi_mug_run_2_treatment "imatinib" "aim"
21 Q0 19119132 779 37.18949 imi_mug_run_2_treatment "imatinib mesylate"
21 Q0 14681327 780 37.188225 imi_mug_run_2_treatment "tandem" "leu" "tyr"
21 Q0 19335275 781 37.1862 imi_mug_run_2_treatment "imatinib" "sunitinib" "drug"
21 Q0 15900576 782 37.180904 imi_mug_run_2_treatment "various"
21 Q0 22273319 783 37.17643 imi_mug_run_2_treatment "adjuvant" "imatinib"
21 Q0 15106018 784 37.172737 imi_mug_run_2_treatment "tyrosine kinase inhibitor" "imatinib mesylate" "basis"
21 Q0 22429770 785 37.16704 imi_mug_run_2_treatment "imatinib"
21 Q0 25572173 786 37.159206 imi_mug_run_2_treatment "imatinib" "icc" "mek162"
21 Q0 17435539 787 37.153473 imi_mug_run_2_treatment "kinase inhibitor"
21 Q0 21666577 788 37.152817 imi_mug_run_2_treatment "imatinib"
21 Q0 21244575 789 37.126274 imi_mug_run_2_treatment "liver"
21 Q0 22150077 790 37.122505 imi_mug_run_2_treatment "imatinib" "imatinib 400 mg"
21 Q0 29887588 791 37.066193 imi_mug_run_2_treatment "imatinib"
21 Q0 18537751 792 37.046196 imi_mug_run_2_treatment "imatinib" "drug" "imatinib mesylate"
21 Q0 20690803 793 37.033577 imi_mug_run_2_treatment "imatinib" "sunitinib"
21 Q0 21479497 794 37.020054 imi_mug_run_2_treatment "ptm"
21 Q0 10824925 795 36.981056 imi_mug_run_2_treatment "antiserum"
21 Q0 20834236 796 36.95556 imi_mug_run_2_treatment "aim"
21 Q0 18792672 797 36.857613 imi_mug_run_2_treatment "imatinib mesylate"
21 Q0 16315926 798 36.854733 imi_mug_run_2_treatment "tyrosine kinase inhibitor" "imatinib" "imatinib mesylate"
21 Q0 11213513 799 36.85018 imi_mug_run_2_treatment "product"
21 Q0 15244191 800 36.8461 imi_mug_run_2_treatment "various"
21 Q0 12678420 801 36.815765 imi_mug_run_2_treatment "drug" "drugs" "epidoxorubicin"
21 Q0 26772734 802 36.79769 imi_mug_run_2_treatment "sunitinib" "imatinib" "metrics"
21 Q0 24833907 803 36.75473 imi_mug_run_2_treatment "protease" "fletcher" "aim"
21 Q0 12856366 804 36.744953 imi_mug_run_2_treatment "basis" "liver"
21 Q0 16297706 805 36.734173 imi_mug_run_2_treatment "genesis"
21 Q0 17373746 806 36.730026 imi_mug_run_2_treatment "aim" "liver"
21 Q0 19585585 807 36.729774 imi_mug_run_2_treatment "lead" "level"
21 Q0 25924988 808 36.724113 imi_mug_run_2_treatment "ras"
21 Q0 26982239 809 36.71818 imi_mug_run_2_treatment "imatinib" "clemastine" "tyrosine kinase inhibitor"
21 Q0 26316776 810 36.715126 imi_mug_run_2_treatment "imatinib" "imatinib mesylate" "tyrosine kinase inhibitor"
21 Q0 17200352 811 36.71311 imi_mug_run_2_treatment "imatinib"
21 Q0 21605429 812 36.711784 imi_mug_run_2_treatment "aim" "others"
21 Q0 24802226 813 36.69329 imi_mug_run_2_treatment "various" "adjuvant" "imatinib"
21 Q0 17633870 814 36.689278 imi_mug_run_2_treatment "imatinib mesilate" "tyrosine kinase inhibitor" "icc"
21 Q0 20718969 815 36.681923 imi_mug_run_2_treatment "imatinib" "drug" "imatinib 100 mg"
21 Q0 20140688 816 36.679153 imi_mug_run_2_treatment "drug" "imatinib" "basis"
21 Q0 24755645 817 36.660873 imi_mug_run_2_treatment "imatinib mesylate"
21 Q0 15712189 818 36.65551 imi_mug_run_2_treatment "imatinib mesylate" "liver"
21 Q0 17921955 819 36.645767 imi_mug_run_2_treatment "gleevec" "imatinib"
21 Q0 17090188 820 36.61152 imi_mug_run_2_treatment "imatinib" "tyrosine kinase inhibitor"
21 Q0 27625077 821 36.61021 imi_mug_run_2_treatment "aim"
21 Q0 12960119 822 36.578247 imi_mug_run_2_treatment "hot spot" "tandem"
21 Q0 23860199 823 36.55451 imi_mug_run_2_treatment "imatinib mesylate" "adjuvant" "imatinib"
21 Q0 18516991 824 36.546127 imi_mug_run_2_treatment "kinase inhibitor" "imatinib"
21 Q0 27472829 825 36.520874 imi_mug_run_2_treatment "aim"
21 Q0 11778355 826 36.506474 imi_mug_run_2_treatment "basis"
21 Q0 16785193 827 36.504303 imi_mug_run_2_treatment "imatinib"
21 Q0 18369405 828 36.504303 imi_mug_run_2_treatment "imatinib" "tyrosine"
21 Q0 15966241 829 36.502384 imi_mug_run_2_treatment "eosin"
21 Q0 16540730 830 36.487225 imi_mug_run_2_treatment "eosin"
21 Q0 20043176 831 36.465916 imi_mug_run_2_treatment "imatinib"
21 Q0 24405315 832 36.464054 imi_mug_run_2_treatment "regorafenib" "imatinib" "kinase inhibitor"
21 Q0 24885725 833 36.445656 imi_mug_run_2_treatment "imatinib mesylate"
21 Q0 24900212 834 36.42841 imi_mug_run_2_treatment "various"
21 Q0 26415883 835 36.42204 imi_mug_run_2_treatment "bisulfite"
21 Q0 29110548 836 36.42204 imi_mug_run_2_treatment "drugs"
21 Q0 19032955 837 36.42052 imi_mug_run_2_treatment "icc" "lead"
21 Q0 16954519 838 36.41792 imi_mug_run_2_treatment "imatinib"
21 Q0 23859518 839 36.406517 imi_mug_run_2_treatment "drug" "imatinib"
21 Q0 18350628 840 36.39899 imi_mug_run_2_treatment "aim"
21 Q0 29196126 841 36.39899 imi_mug_run_2_treatment "drug" "imatinib" "tyrosine"
21 Q0 18510377 842 36.383743 imi_mug_run_2_treatment "imatinib mesylate" "tyrosine kinase inhibitor"
21 Q0 23536347 843 36.378128 imi_mug_run_2_treatment "tma"
21 Q0 23479771 844 36.373604 imi_mug_run_2_treatment "imatinib"
21 Q0 22487918 845 36.363216 imi_mug_run_2_treatment "imatinib" "adjuvant" "lead"
21 Q0 27997714 846 36.357582 imi_mug_run_2_treatment "imatinib" "drug" "basis"
21 Q0 19351841 847 36.35248 imi_mug_run_2_treatment "imatinib mesylate"
21 Q0 16166437 848 36.33032 imi_mug_run_2_treatment "level" "aim"
21 Q0 23599150 849 36.310596 imi_mug_run_2_treatment "imatinib" "adjuvant"
21 Q0 24061512 850 36.264557 imi_mug_run_2_treatment "imatinib" "basis" "liver"
21 Q0 28615132 851 36.262848 imi_mug_run_2_treatment "imatinib" "isoleucine"
21 Q0 20124181 852 36.24882 imi_mug_run_2_treatment "imatinib" "level"
21 Q0 25731561 853 36.23828 imi_mug_run_2_treatment "sunitinib" "drugs" "imatinib"
21 Q0 21434524 854 36.23339 imi_mug_run_2_treatment "imatinib" "mediated"
21 Q0 17894554 855 36.219975 imi_mug_run_2_treatment "liver" "adjuvant" "imatinib"
21 Q0 28983330 856 36.218216 imi_mug_run_2_treatment "eosin" "aim"
21 Q0 15834676 857 36.18512 imi_mug_run_2_treatment "lead"
21 Q0 19011349 858 36.18285 imi_mug_run_2_treatment "imatinib" "level"
21 Q0 15706444 859 36.18018 imi_mug_run_2_treatment "imatinib mesylate" "drug" "tyrosine"
21 Q0 28199021 860 36.178413 imi_mug_run_2_treatment "toceranib phosphate" "palladia"
21 Q0 24778033 861 36.152294 imi_mug_run_2_treatment "level"
21 Q0 20008851 862 36.14403 imi_mug_run_2_treatment "drug" "drugs" "imatinib"
21 Q0 14531349 863 36.137012 imi_mug_run_2_treatment "drug" "imatinib"
21 Q0 20442311 864 36.136906 imi_mug_run_2_treatment "imatinib" "nilotinib" "agent"
21 Q0 20621681 865 36.13295 imi_mug_run_2_treatment "icc" "imatinib" "drug"
21 Q0 18314611 866 36.12512 imi_mug_run_2_treatment "imatinib" "tyrosine" "imatinib mesylate"
21 Q0 29623544 867 36.104565 imi_mug_run_2_treatment "imatinib" "agent"
21 Q0 11507701 868 36.08554 imi_mug_run_2_treatment "product" "aim"
21 Q0 16400320 869 36.039307 imi_mug_run_2_treatment "aim"
21 Q0 20661913 870 36.03825 imi_mug_run_2_treatment "imatinib" "sunitinib"
21 Q0 19509155 871 36.01495 imi_mug_run_2_treatment "imatinib"
21 Q0 19294538 872 36.00141 imi_mug_run_2_treatment "imatinib" "sunitinib"
21 Q0 22577569 873 35.988117 imi_mug_run_2_treatment "drug" "drugs" "imatinib"
21 Q0 27272772 874 35.988117 imi_mug_run_2_treatment "imatinib mesylate" "tyrosine kinase inhibitor"
21 Q0 24947094 875 35.96488 imi_mug_run_2_treatment "aim"
21 Q0 11727254 876 35.955086 imi_mug_run_2_treatment "various"
21 Q0 25294914 877 35.950043 imi_mug_run_2_treatment "imatinib" "adjuvant"
21 Q0 24778765 878 35.947094 imi_mug_run_2_treatment "mediated"
21 Q0 28416775 879 35.939743 imi_mug_run_2_treatment "glutamine" "aim"
21 Q0 16544528 880 35.921295 imi_mug_run_2_treatment "liver"
21 Q0 16242052 881 35.913216 imi_mug_run_2_treatment "imatinib" "sti571" "imatinib mesylate"
21 Q0 14691908 882 35.901546 imi_mug_run_2_treatment "prostaglandins" "anti-inflammatory" "nonsteroidal anti-inflammatory drugs"
21 Q0 19303137 883 35.901474 imi_mug_run_2_treatment "imatinib" "adjuvant" "imatinib mesylate"
21 Q0 22584320 884 35.89936 imi_mug_run_2_treatment "imatinib" "glivec" "imatinib mesylate"
21 Q0 23722018 885 35.89846 imi_mug_run_2_treatment "kinase inhibitor" "eosin" "imatinib mesylate"
21 Q0 18932293 886 35.89358 imi_mug_run_2_treatment "sunitinib" "drug" "imatinib"
21 Q0 20495760 887 35.892235 imi_mug_run_2_treatment "drug" "agent" "prompt"
21 Q0 17217104 888 35.859406 imi_mug_run_2_treatment "imatinib" "drug" "suppressor"
21 Q0 26936919 889 35.854813 imi_mug_run_2_treatment "mediated" "pd325901" "liver"
21 Q0 26722383 890 35.84871 imi_mug_run_2_treatment "various" "imatinib" "nilotinib"
21 Q0 16618383 891 35.84413 imi_mug_run_2_treatment "imatinib" "adjuvant" "tyrosine"
21 Q0 14986524 892 35.824165 imi_mug_run_2_treatment "sti 571" "tyrosine kinase inhibitor" "triumph"
21 Q0 10751339 893 35.81847 imi_mug_run_2_treatment "icc"
21 Q0 27217036 894 35.814655 imi_mug_run_2_treatment "various" "imatinib" "duration"
21 Q0 22009637 895 35.80842 imi_mug_run_2_treatment "immunosuppressive"
21 Q0 21737509 896 35.803276 imi_mug_run_2_treatment "imatinib" "ipi-493" "sterile water"
21 Q0 24078991 897 35.80098 imi_mug_run_2_treatment "imatinib" "liver"
21 Q0 23717541 898 35.792435 imi_mug_run_2_treatment "basis"
21 Q0 18974147 899 35.790466 imi_mug_run_2_treatment "imatinib" "imatinib mesylate" "antitumor agents"
21 Q0 12094372 900 35.78501 imi_mug_run_2_treatment "sti-571" "imatinib" "tyrosine kinase inhibitor"
21 Q0 18227570 901 35.781563 imi_mug_run_2_treatment "aim"
21 Q0 28904693 902 35.75762 imi_mug_run_2_treatment "aim"
21 Q0 25222580 903 35.74814 imi_mug_run_2_treatment "imatinib" "aim"
21 Q0 11740803 904 35.709545 imi_mug_run_2_treatment "imatinib mesylate" "sti571" "pharmaceuticals"
21 Q0 23355099 905 35.705193 imi_mug_run_2_treatment "imatinib" "medicines" "basis"
21 Q0 15510603 906 35.68467 imi_mug_run_2_treatment "imatinib" "drug" "imatinib mesylate"
21 Q0 29686796 907 35.68467 imi_mug_run_2_treatment "imatinib" "tyrosine kinase inhibitor"
21 Q0 24970355 908 35.674282 imi_mug_run_2_treatment "level"
21 Q0 23983708 909 35.660034 imi_mug_run_2_treatment "imatinib" "sunitinib"
21 Q0 19241984 910 35.64528 imi_mug_run_2_treatment "imatinib"
21 Q0 18777214 911 35.62406 imi_mug_run_2_treatment "factor viii-related antigen"
21 Q0 28485054 912 35.60764 imi_mug_run_2_treatment "various" "aim"
21 Q0 17908650 913 35.606823 imi_mug_run_2_treatment "aim"
21 Q0 12410126 914 35.596046 imi_mug_run_2_treatment "drug"
21 Q0 28314314 915 35.56597 imi_mug_run_2_treatment "aim"
21 Q0 23702733 916 35.53209 imi_mug_run_2_treatment "imatinib" "aim"
21 Q0 29277888 917 35.47271 imi_mug_run_2_treatment "mediated" "level"
21 Q0 21160808 918 35.468014 imi_mug_run_2_treatment "lysine" "glutamic acid" "eosin"
21 Q0 20033343 919 35.4638 imi_mug_run_2_treatment "imatinib"
21 Q0 17330260 920 35.463543 imi_mug_run_2_treatment "imatinib mesylate"
21 Q0 20023271 921 35.46315 imi_mug_run_2_treatment "imatinib"
21 Q0 25731247 922 35.461624 imi_mug_run_2_treatment "imatinib" "sunitinib" "regorafenib"
21 Q0 26457546 923 35.458958 imi_mug_run_2_treatment "imatinib" "adjuvant" "imatinib mesylate"
21 Q0 15945512 924 35.456837 imi_mug_run_2_treatment "drug" "imatinib" "imatinib mesylate"
21 Q0 17952524 925 35.436626 imi_mug_run_2_treatment "adjuvant"
21 Q0 23584476 926 35.43651 imi_mug_run_2_treatment "various" "imatinib" "mediated"
21 Q0 19259308 927 35.41813 imi_mug_run_2_treatment "drug" "imatinib mesylate" "imatinib"
21 Q0 17452814 928 35.40132 imi_mug_run_2_treatment "imatinib" "basis" "others"
21 Q0 19488862 929 35.39969 imi_mug_run_2_treatment "somatostatin"
21 Q0 15812822 930 35.38905 imi_mug_run_2_treatment "imatinib" "electrolyte" "imatinib mesylate"
21 Q0 20126584 931 35.37354 imi_mug_run_2_treatment "imatinib mesylate" "liver"
21 Q0 15545668 932 35.36752 imi_mug_run_2_treatment "imatinib mesylate"
21 Q0 23420128 933 35.348305 imi_mug_run_2_treatment "imatinib" "tyrosine kinase inhibitor"
21 Q0 19606013 934 35.346943 imi_mug_run_2_treatment "drugs"
21 Q0 12692842 935 35.3459 imi_mug_run_2_treatment "level" "aim"
21 Q0 12609807 936 35.342556 imi_mug_run_2_treatment "icc" "sti571" "imatinib mesylate"
21 Q0 23375402 937 35.321915 imi_mug_run_2_treatment "imatinib" "sunitinib"
21 Q0 20053766 938 35.320316 imi_mug_run_2_treatment "various" "imatinib" "homoharringtonine"
21 Q0 20806443 939 35.308136 imi_mug_run_2_treatment "imatinib" "aim"
21 Q0 16810068 940 35.29315 imi_mug_run_2_treatment "gleevec" "glivec" "imatinib mesylate"
21 Q0 26187774 941 35.28763 imi_mug_run_2_treatment "imatinib" "drug" "sunitinib"
21 Q0 17193820 942 35.2865 imi_mug_run_2_treatment "collagen" "liver"
21 Q0 23053257 943 35.262108 imi_mug_run_2_treatment "imatinib" "adjuvant" "imatinib mesylate"
21 Q0 10197236 944 35.25719 imi_mug_run_2_treatment "various" "genesis"
21 Q0 11896121 945 35.248917 imi_mug_run_2_treatment "sti571"
21 Q0 23536353 946 35.246895 imi_mug_run_2_treatment "drug" "imatinib" "sunitinib"
21 Q0 14707872 947 35.230705 imi_mug_run_2_treatment "level"
21 Q0 18042065 948 35.21514 imi_mug_run_2_treatment "imatinib"
21 Q0 21286759 949 35.21514 imi_mug_run_2_treatment "program"
21 Q0 26511941 950 35.201786 imi_mug_run_2_treatment "various"
21 Q0 23730622 951 35.201786 imi_mug_run_2_treatment "kinase inhibitor"
21 Q0 19411681 952 35.19164 imi_mug_run_2_treatment "imatinib"
21 Q0 15100500 953 35.19077 imi_mug_run_2_treatment "imatinib mesylate" "cancer drug" "glivec"
21 Q0 18830121 954 35.175518 imi_mug_run_2_treatment "imatinib" "imatinib mesylate" "sunitinib"
21 Q0 21419932 955 35.16205 imi_mug_run_2_treatment "imatinib" "drug" "nilotinib"
21 Q0 16167051 956 35.143944 imi_mug_run_2_treatment "imatinib" "adjuvant" "tyrosine kinase inhibitor"
21 Q0 17597335 957 35.143944 imi_mug_run_2_treatment "imatinib" "tyrosine kinase inhibitor" "aim"
21 Q0 21394667 958 35.143944 imi_mug_run_2_treatment "sunitinib" "imatinib" "liver"
21 Q0 20032375 959 35.130714 imi_mug_run_2_treatment "various" "tk inhibitors" "aim"
21 Q0 21192792 960 35.114964 imi_mug_run_2_treatment "everolimus" "imatinib" "nilotinib"
21 Q0 27375917 961 35.11028 imi_mug_run_2_treatment "tyrosine kinase inhibitor"
21 Q0 16327443 962 35.095314 imi_mug_run_2_treatment "icc" "tyrosine"
21 Q0 24900584 963 35.09213 imi_mug_run_2_treatment "aromatic"
21 Q0 27123107 964 35.088947 imi_mug_run_2_treatment "liver"
21 Q0 24727986 965 35.06955 imi_mug_run_2_treatment "imatinib" "adjuvant" "drugs"
21 Q0 25469264 966 35.067745 imi_mug_run_2_treatment "fletcher's" "duration"
21 Q0 23648119 967 35.06385 imi_mug_run_2_treatment "imatinib"
21 Q0 20818650 968 35.041256 imi_mug_run_2_treatment "imatinib"
21 Q0 28362703 969 35.030853 imi_mug_run_2_treatment "imatinib" "lead"
21 Q0 15633227 970 35.01584 imi_mug_run_2_treatment "drug" "sti-571" "imatinib mesylate"
21 Q0 14639002 971 35.011776 imi_mug_run_2_treatment "drug" "sti571" "imatinib mesylate"
21 Q0 29719410 972 35.009834 imi_mug_run_2_treatment "aim"
21 Q0 28114366 973 35.0037 imi_mug_run_2_treatment "il-6"
21 Q0 15672765 974 34.98101 imi_mug_run_2_treatment "imatinib" "adjuvant" "cladribine"
21 Q0 21977032 975 34.96556 imi_mug_run_2_treatment "blockade" "animals" "mediated"
21 Q0 23307085 976 34.9444 imi_mug_run_2_treatment "imatinib"
21 Q0 17462285 977 34.92497 imi_mug_run_2_treatment "imatinib" "glivec" "imatinib mesylate"
21 Q0 22282465 978 34.894638 imi_mug_run_2_treatment "imatinib" "ras"
21 Q0 25557174 979 34.894638 imi_mug_run_2_treatment "combinations" "afatinib" "imatinib"
21 Q0 21757001 980 34.89171 imi_mug_run_2_treatment "lys" "glu" "imatinib"
21 Q0 15018116 981 34.883984 imi_mug_run_2_treatment "various" "onion"
21 Q0 21171987 982 34.87349 imi_mug_run_2_treatment "pooled"
21 Q0 22662219 983 34.856003 imi_mug_run_2_treatment "drugs" "drug combination" "imatinib"
21 Q0 20137358 984 34.85009 imi_mug_run_2_treatment "imatinib" "tyrosine kinase inhibitor"
21 Q0 15907006 985 34.831696 imi_mug_run_2_treatment "fletcher's"
21 Q0 21708825 986 34.831295 imi_mug_run_2_treatment "methylated" "aim"
21 Q0 22164425 987 34.798386 imi_mug_run_2_treatment "fletcher's" "gleevec"
21 Q0 15018431 988 34.7845 imi_mug_run_2_treatment "drugs" "imatinib mesylate"
21 Q0 22705697 989 34.783478 imi_mug_run_2_treatment "imatinib" "liver"
21 Q0 17101065 990 34.769997 imi_mug_run_2_treatment "imatinib" "drug" "adjuvant"
21 Q0 18684030 991 34.769997 imi_mug_run_2_treatment "melan-a"
21 Q0 23696920 992 34.765625 imi_mug_run_2_treatment "icc"
21 Q0 27470968 993 34.749493 imi_mug_run_2_treatment "blockade" "imatinib"
21 Q0 23820134 994 34.74918 imi_mug_run_2_treatment "imatinib"
21 Q0 29953781 995 34.712776 imi_mug_run_2_treatment "aim" "drugs"
21 Q0 17268837 996 34.668816 imi_mug_run_2_treatment "gleevec" "glivec" "imatinib"
21 Q0 30242244 997 34.630074 imi_mug_run_2_treatment "drug" "tyrosine" "duration"
21 Q0 18488160 998 34.628586 imi_mug_run_2_treatment "imatinib"
21 Q0 18360281 999 34.62851 imi_mug_run_2_treatment "various"
22 Q0 27489350 1 53.60923 imi_mug_run_2_treatment "cisplatin" "pictilisib"
22 Q0 26005817 2 51.319542 imi_mug_run_2_treatment "aim"
22 Q0 29152088 3 49.941795 imi_mug_run_2_treatment "nonsteroidal anti-inflammatory drug" "aspirin" "anti-inflammatory"
22 Q0 27197157 4 43.73596 imi_mug_run_2_treatment "estrogen"
22 Q0 18262558 5 42.371803 imi_mug_run_2_treatment "ly294002"
22 Q0 24231454 6 41.305492 imi_mug_run_2_treatment "various" "bisphosphonate" "fluorouracil"
22 Q0 26001593 7 41.223206 imi_mug_run_2_treatment "plasma"
22 Q0 28448072 8 40.700783 imi_mug_run_2_treatment "aspirin"
22 Q0 27581627 9 40.613335 imi_mug_run_2_treatment "various" "lysine"
22 Q0 29504069 10 40.524307 imi_mug_run_2_treatment "aspirin" "drugs"
22 Q0 22662165 11 40.342136 imi_mug_run_2_treatment "glucose" "antioxidant" "mediated"
22 Q0 25398149 12 40.27959 imi_mug_run_2_treatment "medicine"
22 Q0 23895914 13 40.24965 imi_mug_run_2_treatment "lead" "aim"
22 Q0 18798071 14 39.806774 imi_mug_run_2_treatment "taxanes"
22 Q0 28183140 15 39.14441 imi_mug_run_2_treatment "everolimus" "plasma"
22 Q0 24687028 16 38.098724 imi_mug_run_2_treatment "aspirin" "adjuvant" "low-dose aspirin"
22 Q0 16432179 17 37.934174 imi_mug_run_2_treatment "rad001"
22 Q0 25422220 18 37.72596 imi_mug_run_2_treatment "insulin"
22 Q0 19903786 19 37.716957 imi_mug_run_2_treatment "aim"
22 Q0 18355852 20 37.621326 imi_mug_run_2_treatment "ras"
22 Q0 16533766 21 37.621277 imi_mug_run_2_treatment "kinase inhibitor"
22 Q0 18339877 22 37.60074 imi_mug_run_2_treatment "cetuximab" "ras" "agent"
22 Q0 23094721 23 37.36222 imi_mug_run_2_treatment "aspirin" "bisphosphonate" "adjuvant"
22 Q0 26080840 24 37.279808 imi_mug_run_2_treatment "therapeutic agents"
22 Q0 25027743 25 37.182983 imi_mug_run_2_treatment "epirubicin" "docetaxel"
22 Q0 26820797 26 37.126797 imi_mug_run_2_treatment "pd 0325901" "agar" "drugs"
22 Q0 24355100 27 36.74885 imi_mug_run_2_treatment "aspirin"
22 Q0 19633047 28 36.280003 imi_mug_run_2_treatment "trastuzumab" "cl-387,785" "ly294002"
22 Q0 16168105 29 36.19731 imi_mug_run_2_treatment "various" "ly294002"
22 Q0 19196980 30 35.96859 imi_mug_run_2_treatment "lithium" "antineoplastic" "lithium chloride"
22 Q0 18181165 31 35.737988 imi_mug_run_2_treatment "various" "liver"
22 Q0 24743704 32 35.676323 imi_mug_run_2_treatment "drug" "drugs"
22 Q0 27823983 33 35.620514 imi_mug_run_2_treatment "cisplatin" "pdx" "agent"
22 Q0 24705641 34 35.35703 imi_mug_run_2_treatment "aim"
22 Q0 26633882 35 35.16699 imi_mug_run_2_treatment "anti-epileptic"
22 Q0 16376301 36 35.069874 imi_mug_run_2_treatment "triciribine" "therapeutics"
22 Q0 24440701 37 35.036316 imi_mug_run_2_treatment "mediated"
22 Q0 24504125 38 34.96299 imi_mug_run_2_treatment "plasma"
22 Q0 23888070 39 34.848415 imi_mug_run_2_treatment "drugs" "mk-2206"
22 Q0 28247181 40 34.82587 imi_mug_run_2_treatment "mediated" "plasma"
22 Q0 29169325 41 34.813015 imi_mug_run_2_treatment "ras" "cetuximab"
22 Q0 16322248 42 34.76848 imi_mug_run_2_treatment "agar" "paclitaxel"
22 Q0 19789368 43 34.69436 imi_mug_run_2_treatment "various" "vitamin d" "ras"
22 Q0 27800646 44 34.359142 imi_mug_run_2_treatment "aim" "aspirin"
22 Q0 20233444 45 34.138313 imi_mug_run_2_treatment "hot spot"
22 Q0 29402752 46 34.084534 imi_mug_run_2_treatment "aspirin" "oxaliplatin" "low-dose aspirin"
22 Q0 29128266 47 33.964874 imi_mug_run_2_treatment "program"
22 Q0 16778113 48 33.832554 imi_mug_run_2_treatment "various"
22 Q0 25152245 49 33.623074 imi_mug_run_2_treatment "various" "drug" "lead"
22 Q0 20398348 50 33.58527 imi_mug_run_2_treatment "aim"
22 Q0 27880728 51 33.280907 imi_mug_run_2_treatment "aim"
22 Q0 17363507 52 33.274223 imi_mug_run_2_treatment "enzymes" "ly294002"
22 Q0 17673550 53 32.953217 imi_mug_run_2_treatment "alpha subunit"
22 Q0 21035469 54 32.82471 imi_mug_run_2_treatment "insulin" "lead"
22 Q0 10851074 55 32.692574 imi_mug_run_2_treatment "kinase inhibitor"
22 Q0 24930890 56 32.655193 imi_mug_run_2_treatment "serine"
22 Q0 24624362 57 32.63369 imi_mug_run_2_treatment "aspirin" "ras" "monoclonal antibodies"
22 Q0 18829572 58 32.597973 imi_mug_run_2_treatment "ras" "agar"
22 Q0 29844865 59 32.39819 imi_mug_run_2_treatment "aim"
22 Q0 20833970 60 32.357906 imi_mug_run_2_treatment "proteases"
22 Q0 26715098 61 32.296734 imi_mug_run_2_treatment "cetuximab" "bkm120"
22 Q0 22911782 62 32.289516 imi_mug_run_2_treatment "gabexate mesilate" "protease inhibitor" "cetuximab"
22 Q0 25526474 63 32.19376 imi_mug_run_2_treatment "pdx" "medicine"
22 Q0 20424113 64 31.763636 imi_mug_run_2_treatment "drug" "copper" "disulfiram"
22 Q0 28327908 65 31.725943 imi_mug_run_2_treatment "vitamin d" "adjuvant" "plasma"
22 Q0 22932669 66 31.661865 imi_mug_run_2_treatment "paclitaxel" "agent" "mk-2206"
22 Q0 23792451 67 31.398563 imi_mug_run_2_treatment "aspirin" "bisphosphonate" "various"
22 Q0 22292935 68 31.345596 imi_mug_run_2_treatment "level"
22 Q0 19671852 69 31.142403 imi_mug_run_2_treatment "aim"
22 Q0 24782652 70 31.135683 imi_mug_run_2_treatment "phosphate" "liver"
22 Q0 30413407 71 31.094418 imi_mug_run_2_treatment "fulvestrant" "alpelisib"
22 Q0 22287190 72 30.937904 imi_mug_run_2_treatment "level"
22 Q0 21738740 73 30.916607 imi_mug_run_2_treatment "combinations" "agent" "level"
22 Q0 28190247 74 30.871984 imi_mug_run_2_treatment "various" "drugs" "mediators"
22 Q0 26213461 75 30.852234 imi_mug_run_2_treatment "aim" "genesis"
22 Q0 25541970 76 30.728638 imi_mug_run_2_treatment "product"
22 Q0 29689598 77 30.705719 imi_mug_run_2_treatment "level"
22 Q0 24083111 78 30.69765 imi_mug_run_2_treatment "suppressor"
22 Q0 24970817 79 30.626057 imi_mug_run_2_treatment "ly294002"
22 Q0 23592373 80 30.568258 imi_mug_run_2_treatment "tamoxifen" "aromatase inhibitors" "aim"
22 Q0 9916799 81 30.532715 imi_mug_run_2_treatment "kinase inhibitor" "ly294002" "ras"
22 Q0 25345950 82 30.513145 imi_mug_run_2_treatment "mediated" "chitosan"
22 Q0 26013318 83 30.466616 imi_mug_run_2_treatment "nvp-byl719" "drug" "nvp-bkm120"
22 Q0 27321283 84 30.419956 imi_mug_run_2_treatment "glutamine" "aminooxyacetate"
22 Q0 28587748 85 30.361916 imi_mug_run_2_treatment "plasma"
22 Q0 27525871 86 30.16227 imi_mug_run_2_treatment "pemetrexed" "aim"
22 Q0 20107891 87 30.050026 imi_mug_run_2_treatment "plasma" "scorpion"
22 Q0 18516290 88 30.014248 imi_mug_run_2_treatment "igf2" "level"
22 Q0 27729614 89 29.939373 imi_mug_run_2_treatment "fluorouracil"
22 Q0 30288002 90 29.92714 imi_mug_run_2_treatment "herceptin"
22 Q0 17877460 91 29.90915 imi_mug_run_2_treatment "hot spot"
22 Q0 23708654 92 29.878658 imi_mug_run_2_treatment "mediated" "level"
22 Q0 28886403 93 29.857565 imi_mug_run_2_treatment "tma" "aim"
22 Q0 26915040 94 29.855053 imi_mug_run_2_treatment "aspirin"
22 Q0 21424126 95 29.772018 imi_mug_run_2_treatment "aim"
22 Q0 24505629 96 29.72002 imi_mug_run_2_treatment "various"
22 Q0 25815786 97 29.71652 imi_mug_run_2_treatment "cetuximab"
22 Q0 25686118 98 29.710066 imi_mug_run_2_treatment "bevacizumab" "aim"
22 Q0 21617917 99 29.671768 imi_mug_run_2_treatment "estrogen"
22 Q0 22421194 100 29.668175 imi_mug_run_2_treatment "plasma"
22 Q0 23125007 101 29.65127 imi_mug_run_2_treatment "hot spot"
22 Q0 25549537 102 29.614193 imi_mug_run_2_treatment "aspirin"
22 Q0 21289267 103 29.538872 imi_mug_run_2_treatment "mk2206" "ras" "temsirolimus"
22 Q0 18676830 104 29.521805 imi_mug_run_2_treatment "adjuvant" "tamoxifen" "ly294002"
22 Q0 19075596 105 29.488678 imi_mug_run_2_treatment "drug" "therapeutics" "others"
22 Q0 30109561 106 29.454933 imi_mug_run_2_treatment "medicines"
22 Q0 26276752 107 29.416908 imi_mug_run_2_treatment "liver"
22 Q0 29454261 108 29.368526 imi_mug_run_2_treatment "lead"
22 Q0 23185308 109 29.329178 imi_mug_run_2_treatment "ftc"
22 Q0 21775521 110 29.257523 imi_mug_run_2_treatment "drug" "tyrosine kinase inhibitor"
22 Q0 30425131 111 29.186478 imi_mug_run_2_treatment "tak-228" "everolimus"
22 Q0 23045248 112 29.151096 imi_mug_run_2_treatment "oxaliplatin" "adjuvant" "fluorouracil"
22 Q0 22640628 113 29.113094 imi_mug_run_2_treatment "drugs"
22 Q0 28330468 114 29.108078 imi_mug_run_2_treatment "plasma"
22 Q0 28881720 115 29.01236 imi_mug_run_2_treatment "mbc" "plasma" "duration"
22 Q0 23542178 116 28.997643 imi_mug_run_2_treatment "pp242" "adenosine triphosphate" "ras"
22 Q0 21332555 117 28.979622 imi_mug_run_2_treatment "ras" "aim"
22 Q0 18371219 118 28.977615 imi_mug_run_2_treatment "paclitaxel" "taxane"
22 Q0 20940279 119 28.96859 imi_mug_run_2_treatment "formalin"
22 Q0 27629725 120 28.966503 imi_mug_run_2_treatment "aim"
22 Q0 25367198 121 28.942436 imi_mug_run_2_treatment "ras" "aim"
22 Q0 19573809 122 28.936234 imi_mug_run_2_treatment "therapeutics"
22 Q0 22325221 123 28.933226 imi_mug_run_2_treatment "her-2"
22 Q0 26169833 124 28.823235 imi_mug_run_2_treatment "hot spot" "lead"
22 Q0 26358014 125 28.803669 imi_mug_run_2_treatment "aim"
22 Q0 22579930 126 28.788113 imi_mug_run_2_treatment "aim"
22 Q0 28864978 127 28.776907 imi_mug_run_2_treatment "perifosine"
22 Q0 21990951 128 28.761005 imi_mug_run_2_treatment "mediated" "aim"
22 Q0 17590872 129 28.69191 imi_mug_run_2_treatment "ras"
22 Q0 23301057 130 28.670961 imi_mug_run_2_treatment "letrozole" "everolimus" "estrogen"
22 Q0 25920359 131 28.61937 imi_mug_run_2_treatment "panitumumab" "oxaliplatin" "capecitabine"
22 Q0 19505918 132 28.584257 imi_mug_run_2_treatment "cyclin-dependent kinase inhibitor"
22 Q0 19224914 133 28.54698 imi_mug_run_2_treatment "mediated"
22 Q0 21507233 134 28.525986 imi_mug_run_2_treatment "adc" "calca"
22 Q0 25104442 135 28.49846 imi_mug_run_2_treatment "endocrine therapy"
22 Q0 24500884 136 28.491024 imi_mug_run_2_treatment "adca" "hot spot" "aim"
22 Q0 19029838 137 28.470566 imi_mug_run_2_treatment "various" "platinum" "taxane"
22 Q0 26183044 138 28.41233 imi_mug_run_2_treatment "oxaliplatin" "capecitabine" "panitumumab"
22 Q0 26498688 139 28.360462 imi_mug_run_2_treatment "level"
22 Q0 28179590 140 28.357431 imi_mug_run_2_treatment "others"
22 Q0 18757405 141 28.337345 imi_mug_run_2_treatment "mediated"
22 Q0 24175777 142 28.305794 imi_mug_run_2_treatment "level" "aim"
22 Q0 19789314 143 28.305794 imi_mug_run_2_treatment "agent" "aim"
22 Q0 20954287 144 28.302685 imi_mug_run_2_treatment "level" "aim"
22 Q0 24576621 145 28.286758 imi_mug_run_2_treatment "mediated" "pd-0325901" "nvp-bkm120"
22 Q0 19394761 146 28.237713 imi_mug_run_2_treatment "cisplatin"
22 Q0 25688137 147 28.232306 imi_mug_run_2_treatment "nvp-byl719"
22 Q0 24364210 148 28.199654 imi_mug_run_2_treatment "lead"
22 Q0 15950905 149 28.089249 imi_mug_run_2_treatment "ly294002"
22 Q0 28060766 150 28.080175 imi_mug_run_2_treatment "mediated"
22 Q0 22997091 151 28.03725 imi_mug_run_2_treatment "basis" "hot spot"
22 Q0 24241346 152 28.030834 imi_mug_run_2_treatment "aim"
22 Q0 16288007 153 28.020672 imi_mug_run_2_treatment "ras"
22 Q0 21999454 154 27.907906 imi_mug_run_2_treatment "fiber" "level"
22 Q0 26540293 155 27.888964 imi_mug_run_2_treatment "ras"
22 Q0 29704890 156 27.848776 imi_mug_run_2_treatment "akt inhibitor azd5363"
22 Q0 20557351 157 27.813429 imi_mug_run_2_treatment "mediated"
22 Q0 23593290 158 27.770184 imi_mug_run_2_treatment "therapeutics" "mtor inhibitor"
22 Q0 19723919 159 27.75595 imi_mug_run_2_treatment "cyclin-dependent kinase inhibitor"
22 Q0 24599934 160 27.730953 imi_mug_run_2_treatment "mtor inhibitor"
22 Q0 25623536 161 27.723146 imi_mug_run_2_treatment "medicine" "lead"
22 Q0 23971979 162 27.704796 imi_mug_run_2_treatment "mbc"
22 Q0 29807405 163 27.668627 imi_mug_run_2_treatment "osimertinib" "therapeutics"
22 Q0 22955107 164 27.664555 imi_mug_run_2_treatment "aim"
22 Q0 21324922 165 27.664555 imi_mug_run_2_treatment "animals"
22 Q0 24774510 166 27.65592 imi_mug_run_2_treatment "ras"
22 Q0 27391152 167 27.62732 imi_mug_run_2_treatment "level"
22 Q0 24077110 168 27.56287 imi_mug_run_2_treatment "drugs" "inositol" "aim"
22 Q0 28450943 169 27.530888 imi_mug_run_2_treatment "aim"
22 Q0 28532501 170 27.530792 imi_mug_run_2_treatment "combinations" "lead"
22 Q0 19789347 171 27.504013 imi_mug_run_2_treatment "mediators" "ras" "tet"
22 Q0 28247844 172 27.501438 imi_mug_run_2_treatment "hsa-mir-152"
22 Q0 28843257 173 27.501438 imi_mug_run_2_treatment "drug" "trastuzumab" "drugs"
22 Q0 29169370 174 27.478329 imi_mug_run_2_treatment "various" "platinum" "cisplatin"
22 Q0 26105797 175 27.454542 imi_mug_run_2_treatment "trastuzumab"
22 Q0 28928860 176 27.425707 imi_mug_run_2_treatment "cetuximab" "ras" "everolimus"
22 Q0 15784156 177 27.405922 imi_mug_run_2_treatment "various" "sam"
22 Q0 16150444 178 27.388163 imi_mug_run_2_treatment "igf-1" "lead" "duration"
22 Q0 28536037 179 27.366032 imi_mug_run_2_treatment "adc" "drug" "ras"
22 Q0 28269754 180 27.343555 imi_mug_run_2_treatment "various"
22 Q0 27835884 181 27.316082 imi_mug_run_2_treatment "pdx" "celecoxib" "aspirin"
22 Q0 26452060 182 27.281437 imi_mug_run_2_treatment "aim"
22 Q0 18074223 183 27.266663 imi_mug_run_2_treatment "ly294002"
22 Q0 23768168 184 27.264387 imi_mug_run_2_treatment "therapeutics"
22 Q0 27426307 185 27.185886 imi_mug_run_2_treatment "parp inhibitor" "olaparib" "pi3k inhibitor bkm120"
22 Q0 26266985 186 27.153942 imi_mug_run_2_treatment "program"
22 Q0 27879995 187 27.151136 imi_mug_run_2_treatment "ras" "silver" "aim"
22 Q0 25771729 188 27.112602 imi_mug_run_2_treatment "hot spot"
22 Q0 29720878 189 27.096825 imi_mug_run_2_treatment "aim" "plasma"
22 Q0 25559818 190 27.082676 imi_mug_run_2_treatment "trastuzumab" "lapatinib"
22 Q0 26600545 191 26.992424 imi_mug_run_2_treatment "ras"
22 Q0 22271473 192 26.99138 imi_mug_run_2_treatment "program"
22 Q0 24920352 193 26.989044 imi_mug_run_2_treatment "bisphosphonate"
22 Q0 21113138 194 26.969814 imi_mug_run_2_treatment "ras"
22 Q0 25877892 195 26.94705 imi_mug_run_2_treatment "mediated" "ras"
22 Q0 23986086 196 26.94596 imi_mug_run_2_treatment "drug" "com" "insulin"
22 Q0 26716438 197 26.903582 imi_mug_run_2_treatment "medicine"
22 Q0 24533074 198 26.879845 imi_mug_run_2_treatment "various"
22 Q0 17409929 199 26.860962 imi_mug_run_2_treatment "gefitinib" "tyrosine kinase inhibitor"
22 Q0 25542038 200 26.827457 imi_mug_run_2_treatment "trastuzumab"
22 Q0 26968397 201 26.80002 imi_mug_run_2_treatment "her-2" "aim"
22 Q0 26587011 202 26.735556 imi_mug_run_2_treatment "aim"
22 Q0 18270270 203 26.722809 imi_mug_run_2_treatment "mediators" "suppressor"
22 Q0 28453696 204 26.7127 imi_mug_run_2_treatment "hot spot" "lead"
22 Q0 18000091 205 26.695515 imi_mug_run_2_treatment "various" "ras" "ptc"
22 Q0 26712086 206 26.637724 imi_mug_run_2_treatment "aspirin" "adjuvant" "aim"
22 Q0 26747178 207 26.635067 imi_mug_run_2_treatment "drug"
22 Q0 24467828 208 26.611149 imi_mug_run_2_treatment "tamoxifen" "adjuvant"
22 Q0 18619647 209 26.604736 imi_mug_run_2_treatment "insulin-like growth factor ii"
22 Q0 21216929 210 26.578194 imi_mug_run_2_treatment "program"
22 Q0 30518672 211 26.568268 imi_mug_run_2_treatment "pdx"
22 Q0 29484141 212 26.551168 imi_mug_run_2_treatment "level"
22 Q0 22807617 213 26.542051 imi_mug_run_2_treatment "agar" "aim"
22 Q0 22812189 214 26.527996 imi_mug_run_2_treatment "cisplatin" "drug" "mediated"
22 Q0 28662101 215 26.518246 imi_mug_run_2_treatment "ipa" "inositol" "phosphate"
22 Q0 25199759 216 26.51166 imi_mug_run_2_treatment "taxane" "trastuzumab" "lapatinib"
22 Q0 22810696 217 26.494125 imi_mug_run_2_treatment "drug" "igf2"
22 Q0 27143928 218 26.480755 imi_mug_run_2_treatment "various"
22 Q0 30426328 219 26.472336 imi_mug_run_2_treatment "formalin"
22 Q0 23741067 220 26.378021 imi_mug_run_2_treatment "cetuximab" "oxaliplatin" "fluoropyrimidine"
22 Q0 19010894 221 26.343548 imi_mug_run_2_treatment "lapatinib" "trastuzumab" "tyrosine kinase inhibitor"
22 Q0 24062397 222 26.322807 imi_mug_run_2_treatment "aspirin" "rofecoxib" "anti-inflammatory"
22 Q0 25701704 223 26.307072 imi_mug_run_2_treatment "level"
22 Q0 28069289 224 26.302147 imi_mug_run_2_treatment "plasma"
22 Q0 27491861 225 26.290487 imi_mug_run_2_treatment "aromatase inhibitor" "letrozole" "aromatase inhibitors"
22 Q0 19276248 226 26.247961 imi_mug_run_2_treatment "estrogen" "adjuvant" "product"
22 Q0 26889984 227 26.228748 imi_mug_run_2_treatment "hot spot"
22 Q0 27108388 228 26.228428 imi_mug_run_2_treatment "therapeutics"
22 Q0 29575819 229 26.219648 imi_mug_run_2_treatment "pooled"
22 Q0 19697359 230 26.207878 imi_mug_run_2_treatment "level"
22 Q0 26567140 231 26.145977 imi_mug_run_2_treatment "mediated"
22 Q0 23903756 232 26.139473 imi_mug_run_2_treatment "drugs" "insulin-like growth factor 1" "rad001"
22 Q0 23612454 233 26.110853 imi_mug_run_2_treatment "trastuzumab" "docetaxel" "adjuvant"
22 Q0 23548132 234 26.108072 imi_mug_run_2_treatment "ras"
22 Q0 19223544 235 26.09977 imi_mug_run_2_treatment "cetuximab" "panitumumab" "monoclonal antibodies"
22 Q0 19172191 236 26.086615 imi_mug_run_2_treatment "various" "ras"
22 Q0 22172323 237 26.05728 imi_mug_run_2_treatment "trastuzumab" "adjuvant" "cyclophosphamide"
22 Q0 20479250 238 26.050053 imi_mug_run_2_treatment "tamoxifen"
22 Q0 21829508 239 26.038307 imi_mug_run_2_treatment "ras" "various"
22 Q0 21558396 240 25.977804 imi_mug_run_2_treatment "ch5132799" "trastuzumab" "basis"
22 Q0 26234639 241 25.966093 imi_mug_run_2_treatment "plasma"
22 Q0 15928251 242 25.95748 imi_mug_run_2_treatment "various"
22 Q0 28068936 243 25.948277 imi_mug_run_2_treatment "ras" "bevacizumab"
22 Q0 25176561 244 25.937614 imi_mug_run_2_treatment "sex hormone"
22 Q0 27369359 245 25.930315 imi_mug_run_2_treatment "taxanes"
22 Q0 19027487 246 25.922874 imi_mug_run_2_treatment "hot spot" "lead"
22 Q0 27265061 247 25.834694 imi_mug_run_2_treatment "mbc" "plasma"
22 Q0 27267833 248 25.827713 imi_mug_run_2_treatment "drugs"
22 Q0 23450128 249 25.77586 imi_mug_run_2_treatment "erlotinib" "egfr inhibitor"
22 Q0 30075505 250 25.711853 imi_mug_run_2_treatment "cisplatin" "aim"
22 Q0 23787421 251 25.690086 imi_mug_run_2_treatment "hot spot"
22 Q0 21093899 252 25.689075 imi_mug_run_2_treatment "various" "ors"
22 Q0 21209903 253 25.684082 imi_mug_run_2_treatment "lead"
22 Q0 28572531 254 25.66301 imi_mug_run_2_treatment "osimertinib"
22 Q0 17060456 255 25.619282 imi_mug_run_2_treatment "mediated" "lead" "program"
22 Q0 29401002 256 25.612652 imi_mug_run_2_treatment "alpelisib" "agent" "byl719"
22 Q0 22752425 257 25.611233 imi_mug_run_2_treatment "ras"
22 Q0 22949682 258 25.609005 imi_mug_run_2_treatment "ras"
22 Q0 21358673 259 25.605352 imi_mug_run_2_treatment "drugs" "everolimus" "kinase inhibitor"
22 Q0 29470143 260 25.577099 imi_mug_run_2_treatment "pooled"
22 Q0 23207797 261 25.568537 imi_mug_run_2_treatment "aspirin" "adjuvant"
22 Q0 19790197 262 25.546473 imi_mug_run_2_treatment "various"
22 Q0 29689710 263 25.542105 imi_mug_run_2_treatment "plasma" "mbc"
22 Q0 26334097 264 25.537155 imi_mug_run_2_treatment "aim"
22 Q0 27127129 265 25.537155 imi_mug_run_2_treatment "nervous system"
22 Q0 25979833 266 25.533577 imi_mug_run_2_treatment "cetuximab" "liver"
22 Q0 23940356 267 25.51154 imi_mug_run_2_treatment "combinations" "mediated" "trastuzumab"
22 Q0 23671647 268 25.493015 imi_mug_run_2_treatment "panitumumab" "cetuximab"
22 Q0 26053643 269 25.462067 imi_mug_run_2_treatment "therapeutic agents" "aim"
22 Q0 28181739 270 25.455109 imi_mug_run_2_treatment "various"
22 Q0 19430491 271 25.4272 imi_mug_run_2_treatment "urokinase plasminogen activator" "suppressor"
22 Q0 25886136 272 25.421783 imi_mug_run_2_treatment "ras"
22 Q0 23393606 273 25.393574 imi_mug_run_2_treatment "drugs" "cisplatin" "drug"
22 Q0 26266975 274 25.370518 imi_mug_run_2_treatment "committed"
22 Q0 17050665 275 25.31969 imi_mug_run_2_treatment "enzymes"
22 Q0 24444464 276 25.319057 imi_mug_run_2_treatment "plasma"
22 Q0 17546593 277 25.316105 imi_mug_run_2_treatment "various" "liver"
22 Q0 27436848 278 25.30437 imi_mug_run_2_treatment "pooled"
22 Q0 30085422 279 25.258366 imi_mug_run_2_treatment "ras"
22 Q0 24240111 280 25.257072 imi_mug_run_2_treatment "pf-4989216" "cancer drug" "mediated"
22 Q0 27007084 281 25.194954 imi_mug_run_2_treatment "adc"
22 Q0 15647370 282 25.131945 imi_mug_run_2_treatment "tor" "inositol"
22 Q0 25550888 283 25.113155 imi_mug_run_2_treatment "enzymes"
22 Q0 25908046 284 25.06682 imi_mug_run_2_treatment "various" "hot spot"
22 Q0 24218517 285 25.053776 imi_mug_run_2_treatment "cetuximab"
22 Q0 23219661 286 25.029959 imi_mug_run_2_treatment "hot spot"
22 Q0 25197873 287 24.997816 imi_mug_run_2_treatment "pdx" "lead"
22 Q0 22807977 288 24.997816 imi_mug_run_2_treatment "cyclophosphamide" "docetaxel"
22 Q0 25501831 289 24.931581 imi_mug_run_2_treatment "drugs" "therapeutics" "bortezomib"
22 Q0 25539732 290 24.927923 imi_mug_run_2_treatment "mbc" "level" "isolate"
22 Q0 26301495 291 24.908813 imi_mug_run_2_treatment "trastuzumab"
22 Q0 23574264 292 24.907932 imi_mug_run_2_treatment "trastuzumab" "adjuvant"
22 Q0 23370426 293 24.906122 imi_mug_run_2_treatment "various"
22 Q0 30443844 294 24.87577 imi_mug_run_2_treatment "basis"
22 Q0 24642661 295 24.816196 imi_mug_run_2_treatment "drug"
22 Q0 26453385 296 24.816196 imi_mug_run_2_treatment "various"
22 Q0 24701207 297 24.814287 imi_mug_run_2_treatment "cetuximab" "panitumumab" "anti-epidermal growth factor receptor monoclonal antibody"
22 Q0 30501041 298 24.811968 imi_mug_run_2_treatment "plasma"
22 Q0 26604793 299 24.801558 imi_mug_run_2_treatment "various"
22 Q0 25220802 300 24.798534 imi_mug_run_2_treatment "gold"
22 Q0 23665971 301 24.784101 imi_mug_run_2_treatment "aim" "liver"
22 Q0 27941987 302 24.783367 imi_mug_run_2_treatment "various"
22 Q0 27296758 303 24.741293 imi_mug_run_2_treatment "various" "morpholine" "acetamide"
22 Q0 30237504 304 24.733875 imi_mug_run_2_treatment "gdc0032" "insulin" "combinations"
22 Q0 28036259 305 24.715128 imi_mug_run_2_treatment "bkm120" "hcq" "hydroxychloroquine"
22 Q0 21474066 306 24.707718 imi_mug_run_2_treatment "ras"
22 Q0 30115035 307 24.702345 imi_mug_run_2_treatment "drugs"
22 Q0 26028978 308 24.665823 imi_mug_run_2_treatment "trastuzumab" "level"
22 Q0 20177704 309 24.658854 imi_mug_run_2_treatment "various"
22 Q0 19638206 310 24.607922 imi_mug_run_2_treatment "various"
22 Q0 25838920 311 24.577162 imi_mug_run_2_treatment "enzymes"
22 Q0 30093452 312 24.564606 imi_mug_run_2_treatment "pdx" "drugs" "agent"
22 Q0 24705275 313 24.516804 imi_mug_run_2_treatment "mk-2206" "deoxyglucose" "glucose"
22 Q0 25865669 314 24.49641 imi_mug_run_2_treatment "cetuximab" "bevacizumab" "aim"
22 Q0 21072204 315 24.399586 imi_mug_run_2_treatment "ras"
22 Q0 25106743 316 24.392515 imi_mug_run_2_treatment "aim"
22 Q0 22994622 317 24.388283 imi_mug_run_2_treatment "ras"
22 Q0 29170395 318 24.384712 imi_mug_run_2_treatment "lead"
22 Q0 19305151 319 24.368114 imi_mug_run_2_treatment "various"
22 Q0 29666387 320 24.362549 imi_mug_run_2_treatment "ras"
22 Q0 22828149 321 24.331032 imi_mug_run_2_treatment "ras" "fluorouracil"
22 Q0 19349352 322 24.330254 imi_mug_run_2_treatment "drugs" "platinum"
22 Q0 25458846 323 24.298746 imi_mug_run_2_treatment "suppressor"
22 Q0 26136684 324 24.290323 imi_mug_run_2_treatment "drug combination" "kinase inhibitor" "mek inhibitor"
22 Q0 24666267 325 24.27176 imi_mug_run_2_treatment "ras" "panitumumab" "cetuximab"
22 Q0 16822308 326 24.254423 imi_mug_run_2_treatment "ras" "crest"
22 Q0 27681437 327 24.245018 imi_mug_run_2_treatment "carboplatin" "mediated" "cytokines"
22 Q0 23826249 328 24.224306 imi_mug_run_2_treatment "various" "pf-04691502" "mtor inhibitor"
22 Q0 26909613 329 24.195312 imi_mug_run_2_treatment "parp inhibitor" "drug combination" "olaparib"
22 Q0 25816324 330 24.194126 imi_mug_run_2_treatment "endocrine therapy"
22 Q0 22553375 331 24.18237 imi_mug_run_2_treatment "saracatinib"
22 Q0 23475782 332 24.155952 imi_mug_run_2_treatment "lead" "mtor inhibitor"
22 Q0 23435830 333 24.139032 imi_mug_run_2_treatment "anti-egfr monoclonal antibody"
22 Q0 22417847 334 24.135174 imi_mug_run_2_treatment "ras" "combinations"
22 Q0 23302486 335 24.073027 imi_mug_run_2_treatment "liver"
22 Q0 21663621 336 24.057663 imi_mug_run_2_treatment "various" "mediated"
22 Q0 16906227 337 24.0403 imi_mug_run_2_treatment "gefitinib" "erlotinib"
22 Q0 22840369 338 23.972858 imi_mug_run_2_treatment "drug"
22 Q0 19366826 339 23.855574 imi_mug_run_2_treatment "cetuximab" "irinotecan" "erbitux"
22 Q0 28478451 340 23.84116 imi_mug_run_2_treatment "trastuzumab" "capecitabine" "lapatinib"
22 Q0 29707142 341 23.838589 imi_mug_run_2_treatment "serine" "endocrine therapy"
22 Q0 16353168 342 23.824036 imi_mug_run_2_treatment "basis"
22 Q0 26701847 343 23.794369 imi_mug_run_2_treatment "liver"
22 Q0 27565922 344 23.790543 imi_mug_run_2_treatment "hot spot" "aim"
22 Q0 28133136 345 23.776926 imi_mug_run_2_treatment "cetuximab"
22 Q0 27940576 346 23.774982 imi_mug_run_2_treatment "aspirin" "mediated"
22 Q0 26796526 347 23.76631 imi_mug_run_2_treatment "imatinib"
22 Q0 21826083 348 23.762018 imi_mug_run_2_treatment "medicine"
22 Q0 26243863 349 23.701687 imi_mug_run_2_treatment "drug" "trastuzumab" "pdx"
22 Q0 23878352 350 23.701687 imi_mug_run_2_treatment "level"
22 Q0 26184520 351 23.692179 imi_mug_run_2_treatment "regorafenib" "plasma" "von willebrand factor"
22 Q0 25002028 352 23.680885 imi_mug_run_2_treatment "agent"
22 Q0 29476223 353 23.673393 imi_mug_run_2_treatment "everolimus" "drug" "immunosuppressive"
22 Q0 24838432 354 23.66237 imi_mug_run_2_treatment "asc" "aim"
22 Q0 24366379 355 23.61636 imi_mug_run_2_treatment "level"
22 Q0 26691448 356 23.598986 imi_mug_run_2_treatment "aim"
22 Q0 29482551 357 23.587032 imi_mug_run_2_treatment "plasma" "mbc"
22 Q0 25639985 358 23.559269 imi_mug_run_2_treatment "pooled"
22 Q0 27374168 359 23.500483 imi_mug_run_2_treatment "basis"
22 Q0 25550549 360 23.47659 imi_mug_run_2_treatment "agent" "byl719" "dacomitinib"
22 Q0 21594665 361 23.461948 imi_mug_run_2_treatment "trastuzumab" "mbc" "formalin"
22 Q0 15805248 362 23.45812 imi_mug_run_2_treatment "estrogen"
22 Q0 27582428 363 23.435226 imi_mug_run_2_treatment "various" "gsk690693"
22 Q0 29755687 364 23.42342 imi_mug_run_2_treatment "ras"
22 Q0 28539475 365 23.405048 imi_mug_run_2_treatment "basis" "blockade"
22 Q0 26553611 366 23.386116 imi_mug_run_2_treatment "temozolomide" "gemcitabine" "irinotecan"
22 Q0 21163770 367 23.374813 imi_mug_run_2_treatment "cetuximab" "anti-vegf" "panitumumab"
22 Q0 18782444 368 23.330618 imi_mug_run_2_treatment "bisulfite" "lead"
22 Q0 26995633 369 23.328876 imi_mug_run_2_treatment "adjuvant" "paclitaxel"
22 Q0 18343945 370 23.27277 imi_mug_run_2_treatment "various" "ras"
22 Q0 30187361 371 23.269281 imi_mug_run_2_treatment "alpelisib" "fulvestrant"
22 Q0 26802026 372 23.249363 imi_mug_run_2_treatment "drug" "ras" "bafilomycin a1"
22 Q0 21124076 373 23.211206 imi_mug_run_2_treatment "lithium"
22 Q0 23564819 374 23.204634 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
22 Q0 25239119 375 23.194817 imi_mug_run_2_treatment "aspirin"
22 Q0 22039088 376 23.177774 imi_mug_run_2_treatment "monoclonal antibodies"
22 Q0 29708279 377 23.176643 imi_mug_run_2_treatment "cyclin-dependent kinase inhibitor"
22 Q0 22638623 378 23.151556 imi_mug_run_2_treatment "cetuximab" "irinotecan" "oxaliplatin"
22 Q0 29978469 379 23.151556 imi_mug_run_2_treatment "gedatolisib" "mtor inhibitor" "mediated"
22 Q0 27401370 380 23.14921 imi_mug_run_2_treatment "cisplatin" "serine" "platinum"
22 Q0 26107237 381 23.13643 imi_mug_run_2_treatment "ras"
22 Q0 28004037 382 23.115364 imi_mug_run_2_treatment "ras" "hs-173" "resazurin"
22 Q0 17052259 383 23.113117 imi_mug_run_2_treatment "various"
22 Q0 27107065 384 23.093426 imi_mug_run_2_treatment "aim"
22 Q0 25220666 385 23.082527 imi_mug_run_2_treatment "cytotoxic drugs"
22 Q0 22840368 386 22.947268 imi_mug_run_2_treatment "insulin-like growth factor 2"
22 Q0 25023548 387 22.884241 imi_mug_run_2_treatment "various" "bisphosphonate"
22 Q0 26333383 388 22.844856 imi_mug_run_2_treatment "agent" "neratinib" "taselisib"
22 Q0 19186181 389 22.835848 imi_mug_run_2_treatment "mediators"
22 Q0 19470733 390 22.803242 imi_mug_run_2_treatment "igf2" "level"
22 Q0 20379197 391 22.793102 imi_mug_run_2_treatment "mediated" "shape"
22 Q0 15790433 392 22.730083 imi_mug_run_2_treatment "cddp" "drug" "cisplatin"
22 Q0 21335596 393 22.697691 imi_mug_run_2_treatment "cid1340132"
22 Q0 16391859 394 22.690096 imi_mug_run_2_treatment "program"
22 Q0 20616362 395 22.690096 imi_mug_run_2_treatment "trastuzumab"
22 Q0 26832731 396 22.690096 imi_mug_run_2_treatment "cetuximab" "level" "aim"
22 Q0 28243898 397 22.689804 imi_mug_run_2_treatment "lead"
22 Q0 26155992 398 22.682938 imi_mug_run_2_treatment "others"
22 Q0 21735444 399 22.681683 imi_mug_run_2_treatment "kinase inhibitor"
22 Q0 20664174 400 22.680855 imi_mug_run_2_treatment "drug" "everolimus" "alpha subunit"
22 Q0 24910434 401 22.668188 imi_mug_run_2_treatment "mediated" "hot spot"
22 Q0 26559013 402 22.637894 imi_mug_run_2_treatment "suppressor"
22 Q0 23580570 403 22.631363 imi_mug_run_2_treatment "ras" "mediated"
22 Q0 28685592 404 22.630615 imi_mug_run_2_treatment "aim"
22 Q0 21499301 405 22.63031 imi_mug_run_2_treatment "lapatinib" "mediated" "tyrosine kinase inhibitor"
22 Q0 28356789 406 22.606749 imi_mug_run_2_treatment "bevacizumab" "level" "oxaliplatin"
22 Q0 21225506 407 22.604818 imi_mug_run_2_treatment "product" "aim" "suppressor"
22 Q0 17936563 408 22.590157 imi_mug_run_2_treatment "trastuzumab"
22 Q0 26181325 409 22.586956 imi_mug_run_2_treatment "combinations" "lapatinib" "drugs"
22 Q0 23633485 410 22.569742 imi_mug_run_2_treatment "lapatinib" "mediated" "blockade"
22 Q0 16721043 411 22.560013 imi_mug_run_2_treatment "color" "lead" "level"
22 Q0 23800934 412 22.491917 imi_mug_run_2_treatment "aspirin" "aspirin tablets"
22 Q0 22675430 413 22.451015 imi_mug_run_2_treatment "drugs" "mitogen"
22 Q0 22146979 414 22.44965 imi_mug_run_2_treatment "ras"
22 Q0 22302407 415 22.427845 imi_mug_run_2_treatment "aim"
22 Q0 28231819 416 22.406109 imi_mug_run_2_treatment "cancer vaccine" "cancer vaccines"
22 Q0 17376864 417 22.404833 imi_mug_run_2_treatment "tor" "mediated"
22 Q0 24595598 418 22.388931 imi_mug_run_2_treatment "cetuximab" "formalin" "others"
22 Q0 12874030 419 22.376133 imi_mug_run_2_treatment "ly294002" "kinase inhibitor" "vascular endothelial growth factor"
22 Q0 19492075 420 22.36362 imi_mug_run_2_treatment "ras"
22 Q0 21531819 421 22.347742 imi_mug_run_2_treatment "basis"
22 Q0 30219720 422 22.333328 imi_mug_run_2_treatment "level" "plasma" "vitamin d"
22 Q0 20664172 423 22.331001 imi_mug_run_2_treatment "everolimus" "drug" "medicine"
22 Q0 24352906 424 22.31928 imi_mug_run_2_treatment "therapeutics" "ras"
22 Q0 22983389 425 22.312403 imi_mug_run_2_treatment "various" "lead" "liver"
22 Q0 26175928 426 22.3111 imi_mug_run_2_treatment "ors" "epidermal growth factor receptor tyrosine kinase inhibitor"
22 Q0 26758558 427 22.298473 imi_mug_run_2_treatment "cyclophosphamide" "epirubicin" "taxane"
22 Q0 22658544 428 22.278034 imi_mug_run_2_treatment "cloves"
22 Q0 26733612 429 22.254225 imi_mug_run_2_treatment "antiestrogen" "fulvestrant" "antiestrogens"
22 Q0 24649121 430 22.169022 imi_mug_run_2_treatment "trastuzumab"
22 Q0 22543857 431 22.157467 imi_mug_run_2_treatment "bkm120" "tyrosine" "irinotecan"
22 Q0 28184015 432 22.155153 imi_mug_run_2_treatment "ly3023414"
22 Q0 25103565 433 22.137138 imi_mug_run_2_treatment "bicalutamide" "mtor inhibitor" "gdc-0980"
22 Q0 23317280 434 22.12921 imi_mug_run_2_treatment "ras" "therapeutics" "lead"
22 Q0 29191607 435 22.126556 imi_mug_run_2_treatment "gold"
22 Q0 22245973 436 22.12416 imi_mug_run_2_treatment "temsirolimus" "rapamycin analog" "agent"
22 Q0 26882569 437 22.099009 imi_mug_run_2_treatment "trametinib"
22 Q0 19844788 438 22.093061 imi_mug_run_2_treatment "endocrine therapy" "inositol"
22 Q0 30018674 439 22.071142 imi_mug_run_2_treatment "aim"
22 Q0 28427202 440 22.055864 imi_mug_run_2_treatment "mbc"
22 Q0 24770869 441 22.05222 imi_mug_run_2_treatment "various" "ptc" "lead"
22 Q0 20808308 442 22.050018 imi_mug_run_2_treatment "various" "cytotoxic" "suppressor"
22 Q0 26289070 443 22.021812 imi_mug_run_2_treatment "pdx" "kinase inhibitor" "agent"
22 Q0 29110152 444 22.019135 imi_mug_run_2_treatment "trastuzumab" "lapatinib"
22 Q0 23499052 445 22.0088 imi_mug_run_2_treatment "drugs"
22 Q0 29279289 446 22.007385 imi_mug_run_2_treatment "icc" "ras"
22 Q0 21966435 447 22.003765 imi_mug_run_2_treatment "mtor inhibitor" "blockade"
22 Q0 29380640 448 22.003765 imi_mug_run_2_treatment "ras" "irinotecan" "oxaliplatin"
22 Q0 12569555 449 21.997961 imi_mug_run_2_treatment "methylated"
22 Q0 25388762 450 21.980743 imi_mug_run_2_treatment "aspirin" "abt-737" "drug"
22 Q0 20619739 451 21.962107 imi_mug_run_2_treatment "cetuximab" "panitumumab"
22 Q0 26423386 452 21.944202 imi_mug_run_2_treatment "alcohol" "folic acid" "vitamin"
22 Q0 27177864 453 21.92502 imi_mug_run_2_treatment "trastuzumab" "lapatinib" "taxane"
22 Q0 24908061 454 21.902699 imi_mug_run_2_treatment "progestin"
22 Q0 26907767 455 21.895924 imi_mug_run_2_treatment "aim"
22 Q0 24122611 456 21.89244 imi_mug_run_2_treatment "drugs"
22 Q0 20804548 457 21.884699 imi_mug_run_2_treatment "ptc" "various" "aim"
22 Q0 17924977 458 21.87702 imi_mug_run_2_treatment "ras"
22 Q0 21744334 459 21.848516 imi_mug_run_2_treatment "aim"
22 Q0 29259101 460 21.826895 imi_mug_run_2_treatment "cystine" "methionine"
22 Q0 29153543 461 21.822348 imi_mug_run_2_treatment "aspirin" "anti-inflammatory"
22 Q0 11959846 462 21.81945 imi_mug_run_2_treatment "mediated"
22 Q0 22779686 463 21.81945 imi_mug_run_2_treatment "various"
22 Q0 26350096 464 21.793179 imi_mug_run_2_treatment "ras" "mediated" "docetaxel"
22 Q0 18951408 465 21.780617 imi_mug_run_2_treatment "salt" "product"
22 Q0 27995550 466 21.772522 imi_mug_run_2_treatment "androgen" "medicine"
22 Q0 17471559 467 21.76907 imi_mug_run_2_treatment "level"
22 Q0 24918944 468 21.747202 imi_mug_run_2_treatment "various"
22 Q0 20617378 469 21.668133 imi_mug_run_2_treatment "oestrogen" "level" "aim"
22 Q0 26598515 470 21.604214 imi_mug_run_2_treatment "plasma" "level"
22 Q0 29892689 471 21.603628 imi_mug_run_2_treatment "pembrolizumab"
22 Q0 22723336 472 21.591635 imi_mug_run_2_treatment "mta" "mek inhibitor" "program"
22 Q0 26299862 473 21.563019 imi_mug_run_2_treatment "monoclonal antibodies"
22 Q0 30180809 474 21.561203 imi_mug_run_2_treatment "various"
22 Q0 27806348 475 21.559376 imi_mug_run_2_treatment "mbc"
22 Q0 26436951 476 21.553541 imi_mug_run_2_treatment "mediated"
22 Q0 20416519 477 21.5461 imi_mug_run_2_treatment "aim"
22 Q0 22285706 478 21.544235 imi_mug_run_2_treatment "panitumumab" "cetuximab"
22 Q0 22070922 479 21.524048 imi_mug_run_2_treatment "mediated"
22 Q0 28947962 480 21.512695 imi_mug_run_2_treatment "azacytidine" "mediated" "level"
22 Q0 18755892 481 21.508284 imi_mug_run_2_treatment "product" "basis"
22 Q0 27095166 482 21.497139 imi_mug_run_2_treatment "suppressor"
22 Q0 21804920 483 21.491198 imi_mug_run_2_treatment "ly294002"
22 Q0 26603012 484 21.466318 imi_mug_run_2_treatment "aim"
22 Q0 28384037 485 21.405994 imi_mug_run_2_treatment "various" "aim"
22 Q0 30275180 486 21.40083 imi_mug_run_2_treatment "ras" "basis"
22 Q0 24840525 487 21.372944 imi_mug_run_2_treatment "aspirin" "platelets" "therapeutic agent"
22 Q0 19584150 488 21.367762 imi_mug_run_2_treatment "level"
22 Q0 29550144 489 21.358055 imi_mug_run_2_treatment "saracatinib" "ly294002" "product"
22 Q0 26536195 490 21.350506 imi_mug_run_2_treatment "others"
22 Q0 24947048 491 21.332455 imi_mug_run_2_treatment "dtc" "drug" "therapeutics"
22 Q0 28887744 492 21.314684 imi_mug_run_2_treatment "aim"
22 Q0 18977806 493 21.313766 imi_mug_run_2_treatment "ras"
22 Q0 23739063 494 21.29673 imi_mug_run_2_treatment "trastuzumab" "adjuvant"
22 Q0 15662137 495 21.235659 imi_mug_run_2_treatment "various"
22 Q0 21479466 496 21.235659 imi_mug_run_2_treatment "ras"
22 Q0 25402391 497 21.223999 imi_mug_run_2_treatment "rhtsh" "l-t4"
22 Q0 15542426 498 21.19995 imi_mug_run_2_treatment "others"
22 Q0 26946357 499 21.175755 imi_mug_run_2_treatment "cisplatin"
22 Q0 25625625 500 21.159641 imi_mug_run_2_treatment "bkm120"
22 Q0 24981670 501 21.13266 imi_mug_run_2_treatment "anastrozole"
22 Q0 24839940 502 21.124367 imi_mug_run_2_treatment "anti-egfr monoclonal antibody" "aim"
22 Q0 25490678 503 21.115086 imi_mug_run_2_treatment "mbc"
22 Q0 26957558 504 21.085821 imi_mug_run_2_treatment "enzymes" "level" "aspirin"
22 Q0 29115399 505 21.07555 imi_mug_run_2_treatment "level" "genesis"
22 Q0 19903845 506 20.993221 imi_mug_run_2_treatment "mediated" "lead"
22 Q0 21325073 507 20.989616 imi_mug_run_2_treatment "pki-587" "topoisomerase i inhibitor" "kinase inhibitor"
22 Q0 24320611 508 20.975874 imi_mug_run_2_treatment "tandem"
22 Q0 26991109 509 20.963842 imi_mug_run_2_treatment "silver" "aim"
22 Q0 30496799 510 20.963842 imi_mug_run_2_treatment "hemostatic"
22 Q0 29358619 511 20.951859 imi_mug_run_2_treatment "various" "khs101"
22 Q0 25320628 512 20.94554 imi_mug_run_2_treatment "antiangiogenic" "kinase inhibitor" "bevacizumab"
22 Q0 26920887 513 20.927277 imi_mug_run_2_treatment "t-dm1" "drug" "capecitabine"
22 Q0 21676217 514 20.894886 imi_mug_run_2_treatment "lapatinib" "trastuzumab" "drugs"
22 Q0 26245675 515 20.8874 imi_mug_run_2_treatment "lapatinib" "trastuzumab" "program"
22 Q0 20813970 516 20.883888 imi_mug_run_2_treatment "trastuzumab"
22 Q0 25056500 517 20.88234 imi_mug_run_2_treatment "lapatinib" "paclitaxel"
22 Q0 16357568 518 20.874115 imi_mug_run_2_treatment "various" "therapeutics"
22 Q0 25886409 519 20.872696 imi_mug_run_2_treatment "various" "mtor inhibitor" "everolimus"
22 Q0 22870241 520 20.854275 imi_mug_run_2_treatment "fluoropyrimidine" "platinum" "aim"
22 Q0 23028762 521 20.839933 imi_mug_run_2_treatment "glucose" "glutamine" "lead"
22 Q0 25724520 522 20.829752 imi_mug_run_2_treatment "cetuximab" "cisplatin" "blockade"
22 Q0 29175387 523 20.823366 imi_mug_run_2_treatment "baicalein" "scutellaria baicalensis"
22 Q0 29086897 524 20.822678 imi_mug_run_2_treatment "endocrine therapy"
22 Q0 25559813 525 20.804981 imi_mug_run_2_treatment "adjuvant" "trastuzumab"
22 Q0 29598951 526 20.798658 imi_mug_run_2_treatment "product"
22 Q0 26827608 527 20.780548 imi_mug_run_2_treatment "wortmannin" "various" "arginine"
22 Q0 25444464 528 20.775574 imi_mug_run_2_treatment "ganetespib" "drug's" "agent"
22 Q0 24006859 529 20.733288 imi_mug_run_2_treatment "cetuximab"
22 Q0 29603332 530 20.728985 imi_mug_run_2_treatment "bptc"
22 Q0 23085752 531 20.717594 imi_mug_run_2_treatment "lead"
22 Q0 23154547 532 20.703907 imi_mug_run_2_treatment "formalin"
22 Q0 19366795 533 20.694254 imi_mug_run_2_treatment "estrogen" "estradiol" "endocrine therapy"
22 Q0 22696593 534 20.676731 imi_mug_run_2_treatment "sorafenib" "ras"
22 Q0 27332557 535 20.669563 imi_mug_run_2_treatment "combinations" "drug" "ras"
22 Q0 25453219 536 20.668447 imi_mug_run_2_treatment "drugs" "therapeutics"
22 Q0 25691283 537 20.638874 imi_mug_run_2_treatment "level"
22 Q0 24590635 538 20.635593 imi_mug_run_2_treatment "letrozole" "lapatinib" "medication"
22 Q0 20200425 539 20.631918 imi_mug_run_2_treatment "prostaglandin e2" "product" "igf2"
22 Q0 21168197 540 20.55708 imi_mug_run_2_treatment "various" "ras"
22 Q0 26311717 541 20.556488 imi_mug_run_2_treatment "level"
22 Q0 27095739 542 20.556488 imi_mug_run_2_treatment "drugs" "liver"
22 Q0 29854313 543 20.556488 imi_mug_run_2_treatment "basis"
22 Q0 24011769 544 20.544334 imi_mug_run_2_treatment "ras" "endocrine therapy"
22 Q0 22169769 545 20.541323 imi_mug_run_2_treatment "ras" "gsk1120212" "cytostatic"
22 Q0 30252727 546 20.533503 imi_mug_run_2_treatment "platinum"
22 Q0 19384426 547 20.523151 imi_mug_run_2_treatment "drug" "suppressor"
22 Q0 28874413 548 20.518335 imi_mug_run_2_treatment "mk-2206" "anastrozole" "estrogen"
22 Q0 24739824 549 20.511612 imi_mug_run_2_treatment "aim" "level"
22 Q0 30475534 550 20.511612 imi_mug_run_2_treatment "various"
22 Q0 25349966 551 20.498734 imi_mug_run_2_treatment "mk-2206" "drug" "edu"
22 Q0 27020207 552 20.498734 imi_mug_run_2_treatment "tma" "aim"
22 Q0 21726664 553 20.488068 imi_mug_run_2_treatment "medicine" "formalin"
22 Q0 26880326 554 20.467796 imi_mug_run_2_treatment "various" "enzymes" "level"
22 Q0 25013076 555 20.446768 imi_mug_run_2_treatment "drug" "others"
22 Q0 27174596 556 20.446768 imi_mug_run_2_treatment "fulvestrant" "aromatase inhibitor" "serd"
22 Q0 22729222 557 20.443056 imi_mug_run_2_treatment "epidermal growth factor"
22 Q0 21949851 558 20.433157 imi_mug_run_2_treatment "tgfb1"
22 Q0 22798500 559 20.402252 imi_mug_run_2_treatment "cetuximab"
22 Q0 30001368 560 20.396032 imi_mug_run_2_treatment "cetuximab" "level"
22 Q0 26667234 561 20.389732 imi_mug_run_2_treatment "plasma"
22 Q0 27033063 562 20.3691 imi_mug_run_2_treatment "aim"
22 Q0 22569004 563 20.364359 imi_mug_run_2_treatment "cetuximab"
22 Q0 21362200 564 20.357384 imi_mug_run_2_treatment "combinations" "fulvestrant" "drug"
22 Q0 22336586 565 20.354671 imi_mug_run_2_treatment "chemotherapeutic agent" "fluorouracil" "anti-cancer agents"
22 Q0 28178681 566 20.350245 imi_mug_run_2_treatment "ras"
22 Q0 22095222 567 20.346941 imi_mug_run_2_treatment "gefitinib"
22 Q0 26527317 568 20.327099 imi_mug_run_2_treatment "lead"
22 Q0 19357772 569 20.308266 imi_mug_run_2_treatment "level" "others"
22 Q0 26053092 570 20.308266 imi_mug_run_2_treatment "ras" "therapeutic agents"
22 Q0 25051360 571 20.251522 imi_mug_run_2_treatment "drug" "metformin"
22 Q0 25153497 572 20.220058 imi_mug_run_2_treatment "drugs" "hydrogel"
22 Q0 25850957 573 20.21909 imi_mug_run_2_treatment "aim"
22 Q0 24561032 574 20.1922 imi_mug_run_2_treatment "agent" "carboplatin" "mediated"
22 Q0 28693246 575 20.185835 imi_mug_run_2_treatment "ras"
22 Q0 22383975 576 20.1855 imi_mug_run_2_treatment "aim"
22 Q0 28750640 577 20.185495 imi_mug_run_2_treatment "carboplatin" "docetaxel" "trastuzumab"
22 Q0 29933569 578 20.174856 imi_mug_run_2_treatment "drug" "bosutinib" "alpelisib"
22 Q0 25491172 579 20.17149 imi_mug_run_2_treatment "ras" "liver"
22 Q0 27900088 580 20.167883 imi_mug_run_2_treatment "liver"
22 Q0 27388585 581 20.115246 imi_mug_run_2_treatment "androgen" "progesterone" "lead"
22 Q0 25332247 582 20.101458 imi_mug_run_2_treatment "pertuzumab" "docetaxel" "trastuzumab"
22 Q0 21772091 583 20.086018 imi_mug_run_2_treatment "ras" "various" "mtor inhibitor"
22 Q0 24942275 584 20.03495 imi_mug_run_2_treatment "cetuximab" "ras" "monoclonal antibodies"
22 Q0 19412426 585 20.030666 imi_mug_run_2_treatment "various"
22 Q0 30126855 586 20.027573 imi_mug_run_2_treatment "level" "agent" "oil"
22 Q0 30298385 587 20.025867 imi_mug_run_2_treatment "m4n" "rad001" "everolimus"
22 Q0 20371716 588 20.02371 imi_mug_run_2_treatment "pki-402"
22 Q0 17317825 589 20.021889 imi_mug_run_2_treatment "ptc" "ftc" "bta"
22 Q0 26901314 590 20.020647 imi_mug_run_2_treatment "pooled"
22 Q0 22895070 591 20.015678 imi_mug_run_2_treatment "combinations" "kinase inhibitor" "mtor inhibitor"
22 Q0 28296140 592 19.981853 imi_mug_run_2_treatment "igf-2" "drugs" "cytotoxic"
22 Q0 26665196 593 19.979813 imi_mug_run_2_treatment "trastuzumab" "fibroblast growth factor 2" "aim"
22 Q0 21140203 594 19.972702 imi_mug_run_2_treatment "igf2"
22 Q0 17047397 595 19.961615 imi_mug_run_2_treatment "mediated" "ras"
22 Q0 30231398 596 19.961277 imi_mug_run_2_treatment "drugs"
22 Q0 23236232 597 19.957571 imi_mug_run_2_treatment "aim"
22 Q0 28379870 598 19.918938 imi_mug_run_2_treatment "ras" "bevacizumab" "aim"
22 Q0 29537649 599 19.918938 imi_mug_run_2_treatment "aim"
22 Q0 21283802 600 19.91865 imi_mug_run_2_treatment "cetuximab"
22 Q0 26327923 601 19.906824 imi_mug_run_2_treatment "leucovorin" "oxaliplatin" "bevacizumab"
22 Q0 24913694 602 19.886293 imi_mug_run_2_treatment "various" "drugs"
22 Q0 23374602 603 19.836658 imi_mug_run_2_treatment "cetuximab" "ras" "monoclonal antibodies"
22 Q0 24327733 604 19.823277 imi_mug_run_2_treatment "ras" "agent"
22 Q0 23092874 605 19.823277 imi_mug_run_2_treatment "trastuzumab" "adjuvant"
22 Q0 19685490 606 19.780403 imi_mug_run_2_treatment "tamoxifen" "basis"
22 Q0 19272638 607 19.763577 imi_mug_run_2_treatment "phenol" "alpha subunit" "therapeutics"
22 Q0 19430421 608 19.760614 imi_mug_run_2_treatment "igf2"
22 Q0 27121209 609 19.733261 imi_mug_run_2_treatment "gefitinib" "egfr tyrosine kinase inhibitor"
22 Q0 22888282 610 19.730389 imi_mug_run_2_treatment "her-2"
22 Q0 26630576 611 19.724384 imi_mug_run_2_treatment "docetaxel"
22 Q0 25428177 612 19.724384 imi_mug_run_2_treatment "drugs" "docetaxel" "therapeutics"
22 Q0 28942013 613 19.701702 imi_mug_run_2_treatment "ras"
22 Q0 28085233 614 19.674175 imi_mug_run_2_treatment "aim"
22 Q0 26419959 615 19.645315 imi_mug_run_2_treatment "mediated" "level"
22 Q0 25457635 616 19.640253 imi_mug_run_2_treatment "medroxyprogesterone acetate" "peanut oil" "eosin"
22 Q0 24608574 617 19.619984 imi_mug_run_2_treatment "nvp-byl719" "drug" "therapeutics"
22 Q0 25851630 618 19.618961 imi_mug_run_2_treatment "cetuximab"
22 Q0 23876834 619 19.611078 imi_mug_run_2_treatment "drugs" "investigational drugs" "generic"
22 Q0 24879148 620 19.609438 imi_mug_run_2_treatment "various" "mediated" "andrographolide"
22 Q0 24863535 621 19.597427 imi_mug_run_2_treatment "various" "aim" "others"
22 Q0 21563232 622 19.588585 imi_mug_run_2_treatment "product"
22 Q0 29345357 623 19.588585 imi_mug_run_2_treatment "enzymes" "pooled"
22 Q0 26839307 624 19.586014 imi_mug_run_2_treatment "azd8835" "therapeutic agents" "basis"
22 Q0 24557434 625 19.581144 imi_mug_run_2_treatment "aim"
22 Q0 27146902 626 19.581144 imi_mug_run_2_treatment "lead"
22 Q0 19603024 627 19.576675 imi_mug_run_2_treatment "cetuximab"
22 Q0 21439039 628 19.561926 imi_mug_run_2_treatment "irinotecan" "aim"
22 Q0 24458107 629 19.55927 imi_mug_run_2_treatment "various" "trastuzumab" "phosphate"
22 Q0 29202330 630 19.54411 imi_mug_run_2_treatment "adjuvant" "lead"
22 Q0 21849857 631 19.531414 imi_mug_run_2_treatment "medicine" "anti-vegf monoclonal antibody" "vascular endothelial growth factor"
22 Q0 30519308 632 19.52395 imi_mug_run_2_treatment "ras" "cetuximab" "oxaliplatin"
22 Q0 29807833 633 19.52056 imi_mug_run_2_treatment "mbc" "aim"
22 Q0 29715106 634 19.498608 imi_mug_run_2_treatment "trastuzumab" "bkm120"
22 Q0 29945573 635 19.476793 imi_mug_run_2_treatment "lead" "hot spot"
22 Q0 27863403 636 19.444447 imi_mug_run_2_treatment "vortex" "liver"
22 Q0 24983247 637 19.385548 imi_mug_run_2_treatment "hme" "therapeutics"
22 Q0 21734071 638 19.384434 imi_mug_run_2_treatment "tamoxifen" "antioestrogen" "aim"
22 Q0 19107235 639 19.383728 imi_mug_run_2_treatment "lead" "igf2"
22 Q0 17989125 640 19.378529 imi_mug_run_2_treatment "dtc" "ras"
22 Q0 25341011 641 19.374365 imi_mug_run_2_treatment "combinations" "biologics" "ras"
22 Q0 21293538 642 19.37276 imi_mug_run_2_treatment "trastuzumab" "level" "plasma"
22 Q0 27015560 643 19.37276 imi_mug_run_2_treatment "kinase inhibitor" "glucose"
22 Q0 26244006 644 19.365908 imi_mug_run_2_treatment "drugs"
22 Q0 25641339 645 19.365707 imi_mug_run_2_treatment "axitinib" "dtc" "radioactive iodine"
22 Q0 27892457 646 19.35839 imi_mug_run_2_treatment "enzymes" "lead"
22 Q0 24451154 647 19.335993 imi_mug_run_2_treatment "lapatinib" "combinations" "trastuzumab"
22 Q0 29113237 648 19.332897 imi_mug_run_2_treatment "various" "cci-779" "mtor inhibitor"
22 Q0 22498935 649 19.327646 imi_mug_run_2_treatment "aim"
22 Q0 22261808 650 19.325865 imi_mug_run_2_treatment "mtor inhibitor"
22 Q0 27323812 651 19.321514 imi_mug_run_2_treatment "ly294002" "glucose" "at7867"
22 Q0 28423521 652 19.313692 imi_mug_run_2_treatment "estrogen" "drugs" "pf-4708671"
22 Q0 23314198 653 19.301594 imi_mug_run_2_treatment "scorpion"
22 Q0 21521850 654 19.263268 imi_mug_run_2_treatment "level"
22 Q0 27091708 655 19.232891 imi_mug_run_2_treatment "everolimus" "trastuzumab"
22 Q0 25969993 656 19.226112 imi_mug_run_2_treatment "gefitinib"
22 Q0 29123093 657 19.172417 imi_mug_run_2_treatment "medicine"
22 Q0 24477928 658 19.170818 imi_mug_run_2_treatment "endocrine therapy"
22 Q0 27220763 659 19.155691 imi_mug_run_2_treatment "mbc"
22 Q0 18814837 660 19.142345 imi_mug_run_2_treatment "wortmannin" "ly294002"
22 Q0 28330462 661 19.13782 imi_mug_run_2_treatment "everolimus"
22 Q0 28078112 662 19.136396 imi_mug_run_2_treatment "aim"
22 Q0 29963176 663 19.128 imi_mug_run_2_treatment "hub" "ppi" "aim"
22 Q0 26435479 664 19.12742 imi_mug_run_2_treatment "drug combination" "formalin"
22 Q0 21490305 665 19.125376 imi_mug_run_2_treatment "level"
22 Q0 20604919 666 19.123161 imi_mug_run_2_treatment "combinations"
22 Q0 29599915 667 19.12273 imi_mug_run_2_treatment "trastuzumab" "pertuzumab" "eribulin mesylate"
22 Q0 25742472 668 19.119633 imi_mug_run_2_treatment "ras" "bevacizumab" "capecitabine"
22 Q0 24599305 669 19.11055 imi_mug_run_2_treatment "liver"
22 Q0 26768033 670 19.10263 imi_mug_run_2_treatment "mbc"
22 Q0 25300346 671 19.101112 imi_mug_run_2_treatment "trastuzumab" "lapatinib" "drug combinations"
22 Q0 30122944 672 19.095646 imi_mug_run_2_treatment "various" "trastuzumab" "adjuvant"
22 Q0 16681770 673 19.09446 imi_mug_run_2_treatment "level" "aim"
22 Q0 26433948 674 19.068436 imi_mug_run_2_treatment "cyclophosphamide"
22 Q0 23165447 675 19.066418 imi_mug_run_2_treatment "others"
22 Q0 24755613 676 19.060677 imi_mug_run_2_treatment "vemurafenib" "panitumumab" "vectibix"
22 Q0 27626181 677 19.060677 imi_mug_run_2_treatment "mediated"
22 Q0 24166148 678 19.060677 imi_mug_run_2_treatment "mtor inhibitor" "metformin" "agent"
22 Q0 22145213 679 19.060677 imi_mug_run_2_treatment "panitumumab" "cetuximab" "anti-egfr monoclonal antibody"
22 Q0 28271309 680 19.060677 imi_mug_run_2_treatment "combinations" "isolate"
22 Q0 26708016 681 19.059664 imi_mug_run_2_treatment "various"
22 Q0 17314276 682 19.047981 imi_mug_run_2_treatment "ras"
22 Q0 26771497 683 19.044926 imi_mug_run_2_treatment "drugs"
22 Q0 28537764 684 19.043663 imi_mug_run_2_treatment "gefitinib"
22 Q0 25466244 685 19.041618 imi_mug_run_2_treatment "various" "erlotinib" "gefitinib"
22 Q0 27445490 686 19.041618 imi_mug_run_2_treatment "everolimus" "fulvestrant" "drugs"
22 Q0 24997156 687 19.03719 imi_mug_run_2_treatment "ras"
22 Q0 26078337 688 19.03321 imi_mug_run_2_treatment "tyrosine" "cytotoxic"
22 Q0 23277484 689 19.032124 imi_mug_run_2_treatment "various" "platinum"
22 Q0 23481512 690 19.032124 imi_mug_run_2_treatment "epirubicin" "adjuvant" "cisplatin"
22 Q0 22422409 691 19.02221 imi_mug_run_2_treatment "everolimus" "octreotide" "mediated"
22 Q0 26791794 692 19.01892 imi_mug_run_2_treatment "crizotinib" "ceritinib"
22 Q0 17669465 693 19.011875 imi_mug_run_2_treatment "alpha subunit" "isoleucine" "level"
22 Q0 24328598 694 19.00955 imi_mug_run_2_treatment "carboplatin" "paclitaxel"
22 Q0 23323913 695 18.994795 imi_mug_run_2_treatment "aspirin"
22 Q0 27096951 696 18.99471 imi_mug_run_2_treatment "low-dose aspirin" "aspirin" "basis"
22 Q0 21729679 697 18.992176 imi_mug_run_2_treatment "medicine" "monoclonal antibodies"
22 Q0 27016228 698 18.989399 imi_mug_run_2_treatment "temsirolimus" "tamoxifen" "megestrol acetate"
22 Q0 25336973 699 18.984457 imi_mug_run_2_treatment "drug"
22 Q0 26099045 700 18.984457 imi_mug_run_2_treatment "therapeutics" "others"
22 Q0 23323914 701 18.978657 imi_mug_run_2_treatment "aspirin"
22 Q0 23934607 702 18.957426 imi_mug_run_2_treatment "ras"
22 Q0 21642658 703 18.956486 imi_mug_run_2_treatment "duration"
22 Q0 20139701 704 18.943176 imi_mug_run_2_treatment "ras" "therapeutics"
22 Q0 27590223 705 18.928228 imi_mug_run_2_treatment "lead" "panitumumab" "cetuximab"
22 Q0 29526181 706 18.927624 imi_mug_run_2_treatment "drugs"
22 Q0 22484628 707 18.895369 imi_mug_run_2_treatment "suppressor"
22 Q0 21258250 708 18.886509 imi_mug_run_2_treatment "phosphate" "aim"
22 Q0 23085766 709 18.873047 imi_mug_run_2_treatment "various" "investigational drug" "kinase inhibitor"
22 Q0 20927778 710 18.836472 imi_mug_run_2_treatment "level"
22 Q0 26939876 711 18.825436 imi_mug_run_2_treatment "level"
22 Q0 23323915 712 18.821651 imi_mug_run_2_treatment "aspirin"
22 Q0 27798902 713 18.816704 imi_mug_run_2_treatment "trastuzumab" "paclitaxel" "hot spot"
22 Q0 25071141 714 18.766294 imi_mug_run_2_treatment "exemestane" "endocrine therapy" "estrogen"
22 Q0 20124458 715 18.750574 imi_mug_run_2_treatment "drug" "paclitaxel" "basis"
22 Q0 23525575 716 18.746483 imi_mug_run_2_treatment "rad001" "gefitinib" "egfr tyrosine kinase inhibitors"
22 Q0 22753589 717 18.743551 imi_mug_run_2_treatment "various"
22 Q0 25326806 718 18.65393 imi_mug_run_2_treatment "various" "cetuximab" "azd6244"
22 Q0 26842788 719 18.651955 imi_mug_run_2_treatment "platinum" "aim"
22 Q0 28247712 720 18.637543 imi_mug_run_2_treatment "others"
22 Q0 22851869 721 18.615864 imi_mug_run_2_treatment "ly294002" "aim"
22 Q0 26004768 722 18.58913 imi_mug_run_2_treatment "erlotinib" "platinum" "gcg"
22 Q0 26272063 723 18.57751 imi_mug_run_2_treatment "blockade" "mediated" "ras"
22 Q0 28002797 724 18.576122 imi_mug_run_2_treatment "lead" "aim"
22 Q0 30327465 725 18.573605 imi_mug_run_2_treatment "mediated" "therapeutics"
22 Q0 28280626 726 18.542849 imi_mug_run_2_treatment "balance"
22 Q0 24695632 727 18.53813 imi_mug_run_2_treatment "cisplatin" "mtor inhibitor"
22 Q0 29248501 728 18.532799 imi_mug_run_2_treatment "various" "dideoxycytidine"
22 Q0 27215271 729 18.52201 imi_mug_run_2_treatment "aim"
22 Q0 23359684 730 18.521492 imi_mug_run_2_treatment "mediated"
22 Q0 26469692 731 18.521492 imi_mug_run_2_treatment "arq 092" "arq 751" "chemotherapeutic agent"
22 Q0 23489586 732 18.520687 imi_mug_run_2_treatment "agent"
22 Q0 21277552 733 18.512758 imi_mug_run_2_treatment "lead"
22 Q0 24597345 734 18.512758 imi_mug_run_2_treatment "ras" "bevacizumab" "panitumumab"
22 Q0 29304903 735 18.508743 imi_mug_run_2_treatment "methylene" "medicine" "oxygen"
22 Q0 28271698 736 18.508743 imi_mug_run_2_treatment "various" "estrogenic" "cytokines"
22 Q0 30485824 737 18.508743 imi_mug_run_2_treatment "parp inhibitor" "mek inhibitor" "mek162"
22 Q0 18621636 738 18.505667 imi_mug_run_2_treatment "panitumumab" "ras"
22 Q0 21527065 739 18.505667 imi_mug_run_2_treatment "mbc" "capecitabine" "lapatinib"
22 Q0 26247526 740 18.499245 imi_mug_run_2_treatment "trastuzumab" "adjuvant" "estrogen"
22 Q0 28949453 741 18.499226 imi_mug_run_2_treatment "various" "liver" "plasma"
22 Q0 29739401 742 18.496094 imi_mug_run_2_treatment "lead"
22 Q0 23674493 743 18.46898 imi_mug_run_2_treatment "temsirolimus" "mtor inhibitor" "azd6482"
22 Q0 23992303 744 18.468168 imi_mug_run_2_treatment "ras"
22 Q0 15863375 745 18.461792 imi_mug_run_2_treatment "cetuximab" "panitumumab" "basis"
22 Q0 19509113 746 18.461792 imi_mug_run_2_treatment "etoposide" "oxaliplatin" "cytotoxic drugs"
22 Q0 22101421 747 18.461792 imi_mug_run_2_treatment "ras" "u0126" "gefitinib"
22 Q0 23342270 748 18.446814 imi_mug_run_2_treatment "saracatinib" "leucine" "tyrosine"
22 Q0 30197799 749 18.428835 imi_mug_run_2_treatment "everolimus" "mtor inhibitor"
22 Q0 25723113 750 18.428623 imi_mug_run_2_treatment "estrogen" "basis"
22 Q0 25486071 751 18.425207 imi_mug_run_2_treatment "basis"
22 Q0 21742964 752 18.418793 imi_mug_run_2_treatment "egfr inhibitor"
22 Q0 26503204 753 18.405539 imi_mug_run_2_treatment "everolimus" "aromatase inhibitors" "exemestane"
22 Q0 26486455 754 18.40528 imi_mug_run_2_treatment "cetuximab" "irinotecan"
22 Q0 17426084 755 18.391207 imi_mug_run_2_treatment "ptc" "ftc" "fta"
22 Q0 25231196 756 18.346848 imi_mug_run_2_treatment "ftc" "ras" "calca"
22 Q0 18794883 757 18.3219 imi_mug_run_2_treatment "drug" "ras"
22 Q0 21310826 758 18.3219 imi_mug_run_2_treatment "level"
22 Q0 19686742 759 18.3219 imi_mug_run_2_treatment "igf2"
22 Q0 28424201 760 18.31716 imi_mug_run_2_treatment "cetuximab" "blockade"
22 Q0 27050078 761 18.294746 imi_mug_run_2_treatment "cetuximab" "ras"
22 Q0 25663927 762 18.274103 imi_mug_run_2_treatment "various" "cetuximab" "panitumumab"
22 Q0 20413299 763 18.260815 imi_mug_run_2_treatment "cetuximab" "tma's" "bevacizumab"
22 Q0 25185240 764 18.215893 imi_mug_run_2_treatment "plasma"
22 Q0 28540249 765 18.192768 imi_mug_run_2_treatment "level" "plasma"
22 Q0 25550458 766 18.172955 imi_mug_run_2_treatment "level"
22 Q0 20937558 767 18.155704 imi_mug_run_2_treatment "aim"
22 Q0 23543667 768 18.148365 imi_mug_run_2_treatment "hot spot"
22 Q0 19738166 769 18.147621 imi_mug_run_2_treatment "panitumumab" "cetuximab" "monoclonal antibodies"
22 Q0 26270481 770 18.147621 imi_mug_run_2_treatment "drug" "drugs" "lapatinib"
22 Q0 28154202 771 18.147072 imi_mug_run_2_treatment "aspirin"
22 Q0 24556063 772 18.135838 imi_mug_run_2_treatment "combinations" "new drugs" "aim"
22 Q0 22538770 773 18.128727 imi_mug_run_2_treatment "drug" "drugs" "investigational drugs"
22 Q0 25277176 774 18.124504 imi_mug_run_2_treatment "basis"
22 Q0 23728071 775 18.123291 imi_mug_run_2_treatment "ras"
22 Q0 19903790 776 18.113708 imi_mug_run_2_treatment "adjuvant"
22 Q0 26525104 777 18.08675 imi_mug_run_2_treatment "tep" "platelets"
22 Q0 28336670 778 18.077503 imi_mug_run_2_treatment "lysine"
22 Q0 20507599 779 18.05683 imi_mug_run_2_treatment "tumor infiltrating lymphocytes" "level"
22 Q0 19487299 780 18.052107 imi_mug_run_2_treatment "pdtc" "ras" "ptc"
22 Q0 27069437 781 18.037252 imi_mug_run_2_treatment "aspirin" "balance"
22 Q0 29120753 782 18.02914 imi_mug_run_2_treatment "combinations" "anabolic" "fer"
22 Q0 22938585 783 18.00652 imi_mug_run_2_treatment "ras"
22 Q0 27283768 784 17.97718 imi_mug_run_2_treatment "aim"
22 Q0 23264847 785 17.954365 imi_mug_run_2_treatment "various" "therapeutics" "drugs"
22 Q0 22672749 786 17.947624 imi_mug_run_2_treatment "cetuximab" "irinotecan" "capecitabine"
22 Q0 26476745 787 17.910782 imi_mug_run_2_treatment "estrogen" "uridine"
22 Q0 24658605 788 17.900143 imi_mug_run_2_treatment "adjuvant" "formalin"
22 Q0 28625654 789 17.892296 imi_mug_run_2_treatment "adc"
22 Q0 23251002 790 17.889486 imi_mug_run_2_treatment "drug" "vemurafenib"
22 Q0 22969927 791 17.887901 imi_mug_run_2_treatment "mediated" "blockade"
22 Q0 26585822 792 17.887901 imi_mug_run_2_treatment "platinum" "cisplatin"
22 Q0 27156070 793 17.877106 imi_mug_run_2_treatment "aim"
22 Q0 23520486 794 17.874735 imi_mug_run_2_treatment "irinotecan" "everolimus" "cytotoxic"
22 Q0 23846438 795 17.870209 imi_mug_run_2_treatment "various" "lysozyme"
22 Q0 28268248 796 17.870209 imi_mug_run_2_treatment "insulin"
22 Q0 19806185 797 17.865284 imi_mug_run_2_treatment "cetuximab" "panitumumab" "aim"
22 Q0 22229245 798 17.846544 imi_mug_run_2_treatment "level"
22 Q0 16575012 799 17.840942 imi_mug_run_2_treatment "gefitinib" "ras" "level"
22 Q0 23136191 800 17.821888 imi_mug_run_2_treatment "kinase inhibitor" "paclitaxel" "erlotinib"
22 Q0 24823994 801 17.819263 imi_mug_run_2_treatment "ras"
22 Q0 27289249 802 17.80851 imi_mug_run_2_treatment "aspirin" "agent"
22 Q0 16341083 803 17.801353 imi_mug_run_2_treatment "mediated"
22 Q0 24481326 804 17.767162 imi_mug_run_2_treatment "estrogen" "prolactin" "efatutazone"
22 Q0 23233531 805 17.74494 imi_mug_run_2_treatment "various"
22 Q0 18339543 806 17.743786 imi_mug_run_2_treatment "therapeutics"
22 Q0 25719666 807 17.743786 imi_mug_run_2_treatment "platinum"
22 Q0 29515400 808 17.735527 imi_mug_run_2_treatment "sodium bicarbonate"
22 Q0 25109950 809 17.731636 imi_mug_run_2_treatment "tyrosine" "lead" "balance"
22 Q0 20473920 810 17.715466 imi_mug_run_2_treatment "cyclin-dependent kinase inhibitor" "igf2"
22 Q0 28231576 811 17.692862 imi_mug_run_2_treatment "ras"
22 Q0 20363910 812 17.690376 imi_mug_run_2_treatment "pas" "mediators"
22 Q0 28285689 813 17.67714 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors" "duration" "others"
22 Q0 21750219 814 17.65882 imi_mug_run_2_treatment "pf-04691502" "mediated" "gefitinib"
22 Q0 21225475 815 17.65882 imi_mug_run_2_treatment "various" "ras"
22 Q0 26577117 816 17.647041 imi_mug_run_2_treatment "level" "insulin"
22 Q0 22682934 817 17.640451 imi_mug_run_2_treatment "level"
22 Q0 20007781 818 17.618912 imi_mug_run_2_treatment "mtor inhibitor"
22 Q0 23658859 819 17.592182 imi_mug_run_2_treatment "drug"
22 Q0 21309258 820 17.582407 imi_mug_run_2_treatment "ras"
22 Q0 25617745 821 17.582407 imi_mug_run_2_treatment "ras"
22 Q0 16187281 822 17.554466 imi_mug_run_2_treatment "mediated" "ras"
22 Q0 28095868 823 17.546482 imi_mug_run_2_treatment "aim"
22 Q0 25180765 824 17.54638 imi_mug_run_2_treatment "aspirin"
22 Q0 20193978 825 17.54503 imi_mug_run_2_treatment "trastuzumab" "lapatinib" "her-2"
22 Q0 21478295 826 17.5364 imi_mug_run_2_treatment "level"
22 Q0 29698927 827 17.509468 imi_mug_run_2_treatment "trastuzumab" "capecitabine" "mbc"
22 Q0 27174587 828 17.501667 imi_mug_run_2_treatment "drugs"
22 Q0 20538763 829 17.479298 imi_mug_run_2_treatment "agent"
22 Q0 28486103 830 17.479298 imi_mug_run_2_treatment "therapeutic agents"
22 Q0 27196573 831 17.474888 imi_mug_run_2_treatment "various" "level"
22 Q0 29596783 832 17.459044 imi_mug_run_2_treatment "mga" "therapeutics"
22 Q0 26082939 833 17.446756 imi_mug_run_2_treatment "diethylstilbestrol"
22 Q0 17875760 834 17.441889 imi_mug_run_2_treatment "various" "liver"
22 Q0 24663045 835 17.43796 imi_mug_run_2_treatment "buparlisib" "letrozole" "endocrine therapy"
22 Q0 25970776 836 17.432892 imi_mug_run_2_treatment "drug" "therapeutics" "level"
22 Q0 29868481 837 17.42589 imi_mug_run_2_treatment "oxygen"
22 Q0 24692733 838 17.423622 imi_mug_run_2_treatment "cetuximab" "folinic acid"
22 Q0 29902286 839 17.420546 imi_mug_run_2_treatment "letrozole" "tamoxifen" "adjuvant"
22 Q0 16273224 840 17.415606 imi_mug_run_2_treatment "mediated" "therapeutic agents" "lead"
22 Q0 25757876 841 17.39854 imi_mug_run_2_treatment "various" "drug"
22 Q0 18829560 842 17.372063 imi_mug_run_2_treatment "trastuzumab" "everolimus" "mtor inhibitor"
22 Q0 25340423 843 17.355057 imi_mug_run_2_treatment "therapeutics"
22 Q0 21779535 844 17.334026 imi_mug_run_2_treatment "cetuximab"
22 Q0 22821211 845 17.326937 imi_mug_run_2_treatment "ras"
22 Q0 24436047 846 17.326937 imi_mug_run_2_treatment "ras"
22 Q0 19435916 847 17.324682 imi_mug_run_2_treatment "mbc" "her-2"
22 Q0 25057302 848 17.32452 imi_mug_run_2_treatment "lead"
22 Q0 27578453 849 17.32452 imi_mug_run_2_treatment "aim"
22 Q0 29497091 850 17.32452 imi_mug_run_2_treatment "fulvestrant" "palbociclib" "level"
22 Q0 29790419 851 17.32452 imi_mug_run_2_treatment "everolimus" "exemestane" "mtor inhibitor"
22 Q0 29037125 852 17.32105 imi_mug_run_2_treatment "various" "il-10"
22 Q0 28859058 853 17.304695 imi_mug_run_2_treatment "ras" "cetuximab" "capecitabine"
22 Q0 27588403 854 17.302456 imi_mug_run_2_treatment "progestin" "immunosuppressive" "medroxyprogesterone acetate"
22 Q0 29212173 855 17.300316 imi_mug_run_2_treatment "ras"
22 Q0 26045339 856 17.298912 imi_mug_run_2_treatment "insulin"
22 Q0 27428671 857 17.298428 imi_mug_run_2_treatment "t-dm1" "trastuzumab emtansine" "taxane"
22 Q0 25636880 858 17.292625 imi_mug_run_2_treatment "wortmannin" "drugs" "drug"
22 Q0 23049944 859 17.2896 imi_mug_run_2_treatment "gold" "growth inhibitors"
22 Q0 26018692 860 17.275127 imi_mug_run_2_treatment "various" "level" "aim"
22 Q0 24758538 861 17.275127 imi_mug_run_2_treatment "ras" "drugs" "panitumumab"
22 Q0 24597478 862 17.272228 imi_mug_run_2_treatment "glucose" "carboplatin" "mtor inhibitor"
22 Q0 25993148 863 17.27148 imi_mug_run_2_treatment "adjuvant" "cisplatin" "ras"
22 Q0 24735368 864 17.27148 imi_mug_run_2_treatment "drug" "drugs"
22 Q0 24508317 865 17.27148 imi_mug_run_2_treatment "hot spot"
22 Q0 22722202 866 17.27148 imi_mug_run_2_treatment "oestrogen"
22 Q0 25108739 867 17.268076 imi_mug_run_2_treatment "igf1" "tamoxifen" "trastuzumab"
22 Q0 26084292 868 17.262297 imi_mug_run_2_treatment "epirubicin" "carboplatin" "paclitaxel"
22 Q0 23412099 869 17.260353 imi_mug_run_2_treatment "docetaxel" "cetuximab"
22 Q0 23599689 870 17.260353 imi_mug_run_2_treatment "vaccines" "vascular endothelial growth factor"
22 Q0 28581513 871 17.260353 imi_mug_run_2_treatment "vascular endothelial growth factor"
22 Q0 30181556 872 17.260353 imi_mug_run_2_treatment "tam"
22 Q0 24700479 873 17.258398 imi_mug_run_2_treatment "medicine" "therapeutics"
22 Q0 30116425 874 17.251907 imi_mug_run_2_treatment "adjuvant" "fluorouracil"
22 Q0 25679062 875 17.247843 imi_mug_run_2_treatment "ras"
22 Q0 25267515 876 17.247524 imi_mug_run_2_treatment "basis" "level"
22 Q0 23213241 877 17.24749 imi_mug_run_2_treatment "cetuximab" "lapatinib" "kinase inhibitor"
22 Q0 23943423 878 17.24749 imi_mug_run_2_treatment "ras" "level"
22 Q0 25591616 879 17.234995 imi_mug_run_2_treatment "trastuzumab"
22 Q0 29113722 880 17.232285 imi_mug_run_2_treatment "prompt"
22 Q0 27129168 881 17.231556 imi_mug_run_2_treatment "trastuzumab" "adjuvant" "taxane"
22 Q0 25157276 882 17.22329 imi_mug_run_2_treatment "drug" "hdac inhibitor" "aza"
22 Q0 23387868 883 17.222782 imi_mug_run_2_treatment "wyc02" "chemotherapeutic agent"
22 Q0 25749176 884 17.219728 imi_mug_run_2_treatment "erlotinib" "gemcitabine" "oxaliplatin"
22 Q0 26210103 885 17.21686 imi_mug_run_2_treatment "androgen" "drugs" "androgens"
22 Q0 22525302 886 17.21686 imi_mug_run_2_treatment "ras" "aim" "crizotinib"
22 Q0 26281864 887 17.21497 imi_mug_run_2_treatment "fluorouracil"
22 Q0 22270257 888 17.21497 imi_mug_run_2_treatment "irinotecan" "drug" "fluorouracil"
22 Q0 29666465 889 17.202175 imi_mug_run_2_treatment "various" "interleukins"
22 Q0 26697197 890 17.199802 imi_mug_run_2_treatment "liver"
22 Q0 27588484 891 17.191708 imi_mug_run_2_treatment "level"
22 Q0 21772090 892 17.188469 imi_mug_run_2_treatment "various" "cetuximab" "ras"
22 Q0 26887047 893 17.183586 imi_mug_run_2_treatment "aim"
22 Q0 28406723 894 17.177383 imi_mug_run_2_treatment "various" "nonsteroidal anti-inflammatory drug" "aspirin"
22 Q0 24771645 895 17.155281 imi_mug_run_2_treatment "various" "ponatinib" "tyrosine kinase inhibitor"
22 Q0 24510342 896 17.145779 imi_mug_run_2_treatment "drugs"
22 Q0 29896679 897 17.130402 imi_mug_run_2_treatment "balance"
22 Q0 23640975 898 17.122643 imi_mug_run_2_treatment "mtor inhibitor" "pf-04691502" "pifithrin"
22 Q0 24714777 899 17.099693 imi_mug_run_2_treatment "basis"
22 Q0 29797793 900 17.089424 imi_mug_run_2_treatment "drug"
22 Q0 25477232 901 17.087307 imi_mug_run_2_treatment "taxane"
22 Q0 27247954 902 17.068245 imi_mug_run_2_treatment "drug" "therapeutics" "monoclonal antibodies"
22 Q0 24874471 903 17.058243 imi_mug_run_2_treatment "cancer drug"
22 Q0 27455559 904 17.048214 imi_mug_run_2_treatment "various" "phosphate" "basis"
22 Q0 29738578 905 17.048214 imi_mug_run_2_treatment "medicine"
22 Q0 29094026 906 17.026798 imi_mug_run_2_treatment "cisplatin" "docetaxel"
22 Q0 27628192 907 17.020687 imi_mug_run_2_treatment "combinations" "drugs" "level"
22 Q0 21239505 908 17.00788 imi_mug_run_2_treatment "liver"
22 Q0 28382169 909 17.00788 imi_mug_run_2_treatment "tyrosine" "mediated" "ras"
22 Q0 29505847 910 16.999508 imi_mug_run_2_treatment "ras"
22 Q0 22696596 911 16.972954 imi_mug_run_2_treatment "matrix"
22 Q0 26400062 912 16.931408 imi_mug_run_2_treatment "ras"
22 Q0 25394645 913 16.92952 imi_mug_run_2_treatment "cisplatin" "paclitaxel"
22 Q0 25546926 914 16.88921 imi_mug_run_2_treatment "aim"
22 Q0 23478237 915 16.88921 imi_mug_run_2_treatment "agent" "lead"
22 Q0 19775996 916 16.88696 imi_mug_run_2_treatment "ras"
22 Q0 29252036 917 16.88696 imi_mug_run_2_treatment "combinations" "endocrine therapy"
22 Q0 24508104 918 16.872013 imi_mug_run_2_treatment "medicine" "basis" "level"
22 Q0 18987168 919 16.869364 imi_mug_run_2_treatment "ras"
22 Q0 20932136 920 16.863089 imi_mug_run_2_treatment "cetuximab"
22 Q0 28845578 921 16.846691 imi_mug_run_2_treatment "crizotinib" "kinase inhibitor"
22 Q0 15729202 922 16.841438 imi_mug_run_2_treatment "paclitaxel" "ras" "platinum"
22 Q0 25450577 923 16.834806 imi_mug_run_2_treatment "glucose" "level"
22 Q0 22994502 924 16.834806 imi_mug_run_2_treatment "everolimus" "drug" "endocrine therapy"
22 Q0 21822122 925 16.830212 imi_mug_run_2_treatment "drug" "drug combinations" "medicine"
22 Q0 20682317 926 16.818356 imi_mug_run_2_treatment "igf2" "bisulfite" "insulin-like growth factor 2"
22 Q0 21036793 927 16.818356 imi_mug_run_2_treatment "various" "lead"
22 Q0 28685087 928 16.804605 imi_mug_run_2_treatment "ras" "aim"
22 Q0 25588929 929 16.787493 imi_mug_run_2_treatment "pmm" "adjuvant"
22 Q0 30250552 930 16.787493 imi_mug_run_2_treatment "basis"
22 Q0 25745045 931 16.780891 imi_mug_run_2_treatment "duration"
22 Q0 29614442 932 16.770521 imi_mug_run_2_treatment "aim"
22 Q0 17088437 933 16.76752 imi_mug_run_2_treatment "agent" "level"
22 Q0 28060271 934 16.76752 imi_mug_run_2_treatment "drug"
22 Q0 22927482 935 16.751541 imi_mug_run_2_treatment "bevacizumab" "temsirolimus" "antiangiogenic"
22 Q0 23152013 936 16.751541 imi_mug_run_2_treatment "glycine" "ras" "cetuximab"
22 Q0 30076411 937 16.751541 imi_mug_run_2_treatment "estrogen" "cytotoxic" "others"
22 Q0 21903247 938 16.750444 imi_mug_run_2_treatment "drug combinations" "therapeutic agents"
22 Q0 29675095 939 16.748987 imi_mug_run_2_treatment "gpe" "everolimus" "cisplatin"
22 Q0 26515606 940 16.739857 imi_mug_run_2_treatment "level"
22 Q0 30130984 941 16.739857 imi_mug_run_2_treatment "combinations" "palbociclib" "aim"
22 Q0 26227479 942 16.733427 imi_mug_run_2_treatment "various" "metric"
22 Q0 25997541 943 16.733427 imi_mug_run_2_treatment "ras"
22 Q0 29228676 944 16.733427 imi_mug_run_2_treatment "level" "legacy"
22 Q0 26992457 945 16.733427 imi_mug_run_2_treatment "combinations"
22 Q0 21420991 946 16.721893 imi_mug_run_2_treatment "estrogen" "endocrine therapy" "aromatase inhibitors"
22 Q0 21512767 947 16.70769 imi_mug_run_2_treatment "various"
22 Q0 27528217 948 16.691011 imi_mug_run_2_treatment "lead"
22 Q0 25366782 949 16.690594 imi_mug_run_2_treatment "level"
22 Q0 17626883 950 16.683207 imi_mug_run_2_treatment "lead"
22 Q0 22158333 951 16.680088 imi_mug_run_2_treatment "egfr inhibitor" "aim"
22 Q0 17936554 952 16.667282 imi_mug_run_2_treatment "trastuzumab" "others"
22 Q0 19513541 953 16.65195 imi_mug_run_2_treatment "gefitinib" "mtor inhibitor" "blockade"
22 Q0 24662921 954 16.65195 imi_mug_run_2_treatment "leu"
22 Q0 28698100 955 16.646618 imi_mug_run_2_treatment "asc"
22 Q0 28856682 956 16.630432 imi_mug_run_2_treatment "lead" "level" "suppressor"
22 Q0 22942608 957 16.623646 imi_mug_run_2_treatment "drugs" "cytotoxic" "therapeutics"
22 Q0 23494461 958 16.623096 imi_mug_run_2_treatment "monoclonal antibodies"
22 Q0 25242168 959 16.6202 imi_mug_run_2_treatment "cabozantinib" "antiangiogenic" "vascular endothelial growth factor"
22 Q0 21632860 960 16.6202 imi_mug_run_2_treatment "panitumumab" "anti-egfr monoclonal antibody" "cetuximab"
22 Q0 30241001 961 16.604874 imi_mug_run_2_treatment "fulvestrant" "buparlisib"
22 Q0 11836556 962 16.597256 imi_mug_run_2_treatment "various"
22 Q0 30391779 963 16.593458 imi_mug_run_2_treatment "trastuzumab"
22 Q0 21882832 964 16.56784 imi_mug_run_2_treatment "kinase inhibitor" "zstk474"
22 Q0 23281932 965 16.555876 imi_mug_run_2_treatment "cetuximab" "monoclonal antibodies"
22 Q0 29392540 966 16.489769 imi_mug_run_2_treatment "plasma"
22 Q0 26913069 967 16.485039 imi_mug_run_2_treatment "adjuvant" "her-2" "endocrine therapy"
22 Q0 23899375 968 16.485039 imi_mug_run_2_treatment "deoxyglucose"
22 Q0 17540164 969 16.481224 imi_mug_run_2_treatment "ras" "mediated"
22 Q0 29437753 970 16.469751 imi_mug_run_2_treatment "plasma" "level" "hot spot"
22 Q0 27384237 971 16.459757 imi_mug_run_2_treatment "drugs" "investigational drugs"
22 Q0 24664487 972 16.44247 imi_mug_run_2_treatment "level"
22 Q0 25591738 973 16.44247 imi_mug_run_2_treatment "cisplatin"
22 Q0 25372287 974 16.43602 imi_mug_run_2_treatment "level"
22 Q0 26275293 975 16.43602 imi_mug_run_2_treatment "sorafenib" "tyrosine kinase inhibitor"
22 Q0 30390187 976 16.43602 imi_mug_run_2_treatment "tandem"
22 Q0 22120720 977 16.428795 imi_mug_run_2_treatment "bromodeoxyuridine" "vx-680" "aurora kinase inhibitor"
22 Q0 29850157 978 16.428795 imi_mug_run_2_treatment "adjuvant" "aspirin" "anti-inflammatory"
22 Q0 26801617 979 16.423891 imi_mug_run_2_treatment "enzymes" "insulin" "prostaglandin e2"
22 Q0 29974177 980 16.405392 imi_mug_run_2_treatment "adc"
22 Q0 23602735 981 16.40522 imi_mug_run_2_treatment "azd6244"
22 Q0 27760227 982 16.40522 imi_mug_run_2_treatment "plasma"
22 Q0 28854070 983 16.401802 imi_mug_run_2_treatment "tamoxifen" "aromatase inhibitor" "antiestrogenic"
22 Q0 29549527 984 16.379326 imi_mug_run_2_treatment "arq 092" "wortmannin"
22 Q0 25838391 985 16.37578 imi_mug_run_2_treatment "cetuximab" "regorafenib" "ras"
22 Q0 24482365 986 16.373867 imi_mug_run_2_treatment "suppressor"
22 Q0 26947331 987 16.373224 imi_mug_run_2_treatment "endocrine therapy" "fulvestrant" "palbociclib"
22 Q0 26968843 988 16.371855 imi_mug_run_2_treatment "drugs" "egfr tyrosine kinase inhibitors" "crizotinib"
22 Q0 26439693 989 16.371855 imi_mug_run_2_treatment "agent" "tak-733" "mek inhibitor"
22 Q0 28936923 990 16.36026 imi_mug_run_2_treatment "aim"
22 Q0 29500843 991 16.36026 imi_mug_run_2_treatment "taselisib" "fulvestrant" "aim"
22 Q0 25623215 992 16.358007 imi_mug_run_2_treatment "cetuximab" "panitumumab" "blockade"
22 Q0 25557290 993 16.351374 imi_mug_run_2_treatment "aim"
22 Q0 25713166 994 16.351374 imi_mug_run_2_treatment "drugs" "level" "shape"
22 Q0 30239581 995 16.351374 imi_mug_run_2_treatment "edu" "level"
22 Q0 28103826 996 16.347244 imi_mug_run_2_treatment "megestrol" "tibolone"
22 Q0 25490376 997 16.344942 imi_mug_run_2_treatment "carboplatin"
22 Q0 16309427 998 16.338196 imi_mug_run_2_treatment "ras"
22 Q0 26392535 999 16.338196 imi_mug_run_2_treatment "lead" "others"
23 Q0 25328151 1 48.014095 imi_mug_run_2_treatment "ors"
23 Q0 27366084 2 43.9554 imi_mug_run_2_treatment "mln8237"
23 Q0 29942081 3 43.510677 imi_mug_run_2_treatment "combinations" "drug combinations" "drugs"
23 Q0 26782714 4 41.28346 imi_mug_run_2_treatment "kinase inhibitor"
23 Q0 20464476 5 41.261055 imi_mug_run_2_treatment "ors" "pooled"
23 Q0 23026799 6 39.511765 imi_mug_run_2_treatment "vx-680" "chloroquine" "baf"
23 Q0 28114286 7 39.508797 imi_mug_run_2_treatment "level"
23 Q0 25306619 8 39.058586 imi_mug_run_2_treatment "formalin"
23 Q0 23925655 9 38.899517 imi_mug_run_2_treatment "estrogen" "mediated" "aim"
23 Q0 25169513 10 38.77353 imi_mug_run_2_treatment "ors"
23 Q0 26138431 11 38.707348 imi_mug_run_2_treatment "aminoacids" "mediated"
23 Q0 22527098 12 38.507957 imi_mug_run_2_treatment "therapeutic agents"
23 Q0 7946596 13 37.93122 imi_mug_run_2_treatment "product"
23 Q0 20473280 14 37.840782 imi_mug_run_2_treatment "level"
23 Q0 23186136 15 37.259254 imi_mug_run_2_treatment "adjuvant"
23 Q0 8585979 16 36.99383 imi_mug_run_2_treatment "ras"
23 Q0 21327470 17 36.944725 imi_mug_run_2_treatment "product"
23 Q0 10637239 18 36.93993 imi_mug_run_2_treatment "product" "level"
23 Q0 17417639 19 36.63479 imi_mug_run_2_treatment "adjuvant"
23 Q0 29269934 20 36.59345 imi_mug_run_2_treatment "androgen" "androgens" "alisertib"
23 Q0 18583876 21 36.538963 imi_mug_run_2_treatment "aim"
23 Q0 24240108 22 36.342434 imi_mug_run_2_treatment "cisplatin" "alisertib"
23 Q0 8529465 23 36.242958 imi_mug_run_2_treatment "ras"
23 Q0 12527905 24 36.211685 imi_mug_run_2_treatment "estrogens" "estradiol" "tamoxifen"
23 Q0 19881546 25 35.989315 imi_mug_run_2_treatment "mediated"
23 Q0 19666946 26 35.717327 imi_mug_run_2_treatment "her-2"
23 Q0 28739725 27 35.68684 imi_mug_run_2_treatment "progesterone" "ppi" "aim"
23 Q0 27235164 28 35.646408 imi_mug_run_2_treatment "eribulin" "cytotoxic" "drug"
23 Q0 9607624 29 35.63169 imi_mug_run_2_treatment "gastrin" "phosphate" "color"
23 Q0 1356012 30 35.615395 imi_mug_run_2_treatment "oestrogen"
23 Q0 23634246 31 35.55523 imi_mug_run_2_treatment "docetaxel"
23 Q0 15300811 32 35.473763 imi_mug_run_2_treatment "mbc" "basis"
23 Q0 15756435 33 35.457516 imi_mug_run_2_treatment "basis"
23 Q0 18425397 34 35.32692 imi_mug_run_2_treatment "tamoxifen"
23 Q0 27895501 35 35.31212 imi_mug_run_2_treatment "her-2" "aim"
23 Q0 28967919 36 35.234344 imi_mug_run_2_treatment "kinase inhibitor" "pacritinib"
23 Q0 10667465 37 35.226013 imi_mug_run_2_treatment "ors"
23 Q0 27109433 38 35.184647 imi_mug_run_2_treatment "resveratrol"
23 Q0 17457667 39 35.15091 imi_mug_run_2_treatment "estrogens" "estradiol" "estrone"
23 Q0 9815944 40 34.959114 imi_mug_run_2_treatment "level"
23 Q0 15026619 41 34.937405 imi_mug_run_2_treatment "estrogen" "her-2" "formalin"
23 Q0 27250762 42 34.926323 imi_mug_run_2_treatment "aim"
23 Q0 24091768 43 34.90621 imi_mug_run_2_treatment "aurora kinase inhibitor" "amg 900"
23 Q0 21702909 44 34.871796 imi_mug_run_2_treatment "silver"
23 Q0 9537228 45 34.86618 imi_mug_run_2_treatment "antiestrogens" "progestin" "estradiol"
23 Q0 18812553 46 34.83753 imi_mug_run_2_treatment "level"
23 Q0 27499891 47 34.772026 imi_mug_run_2_treatment "adjuvant" "aim"
23 Q0 24574519 48 34.759747 imi_mug_run_2_treatment "alisertib"
23 Q0 8336939 49 34.710358 imi_mug_run_2_treatment "lead"
23 Q0 22322671 50 34.677444 imi_mug_run_2_treatment "others"
23 Q0 28906374 51 34.648712 imi_mug_run_2_treatment "ile" "phe"
23 Q0 19161979 52 34.47088 imi_mug_run_2_treatment "level"
23 Q0 20139910 53 34.45835 imi_mug_run_2_treatment "level"
23 Q0 21441901 54 34.43964 imi_mug_run_2_treatment "various"
23 Q0 21427727 55 34.39155 imi_mug_run_2_treatment "plasma"
23 Q0 25061104 56 34.354225 imi_mug_run_2_treatment "mediated"
23 Q0 8096076 57 34.306507 imi_mug_run_2_treatment "m-amsa" "mitoxantrone" "topoisomerase inhibitors"
23 Q0 28592839 58 34.29738 imi_mug_run_2_treatment "drugs"
23 Q0 24247619 59 34.062183 imi_mug_run_2_treatment "phb" "prohibitin" "aim"
23 Q0 27630309 60 34.03916 imi_mug_run_2_treatment "tma" "aim"
23 Q0 16380503 61 33.946327 imi_mug_run_2_treatment "lead"
23 Q0 22899999 62 33.88663 imi_mug_run_2_treatment "estradiol" "paxilline" "tma"
23 Q0 29135104 63 33.827293 imi_mug_run_2_treatment "ors"
23 Q0 12196365 64 33.81411 imi_mug_run_2_treatment "trastuzumab" "aim"
23 Q0 24489661 65 33.772163 imi_mug_run_2_treatment "basis" "level"
23 Q0 9858771 66 33.724663 imi_mug_run_2_treatment "level"
23 Q0 19787783 67 33.646427 imi_mug_run_2_treatment "liprin"
23 Q0 16491609 68 33.64292 imi_mug_run_2_treatment "herceptin"
23 Q0 19169812 69 33.622482 imi_mug_run_2_treatment "level"
23 Q0 22056952 70 33.618828 imi_mug_run_2_treatment "program"
23 Q0 10825005 71 33.48307 imi_mug_run_2_treatment "anonymous"
23 Q0 23220880 72 33.376534 imi_mug_run_2_treatment "drug" "kinase inhibitor" "lapatinib"
23 Q0 20814902 73 33.37061 imi_mug_run_2_treatment "various"
23 Q0 25981900 74 33.286457 imi_mug_run_2_treatment "estrogen"
23 Q0 27926948 75 33.285515 imi_mug_run_2_treatment "level"
23 Q0 11431322 76 33.248764 imi_mug_run_2_treatment "basis"
23 Q0 28573512 77 33.182125 imi_mug_run_2_treatment "her-2"
23 Q0 21320029 78 33.18095 imi_mug_run_2_treatment "various" "level"
23 Q0 15732132 79 33.163536 imi_mug_run_2_treatment "herceptin"
23 Q0 24102037 80 33.14889 imi_mug_run_2_treatment "her-2"
23 Q0 20213079 81 33.13346 imi_mug_run_2_treatment "level"
23 Q0 23479212 82 33.119434 imi_mug_run_2_treatment "plasma" "level"
23 Q0 27081639 83 33.119434 imi_mug_run_2_treatment "various"
23 Q0 18992636 84 33.0822 imi_mug_run_2_treatment "aim"
23 Q0 14691457 85 33.06688 imi_mug_run_2_treatment "herceptin" "phosphate" "color"
23 Q0 25996409 86 33.04609 imi_mug_run_2_treatment "drug" "ptx" "drugs"
23 Q0 27308527 87 32.97254 imi_mug_run_2_treatment "level"
23 Q0 19096145 88 32.92929 imi_mug_run_2_treatment "mpla" "taxane" "trastuzumab"
23 Q0 28316110 89 32.918106 imi_mug_run_2_treatment "talazoparib"
23 Q0 17942894 90 32.885212 imi_mug_run_2_treatment "various" "drugs"
23 Q0 7915911 91 32.880997 imi_mug_run_2_treatment "combinations"
23 Q0 28647900 92 32.855247 imi_mug_run_2_treatment "ile" "phe" "level"
23 Q0 10362802 93 32.850384 imi_mug_run_2_treatment "level"
23 Q0 27506314 94 32.837185 imi_mug_run_2_treatment "aim"
23 Q0 29981251 95 32.812256 imi_mug_run_2_treatment "her-2"
23 Q0 28515047 96 32.789257 imi_mug_run_2_treatment "others" "drugs" "mediated"
23 Q0 17018785 97 32.77467 imi_mug_run_2_treatment "tgfb1" "pooled"
23 Q0 18288397 98 32.756367 imi_mug_run_2_treatment "various" "aim"
23 Q0 16823179 99 32.693413 imi_mug_run_2_treatment "level"
23 Q0 12378525 100 32.686028 imi_mug_run_2_treatment "level"
23 Q0 24862872 101 32.602814 imi_mug_run_2_treatment "tma" "level"
23 Q0 17908964 102 32.55599 imi_mug_run_2_treatment "duration" "mediated"
23 Q0 28534994 103 32.51287 imi_mug_run_2_treatment "duration"
23 Q0 23442322 104 32.510704 imi_mug_run_2_treatment "adjuvant" "trastuzumab" "mediated"
23 Q0 8797862 105 32.456146 imi_mug_run_2_treatment "estrogen" "level"
23 Q0 22262870 106 32.447365 imi_mug_run_2_treatment "aim"
23 Q0 15824823 107 32.443214 imi_mug_run_2_treatment "aim"
23 Q0 19616622 108 32.40629 imi_mug_run_2_treatment "mediated" "sage"
23 Q0 24122835 109 32.3855 imi_mug_run_2_treatment "drugs" "fluorouracil" "ras"
23 Q0 29147372 110 32.372753 imi_mug_run_2_treatment "amp" "mediated" "basis"
23 Q0 21741827 111 32.34812 imi_mug_run_2_treatment "paclitaxel" "aim"
23 Q0 20543821 112 32.315666 imi_mug_run_2_treatment "magnesium" "adjuvant" "serine"
23 Q0 12755489 113 32.2974 imi_mug_run_2_treatment "trastuzumab" "her-2"
23 Q0 8099571 114 32.29357 imi_mug_run_2_treatment "estrogen" "progesterone"
23 Q0 18823530 115 32.284267 imi_mug_run_2_treatment "tamoxifen" "adjuvant"
23 Q0 8432027 116 32.262596 imi_mug_run_2_treatment "estrogen"
23 Q0 11893034 117 32.260853 imi_mug_run_2_treatment "formalin"
23 Q0 2141510 118 32.24026 imi_mug_run_2_treatment "level" "estrogens" "protease"
23 Q0 23307494 119 32.239826 imi_mug_run_2_treatment "color" "drugs"
23 Q0 30498084 120 32.216 imi_mug_run_2_treatment "mediated"
23 Q0 24496495 121 32.210094 imi_mug_run_2_treatment "lapatinib" "drug" "trastuzumab"
23 Q0 25762478 122 32.18555 imi_mug_run_2_treatment "trastuzumab" "level"
23 Q0 19320640 123 32.180946 imi_mug_run_2_treatment "endocrine therapy"
23 Q0 28269755 124 32.136013 imi_mug_run_2_treatment "cck-8" "aim"
23 Q0 7656779 125 32.133064 imi_mug_run_2_treatment "level"
23 Q0 22126548 126 32.10624 imi_mug_run_2_treatment "adjuvant" "trastuzumab"
23 Q0 11091612 127 32.104214 imi_mug_run_2_treatment "product"
23 Q0 30446652 128 32.09984 imi_mug_run_2_treatment "cabozantinib"
23 Q0 22585709 129 32.080936 imi_mug_run_2_treatment "her-2" "abc"
23 Q0 26810187 130 32.05264 imi_mug_run_2_treatment "her-2" "trastuzumab" "adjuvant"
23 Q0 17088909 131 32.005768 imi_mug_run_2_treatment "adjuvant"
23 Q0 8605112 132 32.005714 imi_mug_run_2_treatment "various"
23 Q0 2657970 133 31.978182 imi_mug_run_2_treatment "estrogen"
23 Q0 1351679 134 31.95212 imi_mug_run_2_treatment "level"
23 Q0 10485914 135 31.947693 imi_mug_run_2_treatment "estrogen" "antiestrogen" "tamoxifen"
23 Q0 23446853 136 31.94614 imi_mug_run_2_treatment "drugs" "hydroxyurea" "methotrexate"
23 Q0 22750847 137 31.944294 imi_mug_run_2_treatment "trastuzumab"
23 Q0 11552716 138 31.917122 imi_mug_run_2_treatment "herceptin"
23 Q0 22538974 139 31.894484 imi_mug_run_2_treatment "aim"
23 Q0 24304542 140 31.875992 imi_mug_run_2_treatment "basis"
23 Q0 12435291 141 31.869307 imi_mug_run_2_treatment "trastuzumab" "docetaxel" "cyclophosphamide"
23 Q0 18332872 142 31.841808 imi_mug_run_2_treatment "trastuzumab" "therapeutic agents"
23 Q0 12727839 143 31.840422 imi_mug_run_2_treatment "level"
23 Q0 14729606 144 31.808022 imi_mug_run_2_treatment "her-2"
23 Q0 25153153 145 31.723263 imi_mug_run_2_treatment "silver" "adjuvant"
23 Q0 12414653 146 31.700779 imi_mug_run_2_treatment "lead" "level"
23 Q0 30084985 147 31.69713 imi_mug_run_2_treatment "mediated"
23 Q0 22323913 148 31.680065 imi_mug_run_2_treatment "silver"
23 Q0 23894508 149 31.672113 imi_mug_run_2_treatment "level" "mediated"
23 Q0 1349794 150 31.66256 imi_mug_run_2_treatment "level"
23 Q0 14651845 151 31.649532 imi_mug_run_2_treatment "product"
23 Q0 16753605 152 31.630085 imi_mug_run_2_treatment "estrogen" "her-2"
23 Q0 11564899 153 31.619041 imi_mug_run_2_treatment "level"
23 Q0 26312204 154 31.579483 imi_mug_run_2_treatment "tyrosine kinase inhibitor" "crizotinib"
23 Q0 8105035 155 31.533579 imi_mug_run_2_treatment "duration" "level"
23 Q0 28567637 156 31.530388 imi_mug_run_2_treatment "estrogen"
23 Q0 17593621 157 31.511148 imi_mug_run_2_treatment "her-2" "trastuzumab" "egfr tyrosine kinase inhibitor"
23 Q0 23948299 158 31.504566 imi_mug_run_2_treatment "estrogen" "tamoxifen" "estrogenic"
23 Q0 7695959 159 31.435406 imi_mug_run_2_treatment "urokinase plasminogen activator" "oestrogen"
23 Q0 25992689 160 31.420841 imi_mug_run_2_treatment "progesterone" "progesterone's"
23 Q0 26215677 161 31.405386 imi_mug_run_2_treatment "estrogen" "mediated"
23 Q0 30265336 162 31.401863 imi_mug_run_2_treatment "mediated" "trastuzumab"
23 Q0 10702400 163 31.396166 imi_mug_run_2_treatment "drugs"
23 Q0 9552035 164 31.395409 imi_mug_run_2_treatment "adjuvant" "duration"
23 Q0 16412566 165 31.382656 imi_mug_run_2_treatment "ile" "phe"
23 Q0 19767729 166 31.37996 imi_mug_run_2_treatment "cytostatic agents" "trastuzumab"
23 Q0 20682394 167 31.370964 imi_mug_run_2_treatment "aim"
23 Q0 20495751 168 31.331404 imi_mug_run_2_treatment "her-2" "aim"
23 Q0 22287734 169 31.306774 imi_mug_run_2_treatment "aim"
23 Q0 9310246 170 31.292534 imi_mug_run_2_treatment "genesis"
23 Q0 28152093 171 31.271423 imi_mug_run_2_treatment "betel nut" "lead"
23 Q0 27900589 172 31.231712 imi_mug_run_2_treatment "trastuzumab" "leucine" "her2 monoclonal antibody"
23 Q0 10510669 173 31.213705 imi_mug_run_2_treatment "formalin"
23 Q0 16670003 174 31.197704 imi_mug_run_2_treatment "various" "level" "tam"
23 Q0 20179196 175 31.196032 imi_mug_run_2_treatment "endocrine therapy" "hydroxytamoxifen"
23 Q0 24756215 176 31.179562 imi_mug_run_2_treatment "endocrine therapy"
23 Q0 26036635 177 31.169594 imi_mug_run_2_treatment "antineoplastic" "cryptotanshinone" "tanshinone"
23 Q0 16908432 178 31.167755 imi_mug_run_2_treatment "her-2" "mpla"
23 Q0 27375289 179 31.161022 imi_mug_run_2_treatment "tamoxifen" "mediated"
23 Q0 12755491 180 31.151665 imi_mug_run_2_treatment "combinations" "genesis"
23 Q0 20306655 181 31.139698 imi_mug_run_2_treatment "liver"
23 Q0 23658459 182 31.138147 imi_mug_run_2_treatment "dovitinib" "silver" "basis"
23 Q0 17512447 183 31.135365 imi_mug_run_2_treatment "trastuzumab"
23 Q0 12448002 184 31.133718 imi_mug_run_2_treatment "estrogen"
23 Q0 25697104 185 31.117508 imi_mug_run_2_treatment "alcohol" "abc" "alkaloid"
23 Q0 25854334 186 31.106382 imi_mug_run_2_treatment "adjuvant"
23 Q0 27472240 187 31.088997 imi_mug_run_2_treatment "estrogen" "progesterone"
23 Q0 28176176 188 31.082188 imi_mug_run_2_treatment "mediated"
23 Q0 27567264 189 31.066738 imi_mug_run_2_treatment "various" "mediators"
23 Q0 22433433 190 31.054281 imi_mug_run_2_treatment "aim"
23 Q0 29760449 191 31.05027 imi_mug_run_2_treatment "ras" "ppi"
23 Q0 23835033 192 31.025406 imi_mug_run_2_treatment "agent"
23 Q0 18853252 193 31.024403 imi_mug_run_2_treatment "trastuzumab" "grn163l"
23 Q0 8872330 194 31.021557 imi_mug_run_2_treatment "air"
23 Q0 19513621 195 31.011845 imi_mug_run_2_treatment "her-2"
23 Q0 11477142 196 30.983356 imi_mug_run_2_treatment "basis"
23 Q0 21499301 197 30.97211 imi_mug_run_2_treatment "lapatinib" "mediated" "tyrosine kinase inhibitor"
23 Q0 14632728 198 30.93802 imi_mug_run_2_treatment "her-2"
23 Q0 21637642 199 30.93224 imi_mug_run_2_treatment "mediated"
23 Q0 30180881 200 30.914602 imi_mug_run_2_treatment "mitogen" "genesis"
23 Q0 17380298 201 30.910759 imi_mug_run_2_treatment "aim"
23 Q0 17397528 202 30.88757 imi_mug_run_2_treatment "oestrogen"
23 Q0 17353917 203 30.874771 imi_mug_run_2_treatment "level"
23 Q0 9916925 204 30.872278 imi_mug_run_2_treatment "various"
23 Q0 30005627 205 30.81913 imi_mug_run_2_treatment "lead"
23 Q0 7742600 206 30.770565 imi_mug_run_2_treatment "lead"
23 Q0 18266105 207 30.767189 imi_mug_run_2_treatment "her-2" "trail-r2" "estrogen"
23 Q0 22052327 208 30.75869 imi_mug_run_2_treatment "lead"
23 Q0 2915899 209 30.742035 imi_mug_run_2_treatment "ras"
23 Q0 30342037 210 30.740757 imi_mug_run_2_treatment "alisertib" "ras" "agent"
23 Q0 15330190 211 30.737278 imi_mug_run_2_treatment "duration"
23 Q0 7607564 212 30.688026 imi_mug_run_2_treatment "endocrine therapy"
23 Q0 24782652 213 30.677956 imi_mug_run_2_treatment "phosphate" "liver"
23 Q0 17361205 214 30.672865 imi_mug_run_2_treatment "her-2" "trastuzumab"
23 Q0 23752180 215 30.656826 imi_mug_run_2_treatment "level"
23 Q0 23322234 216 30.649696 imi_mug_run_2_treatment "estrogen" "tamoxifen" "tma"
23 Q0 23667369 217 30.646072 imi_mug_run_2_treatment "her-2"
23 Q0 21352579 218 30.640127 imi_mug_run_2_treatment "basis"
23 Q0 24129975 219 30.636885 imi_mug_run_2_treatment "parp inhibitors"
23 Q0 11279343 220 30.628815 imi_mug_run_2_treatment "level"
23 Q0 20966540 221 30.620129 imi_mug_run_2_treatment "adjuvant" "endocrine therapy"
23 Q0 21541733 222 30.620129 imi_mug_run_2_treatment "adjuvant" "endocrine therapy"
23 Q0 29382369 223 30.586058 imi_mug_run_2_treatment "androgen" "anti-androgen agents"
23 Q0 29289986 224 30.57593 imi_mug_run_2_treatment "fulvestrant" "alisertib" "mbc"
23 Q0 8700555 225 30.571075 imi_mug_run_2_treatment "matrix"
23 Q0 11115354 226 30.568977 imi_mug_run_2_treatment "estrogen"
23 Q0 24776696 227 30.560995 imi_mug_run_2_treatment "hydroxypropyl chitosan" "chitosan"
23 Q0 21761347 228 30.553734 imi_mug_run_2_treatment "estrogen" "mediated"
23 Q0 2611995 229 30.546566 imi_mug_run_2_treatment "estrogen" "progesterone"
23 Q0 16529047 230 30.541248 imi_mug_run_2_treatment "trastuzumab" "mbc" "drugs"
23 Q0 22937203 231 30.51921 imi_mug_run_2_treatment "various" "drug"
23 Q0 17285574 232 30.511555 imi_mug_run_2_treatment "com"
23 Q0 28163741 233 30.509558 imi_mug_run_2_treatment "various"
23 Q0 20953835 234 30.505112 imi_mug_run_2_treatment "tamoxifen" "aim"
23 Q0 23776375 235 30.494854 imi_mug_run_2_treatment "mediated"
23 Q0 29848688 236 30.494564 imi_mug_run_2_treatment "various" "aim"
23 Q0 16951389 237 30.493202 imi_mug_run_2_treatment "trastuzumab" "adjuvant" "lead"
23 Q0 15194824 238 30.491007 imi_mug_run_2_treatment "her-2" "herceptin" "trastuzumab"
23 Q0 17113724 239 30.48981 imi_mug_run_2_treatment "mbc"
23 Q0 9061283 240 30.460484 imi_mug_run_2_treatment "various"
23 Q0 28125801 241 30.446974 imi_mug_run_2_treatment "various"
23 Q0 24573687 242 30.446526 imi_mug_run_2_treatment "tamoxifen" "estrogen" "adjuvant"
23 Q0 7904515 243 30.425537 imi_mug_run_2_treatment "her-2"
23 Q0 17143354 244 30.362522 imi_mug_run_2_treatment "her-2"
23 Q0 29774317 245 30.360416 imi_mug_run_2_treatment "aim"
23 Q0 26207617 246 30.357447 imi_mug_run_2_treatment "enzymes" "lysine"
23 Q0 20508983 247 30.35728 imi_mug_run_2_treatment "mediators"
23 Q0 19838757 248 30.356356 imi_mug_run_2_treatment "matrix"
23 Q0 19995430 249 30.351406 imi_mug_run_2_treatment "level"
23 Q0 9812239 250 30.32683 imi_mug_run_2_treatment "alcohol" "aim" "air"
23 Q0 22475046 251 30.324787 imi_mug_run_2_treatment "tamoxifen" "anastrozole" "adjuvant"
23 Q0 1663805 252 30.31908 imi_mug_run_2_treatment "dfmo" "drug" "difluoromethylornithine"
23 Q0 16419056 253 30.318804 imi_mug_run_2_treatment "level"
23 Q0 7904177 254 30.301956 imi_mug_run_2_treatment "product"
23 Q0 15262439 255 30.26659 imi_mug_run_2_treatment "level"
23 Q0 10809222 256 30.257853 imi_mug_run_2_treatment "monoclonal antibodies"
23 Q0 11336460 257 30.254166 imi_mug_run_2_treatment "color" "basis" "aim"
23 Q0 2554239 258 30.222052 imi_mug_run_2_treatment "estrogen" "progesterone" "pooled"
23 Q0 12790787 259 30.20306 imi_mug_run_2_treatment "various" "estrogen" "estradiol"
23 Q0 27566580 260 30.201899 imi_mug_run_2_treatment "level" "trastuzumab" "adjuvant"
23 Q0 25253995 261 30.191505 imi_mug_run_2_treatment "ors"
23 Q0 17158641 262 30.188866 imi_mug_run_2_treatment "various" "epidermal growth factor"
23 Q0 17453369 263 30.17737 imi_mug_run_2_treatment "her-2" "trastuzumab"
23 Q0 21497294 264 30.161686 imi_mug_run_2_treatment "tamoxifen" "adjuvant"
23 Q0 28901323 265 30.160381 imi_mug_run_2_treatment "trastuzumab"
23 Q0 23527311 266 30.156061 imi_mug_run_2_treatment "mediated"
23 Q0 8104440 267 30.146206 imi_mug_run_2_treatment "enzymes" "anticancer agents" "retinoic acid"
23 Q0 9865902 268 30.115376 imi_mug_run_2_treatment "estrogen"
23 Q0 19707416 269 30.090668 imi_mug_run_2_treatment "drug" "trastuzumab" "product"
23 Q0 27940449 270 30.086615 imi_mug_run_2_treatment "mbc" "endocrine therapy"
23 Q0 10678582 271 30.076662 imi_mug_run_2_treatment "her-2" "herceptin" "trastuzumab"
23 Q0 20661016 272 30.07331 imi_mug_run_2_treatment "silver"
23 Q0 22864769 273 30.054153 imi_mug_run_2_treatment "epirubicin" "cyclophosphamide" "paclitaxel"
23 Q0 28218735 274 30.051361 imi_mug_run_2_treatment "various" "mediated" "cytotoxic"
23 Q0 20024612 275 30.041306 imi_mug_run_2_treatment "brivanib" "brivanib alaninate"
23 Q0 10474685 276 30.0363 imi_mug_run_2_treatment "digoxigenin" "aim"
23 Q0 23288634 277 30.034695 imi_mug_run_2_treatment "various" "arsenal" "lead"
23 Q0 21836036 278 30.02458 imi_mug_run_2_treatment "level"
23 Q0 18925859 279 30.020378 imi_mug_run_2_treatment "product"
23 Q0 9331100 280 30.00979 imi_mug_run_2_treatment "aim"
23 Q0 20338615 281 30.008608 imi_mug_run_2_treatment "trastuzumab" "her-2" "adjuvant"
23 Q0 15920544 282 29.996096 imi_mug_run_2_treatment "her-2" "level"
23 Q0 21787752 283 29.96637 imi_mug_run_2_treatment "agar"
23 Q0 20429623 284 29.936844 imi_mug_run_2_treatment "estrogen"
23 Q0 23431153 285 29.93155 imi_mug_run_2_treatment "calcium"
23 Q0 19569235 286 29.91515 imi_mug_run_2_treatment "monolayer" "suppressor"
23 Q0 7909307 287 29.89879 imi_mug_run_2_treatment "dnase"
23 Q0 25677745 288 29.85456 imi_mug_run_2_treatment "lead" "dovitinib" "azd4547"
23 Q0 25642443 289 29.849182 imi_mug_run_2_treatment "cyclophosphamide"
23 Q0 14632727 290 29.842072 imi_mug_run_2_treatment "her-2" "drugs"
23 Q0 22882128 291 29.83868 imi_mug_run_2_treatment "aim"
23 Q0 19365520 292 29.837988 imi_mug_run_2_treatment "estrogen" "progesterone" "lapatinib"
23 Q0 8492318 293 29.830751 imi_mug_run_2_treatment "basis"
23 Q0 21540562 294 29.82373 imi_mug_run_2_treatment "trastuzumab" "drug"
23 Q0 27652326 295 29.80405 imi_mug_run_2_treatment "matrix"
23 Q0 2569032 296 29.797451 imi_mug_run_2_treatment "product"
23 Q0 12476934 297 29.781559 imi_mug_run_2_treatment "oestrogen" "carotenoids" "oestrogens"
23 Q0 19672706 298 29.781494 imi_mug_run_2_treatment "estrogen" "drug" "igf1"
23 Q0 22958056 299 29.771656 imi_mug_run_2_treatment "basis"
23 Q0 30060783 300 29.765686 imi_mug_run_2_treatment "duration"
23 Q0 19784073 301 29.749987 imi_mug_run_2_treatment "lysine"
23 Q0 12755487 302 29.733814 imi_mug_run_2_treatment "new drugs"
23 Q0 23581231 303 29.732527 imi_mug_run_2_treatment "serine" "level"
23 Q0 25509354 304 29.72234 imi_mug_run_2_treatment "various"
23 Q0 14613025 305 29.72118 imi_mug_run_2_treatment "mediated"
23 Q0 17040570 306 29.707 imi_mug_run_2_treatment "various" "tma" "lead"
23 Q0 24508693 307 29.705643 imi_mug_run_2_treatment "aim"
23 Q0 23951298 308 29.702717 imi_mug_run_2_treatment "tamoxifen" "level" "aim"
23 Q0 20948761 309 29.700851 imi_mug_run_2_treatment "medicine" "monoclonal antibodies"
23 Q0 22132735 310 29.694647 imi_mug_run_2_treatment "aim"
23 Q0 18725974 311 29.688438 imi_mug_run_2_treatment "drug" "herceptin"
23 Q0 12132871 312 29.663294 imi_mug_run_2_treatment "contraceptive"
23 Q0 22681620 313 29.654972 imi_mug_run_2_treatment "various"
23 Q0 10604729 314 29.652258 imi_mug_run_2_treatment "p23" "level"
23 Q0 12684415 315 29.64532 imi_mug_run_2_treatment "calcium homeostasis"
23 Q0 22555090 316 29.613415 imi_mug_run_2_treatment "herceptin"
23 Q0 26101715 317 29.605453 imi_mug_run_2_treatment "estrogen" "agar" "lysine"
23 Q0 22426810 318 29.58293 imi_mug_run_2_treatment "aim"
23 Q0 20060649 319 29.581375 imi_mug_run_2_treatment "drugs" "oestrogen" "parp inhibitors"
23 Q0 12362975 320 29.567411 imi_mug_run_2_treatment "estrogen"
23 Q0 12100739 321 29.563519 imi_mug_run_2_treatment "mediated"
23 Q0 11738392 322 29.562757 imi_mug_run_2_treatment "level"
23 Q0 7514954 323 29.539726 imi_mug_run_2_treatment "various" "fcm" "her-2"
23 Q0 9769953 324 29.531336 imi_mug_run_2_treatment "genesis"
23 Q0 28843004 325 29.524948 imi_mug_run_2_treatment "yeast"
23 Q0 9815531 326 29.523209 imi_mug_run_2_treatment "estrogen" "mediated" "level"
23 Q0 16012712 327 29.518202 imi_mug_run_2_treatment "medicines" "therapeutics"
23 Q0 18979234 328 29.516903 imi_mug_run_2_treatment "melatonin" "estradiol"
23 Q0 10469452 329 29.5045 imi_mug_run_2_treatment "level" "lead"
23 Q0 18544963 330 29.493422 imi_mug_run_2_treatment "estrogen"
23 Q0 23634290 331 29.493128 imi_mug_run_2_treatment "dapi"
23 Q0 9185698 332 29.491646 imi_mug_run_2_treatment "estrogen" "pace"
23 Q0 15492841 333 29.49097 imi_mug_run_2_treatment "her-2" "topo" "level"
23 Q0 17928597 334 29.48637 imi_mug_run_2_treatment "estrogen" "paclitaxel" "cyclophosphamide"
23 Q0 25531321 335 29.469572 imi_mug_run_2_treatment "level"
23 Q0 28944112 336 29.461344 imi_mug_run_2_treatment "trastuzumab" "drug" "ado-trastuzumab emtansine"
23 Q0 25818873 337 29.460787 imi_mug_run_2_treatment "trastuzumab" "color"
23 Q0 28271910 338 29.441938 imi_mug_run_2_treatment "investigational drugs" "blockade"
23 Q0 18293085 339 29.436754 imi_mug_run_2_treatment "various" "others"
23 Q0 28930757 340 29.415058 imi_mug_run_2_treatment "aim"
23 Q0 16254685 341 29.397055 imi_mug_run_2_treatment "serine" "suppressor"
23 Q0 15123142 342 29.39535 imi_mug_run_2_treatment "herceptin" "adjuvant" "paclitaxel"
23 Q0 28967900 343 29.392933 imi_mug_run_2_treatment "mediated"
23 Q0 25846735 344 29.391956 imi_mug_run_2_treatment "various" "her-2"
23 Q0 17922223 345 29.390438 imi_mug_run_2_treatment "lead"
23 Q0 11731415 346 29.379196 imi_mug_run_2_treatment "ile" "her-2"
23 Q0 26232424 347 29.377773 imi_mug_run_2_treatment "protease"
23 Q0 25863565 348 29.371714 imi_mug_run_2_treatment "basis" "aim"
23 Q0 30136158 349 29.371277 imi_mug_run_2_treatment "ci 4"
23 Q0 30365827 350 29.36103 imi_mug_run_2_treatment "aim"
23 Q0 23333597 351 29.357388 imi_mug_run_2_treatment "androgen" "mediated"
23 Q0 19945923 352 29.356613 imi_mug_run_2_treatment "tandem" "level"
23 Q0 26942015 353 29.356121 imi_mug_run_2_treatment "various"
23 Q0 17050664 354 29.351555 imi_mug_run_2_treatment "drug"
23 Q0 27121204 355 29.348831 imi_mug_run_2_treatment "level" "mln8237"
23 Q0 19854352 356 29.3386 imi_mug_run_2_treatment "various" "combinations" "estrogen"
23 Q0 17260090 357 29.333603 imi_mug_run_2_treatment "adjuvant"
23 Q0 24377000 358 29.318272 imi_mug_run_2_treatment "tma" "her-2"
23 Q0 8879683 359 29.313156 imi_mug_run_2_treatment "mediated"
23 Q0 14671981 360 29.306965 imi_mug_run_2_treatment "estrogen" "progesterone"
23 Q0 21607366 361 29.306965 imi_mug_run_2_treatment "various"
23 Q0 25749757 362 29.295612 imi_mug_run_2_treatment "therapeutics" "trastuzumab"
23 Q0 30104527 363 29.293293 imi_mug_run_2_treatment "licochalcone a"
23 Q0 28479958 364 29.287502 imi_mug_run_2_treatment "combinations"
23 Q0 28417568 365 29.285639 imi_mug_run_2_treatment "cddp" "cisplatin" "alisertib"
23 Q0 9865918 366 29.27755 imi_mug_run_2_treatment "adjuvant" "ethidium bromide"
23 Q0 9380415 367 29.275517 imi_mug_run_2_treatment "basis"
23 Q0 16086643 368 29.26118 imi_mug_run_2_treatment "combinations" "trastuzumab" "her-2"
23 Q0 28665682 369 29.26118 imi_mug_run_2_treatment "neratinib" "trastuzumab" "adjuvant"
23 Q0 19408071 370 29.253418 imi_mug_run_2_treatment "irinotecan" "antiangiogenic" "abi-007"
23 Q0 15757204 371 29.251392 imi_mug_run_2_treatment "aim"
23 Q0 27788409 372 29.24924 imi_mug_run_2_treatment "aim"
23 Q0 21875466 373 29.234089 imi_mug_run_2_treatment "level" "aim"
23 Q0 10850408 374 29.233423 imi_mug_run_2_treatment "others"
23 Q0 8709940 375 29.229618 imi_mug_run_2_treatment "various"
23 Q0 23984893 376 29.229618 imi_mug_run_2_treatment "pertuzumab" "trastuzumab" "adjuvant"
23 Q0 16707747 377 29.22647 imi_mug_run_2_treatment "cyclophosphamide" "fluorouracil" "epirubicin"
23 Q0 19454617 378 29.190805 imi_mug_run_2_treatment "combinations"
23 Q0 27931045 379 29.190805 imi_mug_run_2_treatment "oestrogen"
23 Q0 9231883 380 29.169167 imi_mug_run_2_treatment "various" "lead" "level"
23 Q0 19636701 381 29.159645 imi_mug_run_2_treatment "tamoxifen"
23 Q0 22172120 382 29.156189 imi_mug_run_2_treatment "her-2" "tma" "color"
23 Q0 19047115 383 29.151022 imi_mug_run_2_treatment "lapatinib" "her-2" "paclitaxel"
23 Q0 16140974 384 29.149284 imi_mug_run_2_treatment "tamoxifen" "adjuvant" "antiestrogen"
23 Q0 14587863 385 29.138733 imi_mug_run_2_treatment "vitamin d" "serms" "retinoids"
23 Q0 26993162 386 29.136848 imi_mug_run_2_treatment "cancer drug"
23 Q0 17486065 387 29.135572 imi_mug_run_2_treatment "tamoxifen" "drug" "adjuvant"
23 Q0 19635209 388 29.122053 imi_mug_run_2_treatment "estrogen"
23 Q0 26608463 389 29.106289 imi_mug_run_2_treatment "kinase inhibitor"
23 Q0 25628946 390 29.085064 imi_mug_run_2_treatment "methylated"
23 Q0 21321214 391 29.083706 imi_mug_run_2_treatment "trastuzumab"
23 Q0 27517156 392 29.067404 imi_mug_run_2_treatment "level"
23 Q0 20589936 393 29.036592 imi_mug_run_2_treatment "trastuzumab" "drugs" "lead"
23 Q0 25625960 394 29.03645 imi_mug_run_2_treatment "various" "paclitaxel"
23 Q0 30074276 395 29.033705 imi_mug_run_2_treatment "blu9931"
23 Q0 17906451 396 29.002293 imi_mug_run_2_treatment "trastuzumab"
23 Q0 12835514 397 29.001808 imi_mug_run_2_treatment "various" "level" "product"
23 Q0 29352243 398 28.97968 imi_mug_run_2_treatment "tyrphostin" "mediated" "as1411"
23 Q0 1989653 399 28.978842 imi_mug_run_2_treatment "others"
23 Q0 28598825 400 28.96628 imi_mug_run_2_treatment "retinoid" "retinoic acid"
23 Q0 18662380 401 28.952194 imi_mug_run_2_treatment "various"
23 Q0 22864622 402 28.951576 imi_mug_run_2_treatment "therapeutics"
23 Q0 21705665 403 28.94246 imi_mug_run_2_treatment "level"
23 Q0 27223437 404 28.922796 imi_mug_run_2_treatment "various" "mbc"
23 Q0 10808369 405 28.922134 imi_mug_run_2_treatment "adjuvant" "adriamycin" "herceptin"
23 Q0 18199546 406 28.906963 imi_mug_run_2_treatment "ras"
23 Q0 23851309 407 28.885756 imi_mug_run_2_treatment "trastuzumab"
23 Q0 28722778 408 28.87902 imi_mug_run_2_treatment "trastuzumab" "aim"
23 Q0 16502015 409 28.86681 imi_mug_run_2_treatment "tma"
23 Q0 26386078 410 28.861626 imi_mug_run_2_treatment "trastuzumab" "adjuvant" "silver"
23 Q0 10815905 411 28.856348 imi_mug_run_2_treatment "various combinations" "level"
23 Q0 8630915 412 28.848436 imi_mug_run_2_treatment "methotrexate" "cyclophosphamide" "fluorouracil"
23 Q0 7507699 413 28.826881 imi_mug_run_2_treatment "level"
23 Q0 28738804 414 28.81659 imi_mug_run_2_treatment "her-2"
23 Q0 17922420 415 28.816267 imi_mug_run_2_treatment "product" "hot spot"
23 Q0 18593897 416 28.816267 imi_mug_run_2_treatment "various" "estrogen" "endocrine therapy"
23 Q0 19792970 417 28.792244 imi_mug_run_2_treatment "adjuvant" "tamoxifen" "aromatase inhibitors"
23 Q0 27859262 418 28.78836 imi_mug_run_2_treatment "mediated" "epidermal growth factor" "shape"
23 Q0 17786023 419 28.78349 imi_mug_run_2_treatment "lead"
23 Q0 17867585 420 28.7708 imi_mug_run_2_treatment "her-2" "herceptin" "adjuvant"
23 Q0 11745673 421 28.768417 imi_mug_run_2_treatment "herceptin"
23 Q0 7912163 422 28.759377 imi_mug_run_2_treatment "drug" "tamoxifen" "adjuvant"
23 Q0 10425298 423 28.751797 imi_mug_run_2_treatment "level"
23 Q0 22207630 424 28.751682 imi_mug_run_2_treatment "aim"
23 Q0 8286193 425 28.749107 imi_mug_run_2_treatment "insulin" "level"
23 Q0 22752290 426 28.736906 imi_mug_run_2_treatment "taxane"
23 Q0 23045280 427 28.733402 imi_mug_run_2_treatment "ras"
23 Q0 15140287 428 28.705101 imi_mug_run_2_treatment "level"
23 Q0 7903524 429 28.702126 imi_mug_run_2_treatment "level" "proteinase" "b 2"
23 Q0 8103591 430 28.698498 imi_mug_run_2_treatment "product"
23 Q0 25663547 431 28.695019 imi_mug_run_2_treatment "tam" "mtor inhibitor" "everolimus"
23 Q0 18593940 432 28.691513 imi_mug_run_2_treatment "paclitaxel" "mmae" "drug"
23 Q0 15812476 433 28.683178 imi_mug_run_2_treatment "trastuzumab" "her-2" "biotin"
23 Q0 15196531 434 28.683083 imi_mug_run_2_treatment "aim"
23 Q0 15803183 435 28.67511 imi_mug_run_2_treatment "various"
23 Q0 25753278 436 28.669994 imi_mug_run_2_treatment "progesterone" "her-2" "oestrogen"
23 Q0 20419393 437 28.666893 imi_mug_run_2_treatment "trastuzumab"
23 Q0 24156016 438 28.665289 imi_mug_run_2_treatment "aim"
23 Q0 12698536 439 28.665154 imi_mug_run_2_treatment "herceptin" "trastuzumab"
23 Q0 7915536 440 28.66092 imi_mug_run_2_treatment "oestrogen" "level"
23 Q0 28508829 441 28.6433 imi_mug_run_2_treatment "ors"
23 Q0 27713932 442 28.62722 imi_mug_run_2_treatment "gold" "product"
23 Q0 19275526 443 28.621857 imi_mug_run_2_treatment "trastuzumab" "adjuvant" "therapeutic agents"
23 Q0 22510516 444 28.619186 imi_mug_run_2_treatment "level"
23 Q0 19168584 445 28.616196 imi_mug_run_2_treatment "various"
23 Q0 11098307 446 28.599667 imi_mug_run_2_treatment "mbc" "agent" "trastuzumab"
23 Q0 1353709 447 28.590845 imi_mug_run_2_treatment "progesterone"
23 Q0 23325583 448 28.590239 imi_mug_run_2_treatment "favor" "agent" "lead"
23 Q0 29970903 449 28.590239 imi_mug_run_2_treatment "vascular endothelial growth factor"
23 Q0 25987188 450 28.578274 imi_mug_run_2_treatment "drugs" "agent"
23 Q0 24915811 451 28.576626 imi_mug_run_2_treatment "color"
23 Q0 20100636 452 28.5741 imi_mug_run_2_treatment "atra" "trans retinoic acid"
23 Q0 15854527 453 28.573292 imi_mug_run_2_treatment "oligo"
23 Q0 15743506 454 28.571198 imi_mug_run_2_treatment "her-2" "amp" "alg"
23 Q0 14965711 455 28.565475 imi_mug_run_2_treatment "level"
23 Q0 11304680 456 28.563915 imi_mug_run_2_treatment "herceptin" "adjuvant" "cytotoxic"
23 Q0 17216002 457 28.562595 imi_mug_run_2_treatment "her-2" "herceptin" "adjuvant"
23 Q0 8094712 458 28.560946 imi_mug_run_2_treatment "tamoxifen"
23 Q0 19167496 459 28.559847 imi_mug_run_2_treatment "estrogen" "estrogens" "enzymes"
23 Q0 11455000 460 28.55841 imi_mug_run_2_treatment "product" "herceptin"
23 Q0 16297088 461 28.549953 imi_mug_run_2_treatment "estrogen" "herceptin" "new drugs"
23 Q0 22524573 462 28.54634 imi_mug_run_2_treatment "basis"
23 Q0 27980912 463 28.54634 imi_mug_run_2_treatment "estrogen"
23 Q0 17428260 464 28.5453 imi_mug_run_2_treatment "trastuzumab" "adjuvant"
23 Q0 17899385 465 28.5453 imi_mug_run_2_treatment "herceptin" "trastuzumab"
23 Q0 9252329 466 28.544931 imi_mug_run_2_treatment "estrogen"
23 Q0 19245352 467 28.544931 imi_mug_run_2_treatment "trastuzumab" "adjuvant" "herceptin"
23 Q0 18719096 468 28.534164 imi_mug_run_2_treatment "kinase inhibitor" "ras" "lapatinib"
23 Q0 3286221 469 28.531021 imi_mug_run_2_treatment "ras"
23 Q0 8616779 470 28.51921 imi_mug_run_2_treatment "level"
23 Q0 8945620 471 28.51741 imi_mug_run_2_treatment "level"
23 Q0 3828999 472 28.515717 imi_mug_run_2_treatment "drug" "adriamycin"
23 Q0 23311575 473 28.509392 imi_mug_run_2_treatment "trastuzumab" "level"
23 Q0 28528450 474 28.501644 imi_mug_run_2_treatment "estrogen"
23 Q0 1670762 475 28.496252 imi_mug_run_2_treatment "others"
23 Q0 8752152 476 28.492897 imi_mug_run_2_treatment "level"
23 Q0 30385370 477 28.484926 imi_mug_run_2_treatment "aim"
23 Q0 26588862 478 28.479733 imi_mug_run_2_treatment "various" "lysine"
23 Q0 9408753 479 28.462584 imi_mug_run_2_treatment "level"
23 Q0 28588715 480 28.460878 imi_mug_run_2_treatment "aim"
23 Q0 30079142 481 28.4603 imi_mug_run_2_treatment "trastuzumab" "lapatinib" "mm-111"
23 Q0 28063737 482 28.45539 imi_mug_run_2_treatment "level"
23 Q0 25219294 483 28.449492 imi_mug_run_2_treatment "duration"
23 Q0 8058337 484 28.444057 imi_mug_run_2_treatment "ras"
23 Q0 18787015 485 28.444006 imi_mug_run_2_treatment "her-2"
23 Q0 27904514 486 28.444006 imi_mug_run_2_treatment "adjuvant" "aim"
23 Q0 22326523 487 28.438229 imi_mug_run_2_treatment "adjuvant" "trastuzumab" "aim"
23 Q0 10436674 488 28.432407 imi_mug_run_2_treatment "product" "duration" "aim"
23 Q0 17695489 489 28.424088 imi_mug_run_2_treatment "product"
23 Q0 26626802 490 28.413174 imi_mug_run_2_treatment "trastuzumab"
23 Q0 22333602 491 28.407455 imi_mug_run_2_treatment "chemotherapeutic agent" "drugs"
23 Q0 18431743 492 28.406519 imi_mug_run_2_treatment "tgfb1"
23 Q0 16682728 493 28.39485 imi_mug_run_2_treatment "cyclophosphamide" "epirubicin" "adjuvant"
23 Q0 18927304 494 28.393415 imi_mug_run_2_treatment "adjuvant"
23 Q0 21034468 495 28.393415 imi_mug_run_2_treatment "mediated" "ethanol" "antioxidant"
23 Q0 19366795 496 28.384039 imi_mug_run_2_treatment "estrogen" "estradiol" "endocrine therapy"
23 Q0 11371225 497 28.378174 imi_mug_run_2_treatment "level"
23 Q0 17330240 498 28.376804 imi_mug_run_2_treatment "mediated"
23 Q0 27621003 499 28.376411 imi_mug_run_2_treatment "phosphate"
23 Q0 16280056 500 28.376295 imi_mug_run_2_treatment "monoclonal antibodies"
23 Q0 7913873 501 28.353586 imi_mug_run_2_treatment "various"
23 Q0 22807578 502 28.35339 imi_mug_run_2_treatment "calcium"
23 Q0 10092063 503 28.349575 imi_mug_run_2_treatment "liver" "alkaloids" "product"
23 Q0 25054056 504 28.321365 imi_mug_run_2_treatment "prostaglandins"
23 Q0 24080492 505 28.31564 imi_mug_run_2_treatment "mbc"
23 Q0 30475534 506 28.31155 imi_mug_run_2_treatment "various"
23 Q0 23372829 507 28.297215 imi_mug_run_2_treatment "estrogen" "hydroxytamoxifen"
23 Q0 25333262 508 28.296818 imi_mug_run_2_treatment "human mammary gland"
23 Q0 22010023 509 28.296818 imi_mug_run_2_treatment "antiestrogen" "estrogens" "estrogen"
23 Q0 25929335 510 28.29366 imi_mug_run_2_treatment "adjuvant" "estrogen" "progesterone"
23 Q0 19760503 511 28.284355 imi_mug_run_2_treatment "trastuzumab"
23 Q0 17872901 512 28.264309 imi_mug_run_2_treatment "her-2" "taxane" "taxanes"
23 Q0 23923010 513 28.26304 imi_mug_run_2_treatment "paclitaxel" "mediated" "formalin"
23 Q0 14731835 514 28.261429 imi_mug_run_2_treatment "her-2" "herceptin"
23 Q0 30398120 515 28.255487 imi_mug_run_2_treatment "estrogen" "phenol" "alkaloid"
23 Q0 17922188 516 28.252651 imi_mug_run_2_treatment "adjuvant"
23 Q0 29521182 517 28.238987 imi_mug_run_2_treatment "ors"
23 Q0 25870251 518 28.229916 imi_mug_run_2_treatment "estrogen"
23 Q0 10706127 519 28.213657 imi_mug_run_2_treatment "color" "level" "aim"
23 Q0 27993109 520 28.203953 imi_mug_run_2_treatment "trastuzumab" "drug" "adjuvant"
23 Q0 16194824 521 28.201431 imi_mug_run_2_treatment "adjuvant" "her-2"
23 Q0 8611372 522 28.193247 imi_mug_run_2_treatment "various" "antiserum" "others"
23 Q0 30200102 523 28.187654 imi_mug_run_2_treatment "taurine"
23 Q0 28523293 524 28.184822 imi_mug_run_2_treatment "estrogen" "progesterone"
23 Q0 26056489 525 28.178614 imi_mug_run_2_treatment "trastuzumab" "pertuzumab"
23 Q0 19167607 526 28.172556 imi_mug_run_2_treatment "various"
23 Q0 17079488 527 28.16716 imi_mug_run_2_treatment "her-2" "urokinase plasminogen activator" "drugs"
23 Q0 27061008 528 28.16322 imi_mug_run_2_treatment "trastuzumab" "level"
23 Q0 26998111 529 28.159323 imi_mug_run_2_treatment "estrogen"
23 Q0 15083194 530 28.155048 imi_mug_run_2_treatment "level"
23 Q0 16601278 531 28.150188 imi_mug_run_2_treatment "various" "drug" "herceptin"
23 Q0 17369913 532 28.149845 imi_mug_run_2_treatment "estrogen"
23 Q0 11064458 533 28.143234 imi_mug_run_2_treatment "autologous"
23 Q0 27069548 534 28.141224 imi_mug_run_2_treatment "adjuvant" "her-2"
23 Q0 25389328 535 28.14014 imi_mug_run_2_treatment "trastuzumab" "level" "silver"
23 Q0 22686613 536 28.138935 imi_mug_run_2_treatment "trastuzumab" "lapatinib" "pertuzumab"
23 Q0 24292870 537 28.126041 imi_mug_run_2_treatment "antineoplastic drugs"
23 Q0 21288332 538 28.118877 imi_mug_run_2_treatment "lead" "level" "aim"
23 Q0 21748818 539 28.11333 imi_mug_run_2_treatment "aim" "endocrine therapy"
23 Q0 25944485 540 28.1095 imi_mug_run_2_treatment "estrogen" "drugs"
23 Q0 20131994 541 28.09589 imi_mug_run_2_treatment "trastuzumab" "lapatinib" "adjuvant"
23 Q0 24057252 542 28.09213 imi_mug_run_2_treatment "various"
23 Q0 10942099 543 28.081491 imi_mug_run_2_treatment "product"
23 Q0 11304576 544 28.052885 imi_mug_run_2_treatment "level"
23 Q0 14997048 545 28.04818 imi_mug_run_2_treatment "dnase"
23 Q0 19474354 546 28.038967 imi_mug_run_2_treatment "her-2" "edta" "tma"
23 Q0 14567724 547 28.031113 imi_mug_run_2_treatment "trastuzumab" "nervous system"
23 Q0 14762215 548 28.006542 imi_mug_run_2_treatment "various" "trastuzumab" "herceptin"
23 Q0 15124233 549 27.996994 imi_mug_run_2_treatment "agent" "therapeutic vaccines" "prophylactic"
23 Q0 20712882 550 27.99458 imi_mug_run_2_treatment "various"
23 Q0 29181861 551 27.992561 imi_mug_run_2_treatment "aim"
23 Q0 24297508 552 27.985832 imi_mug_run_2_treatment "herceptin"
23 Q0 23334327 553 27.969574 imi_mug_run_2_treatment "agent" "alisertib" "drug"
23 Q0 17440925 554 27.956665 imi_mug_run_2_treatment "phe" "com" "yeast"
23 Q0 15805292 555 27.95512 imi_mug_run_2_treatment "various" "taxanes" "mediated"
23 Q0 7749145 556 27.941612 imi_mug_run_2_treatment "isolate"
23 Q0 23762609 557 27.93673 imi_mug_run_2_treatment "various" "taxane" "trastuzumab"
23 Q0 29181099 558 27.93526 imi_mug_run_2_treatment "aim"
23 Q0 19687331 559 27.9305 imi_mug_run_2_treatment "combinations" "adjuvant" "taxanes"
23 Q0 27392311 560 27.911808 imi_mug_run_2_treatment "tyrosine"
23 Q0 29512701 561 27.910744 imi_mug_run_2_treatment "lead" "mln8237"
23 Q0 24803549 562 27.90437 imi_mug_run_2_treatment "drugs"
23 Q0 26937204 563 27.894821 imi_mug_run_2_treatment "pertuzumab" "drug" "adjuvant"
23 Q0 20107891 564 27.894821 imi_mug_run_2_treatment "plasma" "scorpion"
23 Q0 17254832 565 27.888817 imi_mug_run_2_treatment "her-2" "trastuzumab"
23 Q0 11830510 566 27.879738 imi_mug_run_2_treatment "her-2" "adjuvant"
23 Q0 23832666 567 27.876366 imi_mug_run_2_treatment "collagen" "mediated"
23 Q0 30094493 568 27.875202 imi_mug_run_2_treatment "aromatase inhibitors"
23 Q0 16831078 569 27.870811 imi_mug_run_2_treatment "trastuzumab" "adjuvant" "herceptin"
23 Q0 7612910 570 27.869278 imi_mug_run_2_treatment "various"
23 Q0 16784538 571 27.865654 imi_mug_run_2_treatment "various" "pooled"
23 Q0 28669172 572 27.863295 imi_mug_run_2_treatment "aim"
23 Q0 21503112 573 27.862873 imi_mug_run_2_treatment "her-2"
23 Q0 22841444 574 27.862202 imi_mug_run_2_treatment "various"
23 Q0 25304382 575 27.858263 imi_mug_run_2_treatment "viral vector"
23 Q0 25537518 576 27.858263 imi_mug_run_2_treatment "enzymes" "lysine" "hmt"
23 Q0 26143491 577 27.858263 imi_mug_run_2_treatment "cytotoxic" "lead"
23 Q0 21860549 578 27.85699 imi_mug_run_2_treatment "her-2"
23 Q0 21990379 579 27.854645 imi_mug_run_2_treatment "basis" "level" "plasma"
23 Q0 21528268 580 27.849628 imi_mug_run_2_treatment "cdki"
23 Q0 17520678 581 27.844074 imi_mug_run_2_treatment "hme" "pd173074" "level"
23 Q0 22099935 582 27.843401 imi_mug_run_2_treatment "herceptin" "trastuzumab" "color"
23 Q0 8758910 583 27.841488 imi_mug_run_2_treatment "isolate"
23 Q0 18787609 584 27.836033 imi_mug_run_2_treatment "tma"
23 Q0 29402145 585 27.818302 imi_mug_run_2_treatment "aim"
23 Q0 28340968 586 27.810152 imi_mug_run_2_treatment "estrogen" "nervous system"
23 Q0 28239564 587 27.804588 imi_mug_run_2_treatment "adjuvant"
23 Q0 21080741 588 27.796726 imi_mug_run_2_treatment "anti-angiogenic agents" "therapeutic agents"
23 Q0 26114737 589 27.789494 imi_mug_run_2_treatment "prolactin" "antipsychotic medication" "antipsychotic"
23 Q0 26384210 590 27.783934 imi_mug_run_2_treatment "therapeutic agent"
23 Q0 21190077 591 27.783867 imi_mug_run_2_treatment "aim"
23 Q0 28580310 592 27.77998 imi_mug_run_2_treatment "aim"
23 Q0 27373675 593 27.762413 imi_mug_run_2_treatment "cck-8"
23 Q0 16168105 594 27.759418 imi_mug_run_2_treatment "various" "ly294002"
23 Q0 12227416 595 27.759418 imi_mug_run_2_treatment "various" "level" "monoclonal antibodies"
23 Q0 19214513 596 27.754189 imi_mug_run_2_treatment "trastuzumab" "color"
23 Q0 23865076 597 27.753521 imi_mug_run_2_treatment "various" "drug" "cytotoxic"
23 Q0 23496046 598 27.749084 imi_mug_run_2_treatment "trastuzumab" "adjuvant" "drugs"
23 Q0 23473771 599 27.74878 imi_mug_run_2_treatment "level" "trastuzumab" "mbc"
23 Q0 20979875 600 27.739868 imi_mug_run_2_treatment "silver"
23 Q0 9618526 601 27.739449 imi_mug_run_2_treatment "enzymes" "liver"
23 Q0 18727424 602 27.734455 imi_mug_run_2_treatment "her-2"
23 Q0 19548848 603 27.729822 imi_mug_run_2_treatment "autologous" "combinations"
23 Q0 22993582 604 27.720922 imi_mug_run_2_treatment "level"
23 Q0 16033049 605 27.705296 imi_mug_run_2_treatment "trastuzumab" "combinations" "adjuvant"
23 Q0 15607548 606 27.695282 imi_mug_run_2_treatment "trastuzumab" "immunological adjuvant" "her-2"
23 Q0 16261400 607 27.693567 imi_mug_run_2_treatment "aim"
23 Q0 11768601 608 27.693087 imi_mug_run_2_treatment "mitogen" "plasma"
23 Q0 22614884 609 27.688774 imi_mug_run_2_treatment "various" "silver" "level"
23 Q0 20098429 610 27.685446 imi_mug_run_2_treatment "adjuvant" "mediated"
23 Q0 15735025 611 27.679314 imi_mug_run_2_treatment "estrogen" "mediated" "proteinase"
23 Q0 18288420 612 27.679314 imi_mug_run_2_treatment "estradiol" "tamoxifen"
23 Q0 29411539 613 27.679314 imi_mug_run_2_treatment "leu" "antioxidant" "oxygen"
23 Q0 20632056 614 27.662113 imi_mug_run_2_treatment "drugs" "trastuzumab" "drug"
23 Q0 26672755 615 27.659266 imi_mug_run_2_treatment "tma" "trastuzumab"
23 Q0 21233672 616 27.631561 imi_mug_run_2_treatment "adjuvant"
23 Q0 11948114 617 27.629383 imi_mug_run_2_treatment "favor"
23 Q0 8168995 618 27.629036 imi_mug_run_2_treatment "mediated" "anti-sense oligonucleotide"
23 Q0 20459607 619 27.610865 imi_mug_run_2_treatment "level"
23 Q0 9394844 620 27.608572 imi_mug_run_2_treatment "estrogen" "her-2"
23 Q0 12897328 621 27.603004 imi_mug_run_2_treatment "trastuzumab"
23 Q0 17431282 622 27.60252 imi_mug_run_2_treatment "herceptin"
23 Q0 10066073 623 27.588089 imi_mug_run_2_treatment "antiestrogens" "duration" "monoclonal antibodies"
23 Q0 23900867 624 27.587461 imi_mug_run_2_treatment "mediated" "duration"
23 Q0 22035181 625 27.585125 imi_mug_run_2_treatment "silver"
23 Q0 16619488 626 27.58268 imi_mug_run_2_treatment "phenol" "formalin" "isolating"
23 Q0 9624530 627 27.58175 imi_mug_run_2_treatment "yeast" "basis" "others"
23 Q0 15862759 628 27.58175 imi_mug_run_2_treatment "docetaxel" "level"
23 Q0 21808024 629 27.577677 imi_mug_run_2_treatment "serine"
23 Q0 22105362 630 27.577677 imi_mug_run_2_treatment "ras" "lead"
23 Q0 21319970 631 27.560234 imi_mug_run_2_treatment "plasma"
23 Q0 24919593 632 27.559 imi_mug_run_2_treatment "azacytidine" "plasma"
23 Q0 16204032 633 27.554981 imi_mug_run_2_treatment "yeast"
23 Q0 19221791 634 27.552364 imi_mug_run_2_treatment "icc"
23 Q0 19624808 635 27.551344 imi_mug_run_2_treatment "herceptin"
23 Q0 22002566 636 27.550463 imi_mug_run_2_treatment "various" "combinations"
23 Q0 19383354 637 27.548517 imi_mug_run_2_treatment "basis"
23 Q0 26314200 638 27.54294 imi_mug_run_2_treatment "aim"
23 Q0 22517690 639 27.53951 imi_mug_run_2_treatment "her-2"
23 Q0 26285240 640 27.5373 imi_mug_run_2_treatment "favoring" "trastuzumab" "pertuzumab"
23 Q0 28665072 641 27.537014 imi_mug_run_2_treatment "level" "aim"
23 Q0 11731427 642 27.531132 imi_mug_run_2_treatment "estrogen" "aromatase inhibitor" "serm"
23 Q0 21281505 643 27.522373 imi_mug_run_2_treatment "basis"
23 Q0 15671547 644 27.522106 imi_mug_run_2_treatment "level" "aim"
23 Q0 23379971 645 27.521349 imi_mug_run_2_treatment "basis" "aim"
23 Q0 16144943 646 27.516579 imi_mug_run_2_treatment "saha" "docetaxel" "trastuzumab"
23 Q0 16420697 647 27.515808 imi_mug_run_2_treatment "her-2"
23 Q0 16682283 648 27.512974 imi_mug_run_2_treatment "ile" "isoleucine" "her-2"
23 Q0 15743501 649 27.489904 imi_mug_run_2_treatment "level"
23 Q0 9892105 650 27.483276 imi_mug_run_2_treatment "gastrin"
23 Q0 30442682 651 27.48199 imi_mug_run_2_treatment "drug" "bispecific antibodies" "therapeutics"
23 Q0 20832293 652 27.471428 imi_mug_run_2_treatment "adjuvant"
23 Q0 23116406 653 27.46638 imi_mug_run_2_treatment "estrogen" "aim"
23 Q0 15897872 654 27.455223 imi_mug_run_2_treatment "oligo" "others"
23 Q0 20220514 655 27.452522 imi_mug_run_2_treatment "lapatinib" "kinase inhibitor" "anticancer agents"
23 Q0 17335803 656 27.441647 imi_mug_run_2_treatment "mbc"
23 Q0 7543819 657 27.439802 imi_mug_run_2_treatment "emodin" "tyrosine kinase inhibitor"
23 Q0 20927582 658 27.439802 imi_mug_run_2_treatment "mbc"
23 Q0 16150805 659 27.431948 imi_mug_run_2_treatment "trastuzumab" "paclitaxel" "aim"
23 Q0 30413718 660 27.429283 imi_mug_run_2_treatment "trastuzumab"
23 Q0 15743507 661 27.425686 imi_mug_run_2_treatment "aim"
23 Q0 23578469 662 27.422342 imi_mug_run_2_treatment "adjuvant" "taxane" "trastuzumab"
23 Q0 17018586 663 27.422283 imi_mug_run_2_treatment "various"
23 Q0 15687593 664 27.419514 imi_mug_run_2_treatment "anti-estrogens" "tyrosine" "monoclonal antibodies"
23 Q0 18264135 665 27.417545 imi_mug_run_2_treatment "antiestrogen" "mitogen" "tamoxifen"
23 Q0 16827104 666 27.415268 imi_mug_run_2_treatment "combinations" "allogeneic" "mediated"
23 Q0 23695030 667 27.415268 imi_mug_run_2_treatment "estrogen" "therapeutics"
23 Q0 25400686 668 27.415268 imi_mug_run_2_treatment "various"
23 Q0 15335457 669 27.414833 imi_mug_run_2_treatment "favoring" "nervous system"
23 Q0 15217943 670 27.405367 imi_mug_run_2_treatment "her-2" "von willebrand factor" "plasma"
23 Q0 28055972 671 27.396782 imi_mug_run_2_treatment "various"
23 Q0 17288526 672 27.39272 imi_mug_run_2_treatment "mediated"
23 Q0 1350453 673 27.391323 imi_mug_run_2_treatment "oestrogen"
23 Q0 23469012 674 27.391323 imi_mug_run_2_treatment "various"
23 Q0 24870930 675 27.391155 imi_mug_run_2_treatment "ras"
23 Q0 25818297 676 27.38763 imi_mug_run_2_treatment "drug"
23 Q0 23226154 677 27.38763 imi_mug_run_2_treatment "enzymes"
23 Q0 15668283 678 27.387287 imi_mug_run_2_treatment "trastuzumab" "her-2"
23 Q0 8481934 679 27.38613 imi_mug_run_2_treatment "endocrine therapy"
23 Q0 25186909 680 27.378437 imi_mug_run_2_treatment "tandem" "genesis"
23 Q0 2565909 681 27.377146 imi_mug_run_2_treatment "lead"
23 Q0 15031710 682 27.373281 imi_mug_run_2_treatment "aim"
23 Q0 19442060 683 27.37125 imi_mug_run_2_treatment "her-2" "trastuzumab" "herceptin"
23 Q0 27485818 684 27.369137 imi_mug_run_2_treatment "mediated"
23 Q0 19642459 685 27.361408 imi_mug_run_2_treatment "drug" "trastuzumab" "adjuvant"
23 Q0 25823661 686 27.360376 imi_mug_run_2_treatment "mediated"
23 Q0 8262679 687 27.355356 imi_mug_run_2_treatment "level" "estrogen" "duration"
23 Q0 27384237 688 27.354927 imi_mug_run_2_treatment "drugs" "investigational drugs"
23 Q0 9831867 689 27.352081 imi_mug_run_2_treatment "adriamycin" "cytotoxic" "herceptin"
23 Q0 17063271 690 27.352081 imi_mug_run_2_treatment "aim"
23 Q0 21128112 691 27.35171 imi_mug_run_2_treatment "antiestrogen" "troglitazone" "drug"
23 Q0 27567228 692 27.35068 imi_mug_run_2_treatment "program"
23 Q0 16585167 693 27.349035 imi_mug_run_2_treatment "level"
23 Q0 17925008 694 27.346428 imi_mug_run_2_treatment "oligo"
23 Q0 16184453 695 27.346233 imi_mug_run_2_treatment "trastuzumab" "mbc"
23 Q0 21082277 696 27.344315 imi_mug_run_2_treatment "epidermal growth factor" "matrix"
23 Q0 17656250 697 27.340984 imi_mug_run_2_treatment "basis"
23 Q0 10388110 698 27.338974 imi_mug_run_2_treatment "adriamycin" "cytotoxic" "herceptin"
23 Q0 15601761 699 27.332838 imi_mug_run_2_treatment "estrogen" "estrogens" "estradiol"
23 Q0 25897424 700 27.332314 imi_mug_run_2_treatment "plasminogen activator"
23 Q0 21761402 701 27.324532 imi_mug_run_2_treatment "lead"
23 Q0 27087654 702 27.31501 imi_mug_run_2_treatment "estrogen" "antiestrogen" "estradiol"
23 Q0 17223541 703 27.314903 imi_mug_run_2_treatment "her-2" "drug" "adjuvant"
23 Q0 22016618 704 27.314903 imi_mug_run_2_treatment "cisplatin" "taxane" "trastuzumab"
23 Q0 25681734 705 27.288927 imi_mug_run_2_treatment "insulin" "balance"
23 Q0 23253899 706 27.271503 imi_mug_run_2_treatment "trastuzumab"
23 Q0 8104920 707 27.270607 imi_mug_run_2_treatment "estrogen" "diphosphate" "ndp"
23 Q0 25970776 708 27.267647 imi_mug_run_2_treatment "drug" "therapeutics" "level"
23 Q0 20635137 709 27.265083 imi_mug_run_2_treatment "her-2" "estrogen" "adjuvant"
23 Q0 26842935 710 27.264961 imi_mug_run_2_treatment "ras" "mediated" "aurora kinase inhibitor"
23 Q0 1617668 711 27.262915 imi_mug_run_2_treatment "insulin" "agonist"
23 Q0 24833241 712 27.254541 imi_mug_run_2_treatment "drug" "medicine"
23 Q0 25799416 713 27.24342 imi_mug_run_2_treatment "vitamin d3" "various" "cdx"
23 Q0 15064746 714 27.224 imi_mug_run_2_treatment "hydroxyurea" "agent"
23 Q0 26101330 715 27.221783 imi_mug_run_2_treatment "basis"
23 Q0 20102399 716 27.21592 imi_mug_run_2_treatment "aim"
23 Q0 19923073 717 27.213655 imi_mug_run_2_treatment "her-2"
23 Q0 26362298 718 27.212147 imi_mug_run_2_treatment "level" "others"
23 Q0 15823795 719 27.200848 imi_mug_run_2_treatment "level"
23 Q0 8797867 720 27.188824 imi_mug_run_2_treatment "tamoxifen"
23 Q0 11180764 721 27.188824 imi_mug_run_2_treatment "adriamycin" "trastuzumab"
23 Q0 26778597 722 27.188768 imi_mug_run_2_treatment "ppi" "aim"
23 Q0 19269014 723 27.18725 imi_mug_run_2_treatment "trastuzumab" "her-2"
23 Q0 9676832 724 27.179909 imi_mug_run_2_treatment "duration"
23 Q0 18794096 725 27.179615 imi_mug_run_2_treatment "her-2" "adjuvant"
23 Q0 22622817 726 27.179615 imi_mug_run_2_treatment "estrogen" "others"
23 Q0 23129208 727 27.17183 imi_mug_run_2_treatment "various" "basis" "aim"
23 Q0 23939428 728 27.17183 imi_mug_run_2_treatment "acetate" "level"
23 Q0 18690166 729 27.170233 imi_mug_run_2_treatment "level"
23 Q0 24367492 730 27.164917 imi_mug_run_2_treatment "tamoxifen" "adjuvant" "anti-estrogens"
23 Q0 25590580 731 27.164127 imi_mug_run_2_treatment "ras" "aim"
23 Q0 30333908 732 27.159216 imi_mug_run_2_treatment "trastuzumab" "lapatinib"
23 Q0 12890810 733 27.158924 imi_mug_run_2_treatment "igfbp-3" "insulin-like growth factor binding protein 3" "level"
23 Q0 25838920 734 27.1554 imi_mug_run_2_treatment "enzymes"
23 Q0 25278993 735 27.1554 imi_mug_run_2_treatment "brdu"
23 Q0 20499159 736 27.1554 imi_mug_run_2_treatment "estrogen" "duration"
23 Q0 19669600 737 27.1554 imi_mug_run_2_treatment "mediated"
23 Q0 8187086 738 27.136822 imi_mug_run_2_treatment "product" "ethidium" "level"
23 Q0 19821025 739 27.132103 imi_mug_run_2_treatment "estrogen" "progesterone" "tyrosine"
23 Q0 27040927 740 27.130774 imi_mug_run_2_treatment "her-2" "estrogen" "aim"
23 Q0 26625783 741 27.126966 imi_mug_run_2_treatment "trastuzumab" "program" "aim"
23 Q0 26177467 742 27.126966 imi_mug_run_2_treatment "tempol" "gentian violet" "tamoxifen"
23 Q0 12942124 743 27.11723 imi_mug_run_2_treatment "lead"
23 Q0 25882311 744 27.115334 imi_mug_run_2_treatment "daurinol" "topoisomerase inhibitor" "serine"
23 Q0 11221879 745 27.111835 imi_mug_run_2_treatment "estrogen" "level"
23 Q0 9699459 746 27.102625 imi_mug_run_2_treatment "level"
23 Q0 2683275 747 27.101439 imi_mug_run_2_treatment "ras" "level"
23 Q0 19412426 748 27.099213 imi_mug_run_2_treatment "various"
23 Q0 15363198 749 27.098948 imi_mug_run_2_treatment "silver"
23 Q0 9343325 750 27.098457 imi_mug_run_2_treatment "mouse monoclonal antibody"
23 Q0 26687450 751 27.094822 imi_mug_run_2_treatment "enzymes" "drugs" "quinone"
23 Q0 19351835 752 27.0929 imi_mug_run_2_treatment "lead"
23 Q0 28089283 753 27.085217 imi_mug_run_2_treatment "drug" "docetaxel" "cyclophosphamide"
23 Q0 19675743 754 27.072369 imi_mug_run_2_treatment "level"
23 Q0 25961581 755 27.05957 imi_mug_run_2_treatment "tamoxifen" "calcium"
23 Q0 1977159 756 27.049435 imi_mug_run_2_treatment "various"
23 Q0 19060929 757 27.048088 imi_mug_run_2_treatment "vascular endothelial growth factor" "level"
23 Q0 30256064 758 27.045765 imi_mug_run_2_treatment "aim"
23 Q0 16525662 759 27.044743 imi_mug_run_2_treatment "trastuzumab" "endocrine therapy"
23 Q0 27993117 760 27.039827 imi_mug_run_2_treatment "trastuzumab" "herceptin"
23 Q0 22112940 761 27.033688 imi_mug_run_2_treatment "estrogen" "mediated" "others"
23 Q0 20814816 762 27.033688 imi_mug_run_2_treatment "various"
23 Q0 27650498 763 27.030262 imi_mug_run_2_treatment "mediators"
23 Q0 30120594 764 27.018353 imi_mug_run_2_treatment "color"
23 Q0 29455658 765 27.015759 imi_mug_run_2_treatment "various" "tyrosine"
23 Q0 2470152 766 27.009546 imi_mug_run_2_treatment "various"
23 Q0 7912561 767 26.999214 imi_mug_run_2_treatment "combinations"
23 Q0 20658718 768 26.998363 imi_mug_run_2_treatment "level"
23 Q0 20604919 769 26.989914 imi_mug_run_2_treatment "combinations"
23 Q0 22170254 770 26.956554 imi_mug_run_2_treatment "level"
23 Q0 26358790 771 26.954756 imi_mug_run_2_treatment "neratinib" "combinations" "drugs"
23 Q0 16080959 772 26.942432 imi_mug_run_2_treatment "product"
23 Q0 11870541 773 26.938274 imi_mug_run_2_treatment "level"
23 Q0 25124601 774 26.93251 imi_mug_run_2_treatment "rice" "plasminogen activator"
23 Q0 25628026 775 26.921024 imi_mug_run_2_treatment "level"
23 Q0 19884553 776 26.91763 imi_mug_run_2_treatment "adjuvant" "trastuzumab"
23 Q0 1349163 777 26.914085 imi_mug_run_2_treatment "level"
23 Q0 17633393 778 26.910904 imi_mug_run_2_treatment "her-2"
23 Q0 16495929 779 26.9011 imi_mug_run_2_treatment "aim"
23 Q0 28183331 780 26.88949 imi_mug_run_2_treatment "fulvestrant" "dovitinib" "agent"
23 Q0 21418986 781 26.883759 imi_mug_run_2_treatment "her-2"
23 Q0 26471763 782 26.882969 imi_mug_run_2_treatment "suppressor"
23 Q0 28869599 783 26.872122 imi_mug_run_2_treatment "taxane" "various" "mediated"
23 Q0 24367641 784 26.870457 imi_mug_run_2_treatment "level"
23 Q0 12050766 785 26.860428 imi_mug_run_2_treatment "trastuzumab"
23 Q0 11410482 786 26.859695 imi_mug_run_2_treatment "topo" "enzymes" "alkylator"
23 Q0 29790419 787 26.858799 imi_mug_run_2_treatment "everolimus" "exemestane" "mtor inhibitor"
23 Q0 8702311 788 26.856842 imi_mug_run_2_treatment "eosin"
23 Q0 17332282 789 26.851593 imi_mug_run_2_treatment "tamoxifen" "estrogen" "aromatase inhibitors"
23 Q0 8579127 790 26.851389 imi_mug_run_2_treatment "ethidium bromide" "eosin"
23 Q0 17636399 791 26.850216 imi_mug_run_2_treatment "tamoxifen" "adjuvant"
23 Q0 30454901 792 26.840563 imi_mug_run_2_treatment "n-acetylcysteine" "oxygen" "cck-8"
23 Q0 6821863 793 26.840145 imi_mug_run_2_treatment "adriamycin" "duration"
23 Q0 11956627 794 26.827688 imi_mug_run_2_treatment "estradiol" "suppressor"
23 Q0 21279682 795 26.822859 imi_mug_run_2_treatment "estrogen" "drugs" "gnrh-i"
23 Q0 27382390 796 26.821594 imi_mug_run_2_treatment "ethanol" "formalin" "aim"
23 Q0 11694790 797 26.820236 imi_mug_run_2_treatment "estrogen"
23 Q0 24367169 798 26.820236 imi_mug_run_2_treatment "lapatinib" "various" "drug"
23 Q0 21847344 799 26.820236 imi_mug_run_2_treatment "trastuzumab" "adjuvant" "drugs"
23 Q0 15687687 800 26.808886 imi_mug_run_2_treatment "therapeutic agents"
23 Q0 29805554 801 26.803398 imi_mug_run_2_treatment "endocrine therapy"
23 Q0 17699859 802 26.800919 imi_mug_run_2_treatment "level"
23 Q0 7174686 803 26.79818 imi_mug_run_2_treatment "estrogen" "methotrexate" "drug"
23 Q0 16816380 804 26.79739 imi_mug_run_2_treatment "mediated"
23 Q0 29019333 805 26.79739 imi_mug_run_2_treatment "various"
23 Q0 16739306 806 26.795752 imi_mug_run_2_treatment "trastuzumab" "carboplatin" "navelbine"
23 Q0 16739343 807 26.795752 imi_mug_run_2_treatment "trastuzumab" "carboplatin" "navelbine"
23 Q0 19800460 808 26.790081 imi_mug_run_2_treatment "aim" "endocrine therapy"
23 Q0 10759407 809 26.78963 imi_mug_run_2_treatment "enzymes" "herceptin" "agent"
23 Q0 15943788 810 26.78203 imi_mug_run_2_treatment "her-2" "herceptin" "level"
23 Q0 26694831 811 26.781664 imi_mug_run_2_treatment "combinations" "androgen" "estrogen"
23 Q0 21566965 812 26.777163 imi_mug_run_2_treatment "level"
23 Q0 30153557 813 26.774479 imi_mug_run_2_treatment "alisertib" "drugs" "vincristine"
23 Q0 18339869 814 26.774105 imi_mug_run_2_treatment "mediated"
23 Q0 11313686 815 26.773552 imi_mug_run_2_treatment "maspin" "product"
23 Q0 27095932 816 26.773552 imi_mug_run_2_treatment "trastuzumab" "new drugs" "drugs"
23 Q0 21954532 817 26.773552 imi_mug_run_2_treatment "aim"
23 Q0 15623945 818 26.76677 imi_mug_run_2_treatment "aim"
23 Q0 10898115 819 26.765858 imi_mug_run_2_treatment "duration"
23 Q0 11091516 820 26.760235 imi_mug_run_2_treatment "mediated" "level" "suppressor"
23 Q0 15217500 821 26.760138 imi_mug_run_2_treatment "azacytidine"
23 Q0 29863884 822 26.756124 imi_mug_run_2_treatment "drug" "polysaccharide" "mediated"
23 Q0 24556651 823 26.74908 imi_mug_run_2_treatment "agent"
23 Q0 22105650 824 26.735382 imi_mug_run_2_treatment "trastuzumab" "adjuvant" "balance"
23 Q0 21637380 825 26.728167 imi_mug_run_2_treatment "mediated" "trastuzumab" "therapeutic antibody"
23 Q0 24205493 826 26.723597 imi_mug_run_2_treatment "various"
23 Q0 8044767 827 26.715637 imi_mug_run_2_treatment "level" "anonymous"
23 Q0 11056689 828 26.705492 imi_mug_run_2_treatment "hme" "fgf-7"
23 Q0 9610362 829 26.705492 imi_mug_run_2_treatment "iron" "mediated"
23 Q0 25109964 830 26.692871 imi_mug_run_2_treatment "trastuzumab" "lapatinib" "azd8931"
23 Q0 21790246 831 26.687904 imi_mug_run_2_treatment "trastuzumab"
23 Q0 14701769 832 26.685955 imi_mug_run_2_treatment "basis"
23 Q0 25969993 833 26.67624 imi_mug_run_2_treatment "gefitinib"
23 Q0 20201928 834 26.669289 imi_mug_run_2_treatment "ag825" "ethanol" "human plasma"
23 Q0 23779101 835 26.666605 imi_mug_run_2_treatment "level"
23 Q0 21802409 836 26.657873 imi_mug_run_2_treatment "estrogen" "progesterone" "phosphate"
23 Q0 1304832 837 26.657463 imi_mug_run_2_treatment "various"
23 Q0 28800016 838 26.649502 imi_mug_run_2_treatment "her-2" "aim"
23 Q0 10464675 839 26.646496 imi_mug_run_2_treatment "genesis"
23 Q0 21069454 840 26.641953 imi_mug_run_2_treatment "parp inhibitors"
23 Q0 27628328 841 26.631227 imi_mug_run_2_treatment "mbc"
23 Q0 25906114 842 26.629639 imi_mug_run_2_treatment "mbc"
23 Q0 19094582 843 26.62555 imi_mug_run_2_treatment "trastuzumab"
23 Q0 3285482 844 26.620193 imi_mug_run_2_treatment "fcm"
23 Q0 17727094 845 26.620193 imi_mug_run_2_treatment "estrogen" "adjuvant" "progesteron"
23 Q0 23063927 846 26.61763 imi_mug_run_2_treatment "aim"
23 Q0 8664033 847 26.615818 imi_mug_run_2_treatment "plasma"
23 Q0 7880720 848 26.615818 imi_mug_run_2_treatment "oestrogen"
23 Q0 16918262 849 26.611176 imi_mug_run_2_treatment "trastuzumab" "adjuvant" "agent"
23 Q0 26440892 850 26.611176 imi_mug_run_2_treatment "type i interferon"
23 Q0 19404734 851 26.609745 imi_mug_run_2_treatment "estrogen"
23 Q0 2903446 852 26.601927 imi_mug_run_2_treatment "monoclonal antibodies"
23 Q0 18808314 853 26.594765 imi_mug_run_2_treatment "ertumaxomab" "bispecific antibody" "trastuzumab"
23 Q0 20620929 854 26.594765 imi_mug_run_2_treatment "estrogen"
23 Q0 22188678 855 26.592884 imi_mug_run_2_treatment "ipa" "baf"
23 Q0 17157792 856 26.589901 imi_mug_run_2_treatment "level"
23 Q0 23227845 857 26.58608 imi_mug_run_2_treatment "aim" "ile"
23 Q0 15552838 858 26.581238 imi_mug_run_2_treatment "aim"
23 Q0 15842048 859 26.556955 imi_mug_run_2_treatment "level" "her-2"
23 Q0 9702495 860 26.551197 imi_mug_run_2_treatment "alcohol" "biotin" "phenolic"
23 Q0 28035400 861 26.549843 imi_mug_run_2_treatment "metformin" "various" "adenosine monophosphate"
23 Q0 23996866 862 26.549124 imi_mug_run_2_treatment "estrogen"
23 Q0 23103368 863 26.545975 imi_mug_run_2_treatment "taxane" "adjuvant" "level"
23 Q0 2572268 864 26.514574 imi_mug_run_2_treatment "ras"
23 Q0 11498827 865 26.513361 imi_mug_run_2_treatment "her-2"
23 Q0 9421359 866 26.502419 imi_mug_run_2_treatment "oestrogen"
23 Q0 24982406 867 26.501383 imi_mug_run_2_treatment "aim"
23 Q0 16897746 868 26.482212 imi_mug_run_2_treatment "com" "basis" "level"
23 Q0 17592676 869 26.482212 imi_mug_run_2_treatment "aim"
23 Q0 24521023 870 26.478733 imi_mug_run_2_treatment "aim"
23 Q0 15891995 871 26.47296 imi_mug_run_2_treatment "color"
23 Q0 10768865 872 26.471655 imi_mug_run_2_treatment "epidermal growth factor" "her-2" "lead"
23 Q0 9328152 873 26.470701 imi_mug_run_2_treatment "various" "cyclophosphamide" "epirubicin"
23 Q0 12755492 874 26.470148 imi_mug_run_2_treatment "level"
23 Q0 30013101 875 26.469265 imi_mug_run_2_treatment "mediated" "mln8237"
23 Q0 19669636 876 26.467297 imi_mug_run_2_treatment "trastuzumab"
23 Q0 1617667 877 26.460205 imi_mug_run_2_treatment "estrogen"
23 Q0 20063318 878 26.459368 imi_mug_run_2_treatment "trastuzumab" "plasminogen activator" "mediated"
23 Q0 26432753 879 26.457853 imi_mug_run_2_treatment "alisertib" "mediated" "radiochemical"
23 Q0 18835712 880 26.447372 imi_mug_run_2_treatment "water"
23 Q0 26497206 881 26.446342 imi_mug_run_2_treatment "adjuvant"
23 Q0 1565470 882 26.444878 imi_mug_run_2_treatment "anonymous"
23 Q0 20211985 883 26.440308 imi_mug_run_2_treatment "estrogen" "heparin" "estradiol"
23 Q0 26113056 884 26.428413 imi_mug_run_2_treatment "estrogen" "mediated" "aromatase inhibitors"
23 Q0 25277657 885 26.425274 imi_mug_run_2_treatment "various" "aim"
23 Q0 11336244 886 26.425035 imi_mug_run_2_treatment "various"
23 Q0 11376135 887 26.424805 imi_mug_run_2_treatment "aim"
23 Q0 11416960 888 26.41613 imi_mug_run_2_treatment "herceptin" "trastuzumab" "endocrine therapy"
23 Q0 20443098 889 26.40479 imi_mug_run_2_treatment "trastuzumab"
23 Q0 20651409 890 26.402748 imi_mug_run_2_treatment "trastuzumab" "plasma"
23 Q0 24122392 891 26.394142 imi_mug_run_2_treatment "drug" "estrogen" "generic"
23 Q0 24337538 892 26.392662 imi_mug_run_2_treatment "estrogen"
23 Q0 1682035 893 26.378561 imi_mug_run_2_treatment "basis"
23 Q0 15065600 894 26.371279 imi_mug_run_2_treatment "level"
23 Q0 15376260 895 26.37114 imi_mug_run_2_treatment "suppressor"
23 Q0 9331099 896 26.36657 imi_mug_run_2_treatment "aim"
23 Q0 27811150 897 26.363457 imi_mug_run_2_treatment "enzymes" "serine"
23 Q0 17636398 898 26.360716 imi_mug_run_2_treatment "adjuvant" "tamoxifen" "estrogen receptor modulator"
23 Q0 17638622 899 26.360163 imi_mug_run_2_treatment "her-2" "herceptin" "trastuzumab"
23 Q0 23219593 900 26.35437 imi_mug_run_2_treatment "mediated" "proteases" "estrogenic"
23 Q0 17255770 901 26.349552 imi_mug_run_2_treatment "her-2" "level" "cyclophosphamide"
23 Q0 16137435 902 26.349552 imi_mug_run_2_treatment "trastuzumab" "level"
23 Q0 22076473 903 26.344494 imi_mug_run_2_treatment "various" "level"
23 Q0 2915900 904 26.338043 imi_mug_run_2_treatment "her-2"
23 Q0 16650962 905 26.336357 imi_mug_run_2_treatment "enzymes"
23 Q0 11906444 906 26.313429 imi_mug_run_2_treatment "product"
23 Q0 26172299 907 26.298733 imi_mug_run_2_treatment "drugs"
23 Q0 16739104 908 26.275623 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors" "therapeutic agents"
23 Q0 20396915 909 26.259325 imi_mug_run_2_treatment "adjuvant" "trastuzumab"
23 Q0 16247515 910 26.25727 imi_mug_run_2_treatment "anabolic" "herceptin" "trastuzumab"
23 Q0 26720004 911 26.256468 imi_mug_run_2_treatment "bay 61-3606" "mediated" "level"
23 Q0 21338271 912 26.253284 imi_mug_run_2_treatment "silver" "level" "aim"
23 Q0 16570270 913 26.246445 imi_mug_run_2_treatment "level"
23 Q0 10861572 914 26.243345 imi_mug_run_2_treatment "level"
23 Q0 19344493 915 26.234867 imi_mug_run_2_treatment "suppressor"
23 Q0 24389189 916 26.231092 imi_mug_run_2_treatment "various" "trastuzumab" "lead"
23 Q0 16926039 917 26.230999 imi_mug_run_2_treatment "pifithrin-alpha" "lead"
23 Q0 29202431 918 26.230999 imi_mug_run_2_treatment "various" "parp inhibitor" "oestrogen"
23 Q0 28800870 919 26.2281 imi_mug_run_2_treatment "various" "trastuzumab" "lapatinib"
23 Q0 15119991 920 26.227753 imi_mug_run_2_treatment "various" "ile" "prolactin"
23 Q0 14553951 921 26.22752 imi_mug_run_2_treatment "cyclophosphamide" "taxane" "level"
23 Q0 28181567 922 26.226454 imi_mug_run_2_treatment "various"
23 Q0 11786427 923 26.225275 imi_mug_run_2_treatment "androgen" "level" "trastuzumab"
23 Q0 27462779 924 26.223148 imi_mug_run_2_treatment "trastuzumab" "adjuvant"
23 Q0 27738326 925 26.223148 imi_mug_run_2_treatment "lapatinib" "trastuzumab"
23 Q0 22976805 926 26.223148 imi_mug_run_2_treatment "product"
23 Q0 20556506 927 26.222233 imi_mug_run_2_treatment "tamoxifen" "adjuvant"
23 Q0 15449557 928 26.220078 imi_mug_run_2_treatment "aim"
23 Q0 28485352 929 26.220078 imi_mug_run_2_treatment "estrogen" "aim" "basis"
23 Q0 23467725 930 26.21567 imi_mug_run_2_treatment "various" "trastuzumab"
23 Q0 26690729 931 26.209946 imi_mug_run_2_treatment "level" "suppressor"
23 Q0 28439706 932 26.208843 imi_mug_run_2_treatment "various" "aim"
23 Q0 17935269 933 26.207376 imi_mug_run_2_treatment "trastuzumab" "adjuvant" "bevacizumab"
23 Q0 26285246 934 26.207376 imi_mug_run_2_treatment "program"
23 Q0 27403569 935 26.207376 imi_mug_run_2_treatment "interferon" "drugs" "others"
23 Q0 28924522 936 26.205132 imi_mug_run_2_treatment "estrogen" "estradiol" "mbc"
23 Q0 16436641 937 26.20436 imi_mug_run_2_treatment "level"
23 Q0 23558859 938 26.20419 imi_mug_run_2_treatment "silver"
23 Q0 7794815 939 26.203308 imi_mug_run_2_treatment "enzymes" "hghr" "growth hormone"
23 Q0 16958676 940 26.203308 imi_mug_run_2_treatment "ethanol" "oxygen"
23 Q0 11774205 941 26.203308 imi_mug_run_2_treatment "trastuzumab" "combinations" "herceptin"
23 Q0 9815730 942 26.186226 imi_mug_run_2_treatment "estrogen"
23 Q0 25208275 943 26.167522 imi_mug_run_2_treatment "drugs" "trastuzumab"
23 Q0 8664167 944 26.16604 imi_mug_run_2_treatment "sts" "tamoxifen" "antiestrogen"
23 Q0 24588805 945 26.165398 imi_mug_run_2_treatment "level"
23 Q0 24932267 946 26.152431 imi_mug_run_2_treatment "cytotoxic drugs"
23 Q0 21575521 947 26.150648 imi_mug_run_2_treatment "aim"
23 Q0 18182100 948 26.14677 imi_mug_run_2_treatment "various" "herceptin"
23 Q0 8706030 949 26.14376 imi_mug_run_2_treatment "bromodeoxyuridine" "duration"
23 Q0 11770175 950 26.137417 imi_mug_run_2_treatment "trastuzumab" "drug" "paclitaxel"
23 Q0 22043354 951 26.127106 imi_mug_run_2_treatment "arsenal" "trastuzumab"
23 Q0 26301495 952 26.122776 imi_mug_run_2_treatment "trastuzumab"
23 Q0 26833480 953 26.122349 imi_mug_run_2_treatment "aim"
23 Q0 20974626 954 26.109833 imi_mug_run_2_treatment "aim"
23 Q0 20457246 955 26.108994 imi_mug_run_2_treatment "estrogen" "combinations" "aspirin"
23 Q0 2573817 956 26.10575 imi_mug_run_2_treatment "various" "others"
23 Q0 28361952 957 26.105019 imi_mug_run_2_treatment "various" "level"
23 Q0 21317877 958 26.10479 imi_mug_run_2_treatment "color" "silver"
23 Q0 23958087 959 26.099941 imi_mug_run_2_treatment "aim"
23 Q0 29149504 960 26.092102 imi_mug_run_2_treatment "level"
23 Q0 21215703 961 26.090706 imi_mug_run_2_treatment "mediated" "azd6244"
23 Q0 19787624 962 26.088503 imi_mug_run_2_treatment "interleukin-2" "tnf-alpha" "cytokines"
23 Q0 2208136 963 26.084017 imi_mug_run_2_treatment "level" "product"
23 Q0 10961693 964 26.073345 imi_mug_run_2_treatment "level"
23 Q0 25956448 965 26.073345 imi_mug_run_2_treatment "drugs" "basis"
23 Q0 12898274 966 26.072355 imi_mug_run_2_treatment "duration"
23 Q0 20873313 967 26.071835 imi_mug_run_2_treatment "various" "herceptin"
23 Q0 16618726 968 26.071667 imi_mug_run_2_treatment "sage"
23 Q0 29323058 969 26.069294 imi_mug_run_2_treatment "color" "level"
23 Q0 8012996 970 26.068138 imi_mug_run_2_treatment "endocrine therapy"
23 Q0 23818341 971 26.066921 imi_mug_run_2_treatment "tamoxifen"
23 Q0 23340303 972 26.058311 imi_mug_run_2_treatment "bevacizumab" "paclitaxel" "vascular endothelial growth factor"
23 Q0 21204706 973 26.053125 imi_mug_run_2_treatment "her-2" "ile"
23 Q0 1355402 974 26.052456 imi_mug_run_2_treatment "product"
23 Q0 16708381 975 26.050034 imi_mug_run_2_treatment "aim"
23 Q0 29202611 976 26.04766 imi_mug_run_2_treatment "tamoxifen" "letrozole" "aromatase inhibitor"
23 Q0 1445597 977 26.046503 imi_mug_run_2_treatment "vitamins" "estrogen" "prolactin"
23 Q0 11773979 978 26.035122 imi_mug_run_2_treatment "ganciclovir" "mediated"
23 Q0 17067012 979 26.033882 imi_mug_run_2_treatment "formalin"
23 Q0 17889539 980 26.02325 imi_mug_run_2_treatment "herceptin" "trastuzumab"
23 Q0 23552734 981 26.018776 imi_mug_run_2_treatment "drug"
23 Q0 28294295 982 26.014988 imi_mug_run_2_treatment "estrogen" "basis"
23 Q0 11097092 983 26.00882 imi_mug_run_2_treatment "estrogen"
23 Q0 17916906 984 26.008512 imi_mug_run_2_treatment "lipase" "mediated"
23 Q0 25887735 985 26.00586 imi_mug_run_2_treatment "drug" "trastuzumab"
23 Q0 26680921 986 26.002485 imi_mug_run_2_treatment "aim"
23 Q0 26099605 987 26.001537 imi_mug_run_2_treatment "lead" "impdh inhibitors"
23 Q0 24324739 988 25.995605 imi_mug_run_2_treatment "her-2" "trastuzumab"
23 Q0 22135625 989 25.994488 imi_mug_run_2_treatment "estrogen" "level"
23 Q0 8629392 990 25.994484 imi_mug_run_2_treatment "level"
23 Q0 17661168 991 25.982426 imi_mug_run_2_treatment "mbc"
23 Q0 22207430 992 25.980618 imi_mug_run_2_treatment "estrogen"
23 Q0 11180765 993 25.97295 imi_mug_run_2_treatment "emodin" "radicicol" "trastuzumab"
23 Q0 21983861 994 25.96922 imi_mug_run_2_treatment "histidine" "aim"
23 Q0 30386679 995 25.961985 imi_mug_run_2_treatment "pid"
23 Q0 1580300 996 25.95711 imi_mug_run_2_treatment "estrogen" "adjuvant" "level"
23 Q0 16850126 997 25.95711 imi_mug_run_2_treatment "trastuzumab" "adjuvant" "drugs"
23 Q0 24460909 998 25.955372 imi_mug_run_2_treatment "various" "fty720" "serine"
23 Q0 2893663 999 25.955362 imi_mug_run_2_treatment "antiserum" "lead" "level"
24 Q0 23391413 1 31.414772 imi_mug_run_2_treatment "formalin"
24 Q0 26717940 2 29.176504 imi_mug_run_2_treatment "icc" "pcc" "adjuvant"
24 Q0 25826091 3 27.676966 imi_mug_run_2_treatment "level" "liver"
24 Q0 27823638 4 25.699366 imi_mug_run_2_treatment "various" "ras" "therapeutic agents"
24 Q0 24889489 5 25.299717 imi_mug_run_2_treatment "icc"
24 Q0 29066915 6 24.975891 imi_mug_run_2_treatment "drugs"
24 Q0 27563447 7 23.738194 imi_mug_run_2_treatment "pid"
24 Q0 27267833 8 21.752434 imi_mug_run_2_treatment "drugs"
24 Q0 28330462 9 21.692863 imi_mug_run_2_treatment "everolimus"
24 Q0 21538283 10 21.140266 imi_mug_run_2_treatment "drug" "sorafenib"
24 Q0 22180306 11 20.707266 imi_mug_run_2_treatment "product" "liver"
24 Q0 24563076 12 17.459257 imi_mug_run_2_treatment "icc" "tyrosine"
24 Q0 27181912 13 17.43942 imi_mug_run_2_treatment "plasma" "ras"
24 Q0 29893894 14 15.217085 imi_mug_run_2_treatment "gemcitabine" "cisplatin" "s-1"
25 Q0 22453013 1 44.855766 imi_mug_run_2_treatment "combinations"
25 Q0 23660168 2 43.127117 imi_mug_run_2_treatment "ras"
25 Q0 29245078 3 40.89044 imi_mug_run_2_treatment "pdx" "mek inhibitor" "binimetinib"
25 Q0 22926523 4 40.708904 imi_mug_run_2_treatment "mediated" "ras" "pd325901"
25 Q0 24950457 5 40.579582 imi_mug_run_2_treatment "amuvatinib" "cytotoxic" "kinase inhibitor"
25 Q0 16899595 6 40.177017 imi_mug_run_2_treatment "aim"
25 Q0 28497782 7 40.06684 imi_mug_run_2_treatment "various" "mediated" "ras"
25 Q0 15688405 8 39.905937 imi_mug_run_2_treatment "arginine" "glutamine" "aim"
25 Q0 26016894 9 39.740612 imi_mug_run_2_treatment "ras"
25 Q0 14522897 10 39.692177 imi_mug_run_2_treatment "ras" "aim"
25 Q0 25796376 11 39.662857 imi_mug_run_2_treatment "ras" "binimetinib"
25 Q0 24962318 12 39.588463 imi_mug_run_2_treatment "ras"
25 Q0 29076949 13 39.405357 imi_mug_run_2_treatment "ras" "blockade"
25 Q0 26095797 14 39.110054 imi_mug_run_2_treatment "plasma"
25 Q0 30154648 15 39.089294 imi_mug_run_2_treatment "adjuvant" "mek inhibitor"
25 Q0 26684394 16 38.93017 imi_mug_run_2_treatment "lead"
25 Q0 29695835 17 38.614517 imi_mug_run_2_treatment "antioxidant" "ras" "agent"
25 Q0 25736262 18 38.575775 imi_mug_run_2_treatment "ipilimumab"
25 Q0 29843107 19 38.422295 imi_mug_run_2_treatment "ipilimumab" "blockade" "nivolumab"
25 Q0 19954345 20 38.357185 imi_mug_run_2_treatment "animals" "genesis"
25 Q0 28851243 21 38.240524 imi_mug_run_2_treatment "binimetinib" "combinations" "dacarbazine"
25 Q0 26967478 22 38.230396 imi_mug_run_2_treatment "epidermal growth factor" "ras" "trametinib"
25 Q0 23431193 23 38.03795 imi_mug_run_2_treatment "ras"
25 Q0 22180178 24 38.031532 imi_mug_run_2_treatment "ras" "nervous system"
25 Q0 26358384 25 37.904503 imi_mug_run_2_treatment "blockade"
25 Q0 21750866 26 37.758476 imi_mug_run_2_treatment "ras"
25 Q0 22983396 27 37.72129 imi_mug_run_2_treatment "ras" "drug combination"
25 Q0 25252692 28 37.616913 imi_mug_run_2_treatment "ras"
25 Q0 28717400 29 37.249886 imi_mug_run_2_treatment "dacarbazine" "dtic" "temozolomide"
25 Q0 23414587 30 37.236732 imi_mug_run_2_treatment "mek162" "pharmaceuticals" "basis"
25 Q0 28134726 31 37.153458 imi_mug_run_2_treatment "ras" "aim"
25 Q0 26771141 32 37.117935 imi_mug_run_2_treatment "palmostatin b" "mediated" "lead"
25 Q0 18227705 33 37.010784 imi_mug_run_2_treatment "various"
25 Q0 23739925 34 36.914524 imi_mug_run_2_treatment "aim"
25 Q0 28797232 35 36.83458 imi_mug_run_2_treatment "blockade"
25 Q0 22895053 36 36.6784 imi_mug_run_2_treatment "combinations" "drugs" "lead"
25 Q0 25142146 37 36.616936 imi_mug_run_2_treatment "sch772984" "vemurafenib"
25 Q0 23855428 38 36.559692 imi_mug_run_2_treatment "braf inhibitor"
25 Q0 27104669 39 36.55732 imi_mug_run_2_treatment "retinoic acid" "retinoid" "agent"
25 Q0 27151331 40 36.467106 imi_mug_run_2_treatment "mek inhibitor"
25 Q0 25728708 41 36.34794 imi_mug_run_2_treatment "drug" "drugs" "fasudil"
25 Q0 28253523 42 36.34794 imi_mug_run_2_treatment "trametinib" "basis"
25 Q0 23035722 43 36.319798 imi_mug_run_2_treatment "interferon"
25 Q0 25063807 44 36.213684 imi_mug_run_2_treatment "vemurafenib" "cisplatin" "melphalan"
25 Q0 23673558 45 36.195637 imi_mug_run_2_treatment "dtic" "dacarbazine"
25 Q0 26266759 46 36.156544 imi_mug_run_2_treatment "liver"
25 Q0 26399561 47 35.914246 imi_mug_run_2_treatment "aim"
25 Q0 17119447 48 35.826256 imi_mug_run_2_treatment "ras" "level"
25 Q0 27251789 49 35.81982 imi_mug_run_2_treatment "ras" "aim"
25 Q0 27791198 50 35.52968 imi_mug_run_2_treatment "braf inhibitor"
25 Q0 28738256 51 35.452652 imi_mug_run_2_treatment "cyclic adenosine monophosphate" "cytostatic" "drug combination"
25 Q0 16417231 52 35.260128 imi_mug_run_2_treatment "ras"
25 Q0 18323787 53 35.158363 imi_mug_run_2_treatment "kinase inhibitor"
25 Q0 25749811 54 35.158363 imi_mug_run_2_treatment "aim"
25 Q0 28198367 55 34.995914 imi_mug_run_2_treatment "mek inhibitor" "program"
25 Q0 25339196 56 34.958023 imi_mug_run_2_treatment "interferon" "kinase inhibitor" "level"
25 Q0 23538902 57 34.922134 imi_mug_run_2_treatment "nh2" "blockade" "braf inhibitor"
25 Q0 25130256 58 34.811188 imi_mug_run_2_treatment "mek inhibitor" "agent" "trametinib"
25 Q0 27160069 59 34.648495 imi_mug_run_2_treatment "ras"
25 Q0 15917418 60 34.602245 imi_mug_run_2_treatment "various"
25 Q0 25646931 61 34.563583 imi_mug_run_2_treatment "zoledronic acid" "liver" "cisplatin"
25 Q0 26977874 62 34.38601 imi_mug_run_2_treatment "protease inhibitor" "drug" "nelfinavir"
25 Q0 27467925 63 34.26722 imi_mug_run_2_treatment "therapeutics"
25 Q0 27418645 64 34.191612 imi_mug_run_2_treatment "mediated"
25 Q0 24714776 65 34.17344 imi_mug_run_2_treatment "sorafenib" "carboplatin" "paclitaxel"
25 Q0 24895460 66 34.160774 imi_mug_run_2_treatment "ras"
25 Q0 22020736 67 34.061516 imi_mug_run_2_treatment "basis"
25 Q0 26710785 68 33.97472 imi_mug_run_2_treatment "level" "aim" "vemurafenib"
25 Q0 12783933 69 33.843987 imi_mug_run_2_treatment "gln" "kinase inhibitor" "lys"
25 Q0 29349077 70 33.8001 imi_mug_run_2_treatment "ras" "level"
25 Q0 16098042 71 33.795174 imi_mug_run_2_treatment "ras"
25 Q0 24121489 72 33.6679 imi_mug_run_2_treatment "tak-632" "tak-733" "vemurafenib"
25 Q0 25627962 73 33.654892 imi_mug_run_2_treatment "vemurafenib"
25 Q0 30094073 74 33.611256 imi_mug_run_2_treatment "pasireotide" "drugs" "somatostatin"
25 Q0 16474847 75 33.459606 imi_mug_run_2_treatment "nitric oxide" "s-methylisothiourea" "u0126"
25 Q0 26587692 76 33.456688 imi_mug_run_2_treatment "tyr"
25 Q0 18679422 77 33.428307 imi_mug_run_2_treatment "mediated"
25 Q0 24506253 78 33.13418 imi_mug_run_2_treatment "braf inhibitor" "staurosporine" "mediated"
25 Q0 25469513 79 33.04998 imi_mug_run_2_treatment "isothiouronium" "vemurafenib" "salt"
25 Q0 29665313 80 33.035423 imi_mug_run_2_treatment "ras" "drugs"
25 Q0 25341653 81 33.03378 imi_mug_run_2_treatment "formalin"
25 Q0 22817889 82 33.019966 imi_mug_run_2_treatment "basis"
25 Q0 22130161 83 32.988953 imi_mug_run_2_treatment "interleukin-2" "level"
25 Q0 10766161 84 32.965275 imi_mug_run_2_treatment "ras"
25 Q0 25180764 85 32.88279 imi_mug_run_2_treatment "mek inhibitor" "medicine"
25 Q0 29187493 86 32.86523 imi_mug_run_2_treatment "aim" "nervous system"
25 Q0 20140953 87 32.850323 imi_mug_run_2_treatment "interferon" "formalin"
25 Q0 24419498 88 32.805817 imi_mug_run_2_treatment "braf inhibitor" "mek inhibitor" "trametinib"
25 Q0 23893853 89 32.5987 imi_mug_run_2_treatment "ras" "vemurafenib" "dabrafenib"
25 Q0 23860532 90 32.588326 imi_mug_run_2_treatment "isolate" "aim"
25 Q0 26977879 91 32.487747 imi_mug_run_2_treatment "drug" "protease inhibitor" "nelfinavir"
25 Q0 28067895 92 32.486404 imi_mug_run_2_treatment "ras"
25 Q0 25504439 93 32.48378 imi_mug_run_2_treatment "trametinib" "metformin" "combinations"
25 Q0 26282084 94 32.411278 imi_mug_run_2_treatment "genesis"
25 Q0 25363723 95 32.407135 imi_mug_run_2_treatment "autologous"
25 Q0 23362874 96 32.40415 imi_mug_run_2_treatment "ras"
25 Q0 23975010 97 32.276905 imi_mug_run_2_treatment "various" "ras" "mek inhibitor"
25 Q0 24802725 98 32.238564 imi_mug_run_2_treatment "aim"
25 Q0 25766129 99 32.212475 imi_mug_run_2_treatment "ssm"
25 Q0 21836492 100 32.195595 imi_mug_run_2_treatment "cdx" "melan-a"
25 Q0 25645078 101 32.122105 imi_mug_run_2_treatment "mek inhibitor" "trametinib"
25 Q0 28827320 102 32.10035 imi_mug_run_2_treatment "braf inhibitor" "mediated"
25 Q0 25357015 103 32.02772 imi_mug_run_2_treatment "various"
25 Q0 30116025 104 32.021465 imi_mug_run_2_treatment "drug" "mek inhibitor" "selumetinib"
25 Q0 23795354 105 31.903988 imi_mug_run_2_treatment "aim"
25 Q0 26884185 106 31.877205 imi_mug_run_2_treatment "basis"
25 Q0 27903987 107 31.861975 imi_mug_run_2_treatment "cd271" "mapk inhibitors" "palbociclib"
25 Q0 24342721 108 31.773224 imi_mug_run_2_treatment "various" "ras" "lead"
25 Q0 22406360 109 31.755184 imi_mug_run_2_treatment "insulin-like growth factor 2"
25 Q0 25836739 110 31.722954 imi_mug_run_2_treatment "various" "combinations" "basis"
25 Q0 23694694 111 31.689867 imi_mug_run_2_treatment "aim"
25 Q0 16908931 112 31.67574 imi_mug_run_2_treatment "imatinib"
25 Q0 19441164 113 31.67574 imi_mug_run_2_treatment "maspin" "level"
25 Q0 25500121 114 31.617691 imi_mug_run_2_treatment "drug" "drugs" "mediated"
25 Q0 22261812 115 31.54345 imi_mug_run_2_treatment "sunitinib" "kinase inhibitor" "duration"
25 Q0 19383313 116 31.503202 imi_mug_run_2_treatment "ras"
25 Q0 18042149 117 31.484282 imi_mug_run_2_treatment "ras" "lead" "genesis"
25 Q0 28587477 118 31.427849 imi_mug_run_2_treatment "binimetinib" "agent"
25 Q0 30482852 119 31.369736 imi_mug_run_2_treatment "vemurafenib" "braf inhibitor" "unc2025"
25 Q0 25350317 120 31.330801 imi_mug_run_2_treatment "retinoid" "drug" "abt-737"
25 Q0 27273450 121 31.325684 imi_mug_run_2_treatment "vemurafenib" "agar" "braf inhibitor"
25 Q0 29227333 122 31.259705 imi_mug_run_2_treatment "plasma" "level" "monoclonal antibodies"
25 Q0 24458518 123 31.229183 imi_mug_run_2_treatment "hot spot"
25 Q0 24941944 124 31.15466 imi_mug_run_2_treatment "various" "enzymes" "dtic"
25 Q0 23001925 125 31.001085 imi_mug_run_2_treatment "level"
25 Q0 28284557 126 30.937702 imi_mug_run_2_treatment "binimetinib" "dacarbazine" "pharmaceuticals"
25 Q0 24962553 127 30.888958 imi_mug_run_2_treatment "drugs" "ipilimumab" "blockade"
25 Q0 16567964 128 30.864414 imi_mug_run_2_treatment "mitogen"
25 Q0 26813076 129 30.824806 imi_mug_run_2_treatment "ras"
25 Q0 27137746 130 30.771465 imi_mug_run_2_treatment "combinations" "drugs" "therapeutics"
25 Q0 22393060 131 30.723518 imi_mug_run_2_treatment "mediated" "ras" "abc"
25 Q0 30325319 132 30.692554 imi_mug_run_2_treatment "various" "ras"
25 Q0 21203491 133 30.67273 imi_mug_run_2_treatment "agar" "mediated"
25 Q0 23633454 134 30.643911 imi_mug_run_2_treatment "various"
25 Q0 27307593 135 30.615639 imi_mug_run_2_treatment "buparlisib" "antitumor agent" "drugs"
25 Q0 20444198 136 30.608105 imi_mug_run_2_treatment "dopachrome tautomerase" "ras"
25 Q0 28537004 137 30.517046 imi_mug_run_2_treatment "various" "braf inhibitor" "mek inhibitor"
25 Q0 27020391 138 30.497972 imi_mug_run_2_treatment "aim"
25 Q0 28074351 139 30.438978 imi_mug_run_2_treatment "various" "lead"
25 Q0 25812921 140 30.42791 imi_mug_run_2_treatment "trametinib" "mek inhibitor" "dabrafenib"
25 Q0 22661223 141 30.408354 imi_mug_run_2_treatment "agent"
25 Q0 30384563 142 30.398344 imi_mug_run_2_treatment "various" "adjuvant" "aim"
25 Q0 25165098 143 30.374462 imi_mug_run_2_treatment "liver"
25 Q0 24959217 144 30.360983 imi_mug_run_2_treatment "lnd" "ras" "aim"
25 Q0 22535842 145 30.343616 imi_mug_run_2_treatment "various" "mediated" "mapk inhibitors"
25 Q0 27101548 146 30.284824 imi_mug_run_2_treatment "aim"
25 Q0 28445541 147 30.247818 imi_mug_run_2_treatment "ras"
25 Q0 30026510 148 30.207912 imi_mug_run_2_treatment "drug"
25 Q0 20357817 149 30.203644 imi_mug_run_2_treatment "lead"
25 Q0 22292133 150 30.173706 imi_mug_run_2_treatment "ras" "serine"
25 Q0 30003571 151 30.172836 imi_mug_run_2_treatment "pembrolizumab"
25 Q0 16901402 152 30.12524 imi_mug_run_2_treatment "drug" "ras" "sorafenib"
25 Q0 26426340 153 30.109552 imi_mug_run_2_treatment "ipilimumab" "agent" "mek inhibitor"
25 Q0 24710085 154 30.108154 imi_mug_run_2_treatment "various"
25 Q0 25502142 155 30.07783 imi_mug_run_2_treatment "drug" "drugs" "vemurafenib"
25 Q0 27608486 156 30.076996 imi_mug_run_2_treatment "interferon alpha" "drugs" "cytotoxic"
25 Q0 14695152 157 30.0766 imi_mug_run_2_treatment "ras" "lead"
25 Q0 25752325 158 30.064434 imi_mug_run_2_treatment "braf inhibitor"
25 Q0 19799798 159 30.059647 imi_mug_run_2_treatment "level"
25 Q0 16462768 160 30.043465 imi_mug_run_2_treatment "agar" "level"
25 Q0 27320919 161 29.846558 imi_mug_run_2_treatment "pdx" "braf inhibitor"
25 Q0 17260012 162 29.798298 imi_mug_run_2_treatment "various"
25 Q0 15837158 163 29.779202 imi_mug_run_2_treatment "interferon" "imidazole" "dacarbazine"
25 Q0 22493355 164 29.775946 imi_mug_run_2_treatment "ras" "kinase inhibitor"
25 Q0 30405888 165 29.775572 imi_mug_run_2_treatment "mek inhibitor" "blockade"
25 Q0 23476798 166 29.769304 imi_mug_run_2_treatment "interferon" "adjuvant"
25 Q0 23795351 167 29.585281 imi_mug_run_2_treatment "various"
25 Q0 25343173 168 29.428545 imi_mug_run_2_treatment "basis"
25 Q0 25909885 169 29.424397 imi_mug_run_2_treatment "gmps" "agent"
25 Q0 23490205 170 29.36714 imi_mug_run_2_treatment "vemurafenib" "mediated" "plx7904"
25 Q0 28277830 171 29.34665 imi_mug_run_2_treatment "masitinib" "binimetinib" "mek inhibitor"
25 Q0 24880943 172 29.269928 imi_mug_run_2_treatment "mek inhibitor" "trametinib" "vemurafenib"
25 Q0 14961576 173 29.233818 imi_mug_run_2_treatment "ras"
25 Q0 26275246 174 29.222694 imi_mug_run_2_treatment "various"
25 Q0 29077579 175 29.196323 imi_mug_run_2_treatment "bpn"
25 Q0 22621697 176 29.133404 imi_mug_run_2_treatment "ras"
25 Q0 27152946 177 29.094189 imi_mug_run_2_treatment "sorafenib" "mediated" "therapeutic agent"
25 Q0 24276025 178 29.084145 imi_mug_run_2_treatment "aim"
25 Q0 25797573 179 29.08082 imi_mug_run_2_treatment "ras" "liver"
25 Q0 24576830 180 29.078205 imi_mug_run_2_treatment "ras" "mek inhibitor" "pd0325901"
25 Q0 26970965 181 29.071848 imi_mug_run_2_treatment "mek inhibitor"
25 Q0 27833586 182 29.027708 imi_mug_run_2_treatment "estrogens" "agonists" "estradiol"
25 Q0 1439444 183 29.011425 imi_mug_run_2_treatment "various" "monoclonal antibodies"
25 Q0 22594895 184 29.01064 imi_mug_run_2_treatment "various" "agent"
25 Q0 26825879 185 28.9455 imi_mug_run_2_treatment "therapeutic agents"
25 Q0 27572939 186 28.9455 imi_mug_run_2_treatment "gant61" "drug" "obatoclax"
25 Q0 15046639 187 28.927338 imi_mug_run_2_treatment "ras" "glutamic acid"
25 Q0 28278423 188 28.870903 imi_mug_run_2_treatment "digoxin" "mek inhibitor" "trametinib"
25 Q0 19158841 189 28.82249 imi_mug_run_2_treatment "level"
25 Q0 28353383 190 28.806665 imi_mug_run_2_treatment "ras"
25 Q0 20149136 191 28.759254 imi_mug_run_2_treatment "plx4032" "drug" "kinase inhibitor"
25 Q0 25422890 192 28.747091 imi_mug_run_2_treatment "ch5126766" "ro5126766" "mek inhibitor"
25 Q0 19633643 193 28.746134 imi_mug_run_2_treatment "level" "aim"
25 Q0 20562921 194 28.725128 imi_mug_run_2_treatment "ras" "inositol" "mediated"
25 Q0 20975100 195 28.703304 imi_mug_run_2_treatment "level"
25 Q0 17507627 196 28.682167 imi_mug_run_2_treatment "basis"
25 Q0 24934918 197 28.624231 imi_mug_run_2_treatment "resveratrol" "staurosporine" "ascorbate"
25 Q0 19571822 198 28.60762 imi_mug_run_2_treatment "lead" "basis"
25 Q0 25277205 199 28.577269 imi_mug_run_2_treatment "various" "combinations" "mek inhibitor"
25 Q0 27188223 200 28.568348 imi_mug_run_2_treatment "com" "new drugs" "trametinib"
25 Q0 28114255 201 28.53969 imi_mug_run_2_treatment "drug" "mek inhibitor" "glembatumumab"
25 Q0 27069125 202 28.505165 imi_mug_run_2_treatment "aim"
25 Q0 29559732 203 28.504372 imi_mug_run_2_treatment "ras"
25 Q0 23664541 204 28.49541 imi_mug_run_2_treatment "level"
25 Q0 23890154 205 28.430534 imi_mug_run_2_treatment "hot spot"
25 Q0 23432625 206 28.415081 imi_mug_run_2_treatment "trametinib" "drugs" "mek inhibitor"
25 Q0 25189354 207 28.366127 imi_mug_run_2_treatment "kinase inhibitor" "ras" "suppressor"
25 Q0 24866436 208 28.323742 imi_mug_run_2_treatment "lnd" "aim" "others"
25 Q0 23438383 209 28.313034 imi_mug_run_2_treatment "agent" "braf inhibitor" "vemurafenib"
25 Q0 24567366 210 28.296343 imi_mug_run_2_treatment "docetaxel" "selumetinib" "basis"
25 Q0 30086074 211 28.271828 imi_mug_run_2_treatment "various" "pdx" "drugs"
25 Q0 24795008 212 28.271738 imi_mug_run_2_treatment "balance"
25 Q0 26791842 213 28.268019 imi_mug_run_2_treatment "adjuvant"
25 Q0 23076151 214 28.26158 imi_mug_run_2_treatment "vemurafenib" "mediated" "ras"
25 Q0 29112704 215 28.241547 imi_mug_run_2_treatment "plasma"
25 Q0 25056119 216 28.226952 imi_mug_run_2_treatment "vemurafenib" "dabrafenib" "mediated"
25 Q0 22772081 217 28.226952 imi_mug_run_2_treatment "lead"
25 Q0 26448190 218 28.221645 imi_mug_run_2_treatment "melan a"
25 Q0 29485257 219 28.196625 imi_mug_run_2_treatment "color" "shape" "others"
25 Q0 16116595 220 28.175594 imi_mug_run_2_treatment "mlana" "tyr" "magea3"
25 Q0 23454897 221 28.175594 imi_mug_run_2_treatment "mediators"
25 Q0 28210865 222 28.175594 imi_mug_run_2_treatment "blockade"
25 Q0 19037234 223 28.157265 imi_mug_run_2_treatment "com"
25 Q0 21362156 224 28.126423 imi_mug_run_2_treatment "genesis"
25 Q0 23658559 225 28.060905 imi_mug_run_2_treatment "trametinib" "ci-1040" "vemurafenib"
25 Q0 23420410 226 28.050236 imi_mug_run_2_treatment "braf inhibitor" "imatinib" "mek inhibitor"
25 Q0 30190891 227 28.043453 imi_mug_run_2_treatment "pace"
25 Q0 27270434 228 27.922762 imi_mug_run_2_treatment "glutamine" "oxygen" "balance"
25 Q0 24760959 229 27.879448 imi_mug_run_2_treatment "azd6244" "drugs" "crenolanib"
25 Q0 23000456 230 27.866974 imi_mug_run_2_treatment "agonists" "forskolin" "agonist"
25 Q0 24985059 231 27.72165 imi_mug_run_2_treatment "ras" "guanosine"
25 Q0 19788533 232 27.666924 imi_mug_run_2_treatment "dimericine" "drug" "tyr"
25 Q0 28543695 233 27.65694 imi_mug_run_2_treatment "lead"
25 Q0 29481571 234 27.65356 imi_mug_run_2_treatment "vemurafenib" "tyr" "plx4032"
25 Q0 27079618 235 27.598412 imi_mug_run_2_treatment "biflorin" "cytotoxic"
25 Q0 24651527 236 27.56569 imi_mug_run_2_treatment "adc" "drug" "drug combinations"
25 Q0 29574239 237 27.56569 imi_mug_run_2_treatment "cytostatic" "cytotoxic drug"
25 Q0 27533468 238 27.517159 imi_mug_run_2_treatment "messenger" "ras"
25 Q0 26864554 239 27.508226 imi_mug_run_2_treatment "capsaicin" "curcumin" "silymarin"
25 Q0 26217117 240 27.500172 imi_mug_run_2_treatment "combinations" "mek inhibitor" "trametinib"
25 Q0 26844986 241 27.480625 imi_mug_run_2_treatment "mediators"
25 Q0 22092579 242 27.480625 imi_mug_run_2_treatment "sorafenib" "dacarbazine"
25 Q0 24341237 243 27.420624 imi_mug_run_2_treatment "drugs" "immunosuppressive" "imatinib"
25 Q0 26924126 244 27.399946 imi_mug_run_2_treatment "basis" "balance"
25 Q0 26084293 245 27.377369 imi_mug_run_2_treatment "trametinib" "afatinib"
25 Q0 27883322 246 27.28512 imi_mug_run_2_treatment "various" "ras"
25 Q0 26225944 247 27.2584 imi_mug_run_2_treatment "aim"
25 Q0 18980976 248 27.142666 imi_mug_run_2_treatment "imatinib"
25 Q0 23752084 249 27.09917 imi_mug_run_2_treatment "ras"
25 Q0 23738911 250 27.073793 imi_mug_run_2_treatment "hub"
25 Q0 26076063 251 27.066708 imi_mug_run_2_treatment "collagen" "matrix"
25 Q0 24133630 252 27.060566 imi_mug_run_2_treatment "vemurafenib" "monolayer" "braf inhibitor"
25 Q0 29385656 253 27.060566 imi_mug_run_2_treatment "chloroquine" "blockade"
25 Q0 24559688 254 27.046865 imi_mug_run_2_treatment "drug" "vemurafenib" "cyclic adenosine monophosphate"
25 Q0 15578519 255 27.045414 imi_mug_run_2_treatment "level" "duration"
25 Q0 26175403 256 27.045414 imi_mug_run_2_treatment "vemurafenib" "dabrafenib" "various combinations"
25 Q0 22614973 257 27.045414 imi_mug_run_2_treatment "various" "blockade" "braf inhibitor"
25 Q0 21464823 258 26.99416 imi_mug_run_2_treatment "lead"
25 Q0 18006687 259 26.977879 imi_mug_run_2_treatment "genesis"
25 Q0 22876817 260 26.96785 imi_mug_run_2_treatment "combinations" "adjuvant" "basis"
25 Q0 28231855 261 26.938618 imi_mug_run_2_treatment "celecoxib" "level"
25 Q0 21188111 262 26.923067 imi_mug_run_2_treatment "adjuvant" "interferon alpha-2b" "interleukin-2"
25 Q0 21482206 263 26.858322 imi_mug_run_2_treatment "ssm" "basis" "lead"
25 Q0 30089785 264 26.819935 imi_mug_run_2_treatment "mediated" "animals"
25 Q0 23330781 265 26.807613 imi_mug_run_2_treatment "medicine"
25 Q0 18300768 266 26.804321 imi_mug_run_2_treatment "kinase inhibitor" "therapeutics" "agent"
25 Q0 23893239 267 26.782112 imi_mug_run_2_treatment "enzymes"
25 Q0 23825798 268 26.769276 imi_mug_run_2_treatment "lead"
25 Q0 25585249 269 26.724113 imi_mug_run_2_treatment "drugs"
25 Q0 24075834 270 26.724113 imi_mug_run_2_treatment "favor" "program" "suppressor"
25 Q0 27086916 271 26.715889 imi_mug_run_2_treatment "sc-2001" "mcl-1 inhibitor" "drug"
25 Q0 21478863 272 26.604382 imi_mug_run_2_treatment "enzymes" "ras" "cyclic amp"
25 Q0 30070694 273 26.56783 imi_mug_run_2_treatment "tandem"
25 Q0 22945644 274 26.543999 imi_mug_run_2_treatment "mediators" "duration" "vemurafenib"
25 Q0 20182446 275 26.52338 imi_mug_run_2_treatment "ras"
25 Q0 25297634 276 26.52338 imi_mug_run_2_treatment "mek inhibitor" "selumetinib" "mediated"
25 Q0 30124539 277 26.52338 imi_mug_run_2_treatment "gefitinib" "vemurafenib" "pelitinib"
25 Q0 26201960 278 26.499027 imi_mug_run_2_treatment "pd0332991" "kinase inhibitor" "protein kinase inhibitors"
25 Q0 24336958 279 26.499027 imi_mug_run_2_treatment "serine"
25 Q0 29808460 280 26.499027 imi_mug_run_2_treatment "various"
25 Q0 20160028 281 26.493221 imi_mug_run_2_treatment "mediated" "genesis"
25 Q0 15195137 282 26.45353 imi_mug_run_2_treatment "ras"
25 Q0 23633021 283 26.45353 imi_mug_run_2_treatment "tma"
25 Q0 22020039 284 26.45353 imi_mug_run_2_treatment "ras" "basis"
25 Q0 21826607 285 26.44012 imi_mug_run_2_treatment "ras" "lead"
25 Q0 22693259 286 26.437096 imi_mug_run_2_treatment "ras"
25 Q0 23570341 287 26.38018 imi_mug_run_2_treatment "calcium" "mediated" "tam"
25 Q0 24965840 288 26.36848 imi_mug_run_2_treatment "others"
25 Q0 23755070 289 26.36363 imi_mug_run_2_treatment "level"
25 Q0 26693896 290 26.34097 imi_mug_run_2_treatment "drug"
25 Q0 24399611 291 26.34097 imi_mug_run_2_treatment "alkylating agents"
25 Q0 22820643 292 26.34097 imi_mug_run_2_treatment "mediated"
25 Q0 25674907 293 26.325598 imi_mug_run_2_treatment "cbd" "cannabinoid" "cytotoxic"
25 Q0 19492075 294 26.2732 imi_mug_run_2_treatment "ras"
25 Q0 23833303 295 26.2732 imi_mug_run_2_treatment "various" "ssd" "tandem"
25 Q0 22842228 296 26.233753 imi_mug_run_2_treatment "serine"
25 Q0 22962325 297 26.20157 imi_mug_run_2_treatment "drug" "braf inhibitor" "medicine"
25 Q0 22997239 298 26.1968 imi_mug_run_2_treatment "kinase inhibitor" "mek inhibitor" "mediated"
25 Q0 22389471 299 26.12578 imi_mug_run_2_treatment "combinations" "gsk2118436" "gsk1120212"
25 Q0 22293660 300 26.118858 imi_mug_run_2_treatment "selumetinib" "azd6244" "ras"
25 Q0 28715145 301 26.080276 imi_mug_run_2_treatment "antioxidant" "oxygen"
25 Q0 24812408 302 26.07446 imi_mug_run_2_treatment "vemurafenib" "drug" "cytokines"
25 Q0 29650805 303 26.065063 imi_mug_run_2_treatment "drug combinations" "mapk inhibitors"
25 Q0 25217772 304 26.046951 imi_mug_run_2_treatment "various" "lead"
25 Q0 23108403 305 26.046951 imi_mug_run_2_treatment "ras" "mitogens"
25 Q0 16818621 306 26.038177 imi_mug_run_2_treatment "ras" "tet"
25 Q0 26136337 307 26.033133 imi_mug_run_2_treatment "various" "mitogen" "mediated"
25 Q0 30053879 308 26.0291 imi_mug_run_2_treatment "cd271" "mediators" "program"
25 Q0 30457212 309 25.930096 imi_mug_run_2_treatment "mitogen"
25 Q0 24589925 310 25.884777 imi_mug_run_2_treatment "vemurafenib" "ras" "gdc-0973"
25 Q0 23615632 311 25.795708 imi_mug_run_2_treatment "combinations" "braf inhibitor" "mediated"
25 Q0 27846237 312 25.760845 imi_mug_run_2_treatment "vemurafenib" "agent" "sabutoclax"
25 Q0 23704925 313 25.725348 imi_mug_run_2_treatment "drugs"
25 Q0 23528057 314 25.715828 imi_mug_run_2_treatment "aim"
25 Q0 22665063 315 25.678585 imi_mug_run_2_treatment "various"
25 Q0 25088201 316 25.666428 imi_mug_run_2_treatment "genesis"
25 Q0 27157227 317 25.622707 imi_mug_run_2_treatment "nivolumab" "drugs" "ipilimumab"
25 Q0 30028779 318 25.622707 imi_mug_run_2_treatment "adjuvant"
25 Q0 24906137 319 25.616745 imi_mug_run_2_treatment "drugs"
25 Q0 29512974 320 25.585224 imi_mug_run_2_treatment "mms" "ssm"
25 Q0 16367997 321 25.584301 imi_mug_run_2_treatment "ras"
25 Q0 22515704 322 25.584301 imi_mug_run_2_treatment "mek inhibitor" "tak733" "flt"
25 Q0 25993155 323 25.570728 imi_mug_run_2_treatment "agent" "combinations" "trametinib"
25 Q0 27008969 324 25.570728 imi_mug_run_2_treatment "therapeutics"
25 Q0 30355677 325 25.564548 imi_mug_run_2_treatment "ras" "tyrosine" "tet"
25 Q0 25815427 326 25.534512 imi_mug_run_2_treatment "mek inhibitor"
25 Q0 24899684 327 25.491913 imi_mug_run_2_treatment "mek inhibitor" "selumetinib" "mediated"
25 Q0 22383533 328 25.491913 imi_mug_run_2_treatment "drugs" "therapeutics"
25 Q0 24980819 329 25.491913 imi_mug_run_2_treatment "vemurafenib" "mediated" "cytokines"
25 Q0 23950209 330 25.474703 imi_mug_run_2_treatment "program" "bet inhibitor"
25 Q0 19078957 331 25.41045 imi_mug_run_2_treatment "ras" "lead"
25 Q0 30222690 332 25.382702 imi_mug_run_2_treatment "drug" "vemurafenib"
25 Q0 25746036 333 25.380955 imi_mug_run_2_treatment "isolate" "aim"
25 Q0 30290833 334 25.369991 imi_mug_run_2_treatment "mediated" "favoring"
25 Q0 22972589 335 25.363073 imi_mug_run_2_treatment "selumetinib" "arginine" "glutamine"
25 Q0 21949607 336 25.351606 imi_mug_run_2_treatment "combinations" "biologics" "therapeutics"
25 Q0 30190821 337 25.339123 imi_mug_run_2_treatment "combinations" "blockade"
25 Q0 26484880 338 25.323273 imi_mug_run_2_treatment "ras" "basis"
25 Q0 20118982 339 25.32188 imi_mug_run_2_treatment "ras"
25 Q0 28026870 340 25.2998 imi_mug_run_2_treatment "platinum"
25 Q0 22127285 341 25.275185 imi_mug_run_2_treatment "dacarbazine" "dasatinib" "dasatinib 70 mg"
25 Q0 25070294 342 25.261478 imi_mug_run_2_treatment "adjuvant"
25 Q0 21829508 343 25.239464 imi_mug_run_2_treatment "ras" "various"
25 Q0 25722211 344 25.214851 imi_mug_run_2_treatment "mart-1"
25 Q0 22350184 345 25.20319 imi_mug_run_2_treatment "dacarbazine" "ipilimumab" "drug"
25 Q0 20173664 346 25.190067 imi_mug_run_2_treatment "aim"
25 Q0 16609049 347 25.15141 imi_mug_run_2_treatment "ras"
25 Q0 25452114 348 25.119928 imi_mug_run_2_treatment "trametinib" "dabrafenib" "mapk inhibitors"
25 Q0 29061773 349 25.119928 imi_mug_run_2_treatment "drug combination" "mapk inhibitors"
25 Q0 28692456 350 25.119928 imi_mug_run_2_treatment "cobimetinib" "mek inhibitor" "vemurafenib"
25 Q0 23724991 351 25.078281 imi_mug_run_2_treatment "tyr"
25 Q0 20110797 352 25.067581 imi_mug_run_2_treatment "various"
25 Q0 26518880 353 25.030764 imi_mug_run_2_treatment "mediators" "mek inhibitor" "trametinib"
25 Q0 27788045 354 25.030764 imi_mug_run_2_treatment "drugs" "ras"
25 Q0 27153441 355 25.030764 imi_mug_run_2_treatment "kinase inhibitor"
25 Q0 23569304 356 25.006702 imi_mug_run_2_treatment "vemurafenib" "braf inhibitor"
25 Q0 17518771 357 24.972261 imi_mug_run_2_treatment "various" "ras" "cbn"
25 Q0 25746038 358 24.966097 imi_mug_run_2_treatment "various"
25 Q0 27193390 359 24.960957 imi_mug_run_2_treatment "various"
25 Q0 28212889 360 24.951271 imi_mug_run_2_treatment "estrogen" "lead"
25 Q0 29956724 361 24.942032 imi_mug_run_2_treatment "abt-888" "drug" "veliparib"
25 Q0 23992377 362 24.903677 imi_mug_run_2_treatment "protein kinase inhibitors" "dacarbazine" "drugs"
25 Q0 27655122 363 24.903677 imi_mug_run_2_treatment "melan-a" "matrix"
25 Q0 21670085 364 24.866829 imi_mug_run_2_treatment "lead" "basis"
25 Q0 24335517 365 24.866829 imi_mug_run_2_treatment "melana"
25 Q0 26225426 366 24.851112 imi_mug_run_2_treatment "various" "agonists"
25 Q0 19682280 367 24.82579 imi_mug_run_2_treatment "pd184352" "basis"
25 Q0 25886620 368 24.82579 imi_mug_run_2_treatment "duration" "braf inhibitor"
25 Q0 22968732 369 24.819834 imi_mug_run_2_treatment "new drugs"
25 Q0 22588166 370 24.817686 imi_mug_run_2_treatment "phenformin"
25 Q0 29995873 371 24.817686 imi_mug_run_2_treatment "mek inhibitor"
25 Q0 26139106 372 24.816687 imi_mug_run_2_treatment "glutamine" "vemurafenib" "don"
25 Q0 22475322 373 24.764738 imi_mug_run_2_treatment "basis"
25 Q0 16098043 374 24.761883 imi_mug_run_2_treatment "mapk inhibitors" "basis"
25 Q0 29112787 375 24.761883 imi_mug_run_2_treatment "dabrafenib" "vemurafenib"
25 Q0 29180761 376 24.75694 imi_mug_run_2_treatment "trametinib"
25 Q0 23489693 377 24.736172 imi_mug_run_2_treatment "ndp-msh" "ras" "mek inhibitor"
25 Q0 17576930 378 24.719833 imi_mug_run_2_treatment "therapeutics" "program" "suppressor"
25 Q0 22798288 379 24.719833 imi_mug_run_2_treatment "mek inhibitor" "tak-733"
25 Q0 25376610 380 24.714272 imi_mug_run_2_treatment "tak-733" "mediated" "mek inhibitor tak-733"
25 Q0 29180316 381 24.704351 imi_mug_run_2_treatment "aim"
25 Q0 26524482 382 24.695805 imi_mug_run_2_treatment "kinase inhibitor" "dabrafenib" "plasma"
25 Q0 26851802 383 24.66919 imi_mug_run_2_treatment "level" "adjuvant" "mediated"
25 Q0 24028775 384 24.648563 imi_mug_run_2_treatment "interferon-alpha" "ipilimumab" "program"
25 Q0 26339916 385 24.636671 imi_mug_run_2_treatment "ras" "level" "hot spot"
25 Q0 27439913 386 24.598797 imi_mug_run_2_treatment "antitubercular"
25 Q0 29547721 387 24.59531 imi_mug_run_2_treatment "vitamins" "sulfate" "chondroitin"
25 Q0 26559571 388 24.581146 imi_mug_run_2_treatment "others"
25 Q0 29133622 389 24.544762 imi_mug_run_2_treatment "ceritinib" "trametinib" "drug"
25 Q0 23415641 390 24.495884 imi_mug_run_2_treatment "ras" "braf inhibitor"
25 Q0 27771229 391 24.453405 imi_mug_run_2_treatment "ras" "genesis"
25 Q0 27111337 392 24.390308 imi_mug_run_2_treatment "igf2" "basis"
25 Q0 25749171 393 24.368176 imi_mug_run_2_treatment "various" "riluzole" "drug"
25 Q0 17363583 394 24.35157 imi_mug_run_2_treatment "lead"
25 Q0 26206558 395 24.324406 imi_mug_run_2_treatment "pertuzumab" "mediated" "mek inhibitor"
25 Q0 25755683 396 24.30117 imi_mug_run_2_treatment "interleukin-2" "blockade"
25 Q0 28147313 397 24.213879 imi_mug_run_2_treatment "mediated" "amg 337"
25 Q0 26343581 398 24.171417 imi_mug_run_2_treatment "prostaglandin e2" "blockade"
25 Q0 18632627 399 24.159943 imi_mug_run_2_treatment "imatinib"
25 Q0 26440707 400 24.07981 imi_mug_run_2_treatment "plasma" "blockade" "braf inhibitor"
25 Q0 29371009 401 24.047024 imi_mug_run_2_treatment "adjuvant" "aim"
25 Q0 29512873 402 24.042934 imi_mug_run_2_treatment "anti-pdl1"
25 Q0 28410286 403 23.828861 imi_mug_run_2_treatment "imatinib" "nilotinib" "ipilimumab"
25 Q0 28921907 404 23.773993 imi_mug_run_2_treatment "trametinib"
25 Q0 29600692 405 23.756569 imi_mug_run_2_treatment "various" "others" "imatinib"
25 Q0 17575131 406 23.730251 imi_mug_run_2_treatment "tyr"
25 Q0 19244105 407 23.730251 imi_mug_run_2_treatment "others"
25 Q0 26962685 408 23.676271 imi_mug_run_2_treatment "kinase inhibitor" "thr" "mediated"
25 Q0 19234609 409 23.631763 imi_mug_run_2_treatment "decitabine" "proteasome inhibitor" "bortezomib"
25 Q0 20718941 410 23.631763 imi_mug_run_2_treatment "animals" "genesis"
25 Q0 24258979 411 23.59949 imi_mug_run_2_treatment "braf inhibitor"
25 Q0 29951919 412 23.375008 imi_mug_run_2_treatment "interferon" "dacarbazine" "imiquimod"
25 Q0 25795251 413 23.337662 imi_mug_run_2_treatment "vemurafenib" "water" "braf inhibitor"
25 Q0 21680547 414 23.260246 imi_mug_run_2_treatment "various" "aim"
25 Q0 22194965 415 23.249664 imi_mug_run_2_treatment "vemurafenib" "combinations" "drugs"
25 Q0 29305225 416 23.207825 imi_mug_run_2_treatment "formalin"
25 Q0 26308130 417 23.154236 imi_mug_run_2_treatment "various" "braf inhibitor"
25 Q0 27488531 418 23.154236 imi_mug_run_2_treatment "palbociclib"
25 Q0 23948972 419 23.124535 imi_mug_run_2_treatment "vemurafenib" "drug"
25 Q0 30179987 420 23.124535 imi_mug_run_2_treatment "level"
25 Q0 18509361 421 23.00738 imi_mug_run_2_treatment "aim"
25 Q0 26909610 422 23.00738 imi_mug_run_2_treatment "pdx" "level" "drugs"
25 Q0 28110826 423 22.97342 imi_mug_run_2_treatment "drug" "ras" "trametinib"
25 Q0 26870618 424 22.921251 imi_mug_run_2_treatment "cnl" "trametinib"
25 Q0 26101714 425 22.91988 imi_mug_run_2_treatment "vemurafenib" "mek inhibitor" "drug combinations"
25 Q0 28494469 426 22.906197 imi_mug_run_2_treatment "aim"
25 Q0 24885479 427 22.889616 imi_mug_run_2_treatment "ipilimumab"
25 Q0 29664013 428 22.889616 imi_mug_run_2_treatment "mediated" "others"
25 Q0 22018269 429 22.819857 imi_mug_run_2_treatment "symmetry"
25 Q0 25268584 430 22.819857 imi_mug_run_2_treatment "various" "therapeutic agents"
25 Q0 18460031 431 22.789501 imi_mug_run_2_treatment "mms"
25 Q0 26169970 432 22.749947 imi_mug_run_2_treatment "lenvatinib" "drug"
25 Q0 24864047 433 22.702272 imi_mug_run_2_treatment "binimetinib" "mek inhibitor" "encorafenib"
25 Q0 17488338 434 22.617794 imi_mug_run_2_treatment "various" "calcium chloride" "level"
25 Q0 22742762 435 22.61763 imi_mug_run_2_treatment "mms" "tyr" "lead"
25 Q0 18532874 436 22.60789 imi_mug_run_2_treatment "combinations"
25 Q0 17297468 437 22.606358 imi_mug_run_2_treatment "ras" "favor"
25 Q0 22071539 438 22.534523 imi_mug_run_2_treatment "tyrosine"
25 Q0 26152738 439 22.519648 imi_mug_run_2_treatment "agonists" "pdx" "apo2l/trail"
25 Q0 25275595 440 22.503902 imi_mug_run_2_treatment "anti-tumor agents" "azd6244" "pi3k/mtor inhibitor bez235"
25 Q0 24345920 441 22.490936 imi_mug_run_2_treatment "mek inhibitor"
25 Q0 30401679 442 22.490936 imi_mug_run_2_treatment "various" "mediated" "agonist"
25 Q0 28785360 443 22.346672 imi_mug_run_2_treatment "drug" "trametinib"
25 Q0 27218826 444 22.217176 imi_mug_run_2_treatment "igf2"
25 Q0 29883661 445 22.176678 imi_mug_run_2_treatment "program" "crest"
25 Q0 22797077 446 22.070492 imi_mug_run_2_treatment "various" "ras" "messenger"
25 Q0 26562020 447 22.070492 imi_mug_run_2_treatment "plasma"
25 Q0 28815138 448 22.021849 imi_mug_run_2_treatment "drug combinations" "drug" "drug combination"
25 Q0 30393817 449 21.971249 imi_mug_run_2_treatment "plasma"
25 Q0 23552414 450 21.967133 imi_mug_run_2_treatment "interferon" "mediated"
25 Q0 27105345 451 21.967133 imi_mug_run_2_treatment "aim"
25 Q0 28380455 452 21.967133 imi_mug_run_2_treatment "ras" "level"
25 Q0 19568237 453 21.927397 imi_mug_run_2_treatment "ras" "balance"
25 Q0 30237495 454 21.927397 imi_mug_run_2_treatment "mek inhibitor" "lead" "braf inhibitor"
25 Q0 29912415 455 21.852882 imi_mug_run_2_treatment "ssm"
25 Q0 29653142 456 21.77681 imi_mug_run_2_treatment "mek inhibitor" "melan a" "binimetinib"
25 Q0 19996224 457 21.763504 imi_mug_run_2_treatment "sorafenib" "temozolomide" "agent"
25 Q0 26163092 458 21.738506 imi_mug_run_2_treatment "ras" "trametinib" "mediators"
25 Q0 21609436 459 21.738506 imi_mug_run_2_treatment "metformin" "vemurafenib" "drug"
25 Q0 27200346 460 21.738506 imi_mug_run_2_treatment "various" "drug" "drugs"
25 Q0 25092757 461 21.732801 imi_mug_run_2_treatment "drug"
25 Q0 29496665 462 21.732801 imi_mug_run_2_treatment "drug"
25 Q0 17535228 463 21.725693 imi_mug_run_2_treatment "kinase inhibitor"
25 Q0 23576709 464 21.725693 imi_mug_run_2_treatment "drug" "program"
25 Q0 16880785 465 21.643219 imi_mug_run_2_treatment "drug" "sorafenib" "agent"
25 Q0 24050392 466 21.510824 imi_mug_run_2_treatment "drug" "sunitinib" "immunomodulator"
25 Q0 22693489 467 21.465199 imi_mug_run_2_treatment "various"
25 Q0 27776349 468 21.449213 imi_mug_run_2_treatment "basis"
25 Q0 27829238 469 21.412548 imi_mug_run_2_treatment "bcl-2 inhibitor" "abt-737"
25 Q0 26618350 470 21.356564 imi_mug_run_2_treatment "imatinib" "ipilimumab" "sorafenib"
25 Q0 16609060 471 21.301159 imi_mug_run_2_treatment "combinations" "agent" "dacarbazine"
25 Q0 24463461 472 21.281002 imi_mug_run_2_treatment "aim"
25 Q0 26603897 473 21.157045 imi_mug_run_2_treatment "drug" "drugs"
25 Q0 25516806 474 21.111914 imi_mug_run_2_treatment "drugs" "plasma" "blockade"
25 Q0 20417200 475 21.102524 imi_mug_run_2_treatment "balance"
25 Q0 26307673 476 21.075153 imi_mug_run_2_treatment "mediated" "suppressor"
25 Q0 30185827 477 21.075153 imi_mug_run_2_treatment "ras" "plasma" "mediated"
25 Q0 18615679 478 21.060806 imi_mug_run_2_treatment "imatinib" "ras"
25 Q0 25626306 479 20.992113 imi_mug_run_2_treatment "drugs" "therapeutic agents" "vemurafenib"
25 Q0 26214590 480 20.921741 imi_mug_run_2_treatment "ras" "drugs"
25 Q0 28914674 481 20.921741 imi_mug_run_2_treatment "blockade"
25 Q0 27934878 482 20.914467 imi_mug_run_2_treatment "lead"
25 Q0 16273242 483 20.862095 imi_mug_run_2_treatment "ras"
25 Q0 22048237 484 20.830761 imi_mug_run_2_treatment "temozolomide" "selumetinib"
25 Q0 28807052 485 20.742624 imi_mug_run_2_treatment "tremelimumab" "hla-dra" "tgfb1"
25 Q0 21253789 486 20.742624 imi_mug_run_2_treatment "chromium" "others"
25 Q0 25542057 487 20.697975 imi_mug_run_2_treatment "paclitaxel" "trametinib" "ci 4"
25 Q0 28389780 488 20.697975 imi_mug_run_2_treatment "cytotoxic" "cisplatin" "temozolomide"
25 Q0 24132921 489 20.657413 imi_mug_run_2_treatment "imatinib" "crenolanib" "tyrosine kinase inhibitor"
25 Q0 27135738 490 20.601694 imi_mug_run_2_treatment "suppressor"
25 Q0 21244382 491 20.496904 imi_mug_run_2_treatment "acetate" "pma" "ras"
25 Q0 20055910 492 20.234156 imi_mug_run_2_treatment "ras"
25 Q0 24603591 493 20.209785 imi_mug_run_2_treatment "aim"
25 Q0 29423503 494 20.176569 imi_mug_run_2_treatment "ipilimumab" "plasma"
25 Q0 27226552 495 20.101593 imi_mug_run_2_treatment "kinase inhibitor" "mek inhibitor" "braf inhibitor"
25 Q0 22223528 496 20.078613 imi_mug_run_2_treatment "temsirolimus" "sorafenib"
25 Q0 17372901 497 20.062542 imi_mug_run_2_treatment "imatinib" "kinase inhibitor" "dasatinib"
25 Q0 18408659 498 20.062542 imi_mug_run_2_treatment "level"
25 Q0 22869096 499 20.062542 imi_mug_run_2_treatment "ras" "anti-cancer agents" "new drugs"
25 Q0 24842760 500 20.062542 imi_mug_run_2_treatment "aim"
25 Q0 20460471 501 19.975952 imi_mug_run_2_treatment "others"
25 Q0 25746039 502 19.964684 imi_mug_run_2_treatment "dacarbazine" "bevacizumab" "duration"
25 Q0 29121869 503 19.71099 imi_mug_run_2_treatment "tyr" "ras"
25 Q0 19383316 504 19.665382 imi_mug_run_2_treatment "various" "hsp70" "aim"
25 Q0 24947927 505 19.661476 imi_mug_run_2_treatment "ras" "ro4987655" "agent"
25 Q0 28438383 506 19.60463 imi_mug_run_2_treatment "corticosteroids" "nivolumab" "level"
25 Q0 28786531 507 19.602379 imi_mug_run_2_treatment "plasma"
25 Q0 23957481 508 19.568947 imi_mug_run_2_treatment "lead"
25 Q0 26300491 509 19.568947 imi_mug_run_2_treatment "program"
25 Q0 29736211 510 19.568947 imi_mug_run_2_treatment "ras" "vemurafenib" "trametinib"
25 Q0 24325952 511 19.537806 imi_mug_run_2_treatment "dabrafenib" "lead" "mek inhibitor"
25 Q0 22549727 512 19.513622 imi_mug_run_2_treatment "mediated"
25 Q0 29476775 513 19.513622 imi_mug_run_2_treatment "level"
25 Q0 27898753 514 19.513622 imi_mug_run_2_treatment "various" "activin"
25 Q0 15467732 515 19.483086 imi_mug_run_2_treatment "mms" "level" "antisense oligonucleotide"
25 Q0 26862952 516 19.444462 imi_mug_run_2_treatment "ras" "matrix"
25 Q0 26221190 517 19.30491 imi_mug_run_2_treatment "enzymes"
25 Q0 27863474 518 19.204012 imi_mug_run_2_treatment "prima-1" "n-acetylcysteine" "mediated"
25 Q0 26460303 519 19.140644 imi_mug_run_2_treatment "vemurafenib" "agent"
25 Q0 23775962 520 19.140644 imi_mug_run_2_treatment "imatinib" "imatinib 400 mg"
25 Q0 20233623 521 19.116846 imi_mug_run_2_treatment "mediated" "aim"
25 Q0 16827748 522 18.802794 imi_mug_run_2_treatment "mediated"
25 Q0 27926791 523 18.802794 imi_mug_run_2_treatment "casein" "melan-a" "aim"
25 Q0 30373548 524 18.46611 imi_mug_run_2_treatment "ras"
25 Q0 21785329 525 18.461805 imi_mug_run_2_treatment "igf2"
25 Q0 24882974 526 18.461805 imi_mug_run_2_treatment "ras"
25 Q0 24791855 527 18.307905 imi_mug_run_2_treatment "ras" "drug combination" "mediators"
25 Q0 26709572 528 18.186901 imi_mug_run_2_treatment "level"
25 Q0 27047921 529 18.186901 imi_mug_run_2_treatment "cd271"
25 Q0 25360634 530 18.186901 imi_mug_run_2_treatment "vemurafenib"
25 Q0 25310409 531 18.18062 imi_mug_run_2_treatment "brdu"
25 Q0 15948220 532 18.150536 imi_mug_run_2_treatment "ras"
25 Q0 26608120 533 18.092983 imi_mug_run_2_treatment "vemurafenib" "braf inhibitor"
25 Q0 26403583 534 18.070513 imi_mug_run_2_treatment "cbn" "aim"
25 Q0 25965804 535 18.065475 imi_mug_run_2_treatment "ras" "urea" "basis"
25 Q0 25435214 536 18.065475 imi_mug_run_2_treatment "drug" "ras" "drugs"
25 Q0 27911794 537 18.065475 imi_mug_run_2_treatment "ras"
25 Q0 22045652 538 18.013393 imi_mug_run_2_treatment "new drugs"
25 Q0 25243813 539 18.011475 imi_mug_run_2_treatment "trametinib"
25 Q0 28795589 540 17.972027 imi_mug_run_2_treatment "therapeutics" "aim"
25 Q0 24346182 541 17.958607 imi_mug_run_2_treatment "ras" "propranolol" "timolol"
25 Q0 27250023 542 17.958607 imi_mug_run_2_treatment "drugs" "mediated" "mapk inhibitors"
25 Q0 23614898 543 17.954998 imi_mug_run_2_treatment "sch772984" "ras" "mapk inhibitors"
25 Q0 27047932 544 17.891941 imi_mug_run_2_treatment "ras"
25 Q0 17301836 545 17.890625 imi_mug_run_2_treatment "ras"
25 Q0 14508525 546 17.890625 imi_mug_run_2_treatment "ras"
25 Q0 23382536 547 17.863922 imi_mug_run_2_treatment "oxo"
25 Q0 21796150 548 17.831425 imi_mug_run_2_treatment "tam" "mart-1"
25 Q0 27428425 549 17.831425 imi_mug_run_2_treatment "vemurafenib" "braf inhibitor"
25 Q0 24422853 550 17.809258 imi_mug_run_2_treatment "vemurafenib" "dabrafenib" "plx7904"
25 Q0 26965315 551 17.809258 imi_mug_run_2_treatment "level"
25 Q0 30115691 552 17.803745 imi_mug_run_2_treatment "mek inhibitor"
25 Q0 27671167 553 17.629486 imi_mug_run_2_treatment "immunol" "blockade"
25 Q0 27020384 554 16.696316 imi_mug_run_2_treatment "various" "lead"
25 Q0 19936769 555 16.19886 imi_mug_run_2_treatment "mitogen"
25 Q0 18390968 556 15.966728 imi_mug_run_2_treatment "arry-142886" "azd6244" "ras"
25 Q0 22791410 557 15.948819 imi_mug_run_2_treatment "ras"
25 Q0 21107323 558 15.909775 imi_mug_run_2_treatment "plx4032" "mediated" "ras"
25 Q0 30036146 559 15.909775 imi_mug_run_2_treatment "vemurafenib" "ras" "ptc"
25 Q0 18524847 560 15.883755 imi_mug_run_2_treatment "drug" "phenothiazine" "phenothiazines"
25 Q0 26052356 561 15.851569 imi_mug_run_2_treatment "sorafenib" "mediated" "platinum"
25 Q0 27026619 562 15.835838 imi_mug_run_2_treatment "various" "therapeutics" "drug"
25 Q0 22761467 563 15.835838 imi_mug_run_2_treatment "ro5126766"
25 Q0 26477315 564 15.835838 imi_mug_run_2_treatment "mms" "tyr"
25 Q0 28092667 565 15.835838 imi_mug_run_2_treatment "pmm" "trametinib" "vemurafenib"
25 Q0 28724666 566 15.764864 imi_mug_run_2_treatment "combinations" "binimetinib" "encorafenib"
25 Q0 29023842 567 15.722245 imi_mug_run_2_treatment "mek inhibitor" "trametinib"
25 Q0 29461977 568 14.902906 imi_mug_run_2_treatment "ras" "lead" "braf inhibitor"
25 Q0 26498038 569 14.8257 imi_mug_run_2_treatment "ras" "mek inhibitor" "trametinib"
25 Q0 20350353 570 14.811477 imi_mug_run_2_treatment "ras" "various" "aim"
25 Q0 23058743 571 14.811477 imi_mug_run_2_treatment "ras" "drug" "serine"
25 Q0 27499153 572 14.811477 imi_mug_run_2_treatment "melan-a" "eosin"
25 Q0 27496137 573 14.811477 imi_mug_run_2_treatment "bi 847325"
25 Q0 26673799 574 14.77659 imi_mug_run_2_treatment "pdx" "capmatinib" "braf inhibitor"
25 Q0 26364606 575 14.77659 imi_mug_run_2_treatment "ras" "sorafenib" "drugs"
25 Q0 23443307 576 14.77659 imi_mug_run_2_treatment "combinations" "ras" "mek inhibitor"
25 Q0 16964246 577 14.7581005 imi_mug_run_2_treatment "mediated"
25 Q0 25476894 578 14.7581005 imi_mug_run_2_treatment "xl281" "famotidine" "food"
25 Q0 21726664 579 14.7581005 imi_mug_run_2_treatment "medicine" "formalin"
25 Q0 19671679 580 14.7581005 imi_mug_run_2_treatment "level" "others"
25 Q0 26358176 581 13.813358 imi_mug_run_2_treatment "combinations" "drugs" "ras"
25 Q0 21307875 582 13.162104 imi_mug_run_2_treatment "tyr"
25 Q0 22133722 583 12.971886 imi_mug_run_2_treatment "stb" "mitogen"
25 Q0 26682952 584 12.904623 imi_mug_run_2_treatment "leucine" "glutamic acid" "ras"
25 Q0 29190285 585 12.892151 imi_mug_run_2_treatment "animals" "ras"
25 Q0 26485776 586 12.8617325 imi_mug_run_2_treatment "melan a"
25 Q0 27377892 587 12.845545 imi_mug_run_2_treatment "various" "immunosuppressive"
26 Q0 21160078 1 81.53573 imi_mug_run_2_treatment "mediated" "pd173074"
26 Q0 24762544 2 70.29833 imi_mug_run_2_treatment "level" "silver" "aim"
26 Q0 25806220 3 68.164314 imi_mug_run_2_treatment "various"
26 Q0 22684217 4 67.88668 imi_mug_run_2_treatment "level" "color" "basis"
26 Q0 22179561 5 67.31964 imi_mug_run_2_treatment "basic fibroblast growth factor"
26 Q0 22648708 6 65.350006 imi_mug_run_2_treatment "adc"
26 Q0 23469973 7 64.14305 imi_mug_run_2_treatment "therapeutics"
26 Q0 23082000 8 63.982376 imi_mug_run_2_treatment "azd4547" "tma"
26 Q0 24183471 9 62.9553 imi_mug_run_2_treatment "level"
26 Q0 27194548 10 62.781654 imi_mug_run_2_treatment "adc"
26 Q0 24853178 11 61.78991 imi_mug_run_2_treatment "tma" "adjuvant"
26 Q0 25332967 12 61.61942 imi_mug_run_2_treatment "various"
26 Q0 29022097 13 61.59645 imi_mug_run_2_treatment "color"
26 Q0 25819384 14 60.97045 imi_mug_run_2_treatment "cisplatin" "etoposide" "carboplatin"
26 Q0 27551478 15 60.065823 imi_mug_run_2_treatment "drug" "tyrosine kinase inhibitor"
26 Q0 26936993 16 60.030388 imi_mug_run_2_treatment "azd4547"
26 Q0 30515999 17 59.850357 imi_mug_run_2_treatment "honokiol" "various"
26 Q0 24854563 18 59.846474 imi_mug_run_2_treatment "drugs"
26 Q0 28558758 19 59.343132 imi_mug_run_2_treatment "azd4547" "monodansylcadaverine" "fibroblast growth factor 2"
26 Q0 24345494 20 58.972343 imi_mug_run_2_treatment "therapeutics"
26 Q0 26555375 21 58.943275 imi_mug_run_2_treatment "prompt"
26 Q0 23887299 22 58.59506 imi_mug_run_2_treatment "level" "color" "hot spot"
26 Q0 26712871 23 57.30059 imi_mug_run_2_treatment "aim"
26 Q0 29351293 24 55.543034 imi_mug_run_2_treatment "level"
26 Q0 26549034 25 55.304592 imi_mug_run_2_treatment "level"
26 Q0 28968756 26 55.275406 imi_mug_run_2_treatment "drugs" "mediated"
26 Q0 24771645 27 55.234 imi_mug_run_2_treatment "various" "ponatinib" "tyrosine kinase inhibitor"
26 Q0 27315356 28 55.07811 imi_mug_run_2_treatment "dovitinib" "duration"
26 Q0 24977006 29 54.544613 imi_mug_run_2_treatment "prisma"
26 Q0 24077455 30 54.49463 imi_mug_run_2_treatment "various"
26 Q0 28008744 31 54.092304 imi_mug_run_2_treatment "platinum"
26 Q0 24255716 32 54.01362 imi_mug_run_2_treatment "level"
26 Q0 29281903 33 53.49839 imi_mug_run_2_treatment "drug" "cancer drug"
26 Q0 22499828 34 53.459614 imi_mug_run_2_treatment "biotin"
26 Q0 9187134 35 53.147026 imi_mug_run_2_treatment "various"
26 Q0 23207439 36 53.136036 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors" "crizotinib" "xalkori"
26 Q0 27794399 37 52.84161 imi_mug_run_2_treatment "pd173074" "arsenic trioxide" "mediated"
26 Q0 30297175 38 52.58855 imi_mug_run_2_treatment "amp" "ponatinib" "kinase inhibitor"
26 Q0 23563700 39 51.832066 imi_mug_run_2_treatment "ponatinib" "aim"
26 Q0 29858603 40 51.595116 imi_mug_run_2_treatment "fibroblast growth factor 2" "azd6244" "azd4547"
26 Q0 23806793 41 51.421555 imi_mug_run_2_treatment "silver" "level"
26 Q0 23434054 42 51.27616 imi_mug_run_2_treatment "alcohol"
26 Q0 23182986 43 51.012497 imi_mug_run_2_treatment "amp"
26 Q0 25492085 44 50.88736 imi_mug_run_2_treatment "level" "various" "egfr inhibitor"
26 Q0 21460799 45 50.666702 imi_mug_run_2_treatment "level" "aim"
26 Q0 26359452 46 50.53315 imi_mug_run_2_treatment "ponatinib" "mtor inhibitor" "azd4547"
26 Q0 23026827 47 50.407036 imi_mug_run_2_treatment "cytotoxic" "therapeutic agents"
26 Q0 26536195 48 50.23915 imi_mug_run_2_treatment "others"
26 Q0 16807070 49 49.981888 imi_mug_run_2_treatment "tma" "level"
26 Q0 24584974 50 49.672077 imi_mug_run_2_treatment "silver" "level"
26 Q0 28418088 51 49.61197 imi_mug_run_2_treatment "ras" "erdafitinib"
26 Q0 2983887 52 49.260826 imi_mug_run_2_treatment "various"
26 Q0 27956804 53 48.852562 imi_mug_run_2_treatment "level" "aim"
26 Q0 21334718 54 48.824654 imi_mug_run_2_treatment "aim"
26 Q0 25806221 55 48.71328 imi_mug_run_2_treatment "others"
26 Q0 11699727 56 48.64743 imi_mug_run_2_treatment "digoxigenin"
26 Q0 25880284 57 47.77426 imi_mug_run_2_treatment "ndga" "lead"
26 Q0 2549305 58 47.71582 imi_mug_run_2_treatment "epidermal growth factor"
26 Q0 24736083 59 47.694595 imi_mug_run_2_treatment "pd173074" "level" "others"
26 Q0 29452146 60 47.043053 imi_mug_run_2_treatment "verteporfin" "level" "genesis"
26 Q0 26020126 61 46.918415 imi_mug_run_2_treatment "silver"
26 Q0 27578983 62 46.903614 imi_mug_run_2_treatment "aim"
26 Q0 27581340 63 46.714256 imi_mug_run_2_treatment "nintedanib"
26 Q0 19877284 64 46.608524 imi_mug_run_2_treatment "color" "aim"
26 Q0 27367030 65 45.994507 imi_mug_run_2_treatment "nintedanib" "mediated"
26 Q0 23236352 66 45.953064 imi_mug_run_2_treatment "drugs" "gold" "therapeutics"
26 Q0 25477232 67 45.932697 imi_mug_run_2_treatment "taxane"
26 Q0 24946519 68 45.907093 imi_mug_run_2_treatment "drugs"
26 Q0 21507233 69 45.893387 imi_mug_run_2_treatment "adc" "calca"
26 Q0 24966347 70 45.80311 imi_mug_run_2_treatment "mediated" "therapeutics" "tyrosine kinase inhibitor"
26 Q0 29257923 71 45.666862 imi_mug_run_2_treatment "various" "pd173074"
26 Q0 22407829 72 45.495476 imi_mug_run_2_treatment "bevacizumab" "egfr tyrosine kinase inhibitors"
26 Q0 10734317 73 45.32722 imi_mug_run_2_treatment "proteolytic enzymes"
26 Q0 1374598 74 45.252148 imi_mug_run_2_treatment "various"
26 Q0 22899293 75 45.170433 imi_mug_run_2_treatment "level" "monoclonal antibodies"
26 Q0 18829480 76 45.116356 imi_mug_run_2_treatment "basic fibroblast growth factor"
26 Q0 24229629 77 45.016617 imi_mug_run_2_treatment "tarceva" "crizotinib"
26 Q0 26400330 78 45.006306 imi_mug_run_2_treatment "aim"
26 Q0 30060526 79 44.869774 imi_mug_run_2_treatment "combinations" "adc" "level"
26 Q0 23489560 80 44.38838 imi_mug_run_2_treatment "various" "drugs"
26 Q0 16641908 81 44.256084 imi_mug_run_2_treatment "level"
26 Q0 27988457 82 43.6108 imi_mug_run_2_treatment "lucitanib" "tyrosine" "anti-angiogenic agents"
26 Q0 26015511 83 43.531185 imi_mug_run_2_treatment "pdx" "nvp-bgj398"
26 Q0 25130969 84 43.476444 imi_mug_run_2_treatment "drug" "drugs"
26 Q0 20179196 85 43.229107 imi_mug_run_2_treatment "endocrine therapy" "hydroxytamoxifen"
26 Q0 26027392 86 43.18027 imi_mug_run_2_treatment "level"
26 Q0 16080566 87 43.045696 imi_mug_run_2_treatment "trastuzumab"
26 Q0 10805802 88 42.998913 imi_mug_run_2_treatment "others"
26 Q0 30146263 89 42.915493 imi_mug_run_2_treatment "ponatinib"
26 Q0 9002667 90 42.873833 imi_mug_run_2_treatment "mediated" "lead" "autologous"
26 Q0 3096922 91 42.580383 imi_mug_run_2_treatment "epidermal growth factor" "product" "level"
26 Q0 24163741 92 42.450016 imi_mug_run_2_treatment "adc" "lead" "revolution"
26 Q0 27845189 93 42.418118 imi_mug_run_2_treatment "adc"
26 Q0 19755855 94 42.333435 imi_mug_run_2_treatment "imatinib" "sunitinib"
26 Q0 3332004 95 42.12446 imi_mug_run_2_treatment "various" "ras" "monoclonal antibodies"
26 Q0 29970903 96 42.02129 imi_mug_run_2_treatment "vascular endothelial growth factor"
26 Q0 24711160 97 41.854477 imi_mug_run_2_treatment "nintedanib" "ponatinib"
26 Q0 20635059 98 41.851177 imi_mug_run_2_treatment "tma" "egfr tyrosine kinase inhibitors"
26 Q0 24980830 99 41.792564 imi_mug_run_2_treatment "ndga" "lead"
26 Q0 26993162 100 41.758995 imi_mug_run_2_treatment "cancer drug"
26 Q0 17397528 101 41.738968 imi_mug_run_2_treatment "oestrogen"
26 Q0 27760592 102 41.64791 imi_mug_run_2_treatment "drugs" "aim"
26 Q0 15983384 103 41.54181 imi_mug_run_2_treatment "others"
26 Q0 22286583 104 41.48464 imi_mug_run_2_treatment "erlotinib" "crizotinib"
26 Q0 26362179 105 41.334965 imi_mug_run_2_treatment "fibroblast growth factor 1"
26 Q0 23619603 106 41.278034 imi_mug_run_2_treatment "formalin" "aim"
26 Q0 26936917 107 41.122112 imi_mug_run_2_treatment "azd4547" "gefitinib" "egfr inhibitor"
26 Q0 29190880 108 40.86772 imi_mug_run_2_treatment "kinase inhibitor" "nvp-bgj398" "glucose"
26 Q0 26484266 109 40.773304 imi_mug_run_2_treatment "oligo" "blockade"
26 Q0 22733500 110 40.65297 imi_mug_run_2_treatment "level"
26 Q0 17385831 111 40.6299 imi_mug_run_2_treatment "phenol"
26 Q0 27158780 112 40.565956 imi_mug_run_2_treatment "adc"
26 Q0 23086772 113 40.51878 imi_mug_run_2_treatment "adc"
26 Q0 8711937 114 40.45767 imi_mug_run_2_treatment "various"
26 Q0 25384882 115 40.400085 imi_mug_run_2_treatment "aim"
26 Q0 27669755 116 40.14994 imi_mug_run_2_treatment "various"
26 Q0 28192747 117 40.11487 imi_mug_run_2_treatment "agent" "level"
26 Q0 10492640 118 40.078537 imi_mug_run_2_treatment "aim"
26 Q0 26846300 119 40.076107 imi_mug_run_2_treatment "mediated"
26 Q0 7692947 120 40.003468 imi_mug_run_2_treatment "pthrp" "parathyroid hormone" "ben"
26 Q0 27338794 121 39.969788 imi_mug_run_2_treatment "trametinib" "combinations" "mek inhibitor"
26 Q0 17390048 122 39.908054 imi_mug_run_2_treatment "various"
26 Q0 23088463 123 39.658173 imi_mug_run_2_treatment "aim"
26 Q0 26527886 124 39.62992 imi_mug_run_2_treatment "various" "aim" "suppressor"
26 Q0 24636699 125 39.39302 imi_mug_run_2_treatment "mediated"
26 Q0 20668658 126 39.320663 imi_mug_run_2_treatment "mediated" "level"
26 Q0 20161759 127 39.191765 imi_mug_run_2_treatment "various" "tma"
26 Q0 9661888 128 39.08329 imi_mug_run_2_treatment "phosphate"
26 Q0 29905778 129 39.057934 imi_mug_run_2_treatment "antiangiogenic agents" "monoclonal antibodies" "antiangiogenic"
26 Q0 15215173 130 38.979584 imi_mug_run_2_treatment "kinase inhibitor" "mediated"
26 Q0 26845137 131 38.967915 imi_mug_run_2_treatment "therapeutic agents"
26 Q0 15386424 132 38.890724 imi_mug_run_2_treatment "level"
26 Q0 27728803 133 38.80688 imi_mug_run_2_treatment "various combinations"
26 Q0 15123463 134 38.661755 imi_mug_run_2_treatment "fluorophore"
26 Q0 12147242 135 38.65987 imi_mug_run_2_treatment "lead"
26 Q0 17925434 136 38.63668 imi_mug_run_2_treatment "level"
26 Q0 25806314 137 38.516525 imi_mug_run_2_treatment "antiangiogenic"
26 Q0 23842453 138 38.405495 imi_mug_run_2_treatment "gefitinib"
26 Q0 8263009 139 38.31916 imi_mug_run_2_treatment "ras"
26 Q0 29036791 140 38.27561 imi_mug_run_2_treatment "adc" "cancer vaccine"
26 Q0 21730982 141 38.268875 imi_mug_run_2_treatment "ag1478" "aim"
26 Q0 25039982 142 38.235348 imi_mug_run_2_treatment "monoclonal antibodies"
26 Q0 28377632 143 38.201256 imi_mug_run_2_treatment "drug"
26 Q0 25686244 144 38.17893 imi_mug_run_2_treatment "azd4547" "e3810" "tyrosine kinase inhibitor"
26 Q0 23552882 145 38.164818 imi_mug_run_2_treatment "drug" "gefitinib" "mediated"
26 Q0 22197383 146 38.131493 imi_mug_run_2_treatment "various" "basis"
26 Q0 18212743 147 37.899193 imi_mug_run_2_treatment "mediated"
26 Q0 27154822 148 37.863358 imi_mug_run_2_treatment "mediated" "mapk inhibitors" "mek inhibitor"
26 Q0 23536707 149 37.833923 imi_mug_run_2_treatment "gefitinib"
26 Q0 19443885 150 37.773956 imi_mug_run_2_treatment "new drugs"
26 Q0 27150062 151 37.741806 imi_mug_run_2_treatment "ors"
26 Q0 9816093 152 37.73989 imi_mug_run_2_treatment "anti-erbb-2" "basis"
26 Q0 9194027 153 37.67923 imi_mug_run_2_treatment "debrisoquine" "enzyme digestion"
26 Q0 23880303 154 37.67088 imi_mug_run_2_treatment "therapeutics"
26 Q0 26571236 155 37.65902 imi_mug_run_2_treatment "shape"
26 Q0 22321545 156 37.531834 imi_mug_run_2_treatment "basis"
26 Q0 30167080 157 37.527863 imi_mug_run_2_treatment "palbociclib" "mediators" "mek inhibitor"
26 Q0 30311151 158 37.43276 imi_mug_run_2_treatment "level"
26 Q0 7767777 159 37.417614 imi_mug_run_2_treatment "level"
26 Q0 12651874 160 37.416702 imi_mug_run_2_treatment "level"
26 Q0 28460066 161 37.41341 imi_mug_run_2_treatment "pdx" "dovitinib" "mediated"
26 Q0 2573817 162 37.398537 imi_mug_run_2_treatment "various" "others"
26 Q0 25886585 163 37.34503 imi_mug_run_2_treatment "eosin" "aim"
26 Q0 8647646 164 37.277626 imi_mug_run_2_treatment "drug" "cisplatin" "etoposide"
26 Q0 22665522 165 37.11679 imi_mug_run_2_treatment "protease"
26 Q0 15386363 166 37.051136 imi_mug_run_2_treatment "various" "bisulfite" "agent"
26 Q0 21673064 167 37.01547 imi_mug_run_2_treatment "combinations" "fp-1039" "drugs"
26 Q0 27392325 168 36.965256 imi_mug_run_2_treatment "combinations" "mek inhibitor" "mediated"
26 Q0 12455054 169 36.95924 imi_mug_run_2_treatment "product"
26 Q0 1847842 170 36.932434 imi_mug_run_2_treatment "combinations" "cisplatin" "cyclophosphamide"
26 Q0 23658459 171 36.924896 imi_mug_run_2_treatment "dovitinib" "silver" "basis"
26 Q0 19153074 172 36.907402 imi_mug_run_2_treatment "serine"
26 Q0 19046792 173 36.852512 imi_mug_run_2_treatment "mediators" "level"
26 Q0 2713242 174 36.809834 imi_mug_run_2_treatment "epidermal growth factor"
26 Q0 24045665 175 36.80068 imi_mug_run_2_treatment "pd173074" "cytokines" "shape"
26 Q0 23110763 176 36.797726 imi_mug_run_2_treatment "glucose"
26 Q0 25135188 177 36.7771 imi_mug_run_2_treatment "aim"
26 Q0 28199128 178 36.755367 imi_mug_run_2_treatment "therapeutic agents"
26 Q0 23786770 179 36.745426 imi_mug_run_2_treatment "tyrosine kinase inhibitor" "lead" "pazopanib"
26 Q0 24743512 180 36.741863 imi_mug_run_2_treatment "cisplatin"
26 Q0 3041218 181 36.650917 imi_mug_run_2_treatment "ras"
26 Q0 26905262 182 36.647682 imi_mug_run_2_treatment "azd4547"
26 Q0 8943746 183 36.617996 imi_mug_run_2_treatment "aim"
26 Q0 21986963 184 36.59553 imi_mug_run_2_treatment "level"
26 Q0 17498553 185 36.49022 imi_mug_run_2_treatment "eosin"
26 Q0 26762740 186 36.355495 imi_mug_run_2_treatment "fludarabine" "level" "monoclonal antibodies"
26 Q0 9314945 187 36.305546 imi_mug_run_2_treatment "ethidium bromide"
26 Q0 14729606 188 36.21441 imi_mug_run_2_treatment "her-2"
26 Q0 29158193 189 36.17504 imi_mug_run_2_treatment "necitumumab"
26 Q0 25989941 190 36.15668 imi_mug_run_2_treatment "adc"
26 Q0 20107422 191 36.147507 imi_mug_run_2_treatment "various"
26 Q0 17457280 192 36.13226 imi_mug_run_2_treatment "drugs" "bevacizumab" "cisplatin"
26 Q0 23876834 193 36.13075 imi_mug_run_2_treatment "drugs" "investigational drugs" "generic"
26 Q0 24513267 194 36.118908 imi_mug_run_2_treatment "tyrosine"
26 Q0 11894014 195 36.056698 imi_mug_run_2_treatment "trastuzumab"
26 Q0 22866074 196 35.925957 imi_mug_run_2_treatment "adc"
26 Q0 7674546 197 35.92301 imi_mug_run_2_treatment "gat"
26 Q0 27429073 198 35.896877 imi_mug_run_2_treatment "azd4547" "bay1163877" "crizotinib"
26 Q0 11550157 199 35.892273 imi_mug_run_2_treatment "level"
26 Q0 2571355 200 35.789383 imi_mug_run_2_treatment "others"
26 Q0 18506667 201 35.784653 imi_mug_run_2_treatment "erlotinib" "bevacizumab" "sunitinib"
26 Q0 20459770 202 35.781563 imi_mug_run_2_treatment "various" "ras" "formalin"
26 Q0 29567880 203 35.72414 imi_mug_run_2_treatment "formalin"
26 Q0 11153605 204 35.690258 imi_mug_run_2_treatment "aim"
26 Q0 9809028 205 35.61298 imi_mug_run_2_treatment "drugs" "vinblastine"
26 Q0 9591638 206 35.609993 imi_mug_run_2_treatment "level"
26 Q0 22450065 207 35.593918 imi_mug_run_2_treatment "eacs" "therapeutic agents"
26 Q0 25559287 208 35.56743 imi_mug_run_2_treatment "afatinib" "cetuximab" "gefitinib"
26 Q0 15870700 209 35.501648 imi_mug_run_2_treatment "gdnf" "lead" "isolate"
26 Q0 23733083 210 35.458866 imi_mug_run_2_treatment "gefitinib" "erlotinib" "crizotinib"
26 Q0 28630215 211 35.443974 imi_mug_run_2_treatment "drug" "agent"
26 Q0 17463250 212 35.35846 imi_mug_run_2_treatment "gefitinib" "erlotinib"
26 Q0 26387545 213 35.342216 imi_mug_run_2_treatment "azd4547"
26 Q0 27535969 214 35.29403 imi_mug_run_2_treatment "e7090" "therapeutic agent" "azd4547"
26 Q0 2840315 215 35.275066 imi_mug_run_2_treatment "human chorionic gonadotropin" "ddc" "pdt"
26 Q0 24930674 216 35.247734 imi_mug_run_2_treatment "oxygen" "level"
26 Q0 17932690 217 35.220963 imi_mug_run_2_treatment "gefitinib" "gefitinib 250 mg"
26 Q0 14696419 218 35.22052 imi_mug_run_2_treatment "lead" "aim"
26 Q0 25716471 219 35.178417 imi_mug_run_2_treatment "various" "trastuzumab" "cetuximab"
26 Q0 25470237 220 35.174126 imi_mug_run_2_treatment "pdx" "therapeutics"
26 Q0 28315172 221 35.153633 imi_mug_run_2_treatment "various" "tyrosine" "mediated"
26 Q0 24126941 222 35.12061 imi_mug_run_2_treatment "level"
26 Q0 19825995 223 35.07798 imi_mug_run_2_treatment "cytokines" "il-6" "interleukin"
26 Q0 15674328 224 35.05499 imi_mug_run_2_treatment "histidine"
26 Q0 2547415 225 35.033493 imi_mug_run_2_treatment "ras"
26 Q0 29434916 226 35.02482 imi_mug_run_2_treatment "adc" "gefitinib"
26 Q0 10794161 227 35.00599 imi_mug_run_2_treatment "level"
26 Q0 26852079 228 34.98394 imi_mug_run_2_treatment "afatinib" "crizotinib" "drugs"
26 Q0 29017078 229 34.98015 imi_mug_run_2_treatment "igf1"
26 Q0 21911935 230 34.978287 imi_mug_run_2_treatment "ras" "mediated"
26 Q0 11304680 231 34.941463 imi_mug_run_2_treatment "herceptin" "adjuvant" "cytotoxic"
26 Q0 18849352 232 34.807312 imi_mug_run_2_treatment "gefitinib" "mediated" "epidermal growth factor"
26 Q0 12867060 233 34.80596 imi_mug_run_2_treatment "epidermal growth factor" "herceptin" "trastuzumab"
26 Q0 12163360 234 34.774727 imi_mug_run_2_treatment "level" "color"
26 Q0 19147533 235 34.711323 imi_mug_run_2_treatment "kinase inhibitor" "mediated" "level"
26 Q0 24135816 236 34.71111 imi_mug_run_2_treatment "level" "nvp-bgj398"
26 Q0 28765892 237 34.65859 imi_mug_run_2_treatment "basic fibroblast growth factor" "monoclonal antibodies"
26 Q0 21385341 238 34.57419 imi_mug_run_2_treatment "lead" "aim"
26 Q0 22150974 239 34.52646 imi_mug_run_2_treatment "others"
26 Q0 19966867 240 34.52175 imi_mug_run_2_treatment "level" "mediated"
26 Q0 2746668 241 34.490456 imi_mug_run_2_treatment "basis"
26 Q0 30126078 242 34.48259 imi_mug_run_2_treatment "apatinib"
26 Q0 12414649 243 34.439583 imi_mug_run_2_treatment "level"
26 Q0 2248738 244 34.360146 imi_mug_run_2_treatment "ras" "basic fibroblast growth factor"
26 Q0 16955506 245 34.3187 imi_mug_run_2_treatment "antimetabolite" "drugs" "level"
26 Q0 29996114 246 34.266743 imi_mug_run_2_treatment "aim"
26 Q0 2998610 247 34.213413 imi_mug_run_2_treatment "various" "sodium dodecyl sulfate" "polyacrylamide gel"
26 Q0 27748920 248 34.19398 imi_mug_run_2_treatment "gefitinib"
26 Q0 12367789 249 34.10409 imi_mug_run_2_treatment "fluorochrome" "level" "aim"
26 Q0 8384074 250 34.08967 imi_mug_run_2_treatment "drug"
26 Q0 15994928 251 34.021538 imi_mug_run_2_treatment "level"
26 Q0 29022361 252 34.00636 imi_mug_run_2_treatment "quercetin"
26 Q0 21498705 253 33.99913 imi_mug_run_2_treatment "cisplatin" "pi3k/mtor inhibitor bez235" "mtor inhibitor"
26 Q0 10952100 254 33.979534 imi_mug_run_2_treatment "level"
26 Q0 26013599 255 33.92601 imi_mug_run_2_treatment "blockade"
26 Q0 9813719 256 33.92482 imi_mug_run_2_treatment "gamma-interferon" "lead"
26 Q0 2425958 257 33.89269 imi_mug_run_2_treatment "gangliosides" "monoclonal antibodies"
26 Q0 24351833 258 33.863613 imi_mug_run_2_treatment "tyrosine kinase inhibitor"
26 Q0 15658558 259 33.85369 imi_mug_run_2_treatment "level" "aim"
26 Q0 7927946 260 33.849052 imi_mug_run_2_treatment "lead" "level"
26 Q0 17311693 261 33.840347 imi_mug_run_2_treatment "phosphate"
26 Q0 11592773 262 33.825176 imi_mug_run_2_treatment "various" "aim"
26 Q0 21623924 263 33.8193 imi_mug_run_2_treatment "alcohol"
26 Q0 23495865 264 33.79731 imi_mug_run_2_treatment "autologous"
26 Q0 3668732 265 33.776844 imi_mug_run_2_treatment "epidermal growth factor" "monoclonal antibodies"
26 Q0 29805554 266 33.767418 imi_mug_run_2_treatment "endocrine therapy"
26 Q0 26314265 267 33.76066 imi_mug_run_2_treatment "combinations" "level"
26 Q0 28381877 268 33.70988 imi_mug_run_2_treatment "level"
26 Q0 26847053 269 33.68535 imi_mug_run_2_treatment "level"
26 Q0 30484492 270 33.664318 imi_mug_run_2_treatment "cck-8"
26 Q0 21318736 271 33.616493 imi_mug_run_2_treatment "adjuvant" "monoclonal antibodies"
26 Q0 22235505 272 33.562737 imi_mug_run_2_treatment "various"
26 Q0 26617686 273 33.538532 imi_mug_run_2_treatment "fibroblast growth factor 2" "phosphate" "aim"
26 Q0 28185819 274 33.438503 imi_mug_run_2_treatment "polysia" "various" "polysialic acid"
26 Q0 21847121 275 33.433193 imi_mug_run_2_treatment "various" "kinase inhibitor" "mediated"
26 Q0 24551297 276 33.406418 imi_mug_run_2_treatment "various"
26 Q0 19108018 277 33.387955 imi_mug_run_2_treatment "various"
26 Q0 9508209 278 33.38117 imi_mug_run_2_treatment "ras" "lead" "suppressor"
26 Q0 23136191 279 33.38031 imi_mug_run_2_treatment "kinase inhibitor" "paclitaxel" "erlotinib"
26 Q0 1430259 280 33.37191 imi_mug_run_2_treatment "ci 4" "aim"
26 Q0 20663904 281 33.370975 imi_mug_run_2_treatment "gefitinib" "mediated" "epidermal growth factor receptor tyrosine kinase inhibitor"
26 Q0 22152933 282 33.36515 imi_mug_run_2_treatment "scatter factor"
26 Q0 24969895 283 33.35401 imi_mug_run_2_treatment "genesis"
26 Q0 21764851 284 33.27901 imi_mug_run_2_treatment "factor i"
26 Q0 20359736 285 33.26505 imi_mug_run_2_treatment "color" "aim"
26 Q0 10023336 286 33.228493 imi_mug_run_2_treatment "aim"
26 Q0 28714017 287 33.195213 imi_mug_run_2_treatment "pazopanib" "lead" "dovitinib"
26 Q0 26172299 288 33.102913 imi_mug_run_2_treatment "drugs"
26 Q0 1568216 289 33.07361 imi_mug_run_2_treatment "level"
26 Q0 10090922 290 33.05463 imi_mug_run_2_treatment "autologous"
26 Q0 1380281 291 33.050217 imi_mug_run_2_treatment "product" "basic fibroblast growth factor" "phosphate"
26 Q0 25279714 292 33.021637 imi_mug_run_2_treatment "aim"
26 Q0 15251953 293 32.992348 imi_mug_run_2_treatment "isolate"
26 Q0 26640150 294 32.98169 imi_mug_run_2_treatment "inosine"
26 Q0 10188057 295 32.97009 imi_mug_run_2_treatment "cytotoxic"
26 Q0 8875978 296 32.954254 imi_mug_run_2_treatment "mediated"
26 Q0 15870923 297 32.94163 imi_mug_run_2_treatment "tyrosine" "vascular endothelial growth factor"
26 Q0 26673008 298 32.92833 imi_mug_run_2_treatment "lead"
26 Q0 11780337 299 32.8899 imi_mug_run_2_treatment "various" "liver"
26 Q0 3016030 300 32.884243 imi_mug_run_2_treatment "l dopa"
26 Q0 25672611 301 32.845184 imi_mug_run_2_treatment "level"
26 Q0 20579853 302 32.83417 imi_mug_run_2_treatment "aim"
26 Q0 25929848 303 32.82143 imi_mug_run_2_treatment "others"
26 Q0 20064830 304 32.809372 imi_mug_run_2_treatment "adc"
26 Q0 14970861 305 32.79064 imi_mug_run_2_treatment "serpin"
26 Q0 18932182 306 32.747753 imi_mug_run_2_treatment "level"
26 Q0 22594847 307 32.735306 imi_mug_run_2_treatment "crizotinib" "product" "tyrosine kinase inhibitor"
26 Q0 22607702 308 32.725327 imi_mug_run_2_treatment "level"
26 Q0 27863413 309 32.671997 imi_mug_run_2_treatment "drugs" "azd8055"
26 Q0 14678959 310 32.632286 imi_mug_run_2_treatment "cisplatin"
26 Q0 28881794 311 32.609257 imi_mug_run_2_treatment "defactinib" "buparlisib"
26 Q0 22941188 312 32.606346 imi_mug_run_2_treatment "various"
26 Q0 26360781 313 32.599102 imi_mug_run_2_treatment "adc"
26 Q0 23664448 314 32.53999 imi_mug_run_2_treatment "afatinib" "gefitinib" "erlotinib"
26 Q0 29568386 315 32.521122 imi_mug_run_2_treatment "various"
26 Q0 23696246 316 32.44931 imi_mug_run_2_treatment "therapeutics" "dovitinib" "azd4547"
26 Q0 14581340 317 32.41597 imi_mug_run_2_treatment "level" "aim"
26 Q0 27007084 318 32.395847 imi_mug_run_2_treatment "adc"
26 Q0 25806181 319 32.361973 imi_mug_run_2_treatment "tyrosine" "egfr tyrosine kinase inhibitors"
26 Q0 26826182 320 32.340603 imi_mug_run_2_treatment "collagen" "proteasome inhibitor"
26 Q0 7812927 321 32.325928 imi_mug_run_2_treatment "various" "product"
26 Q0 7539284 322 32.300552 imi_mug_run_2_treatment "color"
26 Q0 24816813 323 32.29999 imi_mug_run_2_treatment "various" "mediated"
26 Q0 20434789 324 32.299374 imi_mug_run_2_treatment "hydroxyurea"
26 Q0 3937573 325 32.27973 imi_mug_run_2_treatment "level"
26 Q0 23770855 326 32.26761 imi_mug_run_2_treatment "drug" "mediated"
26 Q0 22271877 327 32.256477 imi_mug_run_2_treatment "gefitinib" "erlotinib" "egfr tyrosine kinase inhibitors"
26 Q0 11355949 328 32.236996 imi_mug_run_2_treatment "level" "aim"
26 Q0 2839114 329 32.232525 imi_mug_run_2_treatment "retinoic acid"
26 Q0 16619035 330 32.201603 imi_mug_run_2_treatment "serine"
26 Q0 2838297 331 32.184433 imi_mug_run_2_treatment "dopa"
26 Q0 8519418 332 32.16969 imi_mug_run_2_treatment "ras"
26 Q0 30029518 333 32.15393 imi_mug_run_2_treatment "drug" "drugs" "cytotoxic"
26 Q0 19047905 334 32.098503 imi_mug_run_2_treatment "kinase inhibitor" "histidine"
26 Q0 24324171 335 32.094635 imi_mug_run_2_treatment "adc"
26 Q0 1716216 336 32.035446 imi_mug_run_2_treatment "various" "cytokines" "interleukin-6"
26 Q0 24354593 337 32.023247 imi_mug_run_2_treatment "protein kinase inhibitors" "crizotinib" "dacomitinib"
26 Q0 24425785 338 32.02276 imi_mug_run_2_treatment "drugs" "others"
26 Q0 29237381 339 31.998451 imi_mug_run_2_treatment "antiprogestin"
26 Q0 15171319 340 31.945715 imi_mug_run_2_treatment "aim"
26 Q0 3053056 341 31.933882 imi_mug_run_2_treatment "biotin" "deoxyribonuclease"
26 Q0 9476914 342 31.928171 imi_mug_run_2_treatment "generic"
26 Q0 22052229 343 31.91233 imi_mug_run_2_treatment "tyrosine kinase inhibitor"
26 Q0 28378892 344 31.91233 imi_mug_run_2_treatment "adc"
26 Q0 21190720 345 31.904747 imi_mug_run_2_treatment "lead" "aim"
26 Q0 24139802 346 31.901623 imi_mug_run_2_treatment "lysine"
26 Q0 23930754 347 31.901077 imi_mug_run_2_treatment "duration" "aim"
26 Q0 16204062 348 31.89385 imi_mug_run_2_treatment "enzymes"
26 Q0 20434485 349 31.819252 imi_mug_run_2_treatment "taspine" "product" "fcm"
26 Q0 16857814 350 31.797226 imi_mug_run_2_treatment "trastuzumab" "egfr tyrosine kinase inhibitor"
26 Q0 27041563 351 31.789507 imi_mug_run_2_treatment "mediated"
26 Q0 16116477 352 31.789467 imi_mug_run_2_treatment "balance"
26 Q0 30293090 353 31.7885 imi_mug_run_2_treatment "decitabine" "dna methyltransferase inhibitor"
26 Q0 29088286 354 31.753994 imi_mug_run_2_treatment "level"
26 Q0 23319332 355 31.698893 imi_mug_run_2_treatment "compound e" "dasatinib"
26 Q0 30088452 356 31.68486 imi_mug_run_2_treatment "various" "therapeutic agents"
26 Q0 8946196 357 31.669186 imi_mug_run_2_treatment "various" "drug" "biotin"
26 Q0 15165086 358 31.65834 imi_mug_run_2_treatment "pah"
26 Q0 18636213 359 31.65614 imi_mug_run_2_treatment "level"
26 Q0 20068387 360 31.63121 imi_mug_run_2_treatment "aim"
26 Q0 10604729 361 31.608637 imi_mug_run_2_treatment "p23" "level"
26 Q0 20545000 362 31.581402 imi_mug_run_2_treatment "others"
26 Q0 27212973 363 31.577883 imi_mug_run_2_treatment "level"
26 Q0 24420742 364 31.577091 imi_mug_run_2_treatment "basis"
26 Q0 27461822 365 31.574102 imi_mug_run_2_treatment "mediated" "anti-egfr monoclonal antibody" "lead"
26 Q0 30143490 366 31.569145 imi_mug_run_2_treatment "aim"
26 Q0 11994765 367 31.5587 imi_mug_run_2_treatment "various"
26 Q0 1426624 368 31.555567 imi_mug_run_2_treatment "mediated"
26 Q0 26498363 369 31.54644 imi_mug_run_2_treatment "drugs" "fluoropyrimidines" "topoisomerase inhibitors"
26 Q0 18317062 370 31.546246 imi_mug_run_2_treatment "lead"
26 Q0 11279599 371 31.539654 imi_mug_run_2_treatment "gastrin" "level"
26 Q0 18834524 372 31.535824 imi_mug_run_2_treatment "bisulfite"
26 Q0 16204011 373 31.535524 imi_mug_run_2_treatment "gefitinib"
26 Q0 2540905 374 31.535172 imi_mug_run_2_treatment "various" "level"
26 Q0 21716144 375 31.52491 imi_mug_run_2_treatment "crizotinib" "drugs" "mediated"
26 Q0 28590585 376 31.516228 imi_mug_run_2_treatment "kinase inhibitor" "drugs"
26 Q0 8529470 377 31.508856 imi_mug_run_2_treatment "others"
26 Q0 15785739 378 31.48765 imi_mug_run_2_treatment "her-2" "hla-a24" "herceptin"
26 Q0 8063608 379 31.485748 imi_mug_run_2_treatment "basis"
26 Q0 29620244 380 31.401058 imi_mug_run_2_treatment "adc" "aim"
26 Q0 11748478 381 31.387812 imi_mug_run_2_treatment "various"
26 Q0 29616327 382 31.373753 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors" "gefitinib" "erlotinib"
26 Q0 10825000 383 31.358541 imi_mug_run_2_treatment "ras" "level" "yeast"
26 Q0 26451614 384 31.333307 imi_mug_run_2_treatment "fibroblast growth factor 2"
26 Q0 17143264 385 31.30933 imi_mug_run_2_treatment "herceptin" "level" "her-2"
26 Q0 28806950 386 31.29819 imi_mug_run_2_treatment "drug" "ras" "pdx"
26 Q0 28368392 387 31.294554 imi_mug_run_2_treatment "drug" "erlotinib" "crizotinib"
26 Q0 30208830 388 31.290169 imi_mug_run_2_treatment "various" "drugs"
26 Q0 28125801 389 31.271168 imi_mug_run_2_treatment "various"
26 Q0 25144301 390 31.270452 imi_mug_run_2_treatment "ras" "mediated" "drugs"
26 Q0 18683738 391 31.269367 imi_mug_run_2_treatment "formalin"
26 Q0 21502435 392 31.264791 imi_mug_run_2_treatment "kinase inhibitor"
26 Q0 26215852 393 31.210438 imi_mug_run_2_treatment "therapeutics" "egfr tyrosine kinase inhibitor" "aim"
26 Q0 11313916 394 31.207672 imi_mug_run_2_treatment "product"
26 Q0 17616691 395 31.141222 imi_mug_run_2_treatment "cisplatin" "cddp" "therapeutic agents"
26 Q0 16767676 396 31.12738 imi_mug_run_2_treatment "genesis"
26 Q0 9192552 397 31.12484 imi_mug_run_2_treatment "various"
26 Q0 20939963 398 31.122149 imi_mug_run_2_treatment "level"
26 Q0 8634783 399 31.120535 imi_mug_run_2_treatment "ras"
26 Q0 16713680 400 31.102169 imi_mug_run_2_treatment "hyaluronan" "various" "hyaluronidase"
26 Q0 16729170 401 31.087212 imi_mug_run_2_treatment "aim" "genesis"
26 Q0 27317650 402 31.082996 imi_mug_run_2_treatment "various" "tam" "level"
26 Q0 26704950 403 31.07846 imi_mug_run_2_treatment "isolate" "level"
26 Q0 24861215 404 31.066214 imi_mug_run_2_treatment "aim"
26 Q0 27095573 405 31.063335 imi_mug_run_2_treatment "adjuvant"
26 Q0 25601485 406 31.059696 imi_mug_run_2_treatment "drugs"
26 Q0 9194028 407 31.04932 imi_mug_run_2_treatment "tyrosine"
26 Q0 25953424 408 31.04631 imi_mug_run_2_treatment "various"
26 Q0 30267839 409 31.036156 imi_mug_run_2_treatment "various" "jnj-42756493"
26 Q0 27870574 410 31.031479 imi_mug_run_2_treatment "kinase inhibitor" "tyrosine kinase inhibitor" "basis"
26 Q0 23026640 411 31.016752 imi_mug_run_2_treatment "eosin"
26 Q0 22553343 412 31.002218 imi_mug_run_2_treatment "crizotinib" "tyrosine kinase inhibitor"
26 Q0 19953948 413 30.985905 imi_mug_run_2_treatment "formalin"
26 Q0 27745897 414 30.967175 imi_mug_run_2_treatment "crizotinib"
26 Q0 28004110 415 30.96621 imi_mug_run_2_treatment "polysialic acid"
26 Q0 28607809 416 30.963196 imi_mug_run_2_treatment "crizotinib"
26 Q0 29748524 417 30.947762 imi_mug_run_2_treatment "drug" "cytotoxic" "cytotoxic drugs"
26 Q0 26772203 418 30.940022 imi_mug_run_2_treatment "abpp"
26 Q0 17681096 419 30.933638 imi_mug_run_2_treatment "others"
26 Q0 17990328 420 30.930279 imi_mug_run_2_treatment "aim"
26 Q0 23378782 421 30.928135 imi_mug_run_2_treatment "various" "tivantinib" "drug"
26 Q0 22873759 422 30.927246 imi_mug_run_2_treatment "drugs" "egfr tyrosine kinase inhibitors" "monoclonal antibodies"
26 Q0 24122611 423 30.926798 imi_mug_run_2_treatment "drugs"
26 Q0 30132854 424 30.924992 imi_mug_run_2_treatment "egfr inhibitor" "azd8931" "various"
26 Q0 29748005 425 30.909985 imi_mug_run_2_treatment "plasma"
26 Q0 24139594 426 30.892384 imi_mug_run_2_treatment "hpv vaccine"
26 Q0 1690210 427 30.885313 imi_mug_run_2_treatment "epidermal growth factor"
26 Q0 30487650 428 30.878487 imi_mug_run_2_treatment "various" "tyrosine"
26 Q0 25012251 429 30.871628 imi_mug_run_2_treatment "formalin"
26 Q0 12172009 430 30.848122 imi_mug_run_2_treatment "liver"
26 Q0 26202045 431 30.848022 imi_mug_run_2_treatment "various" "afatinib" "crizotinib"
26 Q0 11303627 432 30.837505 imi_mug_run_2_treatment "various"
26 Q0 19920824 433 30.823105 imi_mug_run_2_treatment "suppressor" "mitogen-activated protein kinase inhibitor" "aim"
26 Q0 22683979 434 30.817131 imi_mug_run_2_treatment "heparin-sepharose" "mediated" "aim"
26 Q0 27144063 435 30.814974 imi_mug_run_2_treatment "matrix"
26 Q0 11230706 436 30.808212 imi_mug_run_2_treatment "messenger" "aim"
26 Q0 25118293 437 30.78454 imi_mug_run_2_treatment "silver"
26 Q0 29139039 438 30.771557 imi_mug_run_2_treatment "various" "adc"
26 Q0 25806223 439 30.771194 imi_mug_run_2_treatment "drugs" "trastuzumab" "gefitinib"
26 Q0 16490593 440 30.762539 imi_mug_run_2_treatment "genesis"
26 Q0 11454676 441 30.750935 imi_mug_run_2_treatment "level"
26 Q0 8032300 442 30.733921 imi_mug_run_2_treatment "level"
26 Q0 26088290 443 30.727327 imi_mug_run_2_treatment "color" "level"
26 Q0 23426935 444 30.692183 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitor"
26 Q0 10706127 445 30.675076 imi_mug_run_2_treatment "color" "level" "aim"
26 Q0 18788085 446 30.669325 imi_mug_run_2_treatment "centrin"
26 Q0 28332047 447 30.664639 imi_mug_run_2_treatment "osimertinib"
26 Q0 15314969 448 30.656927 imi_mug_run_2_treatment "trastuzumab" "medication" "tarceva"
26 Q0 23453647 449 30.605835 imi_mug_run_2_treatment "asc"
26 Q0 24790411 450 30.596937 imi_mug_run_2_treatment "afatinib" "drug" "program"
26 Q0 11337272 451 30.573586 imi_mug_run_2_treatment "geneticin"
26 Q0 17332333 452 30.561651 imi_mug_run_2_treatment "gefitinib" "erlotinib" "egfr tyrosine kinase inhibitors"
26 Q0 10404083 453 30.557047 imi_mug_run_2_treatment "pred"
26 Q0 28445992 454 30.552523 imi_mug_run_2_treatment "fulvestrant" "estradiol" "estrogen"
26 Q0 18829487 455 30.545471 imi_mug_run_2_treatment "gefitinib" "egfr tyrosine kinase inhibitor"
26 Q0 22307009 456 30.53188 imi_mug_run_2_treatment "nh2" "aim" "monoclonal antibodies"
26 Q0 23723712 457 30.525793 imi_mug_run_2_treatment "combinations" "drugs" "gefitinib"
26 Q0 2995289 458 30.525349 imi_mug_run_2_treatment "level" "epidermal growth factor"
26 Q0 18957054 459 30.520992 imi_mug_run_2_treatment "scorpion" "drugs" "egfr tyrosine kinase inhibitors"
26 Q0 25573625 460 30.488247 imi_mug_run_2_treatment "various"
26 Q0 24722154 461 30.487583 imi_mug_run_2_treatment "color" "crizotinib"
26 Q0 16818711 462 30.434816 imi_mug_run_2_treatment "cetuximab" "gefitinib" "iressa"
26 Q0 8274449 463 30.43473 imi_mug_run_2_treatment "retinoic acid" "chemopreventive agent"
26 Q0 21623265 464 30.432901 imi_mug_run_2_treatment "crizotinib"
26 Q0 22879364 465 30.420837 imi_mug_run_2_treatment "antiestrogen" "estrogen" "letrozole"
26 Q0 15735730 466 30.408682 imi_mug_run_2_treatment "mediated" "level"
26 Q0 16552419 467 30.398733 imi_mug_run_2_treatment "gefitinib" "tyrosine kinase inhibitor"
26 Q0 11559525 468 30.398014 imi_mug_run_2_treatment "various"
26 Q0 1373318 469 30.391804 imi_mug_run_2_treatment "drugs"
26 Q0 1312669 470 30.383366 imi_mug_run_2_treatment "basis"
26 Q0 16863509 471 30.364145 imi_mug_run_2_treatment "gefitinib" "erlotinib"
26 Q0 23726438 472 30.35986 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
26 Q0 9310139 473 30.316475 imi_mug_run_2_treatment "level"
26 Q0 16648870 474 30.298536 imi_mug_run_2_treatment "cetuximab"
26 Q0 18975135 475 30.265335 imi_mug_run_2_treatment "various" "tgfbeta1"
26 Q0 1312699 476 30.24586 imi_mug_run_2_treatment "product"
26 Q0 17112776 477 30.237013 imi_mug_run_2_treatment "alcohol" "level"
26 Q0 19188161 478 30.219488 imi_mug_run_2_treatment "s-1" "fluorouracil" "gefitinib"
26 Q0 23603642 479 30.206924 imi_mug_run_2_treatment "mediated"
26 Q0 28619094 480 30.201712 imi_mug_run_2_treatment "aim"
26 Q0 22586683 481 30.170769 imi_mug_run_2_treatment "epidermal growth factor receptor inhibitor" "ras" "gefitinib"
26 Q0 19453846 482 30.16734 imi_mug_run_2_treatment "various"
26 Q0 12533828 483 30.156801 imi_mug_run_2_treatment "level" "aim"
26 Q0 17363592 484 30.139833 imi_mug_run_2_treatment "fgf-1"
26 Q0 8943688 485 30.139324 imi_mug_run_2_treatment "various"
26 Q0 1624295 486 30.125393 imi_mug_run_2_treatment "human egf"
26 Q0 10339988 487 30.116701 imi_mug_run_2_treatment "color"
26 Q0 16316305 488 30.108873 imi_mug_run_2_treatment "various" "epidermal growth factor" "antiangiogenic agent"
26 Q0 18483355 489 30.067768 imi_mug_run_2_treatment "gefitinib" "erlotinib" "egfr tyrosine kinase inhibitor"
26 Q0 3020069 490 30.043333 imi_mug_run_2_treatment "various"
26 Q0 24253382 491 30.020758 imi_mug_run_2_treatment "leucine" "mediated"
26 Q0 12824902 492 30.003061 imi_mug_run_2_treatment "mediated" "kinase inhibitor" "antisense oligonucleotide"
26 Q0 25328417 493 29.987236 imi_mug_run_2_treatment "tivantinib" "egfr tyrosine kinase inhibitor" "arq 197"
26 Q0 20595807 494 29.965235 imi_mug_run_2_treatment "cisplatin" "platinum" "aim"
26 Q0 24192513 495 29.955734 imi_mug_run_2_treatment "crizotinib" "kinase inhibitor"
26 Q0 26068378 496 29.95445 imi_mug_run_2_treatment "adc" "tyrosine kinase inhibitor" "aim"
26 Q0 22736441 497 29.944536 imi_mug_run_2_treatment "drugs" "egfr tyrosine kinase inhibitors" "level"
26 Q0 15138850 498 29.936289 imi_mug_run_2_treatment "ras" "product"
26 Q0 29061221 499 29.916119 imi_mug_run_2_treatment "drug" "level"
26 Q0 11102898 500 29.915745 imi_mug_run_2_treatment "autologous" "cytotoxic" "lead"
26 Q0 11389082 501 29.907585 imi_mug_run_2_treatment "level"
26 Q0 17011067 502 29.905704 imi_mug_run_2_treatment "adc" "egfr tyrosine kinase inhibitor"
26 Q0 17822621 503 29.898577 imi_mug_run_2_treatment "formalin"
26 Q0 17227238 504 29.898321 imi_mug_run_2_treatment "erlotinib" "mediated" "bevacizumab"
26 Q0 24939008 505 29.895144 imi_mug_run_2_treatment "drugs"
26 Q0 25628462 506 29.893347 imi_mug_run_2_treatment "various" "ras"
26 Q0 22383183 507 29.892994 imi_mug_run_2_treatment "various" "level"
26 Q0 26041880 508 29.892254 imi_mug_run_2_treatment "metmab" "tma"
26 Q0 23185502 509 29.890808 imi_mug_run_2_treatment "pd173074" "level" "aim"
26 Q0 14639106 510 29.8899 imi_mug_run_2_treatment "level"
26 Q0 20625391 511 29.88527 imi_mug_run_2_treatment "suppressor"
26 Q0 14507943 512 29.873028 imi_mug_run_2_treatment "plasma"
26 Q0 20129249 513 29.869572 imi_mug_run_2_treatment "kinase inhibitor"
26 Q0 23035247 514 29.853363 imi_mug_run_2_treatment "drugs" "therapeutics"
26 Q0 28149764 515 29.852425 imi_mug_run_2_treatment "gefitinib" "erlotinib" "afatinib"
26 Q0 26791794 516 29.838608 imi_mug_run_2_treatment "crizotinib" "ceritinib"
26 Q0 25512530 517 29.836576 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors" "basis"
26 Q0 23078618 518 29.797197 imi_mug_run_2_treatment "tma" "aim"
26 Q0 25733707 519 29.79403 imi_mug_run_2_treatment "vaccine" "vaccines" "mediators"
26 Q0 28714692 520 29.771969 imi_mug_run_2_treatment "various" "protein kinase inhibitors" "level"
26 Q0 25514804 521 29.758125 imi_mug_run_2_treatment "afatinib" "duration"
26 Q0 10523844 522 29.755701 imi_mug_run_2_treatment "lead"
26 Q0 12185899 523 29.753996 imi_mug_run_2_treatment "aim"
26 Q0 2018357 524 29.751642 imi_mug_run_2_treatment "epidermal growth factor"
26 Q0 9816271 525 29.740818 imi_mug_run_2_treatment "serine"
26 Q0 24045185 526 29.717262 imi_mug_run_2_treatment "drug" "program"
26 Q0 18196592 527 29.71441 imi_mug_run_2_treatment "com"
26 Q0 25186177 528 29.712818 imi_mug_run_2_treatment "dovitinib" "blockade"
26 Q0 18361882 529 29.712269 imi_mug_run_2_treatment "product"
26 Q0 12536308 530 29.710138 imi_mug_run_2_treatment "suppressor"
26 Q0 19804422 531 29.70963 imi_mug_run_2_treatment "pha-665752" "gefitinib" "erlotinib"
26 Q0 29299828 532 29.696125 imi_mug_run_2_treatment "level"
26 Q0 21656749 533 29.684525 imi_mug_run_2_treatment "various"
26 Q0 19025454 534 29.68301 imi_mug_run_2_treatment "gold" "mediated"
26 Q0 27390594 535 29.681633 imi_mug_run_2_treatment "level"
26 Q0 23895415 536 29.667795 imi_mug_run_2_treatment "brdu" "retinoic acid" "sham"
26 Q0 10376532 537 29.64674 imi_mug_run_2_treatment "mediated"
26 Q0 25521558 538 29.633268 imi_mug_run_2_treatment "ndga" "nordihydroguaiaretic acid" "agent"
26 Q0 22138038 539 29.628332 imi_mug_run_2_treatment "adc" "formalin" "mage-a3"
26 Q0 25945695 540 29.615753 imi_mug_run_2_treatment "mediated"
26 Q0 28554745 541 29.614876 imi_mug_run_2_treatment "silver" "basis"
26 Q0 28700423 542 29.6126 imi_mug_run_2_treatment "various"
26 Q0 1652277 543 29.585316 imi_mug_run_2_treatment "duration"
26 Q0 25919911 544 29.568573 imi_mug_run_2_treatment "level"
26 Q0 22701738 545 29.567715 imi_mug_run_2_treatment "fibre" "fibres"
26 Q0 17150102 546 29.561054 imi_mug_run_2_treatment "gefitinib" "iressa" "ras"
26 Q0 19366796 547 29.551441 imi_mug_run_2_treatment "various" "sunitinib" "mediated"
26 Q0 1360704 548 29.550896 imi_mug_run_2_treatment "drug" "adenosine triphosphate" "messenger"
26 Q0 20737481 549 29.547508 imi_mug_run_2_treatment "drugs" "basis"
26 Q0 16564920 550 29.542011 imi_mug_run_2_treatment "iressa" "gefitinib"
26 Q0 8299311 551 29.532217 imi_mug_run_2_treatment "debrisoquin"
26 Q0 24939105 552 29.528149 imi_mug_run_2_treatment "sulfonamide"
26 Q0 24533074 553 29.526466 imi_mug_run_2_treatment "various"
26 Q0 23592446 554 29.518957 imi_mug_run_2_treatment "gefitinib" "mediated" "cytotoxic"
26 Q0 9334814 555 29.512358 imi_mug_run_2_treatment "drug" "benzbromarone" "cddp"
26 Q0 26013318 556 29.509567 imi_mug_run_2_treatment "nvp-byl719" "drug" "nvp-bkm120"
26 Q0 24362264 557 29.502693 imi_mug_run_2_treatment "mga"
26 Q0 20738166 558 29.499285 imi_mug_run_2_treatment "various" "interferon" "trichosanthin"
26 Q0 8261417 559 29.493334 imi_mug_run_2_treatment "lead"
26 Q0 28324883 560 29.480125 imi_mug_run_2_treatment "kinase inhibitor" "crizotinib"
26 Q0 20406193 561 29.455309 imi_mug_run_2_treatment "various"
26 Q0 25242085 562 29.43713 imi_mug_run_2_treatment "cetuximab"
26 Q0 11979556 563 29.425236 imi_mug_run_2_treatment "level"
26 Q0 3413126 564 29.423672 imi_mug_run_2_treatment "various"
26 Q0 26220094 565 29.413822 imi_mug_run_2_treatment "carboplatin" "cbdca" "pemetrexed"
26 Q0 23490239 566 29.403257 imi_mug_run_2_treatment "silver"
26 Q0 25719557 567 29.383781 imi_mug_run_2_treatment "gefitinib" "erlotinib"
26 Q0 8606928 568 29.36458 imi_mug_run_2_treatment "animals"
26 Q0 24327542 569 29.359432 imi_mug_run_2_treatment "pf-00477736"
26 Q0 16014883 570 29.357307 imi_mug_run_2_treatment "erlotinib" "agent"
26 Q0 28391773 571 29.346355 imi_mug_run_2_treatment "adjuvant"
26 Q0 20473280 572 29.335964 imi_mug_run_2_treatment "level"
26 Q0 17295682 573 29.328667 imi_mug_run_2_treatment "aim"
26 Q0 18852144 574 29.326408 imi_mug_run_2_treatment "mediated" "su5402"
26 Q0 26201468 575 29.326395 imi_mug_run_2_treatment "various" "heparin" "antisera"
26 Q0 18760859 576 29.322163 imi_mug_run_2_treatment "gefitinib" "erlotinib"
26 Q0 16247453 577 29.32175 imi_mug_run_2_treatment "level"
26 Q0 22433462 578 29.310898 imi_mug_run_2_treatment "erlotinib" "drugs" "therapeutics"
26 Q0 21678477 579 29.275223 imi_mug_run_2_treatment "vorinostat" "mediated" "saha"
26 Q0 30111373 580 29.26934 imi_mug_run_2_treatment "com"
26 Q0 12871779 581 29.264246 imi_mug_run_2_treatment "aim"
26 Q0 15629613 582 29.25737 imi_mug_run_2_treatment "trastuzumab"
26 Q0 25525358 583 29.246023 imi_mug_run_2_treatment "basis"
26 Q0 29532558 584 29.239412 imi_mug_run_2_treatment "afatinib" "various" "docetaxel"
26 Q0 18078086 585 29.23592 imi_mug_run_2_treatment "drug" "gemcitabine" "vinorelbine"
26 Q0 28231742 586 29.23552 imi_mug_run_2_treatment "cisplatin" "tetrandrine" "ginsenoside rb1"
26 Q0 11557112 587 29.232067 imi_mug_run_2_treatment "isolate"
26 Q0 28639892 588 29.221107 imi_mug_run_2_treatment "diphenyl"
26 Q0 25769900 589 29.217445 imi_mug_run_2_treatment "plasma"
26 Q0 2830010 590 29.192383 imi_mug_run_2_treatment "various"
26 Q0 28893247 591 29.163467 imi_mug_run_2_treatment "ras"
26 Q0 16047189 592 29.157263 imi_mug_run_2_treatment "product" "duration"
26 Q0 17699796 593 29.131756 imi_mug_run_2_treatment "various" "cisplatin" "therapeutics"
26 Q0 3332010 594 29.103483 imi_mug_run_2_treatment "epidermal growth factor" "level" "monoclonal antibodies"
26 Q0 26497743 595 29.103014 imi_mug_run_2_treatment "fgfr inhibitor azd4547" "platinum"
26 Q0 3472765 596 29.098843 imi_mug_run_2_treatment "level"
26 Q0 17337388 597 29.095308 imi_mug_run_2_treatment "bisulfite"
26 Q0 18559606 598 29.09189 imi_mug_run_2_treatment "erlotinib"
26 Q0 11566495 599 29.085522 imi_mug_run_2_treatment "color"
26 Q0 25468202 600 29.082981 imi_mug_run_2_treatment "adc" "hot spot" "aim"
26 Q0 1317698 601 29.072071 imi_mug_run_2_treatment "biotin"
26 Q0 20105337 602 29.055 imi_mug_run_2_treatment "level"
26 Q0 8160645 603 29.053646 imi_mug_run_2_treatment "alcohol"
26 Q0 19525979 604 29.045479 imi_mug_run_2_treatment "mediated" "level"
26 Q0 24978700 605 29.044525 imi_mug_run_2_treatment "various"
26 Q0 18230607 606 29.040504 imi_mug_run_2_treatment "l-leucine"
26 Q0 1603568 607 29.03931 imi_mug_run_2_treatment "biotin" "epidermal growth factor" "mouse monoclonal antibody"
26 Q0 23620753 608 29.016033 imi_mug_run_2_treatment "adc" "aim"
26 Q0 23026135 609 29.006042 imi_mug_run_2_treatment "mtx" "methotrexate" "mediated"
26 Q0 7923085 610 29.001377 imi_mug_run_2_treatment "p23"
26 Q0 27069126 611 28.992662 imi_mug_run_2_treatment "level"
26 Q0 21904579 612 28.975857 imi_mug_run_2_treatment "various" "drugs" "product"
26 Q0 27180141 613 28.933098 imi_mug_run_2_treatment "platelets"
26 Q0 28192473 614 28.924433 imi_mug_run_2_treatment "cisplatin" "pladienolide b" "drugs"
26 Q0 18803262 615 28.921711 imi_mug_run_2_treatment "antisense oligonucleotide"
26 Q0 25303898 616 28.91645 imi_mug_run_2_treatment "therapeutics"
26 Q0 17217995 617 28.9111 imi_mug_run_2_treatment "various" "androgen"
26 Q0 25872984 618 28.910788 imi_mug_run_2_treatment "griseofulvin" "sulfone" "antifungal drug"
26 Q0 18158564 619 28.883377 imi_mug_run_2_treatment "cytotoxic"
26 Q0 27179038 620 28.872581 imi_mug_run_2_treatment "level" "mediated" "agent"
26 Q0 23991943 621 28.870224 imi_mug_run_2_treatment "tyrosine" "mediated"
26 Q0 22994622 622 28.869184 imi_mug_run_2_treatment "ras"
26 Q0 18382357 623 28.863749 imi_mug_run_2_treatment "favor" "level"
26 Q0 19353596 624 28.849154 imi_mug_run_2_treatment "aim"
26 Q0 16435073 625 28.845959 imi_mug_run_2_treatment "various" "asc"
26 Q0 18804892 626 28.831673 imi_mug_run_2_treatment "various" "plasma" "aim"
26 Q0 20848437 627 28.824005 imi_mug_run_2_treatment "alcohol"
26 Q0 1707753 628 28.815395 imi_mug_run_2_treatment "tyrosine" "product"
26 Q0 19276369 629 28.811954 imi_mug_run_2_treatment "ag1478" "egfr inhibitor"
26 Q0 24033722 630 28.802135 imi_mug_run_2_treatment "gefitinib" "drug" "drugs"
26 Q0 3034645 631 28.789566 imi_mug_run_2_treatment "p23"
26 Q0 18596266 632 28.766462 imi_mug_run_2_treatment "drug" "plasma"
26 Q0 25868865 633 28.763077 imi_mug_run_2_treatment "mediated"
26 Q0 9673367 634 28.759312 imi_mug_run_2_treatment "cdk inhibitor"
26 Q0 2171744 635 28.758024 imi_mug_run_2_treatment "liver"
26 Q0 11714536 636 28.743958 imi_mug_run_2_treatment "enzymes" "gly"
26 Q0 25239274 637 28.732344 imi_mug_run_2_treatment "basis"
26 Q0 14522885 638 28.727411 imi_mug_run_2_treatment "various" "product" "antisense oligonucleotide"
26 Q0 18461365 639 28.723656 imi_mug_run_2_treatment "plasma"
26 Q0 15757523 640 28.719841 imi_mug_run_2_treatment "tandem"
26 Q0 11064458 641 28.711163 imi_mug_run_2_treatment "autologous"
26 Q0 8236825 642 28.705933 imi_mug_run_2_treatment "various" "epidermal growth factor" "monoclonal antibodies"
26 Q0 19423649 643 28.693697 imi_mug_run_2_treatment "lysine"
26 Q0 27920137 644 28.670034 imi_mug_run_2_treatment "blockade"
26 Q0 28028034 645 28.635067 imi_mug_run_2_treatment "kinase inhibitor" "everolimus" "pazopanib"
26 Q0 25453845 646 28.631618 imi_mug_run_2_treatment "adc"
26 Q0 24020871 647 28.628155 imi_mug_run_2_treatment "various"
26 Q0 25115383 648 28.622925 imi_mug_run_2_treatment "afatinib" "pd173074" "kinase inhibitor"
26 Q0 21597243 649 28.619278 imi_mug_run_2_treatment "product"
26 Q0 9713281 650 28.616707 imi_mug_run_2_treatment "cisplatin" "histidine" "carboplatin"
26 Q0 29110101 651 28.60613 imi_mug_run_2_treatment "epidermal growth factor" "matrix"
26 Q0 17923754 652 28.592379 imi_mug_run_2_treatment "adjuvant"
26 Q0 19096299 653 28.569614 imi_mug_run_2_treatment "drug" "adenosine triphosphate" "egfr tyrosine kinase inhibitors"
26 Q0 2842776 654 28.56547 imi_mug_run_2_treatment "monolayer"
26 Q0 20719175 655 28.559908 imi_mug_run_2_treatment "epidermal growth factor receptor tyrosine kinase inhibitor" "aim"
26 Q0 28795418 656 28.54739 imi_mug_run_2_treatment "aim"
26 Q0 30019650 657 28.538527 imi_mug_run_2_treatment "various" "level"
26 Q0 27664271 658 28.528702 imi_mug_run_2_treatment "kinase inhibitor" "gefitinib" "erlotinib"
26 Q0 28056982 659 28.518116 imi_mug_run_2_treatment "tyrosine" "aim"
26 Q0 20723374 660 28.516275 imi_mug_run_2_treatment "aim"
26 Q0 25855050 661 28.510191 imi_mug_run_2_treatment "level"
26 Q0 7733638 662 28.503792 imi_mug_run_2_treatment "cisplatin"
26 Q0 21310827 663 28.497452 imi_mug_run_2_treatment "mediated" "level"
26 Q0 30223007 664 28.492981 imi_mug_run_2_treatment "anti-inflammatory"
26 Q0 27643554 665 28.492004 imi_mug_run_2_treatment "drug"
26 Q0 26030765 666 28.489658 imi_mug_run_2_treatment "level"
26 Q0 25186613 667 28.478312 imi_mug_run_2_treatment "prostaglandin e2" "indomethacin" "mediators"
26 Q0 12722939 668 28.461487 imi_mug_run_2_treatment "interferon" "il-10" "il-4"
26 Q0 9852531 669 28.458744 imi_mug_run_2_treatment "lead"
26 Q0 20331976 670 28.448284 imi_mug_run_2_treatment "tyrosine"
26 Q0 15484403 671 28.445656 imi_mug_run_2_treatment "cisplatin"
26 Q0 25546403 672 28.444735 imi_mug_run_2_treatment "eosin"
26 Q0 20459769 673 28.437595 imi_mug_run_2_treatment "her-2" "tyrosine kinase inhibitor" "lapatinib"
26 Q0 27649287 674 28.43533 imi_mug_run_2_treatment "blockade"
26 Q0 18836087 675 28.433594 imi_mug_run_2_treatment "gefitinib" "tyrosine kinase inhibitor"
26 Q0 29608916 676 28.42698 imi_mug_run_2_treatment "balance"
26 Q0 15192826 677 28.424526 imi_mug_run_2_treatment "level"
26 Q0 22052230 678 28.405842 imi_mug_run_2_treatment "level" "egfr tyrosine kinase inhibitor"
26 Q0 26763254 679 28.39756 imi_mug_run_2_treatment "ras"
26 Q0 22057489 680 28.389997 imi_mug_run_2_treatment "adjuvant" "pdt" "calcium"
26 Q0 9219609 681 28.384762 imi_mug_run_2_treatment "platelets" "basis" "aim"
26 Q0 21757289 682 28.376945 imi_mug_run_2_treatment "adc"
26 Q0 29395668 683 28.358032 imi_mug_run_2_treatment "aim"
26 Q0 8550237 684 28.355646 imi_mug_run_2_treatment "lead"
26 Q0 30425968 685 28.350351 imi_mug_run_2_treatment "plasma"
26 Q0 19279207 686 28.348528 imi_mug_run_2_treatment "cisplatin"
26 Q0 28038457 687 28.33522 imi_mug_run_2_treatment "sym004" "panitumumab" "cetuximab"
26 Q0 28843992 688 28.324265 imi_mug_run_2_treatment "asa" "monoclonal antibodies"
26 Q0 12377411 689 28.322437 imi_mug_run_2_treatment "cytokines" "monolayer" "interleukin"
26 Q0 22009799 690 28.31426 imi_mug_run_2_treatment "alcohol"
26 Q0 19787783 691 28.307236 imi_mug_run_2_treatment "liprin"
26 Q0 11741748 692 28.292404 imi_mug_run_2_treatment "tyrosine kinase inhibitor" "epidermal growth factor"
26 Q0 27217720 693 28.291735 imi_mug_run_2_treatment "tki258"
26 Q0 22207554 694 28.277748 imi_mug_run_2_treatment "level" "aim"
26 Q0 29249325 695 28.276335 imi_mug_run_2_treatment "osimertinib" "plasma"
26 Q0 29666465 696 28.270603 imi_mug_run_2_treatment "various" "interleukins"
26 Q0 16998682 697 28.256334 imi_mug_run_2_treatment "oligo"
26 Q0 15222046 698 28.251625 imi_mug_run_2_treatment "asa" "aim"
26 Q0 25279187 699 28.226673 imi_mug_run_2_treatment "erlotinib" "scorpion"
26 Q0 9193222 700 28.224152 imi_mug_run_2_treatment "genesis"
26 Q0 25683078 701 28.207088 imi_mug_run_2_treatment "mediated" "su5402"
26 Q0 8625145 702 28.202728 imi_mug_run_2_treatment "basis"
26 Q0 16043261 703 28.201637 imi_mug_run_2_treatment "oxytocin" "vasopressin" "mediators"
26 Q0 24073380 704 28.19135 imi_mug_run_2_treatment "various" "blockade" "monoclonal antibodies"
26 Q0 10987278 705 28.18959 imi_mug_run_2_treatment "various" "mediated"
26 Q0 18096709 706 28.188046 imi_mug_run_2_treatment "various"
26 Q0 12796399 707 28.170135 imi_mug_run_2_treatment "level"
26 Q0 20173501 708 28.169888 imi_mug_run_2_treatment "color" "aim"
26 Q0 10646866 709 28.166111 imi_mug_run_2_treatment "vascular endothelial growth factor"
26 Q0 17975136 710 28.159399 imi_mug_run_2_treatment "taxol"
26 Q0 7860142 711 28.15931 imi_mug_run_2_treatment "drug" "cor" "level"
26 Q0 15543620 712 28.152834 imi_mug_run_2_treatment "mediators" "level"
26 Q0 11595720 713 28.131308 imi_mug_run_2_treatment "trastuzumab" "level"
26 Q0 23763474 714 28.130962 imi_mug_run_2_treatment "silver"
26 Q0 3581091 715 28.126595 imi_mug_run_2_treatment "various" "epidermal growth factor"
26 Q0 17696196 716 28.124369 imi_mug_run_2_treatment "rms" "sodium bisulfite"
26 Q0 12419583 717 28.118805 imi_mug_run_2_treatment "level"
26 Q0 27053219 718 28.095152 imi_mug_run_2_treatment "aim"
26 Q0 30017644 719 28.081972 imi_mug_run_2_treatment "aim"
26 Q0 18006781 720 28.078037 imi_mug_run_2_treatment "drugs" "erlotinib"
26 Q0 20389301 721 28.068272 imi_mug_run_2_treatment "plasma"
26 Q0 20836672 722 28.05464 imi_mug_run_2_treatment "therapeutics" "ras" "cediranib"
26 Q0 19238632 723 28.039013 imi_mug_run_2_treatment "erlotinib" "su11274" "mediated"
26 Q0 29437753 724 28.033598 imi_mug_run_2_treatment "plasma" "level" "hot spot"
26 Q0 24324054 725 28.024502 imi_mug_run_2_treatment "erlotinib" "aim" "blockade"
26 Q0 8902564 726 28.02002 imi_mug_run_2_treatment "lead"
26 Q0 27245147 727 28.018288 imi_mug_run_2_treatment "dovitinib" "azd4547" "ponatinib"
26 Q0 27501229 728 27.990572 imi_mug_run_2_treatment "level"
26 Q0 12736744 729 27.964462 imi_mug_run_2_treatment "ras"
26 Q0 28651500 730 27.937168 imi_mug_run_2_treatment "various"
26 Q0 27341790 731 27.927372 imi_mug_run_2_treatment "crizotinib" "medicine"
26 Q0 15467767 732 27.926609 imi_mug_run_2_treatment "product" "level" "suppressor"
26 Q0 23943298 733 27.926203 imi_mug_run_2_treatment "curcumin" "erlotinib" "mediated"
26 Q0 8988677 734 27.92255 imi_mug_run_2_treatment "aim"
26 Q0 29535912 735 27.91959 imi_mug_run_2_treatment "combinations" "arsenal" "cytotoxic"
26 Q0 28759252 736 27.917965 imi_mug_run_2_treatment "mediated" "lactate"
26 Q0 28584208 737 27.91529 imi_mug_run_2_treatment "epidermal growth factor receptor tyrosine kinase inhibitor" "matrix"
26 Q0 8569178 738 27.913437 imi_mug_run_2_treatment "others"
26 Q0 21705376 739 27.909403 imi_mug_run_2_treatment "kyorin"
26 Q0 30275180 740 27.905512 imi_mug_run_2_treatment "ras" "basis"
26 Q0 16557579 741 27.879221 imi_mug_run_2_treatment "various" "tyrosine" "new drugs"
26 Q0 26653553 742 27.873848 imi_mug_run_2_treatment "tcc"
26 Q0 27901069 743 27.872242 imi_mug_run_2_treatment "mediated"
26 Q0 16866851 744 27.84528 imi_mug_run_2_treatment "her-2"
26 Q0 20677568 745 27.844748 imi_mug_run_2_treatment "iressa" "gefitinib" "erlotinib"
26 Q0 24171719 746 27.84217 imi_mug_run_2_treatment "estrogen" "mediated"
26 Q0 10072815 747 27.824284 imi_mug_run_2_treatment "various"
26 Q0 29987671 748 27.813856 imi_mug_run_2_treatment "pd173074"
26 Q0 23236545 749 27.803722 imi_mug_run_2_treatment "various" "formalin" "borate buffer"
26 Q0 27650486 750 27.803013 imi_mug_run_2_treatment "aim"
26 Q0 22292655 751 27.782747 imi_mug_run_2_treatment "various"
26 Q0 28384866 752 27.767696 imi_mug_run_2_treatment "various" "eosin" "level"
26 Q0 8395998 753 27.758068 imi_mug_run_2_treatment "enzymes" "chloromethyl ethers"
26 Q0 20146583 754 27.754208 imi_mug_run_2_treatment "erlotinib" "egfr tyrosine kinase inhibitors"
26 Q0 12079515 755 27.75152 imi_mug_run_2_treatment "cytokines" "tnf-alpha" "interleukin"
26 Q0 21573021 756 27.744148 imi_mug_run_2_treatment "interferon" "aim"
26 Q0 8784478 757 27.742462 imi_mug_run_2_treatment "cddp" "cisplatin"
26 Q0 20825417 758 27.726181 imi_mug_run_2_treatment "various" "l-leucine"
26 Q0 15539458 759 27.713156 imi_mug_run_2_treatment "aim"
26 Q0 26285240 760 27.708138 imi_mug_run_2_treatment "favoring" "trastuzumab" "pertuzumab"
26 Q0 25028470 761 27.706738 imi_mug_run_2_treatment "erlotinib" "quinacrine" "drug combination"
26 Q0 25055117 762 27.69866 imi_mug_run_2_treatment "various" "crizotinib" "drugs"
26 Q0 27563407 763 27.694641 imi_mug_run_2_treatment "kinase inhibitor" "tpp" "erlotinib"
26 Q0 28133304 764 27.680412 imi_mug_run_2_treatment "panitumumab" "ras" "bevacizumab"
26 Q0 14750177 765 27.67836 imi_mug_run_2_treatment "aim"
26 Q0 30042820 766 27.676712 imi_mug_run_2_treatment "timeline"
26 Q0 9267820 767 27.676006 imi_mug_run_2_treatment "mediated"
26 Q0 30279956 768 27.67593 imi_mug_run_2_treatment "l-arg" "drug" "cytotoxic"
26 Q0 24922639 769 27.6689 imi_mug_run_2_treatment "erlotinib" "medicine" "glutamine"
26 Q0 8402711 770 27.661709 imi_mug_run_2_treatment "suppressor"
26 Q0 26706951 771 27.661709 imi_mug_run_2_treatment "epidermal growth factor receptor tyrosine kinase inhibitor"
26 Q0 24636263 772 27.651024 imi_mug_run_2_treatment "various" "gefitinib" "erlotinib"
26 Q0 25936889 773 27.651024 imi_mug_run_2_treatment "epidermal growth factor receptor tyrosine kinase inhibitor"
26 Q0 14746865 774 27.645931 imi_mug_run_2_treatment "isolate" "aim"
26 Q0 26455862 775 27.629715 imi_mug_run_2_treatment "adjuvant"
26 Q0 17996488 776 27.628677 imi_mug_run_2_treatment "vx-680"
26 Q0 21887346 777 27.623543 imi_mug_run_2_treatment "mediated"
26 Q0 24974831 778 27.600767 imi_mug_run_2_treatment "gefitinib" "butein"
26 Q0 17982442 779 27.598427 imi_mug_run_2_treatment "basis"
26 Q0 15067062 780 27.59293 imi_mug_run_2_treatment "autologous" "leu" "aim"
26 Q0 21148746 781 27.591423 imi_mug_run_2_treatment "adc"
26 Q0 12781800 782 27.56438 imi_mug_run_2_treatment "ras"
26 Q0 28741068 783 27.549198 imi_mug_run_2_treatment "product"
26 Q0 7916253 784 27.536703 imi_mug_run_2_treatment "level"
26 Q0 25743841 785 27.526941 imi_mug_run_2_treatment "suppressor"
26 Q0 24465403 786 27.510714 imi_mug_run_2_treatment "lead" "level" "aim"
26 Q0 27437872 787 27.506672 imi_mug_run_2_treatment "ras" "igf-1" "mediated"
26 Q0 27825109 788 27.505222 imi_mug_run_2_treatment "afatinib"
26 Q0 19351754 789 27.487358 imi_mug_run_2_treatment "gefitinib" "erlotinib" "plasma"
26 Q0 7882279 790 27.470913 imi_mug_run_2_treatment "various" "ras"
26 Q0 26425700 791 27.469288 imi_mug_run_2_treatment "bisulfite" "enzyme digestion" "methylated"
26 Q0 26351321 792 27.457005 imi_mug_run_2_treatment "pha-665752" "elacridar" "level"
26 Q0 12530090 793 27.453165 imi_mug_run_2_treatment "silver" "aim"
26 Q0 26124204 794 27.45219 imi_mug_run_2_treatment "drugs" "lde225"
26 Q0 19903855 795 27.450924 imi_mug_run_2_treatment "pd173074" "cisplatin" "animals"
26 Q0 11568603 796 27.450851 imi_mug_run_2_treatment "dapi" "cy5.5" "colcemide"
26 Q0 18549475 797 27.44512 imi_mug_run_2_treatment "adc"
26 Q0 20889570 798 27.444757 imi_mug_run_2_treatment "level"
26 Q0 25760602 799 27.432518 imi_mug_run_2_treatment "drug" "azd4547" "water"
26 Q0 17907153 800 27.431595 imi_mug_run_2_treatment "various" "lead" "level"
26 Q0 24444674 801 27.43012 imi_mug_run_2_treatment "bisulfite"
26 Q0 15896461 802 27.42177 imi_mug_run_2_treatment "amp"
26 Q0 22083977 803 27.419422 imi_mug_run_2_treatment "suppressor"
26 Q0 1325585 804 27.415188 imi_mug_run_2_treatment "basis"
26 Q0 17487429 805 27.409542 imi_mug_run_2_treatment "gse" "various" "fruit extract"
26 Q0 8097369 806 27.408699 imi_mug_run_2_treatment "various" "level"
26 Q0 26630704 807 27.38971 imi_mug_run_2_treatment "blockade" "platinum" "liver"
26 Q0 27207775 808 27.38813 imi_mug_run_2_treatment "afatinib" "level" "cetuximab"
26 Q0 30348976 809 27.38145 imi_mug_run_2_treatment "gdnf" "cytotoxic" "liver"
26 Q0 25621070 810 27.371937 imi_mug_run_2_treatment "formalin"
26 Q0 9155050 811 27.34912 imi_mug_run_2_treatment "suppressor"
26 Q0 22935382 812 27.347027 imi_mug_run_2_treatment "her-2" "trastuzumab" "ras"
26 Q0 29474635 813 27.344492 imi_mug_run_2_treatment "level"
26 Q0 11940351 814 27.33748 imi_mug_run_2_treatment "level"
26 Q0 19029025 815 27.323257 imi_mug_run_2_treatment "mediated" "antisense oligonucleotide"
26 Q0 28961841 816 27.305794 imi_mug_run_2_treatment "various" "osimertinib" "afatinib"
26 Q0 25491297 817 27.301163 imi_mug_run_2_treatment "protease"
26 Q0 8213218 818 27.286041 imi_mug_run_2_treatment "etoposide" "adriamycin"
26 Q0 11551944 819 27.283318 imi_mug_run_2_treatment "heparin" "sulfate" "fibroblast growth factor 2"
26 Q0 24203761 820 27.276176 imi_mug_run_2_treatment "lead" "level"
26 Q0 27866520 821 27.265188 imi_mug_run_2_treatment "plasma"
26 Q0 16172916 822 27.25578 imi_mug_run_2_treatment "mediated"
26 Q0 30316684 823 27.255112 imi_mug_run_2_treatment "cisplatin" "fluorouracil" "leucovorin"
26 Q0 21952621 824 27.232124 imi_mug_run_2_treatment "ipa"
26 Q0 22185756 825 27.22235 imi_mug_run_2_treatment "program"
26 Q0 25773678 826 27.189482 imi_mug_run_2_treatment "cisplatin" "ras"
26 Q0 11454671 827 27.18052 imi_mug_run_2_treatment "urokinase" "urokinase-type plasminogen activator" "various"
26 Q0 23612660 828 27.177048 imi_mug_run_2_treatment "crizotinib"
26 Q0 12527944 829 27.153433 imi_mug_run_2_treatment "edta" "ethidium bromide"
26 Q0 21315025 830 27.149544 imi_mug_run_2_treatment "level"
26 Q0 29862234 831 27.141638 imi_mug_run_2_treatment "etoposide" "irinotecan" "platinum"
26 Q0 28059068 832 27.137287 imi_mug_run_2_treatment "blockade" "egfr inhibitor"
26 Q0 1438701 833 27.12648 imi_mug_run_2_treatment "biotin" "ras"
26 Q0 19784073 834 27.125338 imi_mug_run_2_treatment "lysine"
26 Q0 22352917 835 27.124063 imi_mug_run_2_treatment "various" "matrix"
26 Q0 10944551 836 27.123934 imi_mug_run_2_treatment "retinoic acid" "methylated" "lead"
26 Q0 29121914 837 27.114145 imi_mug_run_2_treatment "various"
26 Q0 16879393 838 27.105175 imi_mug_run_2_treatment "trastuzumab" "aim"
26 Q0 16644573 839 27.101597 imi_mug_run_2_treatment "cisplatin" "nacl"
26 Q0 26879013 840 27.098297 imi_mug_run_2_treatment "aim"
26 Q0 27247353 841 27.087706 imi_mug_run_2_treatment "investigational agents" "drug" "etoposide"
26 Q0 20553532 842 27.077152 imi_mug_run_2_treatment "various"
26 Q0 21748818 843 27.076672 imi_mug_run_2_treatment "aim" "endocrine therapy"
26 Q0 28943954 844 27.073124 imi_mug_run_2_treatment "various" "epigallocatechin-3-gallate" "egcg"
26 Q0 22036563 845 27.0718 imi_mug_run_2_treatment "mediated"
26 Q0 21062933 846 27.042156 imi_mug_run_2_treatment "erlotinib" "gefitinib"
26 Q0 8386710 847 27.027777 imi_mug_run_2_treatment "urokinase-type plasminogen activator" "urokinase" "plasminogen activator"
26 Q0 29322815 848 27.026678 imi_mug_run_2_treatment "aim"
26 Q0 14974952 849 27.024448 imi_mug_run_2_treatment "liver"
26 Q0 30506964 850 27.019958 imi_mug_run_2_treatment "isolate" "air"
26 Q0 26288717 851 27.012009 imi_mug_run_2_treatment "lead"
26 Q0 27794501 852 26.999697 imi_mug_run_2_treatment "kinase inhibitor"
26 Q0 9698532 853 26.999355 imi_mug_run_2_treatment "phenol" "product" "ethidium bromide"
26 Q0 12239607 854 26.99792 imi_mug_run_2_treatment "level"
26 Q0 30401982 855 26.996532 imi_mug_run_2_treatment "mediated"
26 Q0 19351834 856 26.990341 imi_mug_run_2_treatment "erlotinib" "egfr inhibitor"
26 Q0 8176843 857 26.989462 imi_mug_run_2_treatment "ras"
26 Q0 23416461 858 26.988384 imi_mug_run_2_treatment "various"
26 Q0 17506981 859 26.968243 imi_mug_run_2_treatment "sage"
26 Q0 19960436 860 26.951956 imi_mug_run_2_treatment "liver"
26 Q0 30290647 861 26.9466 imi_mug_run_2_treatment "afatinib" "medicine" "gefitinib"
26 Q0 21553054 862 26.940292 imi_mug_run_2_treatment "cisplatin" "level"
26 Q0 9669664 863 26.93699 imi_mug_run_2_treatment "color"
26 Q0 10338000 864 26.928253 imi_mug_run_2_treatment "various" "genesis"
26 Q0 29132384 865 26.915657 imi_mug_run_2_treatment "various" "aim"
26 Q0 19477061 866 26.904772 imi_mug_run_2_treatment "prophylactic" "hpv vaccination" "vaccines"
26 Q0 23874817 867 26.90021 imi_mug_run_2_treatment "mediated" "nerve growth factor" "neurotrophic factor"
26 Q0 21817906 868 26.870079 imi_mug_run_2_treatment "level"
26 Q0 1649386 869 26.862652 imi_mug_run_2_treatment "rif"
26 Q0 24458211 870 26.853838 imi_mug_run_2_treatment "plasma"
26 Q0 9829720 871 26.845087 imi_mug_run_2_treatment "lead"
26 Q0 25982012 872 26.843271 imi_mug_run_2_treatment "vandetanib" "everolimus" "kinase inhibitor"
26 Q0 9673357 873 26.841309 imi_mug_run_2_treatment "cddp" "trf" "cisplatin"
26 Q0 29455642 874 26.837975 imi_mug_run_2_treatment "crizotinib" "ceritinib" "alectinib"
26 Q0 1685773 875 26.83722 imi_mug_run_2_treatment "epidermal growth factor"
26 Q0 15665299 876 26.820488 imi_mug_run_2_treatment "cetuximab" "gefitinib" "erlotinib"
26 Q0 21549910 877 26.81831 imi_mug_run_2_treatment "gefitinib" "erlotinib" "emla"
26 Q0 23631593 878 26.817516 imi_mug_run_2_treatment "aim"
26 Q0 26801869 879 26.806087 imi_mug_run_2_treatment "level"
26 Q0 11724302 880 26.802452 imi_mug_run_2_treatment "antiserum"
26 Q0 25842168 881 26.797718 imi_mug_run_2_treatment "aim"
26 Q0 11173816 882 26.797432 imi_mug_run_2_treatment "cddp" "cisplatin" "drug"
26 Q0 23082258 883 26.794659 imi_mug_run_2_treatment "allogeneic"
26 Q0 18665077 884 26.788471 imi_mug_run_2_treatment "factor i" "epidermal growth factor" "aim"
26 Q0 21517068 885 26.787249 imi_mug_run_2_treatment "various" "tyrosine"
26 Q0 25607753 886 26.77839 imi_mug_run_2_treatment "various" "gefitinib" "radiosensitizers"
26 Q0 18379349 887 26.775173 imi_mug_run_2_treatment "ras" "epidermal growth factor" "tyrosine kinase inhibitor"
26 Q0 21807965 888 26.7724 imi_mug_run_2_treatment "level"
26 Q0 20681447 889 26.765621 imi_mug_run_2_treatment "ras" "aim"
26 Q0 27885740 890 26.75001 imi_mug_run_2_treatment "gemcitabine" "adriamycin"
26 Q0 15251961 891 26.73094 imi_mug_run_2_treatment "isolate" "plasma"
26 Q0 24282290 892 26.724724 imi_mug_run_2_treatment "shogaol" "gingerol" "mediated"
26 Q0 18844034 893 26.723125 imi_mug_run_2_treatment "various" "level"
26 Q0 21107428 894 26.722881 imi_mug_run_2_treatment "suppressor" "lead"
26 Q0 16140420 895 26.71738 imi_mug_run_2_treatment "gefitinib" "kinase inhibitor"
26 Q0 24898159 896 26.715471 imi_mug_run_2_treatment "mediated" "level"
26 Q0 24592134 897 26.70906 imi_mug_run_2_treatment "crizotinib" "aim"
26 Q0 12753701 898 26.707315 imi_mug_run_2_treatment "phenol"
26 Q0 17607666 899 26.699661 imi_mug_run_2_treatment "tma" "level"
26 Q0 17384685 900 26.686602 imi_mug_run_2_treatment "agar"
26 Q0 2555051 901 26.673756 imi_mug_run_2_treatment "retinoid" "retinoic acid" "etoposide"
26 Q0 17052259 902 26.669596 imi_mug_run_2_treatment "various"
26 Q0 7551947 903 26.669441 imi_mug_run_2_treatment "level"
26 Q0 7806940 904 26.667433 imi_mug_run_2_treatment "epidermal growth factor" "brdu" "bromodeoxyuridine"
26 Q0 10363238 905 26.660297 imi_mug_run_2_treatment "aim"
26 Q0 25893986 906 26.6571 imi_mug_run_2_treatment "drugs"
26 Q0 21985355 907 26.654875 imi_mug_run_2_treatment "liver" "product" "others"
26 Q0 11329776 908 26.65206 imi_mug_run_2_treatment "alcohol" "cytokines"
26 Q0 24956168 909 26.638786 imi_mug_run_2_treatment "iplex" "matrix"
26 Q0 22045191 910 26.633196 imi_mug_run_2_treatment "erlotinib" "egfr inhibitor" "program"
26 Q0 3030544 911 26.631905 imi_mug_run_2_treatment "calcitonin"
26 Q0 25147921 912 26.6297 imi_mug_run_2_treatment "lead"
26 Q0 26724472 913 26.622082 imi_mug_run_2_treatment "level" "crizotinib"
26 Q0 19502078 914 26.620087 imi_mug_run_2_treatment "level"
26 Q0 20557064 915 26.61824 imi_mug_run_2_treatment "gold" "polyethylene glycol"
26 Q0 27148699 916 26.617706 imi_mug_run_2_treatment "mediated"
26 Q0 8096076 917 26.61069 imi_mug_run_2_treatment "m-amsa" "mitoxantrone" "topoisomerase inhibitors"
26 Q0 27397481 918 26.609386 imi_mug_run_2_treatment "various"
26 Q0 28849105 919 26.605747 imi_mug_run_2_treatment "ppi"
26 Q0 14691450 920 26.593231 imi_mug_run_2_treatment "various"
26 Q0 17146446 921 26.592953 imi_mug_run_2_treatment "beta-estradiol" "alpha subunit" "blockade"
26 Q0 19204574 922 26.590595 imi_mug_run_2_treatment "gefitinib" "color"
26 Q0 30453282 923 26.587408 imi_mug_run_2_treatment "suppressor" "plasma"
26 Q0 21626008 924 26.583534 imi_mug_run_2_treatment "ras"
26 Q0 28990029 925 26.579693 imi_mug_run_2_treatment "mediated"
26 Q0 26824724 926 26.574802 imi_mug_run_2_treatment "buffer" "gold" "salt"
26 Q0 21750651 927 26.561707 imi_mug_run_2_treatment "mediated"
26 Q0 12479104 928 26.559109 imi_mug_run_2_treatment "level"
26 Q0 29502124 929 26.555634 imi_mug_run_2_treatment "erlotinib" "silver"
26 Q0 12845634 930 26.549892 imi_mug_run_2_treatment "tma"
26 Q0 16857824 931 26.543215 imi_mug_run_2_treatment "pertuzumab" "her-2" "trastuzumab"
26 Q0 7946596 932 26.53693 imi_mug_run_2_treatment "product"
26 Q0 8760589 933 26.535486 imi_mug_run_2_treatment "geneticin"
26 Q0 12057863 934 26.523785 imi_mug_run_2_treatment "combinations" "trastuzumab" "mediated"
26 Q0 22968692 935 26.493849 imi_mug_run_2_treatment "crizotinib"
26 Q0 29360118 936 26.487034 imi_mug_run_2_treatment "drug" "level" "gefitinib"
26 Q0 25503065 937 26.474447 imi_mug_run_2_treatment "various" "mediated"
26 Q0 28670719 938 26.472298 imi_mug_run_2_treatment "plasma"
26 Q0 19275511 939 26.467928 imi_mug_run_2_treatment "pleiotrophin" "genesis"
26 Q0 25732110 940 26.462883 imi_mug_run_2_treatment "various"
26 Q0 19458078 941 26.451778 imi_mug_run_2_treatment "level" "agar" "basis"
26 Q0 27237020 942 26.44365 imi_mug_run_2_treatment "level"
26 Q0 22825335 943 26.435661 imi_mug_run_2_treatment "tyr" "level"
26 Q0 21329599 944 26.42861 imi_mug_run_2_treatment "lead"
26 Q0 28042706 945 26.413633 imi_mug_run_2_treatment "combinations" "cetuximab" "agent"
26 Q0 27203740 946 26.41265 imi_mug_run_2_treatment "herceptin"
26 Q0 19881546 947 26.409443 imi_mug_run_2_treatment "mediated"
26 Q0 23301089 948 26.405602 imi_mug_run_2_treatment "tma"
26 Q0 11346465 949 26.391232 imi_mug_run_2_treatment "various"
26 Q0 17435415 950 26.38185 imi_mug_run_2_treatment "gefitinib" "epidermal growth factor receptor tyrosine kinase inhibitor"
26 Q0 9865902 951 26.37716 imi_mug_run_2_treatment "estrogen"
26 Q0 28507621 952 26.372173 imi_mug_run_2_treatment "aim"
26 Q0 17284363 953 26.370337 imi_mug_run_2_treatment "various" "paclitaxel" "vinblastine"
26 Q0 23644131 954 26.359936 imi_mug_run_2_treatment "level"
26 Q0 30032842 955 26.358732 imi_mug_run_2_treatment "anlotinib"
26 Q0 24700479 956 26.353664 imi_mug_run_2_treatment "medicine" "therapeutics"
26 Q0 21559558 957 26.34378 imi_mug_run_2_treatment "hot spot"
26 Q0 24314215 958 26.340273 imi_mug_run_2_treatment "ras" "ple"
26 Q0 20008850 959 26.340273 imi_mug_run_2_treatment "gefitinib" "erlotinib" "platinum"
26 Q0 14692617 960 26.33601 imi_mug_run_2_treatment "beta-estradiol" "estradiol 3-benzoate"
26 Q0 20207772 961 26.334303 imi_mug_run_2_treatment "scorpion" "gefitinib" "erlotinib"
26 Q0 25982722 962 26.31611 imi_mug_run_2_treatment "human immunoglobulin" "gold" "shape"
26 Q0 22946048 963 26.311804 imi_mug_run_2_treatment "various" "agonists"
26 Q0 19545448 964 26.307518 imi_mug_run_2_treatment "ras" "level"
26 Q0 27148588 965 26.297977 imi_mug_run_2_treatment "androgen" "medicine" "level"
26 Q0 21701773 966 26.284393 imi_mug_run_2_treatment "level"
26 Q0 16670003 967 26.276318 imi_mug_run_2_treatment "various" "level" "tam"
26 Q0 10618413 968 26.272625 imi_mug_run_2_treatment "various"
26 Q0 12499248 969 26.27015 imi_mug_run_2_treatment "level" "ras"
27 Q0 26616848 1 67.85426 imi_mug_run_2_treatment "ras"
27 Q0 24952473 2 67.75939 imi_mug_run_2_treatment "enzymes" "glutamine"
27 Q0 26331885 3 67.64292 imi_mug_run_2_treatment "various"
27 Q0 25170638 4 67.45624 imi_mug_run_2_treatment "aim"
27 Q0 26125448 5 67.453995 imi_mug_run_2_treatment "docetaxel" "selumetinib" "arry-142886"
27 Q0 28407465 6 66.040405 imi_mug_run_2_treatment "gemcitabine" "pemetrexed" "singlet"
27 Q0 27283493 7 64.332275 imi_mug_run_2_treatment "combinations" "bkm120" "ammonia"
27 Q0 19349489 8 63.185688 imi_mug_run_2_treatment "ras" "gefitinib" "erlotinib"
27 Q0 19787214 9 61.501656 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
27 Q0 23524403 10 61.42286 imi_mug_run_2_treatment "ras" "level"
27 Q0 26415993 11 60.489548 imi_mug_run_2_treatment "taxanes" "platinum" "pemetrexed"
27 Q0 23733083 12 59.5659 imi_mug_run_2_treatment "gefitinib" "erlotinib" "crizotinib"
27 Q0 29764594 13 59.499607 imi_mug_run_2_treatment "drugs"
27 Q0 24045185 14 59.476093 imi_mug_run_2_treatment "drug" "program"
27 Q0 27100819 15 59.327003 imi_mug_run_2_treatment "drugs" "ras" "therapeutics"
27 Q0 26714748 16 59.169426 imi_mug_run_2_treatment "drug" "aim"
27 Q0 28961841 17 58.963524 imi_mug_run_2_treatment "various" "osimertinib" "afatinib"
27 Q0 29484842 18 58.93727 imi_mug_run_2_treatment "ras"
27 Q0 24463346 19 58.77607 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitor"
27 Q0 27606136 20 58.34433 imi_mug_run_2_treatment "ras"
27 Q0 23012248 21 58.003345 imi_mug_run_2_treatment "ganetespib" "combinations" "cytotoxic"
27 Q0 25956913 22 57.956528 imi_mug_run_2_treatment "fti" "ipa" "serine"
27 Q0 29748019 23 57.77351 imi_mug_run_2_treatment "erlotinib"
27 Q0 27467210 24 57.664406 imi_mug_run_2_treatment "selumetinib" "docetaxel" "ras"
27 Q0 24389431 25 57.419712 imi_mug_run_2_treatment "cystine" "glycine" "ras"
27 Q0 21849857 26 57.18762 imi_mug_run_2_treatment "medicine" "anti-vegf monoclonal antibody" "vascular endothelial growth factor"
27 Q0 26124189 27 56.95324 imi_mug_run_2_treatment "mediated"
27 Q0 29906244 28 56.934845 imi_mug_run_2_treatment "anabolic" "program"
27 Q0 25257766 29 56.876137 imi_mug_run_2_treatment "trametinib" "selumetinib" "docetaxel"
27 Q0 28710768 30 56.450195 imi_mug_run_2_treatment "gefitinib" "panobinostat" "histone deacetylase inhibitor"
27 Q0 24331409 31 56.438904 imi_mug_run_2_treatment "gly"
27 Q0 28781083 32 56.396736 imi_mug_run_2_treatment "ras" "basis"
27 Q0 22666783 33 56.390312 imi_mug_run_2_treatment "therapeutics" "aim"
27 Q0 30167080 34 56.38793 imi_mug_run_2_treatment "palbociclib" "mediators" "mek inhibitor"
27 Q0 24461128 35 56.12917 imi_mug_run_2_treatment "bosutinib"
27 Q0 23917487 36 55.955128 imi_mug_run_2_treatment "panitumumab" "investigational agent"
27 Q0 27336603 37 55.888794 imi_mug_run_2_treatment "liver"
27 Q0 21277552 38 55.747047 imi_mug_run_2_treatment "lead"
27 Q0 30268480 39 55.693703 imi_mug_run_2_treatment "various" "combinations"
27 Q0 14601056 40 55.517963 imi_mug_run_2_treatment "ras"
27 Q0 25704901 41 55.476036 imi_mug_run_2_treatment "basis"
27 Q0 27068338 42 55.41999 imi_mug_run_2_treatment "ras" "lead" "mek inhibitor"
27 Q0 27826532 43 55.329304 imi_mug_run_2_treatment "plasma"
27 Q0 23724098 44 54.99634 imi_mug_run_2_treatment "gemcitabine" "taxane" "egfr tyrosine kinase inhibitors"
27 Q0 30048458 45 54.99498 imi_mug_run_2_treatment "adc"
27 Q0 27133754 46 54.992317 imi_mug_run_2_treatment "drugs"
27 Q0 26841430 47 54.431034 imi_mug_run_2_treatment "various" "drug" "drugs"
27 Q0 22805266 48 54.376995 imi_mug_run_2_treatment "drugs"
27 Q0 27008036 49 54.2744 imi_mug_run_2_treatment "gold"
27 Q0 28675058 50 54.149864 imi_mug_run_2_treatment "docetaxel" "selumetinib" "ras"
27 Q0 22177492 51 54.137886 imi_mug_run_2_treatment "gefitinib"
27 Q0 24063423 52 54.060616 imi_mug_run_2_treatment "docetaxel" "ras" "selumetinib"
27 Q0 29455666 53 54.033627 imi_mug_run_2_treatment "combinations" "aim"
27 Q0 26951837 54 53.92653 imi_mug_run_2_treatment "ras"
27 Q0 24439569 55 53.3882 imi_mug_run_2_treatment "platinum" "liver"
27 Q0 24688052 56 53.295326 imi_mug_run_2_treatment "antifolates" "antifolate" "methotrexate"
27 Q0 22541434 57 53.227337 imi_mug_run_2_treatment "ras"
27 Q0 25956936 58 53.214745 imi_mug_run_2_treatment "shape" "ras"
27 Q0 18676835 59 53.208305 imi_mug_run_2_treatment "mediated" "collagen"
27 Q0 27199349 60 53.163673 imi_mug_run_2_treatment "cisplatin"
27 Q0 29089357 61 52.964756 imi_mug_run_2_treatment "duration" "platinum"
27 Q0 30087114 62 52.91924 imi_mug_run_2_treatment "blockade" "immunosuppressive" "agent"
27 Q0 24071646 63 52.80951 imi_mug_run_2_treatment "atorvastatin" "gefitinib" "mediated"
27 Q0 28513466 64 52.791855 imi_mug_run_2_treatment "combinations" "cytostatic agents" "cytostatics"
27 Q0 30132854 65 52.40623 imi_mug_run_2_treatment "egfr inhibitor" "azd8931" "various"
27 Q0 23238036 66 52.304573 imi_mug_run_2_treatment "plasma" "vinorelbine" "carboplatin"
27 Q0 27402797 67 52.29873 imi_mug_run_2_treatment "adjuvant"
27 Q0 26486077 68 52.23954 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
27 Q0 23454899 69 52.02824 imi_mug_run_2_treatment "combinations" "ras" "igf1"
27 Q0 22680928 70 52.02153 imi_mug_run_2_treatment "antimetabolite" "drugs" "ras"
27 Q0 26361996 71 51.976788 imi_mug_run_2_treatment "ras"
27 Q0 25029028 72 51.967365 imi_mug_run_2_treatment "enzymes" "phosphate"
27 Q0 27336608 73 51.91761 imi_mug_run_2_treatment "various" "ras" "cytotoxic"
27 Q0 30338041 74 51.84504 imi_mug_run_2_treatment "blockade"
27 Q0 20592359 75 51.488823 imi_mug_run_2_treatment "tyrosine kinase inhibitor"
27 Q0 23352126 76 51.44899 imi_mug_run_2_treatment "phenformin" "drugs" "metformin"
27 Q0 20034871 77 51.36647 imi_mug_run_2_treatment "various"
27 Q0 29526181 78 51.319885 imi_mug_run_2_treatment "drugs"
27 Q0 25158139 79 51.280846 imi_mug_run_2_treatment "guanosine"
27 Q0 24113009 80 51.211845 imi_mug_run_2_treatment "drug"
27 Q0 23064619 81 51.185463 imi_mug_run_2_treatment "aim"
27 Q0 26130327 82 51.168945 imi_mug_run_2_treatment "fluorouracil" "drugs" "level"
27 Q0 20035238 83 51.13385 imi_mug_run_2_treatment "erlotinib" "matrix"
27 Q0 23208496 84 51.123573 imi_mug_run_2_treatment "mediated"
27 Q0 27565922 85 50.95828 imi_mug_run_2_treatment "hot spot" "aim"
27 Q0 26416458 86 50.917763 imi_mug_run_2_treatment "platinum" "aim"
27 Q0 26567140 87 50.91703 imi_mug_run_2_treatment "mediated"
27 Q0 24222160 88 50.862988 imi_mug_run_2_treatment "others"
27 Q0 30352902 89 50.855392 imi_mug_run_2_treatment "ras" "level" "crizotinib"
27 Q0 25897257 90 50.84157 imi_mug_run_2_treatment "lead"
27 Q0 30377342 91 50.756668 imi_mug_run_2_treatment "nivolumab" "program"
27 Q0 25101332 92 50.660057 imi_mug_run_2_treatment "drug" "drugs" "basis"
27 Q0 26728409 93 50.633755 imi_mug_run_2_treatment "mek inhibitor" "trametinib" "palbociclib"
27 Q0 20145159 94 50.632946 imi_mug_run_2_treatment "plasma"
27 Q0 23414467 95 50.607346 imi_mug_run_2_treatment "selumetinib" "hyd" "docetaxel"
27 Q0 25222473 96 50.584007 imi_mug_run_2_treatment "mitomycins"
27 Q0 21306997 97 50.578667 imi_mug_run_2_treatment "drugs"
27 Q0 26977001 98 50.551888 imi_mug_run_2_treatment "docetaxel" "pemetrexed" "aim"
27 Q0 23154547 99 50.478233 imi_mug_run_2_treatment "formalin"
27 Q0 24004591 100 50.43087 imi_mug_run_2_treatment "azd6244" "mek inhibitor"
27 Q0 25173530 101 50.400055 imi_mug_run_2_treatment "nervous system"
27 Q0 24521262 102 50.38665 imi_mug_run_2_treatment "mediated" "therapeutics"
27 Q0 30279957 103 50.35651 imi_mug_run_2_treatment "therapeutics" "duration"
27 Q0 25843002 104 50.297882 imi_mug_run_2_treatment "trail-r2"
27 Q0 24893629 105 50.189636 imi_mug_run_2_treatment "ras" "farnesyltransferase inhibitors"
27 Q0 26807315 106 50.183254 imi_mug_run_2_treatment "biguanides" "phenformin" "metformin"
27 Q0 19638574 107 50.162117 imi_mug_run_2_treatment "sorafenib"
27 Q0 23658296 108 50.15088 imi_mug_run_2_treatment "blockade" "mediated" "basis"
27 Q0 22942608 109 50.076546 imi_mug_run_2_treatment "drugs" "cytotoxic" "therapeutics"
27 Q0 21385341 110 50.065125 imi_mug_run_2_treatment "lead" "aim"
27 Q0 28797845 111 50.049377 imi_mug_run_2_treatment "drugs" "omipalisib"
27 Q0 24192124 112 50.04697 imi_mug_run_2_treatment "cetuximab" "erlotinib" "crizotinib"
27 Q0 23835703 113 50.026108 imi_mug_run_2_treatment "carboplatin" "cisplatin" "pemetrexed"
27 Q0 26893312 114 49.990395 imi_mug_run_2_treatment "ras" "trametinib" "selumetinib"
27 Q0 26723875 115 49.964256 imi_mug_run_2_treatment "drug" "trametinib" "drugs"
27 Q0 27680702 116 49.941467 imi_mug_run_2_treatment "drugs" "level"
27 Q0 30088781 117 49.92392 imi_mug_run_2_treatment "plasma"
27 Q0 23357969 118 49.847336 imi_mug_run_2_treatment "adc" "adjuvant"
27 Q0 24406751 119 49.80706 imi_mug_run_2_treatment "docetaxel" "crizotinib" "afatinib"
27 Q0 24354593 120 49.749695 imi_mug_run_2_treatment "protein kinase inhibitors" "crizotinib" "dacomitinib"
27 Q0 23300028 121 49.749695 imi_mug_run_2_treatment "cetuximab" "monoclonal antibodies" "panitumumab"
27 Q0 21463141 122 49.74351 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
27 Q0 26709701 123 49.62314 imi_mug_run_2_treatment "proteasome inhibitor" "ixazomib" "glucose"
27 Q0 24276238 124 49.56567 imi_mug_run_2_treatment "ras"
27 Q0 28978051 125 49.565334 imi_mug_run_2_treatment "various" "agent" "wee1 inhibitor azd1775"
27 Q0 30254092 126 49.56359 imi_mug_run_2_treatment "drugs" "agent" "blockade"
27 Q0 22964644 127 49.54606 imi_mug_run_2_treatment "mediated"
27 Q0 27285753 128 49.534843 imi_mug_run_2_treatment "combinations" "carboplatin" "drugs"
27 Q0 20921461 129 49.520576 imi_mug_run_2_treatment "monoclonal antibodies" "epidermal growth factor" "ras"
27 Q0 24519547 130 49.515343 imi_mug_run_2_treatment "aim"
27 Q0 22980976 131 49.48757 imi_mug_run_2_treatment "enzymes"
27 Q0 19010912 132 49.44761 imi_mug_run_2_treatment "ras"
27 Q0 26173780 133 49.351025 imi_mug_run_2_treatment "balance"
27 Q0 28085233 134 49.326954 imi_mug_run_2_treatment "aim"
27 Q0 30217639 135 49.28858 imi_mug_run_2_treatment "amino acid" "taxane" "platinum"
27 Q0 27086595 136 49.288292 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitor" "basis"
27 Q0 29112457 137 49.26603 imi_mug_run_2_treatment "various" "mediated" "ras"
27 Q0 29184501 138 49.23846 imi_mug_run_2_treatment "drug"
27 Q0 28971587 139 49.219063 imi_mug_run_2_treatment "crizotinib"
27 Q0 25936883 140 49.2109 imi_mug_run_2_treatment "drugs" "aim"
27 Q0 27780929 141 49.11033 imi_mug_run_2_treatment "ras" "cytostatic" "bisphosphonates"
27 Q0 25992771 142 49.063606 imi_mug_run_2_treatment "blockade"
27 Q0 23208128 143 49.018017 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
27 Q0 29440631 144 49.01801 imi_mug_run_2_treatment "deltarasin" "n-acetylcysteine" "oxygen"
27 Q0 24292713 145 48.989403 imi_mug_run_2_treatment "atn-224" "antioxidant" "various"
27 Q0 17510423 146 48.988567 imi_mug_run_2_treatment "ci-1040" "mek inhibitor"
27 Q0 25529460 147 48.976593 imi_mug_run_2_treatment "eosin"
27 Q0 24509876 148 48.968395 imi_mug_run_2_treatment "ras"
27 Q0 21544811 149 48.962498 imi_mug_run_2_treatment "various" "mediated" "interleukin-8"
27 Q0 29496255 150 48.945366 imi_mug_run_2_treatment "erlotinib" "tivantinib" "agent"
27 Q0 24994038 151 48.93939 imi_mug_run_2_treatment "basis"
27 Q0 29191602 152 48.916367 imi_mug_run_2_treatment "platinum"
27 Q0 22302407 153 48.76501 imi_mug_run_2_treatment "aim"
27 Q0 29464099 154 48.749 imi_mug_run_2_treatment "drugs"
27 Q0 23975858 155 48.743942 imi_mug_run_2_treatment "level"
27 Q0 30147015 156 48.68933 imi_mug_run_2_treatment "drugs"
27 Q0 27323821 157 48.637177 imi_mug_run_2_treatment "plasma"
27 Q0 27223439 158 48.507824 imi_mug_run_2_treatment "egfr inhibitor"
27 Q0 28332047 159 48.472015 imi_mug_run_2_treatment "osimertinib"
27 Q0 25363767 160 48.446156 imi_mug_run_2_treatment "urethane" "nitrosourea" "lead"
27 Q0 25349974 161 48.3614 imi_mug_run_2_treatment "gefitinib" "erlotinib" "egfr tyrosine kinase inhibitors"
27 Q0 29808006 162 48.35886 imi_mug_run_2_treatment "ras"
27 Q0 26668062 163 48.289276 imi_mug_run_2_treatment "drugs" "ras"
27 Q0 26766588 164 48.21422 imi_mug_run_2_treatment "program"
27 Q0 23122493 165 48.147507 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
27 Q0 24533074 166 48.03424 imi_mug_run_2_treatment "various"
27 Q0 24823994 167 47.983994 imi_mug_run_2_treatment "ras"
27 Q0 30089720 168 47.976803 imi_mug_run_2_treatment "adc" "urethane" "blockade"
27 Q0 21336183 169 47.923195 imi_mug_run_2_treatment "pemetrexed" "combinations" "platinum"
27 Q0 29484144 170 47.90276 imi_mug_run_2_treatment "ors" "level"
27 Q0 25714397 171 47.89121 imi_mug_run_2_treatment "erlotinib" "combinations" "adjuvant"
27 Q0 20840818 172 47.848022 imi_mug_run_2_treatment "lead" "egfr tyrosine kinase inhibitor" "aim"
27 Q0 22982650 173 47.820038 imi_mug_run_2_treatment "taxane" "epidermal growth factor" "erlotinib"
27 Q0 28109399 174 47.7651 imi_mug_run_2_treatment "combinations"
27 Q0 26909577 175 47.75132 imi_mug_run_2_treatment "glucose" "mediated" "ras"
27 Q0 24496383 176 47.743057 imi_mug_run_2_treatment "mediated"
27 Q0 24956168 177 47.70924 imi_mug_run_2_treatment "iplex" "matrix"
27 Q0 25077772 178 47.67244 imi_mug_run_2_treatment "dna vaccine" "immunotherapeutic agent"
27 Q0 26077004 179 47.63727 imi_mug_run_2_treatment "aim"
27 Q0 24594201 180 47.613483 imi_mug_run_2_treatment "various"
27 Q0 24513263 181 47.59152 imi_mug_run_2_treatment "others"
27 Q0 27073482 182 47.568394 imi_mug_run_2_treatment "various"
27 Q0 20529262 183 47.557625 imi_mug_run_2_treatment "cetuximab" "drug" "complement inhibitor"
27 Q0 20855820 184 47.522934 imi_mug_run_2_treatment "dasatinib" "diuretics" "agent"
27 Q0 25557115 185 47.296978 imi_mug_run_2_treatment "ras" "glycine"
27 Q0 22770374 186 47.235962 imi_mug_run_2_treatment "gefitinib" "erlotinib" "egfr tyrosine kinase inhibitor"
27 Q0 25114235 187 47.23226 imi_mug_run_2_treatment "cisplatin" "mediated" "therapeutics"
27 Q0 16869787 188 47.201965 imi_mug_run_2_treatment "erlotinib" "epidermal growth factor" "gefitinib"
27 Q0 26968843 189 47.190353 imi_mug_run_2_treatment "drugs" "egfr tyrosine kinase inhibitors" "crizotinib"
27 Q0 22696596 190 47.151825 imi_mug_run_2_treatment "matrix"
27 Q0 24139827 191 47.142178 imi_mug_run_2_treatment "platinum"
27 Q0 29808009 192 47.1192 imi_mug_run_2_treatment "ras" "blockade"
27 Q0 23364532 193 47.113785 imi_mug_run_2_treatment "mediators" "program"
27 Q0 25466244 194 47.101032 imi_mug_run_2_treatment "various" "erlotinib" "gefitinib"
27 Q0 21406400 195 47.100594 imi_mug_run_2_treatment "genesis" "ras"
27 Q0 26162689 196 47.098675 imi_mug_run_2_treatment "therapeutics" "agent"
27 Q0 28525386 197 47.06184 imi_mug_run_2_treatment "docetaxel"
27 Q0 23723294 198 47.017082 imi_mug_run_2_treatment "adc"
27 Q0 25439691 199 47.00721 imi_mug_run_2_treatment "dacomitinib" "erlotinib" "tyrosine kinase inhibitor"
27 Q0 26622666 200 46.998463 imi_mug_run_2_treatment "gefitinib"
27 Q0 24807155 201 46.979607 imi_mug_run_2_treatment "nnk" "mediated"
27 Q0 26483334 202 46.923096 imi_mug_run_2_treatment "tyrosine kinase inhibitor" "aim"
27 Q0 23401440 203 46.849426 imi_mug_run_2_treatment "monoclonal antibodies" "therapeutics" "basis"
27 Q0 20630828 204 46.765938 imi_mug_run_2_treatment "cetuximab" "gefitinib"
27 Q0 29707333 205 46.75978 imi_mug_run_2_treatment "various"
27 Q0 19884551 206 46.750694 imi_mug_run_2_treatment "gefitinib" "gefitinib 250 mg" "duration"
27 Q0 27555497 207 46.71868 imi_mug_run_2_treatment "plasma"
27 Q0 24135919 208 46.665493 imi_mug_run_2_treatment "dep"
27 Q0 24086949 209 46.591606 imi_mug_run_2_treatment "afatinib" "gefitinib" "erlotinib"
27 Q0 17409862 210 46.534664 imi_mug_run_2_treatment "air"
27 Q0 24748981 211 46.52883 imi_mug_run_2_treatment "various" "level"
27 Q0 24183959 212 46.451363 imi_mug_run_2_treatment "limited use"
27 Q0 27154822 213 46.42907 imi_mug_run_2_treatment "mediated" "mapk inhibitors" "mek inhibitor"
27 Q0 25477232 214 46.421997 imi_mug_run_2_treatment "taxane"
27 Q0 21074889 215 46.400146 imi_mug_run_2_treatment "plasma" "adc" "cisplatin"
27 Q0 22887466 216 46.36396 imi_mug_run_2_treatment "combinations" "pemetrexed" "platinum"
27 Q0 23730419 217 46.343605 imi_mug_run_2_treatment "hts" "radiosensitizer"
27 Q0 21224376 218 46.28114 imi_mug_run_2_treatment "sorafenib"
27 Q0 26739882 219 46.2768 imi_mug_run_2_treatment "ras" "therapeutics"
27 Q0 26775573 220 46.25139 imi_mug_run_2_treatment "crizotinib" "program" "gefitinib"
27 Q0 23496196 221 46.238815 imi_mug_run_2_treatment "gemcitabine" "platinum"
27 Q0 21163115 222 46.216183 imi_mug_run_2_treatment "erlotinib" "erlotinib 150 mg"
27 Q0 23976985 223 46.186516 imi_mug_run_2_treatment "heparin"
27 Q0 21543344 224 46.141716 imi_mug_run_2_treatment "mediated" "interleukin"
27 Q0 17671710 225 46.13272 imi_mug_run_2_treatment "glycine"
27 Q0 29720878 226 46.08606 imi_mug_run_2_treatment "aim" "plasma"
27 Q0 30415007 227 46.034935 imi_mug_run_2_treatment "ras" "abt199" "irinotecan"
27 Q0 23200175 228 46.02339 imi_mug_run_2_treatment "selumetinib" "docetaxel" "mek inhibitor"
27 Q0 24857124 229 46.00867 imi_mug_run_2_treatment "crizotinib" "gefitinib" "erlotinib"
27 Q0 21271222 230 45.999214 imi_mug_run_2_treatment "lapatinib" "gefitinib" "erlotinib"
27 Q0 20677568 231 45.996735 imi_mug_run_2_treatment "iressa" "gefitinib" "erlotinib"
27 Q0 26712101 232 45.98349 imi_mug_run_2_treatment "crizotinib"
27 Q0 26471290 233 45.982533 imi_mug_run_2_treatment "platinum" "bevacizumab"
27 Q0 23625632 234 45.975403 imi_mug_run_2_treatment "adc"
27 Q0 26574479 235 45.960846 imi_mug_run_2_treatment "phenformin" "kinase inhibitor" "mtor inhibitor"
27 Q0 27215271 236 45.94066 imi_mug_run_2_treatment "aim"
27 Q0 27480147 237 45.900978 imi_mug_run_2_treatment "erlotinib" "mk-2206" "sorafenib"
27 Q0 17504988 238 45.894146 imi_mug_run_2_treatment "combinations"
27 Q0 26028111 239 45.878326 imi_mug_run_2_treatment "cetuximab" "pooled"
27 Q0 23787801 240 45.828533 imi_mug_run_2_treatment "platinum" "basis"
27 Q0 28492898 241 45.73811 imi_mug_run_2_treatment "docetaxel" "duration" "selumetinib"
27 Q0 17060486 242 45.72309 imi_mug_run_2_treatment "gefitinib" "erlotinib" "basis"
27 Q0 22154278 243 45.71129 imi_mug_run_2_treatment "ras" "igf-1" "insulin-like growth factor 1"
27 Q0 19707304 244 45.64818 imi_mug_run_2_treatment "erlotinib" "combinations" "drug"
27 Q0 27098511 245 45.620068 imi_mug_run_2_treatment "platinum"
27 Q0 27069126 246 45.59057 imi_mug_run_2_treatment "level"
27 Q0 25936644 247 45.54818 imi_mug_run_2_treatment "adc" "oxygen" "phosphate"
27 Q0 19671843 248 45.50982 imi_mug_run_2_treatment "gefitinib" "erlotinib"
27 Q0 16863509 249 45.50426 imi_mug_run_2_treatment "gefitinib" "erlotinib"
27 Q0 29723602 250 45.503063 imi_mug_run_2_treatment "enzymes"
27 Q0 22115706 251 45.49028 imi_mug_run_2_treatment "shh"
27 Q0 20022659 252 45.468903 imi_mug_run_2_treatment "basis"
27 Q0 23455880 253 45.44601 imi_mug_run_2_treatment "sunitinib" "kinase inhibitor" "tyrosine kinase inhibitor"
27 Q0 25366782 254 45.445892 imi_mug_run_2_treatment "level"
27 Q0 28982179 255 45.44245 imi_mug_run_2_treatment "trametinib" "mek inhibitor" "azd5363"
27 Q0 19738040 256 45.38023 imi_mug_run_2_treatment "aurothiomalate" "mediated" "agent"
27 Q0 20871262 257 45.375084 imi_mug_run_2_treatment "everolimus" "gefitinib" "cisplatin"
27 Q0 24260500 258 45.349606 imi_mug_run_2_treatment "il-6" "interleukin-6" "blockade"
27 Q0 25050641 259 45.324623 imi_mug_run_2_treatment "various" "suppressor"
27 Q0 25339352 260 45.322266 imi_mug_run_2_treatment "cisplatin" "mediated"
27 Q0 25323938 261 45.293335 imi_mug_run_2_treatment "mk-2206" "mediated" "erlotinib"
27 Q0 17596643 262 45.277374 imi_mug_run_2_treatment "aim"
27 Q0 24040454 263 45.206383 imi_mug_run_2_treatment "salt"
27 Q0 21899214 264 45.16987 imi_mug_run_2_treatment "drugs"
27 Q0 26542681 265 45.113647 imi_mug_run_2_treatment "ras" "therapeutics" "program"
27 Q0 26045124 266 45.08969 imi_mug_run_2_treatment "various"
27 Q0 26359571 267 45.0789 imi_mug_run_2_treatment "various"
27 Q0 27519791 268 45.07663 imi_mug_run_2_treatment "plasma"
27 Q0 29858031 269 45.065216 imi_mug_run_2_treatment "liver"
27 Q0 30513023 270 45.046803 imi_mug_run_2_treatment "trametinib" "combinations" "dabrafenib"
27 Q0 26176612 271 44.996323 imi_mug_run_2_treatment "enzymes" "agent" "zstk474"
27 Q0 20186026 272 44.994823 imi_mug_run_2_treatment "drugs" "gefitinib" "erlotinib"
27 Q0 26667343 273 44.984406 imi_mug_run_2_treatment "various"
27 Q0 23453624 274 44.982048 imi_mug_run_2_treatment "adm" "ras"
27 Q0 28342334 275 44.98091 imi_mug_run_2_treatment "crizotinib" "dedicated"
27 Q0 26853422 276 44.976395 imi_mug_run_2_treatment "drug" "thr" "tyr"
27 Q0 17075123 277 44.958576 imi_mug_run_2_treatment "gefitinib" "iressa"
27 Q0 29440633 278 44.93386 imi_mug_run_2_treatment "cisplatin" "plasma"
27 Q0 19451690 279 44.9196 imi_mug_run_2_treatment "drug" "therapeutics" "dasatinib"
27 Q0 28451792 280 44.904613 imi_mug_run_2_treatment "blockade" "pembrolizumab" "mediated"
27 Q0 24648382 281 44.90219 imi_mug_run_2_treatment "crizotinib"
27 Q0 22978775 282 44.84199 imi_mug_run_2_treatment "gefitinib" "iressa"
27 Q0 23599689 283 44.822117 imi_mug_run_2_treatment "vaccines" "vascular endothelial growth factor"
27 Q0 25561229 284 44.78167 imi_mug_run_2_treatment "erlotinib" "lead"
27 Q0 23493311 285 44.771202 imi_mug_run_2_treatment "pemetrexed"
27 Q0 21785539 286 44.764404 imi_mug_run_2_treatment "erlotinib" "tarceva"
27 Q0 26789109 287 44.743164 imi_mug_run_2_treatment "adc" "gefitinib" "erlotinib"
27 Q0 23833300 288 44.730003 imi_mug_run_2_treatment "platinum"
27 Q0 23617344 289 44.70571 imi_mug_run_2_treatment "erlotinib" "drugs" "gefitinib"
27 Q0 19786660 290 44.69905 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
27 Q0 28841389 291 44.69905 imi_mug_run_2_treatment "osimertinib" "plasma" "tyrosine kinase inhibitor"
27 Q0 19165201 292 44.683704 imi_mug_run_2_treatment "mek inhibitor ci-1040" "mtor inhibitor" "suppressor"
27 Q0 22235099 293 44.672626 imi_mug_run_2_treatment "crizotinib"
27 Q0 20008850 294 44.66964 imi_mug_run_2_treatment "gefitinib" "erlotinib" "platinum"
27 Q0 24427341 295 44.641674 imi_mug_run_2_treatment "suppressor"
27 Q0 25342139 296 44.636223 imi_mug_run_2_treatment "byl719" "selumetinib" "drugs"
27 Q0 19179890 297 44.624207 imi_mug_run_2_treatment "erlotinib" "histone deacetylase inhibitor" "drug"
27 Q0 26045865 298 44.58608 imi_mug_run_2_treatment "crizotinib"
27 Q0 24868222 299 44.57414 imi_mug_run_2_treatment "mediated" "level"
27 Q0 27825109 300 44.572094 imi_mug_run_2_treatment "afatinib"
27 Q0 27791985 301 44.57039 imi_mug_run_2_treatment "plasma"
27 Q0 24473991 302 44.469826 imi_mug_run_2_treatment "various" "mediated" "level"
27 Q0 26842935 303 44.43579 imi_mug_run_2_treatment "ras" "mediated" "aurora kinase inhibitor"
27 Q0 26517679 304 44.41991 imi_mug_run_2_treatment "crizotinib" "agent"
27 Q0 22200795 305 44.41303 imi_mug_run_2_treatment "sage"
27 Q0 26316937 306 44.359512 imi_mug_run_2_treatment "various" "platinum"
27 Q0 18549475 307 44.30426 imi_mug_run_2_treatment "adc"
27 Q0 28846180 308 44.300793 imi_mug_run_2_treatment "various" "sorafenib" "drug"
27 Q0 23729361 309 44.287678 imi_mug_run_2_treatment "crizotinib"
27 Q0 28103968 310 44.202477 imi_mug_run_2_treatment "aim"
27 Q0 27338794 311 44.196465 imi_mug_run_2_treatment "trametinib" "combinations" "mek inhibitor"
27 Q0 21414214 312 44.16844 imi_mug_run_2_treatment "gefitinib"
27 Q0 25722381 313 44.16844 imi_mug_run_2_treatment "docetaxel" "trametinib" "platinum"
27 Q0 22022614 314 44.141052 imi_mug_run_2_treatment "urethane" "mediated"
27 Q0 27016208 315 44.118164 imi_mug_run_2_treatment "sunitinib" "cytotoxic"
27 Q0 26520779 316 44.10901 imi_mug_run_2_treatment "various" "drugs" "ras"
27 Q0 27597273 317 44.098236 imi_mug_run_2_treatment "medicine" "plasma"
27 Q0 28414306 318 44.076927 imi_mug_run_2_treatment "rocaglamide" "mediated" "ras"
27 Q0 24577055 319 43.985794 imi_mug_run_2_treatment "interleukin-8" "basis" "level"
27 Q0 20439190 320 43.933105 imi_mug_run_2_treatment "vascular endothelial growth factor"
27 Q0 27449344 321 43.933105 imi_mug_run_2_treatment "basis"
27 Q0 19472407 322 43.930534 imi_mug_run_2_treatment "ly294002" "erlotinib" "pha665752"
27 Q0 23496197 323 43.899483 imi_mug_run_2_treatment "various"
27 Q0 24456475 324 43.892563 imi_mug_run_2_treatment "aim" "crizotinib"
27 Q0 24419423 325 43.892563 imi_mug_run_2_treatment "crizotinib" "tyrosine kinase inhibitor"
27 Q0 25665893 326 43.892563 imi_mug_run_2_treatment "pemetrexed" "bevacizumab" "platinum"
27 Q0 23277484 327 43.892563 imi_mug_run_2_treatment "various" "platinum"
27 Q0 24039832 328 43.892563 imi_mug_run_2_treatment "level" "bevacizumab" "erlotinib"
27 Q0 25054035 329 43.88693 imi_mug_run_2_treatment "drugs"
27 Q0 25806192 330 43.88225 imi_mug_run_2_treatment "cetuximab" "platinum" "favor"
27 Q0 29978950 331 43.88225 imi_mug_run_2_treatment "crizotinib"
27 Q0 17634830 332 43.880875 imi_mug_run_2_treatment "erlotinib" "gefitinib" "lead"
27 Q0 24510990 333 43.852898 imi_mug_run_2_treatment "aim"
27 Q0 25044103 334 43.83571 imi_mug_run_2_treatment "vaccine" "interferon-gamma" "yeast"
27 Q0 21636548 335 43.78421 imi_mug_run_2_treatment "bexarotene" "erlotinib"
27 Q0 28866094 336 43.683624 imi_mug_run_2_treatment "selumetinib" "palbociclib" "ras"
27 Q0 21617709 337 43.67473 imi_mug_run_2_treatment "erlotinib"
27 Q0 24413089 338 43.624924 imi_mug_run_2_treatment "adenosine" "immunosuppressive" "mediated"
27 Q0 18757405 339 43.59169 imi_mug_run_2_treatment "mediated"
27 Q0 30224757 340 43.58983 imi_mug_run_2_treatment "com"
27 Q0 30315932 341 43.57479 imi_mug_run_2_treatment "erlotinib" "gefitinib"
27 Q0 27396427 342 43.560215 imi_mug_run_2_treatment "platinum"
27 Q0 23988622 343 43.559742 imi_mug_run_2_treatment "drugs" "plasma"
27 Q0 24781527 344 43.55333 imi_mug_run_2_treatment "erlotinib" "osi-420"
27 Q0 26852079 345 43.553318 imi_mug_run_2_treatment "afatinib" "crizotinib" "drugs"
27 Q0 27337801 346 43.54084 imi_mug_run_2_treatment "plasma"
27 Q0 30268455 347 43.533936 imi_mug_run_2_treatment "plasma"
27 Q0 26474959 348 43.520172 imi_mug_run_2_treatment "erlotinib" "antiemetic" "lead"
27 Q0 30514331 349 43.511784 imi_mug_run_2_treatment "glucose" "glutamine"
27 Q0 23224737 350 43.487778 imi_mug_run_2_treatment "sorafenib" "platinum" "agent"
27 Q0 22586319 351 43.465122 imi_mug_run_2_treatment "erlotinib" "sorafenib" "bexarotene"
27 Q0 28400509 352 43.43892 imi_mug_run_2_treatment "cerulenin" "glucose"
27 Q0 30072474 353 43.416546 imi_mug_run_2_treatment "crizotinib" "mediated" "pdx"
27 Q0 16140420 354 43.409855 imi_mug_run_2_treatment "gefitinib" "kinase inhibitor"
27 Q0 23943799 355 43.388443 imi_mug_run_2_treatment "level" "mediated"
27 Q0 29036791 356 43.341408 imi_mug_run_2_treatment "adc" "cancer vaccine"
27 Q0 23752194 357 43.335648 imi_mug_run_2_treatment "animals" "ola" "urethane"
27 Q0 26582655 358 43.327915 imi_mug_run_2_treatment "plasma"
27 Q0 28554329 359 43.242012 imi_mug_run_2_treatment "blockade"
27 Q0 24342286 360 43.203506 imi_mug_run_2_treatment "drugs"
27 Q0 26554912 361 43.17407 imi_mug_run_2_treatment "oxygen" "mediated"
27 Q0 24205245 362 43.15308 imi_mug_run_2_treatment "lead"
27 Q0 28152508 363 43.14074 imi_mug_run_2_treatment "various" "drug"
27 Q0 25152277 364 43.13927 imi_mug_run_2_treatment "formalin" "isolate"
27 Q0 28920255 365 43.138073 imi_mug_run_2_treatment "cisplatin" "gemcitabine" "nimotuzumab"
27 Q0 23277327 366 43.124428 imi_mug_run_2_treatment "new drugs" "aim"
27 Q0 28453558 367 43.11657 imi_mug_run_2_treatment "sta-8666" "agent" "drugs"
27 Q0 25342991 368 43.03715 imi_mug_run_2_treatment "agent" "mek inhibitor" "nintedanib"
27 Q0 24922005 369 43.004173 imi_mug_run_2_treatment "siltuximab" "il-6" "erlotinib"
27 Q0 28135039 370 42.952507 imi_mug_run_2_treatment "drugs"
27 Q0 22795503 371 42.951324 imi_mug_run_2_treatment "product"
27 Q0 30366101 372 42.9199 imi_mug_run_2_treatment "various" "ras"
27 Q0 27486332 373 42.8972 imi_mug_run_2_treatment "adjuvant"
27 Q0 30522099 374 42.89058 imi_mug_run_2_treatment "ras" "cisplatin" "drugs"
27 Q0 30297175 375 42.803604 imi_mug_run_2_treatment "amp" "ponatinib" "kinase inhibitor"
27 Q0 27121230 376 42.797935 imi_mug_run_2_treatment "bkm120" "gefitinib" "new drugs"
27 Q0 21839537 377 42.769875 imi_mug_run_2_treatment "basis" "duration" "aim"
27 Q0 20878103 378 42.762817 imi_mug_run_2_treatment "combinations" "erlotinib" "docetaxel"
27 Q0 19884861 379 42.74162 imi_mug_run_2_treatment "plasma" "docetaxel" "erlotinib"
27 Q0 21969500 380 42.72935 imi_mug_run_2_treatment "erlotinib" "tarceva" "platinum"
27 Q0 26709987 381 42.709152 imi_mug_run_2_treatment "carboplatin" "paclitaxel" "reolysin"
27 Q0 23441611 382 42.68373 imi_mug_run_2_treatment "water" "agent"
27 Q0 22659961 383 42.67484 imi_mug_run_2_treatment "epidermal growth factor receptor tyrosine kinase inhibitor"
27 Q0 29183007 384 42.67356 imi_mug_run_2_treatment "suppressor" "edu"
27 Q0 23423768 385 42.638077 imi_mug_run_2_treatment "adc"
27 Q0 25345567 386 42.63512 imi_mug_run_2_treatment "basis"
27 Q0 23224736 387 42.62246 imi_mug_run_2_treatment "mediated"
27 Q0 22588152 388 42.556725 imi_mug_run_2_treatment "adjuvant" "platinum" "pooled"
27 Q0 27080983 389 42.532665 imi_mug_run_2_treatment "aim"
27 Q0 25389455 390 42.490585 imi_mug_run_2_treatment "adc" "level" "com"
27 Q0 28453411 391 42.478085 imi_mug_run_2_treatment "pooled"
27 Q0 20155399 392 42.465736 imi_mug_run_2_treatment "various"
27 Q0 26637667 393 42.449303 imi_mug_run_2_treatment "drugs" "mediated" "mtor inhibitor"
27 Q0 28628916 394 42.415558 imi_mug_run_2_treatment "various" "bi2536"
27 Q0 26861459 395 42.403545 imi_mug_run_2_treatment "suppressor"
27 Q0 27591291 396 42.3847 imi_mug_run_2_treatment "plasma"
27 Q0 28966872 397 42.383526 imi_mug_run_2_treatment "nev"
27 Q0 24552817 398 42.335114 imi_mug_run_2_treatment "various" "mediated"
27 Q0 21187500 399 42.300293 imi_mug_run_2_treatment "aim" "gefitinib" "erlotinib"
27 Q0 22624710 400 42.274292 imi_mug_run_2_treatment "fasudil" "mediated" "bortezomib"
27 Q0 18413809 401 42.255093 imi_mug_run_2_treatment "pha-665752" "ras"
27 Q0 24522420 402 42.248985 imi_mug_run_2_treatment "formalin" "aim"
27 Q0 24694341 403 42.21621 imi_mug_run_2_treatment "ras"
27 Q0 28938614 404 42.19857 imi_mug_run_2_treatment "selumetinib" "phenformin" "mek inhibitor"
27 Q0 21428885 405 42.195786 imi_mug_run_2_treatment "her-2"
27 Q0 30060526 406 42.19252 imi_mug_run_2_treatment "combinations" "adc" "level"
27 Q0 19276157 407 42.182983 imi_mug_run_2_treatment "paclitaxel" "matuzumab" "mediated"
27 Q0 28796802 408 42.16753 imi_mug_run_2_treatment "various" "plasma"
27 Q0 19887599 409 42.15722 imi_mug_run_2_treatment "growth inhibitors"
27 Q0 25902737 410 42.14669 imi_mug_run_2_treatment "cetuximab" "gefitinib" "erlotinib"
27 Q0 26432508 411 42.105446 imi_mug_run_2_treatment "juniper" "erlotinib" "platinum"
27 Q0 23103072 412 42.100502 imi_mug_run_2_treatment "pemetrexed"
27 Q0 28670367 413 42.05139 imi_mug_run_2_treatment "various" "agar" "product"
27 Q0 30171261 414 42.038956 imi_mug_run_2_treatment "drug combinations" "drugs"
27 Q0 20009909 415 42.015484 imi_mug_run_2_treatment "pf02341066"
27 Q0 21745016 416 42.011833 imi_mug_run_2_treatment "various"
27 Q0 27593936 417 41.950123 imi_mug_run_2_treatment "mediated"
27 Q0 23842453 418 41.93553 imi_mug_run_2_treatment "gefitinib"
27 Q0 27441499 419 41.93067 imi_mug_run_2_treatment "tor" "mek inhibitor" "trametinib"
27 Q0 22511580 420 41.924397 imi_mug_run_2_treatment "mediated"
27 Q0 23769349 421 41.916607 imi_mug_run_2_treatment "bevacizumab" "carboplatin" "paclitaxel"
27 Q0 16203769 422 41.91055 imi_mug_run_2_treatment "gefitinib"
27 Q0 22267755 423 41.909283 imi_mug_run_2_treatment "adc"
27 Q0 28838394 424 41.892517 imi_mug_run_2_treatment "ci 4" "gefitinib" "egfr tyrosine kinase inhibitor"
27 Q0 26391251 425 41.882366 imi_mug_run_2_treatment "adc" "basis"
27 Q0 29247826 426 41.878864 imi_mug_run_2_treatment "cytostatic" "anti-inflammatory" "antioxidant"
27 Q0 21768463 427 41.852127 imi_mug_run_2_treatment "erlotinib" "tivantinib" "arq 197"
27 Q0 21187472 428 41.794144 imi_mug_run_2_treatment "pulmonary surfactant" "surfactant" "cytotoxic"
27 Q0 23564819 429 41.78161 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
27 Q0 26273395 430 41.751896 imi_mug_run_2_treatment "aim"
27 Q0 30021885 431 41.691944 imi_mug_run_2_treatment "kinase inhibitor" "mek inhibitor" "drug combination"
27 Q0 19667264 432 41.62862 imi_mug_run_2_treatment "platinum" "egfr tyrosine kinase inhibitors" "basis"
27 Q0 22528563 433 41.581844 imi_mug_run_2_treatment "aim"
27 Q0 26353932 434 41.566658 imi_mug_run_2_treatment "cisplatin" "drug" "basis"
27 Q0 26743856 435 41.542404 imi_mug_run_2_treatment "drug" "sorafenib"
27 Q0 16043828 436 41.51615 imi_mug_run_2_treatment "erlotinib" "carboplatin" "paclitaxel"
27 Q0 21597390 437 41.46819 imi_mug_run_2_treatment "gefitinib" "histone deacetylase inhibitor" "erlotinib"
27 Q0 27530552 438 41.43003 imi_mug_run_2_treatment "drugs" "gelatin" "serine"
27 Q0 19057271 439 41.387417 imi_mug_run_2_treatment "erlotinib"
27 Q0 28625654 440 41.336357 imi_mug_run_2_treatment "adc"
27 Q0 23515407 441 41.33202 imi_mug_run_2_treatment "trametinib" "selumetinib"
27 Q0 18927287 442 41.330517 imi_mug_run_2_treatment "carboplatin" "rosiglitazone" "drug"
27 Q0 25499080 443 41.32508 imi_mug_run_2_treatment "cisplatin" "drugs" "taxol"
27 Q0 28647837 444 41.319782 imi_mug_run_2_treatment "aim"
27 Q0 24213573 445 41.262276 imi_mug_run_2_treatment "ras" "mediated"
27 Q0 28765579 446 41.230038 imi_mug_run_2_treatment "ras" "mk-2206"
27 Q0 27835869 447 41.16977 imi_mug_run_2_treatment "various" "mk-8628" "bet inhibitor"
27 Q0 26520186 448 41.14957 imi_mug_run_2_treatment "ras" "adc"
27 Q0 25982011 449 41.14724 imi_mug_run_2_treatment "adc" "pas"
27 Q0 23553849 450 41.13721 imi_mug_run_2_treatment "ganetespib" "crizotinib"
27 Q0 30334450 451 41.111847 imi_mug_run_2_treatment "adca"
27 Q0 26134224 452 41.078552 imi_mug_run_2_treatment "vascular endothelial growth factor" "adjuvant"
27 Q0 29631966 453 41.078552 imi_mug_run_2_treatment "program" "pembrolizumab"
27 Q0 17192902 454 41.07666 imi_mug_run_2_treatment "drug" "gefitinib"
27 Q0 22016476 455 41.06855 imi_mug_run_2_treatment "her-2" "drugs" "gefitinib"
27 Q0 20388064 456 41.061077 imi_mug_run_2_treatment "gefitinib" "erlotinib" "drugs"
27 Q0 29112949 457 41.042633 imi_mug_run_2_treatment "aim"
27 Q0 28957417 458 41.028584 imi_mug_run_2_treatment "mek inhibitor" "trametinib"
27 Q0 26161928 459 40.982513 imi_mug_run_2_treatment "regorafenib" "aim"
27 Q0 24466154 460 40.91383 imi_mug_run_2_treatment "level"
27 Q0 25286762 461 40.903885 imi_mug_run_2_treatment "lipid emulsion"
27 Q0 20660313 462 40.86754 imi_mug_run_2_treatment "oxygen"
27 Q0 21904575 463 40.86519 imi_mug_run_2_treatment "gefitinib" "drug" "crizotinib"
27 Q0 29129434 464 40.850388 imi_mug_run_2_treatment "aim"
27 Q0 30317654 465 40.832977 imi_mug_run_2_treatment "flavopiridol" "flavopiridol's" "cytotoxic"
27 Q0 17607370 466 40.831707 imi_mug_run_2_treatment "ras"
27 Q0 22052229 467 40.822155 imi_mug_run_2_treatment "tyrosine kinase inhibitor"
27 Q0 18467317 468 40.80754 imi_mug_run_2_treatment "gefitinib" "egfr tyrosine kinase inhibitors"
27 Q0 23991695 469 40.78022 imi_mug_run_2_treatment "tyrosine" "vandetanib" "xl184"
27 Q0 26581482 470 40.724392 imi_mug_run_2_treatment "epidermal growth factor" "plasma"
27 Q0 22249257 471 40.692024 imi_mug_run_2_treatment "mediated"
27 Q0 25492085 472 40.679535 imi_mug_run_2_treatment "level" "various" "egfr inhibitor"
27 Q0 23959381 473 40.625557 imi_mug_run_2_treatment "glutamine"
27 Q0 29249325 474 40.596447 imi_mug_run_2_treatment "osimertinib" "plasma"
27 Q0 26967383 475 40.59092 imi_mug_run_2_treatment "cisplatin" "lead"
27 Q0 21994468 476 40.578766 imi_mug_run_2_treatment "suppressor"
27 Q0 26331813 477 40.57493 imi_mug_run_2_treatment "adc" "others"
27 Q0 25008024 478 40.539513 imi_mug_run_2_treatment "gefitinib" "drug"
27 Q0 27346245 479 40.531082 imi_mug_run_2_treatment "formalin"
27 Q0 22969966 480 40.506653 imi_mug_run_2_treatment "tyrosine"
27 Q0 25411474 481 40.49861 imi_mug_run_2_treatment "bisphosphonates" "bisphosphonate" "drug combination"
27 Q0 26597303 482 40.49214 imi_mug_run_2_treatment "drugs" "mediated" "bi2536"
27 Q0 28443025 483 40.46849 imi_mug_run_2_treatment "honokiol" "polyphenol"
27 Q0 25199829 484 40.445816 imi_mug_run_2_treatment "ras" "selumetinib" "drugs"
27 Q0 24922006 485 40.44231 imi_mug_run_2_treatment "radiation sensitizers" "drug" "drugs"
27 Q0 28554746 486 40.420338 imi_mug_run_2_treatment "prompt"
27 Q0 28368426 487 40.390057 imi_mug_run_2_treatment "drug" "topoisomerase inhibitors" "ras"
27 Q0 24503901 488 40.36948 imi_mug_run_2_treatment "adc" "others"
27 Q0 26826182 489 40.355453 imi_mug_run_2_treatment "collagen" "proteasome inhibitor"
27 Q0 29261000 490 40.35049 imi_mug_run_2_treatment "apatinib" "docetaxel" "kinase inhibitor"
27 Q0 24955217 491 40.348442 imi_mug_run_2_treatment "ras" "mediated" "others"
27 Q0 19671679 492 40.2775 imi_mug_run_2_treatment "level" "others"
27 Q0 25842168 493 40.270393 imi_mug_run_2_treatment "aim"
27 Q0 29191600 494 40.25547 imi_mug_run_2_treatment "mitogen"
27 Q0 28894382 495 40.244034 imi_mug_run_2_treatment "apatinib"
27 Q0 29856861 496 40.224804 imi_mug_run_2_treatment "duration"
27 Q0 22485175 497 40.22372 imi_mug_run_2_treatment "iodine" "agent"
27 Q0 20505728 498 40.208176 imi_mug_run_2_treatment "others"
27 Q0 22458769 499 40.1894 imi_mug_run_2_treatment "formalin" "egfr inhibitor" "aim"
27 Q0 25808870 500 40.170113 imi_mug_run_2_treatment "mediated" "antineoplastic"
27 Q0 21943394 501 40.158684 imi_mug_run_2_treatment "anti-egfr monoclonal antibody" "cetuximab" "gefitinib"
27 Q0 20702788 502 40.154068 imi_mug_run_2_treatment "bevacizumab" "erlotinib" "glucose"
27 Q0 17325698 503 40.146965 imi_mug_run_2_treatment "various" "gefitinib" "erlotinib"
27 Q0 23538866 504 40.139416 imi_mug_run_2_treatment "platinum"
27 Q0 27760592 505 40.122395 imi_mug_run_2_treatment "drugs" "aim"
27 Q0 26065573 506 40.098907 imi_mug_run_2_treatment "dsb" "beam"
27 Q0 30186180 507 40.038807 imi_mug_run_2_treatment "alkaloid" "ras" "cytotoxic"
27 Q0 24648348 508 40.033104 imi_mug_run_2_treatment "dsb" "erlotinib" "lysine"
27 Q0 23682782 509 40.005966 imi_mug_run_2_treatment "gse" "ras" "grape seed extract"
27 Q0 22433711 510 39.969246 imi_mug_run_2_treatment "paclitaxel" "sorafenib" "drugs"
27 Q0 28538732 511 39.95542 imi_mug_run_2_treatment "ammonia" "bicarbonate" "phosphate"
27 Q0 25853628 512 39.885857 imi_mug_run_2_treatment "level"
27 Q0 26158441 513 39.88133 imi_mug_run_2_treatment "rose"
27 Q0 22753918 514 39.78698 imi_mug_run_2_treatment "dacomitinib" "erlotinib" "egfr inhibitor"
27 Q0 19841986 515 39.77794 imi_mug_run_2_treatment "aim"
27 Q0 22444159 516 39.75951 imi_mug_run_2_treatment "carboplatin" "agent" "plasma"
27 Q0 17093937 517 39.730877 imi_mug_run_2_treatment "gefitinib" "erlotinib" "drugs"
27 Q0 26881969 518 39.72533 imi_mug_run_2_treatment "enzymes" "ras"
27 Q0 26351321 519 39.7086 imi_mug_run_2_treatment "pha-665752" "elacridar" "level"
27 Q0 27460205 520 39.70337 imi_mug_run_2_treatment "crizotinib"
27 Q0 25118293 521 39.678093 imi_mug_run_2_treatment "silver"
27 Q0 27218826 522 39.64949 imi_mug_run_2_treatment "igf2"
27 Q0 22992338 523 39.63745 imi_mug_run_2_treatment "ras" "gefitinib" "erlotinib"
27 Q0 24743704 524 39.63125 imi_mug_run_2_treatment "drug" "drugs"
27 Q0 29088764 525 39.573624 imi_mug_run_2_treatment "agent" "epidermal growth factor" "il-6"
27 Q0 23302304 526 39.560852 imi_mug_run_2_treatment "scorpion"
27 Q0 25676841 527 39.55072 imi_mug_run_2_treatment "aim"
27 Q0 25588859 528 39.512894 imi_mug_run_2_treatment "crizotinib"
27 Q0 21258250 529 39.493073 imi_mug_run_2_treatment "phosphate" "aim"
27 Q0 26711930 530 39.385468 imi_mug_run_2_treatment "program"
27 Q0 21266922 531 39.30545 imi_mug_run_2_treatment "various" "adc" "aim"
27 Q0 18619559 532 39.219078 imi_mug_run_2_treatment "therapeutic agents"
27 Q0 20086114 533 39.19993 imi_mug_run_2_treatment "cetuximab" "bevacizumab" "gefitinib"
27 Q0 19162366 534 39.18023 imi_mug_run_2_treatment "adc"
27 Q0 29316436 535 39.147556 imi_mug_run_2_treatment "l-asparaginase"
27 Q0 22828149 536 39.142586 imi_mug_run_2_treatment "ras" "fluorouracil"
27 Q0 27007084 537 39.106453 imi_mug_run_2_treatment "adc"
27 Q0 22740923 538 39.105587 imi_mug_run_2_treatment "various" "drug" "basis"
27 Q0 17317677 539 39.089745 imi_mug_run_2_treatment "gefitinib"
27 Q0 26934441 540 39.089745 imi_mug_run_2_treatment "various"
27 Q0 24416147 541 39.058662 imi_mug_run_2_treatment "il-6"
27 Q0 25702091 542 39.0505 imi_mug_run_2_treatment "statin" "statins" "gefitinib"
27 Q0 25267307 543 39.04874 imi_mug_run_2_treatment "various"
27 Q0 27810244 544 38.973213 imi_mug_run_2_treatment "indole"
27 Q0 17020982 545 38.96954 imi_mug_run_2_treatment "gefitinib" "drug" "duration"
27 Q0 27392325 546 38.948093 imi_mug_run_2_treatment "combinations" "mek inhibitor" "mediated"
27 Q0 28967920 547 38.93569 imi_mug_run_2_treatment "antioxidant" "lead"
27 Q0 21239505 548 38.91465 imi_mug_run_2_treatment "liver"
27 Q0 23817662 549 38.836662 imi_mug_run_2_treatment "erlotinib" "gefitinib" "aim"
27 Q0 28099846 550 38.810837 imi_mug_run_2_treatment "asc" "immunosuppressive"
27 Q0 20358631 551 38.795914 imi_mug_run_2_treatment "jak2 inhibitor" "egfr inhibitor" "mek inhibitor"
27 Q0 29764596 552 38.794846 imi_mug_run_2_treatment "anlotinib"
27 Q0 28860576 553 38.766335 imi_mug_run_2_treatment "ors" "pooled"
27 Q0 27245608 554 38.749763 imi_mug_run_2_treatment "drug combinations"
27 Q0 22399565 555 38.73283 imi_mug_run_2_treatment "mediated"
27 Q0 21782507 556 38.686096 imi_mug_run_2_treatment "cetuximab" "cisplatin" "vinorelbine"
27 Q0 30087028 557 38.679806 imi_mug_run_2_treatment "trametinib" "momelotinib" "platinum"
27 Q0 26627242 558 38.65915 imi_mug_run_2_treatment "aim"
27 Q0 26802155 559 38.65887 imi_mug_run_2_treatment "selumetinib" "erlotinib" "kinase inhibitor"
27 Q0 26666244 560 38.656456 imi_mug_run_2_treatment "cetuximab" "selumetinib" "ras"
27 Q0 26740498 561 38.595284 imi_mug_run_2_treatment "duration" "platinum"
27 Q0 23264846 562 38.54442 imi_mug_run_2_treatment "panitumumab" "cetuximab"
27 Q0 25281617 563 38.511017 imi_mug_run_2_treatment "various" "cddp"
27 Q0 27298405 564 38.506973 imi_mug_run_2_treatment "avid"
27 Q0 24728492 565 38.479237 imi_mug_run_2_treatment "gefitinib" "docetaxel" "cytotoxic"
27 Q0 19358724 566 38.444916 imi_mug_run_2_treatment "drugs"
27 Q0 30145409 567 38.43486 imi_mug_run_2_treatment "gold"
27 Q0 21042276 568 38.41486 imi_mug_run_2_treatment "interferon" "mediated"
27 Q0 24489653 569 38.411247 imi_mug_run_2_treatment "ras"
27 Q0 17449174 570 38.290855 imi_mug_run_2_treatment "plasma"
27 Q0 30391211 571 38.279663 imi_mug_run_2_treatment "various"
27 Q0 20395213 572 38.275146 imi_mug_run_2_treatment "erlotinib" "sorafenib" "kinase inhibitor"
27 Q0 26870292 573 38.172447 imi_mug_run_2_treatment "drugs"
27 Q0 21807965 574 38.140087 imi_mug_run_2_treatment "level"
27 Q0 26884725 575 38.131744 imi_mug_run_2_treatment "crystal violet"
27 Q0 23714228 576 38.11623 imi_mug_run_2_treatment "agent" "egfr tyrosine kinase inhibitor"
27 Q0 20108024 577 38.09868 imi_mug_run_2_treatment "gefitinib" "erlotinib" "egfr tyrosine kinase inhibitors"
27 Q0 23565506 578 38.089886 imi_mug_run_2_treatment "bromodeoxyuridine"
27 Q0 24726368 579 38.088753 imi_mug_run_2_treatment "oxygen" "liver"
27 Q0 24138715 580 38.05094 imi_mug_run_2_treatment "various" "ras" "aminoacid"
27 Q0 24346090 581 38.04193 imi_mug_run_2_treatment "level"
27 Q0 23475959 582 38.019245 imi_mug_run_2_treatment "drug" "cancer drug" "ras"
27 Q0 25439692 583 37.997005 imi_mug_run_2_treatment "kinase inhibitor" "dacomitinib" "gefitinib"
27 Q0 23285300 584 37.954308 imi_mug_run_2_treatment "suppressor"
27 Q0 23362162 585 37.91736 imi_mug_run_2_treatment "various" "tyrosine kinase inhibitor" "aim"
27 Q0 25514114 586 37.91156 imi_mug_run_2_treatment "gefitinib" "afatinib" "her-2"
27 Q0 25129367 587 37.884617 imi_mug_run_2_treatment "erlotinib" "kinase inhibitor" "tarceva"
27 Q0 27477280 588 37.883766 imi_mug_run_2_treatment "mediated"
27 Q0 22618808 589 37.872833 imi_mug_run_2_treatment "nitric oxide"
27 Q0 21227397 590 37.87233 imi_mug_run_2_treatment "drugs"
27 Q0 26468985 591 37.85737 imi_mug_run_2_treatment "ras" "tyrosine"
27 Q0 21273183 592 37.85645 imi_mug_run_2_treatment "docetaxel" "erlotinib" "erlotinib 150 mg"
27 Q0 30472330 593 37.826378 imi_mug_run_2_treatment "formaldehyde"
27 Q0 26744530 594 37.821236 imi_mug_run_2_treatment "cytokines" "basis"
27 Q0 27145273 595 37.80169 imi_mug_run_2_treatment "tyrosine kinase inhibitor"
27 Q0 20093389 596 37.798355 imi_mug_run_2_treatment "gefitinib"
27 Q0 27040858 597 37.798183 imi_mug_run_2_treatment "crizotinib"
27 Q0 22729835 598 37.780315 imi_mug_run_2_treatment "tma" "aim"
27 Q0 24982195 599 37.77189 imi_mug_run_2_treatment "brain-derived neurotrophic factor"
27 Q0 27506872 600 37.757202 imi_mug_run_2_treatment "various" "ras" "drug"
27 Q0 26084335 601 37.75686 imi_mug_run_2_treatment "cancer drug" "pdx"
27 Q0 23204236 602 37.753242 imi_mug_run_2_treatment "ras"
27 Q0 18635814 603 37.74654 imi_mug_run_2_treatment "urethane" "ras"
27 Q0 21874163 604 37.7296 imi_mug_run_2_treatment "bortezomib" "drug"
27 Q0 29057096 605 37.723267 imi_mug_run_2_treatment "matrix" "mediated" "integrator"
27 Q0 20559151 606 37.7126 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitor"
27 Q0 26842788 607 37.682785 imi_mug_run_2_treatment "platinum" "aim"
27 Q0 26716514 608 37.663837 imi_mug_run_2_treatment "cisplatin" "erlotinib" "platinum"
27 Q0 28898697 609 37.659164 imi_mug_run_2_treatment "ras"
27 Q0 17384680 610 37.65469 imi_mug_run_2_treatment "adc"
27 Q0 19680292 611 37.644848 imi_mug_run_2_treatment "cytotoxic" "gefitinib" "erlotinib"
27 Q0 25444907 612 37.637802 imi_mug_run_2_treatment "pdx"
27 Q0 26918901 613 37.60922 imi_mug_run_2_treatment "plasma" "edta"
27 Q0 29507676 614 37.605087 imi_mug_run_2_treatment "dmf" "cytotoxic" "dimethyl fumarate"
27 Q0 29454261 615 37.56257 imi_mug_run_2_treatment "lead"
27 Q0 29526175 616 37.545425 imi_mug_run_2_treatment "aim"
27 Q0 25628462 617 37.54412 imi_mug_run_2_treatment "various" "ras"
27 Q0 26363011 618 37.536568 imi_mug_run_2_treatment "adc"
27 Q0 24445999 619 37.52234 imi_mug_run_2_treatment "suppressor"
27 Q0 26860843 620 37.519073 imi_mug_run_2_treatment "various" "ras" "nervous system"
27 Q0 18090579 621 37.49328 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
27 Q0 25131476 622 37.483902 imi_mug_run_2_treatment "eosin" "color"
27 Q0 27312177 623 37.452568 imi_mug_run_2_treatment "lysine" "program"
27 Q0 27215453 624 37.401707 imi_mug_run_2_treatment "new drugs" "aim"
27 Q0 23026641 625 37.37902 imi_mug_run_2_treatment "lead" "hot spot"
27 Q0 24828667 626 37.365646 imi_mug_run_2_treatment "erlotinib"
27 Q0 27133746 627 37.356186 imi_mug_run_2_treatment "drug"
27 Q0 28762849 628 37.32652 imi_mug_run_2_treatment "panitumumab" "carboplatin" "pemetrexed"
27 Q0 25234467 629 37.313206 imi_mug_run_2_treatment "cisplatin" "lead"
27 Q0 24642870 630 37.30699 imi_mug_run_2_treatment "ras" "anti-egfr monoclonal antibody" "phosphate"
27 Q0 18418066 631 37.303204 imi_mug_run_2_treatment "ras"
27 Q0 24884535 632 37.249626 imi_mug_run_2_treatment "cetuximab" "adjuvant" "drugs"
27 Q0 25535726 633 37.2427 imi_mug_run_2_treatment "liver"
27 Q0 20978195 634 37.241062 imi_mug_run_2_treatment "adjuvant" "cisplatin"
27 Q0 25364578 635 37.209133 imi_mug_run_2_treatment "epidermal growth factor"
27 Q0 27550941 636 37.19508 imi_mug_run_2_treatment "dinaciclib" "cdk inhibitor" "mitotic inhibitor"
27 Q0 19597509 637 37.159275 imi_mug_run_2_treatment "adjuvant" "ras"
27 Q0 26622749 638 37.154324 imi_mug_run_2_treatment "combinations"
27 Q0 25615947 639 37.153038 imi_mug_run_2_treatment "drug" "selumetinib" "trametinib"
27 Q0 20624322 640 37.098633 imi_mug_run_2_treatment "lead"
27 Q0 23661337 641 37.09413 imi_mug_run_2_treatment "erlotinib" "pemetrexed"
27 Q0 25061320 642 37.073486 imi_mug_run_2_treatment "platinum" "vinorelbine" "pemetrexed"
27 Q0 23409011 643 37.073486 imi_mug_run_2_treatment "erlotinib"
27 Q0 30225784 644 37.073486 imi_mug_run_2_treatment "cdx" "pembrolizumab"
27 Q0 24317514 645 37.019695 imi_mug_run_2_treatment "uridine" "mediated"
27 Q0 29437753 646 37.016396 imi_mug_run_2_treatment "plasma" "level" "hot spot"
27 Q0 28415793 647 37.014847 imi_mug_run_2_treatment "therapeutics"
27 Q0 26833129 648 37.014786 imi_mug_run_2_treatment "bet bromodomain inhibitor"
27 Q0 23153658 649 37.00054 imi_mug_run_2_treatment "platinum" "aim"
27 Q0 17549418 650 36.996735 imi_mug_run_2_treatment "ras"
27 Q0 30444572 651 36.99345 imi_mug_run_2_treatment "ptx" "drug" "itraconazole"
27 Q0 25973127 652 36.895508 imi_mug_run_2_treatment "crizotinib"
27 Q0 20034872 653 36.891384 imi_mug_run_2_treatment "ras"
27 Q0 21102258 654 36.88597 imi_mug_run_2_treatment "various" "drugs" "others"
27 Q0 30032849 655 36.88259 imi_mug_run_2_treatment "plasma"
27 Q0 24954536 656 36.869587 imi_mug_run_2_treatment "ras" "program"
27 Q0 27055085 657 36.863743 imi_mug_run_2_treatment "plasma" "kinase inhibitor"
27 Q0 29268752 658 36.83521 imi_mug_run_2_treatment "various"
27 Q0 24368337 659 36.792732 imi_mug_run_2_treatment "ras"
27 Q0 26729443 660 36.781498 imi_mug_run_2_treatment "crizotinib"
27 Q0 19589613 661 36.77485 imi_mug_run_2_treatment "aim"
27 Q0 25694286 662 36.75694 imi_mug_run_2_treatment "anti-epidermal growth factor receptor monoclonal antibody" "aim"
27 Q0 29781848 663 36.709023 imi_mug_run_2_treatment "lead" "aim"
27 Q0 23566315 664 36.684185 imi_mug_run_2_treatment "various" "therapeutics"
27 Q0 27609895 665 36.64799 imi_mug_run_2_treatment "enzymes"
27 Q0 22833420 666 36.612648 imi_mug_run_2_treatment "drugs"
27 Q0 21498705 667 36.60324 imi_mug_run_2_treatment "cisplatin" "pi3k/mtor inhibitor bez235" "mtor inhibitor"
27 Q0 29346604 668 36.584057 imi_mug_run_2_treatment "plasma"
27 Q0 20686428 669 36.57258 imi_mug_run_2_treatment "gefitinib" "gefitinib 250 mg" "carboplatin"
27 Q0 30113497 670 36.565617 imi_mug_run_2_treatment "nivolumab" "pembrolizumab" "atezolizumab"
27 Q0 29045535 671 36.56483 imi_mug_run_2_treatment "docetaxel" "selumetinib" "pbo"
27 Q0 22189714 672 36.54783 imi_mug_run_2_treatment "various"
27 Q0 20020061 673 36.51397 imi_mug_run_2_treatment "adjuvant" "fluorouracil" "level"
27 Q0 26959608 674 36.46267 imi_mug_run_2_treatment "ras" "cancer drug" "azd6244"
27 Q0 29163686 675 36.449837 imi_mug_run_2_treatment "platinum"
27 Q0 25819217 676 36.43546 imi_mug_run_2_treatment "crizotinib" "new drugs" "ceritinib"
27 Q0 29199670 677 36.432293 imi_mug_run_2_treatment "duration"
27 Q0 22189054 678 36.430695 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors" "monoclonal antibodies"
27 Q0 24316734 679 36.42691 imi_mug_run_2_treatment "plasma" "level"
27 Q0 28007627 680 36.380566 imi_mug_run_2_treatment "crizotinib" "osimertinib" "erlotinib"
27 Q0 16051643 681 36.339577 imi_mug_run_2_treatment "ras"
27 Q0 28460468 682 36.319923 imi_mug_run_2_treatment "tumor infiltrating lymphocytes" "color"
27 Q0 27936345 683 36.252922 imi_mug_run_2_treatment "mediated"
27 Q0 28961369 684 36.247986 imi_mug_run_2_treatment "ras" "mediated" "level"
27 Q0 28932563 685 36.244408 imi_mug_run_2_treatment "blockade"
27 Q0 22363436 686 36.211666 imi_mug_run_2_treatment "inositol" "tma"
27 Q0 19680293 687 36.20889 imi_mug_run_2_treatment "various" "gefitinib" "erlotinib"
27 Q0 18632602 688 36.19265 imi_mug_run_2_treatment "azd6244" "lysine" "mek inhibitor"
27 Q0 22129856 689 36.181847 imi_mug_run_2_treatment "tma"
27 Q0 22247021 690 36.16652 imi_mug_run_2_treatment "lead"
27 Q0 20603437 691 36.150673 imi_mug_run_2_treatment "cetuximab" "monoclonal antibodies"
27 Q0 25541062 692 36.139915 imi_mug_run_2_treatment "cisplatin" "mediated" "cytotoxic"
27 Q0 25122437 693 36.133434 imi_mug_run_2_treatment "bevacizumab" "erlotinib"
27 Q0 26920031 694 36.10707 imi_mug_run_2_treatment "allitinib" "drug" "agent"
27 Q0 24068620 695 36.088463 imi_mug_run_2_treatment "lapatinib" "azd6244" "mediated"
27 Q0 26423694 696 36.065422 imi_mug_run_2_treatment "ras" "directed"
27 Q0 24193009 697 36.06113 imi_mug_run_2_treatment "ras" "tk inhibitors" "lead"
27 Q0 22319590 698 36.04219 imi_mug_run_2_treatment "various" "agar" "drugs"
27 Q0 25470237 699 36.030773 imi_mug_run_2_treatment "pdx" "therapeutics"
27 Q0 29343688 700 35.976456 imi_mug_run_2_treatment "sorafenib" "drug"
27 Q0 16969076 701 35.917664 imi_mug_run_2_treatment "ras"
27 Q0 18418018 702 35.900116 imi_mug_run_2_treatment "gefitinib" "platinum" "egfr tyrosine kinase inhibitors"
27 Q0 25961464 703 35.8899 imi_mug_run_2_treatment "estrogen"
27 Q0 26068980 704 35.87591 imi_mug_run_2_treatment "aim"
27 Q0 19681124 705 35.854694 imi_mug_run_2_treatment "drugs"
27 Q0 30487290 706 35.844696 imi_mug_run_2_treatment "nimesulide" "bortezomib" "program"
27 Q0 21436633 707 35.835426 imi_mug_run_2_treatment "ras" "egfr tyrosine kinase inhibitors"
27 Q0 26124082 708 35.796707 imi_mug_run_2_treatment "level"
27 Q0 23686769 709 35.79622 imi_mug_run_2_treatment "vorinostat" "histone deacetylase inhibitor"
27 Q0 26316738 710 35.744896 imi_mug_run_2_treatment "level"
27 Q0 28894396 711 35.67151 imi_mug_run_2_treatment "program" "level"
27 Q0 21833472 712 35.65859 imi_mug_run_2_treatment "interferon" "cetuximab" "cetuximab's"
27 Q0 22045191 713 35.658195 imi_mug_run_2_treatment "erlotinib" "egfr inhibitor" "program"
27 Q0 26714745 714 35.637756 imi_mug_run_2_treatment "ras" "oxygen"
27 Q0 30332632 715 35.578392 imi_mug_run_2_treatment "mediated" "basis" "shape"
27 Q0 27846317 716 35.553616 imi_mug_run_2_treatment "acetate" "dimethyl sulfoxide" "myristate"
27 Q0 26418750 717 35.552994 imi_mug_run_2_treatment "ras" "yeast"
27 Q0 29844447 718 35.544216 imi_mug_run_2_treatment "homoharringtonine" "translation inhibitor" "narciclasine"
27 Q0 20482381 719 35.528652 imi_mug_run_2_treatment "enzyme digestion" "product" "monoclonal antibodies"
27 Q0 29997286 720 35.52629 imi_mug_run_2_treatment "immunosuppressive"
27 Q0 18030469 721 35.498394 imi_mug_run_2_treatment "plasma" "erlotinib" "urethane"
27 Q0 27379696 722 35.48181 imi_mug_run_2_treatment "drugs"
27 Q0 24841832 723 35.469173 imi_mug_run_2_treatment "erlotinib" "drugs" "angiogenesis inhibitor"
27 Q0 24479809 724 35.459846 imi_mug_run_2_treatment "drugs" "serine" "ras"
27 Q0 28472537 725 35.45248 imi_mug_run_2_treatment "erlotinib" "erlotinib 150 mg" "amg 102"
27 Q0 19648963 726 35.443367 imi_mug_run_2_treatment "urethane" "kinase inhibitor" "mediated"
27 Q0 30514931 727 35.43598 imi_mug_run_2_treatment "blockade"
27 Q0 29925636 728 35.433437 imi_mug_run_2_treatment "ras"
27 Q0 23604119 729 35.418056 imi_mug_run_2_treatment "mediated" "suppressor" "urethane"
27 Q0 23551582 730 35.39105 imi_mug_run_2_treatment "crizotinib"
27 Q0 21427705 731 35.387077 imi_mug_run_2_treatment "lipid emulsion" "therapeutics"
27 Q0 23475955 732 35.291313 imi_mug_run_2_treatment "navitoclax" "agent" "abt-263"
27 Q0 23857398 733 35.26252 imi_mug_run_2_treatment "agent" "adjuvant" "bevacizumab"
27 Q0 21325979 734 35.23639 imi_mug_run_2_treatment "ras" "antiangiogenic"
27 Q0 17228019 735 35.231716 imi_mug_run_2_treatment "erlotinib" "erlotinib 150 mg"
27 Q0 27062566 736 35.226532 imi_mug_run_2_treatment "liver"
27 Q0 30068711 737 35.175777 imi_mug_run_2_treatment "trametinib" "mek inhibitor"
27 Q0 29555200 738 35.161636 imi_mug_run_2_treatment "oestrogen"
27 Q0 24947927 739 35.15853 imi_mug_run_2_treatment "ras" "ro4987655" "agent"
27 Q0 27393499 740 35.151978 imi_mug_run_2_treatment "erlotinib" "gemcitabine" "platinum"
27 Q0 21655907 741 35.14196 imi_mug_run_2_treatment "drugs"
27 Q0 27876675 742 35.096684 imi_mug_run_2_treatment "pemetrexed" "docetaxel" "combinations"
27 Q0 20101149 743 35.095932 imi_mug_run_2_treatment "bht" "new drugs"
27 Q0 25900221 744 35.0823 imi_mug_run_2_treatment "ptc"
27 Q0 24844134 745 35.07545 imi_mug_run_2_treatment "kinases inhibitor" "monoclonal antibodies"
27 Q0 30042874 746 35.074593 imi_mug_run_2_treatment "various" "vaccines" "glycine"
27 Q0 26837474 747 35.065468 imi_mug_run_2_treatment "docetaxel" "selumetinib" "ras"
27 Q0 27795727 748 35.062717 imi_mug_run_2_treatment "gat" "level" "aim"
27 Q0 26620497 749 35.039253 imi_mug_run_2_treatment "crizotinib" "afatinib" "drug"
27 Q0 23771539 750 35.024582 imi_mug_run_2_treatment "ppi" "aim"
27 Q0 27283993 751 35.003746 imi_mug_run_2_treatment "rociletinib" "egfr inhibitor" "crizotinib"
27 Q0 29659668 752 34.976562 imi_mug_run_2_treatment "alcohol"
27 Q0 21257719 753 34.976128 imi_mug_run_2_treatment "product"
27 Q0 26094080 754 34.95131 imi_mug_run_2_treatment "cisplatin" "pemetrexed" "panitumumab"
27 Q0 19608870 755 34.931595 imi_mug_run_2_treatment "ras" "suppressor"
27 Q0 23790468 756 34.92304 imi_mug_run_2_treatment "cetuximab" "cisplatin" "drug"
27 Q0 30509235 757 34.898277 imi_mug_run_2_treatment "mek inhibitor" "trametinib" "monolayer"
27 Q0 26359453 758 34.880676 imi_mug_run_2_treatment "mediated" "agar" "collagen"
27 Q0 27590223 759 34.854755 imi_mug_run_2_treatment "lead" "panitumumab" "cetuximab"
27 Q0 28231819 760 34.85047 imi_mug_run_2_treatment "cancer vaccine" "cancer vaccines"
27 Q0 25634006 761 34.838734 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
27 Q0 23245996 762 34.837875 imi_mug_run_2_treatment "abt-263" "mek inhibitor" "navitoclax"
27 Q0 23181703 763 34.83774 imi_mug_run_2_treatment "erlotinib" "platinum"
27 Q0 27793936 764 34.817062 imi_mug_run_2_treatment "drug" "metformin" "agent"
27 Q0 28958938 765 34.81239 imi_mug_run_2_treatment "chemosensitizer" "various" "drug"
27 Q0 29137294 766 34.78813 imi_mug_run_2_treatment "vaccine" "cytokines" "adjuvant"
27 Q0 21698197 767 34.777454 imi_mug_run_2_treatment "mediated"
27 Q0 21400670 768 34.776566 imi_mug_run_2_treatment "aim"
27 Q0 24515771 769 34.758305 imi_mug_run_2_treatment "favor" "aim"
27 Q0 18565564 770 34.753777 imi_mug_run_2_treatment "ras" "level"
27 Q0 20126411 771 34.75116 imi_mug_run_2_treatment "tyrosine"
27 Q0 18334834 772 34.746376 imi_mug_run_2_treatment "gefitinib" "mediated"
27 Q0 23317280 773 34.736973 imi_mug_run_2_treatment "ras" "therapeutics" "lead"
27 Q0 22761399 774 34.73455 imi_mug_run_2_treatment "various" "ipa" "glycans"
27 Q0 19545448 775 34.728905 imi_mug_run_2_treatment "ras" "level"
27 Q0 27121209 776 34.72705 imi_mug_run_2_treatment "gefitinib" "egfr tyrosine kinase inhibitor"
27 Q0 25375092 777 34.7269 imi_mug_run_2_treatment "metformin" "monolayer" "agent"
27 Q0 22210048 778 34.704628 imi_mug_run_2_treatment "enzymes"
27 Q0 24420742 779 34.697147 imi_mug_run_2_treatment "basis"
27 Q0 25502773 780 34.69027 imi_mug_run_2_treatment "sedative" "propofol" "hypnotic agent"
27 Q0 20972333 781 34.628044 imi_mug_run_2_treatment "ras" "others"
27 Q0 18758463 782 34.61258 imi_mug_run_2_treatment "ras"
27 Q0 28601386 783 34.609657 imi_mug_run_2_treatment "crizotinib" "plasma"
27 Q0 27195433 784 34.582882 imi_mug_run_2_treatment "eosin" "isolating"
27 Q0 25938344 785 34.570847 imi_mug_run_2_treatment "adc" "silver" "aim"
27 Q0 27007150 786 34.56905 imi_mug_run_2_treatment "perifosine"
27 Q0 29945997 787 34.5533 imi_mug_run_2_treatment "selumetinib" "therapeutics" "mek inhibitor"
27 Q0 29760531 788 34.55124 imi_mug_run_2_treatment "mediated" "animals"
27 Q0 29587142 789 34.53353 imi_mug_run_2_treatment "various"
27 Q0 21830212 790 34.4951 imi_mug_run_2_treatment "basis"
27 Q0 27043547 791 34.46864 imi_mug_run_2_treatment "plasma"
27 Q0 22654667 792 34.45883 imi_mug_run_2_treatment "drugs" "ras" "program"
27 Q0 25734337 793 34.438343 imi_mug_run_2_treatment "mediated"
27 Q0 30466782 794 34.434765 imi_mug_run_2_treatment "ras" "kinase inhibitor" "crizotinib"
27 Q0 19826350 795 34.416874 imi_mug_run_2_treatment "cetuximab" "erlotinib" "panitumumab"
27 Q0 12433719 796 34.351418 imi_mug_run_2_treatment "serine"
27 Q0 22157931 797 34.33679 imi_mug_run_2_treatment "kinase inhibitor" "isolate"
27 Q0 28154798 798 34.324535 imi_mug_run_2_treatment "enzymes" "drug combinations" "azd6244"
27 Q0 26812617 799 34.313644 imi_mug_run_2_treatment "formalin"
27 Q0 28248226 800 34.298912 imi_mug_run_2_treatment "enzymes" "drug combinations" "azd6244"
27 Q0 25626064 801 34.29872 imi_mug_run_2_treatment "gefitinib" "erlotinib" "crizotinib"
27 Q0 26473645 802 34.29305 imi_mug_run_2_treatment "monoclonal antibodies" "blockade"
27 Q0 23792647 803 34.27037 imi_mug_run_2_treatment "various" "paclitaxel" "cink4"
27 Q0 23264847 804 34.26766 imi_mug_run_2_treatment "various" "therapeutics" "drugs"
27 Q0 20034873 805 34.262016 imi_mug_run_2_treatment "gefitinib" "erlotinib" "basis"
27 Q0 23841470 806 34.25151 imi_mug_run_2_treatment "platinum" "prompt"
27 Q0 21632449 807 34.251278 imi_mug_run_2_treatment "arq 197" "erlotinib" "anticancer agents"
27 Q0 25057173 808 34.24972 imi_mug_run_2_treatment "vandetanib" "docetaxel"
27 Q0 28920257 809 34.246662 imi_mug_run_2_treatment "erlotinib" "gefitinib"
27 Q0 30032815 810 34.246662 imi_mug_run_2_treatment "bevacizumab" "erlotinib" "agent"
27 Q0 24158231 811 34.234234 imi_mug_run_2_treatment "eosin"
27 Q0 26338018 812 34.210766 imi_mug_run_2_treatment "level"
27 Q0 27499899 813 34.210766 imi_mug_run_2_treatment "erlotinib"
27 Q0 21825259 814 34.210766 imi_mug_run_2_treatment "erlotinib 150 mg" "erlotinib" "carboplatin"
27 Q0 28838399 815 34.2051 imi_mug_run_2_treatment "insulin" "tyrosine" "agent"
27 Q0 27821131 816 34.2051 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
27 Q0 20038723 817 34.20463 imi_mug_run_2_treatment "gefitinib" "docetaxel"
27 Q0 27227356 818 34.180122 imi_mug_run_2_treatment "aim"
27 Q0 27794398 819 34.15689 imi_mug_run_2_treatment "afatinib" "egfr tyrosine kinase inhibitor"
27 Q0 29892061 820 34.153973 imi_mug_run_2_treatment "therapeutics" "basis" "iacs-010759"
27 Q0 25804888 821 34.14933 imi_mug_run_2_treatment "arsenic" "sodium arsenite"
27 Q0 19336729 822 34.13612 imi_mug_run_2_treatment "sunitinib" "drugs" "angiogenesis inhibitor"
27 Q0 29104111 823 34.114487 imi_mug_run_2_treatment "level"
27 Q0 17487277 824 34.098026 imi_mug_run_2_treatment "ras" "product"
27 Q0 28848083 825 34.061802 imi_mug_run_2_treatment "various"
27 Q0 24860162 826 34.048447 imi_mug_run_2_treatment "drug" "paclitaxel" "mediated"
27 Q0 26018524 827 34.04824 imi_mug_run_2_treatment "drug combinations" "combinations" "trametinib"
27 Q0 19662677 828 34.045742 imi_mug_run_2_treatment "ras"
27 Q0 19997736 829 34.045322 imi_mug_run_2_treatment "gefitinib" "erlotinib" "lead"
27 Q0 16886600 830 34.04206 imi_mug_run_2_treatment "amylase" "alpha-amylase"
27 Q0 26833127 831 34.03119 imi_mug_run_2_treatment "cytokines"
27 Q0 26573509 832 34.026745 imi_mug_run_2_treatment "docetaxel" "erlotinib"
27 Q0 27607580 833 34.0185 imi_mug_run_2_treatment "chemotherapeutic agent" "cisplatin" "drug combinations"
27 Q0 24659889 834 34.0162 imi_mug_run_2_treatment "cytokines" "level" "aim"
27 Q0 24885803 835 34.00533 imi_mug_run_2_treatment "crizotinib"
27 Q0 24880666 836 34.002068 imi_mug_run_2_treatment "liver"
27 Q0 22252751 837 33.98426 imi_mug_run_2_treatment "medicine" "her-2"
27 Q0 25941815 838 33.91624 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
27 Q0 28162270 839 33.89659 imi_mug_run_2_treatment "ras" "nitric oxide"
27 Q0 22436374 840 33.89633 imi_mug_run_2_treatment "cetuximab" "afatinib" "kinase inhibitor"
27 Q0 27409166 841 33.881336 imi_mug_run_2_treatment "level"
27 Q0 29783412 842 33.832844 imi_mug_run_2_treatment "cetuximab" "matrix"
27 Q0 29401004 843 33.809475 imi_mug_run_2_treatment "amp"
27 Q0 21636543 844 33.80105 imi_mug_run_2_treatment "bexarotene" "erlotinib" "program"
27 Q0 20617134 845 33.78671 imi_mug_run_2_treatment "epidermal growth factor"
27 Q0 28259530 846 33.75146 imi_mug_run_2_treatment "ors"
27 Q0 30080912 847 33.73503 imi_mug_run_2_treatment "plasma"
27 Q0 28950878 848 33.687775 imi_mug_run_2_treatment "liver"
27 Q0 27456471 849 33.68688 imi_mug_run_2_treatment "zinc" "egfr inhibitor"
27 Q0 29713040 850 33.681736 imi_mug_run_2_treatment "blockade"
27 Q0 18594528 851 33.670715 imi_mug_run_2_treatment "suppressor"
27 Q0 25359494 852 33.65451 imi_mug_run_2_treatment "angiopoietin 2" "animals"
27 Q0 26657862 853 33.653854 imi_mug_run_2_treatment "ras" "mediated"
27 Q0 24771645 854 33.652706 imi_mug_run_2_treatment "various" "ponatinib" "tyrosine kinase inhibitor"
27 Q0 27705932 855 33.645725 imi_mug_run_2_treatment "plasma"
27 Q0 23373999 856 33.63959 imi_mug_run_2_treatment "various" "level"
27 Q0 25162504 857 33.623276 imi_mug_run_2_treatment "agent"
27 Q0 21062932 858 33.605675 imi_mug_run_2_treatment "basis"
27 Q0 28544061 859 33.600998 imi_mug_run_2_treatment "aim"
27 Q0 24726492 860 33.58113 imi_mug_run_2_treatment "formalin" "matrix"
27 Q0 20736805 861 33.56475 imi_mug_run_2_treatment "pha665752"
27 Q0 25210463 862 33.54641 imi_mug_run_2_treatment "anti-epidermal growth factor receptor monoclonal antibody"
27 Q0 23876834 863 33.545834 imi_mug_run_2_treatment "drugs" "investigational drugs" "generic"
27 Q0 26887348 864 33.545147 imi_mug_run_2_treatment "liver"
27 Q0 24426712 865 33.532913 imi_mug_run_2_treatment "tyrosine"
27 Q0 29185262 866 33.51121 imi_mug_run_2_treatment "icc" "aim" "asc"
27 Q0 22925795 867 33.510906 imi_mug_run_2_treatment "medicine" "her-2"
27 Q0 25009008 868 33.50244 imi_mug_run_2_treatment "ras"
27 Q0 23227266 869 33.49968 imi_mug_run_2_treatment "drug" "pyrvinium pamoate" "salirasib"
27 Q0 27595930 870 33.461845 imi_mug_run_2_treatment "ras" "mediated" "tyrosine"
27 Q0 24470024 871 33.460903 imi_mug_run_2_treatment "mediated"
27 Q0 28783173 872 33.45499 imi_mug_run_2_treatment "mek inhibitor" "pimasertib"
27 Q0 21918971 873 33.449306 imi_mug_run_2_treatment "cetuximab" "bevacizumab" "vascular endothelial growth factor"
27 Q0 27335109 874 33.429382 imi_mug_run_2_treatment "pulmonary surfactant" "mediated" "phosphatidylcholines"
27 Q0 21240995 875 33.423927 imi_mug_run_2_treatment "fta"
27 Q0 30130254 876 33.421722 imi_mug_run_2_treatment "various" "enzymes" "n-acetylglucosamine"
27 Q0 28843257 877 33.39715 imi_mug_run_2_treatment "drug" "trastuzumab" "drugs"
27 Q0 26892442 878 33.384666 imi_mug_run_2_treatment "various"
27 Q0 22987962 879 33.377728 imi_mug_run_2_treatment "product"
27 Q0 25538889 880 33.37512 imi_mug_run_2_treatment "drug" "baf" "aim"
27 Q0 28762087 881 33.329784 imi_mug_run_2_treatment "kinase inhibitor" "ci 4"
27 Q0 29727601 882 33.32069 imi_mug_run_2_treatment "trametinib" "mediated" "mek inhibitor"
27 Q0 23255896 883 33.311275 imi_mug_run_2_treatment "gemcitabine" "various" "sorafenib"
27 Q0 25278450 884 33.31124 imi_mug_run_2_treatment "lead"
27 Q0 23499205 885 33.284267 imi_mug_run_2_treatment "nitrocellulose" "anti-egfr monoclonal antibody" "cetuximab"
27 Q0 19270482 886 33.267063 imi_mug_run_2_treatment "formalin"
27 Q0 30460115 887 33.26089 imi_mug_run_2_treatment "bromelain" "crystal violet" "oxygen"
27 Q0 19794967 888 33.25354 imi_mug_run_2_treatment "gefitinib" "erlotinib"
27 Q0 27439864 889 33.2356 imi_mug_run_2_treatment "jak inhibitors"
27 Q0 24123310 890 33.219105 imi_mug_run_2_treatment "aim"
27 Q0 21896780 891 33.213768 imi_mug_run_2_treatment "basis"
27 Q0 26755660 892 33.206535 imi_mug_run_2_treatment "mediated"
27 Q0 22613842 893 33.195965 imi_mug_run_2_treatment "ras" "others" "matrix"
27 Q0 22383492 894 33.18438 imi_mug_run_2_treatment "ly294002" "phosphatidylinositol 3-kinase inhibitor" "mek inhibitor"
27 Q0 22323609 895 33.17358 imi_mug_run_2_treatment "kinase inhibitor" "brd-8899" "blockade"
27 Q0 29455644 896 33.158962 imi_mug_run_2_treatment "tyrosine kinase inhibitor" "serine" "gefitinib"
27 Q0 27312529 897 33.146355 imi_mug_run_2_treatment "drug" "combinations" "drug combinations"
27 Q0 26272233 898 33.139496 imi_mug_run_2_treatment "plasma"
27 Q0 20591134 899 33.133347 imi_mug_run_2_treatment "ras" "cetuximab"
27 Q0 23063521 900 33.119026 imi_mug_run_2_treatment "gefitinib" "thienopyrimidine" "monoclonal antibodies"
27 Q0 26199566 901 33.111732 imi_mug_run_2_treatment "aim" "egfr tyrosine kinase inhibitors"
27 Q0 21277645 902 33.10876 imi_mug_run_2_treatment "gemcitabine" "ag1478" "u0126"
27 Q0 28007785 903 33.10675 imi_mug_run_2_treatment "hyaluronan"
27 Q0 26862733 904 33.09894 imi_mug_run_2_treatment "various" "afatinib" "egfr tyrosine kinase inhibitor"
27 Q0 29454587 905 33.098194 imi_mug_run_2_treatment "aim"
27 Q0 28391773 906 33.081635 imi_mug_run_2_treatment "adjuvant"
27 Q0 24429876 907 33.058243 imi_mug_run_2_treatment "plasma" "erlotinib"
27 Q0 15466206 908 33.052654 imi_mug_run_2_treatment "bay 43-9006" "urea" "ras"
27 Q0 22617245 909 33.0465 imi_mug_run_2_treatment "crizotinib" "imatinib" "erlotinib"
27 Q0 26777916 910 33.045685 imi_mug_run_2_treatment "duration"
27 Q0 24630986 911 33.037292 imi_mug_run_2_treatment "thr" "mediated" "ras"
27 Q0 28338535 912 33.035255 imi_mug_run_2_treatment "fludeoxyglucose" "aim" "others"
27 Q0 26847053 913 33.020786 imi_mug_run_2_treatment "level"
27 Q0 24130455 914 32.98782 imi_mug_run_2_treatment "lead"
27 Q0 29447458 915 32.98549 imi_mug_run_2_treatment "liver"
27 Q0 29981925 916 32.977226 imi_mug_run_2_treatment "crizotinib" "others"
27 Q0 27877053 917 32.97371 imi_mug_run_2_treatment "vorinostat" "gefitinib" "sorafenib"
27 Q0 27144063 918 32.97159 imi_mug_run_2_treatment "matrix"
27 Q0 26751774 919 32.96536 imi_mug_run_2_treatment "various" "von willebrand factor" "mediated"
27 Q0 23980680 920 32.951096 imi_mug_run_2_treatment "various"
27 Q0 22876814 921 32.937424 imi_mug_run_2_treatment "various" "liver"
27 Q0 27116474 922 32.900158 imi_mug_run_2_treatment "blockade" "plasma"
27 Q0 29761043 923 32.895256 imi_mug_run_2_treatment "various"
27 Q0 23610445 924 32.8675 imi_mug_run_2_treatment "urethane"
27 Q0 30221677 925 32.86154 imi_mug_run_2_treatment "various"
27 Q0 24875857 926 32.859783 imi_mug_run_2_treatment "ras"
27 Q0 26024321 927 32.85626 imi_mug_run_2_treatment "level"
27 Q0 27837635 928 32.85345 imi_mug_run_2_treatment "drug" "aim" "drugs"
27 Q0 27507537 929 32.83955 imi_mug_run_2_treatment "ss1p" "immunotoxin" "cytotoxic"
27 Q0 27320908 930 32.82805 imi_mug_run_2_treatment "bortezomib" "proteasome inhibitor" "urethane"
27 Q0 22845480 931 32.82294 imi_mug_run_2_treatment "trans-retinoic acid" "arsenic trioxide" "trastuzumab"
27 Q0 20028932 932 32.74601 imi_mug_run_2_treatment "gefitinib"
27 Q0 21847063 933 32.738 imi_mug_run_2_treatment "salirasib" "drug trials" "ras"
27 Q0 27342566 934 32.734486 imi_mug_run_2_treatment "mediated"
27 Q0 25153497 935 32.7158 imi_mug_run_2_treatment "drugs" "hydrogel"
27 Q0 23074403 936 32.7016 imi_mug_run_2_treatment "ras" "drug" "oxaliplatin"
27 Q0 16598760 937 32.68495 imi_mug_run_2_treatment "her-2" "basis"
27 Q0 26749487 938 32.68271 imi_mug_run_2_treatment "pooled"
27 Q0 20372787 939 32.67543 imi_mug_run_2_treatment "cetuximab" "basis" "aim"
27 Q0 28584208 940 32.612083 imi_mug_run_2_treatment "epidermal growth factor receptor tyrosine kinase inhibitor" "matrix"
27 Q0 24501009 941 32.588593 imi_mug_run_2_treatment "dacomitinib" "erlotinib" "tyrosine kinase inhibitor"
27 Q0 28692044 942 32.55516 imi_mug_run_2_treatment "glucose" "ras"
27 Q0 29069867 943 32.5113 imi_mug_run_2_treatment "erlotinib" "agent"
27 Q0 27602770 944 32.484318 imi_mug_run_2_treatment "plasma"
27 Q0 22440336 945 32.482883 imi_mug_run_2_treatment "erlotinib" "tivantinib" "guanidine"
27 Q0 24576404 946 32.480885 imi_mug_run_2_treatment "various"
27 Q0 26248464 947 32.468163 imi_mug_run_2_treatment "liver"
27 Q0 24054548 948 32.4628 imi_mug_run_2_treatment "basis"
27 Q0 15741570 949 32.437622 imi_mug_run_2_treatment "drugs" "lead"
27 Q0 29140695 950 32.37988 imi_mug_run_2_treatment "biotin" "ras"
27 Q0 9332768 951 32.331924 imi_mug_run_2_treatment "arginine" "glycine"
27 Q0 25611230 952 32.32927 imi_mug_run_2_treatment "erlotinib"
27 Q0 26140595 953 32.326534 imi_mug_run_2_treatment "tonic"
27 Q0 24883309 954 32.30316 imi_mug_run_2_treatment "mediated"
27 Q0 24500884 955 32.285038 imi_mug_run_2_treatment "adca" "hot spot" "aim"
27 Q0 17001163 956 32.27994 imi_mug_run_2_treatment "adc"
27 Q0 22761469 957 32.243793 imi_mug_run_2_treatment "adc"
27 Q0 30412912 958 32.24336 imi_mug_run_2_treatment "cetuximab" "crizotinib"
27 Q0 24789362 959 32.216904 imi_mug_run_2_treatment "medicine" "various" "therapeutics"
27 Q0 23288781 960 32.203384 imi_mug_run_2_treatment "mediated"
27 Q0 24798549 961 32.174088 imi_mug_run_2_treatment "irinotecan" "mediated"
27 Q0 27244540 962 32.14453 imi_mug_run_2_treatment "liver"
27 Q0 26461287 963 32.14043 imi_mug_run_2_treatment "mediated" "oxygen" "ras"
27 Q0 26973247 964 32.137283 imi_mug_run_2_treatment "vaccines" "liver"
27 Q0 29748010 965 32.13014 imi_mug_run_2_treatment "agent" "reolysin" "docetaxel"
27 Q0 30267839 966 32.1247 imi_mug_run_2_treatment "various" "jnj-42756493"
27 Q0 25521398 967 32.124485 imi_mug_run_2_treatment "dacomitinib" "gefitinib" "erlotinib"
27 Q0 28325280 968 32.12036 imi_mug_run_2_treatment "suppressor"
27 Q0 29658609 969 32.106503 imi_mug_run_2_treatment "abt-263" "trametinib" "mek inhibitor"
27 Q0 19247083 970 32.092773 imi_mug_run_2_treatment "gefitinib" "gefitinib 250 mg"
27 Q0 25167228 971 32.085594 imi_mug_run_2_treatment "mek162" "ras"
27 Q0 29367950 972 32.073654 imi_mug_run_2_treatment "drug"
27 Q0 26304236 973 32.061485 imi_mug_run_2_treatment "antineoplastic" "thr"
27 Q0 22460425 974 32.059418 imi_mug_run_2_treatment "basis"
27 Q0 22882865 975 32.051987 imi_mug_run_2_treatment "suppressor"
27 Q0 24760004 976 32.001945 imi_mug_run_2_treatment "various"
27 Q0 28609226 977 31.971085 imi_mug_run_2_treatment "atezolizumab" "basis" "duration"
27 Q0 21197450 978 31.96994 imi_mug_run_2_treatment "monoclonal antibodies"
27 Q0 26546296 979 31.959715 imi_mug_run_2_treatment "ras"
27 Q0 26273378 980 31.875658 imi_mug_run_2_treatment "adc" "aim"
27 Q0 30297358 981 31.873116 imi_mug_run_2_treatment "sam" "mediated" "basis"
27 Q0 27448221 982 31.865942 imi_mug_run_2_treatment "drugs" "oxygen"
27 Q0 23404247 983 31.8534 imi_mug_run_2_treatment "panitumumab" "cetuximab"
27 Q0 19995647 984 31.835815 imi_mug_run_2_treatment "enzymes"
27 Q0 25667274 985 31.820507 imi_mug_run_2_treatment "erlotinib" "selumetinib" "sunitinib"
27 Q0 22313637 986 31.80668 imi_mug_run_2_treatment "gefitinib" "cetuximab" "egfr tyrosine kinase inhibitor"
27 Q0 26880715 987 31.80336 imi_mug_run_2_treatment "immune modulators"
27 Q0 16112461 988 31.800056 imi_mug_run_2_treatment "genesis"
27 Q0 29781772 989 31.765764 imi_mug_run_2_treatment "egfr tyrosine kinase inhibitors"
27 Q0 24163741 990 31.764082 imi_mug_run_2_treatment "adc" "lead" "revolution"
27 Q0 24108744 991 31.746181 imi_mug_run_2_treatment "gefitinib" "egfr inhibitor" "blockade"
27 Q0 24430184 992 31.73667 imi_mug_run_2_treatment "mln4924" "mtor inhibitor"
27 Q0 29050231 993 31.729527 imi_mug_run_2_treatment "foretinib" "erlotinib" "kinase inhibitor"
27 Q0 26616862 994 31.712442 imi_mug_run_2_treatment "mediated" "basis"
27 Q0 22091388 995 31.702717 imi_mug_run_2_treatment "pd-325901" "mek inhibitor"
27 Q0 24828662 996 31.675621 imi_mug_run_2_treatment "lead"
27 Q0 24696490 997 31.669416 imi_mug_run_2_treatment "various" "type i interferon" "mediated"
27 Q0 23021208 998 31.663889 imi_mug_run_2_treatment "interferon" "antiviral" "therapeutic agent"
27 Q0 19559099 999 31.651125 imi_mug_run_2_treatment "formalin" "mustard agent"
28 Q0 24629067 1 48.91911 imi_mug_run_2_treatment "mediated"
28 Q0 19168207 2 47.667065 imi_mug_run_2_treatment "taxane" "platinum" "mediated"
28 Q0 11773283 3 47.40573 imi_mug_run_2_treatment "various"
28 Q0 24321281 4 46.1295 imi_mug_run_2_treatment "mediated"
28 Q0 23006047 5 45.971657 imi_mug_run_2_treatment "aim"
28 Q0 24321324 6 45.782555 imi_mug_run_2_treatment "bisulfite"
28 Q0 9197534 7 45.76039 imi_mug_run_2_treatment "zinc"
28 Q0 12894890 8 45.62047 imi_mug_run_2_treatment "enzymes" "gly"
28 Q0 22685544 9 45.584316 imi_mug_run_2_treatment "fst" "activin"
28 Q0 9099656 10 45.571312 imi_mug_run_2_treatment "zinc" "product"
28 Q0 10600309 11 45.246048 imi_mug_run_2_treatment "aim"
28 Q0 11972384 12 44.956573 imi_mug_run_2_treatment "aim"
28 Q0 26753012 13 44.899246 imi_mug_run_2_treatment "poly(adp-ribose) polymerase inhibitors"
28 Q0 10634513 14 44.870796 imi_mug_run_2_treatment "aim"
28 Q0 9796975 15 44.81066 imi_mug_run_2_treatment "aim"
28 Q0 12063435 16 44.706406 imi_mug_run_2_treatment "product"
28 Q0 8828444 17 44.692696 imi_mug_run_2_treatment "basis" "others"
28 Q0 21887486 18 44.67 imi_mug_run_2_treatment "various" "mediated"
28 Q0 15477862 19 44.608604 imi_mug_run_2_treatment "level"
28 Q0 16293160 20 44.46794 imi_mug_run_2_treatment "oral contraceptives"
28 Q0 20940403 21 44.4478 imi_mug_run_2_treatment "cisplatin" "drug" "product"
28 Q0 15589605 22 44.366623 imi_mug_run_2_treatment "tamoxifen"
28 Q0 27914478 23 44.182545 imi_mug_run_2_treatment "aim"
28 Q0 11251181 24 44.176334 imi_mug_run_2_treatment "aim"
28 Q0 21119070 25 44.06286 imi_mug_run_2_treatment "level"
28 Q0 12006538 26 43.984085 imi_mug_run_2_treatment "basis"
28 Q0 8946903 27 43.925007 imi_mug_run_2_treatment "program"
28 Q0 29506471 28 43.87722 imi_mug_run_2_treatment "program"
28 Q0 22395474 29 43.671906 imi_mug_run_2_treatment "basis"
28 Q0 29844838 30 43.65206 imi_mug_run_2_treatment "drug" "level"
28 Q0 25537514 31 43.609955 imi_mug_run_2_treatment "platinum"
28 Q0 27513691 32 43.50654 imi_mug_run_2_treatment "duration" "anti-mullerian hormone"
28 Q0 25486197 33 43.47671 imi_mug_run_2_treatment "nicotinamide adenine dinucleotide"
28 Q0 22889437 34 43.46634 imi_mug_run_2_treatment "aim"
28 Q0 25132263 35 43.35898 imi_mug_run_2_treatment "cisplatin" "platinum" "bdnf"
28 Q0 12402332 36 43.35272 imi_mug_run_2_treatment "favoring"
28 Q0 25422243 37 43.295456 imi_mug_run_2_treatment "level"
28 Q0 23544013 38 43.286312 imi_mug_run_2_treatment "lead"
28 Q0 19577280 39 43.280846 imi_mug_run_2_treatment "tamoxifen" "selective estrogen receptor modulator" "serm"
28 Q0 19190154 40 43.24617 imi_mug_run_2_treatment "oral contraceptive" "duration"
28 Q0 24168967 41 43.23056 imi_mug_run_2_treatment "cisplatin" "platinum" "parp inhibitor"
28 Q0 10657950 42 43.166164 imi_mug_run_2_treatment "methylated" "aim"
28 Q0 10921314 43 42.96055 imi_mug_run_2_treatment "basis"
28 Q0 24335192 44 42.954227 imi_mug_run_2_treatment "cisplatin" "igf-1"
28 Q0 23257159 45 42.88984 imi_mug_run_2_treatment "various" "lead"
28 Q0 18591560 46 42.801125 imi_mug_run_2_treatment "various" "aim" "suppressor"
28 Q0 26828981 47 42.77251 imi_mug_run_2_treatment "lead"
28 Q0 21557934 48 42.76934 imi_mug_run_2_treatment "methylated"
28 Q0 10560359 49 42.759308 imi_mug_run_2_treatment "aim"
28 Q0 18094425 50 42.657524 imi_mug_run_2_treatment "platinum" "taxane"
28 Q0 12717416 51 42.61399 imi_mug_run_2_treatment "paclitaxel" "drug" "tandem"
28 Q0 17408542 52 42.55552 imi_mug_run_2_treatment "prophylactic"
28 Q0 23069641 53 42.442947 imi_mug_run_2_treatment "platinum" "cisplatin" "drugs"
28 Q0 9150153 54 42.415504 imi_mug_run_2_treatment "basis"
28 Q0 20537530 55 42.388817 imi_mug_run_2_treatment "stopping" "contraceptive" "oral contraceptive"
28 Q0 20487263 56 42.379303 imi_mug_run_2_treatment "platinum" "cisplatin"
28 Q0 8644702 57 42.282875 imi_mug_run_2_treatment "zinc"
28 Q0 21735691 58 42.26078 imi_mug_run_2_treatment "cytostatic drugs" "drugs"
28 Q0 27242959 59 42.213295 imi_mug_run_2_treatment "parp inhibitors"
28 Q0 17196508 60 42.211132 imi_mug_run_2_treatment "oral contraceptives"
28 Q0 19010876 61 42.210903 imi_mug_run_2_treatment "prophylactic"
28 Q0 17259345 62 42.196205 imi_mug_run_2_treatment "estrogen"
28 Q0 19035463 63 42.16581 imi_mug_run_2_treatment "prophylactic"
28 Q0 17453335 64 42.066994 imi_mug_run_2_treatment "level"
28 Q0 16982732 65 42.047157 imi_mug_run_2_treatment "cisplatin" "paclitaxel" "platinum"
28 Q0 23730208 66 42.04267 imi_mug_run_2_treatment "parp inhibitor" "olaparib" "drugs"
28 Q0 26045998 67 42.00741 imi_mug_run_2_treatment "nicotinamide adenine dinucleotide" "mediated"
28 Q0 29248130 68 41.996563 imi_mug_run_2_treatment "platinum" "olaparib" "lynparza"
28 Q0 19825178 69 41.98398 imi_mug_run_2_treatment "platinum" "drugs"
28 Q0 22262156 70 41.98398 imi_mug_run_2_treatment "various"
28 Q0 15545966 71 41.94654 imi_mug_run_2_treatment "contraceptive" "oral contraceptives"
28 Q0 9516977 72 41.934418 imi_mug_run_2_treatment "cisplatin"
28 Q0 28691938 73 41.81064 imi_mug_run_2_treatment "platinum" "aim"
28 Q0 28373819 74 41.808983 imi_mug_run_2_treatment "aim" "platinum"
28 Q0 10449599 75 41.733788 imi_mug_run_2_treatment "others"
28 Q0 20840667 76 41.685116 imi_mug_run_2_treatment "aim"
28 Q0 20046879 77 41.65374 imi_mug_run_2_treatment "mediated"
28 Q0 24131965 78 41.57985 imi_mug_run_2_treatment "parp inhibitor" "drugs" "parp inhibitors"
28 Q0 21391735 79 41.561928 imi_mug_run_2_treatment "aim"
28 Q0 21945869 80 41.527138 imi_mug_run_2_treatment "platinum agents"
28 Q0 21854619 81 41.525654 imi_mug_run_2_treatment "various" "cisplatin" "m344"
28 Q0 24145348 82 41.520947 imi_mug_run_2_treatment "oral contraceptive" "oral contraceptives" "duration"
28 Q0 9700175 83 41.49826 imi_mug_run_2_treatment "contraceptive" "oral contraceptives"
28 Q0 25192939 84 41.49763 imi_mug_run_2_treatment "program"
28 Q0 16261399 85 41.469234 imi_mug_run_2_treatment "contraceptive" "oral contraceptives"
28 Q0 11474660 86 41.46656 imi_mug_run_2_treatment "oral contraceptives" "contraceptive"
28 Q0 30221688 87 41.463806 imi_mug_run_2_treatment "sage"
28 Q0 22504673 88 41.42264 imi_mug_run_2_treatment "platinum" "lead" "basis"
28 Q0 12354934 89 41.35169 imi_mug_run_2_treatment "aim"
28 Q0 25849179 90 41.310616 imi_mug_run_2_treatment "mediated"
28 Q0 24265793 91 41.274464 imi_mug_run_2_treatment "mediated"
28 Q0 27418218 92 41.23622 imi_mug_run_2_treatment "aim"
28 Q0 9192828 93 41.203903 imi_mug_run_2_treatment "various"
28 Q0 24889916 94 41.203266 imi_mug_run_2_treatment "mediated" "platinum"
28 Q0 11801872 95 41.188923 imi_mug_run_2_treatment "oral contraceptives"
28 Q0 23269703 96 41.10264 imi_mug_run_2_treatment "lead"
28 Q0 22923021 97 41.093254 imi_mug_run_2_treatment "aim"
28 Q0 22684231 98 41.0812 imi_mug_run_2_treatment "program"
28 Q0 11192759 99 41.07957 imi_mug_run_2_treatment "program"
28 Q0 19690636 100 41.040447 imi_mug_run_2_treatment "various" "cisplatin" "paclitaxel"
28 Q0 26631606 101 41.037712 imi_mug_run_2_treatment "aim"
28 Q0 26731315 102 40.98907 imi_mug_run_2_treatment "auranofin" "drug" "n-acetyl cysteine"
28 Q0 8634990 103 40.96469 imi_mug_run_2_treatment "ras" "lead" "others"
28 Q0 18413372 104 40.944946 imi_mug_run_2_treatment "aim"
28 Q0 12124354 105 40.941185 imi_mug_run_2_treatment "methylated"
28 Q0 30103829 106 40.907227 imi_mug_run_2_treatment "platinum" "aim"
28 Q0 22669161 107 40.88075 imi_mug_run_2_treatment "phb" "methylene" "prohibitin"
28 Q0 21857521 108 40.860596 imi_mug_run_2_treatment "ginkgo biloba" "ginkgo" "dimethyl sulfoxide"
28 Q0 29053726 109 40.85094 imi_mug_run_2_treatment "platinum"
28 Q0 16360812 110 40.835323 imi_mug_run_2_treatment "methylated"
28 Q0 26138335 111 40.805454 imi_mug_run_2_treatment "blockade" "parp inhibitor" "cytotoxic"
28 Q0 11104622 112 40.70403 imi_mug_run_2_treatment "animals" "aim"
28 Q0 12938098 113 40.697903 imi_mug_run_2_treatment "lead"
28 Q0 24472143 114 40.672863 imi_mug_run_2_treatment "matrix"
28 Q0 20576130 115 40.5987 imi_mug_run_2_treatment "mediators"
28 Q0 18594935 116 40.59266 imi_mug_run_2_treatment "mediated" "staurosporine" "platinum"
28 Q0 27249597 117 40.5112 imi_mug_run_2_treatment "platinum" "aim"
28 Q0 25323003 118 40.477406 imi_mug_run_2_treatment "nicotinamide adenine dinucleotide" "mediated" "balance"
28 Q0 25428229 119 40.457413 imi_mug_run_2_treatment "schiff"
28 Q0 11896106 120 40.44137 imi_mug_run_2_treatment "program"
28 Q0 14613551 121 40.43656 imi_mug_run_2_treatment "lead"
28 Q0 25251729 122 40.434868 imi_mug_run_2_treatment "oral contraceptive pill" "contraceptive" "oral contraceptives"
28 Q0 21190077 123 40.425674 imi_mug_run_2_treatment "aim"
28 Q0 25556971 124 40.41655 imi_mug_run_2_treatment "pooled"
28 Q0 22351618 125 40.360703 imi_mug_run_2_treatment "lead"
28 Q0 16537453 126 40.30051 imi_mug_run_2_treatment "lead"
28 Q0 20638108 127 40.28762 imi_mug_run_2_treatment "aim" "basis"
28 Q0 9665148 128 40.277145 imi_mug_run_2_treatment "basis" "genesis"
28 Q0 11157798 129 40.271946 imi_mug_run_2_treatment "yeast" "basis"
28 Q0 20406939 130 40.265396 imi_mug_run_2_treatment "liver"
28 Q0 10880552 131 40.25231 imi_mug_run_2_treatment "genesis"
28 Q0 20797776 132 40.245396 imi_mug_run_2_treatment "pace"
28 Q0 27159752 133 40.22319 imi_mug_run_2_treatment "various"
28 Q0 27186285 134 40.218674 imi_mug_run_2_treatment "cisplatin" "mediated" "nicotinamide adenine dinucleotide"
28 Q0 15468897 135 40.204468 imi_mug_run_2_treatment "prophylactic"
28 Q0 10997542 136 40.17438 imi_mug_run_2_treatment "program"
28 Q0 24825122 137 40.170628 imi_mug_run_2_treatment "taxane" "adjuvant" "platinum"
28 Q0 11377596 138 40.150375 imi_mug_run_2_treatment "contraceptive" "oral contraceptive"
28 Q0 21187397 139 40.149445 imi_mug_run_2_treatment "mediated"
28 Q0 12946038 140 40.09278 imi_mug_run_2_treatment "duration" "oral contraceptive"
28 Q0 11894135 141 40.084908 imi_mug_run_2_treatment "cytotoxic drugs"
28 Q0 25943777 142 39.97306 imi_mug_run_2_treatment "follicle-stimulating hormone"
28 Q0 16521688 143 39.954746 imi_mug_run_2_treatment "contraceptive"
28 Q0 18397521 144 39.924156 imi_mug_run_2_treatment "phb" "prohibitin"
28 Q0 20514903 145 39.91867 imi_mug_run_2_treatment "program" "aim"
28 Q0 26341709 146 39.917213 imi_mug_run_2_treatment "oral contraceptives" "prophylactic"
28 Q0 15550590 147 39.90519 imi_mug_run_2_treatment "level"
28 Q0 19263514 148 39.88065 imi_mug_run_2_treatment "prophylactic" "aim"
28 Q0 19996028 149 39.83327 imi_mug_run_2_treatment "gonadotropins" "letrozole"
28 Q0 21371001 150 39.829586 imi_mug_run_2_treatment "diphosphate"
28 Q0 15876585 151 39.806778 imi_mug_run_2_treatment "product" "aim"
28 Q0 22780973 152 39.769306 imi_mug_run_2_treatment "drug" "platinum"
28 Q0 12865453 153 39.74679 imi_mug_run_2_treatment "level"
28 Q0 16515589 154 39.739956 imi_mug_run_2_treatment "androgen" "androgens"
28 Q0 20182637 155 39.730186 imi_mug_run_2_treatment "various" "cisplatin" "aim"
28 Q0 22801507 156 39.709076 imi_mug_run_2_treatment "agent" "curcumin" "oxygen"
28 Q0 25725131 157 39.66925 imi_mug_run_2_treatment "parp inhibitor" "olaparib" "supreme"
28 Q0 10918394 158 39.628548 imi_mug_run_2_treatment "bps"
28 Q0 18197009 159 39.615887 imi_mug_run_2_treatment "estrogen" "progesterone" "ovarian hormone"
28 Q0 12619114 160 39.61576 imi_mug_run_2_treatment "cisplatin"
28 Q0 28454658 161 39.61294 imi_mug_run_2_treatment "medication" "medications"
28 Q0 12849591 162 39.59956 imi_mug_run_2_treatment "basis"
28 Q0 11668223 163 39.593006 imi_mug_run_2_treatment "oral contraceptives" "contraceptive"
28 Q0 27528622 164 39.585396 imi_mug_run_2_treatment "basis"
28 Q0 15010292 165 39.567078 imi_mug_run_2_treatment "her-2" "level"
28 Q0 28692638 166 39.542103 imi_mug_run_2_treatment "platinum"
28 Q0 16176503 167 39.541756 imi_mug_run_2_treatment "tcc" "thr" "aim"
28 Q0 14694444 168 39.528103 imi_mug_run_2_treatment "plumbagin" "drugs" "emodin"
28 Q0 10897034 169 39.495995 imi_mug_run_2_treatment "level"
28 Q0 26109557 170 39.48321 imi_mug_run_2_treatment "suppressor"
28 Q0 20151938 171 39.459057 imi_mug_run_2_treatment "aim"
28 Q0 20216074 172 39.458763 imi_mug_run_2_treatment "various"
28 Q0 15552838 173 39.458153 imi_mug_run_2_treatment "aim"
28 Q0 15797026 174 39.43903 imi_mug_run_2_treatment "mullerian inhibiting substance"
28 Q0 21990299 175 39.4131 imi_mug_run_2_treatment "platinum" "duration"
28 Q0 24389207 176 39.40655 imi_mug_run_2_treatment "lead"
28 Q0 18489799 177 39.377964 imi_mug_run_2_treatment "level"
28 Q0 7795652 178 39.319244 imi_mug_run_2_treatment "suppressor"
28 Q0 23211700 179 39.284264 imi_mug_run_2_treatment "basis"
28 Q0 8559544 180 39.269836 imi_mug_run_2_treatment "medicine" "prenatal"
28 Q0 23047606 181 39.252563 imi_mug_run_2_treatment "hydrogen peroxide" "antioxidants" "antioxidant"
28 Q0 8460637 182 39.24285 imi_mug_run_2_treatment "phb" "anonymous"
28 Q0 26698676 183 39.240585 imi_mug_run_2_treatment "fertility medication" "gonadotropin"
28 Q0 16939956 184 39.23023 imi_mug_run_2_treatment "level"
28 Q0 24385383 185 39.214554 imi_mug_run_2_treatment "aim"
28 Q0 24935384 186 39.20541 imi_mug_run_2_treatment "platinum" "medicine" "aim"
28 Q0 28914618 187 39.205208 imi_mug_run_2_treatment "prophylactic" "parp inhibitors"
28 Q0 19865540 188 39.20028 imi_mug_run_2_treatment "estrogen" "insulin" "igf-1"
28 Q0 18514188 189 39.168633 imi_mug_run_2_treatment "genistein" "isoflavone" "genistein's"
28 Q0 24448423 190 39.1437 imi_mug_run_2_treatment "mediated"
28 Q0 20028858 191 39.12201 imi_mug_run_2_treatment "estrogen" "estradiol" "progesterone"
28 Q0 24680909 192 39.082573 imi_mug_run_2_treatment "cytotoxic" "pegylated liposomal doxorubicin"
28 Q0 27351029 193 39.042046 imi_mug_run_2_treatment "aim"
28 Q0 26961668 194 39.038292 imi_mug_run_2_treatment "parp inhibitor" "cdx" "parp inhibitors"
28 Q0 14959510 195 39.033875 imi_mug_run_2_treatment "tamoxifen"
28 Q0 26691938 196 39.014336 imi_mug_run_2_treatment "basis"
28 Q0 16174860 197 39.002045 imi_mug_run_2_treatment "program"
28 Q0 21344236 198 38.993393 imi_mug_run_2_treatment "dsb"
28 Q0 12566964 199 38.967278 imi_mug_run_2_treatment "level" "aim"
28 Q0 18413725 200 38.954247 imi_mug_run_2_treatment "platinum compounds" "platinum" "cisplatin"
28 Q0 12440810 201 38.945812 imi_mug_run_2_treatment "tribe"
28 Q0 10469748 202 38.885868 imi_mug_run_2_treatment "ovarian hormone"
28 Q0 25248112 203 38.880177 imi_mug_run_2_treatment "platinum" "aim"
28 Q0 18546071 204 38.879944 imi_mug_run_2_treatment "various"
28 Q0 25086635 205 38.869095 imi_mug_run_2_treatment "prophylactic"
28 Q0 10208417 206 38.843796 imi_mug_run_2_treatment "estrogen"
28 Q0 23344037 207 38.81379 imi_mug_run_2_treatment "drugs" "platinum"
28 Q0 16050564 208 38.750816 imi_mug_run_2_treatment "contraceptive" "prophylactic"
28 Q0 14609432 209 38.71825 imi_mug_run_2_treatment "lead"
28 Q0 12722403 210 38.704407 imi_mug_run_2_treatment "aim"
28 Q0 20093589 211 38.704292 imi_mug_run_2_treatment "oral contraceptives"
28 Q0 28927115 212 38.61735 imi_mug_run_2_treatment "agent"
28 Q0 30092674 213 38.615253 imi_mug_run_2_treatment "olaparib" "agent"
28 Q0 12750261 214 38.57805 imi_mug_run_2_treatment "androgen" "tgf-beta1" "androgens"
28 Q0 20223033 215 38.4934 imi_mug_run_2_treatment "basis" "aim"
28 Q0 14722926 216 38.492657 imi_mug_run_2_treatment "amino acid" "generic" "mediated"
28 Q0 20798986 217 38.485268 imi_mug_run_2_treatment "estrogen" "aim" "matrix"
28 Q0 17673924 218 38.46683 imi_mug_run_2_treatment "prophylactic"
28 Q0 25490527 219 38.442696 imi_mug_run_2_treatment "parp inhibitors"
28 Q0 25594018 220 38.432587 imi_mug_run_2_treatment "paclitaxel"
28 Q0 10539900 221 38.356655 imi_mug_run_2_treatment "medicine" "basis"
28 Q0 10595257 222 38.346413 imi_mug_run_2_treatment "program"
28 Q0 8573462 223 38.324707 imi_mug_run_2_treatment "basis"
28 Q0 20400477 224 38.30316 imi_mug_run_2_treatment "lead"
28 Q0 8283492 225 38.271584 imi_mug_run_2_treatment "favor"
28 Q0 11535547 226 38.22976 imi_mug_run_2_treatment "basis"
28 Q0 25482078 227 38.19658 imi_mug_run_2_treatment "contraceptive"
28 Q0 28959512 228 38.189808 imi_mug_run_2_treatment "alkylating agents" "agent"
28 Q0 28704214 229 38.154785 imi_mug_run_2_treatment "cdca" "dca" "chenodeoxycholic acid"
28 Q0 11956590 230 38.14961 imi_mug_run_2_treatment "others"
28 Q0 19383379 231 38.141144 imi_mug_run_2_treatment "prophylactic"
28 Q0 23372765 232 38.13944 imi_mug_run_2_treatment "aim"
28 Q0 23292835 233 38.10606 imi_mug_run_2_treatment "platinum" "aim"
28 Q0 15073127 234 38.103024 imi_mug_run_2_treatment "aim"
28 Q0 22212556 235 38.07488 imi_mug_run_2_treatment "matrix"
28 Q0 11257103 236 38.048836 imi_mug_run_2_treatment "estrogen" "mediated" "lead"
28 Q0 24199689 237 38.034313 imi_mug_run_2_treatment "level"
28 Q0 18060491 238 38.02643 imi_mug_run_2_treatment "program"
28 Q0 17148771 239 38.00006 imi_mug_run_2_treatment "various"
28 Q0 8875189 240 37.94819 imi_mug_run_2_treatment "basis"
28 Q0 26476542 241 37.946365 imi_mug_run_2_treatment "lead"
28 Q0 8776600 242 37.87504 imi_mug_run_2_treatment "others"
28 Q0 16261400 243 37.847725 imi_mug_run_2_treatment "aim"
28 Q0 7942844 244 37.846436 imi_mug_run_2_treatment "anonymous"
28 Q0 25510067 245 37.838776 imi_mug_run_2_treatment "aim"
28 Q0 28508305 246 37.818443 imi_mug_run_2_treatment "drug" "parp inhibitor" "therapeutics"
28 Q0 28186987 247 37.811665 imi_mug_run_2_treatment "favor"
28 Q0 7837387 248 37.778564 imi_mug_run_2_treatment "lead"
28 Q0 23199084 249 37.768486 imi_mug_run_2_treatment "level"
28 Q0 16783967 250 37.751457 imi_mug_run_2_treatment "estrogen"
28 Q0 30322717 251 37.728447 imi_mug_run_2_treatment "basis"
28 Q0 29240602 252 37.710064 imi_mug_run_2_treatment "aim"
28 Q0 30215333 253 37.702564 imi_mug_run_2_treatment "adjuvant" "cisplatin" "drugs"
28 Q0 16137751 254 37.67479 imi_mug_run_2_treatment "progestin" "duration"
28 Q0 25418591 255 37.67373 imi_mug_run_2_treatment "aim"
28 Q0 27246982 256 37.63006 imi_mug_run_2_treatment "progesterone" "ovarian hormone" "estradiol"
28 Q0 9655254 257 37.62833 imi_mug_run_2_treatment "estrogen" "antiestrogen" "ici-182780"
28 Q0 16736282 258 37.572536 imi_mug_run_2_treatment "cisplatinum" "drugs" "platinum"
28 Q0 22617326 259 37.539886 imi_mug_run_2_treatment "mediated"
28 Q0 23913204 260 37.51853 imi_mug_run_2_treatment "drugs"
28 Q0 16084122 261 37.494484 imi_mug_run_2_treatment "gonadotropin" "estradiol" "aim"
28 Q0 10203660 262 37.461475 imi_mug_run_2_treatment "program"
28 Q0 22822606 263 37.45417 imi_mug_run_2_treatment "taxane" "platinum"
28 Q0 9579822 264 37.452812 imi_mug_run_2_treatment "glycine"
28 Q0 12721241 265 37.452217 imi_mug_run_2_treatment "prophylactic"
28 Q0 20825051 266 37.44876 imi_mug_run_2_treatment "various" "methionine" "aim"
28 Q0 10505039 267 37.438957 imi_mug_run_2_treatment "aim"
28 Q0 12767038 268 37.427666 imi_mug_run_2_treatment "suppressor"
28 Q0 8808710 269 37.40654 imi_mug_run_2_treatment "lead" "basis"
28 Q0 18451254 270 37.393215 imi_mug_run_2_treatment "prophylactic"
28 Q0 22264603 271 37.372997 imi_mug_run_2_treatment "parp inhibitors"
28 Q0 17063264 272 37.353348 imi_mug_run_2_treatment "folate"
28 Q0 23415752 273 37.334557 imi_mug_run_2_treatment "parp inhibitors" "veliparib" "olaparib"
28 Q0 24389956 274 37.327038 imi_mug_run_2_treatment "prophylactic" "level" "aim"
28 Q0 11059339 275 37.31881 imi_mug_run_2_treatment "tcc"
28 Q0 15131356 276 37.3152 imi_mug_run_2_treatment "prophylactic"
28 Q0 27271530 277 37.292633 imi_mug_run_2_treatment "lead"
28 Q0 11576847 278 37.285385 imi_mug_run_2_treatment "aim"
28 Q0 24862760 279 37.273087 imi_mug_run_2_treatment "mediated"
28 Q0 12464350 280 37.26287 imi_mug_run_2_treatment "basis" "suppressor"
28 Q0 11668617 281 37.249718 imi_mug_run_2_treatment "product" "basis"
28 Q0 14666193 282 37.248108 imi_mug_run_2_treatment "prompt"
28 Q0 8714791 283 37.235905 imi_mug_run_2_treatment "basis"
28 Q0 22843497 284 37.209908 imi_mug_run_2_treatment "bisulfite"
28 Q0 26740259 285 37.18501 imi_mug_run_2_treatment "pazopanib"
28 Q0 10372578 286 37.171494 imi_mug_run_2_treatment "various" "various combinations"
28 Q0 27558151 287 37.14139 imi_mug_run_2_treatment "platinum" "anti-angiogenic agents" "poly(adp-ribose) polymerase inhibitors"
28 Q0 25927284 288 37.136143 imi_mug_run_2_treatment "basis"
28 Q0 22274543 289 37.13221 imi_mug_run_2_treatment "aim"
28 Q0 26124328 290 37.127743 imi_mug_run_2_treatment "olaparib" "protein kinase inhibitor"
28 Q0 23069884 291 37.118217 imi_mug_run_2_treatment "various"
28 Q0 26807161 292 37.07155 imi_mug_run_2_treatment "aim"
28 Q0 22673632 293 37.041275 imi_mug_run_2_treatment "platinum agents" "mediated" "poly(adp-ribose) polymerase inhibitors"
28 Q0 29567272 294 37.026016 imi_mug_run_2_treatment "olaparib" "parp inhibitor" "rucaparib"
28 Q0 15340362 295 36.981075 imi_mug_run_2_treatment "lead"
28 Q0 22176776 296 36.979233 imi_mug_run_2_treatment "platinum"
28 Q0 19110958 297 36.973106 imi_mug_run_2_treatment "medicine"
28 Q0 7894493 298 36.951885 imi_mug_run_2_treatment "lead"
28 Q0 8352830 299 36.940006 imi_mug_run_2_treatment "isolate"
28 Q0 26047697 300 36.92111 imi_mug_run_2_treatment "bmn 673"
28 Q0 10635299 301 36.91966 imi_mug_run_2_treatment "lead"
28 Q0 18500671 302 36.911602 imi_mug_run_2_treatment "glycine" "suppressor"
28 Q0 15951956 303 36.87742 imi_mug_run_2_treatment "aim"
28 Q0 12234376 304 36.87057 imi_mug_run_2_treatment "zinc" "staurosporine"
28 Q0 9764635 305 36.86484 imi_mug_run_2_treatment "gln"
28 Q0 18855126 306 36.861618 imi_mug_run_2_treatment "program"
28 Q0 25437005 307 36.84613 imi_mug_run_2_treatment "platinum" "parp inhibitor"
28 Q0 16919882 308 36.842484 imi_mug_run_2_treatment "others"
28 Q0 16825437 309 36.823456 imi_mug_run_2_treatment "aim"
28 Q0 8988179 310 36.81136 imi_mug_run_2_treatment "lead"
28 Q0 20810544 311 36.80201 imi_mug_run_2_treatment "prompt"
28 Q0 29021870 312 36.760544 imi_mug_run_2_treatment "various" "cytostatic drugs" "platinum"
28 Q0 10894872 313 36.737423 imi_mug_run_2_treatment "berry"
28 Q0 8648868 314 36.719105 imi_mug_run_2_treatment "program"
28 Q0 28073598 315 36.688103 imi_mug_run_2_treatment "platinum"
28 Q0 22488153 316 36.654892 imi_mug_run_2_treatment "estrogens" "estrogen" "contraceptive"
28 Q0 12872252 317 36.63521 imi_mug_run_2_treatment "yeast"
28 Q0 30266954 318 36.63076 imi_mug_run_2_treatment "pdx" "rucaparib" "parp inhibitor"
28 Q0 26665166 319 36.629097 imi_mug_run_2_treatment "various" "mediated" "vascular endothelial growth factor"
28 Q0 22498944 320 36.613472 imi_mug_run_2_treatment "cyclopamine"
28 Q0 26014432 321 36.58294 imi_mug_run_2_treatment "basis"
28 Q0 15687685 322 36.569016 imi_mug_run_2_treatment "estrogen"
28 Q0 17913048 323 36.567337 imi_mug_run_2_treatment "igf-ii"
28 Q0 29936257 324 36.557236 imi_mug_run_2_treatment "prophylactic" "basis"
28 Q0 9497246 325 36.549507 imi_mug_run_2_treatment "others"
28 Q0 11237395 326 36.545853 imi_mug_run_2_treatment "aim"
28 Q0 16650962 327 36.544567 imi_mug_run_2_treatment "enzymes"
28 Q0 21916573 328 36.53308 imi_mug_run_2_treatment "oral contraceptives" "prophylactic" "duration"
28 Q0 9616738 329 36.527637 imi_mug_run_2_treatment "lead"
28 Q0 8531967 330 36.524857 imi_mug_run_2_treatment "basis"
28 Q0 24748377 331 36.49368 imi_mug_run_2_treatment "drug" "parp inhibitor" "cisplatin"
28 Q0 18417966 332 36.48396 imi_mug_run_2_treatment "basis"
28 Q0 24562705 333 36.468575 imi_mug_run_2_treatment "program"
28 Q0 26301412 334 36.463253 imi_mug_run_2_treatment "antioxidant" "enzymes"
28 Q0 14516936 335 36.45848 imi_mug_run_2_treatment "anticarcinogens" "suppressor"
28 Q0 28629583 336 36.45598 imi_mug_run_2_treatment "gonadotropins" "letrozole" "level"
28 Q0 12237282 337 36.452095 imi_mug_run_2_treatment "program"
28 Q0 9534190 338 36.44689 imi_mug_run_2_treatment "pace"
28 Q0 8724217 339 36.42955 imi_mug_run_2_treatment "oral contraceptives" "contraceptive" "mediated"
28 Q0 10630177 340 36.412285 imi_mug_run_2_treatment "basis"
28 Q0 24984781 341 36.409958 imi_mug_run_2_treatment "paclitaxel" "therapeutics" "parp inhibitors"
28 Q0 28454085 342 36.37922 imi_mug_run_2_treatment "platinum" "olaparib" "parp inhibitor"
28 Q0 22253870 343 36.376774 imi_mug_run_2_treatment "platinum" "drugs"
28 Q0 27297669 344 36.363937 imi_mug_run_2_treatment "platinum" "aim"
28 Q0 24348864 345 36.35407 imi_mug_run_2_treatment "aim"
28 Q0 28057616 346 36.345192 imi_mug_run_2_treatment "parp inhibitor" "rucaparib"
28 Q0 27690218 347 36.314774 imi_mug_run_2_treatment "duration" "pooled"
28 Q0 25683334 348 36.306793 imi_mug_run_2_treatment "aim"
28 Q0 11307153 349 36.30406 imi_mug_run_2_treatment "various"
28 Q0 19723349 350 36.29608 imi_mug_run_2_treatment "contraceptives" "tamoxifen"
28 Q0 18171601 351 36.286644 imi_mug_run_2_treatment "various" "vascular endothelial growth factor"
28 Q0 25191729 352 36.258934 imi_mug_run_2_treatment "level"
28 Q0 15381934 353 36.257217 imi_mug_run_2_treatment "basis"
28 Q0 29185095 354 36.24903 imi_mug_run_2_treatment "lead" "parp inhibitors"
28 Q0 21637635 355 36.24889 imi_mug_run_2_treatment "prophylactic" "basis" "parp inhibitors"
28 Q0 8784888 356 36.238857 imi_mug_run_2_treatment "contraceptive" "level"
28 Q0 11807980 357 36.203854 imi_mug_run_2_treatment "yeast"
28 Q0 27308455 358 36.17495 imi_mug_run_2_treatment "suppressor"
28 Q0 20233478 359 36.174534 imi_mug_run_2_treatment "oral contraceptives" "oestrogen"
28 Q0 18060494 360 36.17381 imi_mug_run_2_treatment "program"
28 Q0 26171949 361 36.16434 imi_mug_run_2_treatment "various" "lead"
28 Q0 8875986 362 36.159145 imi_mug_run_2_treatment "others"
28 Q0 29189915 363 36.13726 imi_mug_run_2_treatment "drug combinations" "taxanes" "cndac"
28 Q0 16715518 364 36.13127 imi_mug_run_2_treatment "various"
28 Q0 9134530 365 36.109055 imi_mug_run_2_treatment "lead"
28 Q0 30334464 366 36.106018 imi_mug_run_2_treatment "level"
28 Q0 21913063 367 36.096977 imi_mug_run_2_treatment "parp inhibitors"
28 Q0 23300358 368 36.09009 imi_mug_run_2_treatment "various" "suppressor"
28 Q0 27875672 369 36.088333 imi_mug_run_2_treatment "program"
28 Q0 17611399 370 36.06284 imi_mug_run_2_treatment "ras"
28 Q0 30353044 371 36.05021 imi_mug_run_2_treatment "olaparib" "parp inhibitor" "parp inhibitors"
28 Q0 12112981 372 36.045494 imi_mug_run_2_treatment "contraceptive" "pill"
28 Q0 22514011 373 36.042336 imi_mug_run_2_treatment "tandem" "level"
28 Q0 19906413 374 36.03218 imi_mug_run_2_treatment "maspin" "mediated" "product"
28 Q0 16741564 375 35.99817 imi_mug_run_2_treatment "progesterone" "lead"
28 Q0 12934104 376 35.975693 imi_mug_run_2_treatment "rosiglitazone" "prostaglandin j2" "mediated"
28 Q0 9684097 377 35.968033 imi_mug_run_2_treatment "mediated"
28 Q0 8173065 378 35.962868 imi_mug_run_2_treatment "yeast"
28 Q0 21920589 379 35.957787 imi_mug_run_2_treatment "platinum" "taxane" "agent"
28 Q0 23232854 380 35.95717 imi_mug_run_2_treatment "basis"
28 Q0 17185394 381 35.883327 imi_mug_run_2_treatment "mediated" "estrogen"
28 Q0 11084537 382 35.875908 imi_mug_run_2_treatment "basis"
28 Q0 20485165 383 35.840923 imi_mug_run_2_treatment "parp inhibitor" "olaparib" "azd2281"
28 Q0 30345884 384 35.82734 imi_mug_run_2_treatment "platinum" "olaparib"
28 Q0 18281473 385 35.821827 imi_mug_run_2_treatment "level"
28 Q0 25366685 386 35.817513 imi_mug_run_2_treatment "olaparib" "poly (adp-ribose) polymerase inhibitor" "gemcitabine"
28 Q0 27167707 387 35.798737 imi_mug_run_2_treatment "aim"
28 Q0 11163768 388 35.798073 imi_mug_run_2_treatment "serine" "tyrosine"
28 Q0 28604461 389 35.788235 imi_mug_run_2_treatment "olaparib" "chemotherapeutic agent" "cisplatin"
28 Q0 20437199 390 35.772976 imi_mug_run_2_treatment "suppressor"
28 Q0 12544504 391 35.770386 imi_mug_run_2_treatment "alcohol" "oral contraceptives" "carotenoids"
28 Q0 16792513 392 35.769077 imi_mug_run_2_treatment "various"
28 Q0 28961279 393 35.768562 imi_mug_run_2_treatment "various" "aim"
28 Q0 15755003 394 35.768208 imi_mug_run_2_treatment "aim"
28 Q0 10609497 395 35.706627 imi_mug_run_2_treatment "fertility drugs" "clomiphene citrate"
28 Q0 21980511 396 35.699944 imi_mug_run_2_treatment "yeast"
28 Q0 18660546 397 35.69273 imi_mug_run_2_treatment "messenger"
28 Q0 20848184 398 35.691353 imi_mug_run_2_treatment "aim"
28 Q0 30111871 399 35.689064 imi_mug_run_2_treatment "platinum"
28 Q0 14529658 400 35.68729 imi_mug_run_2_treatment "oral contraceptives" "chemopreventive agents" "aim"
28 Q0 16944270 401 35.673004 imi_mug_run_2_treatment "aim"
28 Q0 8700535 402 35.653534 imi_mug_run_2_treatment "calcium" "ionophore" "suppressor"
28 Q0 15368961 403 35.644363 imi_mug_run_2_treatment "suppressor"
28 Q0 17901820 404 35.60933 imi_mug_run_2_treatment "various"
28 Q0 23666017 405 35.57876 imi_mug_run_2_treatment "parp inhibitor" "platinum" "olaparib"
28 Q0 29313279 406 35.57392 imi_mug_run_2_treatment "abt-767" "platinum" "food"
28 Q0 11234491 407 35.520172 imi_mug_run_2_treatment "aim"
28 Q0 21720365 408 35.512825 imi_mug_run_2_treatment "duration"
28 Q0 9667663 409 35.50328 imi_mug_run_2_treatment "tyrosine" "guanidine"
28 Q0 28212807 410 35.50328 imi_mug_run_2_treatment "mpla"
28 Q0 11198956 411 35.493004 imi_mug_run_2_treatment "oral contraceptives" "cyclophosphamide" "paclitaxel"
28 Q0 10665701 412 35.488594 imi_mug_run_2_treatment "combinations" "tamoxifen" "prophylactic"
28 Q0 23779253 413 35.476448 imi_mug_run_2_treatment "lead"
28 Q0 22481932 414 35.47594 imi_mug_run_2_treatment "cancer drug" "therapeutics" "revival"
28 Q0 24213462 415 35.46485 imi_mug_run_2_treatment "various"
28 Q0 18720553 416 35.459846 imi_mug_run_2_treatment "platinum" "parp inhibitors"
28 Q0 20944665 417 35.44588 imi_mug_run_2_treatment "genesis"
28 Q0 16507150 418 35.445343 imi_mug_run_2_treatment "aim"
28 Q0 21385923 419 35.439457 imi_mug_run_2_treatment "carboplatin" "paclitaxel"
28 Q0 27692298 420 35.41962 imi_mug_run_2_treatment "auranofin" "n-acetyl cysteine" "oxygen"
28 Q0 28549976 421 35.40463 imi_mug_run_2_treatment "aim"
28 Q0 21559243 422 35.39454 imi_mug_run_2_treatment "various"
28 Q0 9425226 423 35.382736 imi_mug_run_2_treatment "mediated"
28 Q0 21339094 424 35.379444 imi_mug_run_2_treatment "prophylactic" "plasma"
28 Q0 17579243 425 35.372116 imi_mug_run_2_treatment "estrogen" "suppressor"
28 Q0 30392916 426 35.364033 imi_mug_run_2_treatment "lavage fluids"
28 Q0 17404506 427 35.34836 imi_mug_run_2_treatment "dsb" "agent" "level"
28 Q0 29166829 428 35.324593 imi_mug_run_2_treatment "rucaparib" "poly(adp-ribose) polymerase inhibitor"
28 Q0 8571953 429 35.298996 imi_mug_run_2_treatment "tandem"
28 Q0 24078348 430 35.297523 imi_mug_run_2_treatment "enzyme digestion"
28 Q0 27141070 431 35.29722 imi_mug_run_2_treatment "parp inhibitors" "olaparib" "agent"
28 Q0 29856239 432 35.2815 imi_mug_run_2_treatment "niraparib" "diphosphate" "platinum"
28 Q0 30506513 433 35.274628 imi_mug_run_2_treatment "program"
28 Q0 10675491 434 35.246605 imi_mug_run_2_treatment "ras"
28 Q0 29618939 435 35.241047 imi_mug_run_2_treatment "others"
28 Q0 11136250 436 35.237892 imi_mug_run_2_treatment "lead"
28 Q0 11263939 437 35.22358 imi_mug_run_2_treatment "estrogen" "others" "nervous system"
28 Q0 29797793 438 35.17277 imi_mug_run_2_treatment "drug"
28 Q0 27003155 439 35.17276 imi_mug_run_2_treatment "olaparib" "platinum" "basis"
28 Q0 18851829 440 35.161636 imi_mug_run_2_treatment "resveratrol" "mediators"
28 Q0 26848529 441 35.141495 imi_mug_run_2_treatment "level"
28 Q0 15254451 442 35.140873 imi_mug_run_2_treatment "dtc" "salt" "pharmaceuticals"
28 Q0 15796958 443 35.1305 imi_mug_run_2_treatment "others"
28 Q0 18783588 444 35.130314 imi_mug_run_2_treatment "centuries"
28 Q0 19635727 445 35.116714 imi_mug_run_2_treatment "prophylactic" "aim"
28 Q0 10938285 446 35.11045 imi_mug_run_2_treatment "anticancer agents" "fas ligand"
28 Q0 15128012 447 35.107918 imi_mug_run_2_treatment "various"
28 Q0 27385701 448 35.107365 imi_mug_run_2_treatment "platinum" "parp inhibitor" "olaparib"
28 Q0 24755492 449 35.106567 imi_mug_run_2_treatment "various" "contraceptive"
28 Q0 30045136 450 35.105568 imi_mug_run_2_treatment "bisulfite"
28 Q0 16218901 451 35.071392 imi_mug_run_2_treatment "basis" "tamoxifen" "her-2"
28 Q0 15729202 452 35.06221 imi_mug_run_2_treatment "paclitaxel" "ras" "platinum"
28 Q0 10824194 453 35.047855 imi_mug_run_2_treatment "genesis"
28 Q0 19519295 454 35.047165 imi_mug_run_2_treatment "taxanes" "taxane" "paclitaxel"
28 Q0 7894491 455 35.037346 imi_mug_run_2_treatment "glycine" "suppressor"
28 Q0 7987831 456 35.0373 imi_mug_run_2_treatment "yeast"
28 Q0 25499884 457 35.02874 imi_mug_run_2_treatment "carboplatin" "taxol" "taxane"
28 Q0 25036526 458 35.01329 imi_mug_run_2_treatment "various"
28 Q0 24273914 459 35.006935 imi_mug_run_2_treatment "paclitaxel" "cisplatin" "carboplatin"
28 Q0 10972993 460 34.978317 imi_mug_run_2_treatment "androgen"
28 Q0 17764207 461 34.970528 imi_mug_run_2_treatment "various"
28 Q0 30414739 462 34.96661 imi_mug_run_2_treatment "olaparib" "mediated" "lead"
28 Q0 11039575 463 34.959023 imi_mug_run_2_treatment "others"
28 Q0 29298688 464 34.940933 imi_mug_run_2_treatment "agent" "platinum"
28 Q0 12955719 465 34.935104 imi_mug_run_2_treatment "level" "aim"
28 Q0 8566965 466 34.916603 imi_mug_run_2_treatment "color"
28 Q0 11880951 467 34.915333 imi_mug_run_2_treatment "hot spot" "level"
28 Q0 23748177 468 34.909676 imi_mug_run_2_treatment "various" "contraceptive"
28 Q0 9017003 469 34.880867 imi_mug_run_2_treatment "various" "basis"
28 Q0 20973257 470 34.88035 imi_mug_run_2_treatment "poly(adp-ribose) polymerase inhibitors"
28 Q0 11191790 471 34.875557 imi_mug_run_2_treatment "level"
28 Q0 22711610 472 34.869286 imi_mug_run_2_treatment "various" "prophylactic"
28 Q0 12594936 473 34.865253 imi_mug_run_2_treatment "prophylactic" "oral contraceptives"
28 Q0 26983446 474 34.861942 imi_mug_run_2_treatment "aim"
28 Q0 11493692 475 34.861855 imi_mug_run_2_treatment "estrogen" "basis"
28 Q0 8563759 476 34.85128 imi_mug_run_2_treatment "zinc" "suppressor"
28 Q0 27318890 477 34.83864 imi_mug_run_2_treatment "basis" "others"
28 Q0 30186027 478 34.80888 imi_mug_run_2_treatment "drug" "olaparib" "niraparib"
28 Q0 19584259 479 34.774147 imi_mug_run_2_treatment "nh2" "genesis"
28 Q0 7587109 480 34.765152 imi_mug_run_2_treatment "isolate"
28 Q0 19035454 481 34.764786 imi_mug_run_2_treatment "platinum" "cisplatin" "carboplatin"
28 Q0 19606050 482 34.75567 imi_mug_run_2_treatment "program"
28 Q0 21228333 483 34.755005 imi_mug_run_2_treatment "ci 4"
28 Q0 16170371 484 34.75123 imi_mug_run_2_treatment "estrogen" "cyclic amp" "lead"
28 Q0 11084459 485 34.750477 imi_mug_run_2_treatment "basis" "il12"
28 Q0 11102977 486 34.736805 imi_mug_run_2_treatment "favor"
28 Q0 18819462 487 34.729927 imi_mug_run_2_treatment "aim" "basis"
28 Q0 22361722 488 34.719093 imi_mug_run_2_treatment "aim"
28 Q0 9061278 489 34.715015 imi_mug_run_2_treatment "prophylactic"
28 Q0 12362976 490 34.710503 imi_mug_run_2_treatment "asa"
28 Q0 9663595 491 34.709686 imi_mug_run_2_treatment "estrogen"
28 Q0 17570734 492 34.67032 imi_mug_run_2_treatment "prophylactic"
28 Q0 20149041 493 34.663338 imi_mug_run_2_treatment "aim"
28 Q0 16835424 494 34.660843 imi_mug_run_2_treatment "prophylactic"
28 Q0 18776923 495 34.647034 imi_mug_run_2_treatment "glucose" "mediated"
28 Q0 21183737 496 34.63958 imi_mug_run_2_treatment "ag014699" "drug" "cytotoxic"
28 Q0 10388131 497 34.637363 imi_mug_run_2_treatment "basis"
28 Q0 7987646 498 34.630096 imi_mug_run_2_treatment "basis"
28 Q0 30254278 499 34.628265 imi_mug_run_2_treatment "shape"
28 Q0 28188963 500 34.619408 imi_mug_run_2_treatment "aim"
28 Q0 22711857 501 34.601357 imi_mug_run_2_treatment "poly(adp-ribose) polymerase inhibitor"
28 Q0 20811668 502 34.59245 imi_mug_run_2_treatment "aim"
28 Q0 26402249 503 34.57079 imi_mug_run_2_treatment "platinum" "poly(adp-ribose) polymerase inhibitors"
28 Q0 12242698 504 34.56373 imi_mug_run_2_treatment "various"
28 Q0 24529552 505 34.5616 imi_mug_run_2_treatment "adjuvant"
28 Q0 15083174 506 34.561523 imi_mug_run_2_treatment "prophylactic"
28 Q0 26025000 507 34.553143 imi_mug_run_2_treatment "basis"
28 Q0 29236234 508 34.54985 imi_mug_run_2_treatment "aim"
28 Q0 28561656 509 34.537025 imi_mug_run_2_treatment "combinations" "parp inhibitors"
28 Q0 29605737 510 34.51777 imi_mug_run_2_treatment "rucaparib" "parp inhibitor" "olaparib"
28 Q0 27444036 511 34.516308 imi_mug_run_2_treatment "panobinostat" "olaparib" "drugs"
28 Q0 25329591 512 34.51364 imi_mug_run_2_treatment "food"
28 Q0 10464631 513 34.513504 imi_mug_run_2_treatment "various"
28 Q0 10480351 514 34.486294 imi_mug_run_2_treatment "tandem"
28 Q0 28702897 515 34.476727 imi_mug_run_2_treatment "others"
28 Q0 23553196 516 34.470734 imi_mug_run_2_treatment "prophylactic"
28 Q0 26909613 517 34.46749 imi_mug_run_2_treatment "parp inhibitor" "drug combination" "olaparib"
28 Q0 11336395 518 34.46496 imi_mug_run_2_treatment "various" "aim"
28 Q0 21862407 519 34.453377 imi_mug_run_2_treatment "drug" "olaparib" "azd2281"
28 Q0 11745677 520 34.437157 imi_mug_run_2_treatment "oestrogen" "aim"
28 Q0 21281505 521 34.435913 imi_mug_run_2_treatment "basis"
28 Q0 20700108 522 34.43408 imi_mug_run_2_treatment "drugs" "parp inhibitors" "drug combinations"
28 Q0 27282964 523 34.40345 imi_mug_run_2_treatment "metformin" "olaparib" "parp inhibitors"
28 Q0 9698466 524 34.38859 imi_mug_run_2_treatment "aim" "tac"
28 Q0 28497333 525 34.3875 imi_mug_run_2_treatment "aim"
28 Q0 9484627 526 34.379707 imi_mug_run_2_treatment "basis"
28 Q0 16287141 527 34.367767 imi_mug_run_2_treatment "product"
28 Q0 26476890 528 34.367146 imi_mug_run_2_treatment "duration"
28 Q0 29252925 529 34.366898 imi_mug_run_2_treatment "drug" "program"
28 Q0 19298662 530 34.34889 imi_mug_run_2_treatment "estrogen"
28 Q0 12112982 531 34.345966 imi_mug_run_2_treatment "cytostatic"
28 Q0 15557797 532 34.335632 imi_mug_run_2_treatment "aim"
28 Q0 22788971 533 34.331577 imi_mug_run_2_treatment "olaparib" "parp inhibitor" "drugs"
28 Q0 22137482 534 34.32635 imi_mug_run_2_treatment "drugs"
28 Q0 20233484 535 34.319435 imi_mug_run_2_treatment "oral contraceptives" "tamoxifen"
28 Q0 15816544 536 34.28282 imi_mug_run_2_treatment "progesterone"
28 Q0 16773440 537 34.27961 imi_mug_run_2_treatment "estrogens"
28 Q0 9041180 538 34.277554 imi_mug_run_2_treatment "mediated"
28 Q0 16417652 539 34.27176 imi_mug_run_2_treatment "various" "level"
28 Q0 30295091 540 34.269768 imi_mug_run_2_treatment "prophylactic" "suppressor"
28 Q0 25591549 541 34.261433 imi_mug_run_2_treatment "asa" "cisplatin" "thr"
28 Q0 28007588 542 34.261127 imi_mug_run_2_treatment "prophylactic"
28 Q0 22798144 543 34.25952 imi_mug_run_2_treatment "pooled"
28 Q0 28231738 544 34.233368 imi_mug_run_2_treatment "program"
28 Q0 27673289 545 34.23094 imi_mug_run_2_treatment "olaparib" "parp inhibitors" "medicines"
28 Q0 23113749 546 34.221386 imi_mug_run_2_treatment "various"
28 Q0 16998497 547 34.215794 imi_mug_run_2_treatment "oral contraceptives"
28 Q0 23716468 548 34.205677 imi_mug_run_2_treatment "metric" "level" "others"
28 Q0 22187320 549 34.204422 imi_mug_run_2_treatment "ci 4"
28 Q0 7835800 550 34.19657 imi_mug_run_2_treatment "contraceptive" "duration"
28 Q0 7749139 551 34.189346 imi_mug_run_2_treatment "basis"
28 Q0 26691937 552 34.182205 imi_mug_run_2_treatment "basis" "parp inhibitors"
28 Q0 14574155 553 34.168343 imi_mug_run_2_treatment "aim"
28 Q0 15863145 554 34.167244 imi_mug_run_2_treatment "prophylactic"
28 Q0 29671401 555 34.160084 imi_mug_run_2_treatment "level" "matrix"
28 Q0 26569048 556 34.15681 imi_mug_run_2_treatment "clomiphene" "prophylactic" "others"
28 Q0 29470806 557 34.152588 imi_mug_run_2_treatment "basis"
28 Q0 21721203 558 34.132927 imi_mug_run_2_treatment "parp inhibitors" "drugs" "therapeutic agents"
28 Q0 10883018 559 34.106636 imi_mug_run_2_treatment "androgen" "gonadotropin" "contraceptive"
28 Q0 29731958 560 34.103504 imi_mug_run_2_treatment "diphosphate" "platinum" "olaparib"
28 Q0 15970701 561 34.092186 imi_mug_run_2_treatment "basis"
28 Q0 9839517 562 34.068436 imi_mug_run_2_treatment "progesterone" "gonadotropin" "androgens"
28 Q0 19223511 563 34.051064 imi_mug_run_2_treatment "estrogen" "antiestrogen" "tamoxifen"
28 Q0 26303225 564 34.04988 imi_mug_run_2_treatment "lys" "parp inhibitor" "platinum"
28 Q0 16397213 565 34.025642 imi_mug_run_2_treatment "monoclonal antibodies"
28 Q0 23729402 566 34.02358 imi_mug_run_2_treatment "rucaparib" "topotecan" "agent"
28 Q0 19582179 567 34.008614 imi_mug_run_2_treatment "combinations" "contraceptive"
28 Q0 28258387 568 34.002663 imi_mug_run_2_treatment "parp inhibitor" "diphosphate"
28 Q0 9378159 569 34.002243 imi_mug_run_2_treatment "enzymes" "immunomodulators" "drug"
28 Q0 11250724 570 34.00135 imi_mug_run_2_treatment "generic"
28 Q0 29492181 571 34.001133 imi_mug_run_2_treatment "various"
28 Q0 20608970 572 33.9936 imi_mug_run_2_treatment "various"
28 Q0 28831036 573 33.974426 imi_mug_run_2_treatment "platinum"
28 Q0 20606085 574 33.97184 imi_mug_run_2_treatment "platinum"
28 Q0 22384640 575 33.951687 imi_mug_run_2_treatment "prophylactic"
28 Q0 16085232 576 33.946358 imi_mug_run_2_treatment "oral contraceptives" "contraceptive" "prophylactic"
28 Q0 17138902 577 33.94507 imi_mug_run_2_treatment "progesterone antagonist" "mifepristone" "mediated"
28 Q0 11598149 578 33.921814 imi_mug_run_2_treatment "level"
28 Q0 26026974 579 33.92148 imi_mug_run_2_treatment "mbc"
28 Q0 25225577 580 33.917957 imi_mug_run_2_treatment "product"
28 Q0 24752005 581 33.913525 imi_mug_run_2_treatment "fertility drugs"
28 Q0 21521830 582 33.90553 imi_mug_run_2_treatment "platinum" "vascular endothelial growth factor" "platinum agents"
28 Q0 27065456 583 33.894035 imi_mug_run_2_treatment "parp inhibitors" "parp inhibitor" "drugs"
28 Q0 11499181 584 33.889275 imi_mug_run_2_treatment "drug" "carboplatin" "paclitaxel"
28 Q0 11058866 585 33.859497 imi_mug_run_2_treatment "various"
28 Q0 30050740 586 33.79947 imi_mug_run_2_treatment "platinum" "diphosphate" "carboplatin"
28 Q0 17225260 587 33.78103 imi_mug_run_2_treatment "program"
28 Q0 23548269 588 33.77687 imi_mug_run_2_treatment "cisplatin" "gemcitabine" "mediated"
28 Q0 20733460 589 33.775913 imi_mug_run_2_treatment "prophylactic" "level"
28 Q0 11766142 590 33.7711 imi_mug_run_2_treatment "oral contraceptives"
28 Q0 10667571 591 33.759377 imi_mug_run_2_treatment "ors"
28 Q0 10197592 592 33.74482 imi_mug_run_2_treatment "product"
28 Q0 28569838 593 33.74272 imi_mug_run_2_treatment "parp inhibitor" "cisplatin" "dsb"
28 Q0 10667592 594 33.738907 imi_mug_run_2_treatment "hydrogen peroxide"
28 Q0 8116068 595 33.733204 imi_mug_run_2_treatment "anonymous"
28 Q0 29330845 596 33.725067 imi_mug_run_2_treatment "aim"
28 Q0 25033687 597 33.724777 imi_mug_run_2_treatment "platinum" "cisplatin"
28 Q0 10435598 598 33.71737 imi_mug_run_2_treatment "enzymes" "mediated"
28 Q0 20887168 599 33.695198 imi_mug_run_2_treatment "adjuvant" "drugs" "antiangiogenic agents"
28 Q0 29137324 600 33.691048 imi_mug_run_2_treatment "platinum" "mediated" "lead"
28 Q0 16973716 601 33.68756 imi_mug_run_2_treatment "basis"
28 Q0 8401501 602 33.674847 imi_mug_run_2_treatment "estradiol"
28 Q0 12096084 603 33.6746 imi_mug_run_2_treatment "interferon" "lead"
28 Q0 15449557 604 33.674053 imi_mug_run_2_treatment "aim"
28 Q0 15345110 605 33.67287 imi_mug_run_2_treatment "lead"
28 Q0 9538124 606 33.66198 imi_mug_run_2_treatment "basis"
28 Q0 26017449 607 33.580635 imi_mug_run_2_treatment "platinum"
28 Q0 23462720 608 33.56047 imi_mug_run_2_treatment "paclitaxel" "cisplatin" "platinum"
28 Q0 9406579 609 33.550095 imi_mug_run_2_treatment "various"
28 Q0 17342202 610 33.547405 imi_mug_run_2_treatment "level"
28 Q0 18208621 611 33.545097 imi_mug_run_2_treatment "lead"
28 Q0 20349280 612 33.538223 imi_mug_run_2_treatment "product" "program"
28 Q0 27487106 613 33.530907 imi_mug_run_2_treatment "olaparib" "parp inhibitor" "agent"
28 Q0 29054568 614 33.521564 imi_mug_run_2_treatment "combinations"
28 Q0 8075631 615 33.51414 imi_mug_run_2_treatment "basis"
28 Q0 21319511 616 33.5126 imi_mug_run_2_treatment "aim"
28 Q0 17063271 617 33.507496 imi_mug_run_2_treatment "aim"
28 Q0 15924337 618 33.495857 imi_mug_run_2_treatment "dsb"
28 Q0 24249359 619 33.472343 imi_mug_run_2_treatment "aim"
28 Q0 9679765 620 33.4657 imi_mug_run_2_treatment "camptothecin" "etoposide" "nitrogen mustard"
28 Q0 16776856 621 33.459675 imi_mug_run_2_treatment "various"
28 Q0 18410690 622 33.439335 imi_mug_run_2_treatment "bso" "prophylactic" "autologous"
28 Q0 12787778 623 33.431244 imi_mug_run_2_treatment "suppressor"
28 Q0 23009828 624 33.424767 imi_mug_run_2_treatment "basis"
28 Q0 15383145 625 33.421307 imi_mug_run_2_treatment "mediated"
28 Q0 18187487 626 33.399906 imi_mug_run_2_treatment "plumbagin" "estrogen" "cisplatin"
28 Q0 14658222 627 33.38874 imi_mug_run_2_treatment "aim"
28 Q0 16436012 628 33.380943 imi_mug_run_2_treatment "estrogen"
28 Q0 22290577 629 33.37687 imi_mug_run_2_treatment "agent" "plumbagin" "menadione"
28 Q0 10676562 630 33.37314 imi_mug_run_2_treatment "level"
28 Q0 27716873 631 33.361332 imi_mug_run_2_treatment "parp inhibitors" "platinum" "parp inhibitor"
28 Q0 29938003 632 33.359478 imi_mug_run_2_treatment "aim"
28 Q0 21216588 633 33.358795 imi_mug_run_2_treatment "platinum" "taxol" "level"
28 Q0 26785283 634 33.348064 imi_mug_run_2_treatment "platinum" "trabectedin" "pegylated liposomal doxorubicin"
28 Q0 20689651 635 33.344963 imi_mug_run_2_treatment "ors"
28 Q0 9528852 636 33.344566 imi_mug_run_2_treatment "mediated"
28 Q0 19383374 637 33.33892 imi_mug_run_2_treatment "basis"
28 Q0 9415688 638 33.32972 imi_mug_run_2_treatment "favor"
28 Q0 24237098 639 33.282543 imi_mug_run_2_treatment "medication"
28 Q0 12497638 640 33.282227 imi_mug_run_2_treatment "various" "mediated"
28 Q0 11873550 641 33.280193 imi_mug_run_2_treatment "basis"
28 Q0 24857070 642 33.27745 imi_mug_run_2_treatment "level"
28 Q0 24737347 643 33.271427 imi_mug_run_2_treatment "program"
28 Q0 25256924 644 33.26137 imi_mug_run_2_treatment "lead" "level"
28 Q0 27484786 645 33.260178 imi_mug_run_2_treatment "mms" "yeast" "agent"
28 Q0 21276604 646 33.251465 imi_mug_run_2_treatment "lead"
28 Q0 29511213 647 33.23854 imi_mug_run_2_treatment "drugs" "parp inhibitors"
28 Q0 17250664 648 33.225563 imi_mug_run_2_treatment "birth control pill" "tamoxifen" "various"
28 Q0 26822887 649 33.222744 imi_mug_run_2_treatment "basis"
28 Q0 10053113 650 33.20896 imi_mug_run_2_treatment "aim"
28 Q0 21360002 651 33.19226 imi_mug_run_2_treatment "lead" "parp inhibitors"
28 Q0 18235242 652 33.187157 imi_mug_run_2_treatment "various"
28 Q0 21863257 653 33.155598 imi_mug_run_2_treatment "lys" "level"
28 Q0 24624361 654 33.128418 imi_mug_run_2_treatment "platinum"
28 Q0 27623744 655 33.12437 imi_mug_run_2_treatment "program" "aim"
28 Q0 19060844 656 33.107025 imi_mug_run_2_treatment "adjuvant"
28 Q0 20223009 657 33.092182 imi_mug_run_2_treatment "aim"
28 Q0 27939982 658 33.08572 imi_mug_run_2_treatment "platinum" "cyclophosphamide" "taxane"
28 Q0 22836122 659 33.075645 imi_mug_run_2_treatment "mediated" "agent"
28 Q0 18095154 660 33.06376 imi_mug_run_2_treatment "stimulants"
28 Q0 16047333 661 33.05806 imi_mug_run_2_treatment "aim"
28 Q0 29405995 662 33.056625 imi_mug_run_2_treatment "product" "genesis"
28 Q0 22739995 663 33.044823 imi_mug_run_2_treatment "ci 4"
28 Q0 25823848 664 33.03973 imi_mug_run_2_treatment "various" "platinum"
28 Q0 16152612 665 33.01927 imi_mug_run_2_treatment "arginine" "glutamine" "lead"
28 Q0 22370629 666 32.99428 imi_mug_run_2_treatment "favor" "others"
28 Q0 23522120 667 32.993214 imi_mug_run_2_treatment "carboplatin" "paclitaxel"
28 Q0 20380699 668 32.985775 imi_mug_run_2_treatment "aim"
28 Q0 22759740 669 32.98085 imi_mug_run_2_treatment "parp inhibitors" "parp inhibitor" "olaparib"
28 Q0 30247247 670 32.975426 imi_mug_run_2_treatment "cisplatin" "drugs"
28 Q0 18279628 671 32.956444 imi_mug_run_2_treatment "program"
28 Q0 27534398 672 32.95557 imi_mug_run_2_treatment "messenger" "level" "aim"
28 Q0 20603439 673 32.95254 imi_mug_run_2_treatment "cisplatin"
28 Q0 15809716 674 32.950016 imi_mug_run_2_treatment "drugs" "antitumor agents" "vinorelbine"
28 Q0 22085629 675 32.940395 imi_mug_run_2_treatment "aim"
28 Q0 15140370 676 32.93866 imi_mug_run_2_treatment "aim" "others"
28 Q0 7550308 677 32.930077 imi_mug_run_2_treatment "progesterone" "beta-estradiol" "animals"
28 Q0 29259228 678 32.92913 imi_mug_run_2_treatment "plasma"
28 Q0 23047548 679 32.91182 imi_mug_run_2_treatment "platinum" "parp inhibitors"
28 Q0 28423708 680 32.911358 imi_mug_run_2_treatment "cisplatin" "drugs"
28 Q0 8024576 681 32.906773 imi_mug_run_2_treatment "oestrogen" "oestradiol" "oestrogens"
28 Q0 27767231 682 32.903957 imi_mug_run_2_treatment "basis" "poly(adp-ribose) polymerase inhibitors"
28 Q0 12845657 683 32.892754 imi_mug_run_2_treatment "aim"
28 Q0 9482880 684 32.88414 imi_mug_run_2_treatment "mediated"
28 Q0 29710224 685 32.880642 imi_mug_run_2_treatment "estrogen" "progesterone" "prophylactic"
28 Q0 22708332 686 32.87778 imi_mug_run_2_treatment "platinum" "aim"
28 Q0 27225819 687 32.87732 imi_mug_run_2_treatment "parp inhibitor" "aim"
28 Q0 20807817 688 32.864754 imi_mug_run_2_treatment "cisplatin" "platinum"
28 Q0 22887716 689 32.854332 imi_mug_run_2_treatment "lead"
28 Q0 26381082 690 32.84754 imi_mug_run_2_treatment "yeast" "aim"
28 Q0 23339184 691 32.847176 imi_mug_run_2_treatment "mediated"
28 Q0 9625861 692 32.843864 imi_mug_run_2_treatment "k-18"
28 Q0 26780555 693 32.840607 imi_mug_run_2_treatment "duration"
28 Q0 12215246 694 32.829185 imi_mug_run_2_treatment "others"
28 Q0 17070800 695 32.821754 imi_mug_run_2_treatment "cisplatin" "agent"
28 Q0 21734577 696 32.807194 imi_mug_run_2_treatment "platinum" "therapeutic agents"
28 Q0 21331759 697 32.800873 imi_mug_run_2_treatment "combinations" "drugs" "mediated"
29 Q0 23598960 1 49.18113 imi_mug_run_2_treatment "enzymes"
29 Q0 25895133 2 45.754868 imi_mug_run_2_treatment "agi-5198"
29 Q0 26368816 3 45.188744 imi_mug_run_2_treatment "enzymes" "agi-5198" "matrix"
29 Q0 29576625 4 44.68212 imi_mug_run_2_treatment "metformin" "chloroquine" "phenformin"
29 Q0 25648524 5 39.734474 imi_mug_run_2_treatment "aim"
29 Q0 22674453 6 38.35695 imi_mug_run_2_treatment "level" "aim"
29 Q0 25024164 7 36.400646 imi_mug_run_2_treatment "activin" "matrix"
29 Q0 28124097 8 34.21511 imi_mug_run_2_treatment "bay 1436032" "drugs"
29 Q0 23958880 9 33.95844 imi_mug_run_2_treatment "drug" "monolayer" "matrix"
29 Q0 22323113 10 33.499943 imi_mug_run_2_treatment "various"
29 Q0 29581779 11 33.408333 imi_mug_run_2_treatment "aim"
29 Q0 23954893 12 32.89826 imi_mug_run_2_treatment "enzymes"
29 Q0 26198745 13 31.737633 imi_mug_run_2_treatment "arginine" "serine"
29 Q0 23796461 14 28.60387 imi_mug_run_2_treatment "enzymes"
29 Q0 21598255 15 28.043266 imi_mug_run_2_treatment "enzyme digestion"
29 Q0 28601826 16 27.582588 imi_mug_run_2_treatment "chloroquine" "metformin" "antimalarial drug"
29 Q0 24880135 17 26.550007 imi_mug_run_2_treatment "icc"
29 Q0 29773061 18 25.928207 imi_mug_run_2_treatment "enzymes" "mediated" "therapeutics"
29 Q0 26819452 19 25.830173 imi_mug_run_2_treatment "various" "enzymes"
29 Q0 24458248 20 25.777246 imi_mug_run_2_treatment "pthrp"
29 Q0 25753205 21 25.187908 imi_mug_run_2_treatment "msmab" "monoclonal antibodies"
29 Q0 27355333 22 25.138695 imi_mug_run_2_treatment "tca" "ag881"
29 Q0 24995286 23 22.06623 imi_mug_run_2_treatment "various" "cytotoxic" "aim"
29 Q0 27461824 24 21.964376 imi_mug_run_2_treatment "level"
29 Q0 30281149 25 20.685135 imi_mug_run_2_treatment "therapeutics"
29 Q0 27014623 26 18.527155 imi_mug_run_2_treatment "various" "glucose" "lactate"
29 Q0 22387046 27 18.527155 imi_mug_run_2_treatment "others" "therapeutics"
30 Q0 26626801 1 45.733315 imi_mug_run_2_treatment "aim"
30 Q0 21478295 2 45.15506 imi_mug_run_2_treatment "level"
30 Q0 22146979 3 42.424053 imi_mug_run_2_treatment "ras"
30 Q0 28339086 4 39.32006 imi_mug_run_2_treatment "aim"
30 Q0 26045339 5 38.027905 imi_mug_run_2_treatment "insulin"
30 Q0 22888282 6 37.58437 imi_mug_run_2_treatment "her-2"
30 Q0 30349605 7 36.419556 imi_mug_run_2_treatment "combinations" "progestins" "everolimus"
30 Q0 25431800 8 36.322666 imi_mug_run_2_treatment "combinations" "progestins" "everolimus"
30 Q0 28829506 9 34.554256 imi_mug_run_2_treatment "agonist" "level"
30 Q0 26469692 10 32.89732 imi_mug_run_2_treatment "arq 092" "arq 751" "chemotherapeutic agent"
30 Q0 27016228 11 32.68974 imi_mug_run_2_treatment "temsirolimus" "tamoxifen" "megestrol acetate"
30 Q0 26374646 12 32.298584 imi_mug_run_2_treatment "ppi" "hub"
30 Q0 26676464 13 32.16324 imi_mug_run_2_treatment "level" "aim"
30 Q0 25372641 14 31.143759 imi_mug_run_2_treatment "level"
30 Q0 21487925 15 30.835451 imi_mug_run_2_treatment "various"
30 Q0 29527004 16 29.807224 imi_mug_run_2_treatment "various" "enzymes" "glucose"
30 Q0 23166678 17 29.543682 imi_mug_run_2_treatment "mediated"
30 Q0 26366417 18 29.087086 imi_mug_run_2_treatment "hub" "ppi" "aim"
30 Q0 23674493 19 28.477634 imi_mug_run_2_treatment "temsirolimus" "mtor inhibitor" "azd6482"
30 Q0 25528496 20 27.69366 imi_mug_run_2_treatment "pilaralisib" "xl147"
30 Q0 26501081 21 27.495394 imi_mug_run_2_treatment "androgen" "androgens"
30 Q0 30021163 22 27.275043 imi_mug_run_2_treatment "enzymes"
30 Q0 24573554 23 27.129848 imi_mug_run_2_treatment "ras"
30 Q0 18245521 24 26.37495 imi_mug_run_2_treatment "ile" "anti-inflammatory" "nonsteroidal anti-inflammatory drugs"
30 Q0 28240679 25 26.355576 imi_mug_run_2_treatment "arq 092" "arq 087" "ras"
30 Q0 26608077 26 25.000008 imi_mug_run_2_treatment "ras" "aza" "estradiol"
30 Q0 25475121 27 24.920052 imi_mug_run_2_treatment "level"
30 Q0 29725442 28 23.869804 imi_mug_run_2_treatment "aim"
30 Q0 28521404 29 23.803041 imi_mug_run_2_treatment "various" "hub" "aim"
30 Q0 26458310 30 23.277256 imi_mug_run_2_treatment "fructose" "ppi" "hub"
30 Q0 25701704 31 22.715763 imi_mug_run_2_treatment "level"
30 Q0 27291819 32 22.692154 imi_mug_run_2_treatment "aim"
30 Q0 30126855 33 22.662354 imi_mug_run_2_treatment "level" "agent" "oil"
30 Q0 25201530 34 21.79829 imi_mug_run_2_treatment "spink1"
30 Q0 25193464 35 21.61347 imi_mug_run_2_treatment "combinations" "hdac inhibitor" "drugs"
30 Q0 27499902 36 21.410616 imi_mug_run_2_treatment "others"
30 Q0 23980150 37 21.314302 imi_mug_run_2_treatment "insulin" "igf1" "insulin-like growth factor 1"
30 Q0 28714374 38 21.05771 imi_mug_run_2_treatment "level"
30 Q0 21978709 39 20.007751 imi_mug_run_2_treatment "igf2" "aim"
30 Q0 30106120 40 19.867256 imi_mug_run_2_treatment "hub" "level" "matrix"
30 Q0 30283446 41 19.664028 imi_mug_run_2_treatment "parp inhibitor"
30 Q0 30181556 42 19.565147 imi_mug_run_2_treatment "tam"
30 Q0 21567096 43 19.469116 imi_mug_run_2_treatment "various"
30 Q0 25850957 44 19.244339 imi_mug_run_2_treatment "aim"
30 Q0 27633132 45 19.244339 imi_mug_run_2_treatment "tmz" "temozolomide" "magnesium"
30 Q0 28280736 46 18.052132 imi_mug_run_2_treatment "combinations"
30 Q0 20457246 47 18.005096 imi_mug_run_2_treatment "estrogen" "combinations" "aspirin"
30 Q0 29371924 48 17.928745 imi_mug_run_2_treatment "trastuzumab" "cisplatin" "fluorouracil"
30 Q0 26021831 49 17.88284 imi_mug_run_2_treatment "anastrozole" "everolimus"
30 Q0 24659799 50 17.853745 imi_mug_run_2_treatment "mediated"
30 Q0 26684804 51 17.753206 imi_mug_run_2_treatment "gemcitabine"
30 Q0 26419366 52 17.749756 imi_mug_run_2_treatment "egfr inhibitor" "cytokines" "aim"
30 Q0 29703908 53 17.746288 imi_mug_run_2_treatment "drugs" "drug" "cancer drug"
30 Q0 25746038 54 17.630585 imi_mug_run_2_treatment "various"
30 Q0 30181805 55 17.556019 imi_mug_run_2_treatment "trastuzumab" "hub" "ppi"
30 Q0 28478612 56 17.45478 imi_mug_run_2_treatment "insulin" "estrogen" "glucose"
30 Q0 24643999 57 17.340542 imi_mug_run_2_treatment "various"
30 Q0 21571862 58 17.10337 imi_mug_run_2_treatment "drug" "platinum" "cisplatin"
30 Q0 26718977 59 17.026957 imi_mug_run_2_treatment "basis"
30 Q0 29887958 60 16.990616 imi_mug_run_2_treatment "various" "hub" "ppi"
30 Q0 18336616 61 16.692894 imi_mug_run_2_treatment "various"
30 Q0 24189654 62 16.2074 imi_mug_run_2_treatment "tandem"
30 Q0 29693170 63 16.175592 imi_mug_run_2_treatment "hub"
30 Q0 29567332 64 16.028563 imi_mug_run_2_treatment "aim"
30 Q0 23365645 65 16.001385 imi_mug_run_2_treatment "alcohol" "inositol" "igf-binding protein 3"
30 Q0 28727815 66 15.907499 imi_mug_run_2_treatment "everolimus" "exemestane" "drug"
30 Q0 27035903 67 15.731058 imi_mug_run_2_treatment "combinations" "kinase inhibitor" "metrics"
30 Q0 11606375 68 15.663656 imi_mug_run_2_treatment "lead"
30 Q0 30008023 69 15.511475 imi_mug_run_2_treatment "therapeutics" "aim"
30 Q0 28503373 70 15.361689 imi_mug_run_2_treatment "legacy"
30 Q0 27659519 71 15.29583 imi_mug_run_2_treatment "insulin" "aromatase inhibitor" "estradiol"
30 Q0 21266193 72 15.229863 imi_mug_run_2_treatment "ifng" "il7"
30 Q0 28936923 73 14.832575 imi_mug_run_2_treatment "aim"
30 Q0 24069384 74 14.673425 imi_mug_run_2_treatment "flt" "igf1" "program"
30 Q0 24428911 75 14.648348 imi_mug_run_2_treatment "gefitinib" "egfr tyrosine kinase inhibitor" "aim"
30 Q0 29857068 76 14.648348 imi_mug_run_2_treatment "lead"
30 Q0 26988918 77 14.631701 imi_mug_run_2_treatment "combinations"
30 Q0 29206995 78 14.538631 imi_mug_run_2_treatment "plasma"
30 Q0 27203738 79 14.499015 imi_mug_run_2_treatment "drug"
30 Q0 23232578 80 14.466465 imi_mug_run_2_treatment "level"
30 Q0 26185457 81 14.452409 imi_mug_run_2_treatment "level"
30 Q0 30138363 82 14.4176235 imi_mug_run_2_treatment "various" "hub" "ppi"
30 Q0 22285706 83 14.2640705 imi_mug_run_2_treatment "panitumumab" "cetuximab"
30 Q0 30367364 84 14.223743 imi_mug_run_2_treatment "hub" "ppi" "igf1"
30 Q0 17615082 85 13.81196 imi_mug_run_2_treatment "therapeutics" "suppressor"
30 Q0 15492870 86 13.686479 imi_mug_run_2_treatment "lead"
30 Q0 26395574 87 13.615377 imi_mug_run_2_treatment "polyphenols" "drug" "polyphenol"
30 Q0 30453719 88 13.23828 imi_mug_run_2_treatment "combinations" "ginseng" "chinese herbs"
30 Q0 26355232 89 13.142769 imi_mug_run_2_treatment "aflibercept" "plasma" "oxaliplatin"
30 Q0 27792260 90 13.142235 imi_mug_run_2_treatment "others"
30 Q0 28476018 91 13.103142 imi_mug_run_2_treatment "aim"
30 Q0 17620308 92 13.007925 imi_mug_run_2_treatment "mediated" "igfbp-3" "mediators of inflammation"
30 Q0 25951043 93 13.007925 imi_mug_run_2_treatment "various"
30 Q0 27478471 94 13.007925 imi_mug_run_2_treatment "ppi"
30 Q0 23292937 95 13.007925 imi_mug_run_2_treatment "medicine"
30 Q0 22848674 96 13.007925 imi_mug_run_2_treatment "ras"
30 Q0 29016839 97 13.007925 imi_mug_run_2_treatment "lgg"
30 Q0 23609359 98 12.955209 imi_mug_run_2_treatment "ppi" "aim" "sam"
30 Q0 25601220 99 12.955209 imi_mug_run_2_treatment "prophylactic" "level"
30 Q0 29285225 100 12.955209 imi_mug_run_2_treatment "various" "respiratory system" "ppi"
30 Q0 26251039 101 12.95454 imi_mug_run_2_treatment "tet"
30 Q0 18260110 102 12.92145 imi_mug_run_2_treatment "salt" "ras" "basis"
30 Q0 26981779 103 12.92145 imi_mug_run_2_treatment "combinations" "drugs" "therapeutics"
30 Q0 29473816 104 12.92145 imi_mug_run_2_treatment "dmps" "mediators"
30 Q0 30217369 105 12.9195385 imi_mug_run_2_treatment "platinum" "nivolumab"
30 Q0 27738081 106 12.9195385 imi_mug_run_2_treatment "nitrosourea" "aim"
30 Q0 25927147 107 12.83482 imi_mug_run_2_treatment "lead"
30 Q0 27178332 108 12.761354 imi_mug_run_2_treatment "tam" "tamoxifen" "adjuvant"
30 Q0 26275421 109 11.247122 imi_mug_run_2_treatment "kinase inhibitor" "igf1" "insulin-like growth factor 1"
30 Q0 26429956 110 11.247122 imi_mug_run_2_treatment "gsk2141795" "drug" "serine"
30 Q0 28558704 111 11.247122 imi_mug_run_2_treatment "level" "ppi" "others"
30 Q0 27096627 112 11.247122 imi_mug_run_2_treatment "dexamethasone" "beta-estradiol" "ly294002"
30 Q0 28787439 113 11.247122 imi_mug_run_2_treatment "mediated" "eosin"
30 Q0 29946183 114 11.247122 imi_mug_run_2_treatment "ras" "estrogen" "matrix"
30 Q0 27282351 115 9.399475 imi_mug_run_2_treatment "formalin"
30 Q0 29416916 116 9.399475 imi_mug_run_2_treatment "ras" "icc"
31 Q0 25759435 1 51.661167 imi_mug_run_2_treatment "various"
31 Q0 27297344 2 49.575127 imi_mug_run_2_treatment "various"
31 Q0 27375798 3 47.11458 imi_mug_run_2_treatment "basis"
31 Q0 21248741 4 45.365166 imi_mug_run_2_treatment "dnase"
31 Q0 19639654 5 44.639935 imi_mug_run_2_treatment "others"
31 Q0 28509973 6 43.004845 imi_mug_run_2_treatment "glycosaminoglycans" "others"
31 Q0 29049801 7 42.92465 imi_mug_run_2_treatment "aim"
31 Q0 26017485 8 42.21828 imi_mug_run_2_treatment "others"
31 Q0 26334848 9 42.206768 imi_mug_run_2_treatment "various"
31 Q0 28808903 10 42.182243 imi_mug_run_2_treatment "aim"
31 Q0 21937134 11 40.58609 imi_mug_run_2_treatment "basis" "matrix"
31 Q0 29202781 12 39.88891 imi_mug_run_2_treatment "medications" "alerted"
31 Q0 17994018 13 38.792046 imi_mug_run_2_treatment "lead"
31 Q0 26188975 14 38.00626 imi_mug_run_2_treatment "program"
31 Q0 23613326 15 36.909454 imi_mug_run_2_treatment "aminoacid"
31 Q0 27431987 16 36.663315 imi_mug_run_2_treatment "basis"
31 Q0 23977594 17 36.588757 imi_mug_run_2_treatment "various"
31 Q0 21288906 18 36.12273 imi_mug_run_2_treatment "yeast"
31 Q0 30233845 19 33.90107 imi_mug_run_2_treatment "angiotensin ii" "mediated" "normal saline"
31 Q0 28074631 20 33.338684 imi_mug_run_2_treatment "collagen" "duration" "level"
31 Q0 29510914 21 33.262375 imi_mug_run_2_treatment "basis" "collagen"
31 Q0 22753406 22 32.398907 imi_mug_run_2_treatment "yeast"
31 Q0 22978789 23 32.34405 imi_mug_run_2_treatment "balance"
31 Q0 24842835 24 32.342415 imi_mug_run_2_treatment "various" "proteinase" "basis"
31 Q0 27879251 25 30.64281 imi_mug_run_2_treatment "lead" "matrix"
31 Q0 22831780 26 29.686 imi_mug_run_2_treatment "lead"
31 Q0 28328125 27 28.126865 imi_mug_run_2_treatment "histidine" "leucine"
31 Q0 28652363 28 27.42989 imi_mug_run_2_treatment "matrix"
31 Q0 26837258 29 26.935957 imi_mug_run_2_treatment "lead"
31 Q0 24793577 30 26.851917 imi_mug_run_2_treatment "combinations"
31 Q0 24284977 31 26.851746 imi_mug_run_2_treatment "blockade"
31 Q0 23142374 32 26.443954 imi_mug_run_2_treatment "basis"
31 Q0 23591991 33 25.659534 imi_mug_run_2_treatment "imatinib mesylate"
31 Q0 18544034 34 25.426666 imi_mug_run_2_treatment "basis"
31 Q0 26724508 35 23.581053 imi_mug_run_2_treatment "fibres"
31 Q0 28461455 36 22.62466 imi_mug_run_2_treatment "various" "oxygen" "angiotensin ii"
31 Q0 28076932 37 22.389215 imi_mug_run_2_treatment "various" "mediated"
31 Q0 22252507 38 21.672913 imi_mug_run_2_treatment "vasoconstrictors" "cytokines" "matrix"
31 Q0 26693246 39 21.556082 imi_mug_run_2_treatment "resveratrol"
31 Q0 26446364 40 21.52612 imi_mug_run_2_treatment "others"
31 Q0 25433566 41 21.504807 imi_mug_run_2_treatment "glycosaminoglycans" "lead"
31 Q0 24898772 42 21.139627 imi_mug_run_2_treatment "dyne" "tgfb1" "level"
31 Q0 22787517 43 20.826134 imi_mug_run_2_treatment "level" "acetylcholine" "medicine"
31 Q0 29552567 44 20.620615 imi_mug_run_2_treatment "matrix"
31 Q0 29669321 45 20.05387 imi_mug_run_2_treatment "level" "hts"
31 Q0 28392898 46 19.885735 imi_mug_run_2_treatment "tandem" "peroxiredoxin" "aim"
31 Q0 24615040 47 17.010681 imi_mug_run_2_treatment "hub" "program"
31 Q0 25196308 48 15.750061 imi_mug_run_2_treatment "various" "magnesium"
31 Q0 20403466 49 15.675472 imi_mug_run_2_treatment "carvedilol" "thioredoxin" "beta-blocker"
31 Q0 22790431 50 15.671293 imi_mug_run_2_treatment "mydriatic"
31 Q0 27378925 51 15.176205 imi_mug_run_2_treatment "various"
31 Q0 27551047 52 13.709208 imi_mug_run_2_treatment "guo" "lead"
31 Q0 28698179 53 13.64403 imi_mug_run_2_treatment "zinc" "epidermal growth factor" "proteolytic enzymes"
32 Q0 24220024 1 95.331825 imi_mug_run_2_treatment "mra"
32 Q0 16981219 2 88.932755 imi_mug_run_2_treatment "prenatal"
32 Q0 16928994 3 79.73427 imi_mug_run_2_treatment "prophylactic"
32 Q0 28344185 4 79.26201 imi_mug_run_2_treatment "prenatal" "prompt"
32 Q0 25116393 5 71.03916 imi_mug_run_2_treatment "plasma"
32 Q0 26096872 6 70.51189 imi_mug_run_2_treatment "mra"
32 Q0 20101701 7 68.938095 imi_mug_run_2_treatment "lead"
32 Q0 24355923 8 68.938095 imi_mug_run_2_treatment "angiotensin ii" "losartan" "animals"
32 Q0 24146167 9 67.972206 imi_mug_run_2_treatment "losartan"
32 Q0 17935258 10 65.00339 imi_mug_run_2_treatment "various"
32 Q0 18852674 11 63.06597 imi_mug_run_2_treatment "collagen" "fiber" "prophylactic"
32 Q0 30219046 12 60.83701 imi_mug_run_2_treatment "tyr" "lead"
32 Q0 22259224 13 60.61184 imi_mug_run_2_treatment "losartan" "lead"
32 Q0 19883511 14 58.405922 imi_mug_run_2_treatment "basis" "aim"
32 Q0 25163805 15 57.803417 imi_mug_run_2_treatment "lead"
32 Q0 30170566 16 56.406822 imi_mug_run_2_treatment "collagen"
32 Q0 16791849 17 56.292366 imi_mug_run_2_treatment "matrix"
32 Q0 21098638 18 56.10338 imi_mug_run_2_treatment "balance"
32 Q0 26184463 19 55.312527 imi_mug_run_2_treatment "lead"
32 Q0 22326956 20 54.94644 imi_mug_run_2_treatment "mediated" "crest"
32 Q0 23975680 21 54.66563 imi_mug_run_2_treatment "mediated" "telmisartan" "crest"
32 Q0 26333736 22 53.21283 imi_mug_run_2_treatment "basis"
32 Q0 22095581 23 52.823986 imi_mug_run_2_treatment "matrix"
32 Q0 30101859 24 52.64392 imi_mug_run_2_treatment "mediated" "lead"
32 Q0 18544034 25 51.86357 imi_mug_run_2_treatment "basis"
32 Q0 19772952 26 46.093765 imi_mug_run_2_treatment "medicine"
32 Q0 19639654 27 44.620506 imi_mug_run_2_treatment "others"
32 Q0 29768367 28 43.467865 imi_mug_run_2_treatment "various"
32 Q0 26398550 29 43.14438 imi_mug_run_2_treatment "mediated"
32 Q0 30070022 30 43.14438 imi_mug_run_2_treatment "various"
32 Q0 28847661 31 42.41707 imi_mug_run_2_treatment "aim"
32 Q0 19224541 32 41.217545 imi_mug_run_2_treatment "various" "tgf-beta1" "fibre"
32 Q0 23884466 33 36.154114 imi_mug_run_2_treatment "cytokines" "plasma"
32 Q0 29931197 34 35.876274 imi_mug_run_2_treatment "oxygen" "level" "liver"
32 Q0 27508510 35 35.742607 imi_mug_run_2_treatment "medications"
32 Q0 29510914 36 33.856766 imi_mug_run_2_treatment "basis" "collagen"
32 Q0 30275229 37 29.795605 imi_mug_run_2_treatment "aim"
32 Q0 18264665 38 28.993418 imi_mug_run_2_treatment "aim"
32 Q0 16251899 39 28.663818 imi_mug_run_2_treatment "basis"
32 Q0 29051557 40 27.778727 imi_mug_run_2_treatment "various" "glucose" "tgfb1"
32 Q0 24401272 41 27.484705 imi_mug_run_2_treatment "animals"
32 Q0 25315765 42 26.634455 imi_mug_run_2_treatment "suppressor"
32 Q0 23537056 43 23.644608 imi_mug_run_2_treatment "aim"
32 Q0 23228659 44 22.813128 imi_mug_run_2_treatment "level"
32 Q0 21518605 45 21.79776 imi_mug_run_2_treatment "prenatal"
32 Q0 22310065 46 21.702213 imi_mug_run_2_treatment "aim"
32 Q0 29876033 47 20.120094 imi_mug_run_2_treatment "fibrin" "matrix"
32 Q0 17418587 48 19.930248 imi_mug_run_2_treatment "calcium" "epidermal growth factor" "lead"
32 Q0 29116087 49 19.043179 imi_mug_run_2_treatment "androgen"
32 Q0 16820601 50 18.970762 imi_mug_run_2_treatment "timp-3"
32 Q0 25158182 51 18.848354 imi_mug_run_2_treatment "igf2"
32 Q0 16273536 52 17.921795 imi_mug_run_2_treatment "basis"
32 Q0 23996730 53 17.452566 imi_mug_run_2_treatment "mediated" "choline" "oxygen"
32 Q0 22772377 54 17.013424 imi_mug_run_2_treatment "epidermal growth factor" "others"
32 Q0 23312833 55 16.988949 imi_mug_run_2_treatment "prophylactic"
32 Q0 24677762 56 16.658468 imi_mug_run_2_treatment "others"
32 Q0 25845371 57 16.513336 imi_mug_run_2_treatment "glycine" "triple helix"
32 Q0 26446364 58 16.167112 imi_mug_run_2_treatment "others"
32 Q0 16528739 59 16.117954 imi_mug_run_2_treatment "mediated"
32 Q0 22773728 60 15.594423 imi_mug_run_2_treatment "immunosuppressive" "interleukin"
32 Q0 21248741 61 15.265249 imi_mug_run_2_treatment "dnase"
32 Q0 17182941 62 15.145237 imi_mug_run_2_treatment "basis"
32 Q0 28842177 63 15.094988 imi_mug_run_2_treatment "level" "aim"
32 Q0 15731757 64 14.239241 imi_mug_run_2_treatment "collagen"
32 Q0 25701956 65 13.872217 imi_mug_run_2_treatment "various"
32 Q0 16332365 66 13.837615 imi_mug_run_2_treatment "crest"
32 Q0 23142374 67 13.35738 imi_mug_run_2_treatment "basis"
32 Q0 19239848 68 13.22546 imi_mug_run_2_treatment "various" "lead" "cytokines"
32 Q0 12651806 69 13.218405 imi_mug_run_2_treatment "matrix"
32 Q0 18591412 70 13.211997 imi_mug_run_2_treatment "interleukin" "tgfb1" "il-6"
32 Q0 25141837 71 13.211997 imi_mug_run_2_treatment "liver"
32 Q0 21636701 72 13.211997 imi_mug_run_2_treatment "oligo"
32 Q0 19820113 73 13.211997 imi_mug_run_2_treatment "various" "lead" "level"
32 Q0 30376727 74 11.505468 imi_mug_run_2_treatment "matrix" "aim" "beam"
33 Q0 21216356 1 62.92616 imi_mug_run_2_treatment "aim"
33 Q0 24206879 2 62.923035 imi_mug_run_2_treatment "lead"
33 Q0 24357532 3 62.577972 imi_mug_run_2_treatment "insulin" "glucose" "hypoglycemic"
33 Q0 15746441 4 62.288708 imi_mug_run_2_treatment "magnesium" "lead"
33 Q0 12205790 5 61.322826 imi_mug_run_2_treatment "beta-blocker"
33 Q0 26344792 6 61.096287 imi_mug_run_2_treatment "metoprolol" "elder" "aim"
33 Q0 16244680 7 61.06388 imi_mug_run_2_treatment "beta blockers"
33 Q0 18606002 8 58.99501 imi_mug_run_2_treatment "various" "beta-blockers" "lead"
33 Q0 19348785 9 58.907333 imi_mug_run_2_treatment "hot spot"
33 Q0 17192539 10 58.42522 imi_mug_run_2_treatment "potassium"
33 Q0 24184248 11 57.755135 imi_mug_run_2_treatment "isoproterenol" "alpha subunit"
33 Q0 19808498 12 57.693302 imi_mug_run_2_treatment "potassium" "program"
33 Q0 20660394 13 57.60875 imi_mug_run_2_treatment "catecholamine" "duration" "others"
33 Q0 11278406 14 57.427773 imi_mug_run_2_treatment "gly" "lead"
33 Q0 15696484 15 56.85748 imi_mug_run_2_treatment "hot spot"
33 Q0 12766260 16 56.796917 imi_mug_run_2_treatment "stimulant" "epinephrine" "isoproterenol"
33 Q0 15640067 17 55.872463 imi_mug_run_2_treatment "enzyme digestion"
33 Q0 22328875 18 55.79417 imi_mug_run_2_treatment "level"
33 Q0 16564513 19 55.759773 imi_mug_run_2_treatment "lead"
33 Q0 15500450 20 55.5922 imi_mug_run_2_treatment "gly" "tyr" "aim"
33 Q0 14998624 21 55.048332 imi_mug_run_2_treatment "beta-blockers"
33 Q0 16929947 22 54.989704 imi_mug_run_2_treatment "various" "lead"
33 Q0 20981542 23 54.36467 imi_mug_run_2_treatment "adenosine" "glycine"
33 Q0 12442276 24 53.964966 imi_mug_run_2_treatment "beta blocker" "propanolol" "inderal"
33 Q0 22727609 25 53.925064 imi_mug_run_2_treatment "others"
33 Q0 11289718 26 53.5198 imi_mug_run_2_treatment "beta-adrenergic blocking agents"
33 Q0 21244686 27 53.411926 imi_mug_run_2_treatment "beta blocker" "medication" "duration"
33 Q0 12710526 28 53.3996 imi_mug_run_2_treatment "potassium" "various"
33 Q0 25779927 29 53.382004 imi_mug_run_2_treatment "lysine" "animals"
33 Q0 10024302 30 53.21679 imi_mug_run_2_treatment "alpha subunit"
33 Q0 14499862 31 52.931557 imi_mug_run_2_treatment "arginine" "glycine" "basis"
33 Q0 9848024 32 52.88205 imi_mug_run_2_treatment "lead"
33 Q0 25236808 33 52.879734 imi_mug_run_2_treatment "epinephrine" "calcium homeostasis"
33 Q0 15159330 34 52.556164 imi_mug_run_2_treatment "favor"
33 Q0 29688407 35 52.521683 imi_mug_run_2_treatment "duration" "epinephrine" "aim"
33 Q0 10220144 36 52.385956 imi_mug_run_2_treatment "potassium"
33 Q0 25494010 37 52.341496 imi_mug_run_2_treatment "level" "aim"
33 Q0 14731347 38 52.334976 imi_mug_run_2_treatment "duration"
33 Q0 23995305 39 52.313168 imi_mug_run_2_treatment "norfluoxetine" "blockade" "fluoxetine"
33 Q0 10367071 40 52.15258 imi_mug_run_2_treatment "potassium" "sodium" "aim"
33 Q0 21594822 41 52.099087 imi_mug_run_2_treatment "basis" "potassium ion" "aim"
33 Q0 23400408 42 51.843452 imi_mug_run_2_treatment "beta-blocker"
33 Q0 15950200 43 51.80661 imi_mug_run_2_treatment "potassium" "phenylalanine"
33 Q0 15004216 44 51.783775 imi_mug_run_2_treatment "isoproterenol" "beta-adrenergic receptor agonist" "basis"
33 Q0 16556866 45 51.73494 imi_mug_run_2_treatment "basis"
33 Q0 14531214 46 51.707596 imi_mug_run_2_treatment "lead"
33 Q0 25270334 47 51.66256 imi_mug_run_2_treatment "beta blocker"
33 Q0 21185499 48 51.340263 imi_mug_run_2_treatment "aim"
33 Q0 12653681 49 51.31357 imi_mug_run_2_treatment "alpha subunit" "elder"
33 Q0 14682152 50 51.21588 imi_mug_run_2_treatment "various" "aim"
33 Q0 17091796 51 51.2 imi_mug_run_2_treatment "potassium" "sodium" "gly"
33 Q0 28749435 52 51.163605 imi_mug_run_2_treatment "basis"
33 Q0 14678125 53 51.13567 imi_mug_run_2_treatment "duration" "aim"
33 Q0 16253915 54 51.13567 imi_mug_run_2_treatment "prompt"
33 Q0 19843919 55 51.067623 imi_mug_run_2_treatment "antiarrhythmic" "drugs" "antiarrhythmic drugs"
33 Q0 15192825 56 50.933693 imi_mug_run_2_treatment "potassium"
33 Q0 17905336 57 50.88012 imi_mug_run_2_treatment "program"
33 Q0 14510661 58 50.8748 imi_mug_run_2_treatment "lead"
33 Q0 16627448 59 50.595848 imi_mug_run_2_treatment "basis"
33 Q0 28400316 60 50.56899 imi_mug_run_2_treatment "glucose"
33 Q0 22354620 61 50.489994 imi_mug_run_2_treatment "calcium antagonist"
33 Q0 20005993 62 50.4647 imi_mug_run_2_treatment "program" "lead" "level"
33 Q0 19804087 63 50.35749 imi_mug_run_2_treatment "basis"
33 Q0 14576198 64 50.258217 imi_mug_run_2_treatment "benzodiazepine" "drug"
33 Q0 12736279 65 50.221348 imi_mug_run_2_treatment "potassium" "sodium"
33 Q0 11438691 66 50.08471 imi_mug_run_2_treatment "plasma" "potassium" "aldosterone"
33 Q0 16109388 67 49.66598 imi_mug_run_2_treatment "basis" "duration"
33 Q0 24363352 68 49.65759 imi_mug_run_2_treatment "program"
33 Q0 23216910 69 49.43064 imi_mug_run_2_treatment "drugs" "drug" "antipsychotics"
33 Q0 21854832 70 49.40513 imi_mug_run_2_treatment "potassium"
33 Q0 19008479 71 49.386223 imi_mug_run_2_treatment "potassium" "cortisol"
33 Q0 20920651 72 49.224228 imi_mug_run_2_treatment "duration"
33 Q0 21451124 73 49.081398 imi_mug_run_2_treatment "potassium"
33 Q0 17023080 74 49.077454 imi_mug_run_2_treatment "potassium" "mediated" "duration"
33 Q0 29339628 75 49.039757 imi_mug_run_2_treatment "various" "arsenic trioxide" "apd"
33 Q0 18308161 76 48.946117 imi_mug_run_2_treatment "beta-adrenergic blockers" "others"
33 Q0 25174857 77 48.86428 imi_mug_run_2_treatment "lead"
33 Q0 11021476 78 48.48349 imi_mug_run_2_treatment "potassium" "arginine" "drugs"
33 Q0 18266681 79 48.284546 imi_mug_run_2_treatment "potassium" "isoleucine" "lysine"
33 Q0 23130128 80 48.233925 imi_mug_run_2_treatment "antiarrhythmic"
33 Q0 12402336 81 48.221146 imi_mug_run_2_treatment "potassium" "medication"
33 Q0 19822806 82 48.175526 imi_mug_run_2_treatment "duration"
33 Q0 16937190 83 48.081825 imi_mug_run_2_treatment "various" "lead" "basis"
33 Q0 25087487 84 48.0807 imi_mug_run_2_treatment "various" "antiarrhythmic" "sham"
33 Q0 17655673 85 47.991825 imi_mug_run_2_treatment "basis"
33 Q0 16542208 86 47.934372 imi_mug_run_2_treatment "sibutramine" "medicines" "cisapride"
33 Q0 30036649 87 47.92817 imi_mug_run_2_treatment "beta-blocker"
33 Q0 17597962 88 47.90766 imi_mug_run_2_treatment "aim"
33 Q0 23995044 89 47.895653 imi_mug_run_2_treatment "prenatal"
33 Q0 15028050 90 47.88389 imi_mug_run_2_treatment "beta-blocker" "beta-blockers" "aprindine"
33 Q0 20126594 91 47.87633 imi_mug_run_2_treatment "quinidine"
33 Q0 30394905 92 47.82894 imi_mug_run_2_treatment "medicine" "nadolol" "propranolol"
33 Q0 27054604 93 47.58026 imi_mug_run_2_treatment "beta-blockers"
33 Q0 15653031 94 47.495323 imi_mug_run_2_treatment "verapamil" "apd" "epinephrine"
33 Q0 21496168 95 47.482113 imi_mug_run_2_treatment "epinephrine"
33 Q0 26854997 96 47.47831 imi_mug_run_2_treatment "potassium" "apd" "propionic acid"
33 Q0 24218437 97 47.462326 imi_mug_run_2_treatment "prenatal"
33 Q0 17997361 98 47.406136 imi_mug_run_2_treatment "basis"
33 Q0 11434015 99 47.36226 imi_mug_run_2_treatment "duration"
33 Q0 11334843 100 47.248573 imi_mug_run_2_treatment "various" "mibg" "meta-iodobenzylguanidine"
33 Q0 16754261 101 47.208164 imi_mug_run_2_treatment "aim"
33 Q0 18093912 102 47.195824 imi_mug_run_2_treatment "alpha subunit" "apd" "mediated"
33 Q0 24667783 103 47.075928 imi_mug_run_2_treatment "basis"
33 Q0 21779290 104 46.8189 imi_mug_run_2_treatment "meperidine" "drugs" "cardiac drugs"
33 Q0 23678275 105 46.79671 imi_mug_run_2_treatment "anesthesia"
33 Q0 23856471 106 46.695995 imi_mug_run_2_treatment "duration"
33 Q0 17660684 107 46.59979 imi_mug_run_2_treatment "various" "corticosterone"
33 Q0 18400097 108 46.596657 imi_mug_run_2_treatment "methionine"
33 Q0 17292394 109 46.536243 imi_mug_run_2_treatment "basis"
33 Q0 12808265 110 46.465004 imi_mug_run_2_treatment "various" "potassium" "lead"
33 Q0 25935074 111 46.44867 imi_mug_run_2_treatment "beta-blocker"
33 Q0 11802537 112 46.36988 imi_mug_run_2_treatment "potassium" "isoleucine"
33 Q0 22996910 113 46.349148 imi_mug_run_2_treatment "antiadrenergic"
33 Q0 26168993 114 46.292885 imi_mug_run_2_treatment "potassium" "aim"
33 Q0 25634836 115 46.27582 imi_mug_run_2_treatment "beta-blocker"
33 Q0 20348026 116 46.211792 imi_mug_run_2_treatment "ether"
33 Q0 20361479 117 46.196198 imi_mug_run_2_treatment "various" "potassium"
33 Q0 25585005 118 46.109444 imi_mug_run_2_treatment "isoflurane" "potassium" "anesthetics"
33 Q0 17497253 119 45.93733 imi_mug_run_2_treatment "drugs" "quinidine" "sotalol"
33 Q0 19490272 120 45.893368 imi_mug_run_2_treatment "beta-blocker"
33 Q0 17432514 121 45.506798 imi_mug_run_2_treatment "duration"
33 Q0 19160088 122 45.41678 imi_mug_run_2_treatment "lead"
33 Q0 23692438 123 45.411465 imi_mug_run_2_treatment "aim"
33 Q0 19825999 124 45.22853 imi_mug_run_2_treatment "potassium"
33 Q0 18365896 125 45.176414 imi_mug_run_2_treatment "lead" "duration"
33 Q0 23936797 126 45.176414 imi_mug_run_2_treatment "level"
33 Q0 17903632 127 45.102654 imi_mug_run_2_treatment "beta-blockers"
33 Q0 22095730 128 45.0838 imi_mug_run_2_treatment "mediated"
33 Q0 21952006 129 45.0195 imi_mug_run_2_treatment "isoproterenol"
33 Q0 24269949 130 45.01913 imi_mug_run_2_treatment "quinidine"
33 Q0 20975234 131 45.01487 imi_mug_run_2_treatment "various"
33 Q0 14760488 132 44.998875 imi_mug_run_2_treatment "drugs"
33 Q0 17210839 133 44.95365 imi_mug_run_2_treatment "basis"
33 Q0 12522251 134 44.897907 imi_mug_run_2_treatment "alpha subunit" "duration"
33 Q0 27816319 135 44.82249 imi_mug_run_2_treatment "drugs"
33 Q0 27539165 136 44.77635 imi_mug_run_2_treatment "amiodarone" "quantum"
33 Q0 16226079 137 44.762047 imi_mug_run_2_treatment "quinidine" "flecainide" "sotalol"
33 Q0 12838849 138 44.717663 imi_mug_run_2_treatment "prophylactic" "genesis"
33 Q0 24912595 139 44.68055 imi_mug_run_2_treatment "potassium"
33 Q0 27868350 140 44.64491 imi_mug_run_2_treatment "antiarrhythmic drugs" "antiepileptic drugs"
33 Q0 24552659 141 44.597267 imi_mug_run_2_treatment "medications" "medicated"
33 Q0 26669661 142 44.585327 imi_mug_run_2_treatment "level"
33 Q0 29033053 143 44.585327 imi_mug_run_2_treatment "lead"
33 Q0 24499369 144 44.580574 imi_mug_run_2_treatment "various" "verapamil" "proteasome inhibitor"
33 Q0 26346102 145 44.529903 imi_mug_run_2_treatment "potassium"
33 Q0 11861047 146 44.52253 imi_mug_run_2_treatment "blockade" "lead"
33 Q0 15890322 147 44.4958 imi_mug_run_2_treatment "quinidine" "flecainide" "sotalol"
33 Q0 12388934 148 44.481506 imi_mug_run_2_treatment "pill"
33 Q0 16246960 149 44.377434 imi_mug_run_2_treatment "beta-blocker"
33 Q0 22199116 150 44.353947 imi_mug_run_2_treatment "balance"
33 Q0 24133349 151 44.35347 imi_mug_run_2_treatment "various" "beta-blocker"
33 Q0 16945016 152 44.29618 imi_mug_run_2_treatment "benzodiazepine"
33 Q0 21769575 153 44.27613 imi_mug_run_2_treatment "aim"
33 Q0 21426901 154 44.271378 imi_mug_run_2_treatment "glucose" "tolbutamide"
33 Q0 15306731 155 44.153168 imi_mug_run_2_treatment "lead"
33 Q0 28279743 156 44.10427 imi_mug_run_2_treatment "lead"
33 Q0 19618328 157 44.10138 imi_mug_run_2_treatment "propranolol"
33 Q0 28992529 158 44.05545 imi_mug_run_2_treatment "cardiovascular drugs"
33 Q0 16623272 159 43.671417 imi_mug_run_2_treatment "drug" "aminoacid" "cardiovascular drugs"
33 Q0 16076272 160 43.460102 imi_mug_run_2_treatment "drugs" "quinidine" "sotalol"
33 Q0 25037568 161 43.432243 imi_mug_run_2_treatment "mediated" "s27"
33 Q0 11463728 162 43.367756 imi_mug_run_2_treatment "sodium"
33 Q0 18382206 163 43.316196 imi_mug_run_2_treatment "quinidine"
33 Q0 29707106 164 43.249702 imi_mug_run_2_treatment "cytotoxic" "potassium ion" "plasma"
33 Q0 29769222 165 43.23724 imi_mug_run_2_treatment "calcium" "potassium" "duration"
33 Q0 21063070 166 43.18959 imi_mug_run_2_treatment "potassium" "lead" "program"
33 Q0 25804018 167 43.142624 imi_mug_run_2_treatment "beta blocker" "beta blockers"
33 Q0 22515331 168 43.102074 imi_mug_run_2_treatment "potassium" "sodium"
33 Q0 15321698 169 43.091843 imi_mug_run_2_treatment "beta-blockers" "prophylactic" "aim"
33 Q0 26715165 170 43.07771 imi_mug_run_2_treatment "drugs" "others"
33 Q0 27262388 171 42.926132 imi_mug_run_2_treatment "beta blocker" "metoprolol" "nadolol"
33 Q0 19306396 172 42.902023 imi_mug_run_2_treatment "potassium" "disopyramide"
33 Q0 29532034 173 42.867737 imi_mug_run_2_treatment "basis"
33 Q0 16922724 174 42.78959 imi_mug_run_2_treatment "various"
33 Q0 24681627 175 42.75994 imi_mug_run_2_treatment "magnesium" "lead"
33 Q0 16987820 176 42.67015 imi_mug_run_2_treatment "potassium" "lead"
33 Q0 15924777 177 42.641716 imi_mug_run_2_treatment "glycine" "others"
33 Q0 28575668 178 42.59764 imi_mug_run_2_treatment "potassium" "mediated"
33 Q0 15528464 179 42.58362 imi_mug_run_2_treatment "mediated" "lead"
33 Q0 12080180 180 42.02323 imi_mug_run_2_treatment "various"
33 Q0 23241319 181 41.99061 imi_mug_run_2_treatment "mediated" "ibmx" "apds"
33 Q0 23511928 182 41.833965 imi_mug_run_2_treatment "program"
33 Q0 19841300 183 41.78116 imi_mug_run_2_treatment "prompt"
33 Q0 29857160 184 41.764374 imi_mug_run_2_treatment "apds" "potassium" "isoproterenol"
33 Q0 30389366 185 41.751175 imi_mug_run_2_treatment "beta blockers" "flecainide" "mediated"
33 Q0 15107590 186 41.5933 imi_mug_run_2_treatment "lead"
33 Q0 25564553 187 41.531734 imi_mug_run_2_treatment "drugs" "aim"
33 Q0 15511625 188 41.50802 imi_mug_run_2_treatment "potassium" "serine"
33 Q0 25082577 189 41.450363 imi_mug_run_2_treatment "calcium channel blocker" "duration" "nifedipine"
33 Q0 29622001 190 41.38656 imi_mug_run_2_treatment "duration"
33 Q0 28003625 191 41.262474 imi_mug_run_2_treatment "aim"
33 Q0 23092362 192 41.095375 imi_mug_run_2_treatment "oxygen" "balance"
33 Q0 29444113 193 41.011585 imi_mug_run_2_treatment "potassium ion" "drug" "drugs"
33 Q0 22806714 194 40.950283 imi_mug_run_2_treatment "lead"
33 Q0 17999538 195 40.811962 imi_mug_run_2_treatment "various"
33 Q0 16314573 196 40.64158 imi_mug_run_2_treatment "glucose"
33 Q0 28532774 197 40.575745 imi_mug_run_2_treatment "lead"
33 Q0 17984373 198 40.395298 imi_mug_run_2_treatment "beta-blocker" "hot spot" "others"
33 Q0 26370830 199 40.379356 imi_mug_run_2_treatment "water"
33 Q0 23631430 200 40.291092 imi_mug_run_2_treatment "aim" "duration"
33 Q0 22309168 201 40.211716 imi_mug_run_2_treatment "ptc" "level"
33 Q0 16155735 202 40.203014 imi_mug_run_2_treatment "potassium" "sodium"
33 Q0 26063740 203 40.191566 imi_mug_run_2_treatment "medication"
33 Q0 25139741 204 40.188923 imi_mug_run_2_treatment "cyclic adenosine monophosphate" "aim"
33 Q0 24721657 205 40.1402 imi_mug_run_2_treatment "potassium"
33 Q0 11313306 206 39.861927 imi_mug_run_2_treatment "blockade"
33 Q0 17467628 207 39.759434 imi_mug_run_2_treatment "drug" "antiarrhythmic drug" "amiodarone"
33 Q0 12690509 208 39.64608 imi_mug_run_2_treatment "water"
33 Q0 12877697 209 39.64608 imi_mug_run_2_treatment "catecholamine" "dobutamine" "phenylephrine"
33 Q0 20688187 210 39.567207 imi_mug_run_2_treatment "thyroid-stimulating hormone"
33 Q0 15534720 211 39.544876 imi_mug_run_2_treatment "beta-blocker" "atenolol" "propranolol"
33 Q0 16379539 212 39.544876 imi_mug_run_2_treatment "prompt"
33 Q0 19684871 213 39.544876 imi_mug_run_2_treatment "sodium"
33 Q0 26481773 214 39.533314 imi_mug_run_2_treatment "level" "others"
33 Q0 19934648 215 39.4803 imi_mug_run_2_treatment "mediated" "kinase inhibitor" "wortmannin"
33 Q0 19013996 216 39.427 imi_mug_run_2_treatment "antiarrhythmic drugs"
33 Q0 29740400 217 39.389854 imi_mug_run_2_treatment "beta blocker" "beta blockers" "alpha subunit"
33 Q0 12598076 218 39.336792 imi_mug_run_2_treatment "tcp" "epinephrine" "lead"
33 Q0 23981618 219 39.304947 imi_mug_run_2_treatment "ether" "level"
33 Q0 25889101 220 39.272423 imi_mug_run_2_treatment "apd" "drugs" "apds"
33 Q0 17161064 221 39.268135 imi_mug_run_2_treatment "therapeutics" "others"
33 Q0 18052691 222 39.268135 imi_mug_run_2_treatment "genesis"
33 Q0 22129298 223 39.268135 imi_mug_run_2_treatment "various" "flecainide" "antiadrenergic"
33 Q0 11101505 224 39.239902 imi_mug_run_2_treatment "lead"
33 Q0 15828882 225 39.181217 imi_mug_run_2_treatment "propafenone" "agent" "basis"
33 Q0 16931984 226 39.145897 imi_mug_run_2_treatment "local anesthetic" "potassium" "ether"
33 Q0 19351523 227 39.030907 imi_mug_run_2_treatment "anti-arrhythmic" "potassium" "new drugs"
33 Q0 23251633 228 39.018715 imi_mug_run_2_treatment "topical anti-infective" "hexachlorophene" "therapeutics"
33 Q0 30462975 229 38.839447 imi_mug_run_2_treatment "glycine" "serine" "lead"
33 Q0 24068254 230 38.78296 imi_mug_run_2_treatment "insulin" "potassium" "wortmannin"
33 Q0 24373870 231 38.74856 imi_mug_run_2_treatment "product"
33 Q0 29060841 232 38.734116 imi_mug_run_2_treatment "amiodarone" "level" "apd"
33 Q0 24284363 233 38.705093 imi_mug_run_2_treatment "psychotropic drugs" "psychotropic drug" "psychotropic medication"
33 Q0 12566567 234 38.464813 imi_mug_run_2_treatment "potassium" "mediated" "duration"
33 Q0 17293474 235 38.30811 imi_mug_run_2_treatment "mediated" "duration"
33 Q0 20196769 236 38.24576 imi_mug_run_2_treatment "various"
33 Q0 20436212 237 38.189323 imi_mug_run_2_treatment "potassium" "mefloquine" "agent"
33 Q0 10477533 238 38.043407 imi_mug_run_2_treatment "product" "lead" "hot spot"
33 Q0 18803136 239 38.030125 imi_mug_run_2_treatment "lead" "aim"
33 Q0 16887873 240 38.01377 imi_mug_run_2_treatment "mediated"
33 Q0 25890583 241 37.94739 imi_mug_run_2_treatment "duration"
33 Q0 12063283 242 37.87761 imi_mug_run_2_treatment "ether" "drugs" "glycosidase"
33 Q0 18587108 243 37.87761 imi_mug_run_2_treatment "amylase" "chymotrypsin"
33 Q0 24388587 244 37.821735 imi_mug_run_2_treatment "lead" "program"
33 Q0 15194462 245 37.810265 imi_mug_run_2_treatment "serine" "lead"
33 Q0 24561134 246 37.72317 imi_mug_run_2_treatment "drug" "aim"
33 Q0 19214780 247 37.6959 imi_mug_run_2_treatment "basis"
33 Q0 21895724 248 37.667522 imi_mug_run_2_treatment "ether"
33 Q0 17905416 249 37.513596 imi_mug_run_2_treatment "duration" "apd"
33 Q0 11761407 250 37.473457 imi_mug_run_2_treatment "glycine" "serine"
33 Q0 12849668 251 37.445263 imi_mug_run_2_treatment "duration"
33 Q0 19038855 252 37.445263 imi_mug_run_2_treatment "antiepileptic drug" "aed" "medication"
33 Q0 29650123 253 37.392242 imi_mug_run_2_treatment "duration" "beta-blockers" "antiarrhythmic"
33 Q0 15851171 254 37.367077 imi_mug_run_2_treatment "lead" "aim"
33 Q0 15176425 255 37.263115 imi_mug_run_2_treatment "basis" "aim"
33 Q0 11334835 256 37.17009 imi_mug_run_2_treatment "duration"
33 Q0 11956246 257 37.048813 imi_mug_run_2_treatment "apd" "e-4031" "duration"
33 Q0 24419801 258 37.02688 imi_mug_run_2_treatment "drug" "glycine" "serine"
33 Q0 14642002 259 36.75026 imi_mug_run_2_treatment "potassium"
33 Q0 20659946 260 36.75026 imi_mug_run_2_treatment "medication" "level"
33 Q0 22429796 261 36.619633 imi_mug_run_2_treatment "metric"
33 Q0 25344363 262 36.40177 imi_mug_run_2_treatment "combinations"
33 Q0 16132053 263 36.391144 imi_mug_run_2_treatment "various"
33 Q0 18165683 264 36.383263 imi_mug_run_2_treatment "tandem"
33 Q0 22745159 265 36.353348 imi_mug_run_2_treatment "potassium" "duration" "ether"
33 Q0 22189896 266 36.323048 imi_mug_run_2_treatment "potassium" "probucol" "ether"
33 Q0 27255646 267 36.293884 imi_mug_run_2_treatment "epinephrine"
33 Q0 15649981 268 36.22854 imi_mug_run_2_treatment "gly" "leu"
33 Q0 28290961 269 36.06879 imi_mug_run_2_treatment "basis"
33 Q0 18848812 270 35.858337 imi_mug_run_2_treatment "lidocaine" "mexiletine" "lead"
33 Q0 21844197 271 35.743263 imi_mug_run_2_treatment "ether"
33 Q0 26066609 272 35.70582 imi_mug_run_2_treatment "lead"
33 Q0 17597584 273 35.62315 imi_mug_run_2_treatment "isoproterenol"
33 Q0 14756674 274 35.251823 imi_mug_run_2_treatment "beta-blocker" "beta-blockers" "antiarrhythmic"
33 Q0 22039467 275 35.106365 imi_mug_run_2_treatment "celecoxib" "celecoxib's" "celebrex"
33 Q0 19940153 276 34.988503 imi_mug_run_2_treatment "jasplakinolide" "color"
33 Q0 16461811 277 34.96024 imi_mug_run_2_treatment "beta-blockers"
33 Q0 17384445 278 34.83657 imi_mug_run_2_treatment "potassium" "apd" "duration"
33 Q0 17646758 279 34.629387 imi_mug_run_2_treatment "beta-blockers"
33 Q0 20181576 280 34.56522 imi_mug_run_2_treatment "mediated"
33 Q0 25967940 281 34.42447 imi_mug_run_2_treatment "combinations"
33 Q0 19207773 282 34.41909 imi_mug_run_2_treatment "catecholamines"
33 Q0 26546361 283 34.355503 imi_mug_run_2_treatment "mediated"
33 Q0 20386770 284 34.274483 imi_mug_run_2_treatment "mediated"
33 Q0 25645639 285 34.22419 imi_mug_run_2_treatment "lead"
33 Q0 12566121 286 34.200172 imi_mug_run_2_treatment "potassium" "antiarrhythmic" "basis"
33 Q0 21576493 287 34.194958 imi_mug_run_2_treatment "various"
33 Q0 27988371 288 34.16969 imi_mug_run_2_treatment "lead"
33 Q0 28720088 289 33.93499 imi_mug_run_2_treatment "lead"
33 Q0 20421371 290 33.915886 imi_mug_run_2_treatment "basis"
33 Q0 26282245 291 33.8468 imi_mug_run_2_treatment "sodium" "epinephrine"
33 Q0 20959120 292 33.669037 imi_mug_run_2_treatment "nicorandil" "apd" "isoproterenol"
33 Q0 15140888 293 33.651398 imi_mug_run_2_treatment "mediated"
33 Q0 20044973 294 33.516136 imi_mug_run_2_treatment "various" "glycine" "serine"
33 Q0 15368194 295 33.37953 imi_mug_run_2_treatment "potassium" "arginine" "alpha subunit"
33 Q0 28569435 296 33.367126 imi_mug_run_2_treatment "aim"
33 Q0 10620287 297 33.328312 imi_mug_run_2_treatment "potassium" "lead"
33 Q0 18056530 298 33.19173 imi_mug_run_2_treatment "various" "progesterone" "nitric oxide"
33 Q0 25854863 299 33.15577 imi_mug_run_2_treatment "various"
33 Q0 25786344 300 33.09949 imi_mug_run_2_treatment "potassium"
33 Q0 17275752 301 33.017174 imi_mug_run_2_treatment "duration" "flecainide"
33 Q0 17130521 302 32.81275 imi_mug_run_2_treatment "leucine"
33 Q0 29213071 303 32.598274 imi_mug_run_2_treatment "lead"
33 Q0 19149796 304 32.45826 imi_mug_run_2_treatment "sodium" "duration" "program"
33 Q0 14691044 305 32.452904 imi_mug_run_2_treatment "potassium" "drug" "arsenic trioxide"
33 Q0 29020060 306 32.359566 imi_mug_run_2_treatment "potassium" "lead"
33 Q0 15572349 307 32.31015 imi_mug_run_2_treatment "potassium"
33 Q0 22366430 308 32.28192 imi_mug_run_2_treatment "drug" "galantamine" "reminyl"
33 Q0 19546258 309 32.079666 imi_mug_run_2_treatment "sulpiride" "duration" "drug"
33 Q0 26279191 310 31.848593 imi_mug_run_2_treatment "anti-arrhythmic"
33 Q0 30337886 311 31.6894 imi_mug_run_2_treatment "potassium" "quinidine" "anti-arrhythmic"
33 Q0 15891643 312 31.375143 imi_mug_run_2_treatment "toluidine blue" "araldite" "lead"
33 Q0 26412604 313 31.235498 imi_mug_run_2_treatment "aim"
33 Q0 16253912 314 31.230068 imi_mug_run_2_treatment "various"
33 Q0 24395636 315 31.185455 imi_mug_run_2_treatment "mediated"
33 Q0 24190995 316 31.052784 imi_mug_run_2_treatment "aromatic"
33 Q0 19233191 317 30.950985 imi_mug_run_2_treatment "mediated" "kinase inhibitor" "wortmannin"
33 Q0 21410720 318 30.938316 imi_mug_run_2_treatment "aim"
33 Q0 18651418 319 30.900143 imi_mug_run_2_treatment "aim"
33 Q0 28600177 320 30.821362 imi_mug_run_2_treatment "aim"
33 Q0 11414731 321 30.799225 imi_mug_run_2_treatment "tandem"
33 Q0 28223225 322 30.799225 imi_mug_run_2_treatment "genesis"
33 Q0 24070608 323 30.783741 imi_mug_run_2_treatment "alpha subunit" "tyrosine"
33 Q0 29978770 324 30.610834 imi_mug_run_2_treatment "various"
33 Q0 18192214 325 30.30972 imi_mug_run_2_treatment "ether"
33 Q0 16001794 326 30.219631 imi_mug_run_2_treatment "calcium" "catecholamine" "potassium"
33 Q0 24372464 327 30.104794 imi_mug_run_2_treatment "tribe"
33 Q0 25453094 328 29.914898 imi_mug_run_2_treatment "drugs"
33 Q0 26888838 329 29.845228 imi_mug_run_2_treatment "sodium" "metoprolol" "lead"
33 Q0 30108508 330 29.780266 imi_mug_run_2_treatment "calcium" "apd" "duration"
33 Q0 21166127 331 29.657158 imi_mug_run_2_treatment "various" "potassium" "lead"
33 Q0 25087753 332 29.462864 imi_mug_run_2_treatment "drugs" "duration"
33 Q0 15023549 333 29.424046 imi_mug_run_2_treatment "duration" "drugs" "acetylcholine"
33 Q0 23166209 334 29.378918 imi_mug_run_2_treatment "duration"
33 Q0 12051693 335 29.375744 imi_mug_run_2_treatment "potassium"
33 Q0 21459285 336 29.34112 imi_mug_run_2_treatment "potassium" "leucine"
33 Q0 11799244 337 29.337486 imi_mug_run_2_treatment "apd" "adenosine" "mediated"
33 Q0 28882596 338 29.319244 imi_mug_run_2_treatment "insulin" "wortmannin" "ly294002"
33 Q0 19832729 339 29.10722 imi_mug_run_2_treatment "duration"
33 Q0 29738690 340 29.059006 imi_mug_run_2_treatment "chaps"
33 Q0 11208532 341 29.057848 imi_mug_run_2_treatment "various" "beta-galactosidase" "liver"
33 Q0 16818210 342 28.953583 imi_mug_run_2_treatment "calcium"
33 Q0 22042987 343 28.942003 imi_mug_run_2_treatment "potassium" "various"
33 Q0 26084842 344 28.912954 imi_mug_run_2_treatment "mediated"
33 Q0 11448722 345 28.870386 imi_mug_run_2_treatment "cyclic amp" "product" "lead"
33 Q0 24687331 346 28.640894 imi_mug_run_2_treatment "therapeutics"
33 Q0 10090886 347 28.49231 imi_mug_run_2_treatment "potassium ion"
33 Q0 27543307 348 28.358532 imi_mug_run_2_treatment "oxygen" "mediated"
33 Q0 30244407 349 28.271835 imi_mug_run_2_treatment "beta-blocker"
33 Q0 15242738 350 28.26289 imi_mug_run_2_treatment "beta-blockers"
33 Q0 23624022 351 28.128857 imi_mug_run_2_treatment "calcium" "drug" "sodium"
33 Q0 17281968 352 28.098894 imi_mug_run_2_treatment "inf" "potassium" "apd"
33 Q0 20193146 353 27.953392 imi_mug_run_2_treatment "lead"
33 Q0 23431135 354 27.848251 imi_mug_run_2_treatment "potassium" "lead" "basis"
33 Q0 18222468 355 27.708862 imi_mug_run_2_treatment "duration" "level"
33 Q0 19041715 356 27.68993 imi_mug_run_2_treatment "leu"
33 Q0 19439185 357 27.431694 imi_mug_run_2_treatment "blockade" "drug" "drugs"
33 Q0 23542581 358 27.01755 imi_mug_run_2_treatment "sodium"
33 Q0 21317414 359 26.916227 imi_mug_run_2_treatment "potassium" "muscle relaxant" "benzodiazepines"
33 Q0 16945797 360 26.889744 imi_mug_run_2_treatment "mediated" "aromatic" "basis"
33 Q0 21985337 361 26.877167 imi_mug_run_2_treatment "potassium ion"
33 Q0 15389592 362 26.536163 imi_mug_run_2_treatment "various"
33 Q0 23424208 363 26.486656 imi_mug_run_2_treatment "probucol" "potassium" "simvastatin"
33 Q0 28814790 364 26.047203 imi_mug_run_2_treatment "potassium" "anti-arrhythmic"
33 Q0 19632626 365 25.806625 imi_mug_run_2_treatment "serine" "basis"
33 Q0 15731462 366 25.68404 imi_mug_run_2_treatment "duration" "apd"
33 Q0 15528278 367 25.576576 imi_mug_run_2_treatment "potassium" "alpha subunit" "mediated"
33 Q0 16329159 368 25.576576 imi_mug_run_2_treatment "drug" "drugs"
33 Q0 19863545 369 25.576576 imi_mug_run_2_treatment "others"
33 Q0 14640909 370 25.576576 imi_mug_run_2_treatment "analgesic drug" "antiepileptic drug" "flupirtine"
33 Q0 29270100 371 25.576576 imi_mug_run_2_treatment "copper"
33 Q0 22433001 372 25.541813 imi_mug_run_2_treatment "epinephrine" "lead"
33 Q0 11484762 373 25.486382 imi_mug_run_2_treatment "ether" "duration"
33 Q0 25232191 374 25.486382 imi_mug_run_2_treatment "ether" "phenylalanine" "therapeutics"
33 Q0 15887426 375 25.406794 imi_mug_run_2_treatment "calcium" "mediated" "basis"
33 Q0 18697752 376 25.406794 imi_mug_run_2_treatment "aim"
33 Q0 15577518 377 25.340118 imi_mug_run_2_treatment "water"
33 Q0 14769199 378 25.340118 imi_mug_run_2_treatment "adenosine" "apd" "favor"
33 Q0 16691402 379 25.340118 imi_mug_run_2_treatment "gly"
33 Q0 22360488 380 25.340118 imi_mug_run_2_treatment "potassium" "antiarrhythmic"
33 Q0 18595190 381 25.139465 imi_mug_run_2_treatment "aim" "balance"
33 Q0 22016621 382 25.015831 imi_mug_run_2_treatment "potassium" "tca" "aim"
33 Q0 14499861 383 25.00658 imi_mug_run_2_treatment "lysine"
33 Q0 17939752 384 25.004066 imi_mug_run_2_treatment "anti-arrhythmic" "potassium" "drug"
33 Q0 22085535 385 24.829544 imi_mug_run_2_treatment "others"
33 Q0 23028363 386 24.815 imi_mug_run_2_treatment "others"
33 Q0 21394035 387 24.797218 imi_mug_run_2_treatment "paliperidone" "ether" "duration"
33 Q0 21915266 388 24.728855 imi_mug_run_2_treatment "zinc pyrithione" "linopirdine" "retigabine"
33 Q0 23350853 389 24.439713 imi_mug_run_2_treatment "duration"
33 Q0 16480714 390 24.43671 imi_mug_run_2_treatment "potassium" "estradiol" "mediated"
33 Q0 17534376 391 24.182331 imi_mug_run_2_treatment "duration"
33 Q0 23718892 392 24.161453 imi_mug_run_2_treatment "carvedilol's" "metoprolol" "metoprolol's"
33 Q0 11223304 393 24.081337 imi_mug_run_2_treatment "level" "balance"
33 Q0 29058180 394 23.573719 imi_mug_run_2_treatment "drugs"
33 Q0 18599533 395 23.510803 imi_mug_run_2_treatment "salt"
33 Q0 22805636 396 23.27367 imi_mug_run_2_treatment "gastrin" "iron" "basis"
33 Q0 26971948 397 23.007723 imi_mug_run_2_treatment "level"
33 Q0 29213224 398 22.82221 imi_mug_run_2_treatment "apd" "antiarrhythmic drug" "lead"
33 Q0 15670556 399 22.383064 imi_mug_run_2_treatment "duration"
33 Q0 29488358 400 22.258686 imi_mug_run_2_treatment "apd" "duration"
33 Q0 18238816 401 22.183762 imi_mug_run_2_treatment "nervous system" "retigabine"
33 Q0 20403459 402 22.126839 imi_mug_run_2_treatment "sodium"
33 Q0 26418890 403 22.114397 imi_mug_run_2_treatment "directed" "glycerol" "shape"
33 Q0 21712262 404 22.114397 imi_mug_run_2_treatment "adenosine"
33 Q0 21228319 405 22.114397 imi_mug_run_2_treatment "calcium" "salt" "lead"
33 Q0 20479111 406 22.114397 imi_mug_run_2_treatment "methanethiosulfonate"
33 Q0 17675083 407 22.05661 imi_mug_run_2_treatment "flecainide"
33 Q0 19617707 408 22.050804 imi_mug_run_2_treatment "air"
33 Q0 28001120 409 22.050804 imi_mug_run_2_treatment "air"
33 Q0 20132149 410 21.98238 imi_mug_run_2_treatment "anti-arrhythmic" "shape"
33 Q0 28466812 411 21.92033 imi_mug_run_2_treatment "sham" "duration" "melatonin"
33 Q0 29951145 412 21.907825 imi_mug_run_2_treatment "tribe"
33 Q0 27856205 413 21.721615 imi_mug_run_2_treatment "potassium" "avid"
33 Q0 9618174 414 21.61972 imi_mug_run_2_treatment "lead"
33 Q0 18951091 415 21.192183 imi_mug_run_2_treatment "level" "liver"
33 Q0 18708743 416 21.037956 imi_mug_run_2_treatment "sucrose" "triton x-100"
33 Q0 24035801 417 21.037956 imi_mug_run_2_treatment "isoproterenol"
33 Q0 25857626 418 21.01522 imi_mug_run_2_treatment "potassium" "animals" "aldosterone"
33 Q0 21776218 419 20.962658 imi_mug_run_2_treatment "arsenic" "water"
33 Q0 23182821 420 20.844473 imi_mug_run_2_treatment "silver" "igf-2"
33 Q0 20400777 421 20.69538 imi_mug_run_2_treatment "lead" "level"
33 Q0 22721776 422 20.640802 imi_mug_run_2_treatment "mediated"
33 Q0 16010495 423 20.482677 imi_mug_run_2_treatment "prenatal" "igf2" "others"
33 Q0 11877438 424 20.2877 imi_mug_run_2_treatment "igf2"
33 Q0 19122847 425 20.180332 imi_mug_run_2_treatment "sodium"
33 Q0 22205991 426 20.05717 imi_mug_run_2_treatment "level"
33 Q0 16357011 427 20.003319 imi_mug_run_2_treatment "nacl" "mediated" "mediators"
33 Q0 16321503 428 19.851727 imi_mug_run_2_treatment "methylated"
33 Q0 10408028 429 19.503101 imi_mug_run_2_treatment "antiarrhythmic" "drugs" "basis"
33 Q0 11528397 430 19.4613 imi_mug_run_2_treatment "igf2"
33 Q0 26802314 431 19.34254 imi_mug_run_2_treatment "linopirdine" "sildenafil" "bms204352"
33 Q0 24996904 432 19.19466 imi_mug_run_2_treatment "silver"
33 Q0 18729007 433 19.134047 imi_mug_run_2_treatment "calcium" "anti-arrhythmic" "thyroxin"
33 Q0 24460807 434 18.514801 imi_mug_run_2_treatment "potassium" "level"
33 Q0 25127743 435 18.25246 imi_mug_run_2_treatment "potassium" "iron" "ferric"
33 Q0 26385840 436 17.743984 imi_mug_run_2_treatment "various" "level"
33 Q0 28660530 437 17.484894 imi_mug_run_2_treatment "ppi" "proton pump inhibitor"
33 Q0 28336205 438 17.271198 imi_mug_run_2_treatment "duration"
33 Q0 27798108 439 17.270924 imi_mug_run_2_treatment "silver" "food"
33 Q0 23502140 440 17.26696 imi_mug_run_2_treatment "favor" "igf2"
33 Q0 10493825 441 17.024622 imi_mug_run_2_treatment "crest"
33 Q0 21345374 442 16.636433 imi_mug_run_2_treatment "mediated"
33 Q0 28624975 443 16.41821 imi_mug_run_2_treatment "dofetilide" "level"
33 Q0 11087258 444 16.256733 imi_mug_run_2_treatment "others"
33 Q0 17185994 445 16.165157 imi_mug_run_2_treatment "alpha subunit"
33 Q0 25692982 446 16.118673 imi_mug_run_2_treatment "adrenoceptor agonist" "carbachol" "isoprenaline"
33 Q0 14627666 447 15.950195 imi_mug_run_2_treatment "balance"
33 Q0 26784546 448 15.876282 imi_mug_run_2_treatment "mediated" "igf2"
33 Q0 29544605 449 15.855423 imi_mug_run_2_treatment "basis"
33 Q0 20573698 450 15.4033 imi_mug_run_2_treatment "mediated" "methylated"
33 Q0 26868975 451 15.4033 imi_mug_run_2_treatment "level"
33 Q0 21094218 452 15.376524 imi_mug_run_2_treatment "potassium" "loop diuretic" "animals"
33 Q0 19901197 453 15.2599325 imi_mug_run_2_treatment "angiotensin" "sodium"
33 Q0 11106355 454 15.170235 imi_mug_run_2_treatment "igf2"
33 Q0 20406211 455 15.132287 imi_mug_run_2_treatment "lapatinib" "apd" "ether"
33 Q0 23714088 456 15.118771 imi_mug_run_2_treatment "lead"
33 Q0 12135952 457 15.054865 imi_mug_run_2_treatment "halothane" "apd" "duration"
33 Q0 26599349 458 14.870424 imi_mug_run_2_treatment "aim"
33 Q0 21170869 459 14.5754595 imi_mug_run_2_treatment "insulin" "mineralocorticoids" "glucocorticoids"
33 Q0 25998555 460 14.542431 imi_mug_run_2_treatment "imidazole" "pyrrole" "mediated"
33 Q0 26634513 461 14.542431 imi_mug_run_2_treatment "various"
33 Q0 16626671 462 14.475745 imi_mug_run_2_treatment "apd" "duration"
33 Q0 28600629 463 14.4527645 imi_mug_run_2_treatment "paclitaxel"
33 Q0 30471108 464 14.319302 imi_mug_run_2_treatment "level"
33 Q0 23933686 465 13.759275 imi_mug_run_2_treatment "enzymes" "insulin" "mineralocorticoids"
33 Q0 28535504 466 13.608515 imi_mug_run_2_treatment "h2o2"
33 Q0 21131637 467 13.301828 imi_mug_run_2_treatment "oestrogen" "tamoxifen" "selective oestrogen receptor modulator"
33 Q0 12410230 468 12.779362 imi_mug_run_2_treatment "kinase inhibitor"
33 Q0 20042427 469 12.779362 imi_mug_run_2_treatment "sodium"
33 Q0 20553101 470 12.665413 imi_mug_run_2_treatment "program"
33 Q0 17901045 471 12.588406 imi_mug_run_2_treatment "igf2" "lead" "aim"
33 Q0 20021289 472 12.588406 imi_mug_run_2_treatment "enzymes" "insulin" "electrolyte"
33 Q0 22891507 473 11.917516 imi_mug_run_2_treatment "various" "factor 7"
33 Q0 30241939 474 11.917516 imi_mug_run_2_treatment "duration"
33 Q0 28837395 475 11.807413 imi_mug_run_2_treatment "level" "pooled"
33 Q0 29039538 476 11.741681 imi_mug_run_2_treatment "plasma"
33 Q0 11436121 477 11.621213 imi_mug_run_2_treatment "aim"
33 Q0 23506284 478 11.042152 imi_mug_run_2_treatment "enzymes" "insulin" "glucose"
33 Q0 17015487 479 10.9572315 imi_mug_run_2_treatment "insulin" "enzymes" "salt"
33 Q0 24441871 480 10.298621 imi_mug_run_2_treatment "adrenergic receptor agonist" "potassium" "formoterol"
33 Q0 22410439 481 10.281319 imi_mug_run_2_treatment "calcium" "electrolyte" "estrogen"
33 Q0 23984860 482 10.268685 imi_mug_run_2_treatment "kinase inhibitor"
33 Q0 22220513 483 9.204441 imi_mug_run_2_treatment "rtg" "potassium" "ezogabine"
34 Q0 19100032 1 66.28565 imi_mug_run_2_treatment "lead"
34 Q0 16325048 2 65.061386 imi_mug_run_2_treatment "sss" "sodium" "pilsicainide"
34 Q0 17081365 3 63.44385 imi_mug_run_2_treatment "alpha subunit" "isoleucine" "phenylalanine"
34 Q0 17399644 4 61.880264 imi_mug_run_2_treatment "mediated" "pilsicainide"
34 Q0 11748104 5 60.892063 imi_mug_run_2_treatment "lead" "arginine" "flecainide"
34 Q0 19549036 6 60.43592 imi_mug_run_2_treatment "duration"
34 Q0 12051963 7 60.045143 imi_mug_run_2_treatment "glycine" "lysine" "glutamic acid"
34 Q0 23810369 8 59.81461 imi_mug_run_2_treatment "ajmaline"
34 Q0 15028074 9 59.73217 imi_mug_run_2_treatment "ajmaline" "sodium channel blockers"
34 Q0 15338453 10 59.712883 imi_mug_run_2_treatment "glycine" "alpha subunit" "serine"
34 Q0 23905889 11 59.342358 imi_mug_run_2_treatment "potassium"
34 Q0 15057319 12 59.19583 imi_mug_run_2_treatment "basis"
34 Q0 25401102 13 58.9104 imi_mug_run_2_treatment "ajmaline"
34 Q0 15882659 14 58.883038 imi_mug_run_2_treatment "sodium" "testosterone" "prophylactic"
34 Q0 16415541 15 58.72403 imi_mug_run_2_treatment "alpha subunit"
34 Q0 10940383 16 58.468838 imi_mug_run_2_treatment "alpha subunit"
34 Q0 20625312 17 58.35873 imi_mug_run_2_treatment "bepridil" "duration"
34 Q0 22323988 18 58.01645 imi_mug_run_2_treatment "sodium" "egg"
34 Q0 16864729 19 57.52305 imi_mug_run_2_treatment "sodium"
34 Q0 19272188 20 57.50582 imi_mug_run_2_treatment "sodium" "lead"
34 Q0 20638671 21 56.717678 imi_mug_run_2_treatment "antiarrhythmic" "flecainide" "quinidine"
34 Q0 20219395 22 56.33731 imi_mug_run_2_treatment "product"
34 Q0 11420310 23 55.989532 imi_mug_run_2_treatment "alpha subunit" "sodium"
34 Q0 15880981 24 55.961704 imi_mug_run_2_treatment "drug" "ajmaline" "tricyclic antidepressants"
34 Q0 27560382 25 55.31102 imi_mug_run_2_treatment "drug" "sodium" "pilsicainide"
34 Q0 12106943 26 55.20867 imi_mug_run_2_treatment "drugs"
34 Q0 14687250 27 55.088688 imi_mug_run_2_treatment "procainamide"
34 Q0 15135718 28 55.083046 imi_mug_run_2_treatment "sotalol"
34 Q0 29574140 29 54.84556 imi_mug_run_2_treatment "lead"
34 Q0 19279983 30 54.79759 imi_mug_run_2_treatment "aim"
34 Q0 15520322 31 54.67009 imi_mug_run_2_treatment "ajmaline" "drug" "sodium channel blockers"
34 Q0 16426410 32 54.619797 imi_mug_run_2_treatment "quinidine" "hydroquinidine"
34 Q0 12741714 33 54.51635 imi_mug_run_2_treatment "sodium" "flecainide"
34 Q0 16226070 34 54.2277 imi_mug_run_2_treatment "potassium" "calcium" "sodium"
34 Q0 20609320 35 54.086388 imi_mug_run_2_treatment "thr" "flecainide" "ile"
34 Q0 19057056 36 54.084316 imi_mug_run_2_treatment "others"
34 Q0 16934827 37 53.837936 imi_mug_run_2_treatment "basis"
34 Q0 24932359 38 53.28867 imi_mug_run_2_treatment "basis"
34 Q0 15877619 39 53.039078 imi_mug_run_2_treatment "antiarrhythmic drugs" "pilsicainide" "class ic antiarrhythmic drug"
34 Q0 15828879 40 52.939266 imi_mug_run_2_treatment "sodium"
34 Q0 11786529 41 52.92966 imi_mug_run_2_treatment "lysine"
34 Q0 11155778 42 52.744713 imi_mug_run_2_treatment "blockade" "procainamide"
34 Q0 17038146 43 52.730885 imi_mug_run_2_treatment "tricyclic antidepressants" "drugs" "propranolol"
34 Q0 30203441 44 52.687782 imi_mug_run_2_treatment "amp"
34 Q0 30126015 45 52.631115 imi_mug_run_2_treatment "generic"
34 Q0 17420262 46 52.62294 imi_mug_run_2_treatment "ajmaline" "lead"
34 Q0 22682427 47 52.327732 imi_mug_run_2_treatment "drug" "alpha subunit"
34 Q0 19117622 48 52.32003 imi_mug_run_2_treatment "lead" "drugs"
34 Q0 17697823 49 52.17607 imi_mug_run_2_treatment "lead"
34 Q0 16945804 50 52.07697 imi_mug_run_2_treatment "bupivacaine" "anesthetics" "sodium"
34 Q0 18507554 51 52.04654 imi_mug_run_2_treatment "electrolyte" "indapamide"
34 Q0 26036855 52 52.00472 imi_mug_run_2_treatment "sodium"
34 Q0 11150514 53 51.98871 imi_mug_run_2_treatment "sodium"
34 Q0 23840796 54 51.891106 imi_mug_run_2_treatment "lead" "duration"
34 Q0 10727653 55 51.747456 imi_mug_run_2_treatment "sodium" "lead"
34 Q0 11060577 56 51.57715 imi_mug_run_2_treatment "antiarrhythmic drugs" "class i antiarrhythmic drugs"
34 Q0 12136622 57 51.5398 imi_mug_run_2_treatment "antiarrhythmic" "basis" "genesis"
34 Q0 17198989 58 51.52677 imi_mug_run_2_treatment "sodium" "isoleucine" "mexiletine"
34 Q0 25905440 59 51.454414 imi_mug_run_2_treatment "ajmaline" "flecainide"
34 Q0 15306732 60 51.40973 imi_mug_run_2_treatment "lead"
34 Q0 23955615 61 51.313175 imi_mug_run_2_treatment "sss" "pilsicainide"
34 Q0 15161528 62 51.269306 imi_mug_run_2_treatment "lead"
34 Q0 10423670 63 51.222603 imi_mug_run_2_treatment "electrolyte"
34 Q0 11405402 64 51.179897 imi_mug_run_2_treatment "level"
34 Q0 30254039 65 51.13332 imi_mug_run_2_treatment "loperamide"
34 Q0 18599870 66 51.03125 imi_mug_run_2_treatment "lidocaine" "drug" "sodium"
34 Q0 15913579 67 50.956585 imi_mug_run_2_treatment "various" "aim"
34 Q0 26627541 68 50.92901 imi_mug_run_2_treatment "drug"
34 Q0 17446038 69 50.806057 imi_mug_run_2_treatment "antiarrhythmic" "sodium" "alpha subunit"
34 Q0 12325460 70 50.77927 imi_mug_run_2_treatment "pilsicainide"
34 Q0 22490985 71 50.706116 imi_mug_run_2_treatment "histidine" "lead"
34 Q0 19155074 72 50.694195 imi_mug_run_2_treatment "lead" "drugs"
34 Q0 14967959 73 50.661118 imi_mug_run_2_treatment "antiarrhythmic drugs" "sodium channel blockers"
34 Q0 24524602 74 50.62523 imi_mug_run_2_treatment "drugs"
34 Q0 11823453 75 50.608192 imi_mug_run_2_treatment "basis"
34 Q0 14967853 76 50.57544 imi_mug_run_2_treatment "basis"
34 Q0 19843921 77 50.53641 imi_mug_run_2_treatment "sodium"
34 Q0 27668095 78 50.476986 imi_mug_run_2_treatment "ropivacaine" "drugs" "sufentanil"
34 Q0 25261036 79 50.420918 imi_mug_run_2_treatment "lead"
34 Q0 20224390 80 50.413185 imi_mug_run_2_treatment "basis" "level"
34 Q0 9935001 81 50.292953 imi_mug_run_2_treatment "ajmaline" "flecainide" "procainamide"
34 Q0 23893060 82 50.270138 imi_mug_run_2_treatment "drugs"
34 Q0 18081762 83 50.261982 imi_mug_run_2_treatment "ajmaline"
34 Q0 15863661 84 50.234085 imi_mug_run_2_treatment "sodium"
34 Q0 17445919 85 49.990246 imi_mug_run_2_treatment "lidocaine" "sodium"
34 Q0 16119703 86 49.96289 imi_mug_run_2_treatment "calcium" "potassium" "sodium"
34 Q0 19324308 87 49.91263 imi_mug_run_2_treatment "sodium channel blocker"
34 Q0 20159410 88 49.812134 imi_mug_run_2_treatment "propranolol" "antiarrhythmic" "sodium"
34 Q0 11839626 89 49.78769 imi_mug_run_2_treatment "procainamide" "sodium channel blockers"
34 Q0 18464934 90 49.78769 imi_mug_run_2_treatment "sodium" "alpha subunit"
34 Q0 20100972 91 49.753452 imi_mug_run_2_treatment "drug" "aim"
34 Q0 16144991 92 49.706104 imi_mug_run_2_treatment "drug" "lithium" "antiarrhythmic drugs"
34 Q0 19641464 93 49.574326 imi_mug_run_2_treatment "electrolyte" "drugs" "sodium bicarbonate"
34 Q0 22277643 94 49.56292 imi_mug_run_2_treatment "lead" "duration"
34 Q0 29798782 95 49.53155 imi_mug_run_2_treatment "various" "lead" "sodium"
34 Q0 11307783 96 49.261177 imi_mug_run_2_treatment "flecainide" "sodium" "drugs"
34 Q0 10358800 97 49.20209 imi_mug_run_2_treatment "basis"
34 Q0 27381756 98 49.15779 imi_mug_run_2_treatment "sodium"
34 Q0 16972995 99 49.156345 imi_mug_run_2_treatment "quinidine" "lead"
34 Q0 23612926 100 49.12298 imi_mug_run_2_treatment "lidocaine" "mexiletine"
34 Q0 17905336 101 49.093174 imi_mug_run_2_treatment "program"
34 Q0 11535580 102 49.068893 imi_mug_run_2_treatment "flecainide" "blockade" "sodium"
34 Q0 17303635 103 48.95323 imi_mug_run_2_treatment "flecainide" "quinidine" "duration"
34 Q0 22876298 104 48.74874 imi_mug_run_2_treatment "various"
34 Q0 21943787 105 48.73307 imi_mug_run_2_treatment "sodium" "drugs"
34 Q0 24851643 106 48.483124 imi_mug_run_2_treatment "ajmaline" "drugs" "flecainide"
34 Q0 27472692 107 48.283768 imi_mug_run_2_treatment "alpha subunit" "prisma"
34 Q0 15023552 108 48.252445 imi_mug_run_2_treatment "drug" "mexiletine" "sodium"
34 Q0 19141363 109 48.20278 imi_mug_run_2_treatment "level"
34 Q0 25210526 110 48.12156 imi_mug_run_2_treatment "lidocaine" "amiodarone" "quinidine"
34 Q0 18762705 111 48.090176 imi_mug_run_2_treatment "glycerol" "phosphate"
34 Q0 27684715 112 48.007923 imi_mug_run_2_treatment "lead"
34 Q0 10690282 113 47.85035 imi_mug_run_2_treatment "sodium" "blockade"
34 Q0 15968489 114 47.832573 imi_mug_run_2_treatment "lead"
34 Q0 26182783 115 47.821106 imi_mug_run_2_treatment "antiarrhythmics"
34 Q0 12693506 116 47.80817 imi_mug_run_2_treatment "various" "lead"
34 Q0 19706159 117 47.791355 imi_mug_run_2_treatment "alpha subunit"
34 Q0 27625342 118 47.654015 imi_mug_run_2_treatment "various"
34 Q0 17215981 119 47.574333 imi_mug_run_2_treatment "sodium"
34 Q0 28219873 120 47.457413 imi_mug_run_2_treatment "sodium" "epc"
34 Q0 12852283 121 47.365524 imi_mug_run_2_treatment "sodium" "antiarrhythmic drugs"
34 Q0 20031634 122 47.288124 imi_mug_run_2_treatment "various" "sodium channel blockers" "aim"
34 Q0 11196553 123 47.261658 imi_mug_run_2_treatment "flecainide" "disopyramide" "channel blockers"
34 Q0 20812931 124 47.20927 imi_mug_run_2_treatment "sodium"
34 Q0 22987075 125 47.11833 imi_mug_run_2_treatment "basis" "mediated"
34 Q0 19648062 126 47.116898 imi_mug_run_2_treatment "various" "sodium"
34 Q0 29709101 127 47.037567 imi_mug_run_2_treatment "sodium channel blocker"
34 Q0 19406494 128 47.00977 imi_mug_run_2_treatment "alpha subunit" "lead"
34 Q0 18651501 129 46.88881 imi_mug_run_2_treatment "various"
34 Q0 21273195 130 46.85372 imi_mug_run_2_treatment "sodium"
34 Q0 22475738 131 46.665077 imi_mug_run_2_treatment "sodium" "duration"
34 Q0 17761312 132 46.518944 imi_mug_run_2_treatment "lidocaine" "anti-arrhythmic" "lead"
34 Q0 25829473 133 46.493782 imi_mug_run_2_treatment "sodium"
34 Q0 16138883 134 46.431847 imi_mug_run_2_treatment "basis" "sodium" "drugs"
34 Q0 17075016 135 46.42652 imi_mug_run_2_treatment "mexiletine" "sodium channel blockers"
34 Q0 17967977 136 46.399014 imi_mug_run_2_treatment "phosphate"
34 Q0 15673386 137 46.316532 imi_mug_run_2_treatment "various" "aim"
34 Q0 29997009 138 46.183342 imi_mug_run_2_treatment "sodium"
34 Q0 24167619 139 46.06048 imi_mug_run_2_treatment "sodium"
34 Q0 16003713 140 45.980465 imi_mug_run_2_treatment "drugs" "alpha subunit" "balance"
34 Q0 14961552 141 45.777187 imi_mug_run_2_treatment "basis"
34 Q0 21048329 142 45.688396 imi_mug_run_2_treatment "various"
34 Q0 19140927 143 45.567566 imi_mug_run_2_treatment "flecainide"
34 Q0 12687841 144 45.262627 imi_mug_run_2_treatment "flecainide"
34 Q0 15245345 145 45.22928 imi_mug_run_2_treatment "blockade" "antiarrhythmic drugs" "isoproterenol"
34 Q0 17141278 146 45.089195 imi_mug_run_2_treatment "sodium" "aim"
34 Q0 24599044 147 45.071022 imi_mug_run_2_treatment "flecainide" "sodium" "glutamine"
34 Q0 30170230 148 44.985092 imi_mug_run_2_treatment "sodium" "ajmaline"
34 Q0 25626866 149 44.947487 imi_mug_run_2_treatment "lead"
34 Q0 26776555 150 44.937973 imi_mug_run_2_treatment "mediated"
34 Q0 18436145 151 44.929146 imi_mug_run_2_treatment "sodium" "various" "lead"
34 Q0 25842276 152 44.650673 imi_mug_run_2_treatment "sodium" "aim"
34 Q0 19949711 153 44.597305 imi_mug_run_2_treatment "centuries"
34 Q0 30389905 154 44.50076 imi_mug_run_2_treatment "sodium" "carboplatin"
34 Q0 24762805 155 44.310715 imi_mug_run_2_treatment "sss" "sodium"
34 Q0 16836701 156 44.276764 imi_mug_run_2_treatment "sodium" "channel blocker"
34 Q0 26941343 157 44.197212 imi_mug_run_2_treatment "sodium" "ajmaline" "sodium channel blockers"
34 Q0 24768612 158 44.09026 imi_mug_run_2_treatment "ajmaline"
34 Q0 17556186 159 44.001247 imi_mug_run_2_treatment "isoproterenol" "oral medications" "bepridil"
34 Q0 21126620 160 43.95217 imi_mug_run_2_treatment "ajmaline"
34 Q0 12741719 161 43.81628 imi_mug_run_2_treatment "basis"
34 Q0 26921764 162 43.79219 imi_mug_run_2_treatment "antipyretics" "quinidine" "hydroquinidine"
34 Q0 25500878 163 43.785614 imi_mug_run_2_treatment "sodium"
34 Q0 16266370 164 43.69319 imi_mug_run_2_treatment "aim"
34 Q0 15910881 165 43.56118 imi_mug_run_2_treatment "combinations" "sodium" "acetylcholine"
34 Q0 24759840 166 43.54081 imi_mug_run_2_treatment "aim"
34 Q0 11265734 167 43.487274 imi_mug_run_2_treatment "calcium" "balance" "adrenergic agonists"
34 Q0 27122723 168 43.418034 imi_mug_run_2_treatment "lead" "aim"
34 Q0 24963029 169 43.345673 imi_mug_run_2_treatment "aim"
34 Q0 17038144 170 43.319202 imi_mug_run_2_treatment "pilsicainide" "isoproterenol"
34 Q0 29024690 171 43.284157 imi_mug_run_2_treatment "sodium"
34 Q0 19632628 172 43.221886 imi_mug_run_2_treatment "aim"
34 Q0 16415376 173 43.206116 imi_mug_run_2_treatment "sodium" "sodium channel blockers"
34 Q0 20381179 174 43.08753 imi_mug_run_2_treatment "lead"
34 Q0 16764707 175 43.064705 imi_mug_run_2_treatment "flecainide" "duration" "sodium channel blockers"
34 Q0 19497490 176 43.005074 imi_mug_run_2_treatment "sodium channel blocker"
34 Q0 18252757 177 42.96689 imi_mug_run_2_treatment "sodium"
34 Q0 29402340 178 42.955322 imi_mug_run_2_treatment "lead"
34 Q0 26173111 179 42.943882 imi_mug_run_2_treatment "sodium" "lead" "aim"
34 Q0 20621962 180 42.906975 imi_mug_run_2_treatment "apd" "flecainide" "quinidine"
34 Q0 29709244 181 42.834705 imi_mug_run_2_treatment "ajmaline" "sodium channel blockers"
34 Q0 15890323 182 42.76126 imi_mug_run_2_treatment "various" "sodium" "curcumin"
34 Q0 25898860 183 42.73523 imi_mug_run_2_treatment "alpha subunit"
34 Q0 27200363 184 42.640125 imi_mug_run_2_treatment "medicine"
34 Q0 22397033 185 42.45432 imi_mug_run_2_treatment "potassium" "calcium" "sodium"
34 Q0 14625171 186 42.435745 imi_mug_run_2_treatment "alpha subunit" "lys"
34 Q0 24573164 187 42.43049 imi_mug_run_2_treatment "sodium" "lead"
34 Q0 14716629 188 42.407856 imi_mug_run_2_treatment "terfenadine" "mediated" "sodium"
34 Q0 14619194 189 42.36983 imi_mug_run_2_treatment "antiarrhythmic" "sodium" "drugs"
34 Q0 20031595 190 42.262318 imi_mug_run_2_treatment "sodium" "lead"
34 Q0 26713557 191 42.21371 imi_mug_run_2_treatment "sodium"
34 Q0 26304620 192 41.878708 imi_mug_run_2_treatment "sodium" "quinidine"
34 Q0 27676163 193 41.778976 imi_mug_run_2_treatment "alpha subunit"
34 Q0 26279430 194 41.767204 imi_mug_run_2_treatment "lead" "sodium"
34 Q0 23538678 195 41.685417 imi_mug_run_2_treatment "nocturne"
34 Q0 28784436 196 41.67671 imi_mug_run_2_treatment "drug" "ajmaline" "flecainide"
34 Q0 26361848 197 41.61786 imi_mug_run_2_treatment "sodium" "level"
34 Q0 10443304 198 41.563885 imi_mug_run_2_treatment "antiarrhythmic drugs" "beta-blockers" "ajmaline"
34 Q0 24943134 199 41.483658 imi_mug_run_2_treatment "ajmaline"
34 Q0 22090166 200 41.454483 imi_mug_run_2_treatment "calcium" "sodium" "procainamide"
34 Q0 20129283 201 41.292686 imi_mug_run_2_treatment "others"
34 Q0 30476647 202 41.210155 imi_mug_run_2_treatment "sex hormones" "sex hormone" "lead"
34 Q0 20174578 203 41.165276 imi_mug_run_2_treatment "ajmaline" "channel blocker"
34 Q0 28217227 204 41.111397 imi_mug_run_2_treatment "sss" "pilsicainide" "elder"
34 Q0 23874304 205 41.06653 imi_mug_run_2_treatment "basis"
34 Q0 17805561 206 41.022114 imi_mug_run_2_treatment "quinidine" "anti-arrhythmic" "flecainide"
34 Q0 15851227 207 41.00186 imi_mug_run_2_treatment "drugs" "anonymous"
34 Q0 11123251 208 40.863514 imi_mug_run_2_treatment "glutamine" "leucine"
34 Q0 28127136 209 40.857586 imi_mug_run_2_treatment "alpha subunit"
34 Q0 27915266 210 40.841496 imi_mug_run_2_treatment "ajmaline" "class i antiarrhythmic drugs" "sodium channel blockers"
34 Q0 20025708 211 40.82279 imi_mug_run_2_treatment "calcium" "sodium" "mexiletine"
34 Q0 10532948 212 40.58434 imi_mug_run_2_treatment "alpha subunit"
34 Q0 19075525 213 40.557728 imi_mug_run_2_treatment "lead" "pilsicainide"
34 Q0 16707561 214 40.355186 imi_mug_run_2_treatment "others"
34 Q0 16616735 215 40.312378 imi_mug_run_2_treatment "sodium" "lead"
34 Q0 20384647 216 40.209103 imi_mug_run_2_treatment "flecainide" "quinidine" "antiarrhythmic"
34 Q0 26220970 217 40.209103 imi_mug_run_2_treatment "lead"
34 Q0 23257389 218 40.209103 imi_mug_run_2_treatment "sodium"
34 Q0 29649615 219 40.181824 imi_mug_run_2_treatment "prophylactic"
34 Q0 17886758 220 40.034832 imi_mug_run_2_treatment "antiarrhythmic"
34 Q0 15849444 221 40.01487 imi_mug_run_2_treatment "fiber" "sodium"
34 Q0 20564468 222 39.97341 imi_mug_run_2_treatment "sodium"
34 Q0 30116678 223 39.96272 imi_mug_run_2_treatment "anti-arrhythmic" "medications" "basis"
34 Q0 19606473 224 39.808556 imi_mug_run_2_treatment "potassium" "phosphate" "basis"
34 Q0 23818691 225 39.77635 imi_mug_run_2_treatment "various" "sodium"
34 Q0 17971661 226 39.735332 imi_mug_run_2_treatment "various" "sodium"
34 Q0 21447824 227 39.72531 imi_mug_run_2_treatment "sodium"
34 Q0 19632629 228 39.690727 imi_mug_run_2_treatment "sodium"
34 Q0 12845244 229 39.601997 imi_mug_run_2_treatment "antiarrhythmic"
34 Q0 18554195 230 39.501644 imi_mug_run_2_treatment "drug"
34 Q0 18508782 231 39.380993 imi_mug_run_2_treatment "ajmaline" "lead"
34 Q0 25558681 232 39.37555 imi_mug_run_2_treatment "various" "antiarrhythmic" "aim"
34 Q0 11343671 233 39.29651 imi_mug_run_2_treatment "sodium" "antiarrhythmic" "beta-blockers"
34 Q0 17675083 234 39.166153 imi_mug_run_2_treatment "flecainide"
34 Q0 27287068 235 39.109997 imi_mug_run_2_treatment "aim"
34 Q0 23308164 236 39.033447 imi_mug_run_2_treatment "sodium" "alpha subunit" "aim"
34 Q0 26916278 237 38.988617 imi_mug_run_2_treatment "sodium"
34 Q0 24096171 238 38.971672 imi_mug_run_2_treatment "basis"
34 Q0 19875396 239 38.91794 imi_mug_run_2_treatment "ssri" "selective serotonin reuptake inhibitor" "fluvoxamine"
34 Q0 16239976 240 38.86841 imi_mug_run_2_treatment "ajmaline" "flecainide" "lead"
34 Q0 27033637 241 38.816147 imi_mug_run_2_treatment "drug" "drugs"
34 Q0 20331542 242 38.708 imi_mug_run_2_treatment "aim"
34 Q0 11781953 243 38.696915 imi_mug_run_2_treatment "potassium" "sodium" "others"
34 Q0 22486578 244 38.68242 imi_mug_run_2_treatment "apd" "duration"
34 Q0 18375968 245 38.47529 imi_mug_run_2_treatment "quinidine" "verapamil"
34 Q0 22968175 246 38.39849 imi_mug_run_2_treatment "lead"
34 Q0 22840528 247 38.349487 imi_mug_run_2_treatment "mediated" "aim"
34 Q0 16568155 248 38.338142 imi_mug_run_2_treatment "sodium" "lead" "aim"
34 Q0 27761167 249 38.264404 imi_mug_run_2_treatment "drug" "class i antiarrhythmic drugs" "lead"
34 Q0 29325976 250 38.258255 imi_mug_run_2_treatment "prophylactic"
34 Q0 30059973 251 38.228577 imi_mug_run_2_treatment "mediated"
34 Q0 30419068 252 38.138428 imi_mug_run_2_treatment "various"
34 Q0 24657429 253 38.083946 imi_mug_run_2_treatment "procainamide" "sodium channel blockers" "basis"
34 Q0 16022964 254 38.060616 imi_mug_run_2_treatment "lead" "basis" "aim"
34 Q0 11804990 255 38.01295 imi_mug_run_2_treatment "sodium" "glycine" "serine"
34 Q0 12123767 256 38.01295 imi_mug_run_2_treatment "sodium" "mexiletine" "drug"
34 Q0 19666841 257 38.011723 imi_mug_run_2_treatment "glycerol" "phosphate" "sodium"
34 Q0 26467377 258 37.985085 imi_mug_run_2_treatment "sss" "alpha subunit" "human cardiac tissue"
34 Q0 28391114 259 37.945118 imi_mug_run_2_treatment "various" "sss"
34 Q0 25923670 260 37.916405 imi_mug_run_2_treatment "glutamine"
34 Q0 25500882 261 37.857147 imi_mug_run_2_treatment "sodium"
34 Q0 20390067 262 37.767475 imi_mug_run_2_treatment "potassium"
34 Q0 12208804 263 37.766617 imi_mug_run_2_treatment "drug" "cisapride"
34 Q0 24913289 264 37.74454 imi_mug_run_2_treatment "mea" "aim"
34 Q0 18361072 265 37.196724 imi_mug_run_2_treatment "sodium"
34 Q0 26031372 266 37.116364 imi_mug_run_2_treatment "various" "sodium"
34 Q0 29267949 267 37.102173 imi_mug_run_2_treatment "sodium"
34 Q0 29791480 268 36.916744 imi_mug_run_2_treatment "mexiletine" "combinations" "drug"
34 Q0 14985827 269 36.89228 imi_mug_run_2_treatment "aim"
34 Q0 28552050 270 36.827633 imi_mug_run_2_treatment "sodium" "various" "aminoglycosides"
34 Q0 21895525 271 36.738506 imi_mug_run_2_treatment "ranolazine"
34 Q0 19027778 272 36.683205 imi_mug_run_2_treatment "sss"
34 Q0 21097662 273 36.617134 imi_mug_run_2_treatment "anti-arrhythmic" "flecainide" "quinidine"
34 Q0 30389366 274 36.60364 imi_mug_run_2_treatment "beta blockers" "flecainide" "mediated"
34 Q0 10961955 275 36.564133 imi_mug_run_2_treatment "flecainide"
34 Q0 18451998 276 36.52662 imi_mug_run_2_treatment "drugs" "flecainide" "basis"
34 Q0 28534967 277 36.359947 imi_mug_run_2_treatment "sodium" "arginine" "glycine"
34 Q0 12015471 278 36.347157 imi_mug_run_2_treatment "glucose"
34 Q0 16043162 279 36.05245 imi_mug_run_2_treatment "ether"
34 Q0 19829766 280 36.016136 imi_mug_run_2_treatment "lead"
34 Q0 27485484 281 36.004105 imi_mug_run_2_treatment "calcium" "potassium" "sodium"
34 Q0 12569159 282 35.966698 imi_mug_run_2_treatment "combinations" "basis"
34 Q0 24795344 283 35.810154 imi_mug_run_2_treatment "sodium" "nicotinamide adenine dinucleotide" "nadh"
34 Q0 16943925 284 35.63666 imi_mug_run_2_treatment "alpha subunit"
34 Q0 23403368 285 35.5464 imi_mug_run_2_treatment "duration"
34 Q0 22284586 286 35.50104 imi_mug_run_2_treatment "potassium" "sodium"
34 Q0 22529811 287 35.45531 imi_mug_run_2_treatment "mexiletine" "curcumin" "drugs"
34 Q0 25998140 288 35.374477 imi_mug_run_2_treatment "drug" "ajmaline" "duration"
34 Q0 23575362 289 35.346054 imi_mug_run_2_treatment "various"
34 Q0 17854786 290 35.333233 imi_mug_run_2_treatment "various" "sodium"
34 Q0 21779762 291 35.310043 imi_mug_run_2_treatment "flecainide" "apd" "anti-arrhythmic"
34 Q0 18059420 292 35.226086 imi_mug_run_2_treatment "various"
34 Q0 22028457 293 35.005795 imi_mug_run_2_treatment "sodium" "sodium channel blocker" "others"
34 Q0 10688320 294 34.983772 imi_mug_run_2_treatment "mediated" "lead" "duration"
34 Q0 19845816 295 34.89258 imi_mug_run_2_treatment "sodium"
34 Q0 10807875 296 34.887672 imi_mug_run_2_treatment "no" "nitric oxide" "mediated"
34 Q0 23612729 297 34.776035 imi_mug_run_2_treatment "sodium" "calcium" "calcium homeostasis"
34 Q0 16155735 298 34.594986 imi_mug_run_2_treatment "potassium" "sodium"
34 Q0 24011739 299 34.56009 imi_mug_run_2_treatment "various" "duration" "drug"
34 Q0 19181867 300 34.303223 imi_mug_run_2_treatment "flecainide"
34 Q0 20108749 301 34.227165 imi_mug_run_2_treatment "lead" "ajmaline"
34 Q0 23836691 302 34.18302 imi_mug_run_2_treatment "quinidine" "flecainide" "apd"
34 Q0 11405394 303 34.133987 imi_mug_run_2_treatment "prophylactic"
34 Q0 29306474 304 34.0038 imi_mug_run_2_treatment "duration" "ajmaline"
34 Q0 19377496 305 33.867832 imi_mug_run_2_treatment "alpha subunit"
34 Q0 12747584 306 33.81544 imi_mug_run_2_treatment "lev"
34 Q0 20137763 307 33.606873 imi_mug_run_2_treatment "drug" "sodium" "pilsicainide"
34 Q0 11410597 308 33.389725 imi_mug_run_2_treatment "basis" "level"
34 Q0 21378142 309 33.271187 imi_mug_run_2_treatment "flecainide"
34 Q0 20022821 310 33.257362 imi_mug_run_2_treatment "ajmaline"
34 Q0 22155597 311 33.15548 imi_mug_run_2_treatment "potassium" "ajmaline"
34 Q0 19744495 312 33.09723 imi_mug_run_2_treatment "enzymes" "aim"
34 Q0 19336922 313 32.929955 imi_mug_run_2_treatment "sodium" "drug" "channel blockers"
34 Q0 28965168 314 32.929955 imi_mug_run_2_treatment "various" "sodium"
34 Q0 22461438 315 32.651016 imi_mug_run_2_treatment "quinidine" "apd" "flecainide"
34 Q0 19377070 316 32.61637 imi_mug_run_2_treatment "level" "aminoglycosides"
34 Q0 26255078 317 32.534733 imi_mug_run_2_treatment "alpha subunit" "product"
34 Q0 26401487 318 32.530273 imi_mug_run_2_treatment "lead"
34 Q0 17916151 319 32.42793 imi_mug_run_2_treatment "pilsicainide" "sodium channel blocker"
34 Q0 19251209 320 32.414898 imi_mug_run_2_treatment "drug" "sodium"
34 Q0 18081770 321 32.413387 imi_mug_run_2_treatment "lead" "aim"
34 Q0 24352520 322 32.413387 imi_mug_run_2_treatment "sodium"
34 Q0 27108952 323 32.40734 imi_mug_run_2_treatment "sodium"
34 Q0 27012403 324 32.333298 imi_mug_run_2_treatment "duration"
34 Q0 27677334 325 32.171185 imi_mug_run_2_treatment "aim"
34 Q0 12084774 326 32.076797 imi_mug_run_2_treatment "flecainide" "alpha subunit" "channel blocker"
34 Q0 24317018 327 32.048233 imi_mug_run_2_treatment "isoleucine" "aim"
34 Q0 16980337 328 32.030853 imi_mug_run_2_treatment "flecainide" "calcium" "mexiletine"
34 Q0 28734073 329 31.925835 imi_mug_run_2_treatment "sodium" "calcium" "duration"
34 Q0 29908537 330 31.879162 imi_mug_run_2_treatment "sodium" "drug" "allitridum"
34 Q0 20384594 331 31.813612 imi_mug_run_2_treatment "duration" "anti-arrhythmic" "flecainide"
34 Q0 24687990 332 31.760048 imi_mug_run_2_treatment "animals"
34 Q0 27281089 333 31.755898 imi_mug_run_2_treatment "sodium"
34 Q0 11710892 334 31.62254 imi_mug_run_2_treatment "sodium" "alpha subunit"
34 Q0 11273715 335 31.602736 imi_mug_run_2_treatment "antiarrhythmic" "sodium" "blockade"
34 Q0 14720472 336 31.582779 imi_mug_run_2_treatment "sodium"
34 Q0 11239848 337 31.524273 imi_mug_run_2_treatment "level" "alpha subunit"
34 Q0 30193957 338 31.524273 imi_mug_run_2_treatment "lead" "mediated"
34 Q0 14566468 339 31.480984 imi_mug_run_2_treatment "ajmalin" "lead"
34 Q0 11225790 340 31.429869 imi_mug_run_2_treatment "antiarrhythmic drugs" "beta-blockers" "ajmaline"
34 Q0 21454796 341 31.37238 imi_mug_run_2_treatment "various"
34 Q0 23661717 342 31.281853 imi_mug_run_2_treatment "sodium" "ajmaline"
34 Q0 24363796 343 31.11636 imi_mug_run_2_treatment "mexiletine"
34 Q0 23376825 344 30.708939 imi_mug_run_2_treatment "sodium" "l-arginine" "lead"
34 Q0 27733495 345 30.593658 imi_mug_run_2_treatment "sodium" "ranolazine" "sodium channel blockers"
34 Q0 20395683 346 30.462654 imi_mug_run_2_treatment "sodium"
34 Q0 22519808 347 30.291904 imi_mug_run_2_treatment "sodium"
34 Q0 28339995 348 30.28263 imi_mug_run_2_treatment "flecainide" "drug" "sodium channel blockers"
34 Q0 20042427 349 30.168236 imi_mug_run_2_treatment "sodium"
34 Q0 23499630 350 30.127186 imi_mug_run_2_treatment "lead"
34 Q0 10662748 351 30.07713 imi_mug_run_2_treatment "sodium channel blockers" "ajmaline" "flecainide"
34 Q0 18033008 352 30.049591 imi_mug_run_2_treatment "enzymes" "lev"
34 Q0 27232914 353 30.039146 imi_mug_run_2_treatment "drugs"
34 Q0 15123648 354 30.037127 imi_mug_run_2_treatment "various"
34 Q0 19808477 355 29.884275 imi_mug_run_2_treatment "mediated" "sodium" "others"
34 Q0 21361048 356 29.841288 imi_mug_run_2_treatment "antihistamines" "drugs" "antiarrhythmic drugs"
34 Q0 25696119 357 29.722492 imi_mug_run_2_treatment "prophylactic"
34 Q0 24721656 358 29.704535 imi_mug_run_2_treatment "sulfonylurea" "cardiovascular system" "pace"
34 Q0 17967976 359 29.582119 imi_mug_run_2_treatment "sodium" "phosphate" "mediated"
34 Q0 30483629 360 29.575584 imi_mug_run_2_treatment "medicine" "basis"
34 Q0 22287583 361 29.518433 imi_mug_run_2_treatment "animals"
34 Q0 30139433 362 29.381725 imi_mug_run_2_treatment "sodium" "channel blocker" "basis"
34 Q0 23498767 363 29.210033 imi_mug_run_2_treatment "basis"
34 Q0 19083750 364 29.196896 imi_mug_run_2_treatment "various"
34 Q0 16632547 365 29.154446 imi_mug_run_2_treatment "mexiletine" "glutamine"
34 Q0 18591664 366 28.847416 imi_mug_run_2_treatment "sodium"
34 Q0 20552221 367 28.797798 imi_mug_run_2_treatment "duration" "animals"
34 Q0 17210841 368 28.405624 imi_mug_run_2_treatment "sodium"
34 Q0 21385947 369 28.386492 imi_mug_run_2_treatment "sodium"
34 Q0 17145985 370 28.356123 imi_mug_run_2_treatment "sodium" "flecainide" "sodium channel blocker"
34 Q0 21109022 371 28.267797 imi_mug_run_2_treatment "sodium" "level"
34 Q0 11770069 372 28.213934 imi_mug_run_2_treatment "various" "calcium" "sodium"
34 Q0 23425522 373 28.113815 imi_mug_run_2_treatment "cardiac drugs" "sodium" "nortriptyline"
34 Q0 22065308 374 28.0845 imi_mug_run_2_treatment "ptc" "basis" "duration"
34 Q0 18456723 375 28.04874 imi_mug_run_2_treatment "basis"
34 Q0 17023504 376 27.98448 imi_mug_run_2_treatment "quinidine" "flecainide" "apd"
34 Q0 23541953 377 27.966349 imi_mug_run_2_treatment "sodium" "l-nmma" "duration"
34 Q0 11463728 378 27.9393 imi_mug_run_2_treatment "sodium"
34 Q0 26131924 379 27.812263 imi_mug_run_2_treatment "various" "q10"
34 Q0 28430892 380 27.709412 imi_mug_run_2_treatment "sodium" "anti-arrhythmic" "gs-458967"
34 Q0 20384651 381 27.541971 imi_mug_run_2_treatment "sss" "alpha subunit" "lead"
34 Q0 20448214 382 27.541971 imi_mug_run_2_treatment "sss" "carbachol" "level"
34 Q0 23123192 383 27.497643 imi_mug_run_2_treatment "sodium" "duration" "aim"
34 Q0 24815523 384 27.331356 imi_mug_run_2_treatment "sodium" "amiodarone" "prenatal"
34 Q0 24065925 385 27.317146 imi_mug_run_2_treatment "drug" "lead" "basis"
34 Q0 16403066 386 27.273296 imi_mug_run_2_treatment "antiarrhythmic" "isoproterenol" "mexiletine"
34 Q0 29172153 387 27.20671 imi_mug_run_2_treatment "ajmaline" "anti-arrhythmic" "mea"
34 Q0 21596231 388 26.972166 imi_mug_run_2_treatment "aim"
34 Q0 20339117 389 26.943436 imi_mug_run_2_treatment "mexiletine" "sodium" "sodium channel blockers"
34 Q0 14654377 390 26.88602 imi_mug_run_2_treatment "various" "sodium" "lidocaine"
34 Q0 16771953 391 26.84641 imi_mug_run_2_treatment "sodium" "aim"
34 Q0 25780798 392 26.787827 imi_mug_run_2_treatment "various" "animals"
34 Q0 29423467 393 26.765081 imi_mug_run_2_treatment "touchdown"
34 Q0 23825462 394 26.751247 imi_mug_run_2_treatment "class i antiarrhythmic drugs"
34 Q0 10200053 395 26.727692 imi_mug_run_2_treatment "glutamine"
34 Q0 30305584 396 26.699305 imi_mug_run_2_treatment "calcium"
34 Q0 10758053 397 26.64692 imi_mug_run_2_treatment "flecainide" "sodium" "lidocaine"
34 Q0 26820605 398 26.630816 imi_mug_run_2_treatment "sodium" "alpha subunit" "lead"
34 Q0 22766342 399 26.569992 imi_mug_run_2_treatment "hydroquinidine" "quinidine" "basis"
34 Q0 11533705 400 26.549297 imi_mug_run_2_treatment "adrenergic agonists"
34 Q0 17897635 401 26.498917 imi_mug_run_2_treatment "sodium" "sss"
34 Q0 24992280 402 26.451008 imi_mug_run_2_treatment "various" "sodium" "drugs"
34 Q0 18981593 403 26.420353 imi_mug_run_2_treatment "duration"
34 Q0 14871545 404 26.420353 imi_mug_run_2_treatment "various" "balance"
34 Q0 25623181 405 26.350853 imi_mug_run_2_treatment "sodium" "flecainide" "nifedipine"
34 Q0 24582607 406 26.331028 imi_mug_run_2_treatment "sodium"
34 Q0 20870038 407 26.31441 imi_mug_run_2_treatment "calcium" "ajmaline" "sodium"
34 Q0 22739120 408 26.187147 imi_mug_run_2_treatment "sodium"
34 Q0 12650887 409 26.166332 imi_mug_run_2_treatment "mexiletine" "apd" "duration"
34 Q0 21216356 410 26.083126 imi_mug_run_2_treatment "aim"
34 Q0 20403459 411 26.048925 imi_mug_run_2_treatment "sodium"
34 Q0 17110414 412 26.039131 imi_mug_run_2_treatment "nifedipine" "anti-arrhythmic" "apd"
34 Q0 19302788 413 25.907835 imi_mug_run_2_treatment "various"
34 Q0 21840964 414 25.899433 imi_mug_run_2_treatment "sodium"
34 Q0 23799537 415 25.743729 imi_mug_run_2_treatment "sodium"
34 Q0 16001794 416 25.588606 imi_mug_run_2_treatment "calcium" "catecholamine" "potassium"
34 Q0 29868131 417 25.535751 imi_mug_run_2_treatment "insulin" "potassium" "bicarbonate"
34 Q0 22685113 418 25.324104 imi_mug_run_2_treatment "sodium"
34 Q0 26798387 419 25.265661 imi_mug_run_2_treatment "sss" "sodium"
34 Q0 17973950 420 25.26177 imi_mug_run_2_treatment "propranolol" "apd" "duration"
34 Q0 20091048 421 25.099083 imi_mug_run_2_treatment "sodium" "combinations" "various"
34 Q0 19056759 422 25.009308 imi_mug_run_2_treatment "basis"
34 Q0 19745168 423 24.89452 imi_mug_run_2_treatment "nadh" "phosphate" "superoxide dismutase"
34 Q0 17993325 424 24.69232 imi_mug_run_2_treatment "potassium" "basis"
34 Q0 29759671 425 24.665895 imi_mug_run_2_treatment "ajmaline" "lead"
34 Q0 18929244 426 24.624918 imi_mug_run_2_treatment "sodium"
34 Q0 14523039 427 24.622425 imi_mug_run_2_treatment "sss" "alpha subunit"
34 Q0 19863545 428 24.519226 imi_mug_run_2_treatment "others"
34 Q0 22064211 429 24.514376 imi_mug_run_2_treatment "level"
34 Q0 20539757 430 24.510715 imi_mug_run_2_treatment "sss"
34 Q0 27635072 431 24.32806 imi_mug_run_2_treatment "epinephrine" "procainamide" "lead"
34 Q0 26284956 432 24.314018 imi_mug_run_2_treatment "sodium" "ajmaline" "flecainide"
34 Q0 24613995 433 24.275558 imi_mug_run_2_treatment "mexiletine" "sodium"
34 Q0 19351517 434 24.275558 imi_mug_run_2_treatment "nicorandil" "apd" "antiarrhythmic"
34 Q0 9556090 435 24.09911 imi_mug_run_2_treatment "potassium" "mexiletine" "sodium channel blocker"
34 Q0 18848812 436 24.015686 imi_mug_run_2_treatment "lidocaine" "mexiletine" "lead"
34 Q0 28782696 437 23.893612 imi_mug_run_2_treatment "various" "emw"
34 Q0 21937582 438 23.6391 imi_mug_run_2_treatment "sodium" "aim"
34 Q0 28104484 439 23.392773 imi_mug_run_2_treatment "sss"
34 Q0 17556201 440 23.346218 imi_mug_run_2_treatment "sodium" "duration"
34 Q0 15992732 441 23.345829 imi_mug_run_2_treatment "glutamine"
34 Q0 15851319 442 23.216686 imi_mug_run_2_treatment "potassium" "lead"
34 Q0 16929919 443 23.216686 imi_mug_run_2_treatment "basis"
34 Q0 17727828 444 23.208183 imi_mug_run_2_treatment "various"
34 Q0 16650839 445 23.208183 imi_mug_run_2_treatment "lead"
34 Q0 9835781 446 23.203516 imi_mug_run_2_treatment "potassium" "various" "calcium"
34 Q0 16453024 447 23.18486 imi_mug_run_2_treatment "drug" "mexiletine" "basis"
34 Q0 17698727 448 23.161673 imi_mug_run_2_treatment "mexiletine"
34 Q0 11535573 449 23.15007 imi_mug_run_2_treatment "lead"
34 Q0 22647976 450 23.149939 imi_mug_run_2_treatment "duration"
34 Q0 17597962 451 23.146328 imi_mug_run_2_treatment "aim"
34 Q0 9341873 452 23.13211 imi_mug_run_2_treatment "potassium"
34 Q0 15306731 453 23.067043 imi_mug_run_2_treatment "lead"
34 Q0 10904835 454 23.051643 imi_mug_run_2_treatment "potassium" "sodium" "basis"
34 Q0 10613047 455 23.036694 imi_mug_run_2_treatment "potassium" "sodium"
34 Q0 14736542 456 22.969978 imi_mug_run_2_treatment "sodium" "mexiletine" "apds"
34 Q0 28412158 457 22.952806 imi_mug_run_2_treatment "lidocaine" "sodium"
34 Q0 30244407 458 22.642984 imi_mug_run_2_treatment "beta-blocker"
34 Q0 23678275 459 22.545614 imi_mug_run_2_treatment "anesthesia"
34 Q0 20004937 460 22.263683 imi_mug_run_2_treatment "collagen"
34 Q0 18752973 461 22.204094 imi_mug_run_2_treatment "alpha subunit" "lamotrigine"
34 Q0 7788908 462 22.09672 imi_mug_run_2_treatment "lead"
34 Q0 28894151 463 22.086296 imi_mug_run_2_treatment "adrenergic agents" "dobutamine" "agonist"
34 Q0 10377081 464 22.081018 imi_mug_run_2_treatment "lys"
34 Q0 18929331 465 21.9844 imi_mug_run_2_treatment "flecainide" "potassium" "sodium"
34 Q0 23293604 466 21.972164 imi_mug_run_2_treatment "ajmaline" "basis"
34 Q0 20193146 467 21.964752 imi_mug_run_2_treatment "lead"
34 Q0 25757662 468 21.856352 imi_mug_run_2_treatment "sodium"
34 Q0 20728579 469 21.730639 imi_mug_run_2_treatment "duration" "flecainide"
34 Q0 14760488 470 21.722034 imi_mug_run_2_treatment "drugs"
34 Q0 18060054 471 21.68912 imi_mug_run_2_treatment "channel blockers" "flecainide" "mexiletine"
34 Q0 18452875 472 21.681643 imi_mug_run_2_treatment "rice"
34 Q0 8589871 473 21.657173 imi_mug_run_2_treatment "product"
34 Q0 16540748 474 21.635437 imi_mug_run_2_treatment "lead" "basis"
34 Q0 24667783 475 21.559029 imi_mug_run_2_treatment "basis"
34 Q0 10627139 476 21.453 imi_mug_run_2_treatment "glycine"
34 Q0 29754923 477 21.450203 imi_mug_run_2_treatment "anti-arrhythmic" "ranolazine" "calcium"
34 Q0 19808432 478 21.382336 imi_mug_run_2_treatment "propranolol" "mexiletine" "tonic"
34 Q0 17592081 479 21.348415 imi_mug_run_2_treatment "sodium"
34 Q0 8904236 480 21.347473 imi_mug_run_2_treatment "sodium"
34 Q0 22885917 481 21.342186 imi_mug_run_2_treatment "sodium" "beta-blockers" "antiarrhythmic"
34 Q0 26392562 482 21.306183 imi_mug_run_2_treatment "duration"
34 Q0 23998552 483 21.271242 imi_mug_run_2_treatment "apd" "drugs" "mexiletine"
34 Q0 26888838 484 21.17162 imi_mug_run_2_treatment "sodium" "metoprolol" "lead"
34 Q0 26803770 485 21.137577 imi_mug_run_2_treatment "drug" "sodium" "drugs"
34 Q0 16244680 486 21.092857 imi_mug_run_2_treatment "beta blockers"
34 Q0 29572929 487 21.06945 imi_mug_run_2_treatment "aim"
34 Q0 19841300 488 21.06583 imi_mug_run_2_treatment "prompt"
34 Q0 28404070 489 21.061373 imi_mug_run_2_treatment "lead"
34 Q0 28336205 490 21.022495 imi_mug_run_2_treatment "duration"
34 Q0 9495298 491 21.02106 imi_mug_run_2_treatment "sodium" "lidocaine" "class i antiarrhythmic drug"
34 Q0 19419784 492 20.992638 imi_mug_run_2_treatment "lidocaine" "magnesium" "beta-blocker"
34 Q0 25346400 493 20.902327 imi_mug_run_2_treatment "drug"
34 Q0 19184093 494 20.824537 imi_mug_run_2_treatment "apd" "anti-arrhythmic" "quinidine"
34 Q0 22825893 495 20.691898 imi_mug_run_2_treatment "drug" "ajmaline" "isoproterenol"
34 Q0 17157817 496 20.330154 imi_mug_run_2_treatment "calcium channel blocker" "nifedipine" "calcium homeostasis"
34 Q0 25935074 497 20.32548 imi_mug_run_2_treatment "beta-blocker"
34 Q0 16254012 498 20.315683 imi_mug_run_2_treatment "apd" "sodium" "duration"
34 Q0 20226894 499 20.315683 imi_mug_run_2_treatment "various" "duration"
34 Q0 19669871 500 20.309093 imi_mug_run_2_treatment "magnesium" "lidocaine" "esmolol"
34 Q0 8635231 501 20.269054 imi_mug_run_2_treatment "apd" "mexiletine" "dofetilide"
34 Q0 25236808 502 20.200472 imi_mug_run_2_treatment "epinephrine" "calcium homeostasis"
34 Q0 12650885 503 20.184292 imi_mug_run_2_treatment "sodium" "isoleucine" "aim"
34 Q0 11289718 504 19.849575 imi_mug_run_2_treatment "beta-adrenergic blocking agents"
34 Q0 30354299 505 19.832443 imi_mug_run_2_treatment "mediated"
34 Q0 11997281 506 19.630077 imi_mug_run_2_treatment "drug" "drugs"
34 Q0 29764897 507 19.566048 imi_mug_run_2_treatment "alpha subunit" "basis" "aim"
34 Q0 16379539 508 19.562695 imi_mug_run_2_treatment "prompt"
34 Q0 22515331 509 19.562695 imi_mug_run_2_treatment "potassium" "sodium"
34 Q0 9848024 510 19.534714 imi_mug_run_2_treatment "lead"
34 Q0 9686753 511 19.531906 imi_mug_run_2_treatment "glycine"
34 Q0 10816797 512 19.502304 imi_mug_run_2_treatment "sodium" "drugs"
34 Q0 24218437 513 19.440275 imi_mug_run_2_treatment "prenatal"
34 Q0 17210839 514 19.428627 imi_mug_run_2_treatment "basis"
34 Q0 18822425 515 19.400501 imi_mug_run_2_treatment "aim"
34 Q0 17060380 516 19.36621 imi_mug_run_2_treatment "sodium"
34 Q0 27539165 517 19.27665 imi_mug_run_2_treatment "amiodarone" "quantum"
34 Q0 27816319 518 19.077679 imi_mug_run_2_treatment "drugs"
34 Q0 9511785 519 19.070015 imi_mug_run_2_treatment "ether"
34 Q0 18803136 520 19.059362 imi_mug_run_2_treatment "lead" "aim"
34 Q0 8873679 521 19.044182 imi_mug_run_2_treatment "potassium" "ether" "others"
34 Q0 18662191 522 19.044182 imi_mug_run_2_treatment "sodium" "ranolazine"
34 Q0 16967046 523 19.039684 imi_mug_run_2_treatment "fluoxetine and norfluoxetine" "fluoxetine" "prozac"
34 Q0 28493952 524 19.039684 imi_mug_run_2_treatment "calcium" "testosterone" "isoproterenol"
34 Q0 23631430 525 18.958675 imi_mug_run_2_treatment "aim" "duration"
34 Q0 16453014 526 18.900179 imi_mug_run_2_treatment "drug" "mexiletine"
34 Q0 12814325 527 18.706205 imi_mug_run_2_treatment "flecainide" "local anesthetic" "drug"
34 Q0 26965448 528 18.465734 imi_mug_run_2_treatment "flecainide" "antiarrhythmic" "sodium"
34 Q0 7651517 529 18.410988 imi_mug_run_2_treatment "sodium"
34 Q0 17118339 530 18.39657 imi_mug_run_2_treatment "sodium" "verapamil" "apd"
34 Q0 8569466 531 18.36539 imi_mug_run_2_treatment "potassium"
34 Q0 15012599 532 18.34756 imi_mug_run_2_treatment "cortisol" "shape"
34 Q0 16301357 533 18.29609 imi_mug_run_2_treatment "cisapride" "sodium" "drug"
34 Q0 25426816 534 18.265774 imi_mug_run_2_treatment "various" "sodium" "lead"
34 Q0 26412604 535 18.265774 imi_mug_run_2_treatment "aim"
34 Q0 30394905 536 18.099827 imi_mug_run_2_treatment "medicine" "nadolol" "propranolol"
34 Q0 9753711 537 17.856674 imi_mug_run_2_treatment "potassium" "sodium"
34 Q0 18606002 538 17.679483 imi_mug_run_2_treatment "various" "beta-blockers" "lead"
34 Q0 18065446 539 17.598892 imi_mug_run_2_treatment "lysine" "lidocaine" "aim"
34 Q0 18442965 540 17.565065 imi_mug_run_2_treatment "lead"
34 Q0 22402334 541 17.554672 imi_mug_run_2_treatment "sodium" "antiarrhythmic" "channel blockers"
34 Q0 24098284 542 17.55302 imi_mug_run_2_treatment "lead" "sodium" "duration"
34 Q0 20102920 543 17.552237 imi_mug_run_2_treatment "duration"
34 Q0 9600240 544 17.513058 imi_mug_run_2_treatment "basis"
34 Q0 9509262 545 17.508766 imi_mug_run_2_treatment "potassium ion"
34 Q0 11802537 546 17.508766 imi_mug_run_2_treatment "potassium" "isoleucine"
34 Q0 10367071 547 17.508766 imi_mug_run_2_treatment "potassium" "sodium" "aim"
34 Q0 30036649 548 17.508766 imi_mug_run_2_treatment "beta-blocker"
34 Q0 21779290 549 17.458483 imi_mug_run_2_treatment "meperidine" "drugs" "cardiac drugs"
34 Q0 8664531 550 17.439266 imi_mug_run_2_treatment "lead" "blockade"
34 Q0 10959460 551 17.375854 imi_mug_run_2_treatment "ajmaline" "procainamide"
34 Q0 18002037 552 17.259956 imi_mug_run_2_treatment "apd" "level"
34 Q0 27054604 553 17.259956 imi_mug_run_2_treatment "beta-blockers"
34 Q0 22996910 554 17.257557 imi_mug_run_2_treatment "antiadrenergic"
34 Q0 24133349 555 17.257557 imi_mug_run_2_treatment "various" "beta-blocker"
34 Q0 25967940 556 17.219025 imi_mug_run_2_treatment "combinations"
34 Q0 11686910 557 17.168129 imi_mug_run_2_treatment "potassium" "sodium"
34 Q0 21076026 558 17.156237 imi_mug_run_2_treatment "ranolazine" "tyrosine" "class i antiarrhythmic drugs"
34 Q0 15051636 559 17.13013 imi_mug_run_2_treatment "potassium"
34 Q0 23216910 560 17.13013 imi_mug_run_2_treatment "drugs" "drug" "antipsychotics"
34 Q0 16922724 561 17.024803 imi_mug_run_2_treatment "various"
34 Q0 17903632 562 16.8539 imi_mug_run_2_treatment "beta-blockers"
34 Q0 26282245 563 16.73726 imi_mug_run_2_treatment "sodium" "epinephrine"
34 Q0 10921801 564 16.735111 imi_mug_run_2_treatment "genesis"
34 Q0 20009079 565 16.584229 imi_mug_run_2_treatment "sodium" "nitric oxide synthase inhibitor"
34 Q0 12736279 566 16.584072 imi_mug_run_2_treatment "potassium" "sodium"
34 Q0 14998624 567 16.522274 imi_mug_run_2_treatment "beta-blockers"
34 Q0 19214780 568 16.448544 imi_mug_run_2_treatment "basis"
34 Q0 16329159 569 16.441242 imi_mug_run_2_treatment "drug" "drugs"
34 Q0 10920073 570 16.441242 imi_mug_run_2_treatment "calcium" "balance"
34 Q0 24705556 571 16.368944 imi_mug_run_2_treatment "duration"
34 Q0 22360817 572 16.338543 imi_mug_run_2_treatment "mexiletine"
34 Q0 23995044 573 16.271208 imi_mug_run_2_treatment "prenatal"
34 Q0 18048769 574 16.261126 imi_mug_run_2_treatment "sodium"
34 Q0 21410720 575 16.261126 imi_mug_run_2_treatment "aim"
34 Q0 12417563 576 16.117811 imi_mug_run_2_treatment "alpha subunit" "level"
34 Q0 9654228 577 16.117811 imi_mug_run_2_treatment "potassium" "sodium"
34 Q0 26498160 578 16.117811 imi_mug_run_2_treatment "aim"
34 Q0 24059039 579 16.117811 imi_mug_run_2_treatment "sss" "therapeutics" "level"
34 Q0 10772658 580 16.116737 imi_mug_run_2_treatment "lidocaine" "drug" "sodium"
34 Q0 17965736 581 16.116737 imi_mug_run_2_treatment "ketoconazole" "ether" "drug"
34 Q0 12877697 582 16.116737 imi_mug_run_2_treatment "catecholamine" "dobutamine" "phenylephrine"
34 Q0 9570196 583 16.052864 imi_mug_run_2_treatment "hot spot"
34 Q0 21496168 584 16.052864 imi_mug_run_2_treatment "epinephrine"
34 Q0 21063070 585 16.052864 imi_mug_run_2_treatment "potassium" "lead" "program"
34 Q0 10952963 586 16.02966 imi_mug_run_2_treatment "flecainide" "lidocaine" "drugs"
34 Q0 28781330 587 15.996584 imi_mug_run_2_treatment "sodium"
34 Q0 8917568 588 15.988771 imi_mug_run_2_treatment "sodium" "lead"
34 Q0 11333173 589 15.988771 imi_mug_run_2_treatment "sodium" "flecainide" "mexiletine"
34 Q0 15534720 590 15.988771 imi_mug_run_2_treatment "beta-blocker" "atenolol" "propranolol"
34 Q0 25564553 591 15.988771 imi_mug_run_2_treatment "drugs" "aim"
34 Q0 21185499 592 15.988771 imi_mug_run_2_treatment "aim"
34 Q0 20110334 593 15.988771 imi_mug_run_2_treatment "sodium" "carbachol" "blockade"
34 Q0 29544605 594 15.887943 imi_mug_run_2_treatment "basis"
34 Q0 28279743 595 15.82598 imi_mug_run_2_treatment "lead"
34 Q0 15511625 596 15.813878 imi_mug_run_2_treatment "potassium" "serine"
34 Q0 15485686 597 15.574339 imi_mug_run_2_treatment "lidocaine" "mexiletine" "methionine"
34 Q0 25804018 598 15.567626 imi_mug_run_2_treatment "beta blocker" "beta blockers"
34 Q0 16168489 599 15.540019 imi_mug_run_2_treatment "mexiletine" "basis"
34 Q0 17490620 600 15.53658 imi_mug_run_2_treatment "interferon"
34 Q0 24871449 601 15.524542 imi_mug_run_2_treatment "program"
34 Q0 8521555 602 15.456942 imi_mug_run_2_treatment "mexiletine" "catecholamines" "channel blockers"
34 Q0 20920651 603 15.452659 imi_mug_run_2_treatment "duration"
34 Q0 14642002 604 15.414946 imi_mug_run_2_treatment "potassium"
34 Q0 20659946 605 15.414946 imi_mug_run_2_treatment "medication" "level"
34 Q0 23277474 606 15.414946 imi_mug_run_2_treatment "drug" "mexiletine" "channel blocker"
34 Q0 26669661 607 15.414946 imi_mug_run_2_treatment "level"
34 Q0 17275750 608 15.384678 imi_mug_run_2_treatment "sodium" "basis"
34 Q0 24388587 609 15.342285 imi_mug_run_2_treatment "lead" "program"
34 Q0 17161064 610 15.3293 imi_mug_run_2_treatment "therapeutics" "others"
34 Q0 18052691 611 15.3293 imi_mug_run_2_treatment "genesis"
34 Q0 22129298 612 15.3293 imi_mug_run_2_treatment "various" "flecainide" "antiadrenergic"
34 Q0 20975234 613 15.3293 imi_mug_run_2_treatment "various"
34 Q0 16039271 614 15.286669 imi_mug_run_2_treatment "sodium"
34 Q0 24578642 615 15.286669 imi_mug_run_2_treatment "various" "isoprenaline" "duration"
34 Q0 23981618 616 15.286669 imi_mug_run_2_treatment "ether" "level"
34 Q0 19371746 617 15.286669 imi_mug_run_2_treatment "calcium" "ranolazine" "caffeine"
34 Q0 9395171 618 15.050941 imi_mug_run_2_treatment "sotalol" "apd" "drug"
34 Q0 8996300 619 15.009219 imi_mug_run_2_treatment "pooled"
34 Q0 21675815 620 14.969593 imi_mug_run_2_treatment "drug" "drugs" "lidocaine"
34 Q0 25645639 621 14.96733 imi_mug_run_2_treatment "lead"
34 Q0 29691127 622 14.850885 imi_mug_run_2_treatment "calcium" "duration"
34 Q0 9445165 623 14.834814 imi_mug_run_2_treatment "potassium"
34 Q0 11743032 624 14.834589 imi_mug_run_2_treatment "various"
34 Q0 22039467 625 14.748504 imi_mug_run_2_treatment "celecoxib" "celecoxib's" "celebrex"
34 Q0 20197117 626 14.743786 imi_mug_run_2_treatment "beta-blockers" "mexiletine" "medication"
34 Q0 12442276 627 14.743786 imi_mug_run_2_treatment "beta blocker" "propanolol" "inderal"
34 Q0 26022185 628 14.715033 imi_mug_run_2_treatment "calcium" "sodium" "free calcium"
34 Q0 15176425 629 14.703161 imi_mug_run_2_treatment "basis" "aim"
34 Q0 24135497 630 14.689587 imi_mug_run_2_treatment "beta-blockers" "propranolol" "antiarrhythmic"
34 Q0 9272155 631 14.686932 imi_mug_run_2_treatment "gly"
34 Q0 12849668 632 14.686932 imi_mug_run_2_treatment "duration"
34 Q0 19038855 633 14.686932 imi_mug_run_2_treatment "antiepileptic drug" "aed" "medication"
34 Q0 29650123 634 14.666622 imi_mug_run_2_treatment "duration" "beta-blockers" "antiarrhythmic"
34 Q0 12838849 635 14.632623 imi_mug_run_2_treatment "prophylactic" "genesis"
34 Q0 22378279 636 14.632623 imi_mug_run_2_treatment "aim"
34 Q0 26940925 637 14.632623 imi_mug_run_2_treatment "antiarrhythmic" "duration" "sodium"
34 Q0 21552533 638 14.615838 imi_mug_run_2_treatment "various"
34 Q0 20361479 639 14.614035 imi_mug_run_2_treatment "various" "potassium"
34 Q0 10953551 640 14.444199 imi_mug_run_2_treatment "anti-arrhythmic" "agonists" "duration"
34 Q0 9272507 641 14.299051 imi_mug_run_2_treatment "potassium" "mexiletine" "dofetilide"
34 Q0 16818210 642 14.098613 imi_mug_run_2_treatment "calcium"
34 Q0 22693452 643 14.043152 imi_mug_run_2_treatment "vwf" "lead" "shape"
34 Q0 20181576 644 14.041994 imi_mug_run_2_treatment "mediated"
34 Q0 21459285 645 13.966264 imi_mug_run_2_treatment "potassium" "leucine"
34 Q0 23933686 646 13.892524 imi_mug_run_2_treatment "enzymes" "insulin" "mineralocorticoids"
34 Q0 27681629 647 13.8305435 imi_mug_run_2_treatment "sodium"
34 Q0 15665061 648 13.587256 imi_mug_run_2_treatment "phenylalanine"
34 Q0 8893413 649 13.211994 imi_mug_run_2_treatment "potassium" "mexiletine" "dofetilide"
34 Q0 17171344 650 13.198199 imi_mug_run_2_treatment "ether" "glycine" "serine"
34 Q0 23465283 651 13.198199 imi_mug_run_2_treatment "aim"
34 Q0 16253912 652 13.178579 imi_mug_run_2_treatment "various"
34 Q0 17655673 653 13.178579 imi_mug_run_2_treatment "basis"
34 Q0 9323097 654 13.178579 imi_mug_run_2_treatment "mexiletine" "sotalol" "duration"
34 Q0 9631873 655 13.140902 imi_mug_run_2_treatment "duration"
34 Q0 22510251 656 13.1066 imi_mug_run_2_treatment "aim"
34 Q0 14975928 657 13.049324 imi_mug_run_2_treatment "ether" "amino acid" "cisapride"
34 Q0 20102864 658 12.997213 imi_mug_run_2_treatment "analgesics"
34 Q0 20386770 659 12.979569 imi_mug_run_2_treatment "mediated"
34 Q0 18025927 660 12.819307 imi_mug_run_2_treatment "prompt"
34 Q0 18021327 661 12.816723 imi_mug_run_2_treatment "various" "mediated" "acetylcholine"
34 Q0 18708744 662 12.816723 imi_mug_run_2_treatment "alpha subunit" "apd"
34 Q0 15568605 663 12.816723 imi_mug_run_2_treatment "diuretics" "vasodilators" "basis"
34 Q0 21672931 664 12.807795 imi_mug_run_2_treatment "apd" "ranolazine" "duration"
34 Q0 12796143 665 12.762441 imi_mug_run_2_treatment "phenylephrine" "glycerol" "chelerythrine"
34 Q0 16623272 666 12.762441 imi_mug_run_2_treatment "drug" "aminoacid" "cardiovascular drugs"
34 Q0 19546258 667 12.762441 imi_mug_run_2_treatment "sulpiride" "duration" "drug"
34 Q0 23590259 668 12.741782 imi_mug_run_2_treatment "hts"
34 Q0 17275752 669 12.687202 imi_mug_run_2_treatment "duration" "flecainide"
34 Q0 18697752 670 12.687202 imi_mug_run_2_treatment "aim"
34 Q0 26846766 671 12.687202 imi_mug_run_2_treatment "aim"
34 Q0 26636822 672 12.687202 imi_mug_run_2_treatment "basis" "sss"
34 Q0 24737235 673 12.687202 imi_mug_run_2_treatment "sodium" "local anesthetic" "antiarrhythmic"
34 Q0 21193062 674 12.687202 imi_mug_run_2_treatment "sodium" "drugs" "flecainide"
34 Q0 27110552 675 12.687202 imi_mug_run_2_treatment "basis"
34 Q0 24687331 676 12.628468 imi_mug_run_2_treatment "therapeutics"
34 Q0 14516281 677 12.4014435 imi_mug_run_2_treatment "various" "aim"
34 Q0 10408028 678 12.300456 imi_mug_run_2_treatment "antiarrhythmic" "drugs" "basis"
34 Q0 11274952 679 11.225314 imi_mug_run_2_treatment "antimalarial drug" "halofantrine"
34 Q0 23506284 680 11.158134 imi_mug_run_2_treatment "enzymes" "insulin" "glucose"
34 Q0 12031708 681 11.156016 imi_mug_run_2_treatment "sodium"
34 Q0 22721569 682 11.114542 imi_mug_run_2_treatment "flecainide"
34 Q0 15520326 683 11.108509 imi_mug_run_2_treatment "drug" "amiodarone" "plasma"
34 Q0 15242738 684 11.108509 imi_mug_run_2_treatment "beta-blockers"
34 Q0 18250496 685 11.108509 imi_mug_run_2_treatment "stimulants" "antihistamines" "drugs"
34 Q0 18071303 686 11.108509 imi_mug_run_2_treatment "sodium" "antiarrhythmic" "flecainide"
34 Q0 18616619 687 11.108509 imi_mug_run_2_treatment "lidocaine" "mexiletine" "sss"
34 Q0 24373870 688 11.108509 imi_mug_run_2_treatment "product"
35 Q0 28128576 1 56.819405 imi_mug_run_2_treatment "combinations" "bile acid sequestrant" "drug combination"
35 Q0 26687699 2 55.429546 imi_mug_run_2_treatment "glucose" "statins"
35 Q0 22375030 3 54.893715 imi_mug_run_2_treatment "plasma" "level"
35 Q0 30207555 4 54.457188 imi_mug_run_2_treatment "statins" "ezetimibe"
35 Q0 28784313 5 53.55791 imi_mug_run_2_treatment "statin" "drugs" "statins"
35 Q0 28531826 6 52.651314 imi_mug_run_2_treatment "statins" "medicines" "ezetimibe"
35 Q0 19319977 7 52.293755 imi_mug_run_2_treatment "leucine"
35 Q0 23240807 8 52.12596 imi_mug_run_2_treatment "statins" "plasma"
35 Q0 28331223 9 51.974663 imi_mug_run_2_treatment "statin" "monoclonal antibodies" "duration"
35 Q0 27250613 10 51.879883 imi_mug_run_2_treatment "drug" "statin" "statins"
35 Q0 27195910 11 51.720898 imi_mug_run_2_treatment "monoclonal antibodies" "statins" "statin"
35 Q0 27215417 12 51.48839 imi_mug_run_2_treatment "plasma" "statin" "statins"
35 Q0 29038906 13 51.27317 imi_mug_run_2_treatment "drugs" "alirocumab" "evolocumab"
35 Q0 24014831 14 51.00975 imi_mug_run_2_treatment "monoclonal antibodies"
35 Q0 30308187 15 50.82846 imi_mug_run_2_treatment "drugs"
35 Q0 30482120 16 50.551224 imi_mug_run_2_treatment "statins"
35 Q0 27186592 17 50.307915 imi_mug_run_2_treatment "statins" "ezetimibe" "alirocumab"
35 Q0 25023731 18 49.803047 imi_mug_run_2_treatment "mediated" "viral vector" "plasma"
35 Q0 28726204 19 49.76384 imi_mug_run_2_treatment "level" "statins"
35 Q0 27312020 20 49.689903 imi_mug_run_2_treatment "statins" "ezetimibe" "alirocumab"
35 Q0 30360706 21 49.42167 imi_mug_run_2_treatment "mediators" "anti-inflammatory"
35 Q0 30317987 22 49.219727 imi_mug_run_2_treatment "statins" "ezetimibe" "mipomersen"
35 Q0 27888902 23 49.212116 imi_mug_run_2_treatment "statin" "drugs" "statins"
35 Q0 30056842 24 49.16793 imi_mug_run_2_treatment "pcsk9 inhibitor"
35 Q0 17380167 25 49.16264 imi_mug_run_2_treatment "mediated" "statins" "new drugs"
35 Q0 28623742 26 48.583538 imi_mug_run_2_treatment "statin" "ezetimibe" "monoclonal antibodies"
35 Q0 19797716 27 48.5045 imi_mug_run_2_treatment "plasma" "statin"
35 Q0 27494723 28 48.152523 imi_mug_run_2_treatment "statin" "statins" "monoclonal antibodies"
35 Q0 26361156 29 48.116844 imi_mug_run_2_treatment "program"
35 Q0 24632287 30 47.887356 imi_mug_run_2_treatment "mevastatin" "lead" "level"
35 Q0 27274264 31 47.792522 imi_mug_run_2_treatment "evolocumab" "monoclonal antibodies" "statin"
35 Q0 29895529 32 47.6374 imi_mug_run_2_treatment "statins" "drugs" "aim"
35 Q0 28161202 33 47.550182 imi_mug_run_2_treatment "balance"
35 Q0 26822080 34 47.547005 imi_mug_run_2_treatment "statins" "evolocumab" "medications"
35 Q0 30269829 35 47.290977 imi_mug_run_2_treatment "plasma" "level"
35 Q0 25248569 36 47.091213 imi_mug_run_2_treatment "medications" "plasma" "mediated"
35 Q0 27797643 37 46.86098 imi_mug_run_2_treatment "various combinations" "niacin" "statins"
35 Q0 28978220 38 46.82227 imi_mug_run_2_treatment "drugs" "alirocumab" "evolocumab"
35 Q0 23535506 39 46.818245 imi_mug_run_2_treatment "basis" "aim"
35 Q0 18266662 40 46.762566 imi_mug_run_2_treatment "mediated"
35 Q0 29498875 41 46.67476 imi_mug_run_2_treatment "alirocumab" "evolocumab" "hypolipidemic agents"
35 Q0 29210646 42 46.44258 imi_mug_run_2_treatment "new drugs" "level" "liver"
35 Q0 23537802 43 46.39908 imi_mug_run_2_treatment "plasma"
35 Q0 28450903 44 46.211754 imi_mug_run_2_treatment "plasma" "level" "drugs"
35 Q0 30306858 45 46.20749 imi_mug_run_2_treatment "drugs" "lomitapide" "ezetimibe"
35 Q0 17435765 46 46.168087 imi_mug_run_2_treatment "plasma"
35 Q0 28534160 47 46.122627 imi_mug_run_2_treatment "plasma" "human plasma"
35 Q0 26371983 48 46.08943 imi_mug_run_2_treatment "plasma"
35 Q0 29127338 49 46.08943 imi_mug_run_2_treatment "lead"
35 Q0 27477957 50 46.07666 imi_mug_run_2_treatment "statins" "ezetimibe" "mipomersen"
35 Q0 27533159 51 45.99453 imi_mug_run_2_treatment "statins" "ezetimibe" "mace"
35 Q0 28619117 52 45.91826 imi_mug_run_2_treatment "plasma"
35 Q0 25014035 53 45.713066 imi_mug_run_2_treatment "plasma"
35 Q0 30372843 54 45.550552 imi_mug_run_2_treatment "statin" "statins" "alirocumab"
35 Q0 19001363 55 45.351963 imi_mug_run_2_treatment "tyr" "salt" "mediated"
35 Q0 28532784 56 45.274452 imi_mug_run_2_treatment "statin"
35 Q0 27594539 57 45.23751 imi_mug_run_2_treatment "statin" "statins" "plasma"
35 Q0 29096860 58 45.211784 imi_mug_run_2_treatment "drug" "level"
35 Q0 25470376 59 45.171097 imi_mug_run_2_treatment "plasma" "monoclonal antibodies" "statin"
35 Q0 26684558 60 45.095978 imi_mug_run_2_treatment "statins" "mipomersen" "lomitapide"
35 Q0 28587771 61 44.865086 imi_mug_run_2_treatment "plasma"
35 Q0 30317985 62 44.8343 imi_mug_run_2_treatment "drugs" "alirocumab" "evolocumab"
35 Q0 28179607 63 44.77379 imi_mug_run_2_treatment "monoclonal antibodies" "drugs" "statins"
35 Q0 24506872 64 44.753693 imi_mug_run_2_treatment "liver" "plasma"
35 Q0 15166014 65 44.5935 imi_mug_run_2_treatment "leucine" "aim"
35 Q0 27089600 66 44.403526 imi_mug_run_2_treatment "drugs" "medicines" "statin"
35 Q0 23461430 67 44.39783 imi_mug_run_2_treatment "statins" "statin" "mipomersen"
35 Q0 25771732 68 44.310463 imi_mug_run_2_treatment "monoclonal antibodies" "alirocumab" "evolocumab"
35 Q0 26445250 69 44.279205 imi_mug_run_2_treatment "mtp" "lomitapide"
35 Q0 27079874 70 44.23845 imi_mug_run_2_treatment "alirocumab" "mevastatin" "statin"
35 Q0 30270088 71 44.07144 imi_mug_run_2_treatment "statins" "aim" "plasma"
35 Q0 21146822 72 43.975315 imi_mug_run_2_treatment "aim"
35 Q0 28555526 73 43.78921 imi_mug_run_2_treatment "statin" "evolocumab" "statins"
35 Q0 19917273 74 43.785374 imi_mug_run_2_treatment "mediated"
35 Q0 26886466 75 43.691677 imi_mug_run_2_treatment "various" "statins" "alirocumab"
35 Q0 27784735 76 43.531433 imi_mug_run_2_treatment "plasma"
35 Q0 27193908 77 43.442413 imi_mug_run_2_treatment "mediated" "statin"
35 Q0 22417841 78 43.388786 imi_mug_run_2_treatment "plasma"
35 Q0 28965616 79 43.37795 imi_mug_run_2_treatment "plasma"
35 Q0 19635789 80 43.29994 imi_mug_run_2_treatment "epidermal growth factor" "favor" "plasma"
35 Q0 26424774 81 43.225113 imi_mug_run_2_treatment "monoclonal antibodies" "alirocumab" "evolocumab"
35 Q0 26892118 82 43.22094 imi_mug_run_2_treatment "new drugs" "alirocumab"
35 Q0 29877295 83 43.211876 imi_mug_run_2_treatment "level" "drug" "mtp"
35 Q0 25046268 84 43.172417 imi_mug_run_2_treatment "mediated" "therapeutic agents" "monoclonal antibodies"
35 Q0 23129602 85 43.16859 imi_mug_run_2_treatment "statin" "ezetimibe" "product"
35 Q0 28128581 86 43.162003 imi_mug_run_2_treatment "hypolipidemic drugs" "prevent"
35 Q0 27711959 87 43.01582 imi_mug_run_2_treatment "statins" "drugs" "statin"
35 Q0 30270359 88 42.977016 imi_mug_run_2_treatment "statin"
35 Q0 29374275 89 42.91746 imi_mug_run_2_treatment "level"
35 Q0 28104544 90 42.880844 imi_mug_run_2_treatment "prevent" "program"
35 Q0 26482752 91 42.76918 imi_mug_run_2_treatment "statin" "statins" "aim"
35 Q0 24122718 92 42.755676 imi_mug_run_2_treatment "plasma" "sulfate"
35 Q0 29649884 93 42.69998 imi_mug_run_2_treatment "monoclonal antibodies" "vaccines" "experimental agents"
35 Q0 26632531 94 42.55109 imi_mug_run_2_treatment "statins" "level"
35 Q0 30270089 95 42.54397 imi_mug_run_2_treatment "statins" "ezetimibe" "lomitapide"
35 Q0 24267230 96 42.43334 imi_mug_run_2_treatment "basis"
35 Q0 19224862 97 42.423542 imi_mug_run_2_treatment "tyr" "epidermal growth factor" "liver"
35 Q0 23776359 98 42.350983 imi_mug_run_2_treatment "gold" "statins" "basis"
35 Q0 28235710 99 42.297573 imi_mug_run_2_treatment "aim"
35 Q0 28502498 100 42.04602 imi_mug_run_2_treatment "level"
35 Q0 28506389 101 42.020542 imi_mug_run_2_treatment "statin" "ezetimibe"
35 Q0 21657943 102 42.01453 imi_mug_run_2_treatment "level" "lead" "plasma"
35 Q0 28529918 103 41.989746 imi_mug_run_2_treatment "evolocumab" "statin" "product"
35 Q0 24924410 104 41.935276 imi_mug_run_2_treatment "drugs" "statin" "level"
35 Q0 27998977 105 41.773952 imi_mug_run_2_treatment "mediated" "rosuvastatin" "ezetimibe"
35 Q0 28964736 106 41.74783 imi_mug_run_2_treatment "alirocumab"
35 Q0 23510778 107 41.743885 imi_mug_run_2_treatment "plasma"
35 Q0 26068408 108 41.705204 imi_mug_run_2_treatment "drug" "statin" "investigational agents"
35 Q0 25052769 109 41.691254 imi_mug_run_2_treatment "drugs" "lead" "alirocumab"
35 Q0 29758414 110 41.557487 imi_mug_run_2_treatment "statins" "statin" "plasma"
35 Q0 28643240 111 41.498703 imi_mug_run_2_treatment "statin" "statins" "monoclonal antibodies"
35 Q0 27133571 112 41.458885 imi_mug_run_2_treatment "statins" "drug" "drugs"
35 Q0 18666258 113 41.455673 imi_mug_run_2_treatment "liver" "plasma"
35 Q0 21872251 114 41.42812 imi_mug_run_2_treatment "level"
35 Q0 12730697 115 41.42057 imi_mug_run_2_treatment "liver"
35 Q0 24632267 116 41.330383 imi_mug_run_2_treatment "medications" "microsomal triglyceride transfer protein inhibitor" "antisense oligonucleotide"
35 Q0 30270075 117 41.263737 imi_mug_run_2_treatment "program" "level"
35 Q0 17391637 118 41.25173 imi_mug_run_2_treatment "drugs" "statin"
35 Q0 30286489 119 41.23336 imi_mug_run_2_treatment "statin" "statins" "ezetimibe"
35 Q0 27458166 120 41.13542 imi_mug_run_2_treatment "level"
35 Q0 28884604 121 41.05079 imi_mug_run_2_treatment "lomitapide" "statin" "statins"
35 Q0 29548678 122 41.02481 imi_mug_run_2_treatment "statin" "ezetimibe" "level"
35 Q0 20529551 123 41.005905 imi_mug_run_2_treatment "serine" "lead" "plasma"
35 Q0 25904765 124 40.86266 imi_mug_run_2_treatment "glucose" "mouse monoclonal antibody" "statins"
35 Q0 16806138 125 40.837704 imi_mug_run_2_treatment "mediated"
35 Q0 22435370 126 40.812927 imi_mug_run_2_treatment "atorvastatin" "pharmaceuticals"
35 Q0 24222265 127 40.689613 imi_mug_run_2_treatment "drug" "drugs" "mtp"
35 Q0 25775905 128 40.683704 imi_mug_run_2_treatment "broom" "aim"
35 Q0 30386595 129 40.63946 imi_mug_run_2_treatment "various" "glucose" "level"
35 Q0 21204732 130 40.629456 imi_mug_run_2_treatment "plasma"
35 Q0 23283366 131 40.620277 imi_mug_run_2_treatment "liver"
35 Q0 29171950 132 40.5374 imi_mug_run_2_treatment "evolocumab" "statin" "liver"
35 Q0 29650402 133 40.525288 imi_mug_run_2_treatment "mitotane" "rosuvastatin" "ezetimibe"
35 Q0 28958330 134 40.507 imi_mug_run_2_treatment "prompt"
35 Q0 30093300 135 40.468887 imi_mug_run_2_treatment "basis"
35 Q0 27993383 136 40.386436 imi_mug_run_2_treatment "drugs" "alirocumab" "evolocumab"
35 Q0 18708425 137 40.184067 imi_mug_run_2_treatment "leucine" "level"
35 Q0 15178557 138 40.17166 imi_mug_run_2_treatment "statins" "level"
35 Q0 29685591 139 40.154484 imi_mug_run_2_treatment "statin" "program" "monoclonal antibodies"
35 Q0 26285455 140 40.12426 imi_mug_run_2_treatment "statin" "statins" "monoclonal antibodies"
35 Q0 28163543 141 40.119225 imi_mug_run_2_treatment "medicines" "enzyme inhibitors" "statins"
35 Q0 19601924 142 40.053932 imi_mug_run_2_treatment "plasma" "level" "liver"
35 Q0 29096867 143 39.970245 imi_mug_run_2_treatment "drugs" "alirocumab" "evolocumab"
35 Q0 28459663 144 39.899673 imi_mug_run_2_treatment "evolocumab" "pcsk9 inhibitor" "epidermal growth factor"
35 Q0 27578127 145 39.80814 imi_mug_run_2_treatment "product" "level" "plasma"
35 Q0 23469913 146 39.725697 imi_mug_run_2_treatment "statins" "colesevelam" "ezetimibe"
35 Q0 28965614 147 39.725697 imi_mug_run_2_treatment "basis"
35 Q0 28734274 148 39.725697 imi_mug_run_2_treatment "basis"
35 Q0 26586530 149 39.70323 imi_mug_run_2_treatment "pravastatin" "mediated" "lead"
35 Q0 23226021 150 39.695324 imi_mug_run_2_treatment "mipomersen" "aso" "medications"
35 Q0 27878139 151 39.682247 imi_mug_run_2_treatment "program"
35 Q0 18559913 152 39.657814 imi_mug_run_2_treatment "lovastatin" "protease"
35 Q0 23652470 153 39.65457 imi_mug_run_2_treatment "various" "monoclonal antibodies" "statins"
35 Q0 29233637 154 39.57119 imi_mug_run_2_treatment "statin" "simvastatin 40 mg" "ezetimibe"
35 Q0 23898695 155 39.563423 imi_mug_run_2_treatment "statins" "ezetimibe" "plasma"
35 Q0 16224054 156 39.519047 imi_mug_run_2_treatment "simvastatin" "atorvastatin"
35 Q0 22683370 157 39.39411 imi_mug_run_2_treatment "plasma" "liver"
35 Q0 25313916 158 39.208122 imi_mug_run_2_treatment "plasma" "dextran sulfate" "monoclonal antibodies"
35 Q0 15767856 159 39.1834 imi_mug_run_2_treatment "mediated"
35 Q0 25769531 160 39.154434 imi_mug_run_2_treatment "statins" "ezetimibe" "mipomersen"
35 Q0 18663786 161 39.11313 imi_mug_run_2_treatment "lead" "basis" "liver"
35 Q0 28137217 162 39.042946 imi_mug_run_2_treatment "alirocumab" "evolocumab" "drugs"
35 Q0 22683120 163 39.0276 imi_mug_run_2_treatment "tyr"
35 Q0 24160703 164 39.001373 imi_mug_run_2_treatment "drugs" "statin" "monoclonal antibodies"
35 Q0 22111029 165 38.654503 imi_mug_run_2_treatment "lead"
35 Q0 19705336 166 38.61431 imi_mug_run_2_treatment "therapeutics" "liver"
35 Q0 23701724 167 38.609837 imi_mug_run_2_treatment "mtp" "monoclonal antibodies"
35 Q0 30400955 168 38.580585 imi_mug_run_2_treatment "basis"
35 Q0 22701100 169 38.550804 imi_mug_run_2_treatment "mipomersen" "drug" "statin"
35 Q0 24518357 170 38.515175 imi_mug_run_2_treatment "plasma" "level"
35 Q0 27358438 171 38.47847 imi_mug_run_2_treatment "plasma"
35 Q0 27207595 172 38.464844 imi_mug_run_2_treatment "statin" "statins" "alirocumab"
35 Q0 29667842 173 38.386 imi_mug_run_2_treatment "drug" "alirocumab" "pcsk9 inhibitor"
35 Q0 30270094 174 38.352898 imi_mug_run_2_treatment "level" "statin" "statins"
35 Q0 19571328 175 38.312424 imi_mug_run_2_treatment "plasma" "statin" "ezetimibe"
35 Q0 28623954 176 38.30112 imi_mug_run_2_treatment "alirocumab" "statin" "atorvastatin"
35 Q0 25693358 177 38.266716 imi_mug_run_2_treatment "prevent" "prompt" "plasma"
35 Q0 28919772 178 38.228302 imi_mug_run_2_treatment "aim" "alirocumab" "evolocumab"
35 Q0 26935836 179 38.182095 imi_mug_run_2_treatment "alirocumab" "statin" "ezetimibe"
35 Q0 23932550 180 38.17272 imi_mug_run_2_treatment "plasma" "statins" "mipomersen"
35 Q0 26481479 181 38.150517 imi_mug_run_2_treatment "liver" "crf" "level"
35 Q0 25791168 182 38.127747 imi_mug_run_2_treatment "enzymes"
35 Q0 15654334 183 38.067238 imi_mug_run_2_treatment "plasma" "liver"
35 Q0 29770231 184 38.008423 imi_mug_run_2_treatment "level" "drug" "drugs"
35 Q0 21273557 185 37.94073 imi_mug_run_2_treatment "liver"
35 Q0 24133922 186 37.880733 imi_mug_run_2_treatment "rosuvastatin" "level" "plasma"
35 Q0 19768174 187 37.845108 imi_mug_run_2_treatment "statins" "plasma" "glucose"
35 Q0 25839937 188 37.7454 imi_mug_run_2_treatment "plasma"
35 Q0 16487721 189 37.712746 imi_mug_run_2_treatment "statins" "plasma"
35 Q0 22610724 190 37.602467 imi_mug_run_2_treatment "prevent" "basis" "program"
35 Q0 18836590 191 37.56848 imi_mug_run_2_treatment "protease" "statins" "liver"
35 Q0 29066265 192 37.56521 imi_mug_run_2_treatment "evolocumab" "pooled"
35 Q0 26370207 193 37.482006 imi_mug_run_2_treatment "combinations" "niacin" "statins"
35 Q0 27755114 194 37.45976 imi_mug_run_2_treatment "alirocumab" "evolocumab" "statin"
35 Q0 25378007 195 37.43631 imi_mug_run_2_treatment "statin" "statins" "mipomersen"
35 Q0 26798848 196 37.43226 imi_mug_run_2_treatment "drug" "alirocumab" "drugs"
35 Q0 26911578 197 37.42994 imi_mug_run_2_treatment "various" "evolocumab" "statin"
35 Q0 17274457 198 37.39702 imi_mug_run_2_treatment "aim" "lead" "basis"
35 Q0 22534770 199 37.383644 imi_mug_run_2_treatment "level" "others"
35 Q0 21352602 200 37.34716 imi_mug_run_2_treatment "medications" "statins" "drugs"
35 Q0 27231792 201 37.293335 imi_mug_run_2_treatment "alirocumab" "evolocumab" "drugs"
35 Q0 22963620 202 37.228348 imi_mug_run_2_treatment "drugs" "statins" "lomitapide"
35 Q0 28873201 203 37.222168 imi_mug_run_2_treatment "mediated" "level"
35 Q0 26987067 204 37.206406 imi_mug_run_2_treatment "antimalarial" "antiviral" "protease's"
35 Q0 26643308 205 37.16822 imi_mug_run_2_treatment "evolocumab" "statins" "ezetimibe"
35 Q0 22998978 206 37.124863 imi_mug_run_2_treatment "sts" "pill" "drugs"
35 Q0 25896669 207 37.090557 imi_mug_run_2_treatment "ezetimibe" "statin" "plasma"
35 Q0 24166456 208 37.020226 imi_mug_run_2_treatment "liver" "plasma"
35 Q0 25936300 209 37.018883 imi_mug_run_2_treatment "drugs" "statin" "monoclonal antibodies"
35 Q0 18039658 210 37.008347 imi_mug_run_2_treatment "liver"
35 Q0 28351002 211 36.99272 imi_mug_run_2_treatment "aim"
35 Q0 23578522 212 36.978073 imi_mug_run_2_treatment "drug" "drugs" "statins"
35 Q0 25734961 213 36.971016 imi_mug_run_2_treatment "drugs" "statin" "monoclonal antibodies"
35 Q0 25637042 214 36.96602 imi_mug_run_2_treatment "statins" "statin" "monoclonal antibodies"
35 Q0 29241886 215 36.911728 imi_mug_run_2_treatment "drug"
35 Q0 29306457 216 36.8759 imi_mug_run_2_treatment "mace" "pcsk9 inhibitor" "monoclonal antibodies"
35 Q0 26011648 217 36.793106 imi_mug_run_2_treatment "plasma" "dextran sulfate"
35 Q0 27620638 218 36.70586 imi_mug_run_2_treatment "aha" "statin" "bile acid"
35 Q0 29102496 219 36.691414 imi_mug_run_2_treatment "plasma"
35 Q0 29692249 220 36.660046 imi_mug_run_2_treatment "statins" "alirocumab" "evolocumab"
35 Q0 16424354 221 36.594433 imi_mug_run_2_treatment "statins"
35 Q0 21619378 222 36.54927 imi_mug_run_2_treatment "statins" "liver"
35 Q0 26056005 223 36.542953 imi_mug_run_2_treatment "mediated" "human antibody"
35 Q0 23317404 224 36.42704 imi_mug_run_2_treatment "various" "liver" "aim"
35 Q0 17461796 225 36.423332 imi_mug_run_2_treatment "mediated" "lead"
35 Q0 29129821 226 36.363632 imi_mug_run_2_treatment "plasma" "statin" "level"
35 Q0 28577571 227 36.328648 imi_mug_run_2_treatment "enzymes" "lead"
35 Q0 27596133 228 36.32691 imi_mug_run_2_treatment "plasma"
35 Q0 30270065 229 36.323387 imi_mug_run_2_treatment "drugs" "drug" "statin"
35 Q0 23162007 230 36.31669 imi_mug_run_2_treatment "rosuvastatin"
35 Q0 29708512 231 36.257305 imi_mug_run_2_treatment "liver"
35 Q0 24777633 232 36.211365 imi_mug_run_2_treatment "statins" "mtp" "mipomersen"
35 Q0 29578362 233 36.19174 imi_mug_run_2_treatment "statins" "ezetimibe" "therapeutic agents"
35 Q0 24691094 234 36.1868 imi_mug_run_2_treatment "evolocumab" "ezetimibe" "aim"
35 Q0 28709786 235 36.1299 imi_mug_run_2_treatment "monoclonal antibodies"
35 Q0 21596380 236 36.119892 imi_mug_run_2_treatment "fibrates" "hypolipidemic drugs" "statins"
35 Q0 30033948 237 36.110645 imi_mug_run_2_treatment "pcsk9 inhibitor" "statin"
35 Q0 29254691 238 36.107445 imi_mug_run_2_treatment "statin" "ezetimibe" "aim"
35 Q0 30280628 239 36.034725 imi_mug_run_2_treatment "statins" "pcsk9 inhibitor" "medications"
35 Q0 28028691 240 36.01915 imi_mug_run_2_treatment "mtor inhibitor" "everolimus" "calcineurin inhibitors"
35 Q0 30235833 241 36.015095 imi_mug_run_2_treatment "drug" "mediated" "polydatin"
35 Q0 21943799 242 35.962025 imi_mug_run_2_treatment "plasma" "protease" "statins"
35 Q0 16912035 243 35.93997 imi_mug_run_2_treatment "proteinase" "human plasma" "lead"
35 Q0 25002170 244 35.887894 imi_mug_run_2_treatment "plasma" "mtp" "statins"
35 Q0 22714699 245 35.67308 imi_mug_run_2_treatment "statins"
35 Q0 26894473 246 35.667625 imi_mug_run_2_treatment "statins" "new drugs" "mipomersen"
35 Q0 23040868 247 35.63521 imi_mug_run_2_treatment "calcium" "mediated" "cytokines"
35 Q0 28260498 248 35.62769 imi_mug_run_2_treatment "oxygen" "mediated" "interleukin"
35 Q0 22910581 249 35.588703 imi_mug_run_2_treatment "aim"
35 Q0 24987866 250 35.58257 imi_mug_run_2_treatment "mtp" "lomitapide" "liver"
35 Q0 27777316 251 35.52616 imi_mug_run_2_treatment "prisma"
35 Q0 15321837 252 35.499783 imi_mug_run_2_treatment "plasma"
35 Q0 23907036 253 35.451897 imi_mug_run_2_treatment "plasma" "mtp" "mediated"
35 Q0 28639183 254 35.389156 imi_mug_run_2_treatment "medication" "statins" "monoclonal antibodies"
35 Q0 16407292 255 35.35985 imi_mug_run_2_treatment "mediated" "insulin" "glucose"
35 Q0 24859021 256 35.34828 imi_mug_run_2_treatment "aim"
35 Q0 23371064 257 35.279026 imi_mug_run_2_treatment "statin" "statins" "therapeutics"
35 Q0 26596726 258 35.229794 imi_mug_run_2_treatment "statin" "alirocumab" "evolocumab"
35 Q0 26503748 259 35.227707 imi_mug_run_2_treatment "various" "monoclonal antibodies" "statin"
35 Q0 24354905 260 35.220695 imi_mug_run_2_treatment "therapeutic agents" "monoclonal antibodies"
35 Q0 26859553 261 35.220695 imi_mug_run_2_treatment "statins" "monoclonal antibodies" "alirocumab"
35 Q0 20006333 262 35.067192 imi_mug_run_2_treatment "plasma"
35 Q0 19628659 263 35.056526 imi_mug_run_2_treatment "insulin" "plasma" "glucose"
35 Q0 20498851 264 35.056526 imi_mug_run_2_treatment "mediated" "level" "liver"
35 Q0 17080197 265 35.052715 imi_mug_run_2_treatment "plasma" "liver"
35 Q0 30270055 266 35.03126 imi_mug_run_2_treatment "liver"
35 Q0 29997226 267 35.02822 imi_mug_run_2_treatment "medication"
35 Q0 27567901 268 34.990135 imi_mug_run_2_treatment "statin" "statins" "evolocumab"
35 Q0 27246162 269 34.973766 imi_mug_run_2_treatment "aim"
35 Q0 24252255 270 34.958664 imi_mug_run_2_treatment "epidermal growth factor"
35 Q0 29171769 271 34.921 imi_mug_run_2_treatment "alirocumab" "human immunoglobulin" "ezetimibe"
35 Q0 25989132 272 34.882515 imi_mug_run_2_treatment "various" "drugs" "therapeutic agents"
35 Q0 28277798 273 34.821674 imi_mug_run_2_treatment "alirocumab" "drugs" "statin"
35 Q0 28812389 274 34.821674 imi_mug_run_2_treatment "evolocumab" "statins" "drugs"
35 Q0 18355829 275 34.80328 imi_mug_run_2_treatment "berberine" "mevastatin" "epidermal growth factor"
35 Q0 27660454 276 34.781994 imi_mug_run_2_treatment "evolocumab" "statins" "drugs"
35 Q0 27470509 277 34.76158 imi_mug_run_2_treatment "plasma" "angiotensin ii" "mediated"
35 Q0 20018285 278 34.757545 imi_mug_run_2_treatment "ezetimibe/simvastatin" "cardiovascular system" "plasma"
35 Q0 27086681 279 34.66977 imi_mug_run_2_treatment "statin" "ezetimibe" "evolocumab"
35 Q0 27422124 280 34.666607 imi_mug_run_2_treatment "statin" "statins"
35 Q0 28644091 281 34.545357 imi_mug_run_2_treatment "statin" "statins"
35 Q0 25922802 282 34.48183 imi_mug_run_2_treatment "statin" "statins" "drugs"
35 Q0 24857672 283 34.468952 imi_mug_run_2_treatment "mtp" "drugs" "statin"
35 Q0 30318064 284 34.45759 imi_mug_run_2_treatment "overtime" "monoclonal antibodies"
35 Q0 17170371 285 34.390575 imi_mug_run_2_treatment "plasma" "aim"
35 Q0 22027821 286 34.267235 imi_mug_run_2_treatment "mediated"
35 Q0 17215125 287 34.26274 imi_mug_run_2_treatment "plasma" "protease" "level"
35 Q0 29190549 288 34.245037 imi_mug_run_2_treatment "sterols" "sitosterol"
35 Q0 28203441 289 34.23021 imi_mug_run_2_treatment "generic" "monoclonal antibodies"
35 Q0 30253291 290 34.06842 imi_mug_run_2_treatment "liver" "mediated" "viral vector"
35 Q0 18245819 291 34.03719 imi_mug_run_2_treatment "various" "fa" "statins"
35 Q0 25225128 292 33.951847 imi_mug_run_2_treatment "plasma" "mediated" "level"
35 Q0 30011788 293 33.898285 imi_mug_run_2_treatment "agent" "monoclonal antibodies" "alirocumab"
35 Q0 17702855 294 33.823986 imi_mug_run_2_treatment "monoclonal antibodies"
35 Q0 24184943 295 33.823956 imi_mug_run_2_treatment "statins" "drugs" "statin"
35 Q0 25474576 296 33.80443 imi_mug_run_2_treatment "vaccines" "vaccine" "animals"
35 Q0 29411675 297 33.763866 imi_mug_run_2_treatment "statin" "statins" "monoclonal antibodies"
35 Q0 25846081 298 33.685966 imi_mug_run_2_treatment "lead" "level"
35 Q0 19191301 299 33.635925 imi_mug_run_2_treatment "drugs" "others"
35 Q0 28817709 300 33.591118 imi_mug_run_2_treatment "various" "statin"
35 Q0 29353225 301 33.591118 imi_mug_run_2_treatment "aim" "plasma"
35 Q0 27933557 302 33.55543 imi_mug_run_2_treatment "drugs" "statin"
35 Q0 27438893 303 33.54583 imi_mug_run_2_treatment "plasma" "vitamin e" "statin"
35 Q0 27713142 304 33.54533 imi_mug_run_2_treatment "plasma" "level"
35 Q0 28527325 305 33.545147 imi_mug_run_2_treatment "drugs" "mtp" "medications"
35 Q0 26413878 306 33.508636 imi_mug_run_2_treatment "vaccine" "vaccines"
35 Q0 23642322 307 33.3659 imi_mug_run_2_treatment "therapeutics" "lead"
35 Q0 29096824 308 33.3659 imi_mug_run_2_treatment "drugs" "new drugs" "statins"
35 Q0 26374825 309 33.34415 imi_mug_run_2_treatment "alirocumab"
35 Q0 17645871 310 33.31404 imi_mug_run_2_treatment "plasma"
35 Q0 25670367 311 33.29743 imi_mug_run_2_treatment "ezetimibe" "aim" "drugs"
35 Q0 26445568 312 33.278297 imi_mug_run_2_treatment "plasma" "lead" "level"
35 Q0 17142622 313 33.268143 imi_mug_run_2_treatment "statin"
35 Q0 24793346 314 33.21086 imi_mug_run_2_treatment "atorvastatin" "cholesterol-lowering drug" "drugs"
35 Q0 29572319 315 33.177277 imi_mug_run_2_treatment "animals"
35 Q0 23083772 316 33.1609 imi_mug_run_2_treatment "statins" "statin" "rosuvastatin"
35 Q0 27305304 317 33.133926 imi_mug_run_2_treatment "lomitapide" "simvastatin" "statin"
35 Q0 30301542 318 33.08852 imi_mug_run_2_treatment "medications" "com"
35 Q0 29561319 319 33.07316 imi_mug_run_2_treatment "drugs" "monoclonal antibodies"
35 Q0 27620356 320 33.06235 imi_mug_run_2_treatment "statin" "mipomersen" "lomitapide"
35 Q0 30448414 321 33.03652 imi_mug_run_2_treatment "drugs" "alirocumab" "evolocumab"
35 Q0 23537714 322 33.011227 imi_mug_run_2_treatment "aim"
35 Q0 29332570 323 32.98726 imi_mug_run_2_treatment "drugs" "statins"
35 Q0 26364362 324 32.946022 imi_mug_run_2_treatment "drugs" "statins" "alirocumab"
35 Q0 26040332 325 32.888798 imi_mug_run_2_treatment "monoclonal antibodies"
35 Q0 25349780 326 32.87486 imi_mug_run_2_treatment "quercetin" "quercetin-3-glucoside" "agent"
35 Q0 29284604 327 32.844276 imi_mug_run_2_treatment "evolocumab" "mevastatin"
35 Q0 19738285 328 32.82561 imi_mug_run_2_treatment "fenofibrate" "fibrates" "medication"
35 Q0 27920219 329 32.804096 imi_mug_run_2_treatment "protease" "monoclonal antibodies"
35 Q0 18799458 330 32.72519 imi_mug_run_2_treatment "histidine" "annexin a1" "lead"
35 Q0 25915661 331 32.710724 imi_mug_run_2_treatment "level" "statins" "monoclonal antibodies"
35 Q0 26131194 332 32.673775 imi_mug_run_2_treatment "atorvastatin" "lead"
35 Q0 28618994 333 32.64981 imi_mug_run_2_treatment "statin" "fibrates" "niacin"
35 Q0 29937273 334 32.641266 imi_mug_run_2_treatment "evolocumab" "statins" "ezetimibe"
35 Q0 18033751 335 32.57321 imi_mug_run_2_treatment "atorvastatin" "protease" "statins"
35 Q0 18280815 336 32.433445 imi_mug_run_2_treatment "protease" "statins" "liver"
35 Q0 26077586 337 32.368523 imi_mug_run_2_treatment "duration"
35 Q0 25600226 338 32.35595 imi_mug_run_2_treatment "statins" "plasma"
35 Q0 28555288 339 32.332478 imi_mug_run_2_treatment "enzymes" "combinations" "statin"
35 Q0 24625727 340 32.325333 imi_mug_run_2_treatment "lead" "liver" "monoclonal antibodies"
35 Q0 28804094 341 32.325333 imi_mug_run_2_treatment "statins" "statin" "level"
35 Q0 29748315 342 32.315178 imi_mug_run_2_treatment "plasma" "lead"
35 Q0 28262545 343 32.216923 imi_mug_run_2_treatment "liver" "medications" "simvastatin"
35 Q0 22519528 344 32.207176 imi_mug_run_2_treatment "various" "cholesterol lowering drugs" "lead"
35 Q0 25778403 345 32.207104 imi_mug_run_2_treatment "monoclonal antibodies" "plasma"
35 Q0 18354138 346 32.20619 imi_mug_run_2_treatment "plasma" "liver" "human plasma"
35 Q0 16794006 347 32.18084 imi_mug_run_2_treatment "mediated" "fenofibrate" "lead"
35 Q0 25341796 348 32.176506 imi_mug_run_2_treatment "liver"
35 Q0 23743349 349 32.167404 imi_mug_run_2_treatment "insulin" "leucine"
35 Q0 27822850 350 32.115517 imi_mug_run_2_treatment "icon" "statin" "statins"
35 Q0 26702335 351 32.046097 imi_mug_run_2_treatment "statins" "medications" "statin"
35 Q0 30323110 352 32.041023 imi_mug_run_2_treatment "sitosterol" "ezetimibe" "statins"
35 Q0 25936324 353 32.0197 imi_mug_run_2_treatment "drugs"
35 Q0 29562587 354 32.00393 imi_mug_run_2_treatment "plasma" "favoring" "statin"
35 Q0 29985478 355 31.99152 imi_mug_run_2_treatment "liver" "product" "animals"
35 Q0 27785114 356 31.945488 imi_mug_run_2_treatment "drugs" "antisense oligonucleotide"
35 Q0 27523271 357 31.857334 imi_mug_run_2_treatment "monoclonal antibodies" "mediated" "therapeutic agents"
35 Q0 23400816 358 31.852356 imi_mug_run_2_treatment "human plasma" "plasma" "mediated"
35 Q0 24667128 359 31.847971 imi_mug_run_2_treatment "monoclonal antibodies"
35 Q0 29219151 360 31.807232 imi_mug_run_2_treatment "drugs" "statins" "ezetimibe"
35 Q0 18695239 361 31.797924 imi_mug_run_2_treatment "liver" "plasma" "mediated"
35 Q0 28391886 362 31.70367 imi_mug_run_2_treatment "alirocumab" "statin" "pooled"
35 Q0 29562810 363 31.70319 imi_mug_run_2_treatment "aim"
35 Q0 17495605 364 31.695204 imi_mug_run_2_treatment "protease" "statins"
35 Q0 28550993 365 31.693825 imi_mug_run_2_treatment "statin" "pcsk9 inhibitor" "drugs"
35 Q0 18197702 366 31.635008 imi_mug_run_2_treatment "basis" "plasma"
35 Q0 18672372 367 31.620977 imi_mug_run_2_treatment "plasma"
35 Q0 28762908 368 31.609076 imi_mug_run_2_treatment "level" "drugs" "glucose"
35 Q0 29180351 369 31.584372 imi_mug_run_2_treatment "favor" "statins" "ezetimibe"
35 Q0 30270083 370 31.56178 imi_mug_run_2_treatment "bps"
35 Q0 27014949 371 31.539736 imi_mug_run_2_treatment "plasma"
35 Q0 28557865 372 31.465858 imi_mug_run_2_treatment "level" "evolocumab"
35 Q0 29181773 373 31.439787 imi_mug_run_2_treatment "statins" "biologics" "ezetimibe"
35 Q0 29398508 374 31.435116 imi_mug_run_2_treatment "evolocumab"
35 Q0 27015087 375 31.403637 imi_mug_run_2_treatment "berberine" "rice" "plasma"
35 Q0 21040917 376 31.37765 imi_mug_run_2_treatment "lead" "level"
35 Q0 16462892 377 31.337555 imi_mug_run_2_treatment "sterols" "liver" "plasma"
35 Q0 30483910 378 31.289618 imi_mug_run_2_treatment "liver" "level" "lead"
35 Q0 26343872 379 31.222576 imi_mug_run_2_treatment "aim"
35 Q0 15677715 380 31.183434 imi_mug_run_2_treatment "proteases"
35 Q0 17449864 381 31.183434 imi_mug_run_2_treatment "mediated" "protease" "plasma"
35 Q0 27919350 382 31.130072 imi_mug_run_2_treatment "statin" "drugs" "ezetimibe"
35 Q0 27678435 383 31.101978 imi_mug_run_2_treatment "statin"
35 Q0 23578468 384 31.094696 imi_mug_run_2_treatment "drugs" "statins" "ezetimibe"
35 Q0 27886619 385 31.094696 imi_mug_run_2_treatment "alirocumab" "statin" "ezetimibe"
35 Q0 15805190 386 31.029366 imi_mug_run_2_treatment "statins" "liver" "drugs"
35 Q0 28429242 387 30.998203 imi_mug_run_2_treatment "therapeutics"
35 Q0 26968977 388 30.907333 imi_mug_run_2_treatment "pcsk9 inhibitor" "statin" "alirocumab"
35 Q0 20172854 389 30.851906 imi_mug_run_2_treatment "lys" "plasma"
35 Q0 15741654 390 30.673378 imi_mug_run_2_treatment "plasma"
35 Q0 18498363 391 30.625967 imi_mug_run_2_treatment "human plasma"
35 Q0 25079474 392 30.541775 imi_mug_run_2_treatment "drug" "drugs" "statins"
35 Q0 16777760 393 30.512281 imi_mug_run_2_treatment "mediated" "level"
35 Q0 27538393 394 30.502737 imi_mug_run_2_treatment "aha" "pcsk9 inhibitor" "bmc"
35 Q0 26824363 395 30.474566 imi_mug_run_2_treatment "plasma" "metreleptin"
35 Q0 30272645 396 30.455742 imi_mug_run_2_treatment "liver" "drugs" "statins"
35 Q0 19062528 397 30.450481 imi_mug_run_2_treatment "various" "drug" "drugs"
35 Q0 15385538 398 30.441711 imi_mug_run_2_treatment "liver"
35 Q0 24164109 399 30.413618 imi_mug_run_2_treatment "statin" "statins" "level"
35 Q0 16571601 400 30.404434 imi_mug_run_2_treatment "level"
35 Q0 29209441 401 30.40393 imi_mug_run_2_treatment "drugs" "others" "new drugs"
35 Q0 25856746 402 30.396894 imi_mug_run_2_treatment "statin" "level" "monoclonal antibodies"
35 Q0 26456772 403 30.38987 imi_mug_run_2_treatment "drugs" "ezetimibe" "new drugs"
35 Q0 25426564 404 30.360905 imi_mug_run_2_treatment "statin"
35 Q0 21518694 405 30.3112 imi_mug_run_2_treatment "various" "liver"
35 Q0 25682035 406 30.256979 imi_mug_run_2_treatment "liver" "fructose" "animals"
35 Q0 23951290 407 30.243797 imi_mug_run_2_treatment "gln" "plasma"
35 Q0 26961236 408 30.165989 imi_mug_run_2_treatment "statin" "statins" "ezetimibe"
35 Q0 26256967 409 30.142963 imi_mug_run_2_treatment "gold" "therapeutics" "plasma"
35 Q0 29386597 410 30.135393 imi_mug_run_2_treatment "lead" "aim"
35 Q0 18547436 411 30.129498 imi_mug_run_2_treatment "fibrates" "plasma" "statins"
35 Q0 26789774 412 30.101067 imi_mug_run_2_treatment "statins"
35 Q0 30270085 413 29.97928 imi_mug_run_2_treatment "lipid lowering agents"
35 Q0 29747383 414 29.976004 imi_mug_run_2_treatment "drugs" "antisense oligonucleotide"
35 Q0 21262787 415 29.941605 imi_mug_run_2_treatment "ezetimibe" "rosuvastatin" "statins"
35 Q0 18028451 416 29.933365 imi_mug_run_2_treatment "level"
35 Q0 23375686 417 29.888065 imi_mug_run_2_treatment "adh-1"
35 Q0 25662924 418 29.887447 imi_mug_run_2_treatment "statin" "monoclonal antibodies"
35 Q0 30420622 419 29.869495 imi_mug_run_2_treatment "plasma" "monoclonal antibodies"
35 Q0 15118091 420 29.826595 imi_mug_run_2_treatment "mediated" "animals"
35 Q0 23344002 421 29.793222 imi_mug_run_2_treatment "therapeutic agent"
35 Q0 27481380 422 29.792603 imi_mug_run_2_treatment "statins" "drugs" "therapeutics"
35 Q0 21539517 423 29.78069 imi_mug_run_2_treatment "plasma" "atorvastatin" "aim"
35 Q0 23113833 424 29.757717 imi_mug_run_2_treatment "atorvastatin" "pharmaceuticals"
35 Q0 19762784 425 29.75505 imi_mug_run_2_treatment "plasma"
35 Q0 28329114 426 29.708511 imi_mug_run_2_treatment "plasma" "monoclonal antibodies" "anti-inflammatory"
35 Q0 30306859 427 29.629272 imi_mug_run_2_treatment "drugs" "alirocumab" "evolocumab"
35 Q0 29495280 428 29.521448 imi_mug_run_2_treatment "plasma"
35 Q0 25621930 429 29.509796 imi_mug_run_2_treatment "salt" "sodium" "balance"
35 Q0 27312019 430 29.474415 imi_mug_run_2_treatment "drugs" "statins" "ezetimibe"
35 Q0 28445176 431 29.474415 imi_mug_run_2_treatment "statins" "mipomersen" "drugs"
35 Q0 29511875 432 29.38084 imi_mug_run_2_treatment "statins" "evolocumab" "statin"
35 Q0 26834934 433 29.349384 imi_mug_run_2_treatment "statin" "statins" "level"
35 Q0 28868092 434 29.312668 imi_mug_run_2_treatment "plasma"
35 Q0 26563849 435 29.260826 imi_mug_run_2_treatment "alirocumab" "ezetimibe"
35 Q0 21763412 436 29.23299 imi_mug_run_2_treatment "simvastatin" "basis" "aim"
35 Q0 27038318 437 29.225996 imi_mug_run_2_treatment "monoclonal antibodies" "plasma"
35 Q0 25693363 438 29.154665 imi_mug_run_2_treatment "statins" "drugs" "statin"
35 Q0 17578886 439 29.092903 imi_mug_run_2_treatment "animals" "growth hormone" "mediated"
35 Q0 29223954 440 29.086693 imi_mug_run_2_treatment "alirocumab" "evolocumab"
35 Q0 30375244 441 29.026024 imi_mug_run_2_treatment "drug" "program" "duration"
35 Q0 26548322 442 29.023216 imi_mug_run_2_treatment "various" "nicotinic acid" "agonists"
35 Q0 28204827 443 29.021246 imi_mug_run_2_treatment "liver" "rosuvastatin" "mediated"
35 Q0 29606363 444 29.018759 imi_mug_run_2_treatment "drugs" "aim"
35 Q0 25164566 445 28.979189 imi_mug_run_2_treatment "statin" "level" "curcumin"
35 Q0 28879791 446 28.9791 imi_mug_run_2_treatment "aha" "statins" "ezetimibe"
35 Q0 25689006 447 28.96182 imi_mug_run_2_treatment "statin" "liver" "monoclonal antibodies"
35 Q0 26414456 448 28.946144 imi_mug_run_2_treatment "alirocumab" "evolocumab" "drugs"
35 Q0 27363304 449 28.925465 imi_mug_run_2_treatment "alirocumab" "evolocumab" "statin"
35 Q0 23714205 450 28.914648 imi_mug_run_2_treatment "serine" "liver"
35 Q0 29388056 451 28.81797 imi_mug_run_2_treatment "level"
35 Q0 23333725 452 28.806396 imi_mug_run_2_treatment "plasma" "sitosterol" "squalene"
35 Q0 27445021 453 28.76939 imi_mug_run_2_treatment "statins" "statin" "new drugs"
35 Q0 24977977 454 28.76313 imi_mug_run_2_treatment "basis"
35 Q0 20964105 455 28.757645 imi_mug_run_2_treatment "medication"
35 Q0 27919364 456 28.747578 imi_mug_run_2_treatment "plasma"
35 Q0 24373748 457 28.740606 imi_mug_run_2_treatment "various" "monoclonal antibodies" "statins"
35 Q0 26566525 458 28.730412 imi_mug_run_2_treatment "alirocumab" "evolocumab"
35 Q0 25936907 459 28.694572 imi_mug_run_2_treatment "monoclonal antibodies" "statin" "statins"
35 Q0 30471555 460 28.651686 imi_mug_run_2_treatment "berberine" "yeast" "red yeast rice"
35 Q0 28155622 461 28.649963 imi_mug_run_2_treatment "various" "statins" "alirocumab"
35 Q0 19081568 462 28.645681 imi_mug_run_2_treatment "mediated"
35 Q0 25171595 463 28.599834 imi_mug_run_2_treatment "statins" "level" "aim"
35 Q0 29685715 464 28.593113 imi_mug_run_2_treatment "evolocumab"
35 Q0 27498088 465 28.573765 imi_mug_run_2_treatment "statin" "niacin" "fenofibrate"
35 Q0 27668060 466 28.573765 imi_mug_run_2_treatment "evolocumab" "repatha"
35 Q0 17242417 467 28.395296 imi_mug_run_2_treatment "proteases" "antisense oligonucleotide"
35 Q0 22875854 468 28.390379 imi_mug_run_2_treatment "gln" "thr" "lead"
35 Q0 21382890 469 28.340727 imi_mug_run_2_treatment "program"
35 Q0 20828696 470 28.297253 imi_mug_run_2_treatment "aim"
35 Q0 30270071 471 28.294796 imi_mug_run_2_treatment "level" "duration" "aim"
35 Q0 27919366 472 28.285734 imi_mug_run_2_treatment "fibrinogen" "evolocumab" "cytokines"
35 Q0 28025677 473 28.271381 imi_mug_run_2_treatment "various" "monoclonal antibodies" "alirocumab"
35 Q0 22294692 474 28.263092 imi_mug_run_2_treatment "mediated" "duration" "plasma"
35 Q0 28353356 475 28.171858 imi_mug_run_2_treatment "statin" "ezetimibe"
35 Q0 28926730 476 28.101868 imi_mug_run_2_treatment "evolocumab"
35 Q0 28188981 477 28.099545 imi_mug_run_2_treatment "statin"
35 Q0 23973703 478 28.058073 imi_mug_run_2_treatment "statins" "statin" "plasma"
35 Q0 19443683 479 28.009954 imi_mug_run_2_treatment "statin" "therapeutics"
35 Q0 27769814 480 27.9452 imi_mug_run_2_treatment "sterols"
35 Q0 23672094 481 27.944057 imi_mug_run_2_treatment "enzymes" "drug" "abc"
35 Q0 29411770 482 27.862911 imi_mug_run_2_treatment "drug" "statin" "statins"
35 Q0 24619822 483 27.83294 imi_mug_run_2_treatment "sham" "liver" "estradiol"
35 Q0 29056268 484 27.784721 imi_mug_run_2_treatment "various" "insulin" "statin"
35 Q0 26927322 485 27.71947 imi_mug_run_2_treatment "broom" "lead"
35 Q0 24315769 486 27.623594 imi_mug_run_2_treatment "plasma" "peritoneal dialysate" "level"
35 Q0 26655339 487 27.621769 imi_mug_run_2_treatment "plasma" "level"
35 Q0 23666884 488 27.602184 imi_mug_run_2_treatment "mtp" "lead"
35 Q0 27100924 489 27.5882 imi_mug_run_2_treatment "sham" "angiotensin" "antihypertensive drugs"
35 Q0 30287608 490 27.587008 imi_mug_run_2_treatment "alirocumab" "evolocumab" "monoclonal antibodies"
35 Q0 27215418 491 27.548101 imi_mug_run_2_treatment "statin" "liver" "alirocumab"
35 Q0 28289523 492 27.548101 imi_mug_run_2_treatment "medications" "protease" "statins"
35 Q0 27424515 493 27.533506 imi_mug_run_2_treatment "level"
35 Q0 26293511 494 27.531574 imi_mug_run_2_treatment "evolocumab" "plasma" "statin"
35 Q0 30207552 495 27.531574 imi_mug_run_2_treatment "ezetimibe" "generic" "statins"
35 Q0 28744103 496 27.515491 imi_mug_run_2_treatment "evolocumab" "statin" "statins"
35 Q0 29409336 497 27.515491 imi_mug_run_2_treatment "hypolipidemic drugs" "statins" "drugs"
35 Q0 22311433 498 27.498018 imi_mug_run_2_treatment "medications" "plasma"
35 Q0 27502861 499 27.450125 imi_mug_run_2_treatment "statin" "statins" "program"
35 Q0 24454330 500 27.375349 imi_mug_run_2_treatment "plasma" "glucose"
35 Q0 28970592 501 27.306314 imi_mug_run_2_treatment "vaccine" "vaccines" "peptide vaccine"
35 Q0 27179706 502 27.293148 imi_mug_run_2_treatment "basis" "plasma"
35 Q0 24751931 503 27.25108 imi_mug_run_2_treatment "drugs" "mtp" "statin"
35 Q0 28736830 504 27.225552 imi_mug_run_2_treatment "statin" "drugs" "duration"
35 Q0 27478094 505 27.21967 imi_mug_run_2_treatment "evolocumab" "alirocumab" "statins"
35 Q0 15893176 506 27.202988 imi_mug_run_2_treatment "plasma" "leucine"
35 Q0 20423303 507 27.169558 imi_mug_run_2_treatment "level" "lead" "plasma"
35 Q0 25861882 508 27.164616 imi_mug_run_2_treatment "statins" "drugs" "statin"
35 Q0 30310488 509 27.124348 imi_mug_run_2_treatment "statins" "statin" "alirocumab"
35 Q0 27804036 510 27.055676 imi_mug_run_2_treatment "statins" "plasma"
35 Q0 16465619 511 26.96049 imi_mug_run_2_treatment "plasma"
35 Q0 29987994 512 26.958122 imi_mug_run_2_treatment "level" "aim"
35 Q0 28482694 513 26.888962 imi_mug_run_2_treatment "monoclonal antibodies"
35 Q0 27084339 514 26.84757 imi_mug_run_2_treatment "prevent" "basis"
35 Q0 15772090 515 26.84012 imi_mug_run_2_treatment "mediated" "liver" "plasma"
35 Q0 21502677 516 26.838724 imi_mug_run_2_treatment "various" "leucine"
35 Q0 26076948 517 26.764685 imi_mug_run_2_treatment "statin" "statins" "mipomersen"
35 Q0 29231064 518 26.753708 imi_mug_run_2_treatment "drugs" "statin" "mtp"
35 Q0 27877050 519 26.75082 imi_mug_run_2_treatment "various" "alirocumab" "evolocumab"
35 Q0 30310490 520 26.711227 imi_mug_run_2_treatment "medications" "statin" "lomitapide"
35 Q0 23298392 521 26.661644 imi_mug_run_2_treatment "fructose" "plasma"
35 Q0 28405938 522 26.619602 imi_mug_run_2_treatment "basis"
35 Q0 27241838 523 26.535864 imi_mug_run_2_treatment "level" "medication"
35 Q0 25965722 524 26.46042 imi_mug_run_2_treatment "plasma"
35 Q0 17452316 525 26.387901 imi_mug_run_2_treatment "calcium" "epidermal growth factor"
35 Q0 20719861 526 26.31249 imi_mug_run_2_treatment "sitosterol"
35 Q0 23308045 527 26.264072 imi_mug_run_2_treatment "liver" "mediated" "level"
35 Q0 28128575 528 26.193478 imi_mug_run_2_treatment "statins" "ezetimib" "mipomersen"
35 Q0 29451410 529 26.133873 imi_mug_run_2_treatment "monoclonal antibodies" "plasma"
35 Q0 28444187 530 26.044634 imi_mug_run_2_treatment "alirocumab" "evolocumab" "statins"
35 Q0 28750477 531 25.988846 imi_mug_run_2_treatment "alirocumab" "evolocumab" "statins"
35 Q0 29175268 532 25.962168 imi_mug_run_2_treatment "oxygen" "level"
35 Q0 25051126 533 25.923405 imi_mug_run_2_treatment "statin" "statins" "monoclonal antibodies"
35 Q0 27531965 534 25.916658 imi_mug_run_2_treatment "statins" "drug" "ezetimibe"
35 Q0 27389630 535 25.826534 imi_mug_run_2_treatment "vaccine" "vaccines" "statins"
35 Q0 25689751 536 25.749298 imi_mug_run_2_treatment "statins" "drugs" "alirocumab"
35 Q0 16619215 537 25.699661 imi_mug_run_2_treatment "plasma"
35 Q0 22095935 538 25.65064 imi_mug_run_2_treatment "program"
35 Q0 27412663 539 25.62835 imi_mug_run_2_treatment "statins" "ezetimibe" "statin"
35 Q0 20849207 540 25.587757 imi_mug_run_2_treatment "various" "cholesterol lowering drugs"
35 Q0 22764087 541 25.534573 imi_mug_run_2_treatment "mediated" "tyr"
35 Q0 24308640 542 25.531235 imi_mug_run_2_treatment "plasma"
35 Q0 25733326 543 25.480606 imi_mug_run_2_treatment "basis" "plasma"
35 Q0 21115573 544 25.400675 imi_mug_run_2_treatment "aim"
35 Q0 26546829 545 25.381496 imi_mug_run_2_treatment "estrogen" "lecithin" "antipsychotics"
35 Q0 24811296 546 25.351116 imi_mug_run_2_treatment "fibrates" "arsenal" "statins"
35 Q0 30056760 547 25.312775 imi_mug_run_2_treatment "aim"
35 Q0 26868931 548 25.27969 imi_mug_run_2_treatment "drugs" "alirocumab" "evolocumab"
35 Q0 24785115 549 25.274477 imi_mug_run_2_treatment "aim"
35 Q0 29029165 550 25.274477 imi_mug_run_2_treatment "plasma" "statin" "ezetimibe"
35 Q0 29863817 551 25.194012 imi_mug_run_2_treatment "statin" "level" "aim"
35 Q0 21925044 552 25.173409 imi_mug_run_2_treatment "aim"
35 Q0 28886926 553 25.092777 imi_mug_run_2_treatment "ezetimibe" "statin" "bile acid sequestrants"
35 Q0 28096572 554 25.027424 imi_mug_run_2_treatment "statins" "drugs" "antioxidant"
35 Q0 23690465 555 25.021358 imi_mug_run_2_treatment "liver"
35 Q0 28328015 556 24.969868 imi_mug_run_2_treatment "drugs" "product" "alirocumab"
35 Q0 25456764 557 24.949373 imi_mug_run_2_treatment "alirocumab"
35 Q0 27678448 558 24.941921 imi_mug_run_2_treatment "balance"
35 Q0 17765246 559 24.888988 imi_mug_run_2_treatment "level"
35 Q0 22228254 560 24.888988 imi_mug_run_2_treatment "plasma"
35 Q0 29057618 561 24.634193 imi_mug_run_2_treatment "statin"
35 Q0 27352986 562 24.533493 imi_mug_run_2_treatment "statins" "statin" "agent"
35 Q0 23087140 563 24.443707 imi_mug_run_2_treatment "berberine" "cytokines" "interleukin"
35 Q0 26601593 564 24.421293 imi_mug_run_2_treatment "statins"
35 Q0 24278757 565 24.421293 imi_mug_run_2_treatment "statins" "hmg-coa reductase inhibitors"
35 Q0 27844136 566 24.363375 imi_mug_run_2_treatment "ezetimibe" "statin" "statins"
35 Q0 23736819 567 24.35352 imi_mug_run_2_treatment "statin" "statins" "mipomersen"
35 Q0 26908111 568 24.345322 imi_mug_run_2_treatment "statins" "statin" "new drugs"
35 Q0 29706812 569 24.339794 imi_mug_run_2_treatment "evolocumab" "alirocumab" "monoclonal antibodies"
35 Q0 22463922 570 24.33688 imi_mug_run_2_treatment "atorvastatin"
35 Q0 27908345 571 24.330688 imi_mug_run_2_treatment "statin" "ezetimibe" "monoclonal antibodies"
35 Q0 27215141 572 24.31369 imi_mug_run_2_treatment "statins"
35 Q0 28408313 573 24.31134 imi_mug_run_2_treatment "various" "statins" "statin"
35 Q0 25282520 574 24.262802 imi_mug_run_2_treatment "evolocumab" "plasma"
35 Q0 25240705 575 24.14732 imi_mug_run_2_treatment "alirocumab" "statin" "statins"
35 Q0 29361723 576 24.073927 imi_mug_run_2_treatment "nicotinic acid" "drugs" "statin"
35 Q0 26455563 577 24.05527 imi_mug_run_2_treatment "alirocumab" "statin" "level"
35 Q0 26652784 578 24.044743 imi_mug_run_2_treatment "statin" "mediated" "ezetimibe"
35 Q0 25600041 579 24.044743 imi_mug_run_2_treatment "drugs" "statin" "statins"
35 Q0 29980055 580 24.044743 imi_mug_run_2_treatment "drug" "statins" "therapeutics"
35 Q0 29994808 581 24.044743 imi_mug_run_2_treatment "cardiovascular medicine" "lead"
35 Q0 29962499 582 24.044743 imi_mug_run_2_treatment "statin" "drugs" "statins"
35 Q0 20028367 583 24.041973 imi_mug_run_2_treatment "liver" "ethanol" "alcohol"
35 Q0 28902717 584 24.00009 imi_mug_run_2_treatment "drugs" "drug" "ezetimibe"
35 Q0 29544086 585 24.00009 imi_mug_run_2_treatment "combinations" "statin" "antihypertensive"
35 Q0 24420163 586 23.944052 imi_mug_run_2_treatment "plasma"
35 Q0 23812840 587 23.944052 imi_mug_run_2_treatment "statins" "fibrates" "combination drug"
35 Q0 29572815 588 23.944052 imi_mug_run_2_treatment "aim"
35 Q0 22633824 589 23.942417 imi_mug_run_2_treatment "various" "ezetimibe" "statin"
35 Q0 28633452 590 23.899588 imi_mug_run_2_treatment "various" "plasma"
35 Q0 26256279 591 23.898884 imi_mug_run_2_treatment "statins" "drug" "drugs"
35 Q0 23357136 592 23.826382 imi_mug_run_2_treatment "plasma" "statins" "mipomersen"
35 Q0 18566665 593 23.818413 imi_mug_run_2_treatment "various" "plasma" "mtp"
35 Q0 30026278 594 23.78341 imi_mug_run_2_treatment "liver"
35 Q0 18700895 595 23.673485 imi_mug_run_2_treatment "iplex"
35 Q0 30306860 596 23.673485 imi_mug_run_2_treatment "lead" "aim"
35 Q0 27012540 597 23.6669 imi_mug_run_2_treatment "drugs" "cholesterol-lowering drug" "ezetimibe"
35 Q0 29148854 598 23.583246 imi_mug_run_2_treatment "statin" "ezetimibe" "simvastatin"
35 Q0 22017319 599 23.519508 imi_mug_run_2_treatment "level"
35 Q0 22883975 600 23.518276 imi_mug_run_2_treatment "basis" "program"
35 Q0 17351764 601 23.485783 imi_mug_run_2_treatment "various" "lipases" "statins"
35 Q0 29172973 602 23.422287 imi_mug_run_2_treatment "ezetimibe" "statin" "level"
35 Q0 28379035 603 23.328854 imi_mug_run_2_treatment "medicine" "plasma"
35 Q0 28262189 604 23.328854 imi_mug_run_2_treatment "fibrates" "drugs" "fats"
35 Q0 24477778 605 23.323887 imi_mug_run_2_treatment "evolocumab" "statin" "statins"
35 Q0 27126396 606 23.287985 imi_mug_run_2_treatment "therapeutic agents" "level"
35 Q0 27967828 607 23.209675 imi_mug_run_2_treatment "drugs" "statin" "ezetimibe"
35 Q0 20073037 608 23.18268 imi_mug_run_2_treatment "cholesterol-lowering drug" "mediated" "liver"
35 Q0 28437620 609 23.182095 imi_mug_run_2_treatment "various" "calcium" "aha"
35 Q0 16080633 610 23.163439 imi_mug_run_2_treatment "statins" "product" "aim"
35 Q0 26664657 611 23.133778 imi_mug_run_2_treatment "statins" "ezetimibe" "lomitapide"
35 Q0 21920719 612 22.972866 imi_mug_run_2_treatment "leucine" "statins" "statin"
35 Q0 28849360 613 22.897346 imi_mug_run_2_treatment "statin" "medications" "statins"
35 Q0 30033951 614 22.842756 imi_mug_run_2_treatment "sitosterol" "plant sterols" "abc"
35 Q0 24595397 615 22.826199 imi_mug_run_2_treatment "animals" "alpha-lipoic acid" "plasma"
35 Q0 26323342 616 22.797737 imi_mug_run_2_treatment "evolocumab" "drug" "statin"
35 Q0 30270054 617 22.689356 imi_mug_run_2_treatment "lead"
35 Q0 25410046 618 22.590076 imi_mug_run_2_treatment "statin" "mediated" "ezetimibe"
35 Q0 29313544 619 22.555279 imi_mug_run_2_treatment "phenolics" "fiber" "product"
35 Q0 27098076 620 22.553772 imi_mug_run_2_treatment "statin" "drugs" "alirocumab"
35 Q0 29606415 621 22.469439 imi_mug_run_2_treatment "alirocumab" "atorvastatin" "rosuvastatin"
35 Q0 27625344 622 22.440578 imi_mug_run_2_treatment "statin" "alirocumab" "fenofibrate"
35 Q0 28738813 623 22.400784 imi_mug_run_2_treatment "aha" "statin" "alirocumab"
35 Q0 30293936 624 22.317238 imi_mug_run_2_treatment "plasma"
35 Q0 25282519 625 22.173115 imi_mug_run_2_treatment "evolocumab" "ezetimibe" "plasma"
35 Q0 27680772 626 21.94857 imi_mug_run_2_treatment "plasma"
35 Q0 22155345 627 21.930937 imi_mug_run_2_treatment "plasma"
35 Q0 25679794 628 21.853718 imi_mug_run_2_treatment "statin" "drugs" "level"
35 Q0 30289004 629 21.805141 imi_mug_run_2_treatment "statin" "statins" "ezetimibe"
35 Q0 23884353 630 21.794727 imi_mug_run_2_treatment "statin"
35 Q0 29792380 631 21.517698 imi_mug_run_2_treatment "statins" "mediated" "statin"
35 Q0 23913122 632 21.424713 imi_mug_run_2_treatment "mipomersen" "statins" "lomitapide"
35 Q0 21868016 633 21.092278 imi_mug_run_2_treatment "adhs" "plasma"
35 Q0 26278513 634 21.07028 imi_mug_run_2_treatment "medication" "alirocumab" "statin"
35 Q0 28156151 635 20.954098 imi_mug_run_2_treatment "various" "calcium" "aha"
35 Q0 24002899 636 20.929087 imi_mug_run_2_treatment "drugs" "plasma" "drug"
35 Q0 27878791 637 20.903786 imi_mug_run_2_treatment "statin" "statins" "medicines"
35 Q0 26652782 638 20.85734 imi_mug_run_2_treatment "alirocumab" "drug" "statin"
35 Q0 30233497 639 20.818913 imi_mug_run_2_treatment "hypolipidemic drugs" "statins" "natural thyroid"
35 Q0 30464416 640 20.713062 imi_mug_run_2_treatment "evolocumab" "drug" "statins"
35 Q0 27739219 641 20.575024 imi_mug_run_2_treatment "therapeutics"
35 Q0 30257549 642 20.458426 imi_mug_run_2_treatment "alirocumab" "statin"
35 Q0 29455203 643 20.386501 imi_mug_run_2_treatment "mitotempo" "animals" "oxygen"
35 Q0 26653256 644 20.355675 imi_mug_run_2_treatment "statins" "ezetimibe"
35 Q0 30317988 645 20.19528 imi_mug_run_2_treatment "oestrogens" "niacin" "tibolone"
35 Q0 17550346 646 20.17642 imi_mug_run_2_treatment "enzyme digestion"
35 Q0 26318398 647 20.14074 imi_mug_run_2_treatment "statins" "level" "aim"
35 Q0 27430233 648 20.14074 imi_mug_run_2_treatment "nicotinic acid" "fibrates" "drugs"
35 Q0 29544724 649 20.075848 imi_mug_run_2_treatment "evolocumab" "mediated"
35 Q0 27839699 650 20.070177 imi_mug_run_2_treatment "drug" "statin" "lomitapide"
35 Q0 28502508 651 20.061945 imi_mug_run_2_treatment "plasma"
35 Q0 25813802 652 19.975084 imi_mug_run_2_treatment "monoclonal antibodies"
35 Q0 27497240 653 19.96605 imi_mug_run_2_treatment "others"
35 Q0 27668059 654 19.891521 imi_mug_run_2_treatment "pcsk9 inhibitor" "alirocumab" "praluent"
35 Q0 25881720 655 19.770664 imi_mug_run_2_treatment "orphan drugs" "statin" "new drugs"
35 Q0 27206948 656 19.629395 imi_mug_run_2_treatment "mtp" "plasma"
35 Q0 23669246 657 19.61619 imi_mug_run_2_treatment "aim"
35 Q0 26868195 658 19.537186 imi_mug_run_2_treatment "evolocumab" "ezetimibe" "drugs"
35 Q0 26802983 659 19.161465 imi_mug_run_2_treatment "sitosterol" "phytosterols" "aim"
35 Q0 30017729 660 19.101341 imi_mug_run_2_treatment "statins" "ezetimibe"
35 Q0 25257074 661 19.030556 imi_mug_run_2_treatment "mipomersen" "lomitapide" "monoclonal antibodies"
35 Q0 25889601 662 18.801565 imi_mug_run_2_treatment "enzymes" "testosterone" "liver"
35 Q0 23141813 663 18.801565 imi_mug_run_2_treatment "statin" "ezetimibe"
35 Q0 28434482 664 18.683735 imi_mug_run_2_treatment "combinations" "plasma" "statin"
35 Q0 23806330 665 18.678486 imi_mug_run_2_treatment "adenosine" "pge2" "nmda"
35 Q0 17570373 666 18.626781 imi_mug_run_2_treatment "plasma" "mtp" "liver"
35 Q0 21874758 667 18.626781 imi_mug_run_2_treatment "mtp" "drugs" "aim"
35 Q0 24255061 668 18.605158 imi_mug_run_2_treatment "evolocumab" "duration"
35 Q0 26524671 669 18.59048 imi_mug_run_2_treatment "canakinumab" "monoclonal antibodies" "anti-inflammatory"
35 Q0 27151464 670 18.545258 imi_mug_run_2_treatment "combinations" "statins" "fibrates"
35 Q0 27456066 671 18.442606 imi_mug_run_2_treatment "statins" "ezetimibe" "medications"
35 Q0 22794791 672 18.416893 imi_mug_run_2_treatment "estrogen" "progestin" "coagulation factor xiii"
35 Q0 30309697 673 18.363422 imi_mug_run_2_treatment "monacolin k" "statins" "yeast"
35 Q0 26749708 674 18.245857 imi_mug_run_2_treatment "statin" "ezetimibe" "bile acid sequestrants"
35 Q0 26370210 675 18.205173 imi_mug_run_2_treatment "alirocumab" "liver" "pharmaceuticals"
35 Q0 29725996 676 18.161604 imi_mug_run_2_treatment "alirocumab" "mediated" "statin"
35 Q0 30025648 677 18.137985 imi_mug_run_2_treatment "alirocumab" "ezetimibe"
35 Q0 27669716 678 17.579393 imi_mug_run_2_treatment "alirocumab"
35 Q0 30310462 679 17.53674 imi_mug_run_2_treatment "drugs"
35 Q0 28745604 680 17.435362 imi_mug_run_2_treatment "drug"
35 Q0 28115017 681 17.413837 imi_mug_run_2_treatment "aha" "alirocumab" "evolocumab"
35 Q0 30385871 682 16.948782 imi_mug_run_2_treatment "triciribine" "drug" "mevastatin"
35 Q0 18537526 683 16.915752 imi_mug_run_2_treatment "drugs" "combinations" "fibrates"
35 Q0 29503409 684 16.915752 imi_mug_run_2_treatment "statins" "drugs" "statin"
35 Q0 16415294 685 16.874023 imi_mug_run_2_treatment "agonist"
35 Q0 25484037 686 16.874023 imi_mug_run_2_treatment "human immunoglobulin"
35 Q0 24825642 687 16.860092 imi_mug_run_2_treatment "statin" "atorvastatin" "rosuvastatin"
35 Q0 30014724 688 16.825546 imi_mug_run_2_treatment "evolocumab" "drug" "statins"
35 Q0 28215937 689 16.71082 imi_mug_run_2_treatment "evolocumab" "influenza" "statins"
35 Q0 27312021 690 16.69775 imi_mug_run_2_treatment "statin" "statins" "drugs"
35 Q0 30458964 691 16.62955 imi_mug_run_2_treatment "statin"
35 Q0 24001780 692 16.510923 imi_mug_run_2_treatment "plasma"
35 Q0 28674132 693 16.428213 imi_mug_run_2_treatment "mace" "fibrates" "pcsk9 inhibitor"
35 Q0 29424317 694 16.428213 imi_mug_run_2_treatment "enzymes" "drugs" "statins"
35 Q0 22923420 695 16.096457 imi_mug_run_2_treatment "pooled"
35 Q0 28341307 696 15.955549 imi_mug_run_2_treatment "evolocumab" "statins"
35 Q0 24662398 697 15.4721775 imi_mug_run_2_treatment "evolocumab" "statin"
35 Q0 28291870 698 15.203726 imi_mug_run_2_treatment "level" "evolocumab" "duration"
35 Q0 24953393 699 15.153978 imi_mug_run_2_treatment "aha" "statins" "drugs"
35 Q0 25542072 700 15.148113 imi_mug_run_2_treatment "protease" "mipomersen" "antisense oligonucleotide"
35 Q0 29980053 701 15.148113 imi_mug_run_2_treatment "statin" "ezetimibe" "level"
35 Q0 29183623 702 15.134711 imi_mug_run_2_treatment "plasma" "mediated" "basis"
35 Q0 25185437 703 15.017752 imi_mug_run_2_treatment "new drugs"
35 Q0 29078037 704 14.752327 imi_mug_run_2_treatment "atorvastatin" "atorvastatin 40 mg"
35 Q0 27639753 705 14.729111 imi_mug_run_2_treatment "alirocumab" "statin" "statins"
35 Q0 21741043 706 14.723852 imi_mug_run_2_treatment "statins" "antihypertensive drug" "statin"
35 Q0 27631189 707 14.723852 imi_mug_run_2_treatment "rosuvastatin" "drug" "statin"
35 Q0 29353227 708 14.723852 imi_mug_run_2_treatment "ezetimibe" "sitosterol" "aim"
35 Q0 28488460 709 14.687599 imi_mug_run_2_treatment "evolocumab" "various" "statins"
35 Q0 26520899 710 14.645168 imi_mug_run_2_treatment "glucose" "berberine" "animals"
35 Q0 25037695 711 14.553702 imi_mug_run_2_treatment "alirocumab" "ezetimibe" "statins"
35 Q0 28994502 712 14.046491 imi_mug_run_2_treatment "poststatin" "statins" "alirocumab"
35 Q0 29260404 713 13.134487 imi_mug_run_2_treatment "statin" "statins" "ezetimibe"
35 Q0 27026748 714 12.800746 imi_mug_run_2_treatment "statins"
35 Q0 24566256 715 12.277789 imi_mug_run_2_treatment "drug" "liver" "drugs"
36 Q0 22379889 1 80.358284 imi_mug_run_2_treatment "basis"
36 Q0 27617148 2 78.642136 imi_mug_run_2_treatment "various"
36 Q0 10484981 3 78.01015 imi_mug_run_2_treatment "various" "ile" "lys"
36 Q0 7783166 4 77.714096 imi_mug_run_2_treatment "gly"
36 Q0 10660104 5 73.85242 imi_mug_run_2_treatment "suppressor"
36 Q0 30196175 6 72.63728 imi_mug_run_2_treatment "bevacizumab" "alkylating agents"
36 Q0 26818906 7 70.81795 imi_mug_run_2_treatment "various"
36 Q0 23484829 8 69.88432 imi_mug_run_2_treatment "suppressor"
36 Q0 11027425 9 68.69304 imi_mug_run_2_treatment "basis"
36 Q0 28911001 10 68.61393 imi_mug_run_2_treatment "prd"
36 Q0 15342977 11 67.585754 imi_mug_run_2_treatment "prenatal"
36 Q0 24775443 12 67.5302 imi_mug_run_2_treatment "basis"
36 Q0 26833171 13 66.58975 imi_mug_run_2_treatment "silver"
36 Q0 23667851 14 66.104324 imi_mug_run_2_treatment "various"
36 Q0 28772286 15 66.00703 imi_mug_run_2_treatment "lead"
36 Q0 30076369 16 65.67254 imi_mug_run_2_treatment "ado"
36 Q0 25226867 17 65.62346 imi_mug_run_2_treatment "arginine"
36 Q0 9242456 18 65.5879 imi_mug_run_2_treatment "others"
36 Q0 10617473 19 64.898346 imi_mug_run_2_treatment "yeast"
36 Q0 21484931 20 64.381 imi_mug_run_2_treatment "lead"
36 Q0 26014290 21 64.27421 imi_mug_run_2_treatment "sts" "aim"
36 Q0 30137042 22 64.201744 imi_mug_run_2_treatment "temozolomide"
36 Q0 11520573 23 63.974007 imi_mug_run_2_treatment "others"
36 Q0 26823150 24 63.846214 imi_mug_run_2_treatment "lead"
36 Q0 10206274 25 62.911713 imi_mug_run_2_treatment "yeast"
36 Q0 21601526 26 62.847725 imi_mug_run_2_treatment "ci 4"
36 Q0 23587008 27 62.801136 imi_mug_run_2_treatment "suppressor"
36 Q0 26793489 28 62.368977 imi_mug_run_2_treatment "anti-androgens"
36 Q0 29070607 29 62.09739 imi_mug_run_2_treatment "aim"
36 Q0 12076704 30 62.005966 imi_mug_run_2_treatment "gln" "leu" "aim"
36 Q0 12885464 31 61.827217 imi_mug_run_2_treatment "product"
36 Q0 23950206 32 61.695942 imi_mug_run_2_treatment "lapatinib"
36 Q0 29189820 33 61.11812 imi_mug_run_2_treatment "metrics"
36 Q0 27984644 34 60.39586 imi_mug_run_2_treatment "others"
36 Q0 11719428 35 60.35877 imi_mug_run_2_treatment "proteosome inhibitor"
36 Q0 12584563 36 59.904762 imi_mug_run_2_treatment "mediated" "aim"
36 Q0 12710683 37 59.621128 imi_mug_run_2_treatment "others"
36 Q0 19012332 38 59.52697 imi_mug_run_2_treatment "favor"
36 Q0 25821471 39 59.11773 imi_mug_run_2_treatment "liver"
36 Q0 22691290 40 58.945663 imi_mug_run_2_treatment "mediated"
36 Q0 12127401 41 58.50924 imi_mug_run_2_treatment "basis"
36 Q0 22920207 42 58.225616 imi_mug_run_2_treatment "various"
36 Q0 8869100 43 58.012196 imi_mug_run_2_treatment "basis"
36 Q0 12181637 44 57.85633 imi_mug_run_2_treatment "basis"
36 Q0 22392042 45 57.842667 imi_mug_run_2_treatment "combinations" "her-2"
36 Q0 18511570 46 57.820457 imi_mug_run_2_treatment "lead"
36 Q0 29237527 47 57.575886 imi_mug_run_2_treatment "rms"
36 Q0 25313051 48 57.30205 imi_mug_run_2_treatment "basis"
36 Q0 23175693 49 56.79013 imi_mug_run_2_treatment "various"
36 Q0 15695383 50 56.705 imi_mug_run_2_treatment "genesis"
36 Q0 19378321 51 56.562626 imi_mug_run_2_treatment "level"
36 Q0 8649785 52 56.23256 imi_mug_run_2_treatment "leucine"
36 Q0 16772121 53 56.057785 imi_mug_run_2_treatment "others"
36 Q0 7966399 54 56.01389 imi_mug_run_2_treatment "basis"
36 Q0 23172776 55 55.798824 imi_mug_run_2_treatment "basis" "level"
36 Q0 25588929 56 55.59921 imi_mug_run_2_treatment "pmm" "adjuvant"
36 Q0 21311097 57 55.578724 imi_mug_run_2_treatment "mediated" "prima-1"
36 Q0 21535297 58 55.44431 imi_mug_run_2_treatment "aim"
36 Q0 27516001 59 55.1513 imi_mug_run_2_treatment "hot spot"
36 Q0 29746440 60 55.018303 imi_mug_run_2_treatment "lead"
36 Q0 27869650 61 54.96664 imi_mug_run_2_treatment "metformin" "lead"
36 Q0 9018113 62 54.867092 imi_mug_run_2_treatment "duration"
36 Q0 29945152 63 54.684612 imi_mug_run_2_treatment "prophylactic"
36 Q0 15381368 64 54.605812 imi_mug_run_2_treatment "various"
36 Q0 20605095 65 54.411896 imi_mug_run_2_treatment "imidazole" "suppressor" "histidine"
36 Q0 9681828 66 53.65451 imi_mug_run_2_treatment "yeast"
36 Q0 23056559 67 52.84208 imi_mug_run_2_treatment "plasma" "antioxidant" "ascorbic acid"
36 Q0 16033918 68 52.647766 imi_mug_run_2_treatment "histidine"
36 Q0 25981898 69 52.54512 imi_mug_run_2_treatment "various" "adjuvant" "cytotoxic"
36 Q0 28421271 70 52.26909 imi_mug_run_2_treatment "lead"
36 Q0 9067756 71 52.17724 imi_mug_run_2_treatment "various"
36 Q0 19046423 72 51.932854 imi_mug_run_2_treatment "suppressor"
36 Q0 19127115 73 51.892227 imi_mug_run_2_treatment "various" "histidine"
36 Q0 25223899 74 51.454456 imi_mug_run_2_treatment "favor"
36 Q0 29300620 75 51.421104 imi_mug_run_2_treatment "basis"
36 Q0 23612572 76 51.36498 imi_mug_run_2_treatment "aim" "suppressor"
36 Q0 26403419 77 51.312164 imi_mug_run_2_treatment "basis"
36 Q0 8500101 78 51.29809 imi_mug_run_2_treatment "various"
36 Q0 22653678 79 51.139282 imi_mug_run_2_treatment "rms"
36 Q0 21837677 80 51.055107 imi_mug_run_2_treatment "program"
36 Q0 24642672 81 50.584843 imi_mug_run_2_treatment "suppressor"
36 Q0 29406000 82 50.5061 imi_mug_run_2_treatment "glucocorticoids"
36 Q0 23015295 83 48.907406 imi_mug_run_2_treatment "program"
36 Q0 19714488 84 48.793114 imi_mug_run_2_treatment "various"
36 Q0 22265402 85 48.793114 imi_mug_run_2_treatment "shh" "basis"
36 Q0 11461092 86 48.735558 imi_mug_run_2_treatment "dsb" "level"
36 Q0 28988289 87 48.46192 imi_mug_run_2_treatment "lead"
36 Q0 24764719 88 48.142868 imi_mug_run_2_treatment "adjuvant" "radioactive iodine"
36 Q0 15977174 89 47.795616 imi_mug_run_2_treatment "drug" "thioredoxin" "oxygen"
36 Q0 30192230 90 47.570595 imi_mug_run_2_treatment "animals"
36 Q0 9704919 91 47.219566 imi_mug_run_2_treatment "mediated" "product" "level"
36 Q0 30004834 92 47.09084 imi_mug_run_2_treatment "various"
36 Q0 23259501 93 46.2808 imi_mug_run_2_treatment "dbd"
36 Q0 21060032 94 46.03585 imi_mug_run_2_treatment "drugs" "level"
36 Q0 26232255 95 45.79423 imi_mug_run_2_treatment "drugs" "suppressor"
36 Q0 23292496 96 45.41484 imi_mug_run_2_treatment "therapeutics" "level"
36 Q0 24382691 97 45.344204 imi_mug_run_2_treatment "rms"
36 Q0 17505880 98 44.4974 imi_mug_run_2_treatment "lead"
36 Q0 21343334 99 44.038597 imi_mug_run_2_treatment "yeast"
36 Q0 22507745 100 43.591034 imi_mug_run_2_treatment "basis"
36 Q0 11461078 101 43.169167 imi_mug_run_2_treatment "ile" "thr" "product"
36 Q0 22170717 102 43.03208 imi_mug_run_2_treatment "hot spot" "aim"
36 Q0 28499267 103 42.94387 imi_mug_run_2_treatment "aim"
36 Q0 23571737 104 42.88415 imi_mug_run_2_treatment "basis"
36 Q0 28861920 105 42.672577 imi_mug_run_2_treatment "aim"
36 Q0 24702488 106 42.48654 imi_mug_run_2_treatment "basis"
36 Q0 10486318 107 42.380722 imi_mug_run_2_treatment "others"
36 Q0 26628864 108 42.204594 imi_mug_run_2_treatment "basis"
36 Q0 29313943 109 42.178833 imi_mug_run_2_treatment "anonymous"
36 Q0 27551116 110 42.080177 imi_mug_run_2_treatment "bisulfite"
36 Q0 16237564 111 41.722683 imi_mug_run_2_treatment "basis"
36 Q0 24810334 112 41.678024 imi_mug_run_2_treatment "level"
36 Q0 29324801 113 41.583115 imi_mug_run_2_treatment "lead"
36 Q0 18248785 114 41.464333 imi_mug_run_2_treatment "program"
36 Q0 28124295 115 41.421696 imi_mug_run_2_treatment "program" "others"
36 Q0 29572430 116 41.351196 imi_mug_run_2_treatment "mercapturic acid"
36 Q0 24835218 117 41.28136 imi_mug_run_2_treatment "afatinib"
36 Q0 17606709 118 41.229534 imi_mug_run_2_treatment "yeast"
36 Q0 16586494 119 40.911423 imi_mug_run_2_treatment "lead"
36 Q0 29529297 120 40.8358 imi_mug_run_2_treatment "various"
36 Q0 17096342 121 40.524376 imi_mug_run_2_treatment "level"
36 Q0 9724087 122 40.396065 imi_mug_run_2_treatment "kinase inhibitor" "fmm"
36 Q0 21317445 123 39.91735 imi_mug_run_2_treatment "basis"
36 Q0 25201186 124 39.609055 imi_mug_run_2_treatment "balance"
36 Q0 24449472 125 39.587105 imi_mug_run_2_treatment "suppressor"
36 Q0 19127094 126 39.45914 imi_mug_run_2_treatment "ile"
36 Q0 28356770 127 39.333168 imi_mug_run_2_treatment "trastuzumab"
36 Q0 28369373 128 39.277058 imi_mug_run_2_treatment "yeast"
36 Q0 21761402 129 38.992523 imi_mug_run_2_treatment "lead"
36 Q0 29775997 130 38.98265 imi_mug_run_2_treatment "amp"
36 Q0 18348649 131 38.53256 imi_mug_run_2_treatment "animals"
36 Q0 17572079 132 38.424553 imi_mug_run_2_treatment "terminator" "polyacrylamide gel" "aim"
36 Q0 23714463 133 37.855404 imi_mug_run_2_treatment "succinate" "lead" "tca"
36 Q0 18068537 134 36.994686 imi_mug_run_2_treatment "prenatal" "program"
36 Q0 25184754 135 36.994095 imi_mug_run_2_treatment "aristolochic acid" "hot spot"
36 Q0 27663983 136 36.750473 imi_mug_run_2_treatment "suppressor"
36 Q0 15908567 137 36.60541 imi_mug_run_2_treatment "suppressor"
36 Q0 27229128 138 36.326973 imi_mug_run_2_treatment "lead" "shh" "shape"
36 Q0 29564828 139 36.141796 imi_mug_run_2_treatment "mediated"
36 Q0 21192060 140 35.902733 imi_mug_run_2_treatment "histidine"
36 Q0 30268473 141 35.343292 imi_mug_run_2_treatment "stas" "basis"
36 Q0 28405782 142 35.185917 imi_mug_run_2_treatment "basis"
36 Q0 26662151 143 35.020172 imi_mug_run_2_treatment "imatinib"
36 Q0 30092803 144 34.950302 imi_mug_run_2_treatment "various" "medicine" "program"
36 Q0 11102977 145 34.93645 imi_mug_run_2_treatment "favor"
36 Q0 29077933 146 34.93645 imi_mug_run_2_treatment "lgg"
36 Q0 30072235 147 34.259228 imi_mug_run_2_treatment "topoisomerase inhibitor" "etoposide" "docetaxel"
36 Q0 17082810 148 34.027523 imi_mug_run_2_treatment "various" "adrenocorticotropic hormone" "cyclic amp"
36 Q0 12853350 149 33.98514 imi_mug_run_2_treatment "platinum"
36 Q0 19068395 150 33.97997 imi_mug_run_2_treatment "therapeutics" "igf-ii"
36 Q0 19150414 151 33.97997 imi_mug_run_2_treatment "various" "basis"
36 Q0 20704938 152 33.97997 imi_mug_run_2_treatment "various" "basis"
36 Q0 24232458 153 33.82705 imi_mug_run_2_treatment "therapeutic agents"
36 Q0 21741598 154 33.505165 imi_mug_run_2_treatment "ras" "program"
36 Q0 25634217 155 33.017563 imi_mug_run_2_treatment "pge2" "estrogens" "prostaglandin e2"
36 Q0 11328534 156 32.81332 imi_mug_run_2_treatment "color"
36 Q0 15942682 157 32.39098 imi_mug_run_2_treatment "product"
36 Q0 19027287 158 32.096992 imi_mug_run_2_treatment "adjuvant"
36 Q0 22864638 159 32.09574 imi_mug_run_2_treatment "suppressor"
36 Q0 26189108 160 32.05274 imi_mug_run_2_treatment "ras"
36 Q0 16189167 161 31.68856 imi_mug_run_2_treatment "lead" "igf-ii"
36 Q0 18204794 162 30.792942 imi_mug_run_2_treatment "malathion" "estrogens" "estrogen"
36 Q0 27387247 163 30.408138 imi_mug_run_2_treatment "adjuvant" "mitotane" "igf2"
36 Q0 18381604 164 29.264002 imi_mug_run_2_treatment "basis"
36 Q0 21374038 165 28.011654 imi_mug_run_2_treatment "cytostatics"
36 Q0 23435420 166 27.937746 imi_mug_run_2_treatment "dsb"
36 Q0 15526362 167 27.862602 imi_mug_run_2_treatment "various" "level" "aim"
36 Q0 26447779 168 27.598408 imi_mug_run_2_treatment "medicine" "mediated"
36 Q0 27074562 169 27.56666 imi_mug_run_2_treatment "mediated" "committed"
36 Q0 22313596 170 27.12809 imi_mug_run_2_treatment "lgg" "level"
36 Q0 28608266 171 26.799332 imi_mug_run_2_treatment "radium"
36 Q0 7718890 172 25.970625 imi_mug_run_2_treatment "mediated"
36 Q0 25098371 173 25.698189 imi_mug_run_2_treatment "l-leucine" "basis" "suppressor"
36 Q0 16448432 174 25.34203 imi_mug_run_2_treatment "yeast" "therapeutic agents" "aim"
36 Q0 28359080 175 25.066301 imi_mug_run_2_treatment "tmz" "lithium" "temozolomide"
36 Q0 19701813 176 24.952028 imi_mug_run_2_treatment "androgens"
36 Q0 23297687 177 24.589087 imi_mug_run_2_treatment "azacitidine"
36 Q0 22933333 178 24.589087 imi_mug_run_2_treatment "lenalidomide"
36 Q0 27907203 179 24.357996 imi_mug_run_2_treatment "aim"
36 Q0 17019046 180 24.065762 imi_mug_run_2_treatment "nervous system" "genesis"
36 Q0 15942101 181 23.603611 imi_mug_run_2_treatment "cyclosporine a" "histidine" "melphalan"
36 Q0 10741273 182 23.28815 imi_mug_run_2_treatment "interferon-alpha" "aspirin" "captopril"
36 Q0 21786572 183 22.929708 imi_mug_run_2_treatment "iga" "duration" "aim"
36 Q0 9401801 184 22.878883 imi_mug_run_2_treatment "various" "level"
36 Q0 27984642 185 22.146141 imi_mug_run_2_treatment "decitabine"
36 Q0 19797731 186 21.979843 imi_mug_run_2_treatment "lenalidomide"
36 Q0 29484684 187 21.979843 imi_mug_run_2_treatment "ibrutinib"
36 Q0 15257941 188 21.94885 imi_mug_run_2_treatment "tandem"
36 Q0 16116609 189 21.924892 imi_mug_run_2_treatment "level"
36 Q0 27418648 190 21.816872 imi_mug_run_2_treatment "mpl"
36 Q0 28687222 191 21.649801 imi_mug_run_2_treatment "azacitidine" "busulfan" "fludarabine"
36 Q0 28527473 192 21.474586 imi_mug_run_2_treatment "others"
36 Q0 28177873 193 21.467312 imi_mug_run_2_treatment "ras" "others" "allogeneic"
36 Q0 30501707 194 21.0159 imi_mug_run_2_treatment "decitabine"
36 Q0 25092778 195 20.9606 imi_mug_run_2_treatment "allogeneic"
36 Q0 23702729 196 20.620058 imi_mug_run_2_treatment "sucrose"
36 Q0 27157990 197 20.59251 imi_mug_run_2_treatment "sham"
36 Q0 24115570 198 20.512878 imi_mug_run_2_treatment "shh"
36 Q0 29860059 199 20.458927 imi_mug_run_2_treatment "aim"
36 Q0 12066196 200 20.423943 imi_mug_run_2_treatment "adjuvant"
36 Q0 28910164 201 20.213482 imi_mug_run_2_treatment "level" "suppressor"
36 Q0 24493299 202 20.127958 imi_mug_run_2_treatment "color"
36 Q0 21889780 203 20.03096 imi_mug_run_2_treatment "others"
36 Q0 8622078 204 19.93982 imi_mug_run_2_treatment "tamoxifen" "adjuvant"
36 Q0 9365836 205 19.829046 imi_mug_run_2_treatment "others"
36 Q0 29424427 206 19.675896 imi_mug_run_2_treatment "vaccines"
36 Q0 26075044 207 19.53672 imi_mug_run_2_treatment "drug" "l-leucine" "lenalidomide"
36 Q0 27619989 208 19.5216 imi_mug_run_2_treatment "favor"
36 Q0 27448281 209 19.490702 imi_mug_run_2_treatment "crest"
36 Q0 26891131 210 19.480078 imi_mug_run_2_treatment "new drugs"
36 Q0 16362795 211 19.479546 imi_mug_run_2_treatment "arginine"
36 Q0 14732923 212 19.054165 imi_mug_run_2_treatment "ras" "tandem"
36 Q0 12939657 213 18.961073 imi_mug_run_2_treatment "sam"
36 Q0 22661500 214 18.960796 imi_mug_run_2_treatment "oxygen" "level"
36 Q0 26688096 215 18.887852 imi_mug_run_2_treatment "lenalidomide"
36 Q0 28222777 216 18.84333 imi_mug_run_2_treatment "level"
36 Q0 22384858 217 18.65466 imi_mug_run_2_treatment "various" "level" "suppressor"
36 Q0 21719884 218 18.500837 imi_mug_run_2_treatment "lenalidomide"
36 Q0 29696793 219 18.365692 imi_mug_run_2_treatment "lead"
36 Q0 20829611 220 18.341162 imi_mug_run_2_treatment "various" "acth" "others"
36 Q0 30483911 221 18.32119 imi_mug_run_2_treatment "gnrh agonist" "gnrh antagonist"
36 Q0 27342034 222 18.020584 imi_mug_run_2_treatment "level"
36 Q0 8909797 223 18.009962 imi_mug_run_2_treatment "ras" "duration"
36 Q0 12112314 224 17.99263 imi_mug_run_2_treatment "androgen" "histidine"
36 Q0 28549767 225 17.98126 imi_mug_run_2_treatment "various" "ibrutinib" "venetoclax"
36 Q0 24014297 226 17.917212 imi_mug_run_2_treatment "rituximab"
36 Q0 22931676 227 17.776451 imi_mug_run_2_treatment "ras"
36 Q0 28994094 228 17.616257 imi_mug_run_2_treatment "quantum" "aim"
36 Q0 16353134 229 17.612806 imi_mug_run_2_treatment "arginine"
36 Q0 18493137 230 17.611454 imi_mug_run_2_treatment "acth" "adrenocorticotropin" "cortisol"
36 Q0 28460341 231 17.599392 imi_mug_run_2_treatment "prophylactic"
36 Q0 24668897 232 17.493908 imi_mug_run_2_treatment "insulin"
36 Q0 27967292 233 17.493908 imi_mug_run_2_treatment "therapeutics" "lenalidomide"
36 Q0 19731080 234 17.449905 imi_mug_run_2_treatment "lead"
36 Q0 17630856 235 17.426273 imi_mug_run_2_treatment "etoposide" "mediated" "agent"
36 Q0 15725922 236 17.389137 imi_mug_run_2_treatment "alkaloid" "cyclopamine" "shh"
36 Q0 23762142 237 17.378052 imi_mug_run_2_treatment "aim"
36 Q0 30431463 238 17.340069 imi_mug_run_2_treatment "mediated"
36 Q0 25218362 239 17.315304 imi_mug_run_2_treatment "kinase inhibitor" "nucleoside analogue" "alkylator"
36 Q0 28279036 240 17.287899 imi_mug_run_2_treatment "decitabine"
36 Q0 21177507 241 17.25066 imi_mug_run_2_treatment "various combinations"
36 Q0 21056402 242 17.127052 imi_mug_run_2_treatment "mediated"
36 Q0 28484169 243 17.127052 imi_mug_run_2_treatment "aza" "azacitidine" "decitabine"
36 Q0 12175309 244 17.076397 imi_mug_run_2_treatment "cytotoxic"
36 Q0 24349281 245 17.076397 imi_mug_run_2_treatment "icc"
36 Q0 27040710 246 16.929419 imi_mug_run_2_treatment "rituximab"
36 Q0 24421328 247 16.929419 imi_mug_run_2_treatment "platinum"
36 Q0 23779253 248 16.860199 imi_mug_run_2_treatment "lead"
36 Q0 26647899 249 16.808449 imi_mug_run_2_treatment "ipilimumab" "antihistamines" "corticoids"
36 Q0 26806497 250 16.784046 imi_mug_run_2_treatment "lenalidomide"
36 Q0 19690970 251 16.673265 imi_mug_run_2_treatment "igf1"
36 Q0 23089923 252 16.494192 imi_mug_run_2_treatment "lead" "aim"
36 Q0 24832557 253 16.494192 imi_mug_run_2_treatment "tma"
36 Q0 27742070 254 16.461243 imi_mug_run_2_treatment "rituximab"
36 Q0 14561707 255 16.424944 imi_mug_run_2_treatment "insulin"
36 Q0 16965957 256 16.180906 imi_mug_run_2_treatment "genesis"
36 Q0 27023522 257 16.105688 imi_mug_run_2_treatment "mpl" "ras" "agent"
36 Q0 10639595 258 16.064627 imi_mug_run_2_treatment "others"
36 Q0 27407063 259 15.867504 imi_mug_run_2_treatment "fludarabine"
36 Q0 10381517 260 15.795772 imi_mug_run_2_treatment "various"
36 Q0 25811676 261 15.758112 imi_mug_run_2_treatment "lenalidomide"
36 Q0 24747643 262 15.715752 imi_mug_run_2_treatment "cortisol" "others"
36 Q0 23633543 263 15.476734 imi_mug_run_2_treatment "rituximab"
36 Q0 16762487 264 15.436102 imi_mug_run_2_treatment "aim"
36 Q0 29660202 265 15.426538 imi_mug_run_2_treatment "lead"
36 Q0 29692342 266 15.390278 imi_mug_run_2_treatment "dacarbazine" "vinblastine" "adriamycin"
36 Q0 19132118 267 15.335457 imi_mug_run_2_treatment "ras"
36 Q0 30518749 268 15.305561 imi_mug_run_2_treatment "oxygen" "basis" "level"
36 Q0 19206112 269 15.124028 imi_mug_run_2_treatment "prompt"
36 Q0 22538004 270 15.106831 imi_mug_run_2_treatment "tcn" "igf-1"
36 Q0 15086056 271 15.083656 imi_mug_run_2_treatment "ras"
36 Q0 19804904 272 15.083656 imi_mug_run_2_treatment "dasatinib"
36 Q0 26038203 273 15.083656 imi_mug_run_2_treatment "cortisol"
36 Q0 25260319 274 15.069485 imi_mug_run_2_treatment "various"
36 Q0 30097406 275 15.069485 imi_mug_run_2_treatment "lenalidomide"
36 Q0 25775024 276 14.691281 imi_mug_run_2_treatment "ofatumumab" "rituximab" "agent"
36 Q0 24356923 277 14.327058 imi_mug_run_2_treatment "oxygen"
36 Q0 27001309 278 14.309793 imi_mug_run_2_treatment "others"
36 Q0 25224413 279 14.299425 imi_mug_run_2_treatment "aza" "azacitidine" "decitabine"
36 Q0 24004666 280 14.299425 imi_mug_run_2_treatment "lead"
36 Q0 28054536 281 14.299425 imi_mug_run_2_treatment "combinations"
36 Q0 29132872 282 14.287004 imi_mug_run_2_treatment "nrg"
36 Q0 25473022 283 14.245915 imi_mug_run_2_treatment "new drugs" "ras" "poly(adp-ribose) polymerase inhibitors"
36 Q0 27184732 284 14.219835 imi_mug_run_2_treatment "mediated" "aim"
36 Q0 27419369 285 14.046469 imi_mug_run_2_treatment "hmt" "azacitidine" "ras"
36 Q0 26432802 286 13.99475 imi_mug_run_2_treatment "dmso" "level"
36 Q0 25893277 287 13.993425 imi_mug_run_2_treatment "rms" "ras"
36 Q0 29419339 288 13.882941 imi_mug_run_2_treatment "aim" "level"
36 Q0 24627193 289 13.849413 imi_mug_run_2_treatment "lenalidomide" "immunomodulatory agent"
36 Q0 26651421 290 13.849413 imi_mug_run_2_treatment "various" "aza" "azacitidine"
36 Q0 11073960 291 13.839335 imi_mug_run_2_treatment "various"
36 Q0 26883102 292 13.8276825 imi_mug_run_2_treatment "ras"
36 Q0 27378086 293 13.597322 imi_mug_run_2_treatment "ofatumumab" "cyclophosphamide" "prednisolone"
36 Q0 12781455 294 13.4471445 imi_mug_run_2_treatment "retinoid"
36 Q0 23910806 295 13.370506 imi_mug_run_2_treatment "rms"
36 Q0 11087658 296 13.34488 imi_mug_run_2_treatment "basis"
36 Q0 28643044 297 13.332083 imi_mug_run_2_treatment "agent"
36 Q0 28429724 298 13.322453 imi_mug_run_2_treatment "lenalidomide"
36 Q0 30352907 299 13.322453 imi_mug_run_2_treatment "ras" "basis"
36 Q0 30314823 300 13.31999 imi_mug_run_2_treatment "acth"
36 Q0 25603477 301 13.218718 imi_mug_run_2_treatment "azacitidine" "decitabine" "com"
36 Q0 27121473 302 13.17205 imi_mug_run_2_treatment "basis"
36 Q0 27465399 303 13.162195 imi_mug_run_2_treatment "lead" "level"
36 Q0 30001986 304 13.143999 imi_mug_run_2_treatment "lirilumab" "azacitidine" "agent"
36 Q0 10828595 305 13.001789 imi_mug_run_2_treatment "suppressor" "anonymous"
36 Q0 29618722 306 13.001789 imi_mug_run_2_treatment "others"
36 Q0 23961875 307 12.974213 imi_mug_run_2_treatment "methylated" "osm"
36 Q0 23873701 308 12.958265 imi_mug_run_2_treatment "various"
36 Q0 25134314 309 12.958265 imi_mug_run_2_treatment "drug" "vismodegib"
36 Q0 27989630 310 12.958265 imi_mug_run_2_treatment "others"
36 Q0 29246451 311 12.940487 imi_mug_run_2_treatment "various"
36 Q0 21657155 312 12.940487 imi_mug_run_2_treatment "various"
36 Q0 17406026 313 12.931229 imi_mug_run_2_treatment "mediated" "basis" "aim"
36 Q0 28476018 314 12.924689 imi_mug_run_2_treatment "aim"
36 Q0 28432562 315 12.908864 imi_mug_run_2_treatment "acth"
36 Q0 28877066 316 12.61044 imi_mug_run_2_treatment "basis"
36 Q0 29881993 317 12.550274 imi_mug_run_2_treatment "various"
36 Q0 21837511 318 12.390848 imi_mug_run_2_treatment "level"
36 Q0 20448188 319 12.390848 imi_mug_run_2_treatment "liver" "alpha subunit"
36 Q0 29088303 320 12.366401 imi_mug_run_2_treatment "mpl"
36 Q0 22286061 321 12.3575 imi_mug_run_2_treatment "various"
36 Q0 26999444 322 12.3575 imi_mug_run_2_treatment "quinone"
36 Q0 23861036 323 12.346867 imi_mug_run_2_treatment "lead"
36 Q0 25315765 324 12.311677 imi_mug_run_2_treatment "suppressor"
36 Q0 21947821 325 12.311677 imi_mug_run_2_treatment "basis"
36 Q0 27711076 326 12.077357 imi_mug_run_2_treatment "antioxidants"
36 Q0 9305595 327 11.029629 imi_mug_run_2_treatment "tandem"
36 Q0 17163520 328 11.029629 imi_mug_run_2_treatment "various"
36 Q0 12011941 329 11.029629 imi_mug_run_2_treatment "acth" "aim" "others"
36 Q0 22289496 330 11.029629 imi_mug_run_2_treatment "decitabine" "azacytidine" "cytotoxic"
36 Q0 9088032 331 11.008705 imi_mug_run_2_treatment "androgen" "basis"
36 Q0 27799065 332 11.008705 imi_mug_run_2_treatment "pdx" "temsirolimus"
36 Q0 9389568 333 10.997857 imi_mug_run_2_treatment "isoleucine" "methionine"
36 Q0 12357360 334 10.997857 imi_mug_run_2_treatment "drug" "hydroxyurea" "pipobroman"
36 Q0 26662608 335 10.997857 imi_mug_run_2_treatment "serine" "eosin"
36 Q0 26339619 336 10.997857 imi_mug_run_2_treatment "enzymes"
36 Q0 22759592 337 10.997857 imi_mug_run_2_treatment "cytokines"
36 Q0 29961768 338 10.997857 imi_mug_run_2_treatment "platinum"
36 Q0 29936255 339 10.997857 imi_mug_run_2_treatment "pmp"
36 Q0 30256826 340 10.997857 imi_mug_run_2_treatment "aim"
36 Q0 26477319 341 10.989783 imi_mug_run_2_treatment "drug" "anti-inflammatory" "cddo"
36 Q0 20926690 342 10.989783 imi_mug_run_2_treatment "igf1" "mediated"
36 Q0 11177598 343 10.962946 imi_mug_run_2_treatment "level" "autologous"
36 Q0 23413591 344 10.962946 imi_mug_run_2_treatment "cyclophosphamide" "vincristine" "fludarabine"
36 Q0 27478330 345 10.962946 imi_mug_run_2_treatment "combinations" "various" "basis"
36 Q0 25621498 346 10.575825 imi_mug_run_2_treatment "decitabine" "cytotoxic" "azacytidine"
36 Q0 23104868 347 9.6003685 imi_mug_run_2_treatment "lgg"
36 Q0 28675654 348 9.6003685 imi_mug_run_2_treatment "drugs" "chemotherapy agents" "medicine"
36 Q0 15044915 349 9.58227 imi_mug_run_2_treatment "combinations"
36 Q0 19428366 350 9.58227 imi_mug_run_2_treatment "aristolochic acid" "chinese herbs" "lead"
36 Q0 19958752 351 9.58227 imi_mug_run_2_treatment "alkylating agents"
36 Q0 20298761 352 9.58227 imi_mug_run_2_treatment "salicylate" "drug" "mediated"
36 Q0 10954253 353 9.58227 imi_mug_run_2_treatment "oral contraceptive pill" "various" "contraceptive"
36 Q0 7682102 354 9.58227 imi_mug_run_2_treatment "suppressor"
36 Q0 24498881 355 9.58227 imi_mug_run_2_treatment "others"
36 Q0 24713986 356 9.58227 imi_mug_run_2_treatment "others"
36 Q0 29218851 357 9.58227 imi_mug_run_2_treatment "agent" "venetoclax" "combinations"
36 Q0 28135145 358 9.58227 imi_mug_run_2_treatment "basis"
36 Q0 9816337 359 9.572675 imi_mug_run_2_treatment "various"
36 Q0 14751518 360 9.572675 imi_mug_run_2_treatment "level" "suppressor"
36 Q0 26919320 361 9.565577 imi_mug_run_2_treatment "various"
36 Q0 10719362 362 9.542395 imi_mug_run_2_treatment "rms"
36 Q0 27034802 363 9.542395 imi_mug_run_2_treatment "gemcitabine" "nab-paclitaxel" "level"
36 Q0 25645650 364 9.542395 imi_mug_run_2_treatment "pace"
36 Q0 30025230 365 9.542395 imi_mug_run_2_treatment "aim"
36 Q0 12912958 366 7.9794865 imi_mug_run_2_treatment "ras" "anti-inflammatory" "nonsteroidal anti-inflammatory drugs"
36 Q0 20699695 367 7.9794865 imi_mug_run_2_treatment "nitric oxide" "aim"
36 Q0 29590547 368 7.9543457 imi_mug_run_2_treatment "ibrutinib" "venetoclax" "drugs"
36 Q0 27133825 369 7.881629 imi_mug_run_2_treatment "lenalidomide"
36 Q0 27991718 370 6.2534227 imi_mug_run_2_treatment "mpl" "interferon" "aspirin"
36 Q0 27637985 371 6.248681 imi_mug_run_2_treatment "ibrutinib" "iga" "suppressor"
37 Q0 12920062 1 61.530106 imi_mug_run_2_treatment "aim"
37 Q0 16266469 2 61.11932 imi_mug_run_2_treatment "h2o2"
37 Q0 29349732 3 55.349854 imi_mug_run_2_treatment "basis"
37 Q0 20160190 4 54.341743 imi_mug_run_2_treatment "shape"
37 Q0 24846508 5 53.948654 imi_mug_run_2_treatment "lead"
37 Q0 23044536 6 53.63275 imi_mug_run_2_treatment "blockade"
37 Q0 16981056 7 53.432213 imi_mug_run_2_treatment "aim"
37 Q0 22019351 8 53.0464 imi_mug_run_2_treatment "lysine"
37 Q0 19283854 9 52.74019 imi_mug_run_2_treatment "leucine"
37 Q0 20388542 10 50.50625 imi_mug_run_2_treatment "sp600125" "natriuretic peptide"
37 Q0 19318026 11 48.201912 imi_mug_run_2_treatment "lead"
37 Q0 27457270 12 48.19067 imi_mug_run_2_treatment "plasma" "vitamin-d" "antithrombin-iii"
37 Q0 12854972 13 47.991158 imi_mug_run_2_treatment "lead"
37 Q0 29893868 14 47.921288 imi_mug_run_2_treatment "drugs" "paclitaxel"
37 Q0 21846512 15 47.802982 imi_mug_run_2_treatment "serine"
37 Q0 19167105 16 47.594223 imi_mug_run_2_treatment "lead"
37 Q0 21173351 17 47.401882 imi_mug_run_2_treatment "natriuretic peptide" "protein kinase inhibitors"
37 Q0 22837537 18 47.05778 imi_mug_run_2_treatment "temsirolimus" "rapamycin analog"
37 Q0 30221713 19 46.607155 imi_mug_run_2_treatment "potassium" "lysine" "glutamic acid"
37 Q0 20092787 20 46.482708 imi_mug_run_2_treatment "arginine" "gly" "glycine"
37 Q0 22068161 21 46.073647 imi_mug_run_2_treatment "selumetinib" "natriuretic peptide" "lead"
37 Q0 28294881 22 45.96876 imi_mug_run_2_treatment "various"
37 Q0 14755333 23 45.36677 imi_mug_run_2_treatment "basis" "shape"
37 Q0 10580070 24 44.811325 imi_mug_run_2_treatment "enzyme digestion"
37 Q0 22475360 25 44.77014 imi_mug_run_2_treatment "others"
37 Q0 25218145 26 44.511715 imi_mug_run_2_treatment "selumetinib" "benazepril" "lead"
37 Q0 20019332 27 44.211365 imi_mug_run_2_treatment "carvedilol" "beta-blocker" "aim"
37 Q0 30053027 28 44.089405 imi_mug_run_2_treatment "enzymes" "vitamin b3" "nicotinamide adenine dinucleotide"
37 Q0 19913544 29 43.955265 imi_mug_run_2_treatment "animals"
37 Q0 20041886 30 43.579422 imi_mug_run_2_treatment "others"
37 Q0 18927124 31 43.548695 imi_mug_run_2_treatment "pd98059" "natriuretic peptide"
37 Q0 30105555 32 43.312973 imi_mug_run_2_treatment "lead"
37 Q0 28785654 33 43.259434 imi_mug_run_2_treatment "various"
37 Q0 29386531 34 43.16531 imi_mug_run_2_treatment "basis"
37 Q0 14659775 35 42.88633 imi_mug_run_2_treatment "basis"
37 Q0 15539782 36 42.85931 imi_mug_run_2_treatment "various"
37 Q0 18480576 37 42.828575 imi_mug_run_2_treatment "serpinc1" "antithrombin" "heparin"
37 Q0 23631840 38 42.608215 imi_mug_run_2_treatment "sex hormones" "testosterone" "aim"
37 Q0 27576561 39 42.251022 imi_mug_run_2_treatment "pooled"
37 Q0 12898247 40 42.2011 imi_mug_run_2_treatment "araldite" "silver" "aim"
37 Q0 28874324 41 41.917053 imi_mug_run_2_treatment "lead"
37 Q0 23701190 42 41.782913 imi_mug_run_2_treatment "lead"
37 Q0 29982513 43 41.56142 imi_mug_run_2_treatment "n-acetyl cysteine" "antioxidant"
37 Q0 23575224 44 41.070717 imi_mug_run_2_treatment "level" "mediated" "lead"
37 Q0 25656816 45 41.00012 imi_mug_run_2_treatment "prompt"
37 Q0 22177269 46 40.937786 imi_mug_run_2_treatment "aim"
37 Q0 16247757 47 40.80045 imi_mug_run_2_treatment "product" "level"
37 Q0 22773734 48 40.74227 imi_mug_run_2_treatment "collagen" "arry-371797"
37 Q0 15773758 49 40.737675 imi_mug_run_2_treatment "basis"
37 Q0 21151901 50 40.52263 imi_mug_run_2_treatment "collagen" "b-type natriuretic peptide" "bnp"
37 Q0 21483645 51 40.288322 imi_mug_run_2_treatment "basis"
37 Q0 18926329 52 40.126556 imi_mug_run_2_treatment "aim"
37 Q0 22199124 53 40.092472 imi_mug_run_2_treatment "lead"
37 Q0 28620495 54 40.03827 imi_mug_run_2_treatment "metformin" "pioglitazone"
37 Q0 15972724 55 40.016937 imi_mug_run_2_treatment "lysine"
37 Q0 22293021 56 39.9765 imi_mug_run_2_treatment "drugs" "protein kinase inhibitor"
37 Q0 26199943 57 39.57189 imi_mug_run_2_treatment "calcium"
37 Q0 21462202 58 39.250916 imi_mug_run_2_treatment "product"
37 Q0 20307303 59 39.235474 imi_mug_run_2_treatment "hot spot"
37 Q0 27405450 60 38.837524 imi_mug_run_2_treatment "mediated"
37 Q0 23455585 61 38.803886 imi_mug_run_2_treatment "lead"
37 Q0 27287550 62 38.803886 imi_mug_run_2_treatment "lead" "shape"
37 Q0 22837538 63 38.77018 imi_mug_run_2_treatment "mediated" "level"
37 Q0 24001739 64 38.704674 imi_mug_run_2_treatment "ptc" "mediated"
37 Q0 19944109 65 38.44509 imi_mug_run_2_treatment "lead" "animals"
37 Q0 19638735 66 38.001858 imi_mug_run_2_treatment "various"
37 Q0 17446932 67 37.985462 imi_mug_run_2_treatment "various"
37 Q0 30482687 68 37.870525 imi_mug_run_2_treatment "prophylactic"
37 Q0 27069442 69 37.830727 imi_mug_run_2_treatment "carnitine" "histidine" "oxygen"
37 Q0 27120622 70 37.753914 imi_mug_run_2_treatment "brdu" "level" "shape"
37 Q0 30342008 71 37.665474 imi_mug_run_2_treatment "integrator"
37 Q0 20127487 72 37.64836 imi_mug_run_2_treatment "lead"
37 Q0 29367541 73 37.317688 imi_mug_run_2_treatment "basis"
37 Q0 27585670 74 37.171837 imi_mug_run_2_treatment "fiber"
37 Q0 28069793 75 37.16029 imi_mug_run_2_treatment "drugs"
37 Q0 10655060 76 37.11363 imi_mug_run_2_treatment "insulin" "product" "others"
37 Q0 27498076 77 36.652172 imi_mug_run_2_treatment "apd" "sodium" "ranolazine"
37 Q0 30008018 78 36.45967 imi_mug_run_2_treatment "plasma" "aim"
37 Q0 30199159 79 36.396515 imi_mug_run_2_treatment "lead"
37 Q0 29250253 80 36.257256 imi_mug_run_2_treatment "methylprednisolone" "tacrolimus" "basiliximab"
37 Q0 25319090 81 36.191555 imi_mug_run_2_treatment "level"
37 Q0 19021555 82 35.920284 imi_mug_run_2_treatment "mediators" "lead"
37 Q0 22413764 83 35.683495 imi_mug_run_2_treatment "aim"
37 Q0 21156181 84 35.56949 imi_mug_run_2_treatment "aim"
37 Q0 29791652 85 35.56623 imi_mug_run_2_treatment "basis"
37 Q0 17987279 86 35.122818 imi_mug_run_2_treatment "various" "mediated" "epoxomicin"
37 Q0 11792809 87 34.960594 imi_mug_run_2_treatment "others"
37 Q0 12032588 88 34.91546 imi_mug_run_2_treatment "histidine" "leucine"
37 Q0 29047356 89 34.815872 imi_mug_run_2_treatment "various"
37 Q0 23362510 90 34.181572 imi_mug_run_2_treatment "blockade" "u0126" "azd6244"
37 Q0 22999724 91 34.071186 imi_mug_run_2_treatment "amiodarone" "drugs" "flecainide"
37 Q0 16008174 92 33.184074 imi_mug_run_2_treatment "lead"
37 Q0 27506821 93 33.112984 imi_mug_run_2_treatment "alcohol"
37 Q0 18502446 94 33.02095 imi_mug_run_2_treatment "lead" "aim" "shape"
37 Q0 26835025 95 32.99134 imi_mug_run_2_treatment "prophylactic"
37 Q0 29305677 96 32.550888 imi_mug_run_2_treatment "icc" "aim"
37 Q0 28125396 97 32.508266 imi_mug_run_2_treatment "therapeutics" "lead"
37 Q0 25820511 98 32.37255 imi_mug_run_2_treatment "fiber" "shape"
37 Q0 27966284 99 32.25579 imi_mug_run_2_treatment "aim"
37 Q0 16061563 100 32.212814 imi_mug_run_2_treatment "lead"
37 Q0 17067107 101 32.011818 imi_mug_run_2_treatment "antiarrhythmic drugs"
37 Q0 21818413 102 31.958622 imi_mug_run_2_treatment "various" "liver"
37 Q0 29800419 103 31.469196 imi_mug_run_2_treatment "calcium" "anti-arrhythmic" "lead"
37 Q0 23946316 104 31.437893 imi_mug_run_2_treatment "basis"
37 Q0 25469153 105 30.995052 imi_mug_run_2_treatment "others"
37 Q0 18031308 106 30.97409 imi_mug_run_2_treatment "phenylalanine"
37 Q0 10939567 107 30.937447 imi_mug_run_2_treatment "prompt" "others"
37 Q0 29267953 108 30.731537 imi_mug_run_2_treatment "metreleptin"
37 Q0 29197877 109 30.48898 imi_mug_run_2_treatment "lucifer yellow" "mch"
37 Q0 27082122 110 30.136755 imi_mug_run_2_treatment "protein c" "alpha subunit"
37 Q0 23666920 111 29.979984 imi_mug_run_2_treatment "zinc" "farnesyltransferase inhibitors"
37 Q0 26323789 112 29.813488 imi_mug_run_2_treatment "lead"
37 Q0 18564364 113 29.21132 imi_mug_run_2_treatment "hot spot" "others"
37 Q0 10838246 114 27.910454 imi_mug_run_2_treatment "various"
37 Q0 17493612 115 27.548164 imi_mug_run_2_treatment "others"
37 Q0 24485160 116 27.115547 imi_mug_run_2_treatment "metformin" "atenolol" "lysine"
37 Q0 20980393 117 26.885803 imi_mug_run_2_treatment "various"
37 Q0 26455666 118 26.025917 imi_mug_run_2_treatment "hts" "aim"
37 Q0 28844980 119 25.939074 imi_mug_run_2_treatment "shape"
37 Q0 29253866 120 25.44978 imi_mug_run_2_treatment "lead"
37 Q0 30105547 121 24.73846 imi_mug_run_2_treatment "ras" "basis"
37 Q0 17493893 122 24.71306 imi_mug_run_2_treatment "glycine" "elder"
37 Q0 12467734 123 24.200588 imi_mug_run_2_treatment "prompt"
37 Q0 18025927 124 24.15025 imi_mug_run_2_treatment "prompt"
37 Q0 20421363 125 23.93414 imi_mug_run_2_treatment "lead" "protein farnesyltransferase inhibitors"
37 Q0 16278265 126 23.706934 imi_mug_run_2_treatment "zinc" "leucine" "serine"
37 Q0 16364671 127 23.617887 imi_mug_run_2_treatment "various" "zinc" "nervous system"
37 Q0 11503164 128 23.356344 imi_mug_run_2_treatment "various"
37 Q0 21037199 129 22.565178 imi_mug_run_2_treatment "lead"
37 Q0 28913408 130 21.969345 imi_mug_run_2_treatment "enzymes" "interferon" "growth hormone"
37 Q0 23815988 131 20.975142 imi_mug_run_2_treatment "selumetinib" "drug" "eosin"
37 Q0 15372542 132 20.143898 imi_mug_run_2_treatment "lead"
37 Q0 14593639 133 20.123705 imi_mug_run_2_treatment "aim"
37 Q0 27649756 134 20.123705 imi_mug_run_2_treatment "drugs" "aim" "matrix"
37 Q0 21346069 135 19.873077 imi_mug_run_2_treatment "favor" "lead"
37 Q0 15722103 136 19.702038 imi_mug_run_2_treatment "lead"
37 Q0 20576434 137 19.702038 imi_mug_run_2_treatment "collagen"
37 Q0 29497013 138 19.683483 imi_mug_run_2_treatment "basis"
37 Q0 25676813 139 19.502453 imi_mug_run_2_treatment "lead"
37 Q0 27841901 140 18.074997 imi_mug_run_2_treatment "protein c" "glycine" "gla"
37 Q0 29693488 141 17.787361 imi_mug_run_2_treatment "basic fibroblast growth factor" "interleukin 6" "interleukin"
38 Q0 12877386 1 94.646614 imi_mug_run_2_treatment "level"
38 Q0 23415580 2 90.14291 imi_mug_run_2_treatment "various"
38 Q0 28869103 3 86.0516 imi_mug_run_2_treatment "various"
38 Q0 26979979 4 86.03743 imi_mug_run_2_treatment "various"
38 Q0 10353780 5 82.125885 imi_mug_run_2_treatment "lysine" "arginine" "lead"
38 Q0 10517250 6 80.02582 imi_mug_run_2_treatment "various"
38 Q0 22760703 7 79.37025 imi_mug_run_2_treatment "various"
38 Q0 16882735 8 77.02846 imi_mug_run_2_treatment "basis"
38 Q0 14970844 9 76.28735 imi_mug_run_2_treatment "various"
38 Q0 15774015 10 72.72894 imi_mug_run_2_treatment "basis"
38 Q0 12552571 11 72.001724 imi_mug_run_2_treatment "suppressor"
38 Q0 19615099 12 71.60046 imi_mug_run_2_treatment "various" "aim"
38 Q0 29419869 13 71.39292 imi_mug_run_2_treatment "leucine" "basis"
38 Q0 23426006 14 70.88878 imi_mug_run_2_treatment "lead" "basis"
38 Q0 10389980 15 70.78834 imi_mug_run_2_treatment "leucine"
38 Q0 17010210 16 69.99984 imi_mug_run_2_treatment "basis"
38 Q0 19507030 17 69.30873 imi_mug_run_2_treatment "serine"
38 Q0 29948449 18 68.83926 imi_mug_run_2_treatment "level"
38 Q0 22168747 19 67.403946 imi_mug_run_2_treatment "glutamine"
38 Q0 21118512 20 67.26041 imi_mug_run_2_treatment "level" "aim"
38 Q0 28560011 21 66.894325 imi_mug_run_2_treatment "letrozole" "lhrh" "luteinizing hormone releasing hormone"
38 Q0 30143518 22 66.595116 imi_mug_run_2_treatment "lead"
38 Q0 10780518 23 66.4703 imi_mug_run_2_treatment "various" "tcc"
38 Q0 11715436 24 65.84033 imi_mug_run_2_treatment "lead"
38 Q0 11389158 25 65.70037 imi_mug_run_2_treatment "various" "basis"
38 Q0 20623358 26 65.022125 imi_mug_run_2_treatment "mediated"
38 Q0 24154639 27 64.95796 imi_mug_run_2_treatment "various" "lead"
38 Q0 9760200 28 64.80281 imi_mug_run_2_treatment "product" "lead"
38 Q0 24652667 29 64.76555 imi_mug_run_2_treatment "basis"
38 Q0 25841653 30 64.60084 imi_mug_run_2_treatment "bps"
38 Q0 22775437 31 64.13365 imi_mug_run_2_treatment "various" "aim"
38 Q0 9425897 32 64.07756 imi_mug_run_2_treatment "various"
38 Q0 27070770 33 63.670574 imi_mug_run_2_treatment "various" "aim"
38 Q0 20581245 34 63.582016 imi_mug_run_2_treatment "various"
38 Q0 28487883 35 63.434372 imi_mug_run_2_treatment "basis"
38 Q0 27467201 36 62.89151 imi_mug_run_2_treatment "aim"
38 Q0 27004004 37 62.808704 imi_mug_run_2_treatment "serine" "aim"
38 Q0 12112668 38 62.751564 imi_mug_run_2_treatment "various"
38 Q0 29720104 39 62.695473 imi_mug_run_2_treatment "prenatal"
38 Q0 29245219 40 62.66781 imi_mug_run_2_treatment "glycine"
38 Q0 17319781 41 62.53246 imi_mug_run_2_treatment "mediated" "lead"
38 Q0 11668633 42 62.17181 imi_mug_run_2_treatment "various" "level"
38 Q0 26225618 43 61.621178 imi_mug_run_2_treatment "others"
38 Q0 10429654 44 61.01521 imi_mug_run_2_treatment "leu" "hot spot"
38 Q0 11215281 45 61.00643 imi_mug_run_2_treatment "aim"
38 Q0 19541609 46 59.81671 imi_mug_run_2_treatment "glucose" "mediated" "agent"
38 Q0 21503748 47 59.484646 imi_mug_run_2_treatment "com"
38 Q0 10429655 48 59.198067 imi_mug_run_2_treatment "lead"
38 Q0 12438709 49 58.958298 imi_mug_run_2_treatment "lys"
38 Q0 23515270 50 58.571728 imi_mug_run_2_treatment "aim"
38 Q0 11435690 51 57.998837 imi_mug_run_2_treatment "lead"
38 Q0 21826537 52 57.842117 imi_mug_run_2_treatment "mtor inhibitor" "drugs" "mediators"
38 Q0 11595829 53 57.75879 imi_mug_run_2_treatment "cnc" "c-amp" "level"
38 Q0 24179492 54 57.53313 imi_mug_run_2_treatment "various"
38 Q0 11721206 55 56.936066 imi_mug_run_2_treatment "various"
38 Q0 24037887 56 56.822563 imi_mug_run_2_treatment "estrogens" "cyclic amp" "aim"
38 Q0 15287029 57 56.2685 imi_mug_run_2_treatment "color" "basis"
38 Q0 28185117 58 56.04184 imi_mug_run_2_treatment "various"
38 Q0 10441497 59 55.527927 imi_mug_run_2_treatment "serine" "balance"
38 Q0 15343512 60 55.409367 imi_mug_run_2_treatment "various"
38 Q0 26662608 61 54.579506 imi_mug_run_2_treatment "serine" "eosin"
38 Q0 16580634 62 53.00488 imi_mug_run_2_treatment "various" "mediated"
38 Q0 12861065 63 52.69589 imi_mug_run_2_treatment "product"
38 Q0 21335955 64 52.614826 imi_mug_run_2_treatment "anastrozole" "estrogen" "aromatase inhibitor"
38 Q0 25649062 65 52.614826 imi_mug_run_2_treatment "mtor inhibitor"
38 Q0 11212897 66 52.510036 imi_mug_run_2_treatment "various"
38 Q0 26398719 67 52.299408 imi_mug_run_2_treatment "serine"
38 Q0 22698401 68 52.10699 imi_mug_run_2_treatment "ras"
38 Q0 19005389 69 50.78486 imi_mug_run_2_treatment "mediated"
38 Q0 16110486 70 50.760384 imi_mug_run_2_treatment "product" "lead"
38 Q0 12144681 71 49.82813 imi_mug_run_2_treatment "various" "cnc" "aim"
38 Q0 10896921 72 49.82763 imi_mug_run_2_treatment "suppressor"
38 Q0 20057966 73 49.3497 imi_mug_run_2_treatment "serine"
38 Q0 15987703 74 48.659336 imi_mug_run_2_treatment "lead" "suppressor"
38 Q0 10398133 75 48.60534 imi_mug_run_2_treatment "suppressor"
38 Q0 12060709 76 47.975403 imi_mug_run_2_treatment "product"
38 Q0 19165201 77 46.761116 imi_mug_run_2_treatment "mek inhibitor ci-1040" "mtor inhibitor" "suppressor"
38 Q0 27264935 78 46.761116 imi_mug_run_2_treatment "drug" "lactate" "dichloroacetate"
38 Q0 25190708 79 46.646156 imi_mug_run_2_treatment "glucagon" "tyrosine" "suppressor"
38 Q0 11853558 80 46.61375 imi_mug_run_2_treatment "thr" "suppressor"
38 Q0 10430928 81 46.276054 imi_mug_run_2_treatment "mediated" "lead"
38 Q0 25694554 82 45.044746 imi_mug_run_2_treatment "drugs" "metformin" "serine"
38 Q0 25036236 83 44.835926 imi_mug_run_2_treatment "various" "aim"
38 Q0 27550049 84 44.5243 imi_mug_run_2_treatment "diastase" "various" "schiff"
38 Q0 11004696 85 44.202896 imi_mug_run_2_treatment "suppressor"
38 Q0 12912958 86 43.95952 imi_mug_run_2_treatment "ras" "anti-inflammatory" "nonsteroidal anti-inflammatory drugs"
38 Q0 27894106 87 43.37213 imi_mug_run_2_treatment "food"
38 Q0 11297520 88 42.953293 imi_mug_run_2_treatment "agonists" "mediated" "suppressor"
38 Q0 9683800 89 41.601345 imi_mug_run_2_treatment "leucine"
38 Q0 25751324 90 41.353264 imi_mug_run_2_treatment "ptc" "metaiodobenzylguanidine" "duration"
38 Q0 16888680 91 40.610313 imi_mug_run_2_treatment "various"
38 Q0 22732638 92 40.507133 imi_mug_run_2_treatment "cnc" "aromatase inhibitors" "lead"
38 Q0 26745759 93 40.10215 imi_mug_run_2_treatment "metformin"
38 Q0 16785781 94 39.451805 imi_mug_run_2_treatment "tma" "others"
38 Q0 17761947 95 38.68348 imi_mug_run_2_treatment "ptc" "mediated" "animals"
38 Q0 27705915 96 38.68348 imi_mug_run_2_treatment "parp inhibitors" "drugs" "thr"
38 Q0 29540834 97 38.68348 imi_mug_run_2_treatment "various"
38 Q0 17114342 98 38.57849 imi_mug_run_2_treatment "lead" "basic fibroblast growth factor" "vascular endothelial growth factor"
38 Q0 25263448 99 38.574738 imi_mug_run_2_treatment "enzymes" "antioxidant" "n-acetylcysteine"
38 Q0 22846738 100 38.243107 imi_mug_run_2_treatment "prophylactic"
38 Q0 10704392 101 38.17344 imi_mug_run_2_treatment "egg"
38 Q0 17711506 102 38.170372 imi_mug_run_2_treatment "aim"
38 Q0 17216128 103 38.170372 imi_mug_run_2_treatment "yeast" "lead"
38 Q0 12114407 104 38.170372 imi_mug_run_2_treatment "mediated" "lead"
38 Q0 12226664 105 38.170372 imi_mug_run_2_treatment "ras" "suppressor"
38 Q0 23584481 106 38.170372 imi_mug_run_2_treatment "dsb" "mediated"
38 Q0 29637416 107 37.477882 imi_mug_run_2_treatment "amp" "adenosine monophosphate" "basis"
38 Q0 20435009 108 37.381878 imi_mug_run_2_treatment "mediated"
38 Q0 12234250 109 36.559353 imi_mug_run_2_treatment "thr" "mediated" "lead"
38 Q0 10436789 110 35.117813 imi_mug_run_2_treatment "basis"
38 Q0 29309780 111 33.674038 imi_mug_run_2_treatment "pas"
38 Q0 10508479 112 33.670593 imi_mug_run_2_treatment "autologous" "allogeneic"
38 Q0 20354156 113 33.57935 imi_mug_run_2_treatment "insulin" "glucose" "mediated"
38 Q0 11385254 114 33.57632 imi_mug_run_2_treatment "various"
38 Q0 18681789 115 31.48612 imi_mug_run_2_treatment "metformin" "clomiphene" "clomiphene citrate"
38 Q0 23644529 116 31.261532 imi_mug_run_2_treatment "level"
38 Q0 15516847 117 30.626766 imi_mug_run_2_treatment "combinations"
38 Q0 18000088 118 21.19225 imi_mug_run_2_treatment "metformin" "insulin" "androgen"
38 Q0 29967336 119 19.204937 imi_mug_run_2_treatment "basis"
38 Q0 23187834 120 16.338766 imi_mug_run_2_treatment "lead"
38 Q0 24498881 121 11.661151 imi_mug_run_2_treatment "others"
39 Q0 21216356 1 66.35501 imi_mug_run_2_treatment "aim"
39 Q0 24057343 2 61.72651 imi_mug_run_2_treatment "elder" "lead"
39 Q0 29752375 3 60.126907 imi_mug_run_2_treatment "duration"
39 Q0 22821100 4 59.391785 imi_mug_run_2_treatment "epinephrine" "mexiletine"
39 Q0 17192539 5 59.193466 imi_mug_run_2_treatment "potassium"
39 Q0 15500450 6 57.93662 imi_mug_run_2_treatment "gly" "tyr" "aim"
39 Q0 25914329 7 57.631477 imi_mug_run_2_treatment "ether" "pas"
39 Q0 22402334 8 57.549797 imi_mug_run_2_treatment "sodium" "antiarrhythmic" "channel blockers"
39 Q0 27816319 9 57.238167 imi_mug_run_2_treatment "drugs"
39 Q0 23216910 10 56.453888 imi_mug_run_2_treatment "drugs" "drug" "antipsychotics"
39 Q0 22727609 11 56.105286 imi_mug_run_2_treatment "others"
39 Q0 12442276 12 56.070656 imi_mug_run_2_treatment "beta blocker" "propanolol" "inderal"
39 Q0 15851652 13 55.943703 imi_mug_run_2_treatment "ether" "drugs"
39 Q0 15670565 14 55.45327 imi_mug_run_2_treatment "glutamic acid"
39 Q0 19668779 15 55.435097 imi_mug_run_2_treatment "ether"
39 Q0 11289718 16 55.321842 imi_mug_run_2_treatment "beta-adrenergic blocking agents"
39 Q0 28749435 17 55.10572 imi_mug_run_2_treatment "basis"
39 Q0 20438705 18 54.60727 imi_mug_run_2_treatment "potassium ion" "lead"
39 Q0 25819988 19 54.515423 imi_mug_run_2_treatment "beta-blockers"
39 Q0 30047011 20 54.159157 imi_mug_run_2_treatment "lead"
39 Q0 21185499 21 53.930473 imi_mug_run_2_treatment "aim"
39 Q0 29688407 22 53.778206 imi_mug_run_2_treatment "duration" "epinephrine" "aim"
39 Q0 17709632 23 53.64366 imi_mug_run_2_treatment "drugs"
39 Q0 20950623 24 53.5205 imi_mug_run_2_treatment "drug" "dofetilide" "therapeutic agents"
39 Q0 16253915 25 53.39812 imi_mug_run_2_treatment "prompt"
39 Q0 22515331 26 53.39812 imi_mug_run_2_treatment "potassium" "sodium"
39 Q0 18606002 27 52.80216 imi_mug_run_2_treatment "various" "beta-blockers" "lead"
39 Q0 17592134 28 52.609203 imi_mug_run_2_treatment "calcium" "basis"
39 Q0 14682152 29 52.606735 imi_mug_run_2_treatment "various" "aim"
39 Q0 29146210 30 52.59076 imi_mug_run_2_treatment "e-4031" "dofetilide"
39 Q0 21244686 31 52.461494 imi_mug_run_2_treatment "beta blocker" "medication" "duration"
39 Q0 22328875 32 52.192474 imi_mug_run_2_treatment "level"
39 Q0 22382559 33 52.015045 imi_mug_run_2_treatment "magnesium sulfate" "basis"
39 Q0 24218437 34 51.94863 imi_mug_run_2_treatment "prenatal"
39 Q0 21779290 35 51.761024 imi_mug_run_2_treatment "meperidine" "drugs" "cardiac drugs"
39 Q0 19843919 36 51.705902 imi_mug_run_2_treatment "antiarrhythmic" "drugs" "antiarrhythmic drugs"
39 Q0 30036649 37 51.548916 imi_mug_run_2_treatment "beta-blocker"
39 Q0 20005993 38 51.434914 imi_mug_run_2_treatment "program" "lead" "level"
39 Q0 19804087 39 51.36222 imi_mug_run_2_treatment "basis"
39 Q0 22067087 40 51.214245 imi_mug_run_2_treatment "ether"
39 Q0 18675227 41 51.165524 imi_mug_run_2_treatment "macrolide"
39 Q0 16720674 42 50.939384 imi_mug_run_2_treatment "drugs"
39 Q0 12736279 43 50.88368 imi_mug_run_2_treatment "potassium" "sodium"
39 Q0 17497253 44 50.776188 imi_mug_run_2_treatment "drugs" "quinidine" "sotalol"
39 Q0 24363352 45 50.580544 imi_mug_run_2_treatment "program"
39 Q0 16076272 46 50.377403 imi_mug_run_2_treatment "drugs" "quinidine" "sotalol"
39 Q0 15711590 47 50.341206 imi_mug_run_2_treatment "drug" "potassium" "drugs"
39 Q0 16565572 48 50.11001 imi_mug_run_2_treatment "apd" "lead" "duration"
39 Q0 15699249 49 50.08707 imi_mug_run_2_treatment "pas" "e-4031" "drugs"
39 Q0 14760488 50 49.792427 imi_mug_run_2_treatment "drugs"
39 Q0 12402336 51 49.700203 imi_mug_run_2_treatment "potassium" "medication"
39 Q0 15828882 52 49.44937 imi_mug_run_2_treatment "propafenone" "agent" "basis"
39 Q0 27539165 53 49.405914 imi_mug_run_2_treatment "amiodarone" "quantum"
39 Q0 19694797 54 49.335587 imi_mug_run_2_treatment "basis"
39 Q0 16937190 55 49.15178 imi_mug_run_2_treatment "various" "lead" "basis"
39 Q0 25987402 56 49.150482 imi_mug_run_2_treatment "aim"
39 Q0 19926013 57 49.148094 imi_mug_run_2_treatment "beta-blocker"
39 Q0 27555138 58 49.138924 imi_mug_run_2_treatment "sevoflurane" "anesthesia" "anesthetics"
39 Q0 20126594 59 49.052456 imi_mug_run_2_treatment "quinidine"
39 Q0 30394905 60 48.799156 imi_mug_run_2_treatment "medicine" "nadolol" "propranolol"
39 Q0 23995044 61 48.690212 imi_mug_run_2_treatment "prenatal"
39 Q0 15958262 62 48.58949 imi_mug_run_2_treatment "ether" "lead" "level"
39 Q0 24667783 63 48.55498 imi_mug_run_2_treatment "basis"
39 Q0 23678275 64 48.04747 imi_mug_run_2_treatment "anesthesia"
39 Q0 24875677 65 47.981354 imi_mug_run_2_treatment "potassium" "methadone" "drugs"
39 Q0 11802537 66 47.760735 imi_mug_run_2_treatment "potassium" "isoleucine"
39 Q0 26715165 67 47.720066 imi_mug_run_2_treatment "drugs" "others"
39 Q0 26854997 68 47.53715 imi_mug_run_2_treatment "potassium" "apd" "propionic acid"
39 Q0 25935074 69 47.4534 imi_mug_run_2_treatment "beta-blocker"
39 Q0 10735633 70 47.338142 imi_mug_run_2_treatment "atenolol" "glycine" "blockade"
39 Q0 20931094 71 47.33704 imi_mug_run_2_treatment "alpha subunit"
39 Q0 22996910 72 47.31936 imi_mug_run_2_treatment "antiadrenergic"
39 Q0 11009462 73 46.913506 imi_mug_run_2_treatment "e-4031"
39 Q0 25335996 74 46.709408 imi_mug_run_2_treatment "quinidine" "program"
39 Q0 15028050 75 46.568123 imi_mug_run_2_treatment "beta-blocker" "beta-blockers" "aprindine"
39 Q0 23936797 76 46.499554 imi_mug_run_2_treatment "level"
39 Q0 29739726 77 46.44079 imi_mug_run_2_treatment "seizure medication"
39 Q0 19160088 78 46.339733 imi_mug_run_2_treatment "lead"
39 Q0 20975234 79 46.32346 imi_mug_run_2_treatment "various"
39 Q0 19187913 80 46.264256 imi_mug_run_2_treatment "lead"
39 Q0 17432514 81 46.240097 imi_mug_run_2_treatment "duration"
39 Q0 21240260 82 46.223507 imi_mug_run_2_treatment "potassium" "channel blockers" "duration"
39 Q0 29881912 83 46.070637 imi_mug_run_2_treatment "catecholamine"
39 Q0 17210839 84 45.923866 imi_mug_run_2_treatment "basis"
39 Q0 24036083 85 45.88099 imi_mug_run_2_treatment "medication"
39 Q0 20390067 86 45.842403 imi_mug_run_2_treatment "potassium"
39 Q0 16942825 87 45.75744 imi_mug_run_2_treatment "beta-blocker" "amiodarone" "quinidine"
39 Q0 16226079 88 45.73226 imi_mug_run_2_treatment "quinidine" "flecainide" "sotalol"
39 Q0 21130771 89 45.716724 imi_mug_run_2_treatment "quinidine" "sotalol"
39 Q0 21700951 90 45.510384 imi_mug_run_2_treatment "ether"
39 Q0 14676148 91 45.502197 imi_mug_run_2_treatment "basis" "duration"
39 Q0 19083750 92 45.364048 imi_mug_run_2_treatment "various"
39 Q0 24133349 93 45.323685 imi_mug_run_2_treatment "various" "beta-blocker"
39 Q0 15890322 94 45.29036 imi_mug_run_2_treatment "quinidine" "flecainide" "sotalol"
39 Q0 21769575 95 45.188972 imi_mug_run_2_treatment "aim"
39 Q0 28279743 96 44.907616 imi_mug_run_2_treatment "lead"
39 Q0 24015048 97 44.827274 imi_mug_run_2_treatment "potassium ion" "lead"
39 Q0 12690509 98 44.6084 imi_mug_run_2_treatment "water"
39 Q0 19148726 99 44.556973 imi_mug_run_2_treatment "apds" "genesis"
39 Q0 21063070 100 44.51273 imi_mug_run_2_treatment "potassium" "lead" "program"
39 Q0 27492745 101 44.40092 imi_mug_run_2_treatment "magnesium" "lidocaine" "mexiletine"
39 Q0 23277474 102 44.38419 imi_mug_run_2_treatment "drug" "mexiletine" "channel blocker"
39 Q0 19841300 103 44.336124 imi_mug_run_2_treatment "prompt"
39 Q0 25800797 104 44.309128 imi_mug_run_2_treatment "hypaconitine" "alkaloids" "water"
39 Q0 24213244 105 44.29904 imi_mug_run_2_treatment "duration"
39 Q0 20920651 106 44.230904 imi_mug_run_2_treatment "duration"
39 Q0 18382206 107 44.229042 imi_mug_run_2_treatment "quinidine"
39 Q0 21483829 108 44.08004 imi_mug_run_2_treatment "electrolyte" "e-4031"
39 Q0 21109023 109 43.8524 imi_mug_run_2_treatment "glutamic acid" "lead" "duration"
39 Q0 27262388 110 43.808754 imi_mug_run_2_treatment "beta blocker" "metoprolol" "nadolol"
39 Q0 16922724 111 43.67221 imi_mug_run_2_treatment "various"
39 Q0 17916157 112 43.018883 imi_mug_run_2_treatment "sotalol" "drugs" "lead"
39 Q0 29622001 113 42.752056 imi_mug_run_2_treatment "duration"
39 Q0 30389366 114 42.484474 imi_mug_run_2_treatment "beta blockers" "flecainide" "mediated"
39 Q0 25564553 115 42.414356 imi_mug_run_2_treatment "drugs" "aim"
39 Q0 23917959 116 42.366997 imi_mug_run_2_treatment "drug"
39 Q0 25082577 117 42.363205 imi_mug_run_2_treatment "calcium channel blocker" "duration" "nifedipine"
39 Q0 19038855 118 42.13414 imi_mug_run_2_treatment "antiepileptic drug" "aed" "medication"
39 Q0 29016797 119 41.978027 imi_mug_run_2_treatment "lead" "aim"
39 Q0 19731233 120 41.84855 imi_mug_run_2_treatment "magnesium" "flecainide"
39 Q0 26669661 121 41.712578 imi_mug_run_2_treatment "level"
39 Q0 20181576 122 41.64029 imi_mug_run_2_treatment "mediated"
39 Q0 22806714 123 41.588562 imi_mug_run_2_treatment "lead"
39 Q0 15159330 124 41.554535 imi_mug_run_2_treatment "favor"
39 Q0 16155735 125 41.511604 imi_mug_run_2_treatment "potassium" "sodium"
39 Q0 26063740 126 41.500156 imi_mug_run_2_treatment "medication"
39 Q0 28532774 127 41.420235 imi_mug_run_2_treatment "lead"
39 Q0 21594822 128 41.390915 imi_mug_run_2_treatment "basis" "potassium ion" "aim"
39 Q0 16771953 129 41.30868 imi_mug_run_2_treatment "sodium" "aim"
39 Q0 19127321 130 41.254486 imi_mug_run_2_treatment "beta-blocker"
39 Q0 16623272 131 41.029938 imi_mug_run_2_treatment "drug" "aminoacid" "cardiovascular drugs"
39 Q0 27076034 132 40.766495 imi_mug_run_2_treatment "dofetilide" "animals"
39 Q0 12877697 133 40.616295 imi_mug_run_2_treatment "catecholamine" "dobutamine" "phenylephrine"
39 Q0 24623279 134 40.548115 imi_mug_run_2_treatment "corrective" "agent"
39 Q0 29037423 135 40.521057 imi_mug_run_2_treatment "potassium" "magnesium" "mexiletine"
39 Q0 22104571 136 40.49273 imi_mug_run_2_treatment "beta-blocker" "basis"
39 Q0 24973560 137 40.49273 imi_mug_run_2_treatment "medicine" "basis"
39 Q0 15534720 138 40.427498 imi_mug_run_2_treatment "beta-blocker" "atenolol" "propranolol"
39 Q0 19013996 139 40.30962 imi_mug_run_2_treatment "antiarrhythmic drugs"
39 Q0 30496390 140 40.195023 imi_mug_run_2_treatment "duration" "quinidine" "apd"
39 Q0 18052691 141 40.18098 imi_mug_run_2_treatment "genesis"
39 Q0 22129298 142 40.18098 imi_mug_run_2_treatment "various" "flecainide" "antiadrenergic"
39 Q0 17171344 143 40.065456 imi_mug_run_2_treatment "ether" "glycine" "serine"
39 Q0 16132053 144 40.044563 imi_mug_run_2_treatment "various"
39 Q0 24419801 145 39.95644 imi_mug_run_2_treatment "drug" "glycine" "serine"
39 Q0 16227340 146 39.877934 imi_mug_run_2_treatment "drug" "protease"
39 Q0 23207121 147 39.834476 imi_mug_run_2_treatment "epinephrine"
39 Q0 23546015 148 39.780327 imi_mug_run_2_treatment "basis" "duration"
39 Q0 12477631 149 39.758617 imi_mug_run_2_treatment "basis"
39 Q0 29759541 150 39.639713 imi_mug_run_2_treatment "drug" "bepridil" "quinidine"
39 Q0 19215240 151 39.322243 imi_mug_run_2_treatment "lead" "aim"
39 Q0 23470493 152 39.27746 imi_mug_run_2_treatment "apds"
39 Q0 19214780 153 39.086754 imi_mug_run_2_treatment "basis"
39 Q0 12354768 154 38.763653 imi_mug_run_2_treatment "ether" "pas" "cisapride"
39 Q0 30441573 155 38.719208 imi_mug_run_2_treatment "chloroquine" "drug" "anti-malarial drug"
39 Q0 25890583 156 38.587776 imi_mug_run_2_treatment "duration"
39 Q0 18785031 157 38.5288 imi_mug_run_2_treatment "duration" "aim"
39 Q0 16399053 158 38.524887 imi_mug_run_2_treatment "tandem" "lead"
39 Q0 24561134 159 38.491417 imi_mug_run_2_treatment "drug" "aim"
39 Q0 24887423 160 38.40166 imi_mug_run_2_treatment "potassium" "antipsychotics" "drug"
39 Q0 19019189 161 38.393623 imi_mug_run_2_treatment "level" "lead"
39 Q0 26376488 162 38.33355 imi_mug_run_2_treatment "ether" "terfenadine" "duration"
39 Q0 20197117 163 38.305527 imi_mug_run_2_treatment "beta-blockers" "mexiletine" "medication"
39 Q0 24103226 164 38.305527 imi_mug_run_2_treatment "basis"
39 Q0 19306396 165 38.186802 imi_mug_run_2_treatment "potassium" "disopyramide"
39 Q0 29650123 166 38.186802 imi_mug_run_2_treatment "duration" "beta-blockers" "antiarrhythmic"
39 Q0 15851171 167 38.135323 imi_mug_run_2_treatment "lead" "aim"
39 Q0 20544339 168 37.902584 imi_mug_run_2_treatment "ether"
39 Q0 14642002 169 37.720474 imi_mug_run_2_treatment "potassium"
39 Q0 20659946 170 37.720474 imi_mug_run_2_treatment "medication" "level"
39 Q0 23631430 171 37.649616 imi_mug_run_2_treatment "aim" "duration"
39 Q0 29875689 172 37.649616 imi_mug_run_2_treatment "drug" "nocodazole"
39 Q0 23856471 173 37.594078 imi_mug_run_2_treatment "duration"
39 Q0 24530480 174 37.594078 imi_mug_run_2_treatment "ether" "mediated" "ptc"
39 Q0 18991593 175 37.515343 imi_mug_run_2_treatment "lead"
39 Q0 28433559 176 37.43663 imi_mug_run_2_treatment "potassium" "proteasome inhibitor" "duration"
39 Q0 21098441 177 37.427784 imi_mug_run_2_treatment "flurandrenolide" "duration" "mediated"
39 Q0 25140878 178 37.367867 imi_mug_run_2_treatment "apd" "duration"
39 Q0 17852802 179 37.348022 imi_mug_run_2_treatment "medication"
39 Q0 26271031 180 37.325768 imi_mug_run_2_treatment "estradiol" "progesterone" "mediated"
39 Q0 23864605 181 37.26409 imi_mug_run_2_treatment "drug" "e-4031" "drugs"
39 Q0 22429796 182 37.25791 imi_mug_run_2_treatment "metric"
39 Q0 27255646 183 37.216835 imi_mug_run_2_treatment "epinephrine"
39 Q0 17429906 184 37.054424 imi_mug_run_2_treatment "aim"
39 Q0 26066609 185 36.628777 imi_mug_run_2_treatment "lead"
39 Q0 20507645 186 36.48899 imi_mug_run_2_treatment "ether" "blockade" "medications"
39 Q0 26022375 187 36.469963 imi_mug_run_2_treatment "epinephrine"
39 Q0 24284363 188 36.454235 imi_mug_run_2_treatment "psychotropic drugs" "psychotropic drug" "psychotropic medication"
39 Q0 16842817 189 36.06601 imi_mug_run_2_treatment "disopyramide" "drug" "quinidine"
39 Q0 18362027 190 35.965252 imi_mug_run_2_treatment "quinidine" "basis" "agonist"
39 Q0 21410720 191 35.76081 imi_mug_run_2_treatment "aim"
39 Q0 16039272 192 35.510956 imi_mug_run_2_treatment "ether" "lead" "duration"
39 Q0 25967940 193 35.43892 imi_mug_run_2_treatment "combinations"
39 Q0 19207773 194 35.42382 imi_mug_run_2_treatment "catecholamines"
39 Q0 21367833 195 35.315075 imi_mug_run_2_treatment "isoprenaline" "drug" "experimental drug"
39 Q0 22052944 196 35.3028 imi_mug_run_2_treatment "drug" "drugs" "sotalol"
39 Q0 17655673 197 35.06918 imi_mug_run_2_treatment "basis"
39 Q0 20386770 198 35.069042 imi_mug_run_2_treatment "mediated"
39 Q0 29574456 199 34.984787 imi_mug_run_2_treatment "carbachol" "duration" "metoprolol"
39 Q0 16001794 200 34.861988 imi_mug_run_2_treatment "calcium" "catecholamine" "potassium"
39 Q0 21315844 201 34.703907 imi_mug_run_2_treatment "drug" "level" "duration"
39 Q0 26282245 202 34.650146 imi_mug_run_2_treatment "sodium" "epinephrine"
39 Q0 21712262 203 34.456753 imi_mug_run_2_treatment "adenosine"
39 Q0 22706279 204 34.325546 imi_mug_run_2_treatment "antipsychotic" "olanzapine" "drugs"
39 Q0 30244407 205 34.312996 imi_mug_run_2_treatment "beta-blocker"
39 Q0 28569435 206 34.135372 imi_mug_run_2_treatment "aim"
39 Q0 16051125 207 34.121155 imi_mug_run_2_treatment "apd" "duration"
39 Q0 28632743 208 33.763153 imi_mug_run_2_treatment "quinidine" "antiarrhythmic" "disopyramide"
39 Q0 17569659 209 33.747772 imi_mug_run_2_treatment "fk506" "lead"
39 Q0 11468227 210 33.49437 imi_mug_run_2_treatment "pas"
39 Q0 24687331 211 33.270462 imi_mug_run_2_treatment "therapeutics"
39 Q0 22194679 212 33.15453 imi_mug_run_2_treatment "anti-arrhythmic" "apd" "lead"
39 Q0 16253929 213 33.017467 imi_mug_run_2_treatment "drugs" "ether"
39 Q0 18508782 214 32.741463 imi_mug_run_2_treatment "ajmaline" "lead"
39 Q0 16472284 215 32.660652 imi_mug_run_2_treatment "lead" "lysine" "threonine"
39 Q0 18593567 216 32.4291 imi_mug_run_2_treatment "lead"
39 Q0 28466812 217 32.380367 imi_mug_run_2_treatment "sham" "duration" "melatonin"
39 Q0 24074973 218 32.371906 imi_mug_run_2_treatment "duration"
39 Q0 26346102 219 32.341682 imi_mug_run_2_treatment "potassium"
39 Q0 26412604 220 32.148342 imi_mug_run_2_treatment "aim"
39 Q0 20547678 221 32.07162 imi_mug_run_2_treatment "h2o2" "oxygen" "lead"
39 Q0 16253912 222 32.024628 imi_mug_run_2_treatment "various"
39 Q0 16263765 223 31.972061 imi_mug_run_2_treatment "mediated"
39 Q0 14499861 224 31.908566 imi_mug_run_2_treatment "lysine"
39 Q0 21496174 225 31.893131 imi_mug_run_2_treatment "pas"
39 Q0 17227789 226 31.543375 imi_mug_run_2_treatment "medications" "glycin" "lysine"
39 Q0 14975928 227 31.50941 imi_mug_run_2_treatment "ether" "amino acid" "cisapride"
39 Q0 18222468 228 31.206543 imi_mug_run_2_treatment "duration" "level"
39 Q0 18782006 229 30.481483 imi_mug_run_2_treatment "drug" "potassium"
39 Q0 26888838 230 30.377289 imi_mug_run_2_treatment "sodium" "metoprolol" "lead"
39 Q0 29957233 231 30.26313 imi_mug_run_2_treatment "duration" "drugs" "apd"
39 Q0 16329159 232 30.236092 imi_mug_run_2_treatment "drug" "drugs"
39 Q0 15023549 233 30.192291 imi_mug_run_2_treatment "duration" "drugs" "acetylcholine"
39 Q0 23166209 234 30.173477 imi_mug_run_2_treatment "duration"
39 Q0 20215044 235 29.851303 imi_mug_run_2_treatment "duration" "lead"
39 Q0 16818210 236 29.748144 imi_mug_run_2_treatment "calcium"
39 Q0 17993325 237 29.69189 imi_mug_run_2_treatment "potassium" "basis"
39 Q0 29548277 238 29.438408 imi_mug_run_2_treatment "ether" "glucagon" "glucose"
39 Q0 24373870 239 29.131937 imi_mug_run_2_treatment "product"
39 Q0 25453103 240 29.11785 imi_mug_run_2_treatment "ether" "duration"
39 Q0 12829173 241 28.918827 imi_mug_run_2_treatment "duration"
39 Q0 18060054 242 28.6291 imi_mug_run_2_treatment "channel blockers" "flecainide" "mexiletine"
39 Q0 20193146 243 28.615719 imi_mug_run_2_treatment "lead"
39 Q0 24311987 244 28.241652 imi_mug_run_2_treatment "potassium" "glycosaminoglycan" "sulfate"
39 Q0 17384445 245 27.760715 imi_mug_run_2_treatment "potassium" "apd" "duration"
39 Q0 16050273 246 27.63535 imi_mug_run_2_treatment "drug" "drugs" "potassium"
39 Q0 15511625 247 27.558674 imi_mug_run_2_treatment "potassium" "serine"
39 Q0 26857598 248 27.425232 imi_mug_run_2_treatment "ether"
39 Q0 16432067 249 26.815716 imi_mug_run_2_treatment "ether" "drugs"
39 Q0 20876384 250 26.77713 imi_mug_run_2_treatment "drug" "ether" "benzoic acid"
39 Q0 19940115 251 26.344229 imi_mug_run_2_treatment "ether"
39 Q0 19863545 252 26.309872 imi_mug_run_2_treatment "others"
39 Q0 21463633 253 26.309872 imi_mug_run_2_treatment "ether" "lead" "duration"
39 Q0 11709283 254 26.289417 imi_mug_run_2_treatment "alpha subunit"
39 Q0 12063283 255 26.289417 imi_mug_run_2_treatment "ether" "drugs" "glycosidase"
39 Q0 26846766 256 26.289417 imi_mug_run_2_treatment "aim"
39 Q0 22433001 257 26.275108 imi_mug_run_2_treatment "epinephrine" "lead"
39 Q0 28334543 258 26.254131 imi_mug_run_2_treatment "various" "ether"
39 Q0 19457646 259 26.253395 imi_mug_run_2_treatment "sertindole" "sertindole's" "duration"
39 Q0 15577518 260 26.252962 imi_mug_run_2_treatment "water"
39 Q0 14769199 261 26.252962 imi_mug_run_2_treatment "adenosine" "apd" "favor"
39 Q0 27543307 262 26.169765 imi_mug_run_2_treatment "oxygen" "mediated"
39 Q0 23718892 263 25.976875 imi_mug_run_2_treatment "carvedilol's" "metoprolol" "metoprolol's"
39 Q0 17534376 264 25.797846 imi_mug_run_2_treatment "duration"
39 Q0 22378279 265 25.64446 imi_mug_run_2_treatment "aim"
39 Q0 25645639 266 24.731989 imi_mug_run_2_treatment "lead"
39 Q0 25648353 267 24.157356 imi_mug_run_2_treatment "potassium" "dofetilide" "medications"
39 Q0 21951015 268 23.028252 imi_mug_run_2_treatment "potassium" "various"
39 Q0 28413954 269 23.028252 imi_mug_run_2_treatment "various" "ether" "drug"
39 Q0 15242738 270 22.930183 imi_mug_run_2_treatment "beta-blockers"
39 Q0 24587194 271 22.930183 imi_mug_run_2_treatment "tyrosine" "tyrosine kinase inhibitor" "lead"
39 Q0 23136156 272 22.930183 imi_mug_run_2_treatment "ether"
39 Q0 20403459 273 22.930183 imi_mug_run_2_treatment "sodium"
39 Q0 26164358 274 22.908897 imi_mug_run_2_treatment "drug" "program"
39 Q0 19419905 275 22.90081 imi_mug_run_2_treatment "ibmx" "phenylephrine" "cyclic adenosine monophosphate"
39 Q0 26704558 276 22.90081 imi_mug_run_2_treatment "basis"
39 Q0 16923798 277 22.882643 imi_mug_run_2_treatment "potassium" "apd" "mediated"
39 Q0 27190211 278 22.882643 imi_mug_run_2_treatment "drug" "ether" "cisapride"
39 Q0 12837749 279 22.851171 imi_mug_run_2_treatment "ether" "drugs"
39 Q0 17675083 280 22.851171 imi_mug_run_2_treatment "flecainide"
39 Q0 22573844 281 22.797064 imi_mug_run_2_treatment "ether" "urea"
39 Q0 28613240 282 22.696417 imi_mug_run_2_treatment "various" "alpha subunit" "salt"
39 Q0 28336205 283 22.361732 imi_mug_run_2_treatment "duration"
39 Q0 12642353 284 22.225996 imi_mug_run_2_treatment "potassium" "drugs" "cimetidine"
39 Q0 24035801 285 22.008167 imi_mug_run_2_treatment "isoproterenol"
39 Q0 24460807 286 21.97686 imi_mug_run_2_treatment "potassium" "level"
39 Q0 21776218 287 21.84528 imi_mug_run_2_treatment "arsenic" "water"
39 Q0 16043162 288 20.88536 imi_mug_run_2_treatment "ether"
39 Q0 15522280 289 20.015278 imi_mug_run_2_treatment "various" "drugs" "dofetilide"
39 Q0 18729007 290 19.772327 imi_mug_run_2_treatment "calcium" "anti-arrhythmic" "thyroxin"
39 Q0 30481776 291 18.017841 imi_mug_run_2_treatment "disopyramide" "quinidine" "drugs"
39 Q0 25626866 292 17.974178 imi_mug_run_2_treatment "lead"
39 Q0 18948620 293 17.93924 imi_mug_run_2_treatment "calcium" "duration" "cardiovascular system"
39 Q0 28624975 294 16.95027 imi_mug_run_2_treatment "dofetilide" "level"
39 Q0 29544605 295 16.493704 imi_mug_run_2_treatment "basis"
39 Q0 20400777 296 15.935633 imi_mug_run_2_treatment "lead" "level"
39 Q0 23714088 297 15.887016 imi_mug_run_2_treatment "lead"
39 Q0 16343893 298 15.340084 imi_mug_run_2_treatment "icc"
39 Q0 21459285 299 14.627321 imi_mug_run_2_treatment "potassium" "leucine"
39 Q0 29128797 300 14.292202 imi_mug_run_2_treatment "drug" "potassium" "valproate"
39 Q0 23465283 301 13.917091 imi_mug_run_2_treatment "aim"
39 Q0 20042427 302 13.512657 imi_mug_run_2_treatment "sodium"
39 Q0 22742967 303 11.011603 imi_mug_run_2_treatment "potassium" "ether" "cardiac drugs"
40 Q0 28403410 1 63.38801 imi_mug_run_2_treatment "calcium" "caffeine"
40 Q0 18564801 2 62.415638 imi_mug_run_2_treatment "calcium homeostasis"
40 Q0 27857962 3 60.661205 imi_mug_run_2_treatment "agonists" "muscle relaxant" "anesthetics"
40 Q0 1589759 4 58.293457 imi_mug_run_2_treatment "lead" "basis"
40 Q0 1329295 5 57.314774 imi_mug_run_2_treatment "lead" "basis"
40 Q0 8981316 6 56.435368 imi_mug_run_2_treatment "neuroleptics" "level"
40 Q0 27382027 7 56.05043 imi_mug_run_2_treatment "dantrolene" "anesthetics" "ryanodine"
40 Q0 17122579 8 55.82145 imi_mug_run_2_treatment "halothane" "animals" "caffeine"
40 Q0 16310654 9 55.54421 imi_mug_run_2_treatment "ryanodine"
40 Q0 7889656 10 55.33497 imi_mug_run_2_treatment "calcium"
40 Q0 7849712 11 53.07982 imi_mug_run_2_treatment "muscle relaxants" "anaesthetics" "gly"
40 Q0 18063506 12 53.041233 imi_mug_run_2_treatment "sevoflurane" "atropine" "anesthesia"
40 Q0 8669559 13 52.94203 imi_mug_run_2_treatment "alpha subunit" "others"
40 Q0 9237497 14 52.882355 imi_mug_run_2_treatment "calcium"
40 Q0 23476141 15 52.479004 imi_mug_run_2_treatment "calcium" "anesthetic agents" "anesthetics"
40 Q0 22030266 16 52.443024 imi_mug_run_2_treatment "various"
40 Q0 1354642 17 52.346947 imi_mug_run_2_treatment "leu"
40 Q0 19648156 18 52.344803 imi_mug_run_2_treatment "aim"
40 Q0 28902675 19 52.22416 imi_mug_run_2_treatment "various"
40 Q0 20681998 20 51.715446 imi_mug_run_2_treatment "anesthetic" "alpha subunit" "calcium homeostasis"
40 Q0 1510267 21 51.470177 imi_mug_run_2_treatment "calcium" "arginine"
40 Q0 11525881 22 51.40228 imi_mug_run_2_treatment "caffeine" "anesthetics" "halothane"
40 Q0 7586638 23 51.052055 imi_mug_run_2_treatment "calcium"
40 Q0 20142353 24 50.79054 imi_mug_run_2_treatment "m-cresol" "calcium"
40 Q0 16620769 25 50.67852 imi_mug_run_2_treatment "anesthetic" "anesthetics" "halothane"
40 Q0 8431338 26 50.630272 imi_mug_run_2_treatment "calcium"
40 Q0 10823104 27 50.55906 imi_mug_run_2_treatment "tryptophan"
40 Q0 7979121 28 50.283653 imi_mug_run_2_treatment "calcium" "basis" "lead"
40 Q0 9541102 29 50.033035 imi_mug_run_2_treatment "anaesthetic"
40 Q0 16284304 30 49.97323 imi_mug_run_2_treatment "calcium" "caffeine" "isoflurane"
40 Q0 22309018 31 49.58294 imi_mug_run_2_treatment "calcium" "alcohol" "acepromazine"
40 Q0 25189431 32 49.33361 imi_mug_run_2_treatment "anesthesia"
40 Q0 23198031 33 49.25801 imi_mug_run_2_treatment "calcium" "muscle relaxants" "dantrolene sodium"
40 Q0 30236258 34 49.233974 imi_mug_run_2_treatment "calcium" "anaesthetics" "halothane"
40 Q0 10352931 35 49.173256 imi_mug_run_2_treatment "calcium" "caffeine" "halothane"
40 Q0 9788935 36 48.944527 imi_mug_run_2_treatment "calcium" "caffeine" "drugs"
40 Q0 24195946 37 48.635376 imi_mug_run_2_treatment "muscle relaxants" "anesthetics" "metrics"
40 Q0 30459030 38 48.326706 imi_mug_run_2_treatment "calcium" "anesthetics" "succinylcholine"
40 Q0 16244682 39 48.141792 imi_mug_run_2_treatment "muscle relaxants" "anaesthetics" "dantrolene"
40 Q0 12959958 40 47.978485 imi_mug_run_2_treatment "halothane" "anesthetic" "anesthetics"
40 Q0 25958340 41 47.442726 imi_mug_run_2_treatment "muscle relaxants" "anesthetics"
40 Q0 16732090 42 47.10058 imi_mug_run_2_treatment "mediated" "calcium" "ryanodine"
40 Q0 23617272 43 46.9904 imi_mug_run_2_treatment "level"
40 Q0 25466363 44 46.95434 imi_mug_run_2_treatment "anaesthetics" "basis"
40 Q0 15347586 45 46.937157 imi_mug_run_2_treatment "duration" "level" "others"
40 Q0 8012359 46 46.9366 imi_mug_run_2_treatment "anaesthetics"
40 Q0 15210166 47 46.92021 imi_mug_run_2_treatment "calcium" "agonists" "calcium homeostasis"
40 Q0 25658027 48 46.861473 imi_mug_run_2_treatment "general anesthetics"
40 Q0 17293538 49 46.84633 imi_mug_run_2_treatment "calcium" "sucrose" "caffeine"
40 Q0 26631338 50 46.711407 imi_mug_run_2_treatment "m-cresol" "calcium" "calcium homeostasis"
40 Q0 16917943 51 46.700638 imi_mug_run_2_treatment "calcium homeostasis"
40 Q0 20023768 52 46.34836 imi_mug_run_2_treatment "calcium" "halothane" "anesthetic"
40 Q0 25960145 53 46.344906 imi_mug_run_2_treatment "various" "aim"
40 Q0 11803844 54 46.286972 imi_mug_run_2_treatment "anaesthetic" "caffeine" "dantrolene sodium"
40 Q0 25047158 55 46.156345 imi_mug_run_2_treatment "lead" "hot spot"
40 Q0 10051009 56 46.136528 imi_mug_run_2_treatment "anaesthetics" "skeletal muscle relaxants" "enzyme digestion"
40 Q0 16835904 57 46.038563 imi_mug_run_2_treatment "muscle relaxants" "anesthetics"
40 Q0 28527222 58 46.038364 imi_mug_run_2_treatment "calcium" "agonist"
40 Q0 1598899 59 46.008945 imi_mug_run_2_treatment "prompt"
40 Q0 19191329 60 46.008945 imi_mug_run_2_treatment "calcium homeostasis"
40 Q0 14500992 61 45.846317 imi_mug_run_2_treatment "calcium" "muscle relaxants" "lead"
40 Q0 25268394 62 45.605602 imi_mug_run_2_treatment "anesthetic" "dantrolene" "antidote"
40 Q0 18505726 63 45.54889 imi_mug_run_2_treatment "dantrolene" "anesthetic" "anesthetics"
40 Q0 27663056 64 45.44022 imi_mug_run_2_treatment "various" "alcohol" "drugs"
40 Q0 23176990 65 45.34449 imi_mug_run_2_treatment "calcium" "muscle relaxants" "anesthetics"
40 Q0 27147545 66 45.299828 imi_mug_run_2_treatment "calcium"
40 Q0 29355282 67 45.224228 imi_mug_run_2_treatment "dantrolene sodium"
40 Q0 10760701 68 45.073933 imi_mug_run_2_treatment "fibres" "anaesthetics" "caffeine"
40 Q0 19346234 69 44.87905 imi_mug_run_2_treatment "anaesthetics" "suxamethonium" "lead"
40 Q0 11668625 70 44.84146 imi_mug_run_2_treatment "muscle relaxants" "anesthetics" "enzyme digestion"
40 Q0 1774074 71 44.820763 imi_mug_run_2_treatment "anesthetics" "arginine"
40 Q0 19454545 72 44.79248 imi_mug_run_2_treatment "level"
40 Q0 25989378 73 44.724373 imi_mug_run_2_treatment "calcium" "anesthesia" "anesthetics"
40 Q0 9030597 74 44.713894 imi_mug_run_2_treatment "caffeine" "muscle relaxants" "anesthetics"
40 Q0 23267001 75 44.70107 imi_mug_run_2_treatment "succinylcholine" "anesthetics"
40 Q0 15299003 76 44.69677 imi_mug_run_2_treatment "m-cresol" "cyclosporine" "interleukin-6"
40 Q0 21795085 77 44.630463 imi_mug_run_2_treatment "statin" "anesthetics" "anesthesia"
40 Q0 7829078 78 44.358864 imi_mug_run_2_treatment "serine" "tyr" "tyrosine"
40 Q0 21926372 79 44.27968 imi_mug_run_2_treatment "caffeine" "dantrolene" "fiber"
40 Q0 30499100 80 44.091423 imi_mug_run_2_treatment "anesthetic agents" "succinylcholine" "potent volatile anesthetic"
40 Q0 9497245 81 44.081406 imi_mug_run_2_treatment "caffeine" "halothane" "muscle relaxants"
40 Q0 19918671 82 44.081406 imi_mug_run_2_treatment "caffeine" "halothane" "anesthetics"
40 Q0 7751854 83 43.94822 imi_mug_run_2_treatment "muscle relaxants" "anaesthetic" "basis"
40 Q0 27646467 84 43.94822 imi_mug_run_2_treatment "m-cresol" "level"
40 Q0 25256590 85 43.768017 imi_mug_run_2_treatment "dihydropyridine"
40 Q0 27555149 86 43.519085 imi_mug_run_2_treatment "anesthetic"
40 Q0 12709367 87 43.311573 imi_mug_run_2_treatment "anesthetic agents" "others"
40 Q0 21455645 88 43.265236 imi_mug_run_2_treatment "anesthetics" "caffeine" "halothane"
40 Q0 1341035 89 43.24297 imi_mug_run_2_treatment "anaesthetics" "skeletal muscle relaxants" "animals"
40 Q0 28326467 90 43.24297 imi_mug_run_2_treatment "anesthetic"
40 Q0 11389482 91 43.201836 imi_mug_run_2_treatment "calcium" "anesthetic" "glutamic acid"
40 Q0 12123492 92 43.087624 imi_mug_run_2_treatment "calcium" "anesthetics"
40 Q0 19223216 93 43.04908 imi_mug_run_2_treatment "anesthetic agents"
40 Q0 26238698 94 42.97834 imi_mug_run_2_treatment "calcium" "halothane" "muscle relaxant"
40 Q0 15318347 95 42.921227 imi_mug_run_2_treatment "caffeine" "halothane"
40 Q0 24361844 96 42.872864 imi_mug_run_2_treatment "calcium" "m-cresol"
40 Q0 30236257 97 42.65207 imi_mug_run_2_treatment "aim"
40 Q0 20544946 98 42.599174 imi_mug_run_2_treatment "anesthetics"
40 Q0 17182726 99 42.418175 imi_mug_run_2_treatment "calcium" "ryanodine" "drugs"
40 Q0 1427902 100 42.13127 imi_mug_run_2_treatment "muscle relaxants" "inhalation anesthetics"
40 Q0 20461000 101 42.12139 imi_mug_run_2_treatment "ryanodine" "m-cresol" "agonist"
40 Q0 10790202 102 42.096092 imi_mug_run_2_treatment "calcium" "agonists" "level"
40 Q0 8678899 103 41.984726 imi_mug_run_2_treatment "cresol" "caffeine" "chaps"
40 Q0 23159934 104 41.919487 imi_mug_run_2_treatment "dantrolene" "halothane"
40 Q0 11566777 105 41.8409 imi_mug_run_2_treatment "ryanodine"
40 Q0 23558838 106 41.834053 imi_mug_run_2_treatment "calcium" "caffeine" "halothane"
40 Q0 12411786 107 41.702747 imi_mug_run_2_treatment "caffeine" "calcium" "m-cresol"
40 Q0 17023049 108 41.68335 imi_mug_run_2_treatment "anesthetics" "buffer" "level"
40 Q0 9138151 109 41.64332 imi_mug_run_2_treatment "halothane" "level"
40 Q0 29101530 110 41.579056 imi_mug_run_2_treatment "sevoflurane" "calcium homeostasis"
40 Q0 7887423 111 41.56582 imi_mug_run_2_treatment "calcium" "muscle relaxants" "anesthetics"
40 Q0 17710899 112 41.56582 imi_mug_run_2_treatment "anesthetics" "succinylcholine"
40 Q0 22139840 113 41.556015 imi_mug_run_2_treatment "halothane"
40 Q0 15956637 114 41.514977 imi_mug_run_2_treatment "calcium" "anesthetic" "caffeine"
40 Q0 20823761 115 41.509216 imi_mug_run_2_treatment "adenosine" "agonists" "caffeine"
40 Q0 20479108 116 41.49118 imi_mug_run_2_treatment "bay k 8644"
40 Q0 11575529 117 41.441956 imi_mug_run_2_treatment "muscle relaxants" "anesthetics" "caffeine"
40 Q0 12124989 118 41.386326 imi_mug_run_2_treatment "calcium" "halothane" "caffeine"
40 Q0 12066726 119 41.258858 imi_mug_run_2_treatment "hot spot"
40 Q0 18394989 120 41.20314 imi_mug_run_2_treatment "n-acetylcysteine"
40 Q0 26565425 121 41.06789 imi_mug_run_2_treatment "drugs"
40 Q0 20978128 122 41.06789 imi_mug_run_2_treatment "glucose" "halothane" "oxygen"
40 Q0 10213958 123 40.960354 imi_mug_run_2_treatment "calcium" "caffeine" "halothane"
40 Q0 25086907 124 40.960354 imi_mug_run_2_treatment "m-cresol" "agonist" "anaesthetics"
40 Q0 28063098 125 40.884567 imi_mug_run_2_treatment "calcium" "caffeine" "halothane"
40 Q0 24951453 126 40.83638 imi_mug_run_2_treatment "fibre"
40 Q0 12208234 127 40.68206 imi_mug_run_2_treatment "hot spot"
40 Q0 12434264 128 40.60376 imi_mug_run_2_treatment "aim"
40 Q0 26381711 129 40.520844 imi_mug_run_2_treatment "caffeine" "muscle relaxants" "anesthetics"
40 Q0 16732084 130 40.49898 imi_mug_run_2_treatment "anesthetics" "succinylcholine" "calcium homeostasis"
40 Q0 22131268 131 40.498024 imi_mug_run_2_treatment "halothane" "anesthesia"
40 Q0 12810058 132 40.432644 imi_mug_run_2_treatment "m-cresol" "calcium" "calcium homeostasis"
40 Q0 14570802 133 40.369076 imi_mug_run_2_treatment "anaesthetic" "aprotinin" "medication"
40 Q0 11695996 134 40.344513 imi_mug_run_2_treatment "caffeine" "m-cresol" "amino acids"
40 Q0 29193480 135 40.31116 imi_mug_run_2_treatment "calcium" "aim"
40 Q0 10205743 136 40.305557 imi_mug_run_2_treatment "halothane" "hal" "animals"
40 Q0 20479110 137 40.30537 imi_mug_run_2_treatment "nifedipine" "skf96365"
40 Q0 9389851 138 40.29314 imi_mug_run_2_treatment "anaesthetics" "arginine" "leu"
40 Q0 8912676 139 40.286095 imi_mug_run_2_treatment "caffeine" "ryanodine"
40 Q0 26951757 140 40.286095 imi_mug_run_2_treatment "anaesthetic" "dantrolene" "level"
40 Q0 19417098 141 40.282104 imi_mug_run_2_treatment "anaesthetics" "halothane"
40 Q0 20482855 142 40.243057 imi_mug_run_2_treatment "calcium" "general anaesthetics"
40 Q0 24004537 143 40.191734 imi_mug_run_2_treatment "simvastatin" "calcium" "statin"
40 Q0 29930394 144 40.17717 imi_mug_run_2_treatment "calcium" "anesthetics" "capsazepine"
40 Q0 1639409 145 40.167477 imi_mug_run_2_treatment "lead"
40 Q0 11415515 146 40.163372 imi_mug_run_2_treatment "anaesthetic" "calcium homeostasis"
40 Q0 23035052 147 40.110313 imi_mug_run_2_treatment "calcium homeostasis" "anaesthetics" "m-cresol"
40 Q0 23957432 148 40.110313 imi_mug_run_2_treatment "sevoflurane" "halothane" "caffeine"
40 Q0 23848295 149 40.06788 imi_mug_run_2_treatment "anesthetics" "agonist"
40 Q0 1862346 150 40.06767 imi_mug_run_2_treatment "basis" "liver"
40 Q0 27855725 151 40.06737 imi_mug_run_2_treatment "fk506"
40 Q0 8828983 152 40.03 imi_mug_run_2_treatment "various" "anaesthetics" "suxamethonium"
40 Q0 17942409 153 39.957375 imi_mug_run_2_treatment "calcium" "buffers" "nifedipine"
40 Q0 8978780 154 39.45478 imi_mug_run_2_treatment "sts"
40 Q0 28259615 155 39.36449 imi_mug_run_2_treatment "anesthetic" "others"
40 Q0 12059893 156 39.31861 imi_mug_run_2_treatment "caffeine" "halothane"
40 Q0 19931341 157 39.247807 imi_mug_run_2_treatment "anesthetics"
40 Q0 27918309 158 39.24512 imi_mug_run_2_treatment "dantrolene"
40 Q0 29169929 159 39.037334 imi_mug_run_2_treatment "prenatal"
40 Q0 22415532 160 38.989944 imi_mug_run_2_treatment "muscle relaxants" "anesthetics" "caffeine"
40 Q0 12237752 161 38.98692 imi_mug_run_2_treatment "calcium" "muscle relaxants" "anaesthetics"
40 Q0 19919814 162 38.98692 imi_mug_run_2_treatment "muscle relaxants" "anesthetics" "caffeine"
40 Q0 18306019 163 38.94 imi_mug_run_2_treatment "calcium"
40 Q0 15336973 164 38.826145 imi_mug_run_2_treatment "dihydropyridine" "lead"
40 Q0 19220734 165 38.800102 imi_mug_run_2_treatment "anesthetic" "anesthetics" "edta"
40 Q0 9831351 166 38.762154 imi_mug_run_2_treatment "anesthesia"
40 Q0 22752422 167 38.761585 imi_mug_run_2_treatment "anesthesia"
40 Q0 15731587 168 38.708584 imi_mug_run_2_treatment "anesthetics"
40 Q0 12700608 169 38.70263 imi_mug_run_2_treatment "anaesthetic"
40 Q0 12883402 170 38.5171 imi_mug_run_2_treatment "caffeine" "halothane"
40 Q0 7762556 171 38.391384 imi_mug_run_2_treatment "calcium"
40 Q0 15577523 172 38.37669 imi_mug_run_2_treatment "calcium" "general anesthetic" "muscle relaxants"
40 Q0 16163667 173 38.372643 imi_mug_run_2_treatment "calcium homeostasis"
40 Q0 12151923 174 38.242992 imi_mug_run_2_treatment "ryanodine" "caffeine" "halothane"
40 Q0 21156754 175 38.19074 imi_mug_run_2_treatment "buffer" "halothane"
40 Q0 24445638 176 38.078255 imi_mug_run_2_treatment "various" "caffeine" "halothane"
40 Q0 9066328 177 38.062912 imi_mug_run_2_treatment "caffeine" "halothane" "anesthetics"
40 Q0 11673462 178 38.033245 imi_mug_run_2_treatment "calcium" "m-cresol" "anesthetics"
40 Q0 19807743 179 38.03112 imi_mug_run_2_treatment "various" "caffeine" "halothane"
40 Q0 28687594 180 38.000862 imi_mug_run_2_treatment "carvedilol" "dantrolene" "mediated"
40 Q0 18084979 181 37.94377 imi_mug_run_2_treatment "propofol" "calcium" "anaesthetic"
40 Q0 12393358 182 37.8603 imi_mug_run_2_treatment "halothane" "calcium" "anaesthetics"
40 Q0 30329129 183 37.853065 imi_mug_run_2_treatment "diamide" "insect" "animals"
40 Q0 21965348 184 37.817795 imi_mug_run_2_treatment "ryanodine"
40 Q0 8592342 185 37.704052 imi_mug_run_2_treatment "various"
40 Q0 7943985 186 37.704052 imi_mug_run_2_treatment "calcium" "halothane" "animals"
40 Q0 19056269 187 37.435112 imi_mug_run_2_treatment "polysaccharide"
40 Q0 9873004 188 37.30156 imi_mug_run_2_treatment "caffeine" "combinations" "carbachol"
40 Q0 17483490 189 37.145172 imi_mug_run_2_treatment "calcium" "level"
40 Q0 24433488 190 37.07795 imi_mug_run_2_treatment "anesthetics" "halothane" "caffeine"
40 Q0 12411788 191 36.998276 imi_mug_run_2_treatment "caffeine" "halothane" "level"
40 Q0 19825159 192 36.986694 imi_mug_run_2_treatment "calcium homeostasis"
40 Q0 19191333 193 36.973022 imi_mug_run_2_treatment "m-cresol"
40 Q0 19078732 194 36.97028 imi_mug_run_2_treatment "calcium" "anesthetics" "halothane"
40 Q0 15689621 195 36.966087 imi_mug_run_2_treatment "caffeine"
40 Q0 17081152 196 36.959568 imi_mug_run_2_treatment "anaesthetics" "suxamethonium" "calcium homeostasis"
40 Q0 16380615 197 36.916317 imi_mug_run_2_treatment "fiber"
40 Q0 10806523 198 36.837284 imi_mug_run_2_treatment "suxamethonium" "halothane" "thiopentone"
40 Q0 8618963 199 36.814575 imi_mug_run_2_treatment "anesthetic agents" "caffeine" "basis"
40 Q0 23639175 200 36.814575 imi_mug_run_2_treatment "agonists" "caffeine" "halothane"
40 Q0 18505122 201 36.802223 imi_mug_run_2_treatment "halothane" "caffeine" "isoflurane"
40 Q0 29635721 202 36.754036 imi_mug_run_2_treatment "immunosuppressants"
40 Q0 11575546 203 36.69892 imi_mug_run_2_treatment "succinylcholine" "calcium" "anesthetic agents"
40 Q0 15221887 204 36.63494 imi_mug_run_2_treatment "aim"
40 Q0 24896116 205 36.567223 imi_mug_run_2_treatment "calcium" "level"
40 Q0 15677376 206 36.508724 imi_mug_run_2_treatment "chaps" "caffeine" "dantrolene"
40 Q0 10700782 207 36.505672 imi_mug_run_2_treatment "ryanodine" "calcium"
40 Q0 27854207 208 36.505672 imi_mug_run_2_treatment "dantrolene" "anesthesia"
40 Q0 8406483 209 36.425354 imi_mug_run_2_treatment "basis"
40 Q0 15154833 210 36.31613 imi_mug_run_2_treatment "calcium"
40 Q0 29344738 211 36.310875 imi_mug_run_2_treatment "caffeine" "m-cresol" "aim"
40 Q0 23329375 212 36.28383 imi_mug_run_2_treatment "various" "fibre"
40 Q0 10484775 213 36.160805 imi_mug_run_2_treatment "calcium" "thr" "muscle relaxants"
40 Q0 12220451 214 36.160805 imi_mug_run_2_treatment "caffeine" "m-cresol" "muscle relaxants"
40 Q0 25148524 215 36.029396 imi_mug_run_2_treatment "calcium" "calcium homeostasis" "drug"
40 Q0 7989322 216 36.01593 imi_mug_run_2_treatment "various" "product" "nervous system"
40 Q0 12719381 217 35.90207 imi_mug_run_2_treatment "various" "basis" "level"
40 Q0 1312025 218 35.73422 imi_mug_run_2_treatment "liver"
40 Q0 21918424 219 35.712517 imi_mug_run_2_treatment "caffeine" "drug" "anesthetics"
40 Q0 23628358 220 35.689438 imi_mug_run_2_treatment "various" "alcohol" "drugs"
40 Q0 9106529 221 35.56225 imi_mug_run_2_treatment "calcium" "basis" "program"
40 Q0 11216663 222 35.37007 imi_mug_run_2_treatment "dihydropyridine" "muscle relaxants" "anesthetics"
40 Q0 17707769 223 35.33989 imi_mug_run_2_treatment "dantrolene" "m-cresol" "mediated"
40 Q0 14641996 224 35.265743 imi_mug_run_2_treatment "calcium" "caffeine" "halothane"
40 Q0 11278295 225 35.25882 imi_mug_run_2_treatment "skeletal muscle relaxant" "dantrolene"
40 Q0 16394695 226 35.143204 imi_mug_run_2_treatment "agonists" "caffeine" "halothane"
40 Q0 17033962 227 35.124382 imi_mug_run_2_treatment "ryanodine" "dna methyltransferase inhibitor" "level"
40 Q0 9502764 228 34.947792 imi_mug_run_2_treatment "halothane" "anesthetics" "succinylcholine"
40 Q0 21062345 229 34.9188 imi_mug_run_2_treatment "fibres" "others"
40 Q0 23509717 230 34.789055 imi_mug_run_2_treatment "dantrolene" "hydantoin"
40 Q0 10756965 231 34.72372 imi_mug_run_2_treatment "muscle relaxants" "edta" "succinylcholine"
40 Q0 10888602 232 34.716003 imi_mug_run_2_treatment "anaesthetics" "caffeine" "halothane"
40 Q0 23069638 233 34.66259 imi_mug_run_2_treatment "calcium"
40 Q0 15201141 234 34.579376 imi_mug_run_2_treatment "caffeine"
40 Q0 17107340 235 34.579376 imi_mug_run_2_treatment "level"
40 Q0 28818389 236 34.54776 imi_mug_run_2_treatment "fiber"
40 Q0 15521658 237 34.544502 imi_mug_run_2_treatment "enzymes"
40 Q0 28290972 238 34.4934 imi_mug_run_2_treatment "calcium" "anesthetics" "caffeine"
40 Q0 9713855 239 34.431095 imi_mug_run_2_treatment "fibres"
40 Q0 16945924 240 34.166206 imi_mug_run_2_treatment "dantrolene" "calcium" "azumolene"
40 Q0 19246389 241 34.16179 imi_mug_run_2_treatment "calcium" "mediated"
40 Q0 23798702 242 34.136475 imi_mug_run_2_treatment "hydrogen peroxide" "fk506"
40 Q0 18394987 243 33.90394 imi_mug_run_2_treatment "calcium" "calcium ion"
40 Q0 27586648 244 33.838593 imi_mug_run_2_treatment "various" "caffeine" "level"
40 Q0 8288238 245 33.736843 imi_mug_run_2_treatment "calcium" "muscle relaxants" "anesthetics"
40 Q0 22547813 246 33.523144 imi_mug_run_2_treatment "anesthetics" "caffeine" "bmc"
40 Q0 22231556 247 33.386368 imi_mug_run_2_treatment "antioxidants" "oxygen"
40 Q0 26115329 248 33.38098 imi_mug_run_2_treatment "caffeine"
40 Q0 9175745 249 33.309895 imi_mug_run_2_treatment "calcium" "muscle relaxants" "anaesthetics"
40 Q0 16958617 250 32.824455 imi_mug_run_2_treatment "ryanodine"
40 Q0 16621918 251 32.790016 imi_mug_run_2_treatment "fibre" "fibres" "hot spot"
40 Q0 23798496 252 32.613064 imi_mug_run_2_treatment "bapta"
40 Q0 15448513 253 32.482616 imi_mug_run_2_treatment "anesthetics"
40 Q0 19460614 254 32.456882 imi_mug_run_2_treatment "dantrolene" "drug" "acetate"
40 Q0 12167662 255 32.448288 imi_mug_run_2_treatment "dantrolene" "drug" "therapeutic agent"
40 Q0 11063719 256 32.322937 imi_mug_run_2_treatment "level" "caffeine"
40 Q0 9334205 257 32.188305 imi_mug_run_2_treatment "caffeine" "halothane" "calcium"
40 Q0 21862589 258 32.05306 imi_mug_run_2_treatment "caffeine"
40 Q0 19685112 259 31.839197 imi_mug_run_2_treatment "calcium" "caffeine" "calcium homeostasis"
40 Q0 28269792 260 31.8333 imi_mug_run_2_treatment "fibre" "fibres"
40 Q0 11709545 261 31.556242 imi_mug_run_2_treatment "basis"
40 Q0 18313359 262 31.556242 imi_mug_run_2_treatment "calcium"
40 Q0 8395940 263 31.399525 imi_mug_run_2_treatment "muscle relaxants" "anaesthetics"
40 Q0 20566647 264 31.290182 imi_mug_run_2_treatment "halothane" "anesthetic" "anesthetics"
40 Q0 15271719 265 31.24031 imi_mug_run_2_treatment "calcium" "anesthetics" "succinylcholine"
40 Q0 1889818 266 31.24031 imi_mug_run_2_treatment "various"
40 Q0 27142362 267 31.203243 imi_mug_run_2_treatment "medicine" "anesthesia" "calcium"
40 Q0 18305228 268 31.115194 imi_mug_run_2_treatment "mediated" "agonists" "muscle relaxant"
40 Q0 1774073 269 31.060322 imi_mug_run_2_treatment "halothane"
40 Q0 20944434 270 30.96336 imi_mug_run_2_treatment "dantrolene" "anti-arrhythmic" "isoproterenol"
40 Q0 27626045 271 30.916483 imi_mug_run_2_treatment "lead" "drugs" "sympathomimetic agents"
40 Q0 15027895 272 30.505571 imi_mug_run_2_treatment "agonists"
40 Q0 12732639 273 30.18889 imi_mug_run_2_treatment "caffeine" "halothane"
40 Q0 11553045 274 30.127275 imi_mug_run_2_treatment "basis"
40 Q0 21969454 275 29.88903 imi_mug_run_2_treatment "fibres" "fibre"
40 Q0 23704352 276 29.774288 imi_mug_run_2_treatment "vaccines"
40 Q0 14670767 277 29.614662 imi_mug_run_2_treatment "others"
40 Q0 21149547 278 29.413725 imi_mug_run_2_treatment "m-cresol"
40 Q0 9508059 279 29.242527 imi_mug_run_2_treatment "various" "calcium"
40 Q0 9199552 280 29.178242 imi_mug_run_2_treatment "dihydropyridine"
40 Q0 11741831 281 29.12794 imi_mug_run_2_treatment "calcium homeostasis" "calcium" "dantrolene"
40 Q0 20861472 282 28.95322 imi_mug_run_2_treatment "caffeine"
40 Q0 8001396 283 28.660057 imi_mug_run_2_treatment "ryanodine" "caffeine"
40 Q0 22913516 284 28.478138 imi_mug_run_2_treatment "tandem"
40 Q0 8395939 285 28.448528 imi_mug_run_2_treatment "calcium" "dihydropyridine" "muscle relaxants"
40 Q0 19237502 286 28.388903 imi_mug_run_2_treatment "anesthetic" "caffeine" "dantrolene"
40 Q0 17504518 287 28.33049 imi_mug_run_2_treatment "calcium" "basis" "calcium homeostasis"
40 Q0 9855701 288 28.248653 imi_mug_run_2_treatment "calcium" "anesthetics" "calcium ions"
40 Q0 7951247 289 27.900661 imi_mug_run_2_treatment "calcium" "anaesthetic"
40 Q0 22061335 290 27.857689 imi_mug_run_2_treatment "magnesium" "dietary magnesium oxide" "phosphocreatine"
40 Q0 17278373 291 27.81328 imi_mug_run_2_treatment "ryanodine"
40 Q0 15336972 292 27.760113 imi_mug_run_2_treatment "lead" "others"
40 Q0 17631035 293 27.760113 imi_mug_run_2_treatment "calcium"
40 Q0 15336975 294 27.65412 imi_mug_run_2_treatment "lead"
40 Q0 20961976 295 27.65412 imi_mug_run_2_treatment "calcium"
40 Q0 16849381 296 27.629614 imi_mug_run_2_treatment "fibres" "halothane" "sevoflurane"
40 Q0 21088110 297 27.589535 imi_mug_run_2_treatment "calcium" "il-6"
40 Q0 21520599 298 27.539417 imi_mug_run_2_treatment "anesthetic" "anesthetics" "suxamethonium"
40 Q0 19083337 299 27.539417 imi_mug_run_2_treatment "basis"
40 Q0 16477617 300 27.486286 imi_mug_run_2_treatment "calcium" "balance"
40 Q0 15269663 301 27.465788 imi_mug_run_2_treatment "level" "calcium" "anaesthetics"
40 Q0 8602662 302 27.300846 imi_mug_run_2_treatment "caffeine" "halothane" "basis"
40 Q0 19541610 303 26.834644 imi_mug_run_2_treatment "suppressor"
40 Q0 11807805 304 26.447763 imi_mug_run_2_treatment "calcium"
40 Q0 25424378 305 26.37109 imi_mug_run_2_treatment "calcium" "halothane" "aim"
40 Q0 24065657 306 26.37109 imi_mug_run_2_treatment "ryanodine" "color" "basis"
40 Q0 20097179 307 26.37109 imi_mug_run_2_treatment "drug" "calcium ions" "new drugs"
40 Q0 18082125 308 26.31892 imi_mug_run_2_treatment "generic" "lead"
40 Q0 11159936 309 26.250778 imi_mug_run_2_treatment "calcium"
40 Q0 25920678 310 26.250778 imi_mug_run_2_treatment "dantrolene"
40 Q0 23152933 311 25.39427 imi_mug_run_2_treatment "caffeine"
40 Q0 22569151 312 24.546928 imi_mug_run_2_treatment "calcium" "animals" "hal"
40 Q0 19863735 313 23.551334 imi_mug_run_2_treatment "sevoflurane" "various" "calcium"
40 Q0 24579562 314 23.419323 imi_mug_run_2_treatment "polysaccharide"
40 Q0 14593641 315 23.303192 imi_mug_run_2_treatment "aim"
40 Q0 16909197 316 23.241299 imi_mug_run_2_treatment "lead"
40 Q0 15451514 317 22.80053 imi_mug_run_2_treatment "calcium"
40 Q0 24143248 318 22.80053 imi_mug_run_2_treatment "calcium" "anesthetic" "azumolene"
40 Q0 15831441 319 22.758799 imi_mug_run_2_treatment "azumolene" "dantrolene" "drugs"
40 Q0 23897157 320 22.758799 imi_mug_run_2_treatment "ryanodine"
40 Q0 29557500 321 22.758799 imi_mug_run_2_treatment "medicine"
40 Q0 21646399 322 22.67405 imi_mug_run_2_treatment "mediated"
40 Q0 29545923 323 21.188442 imi_mug_run_2_treatment "calcium"
40 Q0 8602659 324 20.256033 imi_mug_run_2_treatment "caffeine" "halothane"
40 Q0 26075051 325 19.920475 imi_mug_run_2_treatment "gssg" "lead" "n-acetylcysteine"
40 Q0 22180651 326 19.846188 imi_mug_run_2_treatment "dantrolene" "antiarrhythmic" "drug"
40 Q0 22286060 327 19.823788 imi_mug_run_2_treatment "inositol" "ryanodine" "abc"
40 Q0 11773235 328 19.735863 imi_mug_run_2_treatment "leu" "duration"
40 Q0 19789379 329 19.735863 imi_mug_run_2_treatment "caffeine" "calcium" "clofibric acid"
40 Q0 26221186 330 16.55218 imi_mug_run_2_treatment "drug" "level"
40 Q0 17968765 331 16.451283 imi_mug_run_2_treatment "basis"
40 Q0 23978697 332 15.4346895 imi_mug_run_2_treatment "calcium" "abc"
40 Q0 15131021 333 14.583353 imi_mug_run_2_treatment "beta-blocker"
40 Q0 18202836 334 10.0446005 imi_mug_run_2_treatment "animals"
